<SEC-DOCUMENT>0000950170-25-045745.txt : 20250327
<SEC-HEADER>0000950170-25-045745.hdr.sgml : 20250327
<ACCEPTANCE-DATETIME>20250327082534
ACCESSION NUMBER:		0000950170-25-045745
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		107
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250327
DATE AS OF CHANGE:		20250327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Septerna, Inc.
		CENTRAL INDEX KEY:			0001984086
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				843891440
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42382
		FILM NUMBER:		25775444

	BUSINESS ADDRESS:	
		STREET 1:		250 EAST GRAND AVENUE, SUITE 65
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-338-3533

	MAIL ADDRESS:	
		STREET 1:		250 EAST GRAND AVENUE, SUITE 65
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>sepn-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-26T21:49:06.9816+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:sepn="http://www.septerna.com/20241231" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_63151228-9489-435d-9784-ebf8edc88d49" name="dei:AmendmentFlag" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f">false</ix:nonNumeric><ix:nonNumeric id="F_fe1cca66-608d-4aa3-b620-14c932fe5210" name="dei:EntityCentralIndexKey" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f">0001984086</ix:nonNumeric><ix:nonNumeric id="F_aef3afc0-37d1-4ba2-9ca9-a6150d604186" name="dei:DocumentFiscalPeriodFocus" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f">FY</ix:nonNumeric><ix:nonFraction id="F_f504efa2-7a40-47fd-bb84-8a0759752c52" name="us-gaap:CommitmentsAndContingencies" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_686e415e-ba5e-4706-8773-3961fbf8dc1e" name="us-gaap:CommitmentsAndContingencies" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cad73126-da80-4c10-b250-cf7f5b289ceb" name="us-gaap:PreferredStockValue" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_1f32640f-4a7f-4970-8dac-aab166485b20" name="us-gaap:PreferredStockValue" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_906a3f33-fb42-4fdf-8d46-17d92b98968d" name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c">http://fasb.org/us-gaap/2024#LeaseholdImprovementsMember</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sepn-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8255216d-10ae-416d-bcd2-76adfb6ba4d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_829daf10-7ff1-4266-a786-57da4f5434c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sepn:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_832c9435-8669-4826-9854-08cb83c395aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8484b4a9-981f-46d8-9a3b-93c7b6a966e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_855d4ac2-b358-4d6c-84c7-2390fea37329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c5cb769-ec5e-4f34-abf9-683e73b6808f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sepn:UnvestedRestrictedStockSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8d0f375e-d4b5-4c8c-83f1-7f68a5d08c43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_902b0c5f-744e-4d30-b174-d36f4e83674d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90d58f63-eee7-4c1a-ab73-d78903f815e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_922c53ab-31f7-4a05-a8b6-af09fe6e78db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9268f199-df5e-4067-91e6-ed2fd39554e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92c1f558-0199-426d-b08a-1870d1dc5677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_92e936a1-7cb3-40e9-993e-bbcd2f3f805e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_94ef1645-1200-4432-b228-36b9fceb7a82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_96b8a98e-2692-42ad-a70e-81071163995f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9763b408-328c-4770-af66-e36b06544fe2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-07</xbrli:startDate><xbrli:endDate>2025-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9b829192-5a7d-4ce3-9261-f21a9ef581b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">sepn:FourZeroOne401KPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6ecf43d-7b17-4dea-a8f9-87bcd2d46ebb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a74bff72-f9bc-4001-b025-78bfed5e56c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a88f3222-aa43-4a22-9616-3208194c63fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sepn:VertexResearchServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ac644248-b031-4c9f-95ab-fa02d59f25be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aecc1d94-7b79-44e5-b57c-d8576c37c857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1dfbbba-4ed3-4a5b-8cf4-81747534a7f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7d146c4-9837-4043-9b52-921a53724e0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b804a170-664e-41ff-a1cb-b608203157b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b818b396-8516-4e7d-b65d-8f906bbc24a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b9128e20-7131-4bd4-a8bd-4763f5a273df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bea6a04f-86e9-4c8b-acac-b19b1baa9ae1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0577abf-fcd1-41ee-8a8a-8523f830af0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c07f1042-7166-4a92-ad8c-816792ab533e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c2a2d5f3-4780-477b-9962-a71c66cb583d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sepn:VertexResearchServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c39d72cd-1218-4091-b5a2-620203948c8c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3d18edf-1da5-48a4-8374-55662573e03e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-18</xbrli:startDate><xbrli:endDate>2024-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c457190a-2591-4660-96fd-0fed98a4b50f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c58ad86c-a8d9-467a-8ff5-d56c8a6e29f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:SamsaraBiocapitalLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c86e56ac-1ccf-4198-83f7-d9fc66656386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8bbdab5-fa45-4f45-b9e3-c2cf656b651c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce391cd8-82f6-405a-84f5-86572717253e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf0a11bc-e4a7-4986-9563-1992ae142565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:RaCapitalManagementLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3127ac5-59a1-444d-b791-71cb86e3ef50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d523acd8-48f9-4426-8ab8-290e484e62bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d5e147f5-aa16-43c8-b905-14514eea7f77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d770876f-2396-4daa-bc4e-7986b296cd59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d928477a-8ca4-45d7-99e7-77f499e78e0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da578283-3385-4d7f-84d8-e4e87678a27a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da5e58c0-03a1-48bc-97cf-7fa1915eebf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e09fe0d5-bb64-4a89-8423-2d8d7f22d329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e2dd8888-638d-419e-b998-f0ffd00c0ded"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e339adb9-8faf-4ae0-a9cf-843428e7c977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e596348e-c390-4f8c-a60e-2c604e7723c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e5a48d22-6857-4c55-a508-102ecc5e3e17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eba777f1-1ccc-44f9-ae7c-9f47032a9edd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecb04bc3-c92f-466d-8619-25482aaef50a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecda3b22-85c8-4a2c-910d-24b3feaec947"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:InitialTrancheMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed3d106f-c9e5-4f47-a732-17fd62714ce4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eea5f8f5-675f-48a9-bc1e-43f7089d6e4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f21eea93-3c79-4715-83bd-5decab49af76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fab6a00f-2fe1-456a-bccf-9474c007d17a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb922ca6-bc1b-4ee2-9ad5-6fa73f26af51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00cbb4d7-f34c-4862-a6ea-df21ab1ac4ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_04364af7-15e7-4170-a9bd-075237a2baca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">sepn:FourZeroOne401KPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_062b5e92-e9a6-4480-9a3e-af692706a741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_094c93bc-0e0d-4909-afb4-955d4d337209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09bfaeb9-dddb-4966-a602-14fa0623c76f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a283eb0-f11e-47f7-8c48-261df37e83d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b34fe95-fedf-421a-b8dd-87db73e425eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b6e5099-66b3-4a19-9c22-90249dab9674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c337934-85a8-4a6b-b0b7-d303a586df92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0dbb3934-d7b1-4512-9408-c82380a608be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e7e5752-e6a2-4a70-b4fa-b116c9416205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ee21c41-88a0-4de2-9908-edb048f164fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1147e1f5-d133-45d8-8f2d-657d2695faa6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_119c49a2-1fd6-4e17-adcd-69be80143f5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1aec0dd0-2f1a-4cc5-908a-9f57b03ace96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1b936336-2026-44b4-a240-c9a3d5378bef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sepn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchase2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c7d04aa-a092-489a-8d60-29ccf842d41e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e38905a-c12f-4042-a1c7-538930041c98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21bcef87-7441-4e70-b3d2-6468e2fd40eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_22e5ca43-623f-4048-99d6-c3938708def1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23cbaddc-7e72-4392-96bd-b68571b9aa1f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25a4e3cd-6869-41f0-a089-39e4a21d16f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_271bef94-fdec-41f8-a570-9d76ab85a875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_273f0762-59ef-4b7e-8052-83d122342ed9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27aa5798-cdf5-4aeb-9c35-f6a7f0ef79c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2982daa7-c87a-47ee-b700-ce6632c5e27f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29adb2c9-12a7-43f9-8228-3116b1608be4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2bb60e06-e9a7-4ee2-9f51-82882892bb75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c23db88-ff79-4c64-b0f7-eb3460655b08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d8e9c9f-db9a-4ef1-8b3c-d563c2fca200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ed61538-be83-4373-9c74-22d2ecd37bbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ed84efc-d353-46ca-bae3-39bc435baebb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f0eb5d6-7026-4c35-ad8b-a69f0b83d927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_31284a09-3922-405e-a80d-24fee73b06af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_33d7d405-ee10-46a7-ba8e-6cecef016263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_35342a71-3904-46c9-8baf-50e827a2f8e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35e15b2a-6b34-49e1-8b87-da8c2cffe44c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36638d69-8200-457e-b4df-f22570660294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_39410be2-488e-40ba-b03f-47c8c6cb10a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39c2eb82-be3a-4f23-96b2-b18b9af896bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b38a128-728f-4bd5-af3c-a2799bc33330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:SamsaraBiocapitalLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d630fbe-3eb4-461e-8c9f-d264488141b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3eda2d3e-77c3-4ee9-833b-51522ca25c9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40118209-d74e-499d-a2c3-dad899119cee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_408fc089-3a81-45dd-951b-6530ea8455e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4189834c-9f3e-45b5-8e93-de02f8ede50d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:RaCapitalManagementLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_42ad5efb-0c6f-42c1-afc8-5cc756e5312e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44baba83-cea1-46e8-978a-dc1f29c93e52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_489a951a-d17d-48d1-be9f-c29fef36aa29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4947aa1a-72b3-47fa-b3bb-2fe7814a8ec3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c5f565b-9309-42f7-86c8-bb16495c890f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_513d2df9-958a-4c81-a310-f93896216a3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_56c6ec77-77b3-426a-9cf6-61c4ee189ee2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_570c8595-7c25-477a-88df-9154a31cf161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_59dc2c7f-ff1c-470d-b96b-f1599335ca16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b8fa8c3-5da3-44aa-abac-9a9744adb4a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:InitialTrancheMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f0437bd-6f52-4254-b099-4a45c3a53aa8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f26eed0-95b3-4a32-95cd-288d74605af3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_612e0da3-d172-44b9-afd1-b4b5f1733b29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6194273a-4c93-49e2-96ac-eb9941334717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sepn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchase2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_64df0564-4699-4346-a9c4-4d4616c5b486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_659a2626-2f0b-4d2e-abe1-7f6b4d5d0915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sepn:UnvestedRestrictedStockSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66bb86ba-4924-40ff-99cf-a77f796a2d06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6989d380-63a6-42fa-baac-f46b7758f062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a1456b0-60b7-4820-b443-f0391e89fbdd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c2685d2-81ab-435e-a0e2-34a378301c88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7079165a-aa57-4eb8-9488-ec1604a2095c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71f42ff7-1a0f-4075-b1ad-7f3659f2ab90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7283d70c-1d46-411d-a51a-777737652129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_734505df-bb5a-463c-bec8-cd2fb71849a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75b103c5-2b1b-4a43-a69a-77670e68c96e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_78682e7a-e6dd-4d19-864a-4e2b28c3d80e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_787857dc-a393-4f80-adbe-f17546eff5f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79b58927-86fc-40d3-9f46-ab96913ff7a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001984086</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_Position"><xbrli:measure>sepn:Position</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:37.733%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:37.731%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_62186c3c-07d7-42f8-8e9b-4de9b1923d0c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:37.733%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:37.731%;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:5.2%;box-sizing:content-box;"/>
    <td style="width:94.8%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_d2302bdf-9abb-4d5e-9269-5a637c1c8f8a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
   <tr style="height:2.9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended </span><span style="font-size:8pt;"><ix:nonNumeric id="F_f9feb204-b961-470e-b956-6091466d0598" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span><ix:nonNumeric id="F_e0dc04b9-e2fd-4a82-8772-034adf2d0c00" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_9c2538da-4e16-41b1-87bb-e2233ad53e02" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">OR</span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_1fcf788a-c8ce-4f33-82e7-4d9bfc043b7c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
   <tr style="height:3.6pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Transition Period From __________to__________</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number </span><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_37d8b421-6ee3-4eb1-bd9a-7b5104209892" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-42382</span></ix:nonNumeric></span></p>
  <p style="margin-left:37.733%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:37.731%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:22pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b9decf49-d026-4e54-a95d-d40be795ae5c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Septerna, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact Name of Registrant as Specified in its Charter)</span></p>
  <p style="margin-left:37.733%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:37.731%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_0d319b36-31aa-4113-8c82-a3df0ce082a2" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_dfabc283-48ff-4769-85db-64a0dcde1256" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">84-3891440</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_504439ab-3d8a-49d0-9137-e8864fe417fb" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">250 East Grand Avenue</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_9f0adcfb-9500-4242-9ce4-8d13de3f7f7a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">South San Francisco</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_1493e679-0fb5-421f-a925-a00ba229a511" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_3aac3ad4-c188-460c-97fe-2ce96255e1f2" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">94080</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab0d2bc9-d6f6-4363-8fe7-2f0865e828ff" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">650</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c25ee667-7b07-441b-9bad-c535e6d9e1c3" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">338-3533</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_082cb7d2-f8a5-4fc5-8eeb-f4a5dc0838f3" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_76dd384a-95c7-4f6a-9f80-dd6afb307745" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SEPN</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_c43b12d2-cabc-48a6-8a70-f56a058cadaa" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: None</span></p>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_391cd3e1-b08c-4eae-87f3-9834a682ada9" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd7e28da-b7a9-4b40-b0f9-5e7cd7da1d30" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c276ac8f-0cdf-450b-b108-18b3602e17cf" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a21189e-68e6-4c3f-a2df-f704b073ce2b" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:63.36%;box-sizing:content-box;"/>
    <td style="width:1.72%;box-sizing:content-box;"/>
    <td style="width:34.92%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large Accelerated Filer </span><span style="color:#000000;white-space:pre-wrap;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated Filer </span><span style="color:#000000;white-space:pre-wrap;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_384f415f-2806-4834-9e38-51ccb20e536d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated Filer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">Smaller Reporting Company </span><span style="font-size:8pt;font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_04eca609-6c7b-4cdf-aa16-157f7623c9e0" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging Growth Company </span><span style="font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_dd7222ef-bc5c-477e-b87a-05c8d7bfd9f5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_343f9b70-6867-44c3-b946-6259d54c6e5a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.    </span><span style="font-size:8pt;font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_7f64d82e-cb41-45cd-b191-95718d6b469b" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.    </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_1ba6402f-d460-4261-bcd4-f55c68b39b4c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).    </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="font-size:8pt;font-family:'MS Gothic',sans-serif;"><ix:nonNumeric id="F_5f971126-500f-49ea-a9cb-5cd00f855381" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'MS Gothic',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 28, 2024, the last business day of the registrant&#8217;s most recently completed second quarter, there was </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b84aff5-5cb7-4b17-a9a1-ccac4fd255f2" contextRef="C_78682e7a-e6dd-4d19-864a-4e2b28c3d80e" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> established public trading market for the registrant&#8217;s equity securities as the Registrant was not a public company and therefore cannot calculate the aggregate market value of its voting and non-voting equity held by non-affiliates as of such date. The registrant&#8217;s common stock began trading on the Nasdaq Global Market on October 25, 2024.</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 17, 2025, the registrant had </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d913c3d-90d7-4fd6-99fb-cf48ffa49743" contextRef="C_25a4e3cd-6869-41f0-a089-39e4a21d16f3" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">44,442,496</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, $0.001 par value per share, outstanding.</span></p>
  <div style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_704f5e29-250b-4812-a20e-e0b623172f78" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.</span></p></ix:nonNumeric></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.1%;box-sizing:content-box;"/>
    <td style="width:82.82%;box-sizing:content-box;"/>
    <td style="width:7.08%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#special_note_regarding_forward"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">i</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factor_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factor Summary</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">iii</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_i"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART I</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_ii"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART II.</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrants_common"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_reserved"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_managements_discussion"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_iii"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART III.</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_of_certain"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_iv"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART IV.</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_statement"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary.</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own various U.S. federal trademark applications and unregistered trademarks, including our company name and logo, that we use in connection with the operation of our business. This Annual Report on Form 10-K (this &#8220;Annual Report&#8221;) includes our trademarks and trade names which are protected under applicable intellectual property laws and are our property. This Annual Report also contains trademarks, trade names and service marks of other companies, which are the property of their respective owners. Solely for convenience, trademarks, trade names and service marks referred to in this Annual Report may appear without the &#174;, &#153; or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent permitted under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names and service marks. We do not intend our use or display of other parties&#8217; trademarks, trade names or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may use our website, our X (formerly known as Twitter) account at Septerna_Inc and our LinkedIn account at https://www.linkedin.com/company/septernainc/ to distribute material information about us and for complying with our disclosure obligations under Regulation FD. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.Septerna.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website or our social media are not incorporated into, and does not form a part of, this Annual Report.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="special_note_regarding_forward"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements are based on our management&#8217;s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this Annual Report include, but are not limited to, statements about:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation, timing, progress, results and costs of conducting our research and development programs and our current and future preclinical studies and anticipated clinical trials, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available, and our current and future programs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to demonstrate, and the timing of, preclinical proof-of-concept </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for multiple programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to advance any product candidates that we may identify and successfully complete any clinical studies, including the manufacture of any such product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, scope and likelihood of regulatory filings and approvals, including timing of Investigational New Drug (&#8220;IND&#8221;) applications or comparable foreign applications, and final U.S. Food and Drug Administration (the &#8220;FDA&#8221;) approval of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, scope or likelihood of foreign regulatory filings and approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the implementation of our business model, and strategic plans for our business, product candidates, and technology; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and other product candidates we may develop, including the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments relating to our competitors and our industry;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to leverage programs within our initial target indications and to progress additional programs to further develop our pipeline;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability of our preclinical studies and clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify and enter into future license agreements and collaborations and the potential benefits of such agreements and collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to rely on third-party manufacturers and successfully manufacture product candidates for preclinical use, clinical trials and on a larger scale for commercial use, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to realize the benefits of collaborations for the development and commercialization of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to commercialize any of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments related to our proprietary Native Complex Platform&#153;;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory developments in the United States and foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain funding for our operations necessary to complete further development and commercialization of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size and growth potential of the markets for our product candidates and our ability to serve those markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our need for and ability to attract and retain key scientific, management and other personnel and to identify, hire, and retain additional qualified professionals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the period during which we will remain an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;);</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our anticipated use of our existing resources;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our financial performance and estimates of our future expenses, capital requirements, and our needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of global economic and geopolitical developments on our business, including rising inflation and capital market disruptions, international tariffs, trade protection measures, economic sanctions and economic slowdowns or recessions that may result from such developments which could harm our research and development efforts as well as the value of our common stock and our ability to access capital markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ultimate impact of health epidemics, pandemics, and other widespread outbreaks of contagious disease, including mitigation efforts and economic effects, on any of the foregoing or other aspects of our business operations, including but not limited to our clinical trials, our research programs, healthcare systems or the global economy as a whole; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other risks and uncertainties, including those listed under the section titled &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;seek,&#8221; &#8220;predict,&#8221; &#8220;future,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;target,&#8221; &#8220;contemplate,&#8221; &#8220;possible,&#8221; &#8220;can,&#8221; or the negative of these terms or other comparable terminology, and similar expressions, although not all forward-looking statements contain these identifying words. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section titled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Annual Report and the documents that we reference in this Annual Report and have filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) thereto completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The forward-looking statements in this Annual Report represent our views as of the date of this Annual Report. We do not undertake any obligation to publicly update any forward-looking statement except to the extent required by applicable law. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report also contains estimates, projections and other information concerning our industry, our business and the markets for our product candidates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from our own internal estimates and research as well as from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources. All of the market data used in this Annual Report involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such data. Industry publications and third-party research, surveys, and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. Our estimates of the potential market opportunities for our product candidates include several key assumptions based on our industry knowledge, industry publications, third-party research, and other surveys, which may be based on a small sample size and may fail to accurately reflect market opportunities. While we believe that our internal assumptions are reasonable, no independent source has verified such assumptions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed as exhibits to this Annual Report. Unless the context otherwise requires, reference in this Annual Report to the terms &#8220;Septerna,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar designations refer to Septerna, Inc.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="risk_factor_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUMMARY OF MATERIAL AND OTHER RISKS ASSOCIATED WITH OUR BUSINESS</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is subject to numerous risks and uncertainties and are subject to change based on various factors, including those highlighted in the section entitled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report. These risks include, but are not limited to, the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a limited operating history and have incurred significant operating losses since our inception and expect to incur significant losses for the foreseeable future.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require substantial additional funding in order to finance our operations. If we are unable to raise additional capital when needed on acceptable terms, or at all, we may be forced to delay, reduce, or terminate certain of our research and product development programs, future commercialization efforts or other operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are early in our development efforts. We have not successfully completed any clinical studies, and as a result it will be years before we commercialize a product candidate, if ever. If we are unable to identify and advance product candidates through preclinical studies and clinical trials, obtain marketing approval and ultimately commercialize them, or experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical and clinical drug development is a lengthy and expensive process, with uncertain timelines and outcomes. If preclinical studies or clinical trials of our product candidates are prolonged or delayed, we may be unable to obtain required regulatory approvals, and therefore be unable to commercialize our therapeutic candidates or any of our future therapeutic candidates on a timely basis or at all.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may encounter substantial delays in the commencement, enrollment or completion of our planned clinical trials or we may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities, which could prevent us from commercializing any product candidates we determine to develop on a timely basis, if at all.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Serious adverse events, undesirable side effects or other unexpected properties of our product candidates may be identified during development or after approval, which could lead to the discontinuation of our clinical development programs, refusal by regulatory authorities to approve our product candidates or, if discovered following marketing approval, revocation of marketing authorizations or limitations on the use of our product candidates, any of which would limit the commercial potential of such product candidate.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates are subject to extensive regulation and compliance obligations, which is costly and time-consuming and which may cause unanticipated delays or prevent the receipt of the required approvals to commercialize our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control, which could adversely affect our business, operating results and prospects.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is based on novel technologies that are unproven and may not result in approvable or marketable products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval, and we may not be successful in our efforts to expand our development portfolio of product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently have no marketing and sales organization and have no experience as a company in commercializing products, and we may invest significant resources to develop these capabilities. If we are unable to establish marketing, sales or distribution capabilities or enter into agreements with third parties to market and sell our products, we may not be able to generate product revenue.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receive marketing approval, such product candidate may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than us.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third-party manufacturers, clinical research organizations (&#8220;CROs&#8221;), contract manufacturing organizations (&#8220;CMOs&#8221;), and suppliers to supply, develop and test components of our product candidates. The loss of our third-party manufacturers, CROs, CMOs, or suppliers, their failure to comply with applicable regulatory requirements or to supply sufficient quantities at acceptable quality levels or prices, or at all, or changes in methods of product candidate manufacturing, development or formulation would materially and adversely affect our business.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The material and other risks summarized above should be read together with the text of the full risk factors and in the other information set forth in this Annual Report, including our financial statements and the related notes, as well as in other documents that we file with the SEC. If any such material and other risks and uncertainties actually occur, our business, prospects, financial condition and results of operations could be materially and adversely affected. The risks summarized above or described in full are not the only risks that we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial may also materially adversely affect our business, prospects, financial condition and results of operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iv</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T I</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ite</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">m 1. Bu</span><span id="item_1_business"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">siness.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a biotechnology company pioneering a new era of G protein-coupled receptor (&#8220;GPCR&#8221;) oral small molecule drug discovery powered by our proprietary Native Complex Platform&#153;. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body. Due to their significant role in human diseases, GPCRs have been the most productive target class in drug discovery history, accounting for approximately one-third of all FDA-approved drugs, representing approximately 500 products with combined global revenue of approximately $125 billion in 2023. Despite the pharmacological and commercial success of GPCR-targeted agents, about 75% of potential GPCR therapeutic targets remain undrugged. For certain validated GPCRs, novel binding pockets may exist that could offer enhanced therapeutic benefits. Each step in GPCR activation involves subtle conformational changes that have been historically challenging to reproduce outside of a cell. The inability to isolate GPCR proteins in their native functional form outside of a cellular context has prevented scientists from leveraging some of the state-of-the-art technologies that have revolutionized drug discovery in other major target classes over the past decade. This complex challenge has limited GPCR drug discovery, particularly the development of novel oral small molecules, such as agonists for peptide GPCRs and allosteric modulators.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary Native Complex Platform&#153; replicates the natural structure, function, and dynamics of GPCRs outside of cells at an industrial scale for, as we believe it, the first time. Our foundational technologies enable us to isolate, purify, and reconstitute full-length, properly folded GPCR proteins within ternary complexes with ligands and transducer proteins in a lipid bilayer that mimics the cell membrane. We then apply state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging our platform, we conduct GPCR oral small molecule drug discovery using an industrialized and iterative structure-based drug design approach for a diverse collection of GPCR targets. Our Native Complex Platform&#153; is designed to enable us to target specific GPCRs, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists (which activate GPCR signaling), antagonists (which inhibit GPCR signaling), and allosteric modulators (which either increase or decrease the degree of GPCR activation by endogenous ligands) to affect GPCR signaling in different ways to achieve desired therapeutic effects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. Our wholly-owned pipeline is focused initially on three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. We intend to evaluate opportunities in other major therapeutic areas, such as neurology, women&#8217;s health, cardiovascular, and respiratory disease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCRs as Therapeutic Targets</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCRs regulate physiological processes in nearly every organ system of the human body and are the most targeted drug class due to their significant role in human diseases and their pharmacological tractability. Nearly one-third of all FDA-approved drugs in the United States, representing approximately 500 products, target GPCR-associated pathways. In fact, GPCR-related drugs comprise approximately 27% of global pharmaceutical sales.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCRs are proteins that span the cell membrane seven times, and their primary function is to recognize extracellular substances, or ligands, and transmit signals across the cell membrane to the inside of the cell. Ligand binding induces conformational changes in GPCRs, forming complexes with signal transducers, including G proteins. These transducers interact with second messengers, modulating various cellular processes. Certain GPCR ligands are capable of activating multiple pathways through different transducers, leading to diverse physiological and pathological effects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCRs constitute the largest and most diverse family of cell membrane receptors, with around 800 identified members. GPCRs are key therapeutic targets due to their vital roles in a variety of physiologic processes including immune regulation, nervous system transmission, mood and behavior regulation, sensory transmission, and maintaining cardiovascular and gastrointestinal homeostasis. Despite the pharmacological and commercial success of GPCR-targeted agents, a majority of GPCR therapeutic targets remain undrugged. Each step in GPCR activation involves subtle conformational changes that have been historically challenging to reproduce outside of a cell. The inability to isolate GPCR proteins in their native functional form outside of a cellular context has prevented scientists from leveraging some of the state-of-the-art technologies that have revolutionized drug discovery in other major target classes over the past decade. This complex challenge has limited GPCR drug discovery, particularly the development of novel oral small molecules, such as agonists for peptide GPCRs and allosteric modulators.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, drug discovery has been highly concentrated on a small number of GPCRs. More than 70% of current GPCR-related drugs target only six subfamilies of GPCRs. There are about 400 known non-olfactory GPCRs, each represented as a branch on the phylogenetic tree in </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_0.jpg" alt="img117602972_0.jpg" style="width:319px;height:222px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GPCR phylogenetic tree highlighting the number of FDA-approved drugs for each GPCR as of February 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Today, approximately 75% of potential GPCR therapeutic targets remain undrugged, representing significant opportunity to address a vast range of therapeutic areas and diseases. And, even for certain validated GPCRs, novel binding pockets may exist that could offer enhanced therapeutic benefits.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Native Complex Platform&#153;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past decade, drug discovery across various target classes has been revolutionized by state-of-the-art tools and technologies, including structure-based drug design, computational docking, and DNA-encoded libraries (&#8220;DELs&#8221;). However, the utilization of these technologies has been limited for discovering oral small molecules targeting GPCRs due to the inability to isolate functional native GPCR proteins outside of a cellular context.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With our proprietary Native Complex Platform&#153;, we can purify GPCRs outside of cells and reconstitute them into fully functional ternary complexes with transducer proteins (e.g., G proteins, beta-arrestins) and ligands (endogenous or synthetic), all housed within a well-defined lipid bilayer environment. These Native Complexes are full-length, properly folded GPCRs that retain their natural structure, function, and dynamics. We then apply state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging our platform, we are advancing a new approach to GPCR drug discovery, designed to expand the landscape of druggable GPCR targets with novel oral small molecule medicines for patients.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Native Complex Platform&#153; is powered by a suite of tools and technologies that we have optimized and integrated into a proprietary and industrialized workflow, forming an efficient and iterative discovery process for identification and optimization of novel small molecule product candidates targeting high-value GPCRs, including:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Native Complex biochemistry and structural biology:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Native Complexes reconstitute native GPCR function in a purified biochemical format, enabling efficient high-resolution, three-dimensional structure determination using cryogenic electron microscopy (&#8220;cryo-EM&#8221;). This reveals receptor binding pockets that we can target with a range of pharmacologies (e.g., agonists, antagonists, and allosteric modulators) as well as novel insights into mechanisms for GPCR modulation.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Native Complex-driven hit identification and optimization:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We virtually screen our GPCR structures against ultra-large-scale computational databases containing billions of candidate molecules to identify the most promising small molecule compounds that bind in pockets on the GPCR structure. We use technologies, including DELs, to screen billions of candidate molecules simultaneously and have developed proprietary technologies to discover and optimize compounds with a variety of modes of action. Additionally, we use our proprietary Native Complex biochemical screens in our hit identification and optimization processes.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advanced cellular and in vivo pharmacology models:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We efficiently evaluate hits and lead compounds through the integration of advanced cellular and in vivo pharmacology models. Prioritized compounds with desired pharmacologies are either advanced as potential drug candidates or fed back into the process for additional Native Complex-driven compound optimization.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our oral small molecule drug discovery process, powered by our proprietary Native Complex Platform&#153;, is depicted in the figure below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_1.jpg" alt="img117602972_1.jpg" style="width:505px;height:267px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our industrial-scale Native Complex Platform&#153; is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies to achieve desired therapeutic effects. Our platform has led to the discovery and development of a pipeline of novel, highly potent and selective oral small molecules, and for our most advanced programs, optimized them into clinical development candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our goal is to develop life-changing GPCR-targeted medicines for patients with significant unmet medical needs. We plan to achieve this goal by efficiently advancing our portfolio of GPCR-targeted programs, continuing to expand our differentiated GPCR-targeted pipeline focused on indications with significant unmet needs, maximizing the potential of our Native Complex Platform&#153; through continued innovation and investment, and evaluating potential value-creating strategic partnerships.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portfolio Opportunities Targeting the Full Breadth of GPCRs</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are significant unmet medical needs across numerous GPCR-driven diseases. Our portfolio is focused initially on three therapeutic areas with the potential to expand to additional therapeutic areas in the future:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Endocrinology</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The endocrine system involves glands that secrete hormones into the bloodstream that have effects on other tissues. Central to this system are GPCRs, which serve as primary receptors for many circulating hormones. GPCR biology is at the center of endocrine diseases, such as hypoparathyroidism and Graves&#8217; disease, highlighting the urgency for therapeutic interventions targeting GPCR-mediated endocrine disorders. Other endocrine disorders, like osteoporosis, impacts more than 10 million older adults in the United States and could benefit from a small molecule GPCR-directed therapy to help rebuild bone mass.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Immunology &amp; inflammation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> GPCRs serve as key signaling molecules in various cellular processes, including involvement in the regulation of immune responses and the activation of immune cells such as macrophages, T cells, and dendritic cells. Upon activation by extracellular ligands, GPCRs initiate intracellular signaling cascades that modulate cytokine production, leukocyte trafficking, and inflammatory mediator release. Dysregulation of GPCR signaling pathways is implicated in numerous inflammatory and autoimmune diseases, such as chronic spontaneous urticaria (&#8220;CSU&#8221;), making them attractive targets for therapeutic intervention.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Metabolic diseases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> GPCRs are known to regulate various physiological processes such as energy metabolism, glucose homeostasis, and lipid metabolism. These receptors are involved in sensing nutrients, hormones, and other signaling </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">molecules, thereby influencing appetite, insulin secretion, and lipid storage. Dysregulation of GPCR signaling pathways is associated with metabolic disorders, such as obesity and type-2 diabetes (&#8220;T2D&#8221;). For instance, GPCRs like adrenergic receptors regulate lipolysis and thermogenesis, while receptors such as the GLP-1 receptor modulate insulin secretion and satiety. Targeting GPCRs is a clinically and commercially validated approach for the development of therapeutics that manage metabolic disorders, offering the potential to manage glucose levels, promote weight loss, and improve metabolic health.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond our initial therapeutic areas of focus, we intend to evaluate opportunities in additional therapeutic areas where GPCRs are directly connected to disease pathology, including in areas of neurology, women&#8217;s health, cardiovascular disease, and respiratory disease.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Pipeline</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a deep portfolio of highly potent and selective oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. Our wholly-owned pipeline is focused initially on three therapeutic areas &#8211; endocrinology, immunology and inflammation, and metabolic diseases &#8211; and is summarized in the figure below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_2.jpg" alt="img117602972_2.jpg" style="width:594px;height:242px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our target selection process considers the validation level of the GPCR and existing preclinical and/or clinical data demonstrating desired biological outcomes upon target modulation for a variety of different indications. We have prioritized indications with well-defined biomarkers to streamline the path to clinical proof-of-concept data, high unmet medical need and significant market opportunities. When analogous molecules exist that are approved or in clinical development, we explore differentiation opportunities and leverage our Native Complex Platform&#153; to address known limitations. We also leverage regulatory insights from established precedents to guide each program&#8217;s development strategy. As we expand our portfolio of GPCR-targeted programs, we will continue to focus on targets and indications with well-understood biology, predictive biomarkers for early proof-of-concept, efficient clinical development pathways, and high unmet medical need. We are building a deep portfolio comprised of programs that we can independently develop and commercialize upon regulatory approval, alongside select programs that may benefit from the development and commercial expertise, infrastructure and financial support of a strategic partner.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PTH1R Program: Oral Small Molecule PTH1R Agonist for Hypoparathyroidism</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing novel, oral small molecule Parathyroid Hormone 1 Receptor (&#8220;PTH1R&#8221;) agonists for the treatment of hypoparathyroidism. While there are peptide products approved and in development for hypoparathyroidism that target PTH1R, to our knowledge, we have the most advanced and comprehensive oral small molecule PTH1R agonist program. We believe our PTH1R agonists offer potent and selective activation of PTH1R, a GPCR highly involved in blood calcium control, with the potential to achieve sustained normalization of serum calcium and phosphate upon once-daily or twice-daily oral dosing.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the third quarter of 2024, we initiated a Phase 1 single- and multiple-ascending dose (&#8220;SAD/MAD&#8221;) clinical trial of SEP-786 in healthy volunteers. SEP-786 is an oral small molecule PTH1R agonist product candidate that was being developed for the treatment of hypoparathyroidism. On February 18, 2025, we announced our decision to discontinue the development of SEP-786 and advance a next-generation oral small molecule PTH1R agonist from our PTH1R program. This decision followed the observation of two unanticipated severe (Grade 3) events of elevated unconjugated bilirubin in the MAD portion of the Phase 1 trial, both of which were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">without elevations in alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase liver enzyme levels. Dosing was discontinued for both study participants, and the bilirubin elevations were reversible. There were no events of liver injury, cholestasis, or hemolysis across all participants, and there were no serious adverse events (&#8220;SAEs&#8221;) in the Phase 1 trial. In completed 28-day preclinical toxicology studies, SEP-786 was generally well-tolerated, without predicted risk of bilirubin elevation. We observed early signals of on-target pharmacology in the MAD portion of the trial including initial increases in serum calcium and decreases in endogenous parathyroid hormone levels. In response to these Phase 1 events, we have initiated non-clinical studies to investigate the underlying mechanism behind the observed effect. We plan to use any potential learnings from this investigation in the selection of the next-generation oral small molecule PTH1R agonist development candidate we plan to advance into clinical development.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on preclinical data observed to date, we believe that our PTH1R agonists have the potential to yield a differentiated treatment for hypoparathyroidism. We are advancing multiple lead compounds towards selection of a next-generation oral small molecule PTH1R development candidate to complete IND-enabling studies and accelerate toward clinical development later this year. Given our findings in Phase 1 for SEP-786, we plan to select a lead compound for advancement from a chemical series unrelated to the one that generated SEP-786.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview of Hypoparathyroidism</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disease Background and Role of PTH1R</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hypoparathyroidism is a rare endocrine disease characterized by insufficient levels of parathyroid hormone (&#8220;PTH&#8221;) that affects approximately 70,000 patients in the United States and 140,000 patients in Europe. PTH is a critical hormone for calcium and phosphate homeostasis and functions through the activation of PTH1R. Under normal physiological conditions, PTH is released from the parathyroid glands when circulating calcium levels are reduced and will act on PTH1R expressed on bone and kidney cells to increase calcium levels. Most patients with hypoparathyroidism develop the condition following damage to or accidental removal of the parathyroid glands during thyroid surgery, while other etiologies include autoimmune and genetic disorders. Patients with hypoparathyroidism are at risk of both short-term and long-term complications and comorbidities, such as tingling or burning of the extremities, muscle cramps and spasms, abdominal pain, abnormal heart rhythm, cataracts, and fatigue and muscle weakness. Chronic hypoparathyroidism is associated with cognitive and emotional symptoms, such as mental lethargy, inability to concentrate, memory loss or forgetfulness, anxiety, and depression. Many patients experience persistent symptoms that negatively impact quality of life and reduce work productivity.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Treatment Options and Their Limitations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The standard treatment for hypoparathyroidism consists of high-dose calcium supplements several times a day and activated vitamin D (calcitriol), which aim to correct serum calcium levels. However, these therapies do not replace other functions of PTH to restore physiological mineral homeostasis, and they also lead to long-term complications, including soft-tissue calcifications and impaired renal function.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Injectable synthetic PTH peptides have been validated in clinical trials to increase serum calcium and provide a more physiological alternative to conventional therapy. These therapies are designed to sustain PTH in the normal physiological range, thereby more fully addressing the underlying condition. In 2015, NATPARA (parathyroid hormone) became the first FDA-approved prescription PTH injection indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. Since then, manufacturer Takeda voluntarily recalled NATPARA in the United States due to manufacturing issues and discontinued global manufacturing of NATPARA at the end of 2024. Palopegteriparatide (marketed as YORVIPATH by Ascendis Pharma), a prodrug of active PTH (1-34), received regulatory approval in Europe in 2023 and in the United States in 2024 for the treatment of adults with hypoparathyroidism. While hormone replacement with injectable PTH peptides, either marketed or in late-stage clinical development, may effectively normalize calcium levels and manage disease complications, they will require life-long daily injections.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solution: Oral Small Molecule PTH1R Agonist</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Program Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe there is an unmet need for an oral small molecule PTH1R agonist that offers hypoparathyroidism patients a convenient, more physiological treatment option. Since conventional therapies, such as calcium and vitamin D, have limitations and do not restore other actions of PTH, such as bone turnover or renal calcium reabsorption, we believe an oral option that can increase serum calcium and replace the other functions of PTH is needed for patients. Our potent and selective PTH1R agonists are designed to address all patients with hypoparathyroidism. This includes the most severe patients, who may start injectable PTH peptide therapy, as</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">well as mild-to-moderate patients who are currently on high doses of calcium and vitamin D and may be less interested in an injectable PTH peptide treatment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, our Native Complex Platform&#153; affords us the opportunity to continuously discover and optimize oral small molecule PTH1R agonists in addition to the lead compounds we have already identified. We may develop additional molecules for hypoparathyroidism or for other indications where PTH1R agonists can address disease pathology, such as osteoporosis.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discovery and Preclinical Activity of Small Molecule PTH1R Agonists</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Native Complex Platform&#153; was applied to PTH1R and yielded multiple tractable chemical series of small molecule PTH1R agonists with distinct binding sites. Iterative structure-based design has led to multiple lead compounds from different chemical series. We plan to select a lead compound to advance into clinical development that is generated from a chemical series that is unrelated to the chemical series from which we generated SEP-786.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have assessed the potency and selective activation of several of our PTH1R oral small molecule lead compounds in human, dog, and rat receptor in vitro models. In vivo, we have demonstrated that several of our lead PTH1R oral compounds showed activity in a translational rat thyroparathyroidectomy (&#8220;TPTx&#8221;) model of hypoparathyroidism (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2.A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). In this model, surgical removal of the parathyroid glands replicates the human disease of hypoparathyroidism with a reduction in serum calcium from the normal range. To assess the activity of our oral PTH1R agonists, we dosed the TPTx rats with our compounds once-daily and analyzed the dose-dependent increases in serum calcium allowing for an assessment of compound activity and pharmacokinetic (&#8220;PK&#8221;) / pharmacodynamic (&#8220;PD&#8221;) relationships.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In a 28-day repeat dose study (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2.B and C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), one exemplar lead PTH1R oral small molecule agonist compound was dosed at 0.15 mg/kg orally once-daily which led to sustained increases in serum calcium to within the normal range and normalized serum phosphate levels over the entire 28-day dosing period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_3.jpg" alt="img117602972_3.jpg" style="width:559px;height:369px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (A) Rat hypoparathyroidism disease model (thyroid-parathyroidectomy model, TPTx). (B) Repeat once-daily oral dosing of example PTH1R agonist in the TPTx model showed sustained calcium control over 28 days of dosing. (C) Repeat once-daily oral dosing of a PTH1R agonist preclinical candidate in the TPTx model showed normalized serum phosphate levels over 28 days of dosing. PO = oral; QD = once-daily.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PK profiles of two potential next-generation oral small molecule PTH1R agonist exemplars were determined across multiple species (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and used to project the human PK profiles based upon allometric scaling of the nonclinical PK parameters, in addition to in vitro-in vivo extrapolation (&#8220;IVIVE&#8221;) of intrinsic clearance in human hepatocytes. These human PK models project that potential next generation exemplar PTH1R Agonist #1 and Agonist #2 will have a human half-life in the range of 17-34 and 43-87 hours, respectively, following oral dosing.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_4.jpg" alt="img117602972_4.jpg" style="width:618px;height:126px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical pharmacokinetic summary for two next generation PTH1R preclinical candidates. (%F) = percentage of fraction; PO = oral; cyno = cynomolgus monkey.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Development Plan and Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing multiple lead compounds towards selection of a next-generation oral small molecule PTH1R development candidate to complete IND-enabling studies and accelerate toward clinical development later this year.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEP-631: Oral Small Molecule MRGPRX2 NAM for CSU and Other Mast Cell Diseases</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing SEP-631, a selective, oral small molecule MRGPRX2 negative allosteric modulator (&#8220;NAM&#8221;), initially for the treatment of CSU. In preclinical studies, SEP-631 demonstrated potent and long-lasting inhibition of MRGPRX2, which is a highly and uniquely expressed receptor on mast cells and when activated is a key driver of CSU and other prevalent mast cell diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate submitting for regulatory clearance for SEP-631 and initiating a Phase 1 clinical trial in healthy volunteers to assess safety, tolerability, PK and PD in 2025.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview of CSU</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disease Background and Role of MRGPRX2</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CSU is a systemic inflammatory skin disease characterized by the spontaneous and recurrent appearance of itchy, painful hives, known as wheals, on the skin and angioedema, or swelling, that affects approximately 1.5 million patients in the United States. These chronic symptoms, which typically last between two and five years, can interfere with daily living, including the ability to work, and are frequently associated with psychiatric comorbidities, including depression and anxiety. Some patients with CSU report associated systemic symptoms including headache and fatigue, wheezing, flushing, palpitations, and gastrointestinal symptoms.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While there is no known trigger, the activation and degranulation of mast cells and release of histamine and other inflammatory mediators lead to these debilitating symptoms of CSU. Two canonical pathways represent the primary mechanisms for activation and degranulation of mast cells: activation of the IgE pathway via receptor cross-linking by antibodies targeting the high-affinity IgE receptor (Fc&#949;RI) or IgE itself, and activation of an IgE-independent pathway via MRGPRX2. Upon activation, mast cells release a plethora of mediators leading to the hallmark symptoms of itching, redness, and swelling.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MRGPRX2 is highly expressed on the surface of mast cells and plays a critical role in mast cell activation and degranulation. This receptor is activated by a variety of stimuli, including neuropeptides, antimicrobial peptides, and certain drugs. Upon activation, MRGPRX2 triggers a signaling cascade that leads to the rapid release of pre-stored mediators such as histamine, proteases, and cytokines from mast cell granules. This degranulation process contributes to immediate hypersensitivity reactions and various inflammatory conditions. The unique ability of MRGPRX2 to respond to a broad range of ligands highlights its importance in host defense mechanisms and its potential as a therapeutic target for treating allergic and inflammatory diseases.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Treatment Options and Their Limitations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patients suffering from CSU are treated initially with antihistamines to control symptoms; however, approximately 37% of patients are inadequately controlled in this first-line setting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A significant proportion of patients have persistent symptoms with antihistamines, highlighting substantial need for additional treatment options. With the expanding knowledge of the pathogenesis of CSU and the role of mast cells, novel therapeutic agents targeting distinct drivers of CSU are in development. We are aware of several new mechanisms aimed at inhibiting mast cells, and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">several programs are being explored in clinical trials, such as anti-c-Kit antibodies barzolvolimab and briquilimimab, Bruton&#8217;s tyrosine kinase inhibitor remibrutinib, and antibody to sialic acid-binding immunoglobulin-like lectin lirentelimab.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solution: Oral Small Molecule MRGPRX2 NAM</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Program Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe an oral small molecule that targets MRGPRX2 could provide a differentiated treatment option for patients with CSU. Our MRGPRX2 NAM program is designed to selectively inhibit mast cells, minimizing the risk of broad immunosuppression, which might be observed with other mechanistic approaches that either eradicate mast cells or inhibit multiple immune cell types. We believe selective mast cell inhibitors have the potential to be safer treatment alternatives and could be used for both monotherapy and combination therapy. With our NAM, we believe that we may be able to universally block all endogenous MRGPRX2 agonists and prevent MRGPRX2 activation even in the presence of high concentrations of MRGPRX2 agonists. We believe that with this combination of features, our NAM could have the potential to control patient symptoms and protect against disease flares.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing SEP-631 initially for the treatment of CSU, as we believe this may provide an efficient path to clinical proof-of-concept. There remains a significant unmet need in CSU, since antihistamine-refractory patients have few oral treatment alternatives. Because multiple diseases are driven by activated mast cells, we believe there is an opportunity to expand into indications across several therapeutic areas, such as allergic asthma, atopic dermatitis, interstitial cystitis, migraine, and prurigo nodularis.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Activity of SEP-631</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEP-631 has been demonstrated to potently block the activation of intracellular signaling in HEK293 cells with overexpressed human MRGPRX2 stimulated by cortistatin-14 (IC50 = 1.6 nM). Experiments using a matrix of different concentrations of SEP-631 versus different concentrations of cortistatin-14 showed strong suppression of maximal agonist effects (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which we believe demonstrates SEP-631 has the potential to be a NAM which, when bound to MRGPRX2, cannot be outcompeted by excess amounts of an MRGPRX2 agonist.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_5.jpg" alt="img117602972_5.jpg" style="width:380px;height:221px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 4. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEP-631 shows strong negative allosteric modulation of cortistatin-14 activation of MRGPRX2 in HEK293 cells expressing MRGPRX2.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEP-631 can block IP1 accumulation in HEK293 cells expressing MRGPRX2 in response to activation by several clinically relevant endogenous MRGPRX2 agonists (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), demonstrating that its inhibitory effect is independent of the activating agonist (i.e., the inhibitor does not show probe dependence).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_6.jpg" alt="img117602972_6.jpg" style="width:376px;height:209px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 5. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEP-631 potently inhibits the activation of MRGPRX2 by a range of endogenous MRGPRX2 agonists.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In different in vitro cellular models of mast cell degranulation, SEP-631 was shown to be a potent inhibitor of activation and degranulation in LAD2 cells (IC50 = 2.3 nM) and primary human cord blood-derived mast cells (IC50 = 0.72 nM). In typical experiments on primary human skin mast cells, SEP-631 fully and potently inhibited tryptase release triggered by an EC90 concentration of Substance P (IC50 = 12 nM) (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_7.jpg" alt="img117602972_7.jpg" style="width:274px;height:206px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 6.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In typical experiments on human skin mast cells, SEP-631 potently inhibited Substance P- stimulated tryptase release from primary human skin mast cells.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A key feature of SEP-631 compared to other third-party MRGPRX2 inhibitors is its long target residence time or slow off-rate of inhibition, meaning it takes a long time for the receptor-ligand complex to dissociate and for the receptor to become activatable again. Two experimental approaches were taken to determine the half-life of the receptor-ligand complex: radioligand binding experiments and one surface plasmon resonance study demonstrated long half-lives of 124 minutes (with a standard deviation of 20 minutes) and 50 minutes, respectively. Long target residence times of receptor ligands are recognized as being potentially advantageous for prolonged drug action in vivo, which have been shown to translate to enhanced clinical activity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For characterization of SEP-631 in vivo, we developed a transgenic knock-in (&#8220;KI&#8221;) mouse model in which the coding region of the endogenous mouse MRGPRB2 receptor was replaced with the human MRGPRX2 receptor, due to the low sequence homology shared between the mouse and human orthologs. In this model, MRGPRX2 agonist ligands such as substance P or cortistatin-14 stimulate robust plasma extravasation, or edema, when injected into the skin. Extravasation can be quantitated by following the redistribution of Evans Blue dye from the circulation into skin tissue (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 7.A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). In the MRGPRX2 KI mouse model, SEP-631 robustly inhibited skin extravasation when dosed orally prior to the cortistatin-14 skin challenge, demonstrating complete blockade of skin mast cell degranulation at an oral dose of 3 mg/kg (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 7.B</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_8.jpg" alt="img117602972_8.jpg" style="width:570px;height:265px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) Human MRGPRX2 KI mouse model of plasma extravasation into skin. (B) SEP-631 potently inhibited cortistatin-14 mediated plasma extravasation into skin in a human MRGPRX2 KI mouse model. PO = oral.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Studies to Support Clinical Advancement of SEP-631</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preclinical drug metabolism and PK profile of SEP-631 across multiple species was determined to support human PK projections. SEP-631 has the potential to be highly orally bioavailable with low clearance and a projected half-life consistent with once-daily oral dosing.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In vitro and in vivo safety studies explored to date support that SEP-631 has a favorable tolerability profile. In 28-day repeat oral dose GLP toxicology in rats and dogs, SEP-631 was generally well tolerated with wide safety margins over projected maximal exposures at human efficacious doses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Development Plan and Status of SEP-631</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to develop SEP-631 initially for patients with antihistamine-refractory CSU. We anticipate submitting for regulatory clearance and initiating a Phase 1 clinical trial in healthy volunteers to assess safety, tolerability, PK, and PD in 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to CSU, we are evaluating a range of other indications in which aberrant mast cell activation has been demonstrated to be central to disease pathobiology. Mast cell activation drives multiple prevalent diseases, including allergic asthma, atopic dermatitis, interstitial cystitis, migraine, and prurigo nodularis, and we believe SEP-631 could offer a novel oral treatment option for these patient populations. We plan to explore these indications as potential future clinical development opportunities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TSHR Program: Oral Small Molecule TSHR NAM for Graves&#8217; Disease and TED</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing a novel, oral small molecule TSHR NAM for the treatment of Graves&#8217; disease and thyroid eye disease (&#8220;TED&#8221;). We believe our TSHR NAM could offer a disease-modifying treatment that directly addresses the pathobiology of both diseases by blocking TSHR overactivation caused by patients&#8217; autoantibodies. We are advancing several lead compounds towards selection of a development candidate for IND-enabling studies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview of Graves&#8217; Disease and TED</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disease Background and Role of TSHR</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Graves&#8217; disease is one of the most prevalent autoimmune conditions affecting over 2 million patients in the United States and is the leading cause of hyperthyroidism. In Graves&#8217; disease, the body produces autoantibodies that bind to and activate TSHR on thyroid cells. These autoantibodies stimulate the thyroid gland to produce excess thyroid hormone, resulting in hyperthyroidism. Thyroid hormones affect many body systems, so symptoms of Graves&#8217; disease can be wide-ranging. Common symptoms of Graves&#8217; disease include anxiety and irritability, tremors, heat sensitivity, weight loss, rapid or irregular heartbeat, and sleep disturbance. Although Graves&#8217; disease may affect anyone, it is more common among women and people younger than age 40.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TED is a related, yet distinct, vision-threatening autoimmune condition that develops in approximately 50% of Graves&#8217; disease patients. In TED, autoantibodies bind to and activate TSHR on orbital fibroblasts located behind the eyes, thereby resulting in inflammation, orbital fat expansion, and fibrosis. TED is a progressive disease and early diagnosis and treatment are important to prevent worsening and serious eye damage, including proptosis (eye bulging), strabismus (misalignment of the eyes), and diplopia (blurred or double vision).</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Treatment Options and Their Limitations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The most common treatments for Graves&#8217; disease have remained largely unchanged over the past 70 years and include antithyroid drugs, such as methimazole and propylthiouracil, designed to lower the amount of hormone the thyroid makes or block the effects of thyroid hormone on the body, radioactive iodine therapies that aim to destroy overactive thyroid cells, and thyroidectomy surgery to remove all or part of the thyroid. For many patients, there is a high rate of disease recurrence after treatment with antithyroid drugs, and lifelong hypothyroidism develops after ablation and thyroidectomy. In addition, these treatment options may initially address the underlying symptoms, but they are not disease-modifying and do not stop disease progression.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Current treatments for TED depend on disease severity and are designed to help manage symptoms and slow disease progression. For patients with mild TED, lifestyle changes and over-the-counter remedies, such as artificial tear drops and selenium supplements, may help with dry eye relief. For severe TED, steroids and/or eye surgery, such as orbital decompression, may be considered. Historically, patients have had to live with TED until the inflammation subsides, after which they are often left with permanent and vision-impairing consequences and may require multiple surgeries that do not completely return the patient to their pre-disease state.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solution: Oral Small Molecule TSHR NAM</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Program Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe there is a significant unmet need for a disease-modifying approach that directly addresses the pathobiology of both Graves&#8217; disease and TED. Our highly selective, oral small molecule TSHR NAM program is designed to block the activation of TSHR by autoantibodies and could lead to a universal treatment option for all Graves&#8217; disease and TED patients. Our NAMs are designed to prevent the activation of TSHR even in the presence of excess amounts of TSHR activating autoantibodies, thus potentially providing protection for patients with high serum antibody levels and for patients with polyclonal activating antibodies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With few innovative, non-surgical or ablative treatments, we believe that there is a significant unmet need in Graves&#8217; disease. While treatments exist for TED, they are focused on the most severe patients, so an oral small molecule TSHR NAM could provide a new option for all TED patients. Because over-stimulation of TSHR is at the center of Graves&#8217; disease and TED, we believe that if we can treat Graves&#8217; disease patients early in their disease course with our oral small molecule TSHR NAM, our treatment may be able to prevent the progression to other manifestations of the disease, such as TED or Graves&#8217; dermopathy.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discovery and Preclinical Activity of Oral TSHR NAMs</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have used our Native Complex Platform&#153; to identify multiple tractable chemical series of oral small molecule TSHR NAMs. Molecular pharmacology studies with TSHR NAMs have demonstrated multiple compound series with high potencies and desired drug-like properties. In cells expressing human TSHR, cAMP signaling activated by an autoantibody isolated from a Graves&#8217; disease patient was significantly inhibited with several of our lead compounds. In addition, our compounds exhibited high selectivity for inhibition of TSHR over a broad set of other GPCRs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An effective treatment for both Graves&#8217; disease and TED will require broad inhibition of patient autoantibodies, which are typically high affinity and present at high titers during active disease. Furthermore, these autoantibodies may bind to different sites on the large extracellular domain of TSHR. We believe a TSHR NAM can have an optimized pharmacologic profile to fully block the activity of all patient autoantibodies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To demonstrate that our TSHR NAM can fully inhibit multiple patient autoantibodies, we assessed the activity of one of our small molecule TSHR NAMs (SP-1351) against Graves&#8217; disease patient-derived polyclonal sera applied to TED patients&#8217; orbital fibroblasts. Fibroblast activation by the sera is measured by quantifying hyaluronic acid production by the cells. SP-1351 was able to inhibit the activity of 10 out of 10 polyclonal sera samples, each from a different Graves&#8217; disease patient (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). This result suggests broad inhibitory activity of our TSHR NAMs against the diverse range of polyclonal autoantibodies found in Graves&#8217; disease patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_9.jpg" alt="img117602972_9.jpg" style="width:458px;height:182px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 8. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SP-1351 inhibits activation of primary orbital fibroblasts by all 10 polyclonal serum samples collected from Graves&#8217; disease patients. mAb = monoclonal antibody.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To characterize the effects of these oral TSHR NAMs on disease manifestations in vivo, we developed a translational mouse model of hyperthyroidism (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 9.A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). Mice chronically treated with a Graves&#8217; disease patient-derived TSHR-activating antibody developed multiple manifestations similar to Graves&#8217; disease patients, including increased plasma thyroid hormone T4 levels (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 9.B</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), increased thyroid weight (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 9.C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), and proptosis (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 9.D</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). After one week of SP-1351 treatment with repeat oral dosing, several of these manifestations showed signs of reversal including normalization of thyroid hormone T4 levels, reduction in thyroid weight, and reduction of proptosis.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_10.jpg" alt="img117602972_10.jpg" style="width:522px;height:316px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 9. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) Translational in vivo mouse model of Graves&#8217; disease.(B, C, D) SP-1351 demonstrates reversal of the hyperthyroid state and proptosis in mice chronically treated with a monoclonal TSHR autoantibody. mAb = monoclonal antibody.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the same mouse model, effects on thyroid tissue were assessed. Thyroid glands of Graves&#8217; disease patients are characterized by follicular hyperplasia and/or hypertrophy, intracellular colloid droplets, follicular colloid reduction and scalloping, increased vascularity and lymphocyte infiltration, all of which manifest in our mouse disease model. After oral treatment with SP-1351, we observed significant reduction in follicular hypertrophy and colloid droplets.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Next Steps</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are continuing to optimize multiple early-stage oral small molecule TSHR NAMs, with the goal of advancing lead compounds towards selection of a development candidate for IND-enabling studies. In our preclinical studies, we have identified multiple TSHR NAMs that demonstrated the ability to reverse hyperthyroidism and proptosis in a novel mouse model of Graves&#8217; disease and inhibit multiple Graves&#8217; disease patient TSHR autoantibodies in cell-based assays using primary human cells. We intend to pursue future clinical development of our TSHR NAM program for the treatment of Graves&#8217; disease and TED.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incretin Programs: Oral Small Molecule Single- and Multi-Incretin Receptor Agonists for Metabolic Disorders Including Obesity and T2D</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on unique chemical and structural insights obtained with our Native Complex Platform&#153; we believe we have an opportunity to discover and develop novel, next-generation, oral small molecules as selective single- or multi-acting GLP-1, GIP, glucagon receptor agonists. We are advancing several lead compounds towards selection of one or more development candidates for IND-enabling studies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview of Obesity and T2D</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disease Background and Role of Incretins</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obesity and diabetes are two of the most prevalent chronic diseases in the world, affecting a combined total of more than 800 million people, and are associated with severe health complications, including cardiovascular disease and kidney failure, as well as an increased risk of death. Obesity is defined as having a body mass index of greater than or equal to 30 and is associated with more than 200 comorbidities, including diabetes, which can lead to blindness, limb amputations, and the need for dialysis. Despite increased awareness about obesity as a global epidemic and the advancement of new treatments, no country has reported a decline in obesity prevalence across its entire population. It is predicted that 1.55 billion people will be living with obesity globally by 2030.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">More than 400 million people worldwide live with diabetes and approximately 90% of all diabetes cases are T2D, which is a chronic disease involving sustained high levels of glucose in the bloodstream. Under normal conditions, insulin is produced by the pancreas, enabling glucose to enter cells to provide energy needed for normal tissue and organ function. T2D results from either the pancreas not producing enough insulin or the body&#8217;s cells not responding normally to insulin, known as insulin resistance. Uncontrolled diabetes can lead to severe health complications, such as an increased risk of heart attack, stroke, neuropathy, kidney failure, limb amputations, and vision loss. The key risk factors for developing T2D include obesity, genetic predisposition, a sedentary lifestyle, or a history of gestational diabetes. Moreover, T2D and obesity are considered co-morbidities, with 90% of people with T2D being overweight or obese.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incretins (e.g., GLP-1, GIP, and glucagon) are a group of metabolic hormones that, along with their associated receptors, play significant roles in glucose metabolism and homeostasis. GLP-1 and GIP are secreted in the intestinal tract after eating, and subsequently activate their respective receptors expressed on pancreatic beta cells, to stimulate insulin secretion in a glucose-dependent manner. Glucagon activates its related receptors expressed on pancreatic alpha cells, to counteract the actions of insulin by stimulating hepatic glucose production and thereby increases blood glucose levels in a glucoregulatory role. The widespread therapeutic effects of GLP-1 and GIP receptor agonism in patients with diabetes are well-documented and include slowing of gastric emptying, increased satiety, reduction of food intake, promotion of weight loss, and reduction of cardiovascular disease morbidity and mortality. Moreover, there is a complex interplay between the actions of GLP-1, GIP, and glucagon, and recent clinical data from the triagonist injectable peptide retatrutide (in development by Eli Lilly and Company) indicate there are potential additional efficacy benefits on weight loss and its maintenance.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Treatment Options and Their Limitations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Standard treatment for obesity and T2D is lifestyle change through a combination of diet, exercise, and behavior therapy, and, in the case of T2D, metformin. According to the 2022 American Diabetes Association Standards of Medical Care in Diabetes, management of obesity is an important factor in the treatment of diabetes since even a small degree of weight loss can improve blood glucose levels, resulting in a decreased need for glucose-lowering medications. While lifestyle modifications can produce weight loss, the magnitude required for disease modification is approximately 10% to 15% of total body weight.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In recent years, several injectable peptide agonists targeting incretins have been approved for the treatment of T2D, and, due to their ability to increase feelings of fullness, decrease appetite, and effectively promote weight loss, for the treatment of obesity. Third-party clinical data with incretin receptor therapeutics have demonstrated substantial and sustained reductions in body weight, as well as the ability to lower blood glucose and improve glycated hemoglobin (&#8220;HbA1c&#8221;). While the benefits of currently marketed GLP-1 and dual GLP-1/GIP receptor agonists are well-documented in patients with diabetes and obesity, they suffer from several limitations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">including tolerability, prolonged titration schemes, and injection administration, and supply challenges. The most frequent adverse events with GLP-1 receptor agonists are gastrointestinal-related issues, including nausea, vomiting, and diarrhea, which necessitate dose titration protocols to manage treatment and often contribute to treatment discontinuation. Finally, certain doses of semaglutide and tirzepatide are currently on several global health authorities&#8217; drug shortage lists, highlighting the need for additional scalable treatment options.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond currently available treatment options, we are aware of numerous injectable peptides in clinical development that are exploring the combination of agonist activities at the GLP-1, GIP, and glucagon receptor metabolic targets. In addition, orally administered GLP-1 receptor small molecules are being clinically evaluated.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solution: Oral Small Molecule Single- and Multi-Incretin Receptor Agonists</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Program Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe there remains a significant unmet need in the treatment of diabetes, obesity, and other cardiometabolic disorders to discover and develop products that can deliver the activity of mono- or multi-acting injectable peptide agonists, like semaglutide or tirzepatide, but as oral small molecules. By exploring novel, single-acting or various multi-acting GLP-1, GIP, and glucagon receptor agonists, we believe that we have the potential to discover and develop oral products that have the potential to increase patient convenience and compliance, and to improve tolerability, ultimately expanding the treated population. Given the significant market opportunity, we are leveraging our Native Complex Platform&#153; to discover novel scaffolds across various product profiles to explore multiple different treatment options for patients.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discovery and Preclinical Activity of Oral Incretin Receptor Agonists</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have used our Native Complex Platform&#153; to identify multiple tractable chemical series of oral small molecule incretin receptor agonists. Structural biology demonstrated that our compounds occupy novel binding sites, distinct from the known orthosteric binding sites occupied by clinical-stage small molecules, danuglipron and orforglipron. Analysis of the respective binding sites show a high similarity of more than 80-90% for GLP-1, GIP, and glucagon receptors, in contrast to the modest similarity of approximately 40-60% at the danuglipron and orforglipron orthosteric sites.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our portfolio of discovery-stage incretin receptor agonists includes several potent, selective mono-GIPR agonists, dual-GIPR / GCGR agonists, and triple-GLP-1R / GIPR / GCGR agonists. Cell-based assay data for an exemplar incretin agonist compound for each of these profiles demonstrates differential potency and selectivity of these compounds in their ability to activate GIPR, GLP-1R, and GCGR-induced intracellular signaling:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mono-GIPR agonist exemplar SP-3561 demonstrated high potency (EC50 = 3.1 nM) and was about 60-fold selective relative to GCGR and greater than 10,000-fold selective relative to GLP-1R. Mono-GIPR agonists may have therapeutic potential alone or in combination with GLP-1R agonists.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dual-GIPR / GCGR agonist exemplar SP-7606 demonstrated comparable GIPR potency to SP-3561 but with significantly improved GCGR potency (EC50 = 17 nM) and still high selectivity relative to GLP-1R. Dual-GIPR / GCGR agonists may have therapeutic potential alone or in combination with GLP-1R agonists.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Triple-GLP-1R / GIPR / GCGR agonist exemplar SP-2297 demonstrated comparable GIPR and GCGR potency to SP-7606 but with significantly improved GLP-1R potency (EC50 = 330 nM). Additional optimization efforts are continuing to try to further improve GLP-1R potency.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Favorable physicochemical and in vitro drug metabolism properties of one of our selective mono-GIPR agonists, SP-3561, translated into promising PK in mice with low clearance and high oral bioavailability. Subsequent evaluation of SP-3561 in an oral-glucose tolerance test (&#8220;OGTT&#8221;) in diet-induced obese (&#8220;DIO&#8221;) mice (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 10.A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) demonstrated significant dose-dependent glucose reduction at oral doses of 10 and 30 mg/kg (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 10.B, C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). DIO mice were fasted overnight, and 30 minutes after oral dosing of SP-3561, a glucose challenge was administered, and blood glucose levels were monitored for two hours after dosing. At 30 mg/kg, SP-3561 demonstrated effective glucose control comparable to retatrutide (clinically studied triple-GLP-1R / GIPR / GCGR injectable peptide agonist) dosed subcutaneously (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 10.B, C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_11.jpg" alt="img117602972_11.jpg" style="width:563px;height:339px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 10. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) OGTT model with DIO mice. (B,C) SP-3561 improves oral glucose tolerance in the DIO mouse model comparable to retatrutide. PO = oral, SC = subcutaneous.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A second selective mono-GIPR agonist, SP-2991, was studied in a 14-day repeat dosing weight loss study in DIO mice (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). SP-2991 was evaluated at a once-daily oral dose of 30 mg/kg, alone or in combination with once-daily subcutaneous injections of the GLP-1R agonist peptide semaglutide at 10 nmol/kg. These cohorts were compared with once-daily semaglutide subcutaneous injections at 10 nmol/kg, once-daily subcutaneous injections of the dual GIPR / GLP-1R agonist peptide tirzepatide at 10 nmol/kg, and historical vehicle controls. Body weights of the mice were measured prior to compound dosing on day 0 and on days 1, 4, 6, 8, 10, 12, and 14 when the study was terminated. SP-2991, when dosed alone, resulted in about 7% average body weight loss relative to vehicle controls, which was statistically significant. When added to a subcutaneous daily dose of semaglutide, SP-2991 resulted in about 33% average body weight loss, which was similar in magnitude to what was observed for tirzepatide in the same study and significantly more weight loss relative to dosing of semaglutide alone.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_12.jpg" alt="img117602972_12.jpg" style="width:451px;height:250px;"/></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 11. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mono-GIPR agonist, SP-2991, when dosed orally once daily in combination with subcutaneous dosing of the GLP-1R agonist peptide semaglutide, resulted in significant body weight loss in the DIO mouse model, which is comparable in magnitude to subcutaneous dosing of the dual GLP-1R/GIPR agonist peptide tirzepatide. PO = oral, SC = subcutaneous, QD = once daily.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Next Steps</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have identified potent, selective mono-GIPR agonists, dual-GIPR / GCGR agonists, and triple-GLP-1R / GIPR / GCGR agonists. Oral small molecule mono-GIPR agonists with favorable PK properties have demonstrated the ability to achieve glucose control in a mouse model of glucose sensitivity and demonstrated weight loss in a DIO mouse model as a single agent and additive weight loss when dosed in combination with semaglutide. We are continuing to optimize multiple early-stage oral small molecule incretin receptor agonists and plan to continue evaluating them in a variety of metabolic models with a goal of advancing lead compounds towards selection of one or more development candidates for IND-enabling studies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The pharmaceutical and biotechnology industries are characterized by rapidly advancing technologies, intense competition, and a strong emphasis on proprietary and novel products and product candidates. While we believe our product candidates, platform, knowledge, experience, and scientific personnel provide us with several key competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies, and public and private research institutions, among others. Our future success will depend in part on our ability to maintain a competitive position with our structure-based drug discovery platform. If we fail to stay at the forefront of technological change in utilizing our platform to create and develop product candidates, we may be unable to compete effectively. Our competitors may render our approach obsolete by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages in our drug discovery process that we believe we derive from our research approach and platform. Several other companies also focus on GPCRs and have platform technologies that are distinct from our Native Complex Platform&#153;.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, any product candidates that we successfully develop and commercialize, including those from our PTH1R program and SEP-631, may compete with existing therapies and new therapies that may become available in the future that are approved to treat the same diseases for which we may obtain approval for our product candidates. There are several large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of product candidates for the treatment of the indications that we are pursuing. Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our competitors, either alone or with their collaborators, have significantly greater financial, technical, manufacturing, marketing, sales, and supply resources or experience than we do. If we successfully obtain approval for any product candidate, we will face competition based on many different factors, including the safety and effectiveness of our products, the timing and scope of marketing approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage, and patent position. Competing products could present superior treatment alternatives, including by being more effective, safer, more convenient, less expensive, or marketed and sold more effectively than any products we may develop. Competitive products may make any products we develop obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. If we are unable to compete effectively, our opportunity to generate revenue from the sale of our products we may develop, if approved, could be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other applicable regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. In addition, our ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products. There are generic products currently on the market for certain of the indications that we are pursuing, and additional products are expected to become available on a generic basis over the coming years. If our product candidates are approved, we expect that they will be priced at a significant premium over competitive generic products.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing and Supply</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of our product candidates and currently have no immediate plans to build our own clinical or commercial scale manufacturing capabilities. We have engaged, and expect to continue to rely on, third-party CMOs to supply our product candidates for use in our preclinical studies and clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we intend to rely on third-party manufacturers for later-stage development and commercial manufacturing if our product candidates receive marketing approval. As our product candidates advance through clinical development, we expect to enter into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufactured by more than one supplier, the number of manufacturers is limited. In the event it is necessary or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advisable to acquire supplies from an alternative supplier, we might not be able to obtain them on commercially reasonable terms, if at all. It could also require significant time and expense to redesign our manufacturing processes to work with another company. If we need to change manufacturers during the clinical or development stage for product candidates or after commercialization for our product candidates, if approved, the FDA, European Medicines Agency (&#8220;EMA&#8221;), and other comparable foreign regulatory authorities must approve these new manufacturers in advance, which will involve testing and additional inspections to ensure compliance with FDA regulations and standards and may require significant lead times and delay. Reliance on third-party manufacturers and CMOs may expose us to different risks than if we were to manufacture and develop product candidates ourselves. Should any of these manufacturers become unavailable to us for any reason, we  believe that there are a number of potential replacements, although we may incur some delay in identifying and qualifying such replacements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have personnel with extensive technical, manufacturing, analytical, and quality experience to oversee contract manufacturing and testing activities, and to compile manufacturing and quality information for our regulatory submissions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property is critical to our business and we strive to protect it, including by pursuing and, once obtained, by maintaining patent protection in the United States and in selected foreign jurisdictions for our product candidates, new therapeutic approaches and potential indications, and other inventions that are important to our business. We also rely on the skills, knowledge, and experience of our scientific and technical personnel, as well as that of our advisors, consultants, contractors, and collaborators. To help protect our proprietary know-how that we elect not to patent, such as our proprietary Native Complex Platform&#153;, processes for which patents are difficult to enforce, and any other elements of our product candidates, technology and product discovery and development processes that involve proprietary know-how, information, or technology that is not covered by patents, we rely on confidentiality and other agreements to protect our interests. We generally require our employees, consultants, scientific advisors and contractors to enter into confidentiality agreements prohibiting the disclosure of our confidential information and requiring disclosure and assignment to us of their ideas, developments, discoveries and inventions important to our business. In addition, we also plan to rely on regulatory protection based on orphan drug exclusivities, data exclusivities, and market exclusivities. See the subsection section titled &#8220;&#8212;Government Regulation&#8221; for additional information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent positions of biotechnology and pharmaceutical companies like us are generally uncertain and can involve complex legal, scientific, and factual issues. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. We also cannot ensure that patents will issue with respect to any patent applications that we may file in the future, nor can we ensure that any of our patents or future patents will be commercially useful in protecting our product candidates and methods of using or manufacturing the same. In addition, the coverage claimed in a patent application may be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged after issuance. As a result, we cannot guarantee that any of our product candidates, if they obtain required regulatory approvals, will be protectable or remain protected by enforceable patents. Moreover, any patents that we hold may be challenged, circumvented, or invalidated by third parties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success will also depend in part on our ability to operate without infringing the proprietary intellectual property rights of third parties, and in part on our ability to prevent others from infringing our proprietary rights. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, or our future drugs or processes, obtain licenses, or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future drugs may have an adverse impact on us. See &#8220;Risk Factors&#8212;Risks Related to Intellectual Property&#8221; for a more comprehensive description of risks related to our intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Applications</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generally file patent applications directed to our product candidates in an effort to secure our intellectual property positions vis-&#224;-vis these programs. For our product candidates, we will, in general, initially pursue patent protection covering compositions of matter and therapeutic methods of use. Throughout the development of our product candidates, we will seek to identify additional means of obtaining patent protection that would potentially enhance commercial success, including by protecting inventions related to additional methods of use, processes of making, formulations and dosing regimens. The intellectual property portfolios for our current product candidates as of March 19, 2025, are summarized below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Small Molecule Agonists of PTH1R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own five patent families directed to certain small molecule agonists of PTH1R and therapeutic methods of using them. As of March 19, 2025, we have two pending Patent Cooperation Treaty (&#8220;PCT&#8221;) patent applications, nine pending foreign applications, and three pending United States provisional patent applications. Any patents that may issue from patent applications in these families (or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the case of provisional applications, if issued from future non-provisional applications that we file) are projected to expire between 2043 and 2045, absent any disclaimers or potentially available patent term extensions or adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Small Molecule Inhibitors of MRGPRX2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own two patent families directed to certain small molecule inhibitors of MRGPRX2 and therapeutic methods of using them. As of March 19, 2025, we have one pending PCT patent application and seven pending foreign applications. We also have two pending U.S. provisional applications.  Any patents that may issue from patent applications in this family (or in the case of provisional applications, if issued from future non-provisional applications that we file) are projected to expire between 2044 and 2045, absent any disclaimers or potentially available patent term extensions or adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Small Molecule Inhibitors of TSHR</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For our TSHR program, we own three patent families directed to certain small molecule inhibitors of TSHR and therapeutic methods of using them. As of March 19, 2025, we have one pending U.S. application and one pending European Patent Organization application. We also have three pending United States provisional patent application. Any patents that may issue from patent applications in these families (or in the case of provisional applications, if issued from future non-provisional applications that we file) are projected to expire between 2043 and 2045, absent any disclaimers or potentially available patent term extensions or adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Small Molecule Agonists of Incretin Receptors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For our incretin programs, we own six patent families directed to certain small molecule single- and multi-incretin agonists of incretin receptors, and therapeutic methods of using them. As of March 19, 2025, we have twelve pending United States provisional patent applications. Any patents that may issue from patent applications in these families (or in the case of provisional applications, if issued from future non-provisional applications that we file) are projected to expire between 2044 and 2045, absent any disclaimers or potentially available patent term extensions or adjustments.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Term Extensions</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the term of a patent covering an FDA-approved drug may, in certain cases, be eligible for a patent term extension under the Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. The period of extension may be up to five years, but cannot extend beyond a total of 14 years from the date of product approval. Only one patent among those eligible for an extension and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and in certain other jurisdictions to extend the term of a patent that covers an approved drug. If one or more of our pending United States patent applications are issued as United States patents covering our products or their therapeutic use it is possible that the patents may be entitled to patent term extensions. If a therapeutic use of a drug candidate or the drug candidate itself receives FDA approval, we intend to apply for patent term extensions, if available, to extend the term of patents that cover the approved use or drug candidate. We also intend to seek patent term extensions in any other jurisdictions where available. However, there is no guarantee that the applicable authorities, including the FDA, will agree with our assessment of whether such extensions should be granted and even if granted, the length of such extensions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trade Secrets &amp; Know-how</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to patent protection, we also rely on trade secrets, trademarks, proprietary information, confidential know-how, and continuing technological innovation to develop and maintain our competitive position. Our trade secrets, proprietary information, and confidential know-how includes our Native Complex Platform&#153;. However, trade secrets, proprietary information, and confidential know-how can be difficult to protect. We seek to protect our trade secrets, proprietary information, and confidential know-how, in part, using confidentiality agreements with any collaborators, scientific advisors, employees, and consultants and invention assignment agreements with our employees. We also have agreements requiring assignment of inventions with selected consultants, scientific advisors, and collaborators. These agreements may not provide adequate protection. These agreements may also be breached, and we may not have an adequate remedy for any such breach. In addition, our trade secrets, proprietary information, and confidential know-how may become known or be independently developed by a third party, or misused by any collaborator to whom we disclose such information. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or obtain or use information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop substantially the same or similar proprietary information and techniques or may otherwise gain access to our proprietary information. As a result, we may not be able to meaningfully protect our trade secrets, proprietary information, and confidential know-how. For more information regarding the risks related to our intellectual property, see the section titled &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union (the &#8220;EU&#8221;), extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting, and import and export of pharmaceutical products. The processes for obtaining regulatory approvals in the United States and in foreign countries and jurisdictions, along with subsequent compliance with applicable statutes and regulations, require the expenditure of substantial time and financial resources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Review and Approval of Drugs in the United States</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the FDA regulates drugs under the U.S. Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and its implementing regulations. The failure to comply with applicable U.S. requirements at any time during the product development process, approval process or after approval may subject an applicant and/or sponsor to a variety of administrative or judicial sanctions, including refusal by the FDA to approve pending applications, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters and other types of letters, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or civil or criminal investigations and penalties brought by the FDA and the U.S. Department of Justice or other governmental entities. In addition, an applicant may need to recall a product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An applicant seeking approval to market and distribute a new drug product in the United States must typically undertake the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of nonclinical, or preclinical, laboratory tests, animal studies and formulation studies in compliance with the FDA&#8217;s good laboratory practice (&#8220;GLP&#8221;) regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an IND which must take effect before human clinical trials may begin;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an institutional review board (&#8220;IRB&#8221;) representing each clinical site before each clinical trial may be initiated at that site;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials in accordance with good clinical practices (&#8220;GCPs&#8221;) to establish the safety and efficacy of the proposed drug product for each indication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation and submission to the FDA of an NDA and payment of user fees;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">review of the product by an FDA advisory committee, where appropriate or if applicable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product, or components thereof, are produced to assess compliance with current Good Manufacturing Practices (&#8220;cGMP&#8221;) requirements and to assure that the facilities, methods and controls are adequate to preserve the product&#8217;s identity, strength, quality and purity;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of the clinical data;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of the NDA; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with any post-approval requirements, including risk evaluation and mitigation strategies (&#8220;REMS&#8221;) and post-approval studies required by the FDA.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Studies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before an applicant begins testing a compound in humans, the drug candidate enters the preclinical testing stage. Preclinical studies include laboratory evaluation of the purity and stability of the manufactured drug substance or active pharmaceutical ingredient (&#8220;API&#8221;) and the formulated drug or drug product, as well as</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and animal studies to assess the safety and activity of the drug for initial testing in humans and to establish a rationale for therapeutic use. The conduct of preclinical studies is subject to federal regulations and requirements, including GLP regulations. Some long-term preclinical testing, such as animal tests of reproductive adverse effects and carcinogenicity, may continue after the IND is submitted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The IND and IRB Processes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An IND is an exemption from the FDCA that allows an unapproved drug to be shipped in interstate commerce for use in an investigational clinical trial and a request for FDA authorization to administer such investigational drug to humans. Such authorization</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">must be secured prior to interstate shipment and administration of the investigational drug. In an IND, applicants must submit a protocol for each clinical trial and any subsequent protocol amendments. In addition, an applicant submits the results of the preclinical tests, manufacturing information, analytical data, any available clinical data or literature and plans for clinical trials, among other things, to the FDA as part of an IND. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time, the FDA raises concerns or questions related to one or more proposed clinical trials and places the trial on clinical hold. The FDA also may impose a clinical hold or partial clinical hold after commencement of a clinical trial under an IND. A clinical hold is an order issued by the FDA to the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the IND. No more than 30 days after imposition of a clinical hold or partial clinical hold, the FDA will provide the sponsor a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation (or full investigation in the case of a partial clinical hold) may only resume after the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A sponsor may choose, but is not required, to conduct a foreign clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When the foreign clinical trial is not conducted under an IND, the sponsor must ensure that the study is conducted in accordance with GCP, including review and approval by an independent ethics committee (&#8220;IEC&#8221;) and informed consent from subjects. The GCP requirements are intended to help ensure the protection of human subjects enrolled in non-IND foreign clinical trials, as well as the quality and integrity of the resulting data. FDA must also be able to validate the data from the study through an on-site inspection if necessary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the foregoing IND requirements, an IRB representing each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution, and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the IRB must conduct continuing review of the study at least annually. The IRB must review and approve, among other things, the study protocol and informed consent information to be provided to study subjects. An IRB must operate in compliance with FDA regulations. An IRB can suspend or terminate approval of a clinical trial at its institution, or an institution it represents, if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the product candidate has been associated with unexpected serious harm to patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, some trials are overseen by an independent group of qualified experts organized by the trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated check points based on access that only the group maintains to available data from the study. The FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about certain clinical trials must be submitted within specific timeframes to the National Institutes of Health (NIH) for public dissemination on its </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ClinicalTrials.gov</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> website.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Human Clinical Trials in Support of an NDA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include, among other things, the requirement that all research subjects, or their legal representative, provide their informed consent in writing before their participation in any clinical trial. Clinical trials are conducted under written study protocols detailing, among other things, the inclusion and exclusion criteria, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1. The drug is initially introduced into healthy human subjects or, in certain indications such as cancer, patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness and to determine maximal dosage.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 2. The drug is administered to a limited patient population to identify possible AEs and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3. The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate enough data to evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product and to provide adequate information for the labeling of the product. Post-approval studies, often referred to as Phase 4 studies, may be conducted after initial regulatory approval. These studies are used to gain additional experience from the treatment of patients in the intended therapeutic indication.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA. In addition, within 15 calendar days after the sponsor determines that the information qualifies for reporting, IND safety reports must be submitted to the FDA for any of the following: serious and unexpected suspected adverse reactions; findings from other studies or animal or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> testing that suggest a significant risk in humans exposed to the drug; and any clinically important increase in the case of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#8217;s initial receipt of the information. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, or at all. The FDA will typically inspect one or more clinical sites to assure compliance with GCP and the integrity of the clinical data submitted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concurrent with clinical trials, companies often complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the drug as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and, among other things, the applicant must develop methods for testing the identity, strength, quality, purity, and potency of the final drug. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Review of an NDA by the FDA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming successful completion of required clinical testing and other requirements, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the drug product for one or more indications. Under federal law, the submission of most NDAs is additionally subject to a significant application user fee as well as annual prescription drug product program fees. These fees are typically increased annually. Certain exceptions and waivers are available for some of these fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA conducts a preliminary review of an NDA within 60 days of its receipt, before accepting the NDA for filing, to determine whether the application is sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The FDA has agreed to specified performance goals in the review process of NDAs. Applications for drugs containing new molecular entities are meant to be reviewed within 10 months from the date of filing, and applications for &#8220;priority review&#8221; products containing new molecular entities are meant to be reviewed within six months of filing. The review process may be extended by the FDA for three additional months to consider new information or clarification provided by the applicant to address an outstanding deficiency identified by the FDA following the original submission.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During its review of an NDA, the FDA typically will inspect the facility or facilities where the product is or will be manufactured. These pre-approval inspections may cover all facilities associated with an NDA, including drug component manufacturing (such as APIs), finished drug product manufacturing, and control testing laboratories. The FDA will not approve an NDA unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as a condition of approval, the FDA may require an applicant to develop a REMS. REMS use risk minimization strategies beyond the professional labeling to ensure that the benefits of the product outweigh the potential risks. To determine whether a REMS is needed, the FDA will consider the size of the population likely to use the product, seriousness of the disease, expected benefit of the product, expected duration of treatment, seriousness of known or potential AEs, and whether the product is a new molecular entity. REMS can include medication guides, physician communication plans for healthcare professionals, and elements to assure safe use (&#8220;ETASU&#8221;). ETASU may include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The FDA may require a REMS before approval or post-approval if it becomes aware of a serious risk associated with use of the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA is required to refer an application for a novel drug to an advisory committee or explain why such referral was not made. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fast Track, Breakthrough Therapy, and Priority Review</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA has a number of programs intended to facilitate and expedite development and review of new drugs if they are intended to address an unmet medical need in the treatment of a serious or life-threatening disease or condition. Three of these programs are referred to as Fast Track Designation, Breakthrough Therapy Designation, and priority review designation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, the FDA may designate a product for Fast Track review if it is intended, whether alone or in combination with one or more other products, for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For Fast Track products, sponsors may have greater interactions with the FDA and the FDA may initiate review of sections of a Fast Track product&#8217;s application before the application is complete. This rolling review may be available if the FDA determines, after preliminary evaluation of clinical data submitted by the sponsor, that a Fast Track product may be effective. The sponsor must also provide, and the FDA must approve, a schedule for the submission of the remaining information and the sponsor must pay applicable user fees. However, the FDA&#8217;s time period goal for reviewing a Fast Track application does not begin until the last section of the application is submitted. In addition, the Fast Track Designation may be withdrawn by the FDA if the FDA believes that the designation is no longer supported by data emerging in the clinical trial process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Second, a product may be designated as a Breakthrough Therapy if it is intended, either alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The FDA may take certain actions with respect to Breakthrough Therapies, including holding meetings with the sponsor throughout the development process; providing timely advice to the product sponsor regarding development and approval; involving more senior staff in the review process; assigning a cross-disciplinary project lead for the review team; and taking other steps to design the clinical trials in an efficient manner.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third, the FDA may designate an NDA review for a priority review if it is for a product that treats a serious or life-threatening disease or condition and, if approved, would provide a significant improvement in safety or effectiveness. The FDA determines, on a case-by-case basis, whether the proposed product represents a significant improvement when compared with other available therapies. Significant improvement may be illustrated by evidence of increased effectiveness in the treatment of a condition, elimination or substantial reduction of a treatment-limiting product reaction, documented enhancement of patient compliance that may lead to improvement in serious outcomes, and evidence of safety and effectiveness in a new subpopulation. A priority designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#8217;s goal for taking action on a marketing application from 10 months to six months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accelerated Approval Pathway</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may grant accelerated approval to a product for a serious or life-threatening condition that provides meaningful therapeutic advantage to patients over existing treatments based upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or on an intermediate clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality (&#8220;IMM&#8221;), and that is reasonably likely to predict an effect on IMM or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. Products granted accelerated approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. An intermediate clinical endpoint is a measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a product, such as an effect on IMM. The FDA has limited experience with accelerated approvals based on intermediate clinical endpoints, but has indicated that such endpoints generally may support accelerated approval where the therapeutic effect measured by the endpoint is not itself a clinical benefit and basis for traditional approval, if there is a basis for concluding that the therapeutic effect is reasonably likely to predict the ultimate clinical benefit of a product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accelerated approval pathway is most often used in settings in which the course of a disease is long and an extended period of time is required to measure the intended clinical benefit of a product, even if the effect on the surrogate or intermediate clinical endpoint occurs rapidly.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accelerated approval pathway is contingent on a sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the product&#8217;s clinical benefit. As a result, a product candidate approved on this basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trials to confirm the effect on the clinical endpoint. Under the Food and Drug Omnibus Reform Act of 2022 (&#8220;FDORA&#8221;), the FDA is permitted to require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Sponsors are also required to send updates to the FDA every 180 days on the status of such studies, including progress toward enrollment targets, and the FDA must promptly post this information publicly. Under FDORA, the FDA has increased authority for expedited procedures to withdraw approval of a drug or indication approved under accelerated approval if, for example, the sponsor fails to conduct such studies in a timely manner and send the necessary updates to the FDA, or if a confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the FDA generally requires, unless otherwise informed by the agency, pre-approval of promotional materials for product candidates approved under accelerated regulations, which could adversely impact the timing of the commercial launch of the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The FDA&#8217;s Decision on an NDA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the basis of the FDA&#8217;s evaluation of the NDA and accompanying information, including the results of the inspection of the manufacturing facilities and select clinical trial sites, the FDA may issue an approval letter or a complete response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A complete response letter generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to reconsider the application. If a complete response letter is issued, the applicant may resubmit the NDA to address all of the deficiencies identified in the letter, withdraw the application, or request a hearing. If the applicant resubmits the NDA, the FDA will issue an approval letter only when the deficiencies have been addressed to the FDA&#8217;s satisfaction. The FDA has committed to reviewing such resubmissions in two or six months depending on the type of information included. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the FDA approves a product, it may limit the approved indications for use for the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess the drug&#8217;s safety or effectiveness after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms, including REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-market studies or surveillance programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Approval Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion, reporting of adverse experiences with the product and applicable product tracking and tracing requirements. After approval, many changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are annual prescription drug product program fee requirements for certain marketed products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon the NDA holder and any third-party manufacturers that the NDA holder may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or voluntary product recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, warning or untitled letters or holds on post-approval clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product approvals;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#8217;s FDA approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug Marketing Act (&#8220;PDMA&#8221;), which regulates the distribution of drugs and drug samples at the federal level, and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, legislation is drafted, introduced, passed in Congress and signed into law that could significantly change the statutory provisions governing the approval, manufacturing, and marketing of products regulated by the FDA. In addition to new legislation, FDA regulations, guidances, and policies are often revised or reinterpreted by the agency in ways that may significantly affect the manner in which pharmaceutical products are regulated and marketed.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hatch-Waxman Amendments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 505 of the FDCA describes three types of marketing applications that may be submitted to the FDA to request marketing authorization for a new drug. A Section 505(b)(1) NDA is an application that contains full reports of investigations of safety and efficacy. A 505(b)(2) NDA is an application that contains full reports of investigations of safety and efficacy but where at least some of the information required for approval comes from investigations that were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted. This regulatory pathway enables the applicant to rely, in part, on the FDA&#8217;s prior findings of safety and efficacy for an existing product, or published literature, in support of its application. Section 505(j) establishes an abbreviated approval process for a generic version of approved drug products through the submission of an Abbreviated New Drug Application (&#8220;ANDA&#8221;). An ANDA provides for marketing of a generic drug product that has the same active ingredients, dosage form, strength, route of administration, labeling, performance characteristics and intended use, among other things, to a previously approved product, known as a reference listed drug (&#8220;RLD&#8221;). ANDAs are termed &#8220;abbreviated&#8221; because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and efficacy. Instead, generic applicants must scientifically demonstrate that their product is bioequivalent to, or performs in the same manner as, the innovator drug through</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or other testing. The generic version must deliver the same amount of active ingredients into a subject&#8217;s bloodstream in the same amount of time as the innovator drug and can often be substituted by pharmacists under prescriptions written for the reference listed drug.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Non-Patent Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Hatch-Waxman Amendments, the FDA may not approve (or in some cases accept) an ANDA or 505(b)(2) application until any applicable period of non-patent exclusivity for the RLD has expired. The FDCA provides a period of five years of non-patent data exclusivity for a new drug containing a new chemical entity (&#8220;NCE&#8221;). For the purposes of this provision, an NCE is a drug that contains no active moiety that has previously been approved by the FDA in any other NDA. An active moiety is the molecule or ion responsible for the physiological or pharmacological action of the drug substance. In cases where such NCE exclusivity has been granted, an ANDA may not be filed with the FDA until the expiration of five years unless the submission is accompanied by a Paragraph IV certification, which states the proposed generic drug will not infringe one or more of the already approved product&#8217;s listed patents or that such patents are invalid or unenforceable, in which case the applicant may submit its application four years following the original product approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDCA also provides for a period of three years of exclusivity for non-NCE drugs if the NDA or a supplement to the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence studies, that were conducted by or for the applicant and are essential to the approval of the application or supplement. This three-year exclusivity period often protects changes to a previously approved drug product, such as a new dosage form, route of administration, combination or indication, but it generally would not protect the original, unmodified product from generic competition. Unlike five-year NCE exclusivity, an award of three-year exclusivity does not block the FDA from accepting ANDAs seeking approval for generic versions of the drug as of the date of approval of the original drug product; it only prevents FDA from approving such ANDAs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A drug product can obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods for all formulations, dosage forms, and indications of the active moiety and to patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection and patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study, provided that at the time pediatric exclusivity is granted there is not less than nine months of term remaining.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hatch-Waxman Patent Certification and the 30-Month Stay</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In seeking approval of an NDA or a supplement thereto, NDA sponsors are required to list with the FDA each patent with claims that cover the applicant&#8217;s product or an approved method of using the product. Upon approval, each of the patents listed by the NDA sponsor is published in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Upon submission of an ANDA or 505(b)(2) NDA, an applicant is required to certify to the FDA concerning any patents listed for the RLD in the Orange Book that:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no patent information on the drug product that is the subject of the application has been submitted to the FDA;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such patent has expired; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which such patent expires; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such patent is invalid, unenforceable or will not be infringed upon by the manufacture, use, or sale of the drug product for which the application is submitted.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, the ANDA or 505(b)(2) NDA cannot be approved until all listed patents have expired, except where the ANDA or 505(b)(2) NDA applicant challenges a listed patent through the last type of certification, also known as a paragraph IV certification. If the applicant does not challenge the listed patents or indicates that it is not seeking approval of a patented method of use, the ANDA or 505(b)(2) NDA application will not be approved until all of the listed patents claiming the referenced product have expired. If the ANDA or 505(b)(2) NDA applicant has provided a paragraph IV certification the applicant must send notice of the paragraph IV certification to the NDA and patent holders once the application has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the paragraph IV certification. If the paragraph IV certification is challenged by an NDA holder or the patent owner(s) asserts a patent challenge to the paragraph IV certification, the FDA may not approve that application until the earlier of 30 months from the receipt of the notice of the paragraph IV certification, the expiration of the patent, when the infringement case concerning each such patent was favorably decided in the applicant&#8217;s favor or settled, or such shorter or longer period as may be ordered by a court. This prohibition is generally referred to as the 30-month stay. In instances where an ANDA or 505(b)(2) NDA applicant files a paragraph IV certification, the NDA holder or patent owner(s) regularly take action to trigger the 30-month stay, recognizing that the related patent litigation may take many months or years to resolve. Thus, approval of an ANDA or 505(b)(2) NDA could be delayed for a significant period of time depending on the patent certification the applicant makes and the reference drug sponsor&#8217;s decision to initiate patent litigation. If the drug has NCE exclusivity and the ANDA is submitted four years after approval, the 30-month stay is extended so that it expires seven and a half years after approval of the innovator drug, unless the patent expires or there is a decision in the infringement case that is favorable to the ANDA applicant before then.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Term Restoration and Extension</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A patent claiming a new drug product may be eligible for a limited patent term extension under the Hatch-Waxman Amendments, which permits a patent term restoration of up to five years for patent term lost during product development and the FDA regulatory review. The restoration period granted is typically one-half the time between the effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the ultimate approval date, provided the sponsor acted with diligence. Patent term restoration cannot be used to extend the remaining term of a patent past a total of 14 years from the product&#8217;s approval date. Only one patent applicable to an approved drug product is eligible for the extension, and the application for the extension must be submitted prior to the expiration of the patent in question and within 60 days of drug approval. A patent that covers multiple drugs for which approval is sought can only be extended in connection with one of the approvals. The U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) reviews and approves the application for any patent term extension or restoration in consultation with the FDA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Review and Approval of Medicinal Products in the European Union</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to market any product outside of the United States, a company must also comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of products. Whether or not it obtains FDA approval for a product,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an applicant will need to obtain the necessary approvals by the comparable foreign regulatory authorities before it can commence clinical trials or marketing of the product in those countries or jurisdictions. Specifically, the process governing approval of medicinal products in the EU generally follows similar lines as in the United States. It entails satisfactory completion of preclinical studies and adequate and well-controlled clinical trials to establish the safety and efficacy of the product for each proposed indication. It also requires a submission to the relevant competent authorities of a marketing authorization application (&#8220;MAA&#8221;) and granting of a marketing authorization by these authorities before the product can be marketed and sold in the EU.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Trial Approval</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, an applicant for authorization of a clinical trial must obtain prior approval from the national competent authority of the EU Member States in which the clinical trial is to be conducted. Furthermore, the applicant may only start a clinical trial at a specific study site after the relevant independent ethics committee has issued a favorable opinion. In April 2014, the Clinical Trials Regulation, (EU) No 536/2014 (Clinical Trials Regulation) was adopted in the EU. The Clinical Trials Regulation is directly applicable in all the EU Member States and repealed the Clinical Trials Directive 2001/20/EC, as of January 31, 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the EU. The main characteristics of the regulation include: a streamlined application procedure via a single entry point, known as the &#8220;Clinical Trials Information System&#8221;; a single set of documents to be prepared and submitted for the application, as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts. Part I is assessed by an elected Reference Member State, with support of the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (the Member States concerned). Part II is assessed separately by each Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure continues to be governed by the national laws of the concerned EU Member State, however overall related timelines are defined by the Clinical Trials Regulation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketing Authorization</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To obtain a marketing authorization for a product in the EU, an applicant must submit an MAA either under a centralized procedure administered by the European Medicines Agency (&#8220;EMA&#8221;) or one of the procedures administered by competent authorities in the EU Member States (decentralized procedure or mutual recognition procedure) for obtaining a marketing authorization in multiple EU Member States. A marketing authorization may be granted only to an applicant established in the European Economic Area (&#8220;EEA&#8221;) (which is comprised of the EU Member States plus Norway, Iceland and Liechtenstein).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid throughout the EEA. Pursuant to Regulation (EC) No 726/2004, the centralized procedure is compulsory for specific products, including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced therapy medicinal products (gene therapy, somatic cell therapy and tissue-engineered products) and products with a new active substance indicated for the treatment of certain diseases, including products for the treatment of HIV, AIDS, cancer, diabetes, neurodegenerative diseases, auto-immune and other immune dysfunctions and viral diseases. The centralized procedure is optional for other products containing a new active substance not yet authorized in the EU, or for products that constitute a significant therapeutic, scientific or technical innovation or which are in the interest of public health in the EU.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the centralized procedure, the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;) established at the EMA is responsible for conducting the initial assessment of a product. The CHMP is also responsible for several post-authorization and maintenance activities, such as the assessment of modifications or extensions to an existing marketing authorization. Under the centralized procedure, the maximum timeframe for the evaluation of an MAA is 210 days, excluding clock stops, when additional information or written or oral explanation is to be provided by the applicant in response to questions asked by the CHMP. Clock stops may extend the timeframe of evaluation of an MAA considerably beyond 210 days. Accelerated evaluation might be granted by the CHMP in exceptional cases, when a medicinal product is of major interest from a public health perspective and in particular from the point of view of therapeutic innovation. If the CHMP accepts such request, the time limit of 210 days will be reduced to 150 days, excluding clock stops, but it is possible that the CHMP can revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment. At the end of this period, the CHMP provides a scientific opinion on whether or not a marketing authorization should be granted in relation to a medicinal product. Within 67 days from the date of the CHMP opinion, the European Commission will adopt its final decision on the MAA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The decentralized marketing authorization procedure allows an applicant to apply for simultaneous authorization in more than one EU Member State of medicinal products that have not yet been authorized in any EU Member State and that do not fall within the mandatory scope of the centralized procedure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The mutual recognition procedure is based on the acceptance by the competent authorities of the EU Member States of the marketing authorization of a medicinal product by the competent authorities of another EU Member State. The holder of a national marketing authorization may submit an application to the competent authority of an EU Member State requesting that this authority recognize the marketing authorization delivered by the competent authority of another EU Member State.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pediatric Development</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulation (EC) No 1901/2006 provides that prior to obtaining a marketing authorization in the EU, applicants have to demonstrate compliance with all measures included in an EMA-approved Pediatric Investigation Plan (&#8220;PIP&#8221;) covering all subsets of the pediatric population, unless the EMA has granted (1) a product-specific waiver, (2) a class waiver or (3) a deferral for one or more of the measures included in the PIP. The PIP sets out the timing and measures proposed to generate data to support a pediatric indication of the product for which a marketing authorization is being sought. Products that are granted a marketing authorization with the results of the pediatric clinical trials conducted in accordance with the PIP are eligible for a six-month extension of the protection under a supplementary protection certificate (&#8220;SPC&#8221;), provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to two years before the SPC expires, even where the trial results are negative. In the case of orphan medicinal products, a two-year extension of the orphan market exclusivity may be available. This pediatric reward is subject to specific conditions and is not automatically available when data in compliance with the PIP are developed and submitted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Data and Market Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, innovative medicinal products approved on the basis of a complete and independent data package qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. Data exclusivity prevents applicants for authorization of generics or biosimilars of these innovative products from referencing the innovator&#8217;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar (abbreviated) marketing authorization, for a period of eight years from the date on which the reference product was first authorized in the EU. During an additional two-year period of market exclusivity, a generic or biosimilar MAA can be submitted, and the innovator&#8217;s data may be referenced, but no generic or biosimilar medicinal product can be placed on the EU market until the expiration of the market exclusivity. The overall 10-year period will be extended to a maximum of 11 years if, during the first eight years of those 10 years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. There is no guarantee that a product will be considered by the EMA to be an innovative medicinal product, and products may not qualify for data exclusivity. Even if a product is considered to be an innovative medicinal product so that the innovator gains the prescribed period of data exclusivity, another company nevertheless could also market another version of the product if such company obtained a marketing authorization based on an MAA with a complete and independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan Designation and Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulation (EC) No 141/2000 and Regulation (EC) No. 847/2000 provide that a product can be designated as an orphan medicinal product by the European Commission if its sponsor can establish that: (1) the product is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition, (2) either (i) such condition affects no more than five in ten thousand persons in the EU when the application is made, or (ii) without the benefits derived from orphan status, it is unlikely that the marketing of the product in the EU would generate sufficient return to justify the necessary investment in its development and (3) there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, the product would be of significant benefit to those affected by that condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An orphan designation provides a number of benefits, including fee reductions, regulatory assistance and the possibility to apply for a centralized EU marketing authorization. Marketing authorization for an orphan medicinal product leads to a ten-year period of market exclusivity being granted. During this market exclusivity period, the EMA, the European Commission or the competent authorities of the EU Member States may only grant a marketing authorization to a &#8220;similar medicinal product&#8221; to the authorized orphan product for the same therapeutic indication if: (i) a second applicant can establish that its product, although similar to the authorized orphan product, is safer, more effective or otherwise clinically superior; (ii) the marketing authorization holder for the authorized orphan product consents to a second medicinal product application; or (iii) the marketing authorization holder for the authorized orphan product cannot supply enough orphan medicinal product. A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The market exclusivity period for the authorized therapeutic indication may, however, be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation because, for example, the product is sufficiently profitable not to justify market exclusivity. Orphan designation must be requested</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">before submitting an application for marketing authorization. Orphan designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Periods of Authorization and Renewals</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A marketing authorization has an initial validity of five years. The marketing authorization may be renewed after five years on the basis of a re-evaluation of the risk-benefit balance by the EMA (for a centrally authorized product) or by the competent authority of the relevant EU Member State (for a nationally authorized product). To this end, the marketing authorization holder must provide the EMA or the competent authority with a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the marketing authorization was granted, at least nine months before the marketing authorization ceases to be valid. Once renewed, the marketing authorization is valid for an unlimited period, unless the European Commission or the competent authorities of the relevant Member States decide, on justified grounds relating to pharmacovigilance, to proceed with one further five year renewal period. Any authorization which is not followed by the actual placing of the medicinal product on the EU market (for centrally-authorized products) or on the market of the authorizing EU Member State (for nationally-authorized products) within three years after authorization ceases to be valid (the so-called sunset clause).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory Requirements after a Marketing Authorization has been Obtained</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Where an authorization for a medicinal product in the EU is obtained, the holder of the marketing authorization is required to comply with a range of requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. These include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with the EU&#8217;s stringent pharmacovigilance or safety reporting rules must be ensured. These rules can impose post-authorization studies and additional monitoring obligations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The manufacturing of authorized medicinal products, for which a separate manufacturer&#8217;s license is mandatory, must also be conducted in strict compliance with the applicable EU laws, regulations and guidance, including Directive 2001/83/EC, Directive (EU) 2017/1572, Regulation (EC) No 726/2004 and the European Commission Guidelines for Good Manufacturing Practice. These requirements include compliance with EU cGMP standards when manufacturing medicinal products and APIs, including the manufacture of APIs outside of the EU with the intention to import the APIs into the EU.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketing and promotion of authorized products, including industry-sponsored continuing medical education and advertising directed toward the prescribers of products and/or the general public, are strictly regulated in the EU notably under Directive 2001/83/EC, as amended, and EU Member State laws and industry codes of conduct.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aforementioned EU rules are generally applicable in the EEA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reform of the Regulatory Framework in the European Union</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The European Commission introduced legislative proposals in April 2023 that, if implemented, will replace the current regulatory framework in the EU for all medicines (including those for rare diseases and for children). The European Commission has provided the legislative proposals to the European Parliament and the European Council for their review and approval. In April 2024, the European Parliament adopted its position on the legislative proposals. Once the European Commission&#8217;s legislative proposals are approved (with or without amendment), they will be adopted into EU law.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brexit and the Regulatory Framework in the United Kingdom</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The UK ceased being a Member State of the EU on January 31, 2020. As a result of the Northern Ireland protocol, following Brexit, the EMA remained responsible for approving novel medicines for supply in Northern Ireland under the EU centralized procedure, and a separate authorization was required to supply the same medicine in Great Britain (i.e., England, Wales and Scotland). On February 27, 2023, the UK government and the European Commission announced a political agreement in principle to replace the Northern Ireland Protocol with a new set of arrangements, known as the &#8220;Windsor Framework&#8221;. The Windsor Framework was approved by the EU-UK Joint Committee on March 24, 2023, and the medicines aspects of the Windsor Framework have applied since January 1, 2025. This new framework fundamentally changes the previous system under the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the UK. In particular, the MHRA is now responsible for approving all medicinal products destined for the UK market (i.e., Great Britain and Northern Ireland), and the EMA no longer has any role in approving medicinal products destined for Northern Ireland under the EU centralized procedure. A single UK-wide marketing authorization will be granted by the MHRA for all novel medicinal products to be sold in the UK, enabling products to be sold in a single pack and under a single authorization throughout the UK.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Review and Approval of Medicinal Products in Australia</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Therapeutic Goods Administration (&#8220;TGA&#8221;) and the National Health and Medical Research Council (&#8220;NHMRC&#8221;) set the GCP requirements for clinical research in Australia.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with the regulations, standards and codes set by the TGA and NHMRC is mandatory. Under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Therapeutic Goods Act 1989</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Cth) and the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Therapeutic Goods Regulations 1990</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Cth), it is a condition (amongst other conditions) of all clinical trials involving investigational medicinal products to comply with the National Statement on Ethical Conduct in Research Involving Humans, published by the NHMRC (the National Statement), and the Guideline for Good Clinical Practice published by the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (&#8220;ICH Guidelines&#8221;). The ICH Guidelines have been adopted in Australia, and must be complied with across all fields of clinical research involving therapeutic goods, including those related to pharmaceutical quality, nonclinical and clinical data requirements and trial designs. The basic requirements for preclinical data to support a first-in-human trial under ICH Guidelines are applicable in Australia. Requirements related to adverse event reporting in Australia are generally similar to those required in other major jurisdictions (and there is alignment with the European Union&#8217;s Clinical Trial Regulations: Regulation EU No 536/2014), although reporting timeframes may differ to other jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials conducted using &#8220;unapproved therapeutic goods&#8221; in Australia, being those which have not yet been evaluated by the TGA for quality, safety and efficacy (and including unapproved indications of therapeutic goods which have otherwise been approved for use in Australia) must occur pursuant to either the Clinical Trial Notification Scheme (&#8220;CTN Scheme&#8221;) or the Clinical Trial Approval Scheme (&#8220;CTA Scheme&#8221;). In each case, the trial is supervised by a Human Research Ethics Committee (&#8220;HREC&#8221;), an independent review committee constituted in accordance with the National Statement that ensures the protection of rights, safety and well-being of human subjects involved in a clinical trial. A HREC reviews, approves and provides continuing oversight of trial protocols (including any amendments), methods and materials intended to be used in obtaining and documenting informed consent of the clinical trial subjects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CTN Scheme broadly involves:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the investigator or sponsor of the Australian clinical trial submitting a &#8216;Notification of Intent to Conduct a Clinical Trial&#8217; form (&#8220;CTN Form&#8221;) to the TGA and payment of the relevant fee (for unapproved medicines, this was AUD 429 at 1 July 2024: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Therapeutic Goods Regulations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 1990, clause 3, Schedule 9, item 14(a));</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the TGA may request further specific information relating to the &#8216;unapproved therapeutic goods&#8217; that are the subject of the clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to a HREC, of all material relating to the proposed clinical trial, including the trial protocol;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the HREC reviews the scientific validity of the trial design, the balance of risk versus harm of the therapeutic good, the ethical acceptability of the trial process, and approves the trial protocol. The HREC is also responsible for monitoring the conduct of the trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the institution or organization at which the trial will be conducted, referred to as the &#8220;Approving Authority,&#8221; giving final approval for the conduct of the trial at the site, in terms no less restrictive to those advised by the HREC; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ensuring that the CTN form is signed by the sponsor, the principal investigator, the chairman of the HREC and a person responsible from the Approving Authority. The TGA does not review any data relating to the clinical trial, however CTN trials cannot commence until the trial has been notified to the TGA. It is the responsibility of the sponsor to ensure that all relevant approvals are in place before supplying the &#8216;unapproved&#8217; therapeutic goods in the clinical trial in Australia.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the CTA Scheme:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a sponsor submits an application to conduct a clinical trial to the TGA for evaluation and comment, which includes payment of the relevant fees (for unapproved medicines, this was AUD 2,046 for a 30-day evaluation and AUD 25,426 for a 50-day evaluation, as at 1 July 2024: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Therapeutic Goods Regulations </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1990, clause 3, Schedule 9, items 1(a) and (b) respectively). The TGA encourages all sponsors to request a pre-submission meeting with the TGA in order to clarify any questions about existing studies or the proposed data package for the CTA application, and obtain specific advice from the TGA relating to the CTA application process, including the best ways to submit the application and dossier;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the TGA will undertake a preliminary assessment to ensure that there is sufficient data to begin evaluation. If critical data is missing, the TGA may request further information;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a sponsor must forward any comments made by the TGA Delegate to the HREC(s) at the sites where the trial will be conducted;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the HREC is responsible for considering the scientific and ethical issues of the proposed trial protocol.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A sponsor cannot commence a trial under the CTA Scheme until written advice has been received from the TGA regarding the application and approval for the conduct of the trial has been obtained from an ethics committee and the institution at which the trial will be conducted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Approval for inclusion in the Australian Register of Therapeutic Goods (&#8220;ARTG&#8221;), is required before a therapeutic good (including pharmaceutical product) may be marketed (or supplied, imported, exported or manufactured) in Australia. Exceptions apply to therapeutic goods/pharmaceutical products that are supplied, imported, and exported to and from Australia for the purposes of a clinical trial, on the basis that certain conditions are met (e.g., the trial is conducted in accordance with the CTN or CTA scheme).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a sponsor decides to register a therapeutic good/pharmaceutical product in Australia, in order to obtain registration of the product on the ARTG, it is required that (amongst others):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sponsor submits appropriate documentation, including the outcomes of clinical trials and studies, to allow the TGA to assess the quality, safety and efficacy of the therapeutic product/pharmaceutical product; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sponsor submits evidence which demonstrates that the manufacture of the therapeutic product/pharmaceutical product complies with the applicable GMP requirements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The TGA has the ultimate discretion to decide whether to include the therapeutic product/pharmaceutical product in the ARTG.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Healthcare Laws</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations. The laws that may affect our ability to operate include, but are not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from government healthcare programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal civil and criminal false claims laws, including the False Claims Act (&#8220;FCA&#8221;), which can be enforced through civil &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; actions, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay money to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating these statutes without actual knowledge of the statutes or specific intent to violate them in order to have committed a violation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), imposes requirements on certain covered healthcare providers, health plans and healthcare clearinghouses as well as their respective business associates and their subcontractors that perform services for them that involve the use, or disclosure </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Physician Payments Sunshine Act, created under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the &#8220;ACA&#8221;) and its implementing regulations, which requires manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the Department of Health and Human Services (&#8220;HHS&#8221;) information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other licensed healthcare professionals (i.e., physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, and certified nurse midwives), and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales, and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; and state and local laws requiring the registration of pharmaceutical sales representatives.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of such laws or any other governmental regulations that apply, we may be subject to significant penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of operations, integrity oversight and reporting obligations, exclusion from participation in federal and state healthcare programs and responsible individuals may be subject to imprisonment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Coverage and Reimbursement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and establish adequate reimbursement levels for, the product. Factors payors consider in determining coverage and reimbursement are based on whether the product is:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cost-effective; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, no uniform policy of coverage and reimbursement for drug products exists among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost- effectiveness of medical products and services and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, results of operations and financial condition. Additionally, a third-party payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus in this effort. There have been a number of federal and state proposals during the last few years regarding the pricing of pharmaceutical products, limiting coverage and the amount of reimbursement for drugs and other medical products, government control and other changes to the healthcare system in the United States. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price (&#8220;ASP&#8221;) and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s revenue generated from the sale of any approved products. Even if we do receive a favorable coverage determination for approved products by third-party payors, coverage policies and third-party payor reimbursement rates may change at any time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) may develop new payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several U.S. Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. Congress has indicated that it will continue to seek new legislative measures to control drug costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside the United States, ensuring coverage and adequate payment for a product also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations with government authorities can extend well beyond the receipt of regulatory approval for a product and may require a clinical trial that compares the cost-effectiveness of a product to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or so-called health technology assessments, in order to obtain reimbursement or pricing approval. For example, the EU Member States have the option to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. EU Member States may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other EU Member States allow companies to fix their own prices for products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the EU have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">many countries in the EU. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various EU Member States, and parallel trade, i.e., arbitrage between low-priced and high-priced EU Member States, can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current and Future U.S. Healthcare Reform</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, there have been a number of legislative and regulatory changes to the healthcare system that could impact our ability to sell our products profitably. For example, in March 2010, the ACA was enacted, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly affected the pharmaceutical industry. The ACA contained a number of provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments and changes to fraud and abuse laws. For example, the ACA, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased the minimum level of Medicaid rebates payable by manufacturers of brand name drugs from 15.1% to 23.1% of the average manufacturer price;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">required collection of rebates for drugs paid by Medicaid managed care organizations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">required manufacturers to participate in a coverage gap discount program, under which they must agree to offer 50 percent point-of-sale discount off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D (later increased to 70% and then later replaced altogether under the Inflation Reduction Act with the Medicare Part D manufacturer discount program); and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposed a non-deductible annual fee on pharmaceutical manufacturers or importers who sell &#8220;branded prescription drugs&#8221; to specified federal government programs.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since its enactment, there have been judicial, administrative, executive, and legislative challenges to certain aspects of the ACA as well as executive orders related to the ACA&#8217;s implementation. It is unclear how other healthcare reform measures of the Biden administrations or other efforts, if any, to challenge repeal or replace the ACA, will impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has been increasing legislative and enforcement interest in the United States with respect to drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. For example, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;), among other things, (i) directs HHS to negotiate the price of certain high-expenditure, single-source drugs and biologics covered under Medicare, and subject drug manufacturers to civil monetary penalties and a potential excise tax by offering a price that is not equal to or less than the negotiated &#8220;maximum fair price&#8221; for such drugs and biologics under the law and (ii) imposes rebates with respect to certain drugs and biologics covered under Medicare Part B or Medicare Part D to penalize price increases that outpace inflation. The IRA permits HHS to implement many of these provisions through guidance, as opposed to regulation, for the initial years. These provisions took effect progressively starting in fiscal year 2023. On August 29, 2023, HHS announced the list of the first ten drugs to be made subject to price negotiations, the negotiated prices of which were announced in August 2024.  The Medicare drug price negotiation program is currently subject to legal challenges, and it is unclear the significance of the impact of the IRA on the pharmaceutical industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2020, FDA released its implementing regulations regarding section 804 Importation Programs under the Medicare Prescription Drug Improvement and Modernization Act of 2003. These regulations provide guidance for states to build and submit importation plans for certain drugs from Canada. On September 25, 2020, CMS stated drugs imported by states under this rule will not be eligible for federal rebates under Section 1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. On January 5, 2024, the FDA approved Florida&#8217;s Section 804 Importation Program (&#8220;SIP&#8221;) proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear how this program will be implemented, including which drugs will be chosen, and whether it will be subject to legal challenges in the United States or Canada. Other states have also submitted SIP proposals that are pending review by the FDA. Any such approved importation plans, when implemented, may result in lower drug prices for products covered by those programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, on December 2, 2020, HHS published a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Medicare Part D, either directly or through pharmacy benefit managers, unless</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. The IRA delayed implementation of this rule to January 1, 2032.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative and regulatory changes have been proposed and adopted in the United States since the ACA was enacted:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, and, due to subsequent legislative amendments to the statute, will remain in effect until 2032.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. American Taxpayer Relief Act of 2012, among other things, further reduced Medicare payments to several types of providers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The American Rescue Plan Act of 2021 eliminates the statutory Medicaid drug rebate cap, previously set at 100% of a drug&#8217;s average manufacturer price, for single source and innovator multiple source drugs, starting January 1, 2024.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IRA also includes several other provisions that may impact our business to varying degrees, including provisions that create a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, and impose new manufacturer financial liability on all drugs in Medicare Part D.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These laws and regulations may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual states have also been increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the Biden administration may reverse or otherwise change these measures, both the Biden administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Data Protection, Privacy, and Security</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, we collect, transmit, store, use, disclose, transfer, maintain and otherwise process sensitive information, including personal data. Accordingly, we are, or may be become, subject to numerous data protection, privacy, and security obligations, including global, federal, state, and local laws, rules, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements and other obligations related to data protection, privacy, and security.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These data protection, privacy, and security obligations are evolving and may impose potentially conflicting obligations. Such obligations may include, without limitation, federal health information privacy laws, state information security and data breach notification laws, state health information privacy laws, and federal and state consumer protection laws (e.g., the Federal Trade Commission Act). In addition, in the past few years, numerous U.S. states have passed, or are in the process of enacting, comprehensive privacy laws, rules, and regulations that impose certain obligations on covered businesses, and similar laws are being considered in several other states, as well as at the federal level. While these laws exempt some data processed in the context of clinical trials, these developments may further complicate compliance efforts, and are examples of the increasingly stringent and evolving regulatory frameworks related to personal data processing, as more fully discussed in the section titled &#8220;Risk Factors&#8221; included elsewhere in this Annual Report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, to the extent we collect personal data from individuals outside of the United States, through clinical trials or otherwise, we are, or may become, subject to foreign data protection, privacy, and security laws, such as the European Union&#8217;s General Data Protection Regulation (&#8220;EU GDPR&#8221;) and the EU GDPR as incorporated into U.K. domestic law post-Brexit (&#8220;UK GDPR&#8221;). Such foreign data protection, privacy, and security laws impose significant and complex compliance obligations on entities that are subject to those laws, as more fully discussed in the section titled &#8220;Risk Factors&#8221; included elsewhere in this Annual Report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees and Human Capital Resources</span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 75 full-time employees, 41 of whom have M.D. or Ph.D. degrees. Within our workforce, 58 employees are engaged in research and development and 17 are engaged in business development, finance, legal, and general management and administration. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity incentive plans are to attract, retain and reward personnel through the granting of equity-based compensation awards in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We were incorporated under the laws of the State of Delaware in December 2019 under the name GPCR NewCo, Inc. and changed our name to Septerna, Inc. in June 2021. Our principal executive offices are located at 250 East Grand Avenue, South San Francisco, California 94080, and our telephone number is (650) 338-3533.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our website address is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.septerna.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Information that is contained in and can be accessed through our website is not incorporated into, and does not form a part of, this Annual Report. We have included our website address in this Annual Report solely as an inactive textual reference.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, including exhibits, proxy and information statements and amendments to those reports filed or furnished pursuant to Sections 13(a), 14, and 15(d) of the Exchange Act, are available through our website free of charge as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Our filings with the SEC may also be accessed through the SEC&#8217;s Interactive Data Electronic Applications system at www.sec.gov. In addition, we regularly use our website to post information regarding our business, product development programs and governance, and we encourage investors to use our website, particularly the information in the section entitled &#8220;Investors &amp; Media,&#8221; as a source of information about us.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All statements made in any of our securities filings, including all forward-looking statements or information, are made as of the date of the document in which the statement is included, and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do so by law.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A. Risk Factors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all of the other information contained in this Annual Report, including our financial statements and the related notes appearing at the end of this Annual Report and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding to invest in our common stock. If any of the events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our common stock could decline and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. This Annual Report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a number of factors, including the risks described below. See the section titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Limited Operating History, Financial Position and Capital Requirements</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a limited operating history and have incurred significant operating losses since our inception and expect to incur significant losses for the foreseeable future.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We are a clinical-stage biotechnology company with a limited operating history, which may make it difficult to evaluate the success of our business to date and assess our future viability. Since our inception in December 2019, we have focused primarily on organizing and staffing our company, business planning, establishing our intellectual property portfolio, raising capital, developing our proprietary and structure-based drug discovery platform, identifying and developing our product candidates, conducting research and preclinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">studies, including IND-enabling studies, initiating and conducting clinical trials, and providing general and administrative support for these operations. Our approach to the discovery and development of product candidates based on our Native Complex PlatformTM is unproven, and we do not know whether we will be able to develop any product candidates that succeed in clinical development or commercially. Further, after discontinuing the Phase 1 clinical trial of our previous lead product candidate, SEP-786, in 2025, all of our current product candidates and development programs are in preclinical development or in the drug discovery stages. Accordingly, we have not yet successfully completed any clinical trials, demonstrated an ability to successfully obtain regulatory approvals, manufactured a clinical- or commercial-scale product, or arranged for a third party to do so on our behalf, or conducted sales and marketing activities necessary for successful product commercialization. Consequently, any predictions made about our future success or viability may not be as accurate as they could be if we had a history of successfully developing and commercializing pharmaceutical products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have no products approved for commercial sale and have not generated any revenue from product sales to date, and we continue to incur significant research and development and other expenses related to our preclinical and clinical development and ongoing operations. As a result, we are not profitable and have incurred significant losses since our inception, with the exception of the year ended December 31, 2023, and negative cash flows from operating activities and capital expenditures and expect to continue to incur significant and increasing operating losses for at least the next several years. If our product candidates are not successfully developed and approved, we may never generate any significant revenue. For the year ended December 31, 2024, our net loss was $71.8 million. As of December 31, 2024, we had an accumulated deficit of $118.4 million. Substantially all of our losses have resulted from expenses incurred in connection with our research and development programs and from general and administrative costs associated with our operations. All of our product candidates will require substantial additional development time and resources before we would be able to apply for or receive marketing approvals and begin generating revenue from product sales. We expect to continue to incur significant losses for the foreseeable future, and we expect that our expenses will increase substantially as we continue our development of, seek marketing approval for and potentially commercialize any of our product candidates, recruit and maintain key personnel and seek to identify, assess, acquire, in-license or develop additional product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we succeed in developing and obtaining marketing approval for one or more of our product candidates, we may never generate revenue that is significant enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis and we will continue to incur substantial research and development and other expenditures to develop and market additional product candidates. Our failure to become and remain profitable could decrease the value of our common stock and impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will require substantial additional funding in order to finance our operations. If we are unable to raise additional capital when needed on acceptable terms, or at all, we may be forced to delay, reduce, or terminate certain of our research and product development programs, future commercialization efforts or other operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development of pharmaceutical product candidates, including conducting preclinical studies and clinical trials, is a very time-consuming, capital-intensive and uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in connection with our ongoing activities, particularly as we identify, continue the research and development of, initiate and conduct clinical trials of, and seek regulatory approval for any product candidates we may identify. In addition, if we obtain regulatory approval for any product candidates we may identify, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing, and distribution to the extent that such sales, marketing, manufacturing, and distribution are not the responsibility of a collaborator. Because the outcome of any clinical trial or preclinical study is highly uncertain, we cannot reasonably estimate the actual amount of capital necessary to successfully complete the development and commercialization of our product candidates. Other unanticipated costs may also arise. Furthermore, we expect to incur additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our research and product development programs, future commercialization efforts or other operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had $420.8 million in cash, cash equivalents and marketable securities. We expect that our cash, cash equivalents, and marketable securities will enable us to fund our operating expenses and capital expenditure requirements into early 2028. However, we have based this estimate on assumptions that may prove to be wrong, and our operating plan may change as a result of factors currently unknown to us, and we may need to seek funding sooner than planned. Our future capital requirements will depend on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and progress of research and development, preclinical and clinical development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number, scope and duration of clinical trials required for regulatory approval of our product candidates;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing, and outcome of regulatory review of any of our product candidates in any jurisdictions in which we or our current or any future collaborators may seek approval for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of manufacturing clinical and commercial supplies of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive regulatory approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting our patent applications, maintaining and enforcing our patents and other intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements, and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of manufacturing clinical and commercial supplies of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive regulatory approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting our patent applications, maintaining and enforcing our patents and other intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements, and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain collaboration and license agreements on favorable terms, if at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any product liability or other lawsuits related to our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our implementation of various computerized informational systems and efforts to enhance operational systems;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred to attract, hire and retain skilled personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of operating as a public company;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate reimbursement from third-party and government payors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or invest in businesses, products, and technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effect of competing technological and market developments; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of global economic uncertainty and geopolitical tensions, which may exacerbate the magnitude of the factors discussed above.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our expenses to continue to increase in connection with our ongoing activities, particularly as we identify, continue the research and development of, initiate preclinical studies and clinical trials of, and seek marketing approval for, product candidates, and we may never generate the necessary data or results required to obtain regulatory approval and achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, declaring dividends, and possibly other restrictions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our product candidates. We have no committed sources of additional capital and, if we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our product candidates or other research and development initiatives. Without</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sufficient funding, our license agreements and any future collaboration agreements may also be terminated if we are unable to meet the payment or other obligations under such agreements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Additionally, if we raise funds through additional collaborations, strategic alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates we develop, or we may have to grant licenses on terms that may not be favorable to us and/or that may reduce the value of our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have never generated revenue from product sales and may never be profitable.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to generate revenue from product sales and achieve profitability depends on our ability, alone or with collaborative partners, to successfully complete the development of, obtain the regulatory approvals necessary to commercialize and eventually commercialize, product candidates we may identify for development. We may not generate revenues from product sales for many years, if ever. Our ability to generate future revenues from product sales depends heavily on our or our collaborators&#8217; ability to successfully:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify product candidates and successfully complete research and development of any product candidates we may identify;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance our product candidates through preclinical and clinical development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek and obtain regulatory approvals for any product candidates for which we successfully complete clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">launch and commercialize any product candidates for which we may obtain regulatory approval by establishing a sales force, marketing and distribution infrastructure, or alternatively, collaborating with a commercialization partner;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">qualify for adequate coverage and reimbursement by government and third-party payors for any product candidates for which we may obtain regulatory approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish and maintain supply and manufacturing relationships with third parties that can provide adequate, in both amount and quality, products and services to support clinical development and the market demand for any product candidates for which we obtain regulatory approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop, maintain and enhance a sustainable, scalable, reproducible and transferable manufacturing process for the product candidates we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">address competing technological and market developments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and performing our obligations in such collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receive market acceptance by physicians, patients, healthcare payors, and others in the medical community;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receive coverage and adequate reimbursement by healthcare payors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, protect, enforce, defend and expand our portfolio of intellectual property and other proprietary rights, including patents, trade secrets and know-how;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">defend against third-party intellectual property claims of infringement, misappropriation or other violation; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">attract, hire and retain qualified personnel. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our expenses could increase beyond expectations if we are required by the FDA, EMA, the competent authorities of individual EU Member States, or other comparable foreign regulatory authorities to perform preclinical studies or clinical trials in addition to those that we currently anticipate. Even if one or more of the product candidates we may develop are approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Additionally, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives. Even if we are able to generate revenues from the sale of any approved product candidates, we may not become profitable and may need to obtain additional funding to continue operations. Our failure to become and remain profitable may have an adverse effect on the value of our company and depress the market price of our common stock and could impair our ability to raise capital, expand our business, maintain our research and development efforts, diversify our product candidate pipeline, achieve our strategic objectives or continue our operations. A decline in the value of our company could also cause you to lose all or part of your investment.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Discovery, Development and Regulatory Approval of Product Candidates</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are early in our development efforts. We have not successfully completed any clinical studies, and as a result it will be years before we commercialize a product candidate, if ever. If we are unable to identify and advance product candidates through preclinical studies and clinical trials, obtain marketing approval and ultimately commercialize them, or experience significant delays in doing so, our business will be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The success of our business depends primarily upon our ability to identify, develop and commercialize product candidates. We are early in our development efforts and recently discontinued our first Phase 1 study of our prior lead candidate, SEP-786. Our other product candidates and development programs are in preclinical development or in the drug discovery stages. We have invested substantially all of our research efforts to date in developing our Native Complex PlatformTM, identifying potential product candidates and conducting preclinical and clinical studies. As an organization, we have limited experience in conducting and managing clinical trials necessary to obtain regulatory approvals, and we may be unable to do so for our product candidates. While we plan to advance SEP-631 into clinical development in 2025 and are advancing multiple lead compounds towards selection of a next-generation oral small molecule PTH1R agonist development candidate, we have not successfully completed any clinical trials to date. Additionally, we have a portfolio of targets and programs that are in earlier stages of discovery or preclinical development and may never advance to clinical-stage development. If we are able to advance these other targets and programs into clinical development, we do not have experience managing multiple clinical trials simultaneously, working with global clinical trials, or working in multiple different disease indications. Our ability to achieve and sustain profitability depends on obtaining regulatory approvals for, and successfully commercializing our product candidates, either alone or with third parties, and we cannot guarantee you that we will ever obtain regulatory approval for any of our product candidates. Before obtaining regulatory approval for the commercial distribution of our product candidates, we must conduct extensive preclinical tests and clinical trials to demonstrate the safety and efficacy in humans of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not have the financial resources to continue development of, or the ability to enter into new collaborations for, a product candidate if we experience any issues that delay or prevent regulatory approval of, or our ability to commercialize, product candidates, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preclinical study results may show the product candidate to be less effective than desired or to have harmful or problematic side effects;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">negative or inconclusive results from our clinical trials or the clinical trials of others for product candidates similar to ours, leading to a decision or requirement to conduct additional preclinical testing or clinical trials or abandon a program;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product-related side effects experienced by patients in our clinical trials or by individuals using product similar to our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party manufacturers&#8217; inability to successfully manufacture our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability of any third-party contract manufacturer to scale up manufacturing of our product candidates and those of our collaborators to supply the needs of clinical trials or commercial sales;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in submitting INDs or other comparable foreign applications or delays or failures in obtaining the necessary approvals from regulators to commence a clinical trial, or a suspension or termination of a clinical trial once commenced;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preclinical studies conducted outside of the United States may be affected by tariffs (including tariffs that have been or may in the future be imposed by the United States or other countries), sanctions, trade protection measures or import/export restrictions imposed by the United States or other foreign governments (including further legislation or actions taken by the United States or other countries that restrict trade);</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conditions imposed by the FDA, EMA or other comparable foreign regulatory authorities regarding the scope or design of our clinical trials;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in enrolling patients in our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">high drop-out rates of our clinical trial patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inadequate supply or quality of product candidate components or materials or other supplies necessary for the conduct of our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability to obtain alternative sources of supply for which we have a single source for product candidate components or materials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">greater than anticipated costs of our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacturing costs, formulation issues, pricing or reimbursement issues, or other factors that no longer make a product candidate economically feasible;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">harmful side effects or inability of our product candidates to meet efficacy endpoints during clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to demonstrate a benefit-risk profile acceptable to the FDA, EMA, or other comparable foreign regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unfavorable FDA, EMA, or other comparable foreign regulatory authority inspection and review of any of the clinical trial sites or manufacturing facilities used in the testing and manufacture of any of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet their contractual obligations in a timely manner, or at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional regulatory oversight around clinical testing generally or with respect to our technology in particular; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">varying interpretations of our data by the FDA, EMA, and similar foreign regulatory authorities.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our inability to complete development of, or commercialize our product candidates, or significant delays in doing so due to one or more of these factors, could have a material and adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical and clinical drug development is a lengthy and expensive process, with uncertain timelines and outcomes. If preclinical studies or clinical trials of our product candidates are prolonged or delayed, we may be unable to obtain required regulatory approvals, and therefore be unable to commercialize our therapeutic candidates or any of our future therapeutic candidates on a timely basis or at all.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successful development of pharmaceutical products involves a lengthy and expensive process, is highly uncertain, and is dependent on numerous factors, many of which are beyond our control. Product candidates that appear promising in the early phases of development may fail to reach the market for several reasons, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trial results may show the product candidates to be less effective than expected (for example, a clinical trial could fail to meet its primary or key secondary endpoint(s)) or have an unacceptable safety or tolerability profile;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to receive the necessary regulatory approvals or a delay in receiving such approvals, which, among other things, may be caused by patients who fail the trial screening process, slow enrollment in clinical trials, patients dropping out of trials, patients lost to follow-up, length of time to achieve trial endpoints, additional time requirements for data analysis or New Drug Application (&#8220;NDA&#8221;) or similar foreign application preparation, discussions with the FDA, EMA or other comparable foreign regulatory authorities, including FDA, EMA or other comparable foreign regulatory authorities requesting additional preclinical or clinical data (such as long-term toxicology studies), or encountering unexpected safety or manufacturing issues;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preclinical study results may show the product candidate to be less effective than desired or to have harmful on-target or off-target side effects;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of extensive post-marketing approval requirements; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proprietary rights of others and their competing products and technologies that may prevent our product candidates from being commercialized.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the length of time necessary to complete clinical trials and submit an application for marketing approval for a final decision by a regulatory authority varies significantly from one product candidate to the next and from one country or jurisdiction to the next and may be difficult to predict. Even if we are successful in obtaining marketing approval, commercial success of any approved products will also depend in large part on the availability of coverage and adequate reimbursement from third-party payors, including government payors such as the Medicare and Medicaid programs and managed care organizations in the United States or country-specific governmental organizations in foreign countries, which may be affected by existing and future healthcare reform measures designed to reduce the cost of healthcare. Third-party payors could require us to conduct additional studies, including post-marketing studies related to the cost effectiveness of a product, to qualify for reimbursement, which could be costly and divert our resources. If government and other healthcare payors were not to provide coverage and adequate reimbursement for our products once approved, market acceptance and commercial success would be reduced. Even if we are able to obtain coverage and adequate reimbursement for our products once approved, there may be features or characteristics of our products, such as dose preparation requirements, that prevent our products from achieving market acceptance by the healthcare or patient communities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, if any of our product candidates receive marketing approval, we will be subject to significant regulatory obligations regarding the submission of safety and other post-marketing information and reports and registration, and will need to continue to comply (or ensure that our third-party providers comply) with cGMPs and GCPs for any clinical trials that we conduct post-approval. In addition, there is always the risk that we, a regulatory authority or a third party might identify previously unknown problems with a product post-approval, such as adverse events ("AEs") of unanticipated severity or frequency. Compliance with these requirements is costly, and any failure to comply or other issues with our product candidates post-approval could adversely affect our business, financial condition and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may encounter substantial delays in the commencement, enrollment or completion of our planned clinical trials or we may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities, which could prevent us from commercializing any product candidates we determine to develop on a timely basis, if at all.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk of failure in developing product candidates is high. It is impossible to predict when or if any product candidate would prove effective or safe in humans or will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete preclinical development, submit an IND or comparable foreign application to permit initiation of clinical studies, and then conduct extensive clinical trials to demonstrate the safety and efficacy of product candidates in humans. We have not yet completed a clinical trial of any product candidate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that support our INDs and other regulatory filings. We cannot be certain of the timely identification of a product candidate or the completion or outcome of our preclinical testing and studies and cannot predict whether the FDA, EMA or other comparable foreign regulatory authorities will accept our proposed clinical programs or whether the outcome of our preclinical testing and studies will ultimately support the further development of any product candidates. Conducting preclinical testing is a lengthy, time-consuming and expensive process. The length of time may vary substantially according to the type, complexity and novelty of the program, and often can be several years or more per program. As a result, we cannot be sure that we will be able to submit INDs or other comparable foreign regulatory submissions for our preclinical programs on the timelines we expect, if at all, and we cannot be sure that submission of INDs will result in the FDA, EMA, or other comparable foreign regulatory authority allowing clinical trials to begin.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, product candidates are subject to continued preclinical safety studies, which may be conducted concurrently with our clinical testing. The outcomes of these safety studies may delay the launch of or enrollment in future clinical trials and could impact our ability to continue to conduct our clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical testing is expensive, is difficult to design and implement, can take many years to complete and is uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, or at all. A failure of one or more clinical trials can occur at any stage of testing, which may result from a multitude of factors, including, but not limited to, flaws in trial design, dose selection issues, patient enrollment criteria and failure to demonstrate favorable safety or efficacy traits.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other events that may prevent successful enrollment, initiation or timely completion of clinical development include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to generate sufficient preclinical, toxicology or other </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> data to support the initiation of clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching a consensus with applicable regulatory authorities on trial design or implementation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in obtaining regulatory authorization to commence a clinical trial;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching agreement on acceptable terms with prospective CROs, other vendors, or clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different vendors and trial sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in obtaining approval from one or more IRBs refusing to approve, suspending or terminating the trial at an investigational site, precluding enrollment of additional participants, or withdrawing their approval of the trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in recruiting suitable patients to participate in our ongoing and planned clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes to the clinical trial protocol;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical sites deviating from trial protocol such as the data collection omission we experienced at a clinical site as discussed above or dropping out of a trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in manufacturing sufficient quantities of our product candidates for use in clinical trials, or delays in sufficiently developing, characterizing or controlling a manufacturing process suitable for clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in having our product candidates being shipped on time, clearing customs and arriving at clinical trial sites intact;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in having patients complete participation in a trial or return for post-treatment follow-up;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">participants choosing an alternative treatment for the indication for which we are developing our product candidates, or participating in competing clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of adequate funding to continue a clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">occurrence of AEs or SAEs associated with the product candidate that are viewed to outweigh its potential benefits;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">occurrence of SAEs in clinical trials of the same class of agents conducted by other companies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of a temporary or permanent clinical hold by regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">selection of clinical trial end points that require prolonged periods of clinical observation or analysis of the resulting data;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials producing negative or inconclusive results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a facility manufacturing our product candidates or any of their components being ordered by the FDA or comparable foreign authorities to temporarily or permanently shut down due to violations of cGMP regulations or other applicable requirements, or contamination or cross-contaminations of product candidates in the manufacturing process;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party clinical investigators losing the licenses or permits necessary to perform our clinical trials, not performing our clinical trials on our anticipated schedule or consistent with the clinical trial protocol or other regulatory requirements or committing fraud; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in regulatory requirements, guidance, or feedback from regulatory agencies that require amending or submitting new clinical protocols or otherwise modifying the design of our clinical trials.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs overseeing the conduct of such trials, by a Data Safety Monitoring Board for such trial or by the FDA, EMA, or other comparable foreign regulatory authorities. Such regulatory authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA, EMA, or other comparable regulatory foreign authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. In addition, changes in regulatory requirements and policies may occur, and we may need to amend clinical trial protocols to comply with these changes. Amendments may require us to resubmit our clinical trial protocols to IRBs for reexamination and approval, which may impact the costs, timing or successful completion of a clinical trial.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, conducting clinical trials in foreign countries, as we may do for our product candidates, presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled patients in foreign countries to adhere to clinical protocols as a result of differences in healthcare services or cultural customs, managing additional administrative burdens associated with foreign regulatory requirements, as well as political, currency exchange and other economic risks relevant to such foreign countries. Investigators and patients may not be able to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. Similarly, our ability to recruit and retain patients and principal investigators and site staff which in turn could adversely impact our clinical trial operations. Additionally, we may experience interruption of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel, quarantines or social distancing protocols imposed or recommended by federal or state governments, employers and others in connection with public health concerns. We may face delays in meeting our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">anticipated timelines for our ongoing and planned clinical trials, which could adversely affect our business, financial condition, results of operations and growth prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability to generate revenue from future product sales and regulatory and commercialization milestones. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional testing to bridge our modified product candidate to earlier versions. Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates, if approved, or allow our competitors to bring comparable products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Serious adverse events, undesirable side effects or other unexpected properties of our product candidates may be identified during development or after approval, which could lead to the discontinuation of our clinical development programs, refusal by regulatory authorities to approve our product candidates or, if discovered following marketing approval, revocation of marketing authorizations or limitations on the use of our product candidates, any of which would limit the commercial potential of such product candidate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have not completed the evaluation of any product candidates in human clinical trials. It is impossible to predict when or if any product candidates we may develop will ultimately prove safe in humans. As is the case with pharmaceuticals generally, it is likely that there may be side effects and AEs associated with our product candidates&#8217; use. Often, it is not possible to determine whether or not the product candidate being studied caused these conditions. Regulatory authorities may draw different conclusions or require additional testing to confirm these determinations, if they occur. In addition, it is possible that as we test our product candidates in larger, longer and more extensive clinical trials with a broader group of patients, or as use of these product candidates becomes more widespread if they receive marketing approval, illnesses, injuries, discomforts and other AEs that were observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials, will be reported by participants. Many times, side effects are only detectable after investigational product candidates are tested in large-scale, Phase 3 trials or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that any of our product candidates has serious or life-threatening side effects or other side effects that outweigh the potential therapeutic benefit, the development of the product candidate may fail or be delayed, or, if the product candidate has received marketing approval, such approval may be revoked, which would harm our business, prospects, operating results and financial condition. In particular, because we are developing our product candidates for chronic indications, the FDA, EMA, and other comparable foreign regulatory authorities will likely require that our product candidates demonstrate a higher level of safety over a longer period of time than would be the case for product candidates intended for short-term use. Moreover, if we elect, or are required, to delay, suspend or terminate any clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed and our ability to generate revenue through their sale may be delayed or eliminated. For example, on February 18, 2025, we announced our decision to discontinue the development of SEP-786 and advance a next-generation oral small molecule PTH1R agonist from our PTH1R program, followed the observation of two unanticipated severe (Grade 3) events of elevated unconjugated bilirubin in the MAD portion of the Phase 1 trial. Any of these occurrences may harm our business, financial condition and prospects significantly.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, if our product candidates are associated with undesirable side effects in clinical trials or have characteristics that are unexpected, we may elect to abandon their development or limit their development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective, which may limit the commercial value for the product candidate if approved. We may also be required to modify our trial plans based on findings after we commence our clinical trials. Many compounds that initially showed promise in early-stage testing have later been found to cause side effects that prevented further development of the compound. For example, we discontinued development of our previous lead candidate, SEP-786, following the observation of two unanticipated severe (Grade 3) events of elevated unconjugated bilirubin in the MAD portion of the Phase 1 trial.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, if any of our product candidates receive marketing approval, the FDA could require us to include a boxed warning in our label or adopt a risk evaluation and mitigation strategy (&#8220;REMS&#8221;), to ensure that the benefits outweigh its risks, which may include, among other things, a medication guide outlining the risks of the drug for distribution to patients and a communication plan to health care practitioners. For example, the FDA required that the product label for NATPARA, an approved, injectable parathyroid hormone product targeting PTH1R for the management of hypoparathyroidism include a boxed warning related to the risk of osteosarcoma based on rodent carcinogenicity studies and also implemented a REMS program to ensure patients and prescribers were appropriately counseled on the benefits and risks of the drug. Similarly, the FDA initially included boxed warnings for FORTEO and TYMLOS, injectable PTH peptides approved for osteoporosis due to the risk of osteosarcoma. While we have not yet conducted carcinogenicity studies for any of our product candidates that target PTH1R, it is possible that absent compelling data to the contrary, the FDA, EMA, and other comparable foreign regulatory authorities will similarly require a boxed warning if any product candidates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may advance to clinical development that target PTH1R are approved for marketing. Furthermore, if we or others later identify undesirable side effects caused by our product candidates, several other potentially significant negative consequences could result, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may suspend or withdraw approvals of such product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may require additional warnings on the label, including &#8220;boxed&#8221; warnings, or issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to change the way a product candidate is administered or conduct additional clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could be sued and held liable for harm caused to patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could be subject to fines, injunctions, or the imposition of criminal or civil penalties;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may need to conduct a recall;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be forced to suspend marketing of that product, or decide to remove the product from the marketplace; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product may become less competitive, and our reputation may suffer.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance of our product candidates and could significantly harm our business, prospects, financial condition and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates are subject to extensive regulation and compliance obligations, which is costly and time-consuming and which may cause unanticipated delays or prevent the receipt of the required approvals to commercialize our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The research, clinical development, testing, quality control, safety, effectiveness, manufacturing, labeling, packaging, storage, record-keeping, advertising, promotion, marketing, import, export, distribution, post-approval monitoring, and post-approval reporting of our product candidates are subject to extensive regulation by the FDA in the United States and by comparable foreign regulatory authorities in foreign markets. In the United States, neither we nor any future collaborators are permitted to market our product candidates until we receive regulatory approval from the FDA. The process of obtaining regulatory approval is expensive, often takes many years following the commencement of clinical trials and can vary substantially based upon the type, complexity and novelty of the product candidates involved, as well as the target indications and patient population. Approval policies or regulations may change, new relevant statutes or regulations may be enacted, and the FDA, EMA and other comparable foreign regulatory authorities have substantial discretion in the drug approval process, including the ability to delay, limit or deny approval of a product candidate for many reasons. Despite the time and expense invested in clinical development of product candidates, regulatory approval is never guaranteed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we or our potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction of the FDA, EMA or other comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. Results from preclinical studies and clinical trials can be interpreted in different ways. Even if we believe the preclinical or clinical data for our product candidates are promising, such data may not be sufficient to support approval by the FDA, EMA and other comparable foreign regulatory authorities, which could require us to delay or abandon clinical development plans. In addition, regulatory authorities may require us to conduct further preclinical studies before evaluating our product candidate in a clinical trial. Once we initiate clinical trials, the FDA, EMA, or other comparable foreign regulatory authorities may require additional clinical trials or suggest changes to our planned clinical trials, prior to and in support of the approval of a NDA or equivalent foreign marketing application. Changes to data requirements by the FDA, EMA, or other comparable foreign regulatory authorities during the development of our product candidates may cause the applicable regulatory authorities to require us to conduct additional preclinical studies or clinical trials for our product candidates either prior to or post-approval, or regulatory authorities may object to elements of our clinical development program.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA, EMA or other comparable foreign regulatory authorities can delay, limit or deny approval of a product candidate for many reasons, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree with the design or implementation of our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">negative or ambiguous results from our clinical trials or results may not meet the level of statistical significance required by the FDA, EMA or other comparable foreign regulatory authorities for approval;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serious and unexpected drug-related side effects may be experienced by participants in our clinical trials or by individuals using drugs similar to our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the population studied in the clinical trial may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may not accept clinical data from trials which are conducted at clinical facilities or in countries where the standard of care is potentially different from that of the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to demonstrate that a product candidate is safe and effective, and that a product candidate&#8217;s clinical and other benefits outweigh its safety risks;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree with our interpretation or analysis of data from preclinical studies or clinical trials; such authorities may not agree that the data collected from clinical trials of our product candidates are acceptable or sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere, and such authorities may impose requirements for additional preclinical studies or clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree regarding the formulation, labeling and/or the specifications of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval may be granted only for indications that are significantly more limited than what we apply for and/or with other significant restrictions on distribution and use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may find deficiencies in the manufacturing processes, approval policies or facilities of our third-party manufacturers with which we or any of our current or future collaborators contract for clinical and commercial supplies; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval policies or regulations of such authorities may significantly change in a manner rendering our or any of our potential future collaborators&#8217; clinical data insufficient for approval.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to foreign markets, approval procedures vary among countries and, in addition to the foregoing risks, may involve additional product testing, administrative review periods and agreements with pricing authorities. In addition, events raising questions about the safety of certain marketed pharmaceuticals may result in increased cautiousness by the FDA, EMA, and other comparable foreign regulatory authorities in reviewing new drugs based on safety, efficacy or other regulatory considerations and may result in significant delays in obtaining regulatory approvals. Any delay in obtaining, or inability to obtain, applicable regulatory approvals would prevent us or any of our potential future collaborators from commercializing our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the large number of drugs in development, only a small percentage successfully complete the FDA, EMA, or foreign regulatory approval processes and are commercialized. The lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market our product candidates, which would significantly harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control, which could adversely affect our business, operating results and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patient enrollment and retention in clinical trials is a significant factor in the timing of clinical trials and depends on many factors, including the size and nature of the patient population, the nature of the trial protocol, the existing body of safety and efficacy data with respect to the study drug, the number, nature and duration of competing treatments and ongoing clinical trials of competing drugs for the same indication, the proximity of patients to clinical trial sites and the eligibility criteria for the clinical trial. As we progress our programs we may not be able to initiate or continue clinical trials for any product candidates we identify or develop if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, EMA, or other comparable foreign authorities, or as needed to provide appropriate statistical power for a given trial. For certain of our product candidates, the conditions which we may evaluate include rare diseases with limited patient pools from which to draw. In some cases, patient populations for rare diseases are located at specific academic sites focused on such indications, often with multiple competing clinical trials. Potential patients for any planned clinical trials may not be adequately diagnosed or identified with the diseases which we are targeting or may not meet the entry criteria for such trials. We also may encounter difficulties in identifying and enrolling patients with a stage of disease appropriate for our planned clinical trials and monitoring such patients adequately during and after treatment. As noted above, other pharmaceutical companies targeting these same diseases are recruiting clinical trial patients from these patient populations, which may make it more difficult to fully enroll our clinical trials. In addition, the process of finding and diagnosing patients may prove costly.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The eligibility criteria of our clinical trials, once established, may further limit the pool of available trial participants. If the actual number of patients with these diseases is smaller than we anticipate, we may encounter difficulties in enrolling patients in our clinical trials, thereby delaying or preventing development and approval of our product candidates. Even once enrolled we may be unable to retain a sufficient number of patients to complete any of our trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the study until its conclusion. We may experience difficulties in patient enrollment or retention in our clinical trials for a variety of reasons. Patient enrollment and retention in clinical trials depends on many factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size and nature of the patient population, in particular for rare diseases such as the diseases on which we are focused initially, and process for identifying patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the severity of the disease under investigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the design of the trial protocol;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the existing body of safety and efficacy data for the product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and nature of competing treatments and ongoing clinical trials of competing therapies for the same indication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity and availability of clinical trial sites for patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the eligibility criteria for the trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the complexity of the trial, including number of office visits, lab tests, patient evaluations, and dosing regimens;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to adequately monitor patients during a trial, clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product candidate being studied;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the risk that enrolled patients will drop out of a trial before completing all site visits; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the drug being studied in relation to other available therapies.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, our efforts to build relationships with patient communities may not succeed, which could result in delays in patient enrollment in our clinical trials. In addition, any negative results we may report in clinical trials of our product candidate may make it difficult or impossible to recruit and retain patients in other clinical trials of that same product candidate. Delays or failures in planned patient enrollment or retention may result in increased costs, program delays or both, which could have a harmful effect on our ability to develop our product candidates, or could render further development impossible. Further, if patients drop out of our clinical trials, miss scheduled doses or follow-up visits, or otherwise fail to follow clinical trial protocols, the integrity of data from our clinical trials may be compromised or not accepted by the FDA, EMA, or other comparable foreign regulatory authorities, which would represent a significant setback for the applicable program. In addition, we may rely on CROs and clinical trial sites to ensure proper and timely conduct of our future clinical trials and, while we intend to enter into agreements governing their services, we will be limited in our ability to compel their actual performance. Such delays or failures could adversely affect our business, operating results and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we receive regulatory approval of any product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities. In addition, we will be subject to continued compliance with cGMP and GCP requirements for any clinical trials that we conduct post-approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturers and manufacturers&#8217; facilities are required to comply with extensive FDA, EMA and other comparable foreign regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations and applicable product tracking and tracing requirements. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any NDA, other marketing application and previous responses to inspection observations. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production and quality control.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any regulatory approvals that we receive for our product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the product candidate. Certain endpoint data we hope to include in any approved product labeling also may not make it into such labeling, including exploratory or secondary endpoint data such as patient-reported outcome measures. The FDA may also require a REMS program as a condition of approval of our product candidates, which could entail requirements for long-term patient follow-up, a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA, EMA or other comparable foreign regulatory authority approves our product candidates, we will have to comply with requirements including submissions of safety and other post-marketing information and reports and registration.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may impose consent decrees or withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with our product candidates, including AEs of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-market studies or clinical trials to assess new safety risks or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of our products, withdrawal of the product from the market or voluntary product recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, warning letters or holds on clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or withdrawal of approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention or refusal to permit the import or export of our product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, under the FDORA, sponsors of approved drugs and biologics must provide six months&#8217; notice to the FDA of any changes in marketing status, such as the withdrawal of a drug, and failure to do so could result in the FDA placing the product on a list of discontinued products, which would revoke the product&#8217;s ability to be marketed. The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Products may be promoted only for the approved indications and in accordance with the provisions of the approved label. The policies of the FDA, EMA and other comparable foreign regulatory authorities may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. In addition, the U.S. Supreme Court&#8217;s July 2024 decision to overturn established case law giving deference to regulatory agencies&#8217; interpretations of ambiguous statutory language has introduced uncertainty regarding the extent to which the FDA&#8217;s regulations, policies and decisions may become subject to increasing legal challenges, delays, and/or changes. As a result of the U.S. Supreme Court&#8217;s decision, the FDA and other agencies may be less inclined to engage in formal regulation and may rely to a greater degree on informal guidance, which may not always be susceptible to immediate challenge. We cannot predict the likelihood, nature or extent of government regulation or guidance that may arise from future court decisions, legislation, or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or guidance or the adoption of new requirements, guidance, or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we do not achieve our projected development goals in the time frames we announce and expect, the commercialization of our therapeutics may be delayed and, as a result, our stock price may decline.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we estimate the timing of the anticipated accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include our expectations regarding the commencement or completion of scientific studies and clinical trials and the submission of regulatory filings. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial or the initiation of other clinical programs. All of these milestones are and will be based on numerous assumptions, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our available capital resources or capital constraints we experience;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate of progress, costs and results of our clinical trials and research and development activities, including the extent of scheduling conflicts with participating clinicians and collaborators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify and enroll patients who meet clinical trial eligibility criteria;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our receipt of approvals by the FDA, EMA, and other comparable foreign regulatory authorities and the timing thereof;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other actions, decisions or rules issued by regulators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to access sufficient, reliable and affordable supplies of materials used to manufacture our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efforts of our collaborators with respect to the commercialization of our product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the securing of, costs related to, and timing issues associated with, product manufacturing as well as sales and marketing activities.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securing product reimbursement</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The actual timing of these milestones can vary dramatically compared to our estimates, in some cases for reasons beyond our control. If we do not meet these milestones as publicly announced, or at all, the commercialization of our product candidates may be delayed or never achieved and, as a result, our stock price may decline.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Results of preclinical studies and early clinical trials on any of our product candidates may not be predictive of results of future clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The outcome of preclinical studies and early clinical trials may not be predictive of the success of later clinical trials. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in early-stage development, and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical findings made while clinical trials were underway or safety or efficacy observations made in preclinical studies and clinical trials, including previously unreported AEs. In addition, while the animal models used in preclinical studies are designed to be representative of disease states in humans, these preclinical models may not be able to accurately predict the way a product candidate will affect patients in clinical trials. We have limited experience in designing clinical trials and may be unable to design and execute a clinical trial to support regulatory approval. In addition, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen, product formulation and other clinical trial protocols and the rate of dropout among clinical trial patients. If we fail to receive positive results in clinical trials of our product candidates, the development timeline and regulatory approval and commercialization prospects for our most advanced product candidates, and, correspondingly, our business and financial prospects would be negatively impacted.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may expend our limited resources to pursue a particular product candidate and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have limited financial and managerial resources, and to date, we have focused on research programs and product candidates within the endocrinology, immunology and inflammation, neurology and metabolic therapeutic areas, with a particular focus on our previous lead product candidate, SEP-786. We are currently working to select and advance a new PTH1R clinical candidate from our research pipeline. Correctly prioritizing our research and development activities is particularly important for us due to the breadth of potential product candidates and indications that we believe could be pursued by leveraging our Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As a result, we may forgo or delay pursuit of opportunities with other product candidates or in other therapeutic areas that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to timely capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. We must continually assess the potential commercial viability of our research programs and product candidates, and we may decide to pause or discontinue development of any of our product candidates based upon such assessments, even if we obtain positive data from our product candidates in preclinical studies and clinical trials.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> is based on novel technologies that are unproven and may not result in approvable or marketable products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval, and we may not be successful in our efforts to expand our development portfolio of product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A key element of our strategy is to use our proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to overcome the historical limitations of GPCR drug development, including the isolation, purification and stabilization of GPCRs in their native forms, in order to build a robust and diverse portfolio of potentially first-in-class and best-in-class oral small molecule therapies that address both well-validated and novel GPCR targets.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The scientific research that forms the basis of our efforts to develop product candidates with our platform is still ongoing. We are not aware of any FDA approved therapeutics utilizing the technology underlying our platform. Further, the scientific evidence to support the feasibility of developing therapeutic treatments based on our platform is both preliminary and limited. As a result, we are exposed to a number of unforeseen risks and it is difficult to predict the types of challenges and risks that we may encounter during development of our product candidates. For example, we have only generated limited clinical data on our prior lead candidate, SEP-786, which led us to discontinue the program, and we have not yet generated clinical data on any of the other product candidates being developed using our platform. Our current data on our development pipeline is limited to animal models and preclinical cell lines, the results of which may not translate into humans. Further, relevant animal models and assays may not accurately predict the safety and efficacy of our product candidates in humans, and we may encounter significant challenges creating appropriate models and assays for demonstrating the safety and purity of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the novelty of our technology, we intend to work closely with the FDA and comparable foreign regulatory authorities to perform the requisite scientific analyses and evaluation of our methods to obtain regulatory approval for our product candidates; however, due to a lack of comparable experiences, the regulatory pathway with the FDA and comparable regulatory authorities may be more complex and time-consuming relative to other more well-known therapeutics. Even if we obtain human data to support our product candidates, the FDA or comparable foreign regulatory authorities may lack experience in evaluating the safety and efficacy of product candidates like those developed using our platform, which could result in a longer than expected regulatory review process, increase our expected development costs, and delay or prevent commercialization of our product candidates. We cannot be certain that our approach will lead to the development of approvable or marketable products, alone or in combination with other therapies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although our research and development efforts to date have resulted in a development portfolio of potential programs and product candidates, we may not be able to discover or identify novel chemical matter to new GPCR targets and thus not be able to develop product candidates to expand our development portfolio. We may also pursue opportunities to acquire or in-license additional businesses, technologies or products, form strategic alliances or create joint ventures with third parties to complement or augment our existing business. However, we may not be able to identify any product candidates through such acquisition or in-license.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we are successful in continuing to build and expand our development portfolio, the potential product candidates that we identify may not be suitable for clinical development. For example, they may be shown to have harmful side effects or other characteristics that indicate that they are unlikely to be drugs that will be successful in clinical trials or receive marketing approval and achieve market acceptance. If we do not successfully develop and commercialize product candidates, we will not be able to obtain drug revenues in future periods, which likely would result in significant harm to our financial position and adversely affect our stock price.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preliminary, topline and interim data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may publicly disclose interim, preliminary or topline data from our preclinical studies and planned clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline and preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the topline or preliminary data we previously made public. As a result, topline and preliminary data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Adverse differences between topline, preliminary or interim data and final data could significantly harm our business prospects.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular product, product candidate or our business. If the topline or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may develop our product candidates in combination with other therapies, which would expose us to additional risks.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may develop our product candidates in combination with one or more currently approved therapies or therapies in development. Even if any of our product candidates were to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be subject to the risks that the FDA, EMA or other comparable foreign regulatory authorities could revoke approval of the therapy used in combination with any of our product candidates, or safety, efficacy, manufacturing or supply issues could arise with these existing therapies. In addition, it is possible that existing therapies with which our product candidates are approved for use could themselves fall out of favor or be relegated to later lines of treatment. This could result in the need to identify other combination therapies for our product candidates or our own products being removed from the market or being less successful commercially.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also evaluate our product candidates in combination with one or more other therapies that have not yet been approved for marketing by the FDA, EMA or other comparable foreign regulatory authorities. We will not be able to market and sell any product candidate in combination with any such unapproved therapies that do not ultimately obtain marketing approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, we cannot be certain that we will be able to obtain a steady supply of such therapies for use in developing combinations with our product candidates on commercially reasonable terms or at all. Any failure to obtain such therapies for use in clinical development and the expense of purchasing therapies in the market may delay our development timelines, increase our costs and jeopardize our ability to develop our product candidates as commercially viable therapies. If the FDA, EMA or other comparable foreign regulatory authorities do not approve or withdraw their approval of these other therapies, or if safety, efficacy, commercial adoption, manufacturing or supply issues arise with the therapies we choose to evaluate in combination with any of our product candidates, we may be unable to obtain approval of or successfully market any one or all of the product candidates we develop. Additionally, if the third-party providers of therapies or therapies in development used in combination with our product candidates are unable to produce sufficient quantities for clinical trials or for commercialization of our product candidates, or if the cost of combination therapies are prohibitive, our development and commercialization efforts would be impaired, which would have an adverse effect on our business, financial condition, results of operations and growth prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Commercialization, Marketing and Competition</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently have no marketing and sales organization and have no experience as a company in commercializing products, and we may invest significant resources to develop these capabilities. If we are unable to establish marketing, sales or distribution capabilities or enter into agreements with third parties to market and sell our products, we may not be able to generate product revenue.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have no internal sales, marketing or distribution capabilities, nor have we as a company commercialized a product. If any of our product candidates ultimately receives marketing approval, we will be required to build a marketing and sales organization with technical expertise and supporting distribution capabilities to commercialize each such product in the markets that we target, which will be expensive and time consuming, or collaborate with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems. We have no prior experience as a company in the marketing, sale and distribution of pharmaceutical products and there are significant risks involved in building and managing a sales organization, including our ability to hire, retain and incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel and effectively manage a geographically dispersed sales and marketing team. Furthermore, we are currently developing products for multiple indications in different medical specialties, which will require us to build different sales and marketing capabilities that are tailored to a given product or medical specialty. Any failure or delay in the development of our internal sales, marketing and distribution capabilities would adversely impact the commercialization of these products. We may not be able to enter into collaborations or hire consultants or external service providers to assist us in sales, marketing and distribution functions on acceptable financial terms, or at all. In addition, our product revenues and our profitability, if any, may be lower if we rely on third parties for these functions than if we were to market, sell and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">distribute any products that we develop ourselves. We likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we are not successful in commercializing our products, either on our own or through arrangements with one or more third parties, we may not be able to generate any future product revenue and we would incur significant additional losses.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receive marketing approval, such product candidate may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never commercialized a product, and even if any of our product candidates are approved by the appropriate regulatory authorities for marketing and sale, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. Historically, several injectable PTH peptides have been approved by the FDA and other regulatory authorities for treatment of hypoparathyroidism and osteoporosis. However, our lead product candidate is an oral small molecule agonist; to date, no such oral small molecule in this indication has been approved by the FDA or any other regulatory agency. Market participants with significant influence over acceptance of new treatments, such as clinicians and third-party payors, may not adopt new oral treatments for hypoparathyroidism or osteoporosis, and we may not be able to convince the medical community and third-party payors to accept and use, or to provide favorable reimbursement for, any product candidates developed by us or our existing or future collaborators. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenue and may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the clinical indications and patient populations for which the product candidate is approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the safety, efficacy and potential advantages compared to alternative treatments and therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of market introduction of the product as well as competitive products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effectiveness of sales and marketing efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength of our relationships with patient communities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of treatment in relation to alternative treatments and therapies, including any similar generic treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to offer such product for sale at competitive prices;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the convenience and ease of administration compared to alternative treatments and therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of third-party coverage and adequate reimbursement;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of patients to pay out-of-pocket in the absence of coverage and adequate reimbursement by third-party payors and government authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength of marketing and distribution support;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inclusion of any REMS program or other restrictions included by the regulators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any restrictions on the use of the product together with other medications. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our efforts to educate physicians, patients, third-party payors and others in the medical community on the benefits of our product candidates may require significant resources and may never be successful. Because we expect sales of our product candidates, if approved, to generate substantially all of our revenues for the foreseeable future, the failure of our product candidates, if approved, to find market acceptance would harm our business and could require us to seek additional financing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we are able to commercialize any product candidate, the third-party payor coverage and reimbursement status of newly-approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for our product candidates could limit our ability to market those products and decrease our ability to generate revenue.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The availability and adequacy of coverage and reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers and other third-party payors in the United States are essential for most patients to be able to afford treatments such as our products or product candidates, if approved. Our ability to achieve acceptable levels of coverage and reimbursement for drug treatments by governmental authorities, private health insurers and other organizations will have an effect on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully commercialize our products, and potentially attract additional collaboration partners to invest in the development of our product candidates. We cannot be sure that adequate coverage and reimbursement in the United States, the EU, Australia or elsewhere will be available for our products or any products that we may develop, and any reimbursement that may become available may be decreased or eliminated in the future. For more information, see the section titled &#8220;Business&#8211;Government Regulation&#8211;Coverage and Reimbursement.&#8221;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party payors increasingly are challenging prices charged for pharmaceutical products, medical devices and services, and many third-party payors may refuse to provide coverage and reimbursement for particular drugs when an equivalent generic drug is available. It is possible that a third-party payor may consider our products or product candidates, if approved, and the generic or biosimilar parent drug as substitutable and only offer to reimburse patients for the generic drug. Even if we show improved efficacy or safety or improved convenience of administration with our products or product candidates, if approved, pricing of the existing parent drug may limit the amount we will be able to charge for such product. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our products or product candidates, and may not be able to obtain a satisfactory financial return on products that we may develop.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, third-party payors, including private and governmental payors, such as the Medicare and Medicaid programs, play an important role in determining the extent to which new drugs, biologics and medical devices will be covered. The Medicare and Medicaid programs increasingly are used as models for how private payors and other governmental payors develop their coverage and reimbursement policies for drugs, biologics and medical devices. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our products or product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada, and other countries has and will continue to put pressure on the pricing and usage of our products and product candidates, if approved, and on related parent drugs. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. Many countries, including the EU Member States, established complex and lengthy procedures to obtain price approvals, coverage and reimbursement. These procedures vary from country to country but are commonly initiated after grant of the related marketing authorization. More particularly, in the EU, potential reductions in prices and changes in reimbursement levels could be the result of different factors, including reference pricing systems. It could also result from the application of external reference pricing mechanisms, which consist of arbitrage between low-priced and high-priced countries. Reductions in the pricing of our medicinal products in one EU Member State could affect the price in other EU Member States and, thus, have a negative impact on our financial results. Other countries allow companies to fix their own prices for medical products, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our products or product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits. As an example, many EU Member States review periodically their decisions concerning the pricing and reimbursement of medicinal products. The outcome of these reviews cannot be predicted and could have adverse effects on the pricing and reimbursement of our medicinal products in the EU Member States.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, increasing efforts by governmental and third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for our products or product candidates. We expect to experience pricing pressures in connection with the sale of our products and product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs, medical devices and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition, and a strong emphasis on proprietary and novel products and product candidates. While we believe our product candidates, platform, knowledge, experience and scientific personnel provide us with several key competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others. Our future success will depend in part on our ability to maintain a competitive position with our structure-based drug discovery platform. If we fail to stay at the forefront of technological change in utilizing our platform to create and develop product candidates, we may be unable to compete effectively. Our competitors may render our approach obsolete by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages in our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">drug discovery process that we believe we derive from our research approach and platform. Several other companies also focus on GPCRs and have platform technologies that are distinct from the Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including Nxera Pharma (formerly Sosei Heptares), Structure Therapeutics, Tectonic Therapeutics, and Confo Therapeutics.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we face competition with respect to our product candidates and will face competition with respect to any other product candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There are several large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of product candidates for the treatment of the indications that we are pursuing. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are aware of several pharmaceutical companies that have commenced clinical trials of product candidates or have successfully commercialized products addressing areas that we are targeting. Takeda owns the rights to parathyroid hormone product (brand name NATPARA) for the treatment of hypoparathyroidism. NATPARA was voluntarily recalled due to manufacturing issues in September 2019 in the United States and is now only available to a limited number of patients through a Special Use Program offered by its manufacturer. In October 2022, Takeda announced manufacturing of all strengths of NATPARA will be discontinued globally by the end of 2024. Ascendis Pharma received regulatory approval for a proprietary once-daily injectable PTH peptide, palopegteriparatide (brand name YORVIPATH), in Europe and the United States. In March 2024, AstraZeneca acquired Amolyt Pharma, who was developing eneboparatide, a proprietary, once-daily injectable PTH peptide, for hypoparathyroidism, currently in Phase 3 studies. In addition, we are aware of several academic groups and companies working on making longer-acting agonists of the PTH1R. Other companies and groups are developing or commercializing therapies for hypoparathyroidism, including Calcilytix (a BridgeBio company), Entera Bio, Extend Biosciences, and MBX Biosciences. Several companies are developing clinical-stage small molecule MRGPRX2 inhibitors, including Escient Pharmaceuticals (acquired by Incyte Pharmaceuticals in April 2024), Evommune, and BioArdis. Further there are several other companies pursuing therapies for Chronic spontaneous urticaria addressing other receptors of interest, such a Genentech, Sanofi, Celldex Therapeutics, Jasper Therapeutics, Acelyrin, Allakos, Novartis, Third Harmonic Bio, and Blueprint Medicines. For TSHR, we are aware that Byondis and Crinetics are also working on research stage compounds, but they have not yet entered clinical development. In addition several companies are working on other mechanisms to address Graves&#8217; disease, such as Immunovant, and TED, including Amgen, Viridian, Argenx, Roche, Lassen Therapeutics, Tourmaline Bio, Sling Therapeutics, and Acelyrin. There are also several currently approved injectable products targeting incretin receptors for the treatment of obesity or type 2 diabetes (&#8220;T2D&#8221;). These include, but are not limited to, products such as Ozempic and Wegovy (semaglutide, each marketed by Novo Nordisk) for T2D and obesity, respectively, Trulicity (dulaglutide, marketed by Eli Lilly and Company) for T2D, and Mounjaro and Zepbound (tirzepatide, each marketed by Eli Lilly and Company) for T2D and obesity, respectively. There are also several injectable peptide products in development pursuing similar indications with similar mechanism of actions along with combination products, including those being developed by Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Roche, and Viking, among others. In addition, there are oral products such as Rybelsus (semaglutide, marketed by Novo Nordisk) approved for patients with T2D and other oral products in development for treating obesity or T2D, including those being developed by AstraZeneca, Eli Lilly and Company, Pfizer, Roche, Structure Therapeutics, and Terns. Based on our continuing evaluations of the competitive landscape, we may decide to reallocate resources and reprioritize our development programs if we determine that a particular product candidate or target indication is no longer commercially viable or advantageous.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our competitors, either alone or with their collaborators, have significantly greater financial, technical, manufacturing, marketing, sales and supply resources or experience than we do. If we successfully obtain approval for any product candidate, we will face competition based on many different factors, including the safety and effectiveness of our products, the timing and scope of marketing approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Competing products could present superior treatment alternatives, including by being more effective, safer, more convenient, less expensive or marketed and sold more effectively than any products we may develop. Competitive products may make any products we develop obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. If we are unable to compete effectively, our opportunity to generate revenue from the sale of our products we may develop, if approved, could be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and subject registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Any failure to compete effectively could harm our business, financial condition and operating results.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU drug marketing and reimbursement regulations may materially affect our ability to market and receive coverage for our products in the EU Member States.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We intend to seek approval to market our product candidates in both the United States and in selected foreign jurisdictions, including the EU. If we obtain approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. In some foreign countries, particularly those in the EU, the pricing of products is subject to governmental control and other market regulations which could put pressure on the pricing and usage of our product candidates. In these countries, pricing negotiations with governmental authorities can take considerable time after obtaining marketing approval of a product candidate. In addition, market acceptance and sales of our product candidates will depend significantly on the availability of adequate coverage and reimbursement from third-party payors for our product candidates and may be affected by existing and future healthcare reform measures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Much like the federal Anti-Kickback Statute prohibition in the United States, the provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to reward improper performance is typically governed by the national anti-bribery laws of EU Member States and the Bribery Act 2010 in the United Kingdom. Infringement of these laws could result in substantial fines and imprisonment. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, further provides that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the United Kingdom despite its departure from the EU.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, in some foreign countries, including some countries in the EU, the proposed pricing for a product must be approved before it may be lawfully marketed. The requirements governing product pricing and reimbursement vary widely from country to country. For example, some EU Member States have the option to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Reference pricing used by various EU Member States and parallel distribution, or arbitrage between low-priced and high-priced EU Member States, can further reduce prices. An EU Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. In some countries, we may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of any of our product candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Historically, products launched in the EU do not follow price structures of the United States and generally prices tend to be significantly lower. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable or limited in scope or amount, our revenues from sales and the potential profitability of any of our product candidates in those countries would be negatively affected.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining marketing approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining marketing approval of our product candidates in other jurisdictions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and maintaining marketing approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain marketing approval in any other jurisdiction. For example, even if the FDA grants marketing approval of a product candidate, it does not mean that comparable foreign regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion and reimbursement of the product candidate in those countries. However, a failure or delay in obtaining marketing approval in one jurisdiction may negatively impact the marketing approval process in others. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining foreign marketing approvals and establishing and maintaining compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we or any future collaborator fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed, which would adversely affect our business, prospects, financial condition, and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our future growth may depend, in part, on our ability to commercialize products in foreign markets, where we would be subject to additional regulatory burdens and other risks and uncertainties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future growth may depend, in part, on our ability to develop and commercialize our product candidates in foreign markets. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from applicable regulatory authorities in foreign markets, and we may never receive such regulatory approvals for any of our product candidates. To obtain separate regulatory approval in many other countries we must comply with numerous and varying regulatory requirements regarding safety and efficacy and governing, among other things, clinical trials, manufacturing, commercial sales, pricing and distribution of our product candidates. If we obtain regulatory approval of our product candidates and ultimately commercialize our products in foreign markets, we would be subject to additional risks and uncertainties, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">different regulatory requirements for approval of drugs in foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced protection for intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the existence of additional third-party patent rights of potential relevance to our business;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unexpected changes in tariffs, trade barriers and regulatory requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident to doing business in another country;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign reimbursement, pricing and insurance regimes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">workforce uncertainty in countries where labor unrest is common;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">business interruptions resulting from pandemics or similar public health crises. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If the market opportunities for any of our product candidates are smaller than we estimate, even assuming approval of a product candidate, our revenue may be adversely affected, and our business may suffer.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The precise incidence and prevalence for all the conditions we aim to address with our product candidates are unknown. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our product candidates, are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations or market research, and may prove to be incorrect. Further, new information may change the estimated incidence or prevalence of these diseases. The total addressable market across all of our product candidates will ultimately depend upon, among other things, the diagnosis criteria included in the final label for each of our product candidates approved for sale for these indications, the availability of alternative treatments and the safety, convenience, cost and efficacy of our product candidates relative to such alternative treatments, acceptance by the medical community and patient access, drug pricing and reimbursement. The number of patients in the United States and other major markets and elsewhere may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our products or new patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our results of operations and our business.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Business Operation and Industry</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur due to a variety of factors, many of which are outside of our control, including, but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, degree of success and cost of, and level of investment in, research, development, regulatory approval and commercialization activities relating to our product candidates, which may change from time to time;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">coverage and reimbursement policies with respect to our product candidates, if approved, and potential future drugs that compete with our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of manufacturing our product candidates, which may vary depending on FDA, EMA or other comparable foreign regulatory authority guidelines and requirements, the quantity of production and the terms of our agreements with third-party manufacturers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenditures that we may incur to acquire, develop or commercialize additional product candidates and technologies or other assets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of demand for any of our product candidates, if approved, which may fluctuate significantly and be difficult to predict;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain collaborations, licensing or other arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to adequately support future growth;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future accounting pronouncements or changes in our accounting policies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and success or failure of preclinical studies or clinical trials or regulatory approval for our product candidates or any competing product candidates, or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any intellectual property infringement lawsuit or opposition, interference or cancellation proceeding in which we may become involved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additions and departures of key personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential unforeseen business disruptions that increase our costs or expenses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effects of macro events, such as inflation, geopolitical conflicts, pandemics, natural disasters and supply chain issues, on our business and operations; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the changing and volatile global economic and political environment.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, from time to time, we may enter into license or collaboration agreements or strategic partnerships with other companies that include development funding and significant upfront and milestone payments and/or royalties, which may become an important source of our revenue. These upfront and milestone payments may vary significantly from period to period and any such variance could cause a significant fluctuation in our operating results from one period to the next.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a price decline could occur even when we have met any previously publicly stated revenue or earnings guidance we may provide.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect to expand our organization, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 75 full-time employees. As we advance our research and development programs, we may need to further increase the number of our employees and the scope of our operations, particularly in the areas of clinical development, biology, chemistry, manufacturing, general and administrative matters related to being a public company, regulatory</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">affairs and, if any of our product candidates receives marketing approval, sales, marketing and distribution. To manage our anticipated future growth, we must:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expand our general and administrative functions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify, recruit, integrate, maintain and motivate additional qualified personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manage our development efforts effectively, including the initiation and conduct of clinical trials for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish and build a marketing and commercial organization; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">improve our operational, financial and management controls, reporting systems and procedures.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future financial performance and our ability to develop, manufacture and commercialize our product candidates, if approved, will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert financial and other resources, and a disproportionate amount of its attention away from day-to-day activities, to managing these growth activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are highly dependent on the services of our senior management team and if we are not able to retain these members of our management team and recruit and retain additional management, clinical and scientific personnel, our business will be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are highly dependent on our senior management team. In particular, we are highly dependent on the development and management expertise of Jeffrey Finer, M.D., Ph.D., our Chief Executive Officer, and the other principal members of our management, scientific and clinical team. The employment agreements we have with these officers do not prevent such persons from terminating their employment with us at any time. The loss of the services of any of these persons could impede the achievement of our research, development and commercialization objectives. In addition, we will need to attract, retain and motivate highly qualified additional management, clinical and scientific personnel. If we are not able to retain our management and to attract, on terms acceptable to us, additional qualified personnel necessary for the continued development of our business, we may not be able to sustain our operations or grow.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to attract or retain qualified personnel in the future due to the intense competition for qualified personnel among biotechnology, pharmaceutical and other businesses. Many of the other pharmaceutical companies that we compete against for qualified personnel and consultants have greater financial and other resources, different risk profiles and a longer operating history in the industry than we do. They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates and consultants than what we have to offer. If we are unable to attract, retain and motivate high-quality personnel and consultants to accomplish our business objectives, the rate and success at which we can discover and develop product candidates and our business will be limited and we may experience constraints on our development objectives.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. For example, employment of our key employees is at-will, which means that any of our employees could leave our employment at any time, with or without notice. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future performance will also depend, in part, on our ability to successfully integrate newly hired executive officers into our management team and our ability to develop an effective working relationship among senior management. Our failure to integrate these individuals and create effective working relationships among them and other members of management could result in inefficiencies in the development and commercialization of our product candidates, harming future marketing approvals, sales of our product candidates and our results of operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or unauthorized activities that violate: (i) FDA, the national competent authorities of individual EU Member States, or comparable foreign regulations, including those laws that require the reporting of true, complete and accurate information to the FDA, EMA, or other comparable foreign regulatory authorities; (ii) manufacturing standards; (iii) U.S. federal and state fraud and abuse and other healthcare laws and regulations, including foreign requirements; or (iv) laws that require the reporting of true and accurate financial information and data. Specifically, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. These activities also include the improper use of information obtained in the course of clinical trials or falsification of clinical trial data, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and other third-parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Additionally, we are subject to the risk that a person or government could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other U.S. federal or non U.S. healthcare programs, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in U.S. and international trade policies, particularly with respect to China, may adversely impact our business and operating results.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. government has recently made statements and taken certain actions that may lead to potential changes to U.S. and international trade policies, including imposing several rounds of tariffs and export control and sanctions restrictions affecting certain products manufactured in China. Both China and the United States have each imposed tariffs indicating the potential for further trade barriers, including the U.S. Commerce Department adding numerous Chinese entities to its Unverified List, which requires U.S. exporters to go through more procedures before exporting goods to such entities. It is unknown whether and to what extent new tariffs, export controls, or other new laws or regulations will be adopted, or the effect that any such actions would have on us or our industry. Most recently, legislation pending in Congress called the BIOSECURE Act would, among other things, prohibit U.S. federal government contracts, grants, and loans in connection with biotechnology equipment or services provided or produced by certain named Chinese &#8220;biotechnology companies of concern,&#8221; which include WuXi AppTec and WuXi Biologics, or collectively WuXi. See the risk factor titled &#8220;Risks Related to Government Regulatory and Legal Requirements&#8212;We rely on third-party manufacturers, CROs, CMOs, and suppliers to supply, develop and test components of our product candidates. The loss of our third-party manufacturers, CROs, CMOs, or suppliers, their failure to comply with applicable regulatory requirements or to supply sufficient quantities at acceptable quality levels or prices, or at all, or changes in methods of product candidate manufacturing, development or formulation would materially and adversely affect our business.&#8221;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any unfavorable government policies on international trade, such as export controls, economic, sanctions, capital controls or tariffs, may increase the cost of manufacturing our product candidates and platform materials, affect our ability to commercialize our product candidates if approved, the competitive position of our product candidates, and import or export of raw materials and finished product candidate used in our preclinical studies and clinical trials, particularly with respect to any product candidates and materials that we import from China, including pursuant to our service arrangements with WuXi. If any new tariffs, export controls, sanctions, legislation and/or regulations are implemented, or if existing trade agreements are renegotiated or, in particular, if either the U.S. or Chinese government takes retaliatory trade actions due to the recent trade tensions, such changes could have an adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical trial and product liability lawsuits against us could divert our resources, could cause us to incur substantial liabilities and could limit commercialization of any product candidates we may develop.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will face an inherent risk of clinical trial and product liability exposure related to the testing of any product candidates we may develop in clinical trials, and we will face an even greater risk if we commercially sell any products that we may develop. While we currently have not completed the evaluation of any product candidates in human clinical trials or that have been approved for commercial sale, the future use of product candidates by us in clinical trials, and the sale of any approved products in the future, may expose us to liability claims. These claims might be made by patients that use the product, healthcare providers, pharmaceutical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">companies or others selling such products. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decreased demand for any product candidates that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of clinical trial participants and inability to continue clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product recalls, withdrawals or labeling, marketing or promotional restrictions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of revenue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial monetary awards to trial participants or patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant time and costs to defend any related litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a diversion of our management&#8217;s time and our resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exhaustion of any available insurance and our capital resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">initiation of investigations by regulators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to commercialize any product candidates that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injury to our reputation and significant negative media attention; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a decline in price of our common stock.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will need to increase our insurance coverage if we continue to commence clinical trials or if we commence commercialization of any product candidates. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. If and when coverage is secured, our insurance policies may also have various exclusions and we may be subject to a product liability claim for which we have no coverage. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or adequate should any claim arise. If a successful clinical trial or product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we or any contract manufacturers and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to numerous foreign, federal, state and local environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources, including any available insurance. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could incur significant costs and liabilities which may adversely affect our financial condition and operating results for failure to comply with such laws and regulations, including, among other things, civil or criminal fines and penalties, property damage and personal injury claims, costs associated with upgrades to our facilities or changes to our operating procedures, or injunctions limiting or altering our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our research and product development efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials. In the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations, which are becoming increasingly more stringent, may impair our research, development or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our future ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception, we have incurred losses and we may never achieve profitability. As of December 31, 2024, we had $13.2 million of federal net operating loss (&#8220;NOL&#8221;) carryforwards and $75.0 million of state NOL carryforwards, available to reduce future taxable income. To the extent that we continue to generate taxable losses, under current law, our unused U.S. NOLs may be carried forward to offset a portion of future taxable income, if any. Additionally, we continue to generate business tax credits, including research and development tax credits, which generally may be carried forward to offset a portion of future taxable income, if any, subject to expiration of such credit carryforwards. Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (&#8220;Code&#8221;), if a corporation undergoes an &#8220;ownership change,&#8221; generally defined as one or more stockholders or groups of stockholders who own at least 5% of the corporation&#8217;s equity increasing their equity ownership in the aggregate by more than 50 percentage points (by value) over a three-year period, the corporation&#8217;s ability to use its pre-change NOLs and other pre-change tax attributes (such as research and development tax credits) to offset its post-change income or taxes may be limited. Similar rules may apply under state tax laws. Our prior equity offerings and other changes in our stock ownership may have resulted in such ownership changes in the past. In addition, we may experience ownership changes in the future due to shifts in our stock ownership, some of which are outside of our control. As a result, if we earn net taxable income, our ability to use our pre-change NOLs or other pre-change tax attributes to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to us and could require us to pay U.S. federal income taxes earlier than would be required if such limitations were not in effect. Additional limitations on our ability to utilize our NOLs to offset future taxable income may arise as a result of our corporate structure whereby NOLs generated by our subsidiary may not be available to offset taxable income earned by our subsidiary. There is a risk that due to changes under the tax law, regulatory changes or other unforeseen reasons, our existing NOLs or business tax credits could expire or otherwise be unavailable to offset future income tax liabilities. At the state level, there may also be periods during which the use of NOLs or business tax credits is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For example, under Senate Bill 167 enacted by California in June 2024, generally, there is a suspension of the NOL deduction for tax years beginning on or after January 1, 2024, and before January 1, 2027 for individual and corporate taxpayers with net business income or modified adjusted gross income of $1 million or more, and a limit of $5 million of business credits on the aggregate use of otherwise allowable business tax credits that any individual or corporate taxpayer could claim for tax years beginning on or after January 1, 2024, and before January 1, 2027. For these reasons, we may not be able to realize a tax benefit from the use of our NOLs or tax credits, even if we attain profitability.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have and may in the future engage in strategic transactions that could impact our liquidity, increase our expenses and present significant distractions to our management.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have and in the future, we may consider strategic transactions, such as acquisitions of companies, asset purchases, and in-licensing or out-licensing of products, product candidates or technologies from time to time. Additional potential transactions that we may consider include a variety of different business arrangements, including spin-offs, strategic partnerships, joint ventures, restructurings, divestitures, business combinations and investments. Any such transaction may require us to incur non-recurring or other charges, may increase our near- and long-term expenditures and may pose significant integration challenges or disrupt our senior management or business, which could adversely affect our operations and financial results. For example, these transactions may entail numerous operational and financial risks, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up-front, milestone and royalty payments, equity investments and financial support of new research and development candidates including increase of personnel, all of which may be substantial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exposure to unknown liabilities, including potential indemnification claims from a potential spin-off or out-license of certain of our intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disruption of our business and diversion of our management&#8217;s time and attention to develop acquired products, product candidates or technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incurrence of substantial debt or dilutive issuances of equity securities to pay for acquisitions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">higher than expected costs in risk-sharing collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">higher-than-expected acquisition and integration costs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lower-than-expected benefits, from out-licensing or selling our technology, intellectual property or any of our subsidiaries or, from in-licensing intellectual property or purchasing assets;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">write-downs of assets or goodwill or impairment charges;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty and cost in combining or separating the operations and personnel of any acquired or sold businesses with our existing operations and personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may disagree with our strategic partners about decisions affecting the business, which could result in litigation or arbitration that increases our expenses, distracts our officers and directors and disrupts the day-to-day operations of the strategic venture, including by delaying important decisions until the dispute is resolved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our strategic partners may take actions that we oppose;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our strategic partners might experience financial distress or become bankrupt;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">impairment of relationships with key suppliers or customers of any acquired or sold businesses due to changes in our senior management and ownership; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability to retain key employees of any acquired businesses.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, to the extent we enter into a strategic transaction that includes ongoing operations or shared ownership and management, our strategic partners may take actions that we oppose or we may disagree with our strategic partners about decisions affecting the business, which could result in litigation or arbitration, distract our officers and directors and otherwise disrupt the day-to-day operations of our business and the business of the strategic partner or entity. Furthermore, to the extent that our directors and officers serve on the boards of our strategic partners, such directors may be required to abstain from board decision-making in the event of a conflict of interest.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, although we cannot be certain that we will undertake or successfully complete any transactions of the nature described above, any transactions that we do complete may be subject to the foregoing or other risks, and could harm our business, results of operations, financial condition and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have conducted and may continue to conduct, clinical trials for our product candidates outside of the United States, and we may do so for our other product candidates. However, conducting trials outside of the United States exposes us to additional risks, which could materially harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted, and may in the future conduct, certain of our clinical trials at centers outside of the United States. The acceptance of study data from clinical trials conducted outside the United States or another jurisdiction by the FDA or another comparable foreign regulatory authority may be subject to certain conditions or may not be accepted at all. For example, in cases where data from foreign clinical trials are intended to serve as the sole basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i) the data are applicable to the U.S. population and U.S. medical practice; (ii) the trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations; and (iii) the data may be considered valid without the need for an on-site inspection by the FDA, or if the FDA considers such inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. In addition, even where the foreign study data are not intended to serve as the sole basis for approval, the FDA will not accept the data as support for an application for marketing approval unless the study is well-designed and well-conducted in accordance with GCP requirements and the FDA is able to validate the data from the study through an onsite inspection if deemed necessary. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. If the FDA, the EMA, the U.K. Medicines and Healthcare products Regulatory Agency, or other foreign regulatory authorities do not accept any data generated from other jurisdictions, we would likely be required to conduct additional clinical trials, which would be costly and time consuming, and delay aspects of our development plan, which could harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conducting trials outside the United States also exposes us to additional risks, including risks associated with:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional foreign regulatory requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign exchange fluctuations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with foreign manufacturing, customs, shipment and storage requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cultural differences in medical practice and clinical research;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diminished protection of intellectual property in some countries; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">interruptions or delays in our trials resulting from geopolitical events, such as war or terrorism. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our information systems or data, or those of third parties with whom we work, are or were compromised, we could experience adverse consequences from such compromises, such as damage our reputation, significant financial and legal exposure, or other adverse effects to our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on information technology systems that we or third parties with whom</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we work, operate to process, transmit and store electronic information, including sensitive information, in our day-to-day operations. For example, in connection with our product development efforts, we may collect and process a variety of personal data, proprietary information, trade secrets, and clinical trial information. As a result, we and the third parties with whom</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we work, face a variety of evolving threats that could cause cybersecurity incidents, data breaches, or other adverse security events.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cyberattacks, malicious internet-based activity, online and offline fraud, and other similar activities could result in the theft or destruction of intellectual property, personal data, or other misappropriation of assets, or otherwise threaten to compromise our confidential or proprietary information and disrupt our operations. Such threats are increasing in their frequency, sophistication, and intensity, have become increasingly difficult to detect, and come from a variety of sources, including traditional computer &#8220;hackers,&#8221; threat actors, &#8220;hacktivists,&#8221; organized criminal threat actors, intentional or inadvertent wrongful conduct by personnel and vendors (such as through human error, theft or misuse), sophisticated nation states, and nation-state-supported actors. Some actors now engage and are expected to continue to engage in cyberattacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities, wrongful conduct by hostile foreign governments and industrial espionage. During times of war and other major conflicts, we and the third parties upon which we work may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our services.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We and the third parties with whom</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we work are subject to a variety of evolving threats, including but not limited to the deployment of harmful malware (including as a result of advanced persistent threat intrusions), ransomware, denial-of-service, credential stuffing, credential harvesting, social engineering fraud (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, attacks enhanced or facilitated by AI, telecommunications failures, earthquakes, fires, floods, and other similar threats.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, ability to provide our products or services, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A successful cyberattack could cause serious negative consequences for us, including, without limitation, the disruption of operations, the misappropriation of confidential business information, including financial information, trade secrets, financial loss and the disclosure of corporate strategic plans. Although we devote resources to protect our information systems, there can be no assurance that our efforts will prevent information cybersecurity incidents or data breaches that would result in business, legal, financial or reputational harm to us, or would have a material adverse effect on our results of operations and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Remote work has become more common and has increased risks to our information technology systems and data, as more of our employees utilize network connections, computers, and devices outside our premises or network, including working at home, while in transit and in public locations. Additionally, future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies. Furthermore, we may discover security issues or other constraints not found during due diligence of such acquired or integrated entities, creating additional challenges to integrate said information systems into our information technology environment and security program.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Like other companies in our industry, we, and our third party vendors, have experienced threats and cybersecurity incidents relating to our information technology systems and infrastructure. While we have implemented security measures designed to protect against cybersecurity incidents and data breaches, there can be no assurance that these measures will be effective. We take steps designed to detect, mitigate, and remediate known vulnerabilities in our information systems (such as our hardware and/or software, including that of third parties with whom we work). We may not, however, detect and remediate all such vulnerabilities on a timely basis for various reasons including but not limited to the impact on the functional operations of affected information systems or the availability of a solution for the impacted technology. While remedial measures and/or patches designed to address identified vulnerabilities are being developed and/or implemented, these vulnerabilities could be exploited and result in a cybersecurity incident or data breach.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Applicable data privacy and security obligations may require us to notify relevant stakeholders, including affected individuals, customers, regulators, and investors, of cybersecurity incidents and data breaches. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. Additionally, laws in all 50 states require businesses to provide notice to customers whose personal data has been disclosed as a result of a data breach. These laws are not consistent, and compliance in the event of a widespread cybersecurity incident or data breach is difficult and may be costly. We also may be contractually required to notify patients or other counterparties of a cybersecurity incident or data breach. Although we may have contractual protections with our service providers, any actual or perceived cybersecurity incident or data breach could harm our reputation and brand, expose us to potential liability or require us to expend significant resources on data security and in responding to any such actual or perceived cybersecurity incident or data breach. Any contractual protections we may have from our service providers may not be sufficient to adequately protect us from any such liabilities and losses, and we may be unable to enforce any such contractual protections. In addition to government regulation, privacy advocates and industry groups have and may in the future propose self-regulatory standards from time to time. These and other industry standards may legally or contractually apply to us, or we may elect to comply with such standards. Determining whether personal data has been handled in compliance with applicable privacy standards and our contractual obligations can be complex and may be subject to changing interpretation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we maintain insurance coverage, we cannot assure that such coverage will be adequate or otherwise protect us from or adequately mitigate liabilities or damages with respect to claims, costs, expenses, litigation, fines, penalties, business loss, data loss, regulatory actions or material adverse effects arising out of our data protection, privacy, and security practices, or that such coverage will continue to be available on acceptable terms or at all. The successful assertion of one or more large claims against us that exceeds our available insurance coverage, or results in changes to our insurance policies (including premium increases or the imposition of large deductible or co-insurance requirements), could have an adverse effect on our business. In addition, we cannot be sure that our existing insurance coverage will continue to be available on acceptable terms or that our insurers will not deny coverage as to any future claim.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Threat actors and their techniques change frequently, are often sophisticated in nature, and may not be detected until after a cybersecurity incident or data breach has occurred. Any failure, or perceived failure, to prevent or mitigate cybersecurity incidents, data breaches or other improper access to, use of, or disclosure of our clinical data or patients&#8217; personal data could result in significant liability under state (e.g., state breach notification laws), federal (e.g., Health Insurance Portability and Accountability Act of 1996), and foreign (e.g., the GDPR) laws, and may cause a material adverse impact to our reputation, affect our ability to conduct new studies and potentially disrupt our business, results of operations and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our reliance on the computer systems of various third parties with whom we work, including our CROs and other contractors, introduce new cybersecurity risks and vulnerabilities, including supply-chain attacks, and other threats to our business operations. We rely on our third-party partners to implement effective security measures and identify and correct for any such failures, deficiencies, cybersecurity incidents or data breaches. However, our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. While we may be entitled to damages if the third parties with whom we work fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or that of the third parties with whom we work have not been compromised.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we or our third-party partners fail to maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to our information technology systems, we or our third-party partners could have difficulty preventing, detecting and controlling such cyberattacks and any such attacks could result in disputes with physicians, patients and our partners, regulatory sanctions or penalties, increases in operating expenses, expenses or lost revenues or other adverse consequences, any of which could have a material adverse effect on our business, results of operations, financial condition, prospects and cash flows. Any failure by such third parties to prevent or mitigate cybersecurity incidents, data breaches or other improper access to or disclosure of such information could have similarly adverse consequences for us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to experiencing a cybersecurity incident or data breach, third parties may gather, collect, or infer sensitive data about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position. Additionally, sensitive data of the Company could be leaked, disclosed, or revealed as a result of or in connection with our employees&#8217;, personnel&#8217;s, or vendors&#8217; use of generative artificial intelligence technologies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of the previously identified or similar threats could cause a cybersecurity incident, data breach, or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive data or our information technology systems, or those of the third parties with whom we work. A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity incident, data breach, or other interruption could disrupt our ability (and that of third parties with whom we work) to provide our services.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Government Regulatory and Legal Requirements</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, which could negatively impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, federal agencies in the U.S. are operating under a continuing resolution that is set to expire on September 30, 2025. Without appropriation of additional funding to federal agencies, our business operations related to our product development activities for the U.S. market could be impacted. The ability of the FDA, EMA, and other comparable foreign regulatory authorities to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the FDA have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government shut down several times and certain regulatory agencies, such as the FDA, furloughed critical employees and ceased critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a prolonged government shutdown occurs, or if global health concerns prevent the FDA, EMA, or other comparable foreign regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA, EMA, or other comparable foreign regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to obtain orphan drug designation or exclusivity for our product candidates, and even if we do, that designation may not provide an expedited development or regulatory review or approval process and any orphan drug exclusivity we may receive for approved products may not prevent the FDA or the EMA from approving other competing products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Orphan Drug Act, the FDA may designate a product candidate as an orphan drug if it is intended to treat a rare disease or condition. A similar regulatory scheme governs the designation of orphan product candidates by the EMA in the EU. Generally, if a product with an orphan drug designation subsequently receives the first regulatory approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA (as applicable) from approving another marketing authorization application for another similar product candidate for the same orphan therapeutic indication for that time period. The applicable period is seven years in the United States and ten years in the EU (which can be extended to 12 years if the sponsor complies with an agreed-upon pediatric investigation plan). The exclusivity period in the EU can be reduced to six years if at the end of the fifth year it is determined that a product no longer meets the criteria for orphan designation, including if the product is sufficiently profitable so that market exclusivity is no longer justified.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order for the FDA to grant orphan drug exclusivity to one of our product candidates, the agency must find that the product candidate is indicated for the treatment of a condition or disease that affects fewer than 200,000 individuals in the United States or that affects 200,000 or more individuals in the United States and for which there is no reasonable expectation that the cost of developing and making the product candidate available for the disease or condition will be recovered from sales of the product in the United States. Hypoparathyroidism is a disease that affects approximately 70,000 individuals in the United States, and accordingly, any product candidate we advance forward in development for hypoparathyroidism may qualify for orphan drug designation. However, the FDA may conclude that the condition or disease for which we seek orphan drug exclusivity does not meet this standard. In the EU, a medicinal product may be designated as orphan if (1) it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2) either (a) such condition affects no more than five in 10,000 persons in the EU when the application is made, or (b) it is unlikely that the product, without the benefits derived from orphan status, would generate sufficient return in the EU to justify the necessary investment in its development; and (3) there exists no satisfactory method of diagnosis, prevention or treatment of such condition authorized for marketing in the EU, or if such a method exists, the product will be of significant benefit to those affected by the condition. Even if we obtain orphan drug exclusivity for a product candidate, that exclusivity may not effectively protect the product candidate from competition because different product candidates can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA or the EMA can subsequently approve the same product candidate for the same condition if the FDA or EMA (as applicable) concludes that the later product candidate is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care compared with the product that has</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">orphan exclusivity. Orphan drug exclusivity may also be lost if the FDA or EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">While we may in the future seek designations for our product candidates with the FDA, EMA and other comparable foreign regulatory authorities that are intended to confer benefits such as a faster development process, an accelerated regulatory pathway or regulatory exclusivity, there can be no assurance that we will successfully obtain such designations. In addition, even if one or more of our product candidates are granted such designations, we may not be able to realize the intended benefits of such designations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA, EMA, and other comparable foreign regulatory authorities offer certain designations for product candidates that are designed to encourage the research and development of product candidates that are intended to address conditions with significant unmet medical need. These designations may confer benefits such as additional interaction with regulatory authorities, a potentially accelerated regulatory pathway and priority review. However, there can be no assurance that we will successfully obtain such designations for our product candidates. In addition, while such designations could expedite the development or approval process, they generally do not change the standards for approval. Even if we obtain such designations for our product candidates, there can be no assurance that we will realize their intended benefits.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, we may seek a Fast Track Designation for one or more of our product candidates. If a product is intended for the treatment of a serious or life-threatening condition and preclinical or clinical data demonstrate the potential to address an unmet medical need for this condition, the product sponsor may apply for Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it. Even if we do receive Fast Track Designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may rescind the Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, we may seek to participate in the PRIority Medicines (&#8220;PRIME&#8221;) scheme for our potential product candidates. The PRIME scheme is intended to encourage development of product candidates in areas of unmet medical need and provides accelerated assessment of product candidates representing substantial innovation, where the marketing authorization application will be made through the centralized procedure in the EU. Eligible products must target conditions for which there is an unmet medical need (i.e. no treatment option exists in the EU or the applicable product candidate can offer a major therapeutic advantage over existing treatments). Many benefits accrue to sponsors of product candidates with access to the PRIME scheme, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated marketing authorization application assessment once a dossier has been submitted. There is no guarantee, however, that our potential product candidate would be deemed eligible for the PRIME scheme and even if we do participate in the PRIME scheme, where during the course of development a product no longer meets the eligibility criteria, support under the PRIME scheme may be withdrawn. PRIME eligibility does not change the standards for product approval, and there is no assurance that any such designation or eligibility will result in expedited review or approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek Breakthrough Therapy Designation for one or more of our product candidates. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA are also eligible for accelerated approval and priority review.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe a product candidate we develop meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of Breakthrough Therapy Designation for a product candidate may not result in a faster development process, review or approval compared to drugs considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if any product candidate we develop qualifies as a breakthrough therapy, the FDA may later decide that the drug no longer meets the conditions for qualification and rescind the designation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even in the absence of obtaining Fast Track and/or Breakthrough Therapy Designations, a sponsor can seek priority review at the time of submitting a marketing application. The FDA may designate a product for priority review if it is a product that treats a serious condition and, if approved, would provide a significant improvement in safety or effectiveness when compared with other available therapies. Significant improvement may be illustrated by evidence of increased effectiveness in the treatment of a condition, elimination or substantial reduction of a treatment-limiting adverse reaction, documented enhancement of patient compliance that may lead to improvement in serious outcomes, or evidence of safety and effectiveness in a new subpopulation. A priority review</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#8217;s goal for taking action on a marketing application from ten months to six months. Priority review designation may be rescinded if a product no longer meets the qualifying criteria.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Where appropriate, we may secure approval from the FDA, EMA, or other comparable foreign regulatory authorities through the use of expedited approval pathways, such as accelerated approval. If we are unable to obtain such approvals, we may be required to conduct additional preclinical studies or clinical trials beyond those that we contemplate, which could increase the expense of obtaining, and delay the receipt of, necessary marketing approvals. Even if we receive accelerated approval from the FDA, EMA, or other comparable foreign regulatory authorities, if our confirmatory trials do not verify clinical benefit, or if we do not comply with rigorous post-marketing requirements, the FDA, EMA, or other comparable foreign regulatory authorities may seek to withdraw the accelerated approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Where possible, we plan to pursue accelerated development strategies in areas of high unmet need. We may seek an accelerated approval pathway for our one or more of our product candidates from the FDA, EMA, or other comparable foreign regulatory authorities. Under the accelerated approval provisions in the Federal Food, Drug, and Cosmetic Act, and the FDA&#8217;s implementing regulations, the FDA may grant accelerated approval to a product candidate designed to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies upon a determination that the product candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage but is a clinically important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the drug&#8217;s clinical benefit. Under FDORA, the FDA is permitted to require, as appropriate, that a post-approval confirmatory study or studies be underway prior to approval or within a specified time period after the date of approval for a product granted accelerated approval. FDORA also gives the FDA increased authority to withdraw approval of a drug or biologic granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a timely manner, send status updates on such studies to the FDA every 180 days to be publicly posted by the agency, or if such post-approval studies fail to verify the drug&#8217;s predicted clinical benefit. The FDA is empowered to take action, such as issuing fines, against companies that fail to conduct with due diligence any post-approval confirmatory study or submit timely reports to the agency on their progress.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to seeking accelerated approval, we would seek feedback from the FDA, EMA, or other comparable foreign regulatory authorities and would otherwise evaluate our ability to seek and receive such accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue or submit an NDA or BLA for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that after subsequent feedback from the FDA, EMA, or other comparable foreign regulatory authorities, we will continue to pursue or apply for accelerated approval or any other form of expedited development, review or approval, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated approval, there can be no assurance that such application will be accepted or that any approval will be granted on a timely basis, or at all. The FDA, EMA, or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering our application or granting approval of any type, including, for example, if other products are approved via the accelerated pathway and subsequently converted by FDA to full approval. A failure to obtain accelerated approval or any other form of expedited development, review or approval for our product candidate would result in a longer time period to commercialization of such product candidate, could increase the cost of development of such product candidate and could harm our competitive position in the marketplace.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to stringent and evolving U.S. and foreign laws, rules, regulations, policies, industry standards, contractual requirements, and other obligations related to data protection, privacy, and security. Our actual or perceived failure to comply with such obligations could adversely affect our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to various data protection, privacy, and security laws, rules, regulations, policies, industry standards, contractual requirements, and other obligations that apply to our collection, transmission, storage, use, disclosure, transfer, maintenance and other processing of sensitive information, including personal data. The legislative and regulatory landscape for data protection, privacy, and security continues to evolve across jurisdictions worldwide. For example, in the United States, federal, state, and local governments have enacted numerous data protection, privacy, and security laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws).</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the federal level, regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended by the Health Information Technology for Economic and Clinical Health Act, and implementing regulations, establish stringent privacy and security standards that limit the use and disclosure of individually identifiable health information, or protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic protected health information. Further, failing to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission (&#8220;FTC&#8221;) Act, 15 U.S.C &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business and the cost of available tools to improve security and reduce vulnerabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulators and legislators in the U.S. are also increasingly scrutinizing and restricting certain personal data transfers and transactions involving foreign countries. For example, Executive Order 1147 of February 28, 2024, on &#8220;Preventing Access to Americans&#8217; Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern&#8221; as implemented by Department of Justice regulations issued in December 2024, prohibits data brokerage and data sharing transactions involving certain sensitive personal data categories, including health data, genetic data, and biospecimens, to countries of concern, including China. The regulations also restrict certain investment agreements, employment agreements and vendor agreements involving such data and countries of concern, absent specified cybersecurity controls. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions, and may result in exclusion from participation in federal and state programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Data protection, privacy, and security obligations remain an evolving landscape at both the domestic and foreign level, with new laws, rules and regulations coming into effect, posing continued legal and compliance challenges. For example, in the past few years, numerous U.S. states&#8212;including, but not limited to, California, Virginia, Colorado, Connecticut, New Jersey, New Hampshire, and Utah&#8212;have enacted comprehensive privacy laws that impose certain obligations on covered businesses, including providing specific disclosures in privacy notices and affording residents with certain rights concerning their personal data. As applicable, such rights may include the right to access, correct, or delete certain personal data, and to opt-out of certain data processing activities, such as targeted advertising, profiling, and automated decision-making. The exercise of these rights may impact our business and ability to conduct our operations. Certain states also impose stricter requirements for processing certain personal data, including sensitive information, such as conducting data privacy impact assessments. These state laws allow for statutory fines for noncompliance. For example, in California, the California Consumer Privacy Act, as amended by the California Privacy Rights Act (collectively, &#8220;CCPA&#8221;), provides for fines of up to $7,500 per intentional violation and allows privacy litigants affected by certain data breaches to recover significant statutory damages. The CCPA and other comprehensive U.S. state privacy laws exempt some data processed in the context of clinical trials, but these developments may further complicate compliance efforts, and increase legal risk and compliance costs for us, the third parties with whom we work.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similar laws are being proposed in numerous other states and at the federal level. Proposed legislation, if enacted, may add additional complexity, variation in requirements, processing restrictions, potential legal risk, require additional investment of resources, impact business strategies, and could result in increased compliance costs and/or changes in business practices and policies. The existence of comprehensive privacy laws in different states will make our compliance obligations more complex and costly and may increase the likelihood that we may be subject to enforcement actions or otherwise incur liability for noncompliance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Several states are also specifically regulating consumer health information. For example, Washington has enacted a consumer health privacy law, the My Health My Data Act (&#8220;WMHMDA&#8221;), which went into effect on March 31, 2024 and regulates the collection and sharing of consumer health information. WMHMDA places restrictions on processing consumer health data (including imposing stringent requirements for consents), provides consumers certain rights with respect to their health data, and creates a private right of action to allow individuals to sue for violations of the law, which further increases the relevant compliance risk. Connecticut and Nevada have also passed similar laws regulating consumer health data, and a similar law is awaiting the governor&#8217;s signature in New York. In addition, other states have proposed and/or passed legislation that regulates the privacy and/or security of certain specific types of information. For example, a small number of states have passed laws that regulate biometric data specifically. These various privacy and security laws may impact our business activities, including our identification of research subjects, relationships with business partners and ultimately the marketing and distribution of our products. State laws are changing rapidly and there are discussions in the U.S. Congress of new comprehensive federal data privacy laws to which we could become subject to, if enacted.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside the United States, an increasing number of laws, regulations, and industry standards govern data protection, privacy, and security. For example, if we conduct clinical trials in the European Economic Area (&#8220;EEA&#8221;) and/or the United Kingdom (&#8220;U.K.&#8221;), we may become subject to additional privacy laws in those jurisdictions, such as the EU General Data Protection Regulation (&#8220;EU GDPR&#8221;) and the EU GDPR as incorporated into U.K. domestic law post-Brexit (&#8220;U.K. GDPR&#8221; and, together with the EU GDPR, &#8220;GDPR&#8221;), both of which impose strict requirements for processing personal data. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to having a legal basis or condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for processing personal data, stricter requirements relating to the processing of sensitive data (such as health data), where required by the GDPR obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, requiring data protection impact assessments for high risk processing and taking certain measures when engaging third-party processors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the GDPR, data protection authorities may impose large penalties for violations of the GDPR, including potential fines of up to &#8364;20 million (&#163;17.5 million GBP) or 4% of annual global revenues, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. Non-compliance could also result in the imposition of orders to stop data processing activities, which could have a material adverse effect on our business, financial position, and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may be unable to transfer personal data from the EEA, U.K., and other jurisdictions to the U.S. or other countries due to data localization requirements or limitations on cross-border data flows. Although there are various mechanisms that may be used in some cases to lawfully transfer personal data to the U.S. or other countries, these mechanisms are subject to legal challenges and may not always be available to us. For example, the GDPR requires certain adequate safeguards to enable the transfer of personal data outside of the EEA or the U.K., in particular to the U.S., such as the EU standard contractual clauses, U.K. International Data Transfer Addendum/Agreement, and the EU-U.S. Data Privacy Framework (&#8220;Framework&#8221;) and the UK extension thereto (which allows for transfers to relevant U.S.-based organizations who self-certify compliance and participate in the Framework). However, these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the U.S. If there is no lawful manner for us to transfer personal data from the EEA, the U.K. or other jurisdictions to the U.S., or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions (such as Europe) at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the U.K. is regarded as a third country under the EU GDPR, the European Commission has issued a decision recognizing the U.K. as providing adequate protection under the EU GDPR, or the Adequacy Decision, and, therefore, transfers of personal data originating in the EEA to the U.K. remain unrestricted. The U.K. government has confirmed that personal data transfers from the U.K. to the EEA remain free flowing. The U.K. Government had introduced a Data Protection and Digital Information Bill which failed in the U.K. legislative process. A new Data (Use and Access) Bill (&#8220;U.K. Bill&#8221;) has now been introduced into parliament. The aim of the U.K. Bill is to reform the U.K.&#8217;s data protection regime. If passed, the final version of the U.K. Bill may have the effect of further altering the similarities between the U.K. and EEA data protection regime. This may lead to additional compliance costs and could increase our overall risk. The respective provisions and enforcement of the EU GDPR and U.K. GDPR may further diverge in the future and create additional regulatory challenges and uncertainties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EEA, the NIS 2 Directive (&#8220;NIS 2&#8221;) is replacing the cybersecurity legal framework under the current NIS framework, aiming to ensure a high level of cybersecurity in the region. NIS 2 brings new medium and large organizations providing services in the EEA within scope of the legal framework. It extends to additional sectors and expands the list of in-scope healthcare organizations, including to certain providers engaged in research and development of medicinal products. The new regime imposes direct obligations on management in respect of an in-scope organization's compliance with NIS 2, requires covered organizations to put in place certain cyber risk management measures, strengthens incident reporting requirements and provides supervisory authorities with a greater oversight. The majority of obligations will come into force when national legislation implementing NIS 2 becomes effective in the relevant EU Member State. EU Member States had until 17 October 2024 to transpose NIS 2 into national legislation, although many countries have still not completed the transposition. As such, the cybersecurity regulatory landscape in the EU is currently fragmented and uncertain. To the extent we are subject to NIS 2,  we will require additional investment of our resources in compliance programs. Under NIS 2 companies may be subject to administrative fines of up to the higher amount of &#8364;10 million or 2% of worldwide turnover.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, if we fail, or are perceived to have failed, to comply with applicable data protection, privacy, and security laws, including applicable HIPAA privacy and security standards, we could face significant administrative, civil and criminal penalties. For example, HHS has the discretion to impose significant penalties, and such enforcement activity can result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal resources. In addition, state attorneys general are authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten the data protection, privacy, or security of the personal data of state residents. We cannot be sure how these laws, rules and regulations will be interpreted, enforced, or applied to our operations. In addition to the risks associated with enforcement activities and potential</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contractual liabilities, our ongoing efforts to comply with evolving laws, rules and regulations at the international, federal and state level may be costly and require ongoing modifications to our policies, procedures and systems.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we rely on certain third-party vendors to process certain confidential, sensitive, or personal data on our behalf. Failure by us or our third-party vendors to comply with any of these laws, rules, regulations, contractual requirements, industry standards, or other obligations could result in notification obligations, enforcement actions, regulatory investigations or inquiries, significant fines, imprisonment of company officials and public censure, litigation and claims for damages by affected individuals, customers or business partners, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our employees and personnel use generative artificial intelligence technologies to perform their work, and the disclosure and use of personal data in generative artificial intelligence technologies is subject to various privacy laws and other privacy obligations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, including personal information, and as a result we may be exposed to reputational harm and liability.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may use and integrate artificial intelligence into our business processes. Use of this technology presents risks and challenges that could affect our business. If we enable or use solutions that draw controversy due to perceived or actual negative societal impact, we may experience brand or reputational harm, competitive harm or legal liability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A growing number of legislators and regulators are adopting laws and regulations and have focused enforcement efforts on the adoption of artificial intelligence, and use of such technologies in compliance with ethical standards and societal expectations. These developments may increase our compliance burden and costs in connection with use of artificial intelligence and lead to legal liability if we fail to meet evolving legal standards or if use of such technologies results in harms or other causes of action we did not predict. For example, the EU&#8217;s Artificial Intelligence Act (&#8220;AI Act&#8221;) entered into force on August 1, 2024, with most provisions becoming effective on August 2, 2026. This legislation imposes significant obligations on providers and deployers of artificial intelligence systems, and encourages providers and deployers of artificial intelligence systems to account for EU ethical principles in their development and use of these systems. The scope of requirements depends on legal and risk determinations that rely on novel legal provisions that have not yet been interpreted by courts or regulators, and non-compliance can lead to significant fines.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Likewise, in the U.S., several states, including Colorado and California, passed laws that will take effect in 2026, to regulate various uses of artificial intelligence, including to make consequential decisions. In addition, various federal regulators have issued guidance and focused enforcement efforts on the use of AI in regulated sectors. The FDA, for example, issued guidance on the use of artificial intelligence in medical devices, requiring detailed risk management and review processes to obtain approvals. If we develop or use AI systems governed by these laws or regulations, we will need to meet higher standards of data quality, transparency, monitoring and human oversight, and we would need to adhere to specific and potentially burdensome and costly ethical, accountability, and administrative requirements, with the potential for significant enforcement or litigation in the event of any perceived non-compliance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rapid evolution of artificial intelligence will require the application of significant resources to design, develop, test and maintain such systems to help ensure that artificial intelligence is implemented in accordance with applicable law and regulation and in a socially responsible manner and to minimize any real or perceived unintended harmful impacts. The use of certain artificial intelligence technologies can also give rise to intellectual property risks, including by disclosing or otherwise compromising our confidential or proprietary intellectual property, or by undermining our ability to assert or defend ownership rights in intellectual property created with the assistance of artificial intelligence tools.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our vendors may in turn incorporate artificial intelligence tools into their offerings, and the providers of these artificial intelligence tools may not meet existing or rapidly evolving regulatory or industry standards, including with respect to privacy and data security. Further, bad actors around the world use increasingly sophisticated methods, including the use of artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information, confidential information and intellectual property. Any of these effects could damage our reputation, result in the loss of valuable property and information, cause us to breach applicable laws and regulations, and adversely impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of these compliance and operational requirements impose significant costs, such as costs related to organizational changes, implementing additional protection technologies, training employees and engaging consultants and legal advisors, which are likely to increase over time. Our efforts to comply with the evolving data protection, privacy, AI and security laws, rules, regulations, and other obligations may be unsuccessful. We may need to devote significant resources to understanding and complying with this changing landscape. In addition, such requirements may require us to modify our data processing practices and policies, utilize management&#8217;s time and/or divert resources from other initiatives and projects. Any actual or perceived failure by us or our third-party partners to comply with such laws, rules, regulations, and other obligations regarding data protection, privacy, AI and security could result in significant government-imposed fines or orders requiring that we change our practices, claims for damages or other liabilities, regulatory investigations and enforcement action, litigation and significant costs for remediation, any of which could adversely affect our business. Even if we are not determined to have violated these laws, rules or regulations, government investigations into these</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issues typically require the expenditure of significant resources and generate negative publicity. Further, any of the foregoing could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare legislative reform measures may have a negative impact on our business and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect our ability to profitably sell any product candidates for which we obtain marketing approval. For more information, see the section titled &#8220;Business&#8211;Government Regulation&#8211;Current and Future U.S. Healthcare Reform.&#8221;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. In 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act was passed, which substantially changed the way healthcare is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical industry.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare may adversely affect:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the demand for any of our product candidates, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to set a price that we believe is fair for any of our product candidates, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to generate revenues and achieve or maintain profitability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of taxes that we are required to pay; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of capital.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical and biologic products. In addition, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2022, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;) was signed into law. The IRA includes several provisions that may impact our business, depending on how various aspects of the IRA are implemented. Provisions that may impact our business include a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, the imposition of new manufacturer financial liability on most drugs in Medicare Part D, permitting the U.S. government to negotiate Medicare Part B and Part D pricing for certain high-cost drugs and biologics without generic or biosimilar competition, requiring companies to pay rebates to Medicare for drug prices that increase faster than inflation, and delay until January 1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The implementation of the IRA is currently subject to ongoing litigation challenging the constitutionality of the IRA&#8217;s Medicare drug price negotiation program. The effects of the IRA on our business and the healthcare industry in general is not yet known.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be sure whether additional legislative changes will be enacted, or whether FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict what healthcare reform initiatives may be adopted in the future. We expect that these and other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and additional downward pressure on the price that we receive for any approved drug. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drugs.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our relationships with customers, physicians, and third-party payors may be subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws, other healthcare laws and regulations and health data privacy and security laws and regulations, contractual obligations and self-regulatory schemes. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare providers and third-party payors in the United States and elsewhere will play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third-party payors may subject us to various federal and state fraud and abuse laws and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute, the federal civil and criminal false claims laws and the law commonly referred to as the Physician Payments Sunshine Act and regulations. These laws will impact, among other things, our clinical research, as well as our proposed sales and marketing programs. In addition, we may be subject to health information privacy and security laws by the federal government, the states and other jurisdictions in which we may conduct our business. For more information, see the section titled &#8220;Business&#8211;Government Regulation&#8211;Other Healthcare Laws.&#8221;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the breadth of these laws and the limited statutory exceptions and regulatory safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legislation or other changes in U.S. tax law may have a material adverse effect on our business, cash flow, financial condition, or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many changes have been made to applicable tax laws and changes are likely to continue to occur in the future. For example, under Section 174 of the Code, in taxable years beginning after December 31, 2021, expenses that are incurred for research and development in the United States will be capitalized and amortized, which may have an adverse effect on our cash flow. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It cannot be predicted whether, when, in what form, or with what effective dates, new tax laws may be enacted, or regulations and rulings may be enacted, promulgated or issued under existing or new tax laws, which could result in an increase in our or our stockholders&#8217; tax liability or require changes in the manner in which we operate in order to minimize or mitigate any adverse effects of changes in tax law or in the interpretation thereof. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A decline in the federal budget, changes in spending or budgetary priorities of the U.S. government, a prolonged U.S. government shutdown or delays in contract awards may significantly and adversely affect our future revenues, cash flow and financial results.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In recent years, U.S. government appropriations have been affected by larger U.S. government budgetary issues and related legislation. As a result, the Department of Defense funding levels have fluctuated and have been difficult to predict. Future spending levels are subject to a wide range of factors, including Congressional action. In addition, in the past, U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns, or a recession in the U.S. Although U.S. lawmakers passed legislation to raise the federal debt ceiling on multiple occasions, ratings agencies have lowered or threatened to lower the long-term sovereign credit rating on the U.S. The impact of this or any further downgrades to the U.S. government&#8217;s sovereign credit rating or its perceived creditworthiness could adversely affect the U.S. and global financial markets and economic conditions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, government spending levels are difficult to predict beyond the near term due to numerous factors, including the external threat environment, future government priorities and the state of government finances. Significant changes in government spending or changes in U.S. government priorities, policies and requirements could have a material adverse effect on our results of operations, financial condition or liquidity.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The U.S. Congress, the Trump administration, or any new administration may make substantial changes to fiscal, tax, and other federal policies that may adversely affect our business</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2017, the U.S. Congress and the Trump administration made substantial changes to U.S. policies, which included comprehensive corporate and individual tax reform. In addition, the Trump administration called for significant changes to U.S. trade, healthcare, immigration and government regulatory policy. With the transition to the Biden administration in early 2021, changes to U. S. policy occurred and since the start of the Trump Administration in 2025, U.S. policy changes have been implemented at a rapid pace and additional changes are likely. Changes to U.S. policy implemented by the U.S. Congress, the Trump administration or any new administration have impacted and may in the future impact, among other things, the U.S. and global economy, international trade relations, unemployment, immigration, healthcare, taxation, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business. Until we know what policy changes are made, whether those policy changes are challenged and subsequently upheld by the court system and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. Compliance with these legal standards could hinder our ability to compete in certain markets. We can face criminal liability and other serious consequences for violations, which can harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations are subject to U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations. Anti-corruption laws generally prohibit us and our employees, officers, CROs, consultants, contractors and other partners and agents from authorizing, promising, offering, providing, soliciting, or receiving, directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities and other organizations. We also expect our non-U.S. activities to increase over time. We expect to rely on third parties for research, preclinical studies and clinical trials and/or to obtain necessary permits, licenses, patent registrations and other marketing approvals. We can be held liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to U.S. and foreign export controls, trade sanctions, and import laws and regulations. Such laws may prevent or prohibit the export or provision of certain products and services to countries, governments, and persons targeted by sanctions. Violations of these above laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, breach of contract and fraud litigation, reputational harm and other consequences.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Third Party Relationships</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may depend on collaborations with third parties for the discovery, development and commercialization of our product candidates. If any of these collaborations are not successful, we may not be able to capitalize on the market potential of those product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may in the future seek third-party collaborators for research, development and commercialization of our product candidates. Pharmaceutical companies are our prior and likely future collaborators for any marketing, distribution, development, licensing or broader collaboration arrangements. If we fail to enter into future collaborations on commercially reasonable terms, or at all, or such collaborations are not successful, we may not be able to execute our strategy to develop certain targets, product candidates or disease areas that we believe could benefit from the resources of either larger pharmaceutical companies or those specialized in a particular area of relevance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to any future collaboration agreements, we expect to have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of our product candidates. Moreover, our ability to generate revenues from these arrangements will depend on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these arrangements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collaborations involving our product candidates may pose the following risks to us:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on preclinical studies or clinical trial results, changes in the collaborators&#8217; strategic focus or available funding, or external factors such as an acquisition that diverts resources or creates competing priorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution of such product or products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to litigation or potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the foregoing, any future collaboration agreements may not lead to development or commercialization of our product candidates in the most efficient manner or at all. If a future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development or commercialization program could be delayed, diminished or terminated. Any failure to successfully develop or commercialize our product candidates pursuant to any future collaboration agreements could have a material and adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, to the extent that any of our future collaborators were to terminate a collaboration agreement, we may be forced to independently develop these product candidates, including funding preclinical studies or clinical trials, assuming marketing and distribution costs and defending intellectual property rights, or, in certain instances, abandon product candidates altogether, any of which could result in a change to our business plan and have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third-party manufacturers, CROs, CMOs, and suppliers to supply, develop and test components of our product candidates. The loss of our third-party manufacturers, CROs, CMOs, or suppliers, their failure to comply with applicable regulatory requirements or to supply sufficient quantities at acceptable quality levels or prices, or at all, or changes in methods of product candidate manufacturing, development or formulation would materially and adversely affect our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate facilities for drug manufacturing, storage, distribution or quality testing. We currently rely, and may continue to rely, on third-party contract manufacturers, including in China, to manufacture and test bulk drug substances, drug products, raw materials, samples, components, or other materials and reports. Reliance on third-party manufacturers may expose us to different risks than if we were to manufacture product candidates ourselves. There can be no assurance that our preclinical and clinical development product supplies will not be limited, interrupted, terminated or of satisfactory quality or continue to be available at acceptable prices. In addition, any replacement of our manufacturer could require significant effort and expertise because there may be a limited number of qualified replacements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The manufacturing process for a product candidate is subject to FDA, EMA and foreign regulatory authority review. In some cases, we, and our suppliers and manufacturers, some of which may be our sole source of supply, must meet applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in order to comply with regulatory standards, such as cGMPs. Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the FDA, EMA, and other comparable foreign regulatory authorities. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory requirements of the FDA, EMA, and other comparable foreign regulatory authorities, we may not be able to rely on their manufacturing facilities for the manufacture of elements of our product candidates. Moreover, we do not control the manufacturing process at our contract manufacturers and are completely dependent on them for compliance with current regulatory requirements. In the event that any of our manufacturers fails to comply with such requirements or to perform its obligations in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may be forced to enter into an agreement with another third party, which we may not be able to do on reasonable terms, if at all. In some cases, the technical skills or technology required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have difficulty transferring such to another third party.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to enable us, or to have another third party, manufacture our product candidates. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines; and we may be required to repeat some of the development program. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to continue to rely on third-party manufacturers if we receive regulatory approval for any product candidate. To the extent that we have existing, or enter into future, manufacturing arrangements with third parties, we will depend on these third parties to perform their obligations in a timely manner consistent with contractual and regulatory requirements, including those related to quality control and assurance. Any manufacturing facilities used to produce our products will be subject to periodic review and inspection by the FDA and foreign regulatory authorities, including for continued compliance with cGMP requirements, quality control, quality assurance and corresponding maintenance of records and documents. If we are unable to obtain or maintain third-party manufacturing for product candidates, or to do so on commercially reasonable terms, we may not be able to develop and commercialize our product candidates successfully. Our or a third party&#8217;s failure to execute on our manufacturing requirements, comply with cGMPs or maintain a compliance status acceptable to the FDA or foreign regulatory authorities could adversely affect our business in a number of ways, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay in the progress on certain research programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an inability to initiate or continue clinical trials of product candidates under development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay in submitting regulatory applications, or receiving regulatory approvals, for product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of the cooperation of existing or future collaborators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">subjecting third-party manufacturing facilities to additional inspections by regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to cease distribution or to recall batches of our product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the event of approval to market and commercialize a product candidate, an inability to meet commercial demands for our therapeutics.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, our contract manufacturers may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or unstable political environments. If our contract manufacturers were to encounter any of these difficulties, our ability to provide our product candidates to patients in preclinical and clinical trials, or to provide product for treatment of patients once approved, would be jeopardized.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we currently rely on foreign CROs and CMOs, including WuXi AppTec (HongKong) Limited, for manufacturing and development activities and will likely continue to rely on foreign CROs and CMOs in the future. Foreign CMOs may be subject to U.S. legislation, sanctions, trade restrictions and other foreign regulatory requirements which could increase the cost or reduce the supply of material available to us, delay the procurement or supply of such material or have an adverse effect on our ability to secure significant commitments from governments to purchase our potential therapies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, if enacted, legislation pending in Congress known as the BIOSECURE Act would prohibit U.S. federal agencies from entering into or renewing a contract with any company that uses biotechnology equipment or services produced or provided by a &#8220;biotechnology company of concern&#8221; in the performance of that contract. It would also prohibit loans or grant funding from U.S. federal agencies to entities that use any biotechnology equipment or services produced or provided by a &#8220;biotechnology company of concern&#8221; in the performance of the government grant or loan. The effects of this legislation, if enacted, is unknown; however, it could have the downstream effect of restricting the ability of pharmaceutical companies that enter into contracts with or receive funding from U.S. federal agencies from purchasing services or equipment from certain Chinese biotechnology companies, including those that are specifically named in the proposed BIOSECURE Act, as well as supply chain disruptions or delays. The current version of the BIOSECURE Act introduced in the House of Representatives names WuXi Biologics and WuXi AppTec as &#8220;biotechnology</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">companies of concern&#8221; and includes a grandfathering provision allowing biotechnology equipment and services provided or produced by named &#8220;biotechnology companies of concern&#8221; under a contract or agreement entered into before the effective date until January 1, 2032.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on whether the BIOSECURE Act becomes law, what the final language of the BIOSECURE Act includes, and how the law is interpreted by U.S. federal agencies, we could be potentially restricted from pursuing U.S. federal government business or government reimbursement for our products in the future if we continue to use WuXi Biologics, WuXi AppTec or other suppliers or partners identified as &#8220;biotechnology companies of concern&#8221; beyond this grandfathering period. In addition to the BIOSECURE Act, any additional executive action, legislative action, or potential sanctions with China could materially impact our work with WuXi STA. U.S. executive agencies have the ability to designate entities and individuals on various governmental prohibited and restricted parties lists. Depending on the designation, potential consequences can range from a comprehensive prohibition on all transactions or dealings with designated parties, or a limited prohibition on certain types of activities, such as exports and financing activities, with designated parties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, the pharmaceutical industry in China is strictly regulated by the Chinese government. Changes to Chinese regulations or government policies affecting pharmaceutical companies are unpredictable and may have a material adverse effect on our collaborators in China which could have an adverse effect on our business, financial condition, results of operations and prospects. Evolving changes in China&#8217;s public health, economic, political, and social conditions and the uncertainty around China&#8217;s relationship with other governments, such as the U.S. and the United Kingdom, or U.K., could also negatively impact our ability to manufacture our product candidates for our planned clinical trials or have an adverse effect on our ability to secure government funding, which could adversely affect our financial condition and cause us to delay our clinical development programs. Any of the foregoing factors could have a material adverse effect on our business, results of operations, or financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, as product candidates progress through preclinical and clinical trials to marketing approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize yield and manufacturing batch size, minimize costs and achieve consistent quality and results. Such changes carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of clinical trials conducted with the altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and jeopardize our ability to commercialize our product candidates, if approved, and generate revenue.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may in the future enter into collaboration agreements and strategic alliances to maximize the potential of our structure-based drug discovery platform and product candidates, and we may not realize the anticipated benefits of such collaborations or alliances. We expect to form collaborations in the future with respect to our product candidates, but may be unable to do so or to realize the potential benefits of such transactions, which may cause us to alter or delay our development and commercialization plans.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Part of our business strategy is to explore additional collaborations with third parties to further utilize our platform capabilities on additional novel GPCR targets and to leverage partners additional disease biology understanding, development and commercial expertise, regional insights or other complementary capabilities to existing or future Septerna programs. We may therefore form or seek further strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our structure-based drug discovery platform or our product candidates that we may develop. These transactions can entail numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our management&#8217;s time and attention in order to manage a collaboration or develop acquired products, product candidates or technologies, incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected collaboration, acquisition or integration costs, write-downs of assets or goodwill or impairment charges, increased amortization expenses, difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business, impairment of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and the inability to retain key employees of any acquired business. As a result, if we enter into acquisition or license agreements or strategic partnerships, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We also cannot be certain that, following a strategic transaction or license, we will achieve the revenue or other anticipated benefits that led us to enter into the arrangement.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development collaborations are subject to numerous risks, which may include the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration, and may not commit sufficient efforts and resources, or may misapply those efforts and resources causing delays or termination of the research;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of our structure-based drug discovery platform or collaboration product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results or changes in their strategic focus;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may delay, provide insufficient resources to, or modify or stop clinical trials for collaboration product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators could develop or acquire products outside of the collaboration that compete directly or indirectly with our products or product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes may arise between us and a collaborator that cause the delay or termination of the research, development or commercialization of our product candidates, or that result in costly litigation or arbitration that diverts management attention and resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital and personnel to pursue further development or commercialization of our structure-based drug discovery platform or the applicable product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we may not have the exclusive right to commercialize such intellectual property.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we could face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming, expensive, and complex. We may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our structure-based drug discovery platform or product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate their desired safety and efficacy profile. If and when we collaborate with a third party for development and commercialization of a product candidate, we can expect to relinquish some or all of the control over the future success of that product candidate to the third party. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of our technologies, product candidates and market opportunities. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be restricted under any license agreements from entering into additional agreements on certain terms or at all with other potential collaborators.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of these risks, we may not be able to realize the benefit of any future collaborations or licensing agreements we may enter into. In addition, we may face regulatory obstacles in completing such transactions. If we are unable to do so, we may have to curtail the development of such product candidate, reduce or delay one or more of our other development programs, delay the potential commercialization or reduce the scope of any planned sales or marketing activities for such product candidate, or increase our expenditures and undertake development, manufacturing or commercialization activities at our own expense. If we elect to increase our expenditures to fund development, manufacturing or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our structure-based drug discovery platform or product candidates or bring them to market and generate revenue.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we may sometimes collaborate with academic institutions to accelerate our preclinical research or development under written agreements with these institutions. If collaborations occur, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to other parties, potentially blocking our ability to pursue our program. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and financial condition could suffer.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our products require specific constituents to work effectively and efficiently, and rights to those constituents are, and in the future may be, held by others. We may also seek to in-license third-party technologies to enhance our Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We may be unable to in-license any rights from constituents, methods of use, processes or other third-party intellectual property rights from third parties that we identify. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, which could harm our business. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology in order to establish or maintain our competitive position in the market. Any delays in entering into new collaborations or strategic partnership agreements related to our product candidates or our structure-based drug discovery platform could delay the development and commercialization of our product candidates in certain geographies or limit our ability to discover and develop new product candidates, which could harm our business prospects, financial condition, and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The manufacturing of our product candidates is complex, and our third-party manufacturers may encounter difficulties in production. If we or any of our third-party manufacturers encounter such difficulties, our ability to provide supply of our product candidates for clinical trials, our ability to obtain marketing approval, or our ability to provide supply of our products for patients, if approved, could be delayed or stopped.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process of manufacturing pharmaceuticals is complex, time-consuming, highly regulated and subject to multiple risks. Our contract manufacturers must comply with legal requirements, cGMPs and guidelines for the manufacturing of pharmaceuticals used in clinical trials and, if approved, marketed products. Our contract manufacturers may have limited experience in the manufacturing of cGMP batches.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing pharmaceuticals is highly susceptible to product loss due to contamination, equipment failure, improper installation or operation of equipment, vendor or operator error, inconsistency in yields, variability in product characteristics and difficulties in scaling the production process. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects and other supply disruptions. If microbial, viral or other contaminations are discovered at our third-party manufacturers&#8217; facilities, such facilities may need to be closed for an extended period of time to investigate and remedy the contamination, which could delay clinical trials and adversely harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, there are risks associated with large scale manufacturing for clinical trials or commercial scale including, among others, cost overruns, potential problems with process scale-up, process reproducibility, stability issues, compliance with cGMPs, lot consistency and timely availability of raw materials. Even if we or our future collaborators obtain regulatory approval for any of our product candidates, there is no assurance that manufacturers will be able to manufacture the approved product to specifications acceptable to the FDA or other regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product or to meet potential future demand. If manufacturers are unable to produce sufficient quantities for clinical trials or for commercialization, commercialization efforts would be impaired, which would have an adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Scaling up a pharmaceutical manufacturing process is a difficult and uncertain task, and our third-party manufacturers may not have the necessary capabilities to complete the implementation, manufacturing and development process. If we are unable to adequately validate or scale-up the manufacturing process at our current manufacturers&#8217; facilities, we will need to transfer to another manufacturer and complete the manufacturing validation process, which can be lengthy. If we are able to adequately validate and scale-up the manufacturing process for our product candidates with a contract manufacturer, we will still need to negotiate with such contract manufacturer an agreement for commercial supply and it is not certain we will be able to come to agreement on terms acceptable to us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot assure that any stability or other issues relating to the manufacture of any of our product candidates will not occur in the future. If our third-party manufacturers were to encounter any of these difficulties, our ability to provide any product candidates to patients in planned clinical trials and products to patients, once approved, would be jeopardized. Any delay or interruption in the supply of clinical trial supplies could delay the completion of planned clinical trials, increase the costs associated with maintaining clinical trial programs and, depending upon the period of delay, require us to commence new clinical trials at additional expense or terminate clinical trials completely. Any adverse developments affecting clinical or commercial manufacturing of our product candidates or products may result in shipment delays, inventory shortages, lot failures, product withdrawals or recalls, or other interruptions in the supply of our product candidates or products. We may also have to take inventory write-offs and incur other charges and expenses for product candidates or products that fail to meet specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. Accordingly, failures or difficulties faced at any level of our supply chain could adversely affect our business and delay or impede the development and commercialization of any of our product candidates or products, if approved, and could have an adverse effect on our business, prospects, financial condition and results of operations. Regional or single-source dependencies may in some cases accentuate these risks. For example, the pharmaceutical industry generally, and in some instances our Company, our collaborators or other third parties on which we rely, depend on China-based suppliers or service providers for certain raw materials, products and services, or other activities. Our ability or the ability of our collaborators or such other third parties to continue to engage these China-based suppliers or service providers for certain preclinical research programs and clinical development programs could be restricted due to geopolitical development between the United States and China, including as a result of the escalation of tariffs or other trade restrictions or if the previously proposed BIOSECURE Act or a similar law were to be enacted.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our process development efforts, we also may make changes to the manufacturing processes at various points during development, for various reasons, such as controlling costs, achieving scale, decreasing processing time, increasing manufacturing success rate or other reasons. Such changes carry the risk that they will not achieve their intended objectives, and any of these changes could cause our product candidates to perform differently and affect the results of our clinical trials. In some circumstances, changes in the manufacturing process may require us to perform </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> comparability studies and to collect additional data from patients prior to undertaking more advanced clinical trials. For instance, changes in our process during the course of clinical development may require us to show the comparability of the product used in earlier clinical phases or at earlier portions of a trial to the product used in later clinical phases or later portions of the trial.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We intend to rely on third parties to conduct, supervise and monitor our preclinical studies and clinical trials, and if those third parties perform in an unsatisfactory manner, it may harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not currently have the ability to independently conduct preclinical studies or clinical trials required to develop our product candidates. We intend to rely on CROs, clinical trial sites and other third parties to ensure the proper and timely conduct of our preclinical studies and clinical trials, and we expect to have limited influence over their actual performance. We intend to rely upon CROs and others for the execution of future nonclinical studies and to monitor, manage and report data for our clinical trials. We expect to control only certain aspects of our CROs&#8217; and others&#8217; activities. Nevertheless, we will be responsible for ensuring that each of our preclinical studies or clinical trials are conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the CROs and others does not relieve us of our regulatory responsibilities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, our CROs and other third parties we might engage will be required to comply with good laboratory practices (&#8220;GLPs&#8221;) and GCPs, which are regulations and guidelines enforced by the FDA, EMA, and other comparable foreign regulatory authorities in the form of International Conference on Harmonization guidelines for any of our product candidates that are in preclinical and clinical development. The regulatory authorities enforce GCPs through periodic inspections of trial sponsors, principal investigators and clinical trial sites. Although we will rely on CROs and others to conduct GCP-compliant clinical trials, we remain responsible for ensuring that each of our GLP preclinical studies and clinical trials is conducted in accordance with its investigational plan and protocol and applicable laws and regulations, and our reliance on the CROs and others does not relieve us of our regulatory responsibilities. If we, our CROs and other third parties we engage fail to comply with GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, EMA, or other comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. Accordingly, if our CROs or others fail to comply with these regulations or fail to recruit a sufficient number of participants, we may be required to repeat clinical trials, which would delay the regulatory approval process.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we will have agreements governing their activities, our CROs and other third parties we engage will not be our employees, and we will not control whether or not they devote sufficient time and resources to our future nonclinical and clinical programs. These CROs and others may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials, or other drug development activities which could harm our business. We face the risk of potential unauthorized disclosure or misappropriation of our intellectual property by CROs and others, which may reduce our trade secret protection and allow our potential competitors to access and exploit our proprietary technology. In addition, certain of our agreements with CROs and other third parties currently or will provide for monetary and other limitations on their liability. If our CROs do not successfully carry out their contractual duties or obligations, fail to meet expected deadlines, or if the quality or accuracy of the preclinical or clinical data they obtain is compromised due to the failure to adhere to our protocols or regulatory requirements or for any other reasons, our preclinical or clinical programs may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize any product candidate that we develop. As a result, our financial results and the commercial prospects for any product candidate that we develop would be harmed, our costs could increase, and our ability to generate revenue could be delayed, decreased or eliminated.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our relationship with these CROs terminates, we may not be able to enter into arrangements with alternative CROs or do so on commercially reasonable terms. Switching or adding additional CROs involves substantial cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can negatively impact our ability to meet our desired development timelines. Though we intend to carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a negative impact on our business, financial condition and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the trial. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or rejection, of our marketing applications by the FDA and may ultimately lead to the denial of marketing approval of our product candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently depend and in the future may continue to depend on single- or limited-source suppliers for some of the components and materials used in the product candidates we may develop.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently depend and in the future may continue to depend on single- or limited-source suppliers for some of the components and materials used in any product candidates we may develop. We cannot ensure that these suppliers or service providers will remain in business, have sufficient capacity or supply to meet our needs or that they will not be purchased by one of our competitors or another company that is not interested in continuing to work with us. Our use of single-source suppliers of raw materials, components, key processes and finished goods could expose us to several risks, including disruptions in supply, price increases or late deliveries. There are, in general, relatively few alternative sources of supply for substitute components. These vendors may be unable or unwilling to meet our future demands for our clinical trials or commercial sale. Establishing additional or replacement suppliers for these components, materials and processes could take a substantial amount of time and it may be difficult to establish replacement suppliers who meet regulatory requirements. Any disruption in supply from any single-source supplier or service provider could lead to supply delays or interruptions which would damage our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we have to switch to a replacement supplier, the manufacture and delivery of any product candidates we may develop could be interrupted for an extended period, which could adversely affect our business. Establishing additional or replacement suppliers, if required, may not be accomplished quickly or at all. If we are able to find a replacement supplier, the replacement supplier would need to be qualified and may require additional regulatory authority approval, which could result in further delay. While we seek to maintain adequate inventory of the single source components and materials used in our therapeutics, any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand for our product candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Intellectual Property</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain, maintain, defend and enforce patent or other intellectual property protection for our current or any future product candidates, or if the scope of the patent protection obtained is not sufficiently broad, we may not be able to compete effectively in our markets.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate that we will file additional patent applications both in the United States and in other jurisdictions, as appropriate. However, we cannot predict:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if and when any patents will issue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the degree and scope of protection any issued patents will afford us against competitors, including whether third parties will find ways to invalidate or otherwise circumvent our patents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether others will apply for or obtain patents claiming aspects similar to those covered by our patents and patent applications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether we will need to initiate litigation or administrative proceedings to defend our patent rights, which may be costly whether we win or lose; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the patent applications that we own, or may in-license, will result in issued patents with claims that cover our product candidates or uses thereof in the United States or in foreign jurisdictions.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely, and may in the future rely, upon a combination of patent, trade secret and trademark protection for our current and any future product candidates and proprietary technologies to prevent third parties from exploiting our achievements, thus eroding our competitive position in our market. These legal measures afford only limited protection, and competitors or others may gain access to or use our intellectual property and proprietary information. Our success depends in large part on our ability to obtain, maintain, expand, enforce, and defend the scope, ownership or control, validity and enforceability of our intellectual property protection in the United States and other countries with respect to our current and any future product candidates and other proprietary technologies we may develop. Our commercial success depends in large part on our ability to obtain and maintain patent protection in the United States and other jurisdictions with respect to our current and any future product candidates. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our current and future development programs and product candidates. The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner, including as a result of factors impacting our, our licensors&#8217; or governmental patent offices&#8217; operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. The patent applications that we own or in-license may fail to result in issued patents with claims that cover our current or any future product candidates in the United States or in foreign jurisdictions. There is no assurance that all of the potentially relevant prior art relating to our patents and patent applications has been or will be found, which unknown prior art can invalidate a patent or prevent a patent from issuing from a pending patent application. Even if patents do issue and even if such patents cover our current or any future product candidates, third parties may challenge their scope, validity, or enforceability, which may result in such patents being narrowed, invalidated, or held unenforceable. Any successful opposition to these patents or any other patents owned by or licensed to us could deprive us of rights necessary for the successful commercialization of any product candidates that we may develop. Further, if we encounter delays in regulatory approvals, the period of time during which we could market a product candidate under patent protection could be reduced.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the patent applications we hold or have in-licensed with respect to our product candidates fail to issue, if their breadth or strength of protection is threatened, or if they fail to provide meaningful exclusivity for current or any future product candidates, it could dissuade companies from collaborating with us to develop product candidates, and threaten our ability to commercialize, future drug products. Any such outcome could have a negative effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Composition of matter patents for pharmaceutical products provide intellectual property protection for those types of products, as such patents provide protection without regard to any method of use. We cannot be certain, however, that the claims in our pending patent applications covering the composition of matter of any of our product candidates will be considered patentable by the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), or by patent offices in foreign jurisdictions, or that the claims in any of our patents that may issue will be considered valid and enforceable by courts in the United States or foreign jurisdictions. Method of use patents protect the use of a product for the specified method. We cannot be certain, however, that the claims in our pending patent applications covering methods of use of our product candidates will be considered patentable by the USPTO, or by patent offices in foreign jurisdictions, or that the claims in any of our patents that may issue will be considered valid and enforceable by courts in the United States or foreign jurisdictions. Further, this type of patent does not prevent a competitor from making and marketing a product that is identical to our product for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for our targeted indications, once approved for therapeutic use by FDA. or counterpart foreign regulatory authorities, physicians may prescribe these products &#8220;off-label&#8221; for those uses that are covered by our method of use patents. Although off-label prescriptions may infringe or contribute to the infringement of method of use patents, the practice is common and such infringement is difficult to prevent or enforce against.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the laws of foreign jurisdictions may not protect our rights to the same extent as the laws of the United States. Patent applications in the United States and certain other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to file for patent protection. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies or products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in either the patent laws or interpretation of the patent laws in the United States and other jurisdictions may diminish the value of our patents or narrow the scope of our patent protection. These changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a negative effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, we may be subject to a third-party pre-issuance submission of prior art to the USPTO or another patent office or become involved in opposition, derivation, reexamination, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review (&#8220;IPR&#8221;), post-grant review (&#8220;PGR&#8221;) or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or drugs and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize drugs without infringing third-party patent rights or obtaining a costly license from a third party. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. An adverse determination in any such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology, products or methods, or limit the duration of the patent protection of our technology, products or methods.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, patents have a limited lifespan. In the United States, if all maintenance fees are paid timely, the natural expiration of a patent is generally 20 years from the earliest filing date of a non-provisional patent application. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. For instance, a patent term extension based on regulatory delay may be available in the United States. However, only a single patent can be extended for each marketing approval, and any patent can be extended only once, for a single product. Moreover, the scope of protection during the period of the patent term extension does not necessarily extend to all claims, but instead only to claims that read on the product as approved. Laws governing analogous patent term extensions in foreign jurisdictions vary widely, as do laws governing the ability to obtain multiple patents from a single patent family. Additionally, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. If we are unable to obtain patent term extension or restoration, or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our product will be shortened and our competitors may obtain approval of competing products following our patent expiration and may take advantage of our investment in development and clinical trials by referencing our clinical and preclinical data to launch their product earlier than might otherwise be the case, and our revenue could be reduced, possibly materially. In addition, although upon issuance in the United States a patent&#8217;s term can be increased based on certain delays caused by the USPTO, this increase can be reduced or eliminated based on certain delays caused by the patent applicant during patent prosecution. Without patent protection for our product candidates, including once the patent life has expired even if patents covering our product candidates are obtained, we may be open to competition from generic versions of such drugs. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. Even if patents covering our product candidates are obtained, once the patent term has expired for a product, we may be open to competition from generic medications. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing drugs similar or identical to ours.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we have or obtain patents covering our products or methods, we may still be barred from making, using and selling such products or methods because of the patent rights of others. Others may have filed, and in the future may file, patent applications covering compositions, products or methods that are similar or identical to ours, which could materially affect our ability to successfully develop our technology or to successfully commercialize any approved products alone or with collaborators.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patent applications in the United States and elsewhere are generally published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications covering our methods and product candidates could have been filed by others without our knowledge. Additionally, pending claims in patent applications which have been published can, subject to certain limitations, be later amended in a manner that could cover our platform technologies or related products. These patent applications may have priority over patent applications filed by us.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor, co-inventor, owner or co-owner. For example, we or our licensors may have inventorship or ownership disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our or our licensors&#8217; ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, we may be required to pay monetary damages and we may also lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are sued for infringing intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends, in part, on our ability to develop, manufacture, market and sell our product candidates without infringing the intellectual property and other proprietary rights of third parties. Third parties may allege that we have infringed or misappropriated their intellectual property. Litigation or other legal proceedings relating to intellectual property claims, with or without merit, is unpredictable and generally expensive and time consuming and, even if resolved in our favor, is likely to divert significant resources from our core business, including distracting our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the market price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our product candidates. We cannot be certain that our product candidates and other proprietary technologies we may develop will not infringe existing or future patents owned by third parties. Third parties may assert infringement claims against us based on existing or future intellectual property rights. In the United States, proving invalidity in court requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents. If we are found to infringe a third party&#8217;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our investigational products or force us to cease some of our business operations, which could materially harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be aware of patents that have already been issued and that a third party, for example, a competitor in the fields in which we are developing our product candidates, might assert are infringed by our product candidates, including claims to compositions, formulations, methods of manufacture or methods of use or treatment that cover our product candidates. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our product candidates and other proprietary technologies we may develop, could be found to be infringed by one or more of our product candidates. In addition, because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents that our product candidates may infringe. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make, use and sell our product candidates. The pharmaceutical and biotechnology industries have produced a considerable number of patents, and it may not always be clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform. If we were sued for patent infringement, we would need to demonstrate that our product candidates, products or methods either do not infringe the patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be able to do this. Proving invalidity may be difficult. For example, in the United States, proving invalidity in court requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents, and there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. Even if we are successful in these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in pursuing these proceedings, which could have a material adverse effect on our business and operations. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. In addition, we may not have sufficient resources to bring these actions to a successful conclusion.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may choose to challenge the enforceability or validity of claims in a third party&#8217;s U.S. patent by requesting that the USPTO review the patent claims in an </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex parte</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> re-examination, IPR or PGR proceeding. These proceedings are expensive and may consume our time or other resources. We may choose to challenge a third party&#8217;s patent in patent opposition proceedings in the European Patent Office (&#8220;EPO&#8221;), or other foreign patent office. The costs of these opposition proceedings could be substantial and may consume our time or other resources. If we fail to obtain a favorable result at the USPTO, EPO or other patent office, then we may be exposed to litigation by a third party alleging that the patent may be infringed by our product candidates or proprietary technologies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are found to infringe a third-party&#8217;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third-party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, and could divert the time and attention of our technical personnel and management,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cause development delays, and/or require us to develop non-infringing technology, which may not be possible on a cost-effective basis, any of which could materially harm our business. In the event of a successful claim of infringement against us, we may have to pay substantial monetary damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties and other fees, redesign our infringing drug or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our technology licensed from various third parties may be subject to retained rights.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future licensors may retain certain rights under the relevant agreements with us, including the right to use the underlying technology for noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether our licensors limit their use of the technology to these uses, and we could incur substantial expenses to enforce our rights to our licensed technology in the event of misuse.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the United States federal government retains certain rights in inventions produced with its financial assistance under the Patent and Trademark Law Amendments Act (&#8220;Bayh-Dole Act&#8221;). The federal government retains a &#8220;nonexclusive, nontransferable, irrevocable, paid-up license&#8221; for its own benefit. The Bayh-Dole Act also provides federal agencies with &#8220;march-in rights.&#8221; March-in rights allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#8220;nonexclusive, partially exclusive, or exclusive license&#8221; to a &#8220;responsible applicant or applicants.&#8221; If the patent owner refuses to do so, the government may grant the license itself. We sometimes collaborate with academic institutions to accelerate our preclinical research or development, creating a risk that federal funds may be commingled. Therefore, we cannot be sure that any intellectual property co-developed from a collaboration with an academic institution will be free from government rights pursuant to the Bayh-Dole Act. If, in the future, we co-own or license in technology which is critical to our business that is developed in whole or in part with federal funds subject to the Bayh-Dole Act, our ability to enforce or otherwise exploit patents covering such technology may be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration date of a third-party patent, which might adversely affect our ability to develop and market our products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have reviewed certain third-party patents and patent filings that we believe may be relevant to our product candidates; and on August 1, 2024, we completed freedom-to-operate searches for the exact structures of SEP-786 and SEP-631, which did not identify any third-party patents and patent filings that we believe are relevant to our product candidates. Nevertheless, we may not be aware of patents or pending or future patent applications that, if issued, would block us from commercializing our product candidates. Thus, we cannot guarantee that our product candidates, or our commercialization thereof, do not and will not infringe any third party&#8217;s intellectual property.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that any patent searches or analyses that are performed, including the identification of relevant patents, the scope of patent claims or the expiration dates of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of our product candidates in any jurisdiction. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our future products. We may incorrectly determine that our products are not covered by a third-party patent or may incorrectly predict whether a third-party&#8217;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our product candidates. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our future products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One aspect of the determination of patentability of our inventions depends on the scope and content of the &#8220;prior art,&#8221; information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention. There may be prior art of which we are not aware that may affect the patentability of our patent claims or, if issued, affect the validity or enforceability of a patent claim.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The landscape of intellectual property related to our product candidates and future products is constantly changing. Therefore, we may not be aware of all third-party intellectual property rights potentially relating to our product candidates or their intended uses, and as a result the impact of such third-party intellectual property rights upon the patentability of our own patents and patent applications, as well as the impact of such third-party intellectual property upon our freedom to operate, is highly uncertain. Because patent applications in the United States and certain other jurisdictions are confidential for typically a period of at least 18 months after their priority date, or may not be published at all, we cannot be certain that we were the first to file any patent application related to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product candidates. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, for U.S. applications in which all claims are entitled to a priority date before March 16, 2013, an interference proceeding can be provoked by a third party or instituted by the USPTO to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. For U.S. applications containing a claim not entitled to priority before March 16, 2013, there is a greater level of uncertainty in the patent law in view of the passage of the America Invents Act, which brought into effect significant changes to the U.S. patent laws, including new procedures for challenging pending patent applications and issued patents. Should we fail to win an interference challenge, a third party may obtain rights to intellectual property related to our product candidates and future products.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be successful in obtaining or maintaining necessary rights to our product candidates through acquisitions and in-licenses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because our programs may in the future require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license, or use these third-party proprietary rights. We may be unable to acquire or in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant program or product candidate, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we normally seek to obtain the right to control prosecution, maintenance and enforcement of the patents relating to our product candidates, there may be times when the filing and prosecution activities for patents and patent applications relating to our product candidates are controlled by our future licensors or collaboration partners. If any of our future licensors or collaboration partners fail to prosecute, maintain and enforce such patents and patent applications in a manner consistent with the best interests of our business, including by payment of all applicable fees for patents covering our product candidates, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, our ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using and selling competing products. In addition, even where we have the right to control patent prosecution of patents and patent applications we have licensed to and from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensees, our future licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may enter into license agreements in the future with others to advance our existing or future research or allow commercialization of our product candidates. These licenses may not provide exclusive rights to use such intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology platform or product candidates in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, subject to the terms of any such license agreements, we may not have the right to control the preparation, filing, prosecution, maintenance, enforcement, and defense of patents and patent applications covering the technology that we license from third parties. In such an event, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced, and defended in a manner consistent with the best interests of our business. If our future licensors fail to prosecute, maintain, enforce, and defend such patents or patent applications, or lose rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated, and our right to develop and commercialize any of our product candidates that are subject of such licensed rights could be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future licensors may rely on third-party consultants or collaborators or on funds from third parties such that our future licensors are not the sole and exclusive owners of the patents we in-license. If other third parties have ownership rights to our future in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is possible that we may be unable to obtain necessary licenses at a reasonable cost or on reasonable terms, if at all. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that event, we may be required to expend significant time and resources to redesign our technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected product candidates, which could harm our business, financial condition, results of operations, and prospects significantly. We cannot provide any assurances that third-party patents do not exist which might be enforced against our current technology, manufacturing methods, product candidates, or future methods or products resulting in either an injunction prohibiting our manufacture or future sales, or, with respect to our future sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties, which could be significant.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disputes may arise between us and our future licensors regarding intellectual property subject to a license agreement, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our right to sublicense patents and other rights to third parties;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our right to transfer or assign the license;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our future licensors and us and our partners; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the priority of invention of patented technology. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the agreements under which we license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we license in the future prevent or impair our ability to maintain our licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In spite of our best efforts, our future licensors might conclude that we materially breached our license agreements and might therefore terminate the license agreements, thereby removing our ability to develop and commercialize products and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying patents fail to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identical to ours. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may be required to license technologies relating to our programs from additional third parties to further develop or commercialize our product candidates. Should we be required to obtain licenses to any third-party technology, including any such patents required to manufacture, use or sell our product candidates, such licenses may not be available to us on commercially reasonable terms, or at all. The inability to obtain any third-party license required to develop or commercialize any of our product candidates could cause us to abandon any related efforts, which could seriously harm our business and operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be involved in lawsuits to protect or enforce our patents, which could be expensive, time consuming and unsuccessful. Further, our issued patents could be found invalid or unenforceable if challenged in court.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competitors may infringe our intellectual property rights. To prevent infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in a patent infringement proceeding, a court may decide that a patent we own or license is not valid, is unenforceable and/or is not infringed. If we or any of our potential future collaborators were to initiate legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent is invalid and/or unenforceable in whole or in part. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge include an alleged failure to meet any of several statutory requirements, including but not limited to lack of novelty, obviousness, or insufficient written description or enablement. Grounds for an unenforceability assertion could include an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties may also raise similar invalidity claims before the USPTO or patent offices abroad, even outside the context of litigation. Such mechanisms include re-examination, PGR, IPR, derivation proceedings, interference proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in loss of rights to, the revocation of, cancellation of or amendment to our patents in such a way that they no longer cover our technology or platform, or any product candidates that we may develop. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. There is also no assurance that there is not prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim in our patents and patent applications, which may, nonetheless, ultimately be found to affect the validity or enforceability of a patent claim. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates or other intellectual property that we may develop. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened or questioned, it could dissuade companies from collaborating with us to license, develop or commercialize our product candidates. Such a loss of patent protection would have a material adverse impact on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if resolved in our favor, litigation or other legal proceedings relating to our intellectual property rights may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or other legal proceedings relating to our intellectual property rights, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims that we or our employees have misappropriated the intellectual property, including confidential information, know-how or trade secrets, of a third-party, or claiming ownership of what we regard as our own intellectual property.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our employees, consultants and contractors were previously employed at or engaged by other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Some of these employees, consultants and contractors executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that our employees, consultants and contractors do not use the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may be subject to claims that we have wrongfully hired an employee from a competitor or that we or these employees, consultants or contractors have used or disclosed such third-party intellectual property, including know-how, trade secrets or other proprietary information, to us. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, it may a have negative impact on our business and our ability to develop product candidates or commercialize our technology. In addition to paying substantial monetary damages, we may lose valuable intellectual property rights or personnel, or access to consultants and contractors. Even if we are successful in defending against such claims, litigation could incur substantial costs and be a distraction to management and scientific personnel.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own, which may result in claims by or against us related to the ownership of such intellectual property. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to our senior management and scientific personnel.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may license intellectual property rights from third parties. Such licenses may be subject to early termination if we fail to comply with our obligations in our licenses with third parties, which could result in the loss of rights or technology that are material to our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may become a party to licenses that give us rights to third-party intellectual property or technology that is necessary or useful for our business, and we may enter into additional licenses in the future. Under these license agreements, we are or may become obligated to pay the licensor fees, which may include annual license fees, milestone payments, royalties, a percentage of revenues associated with the licensed technology and a percentage of sublicensing revenue. These fees may be significant, which could make it difficult for us to achieve or maintain profitability. In addition, under certain of such agreements, we are or may become required to diligently pursue the development of products using the licensed technology. If we fail to comply with these obligations, including due to our use of the intellectual property licensed to us in an unauthorized manner, and fail to cure our breach within a specified period of time, the licensor may have the right to terminate the applicable license, in which event we could lose valuable rights and technology that are material to our business, harming our ability to develop, manufacture and/or commercialize our platform, products or product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the agreements under which we license intellectual property or technology to or from third-parties can be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The licensing and acquisition of third-party intellectual property rights is a competitive practice, and companies that may be more established, or have greater resources than we do, may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our product candidates. More established companies may have a competitive advantage over us due to their larger size and cash resources or greater clinical development and commercialization capabilities. There can be no assurance that we will be able to successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that we may seek to acquire. The failure to obtain or in-license any compositions, methods of use, processes or other third-party intellectual property rights at a reasonable cost or on reasonable terms, could harm our business. If we fail to obtain licenses to necessary third-party intellectual property rights, we may need to cease use of the compositions or methods covered by such third-party intellectual property rights. Furthermore, we may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or applications will be due to be paid to the USPTO and various government patent agencies outside of the United States over the lifetime of our owned and licensed patents and/or applications and any patent rights we may own or license in the future. We rely on our outside counsel, patent annuity service providers, or our licensing partners to pay these fees due to non-U.S. patent agencies. If these fees are not paid to the USPTO or the non-U.S. patent agencies when due, our rights to such patents or patent applications may be abandoned or otherwise materially impaired.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The USPTO and various non-U.S. government patent agencies require compliance with numerous procedural, documentary, and other similar provisions during the patent application process. For example, many jurisdictions, including the U.S. and China, require a foreign filing license before seeking patent protection in a jurisdiction outside of the jurisdiction of which the inventor is a citizen or in which the invention was made. Each jurisdiction&#8217;s laws regarding foreign filing licenses vary and may even conflict. We employ reputable law firms in foreign jurisdictions and other professionals to help us comply and we are also dependent on any licensors to take the necessary action to comply with these requirements with respect to our intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submit formal documents. In such an event, potential competitors might be able to enter the market and this circumstance could harm our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world, which could negatively impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Filing, prosecuting, maintaining, enforcing, and defending patent applications and patents covering our current and any future product candidates worldwide is prohibitively expensive, so we will pursue patents in a limited number of jurisdictions. Moreover, our intellectual property rights in some jurisdictions outside the United States can have a different scope and strength than do those in the United States. Consequently, we will not be able to prevent third parties from practicing our inventions in all jurisdictions, or from selling or importing in and into various jurisdictions products made using our inventions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own product candidates and, further, may export otherwise infringing product candidates to territories where we may obtain patent protection, but where patent enforcement is not as strong as that in the United States. Further, these product candidates may compete with our product candidates in jurisdictions where we do not have any issued or licensed patents and any future patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many companies have encountered significant problems protecting and defending intellectual property rights in jurisdictions outside the United States. The legal systems of certain jurisdictions do not favor the enforcement of patents, trade secrets and other intellectual property rights, particularly those relating to pharmaceutical products, which could make it difficult in those jurisdictions for us to stop the infringement or misappropriation of our patents or other intellectual property rights, including the marketing of competing products in violation of our proprietary rights. Proceedings to enforce our patents and other intellectual property rights in jurisdictions outside the United States could result in substantial costs and divert our efforts and attention from other aspects of our business. Furthermore, such proceedings could put our patents at risk of being invalidated, held unenforceable, or interpreted narrowly, could put our patent applications at risk of not issuing, and could provoke third parties to assert claims of infringement or misappropriation against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Similarly, if our trade secrets are disclosed in a foreign jurisdiction, competitors worldwide could have access to our proprietary information and we may be without satisfactory recourse. Such disclosure could have a material adverse effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in intellectual property laws in the United States and around the world. For example, in Europe, a new unitary patent system took effect June 1, 2023, which will significantly impact European patents, including those granted before the introduction of such a system. Under the unitary patent system, European applications have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court (&#8220;UPC&#8221;). As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty of any litigation. Patents granted before the implementation of the UPC will have the option of opting out of the jurisdiction of the UPC and remaining as national patents in the UPC countries. Patents that remain under the jurisdiction of the UPC will be potentially vulnerable to a single UPC-based revocation challenge that, if successful, could invalidate the patent in all countries who are signatories to the UPC. We cannot predict with certainty the long-term effects of any potential changes. Certain jurisdictions, including China and India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties under certain circumstances. In those jurisdictions, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents. In addition, many jurisdictions limit the enforceability of patents against government agencies or government contractors. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we do not obtain patent term extension and data exclusivity for any product candidates we may develop, our business may be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop and our technology, one or more U.S. patents that we license or may own in the future may be eligible for limited patent term extension under the Hatch-Waxman Amendments. Under certain circumstances the Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved product, a method for using it or a method for manufacturing it may be extended. The application for the extension must be submitted prior to the expiration of the patent for which extension is sought and within 60 days of FDA approval. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable patent term extension or the scope of patent protection afforded could be less than we request. In addition, to the extent we wish to pursue patent term extension based on a patent that we in-license from a third party, we would need the cooperation of that third party. If we are unable to obtain patent term extension or the term of any such extension is less than we request, we may be open earlier than projected to competition from competitive products, including generics or biosimilars following our patent expiration, and our revenue could be reduced earlier than projected. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Confidentiality agreements with employees and third parties may not prevent unauthorized disclosure of our trade secrets and other proprietary information. If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the protection afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect proprietary information and confidential know-how that we elect not to patent, including processes for which patents are difficult to enforce, and any other elements of our product candidates, technology and product discovery, development processes and drug discovery platform that involve proprietary know-how, information, or technology that is not covered by patents. In particular, our trade secrets, confidential know-how and other proprietary information includes our proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> drug discovery platform, which we do not plan to patent. Any disclosure, either intentional or unintentional, by our employees, the employees of third parties with whom we share our facilities or third-party consultants and vendors that we engage to perform research, clinical trials or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of our trade secrets or proprietary information could enable competitors to duplicate or surpass our technological achievements, thus eroding our competitive position in our market. Because we expect to rely on third parties in the development and manufacture of our product candidates, we must, at times, share trade secrets with them. Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trade secrets, confidential know-how and proprietary information, however, may be difficult to protect. We seek to protect our trade secrets, confidential know-how and proprietary information, including our proprietary processes and drug discovery platform, in part, by entering into confidentiality agreements with our employees, consultants, outside scientific advisors, contractors, and collaborators. With our consultants, contractors, and outside scientific collaborators, these agreements typically include invention assignment obligations. Although we use reasonable efforts to protect our trade secrets, we cannot provide any assurances that all such agreements have been duly executed, and notwithstanding the existence of a confidentiality agreement our employees, consultants, outside scientific advisors, contractors, and collaborators might intentionally or inadvertently disclose our trade secret information, including to competitors. In addition, competitors or other third parties may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Despite our efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. Furthermore, the laws of some foreign jurisdictions do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, or misappropriation of our intellectual property by third parties, we may not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our intellectual property rights do not necessarily protect against all potential threats to our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business. These risks and uncertainties include the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may be able to make compounds or formulations that are similar to our product candidates but that are not covered by the claims of any patents, should they issue, that we own or control;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we or any strategic partners might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own or control;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we might not have been the first to file patent applications covering certain of our product candidates or inventions we own or control;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pending patent applications that we own or control may not lead to issued patents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issued patents that we own or control may be held invalid or unenforceable as a result of legal challenges;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our competitors might conduct research and development activities in the United States and other jurisdictions that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in jurisdictions where we do not have patent rights and then use the information learned from such activities to develop competitive drugs for sale in our major commercial markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not develop additional proprietary technologies that are patentable; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patents of others may have an adverse effect on our business. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current or future trademarks or trade names may be challenged, opposed, infringed, circumvented, invalidated, cancelled, declared generic, determined to be not entitled to registration, or determined to be infringing on other marks. During trademark registration proceedings, we may receive rejections of our applications by the USPTO or in foreign jurisdictions. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many other jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. Trademark litigation could be expensive. In addition, we could be found liable for significant monetary damages, including treble damages, disgorgement of profits and attorneys&#8217; fees, if we are found to have willfully infringed a trademark. We may not be able to protect our exclusive right to trademarks or trade names or may be forced to stop using these names, which we need for name recognition by potential collaborators or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks or trade names, we may not be able to compete effectively and our business may be adversely affected. We may license our trademarks or trade names to third parties, such as distributors. Though these agreements may provide guidelines for how our trademarks or trade names may be used, a breach of these agreements or misuse of our trademarks or tradenames by third parties may jeopardize our rights in or diminish the goodwill associated with our trademarks or trade names.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, any name we have proposed to use with our product candidates in the United States must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA (or an equivalent administrative body in a foreign jurisdiction) objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify a suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA or equivalent body. Furthermore, in many jurisdictions, owning and maintaining a trademark registration may not provide an adequate defense against a subsequent infringement claim asserted by the owner of a senior trademark.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Furthermore, assertions of potential trademark infringement or possible market confusion may lead to coexistence agreements in order to avoid costly disputes related to our trademarks. As a consequence, we may be forced to amend the list of goods and services covered by our trademarks more narrowly than as originally filed and intended, which could adversely affect our ability to establish name recognition. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, domain name or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition, results of operations and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rights to improvements to our product candidates may be held by third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of testing our product candidates, we may enter into agreements with third parties to conduct clinical testing, which may provide that improvements to our product candidates may be owned solely by a third party or jointly between the parties. If we determine that rights to such improvements owned solely by a third party are necessary to commercialize our product candidates or maintain our competitive advantage, we may need to obtain a license from such third party in order to use the improvements and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue developing, manufacturing or marketing the product candidates. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain such a license, it could be granted on non-exclusive terms, thereby giving our competitors and other third parties access to the same technologies licensed to us. Failure to obtain a license on commercially reasonable terms or at all, or to obtain an exclusive license, could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. If we determine that rights to improvements jointly owned between us and a third party are necessary to commercialize our product candidates or maintain our competitive advantage, we may need to obtain an exclusive license from such third party. If we are unable to obtain an exclusive license to any such third-party co-owners&#8217; interest in such improvements, such co-owners may be able to license their rights to other parties, including our competitors, and our competitors could market competing products and technology. In addition, we may need the cooperation of any such co-owners of our intellectual property in order to enforce such intellectual property against other parties, and such cooperation may not be provided to us. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Ownership of Our Common Stock</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not know whether a market will be sustained for our common stock or what the market price of our common stock will be, and, as a result, it may be difficult for you to sell your shares of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although our common stock is listed on the Nasdaq Global Market (&#8220;Nasdaq&#8221;), an active trading market for our common stock may not be sustained. If a market for our common stock is not sustained or if trading volume in our common stock is low, it may be difficult for you to sell your shares of common stock at an attractive price or at all. We cannot predict the prices at which our common stock will trade. It is possible that in one or more future periods our results of operations may be below the expectations of public market analysts and investors, and, as a result of these and other factors, the price of our common stock may fall.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The market price of our common stock may be volatile, which could result in substantial losses for investors purchasing shares.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price for our common stock may be influenced by those factors discussed in this &#8220;Risk Factors&#8221; section and many others, some of which may include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the success of existing or new competitive product candidates or technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the commencement, enrollment, completion and results of preclinical studies and clinical trials for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adverse results or delays, suspensions or terminations in future preclinical studies or clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unanticipated serious safety concerns related to our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adverse regulatory decisions, including failure to receive regulatory approval of our product candidates or the failure of a regulatory authority to accept data from preclinical studies or clinical trials conducted in other countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our failure to commercialize our product candidates, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure or discontinuation of any of our development and research programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">results of any preclinical studies, clinical trials or regulatory approvals of product candidates of our competitors, or announcements about new research programs or product candidates of our competitors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commencement or termination of collaborations for our product development and research programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory or legal developments in the United States and other countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments or disputes concerning patent applications, issued patents or other intellectual property or proprietary rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the recruitment or departure of key personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of expenses related to any of our research programs, clinical development programs or product candidates that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts, if any, that cover our stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcement or expectation of additional financing efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sales of our common stock by us, our insiders or other stockholders;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expiration of market stand-off or lock-up agreements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to effectively manage our growth;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated variations in quarterly operating results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our cash position;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to the public;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading volume of our common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">variations in our financial results or those of companies that are perceived to be similar to us;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in accounting practices;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ineffectiveness of our internal controls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant lawsuits, including patent or stockholder litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the structure of healthcare payment systems;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">market conditions in the pharmaceutical and biotechnology sectors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general economic, political, industry and market conditions; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the other factors described in this &#8220;Risk Factors&#8221; section.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the stock market in general, and the market for pharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future sales, or the perception of future sales, of our common stock in the public market by existing stockholders could cause our stock price to fall.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the lock-up and legal restrictions on resale lapse, the trading price of our common stock could decline. The possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 44,422,505 shares of our common stock outstanding. Shares of unvested restricted stock that were issued and outstanding will become available for sale immediately upon the vesting of such shares, as applicable, and the expiration of any applicable market stand-off or lock-up agreements. Shares issued upon the exercise of stock options pursuant to future awards that may be granted under our equity incentive plans or pursuant to future awards granted under those plans will become available for sale in the public market to the extent permitted by the provisions of applicable vesting schedules, any applicable market stand-off and lock-up agreements and Rule 144 and Rule 701 under the Securities Act.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain holders of our common stock have rights, subject to some conditions, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We have registered the offer and sale of all shares of common stock that we may issue under our equity compensation plans, and those shares are available for sale in the open market, unless such shares are subject to vesting restrictions with us or the lock-up restrictions described above. Once we register the offer and sale of shares for the holders of registration rights, they can be freely sold in the public market upon issuance, subject to the lock-up agreements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we expect that significant additional capital may be needed in the future to continue our planned operations, including conducting clinical trials, commercialization efforts, expanded research and development activities and costs associated with operating a public company. To raise capital, in the future, we may issue additional shares of our common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, employee arrangements or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and could cause our stock price to decline.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company,&#8221; and the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies may make our common stock less attractive to investors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an &#8220;emerging growth company&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2022 (&#8220;Sarbanes-Oxley Act&#8221;), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, as an emerging growth company, we are only required to provide two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure in our periodic reports. We could be an emerging growth company for up to five years following the completion of our initial public offering (&#8220;IPO&#8221;), although circumstances could cause us to lose that status earlier, including if we are deemed to be a &#8220;large accelerated filer,&#8221; which occurs when the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30, or if we have total annual gross revenue of $1.235 billion or more during any fiscal year before that time, in which cases we would no longer be an emerging growth company as of the following December 31, or if we issue more than $1.0 billion in non-convertible debt during any three-year period before that time, in which case we would no longer be an emerging growth company immediately. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to comply with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#8217;s report on the financial statements.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">providing only two years of audited financial statements and a correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure in this Annual Report;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even after we no longer qualify as an emerging growth company, we could still qualify as a &#8220;smaller reporting company,&#8221; which would allow us to take advantage of many of the same exemptions from disclosure requirements and reduced disclosure obligations regarding executive compensation in this Annual Report and our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may be more volatile.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the JOBS Act provides that an emerging growth company can also take advantage of an extended transition period for complying with new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this exemption from new or revised accounting standards, and therefore we will not be subject to the same requirements to adopt new or revised accounting standards as other public companies that are not emerging growth companies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred and will continue to incur significant increased costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives and corporate governance practices.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a public company, we have incurred and will continue to incur significant legal, accounting and other expenses that we did not incur as a private company, and these expenses may increase even more after we are no longer an &#8220;emerging growth company.&#8221; We are subject to the reporting requirements of the Exchange Act, which requires, among other things, that we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and Nasdaq to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (&#8220;Dodd-Frank Act&#8221;) was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas such as &#8220;say on pay&#8221; and proxy access. Recent legislation permits emerging growth companies to implement many of these requirements over a longer period and up to the fifth anniversary of our IPO. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Insiders have substantial influence over us, which could limit your ability to affect the outcome of key transactions, including a change of control.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the beneficial ownership of our common stock as of December 31, 2024, our directors and executive officers, holders of 5% or more of our capital stock and their respective affiliates beneficially own a significant percentage of our outstanding common stock. These stockholders, if they act together, will be able to influence our management and affairs and all matters requiring stockholder approval. For example, these stockholders may be able to control elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This concentration of ownership may have the effect of delaying or preventing a change in control of our company and might affect the market price of our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not expect to pay any dividends for the foreseeable future. Investors may never obtain a return on their investment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should not rely on an investment in our common stock to provide dividend income. We do not anticipate that we will pay any dividends to holders of our common stock in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing operations. In addition, any future credit facility may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with  generally accepted accounting principles in the United States (&#8220;U.S. GAAP"). As a public company, we are required to incur additional costs and obligations in order to comply with SEC rules that implement Section 404 of the Sarbanes-Oxley Act. Under these rules, beginning with our second Annual Report on Form 10-K after we become a public company, we are required to make a formal assessment of the effectiveness of our internal control over financial reporting, and once we cease to be an emerging growth company, we may be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. We are engaged in the process of documenting, reviewing and improving our internal controls and procedures for compliance with Section 404 of the Sarbanes-Oxley Act.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implementing any appropriate changes to our internal controls may distract our officers and employees, entail substantial costs to modify our existing processes and take significant time to complete. These changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy or consequent inability to produce accurate financial statements on a timely basis could increase our operating costs and harm our business. In addition, investors&#8217; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis cause investors to lose confidence in the accuracy and completeness of our financial reports and could cause the market price of our common stock to decline significantly.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we experience material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect investor confidence in us and, as a result, the value of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may in the future discover material weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls over financial reporting, we may not be able to produce timely and accurate financial statements. If that were to happen, our investors could lose confidence in our reported financial information, the market price of our stock could decline, and we could be subject to sanctions or investigations by the stock exchange on which our common stock is listed, the SEC or other regulatory authorities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders, and may prevent attempts by our stockholders to replace or remove our current management.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law contain provisions that may have the effect of discouraging, delaying or preventing a change in control of us or changes in our management that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorize &#8220;blank check&#8221; preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">create a classified board of directors whose members serve staggered three-year terms;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">specify that special meetings of our stockholders can be called only by our board of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prohibit stockholder action by written consent;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide that our directors may be removed only for cause;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">specify that no stockholder is permitted to cumulate votes at any election of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expressly authorized our board of directors to make, alter, amend or repeal our amended and restated bylaws; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require supermajority votes of the holders of our common stock to amend specified provisions of our amended and restated certificate of incorporation and amended and restated bylaws.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, because we are incorporated in the State of Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any provision of our amended and restated certificate of incorporation, amended and restated bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock and could also affect the price that some investors are willing to pay for our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our amended and restated bylaws designate certain courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated bylaws provide that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of, or a claim based on, fiduciary duty owed by any of our current or former directors, officers, and employees to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws (including the interpretation, validity or enforceability thereof) or (iv) any action asserting a claim that is governed by the internal affairs doctrine (&#8220;Delaware Forum Provision&#8221;). The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Exchange Act. Our amended and restated bylaws further provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause or causes of action arising under the Securities Act (&#8220;Federal Forum Provision&#8221;). In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the foregoing provisions; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Delaware Forum Provision and the Federal Forum Provision in our amended and restated bylaws may impose additional litigation costs on stockholders in pursuing any such claims. Additionally, the forum selection clauses in our amended and restated bylaws may limit our stockholders&#8217; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court and other state courts have upheld the validity of federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the federal district courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Risk Factors</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">political instability and geopolitical events could adversely affect our business, financial condition, stock price, and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business could be adversely affected by unstable economic and political conditions within the United States and foreign jurisdictions, including as a result of an economic downturn and geopolitical events, such as changes in the U.S. federal policy that affect the geopolitical landscape. The global credit and financial markets have also generally experienced extreme volatility and disruptions (including as a result of actual or perceived changes in interest rates, inflation and macroeconomic uncertainties), which has included severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, high inflation, uncertainty about economic stability, global supply chain disruptions, and increases in unemployment rates. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. A severe or prolonged economic downturn could result in a variety of risks to our business, including a decrease in the demand for our product candidates and in our ability to raise additional capital when needed on acceptable terms, if at all.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial markets and the global economy may also be adversely affected by the current or anticipated impact of military conflicts, such as the ongoing conflicts between Russia and Ukraine, and Israel and Hamas, terrorism, or other geopolitical events. Sanctions imposed by the United States and other countries in response to such conflicts, including the one in Ukraine, may also continue to adversely impact the financial markets and the global economy, and any economic countermeasures by the affected countries or others could exacerbate market and economic instability. Additionally, changes to policy implemented by the U.S. Congress, the Trump administration or any new administration have impacted and may in the future impact, among other things, the U.S. and global economy, international trade relations, unemployment, immigration, healthcare, taxation, the U.S. regulatory environment, inflation and other areas. For example, during the prior Trump administration, increased tariffs were implemented on goods imported into the U.S., particularly from China, Canada, and Mexico. On February 1, 2025, the U.S. imposed a 25% tariff on imports from Canada and Mexico, which were subsequently suspended for a period of one month, and a 10% additional tariff on imports from China. Historically, tariffs have led to increased trade and political tensions, between not only the U.S. and China, but also between the U.S. and other countries in the international community. In response to tariffs, other countries have implemented retaliatory tariffs on U.S. goods. Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. There has also been proposed United States legislation, such as the bill titled the BIOSECURE Act, that may restrict the ability of United States pharmaceutical companies to purchase services or products from, or otherwise collaborate with, certain Chinese biotechnology companies of concern without losing the ability to contract with, or otherwise receive funding from, the United States government. We continue to assess the legislation as it develops to determine whether it could have an effect on our contractual relationships. Any changes in political, trade, regulatory, and economic conditions, including U.S. trade policies, could have a material adverse effect on our financial condition or results of operations. Until we know what policy changes are made, whether those policy changes are challenged and subsequently upheld by the court system and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, any disruptions to our supply chain as a result of unfavorable global economic conditions, including due to geopolitical conflicts or public health crises, could negatively impact the timely execution of our ongoing and future clinical trials. In addition, current inflationary trends in the global economy may impact salaries and wages, costs of goods and transportation expenses, among other things, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures may create market and economic instability. We cannot anticipate all of the ways in which the foregoing, and the current economic climate and financial market conditions generally, could adversely impact our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults, or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect our Company, the financial institutions with which we have credit agreements or arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential or actual breach of statutory, regulatory or contractual obligations, including obligations that require us to maintain letters of credit or other credit support arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, investor concerns regarding the United States or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity, our current and/or planned business operations, and our current or projected financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, any further deterioration in the macroeconomic economy or financial services industry could lead to losses or defaults by our suppliers, which in turn, could have a material adverse effect on our current and/or planned business operations and our current or projected results of operations and financial condition. For example, a customer may fail to make payments when due, default under their agreements with us, become insolvent or declare bankruptcy, or a supplier may determine that it will no longer deal with us as a customer. In addition, a customer or supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on the Company, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. Any customer, collaborator or supplier bankruptcy or insolvency, or the failure of any customer or collaborator to make payments when due, or any breach or default by a customer, collaborator or supplier, or the loss of any significant supplier or collaborator relationships, could result in material losses to the Company and may have a material adverse impact on our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our common stock will depend in part on the research and reports that industry or financial analysts publish about us or our business. If one or more of the analysts covering our business downgrade their evaluations of our stock or publishes inaccurate or unfavorable research bout our business, the price of our stock could decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, we could lose visibility in the market for our stock, which in turn could cause our stock price and trading volume to decline.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become involved in litigation that could divert management&#8217;s attention and harm our business, and insurance coverage may not be sufficient to cover all costs and damages.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time we may be subject to litigation claims through the ordinary course of our business operations regarding, but not limited to, securities litigation, employment matters, security of patient and employee personal data, contractual relations with collaborators and licensors and intellectual property rights. In the past, securities class action litigation has often followed certain significant business transactions, such as the sale of a company or announcement of any other strategic transaction, the announcement of negative events, such as negative results from clinical trials, or periods of volatility in the market price of a company&#8217;s securities. These events may also result in or be concurrent with investigations by the SEC. We may be exposed to such litigation or investigation even if no wrongdoing occurred. Litigation and investigations are usually expensive and divert management&#8217;s attention and resources, which could adversely affect our business and cash resources and our ability to consummate a potential strategic transaction or the ultimate value our stockholders receive in any such transaction.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our insurance policies are expensive and only protect us from some business risks, which will leave us exposed to significant uninsured liabilities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we maintain commercial insurance at a level we believe is appropriate against certain risks commonly insured in the industry in which we operate, there is no guarantee that our insurer will cover costs or that we will be able to obtain the desired level of coverage on acceptable terms in the future. Some of the policies we currently maintain include property, general liability, crime insurance, workers&#8217; compensation, and directors&#8217; and officers&#8217;, employment practices and fiduciary liability insurance, clinical trial insurance, transportation insurance and umbrella insurance. We do not know, however, if we will be able to maintain insurance with adequate levels of coverage. Changes in the market conditions and our business operations may necessitate the addition of new insurance policies or change of our existing insurance policies. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our financial position and results of operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our operations are vulnerable to interruption by disasters, terrorist activity, pandemics and other events beyond our control, which could harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our facilities are located in California. We have not undertaken a systematic analysis of the potential consequences to our business and financial results from a major flood, power loss, terrorist activity, pandemics or other regional or global disasters and generally do not have a recovery plan for such events. In addition, we do not carry sufficient insurance to compensate us for actual losses from interruption of our business that may occur, and any losses or damages incurred by us could harm our business. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Increased attention to, and evolving expectations for, environmental, social, and governance initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Companies across industries are facing increasing scrutiny from a variety of stakeholders related to their environmental, climate change, social, and governance (&#8220;ESG&#8221;) and sustainability practices. Investor advocacy groups, certain institutional investors, investment funds, and other influential investors have increasingly focused on ESG practices and have placed increasing importance on the non-financial impacts of their investments. Expectations regarding voluntary ESG initiatives and disclosures may result in increased costs (including but not limited to increased costs related to compliance, stakeholder engagement, contracting and insurance), enhanced compliance or disclosure obligations, or other adverse impacts to our business, financial condition, or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we may at times engage in voluntary initiatives (such as voluntary disclosures, certifications, or goals, among others) to improve the ESG profile of the Company, such initiatives may be costly and may not have the desired effect. Moreover, we may not be able to successfully complete such initiatives due to factors that are within or outside of our control. Even if this is not the case, our actions may subsequently be determined to be insufficient by various stakeholders, and we may be subject to investor or regulator engagement on our ESG efforts, even if such initiatives are currently voluntary.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain market participants, including major institutional investors and capital providers, use third-party benchmarks and scores to assess companies&#8217; ESG profiles in making investment or voting decisions. Unfavorable ESG ratings could lead to increased negative investor sentiment towards us, which could negatively impact our share price as well as our access to and cost of capital. In addition, in recent years &#8220;anti-ESG&#8221; sentiment has gained momentum across the United States, with several states and Congress having proposed or enacted &#8220;anti-ESG&#8221; policies, legislation, or initiatives or issued related legal opinions, and the President having recently issued an executive order opposing diversity equity and inclusion (&#8220;DEI&#8221;) initiatives in the private sector. Such anti-ESG and anti-DEI-related policies, legislation, initiatives, litigation, legal opinions, and scrutiny could result in us facing additional compliance obligations, becoming the subject of investigations and enforcement actions, or sustaining reputational harm. Therefore, to the extent we take actions that are seen as positive to some investors, other investors may take issue with such actions or face regulatory pressure to refrain from investing in, or divest from, our business. To the extent ESG matters negatively impact our reputation, it may also impede our ability to compete as effectively to attract and retain employees, which may adversely impact our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we expect there will likely be increasing levels of regulation, disclosure-related and otherwise, with respect to ESG matters. For example, the SEC has issued rules that require companies to provide significantly expanded climate-related disclosures in their periodic reporting. The new climate disclosure rules were the subject of multiple legal challenges, and the SEC voluntarily stayed the climate disclosure rules pending the completion of judicial review. Therefore, it is unknown whether the new rules will go into effect and if they do, whether there will be significant changes. If the new rules go into effect and are not substantially different than the rules adopted by the SEC, we may be required to incur significant additional costs to comply, including the implementation of significant additional internal controls processes and procedures regarding matters that have not been subject to such controls in the past, and impose increased oversight obligations on our management and board of directors. Even if the SEC rules are not adopted, states or ex-U.S. jurisdictions in which we currently or may in the future operate may also have or adopt ESG or climate-related disclosure rules requiring similar or broader disclosure obligations. These and other changes in stakeholder expectations will likely lead to increased costs as well as scrutiny that could heighten all of the risks identified in this risk factor. Additionally, our business partners may be subject to similar expectations, which may augment or create additional risks, including risks that may not be known to us.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The increasing use of social media platforms presents risks and challenges.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We and our employees are increasingly utilizing social media tools as a means of communication both internally and externally. Despite our efforts to monitor evolving social media communication guidelines and comply with applicable rules, there is risk that the use of social media by us or our employees to communicate about our product candidates, operations, or business may cause us to be found in violation of applicable legal or contractual requirements. In addition, our employees may knowingly or inadvertently make use of social media in ways that may not comply with our social media policy or other legal or contractual requirements, which may give rise to liability, lead to the loss of trade secrets or other intellectual property, or result in public exposure of personal information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our employees, clinical trial patients, collaboration partners, and others, and which could have an adverse effect on our business, financial conditions and results of operations. Furthermore, negative posts or comments about us or our product candidates in social media could seriously damage our reputation, brand image and goodwill.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, it is possible for individuals or groups to target companies with disruptive social media campaigns related to a request for access to unapproved drugs for patients with significant unmet medical need. If we experience a similar social media campaign regarding our decision to provide or not provide access to our product candidates under an expanded access policy, our reputation may be negatively affected and our business may be harmed.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolv</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ed Staff Comments.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_97ab89d2-7260-49f2-86f0-e968080186dc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented a cybersecurity risk management program in accordance with our risk profile and business size that is informed by recognized industry standards, including elements of the National Institute of Standards and Technology Cybersecurity Framework and International Organization for Standardization 27001 Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program is comprised of a number of components, including but not limited to written information security policies, external cybersecurity risk assessments, and system monitoring. We also have an employee privacy and data security training awareness program that includes cybersecurity risk awareness trainings and phishing campaigns. We maintain an incident response plan to help guide our response to cybersecurity incidents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We leverage the cybersecurity services of third-party vendors, including a third-party managed services provider and IT consultants, to support our cybersecurity risk management program and assist us in conducting external cybersecurity risk assessments. As part of our cybersecurity risk management program, we take a risk-based approach to the evaluation of third-party vendors. As part of our vendor diligence process we require vendors with access to our information technology systems and infrastructure to complete information security program questionnaires.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0d2a9db3-ead3-47c8-9054-afa3128d5d59" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not identified any cybersecurity incidents or threats that have materially affected us or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab46c9e1-bbc0-4111-afba-91b67605b2ff" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">However, like other companies in our industry, we and our </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_234f46f8-3ef2-4e01-8d53-2f32609569aa" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> vendors have from time to time experienced threats relating to our and our third-party vendors&#8217; information systems and infrastructure.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For more information, please see &#8220;Item 1A, Risk Factors.&#8221;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6643f76f-33ee-4dfc-8521-94c9a70f6a4d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance Related to Cybersecurity Risks</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93a95915-cf1b-4393-b464-bccf50c3354e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0311ff13-87be-4025-95c6-82176cbe718e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#8217;s general risk oversight function.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0fa09c90-de95-4e4d-a61f-995f9c049b6c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></ix:nonNumeric></span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1db187d6-c87f-41df-9af6-5790def05757" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#8220;IT&#8221;), and is responsible for the strategic leadership of our cybersecurity risk management program.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_90bd8c01-389d-4015-8971-ab24bc6333bc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ffee996d-cb4f-43bf-b9aa-ed9e91927b0f" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Head of IT relies on both internal and external cybersecurity resources to manage and remain appraised of overall cybersecurity risks to our business and our industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_e262a680-977f-494c-a34c-558371b501d7" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c296fcb1-d97d-435a-8641-b7e7e8f57a75" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Pro</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">perties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters are located in South San Francisco, California, where we lease and occupy approximately 44,819 square feet of combined office, research and laboratory space at 250 East Grand Avenue, South San Francisco, California 94080. The current term of our lease expires in July 2032.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that our existing facilities are adequate for our current needs and for the foreseeable future. To meet the future needs of our business, we may lease additional or alternate space. We believe that suitable additional or substitute space at commercially reasonable terms will be available as needed to accommodate any future expansion of our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Le</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">gal Proceedings.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may become involved in or be subject to legal proceedings, claims and litigation arising from the ordinary course of business. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are probable to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of defense and settlement costs, diversion of management resources and other factors.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">afety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T II</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrants_common"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Registra</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nt&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock began trading on the Nasdaq Global Market under the symbol &#8220;SEPN&#8221; on October 25, 2024. Prior to this date, there was no public trading market for our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock Holders</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 17, 2025, we had approximately 103 holders of record of our common stock. The approximate number of holders is based upon the actual number of holders registered in our records at such date and excludes holders in &#8220;street name&#8221; or persons, partnerships, associations, corporations, or other entities identified in security positions listings maintained by depository trust companies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not declared or paid cash dividends on our capital stock since our inception. We intend to retain future earnings, if any, to finance the operation and expansion of our business and do not anticipate paying any cash dividends to holders of common stock in the foreseeable future. Any future determination regarding the declaration and payment of dividends, if any, will be at the discretion of our board of directors, subject to applicable laws, and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant. In addition, our ability to pay cash dividends on our capital stock in the future may be limited by the terms of any future debt or preferred securities we issue or any credit facilities we enter into.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Authorized for Issuance Under Equity Compensation Plans</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about securities authorized for issuance under our equity compensation plans is incorporated herein by reference to Part III, Item 12 of this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;).</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Use of Proceeds from our IPO</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 24, 2024, our Registration Statement on Form S-1 (File No. 333-282469), as amended, relating to our IPO was declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) (the &#8220;Registration Statement&#8221;). Pursuant to the Registration Statement, we registered the offer and sale of 18,400,000 shares of our common stock. On October 28, 2024, we closed our IPO, pursuant to which we issued and sold 18.4 million shares of common stock at the public offering price of $18.00 per share, which included 2.4 million shares of our common stock issued and sold on October 30, 2024 to the underwriters pursuant to the full exercise of their option to purchase additional shares of our common stock, at the public offering price of $18.00 per share. Pursuant to the IPO, we received gross proceeds of $331.2 million, which resulted in net proceeds to us of $302.8 million, after deducting underwriting discounts and commissions and other offering costs payable by us of $28.4 million. J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald &amp; Co. and Wells Fargo Securities, LLC acted as joint book-running managers for the IPO.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds from our IPO have been invested according to our approved investment policy in a mix of money market funds and high-quality, fixed income securities. Our planned use of the net proceeds from the IPO as described in our final prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) on October 25, 2024 has changed due to the discontinuation of the development of our prior lead product candidate, SEP-786. As a result, we currently expect to use our cash, cash equivalents and marketable securities, which include the net proceeds from the IPO, to advance a next-generation oral small molecule PTH1R agonist from our PTH1R program into clinical development, advance SEP-631 into clinical development, continue to advance the other programs in our pipeline, and the remainder to fund working capital and other general corporate purposes.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series B Convertible Preferred Stock Financing</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we sold an aggregate of 60,828,732 shares of our Series B convertible preferred stock, at a purchase price of $1.23297 per share, for an aggregate amount of $75 million. We incurred $0.1 million in issuance costs.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No underwriters were involved in the foregoing sale of securities. The sale of securities described above were deemed to be exempt from registration pursuant to Section 4(a)(2) of the Securities Act, including Regulation D and Rule 506 promulgated thereunder, as transactions by an issuer not involving a public offering. All of the purchasers in these transactions represented to us, in connection with their purchase, that they were acquiring the securities for investment and not distribution, that they could bear the risks of the investment and could hold the securities for an indefinite period of time. Such purchasers received written disclosures that the securities had not been registered under the Securities Act and that any resale must be made pursuant to a registration or an available exemption from such registration. All of the foregoing securities are deemed restricted securities for the purposes of the Securities Act.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reserved]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_managements_discussion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations together with our audited financial statements and related notes included elsewhere in this Annual Report. This discussion and other parts of this Annual Report contain forward-looking statements based upon current beliefs, plans, and expectations related to future events and our future financial performance that involve risks, uncertainties and assumptions, such as statements of our plans, objectives, expectations, intentions, forecasts and projections. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors including, but not limited to, those set forth under the section titled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report. Our historical results are not necessarily indicative of the results that may be expected for any period in the future, and you should carefully read the section titled &#8220;Risk Factors&#8221; to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a biotechnology company pioneering a new era of G protein-coupled receptor (&#8220;GPCR&#8221;) oral small molecule drug discovery powered by our proprietary Native Complex Platform&#153;. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary Native Complex Platform&#153; replicates the natural structure, function, and dynamics of GPCRs outside of cells at an industrial scale for, as we believe it, the first time. Our foundational technologies enable us to isolate, purify, and reconstitute full-length, properly folded GPCR proteins within ternary complexes with ligands and transducer proteins in a lipid bilayer that mimics the cell membrane. We then apply state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging our platform, we conduct GPCR oral small molecule drug discovery using an industrialized and iterative structure-based drug design approach for a diverse collection of GPCR targets. Our Native Complex Platform&#153;  is designed to enable us to target specific GPCRs, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists (which activate GPCR signaling), antagonists (which inhibit GPCR signaling), and allosteric modulators (which either increase or decrease the degree of GPCR activation by endogenous ligands), to affect GPCR signaling in different ways to achieve desired therapeutic effects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. Our wholly-owned pipeline, summarized in the figure below, is focused initially on three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117602972_13.jpg" alt="img117602972_13.jpg" style="width:582px;height:238px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We were incorporated in Delaware in December 2019 under the name GPCR NewCo, Inc. In June 2021, we changed our name to Septerna, Inc. We are headquartered in South San Francisco, California.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since our inception, except for the year ended December 31, 2023, when we recorded net income of $4.2 million, resulting from the gain on sale of non-financial asset of $47.6 million for the sale of an in-progress research and development (&#8220;IPR&amp;D&#8221;) asset related to a GPCR program. Our revenue to date has been generated solely from</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">research services. Since our founding, we have devoted substantially all of our resources to organizing and staffing our company, business planning, raising capital, developing our proprietary and structure-based drug discovery platform, identifying and discovering our product candidates, establishing our intellectual property portfolio, conducting research and preclinical studies, including investigational new drug(&#8220;IND&#8221;)-enabling studies, initiating and conducting clinical trials, establishing arrangements with third parties for the manufacture of our product candidates and related raw materials, and providing general and administrative support for these operations. We have not had any products approved for sale and have not generated any revenue from product sales. Further, we do not expect to generate revenue from commercial product sales until such time, if ever, that we are able to successfully complete the development and obtain marketing approval for one or more of our product candidates. Our ability to generate product revenue will depend on the successful development and eventual commercialization of one or more of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net loss was $71.8 million for the year ended December 31, 2024 compared to net income of $4.2 million for the year ended December 31, 2023. As of December 31, 2024, we had an accumulated deficit of $118.4 million. We have incurred net losses in each year since inception, except for the year ended December 31, 2023. We expect to continue to incur net losses for the foreseeable future. Our net losses may fluctuate significantly from period to period, depending on the timing and expenditures of our operational activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to continue to incur significant and increasing net operating losses for the next several years as we:</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue to advance our product candidates through preclinical studies and into clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">attract, hire and retain additional personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operate as a public company, including expenses related to compliance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and those of any national securities exchange on which our securities are traded, legal, auditing, additional insurance expenses, investor relations activities, and other administrative and professional services;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue our research and development efforts and expand our pipeline of product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acquire, discover, validate, and develop additional product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require the manufacture of supplies for our preclinical studies and clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain, maintain, expand, and protect our intellectual property portfolio;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">implement operational, financial and information management systems;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">make royalty, milestone or other payments under any future, license or collaboration agreements; </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potentially seek to identify, assess, acquire, or in-license or develop new technologies or additional product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potentially experience any delays, challenges, or other issues associated with the clinical development of our product candidates, including with respect to our regulatory strategies;</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursue regulatory approval of product candidates that successfully complete clinical trials; and</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a sales, marketing and distribution infrastructure to commercialize any product candidate for which we may obtain marketing approval and related commercial manufacturing build-out.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net losses may fluctuate significantly from period to period, depending upon the timing of our expenditures on research and development activities. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses and other current liabilities, which includes accrued research and development, in the statements of cash flows in our audited financial statements included elsewhere in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, we will require substantial additional funding to further develop our product candidates and support our continuing operations. Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. See the section titled &#8220;Liquidity and Capital Resources - Future Funding Requirements&#8221; below for additional information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We historically financed our operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and, most recently, through an initial public offering (&#8220;IPO&#8221;). In October 2024, we completed our IPO, pursuant to which we issued and sold an aggregate of 18.4 million shares of our common stock (inclusive of an additional 2.4 million shares of our common stock issued and sold pursuant to the underwriters' exercise of their option to purchase additional shares in full). The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">aggregate net proceeds received by us from the IPO was $302.8 million, after deducting underwriting discounts and commissions, and other offering costs of $28.4 million.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception, we have devoted substantially all of our resources to raising capital, organizing and staffing our company, business and scientific planning, conducting discovery and research and development activities, establishing and protecting our intellectual property portfolio, developing and progressing our product candidates and preparing for clinical trials, establishing arrangements with third parties for the manufacture of our product candidates and component materials, engaging in collaboration activities, and providing general and administrative support for these operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our cash, cash equivalents, and marketable securities of $420.8 million as of December 31, 2024 will be sufficient to fund our operations and capital expenditure requirements into early 2028.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use contract research and development organizations to conduct our preclinical works and clinical trials. Additionally, we utilize third-party contract manufacturing organizations (&#8220;CMOs&#8221;), to manufacture and supply our preclinical and clinical materials during the development of our product candidates. We expect to use similar contract resources for the commercialization of our products, at least until our resources and operations are at a scale that justifies investment in internal manufacturing capabilities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vertex Asset Purchase and Service Agreements</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Asset Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2023, we entered into an asset purchase agreement with Vertex Pharmaceuticals Incorporated (&#8220;Vertex&#8221;) for a total of $47.6 million under which Vertex acquired all of our IPR&amp;D asset related to a GPCR program, including all intellectual property, materials, and compounds associated with the program (&#8220;Vertex purchase agreement&#8221;). Of the $47.6 million, $25.0 million was received in cash in September 2023 and the remainder during the year ended December 31, 2024. Additionally, as part of the agreement, Vertex assumed all claims, counterclaims and credits associated with the program, and we gave up all rights to the intellectual property. The transfer of the IPR&amp;D asset to Vertex was completed in November 2023 and we recognized $47.6 million of gain on sale of non-financial asset for the year ended December 31, 2023 in our result of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the same time in September 2023, we entered into a research service agreement with Vertex under which we agreed to perform certain exploratory research activities for Vertex. See the subsection titled </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Service Agreement&#8221; below.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Vertex purchase agreement also provides for a potential milestone payment payable to us contingent upon achievement of a certain research milestone. The milestone payment amount is determined based on the timing of achievement of the research milestone. The variable consideration related to this milestone payment was determined to be improbable of receipt at this time. As a result, the milestone payment was excluded from the transaction price. After the potential milestone payment, we will not receive any other payments or future royalties related to this IPR&amp;D asset.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Service Agreement</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the Vertex purchase agreement, we also entered into a research service agreement with Vertex (&#8220;Vertex service agreement&#8221;) under which we agreed to perform certain exploratory research activities for Vertex. The Vertex service agreement is for a two-year term, however, Vertex has the ability to terminate the agreement with a 30-day notice at any time. As a result, we concluded that the contract duration is 30 days, representing a month-to-month service contract. We recognize revenue associated with the Vertex service agreement over the performance period of the research services as the services are provided.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Components of Results of Operations</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not generated any revenue from product sales and do not expect to do so in the foreseeable future. Our ability to generate product revenue, if ever, will depend on the successful development and eventual commercialization of any product candidates that we identify. If we fail to complete the development of any future product candidates in a timely manner or to obtain regulatory approval for such product candidates, our ability to generate future revenue and our results of operations and financial position would be materially adversely affected. Our revenues to date have been exclusively related to research services. We recognize revenue as specified research services are performed and the results of the research and development services are provided to the customer.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operating expenses consist of (i) research and development expenses and (ii) general and administrative expenses.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses account for the largest component of our total operating expenses. Research and development expenses consist primarily of direct and unallocated costs incurred for the research and development of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our research and development expenses consist of:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Direct costs, including:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preclinical and research program costs, which include external research and development costs related to (i) the production of preclinical materials, including fees and milestones paid to contract manufacturers and (ii) agreements with contract development organizations, consultants and other third-party contract organizations to conduct our preclinical studies and other research and development activities on our behalf, costs incurred in connection with laboratory operations, materials and supplies, and other preclinical studies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical program costs, which include external costs to conduct clinical trials, including costs paid to contract research organizations (&#8220;CROs&#8221;), the production of clinical materials and fees paid to contract manufacturers, costs incurred in connection with clinical laboratory operations, materials and supplies; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unallocated costs, including:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payroll-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">external research and development costs, including contract research and development and professional service fees for consulting and related services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">facility-related and office costs, including lease/rent, building-related expenses, facility-related overhead, and depreciation expense; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#9642;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other costs, including expenses related to our funded, sponsored research activities and technology licenses, laboratory operations, information technology (&#8220;IT&#8221;)-related expenses.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expense all research and development costs in the periods in which they are incurred. Costs for certain development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and third-party service providers.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A significant portion of our research and development costs have been external costs, which we track by stage of development. However, we do not track our unallocated costs on a program specific basis because these costs are deployed across multiple projects and, as such, are not separately classified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At this time, we cannot reasonably estimate or know the nature, timing, and estimated costs of the efforts that will be necessary to complete the development of, and obtain regulatory approval for, any of our product candidates. We expect that our research and development expenses will increase substantially in absolute dollars for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, as our product candidates advance into later stages of development, as we begin to conduct clinical trials, as we seek regulatory approvals for any product candidates that successfully complete clinical trials, and as we incur expenses associated with hiring additional personnel to support our research and development efforts. The process of conducting the necessary clinical research to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. This is due to the numerous risks and uncertainties associated with developing product candidates, many of which are outside of our control, including the uncertainty of:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and progress of preclinical and clinical development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of preclinical and clinical programs we decide to pursue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain our current research and development programs and to establish new ones;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing an appropriate safety profile with IND-enabling studies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of sites and patients included in the clinical trials;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the countries in which the clinical trials are conducted;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per patient trial costs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful patient enrollment in, and the initiation of, clinical trials, as well as drop out or discontinuation rates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the successful completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), European Medicines Agency (&#8220;EMA&#8221;), or any other comparable foreign regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of trials required for regulatory approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, receipt and terms of any regulatory approvals from applicable regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish collaboration arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the performance of any future collaborators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant and changing government regulation and regulatory guidance;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of any business interruptions to our operations or to those of the third parties with whom we work;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining, maintaining, defending and enforcing patent claims and other intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">launching commercial sales of our product candidates, if approved, whether alone or in collaboration with others; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintaining a continued acceptable safety profile of the product candidates following approval.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any changes in the outcome of any of these variables could mean a significant change in the costs and timing associated with the development of our product candidates. For example, if the FDA, EMA or any other comparable foreign regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required for the completion of clinical development of a product candidate, or if we experience significant delays in our clinical trials due to patient enrollment or other reasons, we would be required to expend significant additional financial resources and time on the completion of clinical development. We may never obtain regulatory approval for any of our product candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of personnel-related costs, costs related to maintenance and filing of intellectual property, legal fees related to corporate matters, professional fees paid for accounting, auditing, consulting, tax and investor relations services, insurance costs, general corporate expenses, and IT-related and facility-related costs not otherwise included in research and development expenses. Personnel-related costs include salaries, benefits, and stock-based compensation for our personnel in executive, legal, finance and accounting, human resources, and other administrative functions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that our general and administrative expenses will increase substantially in absolute dollars for the foreseeable future as we continue to increase our headcount to support our business growth. We also anticipate that we will incur increased expenses as a result of our operating as a public company, including expenses related to compliance with the rules and regulations of the SEC and expenses related to audit, legal, regulatory services associated with maintaining compliance with exchange listing and SEC requirements, director and officer insurance premiums and investor relations costs.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest income consists of interest earned on our cash, cash equivalents and marketable securities during the period.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income (Expense), Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income (expense), net consists primarily of changes in the fair value of our cash equivalents held in money market funds, loss on disposal of our fixed assets and foreign currency transaction gain or loss.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Benefit (Provision) for Income Taxes</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to corporate United States federal and state income taxation. Our provision (benefit) for income taxes are recorded in accordance with Accounting Standard Codification (&#8220;ASC&#8221;) 740, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting for Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which provides for deferred taxes using an asset and liability approach. We establish a valuation allowance against all of our net deferred tax assets. We consider all available evidence, both positive and negative, including but not limited to our historical operating results, income or loss in recent periods, cumulative losses in recent years, forecasted earnings (losses), future taxable income (loss), and significant risk and uncertainty related to forecasts, and concluded the deferred tax assets are not more likely than not to be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth our results of operations for the years ended December 31, 2024 and 2023:</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,075</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">924</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses (income):</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,337</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,979</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,358</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,561</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,722</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,839</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(47,625</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,625</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses (income)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,898</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,924</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,822</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(80,823</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(82,898</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,617</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,786</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,831</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (expense) income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(90</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,527</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,796</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,731</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income before provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(72,296</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,871</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(77,167</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(498</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">691</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,189</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(71,798</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(75,978</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our service revenue of $1.1 million and $0.2 million for the year ended December 31, 2024 and 2023, respectively, was generated from research activities performed for Vertex in connection with the Vertex service agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses (Income)</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our research and development expenses for the periods indicated by direct and unallocated costs (in thousands):</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Direct costs:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PTH1R</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,719</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,334</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,385</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MRGPRX2</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,866</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,981</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">885</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other programs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,222</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,478</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">744</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unallocated costs:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll-related costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,924</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,490</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,434</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External research and development costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,287</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,313</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,974</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and office costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,390</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,181</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,209</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,929</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,202</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,727</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,337</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,979</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,358</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expense was $65.3 million and $36.0 million for the years ended December 31, 2024 and 2023, respectively. The increase of $29.4 million was primarily due to (i) $10.0 million of higher expenses attributable to unallocated external research and development costs, (ii) $7.4 million of higher direct costs associated with our SEP-786 clinical, preclinical and research program, including $2.4 million of clinical trial expenses, (iii) $5.4 million of higher employee-related costs as a result of increased headcount as we grow our business, (iv) $3.2 million of higher facility-related and office costs as we expanded our office space to accommodate higher occupancy and larger operational activities, and (v) an increase of $1.7 million in other research and development expense, primarily driven by higher IT operational expenses. The SEP-786 clinical study was discontinued in February 2025 and we do not anticipate incurring significant additional clinical trial costs associated with that study.  We expect to continue to incur increased research and development expenses as we advance next-generation oral small molecule PTH1R agonists from our PTH1R program toward clinical development, advance SEP-631 into clinical development, and continue to advance other programs in our pipeline.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses were $16.6 million and $9.7 million for the years ended December 31, 2024 and 2023, respectively. The increase of $6.8 million was primarily due to (i) $2.3 million of higher consulting, audit and accounting-related fees, and $0.9 million higher legal fees, mainly attributable to costs associated with becoming a public company and ongoing operations as a public company following our IPO in October 2024, (ii) $2.4 million of higher employee-related costs as a result of increased headcount to support our growing operations, (iii) $0.5 million of higher facility-related and office costs as we expanded our office space to accommodate higher occupancy and larger operational activities, and (iv) $0.4 million increase in corporate development expenses primarily attributable to higher public and investor relations costs associated with our transition to and operations as a public company following our IPO.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gain on Sale of Non-Financial Asset</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset of $47.6 million was attributable to the sale of our IPR&amp;D asset related to a GPCR program to Vertex during the year ended December 31, 2023. No gain on sale of non-financial asset was recorded during the year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest income was $8.6 million and $2.8 million for the years ended December 31, 2024 and 2023, respectively. The increase was due to higher interest rates and higher balances of invested cash in cash equivalents and marketable securities.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(Benefit) Provision for Income Taxes</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized $0.5 million of benefit for income taxes for the year ended December 31, 2024. Provision for income taxes of $0.7 million for the year ended December 31, 2023 was primarily due to the gain on sale of non-financial asset, which resulted in net income.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net loss was $71.8 million for the year ended December 31, 2024 compared to $4.2 million of net income for the year ended December 31, 2023. As of December 31, 2024, we had an accumulated deficit of $118.4 million. We have incurred net losses in each year since inception, except for the year ended December 31, 2023. During the year ended December 31, 2023, we recorded a gain on sale of non-financial asset of $47.6 million for the sale of an IPR&amp;D asset related to a GPCR program and $0.2 million in revenue related to research services. Of the $47.6 million gain on sale of non-financial asset, $25.0 million was received in cash in September 2023 and the remainder during the year ended December 31, 2024. We expect to continue to incur net losses for the foreseeable future. Our net losses may fluctuate significantly from period to period, depending on the timing and expenditures of our operational activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We historically financed our operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and most recently, through an IPO. Additionally, during the year ended December 31, 2023, we recorded a gain on sale of non-financial asset of $47.6 million for the sale of an IPR&amp;D asset related to a GPCR program and $0.2 million in revenue related to research services resulting in net income of $4.2 million. Of the $47.6 million gain on sale of non-financial asset, $25.0 million was received in cash at the closing of the Vertex purchase agreement in September 2023 and the remainder during the year ended December 31, 2024. In October 2024, we completed our IPO, pursuant to which we issued and sold an aggregate of 18.4 million shares of common stock (inclusive of 2.4 million shares of common stock sold pursuant to the underwriters' exercise of their option to purchase additional shares). The aggregate net proceeds received by us from the IPO was $302.8 million, after deducting underwriting discounts and commissions, and other offering costs payable by us of $28.4 million. As of December 31 2024, we had $420.8 million in cash, cash equivalents, and marketable securities, which we believe will be sufficient to fund our operations and capital expenditure requirements into early 2028.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any off-balance sheet arrangements other than our indemnification agreements as described in Note 8 to our audited financial statements included elsewhere in this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our cash flows for the periods indicated (in thousands):</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(67,470</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(38,723</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(160,598</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,122</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">377,781</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,520</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in cash, cash equivalents and restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">149,713</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,919</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash Used in Operating Activities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in operating activities was $67.5 million for the years ended December 31, 2024. The net cash used in operating activities for the year ended December 31, 2024 was due to our net loss of $71.8 million, which was partially offset by (i) $4.1 million of non-cash charges for depreciation and amortization, stock-based compensation, non-cash operating lease expense, deferred income tax and accretion of premiums (discounts) on marketable securities, and (ii) $0.2 million of net change in operating assets and liabilities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in operating activities was $38.7 million for the years ended December 31, 2023. Net cash used in operating activities for the year ended December 31, 2023 was attributable to $47.6 million of non-cash adjustment related to gain on sale of non-financial asset, partially offset by (i) our net income of $4.2 million, (ii) $3.8 million of non-cash charges for depreciation and amortization, stock-based compensation, non-cash operating lease expense and deferred income tax, and (iii) $0.9 million of net change in operating assets and liabilities.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash (Used in) Provided by Investing Activities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities of $160.6 million for the year ended December 31, 2024 was due to $213.4 million of purchases of marketable securities and $2.1 million of purchases of property and equipment, partially offset by the receipt of the remaining $22.6 million from the sale of non-financial asset in 2023 and the maturity of $32.3 million of marketable securities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by investing activities of $22.1 million for the year ended December 31, 2023 was due to $25.0 million proceeds from the sale of non-financial asset, partially offset by $2.9 million of purchases of property and equipment.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash Provided by Financing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities was $377.8 million for the year ended December 31, 2024. Net cash provided by financing activities for the year ended December 31, 2024 was primarily due to $302.8 million of net proceeds from the issuance of our common stock in our IPO and $74.9 million of net proceeds from the sale and issuance of our Series B Convertible Preferred Stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities was $74.5 million for the year ended December 31, 2023. Net cash provided by financing activities for the year ended December 31, 2023 was primarily due to net proceeds from the sale and issuance of our Series B Convertible Preferred Stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future Funding Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our primary use of cash is to fund our operations, primarily research and development expenditures. Cash used for operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable, accrued expenses and prepaid expenses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, timing, progress and results of discovery, preclinical development, laboratory testing and clinical trials for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expenses of manufacturing our product candidates for clinical trials and in preparation for marketing approval and commercialization;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we enter into collaborations or other arrangements with additional third parties in order to further develop our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expenses of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expenses and fees associated with the discovery, acquisition or in-license of additional product candidates or technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish additional collaborations on favorable terms, if at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expenses required to scale up our clinical, regulatory and manufacturing capabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expenses of future commercialization activities, if any, including establishing sales, marketing, manufacturing and distribution capabilities, for any of our product candidates for which we receive marketing approval; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will need additional funds to meet operational needs and capital requirements for clinical trials, other research and development expenditures, and business development activities. Because of the numerous risks and uncertainties associated with the development and commercialization of our product candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures associated with our current and anticipated clinical studies.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, existing stockholders&#8217; ownership interests will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect existing stockholders&#8217; rights as common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We historically financed our operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and most recently, through an IPO. In June 2023, we entered into a total of $150.0 million of Series B Convertible Preferred Stock financing, which was divided into two tranches of equal amounts. The first tranche, which was the issuance of $75.0 million of Series B Convertible Preferred Stock, was completed in June and July 2023 for total net proceeds of $74.5 million. The second tranche, which was the issuance of the remaining $75.0 million, was completed in May 2024 for net proceeds of $74.9 million. In October 2024, the we completed our IPO which resulted in net proceeds of $302.8 million, after deducting underwriting discounts, commissions and offering expenses payable by us of $28.4 million. Since our inception, we have devoted substantially all of our resources to raising capital, organizing and staffing our company, business and scientific planning, conducting discovery and research and development activities, establishing, maintaining, and protecting our intellectual property portfolio, developing and progressing our product candidates and preparing for clinical trials, establishing arrangements with third parties for the manufacture of our product candidates and component materials, engaging in collaboration activities, and providing general and administrative support for these operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Use of Estimates</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generated revenue for the years ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex. We consider revenue to be earned when all of the following criteria are met: (i) we have a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount we expect to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and we have transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration we expect to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#8217;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation is measured based on the estimated grant date fair value of the award and is recognized as expense on a straight-line basis over the requisite service period (usually the vesting period). Forfeitures are accounted for in the period in which they occur.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the fair value of the options granted, we use the Black Scholes option pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8212; See the subsection titled &#8220;&#8212;Fair Value of Common Stock&#8221; below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8212; The expected term represents the period that our stock options granted are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). We have very limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for our stock option grants. We will continue to apply this process until a sufficient amount of historical information regarding employee exercise patterns and post-vesting employment termination behavior becomes available.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8212; Due to our limited operating history and lack of company-specific historical volatility as a public company due to our recent IPO in October 2024, or implied volatility as a private company, the expected volatility was estimated based on the average volatility for comparable publicly traded biopharmaceutical companies over a period, where available, equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar size, life cycle stage and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-free Interest Rate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8212; The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8212; We have never paid dividends on our common stock and have no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recorded stock-based compensation of $3.2 million and $1.6 million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, total unrecognized stock-based compensation expense related to unvested restricted stock awards and unvested stock options was $15.0 million, which is expected to be recognized over a weighted-average period of 2.8 years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As there has been no public market for our common stock prior to the IPO, the grant-date fair market value of our common stock underlying stock options has historically been determined by our board of directors with assistance of unrelated third-party valuation specialists. Because there was been no public market for our common stock, our board of directors have exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair market value, which include important developments in our operations, the prices at which we sold shares of our convertible preferred stock, the rights, preferences and privileges of our convertible preferred stock relative to those of common stock, actual operating results, financial performance, external market conditions in the life sciences industry, general U.S. market conditions, equity market conditions of comparable public companies, and the lack of marketability of our common stock. Given the absence of a public trading market for our common stock, our board of directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our common stock, including: our stage of development and material risks related to our business; the progress of our research and development programs; sales of our preferred stock; the rights, preferences and privileges of our convertible preferred stock relative to those of our common stock; the lack of marketability of our securities; our financial condition and operating results, including our levels of available capital resources; the likelihood of achieving a liquidity event such as an initial public offering in light of prevailing market conditions; equity market conditions affecting comparable public companies; the trends, developments and conditions in the life sciences and biotechnology industry sectors; and general U.S. market and economic conditions. Valuations of our common stock were prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants 2013 Practice Guide, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, referred to as the &#8220;Practice Aid.&#8221;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the Practice Aid, prior to April 2024, the fair value of our common stock was determined using the Option Pricing Method (&#8220;OPM&#8221;) method as we determined the OPM method was the most appropriate method to utilize based on our stage of development and other relevant factors. The OPM uses the preferred stockholders&#8217; liquidation preferences, participation rights, dividend policy, and conversion rights to determine how proceeds from a liquidity event shall be distributed among the various ownership classes at a future date. Starting April 2024, in accordance with the Practice Aid, we determined the hybrid probability-weighted expected return method (&#8220;PWERM&#8221;) method was the most appropriate method for determining the fair value of our common stock based on our stage of development and other relevant factors. The hybrid PWERM is a scenario-based methodology that estimates the fair value of common stock based upon an analysis of future values for the company, assuming various outcomes with one of those outcomes incorporating the OPM method.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After the equity value was determined and allocated to the various classes of equity securities, a discount for lack of marketability (&#8220;DLOM&#8221;) was applied to arrive at the fair value of common stock on a non-marketable basis.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A DLOM is applied based on the theory that as an owner of a private company stock, the holder has limited information and opportunities to sell the stock. A market participant that would purchase this stock would recognize this risk and thereby require a higher rate of return, which would reduce the overall fair market value.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The assumptions underlying these valuations represented management&#8217;s best estimates, which involved inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common stock and our stock-based compensation expense could have been materially different.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since a public trading market for our common stock has been established in connection with the completion of our IPO, the fair value of our common stock will be determined based on the quoted market price of our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits, and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of preclinical and clinical materials, IT-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations, and fees paid to other entities that conduct certain research and development activities on our behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into various agreements with outsourced contract manufacturing and development vendors. We estimate accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. We periodically confirm the accuracy of our estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, we will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See Note 2 to our audited financial statements included elsewhere in this Annual Report for more information.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We qualify as &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;), which permits us to take advantage of an extended transition period to comply with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of accounting standards that have different effective dates for public and private companies until those standards would otherwise apply to private companies. We have elected to use this extended transition period under the JOBS Act until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. We could be an emerging growth company until the earliest to occur: (i) the last day of the fiscal year in which we have more than $1.235</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">billion in annual gross revenue; (ii) the date we qualify as a &#8220;large accelerated filers&#8221; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), with at least $700.0 million of equity securities held by non-affiliates; (iii) the issuance, in any three-year period, by us of more than $1.0 billion in non-convertible debt securities; or (iv) the last day of the fiscal year ending after the fifth anniversary of our IPO. Even after we no longer qualify as an emerging growth company, we may continue to qualify as a &#8220;smaller reporting company,&#8221; which would allow us to take advantage of many of the same exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, if either (i) the market value of our stock held by non-affiliates is less than $250.0 million or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0 million.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_and_qualitative"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Quantitative and Qualitative Disclosures About Market Risk.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inancial Statements and Supplementary Data.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item is presented at the end of this Annual Report beginning on page F-1. An index of those financial statements is found in Part IV, Item 15, Exhibits, Financial Statement Schedules, of this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_and_disagreements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Chang</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">es in and Disagreements With Accountants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Con</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trols and Procedures.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. As required by Rule 13a-15(b) or Rule 15d-15(b) promulgated by the SEC under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Annual Report. Based on the foregoing, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Annual Report at the reasonable assurance level.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report does not include a report of management&#8217;s assessment regarding internal control over financial reporting or an attestation report of the Company's independent registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies. Additionally, our independent registered public accounting firm will not be required to opine on the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an &#8220;emerging growth company&#8221; as defined in the JOBS Act.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended December 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Limitations on Effectiveness of Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, including our principal executive officer and principal financial officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, the effectiveness of any internal control over financial reporting is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Information.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Trading Plans</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_34b4ff66-fe94-467f-8582-df70ea245768" contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_81f33637-4305-42c6-87b9-2f5ee0f60005" contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_5d955eb8-2ec0-4ae7-bf4a-ddb647ecca09" contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_ac760b36-a6a2-47b6-9883-fba97dc376ce" contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1 trading plan or arrangement, as defined in Item 408(c) of Regulation S-K, during the three months ended December 31, 2024 covered by this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T III</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_officers"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Dir</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ectors, Executive Officers and Corporate Governance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item will be included in our definitive proxy statement relating to our 2025 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;), which we will file with the Securities and Exchange Commission (the &#8220;SEC&#8221;) not later than 120 days after the end of our fiscal year ended December 31, 2024, and is incorporated in this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;) by reference.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a code of business conduct and ethics (the &#8220;Ethics Code&#8221;), that applies to all our employees, officers and directors. This includes our principal executive officer, principal financial officer and principal accounting officer, or persons performing similar functions. The full text of the Ethics Code is available on our website at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.septerna.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If we ever were to amend or waive any provision of our Ethics Code that applies to the Company&#8217;s principal executive officer, principal financial officer, principal accounting officer, or any person performing similar functions, we intend to satisfy our disclosure obligations, if any, with respect to any such waiver or amendment by posting such information on our website set forth above rather than by filing a Current Report on Form 8-K. Information contained in, or that can be accessed through, our website is not incorporated by reference herein, and you should not consider information on our website to be part of this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Exec</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">utive Compensation</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item (excluding information under the subheading &#8220;Pay Versus Performance&#8221;) will be included in the Proxy Statement and is incorporated in this Annual Report by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security_ownership_of_certain"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Securit</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">y Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item will be included in the Proxy Statement and is incorporated in this Annual Report by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Cert</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ain Relationships and Related Transactions, and Director Independence.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item will be included in the Proxy Statement and is incorporated in this Annual Report by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting_fees_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Accounting Fees and Services.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this item will be included in the Proxy Statement and is incorporated in this Annual Report by reference.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T IV</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibits_financial_statement"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits and Financial </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statement Schedules.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Statements. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statements of Septerna, Inc. and the report of Ernst &amp; Young LLP, Independent Registered Public Accounting Firm, are included in a separate section of this Annual Report on Form 10-K beginning on page F-1. All financial statement schedules are omitted because the information is inapplicable or presented in the notes to the financial statements.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The following is a list of exhibits filed as part of this Annual Report on Form 10-K:</span></div></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.982%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:41.588%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:6.741%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:12.362%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:6.741%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:17.984%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="7" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524245578/d851611dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of the Registrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-42382</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 28, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524245578/d851611dex32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of the Registrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-42382</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 28, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524231178/d762905dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Investors&#8217; Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of June 28, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 24, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex42.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Common Stock Certificate</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 24, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524231178/d762905dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2021 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2024 Stock Option and Incentive Plan and forms of award agreements thereunder</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex103.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2024 Employee Stock Purchase Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex104.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Non-Employee Director Indemnification Agreement, by and between the Registrant and each of its non-employee directors</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex105.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Employee Director / Officer Indemnification Agreement, by and between the Registrant and each of its executive officers</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex106.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Jeffrey Finer, dated as of September 9, 2022</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex107.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Ran Xiao, dated as of January 18, 2022</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex108.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Liz Bhatt, dated as of May 20, 2022</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex109.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Jae B. Kim, dated as of September 4, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1010.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Samira Shaikhly, dated as of December 22, 2022</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1011.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Uwe Klein, dated as of February 17, 2021</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12#&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1012.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, by and between the Registrant and Daniel Long, dated as of September 27, 2021</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1013.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation Policy</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1014.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Senior Executive Cash Incentive Bonus Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312525001834/d753888dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter, by and between the Company and Gil M. Labrucherie, dated as of December 6, 2024.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-42382</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 6, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1016.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Severance Plan of the Registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.982%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:41.588%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:6.741%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:12.362%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:6.741%;box-sizing:content-box;"/>
    <td style="width:1.12%;box-sizing:content-box;"/>
    <td style="width:17.984%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524231178/d762905dex1017.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Lease Agreement, by and between the Registrant and Britannia Pointe Grant Limited Partnership, dated as of April 20, 2021, as amended by the First Amendment to Lease Agreement dated as of September 14, 2022, Second Amendment to Lease Agreement dated as of September 23, 2022, Third Amendment to Lease Agreement dated as of December 22, 2022, and Fourth Amendment to Lease Agreement dated as of December 12, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524231178/d762905dex1018.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Service Agreement, by and between the Registrant and Third Rock Ventures, LLC, dated as of August 25, 2021</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sepn-ex19_1.htm"><span><ix:nonNumeric id="F_77e8e60b-33a6-497c-9d9e-c943b2332764" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;"> of the Registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524231178/d762905dex211.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subsidiaries of the Registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sepn-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Power of Attorney (included on signature page)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sepn-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sepn-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1*+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sepn-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1984086/000119312524239994/d762905dex1015.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Compensation Recovery Policy of the Registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282469</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 21, 2024</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page formatted as Inline XBRL and contained in Exhibit 101</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+ The certifications furnished in Exhibit 32.1 hereto are deemed to be furnished with this Annual Report and will not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, except to the extent that the Registrant specifically incorporates it by reference.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"># Indicates a management contract or any compensatory plan, contract or arrangement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134; Annexes, schedules and/or exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 16. Form 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIG</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:43%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:48%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Septerna, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Finer, M.D., Ph.D.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Finer, M.D., Ph.D.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">POWER OF ATTORNEY AND SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KNOW ALL BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints each of Jeffrey Finer and Gil M. Labrucherie, as such person&#8217;s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person&#8217;s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following person in the capacities and on the date indicated.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.92%;box-sizing:content-box;"/>
    <td style="width:2.88%;box-sizing:content-box;"/>
    <td style="width:40.34%;box-sizing:content-box;"/>
    <td style="width:1.42%;box-sizing:content-box;"/>
    <td style="width:28.44%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Finer, M.D., Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President, Chief Executive Officer and Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Finer, M.D., Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(principal executive officer)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gil M. Labrucherie, CFA, J.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gil M. Labrucherie, CFA, J.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(principal financial officer and principal accounting officer)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Tong, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chairman and Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Tong, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Abraham Bassan, M.S.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Abraham Bassan, M.S.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Bernard Coulie, M.D., Ph.D., M.B.A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bernard Coulie, M.D., Ph.D., M.B.A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Alan Ezekowitz, M.D., D.Phil.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Alan Ezekowitz, M.D., D.Phil.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Shalini Sharp, M.B.A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shalini Sharp, M.B.A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jake Simson, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jake Simson, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Index to Financial Statements</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statements as of and for the Years Ended December 2024 and 2023</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:94.061%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:4.929%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_registered"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PCAOB ID:</span><span><ix:nonNumeric id="F_10f4e458-f188-4a44-93e7-6cf05d7e337e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financial Statements</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Balance Sheets</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_operations_comprehens_income"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Operations and Comprehensive (Loss) Income</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_convertible_pref"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Cash Flows</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Financial Statements</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_of_independent_registered"><span style="color:#333333;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report of Independent Regi</span><span style="color:#333333;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stered Public Accounting Firm</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Septerna, Inc.</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_972cce12-91e1-4379-bb8e-407212cf0437" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying balance sheets of Septerna, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive (loss) income, convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_05001549-071e-41ae-b58a-80a5259a4903" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2023.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f96be0ca-7bd7-4bb4-b6a4-2614cae4a221" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Mateo, California</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">alance Sheets</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except for share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b16c16ac-868e-46d0-90f3-21c0c28f6b25" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238,196</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56737c68-2bbe-4d56-83b6-0b276a26eaa5" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,483</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1480639b-17c5-46a1-95b7-e4c2bb1f5dd2" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">112,727</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f14376-9ac7-4243-9a3a-df221f68858c" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_794adb4e-ce81-4456-bf13-45285f0510e7" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78c56094-0adf-48bc-ace5-ee5d7263148f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivable related to sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4cf34e9-f297-4fce-a33b-aa79ee40a373" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10bac446-8852-4e29-92f4-f83e4694e8c0" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8054cac2-4c37-4880-b597-52ce89f84cd3" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,730</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f0b03b5-417b-43e1-89d3-3309bc101abb" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,419</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a9df592-4e75-450f-ac7c-3581f6b33348" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">356,824</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0f4b594-f26e-4ee8-a70c-7e63dea6bd03" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">112,678</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, non-current</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cc2cfbc-b08f-4a18-9bf2-0e8a01ba419d" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,866</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7ff1a9e-87c1-4752-8318-b96c75155c4d" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20de920d-e130-4d4f-b7a1-2f3f12f2af78" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,090</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56e8c2be-b842-4f1e-a1a6-3e12a0a29dbf" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,665</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c6bde1c-d241-4ca1-ae98-50c7da08e021" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,602</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_288c2248-9edf-4b68-896c-eb9087f0d734" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,522</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04e44f94-9d41-40b5-bda3-752f0553ea01" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_615a4244-7716-411f-abc4-ed7622831789" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other non-current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d38b83d-3603-4a58-b400-d7f45a2ba67d" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_540e54e6-e5c5-4854-b96c-41b864407c38" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0a0adb6-9e5f-48a4-b44c-97dc8123cdb3" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">456,554</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5358a71d-fc75-4751-97c7-130d4e2f7dca" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,867</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_189950f6-8024-4428-b475-aca178a2a9f3" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,200</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d14b3a0f-927f-40e6-bb0c-fc3981ed43b6" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f6fcdba-58cf-42c0-a118-7927ceeab009" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ffb7f83-5d53-4b6c-b78d-a56eae4bb91d" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,277</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3a6884e-d38c-493d-bb06-636b9356f023" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,851</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99d03004-f7ad-43d8-8719-47d2f1297548" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3832fd11-f4f3-46af-b7fa-9efdad2f4cb2" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,849</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a05d7d5a-ab98-4923-8969-8070c0c1ac40" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,914</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, non-current</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36503753-880d-41ae-92f8-1db1a83895e7" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7bc753d-4d5a-4ff1-b24b-ba96107045d8" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other non-current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df2866f8-eab0-4bcf-8658-fb8e6cdd320a" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08782caf-2425-4026-b8ef-564b8c5d4a69" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">546</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8187ea64-4b54-4272-a6c6-b1a19ab7cdfb" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,507</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21946412-0590-4961-b45d-e875544a8a2d" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,026</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_f504efa2-7a40-47fd-bb84-8a0759752c52;"><span style="-sec-ix-hidden:F_686e415e-ba5e-4706-8773-3961fbf8dc1e;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(Note 8)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A Convertible Preferred Stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa08920a-e479-4c6b-a3b1-e0955a35e719" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_193b2d5b-a2a1-4bca-81b1-f525928d60e6" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value per share; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63b59963-a34a-43d2-9c04-847b53c340e0" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f9b5930b-635c-4952-9d43-5458b27b716e" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_7ea836f7-9998-46ae-97f8-3068c94d812e" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized,<br/>&#160;&#160;&#160;issued or outstanding at December 31, 2024; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50e057c0-6eb3-4308-a398-63361596720d" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_035b4ca3-191e-4779-b8bf-3e2d98304b03" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4f3614a9-fd9a-48f8-bcbd-9346794d9819" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized, issued <br/>&#160;&#160;&#160;and outstanding as of December 31, 2023; liquidation preference of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_211d185e-f8e4-4876-be52-976fa1babd33" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;at<br/>&#160;&#160;&#160;December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2ac1c62-aba4-4069-be3e-ce8428117015" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25b2be69-ef5e-4e5b-afb7-6580fea8ad97" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B Convertible Preferred Stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b681c06-4e0c-4c9c-ace9-e07611da3783" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6b7b90be-8198-4c90-85f9-0fc7d25a9a14" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value per share; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d0d5265-4db1-49e7-8bbb-ef586e9168b0" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_285f150c-0487-45aa-b489-30706e216c16" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ff6fe47c-1365-4abd-af36-ac430dde3e9a" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized<br/>&#160;&#160;&#160;issued or outstanding at December 31, 2024; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da1c4f5c-a027-4d25-b8b6-9c60c61fa364" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">121,657,452</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at<br/>&#160;&#160;&#160;December 31, 2023; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbae4dca-d2f7-4228-99c5-d3043e31f2ba" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_061ed718-cffe-4c5b-a50f-82af4c7712a9" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">60,828,720</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding as of<br/>&#160;&#160;&#160;December 31, 2023; liquidation preference of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b42e5170-e2b8-4aae-8c1f-b154861cc3d3" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;at December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37aae099-cdca-4dc7-9ed1-648c31a1dac6" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7559cd27-6821-4046-9cc2-23cc62ab2a57" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,521</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders' equity (deficit):</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a18bbf2-e8d6-4350-958a-31826b9f1888" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bb64737-a55d-4512-bd7c-cff4322c7c8b" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c90a9ebe-3db1-47f8-94df-9c30ae1d01af" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares<br/>&#160;&#160;&#160;authorized as of December 31, 2024 and December 31, 2023, respectively; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7b3749d-3a8b-4855-9e40-e87c8f090fb8" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6c010afc-903c-4d8b-880a-bc1f8751311b" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_993a3547-55f4-47a9-85c5-f599c9e2eda2" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_33394037-21f8-48d2-a35c-a5b0e96f013e" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;<br/>&#160;&#160;&#160;shares issued and outstanding as of December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_cad73126-da80-4c10-b250-cf7f5b289ceb;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_1f32640f-4a7f-4970-8dac-aab166485b20;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a047a432-bc69-4f24-88da-831fe946c532" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_963e9659-c2b2-43b7-b91d-18516307821e" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value per share, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e31daf8-5d6b-4198-8fb6-99672587eba6" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">500,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_513a74b2-067c-449d-b5fa-9e0bab2ad854" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">260,590,689</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares<br/>&#160;&#160;&#160;authorized at December 31, 2024 and 2023, respectively; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70cf36a5-e113-4d72-a8b6-d4cdb6f67f33" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ae912afb-5896-4d8c-80aa-e7926058e8ba" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">44,422,505</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and<br/>&#160;&#160;&#160;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0ad0afd-9521-4edf-a78d-bbcf14133ba4" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7432e112-79b9-4202-be4a-830c3c56b53c" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,168,134</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023,<br/>&#160;&#160;&#160;respectively; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cebc654b-3c24-4068-9f07-ee8a0418b237" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:RestrictedStockOptionsSubjectToRepurchase" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">576,829</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2ca6988-43ea-4171-8076-8dcbb5053704" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:RestrictedStockOptionsSubjectToRepurchase" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,002,044</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares subject to repurchase as of<br/>&#160;&#160;&#160;December 31, 2024 and 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09f0a63f-9521-4ce5-a619-efaaa74284e7" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdc7c797-7333-4eaa-adb4-96df5ba7d7fa" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1be35de-9a54-4d45-87e0-d6cabdc3b74d" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">538,321</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24609f62-961d-4e7d-ab5f-c611ab5b8394" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,199</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7204a819-43c0-428f-affa-71348f2c2780" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a091a7f3-98dd-4c2f-a7bb-0164b9263b1f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a92a53-62e2-4495-b609-3451ec3a5949" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">118,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d523ede4-47e4-4420-abba-77fc9cb9f838" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">46,576</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders' equity (deficit)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44ecf5d4-0a1d-49b2-b2c8-532ead95f069" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">420,047</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca108eec-c7c2-4329-b761-f44fa59ba4be" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_652ef7c2-9c0a-4a01-9283-6523ad2eab94" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">456,554</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1bef332-3c02-4285-bfb9-b3398b575a38" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,867</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_operations_comprehens_income"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements of Operations an</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d Comprehensive (Loss) Income</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except for share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:70.434%;box-sizing:content-box;"/>
    <td style="width:1.84%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.942%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.84%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.942%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19a9ebcb-fa44-4769-b6c3-60f8c00adb0a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,075</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_360458d9-b6df-4772-b607-c533bd075f9e" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses (income):</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c849f580-a526-438c-b0be-e83fc60e45f5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,337</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9809f4a5-7a4d-46d2-a1dd-f0228a1d9554" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,979</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c04db054-c566-41dc-b02f-5dedee41c027" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,561</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b347472c-bcd3-4c5a-a791-bb79b6011d34" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8317422d-904f-4a22-ae0d-eb71c7284d69" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41aefb92-aa72-4dac-8a54-acb000ca879c" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses (income)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc3675be-fc54-4c88-b03e-4a393c8eabaa" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,898</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c20e87c6-e626-41ad-9e20-c3dcee01b2cc" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,924</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62dd6e49-b8cd-4be9-8b45-8e780cb7978d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">80,823</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a118970-7206-484c-8462-604d9b2ebad2" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,075</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97959dbe-81ac-4b14-a132-62ec1dd5220e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,617</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7d9570e-62ab-43b0-b9ce-8d6c6744aa38" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,786</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (expense) income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c5cb5f3-33f7-4211-90c8-8dbde1e447b7" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">90</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09a8b99c-4946-4c7b-a493-617207c59d42" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fc6469a-10a4-46e3-8b99-1504d0722ed5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,527</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c74daead-0327-4317-8ea1-80915b7b8819" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,796</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income before provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1942474-32a7-4cfe-987f-5dfe2607de01" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">72,296</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1b964e4-c83c-47ef-b44d-50d375e9a127" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,871</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_239b4425-9ce0-4b44-bc97-d525ff827d17" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">498</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97bbe10c-dbfa-480b-bcc9-80d0199fe9c3" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b997ba9-7fbe-4f15-9f72-265f9f862f62" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35f96db2-39d1-4ff8-8205-32201f6d4951" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income attributable to common stockholders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47a9b043-95f1-4f4e-aa65-2fb61d290eab" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_146d7339-9343-4db3-bdbd-5177df5a54b5" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">567</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share attributable to common stockholders:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9862d201-4663-4cdb-ac40-47880c58927d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46399a22-19ed-46b0-9a37-8af3ed04a9a4" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.29</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_501f79ca-5ee7-4eb1-8eeb-c0a311847754" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05006552-b673-477e-ad28-3f3d3e7536d5" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.29</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used in computing net (loss) income per share <br/>&#160;&#160;&#160;attributable to common stockholders:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92fb0537-d6ec-4ecb-b6cd-f4cd663cc8a0" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,891,126</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afdd2238-6613-48b2-aa2f-b86843eb4e27" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,928,586</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c64166f-3f0d-4e2c-9d1a-6b13d49ceb89" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,891,126</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daf2c125-45ba-48ad-95a7-08176d6e4d4a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,177,124</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive (loss) income:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ac18a4c-8515-4314-bb02-f6083a7200dd" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98760558-d5e4-414e-9185-83ca77c9c9ef" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net unrealized gain on marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08eda6e6-6783-400d-a253-10de70fd37da" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_615d63ba-f248-459b-b0bc-88f2b28a2473" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cddd5395-619b-48bc-ad92-b9c5a1d8a0a0" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a9ce68b-c3eb-4c24-82cb-21bf3ffbfce1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive (loss) income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82020cde-eb7f-44b4-8429-0992e832a9c9" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,742</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98734c28-8c40-483c-a742-788bf6395353" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_convertible_pref"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements of Convertible Prefer</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">red Stock and Stockholders&#8217; Equity (Deficit)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:16.957%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.759%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.599%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.759%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.039%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.759%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.919%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.439%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.459%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.439%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.879%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="41" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except for share data)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Other</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series A</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series B</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity (Deficit)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_149734c7-38bb-4e3f-acad-a4ad0a763ab0" contextRef="C_ecb04bc3-c92f-466d-8619-25482aaef50a" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7aaaf6ac-8157-4f6c-8596-575cb02331f2" contextRef="C_ecb04bc3-c92f-466d-8619-25482aaef50a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f5dc6ec-087d-467f-90ee-1ff0e9e8095a" contextRef="C_271bef94-fdec-41f8-a570-9d76ab85a875" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,181,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_525bc5da-5a1e-439d-aa7f-76888e84327a" contextRef="C_271bef94-fdec-41f8-a570-9d76ab85a875" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_063af631-c7f2-4da1-8225-e6df6bcf81ec" contextRef="C_00cbb4d7-f34c-4862-a6ea-df21ab1ac4ff" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,552</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ad6954f-b389-47bc-9674-3a80048e2fce" contextRef="C_1c7d04aa-a092-489a-8d60-29ccf842d41e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">50,756</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_240f9406-102e-438d-959e-cbd44efc3954" contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">44,201</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">Issuance of Series B Convertible<br/>&#160;&#160;&#160;Preferred Stock, net of issuance<br/>&#160;&#160;&#160;costs of $</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad9e5924-67e4-4113-b73b-00f20277793a" contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5" name="sepn:StockIssuanceCostsOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">479</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e415f833-a366-4cca-949d-b6d8100d765a" contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">60,828,720</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b71e3a83-2e96-4089-8f27-b4747799ff36" contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,521</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vesting of restricted common <br/>&#160;&#160;&#160;stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697b7a87-c46e-456b-b8ee-6064d6ca9e3c" contextRef="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca" name="sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_272fb09f-acd3-4aa2-934e-e83a2a8b1194" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchases of unvested restricted<br/>&#160;&#160;&#160;common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8791b0ab-048d-48e3-b83d-e258262d15b1" contextRef="C_f21eea93-3c79-4715-83bd-5decab49af76" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,695</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c6ecb32-59ca-4701-ba96-854acd405523" contextRef="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_154702ad-7ec2-4bb9-b797-ba8fd23b85fe" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c636e06-ba43-4db5-a74b-5d186967f0b4" contextRef="C_5b8fa8c3-5da3-44aa-abac-9a9744adb4a5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2d5b4e1-17f2-4328-acf7-397cfb4c8ae9" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14fe7bda-0629-4b6c-aae9-3d84c56441b3" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8b1cdff-23dc-4b1f-9d2f-c0fb2303c3e0" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d3d956c-746b-45e3-be87-94c702ae0555" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">60,828,720</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5554de34-353f-43de-9d7b-dde584754540" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,521</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28a1a856-72bc-47a8-b699-f5e7f782cc89" contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,168,134</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d6110fe-87ac-4e74-be57-44c901bc222c" contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3cb370b-caa9-45dc-990d-c80fc72fb07c" contextRef="C_c0577abf-fcd1-41ee-8a8a-8523f830af0b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,199</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2151956e-6236-4218-8659-8829f33ebe79" contextRef="C_094c93bc-0e0d-4909-afb4-955d4d337209" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">46,576</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1e5c118-9d0d-4c78-8493-e76ca76001f5" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">Issuance of Series B Convertible<br/>&#160;&#160;&#160;Preferred Stock, net of issuance<br/>&#160;&#160;&#160;costs of $</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb966053-2185-4a15-b248-893011df6b5d" contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81" name="sepn:StockIssuanceCostsOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74b22863-b2cd-4455-8101-647493ab73c7" contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">60,828,732</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74646486-5f50-498a-9470-c186bc9ea893" contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,942</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">Issuance of common stock in <br/>&#160;&#160;&#160;connection with initial public<br/>&#160;&#160;&#160;offering, net of issuance costs <br/>&#160;&#160;&#160;of $</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7b1463c-4d33-4ce4-ac6e-f89f94957d3f" contextRef="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,431</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f291f75-8065-4de4-8fc9-3327081b874e" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,400,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c977527d-e28f-4a9b-be02-9b04741c5e12" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ec88eba-1687-4a2d-b420-c1054878b9e7" contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">302,749</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_415c381a-8173-4722-95f0-f3e35438b0cc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">302,767</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible<br/>&#160;&#160;&#160;preferred stock to common<br/>&#160;&#160;&#160;stock upon initial public offering</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ca071af-f8db-430e-bfbc-c36467a9aa70" contextRef="C_6989d380-63a6-42fa-baac-f46b7758f062" name="sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eab61c13-695f-4d4b-a7d2-6a1423a5ad8c" contextRef="C_6989d380-63a6-42fa-baac-f46b7758f062" name="sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf4820e2-971e-4cb6-9277-e935978a0a82" contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81" name="sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">121,657,452</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d7d620f-4e5b-4d1d-b094-827b3c6e67b7" contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81" name="sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">149,463</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4e96fe9-c329-4aec-8777-6a33491ab7bb" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">22,839,774</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04bb01d0-dac7-4477-b936-159e2bab3f04" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc7f5076-dca3-4855-93b9-1c06a3ae0dfe" contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224,134</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6f92bd8-5d53-497f-8689-acd5d3d83c70" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock <br/>&#160;&#160;&#160;upon exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f597429-132e-4eb7-9814-fb8fd370ff0b" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">28,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbbd6fd3-1161-4b97-a1c8-41968980c46e" contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b86185b-5a54-4e03-a63c-43e798a34666" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vesting of restricted common <br/>&#160;&#160;&#160;stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_205064d6-a42b-4807-923b-ed7dc2a9a21d" contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a" name="sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34eafcd4-a479-4a43-8fd5-b0c3667026b0" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchases of unvested restricted<br/>&#160;&#160;&#160;common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9086ae62-6663-4cb2-807d-b81a445e69fc" contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,299</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e863014-1248-4fbc-9915-adae5227807f" contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,152</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21c7cbbb-28c0-4f09-b0e9-a64f4ee633ec" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,152</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net unrealized gain on <br/>&#160;&#160;&#160;marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_767a35a8-9a92-4790-878c-43cf726b5d18" contextRef="C_0a283eb0-f11e-47f7-8c48-261df37e83d8" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5213e98e-4c99-4c03-baf4-15e31f1199ec" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:4pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:4pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96b98c19-9989-4a4e-aa50-ec549d1c24b4" contextRef="C_489a951a-d17d-48d1-be9f-c29fef36aa29" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e36c6762-d603-4660-9d78-2e1053b23491" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73b4428c-7514-4a14-9ebc-ee6a5a1d4b29" contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">44,422,505</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a390976-d6c6-44df-af9f-05553ab51004" contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81dbdfd0-ddf5-4a4d-9dba-e10a12be9a9b" contextRef="C_0e7e5752-e6a2-4a70-b4fa-b116c9416205" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">538,321</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37987824-24b3-4181-b77a-b780f6c2a9bf" contextRef="C_92e936a1-7cb3-40e9-993e-bbcd2f3f805e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19e49f90-e675-4265-8620-f25c55744a03" contextRef="C_35342a71-3904-46c9-8baf-50e827a2f8e2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">118,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a9efbc0-d1b9-4eae-8c43-5f17f8d8c8a3" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">420,047</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statem</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ents of Cash Flows</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b719b12-ecd6-4298-98d7-b821a0da9001" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edc9924c-0de3-4c2c-8bf4-a03d0859c0f0" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net (loss) income to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcd11cc7-5e6c-4fe2-87a8-9066d14b7b65" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,401</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b28b8bc-b455-4dfa-969d-86650f1c4ef5" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">848</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01d348da-9de8-477c-9b20-81045eaad639" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:GainOnSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0866bcc2-8d2e-4420-952a-12812fc7f08d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:GainOnSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash operating lease expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_596b9514-9605-4ddb-b4b3-c608977bae3d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,383</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8606e2a7-2a89-43b6-88b5-956cce55718c" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">807</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f40d2dc-5a72-4d5a-82ac-d05e4d46b965" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,152</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96f7276a-9067-4e03-8d67-4652f5569afa" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion of premiums (discounts), net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a68f7ac4-ee6c-4316-bd0a-e8db30ed5922" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,410</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02f1c4a7-039f-4ca4-90eb-9196b7ea6cd1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred income tax</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_619d64b9-7161-4645-a0fb-77eaaa4714bd" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e2af7e1-31cf-4d0e-8ca2-5e7c28b07e48" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8de27708-0e40-411d-a0a4-00672ce3ed88" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_967b78d3-25ed-48a4-a3b6-90a371b48d07" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ae7832e-18c6-4c6b-9d14-8448fc43076f" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,297</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e29211d5-9a26-4149-a544-0f32e4317b6c" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8227842-3acf-4025-8284-7b6a63f28eed" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96cb6013-6bcd-4033-99ac-0a817a62c23a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other non-current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37bdca54-baff-4e9f-a5f7-3a3dac79df9b" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a573dbd-8aff-4ec7-b098-ff345eb10439" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">165</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17df319f-0ef8-40d7-8cec-1382e06acf72" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">723</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6474e9c-0029-4e75-8ac2-dd9ffe649d65" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">653</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14460b3b-10f0-4c2b-8330-a30dd7c04100" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,564</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7668aa2b-bb41-473d-b16f-62a6676aaf98" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,471</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b88324c-31fe-4734-852c-b1de53e0630d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fc04d91-790c-4d6a-bf7a-b8b5624248cc" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">770</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_849143b7-d225-4e33-bbf3-d1b45c819bbe" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">67,470</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b05c156-5056-4dee-8915-bb8cab33c647" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,723</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b2fb0e0-cc97-419c-b475-8573a86a41f1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,103</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f17fc123-06a9-443f-a199-7f8ef74c3bfb" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,878</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5855f83-4d95-4140-a736-d7ce5250a146" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ProceedsFromSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63f3ef3c-a93b-4a90-930c-a9540e9826ce" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ProceedsFromSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0b6adeb-3b33-4871-a89c-d5f9b5790aa1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213,390</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e67d9fec-5902-4aed-af7a-8d47f49069b0" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Maturities of marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b06dcb12-68e6-4c27-a660-3bcef8cb0291" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,270</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91419886-038b-4770-b25a-ae70602a99e7" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1c2a464-d97f-4768-bdbf-fd51d1238cac" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">160,598</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b4f8a6e-b51e-49e7-948a-55bc1520e05e" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,122</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from Initial Public Offering, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5786167f-6cab-465c-ba5a-218f7a99a08d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">302,788</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_336c6ead-7374-4a25-b533-4fe7874ab7ae" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of Series B Convertible Preferred stock, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8fdd304-0d89-4f33-8d74-2d76aa4260c1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,942</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_874b08be-681d-4191-a319-26d0f14aaa6a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,521</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchases of unvested restricted common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b098a0-5a7b-420c-b69e-229b0a978a51" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:RepurchasesOfUnvestedRestrictedCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f535992-0a38-4895-bdd3-61aed0867ec0" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:RepurchasesOfUnvestedRestrictedCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59da83c1-11d5-4bc0-8cec-b0af5c9bb772" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce9baa0c-b5cf-427a-a94f-59811d00c403" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_927c6965-2df9-46e2-8392-ffb15661b75f" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">377,781</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f17892f-54d4-4e69-b689-3633b88f0ca8" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,520</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in cash, cash equivalents and restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10fbdeed-b74d-4183-92a8-e4cc237b1a8e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">149,713</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4298511f-a74a-4815-b2a9-7fa253b88324" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,919</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and restricted cash, beginning of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3e9405c-74a6-4f57-9b87-5f9f1214268c" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,388</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd03b425-83aa-4196-90bd-06a5cc0a7060" contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,469</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and restricted cash, end of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e224858-97fe-4917-a6cd-ca3f7aca5fbd" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239,101</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa39b14c-edbb-44c7-8c53-ae98ac8e8b32" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,388</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental cash flow information:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a83ea36f-bfc3-4df1-8eb6-0e1741c3f06e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">232</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4568e6d-9281-4768-9308-e11d8ad8cec9" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure for noncash investing and financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset recognized in exchange for operating lease liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_128e7be3-b15f-446a-a691-dd9c08a1aa25" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,462</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_437b05f1-0bc6-4dae-838c-0612bf94e978" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,579</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivable related to sale of non-financial asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b31dbebd-6f12-45f8-90e4-bcee11f95bb1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba209983-bd3e-42dc-b2f1-e8530386047c" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible preferred stock to common stock upon initial public offering</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34b81f02-981e-44d8-bdc7-5f4e8431d43d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aabd0b34-72bb-4886-a1a6-b1917c012567" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unpaid offering costs included in accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0efb19b-3c22-4179-83d8-c7736b213355" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:UnpaidOfferingCostsIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39a74a8c-37f7-47c1-8bdc-ff0a6cafd81b" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:UnpaidOfferingCostsIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment included in accounts payable and accrued expenses and other <br/>&#160;&#160;&#160;current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_545369b5-eaeb-40f8-a2cc-b0718569e091" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebb149a9-3e8a-4537-9cb0-dbfba008a322" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">262</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents and Restricted Cash</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5865863-db22-4196-9100-09f083ba4b8f" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238,196</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d33bf56-556e-4e88-b334-f2dee5b2e71b" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,483</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a4b2fe2-7891-44c9-8697-3565ab8e02c3" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fed5dca2-7723-4e98-a8a4-dd754c3abd5f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and restricted cash at end of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d139f1c-4e96-4d2c-ae47-ca967eb0a6e1" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239,101</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4b5ff4c-3c70-4fe7-ae5a-5e7abd49e5bd" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,388</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notes to Financ</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ial Statements</span></p>
  <div><ix:nonNumeric id="F_b3836b39-b9b3-4c59-a1b5-9499684fb314" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:OrganizationDisclosureTextBlock" escape="true" continuedAt="F_b3836b39-b9b3-4c59-a1b5-9499684fb314_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Organization</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Septerna, Inc. (&#8220;Septerna&#8221; or the &#8220;Company&#8221;) is a biotechnology company pioneering a new era of G protein-coupled receptor (&#8220;GPCR&#8221;) oral small molecule drug discovery powered by its proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of its deep pipeline of product candidates focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s proprietary Native Complex Platform&#153; replicates the natural structure, function, and dynamics of GPCRs outside of cells at an industrial scale for, as the Company believes, the first time. The Company&#8217;s foundational technologies enable it to isolate, purify, and reconstitute full-length, properly folded GPCR proteins within ternary complexes with ligands and transducer proteins in a lipid bilayer that mimics the cell membrane. The Company then applies state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging its platform, the Company has transformed GPCR oral small molecule drug discovery to an industrialized and iterative structure-based drug design approach to expand the landscape of druggable GPCR targets with novel oral small molecule medicines for patients. The Company&#8217;s Native Complex Platform&#153; is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to affect GPCR signaling in different ways to achieve desired therapeutic effects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company was incorporated in Delaware in December 2019, under the name GPCR NewCo, Inc. In June 2021, the Company changed its name to Septerna, Inc. The Company is headquartered in South San Francisco, California.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Stock Split</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 18, 2024, the Company effected a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70392097-1415-4b49-acce-5b9e63138d9f" contextRef="C_c3d18edf-1da5-48a4-8374-55662573e03e" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-8.6103</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of its issued and outstanding shares of common stock. Upon the effectiveness of the reverse stock split, (i) all shares of outstanding common stock were adjusted; (ii) the conversion ratio of the convertible preferred stock was adjusted; (iii) the number of shares of common stock for which each outstanding option to purchase common stock is exercisable were adjusted; and (iv) the exercise price of each outstanding option to purchase common stock was adjusted. All of the outstanding common stock (including shares of common stock subject to the Company&#8217;s options and as converted for the outstanding convertible preferred stock), share prices, exercise prices and per share amounts contained in the financial statements have been retroactively adjusted to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of common stock and preferred stock were not adjusted as a result of the reverse stock split. The number of authorized shares did not change.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Initial Public Offering</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company completed its initial public offering (&#8220;IPO&#8221;), pursuant to which it issued and sold an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe17e5d9-370a-4c0b-807d-7056ce09d0b4" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">18.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock at the IPO price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a11a0861-5389-4ed5-ad17-03c9c4bb1561" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, including </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db3d2bc8-fdad-45ac-a154-e70b77fd9f20" contextRef="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares, resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8803fb0-d4ef-407e-9749-5767a60c0d8d" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">302.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting discounts and commissions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77912a1c-80dd-413c-9c18-818410677df1" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="sepn:UnderwritingDiscountsAndCommissions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">23.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and other offering expenses payable by the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65f6e817-04ab-46b9-95ec-f5f117f4fb67" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="sepn:UnderwritingOtherOfferingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Immediately prior to the closing of the IPO, the Company&#8217;s then outstanding convertible preferred stock automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_523581b3-2d87-4177-bd54-f6118ffd1475" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">22,839,774</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the closing of the IPO, no shares of convertible preferred stock were authorized or outstanding. In connection with the completion of the IPO, on October 28, 2024, the Company&#8217;s certificate of incorporation was amended and restated to (i) authorize </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f13bee4b-dee6-4e43-ad14-3fc2b91af385" contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">500.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f3b6590-3290-4c96-9982-5823a56e869b" contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which eliminates all references to the previously existing series of convertible preferred stock; and (ii) authorize </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de95328b-e9fa-4a7e-8390-7028c7b164c9" contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0" name="sepn:UndesignatedPreferredStockSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of undesignated preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3443ecc-9e25-4936-bdae-72fdcddcdc4c" contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0" name="sepn:UndesignatedCommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share,  that may be issued from time to time by the Company&#8217;s board of directors in one or more series.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b3836b39-b9b3-4c59-a1b5-9499684fb314_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which assumes that the Company will realize its assets and satisfies its liabilities in the normal course of business. The Company is subject to risks inherent in operating an early-stage biotechnology business. These risks include, but are not limited to, dependence on the development of marketable products, the ability to attract, retain, and motivate qualified personnel, rapid technological changes and the rapidly evolving nature of the biotechnology industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred significant losses and negative cash flows from operations since its inception and expects to incur losses as a result of its continued research and development activities. To date, none of the Company&#8217;s product candidates have been approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) for commercial sale and, therefore, the Company has not generated any revenue from product sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company historically financed its operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and most recently, through sale of its common stock in an IPO.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company incurred net loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83b256fb-1b64-4224-807d-4c6f66fe77aa" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">71.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company had an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9f7f312-93e3-4f97-9eda-ffe2a3cdd280" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">118.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. The Company believes its cash, cash equivalents, marketable securities, and marketable securities, non-current of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f63c81d5-3161-48c0-a5c7-b4d94569b2ba" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">420.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024 will be sufficient to fund its operations for, at least, 12 months from the date of issuance of the financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects to continue to generate operating losses for the foreseeable future. The Company will need additional financing to support its continuing operations and pursue its growth strategy. It expects to finance its operations through equity offerings, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain funding on acceptable terms, or at all. Any failure to raise capital as and when needed would compromise the Company&#8217;s ability to execute on its business plan and may cause the Company to significantly delay, scale back or discontinue the research and development of some of its programs or curtail any efforts to expand its product pipelines and will materially harm its business, financial position and results of operations.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_374c8556-8592-4dbd-b81e-352112f665f6" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4cbc813e-cdde-46d0-a3fa-545b21ae644a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;), stated in U.S. dollars and include all adjustments necessary for the fair presentation of the Company&#8217;s financial statements as of December 31, 2024 and 2023, and for the years then ended. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification and Accounting Standards Updates </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASUs</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Financial Accounting Standards Board </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FASB</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;).</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2fd40fdc-3b88-4bde-a1d0-c429245c2602" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures at the date of the financial statements and reported amounts of expenses during the reporting periods. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources and adjusts those estimates and assumptions when facts and circumstances dictate. Estimates are used in determining the fair value of assets and liabilities, the useful lives of property and equipment, the rate used in determining the present value of lease payments, fair value of assets and liabilities, research and development accruals, the estimated fair value of common stock prior to the Company's IPO, and stock options, the allocation of a revenue contract&#8217;s transaction price to each distinct performance obligation on a relative standalone selling price basis, uncertain tax positions and the valuation allowance for deferred income tax assets. Actual results may differ from these estimates and assumptions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_1" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82962e70-e5cc-4cab-a753-d339ec59bf55" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s CODM is its chief executive officer. Based on the information used by the CODM to allocate resources, the Company has determined it operates in one segment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5870e22f-1032-4886-b9ee-61a5b023feb8" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:RisksAndUncertaintyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company limits its credit risk by placing its cash, cash equivalents, and marketable securities with banks and institutions that are highly creditworthy. Such cash may be in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured limits, and the Company's cash equivalents and marketable securities are not insured by the FDIC. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and marketable securities to the extent recorded in the balance sheet.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. Management believes that the Company is not exposed to significant credit risk due to the high-credit-quality financial institutions in which those deposits are held. The Company has not experienced any losses on its cash, cash equivalents and marketable securities since inception. The Company has no significant off-balance sheet concentrations of credit risk.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to all of the risks inherent in an early-stage biotechnology company. These risks include, but are not limited to, limited management resources, efficacy of product candidates, intense competition, and dependence upon the availability of cash to sustain operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8d90b95f-50b7-4d51-9175-a4d1954d1458" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds marketable securities that consist of highly liquid, investment grade debt securities. The Company's cash and marketable securities are held or issued by financial institutions that management believes are of high credit quality. Marketable securities are classified and accounted for as available-for-sale. Marketable securities with original maturities of 90 days or less are classified as cash equivalents. Marketable securities with original maturities over 90 days and remaining maturities of less than 12 months are classified as current. Marketable securities with remaining maturities of more than 12 months for which the Company has the intent and ability to hold the security for more than 12 months are classified as non-current. The Company&#8217;s marketable securities are carried at estimated fair value, which is derived from independent pricing sources based on quoted prices in active markets for similar securities. Unrealized gains and losses are reported in stockholders&#8217; equity (deficit) as accumulated other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in interest income on the statements of operations and comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12 months. The Company does not generally intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews its portfolio of marketable securities, using both quantitative and qualitative factors, to determine if declines in fair value below amortized cost have resulted from a credit-related loss or other factors. If the decline in fair value is due to credit-related factors, the Company recognizes a loss in its statement of operations, whereas if the decline in fair value is not due to credit-related factors, the Company recognizes the loss in other comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excludes the applicable accrued interest from both the fair value and amortized cost basis of marketable securities for purposes of identifying and measuring an impairment. Accrued interest receivable on marketable securities is recorded within prepaid expenses and other current assets on the balance sheets. The Company&#8217;s accounting policy is to not measure an allowance for credit loss for accrued interest receivable and to write-off any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which is considered to be in the period in which it is determined the accrued interest will not be collected.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_2" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d672a573-e22a-4f9b-93ce-ffbf984f13a1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash is comprised of cash that is restricted as to withdrawal or use under the terms of certain contractual agreements. In connection with the Company&#8217;s lease agreement (see Note 7), the Company is required to maintain a collateral account to secure a letter of credit issued to its landlord. The collateral account is classified as restricted cash on the Company&#8217;s balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_565b1e79-52d4-4155-97d7-3aef9cc2faad" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable and Other Receivables</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes a receivable when the Company has an unconditional right to payment, which is generally at the time of delivery of assets, or at the time services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An allowance for expected credit losses over the life of the receivables is reserved for based on a combination of historical experience, aging analysis, current economic trends and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. The reserve is re-evaluated on a regular basis and adjusted as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. No allowance for credit losses was recorded during the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the Company&#8217;s accounts receivable was entirely attributed to Vertex Pharmaceuticals Incorporated (&#8220;Vertex&#8221;). As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s other receivable related to sale of non-financial asset balance was entirely attributed to Vertex (see Note 4 and Note 5).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_300c602f-5600-4b49-a30f-1bfe03218a0c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment, Net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment is recorded at cost, subject to adjustments for impairments, less accumulated depreciation. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5a702a49-41f7-4519-bd98-65c9f159344c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" escape="true" continuedAt="F_5a702a49-41f7-4519-bd98-65c9f159344c_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5a702a49-41f7-4519-bd98-65c9f159344c_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.54%;box-sizing:content-box;"/>
          <td style="width:1.94%;box-sizing:content-box;"/>
          <td style="width:40.52%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_12867c50-d3a4-4496-8bed-787760d8d788" contextRef="C_d770876f-2396-4daa-bc4e-7986b296cd59" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_af40efa3-c530-4b35-834b-bfb4144444e4" contextRef="C_7079165a-aa57-4eb8-9488-ec1604a2095c" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a1bfb1df-e539-4fc0-a3a3-2682c9fa6c18" contextRef="C_0b6e5099-66b3-4a19-9c22-90249dab9674" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer Equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8cd094bc-09f0-447b-9109-7b1071a22a29" contextRef="C_96b8a98e-2692-42ad-a70e-81071163995f" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease term or estimated useful life</span></span></span></p></td>
         </tr>
        </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation or amortization begins at the time the asset is placed in service. Maintenance and repairs that do not improve or extend the life of the respective asset are charged to expense as incurred. Upon disposal of assets, the cost and related accumulated depreciation is removed from the balance sheet and the resulting gain or loss is reflected in the statements of operations and comprehensive (loss) income within other income, net.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_487bdae9-b16a-4c47-b3c0-552bc85ff104" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its long-lived assets for impairment, primarily its property and equipment, whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the undiscounted expected future cash flows the asset is expected to generate over its remaining life. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset or asset group and its eventual disposition are less than its carrying amount. Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_556c718b-f25d-47e9-9cd1-43c4efe395e2" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_86b0fa77-ae37-4651-9702-d64c3ac382a2" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of the Company&#8217;s long-lived assets for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_95ac5ad5-d231-4fea-a739-1f9f244e68d1" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true" continuedAt="F_95ac5ad5-d231-4fea-a739-1f9f244e68d1_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for its leases in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2021, prior to entering into the lease agreement for its office and research and development space. At inception of a contract, the Company determines whether an arrangement is or contains a lease. For each lease, the Company determines the classification as either an operating lease or a financing lease. Lease recognition occurs at the lease commencement date and lease liability amounts are determined based on the present value of lease payments over the lease term. The lease term may include options to extend or terminate the lease only when it is reasonably certain that the Company will exercise that option.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_3" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95ac5ad5-d231-4fea-a739-1f9f244e68d1_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments if the Company&#8217;s leases do not provide an implicit rate. The Company determines its incremental borrowing rate based on the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. Right-of-use assets represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s right to use underlying assets for the lease term and operating lease liabilities represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s obligation to make lease payments under the lease. Right-of-use assets also include any lease payments made prior to the commencement date and exclude lease incentives received.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to apply the practical expedient of combining lease and non-lease components for the real estate lease asset class. Fixed lease payments on operating leases are recognized as lease expense over the expected term of the lease on a straight-line basis. Variable lease expenses that are not considered fixed are recognized as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company elected the short-term lease practical expedient that allows the lessee to not record a lease liability and right-of-use asset for all leases with a term of 12 months or less. See Note 7 for additional information on the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> leases.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4e8cb3d7-48fd-4eef-afc3-105ca675a33d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ConvertiblePreferredStockPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a deemed liquidation event, such as a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#8217;s certificate of incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred stock into shares of common stock. Convertible preferred stock is therefore classified outside of stockholders&#8217; equity (deficit) as events triggering redemption are not solely within the Company&#8217;s control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No shares of convertible preferred stock were authorized, issued or outstanding at December 31, 2024. As of December 31, 2023, the Company did not adjust the carrying values of its convertible preferred stock to the liquidation preferences because of the uncertainty of whether or when such an event would occur. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it was not probable that such a redemption would occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a3f2c478-07fb-4778-9155-82c3a7cb3683" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company generated revenue for the year ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex (see Note 5). The Company considers revenue to be earned when all of the following criteria are met: (i) the Company has a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#8217;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> revenue was entirely attributable to Vertex.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82051a25-16e6-49ae-96f1-3c4ac9963e31" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:SaleOfNonFinancialAssetsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sale of Non-Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of non-financial assets that are outside the scope of the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ordinary activities are accounted for under ASC 610-20, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income - Gains and Losses from the Derecognition of Non-financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 610-20&#8221;). Pursuant to ASC 610-20, the Company applies the guidance in ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASC 606</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to determine if a contract exists, identify the distinct non-financial assets, and determine when control transfers and, therefore, when to derecognize the non-financial asset. Additionally, the Company applies the measurement principles of ASC 606 to determine the amount of consideration, if any, to include in the calculation of the gain or loss for the non-financial asset.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_4" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_daeebddc-2e81-429d-affd-7c6492a1ad28" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of clinical and preclinical materials, information technology-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations and fees paid to other entities that conduct certain research and development activities on the Company&#8217;s behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into agreements with outsourced contract manufacturing and development and clinical research vendors. The Company estimates accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. The Company periodically confirms the accuracy of its estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3da9a726-9a15-4a20-b915-4749878faebf" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:PatentExpensesPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs to secure and maintain patents covering the Company&#8217;s technology and product candidates are expensed as incurred and are classified as general and administrative expenses in the statements of operations and comprehensive (loss) income.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dd02b5b2-1968-4c23-a157-3a5fe1c189de" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f1cbbc43-e254-4981-97bd-e258ee26014c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The carrying values of the Company&#8217;s cash and cash equivalents, restricted cash, accounts receivable, other receivable related to sale of non-financial asset, accounts payable and accrued expenses, approximate their fair values due to their relatively short maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_5" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_6"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_877c63d2-ccc6-41df-bd83-2d4d65f4f75d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and restricted stock awards granted to employees and non-employees is recognized based on the grant-date fair value of the awards. The fair value of stock options is determined using the Black Scholes option pricing model on the date of grant. The fair value of restricted stock awards is determined using the estimated fair value of the Company&#8217;s common stock on the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the IPO, the Company utilized estimates and assumptions in determining the fair value of its common stock, including stock-based awards. The Company has granted stock options at exercise prices that represented the fair value of its common stock on the specific grant dates. The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants Technical Practice Aid, Valuation of Privately Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of the convertible preferred stock senior to the Company&#8217;s common stock at the time, and a probability analysis of various liquidity events, such as a public offering or sale of the Company, under differing scenarios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock-based awards with service conditions only, the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is generally the vesting term of the award of four years. For stock-based awards with vesting criteria subject to the achievement of performance-based conditions, in addition to service conditions, the Company recognizes stock-based compensation expense on an accelerated basis over the vesting period when achievement of the performance criteria becomes probable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is recorded within research and development and general and administrative expenses in the accompanying statements of operations and comprehensive (loss) income based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_181c3f8a-24d7-4a44-9b16-5091979594df" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes the asset and liability approach to account for income taxes. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. Deferred tax assets and liabilities are determined based upon the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and for loss and credit carryforwards, using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertain tax positions recognized in the financial statements by prescribing a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related interest and penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1612229c-a351-4830-96d0-303b1576fb2c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive (Loss) Income</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive (loss) income is defined as a change in equity of a business enterprise during a period resulting from transactions from non-owner sources. The Company&#8217;s other comprehensive (loss) income is comprised solely of unrealized gains (losses) on marketable securities. The Company has not recorded any reclassifications from other comprehensive (loss) income to net loss during the periods presented.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_e770a503-f780-4e84-b932-22061cf29a1e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_e770a503-f780-4e84-b932-22061cf29a1e_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration of potential dilutive securities. Vested restricted stock is treated as outstanding for accounting purposes. Unvested restricted stock is not considered to be outstanding for purposes of the calculation of basic net (loss) income per share. Diluted net (loss) income per share is computed by dividing the net (loss) income by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options, unvested restricted stock and convertible preferred stock. The dilutive effect of stock options and unvested restricted stock is computed using the treasury stock method and the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_6" continuedAt="F_374c8556-8592-4dbd-b81e-352112f665f6_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e770a503-f780-4e84-b932-22061cf29a1e_1" continuedAt="F_e770a503-f780-4e84-b932-22061cf29a1e_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">dilutive effect of convertible preferred stock is calculated using the &#8220;if-converted method.&#8221; For all periods presented in a net loss position, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive.</span></p></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_e770a503-f780-4e84-b932-22061cf29a1e_2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holders of its convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. Net (loss) income is attributed to common stockholders and participating securities based on their participation rights.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70286c28-15d5-449d-a4bf-056ab149ee33" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. ASU 2023-07 will improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods after December 5, 2024, with early adoption permitted. The Company adopted Topic 280 on January 1, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments &#8211; Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326),</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. Topic 326 is effective for annual periods beginning after December 15, 2022, and early adoption is permitted. The Company adopted Topic 326 on January 1, 2023, and the adoption did not have a material impact on its financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8f0e05c0-a809-44e7-9e1e-40f29e2e74f7" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB, under its ASC or other standard setting bodies, and adopted by the Company as of the specified date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an accounting standard update that requires the Company to disclose more detailed information about the types of expenses (including employee compensation, depreciation, and amortization) included in each relevant income statement expense caption. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and decision usefulness of income tax disclosures. The standard is intended to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2025,  on a prospective basis. Early adoption and retrospective reporting are permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_597e2f82-56f8-41cc-82da-de323e232fcc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" escape="true" continuedAt="F_597e2f82-56f8-41cc-82da-de323e232fcc_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status and Smaller Reporting Company Status</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company is also a smaller reporting company as defined in the Securities Exchange Act of 1934, as  amended (the &#8220;Exchange Act&#8221;). The Company may continue to be a smaller reporting company even after it is no longer an emerging growth company. The Company may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as its voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of its second fiscal quarter, or its annual revenue is less than $100.0 million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_374c8556-8592-4dbd-b81e-352112f665f6_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_597e2f82-56f8-41cc-82da-de323e232fcc_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the most recently completed fiscal year and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its second fiscal quarter.</span></p></ix:continuation></div></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aed3e266-dce7-47a4-af8c-b58c8e89103c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Balance Sheet Components</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2fc14aa-ab47-44f1-8ec4-9e6db0170bfe" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0a7be18-6445-4938-8f0d-52e25f3d242e" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,114</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ca53790-ba53-416a-a20e-3f3fe8d64ebb" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical trial costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95e8039d-fadb-4041-bd7a-20ef9ade1501" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:PrepaidClinicalTrialCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,164</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e24c193-66d9-4afb-ba84-c2ae074b21c9" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:PrepaidClinicalTrialCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bed50b51-e4db-4959-9118-6fdd967c0263" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">953</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69484787-3888-4646-860b-7987dccb5007" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid bonus</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dde097f-edad-4181-ae6b-11d28551d975" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:PrepaidBonusCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">260</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9e5ae37-a764-4040-8464-677bbbaf670f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:PrepaidBonusCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">378</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01bc1f6d-587e-4a83-a222-1c777835498f" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:PrepaidTaxesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4caeb40-e603-43eb-8515-78a2e4b80505" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:PrepaidTaxesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3df0d6c7-c470-4f3a-b29d-4438d15e1092" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3b823b1-1549-44eb-bcc3-0879596dfed6" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb3703b7-80c1-43b0-a4ba-8e459d9db974" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,730</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc627148-8ad4-4b02-b39e-99f5ea44686b" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,419</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment, Net</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18caea63-3349-4e65-9019-57d1c29e940a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd9e57b9-938a-46bc-bd90-cf762116c217" contextRef="C_d770876f-2396-4daa-bc4e-7986b296cd59" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,679</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba3fb62a-2049-4a56-9739-28b9731a3cb8" contextRef="C_832c9435-8669-4826-9854-08cb83c395aa" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,967</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture, fixtures, and office equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12fa13fc-543a-4439-baad-7056ec008ae9" contextRef="C_35e15b2a-6b34-49e1-8b87-da8c2cffe44c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,222</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48a95b04-3c25-4d4e-a417-13c110d1aba5" contextRef="C_c8bbdab5-fa45-4f45-b9e3-c2cf656b651c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">713</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b959a22-3a61-444a-a8cb-7a23c6b768ef" contextRef="C_b804a170-664e-41ff-a1cb-b608203157b8" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">717</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc0291b9-a169-41b1-b75b-449c5b3d3d1f" contextRef="C_eea5f8f5-675f-48a9-bc1e-43f7089d6e4b" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">389</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82845a71-cf80-4a39-bc79-803ab5c2e1c9" contextRef="C_96b8a98e-2692-42ad-a70e-81071163995f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">401</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b704009b-af2a-4fd7-91ac-7579c134d2b5" contextRef="C_94ef1645-1200-4432-b228-36b9fceb7a82" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">218</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4744a549-bf24-45da-afbb-10501b88f2c0" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,019</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e00fde8-b459-43fe-84a7-38f5a7994852" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,287</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9d038e3-a531-44f8-a516-cce84832c771" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,929</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8630181-824f-400f-8f2f-127c987698c0" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,622</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11d62068-dfd8-4488-950b-4d176c1f8c80" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,090</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3f60eb0-2fa5-4720-a0fc-060bfd3d3a4f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,665</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd14bcf9-8bcc-44aa-97ee-b757e57e6cf5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2cc2602-a4eb-4800-8c2c-32f018ead855" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Expenses and Other Current Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d21ca3fd-a375-4db7-923e-df5263aac615" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5896f02-a3c7-494b-ab58-b5ba441fca68" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,129</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00230f08-db69-41d7-b586-74c7958903bb" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,954</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2352e85-2ed0-488c-8f31-3d9a55e13adf" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:AccruedResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,888</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0b74237-03c0-4ada-8d44-fbbacf0ebd6f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:AccruedResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">829</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued general and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c7cd745-9f94-47d0-af45-f03284dee834" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:AccruedGeneralAndAdministrativeExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">703</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90618927-2f75-4708-8ee7-387c0251e01a" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:AccruedGeneralAndAdministrativeExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued income taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c1e69aa-5da7-4111-a2e4-afa11a31c870" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e15fd7a-d51c-4929-934c-cfe2d91a7fd6" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5a80260-fa5f-4a3a-9c2e-21655324ccfe" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12416a31-e0b2-4c1d-a83c-0409b010d9e7" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38316a8f-d419-4f0e-87c6-dc11cc516b80" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_555b7453-2a56-4770-9872-7a699246e348" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_5fed179a-f237-4d21-9488-cde75268faf2" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:GainOnSaleOfNonFinancialAssetTextBlock" escape="true" continuedAt="F_5fed179a-f237-4d21-9488-cde75268faf2_1"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Gain on Sale of Non-Financial Asset</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Vertex Asset Sale</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2023, the Company entered into an asset purchase agreement with Vertex under which Vertex acquired an IPR&amp;D asset related to a GPCR program, including all intellectual property, materials, and compounds associated with the program (the &#8220;Vertex Purchase Agreement&#8221;). Additionally, as part of the agreement, Vertex assumed all claims, counterclaims and credits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5fed179a-f237-4d21-9488-cde75268faf2_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">associated with the program, and the Company gave up all rights to the intellectual property. The transfer of the IPR&amp;D asset to Vertex was completed in November 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the same time in September 2023, the Company entered into a research service agreement with Vertex under which the Company agreed to perform certain exploratory research activities for Vertex (the &#8220;Vertex Research Service Agreement&#8221;) (see Note 5).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the IPR&amp;D asset sale should be accounted for under the guidance at ASC 610-20, as this type of transaction did not meet the definition of &#8220;ordinary activities&#8221; of the Company and Vertex should not be considered a &#8220;customer&#8221; in this transaction. However, since both the Vertex Purchase Agreement and the Vertex Research Service Agreement were entered into at the same time with the same counterparty with a single commercial objective, the Company combined the contracts and applied the allocation principles under ASC 606. The Company identified the performance obligations in both contracts, determined the transaction price and allocated the transaction price to the performance obligations in the contracts based on the estimated standalone selling price for each performance obligation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a gain on sale of non-financial asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_180348c4-1f53-473b-8d37-39aa9a17d568" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:GainOnSaleOfNonFinancialAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">47.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the sale of the IPR&amp;D asset to Vertex on its statements of operations and comprehensive (loss) income. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_478ec62d-3cc8-40ca-afd0-5732539dc10c" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ProceedsFromSaleOfNonFinancialAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash at the closing of the agreement in September 2023 and recorded the remaining balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2eeb52b1-b611-4b7c-94fd-2ae8a6d462f8" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other receivable related to sale of non-financial asset on its balance sheet as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the sale of the IPR&amp;D asset was complete and the Company had an unconditional right to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8da9885f-6bc0-40db-a39a-eed4b3b17ffb" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:UnconditionalRightOnNonFinancialAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company received the payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4d3d071-ab2b-4bef-b56d-9e7b3f051ea3" contextRef="C_27aa5798-cdf5-4aeb-9c35-f6a7f0ef79c9" name="sepn:PaymentReceivedOnSaleOfNonFinancialAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of this balance in the first half of 2024. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ceffb22-7e6e-4cd4-978d-f1c98fae4c84" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:GainOnSaleOfNonFinancialAsset" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gain on sale of non-financial asset was recognized during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Vertex Purchase Agreement also provides for a potential milestone payment payable to the Company contingent upon achievement of a certain research milestone. The milestone payment amount is determined based on the timing of achievement of the research milestone. The variable consideration related to this milestone payment was determined to be improbable of receipt at this time. As a result, the milestone payment was excluded from the transaction price. After the potential milestone payment, the Company will not receive any other payments or future royalties related to this IPR&amp;D asset.</span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a46da2f-0ddd-43ef-9107-4b726c518bea" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RevenueFromContractWithCustomerTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Revenue</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Vertex Research Service Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 4, the Company entered into the Vertex Research Service Agreement in September 2023 under which the Company agreed to perform certain exploratory research activities for Vertex. Although the Company accounted for the IPR&amp;D asset sale under the guidance at ASC 610-20, the research services portion of the transaction fell under the scope of the revenue from contracts with customers guidance, ASC 606.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_94dbc2c5-0d90-42ea-aced-dca3bf0f8671" contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c" name="sepn:AgreementDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Vertex Research Service Agreement is for a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e8e0ae5-4e2a-400d-91a7-6c308dc74de3" contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c" name="sepn:TermOfResearchServiceAgreement" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> term, however, Vertex has the ability to terminate the agreement with a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_96855698-55e3-4a52-931a-bb7a1e4f22e8" contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c" name="sepn:RequiredPriorNoticeDurationToTerminateAgreement" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30-day</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> notice at any time. As a result, the Company concluded that the contract duration is 30 days, representing a month-to-month service contract.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company recognizes this service revenue over the performance period of the research services as the services are provided. The Vertex Research Service Agreement also includes a provision related to additional research services, which the Company concluded met the definition of a customer option under ASC 606. The Company will recognize revenue related to the customer option if and when it is exercised.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company recorded revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e97c744d-2da7-4103-bfc4-ed8159107cee" contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> related to research activities performed in connection with the Vertex Research Service Agreement and customer options exercised. During the year ended December 31, 2023, the Company recorded revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85743f0d-c027-417f-96e9-0c82cfbef1e8" contextRef="C_c2a2d5f3-4780-477b-9962-a71c66cb583d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> related to research activities performed in connection with the Vertex Research Service Agreement and no customer options were exercised.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:MarketableSecuritiesAndFairValueMeasurementsTextBlock" escape="true" continuedAt="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Marketable Securities and Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records marketable securities and cash equivalents at their estimated fair values, which are based on market prices from a variety of industry standard data providers and generally represent quoted prices for similar assets in active markets or have been derived from observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d_1" continuedAt="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c335dd3d-4f56-4eb5-87da-bf804bc4ed1e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8256cdc-8e5a-4b4d-bc90-fd94b1f44780" contextRef="C_31284a09-3922-405e-a80d-24fee73b06af" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141,779</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68005bd4-cdf0-4073-8c3f-aaa82fa017ca" contextRef="C_2982daa7-c87a-47ee-b700-ce6632c5e27f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141,779</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffc859f7-c259-40f2-a949-73d02b30c8b2" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,527</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b17aea50-16e2-42f4-81e9-4312f29daa73" contextRef="C_ac644248-b031-4c9f-95ab-fa02d59f25be" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,527</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2c80933-5202-4c7c-9208-6f26686e30e2" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,059</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ce85cf9-c07b-478a-acff-7cf7f726c123" contextRef="C_7283d70c-1d46-411d-a51a-777737652129" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,059</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d6ad656-a091-48f5-8868-db6db134a896" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,555</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be73e842-89ed-497b-b834-3291802dd485" contextRef="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,555</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac9b78eb-d06e-4c1b-9868-c03042209efe" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,487</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3f15009-014c-4a0a-ae04-be82b8123b98" contextRef="C_ac644248-b031-4c9f-95ab-fa02d59f25be" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,487</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fed9e334-80e6-40cd-8a68-a329d1ee5aca" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da427cc1-0888-4799-ab2b-7cb9a454357c" contextRef="C_7283d70c-1d46-411d-a51a-777737652129" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceba37ad-55ea-4827-98d0-ae41be58bfd3" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f499b3dd-f565-4296-b164-b81fee2d66ed" contextRef="C_b7d146c4-9837-4043-9b52-921a53724e0c" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, non-current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e96bf34a-8ccf-4b4b-b207-f59b15864388" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,406</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d273ba5c-979b-49ca-92a9-2b54bdbc91c5" contextRef="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,406</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14c00eca-b141-4408-bacf-6ee6dcafa96d" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,514</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94cf61fa-3c43-4c39-9494-12635f135168" contextRef="C_7283d70c-1d46-411d-a51a-777737652129" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,514</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7e571fc-9bbd-4ca1-aad9-f3a9521a0142" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4945ff92-a716-485a-ac68-7e9fa8ec14fb" contextRef="C_b7d146c4-9837-4043-9b52-921a53724e0c" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1eed662f-629c-48e7-acbd-ae0d11b167b9" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">414,958</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d7fabb0-5296-4d80-8e99-095d4170a951" contextRef="C_90d58f63-eee7-4c1a-ab73-d78903f815e7" name="sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141,779</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b248cbd-1fb2-4dbb-a720-bc6cf93b5488" contextRef="C_33d7d405-ee10-46a7-ba8e-6cecef016263" name="sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">273,179</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_038fc835-9367-448d-afb9-9ace6c6c461d" contextRef="C_aecc1d94-7b79-44e5-b57c-d8576c37c857" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,574</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89f5f5a1-d805-4987-8acb-02a949b704b6" contextRef="C_6a1456b0-60b7-4820-b443-f0391e89fbdd" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,574</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80f0d21e-d306-46f5-a081-9414b79a17f7" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,574</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9baad6eb-09a1-402c-b2f3-1ec4b8f984d8" contextRef="C_ed3d106f-c9e5-4f47-a732-17fd62714ce4" name="sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,574</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company&#8217;s marketable securities consist of debt securities, including U.S. treasury and agency securities, corporate debt securities and commercial paper. These marketable securities are carried at fair value and are included in the tables above. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. At each reporting date, the Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. The Company evaluates, among others, whether the Company has the intention to sell any of these marketable securities and whether it is not more likely than not that the Company will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met at December 31, 2024. The credit ratings of the securities held remain of the highest quality. Moreover, the Company continues to receive payments of interest and principal as they become due, and the Company's expectation is that those payments will continue to be received timely. Based on this evaluation, as of December 31, 2024, the Company determined that unrealized losses of its marketable securities were primarily attributable to changes in interest rates and non-credit related factors. As such, no allowances for credit losses were recorded at December 31, 2024. The Company did not hold marketable securities at December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest receivable as of December 31, 2024 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14af7744-45fd-4085-90fc-c37760d14102" contextRef="C_56c6ec77-77b3-426a-9cf6-61c4ee189ee2" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and is recorded as a component of prepaid expenses and other current assets on the Company&#8217;s balance sheets. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b69e754c-a465-4b86-bdb7-705babc9e21e" contextRef="C_eba777f1-1ccc-44f9-ae7c-9f47032a9edd" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have interest receivable at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, all marketable securities in an unrealized loss position had been in an unrealized loss position for less than 12 months. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ffe2299-e553-4465-80e6-f1a99982be14" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" unitRef="U_Position" decimals="INF" format="ixt:num-dot-decimal">36</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> marketable securities which have been in an unrealized loss position for a period of less than 12 months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_75952903-6b91-4919-8953-3697ec72bc02" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes the amortized cost and the unrealized gains (losses) of the marketable securities presented within marketable securities, marketable securities, non-current and cash equivalents (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.42%;box-sizing:content-box;"/>
        <td style="width:1.4%;box-sizing:content-box;"/>
        <td style="width:15.36%;box-sizing:content-box;"/>
        <td style="width:1.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.440000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.440000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.440000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Remaining<br/>Contractual<br/>Maturity (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Estimated Fair<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d51b9603-469c-454b-a640-ea942ebb2fe9" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,017</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a59c1f01-b309-4f66-aed1-060289a4b594" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34cdaf15-6f40-4ce0-86b9-e3147da4442a" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8b22de9-7618-4a81-91a7-49d90e7958a5" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,014</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a81eda1-4383-4b31-8450-fca0ed47cf73" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,511</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b505e706-7ff8-42d6-8b17-eee6cb777617" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c45c367-5c47-4f27-a819-be01484a6e9f" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ced00bdf-02cd-48ba-8b40-25a1c9450476" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,555</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5e66848-020f-4cdb-aa8c-623590a76cd5" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,245</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e264a406-7688-4112-b98a-0b17016c8a47" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3509a6a4-5c07-44fb-bff6-a6186d4d73e2" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76dd1446-fcaa-4892-bf6e-8892d2764d38" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,252</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d85e562-75a1-45fb-bbe7-fc3267439500" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,491</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a8b3bcf-ee6f-4d57-a37c-cd53d3b12f51" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcd15a5e-5d63-46d3-86f3-d4ff96aeed83" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf60ff1c-d804-4c4c-97d0-ff24936cbd94" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total maturity less than 1 year</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5a9eb6b-a525-4cbf-8c10-effaaa5361cf" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">203,264</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a03cf009-d769-4806-931a-cf2db10d121a" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1149fb9-b6a8-4f80-9612-1ff6ea98a2fd" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f62ca3b1-27a4-4019-a023-8c798b35638f" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">203,313</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5224ae74-c8a8-498f-82c5-b6cc56f4ce0c" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,427</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47925018-acb6-419a-bdd4-1f92e8242cb4" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82ececc6-39aa-4cb2-b57b-a676ee20176d" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c816f2f8-da51-49b0-8348-3008ffe07142" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,406</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3f0d56f-e180-4d7a-a928-9f71302e4588" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6ca890b-fbba-4003-b294-007fbaa69741" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86b65a0f-65d7-4201-a1c0-d0f787176860" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2b435db-5c88-441e-aeac-a89b5b7ba1ad" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,514</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea3d41b3-2137-4c39-8ae7-0ab7bc305c68" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,940</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d087a5f6-cd12-42f6-b00a-566f63fcf831" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e35fcacf-18f7-45fc-8c36-6d8495b65960" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61766efd-81e5-4a92-b631-3a373b8c5ab3" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6fc0963-63e5-47ec-8a2c-d67c8a311be8" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">273,123</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a111612e-6d0d-4a2f-b599-3b9308b5324c" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">127</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a2170b5-608a-4952-9c84-a570b6045e1b" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5f72bd0-00d8-4a80-ac64-7f044ad651b1" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">273,179</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9a9b59a-ae14-4b67-8370-ec19fcaa8627" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes marketable securities in an unrealized loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 Months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>Unrealized Loss</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_548dff28-111a-4b02-9459-79b089b04457" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">987</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e783d450-9bd5-4c85-a6bc-b159f9ecb0ce" contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6b65573-de08-4f71-93ff-b8843be6cc3e" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,172</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f4b148-c8e7-405d-b377-2625dec6e5ff" contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a01e9959-282e-4cc8-89a4-0989bd810359" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,469</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d275aae-476a-457f-b506-ad4c029a0cfa" contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac3b30f9-6324-4e66-b572-2edc38819bb1" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,508</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_996a8c1c-1345-4500-bcce-533aa565ac45" contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75b78b8a-399f-4490-8f43-19e08b96ec48" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,136</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58d4bd95-ac64-4f4a-b470-cc6f3519eb87" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_9849e3c8-efdc-4eac-acbd-2aaa8b3a585a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true" continuedAt="F_9849e3c8-efdc-4eac-acbd-2aaa8b3a585a_1"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Leases</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office and research and development space at the Company&#8217;s headquarters in South San Francisco, California under an operating lease. In April 2021, the Company entered into a lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f053cb5-c592-4830-ba7f-de4d6811a1c3" contextRef="C_e339adb9-8faf-4ae0-a9cf-843428e7c977" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">12,560</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet, set to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_857c6a59-397d-4168-a6f3-5278eba73ef2" contextRef="C_36638d69-8200-457e-b4df-f22570660294" name="sepn:LesseeOperatingLeaseExpirationYearAndMonth" format="ixt:date-monthname-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In September 2022, the lease was amended to add </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bbb738ca-1b77-4c4f-853c-340ce2f15477" contextRef="C_062b5e92-e9a6-4480-9a3e-af692706a741" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">9,348</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e5ae9cb-9022-486f-804d-e37ab261a450" contextRef="C_fb922ca6-bc1b-4ee2-9ad5-6fa73f26af51" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">21,908</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Original Leased Space&#8221;), also expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_de4c479e-9883-4b18-9a5b-8e1138ff8941" contextRef="C_e2dd8888-638d-419e-b998-f0ffd00c0ded" name="sepn:LesseeOperatingLeaseExpirationYearAndMonth" format="ixt:date-monthname-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In December 2022, the Company entered into another lease amendment to extend the term of the Original Leased Space and add </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9d64df7-78fc-4dc8-85d8-51bbdcd6adff" contextRef="C_1e38905a-c12f-4042-a1c7-538930041c98" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">22,911</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Additional Leased Space&#8221;). The Company took control of the Additional Leased Space in November 2023, at which point the Company vacated the Original Leased Space to allow the landlord to renovate it.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Renovation of the Original Leased Space was completed in July 2024. Upon completion of the renovation of the Original Leased Space, the lease of the Original Leased Space commenced, resulting in the total leased premises increasing to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19530eda-bbcd-46ad-9ec2-aa856388d8fd" contextRef="C_21bcef87-7441-4e70-b3d2-6468e2fd40eb" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">44,819</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Leased Space&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lease term for the Leased Space expires in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eb210713-1ef6-4706-b7f0-b5c34314cb62" contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe" name="sepn:LesseeOperatingLeaseExpirationYearAndMonth" format="ixt:date-monthname-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 2032</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, with an </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f511122c-bd04-48bd-889d-563cf09478b4" contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe" name="us-gaap:LesseeOperatingLeaseOptionToExtend"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33d58c4f-05ed-4122-b664-affc42bed7ae" contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">option to extend</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the lease for eight additional years (the &#8220;Extension Option&#8221;)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, it was not probable that the Company would exercise the Extension Option, therefore, it was excluded from the right-of-use asset and lease liability calculations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6fcaff3-0647-48dc-b44c-1d5b4cf5e1c2" contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8167dd1d-999d-4ac8-8a37-0c5d9fd5cb49" contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million operating lease right-of-use asset and operating lease liability upon completion of the renovations of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_755857a7-be8d-43d3-8565-44570de54335" contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">21,908</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square foot office and research and development space (the "Original Leased Space") as the Company occupied the property.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72c49de2-7751-4757-965d-3ae8839b73b7" contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9380f5b0-b007-418c-a994-87d15e2cb6ae" contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.6</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million operating lease right-of-use asset and operating lease liability for the Additional Leased Space as the lease commenced in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd660af0-6177-476c-bab6-f1806a1efdcc" contextRef="C_b1dfbbba-4ed3-4a5b-8cf4-81747534a7f0" name="sepn:LeaseCommencementPeriod" format="ixt:date-monthname-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, when the Company took control of the property. These amounts are disclosed in the supplemental information of noncash activities on the statements of cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28a474ac-6178-4d1a-9e2a-94d2ba2f3505" contextRef="C_cf0a11bc-e4a7-4986-9563-1992ae142565" name="us-gaap:LesseeOperatingLeaseDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, the entire balance of the operating lease liability associated with the Additional Leased Space was classified as non-current as the Company received a rent abatement for four months in the first year of the lease and, therefore, the operating lease liability increased over the 12 month-period starting from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_9849e3c8-efdc-4eac-acbd-2aaa8b3a585a_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the weighted average remaining lease term of the Leased Space was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_676ee99f-6385-4056-8d90-fe7d65c2307a" contextRef="C_c86e56ac-1ccf-4198-83f7-d9fc66656386" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.6</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The weighted average incremental borrowing rate used for the calculation of the present value of lease payments over the lease term was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afa8e7bc-33d5-4693-823b-52c7a56419d0" contextRef="C_c86e56ac-1ccf-4198-83f7-d9fc66656386" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">11.34</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the remaining lease term of the Additional Leased Space was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5fab8a83-bf7d-44b9-a658-be012bd46a76" contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The incremental borrowing rate used for the calculation of the present value of lease payments over the lease term at the lease commencement date was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89c5e0a5-5261-46cb-8591-1081e2991284" contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b52bbb3-2dcd-4e72-b5a3-1bae67ae0b55" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the expenses recognized and cash paid for the Leased Space (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_567b3364-5961-4801-ba62-624c8507e07b" contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,631</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdb22502-9ed3-4b90-861f-36c31509cd27" contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">897</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dee0330-c77f-4b4c-a9f7-2b2d0b565401" contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,462</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c95c83e0-0a54-447a-b8cb-d88325995e52" contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">964</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_760846af-e566-40f9-9d1c-d0cc2a4e6b2a" contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b" name="us-gaap:ShortTermLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ed8df0a-b7ad-4994-9933-4d6d08b21113" contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2" name="us-gaap:ShortTermLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,018</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a2f15bd8-f3eb-4cfa-afff-ce3b43128dcf" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum rental payments for operating leases were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.823%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Future<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1af6b153-2f99-4e7d-8e43-b1cafeaa3a28" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,469</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0379ebf7-a809-4404-b359-db4f5f2d7b22" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,611</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6faa473a-117f-4ca4-b338-7f3c3eeabb0e" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,760</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d868904-a969-4505-ae92-279ee032069c" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,912</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5a2057e-4559-4989-acfc-c158c01c6299" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,071</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ab64750-176c-46ec-b334-8104362fcdc0" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,851</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4b95648-02ab-4883-904a-7cfa022dce0a" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,674</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e686620-8bb9-4ad7-9352-3bd7f2851a95" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,198</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2c5f467-37e2-4654-bda6-b524f4634a82" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,476</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9087660-feee-45c1-bf34-ec0955c69918" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,851</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, non-current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4e072da-3b98-4d2a-a7ca-7ba68e9cf5a4" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,625</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7826adf7-81ed-4055-9e6e-6f356c244fb2" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,476</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not have any finance leases.</span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7507e2b-aa44-4906-8dfd-28abf33ce614" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation, as the Company operates in an industry susceptible to patent or other legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company was not subject to any material legal proceedings as of December 31, 2024 and 2023, and the Company is not currently a party to any legal proceeding that, if determined adversely to the Company, in management&#8217;s opinion, is currently expected to individually or in the aggregate have a material adverse effect on the Company&#8217;s business, financial condition or results of operations taken as a whole.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. As permitted under Delaware law and in accordance with its bylaws, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is or was serving in such capacity. The Company is also party to indemnification agreements with its officers and directors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The maximum potential amount of future payments that the Company could be required to make under these provisions is not determinable; however, the Company currently holds director and officer liability insurance. This insurance limits the Company&#8217;s exposure and may enable it to recover a portion of any future amounts paid. The Company believes that the fair value of these indemnification obligations is minimal. In addition, the Company is not currently aware of any indemnification claims</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Accordingly, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dce2358-1cf2-41ee-8f34-9dbb51ec5129" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_dcfd680c-c403-4d3f-b940-a3e05ba066d0" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t record any liabilities associated with these indemnification rights and agreements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ConvertiblePreferredStockTextBlock" escape="true" continuedAt="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the closing of the Company's IPO in October 2024, the Company&#8217;s outstanding convertible preferred stock automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34d5a781-1de6-4936-a86f-fa5450901be3" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:PreferredStockConvertibleSharesIssuable" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">22,839,774</ix:nonFraction></span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shares of common stock. Converted preferred stock outstanding as of the date of the IPO consisted of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a80f53a-fb12-4078-ae02-9e73311dabfa" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">196,657,452</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. Each share of outstanding convertible preferred stock was converted into common stock at a ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd1474fa-24de-4019-b356-75f4b8f2ee59" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">8.6103</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible preferred shares to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6239742-4a8a-45ee-9fc7-3bc6112055a8" contextRef="C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60" name="us-gaap:PreferredStockConvertibleSharesIssuable" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common share. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56e6a7c4-155f-4302-a011-c371ec7a7796" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c09103c7-876a-4c98-9202-120a3d40ec43" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3fe2f917-0041-4bb4-99bf-e7a69f5a3b55" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of convertible preferred stock were authorized, issued or outstanding at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af299ae4-d593-4905-8748-997aaaf76270" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:TemporaryEquityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, convertible preferred stock consisted of the following (in thousands, except for share and per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.291%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.685%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.025%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.545%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.545%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.545%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Authorized<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Issued and<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Carrying<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liquidation<br/>Preference</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Conversion Price<br/>Per Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c409db0-842e-4c29-b0d1-08530726b5eb" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dde23cf-3618-4f65-a666-5fa9c11707d6" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1510339b-96a3-4432-9640-56fdc69d9f35" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">75,000,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1df51d84-02df-48d0-be7d-e2f93fdefb16" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,694</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_850adab2-647d-4557-b43f-21fa92a9b4c8" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_864c2e47-7f2f-4f77-8cd9-6c52756c8838" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.00000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81ac9a67-cc6a-4ea6-b005-16067db51d59" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">121,657,452</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2e6ea57-f655-471e-8910-8a7be6d3b3f3" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b50b4379-7cfd-46cf-8d4f-d3549e537193" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">60,828,720</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_084b82b1-3aed-4b1f-aee5-ed15f653659b" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,521</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97cd32d0-abd3-4601-9e1e-14cb7037da00" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7e1fa91-27c7-4b66-8ed3-fed627f7814c" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.23297</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2021, the Company executed a Series A Convertible Preferred Stock financing arrangement that would provide financing of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e00f01cf-aac1-4be4-9bf4-3d5d27dba408" contextRef="C_ecda3b22-85c8-4a2c-910d-24b3feaec947" name="sepn:TemporaryEquityStockFinancingArrangementFinancingValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over an initial tranche and subsequent callable tranches through the issuance of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fbf62c3-99ec-4065-a611-c0ef5c71cde8" contextRef="C_d928477a-8ca4-45d7-99e7-77f499e78e0e" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4d20e83-df5a-4abb-bbe5-f805f9909314" contextRef="C_5f0437bd-6f52-4254-b099-4a45c3a53aa8" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. In the initial tranche, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5008c54-2677-4c7d-a567-7e3245a303a3" contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">45.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1993104-4264-4dd5-99e7-37daa58676e3" contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">44.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_149ec3c8-3d48-4164-bf5d-6d7e1d066c10" contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00" name="sepn:CashProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was received in cash, net of issuance costs, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3934c264-c924-4124-b840-f44f7217217c" contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00" name="sepn:NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was for the conversion of the then outstanding convertible promissory notes plus accrued interest. The Series A Convertible Preferred Stock financing arrangement represented an equity financing, per the terms of the outstanding convertible promissory notes, and as such the unpaid principal and accrued interest outstanding of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05c8689f-1fa5-4a40-871d-07181e0011dd" contextRef="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd" name="sepn:ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6be11bfa-108a-4fa4-b9e6-e732760a8a4e" contextRef="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">14.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock. Additionally, in November 2022, the Company executed the second tranche and issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14311b8b-23d7-4095-acf4-81f134b099a2" contextRef="C_2ed84efc-d353-46ca-bae3-39bc435baebb" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock and received net cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_745acd1b-f61b-4fbd-8c53-4b712e40e534" contextRef="C_2ed84efc-d353-46ca-bae3-39bc435baebb" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series A Convertible Preferred Stock Purchase Agreement provided that, upon the fulfillment of certain conditions, each investor would purchase its pro rata portion of the shares to be issued in additional Series A Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series A Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of the Company&#8217;s convertible preferred stock to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b775d871-47c5-4a6e-b867-aa6168a8b368" contextRef="C_42ad5efb-0c6f-42c1-afc8-5cc756e5312e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">196.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares, of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99a3cc11-3473-4caf-b200-3d05a54adc12" contextRef="C_ce391cd8-82f6-405a-84f5-86572717253e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">121.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares are designated as Series B Convertible Preferred Stock, and to establish the rights, preferences, privileges and restrictions of the Series B Convertible Preferred Stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company entered into a Series B Convertible Preferred Stock financing arrangement in which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4116205d-da40-457a-9046-2ba149888f25" contextRef="C_c07f1042-7166-4a92-ad8c-816792ab533e" name="sepn:TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">121,657,452</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series B Convertible Preferred Stock were authorized to be issued at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f78e160-6434-4e2d-bba5-b254646fc1f0" contextRef="C_2ed61538-be83-4373-9c74-22d2ecd37bbc" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.23297</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share over two tranches, for total proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_826e8c8c-b58c-4162-94c4-2374074e1311" contextRef="C_23cbaddc-7e72-4392-96bd-b68571b9aa1f" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">150.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In June 2023 and July 2023, the Company issued an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af01b48b-9b59-44aa-a553-0bb1c7385803" contextRef="C_75b103c5-2b1b-4a43-a69a-77670e68c96e" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">60.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series B Convertible Preferred Stock at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8abfed12-714a-496c-845f-fa3a90867bba" contextRef="C_1aec0dd0-2f1a-4cc5-908a-9f57b03ace96" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.23297</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_236629e1-68bd-4dfb-815b-db90038e16b0" contextRef="C_75b103c5-2b1b-4a43-a69a-77670e68c96e" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">74.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the first tranche, with a potential second tranche of additional funding for up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_646d8111-ded3-45fb-9d06-5ee436c99356" contextRef="C_3d630fbe-3eb4-461e-8c9f-d264488141b7" name="sepn:TemporaryEquityStockAdditionalFundingBasedOnApproval" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million based on approval of the Board of Directors and consent of the majority of the holders of the then-outstanding Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock Purchase Agreement provides that, upon the fulfillment of certain conditions, each investor will purchase its pro rata portion of the shares to be issued in additional Series B Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series B Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon issuance of the Series B Convertible Preferred Stock, the Company also amended the Series A Convertible Preferred Stock agreement to cancel the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_131094e0-a13b-4642-a732-5195212e0507" contextRef="C_e09fe0d5-bb64-4a89-8423-2d8d7f22d329" name="sepn:ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unissued shares of Series A Convertible Preferred Stock originally authorized under the agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company executed the second tranche of the Series B Convertible Preferred Stock financing arrangement and issued the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d5268e8-27e8-4945-b053-6a13a9b1a1f2" contextRef="C_2c23db88-ff79-4c64-b0f7-eb3460655b08" name="sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">60.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series B Convertible Preferred Stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c731249-60e7-4d4b-bd67-44f4876e734d" contextRef="C_2c23db88-ff79-4c64-b0f7-eb3460655b08" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">74.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d_1" continuedAt="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rights, privileges, and preferences of the Series A and Series B Convertible Preferred Stock (together, the &#8220;Convertible Preferred Stock&#8221;) are as follows:</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Redemption</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Preferred Stock does not have redemption rights, except for the contingent redemption upon the occurrence of a Deemed Liquidation Event.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Conversion</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Convertible Preferred Stock is initially convertible, at the option of the holder at any time after all authorized shares of the Convertible Preferred Stock have been issued or if otherwise approved by the holders representing at least a majority of the then outstanding shares of the Convertible Preferred Stock, including at least one holder that, together with its affiliates, holds only shares of Series B Convertible Preferred Stock and is a major investor, as defined in the Company&#8217;s amended and restated investors&#8217; rights agreement (the &#8220;Required Vote&#8221;), into shares of common stock as determined by dividing the original issue price by the conversion price in effect at the time of conversion. The Series A Convertible Preferred Stock conversion price is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4570712b-f8dc-4aba-ad62-16f6774744f6" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and the Series B Convertible Preferred Stock conversion</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">price is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e19dc350-bea5-4d3f-be7b-caeaea4d6362" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.23297</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The conversion prices are subject to adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Convertible Preferred Stock. The conversion prices are subject to adjustment in the event the Company issues additional shares of common stock without consideration or for a consideration per share less than the conversion price in effect prior to such issuance, unless the Required Vote determines that no such adjustment shall be made to the conversion price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special mandatory conversion will occur if a convertible preferred stockholder fails to purchase their agreed upon share, as originally allocated to such holder in the purchase agreement, in additional closings of the Convertible Preferred Stock as defined in the purchase agreement, and such failure is not cured as specified in the purchase agreement following receipt of the subsequent closing notification. Holders of Series B Convertible Preferred Stock have the option to waive the special mandatory conversion as specified in the purchase agreement. Upon such event, each share of the Convertible Preferred Stock held by such holder will be automatically converted into that number of shares of common stock equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_454ab157-85b3-4cdd-ad52-eed2e6a6dcb6" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:PercentageOfShareIssuePriceDividedByConversionPriceInEffect" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the original issue price divided by the conversion price in effect.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mandatory conversion of all outstanding shares of the Convertible Preferred Stock at the then effective conversion rate will also occur automatically upon (i) consent of holders representing the Required Vote or (ii) the closing of the sale of shares of common stock to the public at a price of at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33600461-f1de-4808-ba43-e74743f387f8" contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:num-dot-decimal">1.849455</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the common stock), in a firm commitment underwritten public offering resulting in at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b509442c-9f4e-4302-9059-77c2151c5b34" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in gross proceeds to the Company, after deducting underwriting discounts and commissions, and in connection with such offering the common stock is listed for trading on the Nasdaq, the New York Stock Exchange or another exchange approved by the board of directors, including the approval of at least a majority of the Convertible Preferred Stock directors.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Company, other than dividends on shares of common stock payable in shares of common stock, unless the holders of the Convertible Preferred Stock first receive, or simultaneously receive, a dividend on outstanding shares of the Convertible Preferred Stock in an amount at least equal to the dividend payable based on the number of shares of common stock at the then conversion rate, such that the calculation should result in the highest preferred stock dividend. The board of directors has not declared any dividends to-date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voting and Board Representation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each holder of outstanding shares of the Convertible Preferred Stock is entitled to one vote for each share of common stock into which such shares of preferred stock are convertible and shall vote together with the holders of common stock as a single class and on an as-converted to common stock basis, except as provided by law or by the other provisions of the Company&#8217;s certificate of incorporation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of shares of Series A Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect three directors of the Company. The holders of shares of Series B Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect one director of the Company. The holders of record of the shares of common stock and any other class or series of voting stock (including the Convertible Preferred Stock), as a single class, are entitled to elect the remaining directors. The size of the board shall be set and remain at seven directors.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Protective Provisions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At any time when shares of the Convertible Preferred Stock are outstanding, the Company shall first obtain the approval of the Required Vote, voting separately as a class, with respect to the following actions: (i) consummation of a liquidation, dissolution or winding up of the Company, or effect any merger, acquisition or consolidation or any other deemed liquidation event, (ii) amend, alter or repeal any provision of the Company&#8217;s certificate of incorporation or bylaws, (iii) create, authorize, issue or obligate the Company to issue shares of any equity security or increase the authorized number of shares of the Convertible Preferred Stock or of any additional class or series of stock unless it ranks junior to the Convertible Preferred Stock, (iv) reclassify, alter or amend any existing security of the Company that is pari passu with the Convertible Preferred Stock, or is junior with the Convertible Preferred Stock , in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification alteration or amendment would render such other security senior to the Convertible Preferred Stock, or in the case of a previously junior security would render such security senior to or pari passu with the Convertible Preferred Stock, (v) pay or declare any dividend, other than dividends on the Convertible Preferred Stock, or make any distribution on any shares of capital stock prior to the Convertible Preferred Stock, other than common stock or options to acquire common stock repurchased from former employees or consultants in connection with the cessation of their employment/services, pursuant to the provisions of existing plans or agreements, (vi) create, adopt, amend, terminate or repeal any equity or equity-linked compensation plan, (vii) increase or decrease the authorized number of directors constituting the Board of Directors, change the number of votes entitled to be cast by any director or directors on any matter, or adopt any provision inconsistent with Article Sixth; (viii) create or hold (or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue) any shares of capital stock in any subsidiary that is not a wholly-owned subsidiary of the Corporation, or sell, lease, transfer, exclusively license or otherwise dispose of any direct or indirect subsidiary capital stock or all or substantially all of any direct or indirect subsidiary assets; or (ix) sell, assign, license, pledge or encumber material technology or intellectual property, or enter into or grant any royalty streams related thereto, other than licenses granted in the ordinary course of business.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidation Preference</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of any voluntary or involuntary liquidation, dissolution or winding up, or in the event of a deemed liquidation event of the Company, the holders of shares of the Convertible Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, or out of the consideration payable to stockholders, as applicable, before any payment shall be made to the holders of common stock, an amount per share equal to the greater of (i) the original issue price, plus any dividends declared but unpaid, or (ii) such amount per share as would have been payable had all shares of the Convertible Preferred Stock been converted into common stock immediately prior to such event. If, upon the occurrence of such event, the assets of the Company available for distribution to its stockholders are insufficient to pay the holders of the Convertible Preferred Stock the full amount to which they are entitled, the holders of the Convertible Preferred Stock shall share ratably in any distribution of the assets available for distribution.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Classification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified the Convertible Preferred Stock outside of permanent equity on the balance sheet as these shares can be redeemed upon the occurrence of certain change in control events that are outside of the Company&#8217;s control, including liquidation, sale or transfer of the Company. The Company has not adjusted the carrying values of the convertible preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur that would obligate the Company to pay the liquidation preferences to holders of shares of convertible preferred stock, and at the balance sheet dates these circumstances were not probable. Subsequent adjustments to the carrying values of the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it was not probable that such a redemption would occur.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_95482d06-b883-4e8c-bcfd-459757c29804" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:CommonStockTextBlock" escape="true" continuedAt="F_95482d06-b883-4e8c-bcfd-459757c29804_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company was authorized to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ab549a1-319f-4846-b1be-025e2e147d7f" contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">500.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ec78476-3ff7-41cc-af7d-2333f6226dbc" contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company was authorized to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7fc106c-c219-421d-a262-e9246c7e877c" contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">260.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2250ac4c-26b5-4840-a4a6-b654c705bfbf" contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of common stock of the Company to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ff2609e-c27b-4923-885b-54d9d2f74dab" contextRef="C_2bb60e06-e9a7-4ee2-9f51-82882892bb75" name="sepn:IncreaseInSharesReservedForFutureIssuanceInShares" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">260.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95482d06-b883-4e8c-bcfd-459757c29804_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company amended and restated its certificate of incorporation, which was filed immediately prior to the closing of its IPO and among other things, increased the number of shares of common stock authorized for issuance to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85e09513-4dbf-4ead-81ba-4617545939bf" contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">500.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company completed its IPO of its common stock. In connection with the Company's IPO, the Company issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b007e1fb-96c7-4839-b684-715cc475d5ea" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">18.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock, which included an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed1eb5bb-97fb-4f3e-b49d-d70bf3e952eb" contextRef="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares of common stock, at the public offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8f3230a-cc0b-456a-bc2b-6ba02d94a03c" contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As a result, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c55c343d-bbd5-4b22-b765-b21307034f92" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">302.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net proceeds, after deducting underwriting discounts and commissions and other offering costs payable by the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdfc7033-9a93-4911-ac40-157d9063f738" contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0" name="sepn:UnderwritingDiscountsCommissionsAndOtherOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">28.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of common stock are entitled to dividends when and if declared by the board of directors, subject to the preferences applicable to outstanding shares of the Preferred Stock. The board of directors has not declared any dividends and the Company has not paid any dividends. The holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5719409b-32a3-41dd-8fac-2def7943b971" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_125dd8d8-416d-4e7b-8f8c-3a9b818d7563" contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61ff620d-8d4b-4411-9017-ad24c77284cc" contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,710,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f4d78cf-9f9c-43e1-bdbe-0474699753fe" contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3610b10c-d27d-4f0d-a5e5-78ca2f58b8e0" contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">14,129,284</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b83c29d9-54d4-459e-92ba-ec9936a0dc73" contextRef="C_0c337934-85a8-4a6b-b0b7-d303a586df92" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,938,982</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a78c6b88-ae11-4962-b614-d39ced0f7259" contextRef="C_44baba83-cea1-46e8-978a-dc1f29c93e52" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,123,296</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2021 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cc885d6-abd8-4437-a03f-4c3bd586e22d" contextRef="C_66bb86ba-4924-40ff-99cf-a77f796a2d06" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bed3ae8-1003-41cf-bf18-a7751aa1cda0" contextRef="C_0b34fe95-fedf-421a-b8dd-87db73e425eb" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,634,488</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2024 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ea84b8c-0e1d-4923-97f6-c7f546eb92ec" contextRef="C_c58ad86c-a8d9-467a-8ff5-d56c8a6e29f6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,743,915</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1386b303-b163-4a38-80ed-6aaf80c1276c" contextRef="C_4947aa1a-72b3-47fa-b3bb-2fe7814a8ec3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for 2024 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bc4c389-b949-4b98-948a-63cc9130679e" contextRef="C_1b936336-2026-44b4-a240-c9a3d5378bef" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">369,402</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18c52044-7206-43f7-baba-5340a9c16746" contextRef="C_6194273a-4c93-49e2-96ac-eb9941334717" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa828c27-3700-483f-9cc8-b081edb49c64" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,052,299</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4fd9a10-9e79-4981-80f5-b43c32029d40" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">25,597,558</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_a094afd0-eaa9-4774-bd59-a9830514b2fb" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company's board of directors adopted, and its stockholders approved the 2024 Option and Incentive Plan (the &#8220;2024 Plan&#8221;) which became effective on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5509993f-1df3-4d5f-9a2e-fb65a5126867" contextRef="C_79b58927-86fc-40d3-9f46-ab96913ff7a1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 25, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The 2024 Plan allows for the issuance of equity-based and cash-based incentive awards to the Company's officers, employees, directors and consultants. The 2024 Plan is administered by the Company's compensation committee. The exercise prices, vesting and other restrictions are determined at the discretion of the compensation committee, subject to the provisions of the 2024 Plan.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company initially reserved for issuance under the 2024 Plan </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09b7d0b6-f984-4d94-98dd-b593bdb8d26b" contextRef="C_59dc2c7f-ff1c-470d-b96b-f1599335ca16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase on January 1, 2025 and each January 1 thereafter through January 1, 2034, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_671a7347-77e8-4422-b211-ff8d7c2fd06f" contextRef="C_b9128e20-7131-4bd4-a8bd-4763f5a273df" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares of the Company's common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company's compensation committee. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80953114-796b-45c2-8322-4daefc9709df" contextRef="C_3eda2d3e-77c3-4ee9-833b-51522ca25c9a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares remained available for future issuance under the 2024 Plan as of December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares reserved under the 2024 Plan is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization. The 2024 Plan replaced the 2021 Plan as the Company&#8217;s board of directors determined not to make additional awards under the 2021 Plan following the completion of the IPO. However, the 2021 Plan will continue to govern outstanding equity awards granted thereunder. The shares of common stock underlying any awards under the 2024 Plan and the 2021 Plan that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated (other than by exercise) will be added to the shares of the Company's common stock available for issuance under the 2024 Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Stock Option and Grant Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021, the Company adopted the Septerna, Inc. 2021 Stock Option and Grant Plan (the &#8220;2021 Plan&#8221;), which authorizes the Company to grant incentive stock options, non-qualified stock options, restricted stock awards, unrestricted stock awards and restricted stock units, to officers, employees, directors, consultants, or other key persons of the Company. The terms of the stock option and restricted stock agreements, including vesting requirements, are determined by the Board of Directors, subject to the provisions of the 2021 Plan. Stock option awards expire </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b483ebb2-3e3b-48b0-9b24-b7ab765ef769" contextRef="C_2f0eb5d6-7026-4c35-ad8b-a69f0b83d927" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the grant date, or as otherwise determined by the Board of Directors, or in the case of incentive stock options granted to 10% stockholders, the term is no more than </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6253d66-b971-4cc5-bb2d-86aeffe1d7f9" contextRef="C_fab6a00f-2fe1-456a-bccf-9474c007d17a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the grant date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_1" continuedAt="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company granted and issued restricted stock awards and allowed the recipients to purchase the unvested restricted stock awards at par value per share. The shares issued for unvested restricted stock awards under the 2021 Plan are subject to repurchase by the Company at the original issuance price in the event of the holder&#8217;s termination of its relationship with the Company. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#8217; equity (deficit) as the related awards vest over the requisite service period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Plan initially authorized a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba5926e8-1f0e-4ec9-9981-4071a23773bd" contextRef="C_9268f199-df5e-4067-91e6-ed2fd39554e8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares reserved for future issuance. In June 2023, the Company amended the 2021 Stock Option and Grant Plan to, among other things, increase the shares reserved for issuance under the 2021 Plan to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c706372-9401-4df2-9c01-79e7053e786e" contextRef="C_612e0da3-d172-44b9-afd1-b4b5f1733b29" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares. In September 2024, the Company amended the 2021 Stock Option and Grant Plan, as amended to, among other things, increase the shares reserved for issuance under the 2021 Plan to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f54fe4af-88de-48e7-a079-02db5205ce45" contextRef="C_0dbb3934-d7b1-4512-9408-c82380a608be" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35095459-ab5e-4838-b2ed-a06349ff3d63" contextRef="C_71f42ff7-1a0f-4075-b1ad-7f3659f2ab90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares remained available for future issuance under the 2021 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54af3a9f-4f2f-489e-a3e8-d0c81324cc12" contextRef="C_902b0c5f-744e-4d30-b174-d36f4e83674d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares re</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mained available for future issuance under the 2021 Plan as of December 31, 2024 as the 2021 plan was replaced by the 2024 Option and Incentive Plan (the &#8220;2024 Plan&#8221;), which is further discussed above.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 ESPP</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company's board of directors adopted, and its stockholders approved, the 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;), which became effective upon the date immediately preceding the date on which the IPO registration statement was declared effective by the SEC. The 2024 ESPP initially reserved and authorized the issuance of up to a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91df1eb9-83ee-4eeb-be48-2b8b4d81b524" contextRef="C_513d2df9-958a-4c81-a310-f93896216a3a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company&#8217;s common stock to participating employees. The 2024 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2026 and each January 1 thereafter through January 1, 2034, by the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d17f8309-5b9c-479b-98e4-595f00ffa78a" contextRef="C_39410be2-488e-40ba-b03f-47c8c6cb10a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9fc3416-225f-4650-b89c-c344a8c2b21a" contextRef="C_8255216d-10ae-416d-bcd2-76adfb6ba4d9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares of common stock on the immediately preceding December 31, or (iii) such lesser number of shares of common stock as determined by the administrator of the 2024 ESPP. The number of shares reserved under the 2024 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1bca1b8-4366-48df-bc53-2aa9ef16abca" contextRef="C_29adb2c9-12a7-43f9-8228-3116b1608be4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" scale="6" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares under the ESPP as the first offering period has not begun. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4d6b273-f587-4133-bb53-a43de8980071" contextRef="C_d3127ac5-59a1-444d-b791-71cb86e3ef50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares available for issuance under the ESPP.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive Officer and Director Equity Awards Modification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company&#8217;s board of directors modified the terms of stock option awards for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa25152a-2285-45a0-9144-94c7feae7107" contextRef="C_92c1f558-0199-426d-b08a-1870d1dc5677" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company&#8217;s common stock and restricted stock awards for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_665e52c8-b929-4b63-aa0b-49f6889a4746" contextRef="C_da5e58c0-03a1-48bc-97cf-7fa1915eebf3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company's common stock to certain executive officers and members of the Company&#8217;s board of directors. Under the modified terms, accelerated vesting provisions were added associated with certain change of control events. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26fdb75c-dd1b-498c-82eb-aa1760abbb62" contextRef="C_22e5ca43-623f-4048-99d6-c3938708def1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> incremental stock-based compensation expense was recognized as a result of the modification.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has granted restricted stock awards from the 2021 Plan and from outside of its stock plans, under the terms of restricted stock purchase agreements and subscription agreements. Unvested shares are subject to repurchase by the Company upon the holder&#8217;s termination of its relationship with the Company at the original purchase price. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#8217; equity (deficit) as the related awards vest.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_164dcd11-4396-4f00-9006-e3fb9cf52f31" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes restricted stock award activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.98%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.36%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.88%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value<br/>Per Share</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68656850-e687-4bae-b16d-afb27fb5da43" contextRef="C_1147e1f5-d133-45d8-8f2d-657d2695faa6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,002,044</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca43932b-87f5-4587-ac5b-378aecb6e3fc" contextRef="C_1147e1f5-d133-45d8-8f2d-657d2695faa6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.67</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards vested</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_848acf00-ac04-447d-a026-35e39213af06" contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">410,916</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e389903-ac32-4a6f-a9cb-87ba705e2122" contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.77</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards repurchased</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1657d00-5527-4019-9c79-d7bc59172c00" contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4" name="sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" unitRef="U_USD" decimals="INF" format="ixt:num-dot-decimal">14,299</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b63304d-74d6-4291-8d4a-0c47efd62ea9" contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4" name="sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">2.31</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ecde77d-7a28-43ba-8a33-817c464d79b6" contextRef="C_119c49a2-1fd6-4e17-adcd-69be80143f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">576,829</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d5dc31c-c62f-4d9c-a47b-c58ec7e3d9e2" contextRef="C_119c49a2-1fd6-4e17-adcd-69be80143f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.62</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_2" continuedAt="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_3"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The restricted stock awards generally include a service condition for vesting and vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter, but some awards vest over different time periods. In addition, some restricted stock awards include vesting criteria subject to the achievement of performance-based conditions in addition to service conditions, for which the Company periodically assesses the probability that the performance criteria will be met and only recognizes stock-based compensation expense related to these awards when achievement of the performance criteria becomes probable. The aggregate grant date fair value of shares vested during the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3ed56c5-295d-4162-bb18-4641b0ef59a5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77054231-3911-4a26-8171-1ac9d6409b1e" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes stock option activity under the 2024 and 2021 Plans:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.667%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.443999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.443999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.443999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.555%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Options Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_187a6d1c-c494-4fda-b630-aa34f2359c74" contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,123,296</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77c73294-6161-4f85-b828-5b73790f348b" contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.62</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_7bf49bb0-6ea2-4f6f-9afa-d3f7752aead8" contextRef="C_09bfaeb9-dddb-4966-a602-14fa0623c76f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.78</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d32c046e-d2fc-4135-b8e7-178a364d9fe1" contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,287</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54e1df9d-c97c-47eb-9d41-9a6cbe60de84" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,965,907</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9d9d900-5b90-43db-b935-30bd1487d0b3" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.66</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b41c4f1d-464e-4c84-81d0-925078aa040d" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">28,896</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4f570ac-3eb2-4d7a-9023-626ab75a04ce" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.28</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d77ccbbb-4975-48d9-9351-f2ab4d13befb" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">121,325</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed5e39b2-2a37-4787-98d7-cdd62a15d6c4" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.02</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f165d97-870f-45ba-b7cf-19c73a93d2ab" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,938,982</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d73993f-7175-4cf0-ae48-f13e8fc7d69f" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.64</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_76d6bc30-310b-4b39-a1bd-42560c6102de" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.11</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3229afcf-d456-46e9-8477-e99d60b6bd55" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5ffe730-fa31-454c-a2c9-ec4de232ec4c" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">514,144</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ae57dc9-b4d2-4b9d-b2b7-e8fdf835d9d4" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.90</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_70b1bc67-e7cc-482a-9ec4-12a346ec845c" contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.23</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83ff5174-7f9f-4f18-94b8-05d1799cd336" contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,285</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options include a service condition for vesting and most stock options vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter. The aggregate intrinsic values of options outstanding and exercisable were calculated as the difference between the exercise price of the options and the closing market price of the Company&#8217;s common stock as of December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate grant date fair value of options that vested for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02e1c944-87b8-40b1-b803-b5101885c75b" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The options granted in the year ended December 31, 2024 had a weigh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ted-average per share grant-date fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16e257e6-12d0-4dd4-88b0-56fe239834b3" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.65</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and a total grant date fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c49d095-741a-4312-86cc-be1a945a78f6" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The total intrinsic value of stock options exercised during 2024 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e103e3f8-84bf-4966-9b0d-ae212f0faab6" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company granted a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc017ebe-4444-4138-a641-4cc818230a48" contextRef="C_829daf10-7ff1-4266-a786-57da4f5434c0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of stock options to its employees. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1efc23c-3a19-4fc3-a0f7-8a8a7ceeaf6b" contextRef="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the stock options granted in the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 include vesting criteria subject to both service conditions and the achievement of performance-based conditions, related to the consummation of the Company&#8217;s IPO or a Sale Event, while the remainder include vesting criteria subject to service conditions only. As a result of the consummation of the Company's IPO in October 2024, the performance-based condition related to these stock options was met, triggering commencement of vesting of the options, and the Company began recognizing expense related to these grants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42dac764-d05a-4439-83fc-ac177b5dadcf" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the stock options granted in the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 also include accelerated vesting provisions associated with certain change of control events.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Valuation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e0f2939-c46a-4f39-92ce-c47bd9da7d13" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, using the Black Scholes option pricing model, were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.882%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.882%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fair value of common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ced8e00-83fe-4bff-b1dd-9479d6017b00" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.65</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_567a6007-d17d-405d-abcd-8b89105f7ffc" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.01</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a0734de-ae89-4332-a351-35611fe7d6a7" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.83</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d200db2e-6d91-44a2-8f2d-de49ba2b4150" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.56</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0e8e78c-3d2a-42fd-992d-689490500303" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">91.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71d56c05-7982-43b0-a218-e8a500278bef" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">86.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_9de8869f-c6c3-4ec6-ab03-dd109f41c6b9" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.03</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ffb283c8-aa80-4e96-b2fe-8895b3babd3b" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.90</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cd837af-865f-49ba-954d-7625402b5ccc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80231069-7172-40e3-ba90-5c153ba5b2b1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a094afd0-eaa9-4774-bd59-a9830514b2fb_3"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the fair value of the options granted, the Company uses the Black Scholes option pricing model and assumptions discussed below. This model utilizes inputs that are highly subjective including the fair value of the Company's common stock prior to the IPO, and expected volatility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the IPO in October 2024, because there had been no public market for the Company&#8217;s common stock, the Board of Directors, with input from management, determined the fair value of common stock by considering a number of objective and subjective factors including (i) valuations performed by independent third parties, (ii) important developments in the Company&#8217;s operations, (iii) the rights, preferences, and privileges of the Company&#8217;s preferred stock relative to those of the Company&#8217;s common stock, (iv) actual operating results and financial performance, including the Company&#8217;s levels of available capital resources, (v) the conditions in the capital markets, biotechnology industry and the U.S. economy in general, (vi) the stock price performance and volatility of comparable public companies and (vii) the lack of marketability of the Company&#8217;s common stock, among other factors. After completion of the IPO, the fair value of common stock is based on the closing market price on the date of grant.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected term represents the period that the Company&#8217;s stock options granted are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). The Company has very limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The Company will continue to apply this process until a sufficient amount of historical information regarding employee exercise patterns and post-vesting employment termination behavior becomes available.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the Company&#8217;s limited operating history and lack of company-specific historical volatility as a public company, due to the Company's IPO in October 2024, or implied volatility as a private company, the expected volatility was estimated based on the average volatility for comparable publicly traded biopharmaceutical companies over a period, where available, equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar size, life cycle stage and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-free Interest Rate &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c40706ab-1d2c-4834-8e09-356c6eea91fc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense for restricted stock awards and stock options recognized in the Company&#8217;s statements of operations and comprehensive (loss) income is presented as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ace821d4-62eb-46bf-85b8-07b87902a993" contextRef="C_a88f3222-aa43-4a22-9616-3208194c63fc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,619</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_332a2d82-b96a-46bc-b761-fd73ede844f1" contextRef="C_4c5f565b-9309-42f7-86c8-bb16495c890f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">887</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e11c63af-f626-45c4-942c-c5c20cfc12c1" contextRef="C_8484b4a9-981f-46d8-9a3b-93c7b6a966e2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,533</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e112702-7714-416d-873a-82256fa1d9ea" contextRef="C_6c2685d2-81ab-435e-a0e2-34a378301c88" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53e9b36f-0e57-414d-93ba-57999b65e727" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,152</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a208bb9-2a56-407b-8488-736e1c1f6b74" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total unrecognized stock-based compensation expense related to unvested restricted stock awards and unvested stock options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0d71888-a41b-41be-a22c-1b122183f5b7" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_97afab74-0b1a-4ecb-ae29-70457177d492" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.8</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_b2a549c5-a277-44da-9517-e4f30f292b06" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_b2a549c5-a277-44da-9517-e4f30f292b06_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8cbb31ae-3a4c-4d3b-8418-77c3f04f1194" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the (benefit) provision for income taxes were as follows for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a4ced94-0bd2-4267-ac1f-e89ca676c5d5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ac5dbcf-c668-4c23-bd40-a8ed557bc392" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0b1d5fb-0738-44ce-b69f-43d155062b82" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_231d97d6-8c38-4ac8-99ef-d710bb90a907" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c764e70c-c8a9-4ef1-b8c2-2a97716c28cc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b268d819-8133-4054-a90c-84862faefc3d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73f2762a-c593-46a1-9086-6e83046c8f21" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_179929a7-e91a-4f9d-8d4d-49f9e98e9047" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4ba24b8-632c-47b3-a1c6-c92fe532b8f4" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a9ababb-2313-420c-8d3b-e957e6ad9212" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_765329d2-0dbb-4d0d-8b8b-c267e32daf77" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6738773c-f36e-473a-bca1-6890036d797a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f247323-0d33-488b-8925-fa6fa3ee8e7c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">498</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5de72a67-e2a5-4b19-b0b8-05341c1c5123" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded an income tax benefit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_521f78c1-bcd7-4067-b06a-c1da6db56dad" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. For the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded income tax expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd838b0b-b39b-498b-b007-97c26f2f0d9a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1acdf1a2-317d-4e32-b7ac-1efa006f2820" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the Company&#8217;s effective tax rate to the statutory U.S. federal rate is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.343%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.343%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal taxes at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8110d5a-78a3-4e8e-8ee2-c3ca0cd3492f" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9aa3952a-6587-4a0c-999b-21fbfc3b99a7" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4c702bd-7049-4cab-a7dc-3db60a9e6720" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2d1ed88-0f32-435d-8042-4916aa2a6b98" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">34.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43e6d59b-83b2-42a2-91f9-9a467b78e31e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1e05821-5e61-4e1d-81fb-a87ff765cf0e" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12e9ee61-55b2-493a-bb3f-599d90f8cc95" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27e81d23-d0c8-4b0f-a712-41b1a91498be" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">19.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_babdf0c0-69f0-4b76-90c0-b409608ebcab" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">29.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_109a867d-1049-4b4a-886d-c2598bd1e66d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">39.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc3e86a4-823e-4643-8d4c-21559e9953d0" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ecc0c7f-e8f4-467d-ace7-1a05db59394f" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0130fb29-a16d-4dbb-a09a-958452dcbcea" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7c20d67-d046-4998-9a96-0567440914c1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">14.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span><ix:nonNumeric id="F_142de06c-9414-4df5-a7fa-c201ac98acd6" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_142de06c-9414-4df5-a7fa-c201ac98acd6_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The types of temporary differences that give rise to significant portions of the Company&#8217;s deferred income tax assets and liabilities are set out below (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_142de06c-9414-4df5-a7fa-c201ac98acd6_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e577cf6e-8d49-4dc4-a29d-c5276b22e0a1" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,122</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8226f4ef-7e2f-4492-b6ab-f323ef5a3feb" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,940</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41c7e801-f2dc-49e8-922a-7b203dae99bf" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,102</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb7934e5-951c-4265-b1ce-fa83604ce299" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,338</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eac9f5e4-b86d-494c-b889-dcfac6415f99" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,129</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0462104e-c3b1-4ee8-a259-390671438872" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,516</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9e580fe-4a61-4cbb-9787-e39cc9ece3ee" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42a7811c-215d-44cc-a98c-3dc2ddf12b0f" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55019d7c-72f8-479a-9be8-36988bb01081" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,163</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a40fedb4-cfee-42d1-a959-fae34ce371bf" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">841</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sec 174 capitalized research and development costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3727e500-ae44-458b-b803-8ebd40af466a" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,855</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9cb2ffd-2f0a-46d7-9c5a-b1f467ff6433" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,313</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65a2d777-cdc4-4591-a164-da684a84a423" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,432</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8723b53e-488d-4d1b-bddd-f4c81da0e6ec" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,957</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8044b8a9-a094-4cf9-b34b-ed50ac9da1b2" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,061</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aefb70d8-c2b6-432b-a98e-6560b63048c3" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,127</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9c075a5-37d5-489c-883d-4638ed5559a4" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,371</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d8bf463-39e4-416d-8a8b-1376f64933fe" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,830</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d7fc10c-f0c8-4c53-9f70-b25f89f36f89" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">766</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_136629a0-d1e6-4be3-9d50-e94306f8e6c6" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">521</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a359925-11bb-465e-b14a-f78ef422b55c" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,605</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3df4fd08-af65-4e13-a823-9f25df131094" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,504</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6ae0f7c-0501-4296-9a16-25a40df3b10b" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7eeb85a8-c14e-463b-853e-0fff49ef7ba4" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,296</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b85cfa6-86bf-4be5-bc69-a00af6c10210" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,371</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e60129b9-ce65-4260-b997-8ed220aef1b5" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,321</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred income tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90692118-4d66-45a4-9a5e-d6369f07ab75" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_654c452c-8f13-4044-9c1e-f2f5ec45091d" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has established a valuation allowance for the amount of deferred tax assets that are not more likely than not be realized. Management considered all available evidence, both positive and negative, including but not limited to the Company&#8217;s historical operating results, income or loss in recent periods, cumulative losses in recent years, forecasted earnings, future taxable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b2a549c5-a277-44da-9517-e4f30f292b06_1"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">income, and significant risk and uncertainty related to forecasts, and concluded the deferred tax assets are not more likely than not to be realized. The net change in the total valuation allowance for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was an increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecb147a2-cf3d-408c-b5e6-1bd721869c1e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7690278-4e71-496a-9959-12ba67f80794" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa3c7820-91f0-45d4-a345-a5ccc4961743" contextRef="C_da578283-3385-4d7f-84d8-e4e87678a27a" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of federal net operating loss carryforwards and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e1dd8e4-f54e-4010-bfd7-881aaad7330b" contextRef="C_a6ecf43d-7b17-4dea-a8f9-87bcd2d46ebb" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of state net operating loss carryforwards, available to reduce future taxable income. Of the federal net operating loss carryforwards, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cba54910-3d2e-4216-acf3-7719c569d6ab" contextRef="C_da578283-3385-4d7f-84d8-e4e87678a27a" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million will carryforward indefinitely. The state net operating loss carryforwards will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58ccac04-7522-4072-ba37-603f582366f5" contextRef="C_d5e147f5-aa16-43c8-b905-14514eea7f77" name="sepn:OperatingLossCarryforwardsExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2041</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, if not utilized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credits carryforward of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b10d5649-390c-455d-9b67-5ff9e4b338d2" contextRef="C_5f26eed0-95b3-4a32-95cd-288d74605af3" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and state research and development tax credits carryforward of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37b80574-5b4e-4162-a6d9-3c8cd8a2e7c0" contextRef="C_39c2eb82-be3a-4f23-96b2-b18b9af896bd" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, available to reduce future income taxes. The federal research and development tax credits will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68449311-641e-4ef6-9f40-5b25e9e40083" contextRef="C_8d0f375e-d4b5-4c8c-83f1-7f68a5d08c43" name="sepn:TaxCreditCarryforwardExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2040</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized. The state research and development tax credits have no expiration date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Revenue Code section 382 (&#8220;IRC Section 382&#8221;) places a limitation (the &#8220;Section 382 Limitation&#8221;) on the amount of taxable income that can be offset by net operating loss (&#8220;NOL&#8221;) carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. When an ownership change occurs, IRC Section 382 limits the use of NOLs and credits in subsequent periods based on the annual 382 limitations. The annual 382 limitations may limit the full use of available tax attributes in one year but the identified ownership changes may not result in expiration of tax attributes for use prior to expiration of their respective carryforward periods. The Company performed a Section 382 analysis through the year ended December 31, 2024 and determined there were ownership changes in 2021 and 2023 that resulted in 382 limitations limiting the full use of carryover attributes in 2024. The ownership changes did not result in a reduction of its net operating loss or in its research and development credit carryforwards expiring unused. Accordingly, none of the tax attributes have been reduced but limited the full use in 2024. If additional ownership change occurs, the utilization of net operating loss and credit carryforwards could be significantly reduced.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cf7fab1d-22a3-47ae-b12f-c1640bf7874f" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_961d9eb0-bd3b-4fad-8291-83d518610591" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22cd24e9-5b88-41bf-b465-2d4a8ad66aad" contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,828</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions based on tax positions related to current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55ab8b2d-13e1-48d7-82af-79901f5d0297" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">998</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_307dbd2e-070e-43f5-8e76-dfce692cce5d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">728</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustment based on tax positions related to prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d45d2e0c-7a47-4e66-822c-f9fb584e15b2" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab93e12f-3a97-462a-ae27-704696402ac1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7279c585-c387-4e8c-a2e2-1161d24b653d" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,567</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08eb6644-dbba-4afc-b98d-285f962553bc" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The reversal of the uncertain tax benefits would not impact the Company&#8217;s effective tax rate as the Company continues to maintain a full valuation allowance against its deferred tax assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. During the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a01e548-c9f5-4600-b30f-2971da2a7eeb" contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_40ec9324-38d3-4987-bb41-6c7c1099e327" contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recognize accrued interest and penalties related to unrecognized tax benefits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company files income taxes in the U.S. federal jurisdiction, the state of California and various other U.S. states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All income tax returns will remain open for examination by the federal, state and foreign authorities for three or four years, from the date of utilization of any NOLs or credits.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_e609fca9-cc22-41d8-8edc-d9f8110f5d44" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_e609fca9-cc22-41d8-8edc-d9f8110f5d44_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Related Parties</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third Rock Ventures</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e03371f-55e6-4c1a-9589-8b753806898d" contextRef="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_956cae5c-d73d-4ea8-b24f-c485e622cd0e" contextRef="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d09bffcc-1f09-480e-aae1-efc55e3214ab" contextRef="C_855d4ac2-b358-4d6c-84c7-2390fea37329" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75f141e5-0eb7-4dd7-a16d-87a37f3865b3" contextRef="C_855d4ac2-b358-4d6c-84c7-2390fea37329" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e609fca9-cc22-41d8-8edc-d9f8110f5d44_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2021, the Company entered into a service agreement with Third Rock Ventures, LLC (&#8220;TRV&#8221;), a holder of more than 5% of the Company&#8217;s outstanding capital stock, (the &#8220;TRV service agreement&#8221;) under which TRV provides consulting services to the Company. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b5fd424-0ad7-4c10-ba9b-e037614b10b7" contextRef="C_570c8595-7c25-477a-88df-9154a31cf161" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e32d8109-4bc7-4be4-a90b-ff2b7a862011" contextRef="C_c39d72cd-1218-4091-b5a2-620203948c8c" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, for such services as general and administrative expenses in the Company&#8217;s statements of operations and comprehensive (loss) income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e292c94a-77d6-4581-9b8d-b238ffb75437" contextRef="C_b818b396-8516-4e7d-b65d-8f906bbc24a9" name="sepn:AccruedExpenseAndOtherCurrentLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of expense related to TRV was recorded in accrued expenses and other current liabilities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f813e13d-2d8f-4333-95be-ff72019ee70f" contextRef="C_273f0762-59ef-4b7e-8052-83d122342ed9" name="sepn:AccruedExpenseAndOtherCurrentLiabilities" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> expenses related to TRV in accrued expenses and other current liabilities on the Company&#8217;s balance sheets. at December 31, 2023. As of December 31,  2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, outstanding accounts payable to TRV was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dcd2c7d-46bc-4fa1-89e6-bd2be028a7a6" contextRef="C_273f0762-59ef-4b7e-8052-83d122342ed9" name="us-gaap:AccountsPayableCurrentAndNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_236676c9-091d-4777-9225-3094edd69d8a" contextRef="C_b818b396-8516-4e7d-b65d-8f906bbc24a9" name="us-gaap:AccountsPayableCurrentAndNoncurrent" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding accounts payable to TRV at December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's former interim Chief Medical Officer, and also a member of the Company's board of directors, was designated to the Company's board of directors by TRV and is affiliated with TRV. He did not receive any cash compensation from the Company for his service as its interim Chief Medical Officer, as his services were provided to the Company through the TRV service agreement. The board member ceased serving as interim Chief Medical Officer in September 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2024, the Company entered into a separate consulting agreement with the board member, under which he may provide up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e437cd2b-abe1-4fcb-85ad-d241b0a73992" contextRef="C_40118209-d74e-499d-a2c3-dad899119cee" name="us-gaap:ProfessionalFees" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">9,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of consulting services per month, which are also provided to the Company through the TRV service agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the total fees the Company incurred under the TRV service agreement for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fcff006-faa6-4c0b-8186-a7b91c82a5c1" contextRef="C_2d8e9c9f-db9a-4ef1-8b3c-d563c2fca200" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bff23dcd-db38-43f9-a383-709aaa856855" contextRef="C_a74bff72-f9bc-4001-b025-78bfed5e56c9" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, were attributed to consulting services provided by the board member. Additionally, as compensation for his services as the Company's interim Chief Medical Officer, the Company granted him options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34d770f9-4612-4a86-aa67-91861af05ae4" contextRef="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">23,227</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9dec50e-a4fc-4b23-98da-170ee2d5b308" contextRef="C_bea6a04f-86e9-4c8b-acac-b19b1baa9ae1" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">26,712</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares during the year ended December 31, 2024 and 2023, at exercise prices of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_081b4d15-e01a-4929-9e9e-2ca52dc590ef" contextRef="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.76</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">RA Capital</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82a7ad8e-97a2-43d2-a0b6-096fdd263c1e" contextRef="C_4189834c-9f3e-45b5-8e93-de02f8ede50d" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P. (collectively, &#8220;RA Capital&#8221;), which held more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for total cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0449e278-2122-4f7e-8e8a-44947cfe2136" contextRef="C_4189834c-9f3e-45b5-8e93-de02f8ede50d" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7a54033-80f5-4e96-96bd-eb82d29e4aba" contextRef="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P., which collectively hold more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6aa91e64-0056-4c76-ac78-323e07fd7b9e" contextRef="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Samsara BioCapital</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b36dd49-0f10-4f8f-b248-fb81ebf2fb5f" contextRef="C_3b38a128-728f-4bd5-af3c-a2799bc33330" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P. (&#8220;Samsara BioCapital&#8221;), a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_473d8228-381a-44f6-8374-deafa5f065f2" contextRef="C_3b38a128-728f-4bd5-af3c-a2799bc33330" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10792e08-ad7f-483a-bd9a-b823e5f4a23f" contextRef="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_695f09c1-5511-471b-aabd-6f1009555469" contextRef="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f4fcf633-7c14-4d32-91cd-7436cff33a0a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Net (Loss) Income Per Share</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f2c4153d-1dbe-4140-bce6-82839bdf40ca" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.813%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.88%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9fe7e3e-dbff-4e3f-a55c-3486483d9767" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc291e93-86c5-42f2-a23d-8f5805027532" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dbd1230-2869-42dd-bf03-b4539a2579dc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0b3fc13-7ff4-4d64-af07-6c555f65bda4" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,613</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e4cfa3a-c822-42e0-ad57-b8d8a5049501" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8681d7f7-bb40-4d5d-b6d7-abecdce7a977" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">567</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13415b32-fc42-4bfb-89b1-8cec7d7c8ef5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,891,126</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e4640a9-2469-4067-b4d3-c2c2cec6db97" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,928,586</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e431f7d6-63b4-47b5-9023-848bfdfd9a04" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_256dc391-7b5f-464e-9937-f94dcab6ff9e" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e00281a-bded-4755-8105-a846d5ee0e52" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_690544dc-4cea-4e81-a8e0-794eff685fde" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,551</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af40d9b6-42db-4770-96aa-73c6c225faa5" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3f7c999-b2ff-44f9-9b0c-30d2e1882a18" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_984bb4ae-6031-4788-94fc-fa3e04086cde" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,891,126</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_450e539a-e93c-4552-89a7-15075436d1e8" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,928,586</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7793cb3f-3db6-41b4-b98a-10418ddd009e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:CommonStockOptions" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13226636-6018-4f5b-8e37-5569f5c8b739" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:CommonStockOptions" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,737</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcca64b5-54b3-475b-ae8d-c9bf7cd5261e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:UnvestedRestrictedStock" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6433fc2f-e490-4df0-9be1-ec702cac2e26" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:UnvestedRestrictedStock" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">233,801</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7389d4b-d154-4fda-bc24-eda74e39ea57" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,891,126</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_343e863b-d37d-4bc5-ad1f-67641db421b9" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,177,124</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_660fb9d1-2ea3-4dbc-a6a5-efb057166042" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.26</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5dfe2a6a-dcae-4f9b-b9bd-52a1d5449c52" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.29</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9d606b9-d345-4abe-992f-b563b686d7bc" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.26</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8321118f-fb1e-432f-852b-7d51d3b1f0b6" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.29</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85db8757-6268-4471-90f2-d38adfa0681e" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.04%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8701dd6a-c07d-40d9-818f-926e7e6c4597" contextRef="C_64df0564-4699-4346-a9c4-4d4616c5b486" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,938,982</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_287bedc6-0381-4b0b-b5c3-fdea7118917c" contextRef="C_922c53ab-31f7-4a05-a8b6-af09fe6e78db" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">198,084</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock awards subject to repurchase</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40cdfa90-7974-4229-85f6-b7c191b3ccf0" contextRef="C_8c5cb769-ec5e-4f34-abf9-683e73b6808f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">576,829</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afaa1f29-1600-43e5-8d3c-0ee233b3e893" contextRef="C_659a2626-2f0b-4d2e-abe1-7f6b4d5d0915" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">340,649</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total antidilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d97db2a-9804-42aa-9ec5-b0f45a6810f9" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,515,811</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f282f046-fba1-4b7c-aac2-ce91fae1b068" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">538,733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_91697a72-fe54-4ea0-8b5c-22611f66e248" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15. Employee Retirement Benefit Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains a 401(k) retirement savings plan (the &#8220;401(k) Plan&#8221;) for its employees. The 401(k) Plan allows eligible employees to make contributions up to the maximum allowable by the Internal Revenue Service (&#8220;IRS&#8221;). For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company made matching contributions of and recorded contribution expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b9622ca-6932-4251-94b6-54d583fff8c4" contextRef="C_04364af7-15e7-4170-a9bd-075237a2baca" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6a3bc66-96cb-491f-9fa4-e3d8353dfa6f" contextRef="C_9b829192-5a7d-4ce3-9261-f21a9ef581b0" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_5806bb06-b936-4144-b458-dc35dcf6e8ff" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="F_5806bb06-b936-4144-b458-dc35dcf6e8ff_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM assesses performance for the Company&#8217;s operating segment and decides how to allocate resources based on the Company&#8217;s available cash resources. Total operating expenses and net (loss) income of the Company&#8217;s operating segment are used to monitor budget versus actual results. The measure of segment assets is reported as total assets on the Company&#8217;s balance sheet.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5806bb06-b936-4144-b458-dc35dcf6e8ff_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_164ffcb7-73b0-4ce8-a07f-59506e2f5808" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM is regularly provided with the following significant segment expenses:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_912069d7-ea94-4a0f-a445-858cfa4195a9" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,075</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87eb56c5-ae76-4b5c-bee8-dd33aad5b38d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee-related expenses, excluding stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_011bf971-2936-42f8-a0a5-9f016a61236c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,233</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c7d882f-4f61-4c6f-b0db-0a391d4aa969" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,726</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a68ddce7-189b-4e53-94d4-e3a960034b61" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,152</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e098617b-a1f7-4bd5-8c75-0e44d3e05b91" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External research and development expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41243c4f-7bf4-4aa5-8936-ce966d04f013" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ExternalResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,786</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ffe30e9-498e-4caf-8a1f-648e4a9cf18a" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ExternalResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,106</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External general and administrative expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_800b9d1f-d0d7-47d9-adf1-474e1797f0ff" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="sepn:ExternalGeneralAndAdministrativeExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,511</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d338378-7f9f-482f-a70c-70c0f195f527" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="sepn:ExternalGeneralAndAdministrativeExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,415</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1844dff2-a32d-48a9-83e1-a58902d88ffd" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6445d974-b9f1-4463-92b9-e4f61b6e0113" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,625</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses*</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5855e50-ef84-4f12-870e-97ddf999f39a" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,216</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2bb8a30-7b58-4c1a-8801-ee9315b4dedb" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,834</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses (income)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3662d7f9-cebe-4465-a734-23ce20872652" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,898</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8872e2b4-777f-4136-8a28-936bdbf34c69" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,924</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d501b38-2088-465e-8d46-f32b77d2e892" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">80,823</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa6f0bef-3641-45fb-8e51-d62c405b12b1" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,075</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a39d8237-0d36-4fd5-817f-1f42c299040c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,527</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b51a4686-78f4-4d47-b5cf-876ef074f362" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,796</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed5281a1-f98b-4a8f-abe9-83939bf32a9c" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">72,296</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3193958-91e4-4b8c-b968-254187da17a0" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,871</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1451f5ea-223a-47ac-91c1-1feb0fc08213" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">498</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96aaed9e-3648-4aaf-8c88-27525727435d" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbbaa5fe-0720-41dc-88e4-c856fd80a7db" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de7489c5-26a4-4e1d-8797-a9f4c639b29f" contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(*) Other segment expenses include facility related and office costs, information technology costs, general laboratory costs, and other operating expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s property and equipment was maintained in the U.S. For the year ended December 31, 2024 and 2023, the Company&#8217;s revenue was generated from providing research services and was earned in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4b1ce0a-90cc-4259-a0c2-9af624a4819b" contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17. Subsequent Events</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company appointed Gil M. Labrucherie, CFA, J.D. as the Chief Financial Officer (&#8220;CFO&#8221;), principal financial officer and principal accounting officer of the Company, effective January 6, 2025. On February 7, 2025, the Compensation Committee of the Board granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f56d9c23-a79a-4985-a6ca-cd8daff274ab" contextRef="C_9763b408-328c-4770-af66-e36b06544fe2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of stock options to the CFO.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, the Company announced its decision to discontinue the clinical study of SEP-786. There was no impact to the assets and liabilities reported on the Company's balance sheets as a result of the discontinuation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>sepn-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Septerna, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) has adopted the following policy and procedures for securities trading by Company directors and employees (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Our Insider Trading Policy is intended to prevent the misuse of material nonpublic information, insider trading in securities, and the severe consequences associated with violations of insider trading laws.  It is your obligation to review, understand and comply with this Insider Trading Policy and applicable laws.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) has approved this Insider Trading Policy, and we have appointed Gil M. Labrucherie, our Chief Financial Officer as the Compliance Officer (with his designees, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to administer the Insider Trading Policy and to be available to answer your questions.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I.  OVERVIEW</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A.	Who Must Comply?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy applies to all of our employees, members of the Board and designated consultants, as well as any other individuals whom the Compliance Officer may designate as Insiders (as defined below) because they have access to material nonpublic information about the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, all of our directors, executive officers (as defined by Section 16 of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)) and any other employees designated by the Compliance Officer because they have access to material nonpublic information about the Company must comply with the Trading Procedures included in Part II of this Insider Trading Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;); we will refer to these individuals in this policy as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insiders</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; The Trading Procedures provide rules for when Insiders can trade in our securities and explain the process for mandatory pre-clearance of proposed trades. You will be notified if you are considered to be an Insider who is required to comply with the Trading Procedures.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy and, for Insiders, the Trading Procedures also apply to the following persons (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliated Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;):</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">your &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Members</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; (&#x201c;Family Members&#x201d; are (a) your spouse or domestic partner, children, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws who reside in the same household as you, (b) your children or your spouse&#x2019;s children who do not reside in the same household as you but are financially dependent on you, (c) any of your other family members who do not reside in your household but whose transactions are directed by you, and (d) any other individual over whose account you have control and to whose financial support you materially contribute. (Materially contributing to financial support would include, for example, paying an individual&#x2019;s rent but not just a phone bill.));</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all trusts, family partnerships and other types of entities formed for your benefit or for the benefit of a member of your family and over which you have the ability to influence or direct investment decisions concerning securities; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all persons who execute trades on your behalf; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all investment funds, trusts, retirement plans, partnerships, corporations and other types of entities over which you have the ability to influence or direct investment decisions concerning securities; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the Trading Procedures do not apply to any such entity that engages in the investment of securities in the ordinary course of its business (e.g., an investment fund or partnership) if the entity has established its own insider trading controls and procedures in compliance with applicable securities laws and it (or an affiliated entity) has represented to the Company that its affiliated entities:  (a) engage in the investment of securities in the ordinary course of their respective businesses; (b) have established insider trading controls and procedures in compliance with securities laws; and (c) are aware the securities laws prohibit any person or entity who has material nonpublic information concerning the Company from purchasing or selling securities of the Company or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell securities.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are responsible for ensuring compliance with this Insider Trading Policy, including the Trading Procedures contained herein, by all of your Affiliated Persons.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">B.	What is Prohibited by this Insider Trading Policy?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You and your Affiliated Persons are prohibited from engaging in insider trading and from otherwise trading in securities in violation of this Insider Trading Policy. &#x201c;Insider trading&#x201d; is (1) trading (buying or selling) the securities of a company whether for your account or for the account of another, while in the possession of material nonpublic information (see definition below) about that company or (2) disclosing material nonpublic information about a company to others who may trade on the basis of that information. Insider trading can result in criminal prosecution, jail time, significant fines and public embarrassment for you and the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Trading in Company Securities</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When you are in possession of material nonpublic information about the Company, whether positive or negative, you are prohibited from trading (whether for your account of for the account of another) in the Company&#x2019;s securities, which include common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants and exchange-traded options), and any derivative securities that provide the economic equivalent of ownership of any the Company&#x2019;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#x2019;s securities, except for trades made pursuant to plans approved by the Compliance Officer in accordance with this policy that are intended to comply with Rule 10b5-1 under the Exchange Act.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions in this Insider Trading Policy do </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> apply to: (1) an exercise of an employee stock option when payment of the exercise price is made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions in this Insider Trading Policy </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">do</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> apply, however, to the use of outstanding Company securities to pay part or all of the exercise price of a stock option, any sale of stock as part of a broker-assisted cashless exercise of an option and any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Tipping</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Providing material nonpublic information about the Company to another person who may trade or advise others to trade on the basis of that information is known as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tipping</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and is illegal.  You are prohibited from providing material nonpublic information about the Company to a friend, relative or anyone else who might buy or sell a security or other financial instrument on the basis of that information, whether or not you intend to or actually do realize a profit (or any other benefit) from such tipping.  Additionally, you are prohibited from recommending to any person that such person engage in or refrain from engaging in any transaction involving the Company&#x2019;s securities, or otherwise give trading advice concerning the Company&#x2019;s securities, if you are in possession of material nonpublic information about the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Trading in Securities of Other Companies</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whenever, during the course of your service to or employment by the Company, you become aware of material nonpublic information about another company (1) with which the Company has an existing business relationship, including but not limited to, the Company&#x2019;s distributors, vendors, customers or suppliers or collaboration, marketing, research, development or licensing partners, or (2) with which the Company is in active discussions concerning a potential transaction or business relationship, neither you nor your Affiliated Persons may trade in any securities of that company, give trading advice about that company, tip or disclose that information, pass it on to others or engage in any other action to take advantage of that information.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If your work regularly involves handling or discussing confidential information of companies in either of the foregoing categories, you should consult with the Compliance Officer before trading in any of those company&#x2019;s securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, if you believe you may be in possession of nonpublic information about the Company that could potentially have a material effect on the stock price of a company with which the Company does not have an existing business relationship or with which the Company is not discussing a potential transaction or business relationship, you should exercise caution when trading in the securities of that company because the U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) has successfully brought an insider trading claim against an insider in those circumstances.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Prohibited Transactions</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Short Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may not at any time sell any securities of the Company that are not owned by you at the time of the sale (a &#x201c;short sale&#x201d;).  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Purchases or Sales of Derivative Securities or Hedging Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent of ownership of any of the Company&#x2019;s securities or an opportunity, direct or indirect, to profit from any change in the value of our securities or engage in any other hedging transaction with respect to our securities.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Company Securities Subject to Margin Calls</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not use the Company&#x2019;s securities as collateral in a margin account.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Pledges</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. You may not pledge Company securities as collateral for a loan (or modify an existing pledge).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Duration of Trading Prohibitions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These trading prohibitions continue whenever and for as long as you know or are in possession of material nonpublic information.  Remember, anyone scrutinizing your transactions will be doing so after the fact, with the benefit of hindsight.  As a practical matter, before engaging in any transaction, you should carefully consider even the appearance of improper insider trading and how enforcement authorities and others might view the transaction in hindsight.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy applies to you and your Affiliated Persons so long as you are associated with the Company. If you leave the Company for any reason, this Insider Trading Policy, including, if applicable, the Trading Procedures described in Part III, will continue to apply to you and your Affiliated Persons until the later of: (1) the first trading day following the public release of earnings for the fiscal quarter in which you leave the Company or (2) the first trading day after any material nonpublic information known to you has become public or is no longer material.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">C.	What is Material Nonpublic Information?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy prohibits you from trading in a company&#x2019;s securities if you are in possession of information about the company that is both &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">material</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">nonpublic</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d;  If you have a question whether certain information you are aware of is material or has been made public, you should consult with the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about our Company or any other company is &#x201c;material&#x201d; if it could reasonably be expected to affect the investment decisions of a stockholder or potential investor or if disclosure of the information could reasonably be expected to significantly alter the total mix of information in the marketplace about us or any other company.  We speak mostly in this Insider Trading Policy about determining whether information about us is material and nonpublic, but the same analysis applies to</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information about other companies covered by this policy that would preclude you from trading in their securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In simple terms, material information is any type of information that could reasonably be expected to affect the market price of our securities.  Both positive and negative information may be material.  While it is not possible to identify all information that would be deemed &#x201c;material,&#x201d; the following items are examples of the types of information that could be material:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant new scientific discoveries or other events, late-stage preclinical development achievements or failures from any lead or other important preclinical programs, clinical program developments, filing of an Investigational New Drug Application or other significant regulatory events or interactions, relevant regulatory changes, data that have been recently generated from ongoing or recently completed clinical trials;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">plans to pursue, entry into, or termination of a major licensing, partnership, collaboration, manufacturing or supply agreement, or changes in relationships, including significant disputes, with major licensors, licensees, partners, collaborators, manufacturers, or suppliers;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">projections of future earnings or losses, or other earnings guidance;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quarterly financial results that are known but have not been publicly disclosed;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential restatements of the Company&#x2019;s financial statements, changes in auditors or auditor notification that the Company may no longer rely on an auditor&#x2019;s audit report;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pending or proposed corporate mergers, acquisitions, tender offers, joint ventures or dispositions of significant assets;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in senior management, significant employees, or member of the Board;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant actual or threatened litigation or governmental investigations or major developments in such matters;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity risks and incidents, including the discovery of significant vulnerabilities or breaches;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant developments regarding products, customers, suppliers, orders, contracts or financing sources (e.g., the acquisition or loss of a contract);</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in dividend policy, declarations of stock splits or proposed securities offerings or other financings; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential defaults under our credit agreements or indentures or potential material liquidity issues; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bankruptcies or receiverships.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The above items will not always be material. For example, some new products or contracts may clearly be material while others may not be. No &#x201c;bright-line&#x201d; standard or list of items can adequately address the range of situations that may arise; information and events should be carefully considered in terms of their materiality to the Company.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Nonpublic&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material information is &#x201c;nonpublic&#x201d; if it has not been disseminated in a manner making it available to investors generally.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To demonstrate that information is public, one must be able to point to some fact that establishes that the information has become publicly available, such as the filing of a report with the SEC, the distribution of a press release, publishing the information on our website or posting on social media if those are regular ways we communicate with investors, or by other means that are reasonably designed to provide broad public access.  Before a person with material nonpublic information can trade, the market must have adequate time to absorb the information that has been disclosed.  For the purposes of this Insider Trading Policy, information will be considered public after the completion of one full day of trading following our public release of the information.  For that purpose, a full day of trading means an entire calendar day in which a session of regular trading hours on the Nasdaq Stock Market (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) between 9:30 a.m. and 4:00 p.m. Eastern Time (or such earlier close time as has been set by exchange rules) has occurred.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, if the Company publicly discloses material nonpublic information of which you are aware before trading begins on a Tuesday, the first time you can buy or sell Company securities is the opening of the market on the following Wednesday.  However, if the Company publicly discloses material information after trading begins on a Tuesday, the first time that you can buy or sell Company securities is the opening of the market on the following Thursday.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">D.	What are the Penalties for Insider Trading and Noncompliance with this Insider Trading Policy?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Both the SEC and the national securities exchanges, through the Financial Industry Regulatory Authority (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), investigate and are very effective at detecting insider trading.  The U.S. government pursues insider trading violations vigorously, successfully prosecuting, for example, trading by employees in foreign accounts, trading by family members and friends of insiders and trading involving only a small number of shares.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The penalties for violating rules against insider trading can be severe and include:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">forfeiting any profit gained or loss avoided by the trading;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of the loss suffered by the persons who, contemporaneously with the purchase or sale of securities that are subject of a violation, have purchased or sold securities of the same class;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of criminal penalties of up to $5,000,000; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of civil penalties of up to three times the profit made or loss avoided; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imprisonment for up to 20 years.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and/or the supervisors of the person engaged in insider trading may also be required to pay civil penalties or fines of $2.5 million or more, up to three times the profit made or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss avoided, as well as criminal penalties of up to $25,000,000, and could under some circumstances be subject to private lawsuits.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Violation of this Insider Trading Policy or any federal or state insider trading laws may subject you to disciplinary action by the Company, including termination of your employment or other relationship with the Company.  The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Insider Trading Policy has been violated.  The Company may determine that specific conduct violates this Insider Trading Policy whether or not it also violates the law.  It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against an alleged violator before taking disciplinary action.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">E.	How Do You Report a Violation of this Insider Trading Policy?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you have a question about this Insider Trading Policy, including whether certain information you are aware of is material or has been made public, you should consult with the Compliance Officer.  In addition, if you violate this Insider Trading Policy or any federal or state laws governing insider trading or know of any such violation by any director or employee of the Company, you should report the violation immediately to the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II.  TRADING PROCEDURES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A.	Special Trading Restrictions Applicable to Insiders</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to needing to comply with the restrictions on trading in our securities set forth above, Insiders and their Affiliated Persons are subject to the following special trading restrictions:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	Special Closed Trading Periods</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compliance Officer may designate, from time to time, a &#x201c;Special Closed Window&#x201d; during what would otherwise be a permitted trading window. During a Special Closed Window, designated Insiders (which could be all Insiders or a subset of them) may not trade in the Company&#x2019;s securities. The Compliance Officer may also impose a Special Closed Window on Insiders or a subset of them to prohibit trading in the securities of other companies to ensure compliance with this policy. The imposition of a Special Closed Window will not be announced to the Company generally, should not be communicated to any other person, and may itself be considered under this Insider Trading Policy to be material nonpublic information about the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	Gifts and Other Distributions in Kind</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may donate or make any other transfer of Company securities without consideration when the Insider is not permitted to trade. In addition to charitable donations or gifts to family members, friends, trusts or others, this prohibition applies to distributions to limited partners by limited partnerships that are subject to this Insider Trading Policy. Making a gift shall be considered trading in securities for purposes of the Pre-Clearance Procedures and Post-Trade Reporting Procedures in Section II.B. below.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">B. 	Pre-Clearance Procedures</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may trade in our securities, even during an open trading window, unless the trade has been approved by the Compliance Officer in accordance with the procedures described below.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gifts</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of Company securities are considered a trade in securities for purposes of this Part II.B.  In reviewing trading requests, the Compliance Officer, acting together or individually, may consult with our other officers and/or outside legal counsel, and must seek approval of their own respective trades from the Chief Executive Officer.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Procedures.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may trade in our securities unless:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Insider has notified the Compliance Officer of the amount and nature of the proposed trade(s) using the Stock Transaction Request form attached to this Insider Trading Policy.  To provide adequate time for the preparation of any required reports under Section 16 of the Exchange Act, a Stock Transaction Request form should, if practicable, be received by the Compliance Officer at least two (2) business days before the intended trade date;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Insider has certified to the Compliance Officer in writing before the proposed trade(s) that the Insider does not possess material nonpublic information concerning the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Insider is an executive officer or director, the Insider has informed the Compliance Officer, using the Stock Transaction Request form, whether, to the Insider&#x2019;s best knowledge, (a) the Insider has (or is deemed to have) engaged in any opposite way transactions within the previous six months that were not exempt from Section 16(b) of the Exchange Act and (b) if the transaction involves a sale by an &#x201c;affiliate&#x201d; of the Company or of &#x201c;restricted securities&#x201d; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)), whether the transaction meets all of the applicable conditions of Rule 144; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compliance Officer has approved the trade(s) and has certified their approval in writing (which may be by email). </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compliance Officer does not assume responsibility for, and approval by the Compliance Officer does not protect the Insider from, the consequences of prohibited insider trading.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional Information.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insiders shall provide to the Compliance Officer any documentation that the Compliance Officer reasonably requires in furtherance of the foregoing procedures.  Any failure to provide such information will be grounds for the Compliance Officer to deny approval of the trade request.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notification of Brokers of Insider Status</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Insiders who are required to file reports under Section 16 of the Exchange Act shall inform their broker-dealers that (a) the Insider is subject to Section 16; (b) the broker shall confirm that any trade by the Insider or any of their affiliates has been precleared by the Company; and (c) the broker is expected to provide transaction information to the Insider and/or the Compliance Officer on the day of a trade.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Obligation to Approve Trades.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing approval procedures do not in any way obligate the Compliance Officer to approve any trade.  The Compliance Officer has sole discretion to reject any trading request, and the rejection of a trading request by the Compliance Officer acting individually shall be conclusive.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, an event may occur that is material to the Company and is known by only by a limited number of directors and employees.  The Compliance Officer may decline an Insider&#x2019;s request to preclear a proposed trade based on the existence of a material nonpublic development &#x2013; even if the Insider is not aware of that material nonpublic development.  If any Insider engages in a trade before a material nonpublic development is disclosed to the public or resolved, the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute even if the Insider was unaware of the development.  So long as the event remains material and nonpublic, the Compliance Officer may decide not to approve any transactions in the Company&#x2019;s securities.  The Compliance Officer will subsequently notify the Insider once the material nonpublic development is disclosed to the public or resolved.  If an Insider requests preclearance of a trade during the pendency of such an event, the Compliance Officer may reject the trading request without disclosing the reason.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Completion of Trades.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After receiving written clearance to engage in a trade signed by the Compliance Officer, an Insider must complete the proposed trade within two (2) business days or make a new trading request.  Even if an Insider has received clearance, the Insider may not engage in a trade if (i) such clearance has been rescinded by the Compliance Officer, (ii) the Insider has otherwise received notice that the trading window has closed or (iii) the Insider has or acquires material nonpublic information.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Post-Trade Reporting.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The details of any transactions in our securities (including transactions effected pursuant to a Rule 10b5-1 Plan) by an Insider (or an Affiliated Person) who is required to file reports under Section 16 of the Exchange Act must be reported to the Compliance Officer by the Insider or their brokerage firm on the same day on which a trade order is placed or such a transaction otherwise is entered into.  The report shall include the date of the transaction, quantity of shares, the price, the name of the broker-dealer that effected the transaction and whether the trade was made pursuant to a valid Rule 10b5-1 Plan (as defined below).  This reporting requirement may be satisfied by providing (or having the Insider&#x2019;s broker provide) a trade order confirmation to the Compliance Officer if the Compliance Officer receives such information by the required date.  Compliance by directors and executive officers with this provision is imperative given the requirement of Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Exchange Act that these persons generally report changes in ownership of Company securities within two (2) business days.  The sanctions for noncompliance with this reporting deadline include mandatory disclosure in the Company&#x2019;s proxy statement for the next annual meeting of stockholders, as well as possible civil or criminal sanctions for chronic or egregious violators.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">C.	Exemptions</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Approved Rule 10b5-1 Plan.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions made pursuant to an approved Rule 10b5-1 Plan (as defined below) will not be subject to our trading windows or pre-clearance procedures and Insiders are not required to complete a Stock Transaction Request form for such transactions.  Rule 10b5-1 of the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading plans, arrangements or instructions that meet specified requirements.  A trading plan, arrangement or instruction that meets the requirements of the SEC&#x2019;s Rule 10b5-1 (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) enables Insiders to trade in Company securities outside of our trading windows, even when in possession of material nonpublic information.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has adopted a separate Rule 10b5-1 Trading Plan Policy that sets forth the requirements for putting in place a Rule 10b5-1 Plan with respect to Company securities.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employee Equity.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Stock Options</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the exercise for cash of an option to purchase securities of the Company.  However, the exercise is subject to the current reporting requirements of Section 16 of the Exchange Act and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction.  In addition, the securities acquired upon the exercise of an option to purchase Company securities are subject to all of the requirements of this Insider Trading Policy, including the Trading Procedures.  Moreover, the Trading Procedures apply to the use of outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock appreciation right, share withholding and any sale of stock as part of a broker-assisted cashless exercise of an option or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Withholding on Restricted Stock/Units</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy tax withholding requirements if (a) withholding is required by the applicable plan or award agreement or (b) the election to exercise the tax withholding right was made by the Insider in compliance with the Trading Procedures.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading prohibitions and restrictions set forth in the Trading Procedures do not apply to periodic wage withholding contributions by the Company or its employees that are used to purchase Company stock pursuant to the employees&#x2019; advance instructions under the Company&#x2019;s 2024 Employee Stock Purchase Plan.  However, an Insider may not: (a) elect to participate in the plan or alter their instructions regarding the level of withholding or purchase by the Insider of Company securities under the plan; or (b) make cash contributions to the plan (other</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than through periodic wage withholding) without complying with the Trading Procedures.  Any sale of securities acquired under the plan is subject to the prohibitions and restrictions of the Trading Procedures.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">D.	Waivers</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A waiver of any provision of this Insider Trading Policy or the Trading Procedures may be authorized in writing by the Compliance Officer or the Audit Committee of the Board. All waivers shall be reported to the Board.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III.  	AMENDMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	This Insider Trading Policy may be amended from time to time with the approval of the Board or a designated committee thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV.	ACKNOWLEDGEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will deliver a copy of this Insider Trading Policy to all current employees and directors and designated consultants, and to future employees and directors and designated consultants, at the start of their employment or relationship with the Company.  Each of these individuals must acknowledge that they have received a copy and agree to comply with the terms of this Insider Trading Policy, and, if applicable, the Trading Procedures contained herein.  The attached acknowledgment must be completed and submitted to the Company within ten days of receipt.  From time to time, directors and employees and designated consultants may be required to re-acknowledge and agree to comply with the Insider Trading Policy (including any amendments or modifications thereto).  For that purpose, an individual will be deemed to have acknowledged and agreed to comply with the Insider Trading Policy, as amended from time to time, when copies of the attached acknowledgment have been delivered by regular or electronic mail (or other delivery option used by the Company) to the Compliance Officer.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Questions regarding this Insider Trading Policy are encouraged and may be directed to the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*****</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adopted: October 1, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective: October 24, 2024</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STOCK TRANSACTION REQUEST</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x2019;s Insider Trading Policy, I hereby notify </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEPTERNA, INC.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of my intent to trade the securities of the Company as indicated below:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><img src="img222063773_0.jpg" alt="img222063773_0.jpg" style="width:623px;height:701px;"></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><img src="img222063773_1.jpg" alt="img222063773_1.jpg" style="width:639px;height:281px;"></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">*NOTE: Multiple lots must be listed on separate forms or broken out.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACKNOWLEDGEMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby acknowledge that I have read, that I understand, and that I agree to comply with the Insider Trading Policy of Septerna, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  I further acknowledge and agree that I am responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures by all of my &#x201c;Affiliated Persons.&#x201d; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I also understand and agree that I will be subject to sanctions, including termination of employment, that may be imposed by the Company, in its sole discretion, for violation of the Insider Trading Policy, and that the Company may give stop-transfer and other instructions to the Company&#x2019;s transfer agent or any brokerage firm managing the Company&#x2019;s equity incentive plan(s) against the transfer of any Company securities that the Company considers to be in contravention of the Insider Trading Policy.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	This acknowledgement constitutes consent for the Company to impose sanctions for violation of the Insider Trading Policy, including the Trading Procedures, and to issue any stop-transfer orders to the Company&#x2019;s transfer agent that the Company, in its sole discretion, deems appropriate to ensure compliance.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.102%;box-sizing:content-box;"></td>
    <td style="width:23.725%;box-sizing:content-box;"></td>
    <td style="width:17.784%;box-sizing:content-box;"></td>
    <td style="width:13.203%;box-sizing:content-box;"></td>
    <td style="width:37.187%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Send signed Acknowledgement to:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gil M. Labrucherie</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c/o Septerna, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">250 East Grand Avenue</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">South San Francisco, California 94080</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>sepn-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-282837) pertaining to the 2021 Stock Option and Grant Plan, 2024 Stock Option and Incentive Plan and 2024 Employee Stock Purchase Plan of Septerna, Inc. of our report dated March 27, 2025, with respect to the financial statements of Septerna, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Mateo, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sepn-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Jeffrey Finer, certify that:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Septerna, Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.3%;box-sizing:content-box;"></td>
    <td style="width:1.02%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:64.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Finer, M.D., Ph.D.</font></p></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:middle;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Finer, M.D., Ph.D.</font></p></td>
   </tr>
   <tr style="height:19.45pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sepn-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:7.467%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Gil M. Labrucherie, certify that:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Septerna, Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.294837131453586%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div></div>
  <p style="margin-left:11.707%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.3%;box-sizing:content-box;"></td>
    <td style="width:1.02%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:64.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gil M. Labrucherie, CFA, J.D.</font></p></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gil M. Labrucherie, CFA, J.D.</font></p></td>
   </tr>
   <tr style="height:19.45pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sepn-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Annual Report of Septerna, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), the undersigned officers of the Company hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-5.678%;padding-left:5.373%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.3%;box-sizing:content-box;"></td>
    <td style="width:1.02%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:64.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Finer, M.D., Ph.D.</font></p></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:middle;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Finer, M.D., Ph.D.</font></p></td>
   </tr>
   <tr style="height:19.45pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.3%;box-sizing:content-box;"></td>
    <td style="width:1.02%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:64.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gil M. Labrucherie, CFA, J.D.</font></p></td>
   </tr>
   <tr style="height:10.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:middle;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="text-indent:7.32%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gil M. Labrucherie, CFA, J.D.</font></p></td>
   </tr>
   <tr style="height:19.45pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img117602972_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_0.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $6 8\# 2(  A$! Q$!_\0
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M^6_PH\Q?4_\ ?+?X477=?U_PZ^\!]%,\Q?4_]\M_A1YB^I_[Y;_"BZ[K^O\
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M=:G=SQZ]_93:3';PZK$=5+RWBW$U]^C'[3?[4'[-6I:OX;\07?[6/BSX0R_
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M&98VG26(GB_J].&'IQGB,1RTXQE4J3]AA\3RM:3E^Z2339QX_%1P>$Q&(?\
MRYI2DO=;]^5HT]=DE-K5Z*]VTD?C'\;O^"C?[5/C/4O$K7_C?PQ8V7Q$N-2O
MO$OA#2OAC\.+7PHT.I-Y5TZQ3>%;G6CK$\1^RP>+'UE_%]K'")[77+6[@MI;
M?-\/ZO\ &/XB^(_ 7BWPSI%B/@YKWAZUE\1:#"^B_:$NK#[=I_B&&2:_V:U/
MK$.K62S>'[ZWO8X5AA@DN)(V%WN_)O6]7ET'7(K#3]1MM6:26.T^W*;R"V"M
M-Y;"ZMV@8)= 2;Q;QW#/)+L17Y.W]$?A1^UG\5/AIX1TG0/ &J>%+;2O#T5S
M$EK)X3TVZNI8[VPNK+4;;49;YKF^N;6_CO;RXN+::<6\MW(9HU!P1_<^+X2R
MW+L/A_\ 5;(\OHU8TY4L3*.'A@(27*E152?)[26(A*SIUKSE!KGG-RY>;\OI
MYI7JRJ+,\96=-RC*FG)U+/13<8_!&+CJXVBFFHI65C]#/!7Q1\5?#1M3.E0:
MK:WENUG+J7A_4$_L_3_'FE6FIVC1PWMK$\E@NO6-S]G%MK=J3J&AZG]FU"RN
M(;>[NK.3^G[XP_#'X"_&7X6:!^U7X4^'?PZN/'3>$M!\<:)\3=6\&Z#+XOL?
M".LZ2MOJ<]WK:V5SJD%_X;\/:I?:K;A+N5[#5]&BCCE7R]X_C;\6?M1ZKXAN
M/$&K?'3PCJ_AGQ-I^J^'->U7QCHOAVXL_#=KJOB#3FUO1F\0:6S1SZ!+XHL;
M::^>T@DN+;4K6YEU&!8-HA3N-'^+'[3GQ&\&_##26_:LU+P3X9UWPA)IVB>
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MEBI588/V%2;A&,5S58MSA!.--R=J\54NHN*C)6I\]*DZG*?FOXK^*'Q&\?\
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M\=5NO#MJD6B:/H9C\1Z;>+&;C]6?&::A\7O!?_"&Q:C:70_:O^ .E6>K>*O
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MN[_5K>X^P)O@K^R%^W]^S1X6_9-\*_M0^./BCXL^$NHZQXZTGXIZO=ZEK_C
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MJ+JRG:.5"C-#=V5W XEM=0TZ\B9;FPU&SF"S6E[:R17%O*H>-U-?-UGK6M_
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MX(BE&WX4\:_\$I/A;XH\.WGA&^_9Z^(5SI-]J>GZB=;\-?&:P\'^*-+%E?\
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M/*E^XHS6399**35-2JYTI1=ZE&E)<DOP4^#WQ3\>?L1_MD>.?%7[5GAOP9\
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M2K:WNY,/=ZUJ<^K7_BB\CT/P_;,VIZI(CK)-% EA"QN[V '*^%VE>&=+\?\
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ME^84JV'QN"PF,P^(<7B*.)P]&O2K2@H*$JD*D)1J2IJ*4)23E"R46DE;\J/
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M)2[:&$67NK6FUB:]5N%)02I3Q52<82OB+*7/67LY)UYSJ.-!.<FXJ7+U%O\
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M)-7UB"]@T&QL=7N'\9>'M'TO7)(O#MS9ZSI$5IXI%Y87]EJ>LZ;8_;/M,O\
M9=Q]A_ /]L+]D;QOXNMOA%\,_%/A+2?BMJ,]S:ZS\/-*\+:_X6U-=<T/PXGB
M'Q#"UIJWA?0+B1="L9&BN9K^WMI;:?9I\L4-XPMJ]9\*?LA?LP>"/"UMX*\+
M_ GX9Z3X6M-;U3Q';:+'X7TZ>TBUS6;5K'4M3'VN*>4W5U8L+%G:1O+LHH+6
M()!;P1Q]MX9^!?P8\&:K8ZYX2^%G@'PYK6E0B#3=7T;PMH^GZI8PFTN+!H[6
M_MK2.[@1[*YGM95CE42P2O')O4XK/-<UP&,^L4</+.Y82-2H\!#'XZC7K4J3
ME>E2Q52%"*KQ@TI-6O%W5*5.+DI=V%R^CAFJL:.%IXB<4JTJ%!4J4IZ*4Z<+
MRE!RBFG[[YU;VCDTI+U96##(I:0  8'3_/K2U\VME??J>@%%9.MZWI/AZP?5
M-:U33]'T^*2-);[5+RWL+2-I6V1H]S=210HTC$*@9P6/"\UQFM_%WX9^&M2M
M='\0_$3P-H>K7NG_ -K6>E:MXIT33M0NM,,4MP-1M[2[OXKF;3S!;7,HO$A:
M Q032^;MB?:U&<OAA.;=VE&+;:C;FMWY4TY6V35]U=-I;_-]MM[>IZ317G^C
M_$[X?^(-+L]=T+QWX/UG1-1UB#PY8:KI7B/1M0TV]\0W;Q+:Z):W]K>2VT^K
M7#3VZV^F1RM?3>='Y<#F2/=Z!0U)-J491:=FI)III)M-/9JZNN@][6:=TGOT
M>P4444@"BBB@ HHHH *:Z[ACT9&_[Y=6]#Z>E.HH 3GT'YG_  KS_P"('PL^
M'7Q5LK'2_B1X%\+>.=-TVZ-]86GBG1['6;:RNWB:WFEMHKV"81&YMGDMKQ%Q
M%=VK&UN4F@DD2O0:*J$ZM*<:E&K4HU8.\*M*<J=2+LTW&<&I1;BVKQ:T;&FX
MM.+::V:=FOF>#ZC^S-^SWJNHIJNI? _X6WNI+:76FI>S^"M EN%L;Y=6-Y;J
MSZ>FU)5U[75;D,J:QJB1LJWUQ%-O^#?@1\&?AYK4'B/P-\+O OA+7K;1/^$<
M@UCP_P"&]+TO48M$:6&>33([JTMHYEM9YK>WEN4#@W4MO;O<>:T$3)ZP1DK[
M')_[Y(_K2DX_S_GZ?6MY8W'2A*G/'8R=*4>65.>)K2IN"3]QQ<VG&[;<975V
M]-7>G4FU9SFU:UG)M6[6OL>1_%?PM%XDM-)6'X5>$?B;JD=Q/;VA\97>FZ;I
M/AV&XA+SZA/J%QI.NZM''+)#;PFWT+2;RZN&V^=]GBC$P\&B_9%T_7Y1<^+-
M8L?"<1=9'T7X-QZSX.$/R?/ /$]SJUWK) )_X^M,MM"F*8,:6P(1?J34/B)\
M/])U>70-4\<^#]-UV!(I)M%O_$VBV>K0QSKO@DETVXO8[Q$F7YHF:$"0$%"0
M:SO$QN/$=G;VWACXAVWA?S+@M<ZCI-OH.M7MS:&%T^SV9U1KNRLY/-99!>&S
MO'RIC6)0P<=%#'8_"4Z=.C5GA(3YG[>:Q%N1WFI13C6C&*OI+#T(S;?/*3<7
M):TZM:"C&+=-/[;4WH[/1>\DK;.$;[;[GB#_ +&OP=C8S:9J_P ;] N23))=
M:)^T=\?;&XDD/#3.7^(\\.]S\SE8U#-R #@5\T?&'X3?LF>'X(M.^)7[5?QO
MA=[Y;*QT2\_:'\6>.]934PKRQV^FZ7J#>+]9@U6(1O/ ;6".^B$+SHZ"/S$]
M7\3Z3I'BW7M1\ >";?Q'\>?&&G3)IWBCQ+\0_%FL/\&/ E\B1N8_$]CH3:?X
M>\2:_90S1W<G@31=-NM2+/:V^LWOAV&]AU".#PKHW@/X4^*;O2/ 'AL?'K]H
M&UMFL-:N]*LM(\+^$?AW;ZALN9=)FO+&QNO"7PCT&Z\V*8>&])M]4\9:M8QV
M]U?6FO\ DQWI]W#8G&4VJF(S3-:]6--5:="-6G1JQA:+C7J8K%RQ$,'A/>BX
MUL71I2E&=.5.E4A/FCUTYUHM2G7Q-1VYN3FY=&E9N=3VOLX-W7-.,;W5HM>\
M> GQ7^RGHFCJVO\ [:W[77]A:)9@27.K?$?XK:!!:6$ &V74=>TCP;H.I2"-
M-JRWFHZI),5P7N,D$I;:=_P3:U&]D\2:SXD^(GC/5M3@BBNO$'BWQQ^U'K]_
MJEB&,L$5Y/=:JT-_:,3Y\,<\<EN^\-'D&OKW7/ VB^'=+?XM?M0^,],\5MX9
M9-8LO#<-E-IWPO\ ">IF2)K"S\,^#FEO+WQGXE^UK;VNAZIXB_MC7KW5?+DT
M'2M&N[M;&.+P5K?Q=_:*\+:/XTL+^/X$_##Q/9C4="L;/38-;^+VO:'/).-/
MU+4]0U>!?#7P_CU&T%O>1Z39:-XJU5+>52VN:?/)Y,&W]H4U3=>EBLXHT(S5
M+$XREG%/"89U9+VBP]!8?)Z>*Q51\CE-QPZC!I2G^[Y:[U5>/*YQJ8N$.;EG
M5CB52@Y-)J$>3"<]5V3<K05M;\J:;^8QJW_!*71KFPL[OP9\*+C5]6CN+32(
M_$7PN\2Z]XBU-8@;FZ@T>;Q)X:U#6;R5!'Y\JV$C2H5\UB,!JIS:!^QS=S2S
M_#']FK]IO5+]2RQM\(/#OQS^%L:$ !)K>^NO%_PTT(*"Q,1-UY<>2VQ4!S]I
MOHGP(_9W0>)M9NK.'Q3K(335\3>)KV]\8_%+QE=,X:/1=)GN6U3Q;KDC, ;;
MPWX=MFM(0NZWTV&*-F'D%[\:?C9\:O'DGPP^#OA/_A5_AS3A%)\2/BKXU2/4
M/%?A32KZ 36>C^'O!5N9-,TGQ]K5J\=SIUKXGU.ZOO#EG)'JWB+PG"'TVWOY
MIXVI6<ZV#KY]]5A"52KC<SSZ=#"^XTJC<*&'IUZJBYPC&CAZE6O4G."4(SJ0
M@U&O.?O4ZF-4(J\JN(QSC3LGK90I)S2O;E4N=R:]U<UE^3_B;]E"R\:?%34?
M#'[/?['FNWGQ,OM235M4^(7[9GQ:TSXL_#[]GL:T_P!JO/$;_"[2O&/Q!TW4
M/&VK2R2ZYI^@>(+G4M4OKF5-3N[2*SEBN&_5S]E/]@+X7_LWZA-\1/$5Y=_&
M7]H/6K<1^)/C;XYMK6;6XE>,J^C>!](C4Z5X \*6T>VTL=$\.PVJ):Q1032R
MQ1QHOUUX#\"^%OAOX>MO#'A.P:TTZ*66[O+FXFEU#5-9U6[D$FI:SKNJ7+R7
MNKZSJEP6GU'4[R::>XE<[F$:I&GEOQ=_:P^ WP6OT\.^-?'5G+XXN1"VG?#3
MPK:WGC7XEZJ9C&UN+#P)X6@U7Q(ZSJZR13SV$%J8]TAGV*Q'%G?&N-KX1X:I
MC)8'+5&-*K5KXFO[;&1LO<KU\7B*]6&'DXJ4,OH58X5S2G.%>O>L^S#_ -M\
M05H95DN"S#,L1*FVL-@*.+QV-KTH).4IQ@Z]:&'AI*I&/+AX_P 2HF_>/HTL
MJXW$*,@#) YYP/R!_(U\ _MM?M#^,?!Z^#_V=/@ (M5_:=^/YO-%\#@ SV?P
MU\*Q[+?Q1\7_ !2(EE-EHOA6TN))=/$\3?VGK"0V\$5Q]GGA/+^+OVA/VLOB
M3%HVF?"3X&1? W0O&6O:=X6TGXH?M 7\'_"56QU;[2SZOX=^"WA]KJ^FO=-T
MRUO=8$'B_P 2^'HTCLI%OM/VJT5=W^S/^S?X2^$?Q2^+WB5K[6/B'\1[W1O
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M98>)/#O@B_MO"6N7^M)-?+?:(UG(VKQ:E<65ZZ78A>!X[C]\T%LT/S3\=/\
M@FKX!^,R_ 2Q^$/[;NK^"+;X0>)K+5;NTU3Q2_BK4GEM_#'@/PTVO>&_L_BK
M1;K0?%B+X&.II->076EOJGB76[Q+>U+RPWOZ-D_'V1YC6HX;,.-LJI2Q%&JZ
ME:*J4Z^&K*A*K3C5_L7%X7%8Z-:M3C0JJO"M%PJSJRY91YGY=7*LIBHSP+IR
MFITY?5WB,/B*<X2E&,E"&8+$PP[A&3G3>'C2;E",;\LK'Y2>#/\ @G=^V=\
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MUHRYXQE>*J,N9:Q:MW5K^BWWOOTL%%%%<)04444 %%%% !1110 5XEJ7Q_\
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M5XYH)9(W5@RL5()TZ?R:\FFFO)IV:?DT,**** "BBB@ HHHH **** "BBB@
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MNH6=CK&&VJUUK%X8QU ]DKPJ^E9/')\<#)L=)\16?P\FD'"G3=1M%CO)QNX
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M,D[1<IV7+)HGE6F^COHVM;WU\GU6EW9]+ /\_A_G\:***XTK*U[^;*"BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img117602972_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_1.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $+ ?@# 2(  A$! Q$!_\0
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MG[S#_@O-\=L#_BS/PNSCD'5/$N<^G$I&<^]'_#^7X\=O@O\ "_\ \&GB4?\
MM0U\K?LI>$OV6?$WPJ\/6'Q<_P"$-TOXBKXX^)GB#3->URZLC%JVA^%OA[I4
MUOX \3VLD\<MK9Z[=ZO>:KX1U64K!'XD\-I8#=)J;&/>M/V??V7O#'@32-:N
M?$OA?QGXS\1?"CQL\FEM\2M&FTC3_%EEX>^'/B#1-;L;MX+":._"ZQXML_[/
MU.TCA:ZT2>S@@N)K..>?Y^IDW!='$5<-4X<J^TIU?9Q:CB7"KK6O4IS>+C%4
MU&A-RE)IQDW%I-,_1L'Q;XUX_+\)F>'\2,$J%?#+$5H3GED:^$3C@&J.(HQR
MFK4EBF\=3Y:5&,E."52,I*<4OHD_\%YOCQ_T1CX7#_N*^)?ZO2_\/Y/CSC/_
M  ICX7X_["OB7^>['ZU\T:K\ _V/-3\9K=R?%==%TG5OC)KWPL?2--UW0HXK
M"?0=2\0:Z/&=JMM9Q6-IX*\7>%7\(Z!HM_Y4=I8>);S4[F1C!81(OEGA/P%\
M%/#OQY^+'A71O^$8\41Z/\,;F^^#FB_%K5]$/@W5?BQ/I_AF>YT77M7MM9B\
M.ZG::5;W/BQ] 34-0M;6^U*TTV+43'=M+;KK2R3@JK&;CP[44Z>'^L.%2GBZ
M<7%5:=*2566(Y;1G*\Y7<84XU*C]Q)RYL3QKXV82KAU5\1,)/#U\S66JKAJ^
M38FJJDL-5Q=*3PE++77YJ]&C*-&C95:F)JT,(DZ\ZD:/W3_P_E^/(Z_!CX7X
M[_\ $U\2C_V:@_\ !>?X[GI\%_A?^&J^)6_DU?'TGP4^ OB)_%NK>*?$OPZ\
M,:Y%KOB*VU^T^%GCO3X_ 7PYGTKPCH&IZ#;^'M#UI;O4O&<'C+Q==:OH$\>B
M7+:1X<N;*6/3;EK.&&9O0-5_9B_9'U+Q=HGA+P;XRUB:YU;XC:1X<MW@^(7A
M[6I]3TN;]HG1?A/);Z?:1:-"S76M^$-4N/&-E(DTZVR6Z306\]D\\S1+)^!H
M2A&7#]2\K.3C#$SA#2+]Z:Q=DK>\M+N#511]E4I3EK2XM\<Z].O6I>(&$<*-
MN6%2OE=*O6O)Q2IT)Y/S-W2C.TFH5I2PKE]<PN-P^&^@1_P7F^//_1%_A>?K
MJOB8?^SBE_X?R_'G_HB_PN_\&OB;_P"+KPZT_9W_ &3;6*Y\'>(/&.C>&-7U
M+Q'HK:E!<^.?#OB'Q1X7FT@?&V*T\,6'BRS%GI\=K\0#X:\ W.K"6W#Z!>:]
M;+++'-Y#1^0^-/V?OV;=.^'WQ'UWP]X]>S\4Z!X[AT'PO8^(O&/AJ[E;P///
MX7C\1^-[W1/#\.M7FM'P3JVH7>@1:3H]U->>);28>);:"(:1J%F52RC@:K4]
MFN'ZB;J4H0;IXMQFJLJ<(336*:E!RF[RI\Z4$ZBO#EDZQ?%7CIA<*L6_$'!U
M(1H5ZU>$,3DZJT)X:%6K5H5*<\JA4I5?94G*$<3'#OVTXX.JJ6*C4I0^SO\
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MK^93_3,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<KRCC;ZIE6!P65X:&%P\HT,#AZ6$HIRPF$G)QI45"FG*<W*3Y;N3;W9,&;<
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M#*5],/Q O_-?S'S/ZE****_F0_TR"BBB@ HHHH **** "BBB@ HHHH ****
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MG3E*CA:5?*<;A*,L142Y*7M,55HX>"DTY59^S2YE)+^DJBBBOYJ/]*0HHHH
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M]9P__/\ H_\ @R%NE[.]GO\ \,?LI17XV?\ #_\ _P""3'_1V&C?^$)\3/\
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MDUZ#\-OA9XT^*OB&W\->!]%NM8U*XDC23RH76WLH9F*++=W&)$B8D-MCQYI
MSY>3@>Q^ ?V1OC'XP^-%Y\%M0\):MH'B+0M2_L_Q0+ZW>(:2RRA(WM74&&\^
MVQGS;$JTL4T+BY+JB*M?UK_L=_L/_#O]FSPCIHCT:UN/$C6]M<7=Y,HN)A=L
MFZ62267<TUP9&#%W.5/RJ2%Q7Z#Q;QY@\BH1H9?*CCLRQ-*-6ERRC4PV&I3C
MSPK5I0E><IQM*E1@TYP:J3E&FXJ?X!X3^!6;\=8R68<0T\5D7#678NMA<1[2
MG5H9IF.+P]14\1@\%2JPC"C3H5(SHXS%UHSC2JJ6&HTJF)55X7\^/V/?^"0G
MAS0X-+\8?&8-JVJ(T5U'ITZ1BWB.%D40V;H^W#' GN&=V*AHQ#A@W[5:3X4^
M%_P9\/--;6_A[PCH>E0#[1JNHS66GPPQA#M:YOIS!%&I . Q4,?E4,>*_*__
M (*/?\%H/@+^PM#J7P[\+"#XQ?M#&T+6O@+1+V)= \(/*76"Z^(6O6YD73&0
MKYD>@6,5SK=U&%,T5C;R)<'^-7XQ?\%"_P!JK]N'XY^ [KX^_%/5KSP9<?$7
MPG]C^&?AZ>3PY\-]"T]O$&GK]FM_#NGO%!?R)#D2ZIKDNIZI.Q8RWFW:J?$9
M/P+Q;QU)YUG&*K8# 3C*I#%8U3G7Q%)6E_PGX%.G&.'GJHS;PU&2?-3]K9I?
MV[@Z7"GA_E<\KX<RK"86&%HRG+"X.,8NI4H4FE+&XQ^TK8C$N,+>TKU*]:Z<
M;Q32?]Y?PYO+OXB>+_B)^T=J'AG5_'-GX?U3_A&?AIX9T4637C:3!=QPSZKI
M]OJ-W9VL]S%:3K=;7N49FENWBC>X6W6/XN\+?M._MG_LC:3?_!7XU? WP_\
M$G]HKX^^+_BQXG_9?TWX7^(=;U'X8WE]<7<-_IO@/QIXO\2^0?#KZ3J&K#4K
M@S7%G8P^%8;ZX2\A-E*Z?IK^R!#:1? ;PD+,1X>?7'N"O_/S_;$ZD' /\"J"
M<;MH&>0,^/\ [:7[,/QE^,&H_#7XQ? +XTZ]\.?C!^SY9^-O$'P[\#W4=K<?
M"[XF>+=9TJV@TO2/B+%.OVJVTR[-A)H5QJ=LTTEGI6N:C+]F9T5C\?6KT*F;
M8K+,54P>#P"J0PE'%XO!U,5]166N?U:G!T6J]"AC,1"-/'3I*7-3KRK3I5'2
MBC;@+"^QX3RK,FGB,PSNBN(,RK1FH3QF.SB$<77G4;]VI["G7CA\+"3:I4<-
M3I0E&,5;X:\<_MG?M9_$7X4>+/V,-;^ .F:;_P %)M>^%%IXN/@_1/%:^'_@
M_!H&H>(+B=/%VD_$"U\4R7L:Z/HNDW%O,ECK$H7QO]ATEYQ97<CI^M?[.'C+
MXA^+OA7X?'Q<\$ZCX"^*/AZSL_#7C_1[J*>31KGQ1I=I;V^J:QX0UB:>Y7Q!
MX3U2X+W>BZO'=W!FMW\J=UNXIT7\I-<T[]N;]GJUUG_@HQ\?CX(\?^-/#GP>
M\-^"?&?[+/PR\/O++X<T^]\8VEAJMQX5\?0:CJTFM1:7_:R>.M=LA8W,UV=,
MU'3=)O&CCM(I.VO_ -K[XW?LY?%R\^-?[3WP@O\ 0/V=/VA[OX2> O@Y>> ]
M8O\ Q5XE\*>*-8\-2ZM8:7\3?!][-IUKX:U*:[C\1Z??:K90".]NDT'2K::]
MNU\NO)S#$7J8S"+#Y3!+,L1B5B,NC*5.\G[-T,'B>>?/ECY%4PU.7P*3J)M5
M+'VM.-XPFW5?[N,>6H_>3M&5ZD;I*IJU-I.[BM7;3Z^_:Y\!RZ99:+\;/"J/
M9>*?!=_9QZO<6JA6O]'N+F..)[@(%,K64[!!(7+&UN)(CG",OOGP9^*W@[XV
M>!+#Q#H6KZ%XBVB33->MM.U"RU$:9K-DWD:CIU]!#)(;6Y@F5UE@G5)48$,.
M]8'Q&UT^,OV</&NNZKX=UGPK/J?@76+J?P[XFAMH-8TNZAMY?)@O8[2YO+7=
M]HB26"2&YECEB>&16 ;:/X _$O[2GQ?_ &9OVROCSX@^ _Q*\2> +VR^)VHW
M171;YCI%_+)%:R7UOJ^B7?GZ-J]K+<F9)[;4;"XB;+K@$!A^B\#<"U_$C!8O
M!T,?# YEDU&K/!U,11G5P^*H3G0:PF(J4FJU&G"I6G*G4A"MR1=2/LI1M;\[
MAB*?#W'>:86C!_4L_P DPF>8BC!J,*.:83&RRROBX1;Y%4QV%GA?K#5G6G@_
M::S;9_<!^U!_P3F_9]_:8L+VXU7P[%X6\:,C-I_C#PU'!I^J0W"QXC-PH@:"
M]B0!$:&[CF0H,)L(W#^6K]KK]@WXT?LDZU++XHTJ3Q#\/;NZ:+2/B!I,,ATU
MDW?NX-;A7SGT>\D0@KYH:U=@1#/*<JOZV_L _P#!=CP+\8KK1/A;^U7#IGPW
M^(=Z8[#2?B/8*+7X?^)[YGV0P:Q"9&;PGJ=R641.S3:+--N4W&GL\<!_?SQ5
MX4\'?$GPM>Z#XFTG2?%7A?7[ PW-G=P6^H6-_8WD.%= RR1R))#('AE0\@JZ
M-@@UDL9QGX8YG'*<_P '6EA%=QPU><JF%Q%!22^L93C=81C>S<87@I-T\30A
M4^'Y[Q!\'N#_ !,PE;'8=4<HXB<6Z.>X&C%5:E11TI9QA4Z<<?2::BYU''%T
MH\KH8F*3C+_.XVA1D+M.Y@1N# @,0C*1C<C@%@<=O>I$3>455+LSJA50S/EV
M"IA5Z G@DD9)4(&)('ZW?\%%_P#@FQKO[,FLM\1_A79:AKOP3UF\CC-A LU[
MJ?@34;F8I::3=N_G2W>BW<KK#87S>;- [+:7)1&AD?U'_@GA_P $T];^(^JZ
M3\3?BQIK6FAV$HN]-TFZ1HE3!!CDNH<!;B^*%#'#(7CMP6E<>80!^G8KC?(<
M/DL,ZAB%6IUU*.&P<6EBYXF,>:6&J4VW*DZ+<?;U)<T*=-QG&57GI^T_BK*O
M!/CK'\:5^"*N73P5? RI5<RSF<7/*,/ELZD80S*AB(J/UN.,A&J\#AZ<*=?$
M5Z=6A7IX)TL0\/PO_!/S_@G%XB^-&NZ;\0/B/I=QIGA"V-O=6.G7D2J9EWQ2
M0W-^LB$,V /(LT*AB1+/&77%?U=>!/ 7ASX=^'['P[X:L(K"QLH(H=L:JK2F
M- I>0JJY)QG&,#CKC-7O"7A+0?!FA6&@>'M/AL--LH(HXH8XU4ML51OD( W2
M$C+$]^E=-7\\Y]GV/XAQL\9CJETO=H8>%U0PU);4Z,6W;O.;]^H[2FV[)?Z%
M<"<!9!X?9)2R;(\/:[57'X^M&#QV9XMI*6*Q=6,8W=[JC1BHT<-3E[.C"*YG
M(HKD_''C7PQ\.O"NM^-O&FNV'AKPMX;T^?5-;UK4YE@L["RMP"\LLC DEB1'
M%%&KRSS/'#%')(Z1M\-#_@JS^P9@9^/6EDXZ_P#"->,>??\ Y 'Z=1T/-<V!
MR;-\TC4GEN59CCX4I*%2I@L%B<5"$VKJ,YT:<XQE9WY6U*S4K6:;^U;2U=E=
MV6J\EW\^I^B-%?G?_P /6OV"_P#HO6E_^$UXQ_\ E!1_P]9_8+_Z+UI?_A->
M,?\ Y05W?ZI<4_\ 1-Y[_P"&G'];?].//^K,GGCW7WKR\_-?B?HA17YW_P##
MUG]@O_HO.E_^$UXQ_P#E!1_P]9_8+_Z+SI?_ (37C'_Y04_]4N*?^B;S[_PT
MX_\ ^4>?Y]F'/'NNG5=;>?G^9^B%%?G?_P /6OV"_P#HO6E_^$UXQ[=?^8!V
MH_X>L_L%_P#1>M+_ /":\8__ "@H_P!4N*?^B;S[_P -./\ _E'G^?9ASQ[K
M6W5=;>?G^#/T0HK\[_\ AZS^P7_T7K2__":\8_\ R@H_X>L_L%_]%YTO_P )
MKQC_ /*"C_5+BG_HF\^_\-./_P#E'G^?9@JD']I?>NMO/S_!GZ(45^=__#UG
M]@O_ *+UI?\ X37C'_Y04?\ #UG]@O\ Z+SI?_A->,?_ )04?ZI<4_\ 1-Y]
M_P"&G'__ "CS_/LPYX]U]Z\O/S_,_1"BOSO_ .'K7[!?_1>M+_\ ":\8_P#R
M@H_X>L_L%CK\>M+_ /":\8__ "@H_P!4N*?^B;S[7_J4X_R_Z<>:_JX<\7U7
MWKR\_-?B?HA17YW_ /#UK]@O_HO6E_\ A->,?_E!1_P]9_8+_P"B]:7_ .$U
MXQ_^4%'^J7%7_1-Y]_X:<?UM_P!.//\ JS#GCW2]6O+S\_P9^B%%?G?_ ,/6
M?V"_^B\Z7_X37C'_ .4%'_#UG]@O_HO.E_\ A->,?_E!2_U2XI_Z)O/?_#3C
M_+_IQY_U9ASQ?5?>O+S\U^)^B%%?'?PD_;V_90^.WC2V^'OPM^+6F^)?%UY8
MWNHVVE)I/B'3WEM-.5'NY%GU/2K*UW1K(K"/SA))RJ*W-?88Z#)R<#GU]^./
MRKRL9@,=EU;ZOF&"Q6!KN$:BHXS#U<-5=.3DHS]G6A"?))QDHRY>67*[-V=J
M4D]FMKVNKV8M%%%<@PHHHH **** /XO_ /@[M_Y!7[%!_P"HE\8?_2+P=_C7
M\4(7IDCGGK]/UK^U[_@[M/\ Q*OV)QC_ )B7QA/_ ))>#1_]>OXH0V/X0?PY
M_.OZ+X%_Y);+'YXO\,97_P SY7,_]^J?X8?^FZ9[-^SM\'KK]H'X[?"7X'67
MB"U\*W/Q7\>>'? UOXEO;&74[/0I/$%_%9+JESI\%Q:37D%F9/.F@AN89'C4
M['5L5]I^,?\ @E/^T;H'C7P!\-?#T_A[QEX]^(&B>/?$.EZ-93MI]A>:%X3^
M(EWX$T#6_#^MW#SVGB'2?'MI'I_BG0]31;#3[72=3MA?W".DDZ_GW\.?B'XL
M^%'CSPC\2_ >JMH/C3P+KVG>)O"VLQP6]T^EZWI4ZW%A>K;W<4UK,;>95<1S
MPRQ,0 Z,,BOIOPI_P4(_:X\%V/@C3-$^+=^;/X<>&M(\)>"H=3T?0=:7P_H?
MA[QG<?$'P]:V+:KIMXZMH'BR[N-3T6=V:?3?,-O;2) J(ON8N.:>U4L#4PJI
M*FDZ6(4E>KRU_?<X4Y345)T'R)KFY96E3L_:<]-T+-5HU&^9VE![1?L]HN25
MVE-)[J_6^GH'BO\ X)M_&C0=%TJ]T#5O#7CO6-4\$>"_'*Z+X<N[4+##XN^#
MWBKXVR>&5FU#4+74;WQ?IO@WPCJ<]OH]CHMS#K4D4@T^^,WV2"]\Y^(O[!7[
M37PM^&OB[XL>+O!%O;>"O NLW.C>)=2M-8L=0%E-I_B.Q\%ZI=(MN\D=U9:1
MXSU&U\*ZD]O-)+!K)FB\HP6UQ<1:W@[]KC]M7Q#J/@_4/AYK_C#6]:^#6I^!
MO'.A:AX*\!V^K:IX;N_A=HVL>'/!&M:S=:)H5S/+9>'O#^MZEH<$NML]D^EL
MEE<^='!&!S7BSQE^V#XU\":7\.?&/A3XD^(O#?C'7=>\3^&(]7^%6I7>M:UJ
M/B;4#\1O$'_"(:]-X<?6;K3]7O;W_A+KZQT*]>TF@N_[2*&QN)&DSIO-83@J
MV)RZ24Z;J*T_:N.]7E2]E"+Y(IP;37O2<O@2=26':;IT\0K1E91BN731.Z<F
MM6KI-M-.R=T=CKG[$LEC_P *X\!Z%\5].\3_ +2WQ*T7X->(]$^ MEX+U^VC
MN-*^.FG66L^#[;3_ (DR74OAVZUVPT/5]%U?Q19:GIVAZ7I]GJ2I9:WJ=U9W
MD$&AH/\ P39_:;\26*ZOHMG\.[SP[>6#ZIX<\3_\+)\,0^'O&6F6_ACQWXOO
MM1\)ZK+=)!K-II>A_##X@3:K)$5-C/X2U>TG5;B!8Y?7/".J?\%'E\77'[.V
MB^*=.\'>)_V<]%^&_C3Q'K.OZQ\,? TG@CPUX'NM$UWX6VWCCXLZ^-+>YT#P
MUJOBS18="\-^(]?NK&RU.^M].EL5:R6*UQ/$_CS_ (*4^&-*T.YNO#_C>/PO
M>I\0].\)P^!?A[HNN>"[71_!>C>._@CX_/A:/P/H^H>'[+PM::?\2O'NDW.H
M:84T?4+[Q'J6O07-S=3)?M@\1F#M"GC<K=224HNK5YG)5(.=-PA3ITN6G*,>
M>$6ZKC3YVZT^:#C?)1LW*CB4H[J$&U[O+S*\I33E>U]4VXJRCRW?F$?_  3L
M_:16\UBSN]-\'PS:'XAUO09;.U\:Z#?ZQK">%O"'AOXA>)M7\)Z/#=+=>)--
MT;P!XKTGQ=+<6+J)],>182;B.2).W^(7_!+7]I_P5XN\0Z+8Z3H^M^&+#XPZ
MO\'?#GC:_P!3LO"NG^*=2M/'GB+X;^']=2UU6ZDCTG2O&'B[PY>:'HGVK4)&
M&I7%G;W!6&Z@NI;1_:P_;;U;P;'\.=*\!^-CX\N?%OQ!U36?&UC\,]0O_'6I
M6MQX!^'WPP\2^%;*S'A22Y\/0^'_  EX4T+1?$LNBR07DEGK/V/78XS=Q//#
MXW^,_P#P46L-6^&GC;QMH7C:\\0>)=7L_C1\,/$]_P#"?3-:UF34OB+XF\9>
M)/#VH:!J,/AJ[N=/.K^*I/%_B3PUX;\R%H=2AEU+3]-464#0M5<VYX<U?*Z:
M?/'DE*;=22VG"S4N5\C:]YN,9R<X7245RX=+2&)E\+NHN^O*DG=)/XM6M&]G
M+5/C?@W^P7XS^(7QT^,'P&\;^)1X%\6_!#X?ZQXW\;6GAC2=)^)&K0WFAZEX
M:TS4/!UI9CQ?X/T:3Q!IUYXFBM]66Y\46L&F76G:A:2O)<P".NE^)G_!-?XO
M>!/%'CKP_H^O:'K^C_#[Q9XHT'Q-X\UQ]/\  G@W1M&\-Z!\,=;.O:WJ.KZ[
M>7&ER75]\5_"OAD63VES8SZ]>P0:+K6MQSM-%P5A\3?VU;7QYXT^-<W@?QUK
M?B?XF_#AK?X@:_XD^"4OB'0O''PZ\G2KBY\1>);'6/"=YH&LZ7?/X=TO4M3\
M77D#QWU]:2:E>:B]RUQ,_P!#Z;XP_P""BGC#XJ_%7P#JGC7P58Z_X!\(0?$7
MXL:?\0-7^$GA[X7Z;X'\:Z'\&/#.E0ZY+XA2U\"S:"-/L?@U8:!X>7?;Z-J>
MF:&^F6MO?VLCJ5*N94ZJJ?7<NC15"E*=*<[)5%["%:<)*GS\KJSY8<TVDZE)
M.+;L5".&E%1=#$.;G**:3YG%V=-*\K.:47*W*F_>LVN6_D'@O_@F_P#'/5_B
M?X+^%_Q$U#P;\)=:\9>+_$'@^VL?$GB;0[KQ/;OX;O/%>C7WB*'PE!JMOJ6I
M^$U\1>$=4TEO$%E/)9P*J:I(W]FD3MDV_P#P3=_:PO?#^O\ BW2O ^EZUX6T
M/3=(UB+Q%HWB33-1T?Q!I.L>&--\9KJ/AR_MFD@U*VTWPQK&GZOJS%H#:0W*
M0XEN5:)?3/&_Q'_X*,^ ?'+^&O$PU[Q'\4?#OQ&^(,4<VF>!_#WQ(\=6OB"U
MO+KQ+XRBTCQ+HWAW6[ZX\)SWGCZ;7X8-$U.;0776ENDBC@>W4\1J7Q'_ &\+
M'P%X,\,W-AXE\2^$-:^'^B>,/".D67@/3?&-QX2\(^ )KSX8VGB!8+/0]2U+
MP)>6A\%2^'M6U&Y_LS4+V'1+0ZE-+]GMY5<:N9S<)QQ>52A45-0493E!VE*4
MJE-IQD^>FK+FG*-X2:^%\T\E!*SI8I2AO[J<K<J7+):?;L[17,XNZO%IQNZU
M_P $P_VG?"FH:5;^);#P<MG?>+='\*7<GA?QSX6\3ZK9W&H_%>7X*7=W'I%O
MJ]BT\&D?$F&3PM?R2W=I;1Z@T*M<K;LUS'2T_P#X)Q?')=7T6Q\7ZEX-^'^G
M>*/AA\3?BSX9U?Q)K"R1ZOX7^&G@O5/'$X2/2Q?6ZWNLZ9I;V]ND&H7D&G7T
MDUGJTMK=6DUNL-Y^TS^WUJ.G6WCJZ/Q,GT.5KOQ=:>*_^%6S#0+B"'XKW/[0
M-]K<&L+X:_LR?3[;XDPWGB^XNTN7M(%AN+=W33(7A7B+[]LS]J[PI;6/@34O
M%%UX:M?#5UXFGN?!^H>"-!T=)KWQSX0U+P?XAG\2Z%=:);'4+W6?!^OWVFS3
MZE;/<3V>HM=,S7,J7%5'^V91:^L9:Y?O$_9*I>*Y?<:YO:+F4^3G3336GNV=
MQK"JS<*]FE*\HIQ:NKI7<5M=\UGM?WHV1L^+O^">O[1_@NVUN\U/3_!5]!X2
MLM1OO'3Z#X\T#6QX!&G_  Z_X6G':^-C93,OA^_U7P>&N]%M;MO-U*^BETJ#
M.I0R6R?#O;<H(/7@' !'N!]>@X/%?9"?ML_%6;X=?M.>$M6FFUGQ1^U?<?#B
M#XG>-9]5:RA/A_X:RF?2M+T[PCINGVFEKJ=Z5CT^\UV2[8IH7VO2H=-4WUQ=
MM\<9R/<<D>N,9)]<^G7D\FN["_7.6HL9['FC*"IRHIQC->RIRJ3Y7*;C'VLJ
ME.FI.,G"FJDDN=(QJ>RO'V7-9J3ES.[3O:*O97=E=M*VJ5]-?OC_ ()Y_P#!
M0KXV?\$[/CAI?Q5^%VHW6J>%K][>P^)7PQN[^>+PS\0/#BRYEM;N ;X+36[(
M,\^AZXD+7%A< Q.)+.XNH)O].G]BO]L[X+?MT_ _PS\<O@MK\5_I&KV\46O^
M';F2)?$/@GQ$D$;ZCX8\262.[6NI:?+(55@/L][ 8KVTDD@G4U_D.D@XR.@Q
MP<#^1K[_ /\ @G7_ ,%$?C5_P3F^-UI\4_A?=OJ_A;6&M-.^)GPSO[N6/P_X
M[\/0S!VBFC =+'7;"-IGT37(H_M%E-))#)YEE<7,#_(\7\(4<^HRQ>#C3HYM
M1C%0FURPQE.%[4*[V4TF_8UFFX/W)>YR\G9@<=+#3Y)MRH2;NKW<&TO>BFF[
M::Q32U;75/\ UG0P8D#/ SR"!R2.I !Y4_SZ&G5\G?L;?MC_  1_;@^"?ASX
MX? [Q-::WH6K6\=OK6BR3P#Q%X/\0)#$]_X9\4:;&[S:9JVGR/@QR@174#QW
MUH\MG/#*_P!7JVX$XQR1UST_SVR/0FOP*K2JT*M2A7I3HUZ,W3JTJD7&=.<=
M)1DFDTT[KSM=:'TT9*<5*+4HR2<9)IIII.^C:^5W;N<E+X,\*_\ "0'Q2="T
MO_A(7C$)U86< OFC0816G""21HU78AD9BJ91"JG:/YT_^"T?_!8N;]G.+5_V
M6_V8];AE^.6IV,UM\1_B)83QRP_"2PO(%$>D:,1O2;QY?03M*)F"KX<MUCN"
MLFH3P"U_03_@K=^WW9_L(?LVW^M>&[VPE^-GQ,FNO!_PGTB:2*2:TO9+21]7
M\:7=F6+MI?A2T*S[G0Q7.L76DV.?](<Q_P"=1K^LZSXGUS6?$OB'4[W6=?\
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MV8M<SXQ\8>&? 7A?7?&?C'6K#P_X8\-Z;=:MK6LZE<);65C8649DGFEE<XR
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MU^D=N:_M^7H/H/Y5_)WC;_R6D'_U)L!_Z>QG^9I#_/\ ]M%HHHK\@- HHHH
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MWKO?!7[(_P 'O!UU#J T5];U"$AH[G5YGNBK+@A@K';G(R, 8YQQ6[>?M/\
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M3WIZ?BO\Q7P#6Z;O9VNM-GZ[W1[2U2=WJET[I>7]:_+^'/\ X.U<CQA^S0"
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MIS3C)R_>+F;FFW&5I63EHKIM7;U33MK>$?\ @D'\+/#=A;:)>_$[Q-K^B1^
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M'WK]HGPWXA\2> ?)\+:5+K.MVFKV$]M81,5:2)S)!<2$@'Y8HY/,?I\JGD$
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M-?QVXR1VX&,\9X XK^C^#?\ DGLO_P"O%/\ ](B?FF6/WLW[+B'/5_YD)O\
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MANV\/6U[?)(\PNL(5,YC.3IT>#Z<)8:GAI8?VOL<-4C@Y9E6O+!>VA"M*O\
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MI(TO]B<#_H)?&(Y_[<O!HQ_GZ8K^*#(R21GOUQCGUK^U_P#X.[?^07^Q.?\
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M:=;V;<7/V4Y\3580F^5\LITJD8NS<)*Z<NG9&G6(((/V6'(/;$2#^8/':KE
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MI[F/3+18U62_D2=Y]0N%_>2) (X$_H?AABMXHX((TBAB18XXXU"HB*,*JJH
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MT_\ P@RKR_Z@/+\7W!4UZ_-^7GY?CZW_ )5_^'%WQ@_Z*#HO_@M/_P ET?\
M#B[XP?\ 10=%_P#!:?\ Y+K^JBBC_B*_'O\ T/I_^$&5>7_4!Y?B^X<B_+K+
MR_O>7X^M_P"5?_AQ=\8/^B@Z+_X+3_\ )=!_X(7?&#!_XN#HOX::<_\ I77]
M5%%'_$5^/?\ H?3_ /"#*O+_ *@/+\7W#D7Y=9>7][R_'UO_ "JC_@A;\8!_
MS4'1_P =-)_E=T[_ (<7?&#_ **#HO\ X+3_ /)=?U444?\ $5^/?^A]/_P@
MRKR_Z@/+\7W#D6GEZZ[;Z^3^_P"_^57_ (<6_&#/_)0='Z_] WC\OM?3\*4_
M\$+?C 1_R4'1OPTTY_6[K^JFBC_B*_'O_0^G_P"$&5>7_4!Y?B^X*"7G]_EY
M^3^_[_Y5A_P0M^, _P":@Z-^.FD_RNZ7_AQ=\8/^B@Z+_P""T_\ R77]5%%'
M_$5^/?\ H?3_ /"#*O+_ *@/+\7W%[->?3J_+S\G][/Y51_P0M^,&?\ DH.C
M_CIO'Y"[IW_#B[XP]OB%HP^FFG_Y*K^JBBC_ (BOQ[_T/IOUP&5=+?\ 4!Y?
MB^XU!+S^_P O/R?W_?\ SV?LD?\ !)CXH_L^_'+PK\4=6\9:7J]AHB7<,]C#
M:?9I&6[1$,JRF>3!CV@@;3GFOZ$E&% /8 ?D*6BOD<[SW-.(L:LPS?$O%XM4
M*>&59TL/1?L:4IRA#DP]*C3TE4F[\G,V]6TE9QCRZ*_WMV]+M]=?F%%%%>04
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !3=@W!^<@8[8]/3/Y$#VIU% !63JNEZ9K%M-9:G96=_;R*4EMKJ
M"*=71TY!1\Y&TDD,"",Y! %:U?-?QR^ ,WQ,D@\3^"_'/BSX8?$K2H0FE>+?
M"NLWUL)$13Y=IK&AR32:%K=H<!3%?V$DBIN6.90<54(P<DIRY$_M\GM%%W5G
M**:ERIZOE4I=H29%1RC%N,5-W7N\_(VNO*VK<W5*3C'>\XH^9OCM_P $H?V0
M/CG<W6J:E\/K3PSKMXTDDVK^%F.B73S2DDRN;#R$E?<<@3)*H[+DYK\P/'__
M  ;R^&9KB>7X?_&#Q/8Q.&:*TUBWTO54C/.U3.;?3[@KT&#,YX[DEA]E^.?V
MJ?V[OV4;@P_&3X;^&OC/X'MG,,'C[PY9SZ#J4\$60LVK1:4+FRM9VC =W_LN
M*!VW$3R '%WPK_P6<^"E^D7_  E_PU^(7AZ<J!.^E-HFOVRL3RT>;W3;E@%_
MA:+< #SS7V>6Y[QEEM**RG.<94PR45"%+%+%4*:NFHK#XKVBI-=8JC"ST<GL
MOSW.>"_#W.\1.KG?#.5O&5)<U7$3P7U+%3;M>4L9@O85*ZEMSRK3371NQ^4E
MU_P;X_%R*=E@^+FDRP;SL9O#.) GHS#750MQG(4#/ '6NX\*_P#!O%J\\T;^
M+_BWJ+094RQZ38:9IX;)&Y5>X;5) #R,A<KP0V>#^NT'_!77]D*6+?+>?$JW
M;J89? LKOVP-T&H2Q=00/W@&>I[US.M_\%B/V8]/AD;0_#WQ1\03Y;;&/#VE
MZ/$V <$S7FMEU!(&3Y.X YV@@BO4GQSXDUH\G]HXR%TKN&!P%!NUFG[2&#BT
MVMFIN^F^MO'H>%GA1A9<]/),"U>ZC6S+-<5%74='2KYA6@[[? XK:W0\E^#?
M_!##]ESX>3V>H>);*Y\9W]J\,@DUZ=M5!=#N8B&X5;!1D X2S X&,8Y_6+X?
M? WX7_"RQM['P?X6TS2X[9$CBD2UMU>-5PH$>R)$B!' 5% STYQ7Y-1?\%4_
MBQ\6-2.@_ 'X V_GSRB&+6_&>KW-_:68D;8DMQ::/#;)*5Y8Q1WSLQ 7<<DU
M]B?"/X6?'_Q]>:=XU^/_ ([U74[J">&]T_POIBQ^%_!^DRHPDB-KX9TAXGU2
M:/=A;_Q+>:JZD!HH8I$#GY'-L3FV.J>TSS,L1BJZNXPQ6+J8RM%O5J,)5)0H
MWUM%RIIWM%/9??9/@,FRRC['(<JPN!P[45+ZG@Z6#HSY;1BY2A2A.NXI-*7+
M4>C;E'<^_P!0  !D <#)R>/<Y_"EJ.%&CBCC9BY10I=L;FVC&3CC)'7%25XB
MV7]?F>\MEYI?E]WW:!1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
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MX4;U]?T/^%?R;'_@X$_:0_Z(G\%1_P!MO'']=?--_P"(@7]I'M\$_@I_W_\
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M HHHH **** "BBB@ K\I?^"SS'_A@/XEXX_XJ;X=C\!XOTS'X\FOU:K\I/\
M@L__ ,F!_$O_ +&?X=_^I?I=?6<!_P#);<)?]E%D_P#ZGT#SLV_Y%N/_ .P+
M%?\ IIG\41Y)/K1117^BA^,$L,$UQ-#;V\4D]Q<2QPP00H9)9II7$<4,4:99
MY9'942-1N9F"@9(K2US0M8\,ZK?Z#XATC4M#US2[EK/5-(UBSN-/U+3KI4#M
M;WME=QP7%M.H=2T4T2. 5;A3@W?!LB1>,/"4TCK'%%XH\/222.RHD:)J]F[N
M[,55455+,S$*J@EB ,U^Q?Q&_9ZTF\_X*"ZA\8OCD/ EW^S#XO\ C?!<W>NI
M\2_ FI6.IV>K6"1^&TU71M&\57?B"WT6^UY+&WU62YT^&&ULWG74WM[<R%?G
M<WS^AD^+IT<2HNG/*LSQ].$9Q6*Q>(P%3!J& P5*4H+$8G$PQ%1TJ,7SSG!1
MBFFSOPN"GBJ3E3O=8JA0E+E;ITJ=:-1NM5DHR<*<'!*4VN6*DVW'<_%)=O)8
M9'."", C\<8Y&3FKEC87FJ7MEINF6EQJ&HZE=06.GZ?9PRW-Y>WEU*L%O;6M
MO"KRW$]Q,Z1000JTLLCJJ!B0M?NO_P ()\)]2^+]C>77@CX.>$/B%X4^"7BG
M5]?\.36W[/\ K=O\0[B7QI#9>'+WPQX+T_Q,OP5\)^,-(\.RZ@+N?Q-)>M?^
M&K:WUA-&O-7:-SVJ>$O@KX3^-WQ'O/@5X6_9YGU[3OVEO@)JVOIXRO\ P%>:
M9X7^!NI_#GPSXA\2ZS\.IM6U2+P]I\ \?76I3:EJ/A!EUC2[E+6UTX6]I&+:
M/YJIXA44I1AEE9U5@98M2>)IO"QE'%4,(O:8B,.586K]9I5L-B8<WMES4:E+
M#XB+IKOCDLO=;KQ<755.T:;]JTZ<JKY8N6M6*A*$Z<U:$FI)U(69^!*>$/%,
MOB=_!4/AK7)?&*:O+H+^$XM+OI/$*:U;W#VL^DG2%A.H#4H;F.2"6R:#SXY8
MV1DSR-SXA_"GXF?"74[31?B?X \7?#[5KZT%]96'B[0=1T&XO;/.TW5I'J,,
M)N8 V%:2$NB$JC$/D5^CGPP\=>#="_X*,_M.:M>^+]#\.7/C/7?VH_#GPO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\$ [8_\ -8-<'_;GI'Y<V8I/QQ\//^AACMO^A5C>MG_SZOVVZKRT2X6SA_\
M+FBMO^8BGKMOK;JM'?9==#^:DD$GJ,@C"@#:"", ]<$$@\C*ML/R@ F5.>,#
M@8&!D#H#@ D8"C'3 Z=!7]*O_#@.W_Z+#KO_ (!:1_\ (7]!^-'_  X#MO\
MHL.N_P#@'H__ ,A4O^(X>'?_ $,<?O?_ )%>._NZ_P /KWW7O:K4?^J^<O\
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MM^!_PN'7?J++1_3WL3_^OZTO_#@.V_Z+#KI_[<M'_I8BC_B.'AW>_P#:&/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img117602972_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #R E(# 2(  A$! Q$!_\0
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M_P##QAO_ )UA_;^/_P"H?_P5+_Y9Z_TM?[^/^(E;_@FI_P _'[07_AE]0_\
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MAO\ YUA_;^/_ .H?_P %2_\ EGK_ $M?[^/^(E;_ ()J?\_'[07_ (9?4/\
MY=4?\1*W_!-3_GX_:"_\,OJ'_P NJ_@'HH_XE7\+?Y^*/_#QAO\ YUA_;^/_
M .H?_P %2_\ EGK_ $M?[^/^(E;_ ()J?\_'[07_ (9?4/\ Y=4?\1*W_!-3
M_GX_:"_\,OJ'_P NJ_@'HH_XE7\+?Y^*/_#QAO\ YUA_;^/_ .H?_P %2_\
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MAO\ YUA_;^/_ .H?_P %2_\ EGK_ $M?[^/^(E;_ ()J?\_'[07_ (9?4/\
MY=4?\1*W_!-3_GX_:"_\,OJ'_P NJ_@'HH_XE7\+?Y^*/_#QAO\ YUA_;^/_
M .H?_P %2_\ EGK_ $M?[^/^(E;_ ()J?\_'[07_ (9?4/\ Y=5]Z?L.?\%.
M?V8_^"A-]\0=/_9[D^(DEQ\,[?1;GQ-_PG7@FX\(QB/7WNDL/[.>>^O/MK;K
M2;SPH3RAMR3NX_S$Z_K9_P"#5K_D:?VPO^P1\,?_ $HUZOSKQ8^C_P  \&<
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M_P (\U_^?']7?E8_U>P?_/W$_P#@5/\ ^5?U=^5O\V[_ (<;?\%0O^C:+O\
M\+7P;_\ +>C_ (<;?\%0O^C:+O\ \+7P;_\ +>O])&BC_B;3Q!_Z$O"7_A'F
MO_SX_J[\K'^KV#_Y^XG_ ,"I_P#RK^KORM_FW?\ #C;_ (*A?]&T7?\ X6O@
MW_Y;T?\ #C;_ (*A?]&T7?\ X6O@W_Y;U_I(T4?\3:>(/_0EX2_\(\U_^?']
M7?E8_P!7L'_S]Q/_ (%3_P#E7]7?E;_-G7_@A_\ \%/'N9K1?V:[LW$$,$\L
M?_"9^#QMAN7G2"3<=5",)'M;A1M8D&)]P'&9_P#AQM_P5"_Z-HN__"U\&_\
MRWK_ $9+'_D=O$/_ & /#7_I7XA_S_DU\$_$[]NGQO\ !GQO\9=+^(7P0L8/
M /P4LOA)K/B+Q?X?^(0US6=0T/XW^+O%'@[P)/I7A&+PM%>W&HIJ/A._EUS3
M%NWEMXKFS6P>_=Y B_XFT\0?^A+PE_X1YM_\^/ZN]M+'^KV#_P"?N)_\"I__
M "K^KORM_$C_ ,.-O^"H7_1M%W_X6O@W_P"6]'_#C;_@J%_T;1=_^%KX-_\
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M //C^KORL?ZO8/\ Y^XG_P "I_\ RK^KORM_#[_PXV_X*A?]&T7?_A:^#?\
MY;T?\.-O^"H7_1M%W_X6O@W_ .6]?WDK^WW^RL=$TCQ%)\2'MM'U3Q/!X/N[
MVZ\+^*K>'POKUYJ'AG2].M/&LDFC+'X1.JW_ (U\'0Z4==>R.HIXHT>YLUFM
M)Y9X?LBC_B;3Q!_Z$O"7_A'FO_SX_J[\K'^KV#_Y^XG_ ,"I_P#RK^KORM_F
MW?\ #C;_ (*A?]&T7?\ X6O@W_Y;T?\ #C;_ (*A?]&T7?\ X6O@W_Y;U_I(
MT4?\3:>(/_0EX2_\(\U_^?']7?E8_P!7L'_S]Q/_ (%3_P#E7]7?E;_-N_X<
M;?\ !4+_ *-HN_\ PM?!O_RWH_X<;?\ !4+_ *-HN_\ PM?!O_RWK_21HH_X
MFT\0?^A+PE_X1YK_ //C^KORL?ZO8/\ Y^XG_P "I_\ RK^KORM_FW?\.-O^
M"H7_ $;1=_\ A:^#?_EO1_PXV_X*A?\ 1M%W_P"%KX-_^6]?Z2-%'_$VGB#_
M -"7A+_PCS7_ .?']7?E8_U>P?\ S]Q/_@5/_P"5?U=^5O\ -N_X<;?\%0O^
MC:+O_P +7P;_ /+>C_AQM_P5"_Z-HN__  M?!O\ \MZ_TD:*/^)M/$'_ *$O
M"7_A'FO_ ,^/ZN_*Q_J]@_\ G[B?_ J?_P J_J[\K?YMW_#C;_@J%_T;1=_^
M%KX-_P#EO1_PXV_X*A?]&T7?_A:^#?\ Y;U_I(T4?\3:>(/_ $)>$O\ PCS7
M_P"?']7?E8_U>P?_ #]Q/_@5/_Y5_5WY6_S;O^'&W_!4+_HVB[_\+7P;_P#+
M>C_AQM_P5"_Z-HN__"U\&_\ RWK_ $D:*/\ B;3Q!_Z$O"7_ (1YK_\ /C^K
MORL?ZO8/_G[B?_ J?_RK^KORM_FW?\.-O^"H7_1M%W_X6O@W_P"6]1R_\$-/
M^"HC1R*O[,]V69& !\;>#0"2.!G^UN/K7^DK10OI:>(*:?\ 8O"6G_4'FWE_
MU./+\7Y6/]7<'_S]Q/\ X%3_ /E7]7]+?Y_'Q$_X)1?\%1X?VA8OC7\%O@IJ
M5IJ/AZ+X9W/A+Q98>+O!T5SIWB/P7\-?!WA;5)8;?4+_ !YVE^(=$U;3V$]N
M\,QMF=1)#(C,_5?^"=O_  7-UG7?#7B"\^&NO177@^#Q!:^'M,T[Q'\,=)\+
MV5OXMB6W\5Q2^$--EMO#-^GB>W2*WU\:AI=U_:L$$$5YYJ0Q*G]Z7@'_ )%F
M#_L+>)__ %*-9KLJ\J'TF>+52PE.MPOP/BYX/ TLOI8C%95CJ^(^JTZ+P_LG
M5GF;ER5*<JJJ0CRTY>VJKE4:DD:?V%A[R:Q&+CS2<VHU()<UU*]E3Z-*S=WH
MM;I-?YY^J?\ !+;_ (+4ZS8?$/2K[X5>*!I7Q7N?!]U\0-*L?''@32M,\12?
M#]D/@A);#3;^UM;.W\+I'%#I%M816L%K;116X0PQJ@Z36O\ @G)_P7*U\R/J
M/PZ\4"YGL+S3[R_T_P 7_#G2-3U'^T+K2KV^U/5-3TNYM+_4_$%U>:'I%S-X
MBOKB?6GET^W8WN5);_0,HK1_2=XK;@WPCP$W3=X-Y/C6X-4:&'O'_A3]U_5\
M+AJ%U9JC0HTE[E*G&*_L+#K_ )B,7KO^]AKJY:_N_P"9R?K*3W9_"#X:_8R_
MX+J:"OQ%N+[X+W7B36?'O@.T\!VNJ:OXE^&SVOA.U7X@^'?B+K.LZ7X=20^'
MK[7/%.L>&K)/$>I:EI\UYJIV7EY<SW5K;NGAFL_\$M?^"U7B.WNK;Q!\+O%V
MMQWNB>*_#EZ^J>/_  5>W%YHOCCQ5/XW\66%U=3ZF]Q/'K?BJYFUFZ>25I1<
M.$B>.%$C7_0QHK'#_25XEPM2=7#\'< T:E2I3JRE3RC'1:G2HQH4Y0MFEJ7+
M2CRI4E"-Y5)VYZE24F\CH224L3C&DK6=6%K7N[_N];OOZ;)6_P _F]_X)V?\
M%S]2M]7M]2^'7B74#K>JR:U>7=]XJ^&MWJ<%]<3:;<WRZ3JMQ-)J&AV.J7.D
M:?<ZMIFD7-EI^IW$!FO;>:2:9I,.V_X)D?\ !;2ULO$VFQ?"SQ&VF^,KGXC7
MGBK3I_&'P]N;#7[KXMZCI^L?$6;4[2XO)(+A_$^KZ3I>JW)9,6VI:=97MB+:
MXMHG7_0BHK2/TFN*81Y8<(< QBI*?+')L8H\\8J"G99FES**Y5+=)M)V#^PL
M.]\3C'TUJPVT;7\/JU=^OI;_ #Y/ W_!-'_@M[\-/!H^'_@?X:^*M \)07&L
MWFE:9#XU\ 74GAF\\16_V77[SP;J-]>W.I>#[O6X>-4N?#=WILMY)^_F9I_W
ME='HW["/_!=[P)IFEG1_!OBO2+'P=:Z+<:-<CQ5\-KFYT >#]*DTK1]3T^[G
MDN+VVU33O#ID\/-JL$@U*Z\-YT*YGFTS%J/[^*Y;QS_R)?BW_L6M<_\ 39<U
M-7Z3'$]=UI5^#O#^M+$3E4KRJY)BZCKU)-N52LYYFW4G)N3E*;;DY2;=VP61
MT(VMB<8K62M5BK)6LE:GIMT^72W\&WA?]@;_ (+Q^#%TP>&/ WBO2CH]GH%E
MI,D?BOX:S3Z:GA>&\M?#MU9S74TLUOJFC:;J%[HUCJR.NIP:%<S:*+G^S6^S
M#@/&?_!+3_@M+\0_"&F> O&?PC\0ZYX3TJZTR^ATF?QEX @6]OM#TQ]%T&\U
MRZM+V"\\076@:+(^CZ%<:U/?2Z1I9%C8-!;J$'^A9!_J(?\ KE'_ .@+4M53
M^DUQ31KK$TN#^ *6(4X5%7IY+C(5E.G=4Y^UCF:J<T%*7)+FO'FERM7!Y%AV
MN5XG&./9U8-:VOI[.VMM?^ K?YMW_#C;_@J%_P!&T7?_ (6O@W_Y;T?\.-O^
M"H7_ $;1=_\ A:^#?_EO7^DC17I_\3:>(/\ T)>$O_"/-?\ Y\?U=^5L_P#5
M[!_\_<3_ .!4_P#Y5_5WY6_S;O\ AQM_P5"_Z-HN_P#PM?!O_P MZ/\ AQM_
MP5"_Z-HN_P#PM?!O_P MZ_TD:*/^)M/$'_H2\)?^$>:__/C^KORL?ZO8/_G[
MB?\ P*G_ /*OZN_*W^;=_P .-O\ @J%_T;1=_P#A:^#?_EO1_P .-O\ @J%_
MT;1=_P#A:^#?_EO7^DC11_Q-IX@_]"7A+_PCS7_Y\?U=^5C_ %>P?_/W$_\
M@5/_ .5?U=^5O\V[_AQM_P %0O\ HVB[_P#"U\&__+>J]Q_P1 _X*=6K6RW'
M[-EU&UW<I9VP/C3P>?-N7CEE6(;=5;:3'#*VY]J (<L"0#_I,UQGC#_7^#?^
MQSTW_P!-VKT?\3:>(/\ T)>$O_"/-O\ Y\+^F/\ U>P?_/W$?^!4_P#Y5_5_
M0_SH?^'&W_!4+_HVB[_\+7P;_P#+>C_AQM_P5"_Z-HN__"U\&_\ RWK_ $D:
M*/\ B;3Q!_Z$O"7_ (1YK_\ /C^KORLO]7L'_P _<3_X%3_^5?U=^5O\V[_A
MQM_P5"_Z-HN__"U\&_\ RWH_X<;?\%0O^C:+O_PM?!O_ ,MZ_P!)&BC_ (FT
M\0?^A+PE_P"$>:__ #X_J[\K'^KV#_Y^XG_P*G_\J_J[\K?YMW_#C;_@J%_T
M;1=_^%KX-_\ EO1_PXV_X*A?]&T7?_A:^#?_ );U_I(T4?\ $VGB#_T)>$O_
M  CS7_Y\?U=^5C_5[!_\_<3_ .!4_P#Y5_5WY6_S;O\ AQM_P5"_Z-HN_P#P
MM?!O_P MZ/\ AQM_P5"_Z-HN_P#PM?!O_P MZ_TD:*/^)M/$'_H2\)?^$>:_
M_/C^KORL?ZO8/_G[B?\ P*G_ /*OZN_*W^;=_P .-O\ @J%_T;1=_P#A:^#?
M_EO7]%O_  ;\_L(?M4_L:>(/VE;S]H_X82_#RV\=:;X#@\+22ZYHNL?VG+H\
MVK-J*A=)N[HP?9Q<PG,VT/O^3.#C^F2BOE^,OI$\8\;\-YEPOFF5\.X? YI'
M#QKUL#ALPIXJ"PV+P^,@Z4ZV95Z2;JX:$9<U*=X2DE9V<>C#9+AL+7A7IU*\
MIT[V4Y0<7>+CK:G%Z7NK-:^6@4445^!'KA7PIJ/PH_9#OY/VC]&O+_0U\4?M
M1_$+QG\+OB3KQ6PC\<1>-?%WP2\+_#W7_!?AK7WTH:KI$</PV\)Z9JD%KY]S
M86LYO=0:1ED:"/[KKY'\3_L<_#[Q5XL\0>+;_P 0^,(;KQ'K=WXAO+*UN]-C
MLK?5[K2]8T(W^G@Z8T]G>1Z%KVJ:2MU%-Y[VMPHED=X8F4 ^:?C_ /L:_L]>
M-](U1X/BG):ZA\1-0TC4?AWX3\1^.KZ^^%\OQQ\,^$?#/@+P_P#%.#2?#%YI
MVO2>*-&\/_#SP_:"^LM9D\/Z%K>E'Q/-H4VK/?"^S/AE_P $_/!EE\(_B)%\
M</CEXB\2^/\ X_\ BK1?$/C7XA^&/'W]FZ?<:AX;^*?CCXF>"?#^BZA=VUG;
M>);&PO?&NH:-K=EJ.D0:)XNL+=;23PGIM@D>GP^[ZM^P5\.M:C>._P#%_BK%
MYJ6C:MJRV>F^#-/AN;OPXE[#HL6DV]GX;A@\*:<8;UD\0Z9X832[3Q@Z&?Q+
M'J,\]S)-Z5??LK>"KSP/X.\"V^H2Z1IG@W5?$NI62Z-X<\(V=C/_ ,)8U\VL
M1C0FT.;1-/N2U_+-8ZKI=C9ZIIMWF\LKJ&>25F /E#X8_LG_ +%GP>^'_A._
M\,^//%D?@K4OB,VC>%M:UCQ=+>Q:MXON_"7CWX/?8H+T::C7-M_9?B[Q0C7<
MP%O;W%K%?7%U%:V#*?L'PUX=^"OPT\7>"[.S\7V<WBOP[\,-&^"7A#P_J'B3
M3[_4;+PWX-DBO-0-KI:LES#K=_&^B-XKO=L;7EMHV@B6&,6D6_"U3]D;P!JW
M@/P7\-YM?\967A;P)I?BZTTBTT;5+71I[C5/%DI+>(=4N-/L8'U#4]+M+C5K
M&VCG#6%[%K-_-JUI?W31S1\_??L7>#-6L]'L-7\8^)=031I-3ECU%](\%0>)
M;^?7&CFUJ\U;Q3;^&H]<U#4-0NH8K@ZA->&ZMMGD6\D<#&,@'GGQM_8C_9E_
M:+U+7)O%'Q \4VMS\1/'-WXFU>P\(?$NTTRV\1:K;^!]+^&NIZ1!IL(N(+EK
M31=$M%AFB@GUKP_JHO;G3;W3Y;R[CD\F^,__  32O=9\#>$_AA\!/B3=?#;P
MK<^'_B#\.OBAKFK:KKT_BW7?AG\3;S0[SQ/X=A&E1IHGB#3'ETF>:V\.ZK9:
M0$N]0N6C\26^F7>K:1JGU)X7_8O^'7AC5K77H]:UV_UBQN_ =S97L]CX8M?L
M$?P]\1Z'K^DQZ=!8:%:PZ=<:K#H5OI/BK4K)8-1\2VMS>W6J7,VH7#70^PZ
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M^TW*V/@RRN))-8CUX7,RO8>&;80M)<^(]3OKN.$1P:C=R))?13*NP@'ENO\
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M7L_$5Y<Z7=^%KK3+VWTV/]RZ* /YL_"7Q%_X*9ZQ\2X/B!JOA[]HV+Q9X?\
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M4 9.JZ'I>MI#'J=LUPEN[R0A;FZM]CNH5CFUGA+948PY8#L 2:Q?^$"\*?\
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M_P#P@7A3_H&2?^#/5O\ Y.H_X0+PI_T#)/\ P9ZM_P#)U=A10!Q__"!>%/\
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M ./_ .$"\*?] R3_ ,&>K?\ R=1_P@7A3_H&2?\ @SU;_P"3J["B@#C_ /A
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MQG&2LUW/KS_A O"G_0,D_P#!GJW_ ,G4?\(%X4_Z!DG_ (,]6_\ DZOCYO\
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M4DKJS5TTWZ\)PJ0C4IRC.$TI1G%IQE%[--:-,X__ (0+PI_T#)/_  9ZM_\
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MO?Z'^=<7?]'^I_E_G]*_9.?_ ()+_$V7./C#X$7((Y\->(#U.?\ G_K!N?\
M@D#\49\[?C/X 7.2-WACQ$>3QVU#_/(KW,+X_P#@[3^/CK+X[?\ ,!GCVMVR
MI_C\['UN X"XOI<GM,DQ$+)7OB,$]N3MBG;9GXGZC_'^/_H+5Y]JG0XSVSGC
MU_3'3KD<<<Y_<^Z_X(S_ !7GW;?C=\/%S_>\*^)#S@CMJ/N?TZUS5Y_P1+^+
MUSG9\=?ANF?[WA+Q.?7DXU(=>_\ 6OJ,'](SP2IN+GX@Y;';?+\_=MNV4/\
M5;ZGW66<,9]0M[7+:L-MZN&?;M6>VOS7HS\XOV(/C1\??A#^T'X4@^ .E7_C
M/6/&>I6FC>(OAFDDHT?QIHOG W)U-_F@TB328&EO+;Q+(%72-C-<-):O+ _]
MI]L\\MM;R7, M;F2")[BV687"V\[QJTL"SJJ+,(9"T8F5$$@7>%4-@?"?[$7
M["/@3]C_ ,,W5TT]GXQ^+/B*/R_%7C]K$VP%J'WQ:%X:MIVFGTK1(L+),AF:
MZU"YS-=R,JPQ1?>=?P%])CQ1X4\4.-Z.-X3R?#T<'D^%EEM7B;V57#YAQ2X2
MC[/$8BA+V:A@L'&#HY9+$4%F$Z$YRQ-2%)X;!X3]9R?!U\'A(TZ\GSRM+V5U
M*-*ZUBFK^\]Y\K<;[7UDRBBBOYQ/6"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,/6O$>D^'EMWU66ZB6Z9TA-MIFJ:D6:-0S!UTRRO&B
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MT>H:U.OAZZTR.2SUN*6$ _2W_A9/A#_G[U7_ ,);Q5_\I:/^%D^$/^?O5?\
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MO_E+7=T4 <)_PLGPA_S]ZK_X2WBK_P"4M'_"R?"'_/WJO_A+>*O_ )2UW=%
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MA^VE\8>$GFTNW3Q3X<>?7+-=0T2%=;TQIM8L&!9;[2XQ=%]0LV525N;19H2
M2'(!KC=5^-WPITJXL+%O'?AK4-3U:QU/5-*TK1]8T[5=1U+3-#O]-TW7M0LK
M>SN9#/9Z%<ZM8_VQ,C%=.AD>>YV10S,GT>=>*>*S"68/+\KIX..:8W,<5C8X
MVM@\;ST,UI2P^-P%..795D=&&'Q&&G4P]2O.C5S!PJ2E#&TZRIU83&BE:[OR
MI)6NOALTW>4KM-)VVTU1^;?BB'X@:7\=O'VK>-+#3-2^*6K?%3X$:CX#^&D'
M@3_A,?"_BKPG:Z%X8L-7OO#?Q'U7PU;:SHEIX.U-/$^I6M_87?A/^Q-9TZ]U
M37=-U1=9AB'HGPST?P?J_P"TEI ^$\?B32O"=W\)/BKX*\6Z%;^#-=\!>)OA
M+J<WBCP_J,VM>(O%M^KW/BCQ/XR\00ZC_8YU*>\O='BMYM5T>46]S/++^B]Y
MXI\,:?\ 9OM_B/0;'[;+8PV?VS5]/MOM<VJ"4Z9#;>=<)Y\NHB"<V,<6][L0
MRFW$@C?;S'BCXK^!/!OC7P!\/?$6MK8>+/B<_B-/!NFFVNIAJ1\*Z;'JNLF:
M[AA>TT]8K::&.U-_-;C4+R:*QL?/NW$-&)\4)U\!]5ADJPM59!#(T\-CZ-/
M.,,GHY/1K3P']EN=3ZG##QQ>!F\;_:5+$U\;A\5FF-RG%SRR*5&SOS7][FU5
MW\7,U>_79Z<K2C:*DE(^>OV3_#MQX#^!OCO0]&T[5;)]$^)GQN_L"WU<:E<Z
ME<K'XJUF;3;J:YU;S-0U22_DV7']H7,EP^H/*9S-+YFX_ D=CJF@:Y^R[^T'
MHVB^(-?U3X2_LXR_$WQ?)I&F:CJ5[KEUXP^()L/C9H.^WAN!>ZZP\1ZYK/\
M9):2_>\\.6D4$2^2@7]8OA_\??A1\3+6:\\*^++-X8]:MO#L8U>.;0);W6[R
MU2\MM-TV#64LI=2NY;=U=(+))Y#G:%W<5/H/B/X-> I[/P=HGBOP?HT_B7Q;
MXFATOP]%XCL':X\6,EQXE\3Z5IMB;R3[)=P*]UJ][I$"0"T\^:86T7G89Y3X
MF_V?F/$^;8C*YXS$\2YE+$8S#3QDHT\3@,?EV=99G&"Q6,=*5=O%X;-ZM.-6
M-%N2K8B4N6?LY!*C>,(J5E!))VU34H2BTMMXK1OM;K?\H/!_PN\?/\0O-N-)
MCT_QC\0/VH_AG\4O$6I>+_!&H>,?#UAJGB_]G;XD:O?1:KI0O=&AOX/#%G>:
M7X,6X76;."PU33K+?/\ :0EO+U-AX5UW1/$6O3_%SPQ))!X=_::T#Q/^T-X;
M\%>"M1L/AC?>";7P#J&D_!_Q]X3\-VPU1];\%_;O[/U3Q_:&XU?5K?Q'9LVM
MV1M]'@DF_5G4?B5X'T_3+'55\3:-J5MJKQ1Z0FC:G8:I<ZR9=0CTQFT>WM+F
M234TMKJ0K=M9"86RQ3M+M\EP*WBSXJ> O!G@WQSX]UCQ%8S>&_AOIVK:GXSN
M-%?^W[O1(=$MI+O4K>YTW1_ME_\ VC;PQ.3IJVYOG<"-(&<A3ZF)\:<PQ=6I
M*MDN&A2JY3@LKFL-BE0Q5)83V5*53"8[ZE4K8:DJ%.-3 X5*I#+LRPN5YA0G
M/ZE5PV,7U=*UIO1MJZNN^JOJ[[O1N+:>Z:_*SQM>W_C[7_%,?PY^%7@.YT.\
M^,?[.-_9>,M"TKQY%\._%>L:;XOUZUBT?Q3X9U7P[:V<6HZ!X?FM;WQ3K_AW
M2KJW>"ZT^SO[R?['"L/HWC?]GOQ_HOQ-^'WB:;_A6NG^(OB9\<-"O9M$\-?#
MS5?$OPL\&Z;X/^%7C;2(=4U#1+G4- FU/6]=;4F74=9N+C08?/MM&A0326JF
M3[ELOVA_@_J'B;1_"=OXST]=3USX5V/QIL9[E9K31U^'&J7MK8:9X@O=<NHX
M=*T]-1N+R+[%:WMW!=W$23S1PF*"5EZC7?BM\/?#>L>%M U?Q9HMOJ_C.5(_
M#UBM_;33WL,EC>:A%J+)%*[0:1+;6-R8M6F":?)*J0)<F:6)'X9>+F.H*E1R
MO*:6"PD,!B\OK0Q6-GFV)Q5&OEF6X&BJV(QN&=)1H8K*L'CW1I82G1G[*.!I
MPH8+FI3?L%KS2N[IJRY4FI-WLGV?+=N_5W=FORSN?#6OOX;^,OPYU7PU<VW[
M6/BCX\^&;CP#)X$\+ZAX4^&O@_Q)HOAZQ/P_^-G@J\6'5+;2/!UIX0TJ?6/'
M\FH7U]J>K:K#K/A+4;*XDO;5)[DWC3X?_#_X5^$?"7C+X<++^T?_ ,)1\2_!
M7BC7?B1HGB77/!VG^/\ 7+.SD^(_QF\5:W8Z)>66O^'?$NESZ9JGA(P6,E]?
M6.I6?@_1UTM(-16U_4._^*7@#2O$5YX8U3Q3I&FZEIV@IXDU"34+R"STRQTN
M35(]'C:\U>XDCTVVNGOY8HDL9[E+MEDCE$)C=6+[+XI?#74;W6M.LO'OA"XO
MO#NO:?X7UNV3Q!I8ET[Q'JNF6NLZ9HEPKW*XU/4-+O;:]L[12TUQ%(?*5FCE
M5-GXM1K^QI8[(*]3#0QE'-*M/ 9]7RVK+'4LGCDWU&C5IX"M3H<,/#4Z4HY
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M5T>2GQ$TX=L?\(3X//<COH^:^3IW3#?.OW>FY?RZ_C7/W;I\WS+U'\0]2/\
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M#,7C;PWXE\/ZIJ6C:[JWBJ_URRUS;K5G+%]FOXM,MXK*>*WM(C<Q/;?H_O\
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MZXV^$M8/7D?\NGKUZ]*\[U?]G3X_2*_E?!;XFOG.-G@S6V)^F+/K^!]>W/\
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M*>'E+$8BES4U.)34+7ZIO=+1.*;O)I;R2WN[Z(^ZO^$)TW_H*>*__"M\0?\
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M)9?CJ&*<8\TE3D[J-TN:TE%M)M)M)VNKVNC>_P"$)TW_ *"GBO\ \*WQ!_\
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M?^@IXK_\*WQ!_P#+"C_A"=-_Z"GBO_PK?$'_ ,L*[&B@#CO^$)TW_H*>*_\
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M7-S=ZGK>I76KZMJ-Y=W#R7%U>:AJ5[=7=S/-([O)*0"J*B* =!1110 4444
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MGKW/J,G&.*\QUH<.!UYP.G''.<=OIS[]:_<6Y_X):6UP,?\ "Z+E.",_\(/
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M;2YFVE]"4445_FX?JH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!D:MKVC:"D$FL:C;:<ER[QP-<OL$KHH=U3@Y*J0
M3[&L3_A87@G_ *&72_\ O^?_ (FNRHH \E\17GP8\7RZ9/XJC\%^(YM%N?MF
MDRZWI]CJ<FG7.Y',MF]Y;3- 6>*&1Q&0KR0P2.K/#$R=1_PL+P3_ -#+I?\
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M\_\ Q-'_  L+P3_T,NE_]_S_ /$UV5% '&_\+"\$_P#0RZ7_ -_S_P#$T?\
M"PO!/_0RZ7_W_/\ \37944 <;_PL+P3_ -#+I?\ W_/_ ,31_P +"\$_]#+I
M?_?\_P#Q-=E10!QO_"PO!/\ T,NE_P#?\_\ Q-'_  L+P3_T,NE_]_S_ /$U
MV5% '&_\+"\$_P#0RZ7_ -_S_P#$T?\ "PO!/_0RZ7_W_/\ \37944 <;_PL
M+P3_ -#+I?\ W_/_ ,31_P +"\$_]#+I?_?\_P#Q-=E10!QO_"PO!/\ T,NE
M_P#?\_\ Q-'_  L+P3_T,NE_]_S_ /$UV5% '&_\+"\$_P#0RZ7_ -_S_P#$
MT?\ "PO!/_0RZ7_W_/\ \37944 <;_PL+P3_ -#+I?\ W_/_ ,31_P +"\$_
M]#+I?_?\_P#Q-=E10!QO_"PO!/\ T,NE_P#?\_\ Q-'_  L+P3_T,NE_]_S_
M /$UV5% '&_\+"\$_P#0RZ7_ -_S_P#$T?\ "PO!/_0RZ7_W_/\ \37944 <
M;_PL+P3_ -#+I?\ W_/_ ,31_P +"\$_]#+I?_?\_P#Q-=E10!QO_"PO!/\
MT,NE_P#?\_\ Q-'_  L+P3_T,NE_]_S_ /$UV5% '&_\+"\$_P#0RZ7_ -_S
M_P#$T?\ "PO!/_0RZ7_W_/\ \37944 <;_PL+P3_ -#+I?\ W_/_ ,31_P +
M"\$_]#+I?_?\_P#Q-=E10!QO_"PO!/\ T,NE_P#?\_\ Q-'_  L+P3_T,NE_
M]_S_ /$UV5% '&_\+"\$_P#0RZ7_ -_S_P#$T?\ "PO!/_0RZ7_W_/\ \379
M44 <;_PL+P3_ -#+I?\ W_/_ ,31_P +"\$_]#+I?_?\_P#Q-=E10!QO_"PO
M!/\ T,NE_P#?\_\ Q-'_  L+P3_T,NE_]_S_ /$UV5% '&_\+"\$_P#0RZ7_
M -_S_P#$UM:3X@T77A.VCZE:ZB+9D6X-L^_RFD#-&'X&"X5B/7!K8HH ****
M "OD&/Q/\9_BYX\^-&E?#KQYHWPUT;X/>)++P%I=EJ'@ZQ\4S^+O%;>$]%\7
M7^J>(;B_N(;C2O#@'B'3-*L;?1$COIX(M1U!KHNUI&OU]7RYXS^%_P &_%_B
MKQEKL'Q-UGP3K6K7FB>!/BI9> ?B-9>'(O$6JRZ=;'P_X>\:V2_:I;+Q+=:%
MJMK;Z=)9-HOB:]T74+.*.ZFM6LBGU'"^.RK U\P>91H0JU\#3I9;C<5E.&SS
M#8'%1S# UZ]2ME>,YJ%?V^74<;A*4Y4ZKI5L13<8TN9XO#1-2:5KV3NTI.+:
MLTO>335FTWW2^3^1M(_;=^,?BRT?7M'\ 64.F>9^RN+;2]-GL+^_U._^*OB'
MQ=HGC?1M..H2VP6VOKC03'H>J7<Z?V796$E[,MS)>)&OMGB+]O3P+X74:5K'
MA34M-\;Z?=>/8O%/A'5?$OA;2/[$@^'.I6NF:X]AKNHW\&F^)+[4[B^LQX7T
MK2_],UD22^<-/%NY/LLW[+?PH&O:9K>F6>L^'[?2K/X86=MX;T+5/L/AEE^#
MNI:EJ7@":;3FMIYC<:.VKW]F[QWD2WUE/Y=ZD\J).M+6?V5?AQJ&K:MXETW6
M/'O@[Q-K>K^--4U?Q-X0\5RZ+K%[9>/IK"Z\3^'9[IK2YC7P_=76EV5Y:01P
MQWVE7< N=,U&TF+.?TC$Y]X.9AC*3J<+XO X&"]K1HX*6+PU:,_[*P6$CA,Q
MQ$,;B98B@L?0Q&-J8C#TGB95*L9TYQA4Q&'GBH8A+2:;\]5\5[I65G9VUTTU
MZ,T?A+\?[;XT^(O%FG>$?"&O6OA/PO'I%O+XZU:>QM+>[U;7O"WA_P 6V6FV
MF@2%M4\^WTKQ':-?27"QP6]S&]N&F+ CY^U3Q)^T%X>\?_'?2+CX[)JFC_"#
MX6Z)\2M.L)OA3X-MWUF?7+/QW='1=1O;29;B.RLF\,Z>D$]G'%>S"XNO.D9E
MCW?6GPL\#^ /"UGK_B#X>Z@^KZ7\0]4T_P 3W6JKX@?Q+8ZA<6'AO1/"5K<Z
M=JCSW37%N^E^'+#SIFO+M[F]%U=2SO),X#]3^$'@_5M:^(VOW::H=0^*7@S2
M_ ?BHQ:@\<+:!I$&O6]HNG0A"+&\\OQ'J7FW2%VD8P,5'DC/RN$X@X5R[-,V
M>!RBC_8V*RO)L/@J69Y5E^=8R..H8S)JF:XB57-88MX6KB,+'/*7M, \-2G[
M7#<F'HN-.='1PFU&\GS*4FVI.*Y?>LK1M?[.]^OF?*^F?MP:7X<\$Z5<_%3P
M9K/A7QK=^$O@]K6FV&HZGX;LM-\5R?%B'4;32M0&JC4&TKPM;1:GX>\0W.L6
M^J3M_9&FV:S1O>2R1VQZ?P=^V;HGQ UK0M!\&_#SQ)KU[=:7XRU?Q//9:MH$
MFE>&;/P'KMGH6O20:N+HZ?XD2ZEO[:Z\.3Z3.;;6K=I5,UE-;S1IN^./@Q^S
MU9O=7OBOQB/".J>#_ ?PGTB+7KCQY8:!JO@;0_ 7B#78OAQXKM[J^=(])U"X
MUS5]9TA-9OXI+'7I'GT>2WN<36[=%H/P"^$]T_B"$^(/$GCK4SX2\9?"OQI>
MZ[XWN/$.K7-CXXO8M=\26.NRQ2(VF:O+]HMVM+>SCTN'2]/EACL-/MH9%9O7
MQ&9>$=7#XBM3R+-:6/KUISC3A7QGU+"NKET8<M#"K'PE/"4<>YXBG3J9A#$.
MK&--S^I/V4)2KW7O1LM]KNS76VC:[)I*^[L>5Z3^W'X;UF77])T[P!K.K>+-
M)F^'JV?AGPYXH\(>));Z+XE:Y=>'-#AO-4TK4IM-T75M-U:UDC\1Z7>S,=+M
M@]W%=7L4;9J>)/V^/ 'A:YD\/:QX6U+3O'^C2>+_ /A-?!6K>)/"VCW'AN+P
M5)I:Z@MGJVHZA!IWB:_UF#6M+N_">G:4PGUN"Z!E;3F1P+>K_L/^$;>UL3X3
M\7^/8-8:Z^&&DZCKNJ^* -2L?!?PS\1S>(=%L?#3Z9I-G9:5J^F7$NVPOOL$
M@N54)JZWX+LW?S?LD_#*U@BU#3_$7Q&\->)EB\5#Q+\0]%\9R:=XU\8VGC"X
MM;[Q-%XPUQK*2&^ANYM/LI89;:TT^?1A8V_]C3Z:L7/I5*W@E3K4ZRP&;5\-
M4J5$L-2KYE1K4JE/+,-3Y\55J8NNXY95S'ZW5ITJ-&>9<TJ$I8A8:G5PLY7U
MBUKQ326K2MOK:R6MOEOI>S'6/[5?A/6M*N]7T#P[KFIVJ_$_P%\+]*\UH-.?
M5M2^(G@OPSXTT+4MET!)8V:VOBFQL;R*Y3[3!<QS,4*  ^)?"_\ :_\ %-]X
M0\ :WX^\.7=YXS\?^%?#J>'? GAM-(6'Q%XK\3>-=<T'2IK/6IYH5TNS>QTJ
M6YU%=09K;3+&SFN]]S<.L#^Y6_[,_P )/$/B+1OB1H^O^+[O3+CQ#X'^)=CI
M>D^-Y[_P/KWBCPAH%GHGA;QI/&RWLVLWLN@6FG6\]XVK36FJQ6MI>7$4UTBW
M)YK1_P!FW]G^ZT3PQI&B>+]8O$OM+L[_ .%VKZ=X\L[C6-&T[P]X@N/&&CZO
M\.=1MHF:2'P_>:O+]EO435;?^RKP6>HF\MIOGX,/F'A+0P53#/+LSK3Q5;)J
M\ZV(P]2KBL)"C@\52S#!1Q$<;"/LIXVK1Q.(J86EAZV)H05/"UL+4ITU&FJ[
M::<4ES*U]'K%IVMO9-)-V5];WT[WXA?'2?P!\ O&_P 7O$_A;4/!.L>%],U>
MW3PQXDN=.F<^)DO3H>@P1W]A=365_I6LZQ<:?)8WT4D33Z;=+/+;VT@DBC\$
M^%7[6_B&;P+X7T+Q5I^D_%7XS#XS7WP)\0GX=:CI&F^&K[Q%#X6U/QUIWBR"
M>>YN+2Q\,W_A:SCF>2"2Z>&Y$T21RR0R(/H/4_@+\,;;P1HFA^+-1UK4?#'@
MKQJ?BYK&H^+O$8NX]?\ $FFW=[KUSKGCV]OXTLM1TR"_G?6+FQDBL=&MI+*T
M9+:WM;*.)<:#X%_ C6/B[H_Q0\/W5K:>,].AT3Q)%HOA/7["TT+4_P"PM/\
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M:\7?]"4/_"DTW_XQ1_;7B[_H2A_X4FF__&* .QHKCO[:\7?]"4/_  I--_\
MC%;.DWNKWGG_ -JZ)_8_EE/)_P")E;:A]H# [S_HZ)Y6P@##YW;LCH: -BBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img117602972_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_3.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '- KL# 2(  A$! Q$!_\0
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M%?E+J'[:W[37@C1OV@?"WQ(^#'PO'QO^"GP:\'?M(:=H7P^\5^*O$_@OQ?\
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M1073:A9W$-OZ/X?_ &W?V8?%7Q7N?@GH'Q-CU'XB6UYXGTU=.C\*>.(M$O\
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M/K5K:ZE#!;Q:I81WZV&J1VULFH6URMM (_SJ^ W[3'[47[0'CSXI_!KX8_M
M_LW_ !.3POX"\$>/M!_:;\"?!WQ1J'PQT[5=4\4ZOHVO_"O7?"S_ !.$.I>*
M)=)LX-;L-0T/QC<VUA9J_P#:,27CM81>6:G^U3^WIX2_9$_:&_:LUSXI? /6
M[7X.>)_BI\/=.\%Z?\#_ !#I5SJ7B#X=_&0?"F+Q%/KDOQ4U")--U 6EWJYT
M8:6TT(N8;0ZG(UNUQ, ?JA)^R+^SDS:D8OA=I-C'JW[/UW^RS?6FE:GXBT?3
MV^ M]>:AJ%WX MM-TK6;/3["WGO=5U&Y?7K"VMO%0DNI"NN@! NWHG[-'P-\
M/>(--\3Z9\/M-_M?2O@7I7[-%H^HZAKFMZ>_P-T6];4+#X?7^B:UJFH:)JNF
MK=.YNM0U33KS7-1@DDM-1U2ZM'> _)WBG_@H;\&_%GQA_9=^&/[.?QK^$7Q/
MO?BE\9;OPI\1=(\/:U9^)M9T[P+;?#/Q]XD.J6*:??QMIDJ^)M"\/6C:A<17
M4/E74EKY'F7,<L?F?A']MW]H;Q#9_P#!234/&'POTOX1ZC^R]^S[X,^*_P )
M/ OB06^M^)]-O?$_PO\ C'XUMS\3+C1]5DTN[NKNX\#^'KBXT#2;F)=)@FO=
M/?5+J>0SP 'T/8_\$T?V'M+\/Z_X7TOX":/IFA^*M UGPMXCM--\6?$.PDUG
MPYKVK^'==O\ 1=0OK3Q?#J%QIT6J^$] N])MGNO+\/\ V%H-!&FVU[?PW7U=
MX+^&7@?X>:AX_P!5\':$NC7_ ,4/&US\1O'=PM_JMZ=>\9WFA:#X:N=::/4K
MZ\AT]I=$\,Z'8FQTF.PTQ18BX2R6ZN+N>?\ %7X+?\% _C/XHUK]FR2']I?]
ME[]H35_C#XE^&&D>._@+\*?ACXDT7XD_#O2/',>FGQ;K%]XAM_B+XMTRU_X5
M@VH2-KW]N:5HMO>Q:?>BU?[<L.G2_J;^TS^U-X/_ &7= \/ZSXF\#_%?XB7O
MB>\U.VTCPS\(_!\'BG7'@T6RCO\ 6-2OYM5UCPYX<T?3=/MY[<O-J_B"QENI
M)UBT^"\>.=80#H=-_9E^!VD?\(H-.\#16W_"$?%[Q?\ 'CPOC7_%4O\ 97Q8
M\>?\)3_PEGBU?.UR3[7)JW_":^)]VCW_ -J\/6?]J-_9^DVGV2Q^RYNM_LE_
ML[^)/AGXE^#VO?#+2]6^'7BWQIXI^(FN>'K[5/$4[2^./&?B#4/%/B/Q-IVL
MOK)U_0M4O=>U6_U"WFT+5=-&E/<M!I"6%JD<">(WO_!1OX!_V5\&-3\+:+\6
MOB/+\;? E[\4]#T;X=^ )O$NN>%/AGI>H_V1JWCSQ[I\>I6YT+P]IFJI<Z?=
M/:2ZM?M<V-\+6PN([6608<G_  4Q^",_P[^#GC_P[\/_ (\^.+OXU>"-8^)N
M@_#KP+X TKQ/\1?#?PX\/:Q+H>N^-_&FDZ?XL?1=)T#2[Z&43S6'B'5[N=8W
MCL;2[N5-N #Z,\*_LG_L]>"/#_PN\+>$_AGI>@Z%\&?&DOQ$^'-E8:GXBC;1
M/&]QH6M>&KGQ+>WC:P]]XFU.ZT3Q%K%G=S>*[G7%NC>?:KA)+RWM;B"C\/?V
M.OV8_A5X^\9_$_X?_!KPCX;\;_$"WU:S\5:Q;Q7UW%>V6O7*WFNV-EH^I7U[
MH>@V.N72B?6;+P_INEVNJRY:_BN"S9^?_&O_  4T^"'AKQ!X+\->$OAY\?/C
M7J?Q"^!.F_M#>$$^"WP]TWQ?_:O@/4?$>J>&FA>"]\5Z%?:9K6G7.C:A=ZFF
MK6=CHUM:0I"FMS:M-#IDEOP/^W1\/OB!\8-/GT#QE<'X(:A^Q!=?M8&6\^'L
ML,EAI&E_$G4/"^M:U?>*XO%MQKHOM'L=,O\ 3[[P%:_#6ZB,]E-JUEXSO)7A
MT60 ];\ _L+_ +(_PPT/XD^&O _P(\$:-H/Q>TMM"^(>F20:CJ]MX@T$FY=-
M 5=<U#4FT?0+>:[FN;/1-!;2]*L;SR;RSM(+JVMIHN!T#_@F9^P[X7TCQ=H6
M@_ C3M.TWQ[\/W^%WC&.+QM\3)+GQ#X&?Q/I?C$Z-J.HW'C27499AX@T32;N
M/6ENTUZ*VT^VTJ+5$TB,6%?,GQ3_ ."L_A6;]F3XV?&#X(_"CXR#Q9\/_"7A
MCQ7X4A^)OPV;2_"WB/PWXK\0Z?H5IX[M]5TKQ+>V%QX3TXW]M-J=O-JFG^);
M==1TR;^P)+:6YEMOU/\ AIXWE^)'@3PWXXG\%>.OAS+XBL7O7\$_$O1[/P_X
M[\/%+JXMOL7B31M/U76[*POG$ N4AM]5O4-K/;R&4,[(@!Y7\3_V1/V;/C/\
M0_"?Q6^*'PB\+^,/B#X*.G_\(_XDU$:E#<)'I-Z^I:5;:O9V%_::9XFLM,U"
M22]T^P\366KV5E<NTUM!$Y+5]'444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5EZW+K4.C:K-X;LM+U'Q!%I]Y)HFGZWJ=WHNC7NJI;R-86N
MJZO8:3K][IFGSW0BCO+^TT35[FUMVDGATV\D1;>34HH>J:[]MQIV:=D[-.SO
M9^3LT[/K9I^9^%7Q+_X)<>/OVG/V9OVG-$_:>TK3M1_::^/6H>*M6EM?AU^W
MY^VIH_[,FKZQ=7-M;?#75-?^%]IX5\+?#?2U^%/AO1_!NCZ7IMW\ OB$OB2;
MP+I6J:[?OJ6IW5W9?37_  2<_9[_ &S/V2_V3O!/[,_[8&O? [QS??!VR/A?
MX:>/O@]XX\?^)[O5? <=U=3Z)H'BW3?'/PJ^'?\ 9UUX0LIH=!T>^TR]U:._
MT2ST^"YMK*XLGGO?T[HKWZO$>85LLQF3S5!Y;BL1@,32PC5>='+JF6X>>$PO
M]EPJ5YQP4(X6I4P\X4URSH.%&2]E0PT*/F_V9A_K6%QKE5>,PKQ]\5>G&OBH
MYE.C5Q5/&SA2C]9A*KAZ-6$9K]W5A[2+4Y2DRBBBO /1.;LO^1K\0?\ 8'\-
M?^E/B.NDKF[+_D:_$'_8'\-?^E/B.NDH _+O_@I/^T?XD^'7ASPQ\$OAWJDV
MB^-?BQ#J,NM^(+*39J7AKX?V($.KW&G2J=]GJ6M2L^EVE\@$]K"MY):-'=^3
M-#^1_A[3],TK2K6RTV..&&) 7P09I)B<R2W,A)DEF=\O)+(S/(Y9V9BQ->Z_
MMZZO=:U^VW\0[:\D=XO!WP^^'F@:1&Q.(;34]+7Q+=M&.@66^U2;>?XF'/W5
MQ\S D=#C/7'%8R^)_P!;:'J48J-*"6\ES2>EVWMKY)VMMN=WY\!;9YT18_P^
M8N?3&,YS[=:)8(IT,<L:NA&,$#(_W6ZJ?<&N$K0@U.[@3RPX=1G;Y@+%?8'(
M.T=@<@=JG<T-SP_?6WA:34M+F5FTV[OI=6A$4:N;2[O8;:.\41[HP;:[^S0W
M$BJ6:.[\Z5%<7#HF7<ZCX0GEOUT7PKI%GJBR2+/J#:1I]GJ :<+F[AGMXOM,
MJW"CY9FFP=I5T#*RC,FFDN)&EE;<[8SZ  8  [ #@#L*HSVEO<,DDJ,)8_\
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M?P>FTOQOXTF@\4?$F" 2VV$$F@^%KJXC*SG2895S>:E%&[VZZO<*#$I8V$4
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M1+GPWH6JZJN?M%YI>@WFJZY<Z5:2_+Y=G/J^H218.;E\\=510 4444 %%%%
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M\._#OX=^ ?AWX[^,WQ,\$^%/&?AOQ7!XI3QI'>?%Q1XH\$>&-9CTC0_#-_\
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MXD_Z&#6O_!I>_P#Q^C_A)_$G_0P:U_X-+W_X_0!^\E%?@W_PD_B3_H8-:_\
M!I>__'Z/^$G\2?\ 0P:U_P"#2]_^/T ?O)17X-_\)/XD_P"A@UK_ ,&E[_\
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MH_X8R^-7_/W\./\ PI_$/_S$U^JM% 'Y5?\ #&7QJ_Y^_AQ_X4_B'_YB:/\
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M1_PQE\:O^?OX<?\ A3^(?_F)K]5:* /RJ_X8R^-7_/W\./\ PI_$/_S$T?\
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MM[ZPO[:"]L;VTFCN+6\L[J))[:ZMKB)GBGM[B&1)89HV:.6-U=&96!/^<_\
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M03^.?@RMA;+JSZ=JMG!XU@U3Q'X926WU.S\.W$=S<RIX>7[+Z'J/@'QKKO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!"ZN>-B_;,_9XG\72^"H?'$DVL#5]<\/6=Q'H'B!]#UGQ%X<M[RYUCP]H/B
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MG[.5L,^6:ABL-)Q=FEB*#:_?4^8]K2_Y^0[_ !Q_S_K7L?95%?-/C_\ :[^
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MM;:'J=%%%?*%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,C#JB"1P\@11(ZIY:NX #.J;GV!FR0F]MH.-S8R7U\;^/]>9H%%%% !1110
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M;G8? 7QDUO\ 9S^%W[&H_9X\3Z%XS\'_ !0\!R:Y\5[FVT2/X5:=X?\ A_\
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MQ9H^C>#_ -HG0+RS_9S^('@ZT\2_M&^++!8[?QEXJCT0V_@3P;I&CW-S!?\
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ME_9M.@\+%2HU,*>PDK6DN9W4I:IM<U.2?6[7(U;3XKWWO^,OASP-XCN_@_\
M!+XL?\+G^.-MXU^)'[:.I_!K7+RV^*?BW^SH/AGXL\>^.O"^I>'-.T2?4I]*
MM98=(L@NG:L+5M3TV[D%W97,$EO;"+]&OV1-/NO OQB_;%^"]EXD\8:_X'^&
M/C_X53^"H/&OBG6?&6K:-#X^^#_AOQ?KUC'KOB"ZOM6FL6UJ\N)K6VN+N6.U
MC<10A%W;OJR#X/\ PKM=%T3PW;_#WPA!H'AKQ8GCSP_HT6@Z>FFZ-XTBOKO4
MX_%.FVBP"&SUU-1O[V]74H42Z6ZNIYA)YDKL>DTKP?X6T/7?%/BC1O#VD:9X
MC\;W&DW?C#6[&PM[;5/$UUH6E0:%HMQK=Y%&L^HS:7HUK;Z78R73R-;6,$5M
M$5B15'E\7>+&'XHRWB++:F"Q:H9I3S)973K0P2IY?4J\89'G>42?LDI1_LO(
M\'G.3T/9-^P6;UZ=!*AB,2Y53H<C@[J\;<SUU_=RC*W^*3C+I\*OJD? W['.
MLZ/X.^(O[9'AKX@:KINC?$=OVA/$?BS4O[?O;:SU'4_ 6LZ5ID_@75+>XO94
M:^T.UT!(M/MY()9+:QDM)K-Q#+%)&/"/B3X^^!WQ @\ ?#S]GOP[\0CIGB_X
MD?&/65\->#?B ?@#\/O'6L^%I[.Q\9>.];\>PWL6M:EX;AU;4GGTJ/PK<$ZS
MJ274\NG306D[1_IWX]^!'P8^*6H6NK?$;X6^!?&VJ65O]DM=1\2^&M+U:]@M
M=Q?[,ES=VTDP@WDMY)<QY).WDTGB;X#?!7QEHGAWPUXJ^%7@'7_#_A'=_P (
MMHVJ>%M(NM.\/!XA"XT>TDM3#IZO$!'(MJL:R*,.&J<'XB<,0S]<3XK"<3+,
M<90R^.-P.$Q=*AD^!Q66\.8G)\/BL-1PV,P>,S*$,;+#8S T'B\DKY1A5B,)
MA<?6K5*>,IGLI\J@G"T;V;C>33FI6=TTKJZEI)2=FUT/RL_9?T7X[_''X8?$
M7X90^,_#.M_#3P!^T)XW\,Z]H7B7Q[XL\9W6N>%M-AT;4M)^']G\4$L9];U_
MP7:ZQ-=#5+VY2._UZP0Z8+Q-+N)TF_0RW_9=\$2?&7P]\;;RWEM/$&D>$X]'
MET32M=\5Q:)'K<=]IUY!J5A -<@LH]-LH[#[#!HC:4FF3PLL]S:-.@(]J\%?
M#;X?_#>#4[7X?^#/#7@RUUJ]AU'5K;PUH]CHT&HW\%E;:;#>7<-C##'/<QV%
MG:V:S.I<6]O%%G:B@=M7A\7^)>/S?.<SQ7#BJ<.Y5CHXV#PN$C'"8C$0S?#8
M6GG+S&6'JSAC*V.KX=.>*JRJ8J=&GAX5*S]C3C"J=)1BE/WY*VKUMRM\MK[)
M)[+1.]EJ?%'[0-]8Z;^U/^Q!>:C>6FGV<7B/X\B6ZO;B&TMHS)\$_$$<8DGG
M>.)"\CJB!F&YV51DD"O'OV\?'WBW6-5_9]^&?P]\06K^%/B1X]UC3O&=SH_Q
M.F^&L6L2Z-X>NM7T7P==?$G0XM0O?#(UBYB>Y$5H(+S5A8C3XIXQ.<_=WQ'^
M#?PH^,%OI-K\4_AWX/\ B#;:%<7%WHL/B[0=/UR/2[J[A%O=7%@M_!,+6:X@
M589I(=K21@(Q*\5RFG_LP_L[:5X9U;P9IOP3^&5EX3UV^M=3UGP[;^#]%CTC
M4M1L5"6=]=V(M/(EN[5!M@N&3S8ER$< FNKAWC+A;*ZG!69YA@\TQF9\)Y/F
M>3_4?J6$JY96ECLWXGS+"YO2Q?\ :N$QM/&97+B&EBL-AXT*+EC,MI>SQ^%=
M6.)PZG3F_:).*4Y*5[M/2--.+7*U:7(T]7I+9V:?Y.^'=:^+OPQT7Q/\1&^(
M0U7PE^R?^T+X&U+5O VD?%KQ7\6)_#WPL^(GARW\._%SPCXK\8ZMHFDV_C"/
MPX-=M_'F@Q7MWXAG\)PKJ*7%Y9W^GQP5E>+/$/QC\?3?#O7CXCUP^$_VNOC5
M\4?%UMH5S\6O$/PETZ3X??#O1(M#^$7@W3O&UC:W=QX2@\26.BW'C.[T[0HK
M"7Q7+<(9;HO/+N_:70_@_P#"OPSX*U/X;^'OAYX.T7P#K5OJ5KK'@_3?#^FV
MGAW5;;6(WAU6'4=+AMUM+R/48I'BO%N(Y/M$;%)-R\4[7?A%\+?$_@S3?AWX
MB^'WA#6_ FCP:?;:1X1U/0--O- TN#28TATR+3],GMWM;-+"*-([06\<?D1J
M$CVJ,5]A3\:,@AF+Q\N%54Q+QE7#+,'2H0Q"R*>4S=-^PIXF%=YK1XRJ2XQ6
M(>;?7IXI0P]3.Y8F+S*4>PG:W/I:]KNW/S+K;6/LU[.W+9+7EM[I^(OAG5?'
M5MXP^"/A/Q3XVT?7=&\ ?MJ7VE^$4L_'GB+XLZG\/K27X.Z_J&I>$-:\<ZYX
M?TF3Q.^A:C(U]9-#<ZW<P6E\+"\O1+#' G=_LU>)-8\ _&?X*:OXV\5>-_&\
M?QEUSQ1HN@?%WP3\;]8\=_#_ .*-[K%OKE]96GC;X-^,%M=5^'4VG06(DB70
M=%LH/#MY81VU[<H&FM!^N.D_ [X.:#IWA72-%^&'@;2M,\#ZW/XE\'V%AX:T
MJUM?#?B&Z@N+6YUO1X8;9$L=5GMKJY@FOH0MS)#/+&\A1V!K>&_@'\$O!WBJ
M?QSX4^%'@#P[XQN9+R:;Q+H_A;2+#67EU L;^47]O:QSI)>%W-RZ.K3%W\PM
MO;.F9^,O#68X#.<#+(,?3IYCDN,RQ1IK"T%7Q%>IQ!4CBZM6ABXU\.Z^*S?#
MYEC(8F>=8:MBJ5?ZSA,=CU@\ZPJCAYQ<6IKW9*3WV2@N77=)0<5;E=FK67-&
M7KE%%%?S@=84444 %%%% !1110 4444 %%%% !1110 5Y7\5;KXS1:9IEI\%
M=)\ 7>N7NH>7JNK_ !&U76K/1-!TE$'FW5MIGA^PNM2UO5)6?_0[,W.G60:%
MA>7:)*I7U2OE[]JSXM?%;X-^!=)\5_"[P!=^.7.O1V?BJ2R\!_$3XH3^'-#E
ML[DQ:JO@#X/VNM_%;Q%YVJ"RT\Q^"?!WBZZL1='4-4T^QT:VOM5L@#B'L/VY
M?"5YIT]Q\5/V9?B-/?W#6]MX+U7P+XO^%EUK$<$3WM__ &)XAM?&?C>675;>
MPMKAX;.30);0*SW=Y<06]J^_[/LY+F:TM9;RV6SNY;>&2ZLUG6Z6UN'C5IK=
M;E4C6X6"0M&)UCC64*) BAMH_)_P3J?Q!_:P^.7[-?Q)G^-?[)U[I_[/7CGQ
MMXUO/#?PJU+X@7?Q%U)?$'PW\7?#'6/#VI>&/&?]G3: +5_%+-J4VJ:1]NT^
M[L)+.-+:]#O%^D/QC^(,7PF^$?Q1^*4]A>:K%\-_AWXT\=OI6GV=UJ%_J8\)
M>'-2U[^SK&PLDDO;Z\OC8"UM;2TC>YN9Y8X8$:5U! /2**_.#]B_]K;4OB3\
M-O&GBGX_?%;PY:^,? WP_P#"/Q*^(7@K5?V9/C+^RCK'PK\*ZSHVN7][XHO-
M"^.7BC6O$OCWX;ZC?>'_ !)IWA?XHZ%I6F^$-7N/!GB>VTZ]U.\L-0@TSZ@^
M%?[5/[.7QOUR[\,_"3XS_#_Q_P"(;&Q;4[G1?#FOVM[J<>GI(L4EXMGN2>6W
MBD=%FDA2182Z&4H'4D ]_HHHH **** "BBB@#\Q_&EAIVH_M1_&;5/@1\>8?
M@C\<](\.^ ],^*'ACXE>&=(U7P'\0](32/[3\+>(]"35;VUU"2#3;&]DT/4]
M6T*XA2WO;22SGMFFB:9_E_Q)\8_B=\9]$^!?P\T_0O"GAO2]>^*/QYT#Q['\
M.OB+J7P1\"_%;Q/\-1I<UAJGA[XB:!I\VJ6VG^([C4]7UFYTVWECNM;O]'OK
M6?4+A()!)^P/Q#^!'P7^+5W8W_Q.^%G@/Q[?:9$T&GWOBKPQI.M7=G [%V@M
M[F^MI9HH2S,QB5Q'N9CMR239UCX*_"+Q!X-T[X>:W\-/ ^J>!=(>&32O"5YX
M:TF;P_ILEON\B6QTMK4VMI+%O?9)!&C@NQW?,<_O&3>*'#.74<BJ8S),=FN8
MY;@\!@HXG&X;+%B<J>!X;S#(X8G"YME]7+,TSVGA\5B<)F638'-:V$K9!3P-
M' Y;FT'3I8R'-*C-N7+)13;;2<K2O.,K.,N:,+V<9.-U.]W'H?C%X'TGXA_$
M3Q/\)_@;XR^*^MGP-:_M1_$;PS GPZ^,OCWQ#XATOPMI?P1UCQ7JOPM\3?$X
M:=X5O/$PTS5K0FTU"UOM:NK"SU=8I-2BO;*V6+M=7\:-\./V>_\ @I3X9E^)
M'B33+_P+XXN_#_@4Z_X]UVZ\6:-82> _!::%!HNHZGJLFO0O>23&>">RF1KJ
MYGFNB[2RRR'];] ^#WPJ\*VWA.S\-?#OP=H-KX$O]4U7P9;Z3X?TVQB\,:GK
M=C=Z9K&H:*EO;QBPO=3TZ^O+*^N;?9-=6MS-#,[QR,IY[Q=^SE\ _'^O7WBG
MQM\'/AQXK\1ZG9C3]2UO7O".BZGJ=_9+$8%MKR[NK22:YB2 F)%F9]D?R*0H
M KU*GC)P]C<VP[QF3YE1R##K*\7]1P5'+G4K9QEG&M/B2OCYT*U94E4SO+Z%
M/ XZO5Q.*Q%"M4J2E/,(*I/$)8>2B[23DVU=W^%T^3EOUY7JM$FOY;Z?CIJO
MA'7?'FC_ /!0'XC:E\5OC%IFL_ KX7^#/%_PQM/#WQ-\7:-I&@^*-)^ 4'C2
M35)M+L]52RU)=2U+2K*&_L;V*6QGA>_D> W5[+<'ZW^!OA_4?AE^TU\(='T[
MQU\1?$=A\:/V7]=^(_CZT\:^-M>\56-_XVTG6O!30ZYIFGZO=W-EX?>1/$^H
MP26>APV%CY MXEM@L*X^]X?A#\+8+'QMIL'P_P#",6G_ !)TV/1_B!91Z%IZ
M6WC/2HM$;PW%IWB2$0!-7LX_#[-HR6]Z)8UTUC9A?))2MJ'P)X,M]<T/Q+!X
M7T*'Q#X:\/7'A+P_K4>FVJ:EHOAB[DLI;G0--O%C$]GI,\NFZ?)+8PNEN[V=
MLS(3"F/(SOQ>P^;9?B\I6!QD<LKY1/+*6"G'!*C2Y>"LCR/"OE@KJG0XDRNO
MQ HQ=_;5XXI)XQS8XT.5J5US*5V];O\ >.7WN#46_*VUK?FUXVM?C-=_\%%_
M&2?!?6/A]HVLK^R_X,.K3?$/2-=U?3Y=._X3G6=D=A#H6H:?-%=BXV,\D[R1
M&$%54/S7D7Q/_95USPW\1/@H_P 0_B+?ZG\0?VB?VJ#XG^(_B3X>B[\#V]C8
MZ7\,=?TBU\/^$);:XDU;2(3H\=S92ZLMVNK.U[).D\4T4;C]A8O!/A"#Q?=^
M/X?#6BQ>-[[1+;PW>^+$TZV77[KP_9W4E[:Z-/J@C%W+IMO=RR7,-H\IA2=V
MD5 Q)J;6O"'A?Q'J'AW5M>\/Z1K&I^$=3?6?"]_J-C;W=WX?U:2UFL9-1TF>
M9&DL;Q[.XGM6N+=DD,$TD1;8[ \F7^+^+RJOE4<NPE/!X3"<'87AS'UJ&!RY
M9MC\3@LFQ&$PDZN8SISQ$\NP^;RP>94\,ZD$_J='GISE2IQ3=!24KN[=1S5V
MW%)R3?NZ+FY4U?I=]#\7+N_U_P )^+/'O[-;?%GXB^'O@M)^V-X&^'-]XDU+
MQSKESXL\/^!_$WP=LO',_A.U^)&J7<_B#1[7Q)XR\C2H+]]52\MH]3-C874#
M21 8?Q&N==\(^-/C9^S;\+OCOK4GPVA\1_L[ZGH$7C?XH>-W\[Q7XLU/61XG
M^!UO\;-.37?$?@X>.-,TG3]1MKN\U(?V9,&@2YM8;V4-^S.J_![X5:[:^,K+
M6OAWX-U6T^(>H66K>.K;4/#^FW</BW5--LK;3M/U'7XY[=UU.]LK"RM+2UN;
MH2306]M#%$ZK&H&18_L_? W3?!NJ?#NP^$GP]M/ NMW:7^L>$X/"FC)H6IWT
M1C:*\OM/%IY%U=1&*,Q7$R/+%L7RW7%?0X3QDR&G+#U\1D^95*L<-DL<9A50
MR>IA,;GN"K\/8O&\9XB=:+KU<_G4RK'X2FE[*M7PN-Y_[6P-6MBHU)=">J4E
M;WK.\DU%J25/33DNT^J6W*TD?B[)XM^T^%]"^#>H^-_C7\%+W0?VNOA9X=\?
M)K'QG?QK#X3T'QMX2U.Z33O!WQ5LM0GOM2\.>(/L^^2P\2:C<7^CWNH))Y%M
MLMUAE^*.AW%I\1_$O[-_@SXG>/=>^$6E_M+?L67FA>);OQOJGB_Q)\.O%?CO
MQ#K=KXKT/P_XXU>ZU/4EOAI]K8ZYI\,][=R:#>2QSJL8G1&_5?QK^R%\&?$_
MAKP9X.T/P?X4\%>%O"7Q+T3XD7/AW0_"FD?V)XCNM+@N[.\TO6=**0V-U!JU
ME>26L]U=0W<L"JDD,?F(C+Z?HOP*^#/AS1=-\.:!\+? FCZ#H_BG3/&^EZ3I
MWAG2K2QL?&&BSBZTCQ/;P0VRI'KFF7"K-8ZF!]KMI%#0RH0*]:?C3PQA/8XW
M 8'-JE:I4JUIY36HX2>&PN9QS/)L=#B.6*QE7&8NKF,HY=C:&$PU7&YC4P^$
MS;$T,7FN)DL9+-I6'F[J3C;3WM;N/*UR65DHZ[I+5745=<OY*_$/Q%;?LZ^-
M?VI_@M;^._CE>?#N]\.?L\S^$M(T[XCWFI^.H/&/Q(\0ZMH&IZ1H7Q"\=7M]
M<>$])\3K8QQZO?RZC FF0R7%QITEM<^1CY5^+^FZ]:^%_P!L/X7:[J7B'2/#
M6@?L_>#/B=;^ D_:!\6_&.'0O%Z^-!I45SJGB/4[E7AGO]*NA_:GA9+B^T21
MHK.\>-Y1$R_T.^)/@O\ "3QC<^)[WQ7\-O!?B.[\::9I.B^+;G6O#NF:C-XC
MTG09Y;K1=.UB2ZMY&O[32;F>:?3X;@NEI+*\D 1F)K!TW]F[X :/I^HZ5I?P
M:^&UAINK^'[OPIJME:^$-%BM]3\-7UX-0O-#U"-;0+>:9<7P%W+:7'F0M< 2
M[=P!J.'_ !SX?R>.#QF(R3-\3G$:G#.*S/%*M17]H9ED6'X0C5S3VBQE.BL9
MB*_#^8MU\5E^,QM1YHL1''X5K%X7%D\-*3LI144IJ*UNE)STVO9<RT4DE;9Z
M-?D!X\L/'WBGXS_&/X;Z?KNJ6OP__9^^'GP]M?ADNK?M2^+?A%/H6A:QX5N-
M=U#XGW&HVUIK%W\3)[C5X94FU;7[_4;32H])32)K5S*^[[E\4^(?%7BO_@FS
MXO\ $/C;7=+\3^*-4_9O\2W.K^)=%-^VF>(+@^&;U5UJU;4])T.]9=2A6.[=
MI])L2TDKLL*H5)^EM<_9I_9\\36?AS3_ !#\%_AKK5EX1TV/1_#%MJ?A#1;R
M+0M)BE$\>F::L]H_V:PCF'FI:)B!9,L(P22?4-3\*^&M9\-7G@W5=!TG4/">
MH:5)H5]X;NK"VFT6ZT6:W-I+I4VFM&;5["2U)MVM3%Y)A/E[-O%?)9_XHY)F
MD.#(X;)\13GPSG&0YCB*M2G3A6JQRC#8>CF56C5EC\9%XKB;&49YWF4:5++Z
M4,PJ/ZW/.,0EF2N%"4?:7DO?C-:?WGIIRK2"]U:O3;E6A\IZ9\3&\*?L6GQ!
MX"U71=7^(/A/]F34/$7A/0K>]LM1OKWQ3X<^%]SJ^CV(TJ&:2YNI)-2LK>-[
M18F>0%HRO)K\VO@[X?\ BAJNJ_ MKGXA)I\7[0OAO7](\<:D_P"T]X^^(>N?
M$>R\1^#;R^U'6?#O@JU\/+9> -?\*ZI<QZQ9W.EWOANQT7[.VDRWC?NT?]=?
M!W[+/[-_P]U_3O%/@;X'?##PGXCT@3KI>MZ!X/T73-2L%NK6:QN5M;NUM8Y8
M5GL[B>UE", \$LD; HQ!Z#PC\!/@GX!\27?C'P3\*? /A7Q5?+=+=>(-!\+Z
M1IFK3)?2F>\0WMK:QSJEU,3).J.JRN<N":K*O$?A;AW#<5T,JR_,\;7X@Q&+
MS"CCLQP&#PV)AB<3A,RH8? 5X8?.<1AW@LMQ>*PN:X7$U:6.E+%4ZO)@,)BJ
M6#S&@2HSFX7:2BDK)MK1Q?,KQ3O)*46DXZ->\U='X_2?'CXR>(O ][;^%[_Q
M)=^/?V)_V??B=>?$(PW.K3+K'QA2?4O ?A2;7K9+AXO$C:5X9T35_B +?4%O
MK6:>YAN)H6VHPM?!2'XF^%/%/PCU1_&=A%I_Q9^&OCVX\96VK?M)>+_C-??%
M*Q7X<W^OKKVE>#+[PU)I/@W4](UQK&ZFN;6_T#3;:QO+C1C]JN1:6Y_:+1/A
M[X%\-ZCXMU?0/"'AS1M3\>WRZGXUO].T>QM+KQ7J"6::>EYX@FAA1]5N%L8D
MM!)>&5OLZB+.W(/'^$_V??@=X#U34];\%_"7X?>%M7UJRNM-U74M"\*Z1IM[
M?:??,SWEE/<6MK'(UI=,S-/;AA%*22ZG->M4\8N&'E^=9?A>$OJ5#'4<1]6C
M"%&M.I4S+ XRMB\-BIQQ6%H1P>6<2YGF&;Y,ZV"S2=+#SP^'A2P.,PV'S"C*
MP\[Q;J7::OTMRN*32LW>4(1C+6.J;U3:/PL3_A)]2^'OPGU"Q\5^(O&7ASX=
M_LC_  LU;5/AEX"^-^O_  0^('PLDGL-7OKGXDZ);7/]E^"?B.=;MK:$06>J
M:I?C3I_#[6,]B5U#RI/WJ^#GBS3_ !U\*?AUXPTJ\UO4-.\2>#?#VKVE]XDA
MCM]?NX;S3+:9;G68H$CMUU*;<9+PVZ+;M.SO /*9#7-:U^S5^S[XCM/#=CKW
MP7^&FKV?@_2K?0_"UMJ'@_1+J'0-%M,&UTG2TELV6TTZW*CR;*("WCQ\L8R:
M]GMK6VLK:"SL[>&UM+6&.WMK:WB2&WMX(4$<4,,,:K'%%&BJD<:*JHH"J  !
M7ROB3XA9-QKE^6X? Y9C<'BL%F698OVF)E1A2IX;'-3G0C2P]:>&JU:U=+$S
MQ&'P65U$^99C+.\;4GFCTI4I4Y-MIIQ2TWNMMU=):Z-RWTY5H3T445^0&X44
M44 %%%% !1110 4444 %%%% 'SY\5O#?[2/BS6X]*^%?Q,\!?"/P>-,MY+KQ
M5>>!IOB)X^FUH7,DLEOIVCZMJND^$++2/L\4-M/)?1ZI?3B[FEM3826L9G\_
M^'%E^TAX5^),?@_Q3^T7\)/CKI]I:V>K^-O#U_X"L/AO\4O">CZL+VVT;5]+
MLO!^OZMI<VD7MW83B(>(-$@?498;N.RU>$6CQ-P?[4_QY_:_^#/C:UN?AI^S
MOHOQ#^ R^&K.^U_XH:2/&OQ$\7^$_$ NM0CU.TUCX(_"_3=8^,GB+2&A_L1-
M%F^$'@3XLZ]<W-YJ<VMZ!X>TC2GU2;COV-H=7^*'Q]^-O[4.J_%+X ^,YO&W
MPY^&'PMD\(_!/6O%&JWO@V[^'^J>+]6NX_'=CXQT[1/$GA?Q'(_B@6-[X5UO
M1--U?1KO3[FVU.WM[P2VL !]R?%3X/\ PX^-/A/6O!OQ(\)Z'XFTG6M#UK0'
MEU+2=+O]1TRTUZPETZ_GT2]U&RO'TJ_-O,6AN[95DBF2*3#&-16_X!\$>'OA
MKX(\(_#WPG:?8?#'@CPYHWA70+0^5N@TG0K"#3;%)##%!$\WV>WC,TB0QB64
MO)L4L176T4 ?"W[,0 _:F_X*2D 9/[0/P0S[_P#&%W[.0Y]>.*^Z:^%OV8O^
M3IO^"DG_ &<#\$/_ %B_]G*ONF@ HHHH **** "BBB@ HHHH **** "BBB@
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MQX0U[4?"WBO2;;6]/N-.EU/PWXDTB:WU/0==L$N#=:5JUC-'<V%]%!<Q$M&
M?R:_8=\%^!9/%/PN^+'@_P"'?_!/SPHOC3P7'K%C'\%_B9XJ\8?$/P]I/B[0
MX-<GT7P9I^J6$6A642R-;6NKC1(=)MGL+65(H5@CCMU_9&@#Y3^ _P"S->_"
MKQWXV^+WQ ^*.M?&CXP>-O!/@#X67GCK5_#>@^$%L_AC\+]4\:Z]X,\-0Z'X
M>#VD^HPZ_P#$;QEJVN^)+FXDO=<GU&RC>"TATR%),#XP@?\ #9G[%_'3PI^U
M/CV_XIGX9]*^RZ^-/C#_ ,GF?L7_ /8J?M3_ /J,_#*@#[+HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /R^_P""A5[\0/ ]U\+_ !!X _:8
M_:J\ ^,OC#\0/!_P"^%WP<^#-W^REH/@#7_B#X@3Q#K:^(_%WB_X[?LQ?&?7
M?#-I;:!I.K7NMWUMKES;S6NB6.F^'/"E[XAOX[;4W_L*:C\2=#^+OQ]^$OQ\
M^(GQB\=_'+P7H?PXUO4I?B1KG[.?C3P\/ 7BJ/7)O#%[X1\9? S]FW]G/67E
M?4++6[+6_#OC[0[NXTZXM(;[0U.G:C]MN^^_X**^+O"^A_";X=>$/%OP?\%_
M%K3OB[\<?AW\,K.;XF^)KOP+\-?ASKFLSZAJ.B?$#Q;X]TRUN];\'26.I:1;
MZ)X0U/01;ZW>>/-=\+:'IEY;7>JQ2#6_8J^'%A\.;;Q_;6/@C]GKPM)K=_I>
MJ:EJ?P8^*_C/XO:_X@O8[9[*.7QOXE\>V$7B%DL+.""UT.WFU.^MK:W$T-K%
M:QJ5< ^ZJ*** /A;]F+_ ).F_P""DG_9P/P0_P#6+_V<J^Z:^%OV8O\ DZ;_
M (*2?]G _!#_ -8O_9RK[IH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\8_:.\(V'Q _9[^.G@35/$UOX+TSQI\'_B3X4U'QC=Z[/X8M?"EAXA\':SI
M-YXDN?$EJ\=QH$&AV]W)J<NLPNLFF):M>*P,->SU\^?M:V,^I_LK_M*:;:^#
M-,^(UUJ'P%^+MC;?#[6M(\7^(-'\<W%WX U^W@\(:KH7P_L=3\=ZSIWB261=
M'O=+\&:=?>*K^VO)+7P_:7&JRVL3 'Y;?L&?$3X;KXK^"?P]T'5_V#O%NIZ1
MX0L-"LO&7P4^ 'Q:\#>-O$L.B>$3;+KWAO7M?\*?\(YI\>KVMH+VZ:3Q/=P7
M5C/.EK>W331&3]S*_#C_ ()[_%7Q9?S?L^^!_$G[4G_!0?Q+J-G\._#^DZO\
M(/CM_P $POB%\"/ =GJ&D>"8H;K0O$GQLUC]C/P)H^CGP_<VKQV%]/\ &#.M
MW=E:V@U?7)KX+>?N/0 5\:?&'_D\S]B__L5/VI__ %&?AE7V77QI\8?^3S/V
M+_\ L5/VI_\ U&?AE0!]ET5E3Z[HEK*\%SK&E6\\9VR0SZA:0RQM@'#QR3*Z
MG!!PR@X(-:$,\-S$D]O-%<02KNCFAD26*1>FY)(RR.N01E21QUH EHK-NM9T
MBQE,%[JNFV<X57,-U?6MO*$;.UC'+*C[6P=K8P<'!.*M6UW:WL*W%G<V]W Q
M95GMIHYX69"58+)$SH2K JP#94@@X(H L4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!^5/_!6FV\/+\)/@)KVMZGX2N+WPE^U-\+?$/AGX:>,OAW\5?C-I
M7QL\00VOB.RA^&<'P6^"_A3QIX_^)>JWEC>W_B/2K'2_#^H6WA*^\.0_$/5+
M6]TSPC=V%UVW[ /CZ'QM_P +&\G]FSP_^S]]@_L/=_87[+'[1_[-G_"2>=]M
MQ]H_X7]\"/@M_P )3]@V?)_PCG]N_P!G>>WV[[']H@\['_X*B>!?B?XX^''[
M/Z_#+PG\7/$K>%?VI/A;XS\:7_[/NG^%9OCMX/\ !7A^W\17&I^*/AAK/C/4
M++0/#VJVUX^G6&NW%U!JCZWX-U#Q)X5ATRYDUY=GJ'[&<7B"/_A./[<U+]NC
M4-W]D?9Q^V9:?#*V\K'VO?\ \(/_ ,*\TO3=V[Y?[7_M/S<8M/L^W,F0#[HH
MKQ/XW_M%_!S]G/1-&U_XP^,&\,67B+59-&T*UL/#GBOQEK^K7EM8W.JZC)I_
MA;P-H7B3Q-<Z9HFDV=UJWB/6XM(;1O#>DV\NIZ_?Z=8*;BO5]#US1O$^BZ3X
MC\.ZI8:WH&O:;9:QHNLZ7=0WNFZKI6HV\=W8:A87EN[P75G>6LL4]O/$[1RQ
M2*Z,5(- 'Q7^S%_R=-_P4D_[.!^"'_K%_P"SE7W37PM^S%_R=-_P4D_[.!^"
M'_K%_P"SE7W30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y;\6/AIX.
M^)^A6>D^+M8\6^'#IVH+J6A^(_ OQ'\9?"WQ1HVK)#+%%<Z?XE\$>(/#VI31
M%)&%YHFHW&H>'=9@!LM>T;5=.>:TD]2KYQ_:N\&>&O%'P+^(NL:U\%-(_:"U
MOX>^"O&7C[P'\*]5MXIF\8>-_#GA;5K[P_X<TYY<K;:AXBOHHM"M[C!,;:@"
M 3Q0!XGH/[(?B?4M3@MOBK_P4-_;1^/_ (2(=Y_AMX@\1_LK_!O1]4ND&;>?
M4/%?[&_[+_[,WQBN[6V^?S_#_P#PLP>%-:ADDM?$N@ZU9D6X^L?B/X\\'_ G
MX3>,?B-XCAO[3P-\*?!&K^)M4M=!TJ^UO5(_#_A/2)KR2RT71=.BN-0U34&M
M+,6NFZ=:12W-Y<M#;Q*SR"OYV?\ @G?\7? _B?X^?#6R\(>'?V>?&?Q!N/CC
M\4_#7BW2/AE\)T\'^-_A)\*'_9Y^%_Q&TKQ;XAM;;6+_ %SP!#X*^)?B;Q5\
M%KF+X@VEAJOBC4;J71KB!/%7A?5XHOZ;Z /Q?_X)R?MIW_QCO_\ @H'XS\?_
M !9/Q=D^'GQ+\+_$#1OAU\*K'6OB=>_"_P"&>L_ #P#XDMOAM\/_  EX(T[6
M_$/C35+#7;3Q-I<EIX6TO5M9\:>/H=<&CV%W=7MI;/Z7I_[3G@CX_?MN?LGZ
M=X2\"?M&>$)O#?@?]IJ_O;CXX?LN?M#_ +/>G7L5_H/PWMH8- U3XV_#7P'I
M_B6_C>%Y+O3M N=1OK&VV75W;PV\B2M^D'AKX=^#/!_B'Q]XK\-Z'!I?B#XH
MZ]IGB?QYJ45Q>RR>(M>T?PQHO@W3=1N8KFYFM[>6U\,^'=%TE(["&U@>"PBD
MDB>X:6:3YI^,/_)YG[%__8J?M3_^HS\,J /6?'O@[PC?_$+X77-]X6\.WEQJ
M.O\ B7^T+BZT73;B:^\OP7K+Q_;)9;9WN=CQQNGG,^UD1A@JI'M-E96>G6L%
MCI]I;6%E;((K:SLX(K6UMXP21'#;PHD42 DD*B*N23C)KSGQG_R/?PB_[#_B
MC_U"=<KT^@#P_P".7A;PSJ/A*34]0\.Z'?ZD?%'PUM3J%YI-A<WIMF^(_A6%
MK<W4UN\Y@:&::%HC)Y;12R1E2CL#[#INEZ9HUHEAI&G6.E6,;2/'9Z=:6]E:
MQO*YDE9+>VCBA5I'9G=E0%V)9B22:\[^,W_(B/\ ]C?\,_\ U9?A&O4Z "BB
MB@ HHHH **** "BD) !)S@ DX!)P.>  23[ $GL*\8@_:!^%]QJ5KH\>H^*1
MJEZ@EMK";X9_$VWNI+?[1!:-=F&X\'Q/'8Q7-U;0W%]*$M+:2>);B:,NN0#V
MBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^2OCU\-/"?B?Q!%KVF?M1_$K]E_XGII%G80^)_AU\0_ $
M#W&AQW<\@74_A/\ &WPO\3_@IXDDF26_L+3Q!XC^%FL:[I,-Q=-X>U?2KU([
MF+!^"_P'T^/Q/;>,O%_[8_QS_:U\0^%9Q/H(\<>-/@[H/A?PN9X)84>Z^'/[
M+WPR^!WPW\17^YYYK#7/'OA'Q/K^GLTD6E:K:6V8!X#_ ,%3_"LEK\(-(\>^
M&?@SX2\4:I<>+M$\*_%7XOV_P+\$_&OXK_"#X,R:;XCN]2\9^!_#WBGPAXR&
MIW.D>(AHME(UUX;\6Z;X8TO7-9\52^$M<73);&?S;_@DKXAUSQ19^.];TWP5
M!I_PWOOAK\ YI/&UU^S_ .&_@)JM_P#&H^!(T^,G@VQL]#\ ?#6?Q9X>\/:T
MEGJCZE>^&VATCQ/KWB#0]-U.ZL+."UL #[ _;:UR#1O L-M=Z%\>M%B\4Z-X
MG\(VWQW_ &9_@K)^T'\7?A)?ZS'I933=)^&NE?"#XZ^)#I'Q%L;:_P##^M>*
M[?X:ZKX?\-VL'G:YJOAF]N=!UNUH?"WX+?&+Q%^Q]^SK\/(_BI\1OV./'W@_
MP!X)LO$*_!#1/@OXFU.SAT;PX-)C\(WMI^T7\*?C[H5K9^4+*^U%;;3%\06>
MJVQLAXBEM4NX[S[IHH _-+]@[P9XH^'_ ,</^"B/A;QC\7/'OQRU^P_:(^$,
MUW\2?B7I/PLT/QCK,5[^Q[^SS=VMKJ.G?!GX<?"?X?0P:/;RQZ9I[Z3X'TRZ
MFLK:&35;C4M1:XOY_P!+:^%OV8O^3IO^"DG_ &<#\$/_ %B_]G*ONF@ HHHH
M **** "BBB@ HHHH ***AGN;>U027-Q#;H6"AYY8X4+$$A0TC*"Q ) !S@$X
MXII-M))MO9)7;]$@)J*JP7UE=,R6UY:W#J-S)!<12LJYQN98W8@9XR1C-6J'
M&47:2<7V::?W/4 HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5X_\ M"221? ;XTRPWGQ<T^6/X5?$!XK_ . &G0ZO
M\=;*1?"NJLEW\&M*N-/U:WU+XI6[ 2^ ;"?2M2AN_%*:7!+87:2-;R>P5\]_
MM2:MX(B^!GQ*\'^,_CIX=_9U/Q/\"^-/AOX;^*FN^+_#W@VZ\*^(_%GA;5M)
MT[7?#FH^(]1TRSF\0:!)<_VYIUO%<>?YM@)%V*AD4 _+W]AC6?\ @HVGQ>TZ
MP\0:@GC#]E&^\07T-[XD_;&\/_LY:#^V[;^&-.^'.B2VD-C=_L<>,[+X=ZE)
M%XZNH!XBL/BO\+=*^)>FRWFM+XEO!<C2C+^XU?SC?L&_!NWT/XY_#W1A\8_V
M(+.#P7\;?'WQDTT?L^?'/PMXU\=?$S_A(?V=_AU\%M1\'6'@RPM[+4M(T+7M
M3\!7?Q7\7O=7_B"[GO8M%@N&N;VPN]7;^CF@ KXT^,/_ ">9^Q?_ -BI^U/_
M .HS\,J^RZ^-/C#_ ,GF?L7_ /8J?M3_ /J,_#*@#\VOVZOCU\?/#?[25_X=
MT+Q-XE\&:7X9L]*'@JPT&^B NXM5TZ6*;78390^:]]JYN[NS>&X::[@A1;3*
MQB*-?UA^&?Q@\87?PR\#>)/B/\+_ (B6&HW_ (5T&_\ $&LZ+I&A>+;6>[O;
M&W<:E:>'/ ^L:MXTFCU-Y8KM[*P\$^9I9NGCN[6TM;2>:+K?'FBZ->_$;X.Z
MA>:1IEW?P:]X@6"]NK"TN+N 6GA/6KZT$-S-"\T0M;U5O+?8Z^1= 7$6V4!Z
M]BH _,7]KK]N3P?X&L-(\#^'/"?BG7?$=_J/AOQ)J5MXK\.>+OAJ-*TSP_XE
MTS7K3%IXR\,Z;J]]+JT^CM:QS6NF/800M),;N2>/[*?M+]G[XRZ=\>_A5X<^
M)FFZ5<Z(NLB]M;W2KJ5+@V.J:5=RZ?J4$%U&$%U:+=P2&TN6B@DF@*/+;PN6
MC'DW[7G[/?PV^,GA?1-;\86%_'KGASQ!X3TG3=:T:\CL-272?$WC+0M$U739
MI9;6\AGM&@U.>ZMDE@8VU^D5Q&VPSPS^F_ OPWX?^%_AT_!C2].@T67P.T\F
MGP+Y@/B7P_J-Q]KM?%L$D[N]_//<7;Z;XDG0J+?Q':W>;:SL;W2DF /=**\S
M^*/Q4T3X2:!)XF\1:)XTU71;6UU2_P!4O/"'A35?%0T33='LGU'4-2UF/2HI
M9;"QAM(Y9!<2(0_E2*@++BG_  \^)NG_ !(BO;C3?"OQ!\.VUG;Z;=17'CCP
M9J_A*'4X-46Z>!](?58H_P"T/)CMM]X(03:K<V9E ^TQY]/^QLT_LS^V?J-?
M^RO:2I?7N5?5W5C4A2E34[ZSC4J4XR@DY+GC)I1DF+F5^6_O;VZV[GI-%%%>
M8,**IZA)>PV-Y+IMK%>ZA';3/96<]S]CANKI8V,$$MT(I_LT<L@5'G\F7RE8
MOY;XVGRKPGXZ\>^(M:U;3KKP+H^G67A[Q - UJ^3Q>;R6&4:9IVJM<6=H-#@
M^U((-3MD"-- 3()!D!06 /8:\AN_^2]^'_\ LD/B_P#]3/P/7K<CK%&\C'"Q
MHSL20 %12Q)+$ < \D@#N0*_ ;PW^VQ\?-6_:QTZYEM(KVTNO%]_\,[7X=2:
M#86=]I_A?4/%5I%<:7YD=S+>1>*+?^RK*XU&[GU6_M(]0M;Q;:V6SD2!0#]_
M**** "BBB@ HHKS;XB^/[[X>Z3JOB!O!>N>(M T'P_J?B/6]3TB^T" :?8Z/
M;7-[?(;35-5L;RYGCLK5[A%MH95D!6)&,N4 !Z37-^(Y/%\<=K_PB5EX;O)2
M\OVT>(]3U338XXPJ>2;5M,TG56E=F\P2K,L*HH0HSDL%D\.:MJNL6<MSJ_AG
M4?"UPEPT4=CJ5[I%]--"(XW%TDNC7VH6RQL[O$$DF68-$S&,(R,S/%GB[PQX
M%T&_\4>,==TWPYX>TN-9;_5]6N4M;.V1G6--\CGEG=E1(T#2.Q 12: .*^$W
MB_QMX]\+^&?&6OZ)X6T;1?%?A31_$FG6VCZWJVJ:I;2:U9V6H6]I>I>Z'IEI
MLBM;F59IX+B1O/CC5(C&[.GK%?/G[+/C#PMXP^ OPOD\+Z]IFNKH7@?PGX=U
MG^SKE+AM+US2O#^G6^HZ5?1KB2VO+292DL4JJ3C<A9"&/T'0 4444 %%%% !
M1110 455>^LHW:.2\M8W4X9'N(E=3C.&5G!!P0<$#@U81TD57C=71P&5T8,K
M*>A5E)!![$$@T .HHHH **** "BBB@ HHHH **** /@3_@H3J_C[1OAO\-[G
MX9^,?VN?!?C%OBSI*Z1>_LC?#OX6_$35]1N8_#/BJXCTKXO6WQITF_\ AGX>
M^#=S)"DGB+Q%XKU/PO86VLP^'K/_ (2*RFOHX[C)_8#\7_\ !0'Q3H7B!?VV
MO#OPGT_3[#0/!?\ PK_7_"=GIFA?$_7M1N;&YF\4M\6O"_A#XF?%+X;Z/K4(
M.E31MX$UVTT2YN;J^-CI=K8): ^&_P#!6+QY\)-6\#^$OA-KOQ\^$'@GQKX=
M\7:!\4M;^"?Q;\17&@>%?CAX!32_%?AZ7P5XHN8--U5+?2[K4KY/$>CRW^GZ
MCHTOB7PGI<&MV,VF-<[>/_X)#6^DZ@/B%XCTSXA?!N_FL/A;^S_\+M5^'/P8
M\9R>.--M]3^%G@V7PS<?%+Q5JR:'X>T^/Q#XV2*'2K*SLK*>6V\.^&]+CU&^
MGNAY4 !^V=%%% 'PI^S)(B_M3_\ !20,Z*?^&@?@APS '_DR_P#9R]2*^Y_.
MB_YZQ_\ ?:_XU^4OPW_Y.\_X**_]EP^!G_K''[/M?2U 'V)YT7_/6/\ [[7_
M !H\Z+_GK'_WVO\ C7QW10!]B>=%_P ]8_\ OM?\:/.B_P">L?\ WVO^-?'=
M% 'V)YT7_/6/_OM?\:/.B_YZQ_\ ?:_XU\=T4 ?8GG1?\]8_^^U_QKP+]I/P
MWX>UKX0_$37M2EO(=1\(?#WQWKFAZA8>(=7T.33-0L_#.H7D-\9-)U*P61K:
M:UAG1KKS8XC&6 4%L^<5\1_M_6/QJU[]GKQ1X5^#&AS7]QKEM=R>.M:BUO0=
M&;0_ &C6DVK^(HXAK%U;W%Y-J]K:&P,.E8O5M6NMDH+K;W'V7AY@9YGQSPIE
M\,VP61+%YYE]"MF^8XZGEV"P.%G7A];K8C%5:M&*@L+[:*HJHIXN4HX6FIU*
MT82SJOEISERN=HMJ*7,V^B27G;7IOLC]3/A)X5\#^'/"^FZMX-F^T6OBC1="
MU.74O^$FU3Q):ZFC6"SVUY9W>I:KJ<)AG6[DE6:QD6*Y61'+2*L9'6^*_"O@
MWQGIR:=XRT70_$.EVLXOTM-;MK6]LX+B**6,70CN0T:21PRS+YN 51W&0":_
M%']BOX+_ !4TCX.6/A3X_P!C\1O#OB'PS=O:>&M1TOXZ>*)=-USP?=1I>Z,L
M6F>#?&B6&B3:&DSZ*;)K5/.L[2ROOM$MQ=74-KZ+^TG\)O'B?!_Q98? >/XG
M^(OB9KEJNAZ$+GX[^-M.L]%CU)Q;ZAKURWBCQLNE7@TZP:X>WTV:&X%_=-!;
MR+#"\ES#]-FW#F5TO$?$\/P\0(8G$?ZQ0RRAQC&MEL\CEAZN(IT,-G,^(EQ(
MJ-+ 4L'.G6K5IU(5<)2A/#U:-.O2GAX1&4O8J7LK+DNZ;4E/1:QY.3XKZ6ZO
M6]G<^YOV2?"_PWL?A=I/BWP?I/A6.[UG5/'ML_B+0DT^1]3TNW^(OB=+"(:E
M:,ZW=G%:P6BVH65XA!' (_D"5]5>=%_SUC_[[7_&OYS?^"=&E_'+X#>"-?\
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MY&CN;NWOK>5KU-UJ! PEY[X<$+^UW_P469B%5?C?\#2S,0% '[&_[/Q)).
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M.0RN=8UW3&L5FLG^Q:@9;F&T^3O^"A7[$7P^_:.M]!^)7CWX@_%JSN/">I>
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MA+,=/O+_ $X:/-IUU;AKH7RWJSVT*U^IM !37=(U9W941%9W=V"JB*"69F)
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MZ@FGW]SJ&G6;ZC>R7$=G9RW"1*J0Q%!*+>*.!YS)*JEG9F /IFBBB@ HHHH
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M&7B:WT[3=+U'QCKVK^(]0:6QT)-0T?1-'M-.L8-<U>=[B>, POVZ]<\2^#O
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M?_H!W_\ W[7_ .+H_P"$0\3_ /0#O_\ OVO_ ,77=ZMXU^*FG>*-&\-Q>!?
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M2FHRG&*FXQYN5*+YHJ5K<R3MY/5?@>O> /#OQ,\/ZUKL_B*[\!W.D>(]>O\
MQ#?+HJ>((]2M;JZL+2TAMK4WS-:R0))91/))+LD*22!4#*I/LF1ZC\Q7Q[Y\
M_P#SVE_[^/\ XT>?/_SVE_[^/_C7FE'V%D>H_,49'J/S%?'OGS_\]I?^_C_X
MT>?/_P ]I?\ OX_^- 'V%D>H_,49'J/S%?'OGS_\]I?^_C_XT>?/_P ]I?\
MOX_^- &S\6V^/.@^(_#$WA/XO>$M)T'QK\0M'\)V>BZE\)$UNZT&PU+3-1N9
M)SK"^/-,.J7,<^F,R-+I]K&4N3&R9B5W^DM MM7L=%TNS\0ZQ;:]KEM900ZK
MK5II:Z);:G>H@$]Y!I"WNHKIT<[Y=;07]V(0=@GDQNK\G?VE?CWX"^%OC/\
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M*D%O;?'OX*7%Q-(P6.&&']BS]G22661CPJ1QJSNQX"@D]*L_"C]K?X(_$?\
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MMK73H;6/6-.>6[U"6VM MR")R(Y=GBW[,7_)TW_!23_LX'X(?^L7_LY5]TT
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MC5//_9HN1)JC7'B"Z2>6 6T#0I;A+6-E9G^@/^&7OC'_ -']_M7?^$Y^R/\
M_0OT ?9E%?&?_#+WQC_Z/[_:N_\ "<_9'_\ H7Z/^&7OC'_T?W^U=_X3G[(_
M_P!"_0!]F45^3LO@+]H5/VQ+']GP?MX_M+?\(E<_LTZK\9'O3X6_9/\ ^$@'
MB*R^*.C^"8K59_\ AFH6@T8Z9J$TLD)L3<&]$;B[6,&%OI;_ (9>^,?_ $?W
M^U=_X3G[(_\ ]"_0!]F45^6?QX^&G[0'POO_ (#VFB?MY?M,W"?%#X^^#OA9
MK;:IX7_9.D:WT/Q!H/BW5;RXTSR/V:+81ZHDV@6J6\LPN(%C></;2$J4^@/^
M&7OC'_T?W^U=_P"$Y^R/_P#0OT ?9E%?EM^TO\,OC_\ !KX5OXX\._MY?M,W
M>J#QY\)O"RPZSX8_9.FL!9>//BEX0\$:I*T=M^S19S&Y@TSQ!=S6!%PJ)?);
MO+'/$KP2?3WA/]GCXI^'?$FC:YJO[:7[27C;3=+OX;R\\)^)="_9EM]!U^"(
MDOINK3>%_P!GCP[XACLI\XE;2-<TN] '[J\B.30!]5T444 %%%% !1110 44
M44 %%%% !1110!X5\>OVD_@Y^S)X=TCQ?\;O%9\#>$]:U630[;Q1?:3K%SX<
MM-9:RGNM-TS6]>LK&XTGP[=>(KF&/0?"RZ]>:<GB7Q3?Z3X7T9[S7M6TZPN8
M?@A^TA\-_CVWB[3?"@\3>'?&7P_O["P\=?#?XA^&]0\%?$3PHNM6AU'PWJNJ
M^%]5"W3>'?%6FJ]]X:\2:?)?:%K"V^H6=KJ#:GI&L6-A^/W[67[)7QYO_P!H
MCX]^(K7P?XJ^(OA3XS^!]0A^'7CCP'X-^&'C35[N[UK3=(T6\_9M_:1M/B/8
MOJI_9RTB_P!*G\1>'K/P3KFAV<?_  ENMZN3H_CO0['Q1=_L%\#?@7HWPE\+
M^%H-3O;WQWX\T#PLWA"+XE>-X- UOXDVW@Q]4EUK3_AY/X]L]"TK7M>\*^%I
MYDL-(?7+B^U;48;"UU3Q%J.L:_+>:K<@'2?&?XU_#G]GWP'?_$_XLZW<>&/
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M<PPQ6\45O;Q1P001I###"BQ10Q1*$CBBC0*D<<:*J(B*%10%4  "@"2BBB@
MHHHH **** "BBB@ HHHH ***BG,ZP3-;1Q37*Q2&WBGF>W@EG"$Q1S7$<%U)
M!$\FU9)DMKAXD)=8)F41L 2T5\/W'C[_ (*2K/.MK^R?^P_-:K-(MM-<?\%"
M/CS;3RP!V$,D]M'_ ,$R+N.WFDCVM)!'=7*1.6C6XF51(V5>?%7_ (*,Z<T:
MZA^RY^P58-+GREO/^"C?QTM6EP0#Y8G_ ."8B%\$@';G!(SUH ^]:*^&!\0?
M^"E; ,O[)?[##*P!5A_P4/\ CX001D$$?\$P,$$<@C@BE_X6!_P4M_Z-*_89
M_P#%A_Q]_P#I8% 'H?Q?_9&^%7QT^*_PZ^*7Q(35]>3X=:5>:=;^ IKN,> _
M%,KZWI7B/1KSQIHIA)\1+X:US2+75]&TN]G;1UU2.WO[RQN[BRLV@^HE5454
M151%4*JJ JJJC"JJC "@      8'%?#'_"P_^"E._P O_ADW]A;S-N_R_P#A
MXA\>]^S.W?L_X=@[MN[C=C&>,YIW_"P/^"EO_1I7[#/_ (L/^/O_ -+ H ^Y
MJ*\L^$.K_&W6O#%U=_'OX??"SX:^,TUJZ@LM ^$/QB\6_&[PQ<>'4L]/>RU2
MZ\7>,_@9^S[JMIK5Q?R:I;76@Q>"+VQL[.ST^^A\27TVI7&GZ3ZG0 45\J?$
MOQ?^W!I7C76;#X/?L\?LI^._AU -._X1_P 4_$O]LKXN_"?QKJ9ETJQFU8:S
MX!\+_L(_&?0M"%EK<FI:?IQLOB3XB.J:5:6.L7(T>[U"?0M,X3_A8'_!2W_H
MTK]AG_Q8?\??_I8% 'W-17PS_P + _X*6_\ 1I7[#/\ XL/^/O\ ]+ H_P"%
M@?\ !2W_ *-*_89_\6'_ !]_^E@4 ?;UY;1WMI=6<V?)N[>>VEVG#>7/&T3[
M3V.US@]CS7S7^S/^R=\+?V6O#VHZ7X'36-=\1:]]CC\2_$'QC>KK/C37=.T@
M30>&O#TNIF*&/3_"GA+3I?[-\,>%])@L=$TF W%S#9G4M0U*^O/-?^%@?\%+
M?^C2OV&?_%A_Q]_^E@4?\+ _X*6_]&E?L,_^+#_C[_\ 2P* /N:BOG/X/^)_
MVM]:UZ_M_C[\$?V<_AIX8CTUI=,UCX/_ +4OQ,^.&O7FKB>)5L;_ ,.>-/V/
M?V>]/T[33;&:5M5M_%6JW2SQQ6XT9HYGNH/HR@ HKE_&UWXUL/">OWGPY\/^
M%O%7CFWTZ:7POX<\;>,-6\ >$]8U9<?9[+7_ !IH7@?XEZQX;TZ7YO.U33O
M7BJY@P-FCW.X[?D'_A8'_!2W_HTK]AG_ ,6'_'W_ .E@4 ?<U%?#/_"P/^"E
MO_1I7[#/_BP_X^__ $L"C_A8'_!2W_HTK]AG_P 6'_'W_P"E@4 ?<U?/7[1W
M[.'A+]IGPKX9\(^,-?\ %_AS3_#?C?0_&D=[X)UC^P=:O#I(N8+S0WU:.&6\
ML=,U[3;V\TG5)],DL]46QNIUL+^SG99U\>_X6!_P4M_Z-*_89_\ %A_Q]_\
MI8%'_"P/^"EO_1I7[#/_ (L/^/O_ -+ H ^Q?"7A+PSX#\,Z'X-\&Z'IOAKP
MMX:TVUT?0=!T>TBL=,TK3;*)8;:TL[6%5CBBBC4#@;F8L[EG9F/0U\,_\+ _
MX*6_]&E?L,_^+#_C[_\ 2P*^U='EU:?2=+FU^RT[3-=FTZREUK3='U2YUS2=
M/U:2VB?4;+2]:O='\/7FL:=:7AF@LM4N] T.YU"VCBNY]'TR69[*  T:**\(
M^,_B']IS0Y?#R_L\?"'X$?%&"YCU0^+)/C/^T9\0?@-+HLL36 T5/#T/@?\
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MH88UR!NDED_X)@JB+D@99@,D<U#9_$__ (*/:C$9]/\ V5_V#KZ%7,;36?\
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M)U'6O#VG_P#!-[Q58:#JU[8+;W.HZ-8^)_$=GI=Y+-8VVO:Q# FH7&3_ ,+
M_P""EO\ T:5^PS_XL/\ C[_]+ H ^YJ*^&?^%@?\%+?^C2OV&?\ Q8?\??\
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M-17PS_PL#_@I;_T:5^PS_P"+#_C[_P#2P*/^%@?\%+?^C2OV&?\ Q8?\??\
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MT>C^(9],C=U>Q-E?S0JAC=Q&I3]?J* /Y2_C+\:?VJ_A/\ ?AKX)\!ZS\:O
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M3+9BVD$:1=]^V3XO^%>H_M/3>#? O[2GB'0/VD] U_X/>*M=EU'X_MX,\(?
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M#ANM=UF70=&@U:3=J6HZ?X6:^/AVW\07D'^@3^(TTP:VVEEM,^W"Q9H#Z%0
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MNK2[NI_W=^*O[-OP#^.7@KP_\./C!\(O 7Q'\!^$[W2]2\,^$_%OAVPU?1-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXM[>[@GM;J"&YM;F&2WN;:XB2:"X@F1HYH)X9%:.6&6-F22.161T9E92I(H
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M)KEI]F<2^'M(\166C:\FEVIMH9[S1-/AG\RR66WD]AH **** "BBB@ HHHH
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MK'6/"</B;X?^,;*Q74=2U.WLM)O+>'7++\;_  QX!\$_'G]J;X ?L_\ @/\
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M_@7X=V&D^+/AS9_9/">A:7860DU#4[IKO4-8\1:W/JFMWGGPZ>EW!IMC:VJ
M'ZUK-"[;4FB=N?E61&;CKP"3QWXXJ0D*"S$  9))   ZDD\ #U-?Q]_L@?#O
MPE86W_!) ^$?V0/A[^QU\2?&'Q:3QC>_MY:?IWP3T;6?C_H/A'2?'-_XS^ ]
MYK?PTNV^(FO>*OV@]%N9=-B\.?%U+73[S2]&US6(VN_%>B:'97'[%_\ !6[Q
MEJ?BKP1\'?V-O#>@_$#Q7<_M5_$*ST_XM:)\+=$?Q#XUC_9A^'UQ9>*/CD;#
M38K_ $U@GBG2(].^'7VE[R&.)_&.YO-56B8 _7D$$ @@@\@@Y!'J".M+7\Z7
M[(W[6?Q@U?1/@%^P'H&L:]\ OB?\/?BY\:_@IX\\3?$?P7IFI_$'0/AE\*/
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M[4/C=!H=M8+&XU?Q!\+QXYM;>#2D2\DN+SRM*C%X]LE=7XI^/?[!>C_\*/\
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M^YE,S27&B>'])TJ>1KDQFX9Y;"TMY'-P8HC,68F4QQF3=L7'44 ?FY_P4/\
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MU56$.5U*2)WC>^!%T\;LC2E6((!_)?\ ##]LGXW?%&RU&R\2?&O_ (2SP/\
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M.RTG4+N\\&ZE<U_5D/"GA8:ZWB@>&M 'B9H/LK>(AHVG#76MBNTV[:O]F_M
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M=2TJ[?XBW/B+QK=ZSX3$>E*]CX'.A">"VM)YI)9?HK4?VKOVL]0_:Y\<6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img117602972_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_4.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "> P4# 2(  A$! Q$!_\0
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M ,V9_P#R?:/^(HS_ *L:_P#-F?\ \GVOY+Z*/^)8/ S_ *(?_P V7C#_ .B
M/^)BO&3_ *+'_P U[A;_ .<9_6A_Q%&?]6-?^;,__D^T?\11G_5C7_FS/_Y/
MM?R7T4?\2P>!G_1#_P#FR\8?_1 '_$Q7C)_T6/\ YKW"W_SC/ZT/^(HS_JQK
M_P V9_\ R?:/^(HS_JQK_P V9_\ R?:_DOHH_P")8/ S_HA__-EXP_\ H@#_
M (F*\9/^BQ_\U[A;_P"<9_6A_P 11G_5C7_FS/\ ^3[1_P 11G_5C7_FS/\
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M)?11_P 2P>!G_1#_ /FR\8?_ $0!_P 3%>,G_18_^:]PM_\ .,_K0_XBC/\
MJQK_ ,V9_P#R?:/^(HS_ *L:_P#-F?\ \GVOY+Z*/^)8/ S_ *(?_P V7C#_
M .B /^)BO&3_ *+'_P U[A;_ .<9_6A_Q%&?]6-?^;,__D^T?\11G_5C7_FS
M/_Y/M?R7T4?\2P>!G_1#_P#FR\8?_1 '_$Q7C)_T6/\ YKW"W_SC/ZT/^(HS
M_JQK_P V9_\ R?:/^(HS_JQK_P V9_\ R?:_DOHH_P")8/ S_HA__-EXP_\
MH@#_ (F*\9/^BQ_\U[A;_P"<9_6A_P 11G_5C7_FS/\ ^3[1_P 11G_5C7_F
MS/\ ^3[7\E]%'_$L'@9_T0__ )LO&'_T0!_Q,5XR?]%C_P":]PM_\XS^M#_B
M*,_ZL:_\V9__ "?:/^(HS_JQK_S9G_\ )]K^2^BC_B6#P,_Z(?\ \V7C#_Z(
M _XF*\9/^BQ_\U[A;_YQG]:'_$49_P!6-?\ FS/_ .3[7UYX2_X+M:EXG_9Y
M\)_M!2?LGV6GZ9XL^+'Q%^%<'AM/C]/>W]I<_#_PO\-_$KZS-?-\#[.WD@U4
M?$![-;-(1)9G1UN#<70U$PZ?_#G7[)_"O_E&M\&_^SO?VC__ %5O[.E>=B?H
MT^"-'..$\+#@A>PS3B"67XVF^).+W[7"_P!@Y[C5!27$"G3:Q."PU13IRC/]
MWR-NG.<9?L'@AXP^(W&'&W]D<1<1O,,N63YAB_JRRC(<)>O0EAXTINM@<KPU
M>T/:R?*JJC)VYE)*Q^[O_#_S_JTW_P SO_\ B:H_X?\ G_5IO_F=_P#\35?S
MGT5^F_\ $HWT>O\ HWW_ )M?&_\ ]$I_8'U_%_\ /W_RG2_^0/Z,/^'_ )_U
M:;_YG?\ _$U1_P /_/\ JTW_ ,SO_P#B:K^<^BC_ (E&^CU_T;[_ ,VOC?\
M^B4/K^+_ .?O_E.E_P#(']&'_#_S_JTW_P SO_\ B:H_X?\ G_5IO_F=_P#\
M35?SGT4?\2C?1Z_Z-]_YM?&__P!$H?7\7_S]_P#*=+_Y _HP_P"'_G_5IO\
MYG?_ /$U1_P_\_ZM-_\ ,[__ (FJ_G/HH_XE&^CU_P!&^_\ -KXW_P#HE#Z_
MB_\ G[_Y3I?_ "!_1A_P_P#/^K3?_,[_ /XFJ/\ A_Y_U:;_ .9W_P#Q-5_.
M?11_Q*-]'K_HWW_FU\;_ /T2A]?Q?_/W_P ITO\ Y _HP_X?^?\ 5IO_ )G?
M_P#$U1_P_P#/^K3?_,[_ /XFJ_G/HH_XE&^CU_T;[_S:^-__ *)0^OXO_G[_
M .4Z7_R!_1A_P_\ /^K3?_,[_P#XFJ/^'_G_ %:;_P"9W_\ Q-5_.?11_P 2
MC?1Z_P"C??\ FU\;_P#T2A]?Q?\ S]_\ITO_ ) _HP_X?^?]6F_^9W__ !-4
M?\/_ #_JTW_S._\ ^)JOYSZ*/^)1OH]?]&^_\VOC?_Z)0^OXO_G[_P"4Z7_R
M!_1A_P /_/\ JTW_ ,SO_P#B:H_X?^?]6F_^9W__ !-5_.?11_Q*-]'K_HWW
M_FU\;_\ T2A]?Q?_ #]_\ITO_D#^C#_A_P"?]6F_^9W_ /Q-4?\ #_S_ *M-
M_P#,[_\ XFJ_G/HH_P")1OH]?]&^_P#-KXW_ /HE#Z_B_P#G[_Y3I?\ R!_1
MA_P_\_ZM-_\ ,[__ (FJ/^'_ )_U:;_YG?\ _$U7\Y]%'_$HWT>O^C??^;7Q
MO_\ 1*'U_%_\_?\ RG2_^0/Z,/\ A_Y_U:;_ .9W_P#Q-4?\/_/^K3?_ #._
M_P")JOYSZ*/^)1OH]?\ 1OO_ #:^-_\ Z)0^OXO_ )^_^4Z7_P @?T8?\/\
MS_JTW_S._P#^)JC_ (?^?]6F_P#F=_\ \35?SGT4?\2C?1Z_Z-]_YM?&_P#]
M$H?7\7_S]_\ *=+_ .0/Z,/^'_G_ %:;_P"9W_\ Q-4?\/\ S_JTW_S._P#^
M)JOYSZ*/^)1OH]?]&^_\VOC?_P"B4/K^+_Y^_P#E.E_\@?T8?\/_ #_JTW_S
M._\ ^)JC_A_Y_P!6F_\ F=__ ,35?SGT4?\ $HWT>O\ HWW_ )M?&_\ ]$H?
M7\7_ ,_?_*=+_P"0/Z,/^'_G_5IO_F=__P 35'_#_P _ZM-_\SO_ /B:K^<^
MBC_B4;Z/7_1OO_-KXW_^B4/K^+_Y^_\ E.E_\@?T8?\ #_S_ *M-_P#,[_\
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M_9/9M_Z<P9Y91117[2?W^%%%% ']9'[4?[1/_"K/%G@#PS_P\9_X94\WX.^
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M5-U3Q;3O*4H)XFE5<8.2@J:<W4BE?9MQ;B_B:N[M'Z)?LT?"W]G#X??L[_\
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M9_Y@S]I+_P"<]1_P_J_X)/?]'6?^8,_:2_\ G/5_G"T4?\2E>''_ $.N-O\
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M5^I_V;GG_125?_#5EWE_<\G]_D?A_P#:&3?]$_2_\.>/_P#D_P"KORM]>_\
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M7_AT?$W_ ,[ZOD*BC^S<\_Z*2K_X:LN\O[GD_O\ (/[0R;_HGZ7_ (<\?_\
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MWQ0\3"6RU/2KN:QO[24?\*^XDM[J"6%QV9#65_PR7I__ $=;^R%_X='Q-_\
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M='Q-_P#.^KY"HKVO[-SS_HI*O_AJR[R_N>3^_P CQ_[0R;_HGZ7_ (<\?_\
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MQA*2[Z-QU\F<=_PSG9?]'#_LV?\ A?Z]_P#,91_PSG9?]'#_ +-G_A?Z]_\
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M-AZ5'_4F"IPIX?.9SS*MAZL*N'KUL16I930E@X9KAJ5&>+5>G*5+#8NC6O\
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M6\%?\HKO&G_:0+X>_P#K.?Q+KXIK;@3_ '?B/_LJLR_]1<O/X1^D-_R<>O\
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M\*U\SU],?L6?\GC_ +)G_9S'P'_]6EX5K[+B3_DG<_\ ^Q+FO_J#7/E.'_\
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MY^S3\%_&?PP;XWC1])^+OQ%^*/QHTOXP>/M8\">'-7TKQ'I7PY\'W?A'X._
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MXJSN;7Q'===\'/\ @FS\.O'OQ'^!7P$^(?[36M_#/]H#X\_!C1_CEH'A.P^
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MK^AS\*/OW]AS_D1?^"AW_9@7C3_UHS]F6O@*OOW]AS_D1?\ @H=_V8%XT_\
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M>>(HHO#<ES)I?A#P)XOM-9T"75=(\3:9;ZO<:3;_ "5^TK\>O$W[3GQP\?\
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M^-@L>MM!I5S#KGI\?Y5QO7S[AS.^#5*=7)LBXLPTZ-7&8?#Y?B,QSS'\'X'
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M>5+>!9&!=88@0BQU_2Z=TFTTVD[.UUY.S:NMG9M=FT<9]B?\$_/^3T?V<O\
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M3DY*SLDM+O@S#*XX^=.<JTJ7LXN*2@I7N[WNY*Q_E"?\,I?M1_\ 1MGQ]_\
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M[Z.67<=\03S^OQ3C<NJ3P>$PGU:CEE#$04<)!P4_:3Q=.3<TVVN6T=+-]?\
M+5_X9;_::_Z-T^.W_AHOB!_\SU'_  RW^TU_T;I\=O\ PT7Q _\ F>K_ %*J
M*]O_ (G;SO\ Z(#*O_#[B_\ YW^O]+7XK_B4#*/^BWS+_P ,V%_^;_7^EK_E
MJ_\ #+?[37_1NGQV_P##1?$#_P"9ZC_AEO\ ::_Z-T^.W_AHOB!_\SU?ZE5%
M'_$[>=_]$!E7_A]Q?_SO]?Z6I_Q*!E'_ $6^9?\ AFPO_P W^O\ 2U_RU?\
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M6RVAAH<N*=&3J>TABZLKP=%6CR6:ENK7?\*G_"@?CO\ ]$4^+?\ X;?QC_\
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M[_\ 1%/BW_X;?QC_ /*:C_A0/QW_ .B*?%O_ ,-OXQ_^4U?Z M%'_$_^?_\
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MCO\ ]$4^+?\ X;?QC_\ *:C_ (4#\=_^B*?%O_PV_C'_ .4U?Z M%>Q_Q/\
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M_P _K_A0/QW_ .B*?%O_ ,-OXQ_^4U'_  H'X[_]$4^+?_AM_&/_ ,IJ_P!
M6BC_ (G_ ,__ .C;9/\ ^)%C?_G9Z_TM3^RH?\_I?^ +_P"2/\_K_A0/QW_Z
M(I\6_P#PV_C'_P"4U'_"@?CO_P!$4^+?_AM_&/\ \IJ_T!:*/^)_\_\ ^C;9
M/_XD6-_^=GK_ $M3^RH?\_I?^ +_ .2/\_K_ (4#\=_^B*?%O_PV_C'_ .4U
M?6?P9^#'QALOV9/VR]*O?A1\2K34];T/X$QZ-IUUX%\46]_J[Z?\7M/O+]-,
MLY=+2XOWLK-6NKM;6.4VULIGF"1 M7]J5>3>-2?^%E_!@9.#JGCC(]?^**U
M\^O//UKQ\[^G1GF=8*A@ZGAYE5"-'-^'\W4X9_C)N4\@S[+,]IT7&66Q2CB:
MF6QP\YW;IPJNI&,I0495'+(1;?MI.\9Q^!?;A*-]^G-<_A3_ .% _'?_ *(I
M\6__  V_C'_Y34?\*!^._P#T13XM_P#AM_&/_P IJ_T!:*]C_B?_ #__ *-M
MD_\ XD6-_P#G9Z_TM9_LJ'_/Z7_@"_\ DC_/Z_X4#\=_^B*?%O\ \-OXQ_\
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M'9/%=A:Z7XB-CK?PV\6>$M4*ZMIMG#8727%W,AM#/;HJ17=TLW.Z%^RU\$-
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M89)9-=M[O6+F+6KR:?4-46[OYI;E_6O^%A^ /^AY\'_^%-HO_P FT?\ "P_
M'_0\^#__  IM%_\ DVMH\8\70CAXPXJXCA'"RQ,\+&.>9G&.&GC(8REBYX=+
M%)498JGF&/IXF5/E=>&.QD*KE'$UE->SIZ^Y#6U_=CK:UKZ:VLK=K*VR/-_
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MSCN7TLS-*[]]_P +#\ ?]#SX/_\ "FT7_P"3:/\ A8?@#_H>?!__ (4VB_\
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MV,?B!]-N4LX?:O\ A8?@#_H>?!__ (4VB_\ R;1_PL/P!_T//@__ ,*;1?\
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M<>]\+OD1<[G4'U7_ (6'X _Z'GP?_P"%-HO_ ,FT =A17'_\+#\ ?]#SX/\
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M= U^PGTS5;$W=A<6FH6;W%G<S)%>Z?=VFH64I2ZL;JVNH89X_G[X9?LC^#O
MOB+_ (2_QGX]^)7[0'BFU^%T?P5T+6OCA+\/M7;PW\+9)TNM:\*:?I/@3X>?
M#[P]J7_"6W%OI[>,?$GBG1_$/C#Q-#I.F6&J^(I]-M19M[[_ ,+#\ ?]#SX/
M_P#"FT7_ .3:/^%A^ /^AY\'_P#A3:+_ /)M 'S7\)_V+? GPI\5_#KQ+_PL
M;XQ?$2P^"GA_Q)X5^ _@SXD>(O"VK^%_@OH'BB"/2KVR\(RZ%X*\-^*M?N++
MPK#%X(T36?B=XH^(&OZ/X/671K'58EN[V:Y^Q*X__A8?@#_H>?!__A3:+_\
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M_P"%A^ /^AY\'_\ A3:+_P#)M '845Q__"P_ '_0\^#_ /PIM%_^3:/^%A^
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M?X6_\)_2?_D2NIHH Y;_ (0;P3_T)_A;_P )_2?_ )$H_P"$&\$_]"?X6_\
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M_"?TG_Y$KJ:* .6_X0;P3_T)_A;_ ,)_2?\ Y$H_X0;P3_T)_A;_ ,)_2?\
MY$KJ:* .6_X0;P3_ -"?X6_\)_2?_D2O*?&?@OP<GQ(^#<:>$_#21S:GXV$T
M:Z%I:I*$\&:@Z"1!:A7". ZA@=K ,,$9KW^O)?&O_)3/@O\ ]A3QQ_ZA6H4
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M-X0NOA'XY^*?[-UWX.^#B_L_VMU\$M6\'VTVI_".UOH]4T;PMJ'_  LKP/\
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M_*.C_AG3]GS_ *(3\&__  V'@G_Y1T >J?VMI7_03T__ ,#;;_XY1_:VE?\
M03T__P #;;_XY7E?_#.G[/G_ $0GX-_^&P\$_P#RCH_X9T_9\_Z(3\&__#8>
M"?\ Y1T >J?VMI7_ $$]/_\  VV_^.4?VMI7_03T_P#\#;;_ ..5Y7_PSI^S
MY_T0GX-_^&P\$_\ RCH_X9T_9\_Z(3\&_P#PV'@G_P"4= 'JG]K:5_T$]/\
M_ VV_P#CE']K:5_T$]/_ / VV_\ CE>5_P##.G[/G_1"?@W_ .&P\$__ "CH
M_P"&=/V?/^B$_!O_ ,-AX)_^4= 'JG]K:5_T$]/_ / VV_\ CE']K:5_T$]/
M_P# VV_^.5Y7_P ,Z?L^?]$)^#?_ (;#P3_\HZ/^&=/V?/\ HA/P;_\ #8>"
M?_E'0!ZI_:VE?]!/3_\ P-MO_CE']K:5_P!!/3__  -MO_CE>5_\,Z?L^?\
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M2O\ H)Z?_P"!MM_\<H_M;2O^@GI__@;;?_'*\K_X9T_9\_Z(3\&__#8>"?\
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MZ?L^?]$)^#?_ (;#P3_\HZ /5/[6TK_H)Z?_ .!MM_\ '*/[6TK_ *">G_\
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MMO\ XY1_:VE?]!/3_P#P-MO_ (Y7E?\ PSI^SY_T0GX-_P#AL/!/_P HZ/\
MAG3]GS_HA/P;_P##8>"?_E'0!ZI_:VE?]!/3_P#P-MO_ (Y1_:VE?]!/3_\
MP-MO_CE>5_\ #.G[/G_1"?@W_P"&P\$__*.C_AG3]GS_ *(3\&__  V'@G_Y
M1T 1?!75=,7P3>AM2L%/_"R?C4<&\MP<-\9O'S*<&3HRD$'H001P:]9_M;2O
M^@GI_P#X&VW_ ,<KRA/V</V>8E*Q_ ;X,1J7DD*I\+O Z*9)9&EE<A=# +RR
MN\DC?>>1V=B68DO_ .&=/V?/^B$_!O\ \-AX)_\ E'0!ZI_:VE?]!/3_ /P-
MMO\ XY1_:VE?]!/3_P#P-MO_ (Y7E?\ PSI^SY_T0GX-_P#AL/!/_P HZ/\
MAG3]GS_HA/P;_P##8>"?_E'0!ZI_:VE?]!/3_P#P-MO_ (Y1_:VE?]!/3_\
MP-MO_CE>5_\ #.G[/G_1"?@W_P"&P\$__*.C_AG3]GS_ *(3\&__  V'@G_Y
M1T >J?VMI7_03T__ ,#;;_XY1_:VE?\ 03T__P #;;_XY7E?_#.G[/G_ $0G
MX-_^&P\$_P#RCH_X9T_9\_Z(3\&__#8>"?\ Y1T 1?'?5=+;X-_$E5U*P9CX
M1U< "\MR2?L[< "3)/TKUG^UM*_Z">G_ /@;;?\ QRO*7_9Q_9ZD1HY/@/\
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)B9RD,:J4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img117602972_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_5.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #= 7P# 2(  A$! Q$!_\0
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M4VY4ZL(5(-QE%N$XJ46XS49Q;BTW&45);22::"BBBLRPHHHH **** "BBB@
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MT$EQX]\;/^"=/A;XD7OA_P 1^$_BQ\5M(\5^&OC;;?';2+;XM?$KXO\ Q_\
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M\.)\6AXHET$6Y72H_BVEZUD%\7J"/'>+2P^*Q'LY-8;AS <0*,7?VWUW'X/
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M*,[2H*FHI.BXQ<.9*O&EC%BL+ABH?L]OY0@\B'R%*E8?*3RE*.)$(CV[ 5D
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MV6ZN1"4$\N[L=7T71O$%C)IFO:3IFMZ;*\4DNGZO86NI6,DD$BRP226EY%-
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MPZ\=:UHDMK?7)D\.Z[XAU#1;^XMM'U;5=.O-;T;2[^R\*_9D^#OA+X(_M_\
M[7OA3P9J_P 5-:TO4/V//V O$,]U\7?CI\;?V@O$D=_=_&K_ (*1Z;+;V/C/
MX]?$+XD^,-,T-+?2;62V\,:;KMIX;LK^74]5L])@U36M8O+_ +\4J,<3B(X>
M7/AXUZRH2LX\U%5)*E+E<ZCC>'*[.I4:O9SD_>?)AG5>'I.O95W0I.LHZQ]J
MXP]I:3A2;7/S6?LJ=U_R[A\*_3.BBBL#0**** "BBB@ HHHH **** "BBB@
MHHHH *\_^*?Q-\)_!WP%XB^(WC6ZN;?0/#EK%++#86KW^K:K?WMU!IVC>']"
MTV(K+JGB#Q#K%W8Z+H6F1,LE_JM]:6RN@D+K^.'_  4G_P""B'[1G[,?[0VF
M?"'X&>-?V5?#>F6W[/EK\7/$%O\ 'OX/_';XC:_?^)=2\8>-M \-^$] U;X1
M_%;P7INF7GC>S\(ZBGABU\2Z';Z';7GAWQ!>>*?'?A^SO="M[FU^P)\6OCE^
MWI\3=<\7_M*^,O@#XT\)_LL>)K#6?AQIGP!^'/Q5^'G@GQIXY\66.I6/ASXE
M:SH7QD\<>-/%.H)X'M-%\50>#;F^LO"\UOKVL75\-'M[_P /PW=S\GB>+LIG
MF];A?+<=0K\3PY%++Y4L1)X*G4IJM+&XM^SA3>'P^&:Q'(J]-XB4\-AH5*<\
M90F_UO+?"'BRAPC@_%+B7(\;@?"^K[6=//Z>+R^']M5Z.)^I4LDRE.O6Q"S#
M,<Q3P"KRP5>.74Z.99E6PV(HY/C:"^]O@3\"]>UOQ=-^T]^T/IEM=?''Q1;@
M^$/!D\T6K:'^SQX(D6X&C>!O#,K1BWN?&@TZ\D?Q_P",K>.,WNN7VLZ=H M=
M$ENYM:P?BE^R_P#%Y/BGXY^*G[._Q+^$OAG_ (6]>_#[Q!\5?AQ\>O@WKOQ>
M\!:A\2/A79:/I7@'XR>#F\(?%+X3>(O#/CW2M$\+^"M#UFVOM4U_0]>T[P)X
M+FTV#PGK.CW>KZO]VT5[^$P&'PF'E0BG6=9RGBZV(Y:E;&UIQ4*M?%2Y5&I.
MI&,8<JC&E2I1AAZ%.EAZ5*E#\_S7B#,,VS"GCYSC@EA(TZ&58/ >TP^#R7!T
M*DJN%P65T_:3GAZ.'G.57VDJM3%XG%5*^/QN)Q688K%8JMX)^SK\#A\!_!&K
MZ+J7C#4/B-X\\<^./%/Q2^*WQ'U32[+0KGQQ\1O&5S#+J^JVOA[3I;BQ\-^'
MM)TRQT7PCX,\-07>HOX>\%>&O#NC7>L:Y?6-UK-_[W117:>(%%%% !1110 4
M444 %%%% !1110!\:_MJ?'+XH?!;X'_&S7OAI\)/B?X@U?P]\!_B=XRT;XN>
M%KGX$S>#OAMXDT3PCXEO-+U?Q+H/Q,^*7AWQ9K*>%KK3K/Q-J=EH/PW\<6E_
MI82SL['7M2>YT$?QX_\ #Z3_ (*7_P#1RG_F'/@#_P#.KK^Z_P <^"O#/Q)\
M$^,/AUXUTS^VO!OC[PMX@\%>+='^V:AIW]K>&?%.DW>AZ]IG]H:3=V&JV'V_
M2K^[M?MFF7UGJ%KYOGV=W;W*1S)^;W_#E[_@F:7,8_9N3S H<Q_\+E^/F\(3
M@,5_X6IN"D@@-C!(QG->9C<+C*\XRPV)=**BU*+JU*:O?1I4H.Z\Y-N^BT/[
M5^C5XV?1U\..',]RSQB\',)QMFV+S'"U\KS3#\%<+<75HX.EAI4Z\<77XUXA
MHO U9UVG'#Y-AL-@JD(JI5INO>3^^_AKX^\5^.HM7D\4?!+XG_!I]->Q6SA^
M).K?!C5)/$*W:W33RZ.?@_\ %SXK0P)IIMXEO1K\NAR2-?6O]G1Z@J7K6?4>
M,/$Q\(:%<:X/#OB?Q28)K6'^Q_!^EIK.NS?:KB.W\ZWL'NK-9(;;S//NW\]3
M%;I)(%<KM/3]**]))KEO)NTHMMVO**DG*+LDES1O&Z5U>ZU1_&N-Q-'%8JMB
M*&7X3+:-3EY,#@9XZ>%P[C2C#]U/,L;F&.DISBZTU7QE;]Y.<8.%+DIP_.CX
M _M(>+?$/CCX_:%\9_'FD^$/#N@ZEK-I\,?$^I/X)T+1=0TJT\=?&^SFU.VF
MO[>SO/#'BSPQX=\"?V=KOP\\=6NM7<6G^!)_B/!JFI:/XBUFQT3RG3?VG_CE
MH=K\!_#&KR_$K7CJ_P"U/?\ @/Q5\46\ ^$/%VB>/O 6I_$KQGHGA'0--\9?
M#3PUIOP^:TA\*0:->:SXLT[P]X0UF1]/MK<:=;WY\32VWZTF&([\Q1G>Q9\H
MIWL8_*+/D?,QB C).3Y8V?=XIZJJJ%4!54!550 JJ!@  <  < #@#@4Z/[NO
M@:M3][3PE;+*M>B[J.-67YAA<95A5DW)P^O4:%;"XKE3HU(XJ:G0EA(1P+Y*
M[]K2Q].'[J>+AC%1JQ2Y\#/%97B\OA*@H\D7#"U\12QM"+4:D*N$I3598V4L
M>EHHHH **** "N4\>3V-KX'\9W.IWEYI^FV_A3Q%/J%_IT7GZA8V,.D7DEW>
M6,(!,UY;6ZR36L0!\R=$3!S75U\S?M4_%+QQ\&? &D_$/PSKWP!\+^$M \56
M<_Q>U_\ :$\7ZSX+T&P^&S:9JRWR>#=2TRVEL+OX@WVO'0+#P_I7B*ZTW1=1
MBN;ZW>\6^>R1^',W3_L_%QK2C"G5H3H3G./-3IQQ"]A[2JE*+]E#VG/5:DK4
MXR=U8[,NC-X["NE%SJ0K0K0IQE&$ZKH/VRI4Y3A4BJM7D]G24J<XNI**<9)V
M?X'?\$R_"OQ0\&?M5_":'QYXN_;WC^%5SH_BG2?@1:?&7_@J!^S#^UM\,?&-
MM!\-_$$^FVWC+]GOX1Z'HOB#X?7UAX/M+_5_#>HZ'KWC_P -^&=2L+?1=1U"
MW-[8W;?U%5_,3_P38N(O#_[87@?Q/IW@_P#X(6>%[WX_:3XTO/$M[^P=XY\<
M^)_VEKV%? ^K^-QI\'A[Q#HMAI7@[P_+J5C9:AXXL[/^SC--9+'-97%U"9(/
MZ=J]S&>T5+ 1K1E&M#"U(UE.2G5]LL=C/:^VJ)4XU:JGS*56&&P<)I1<<)2:
M;GY5%PE6Q<Z4E*C.K2G2<8RA3=-X3#<DJ-.<ZTZ5*4>5QI5,5C:D'S.6,J\R
MA2****X3I"OB#P#_ ,I(_P!J_P#[,@_X)\_^KY_X*:U]OU\0> ?^4D?[5_\
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M:ZG9>,]*ET>\%]X7N-/OHIK.\CURWWZ:8+F*2&0W(5U(S7=5\K?M?? >Z_:
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MI8&,CR)#)_.3X&_X*+?M;Z;8_"OX&^,?BM\?M/\ V@?$OQ8_:;T?XW_\-!?
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M^1W[3W_!9S]E[]D_XY>-_@!\1? ?Q[UKQEX!_P"$:_MC4_!7A?X>:CX9N?\
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MVT6BFTMX]3'BN?PQ-*^IV)T:'5DCU)]/](\8>)CX0T*XUP>'?$_BDP36L/\
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M%2J>SK5$FU%.-"E.M-7=E=PIR44VKRM&^I^BU?$'@'_E)'^U?_V9!_P3Y_\
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M5'VE6,H+]]Z*\&B_:H_9@GD2*']H_P" TTLAVI%%\7_A[)(['HJ(GB(LQ/H
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M%O;6$/XD?\%5O^"K7[0G[#?[0_@_X2?"3P?\%_$?AW7O@UX=^(6H7GQ#\/\
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MYQ=7DY5.GF>$G3<54IU8.LIQBZ"E3=ZZII.+:DNS W]M-)57?!Y@FJ7/S-/
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M>&?A?X>U/XCMILVF7'PVBD\)W6I:E:S6EI_877XA?M<_LP?%3]L/]K+]M/\
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MO/"WQ:\%Z#X+N_BMXFM1%JUQ\1 ]WX_N-(\*:AI[75SIM[JDD?\ 5]_P@/\
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M.?#;P;HG_"JS\0O/_P"$^/PX_LS1;7_A!SXX^U7/_"8?\(Q_9?\ PDOVB?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img117602972_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 7@# 2(  A$! Q$!_\0
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M]YE&95,JQL4W95/9XNFUS4?:05.=&<Y0]M24_?J*\0^#7[3?[-O[1G_"2?\
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M.7EY?K/]K1_LKV=WS<O]F>T_AVC[/V/UG_:_:GEO@'_E)'^U?_V9!_P3Y_\
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M  E?_"5?VE;26U[%KH^%8T<>'1I0NXKC27\.'4FU0VUY'K:VJRV#?KGA7GG
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MM-,_2Z-15:5.HG%\T4Y.#O%2M[R5]?=E=-.TDU:23304445F:A1110 4444
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M0> ?^4D?[5__ &9!_P $^?\ U?/_  4UK[?J2GO\H_D@HHHH$%%%% !1110
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MHN*E=/1ZGO-%?)'@[]K7PE=Z?X8NOB,/#7A__A96J^*_^%,:S\+/$7B3X\>
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M,9_A1\7OA5\2]8\)_#:Y^*%Q8_#W7?BC!\6[KQ;K3^$]4L_!EIXM\-:5JS^
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MXA>./A9\2_V7/!?PZT7P[K'PC\8? SXG?";Q)\//BG-=^%;'X5Z7J7A/X?\
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MS(/^"?/_ *OG_@IK7V_4%2W^4?R04444""BBB@ HHHH **** "BBB@ HHHH
M^.([E/V;/C@]C=&2T^!O[2?BPSZ1<E96TOX:_M&ZY*[:AI-W,S-#I'AKX]2!
M+_1BWD6,7QA@U6P+RZS\4=)MC\S_ /!4Y+;X,>$/A7^W3H=U9Z?XV_9<^(/A
MB>\LY)DMKOQ[X!\::]8^&-?\#V):>"*75KM-7N+.UO+A;N71_!^O_$<:9;K=
MZQ))7Z7?$#P#X3^*/@SQ%\/_ !QI$.N>%O%&GOIVJZ?,TD3E/,CN+6]LKN!H
M[K3=6TN^AMM4T75[":WU+1]7L[+5--N;:_L[>>/^(S_@MOH_Q<T+]JCP%X2^
M+^I0^*-4\$? #PGX8\+_ !($UA_:?Q2\"1?$/XJ:CX;\;^)](T^."'P_XM#:
MG?\ @_Q7:)%#::MXD\)ZGXJTFUT_1/$>E:?;?JGA]DT^+\_PE*AB8T<RP^#K
MPQ^%G&D_[:P$:,<+.$95L1A:4:M;"598/'2]I*O%*ACZ-'%5IXN=#X3Q'Q&9
MX7@[.I9-ECS7-9X=0RS#QKT,,\/CI5(/#8_VV(J4J<?[-KJ.8)>UIRE]7<(3
MC+D/[?/ _C/PW\1O!GA/X@>#M3AUKPEXW\.:+XL\-:M;[A#J6A>(-.M]5TJ]
M16 >,7%E=0R&*15EB9C'(JR*RC\7_P#@N+X#^/'C#X5?!?5/A)X;\1^(O#'A
M/Q=XNO?'[>#-+OM3\3Z3=:IH6GZ3X6O\:/#-K5OX;EL;CQAIVO20;=->XO=&
MCU3):R*_,G_!NQ\;M'T[X9?$W]G;6["YTC5M=^)/BGXJ?#[7[P2Q:7XY.F^$
M/A?X=^(_A;1YY(4M9==^'UI_P@&OZEIT-W/?S:/XZAOQ9Q66F7-PW],=?*\0
MY-B>#>)L7E=>$JD\OK6@Z\(0]M3J4OB3HU:].2BY2IJI3J23G3;<824J4?1X
M>S2IQ5PUA,5BZ#RW,*]"G2S7 PJ0JSR[,J/)+%8;GC*49T^>U6A44G'$8.M0
MQ%.<J=:$Y?DA_P $8)?C;/\ LCW4WQAU'7;_ $Y/B7XJT[X9IXIO;F]U_3O"
MFAQ:;H>KZ7*+V66^L-,TWQMIWB>PL-*U#RKVPN;;4HU@BTUM-6OUOKXZ\52_
M\,T?%>Z^)$:R1_ OXX>(])LOBK$IF^P?"OXLWL$.BZ%\6G#,UEI/@KQ_%::1
MX1^),P%I9Z5XKA\*^,YP!KGC?5#]BU\]BY^VK3Q"C&,:[<U&"M&+TYH/^]%_
M$].:ZFDE-(^APD/8T88=RE*5"*@W)W<E]F:_NR7P[J-G3NW!A1117,=(4444
M %%%% !1110!YQ\0OBIX9^&,>E2^)-+^(^I+K+WD=F/A[\'/B[\7)(6L5MFG
M.JQ?"CP/XTET)'%W$+.37$TZ/462Y73VNFLKP0?A'\3_ /@NL_@G]HO6O ^C
M?!:/4?@QX2\77'A+7M8UY_$WACXH7J:5?MIFO:W;>&=<T[3&\-7-A<Q7C6W@
M_P 3Z-#K<@LTM-9N?#VH7-Q:Z7_1'7P%XV_X)D?L>?$'XY2?M >)_AO<7GC.
M]UN'Q/KFDQ:_J=OX*\2>)H9DN?[=UWPQ'*+:[NKFZBBNM4M(9;;2-;NA-<:W
MINHRWVH-=]^"J8&FYO&4*E6]-J'+/3GNK>ZN1IVTYG.23^SKIP8VGCYJ'U.O
M2I6J1<^>#NX6UO)\ZDKZN*A!M:<SMK]0_#WXV^#/B=J-SI?AG2?BO8SVNFG5
MGN?'GP%^.GPJTB:T\^VMPMCKWQ0^'/@_0]2O7>[BDCTO3M1NM3EM5N+V.T>S
MM+J>'QS]O3XZ>//V:/V4/BS\<_AM_P (4?%OP^L_#>HV4?Q"T/6O$'A.6UU+
MQAX?\/ZDNIZ?X?\ %O@C5/W=AJ]Q<6]Q!X@MDM[B&.2>&YAWQ-]?UX3^TK\
M?#7[4/P6\9? WQAXF\8^$O#'CA-'BU?6O 4_AFU\40PZ+KVF>(K>'3[GQ=X7
M\8Z)"L]]I-K'=//H-S,;8RQV\EO*XF7SZMI?PU*/O0MS2YFK3C>4G'V7-%*[
ME%6<HIQ5V[/T*7NRBZKC))^]:/*G'JDI>UM)JZ4K.TK2LK'Q1=?ME_M#V/@W
M]IR?PY\-?!OQA\2> ?$7AOP[^S!XL\/:'XO^&G@#]HW6=0^'=U\0O&V@Z18>
M)?$?C"[N?^%9V6B:_:ZAXP\.>+=4\*>*;^*'2-,FTO6+'5;.WT?VG_V[O$WP
MW_9\_9F_:U^!FD^$_'_P.^(?B7PCXK^+]EK.C:_>^+]/_9UU/P+KOCSQUXT\
M#76C>)=+M-,\8?#CP[HMWX@U;1]>T/Q#;WMCI&M:7]GL-2AAD/V?XM^ W@[X
M@>-O"'C#Q_<7OCFR\%^$M=\,Z9X"\6:-X$USP%<:EXAN]#N+_P =WVDWO@V3
M4CXXCM]!@TJPO['6K#1]/TG4-9M+30HCJMU*_A_PZ_82^'7PT\+^&_A_H_Q$
M^*>J?#+PI\4?C%\2M)^&6OI\)KOP7%8_&S3O&^F^)_A6+*R^$^G:C;_"C28?
MB+XL/A7P[8:I9:MI*:A%83^(M0TBQLM.@ENK&G4E"-.IB*;P.)P2K2<,,ZN6
MU51K8+'^RASU<)G;C2Q=:4*<Z^&P:Q%!UYXVO#V-Q]DY4.=5%2DL51QT:7+]
M8E3QU%U(XG"5*LI0I8G+.3ZMAXOV=*>-Q+Q#B\%0IP7D?C?]LKXIW7[8,?P0
M^%4/PNE^#\?[*GQQ^+R^/=>T#Q+XIUOQ!\4?A?)\(I[+2] N-$\>^%=#_P"$
M!M-*^,?AR76I_LFHZGJ^L6FL:)8ZIH,FGRW38G["_P"VE\;OVCKGX,WGC72/
MAMXI\#_$O]D?P?\ ';QO\1?A9X*\;>"?"7P@^+?B&?PJ(_@OJFK^+/'WQ$T7
MQ?J>NZ?KNNZK86NDZUI?B+PG:^#[C_A*-)FA\1:1=)ZYX1_X)W?!_P"'MU\)
M9/ 'C?XN>$M,^#'[.GQ-_9G\'Z%9ZQX&UC3Y?!?Q:U+POK7BWQ'KM]XL^'OB
M'Q'JWCI]8\':!J5AJKZ[%HT$]K+#<>'KNSNKFUD]S^&O[,?PM^'W[.GPX_9>
MUG3%^,'PM^&7@CPCX TFS^,NB^#/&%QK6A^!K*RL/#4OB?3[7PIHOA/4]2T^
M'3;%TO+?PQ8@W5M'>"%;H&4[4%3HQJ-N>(<$H4HXBT'7]IF?'4:E:HZ?M?8.
MEE^8\)XNA1ISE+VV64<#4Q,Z%'&/&95>>HJ4?<IN3;JU<.GRTE3PG"<J<:=.
MHX.I[7$X'B'#UI3?*H9C5Q,:<JD\-+#YOB/XR>*]&_:Q^%'P-M=/\.77@KXB
M? ?XV?%"XU,QZ@?$UOX@^%OC'X*>']-L[2\74$T<:)JMC\5+Z2ZCETN>\6ZT
MRSEAOXX)9H#ROPJ^(_[1<O[1OCGX1_%BR^%6O^#;;X4^&/BCH?B;X9>'O%WA
MN\^'>L>(?%.MZ#'\*/'=SXE\9^,+'Q[JMWI^D76NZ'XXT&R^'JWUGI.I_P!H
M?#[2([G2KBY])N?V>_"+_&;X8_&C3-8\1>&[[X2_"KQU\'?"7@3P[!X.T[X=
MP^$?'^J?#_5M4$VDGPC/KD%YILWPS\*6^@QZ1XCTK2-.L;:YM6TFX2Y)3"^#
MG[/?B3X3>*/$7B/5?VE_CU\8++Q%<:SJ$_A3XFZ=^SO9:%::WK-Y9SOKJZA\
M)?@!\+/&FL:AINGV4/AW18?%?BWQ#I6D^'D@TZTTU/L&ES6,T+1^J<[<I4Z.
M=+$NJOW=?VN89P\LIR5-RE"K3P5?*<13K4_X=?+Z6#JU%A<3F*KU5;E2Q"BH
MJ=2IE;I.G?GH^RA@9XV=-SC",Z<W1QF%K4ZG+ST\;4Q=*$\10PW)]*T444A!
M1110 5^'/_!3+]HOPSX(^'GA[XR^+/BK^T7^PAK_ ( \<^//AEX,^+.D?#3]
MFKXK7'Q&LM3\56WA[6/#WAOX,?%/6O$_BGQU8^+I?!NA>+/#-UX2\):;XJM-
M&2WU>;.A7&H02_N-7X[^%O\ @E]XW?\ :_\ 'G[;?QB^.O@?X]_%VX\6>)7^
M >F?&;X.>)O'/A#]ESX;RZ_J%QX1\*?"'0=(^-?@#PUIWB&TT(Z4-=\;S>%?
M^$BN=:AO+VQOX;F\U+4M7PE3E5Q6&@Y2HT(>TKUL5%R<Z?LI48*A0ITJM"M4
MKXRE5KT+2K4L''"/&/&/$1]GE^-Z*<X4J->K95:]XT:.':BE4]M3K1G5JU*E
M*M1I4,/:%2<E2K8IUOJ\,+3IN57&83[J_8UTFTTK]F[X:/:W7Q9U*37=/U/Q
M9J6M_'/P;HGPY^*WB/6_%VN:GXCUKQ)XP^'_ (=T?P]HW@F^U[4]3N=3MO"U
MEX?T-=$TZYL[";2[2YAF2OIZN#^&VG?$;2_"T=G\5?$_AKQ?XR&M>*+BXUWP
MAX:O/!_A^;1;SQ+JUWX5L[/P[J&M^);W3I-)\+S:/I5\MUXAUN:YO[*YNWU*
MZ-QYA[RNW$5(U:]6I",80G.4H0BHJ-.#?N4XJ%*C",:<;04:=&C3BH\M.E3@
MHPCQ482ITU"<G.HI3]K4DY-UJKJ2=6NY3JUJDW7J.59U*M:K6J<_/6J3J2E)
M^1_&#X\?";X":/I.N?%GQC:^$['7K[4]-T.-M.UK6]4UF]T3PQKOC76XM*T+
MPYINL:YJ"Z)X1\,>(?$VLSVFG36^E:'H^H:G?RV]I;R2CT;0=>T7Q3H>C>)O
M#>JZ?KOAWQ%I6GZ[H.MZ5=0WVEZQHVK6D-_IFJ:;>V[R6]Y8:A97$%W:74#O
M#/;RQRQNR."?S'_X*/\ [*7Q;^/GBS]FCXF_":PC\4WGP1B_:AT?7? C:UHV
M@W&MVOQY_9I\>?"O0=:L+WQ%J&E:(TWA[Q??^'X]1AN]0MYTT#6-8OK$75S8
MC3[WZ"_9]_9H\<_"?]AKX$_LM#XS^,?A[X_^&/P5^%'P[U'XP_"VS^'FL>)M
M,UKP1IGA^+79O"MI\9OAU\4/ =SIFK-I=]X=4^*/A]K,L?AO4)IM-BT?7X].
MU;3<</\ O*68RK?NYX;$Y;3P<?A^L4L31S*6-E:5W4^J2PN E[:G:E;,%0E'
MVU";>V)2I5<KA1?M(8K 8^OCI?%]6Q5#'4:&%H\T4HT_K&&J5:OLJBE5E['V
ML9*G-1,SP#_RDC_:O_[,@_X)\_\ J^?^"FM?;]?F9^S)\/?%OPV_;_\ VO="
M\9_'3XJ?M!:I=_L>?L!:M!XS^+ND?!+1?$FF6$_QJ_X*1V<7ABQM?@+\'?@C
MX/DT.RN+"ZU6VN-2\*:AXD>_UK4X[SQ#=Z7%H^FZ3^F= 2W^4?R04444""BB
MB@ HHHH **** "BBB@ HHHH *_ 3_@O9^RI)\2O@IX2_:3\)Z2]WXP^"]_#X
M<\7"RMC-?:G\-/%VI0VUM(ZPI)<W9\*>,+JRGM+>-1':V'BCQ+J$S". D?OW
M52^L+'5+.XT_4K.UU"PNXVANK*^MX;NTN86^]%<6TZ20S1M@921&4XY%?0<+
M<08KA;/LMSS")SG@:ZE5H<[@L3AJD72Q6&E*TE%5Z$ZD%-QG[.;C447*"(J0
M52$H/126_9[I_)G\W&@? 3XE?L8_L@^ O!GQ.\#3?#_6?AW>W'[2_P *_P!L
MCX76/C;QS_PIOXZ7_A6+5M>\!?M)_#?PGH.N^-=(^&^IZ)9:O\'?'?C/PS9^
M+?ASXE\$2Z/'XCT+0O$+6TE?*W_!23_@J5XG^,GPP_90UW]GSXS>-_@MX\@O
MOC;X?_:&^'OPM^*&JZ)=Z)XT\/K\*K30Y6\1>"-9M;?QQ\/=2GN?%=W\-_&>
MFWVH>&_$=A-J7V>:/7=(UW3=)_K[K^=W_@KO_P $N+OXR0> ?'_[&W[-VD7G
MQ;N]9UZT^)B^#=6^&/PT\*:CX;N1+K8\2>(=*\0>)/!D.K?$&X\1W,D-EKVA
MPWFH:II=[KL?B^2]GT_P7)IOZ7P;QGP]CN*\'F?%V7Q6,^MYEBEC57H/*Y5\
MPP6,HU5C<-F'/]6H.K7CB;4,14H4\71HSP6"PLJF+6+^*XGAB\CPN.X@RJEC
M\9.-'!PQV49;@:^/Q69.CB\/##5Z%#"*6(6(P]*<Z.+K4*&)K5<K4HSH8B>!
MP,:6/_P0<^./Q<_:2\,?M@^!?C]\2/&/QM\)Z(?A+%IFG?%77K_Q_+#:?$#3
M?BKI'C+3'U3Q1-J>K7.A:Y8^%-%AET"YOY]$MV@N[FQL+:ZU?6)[_P"I?VK?
MVR_%O_!,'P5IW@+4/#+?%O0_$QGMOV:O$GB3Q6L5WI&A:&;=?$O@3XHW%U<3
M>)M>;X<VVI>'HO"'BBS%S?>,M U>RTOQ1J-AXA\.:AXC\3_D;_P2[^)GB;]C
M?P/\3]'USQ#\,_V</B1\1_&6F:'?:S^TQ\%_BIJ?PVU3Q9X6L_%-MX*^#7Q!
M^-'@SX^Z9HG[-_C#398/'OB'4_#GQ3^">D^,M/\ #&OVOC::7QQX;U#P?I6G
M_>'_  62\0?&OQ5^RG8:?\2XOV2?A0EGXFL/B'X8TO3_ -IYO''CWXG6?A^*
M/1]7T_X8^%/B'^S'\,KG6-2TB'QII>KZE?\ @WQI8:E%HLDVES6VL0:_!I=Y
MT\6\.4<\\1N? 87!X?(<^KX&GA*+JK*:3J87*<#A\57P\EA*D<1#Z["M5Q%;
M+</CDH2JRQBPU2<I4ZX<SNGG'"V"SB&+C"O7PL\7.=1U:3PRQ=:I5CAJ\<90
MHUZ*HQ<:,?;X>GK2C*DI4[.7WG_P3<_;^@_;N\"^.[[5/">G>#O'GPQU;0K#
MQ3INAZG-JN@7VG^*;;5+CP]K.F27:B^L#=2Z#KMG<Z7=2WS6[:='<IJ,Z7OD
M6OZ25_*U_P $:_C'\:_@U\(_&U_X4^!^H?M%_"^^U&X\5_$.R^#?BG]G>Z^,
MGPIBTK3];TKP[,WP^7XI6WQ<\>7WCBY\.ZK::1X(\9>&?!5_9V.B2Z]\.KKQ
MG'K=UILWT+^W]_P4"_9A_:!_8L^)&A^-_A%\<M(T+6]=L?!_AO7I)OV<-6\3
M?#CXW6\7C'6O *>-_AUHG[16I_%7P +VZ^'?BZVOQXG\&:)/J'ARR\06-L9'
MO[>*Y^3S#@+$+C*IP[@YT7A7F>'P*JX3&8/,L52A55-5*D<#.OE^+KU8*52L
ML)[*E4E"+C2G6IJ%>I]'0QU*.#A5KXFE)J$Y.M.<(4ZD8/XU5LJ;BDXQE./N
MQE=2M)-+^B"BOY2_^"&/[3O[-'PGT7X@?#5O!WQUU[XZ^,Q=^-_&_BCP3\%?
M%'Q3\/:=X%\)WNFZ#X7\/:?9?"A/'7Q'-M#?>);C4]1UB]^'^F:#'J^O+I=[
MJH>VT.34?W2^+'[</AWP9\./&'BOX>?!O]H_XD^,O#^C3ZKHG@75/V6/VOOA
MS9>)9K1HY;G3Y/&^L_LXZKH_AV0V(NIK:^U:T&EFYAA@U"\TVTFFU&TX.).
MLZR+B+$9#A\)F./A"M0I8;'U<NE@*.*590BJSY\1B,/A\/[:4XQK5L6H.C&.
M(J.E"=H]6'Q=#$TE6I5:4XMR3=*K&JE*+LX\T-Y+K%*Z>EKGW%17XJ?L:?\
M!89OVJ?$OBFUUW]EGXF> / _A71XYKOQO\/=.^,_[2SGQ+>W<":5X9N] ^$7
M[.MV^B-?Z<FK:F-3US5-/B\O2_(M+6_DN)&M/N;QI^V;X/T?PCXGU;P7\+?V
MEO&GB_3-!U;4/#/@^\_9"_;*\*6OBG7;.QGN-+\/S>)KC]G+5;;0%UB\CAL!
MJ]UIUY:Z>UP+FYA:".0CS,QX-XGRK'O+,;D^*IXR+I*4:3HXNA!UE%TU4QF$
MJU\'3]V<93YZ\?91:E5Y%J:QJTY1YE)6UWNGIY.S]-->A]BT5^/'[ ?_  5/
M\7_MU?%[Q'\-K+]ER7X9Z!X*\,WGB'QGXWN_B[-XH&AW'VV+2]%T'^P6^%'A
M@SZOK6HO<+%;SZS8M;V&E:S>[;A[#[)-^P]<.>9!FO#>/EE><X:&$QT*5*M/
M#QQ6#Q;A3K)RI.=3!8C$4H2G"TU3E-5%"4)N*C.#DX3C4CS0=XW:O9K;?=)A
M1117CEA1110 4444 %%%% !1110 4444 %%%% !7X]_M$?M8?'O6-)\4:!\)
M_"_AR[U_X:_'7Q1IEK<67B[XG^%/ _QR\!^ (-5TKQAX3D\;^%O",OQ ^'?B
M3PKJ^K6;:]XM^'^B?&+X<>%_%WPZUK3?BUJWA3P;J%_$O["5\<>'_P!A']G_
M ,(_M$ZA^TQX2M?B+X7\9ZSXAU?QOX@\%Z%\6?B)I_P3\0?$G7-"U+PSJ?Q0
MUCX*Q>(O^%<W'Q"NM"UC5;&X\1QZ##-=S:A=:M>17.N2'4QGR2GB(<U25/#K
M#UO>@HRJ4\=3Q.!Q.#K*G)*-2"IX?%X><)3=-O$P]KAZT+SH:J<(4*G+!3K^
MUA:,W*%.KA9X;&8?$T'5@^>C.=2OAJL:U.+JTHT*DZ,X5E34_1OV6_%?Q(\=
M? GP'XO^*\?A*'QGXAM=5U*XA\%?$#0_BIH<.C3Z[J9\+Q?\+$\+^&?!WACQ
M?JL?AL:4FNZSX<\-:3H=SK*WW]FP/;*D\WT#52RT^PTV*2#3K*TL();J[O98
M;*VAM8I+S4+F6]O[N2.!(T>ZO;R>>[N[A@9;FYFEGF=Y9'<VZZ*LXU*LZD*<
M:49R<HTHN4HTT]H*4W*<U';GFW*=N:6K9STXRA!1E-U&G*\W&,.:\FT^2"4*
M:LU:G!<M-6A%M139111699\0> ?^4D?[5_\ V9!_P3Y_]7S_ ,%-:^WZ^(/
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MS3A3J).IAYU*?M*5*52C4I5^11K1;****_'#]#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /RQ\4?"?QY\3_^"D?[1G_"$?M-_'#]G/\
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M8 D]J_._2_V]/V5))_C/\3]/\,^)M/\ &7@S]H[X>_L%>)+Z]^'VE^&_B/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img117602972_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_7.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #. 1(# 2(  A$! Q$!_\0
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M+FE)W;B"Y8N-W)VNY-).4G)-MV22NVWRQ2BKVC%))+[?HHHK( HHHH ****
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ML'%PI0I2K6]^MELITJ,9/GO@JD:/-3IY;&#SYXJIR<RO)-\M]4_3M+5^JO\
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M7,$]M(TRQW$,D$C6]Q/:3JDJ-&S075K)#<VTP5B8[BVFBGA?;)#(DBJP^%_
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M2Y$J;E&'*J<*LH<LJT*:A"-.G6<X0C"$8Q48Q2"0 23@#DD] /4UXM9_M'?
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M97_!2/\ ^A0K(=GV?W,^WZ*^(/\ AX-\!O\ H0?VW_\ Q65_P4C_ /H4*/\
MAX-\!O\ H0?VW_\ Q65_P4C_ /H4* L^S^YGV_17Q!_P\&^ W_0@_MO_ /BL
MK_@I'_\ 0H4?\/!O@-_T(/[;_P#XK*_X*1__ $*% 6?9_<S[?HKX$\,?\%+?
MV8O&WAOP]XS\&:%^V'XN\'^+M#TGQ/X4\5^&/^"<'_!137O#?B?PWKUA;ZKH
M7B'P]KNE?LKW>EZUH>M:7=VNI:3JVFW5S8:C87-O>6=Q-;S1R-N?\/!O@-_T
M(/[;_P#XK*_X*1__ $*% 6?9_<S[?HKX@_X>#? ;_H0?VW__ !65_P %(_\
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M-_A[QEXNUS7=#\=^./C!XKU[2=3\?ZAIFI6L4]U9Z1?B_P#$\<MSKD-S4/\
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BVOL[2<'4F4445S&X4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img117602972_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_8.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %8 N,# 2(  A$! Q$!_\0
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M6O?KJM;:K=7L_NU-4[W\M._1/\F@HHHJAA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 444A. 3Z F@ +*.I ^I%+7.Z_.]OHFM7<+ S6NF:A<Q9/
M FM[626-N".C(,@8[@>I_D*U#_@J)^UC8^.O&-_#\4-/*^&_V@#\/K3P++X6
M\1R:;/X97Q#9:>9[KQ%'C1+>46L\C,LUU$P*#*U[^0<.8_B%XM8.5""PD*4Y
MRJRG9NM+DA!>SISL^9-2E*T8I7;77GQ&)AAXPE/7GG*"BFD_=3DW9M7T3=EK
MZZV_L6!!Z$'Z$&EKD_!.J3:YX7T'6YS 9=7TJTU"0VLBRVWF7,22,()$9T>+
M)^1E=@1T)'-=97@RBXRE&6\6XNVUT[/MU79&\7S14ELU=>CV_ ****0PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:X\,^-=+U/Q]8>#=3DTBY?PQJ0\)H[PK)?"-+/SI!Y6^(S!V+!<9Y.K\)_\
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M/&>*Y;P/^T%\+OB1IOBK5_!_BS2]0TSP9J_]A^(+[[3"+:PU'9YGDRRAV5>
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M:RU&2UN$TU880[++$;Q(MY? "$D ]*_1CXZ_L]> _C_\,/\ A57C>VFG\/\
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M2I-O^TWYT7?1+OMYKI;M]VW5C6R7*]++H]O.^OJ?A]]N_P""V/\ T!/V<O\
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M%I_"'A;7_%%YH7[.LEIH&EW>JW$<>J>(O,>"SA>:0(/L ^;:AQGCU]:^[O\
M@G!^T7X^_:I_96\ _&3XE:?I6D>,M>AO8=:L-$DFDTR.[L;^[LI'MGN LI0F
MW! 8#.>,=:^L_BYH&I>*?ACXZ\.Z.@EU36O#&KZ=8QL3M>YNK.6*%"<Y +L
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M,]$DXMM)M-ZI]-4^C_F,_88D5?VHOAJI)R/$,7J>/ML!Y_$9S@GGTS7]I3N
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M\-_:?#BQWKP!O$-N8$M9LQ3H9)EB#J"V01G.<5_3,8Y#*6\E   00JYW#O\
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M4O\ P./EY^?0_KW_ &LR/^&9?CWR/^23>.QUZG_A&]2Z?G7R#_P1R(_X=]?
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M&V,_].R/T; ?[IA_^O5/_P!(B%%%%?+G6%%%% !1110 4444 %%%% !1110
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M&2Q*C"--32?OJ#49QL[<LD[V5VE%J,7#3F<;:MW7O.R=I<MW>ZO=H]$\"_\
M!,K0/#&N:KXAOO'-[J>KZSX-\0>$KNX,4J!DU_39=.FN0&D;YD65I  2<CK7
MOOPB_8:^$?P;\(:OHWAJP"^*-;\)7GA'5O%7"W-S:7=B;)F92-^X(S$9?()/
MK7XZ^&/^"H_[1.O_ !%N?A?8^/?!%U9>()/#]QIGQ.N?#5GI^F^$;;59W%VF
MHZ>]RT5T/+*BWEEN8MQC8KR<#L?"W_!1/]I+7]3^(6D7?Q/^&UA%\(-3U!3J
M;Z#IVWXP0VDTP@L?#<37@%M.ZVHCD:V>[8-<QY3( ::^!SJ<7&MBE*#C3ERJ
M;:<+)14^6DW\4^5QMU;:Y;C]I!M/DO>SOKIL[15U9)K9ZZ/RO^@/Q(_X)H?!
M'X@>!-!T;Q1J6IVFL^%KB.YA\3V]^]D%LT97E@EZX25(U4L9,#!)R*_1+P9I
M.G>$_"/ASP_8W1N--T'1-/TJSNWD$OG6MA:PVT,K3?Q;HX@=V2#R>]?SJR_M
MX?M4^+_@EKWQ7\4:YX6M?!GB>P\9Z):>!H?#]O:ZMIL^FN;2WNY-;$WFLT1<
M.4-LI/(!!Z>8ZC_P4%_:%US3?$_PVU;XB>'O!NE7/P::\\)PZ5H\-]JL&IV^
MDVH@OY]9@N8)8&620.\;+DDG+?+64LKS/$)0K8FG/V=9MQE-S4/:*FYN/+!7
MLI1E)I+1/J.,X)Q?*TG[G,MFXVCU5V[JR226J[G]3EKJ-E>F1;6YBG:%@LRQ
MNK-$S#*B0 DH6 )4'&0">E7<\X[]:_(?]D;QOXQT_P".WA/PQ?>,9O%]A\0O
M@S9>*_$$S2-)!#KNA:9I=K');1-)(MK]I^TS2S*#F20AFR17ZZH202<\GO\
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MVMWT[)7N)-Z)J]K7:<7;:U^O5=VVM6C^EFW "#H2"<G\3^O;]*6X_P"/>?\
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MD?HN!_W3#_\ 7JG_ .D(****^7.L**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I"JMC(!QTS2T4 1B*('(10?4#G\ZH7NEZ5J,9AO[&TNXV
MSE+FW29#GU5U(/XUID9X-(  ,8X_/^=)WZ.WR_X83UTMIWOU3/+;CX.> +FZ
M^W#0K:SN<G:]BJVGOTB4=\^O'L:\,\=_#FZ\,:YINI:+X?\ ^$FL?.,ES8/
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MVC6RC4]<M;+3["W"[+;0-*M+9+=K#3HA\D,-R%BDE6)44O&"P/&/H^FA%4Y
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M?\)'I;^'+3X>^'!XMN[W65^T?8HM6T.6[M;:[T9Y2%O1<F6((5W1,#BOGO\
MX(?V_P"U_;_##QX/VC? _P .O"G@]]2L/^%:W7@_1=(\,:_J&EQP3JTGB[P_
MHVG6<%EJ*'RAMDEN9!F3YZ]V_P""P7PX^+/Q _9OT./X;Z)KWBWP_H'CWPYK
M7Q.\'>#Y;JW\7^(? ]E-.^M6WA^:P>&\2\>VRB""XA8R.OS@X(^6_P#@C/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9Q6GC<31RN@U:4E+$22T3;BM7>]J<7S2[W796_:C_@FI^R_9? 3X+V/B'5;
M1^._'<<>IZM<2Q@3PV,JI/968+?,GDF253@*2&YSTK],*H6UO#;0PPPQK%!!
M&L4,2#:B(B@*J <!0 ,# Q[<&K]?.U\1/$UJM:=W.<FW=W26RBO\*23\[GT>
M&HPP]&%"G90I1C%)+=\JO)[[N["L;6]-LM:T^^T?5($NM-U.UEL[RVD57CGM
MYE*RQNK9!#*<'/'X5LU7N$+@;20XZ ?CS_\ JYK+71IV:::>VSONM;K=>9K*
MUFFKIZ6[IZ-6Z[G\;G[>W[-^I?LV_'/4X],@N+'POXHNI]<\*WT0:..%Q+Y]
MQ'%(O$9@FF5$"D$8XP!7[V_\$S?VHD^.?P:T_P *^(;])/'7@6%--U)9'!FN
M[)%*V<ZJ<,PCMD1'.!SR>37HW_!03]F>V_:+^!VJVMA:1R^,O"MO/K'AZX$>
M;AY;:-IFLT95+%+B14RH^\0/7%?S,_LG_''7_P!E7X^Z/KFI-<6VF6NM+H7C
MC3LLA-BMSY-Y*8B5!:/RSMWX !'..#];%K.LJY7RO&85+XOC<TE:5M-)P7*M
M4G+E6K/DI7R;-5.*<<'BVDVM8Q5TY+MS1D^:V]F[-11_:V64AL$< Y]O\YKD
M_%%E/J6@ZYIUKM^T7^FWEM"&X!>:WD0<@$G);_\ 5SEWA+Q1I'C+P]I'BC0[
MJ.\TK7+*WO[:XC<.K13QQR[#M+#>F\(P!R"#UP:7Q/KNF>&-$U;Q%K-U'9Z/
MHUG-?WMU)E5@MX%+.['''91QU()&,U\A.ZER_#)2M[T7I*,EI:^LE)62:Z]S
MZZ+YDG'WE:,M-G&5M5:[UNEZZ'\SEC_P3D_:9B\'ZI\-6TNS3P%%)KWQ*TC3
M=TA0?$B37KF'3X'B\K8('TF<W#-DMO ^0\FDT;]BC]MK0]8\32";5M;UB&TB
ME=+W4+ZQT/6[58XH_L4-_;$W'F0K]R)8@A\L [06%?;?QR_X*EWL/PYU3_A4
MOPS\;V'C;5H)+_P%<^(;*SAL=<T.UU5=(N=<L6M[RX>2W%TLL2&2-,@ E5KW
M_P#:$_;@N_V?_AQX;T6Y\*^)?&/QKUWP%8^+SHVB6MM*NF6MRR0OJ6I^;<0&
M.VCN3)$QC5R"/NDG(^J>-SEPA[7"X9JO.K",'R\S<(493JMMW22Y(-I)WC9:
M[86IRYH<TDT^:7N+1.2CR/3HXN5[K7>Y^0O_  Q)^V/)X5OKN2U\3P21^-?[
M?TJSBNKPSQQO;PVYMY[ R"W:UWA_WA+OM.\+D5[K8?LZ_MGZ1X?\0?#R^\*R
MRW/C-[W7EUZQUO5KBRTC[38"UCTX7,@5TF5H0Y0+A6E^4YXK[,\ ?\%1?ALG
MPK\)Z[\3--UZR\8ZA//IVL:5:V\#,DD,$EU_:<:F=6.FN%6T6<@9N59-N.:]
MJ_9P_;W^&G[3=OX^L_".E>(] UWP;X;U+Q/]DUVW@@:ZT>"&X6VU"V,-Q.&1
M[B!E&\*,*>.QQKXS,XPJNK@Z+A2;4IPIOE33@D[\ZYDI+5M:ZO9 H1;3YFKR
M25TF[JW5INU[;73ND[['Y+^//V!_VDM+\(_!D>%I?$,9B\-Z9;>,M,TS4=0U
M"X@\81W,[WVL7+7,HDCC>-K8%@W C^[Q7UU^VU^S1^T7\0?@/^SAX8\&:[K-
M]JW@2VU.'Q_;:9)(U_J]Q?:-#9:?,0K*TPMKX":0NPV*A=?FZ[WA[_@J?X4L
M?#$=WJ_@+XA>(TL=&34_$_BW3=.L&T329-0O)]-TF.ZF^V1,AGU%8H6Q"3M<
M$9/2UX+_ ."HU@NEW4/C/X6^-;CQ1I]^;S6[?PY9V=S!X?\ !EPZIIWB#4#=
M7L+QP3N+G+('(,+X7/!;J9QS492PE*3PM251-N&KJ1>D[ZVC"HDG9NTJ<D[I
M#48)MW;33B_=U=FE=6=[S:V;W6RO8^+9/V(?VHI]5^'.HZOIVI:]X>\-_#?_
M (13QEI=YK>JQ3^)-1U#3KC3K)I;6-C$T>BW4PO9)2=\BD[P5 %:WPQ_8C^-
M7A;0?C-?-\/G?6['PIX1T'X>6,VNZS:6BWEE/?1^)-1LH(&V2RW%K);LBL@6
M5E4-@9-?J5\</V]_AA\&O#/PM\53Z-XF\3:?\6A;7GAU]#MK:8#3IEBDDN+H
MS7$*QL(),H 2-X() KY1T3_@J!HVM^(OB'X+T^TU6\\2V(GU718+6&W>7PYX
M>/G2V5QKY:41Q2W$,3!5M6N!YD;!B!R2EC,XQ%&;CAJ:IOFNUS0LJ=>/.G:2
M2<6I0<WM'W-DF-TX1<;MMP<6FU=W:Y4UUY7)ZKKOY'QU\+OV,?VS_#WA/6=1
MM&U&Q\3:UKT&@Q6VHZGJ"+9^$/&-R;#Q1=QP#=&MSINF.9;=@ ?, .]2,TWQ
M]^PU^U</B-I^C^%-,U6U\/>'(=&TT:M::SJLT.MV,:B'4+R6\=_.CN;F- \D
M,;&-7?:&Q7Z3?!3_ (*5^ _B3XE\'^"Y_!WCV(ZY<_V%_P )W=:?8IX9N?$,
M+1V\UJEREX9?FN)41 +<?>'':OU,J<3F.8X:M?$X>E3E-.RL[62@ERN,[6@X
MWM9.\Y<VZ%&,9K26B2TLDUZK5/165[I:6L?RX67[(O[:NE:3XUT2W\+7VJ>&
M-7\3:4UMJE]JNIP^)+6*VFN!*;;28]UC<VD0=2L\LH>90KR#<QJ#2?V#?VK;
M73O+?PY<GQSK,MZ]CXTGO;XW&CV$,I6"WN004CDDC=2D8!1-C!2!BOZEJ*Q_
MMW$I3Y:5!.HES2Y6V[14=;RLT[7:TN_0OV:TU>G_  +-)W2:MO;5:,_F&N/V
M&OVH?$%GX<T&R\+ZIX:N=#6[LOB1K0\1:YCQY'?7"31/;;I-J+';*\3&$1F)
MG"J<"OU__8Q^!?BOX':C\1]%O;6YL/"%]<^&I_#5E<7UW?B)H=&2+5&22[9I
M%WWWF,P!.6SN]OOJBN;$9G7Q%*5*481A)>\DF^9N<9WU;=TXI1UM".D=$"I)
M-.[=FGKJ[J^M_G9Z7:T;L%%%%>::!1110 4444 %%%% 'YK?\%0O$O@.Z_9C
M^(7PMU[QUX>\+>+/&F@:A/X8T[7-8O-$76?[(MGNKRW-[81O=16HB(%W)%\R
MQ,2 3@'\)O\ @C=XG\&CX\>#_">G_#7]G'2-:TKPV]K<>*/A_P#$WQGXF\47
MTMM:!)+EM/UK3;>T=IRI:=C,2N>_?]A?^"M'Q=^!'PJ^%UM-\1M#.H_$/5].
MUNU^&]Z^G&]M+>^^RJMU9WTBK(\%KJ"M';2E(G<HQV8*X/XB?\$8?C%;_'/]
MJFVU3Q#\.M!^!>I^$+'4-'TKPMX9L;AE\9-;Q&&?Q#>3ZC;)<06UX%6XM?*D
M3<&(,:X H6NFF_EV6[Z=>MK6%=+76[]WMNUTO=IV2O;3R6K_ &9_X+<_ WX*
M?$7]D/7/B1\6_"%EXI/PGU33M>T^UU#Q)K?AR*>TBN//U"Q@FT219I[Z]C@$
M5G%(IS,0JNF37Y@?\$,OBE^SA\8OVBO%5Y^SU^SW%\$])\*>!-+MM7?QSXK\
M5ZG\0-:OK_3@7N-$TK7I;ZUCT%GB=A<6]U%)) \+R19P!^U/_!6K7_$WAG]B
M7XAZWX7\'V_C/5;'5M!F^P7$#W<&F6GVIVN?$,ELB2+.-%CS>&&2.2%MA5T8
M<5^+W_!%W]H'QQ\;OVEK2XO=(TSQI:Z-X-UG3?$?Q T_PY!X=;PV]O;P1:1I
M$D6G6&GVMR;M$EC0SI(ZB([&7)RXZ):]+)[;>?3?5WOI;1,'U6BZV=I;VZ7Y
MNMDMKM-)M'WU_P %._VSOVZ?V2_&O@67X.>!/A)K'PO\>>*-%\#Z;K'CGQ!J
MVF3PZ]KL@M[?[<MKIEU!#9K*LGF2M)P@R5Y(KKO^";?[<'[1?QX^,OQL^!G[
M2'A_X5Z3XG^&D>AWFES?"O7+_7='NK/4],-],9KFZL+%$E#% JHK9Y)Y&*\>
M_P""S&D?M2:IX&UZ.XU']FZU_94*6S:K_P +7\1^)-$\1KX@6)OL)T>30])N
MYX[W=]I^S&WN8Y-V.0:\Z_X-]M(M])\(?&$:)J'P/U'2I-4TDSS?#CQ)XH\2
M^*XYELYQ GB*X\66-O?P1E"?LR0S21M#@L 0!222B]$G:[T27GJE>R;;O?H[
MJVK2Z.Z_EM?M:VFEG:^EE^=OZ2X60;AG!&"01R.N><?G_+U;=2J;>< @DP38
M'0Y$;=B/_P!5?CQ_P5*_:$_:R_9T\,6_Q"^#'B/X;>&_!6A:5<WUW;>)]0NH
MO%?C'Q,ES$-,\+:'I\=E<PW(U&V:<EB\;[X5 .#FO4+C_@HK\._@U\$_@KXQ
M_:E^W>!O&_Q2\')KKZ)964UT(':)(Y#)WC,C.)$##.U@<<8H2>BT>B^;TO?5
M=_O_  &^Z?1[V=KJSM9MZWOMM;1[^*?\$K75?CK_ ,%$-Q )^/VDC\?^$9C.
M,_@:_:T'(R.AY%?@C_P1E^(WA7XN^-_V[?B/X'N9KWPOXI^.NE7NDW,\9CFE
MMQX96-F9&&582 X!P0.XYK][5^ZOT'\J;^*5^K_))?I_P!KTMJ]_/7];"U_,
MW_P=,?\ )A'A?_LID'_IN-?TR5_,W_P=,#/[ _A<'_HID'_IN->CDU_[8RFV
M_P#:>7K[\711G7THUGVI5/\ TAG\%#=/^ 1_RJ*G.!E3WV+_ .@@4VO]#5W[
MV?X+_(_,H_"OZZA1113*"E7[\?\ OC^M)2K]^/\ WQ_6@.L?\4?_ $I']?'_
M  :3_P#(6_;D_P"O_P"%7_I/KU?VCU_%Q_P:3_\ (6_;D_Z__A5_Z3Z]7]H]
M?P/QM_R5O$7_ &-L9_Z=D?HN!_W3#_\ 7JG_ .D1"BBBOESK"BBB@ HHHH *
M*** "BBB@ HHHH **,CU%&1USQZT %%)D>H_.ER/44 %%%)D=,C/IF@!:*"0
M.I ^M!('4@?6@ HI,CU'YTM !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7SA\:?VE/AI\$7NK;QIK,&EZLVCW6I:3!<ML2_DB@F>&")B
M,-(S18([ CJ:^CZ_(3_@KS\&=:^(_P &-!\1>$=!O==\2>%M99_LVF1EKV:U
MNUBMDB 7!9%>1C@G!&<UTX2E1K8FC2KRE"G.34I1DHI:77-=I-:/^M#FQE6K
M1PU6K1BIU*<>:,&K\[6T59-IMVL[,_GT^,/Q!\9_M6?'[4=>"7%_K'B[74T;
M0;2/S)?LFE2WACMDC7#%$@$S2$@$8SR:_K8_8]_9]TC]G?X->&?!=K"C:Q)8
MP7_B.[**LL^JW,2-<H6'+1I(@V9.0<\5^$'[ O[)/[2?@?XO^&OB;XA^#3P^
M'X&41W'B41 V\<JE'NK:&*8L)$5MX+IC('<5_3W:.[.N[Y25 =1T# $@#VZG
MOV_'VL]Q47[#!X:4'AZ44VZ<E-<T;**=GHXIM+5WO?1[^)D6%G'V^,Q,:BQ-
M>;3C4@X\L6E.32=M)-VVT22-' ]!2T45\X?2!1@=<<^M%% $$Y1$.4W!OE(P
M""&X(8$$8(SGCI^5?RQ?\%5?V5E^%?Q2?XL^&+%T\(^/9%EU."&+%OIVK*0I
MQL7:OVIVEE;)YQQCI7]3=WDQ8#;"6&#C)[^Q_P _G7PG^WQ\-/'_ ,5_@;K'
M@;P!X.T_QAJ6HHYB2Y^6ZL)PCJEU9,7C43)G*AB%R>PKTLIQ4L)CJ4U*,857
M[*JIMQBX-I\W-HFXOST/+S7"0Q>#K0<6YTE[:CR6<E-<JLHK7WDW%NVJ;70_
M._\ X)F_MT^%] ^'FI?"WXN:[%I[^%-L_ABZN)&:2^M&.YK12VXM+YCJD: 8
M"BOW+NK;0?B%X4ELKN$7OA_Q1I9CN()!@7%E>Q9&X<<LC*0!W ]J_DK^ 7[&
MOQUTS]HOX;^&/B-\,]?\/Z='XAL;K4+R[B5K!X890"7DMY)$V8Y(8X(Y/M_7
MYIVFV]AIUAI\,:K%8VL%M$J<*HAB6,8QC/W>*WSJCA:6(A5PU1RE6O6DH3BX
MPDI+6#3]UR>K37175UKCD=;%3P[AB*<H>QY:*YXRA.:BEJ[I:15E%K1R3:>E
MS\V-$_X)@_!;1GNWO_%OC'7D-I/I?AV'4#:%/"FDW6I_VO)IFDB/!%NUYF3]
M]N;)/M7JO[17[$/PX_:.DT'4-7\1^(_"6OZ!H=MX877?#GV<WU]X?M6$JZ5=
M?:<Q^0\P,KA1OW$C=TK[=\A<Y))^O\^O7D\TTVJ$$ E1[<'/UY/KUS7F2Q>,
MG.%26(FY0ORWLTDU%25K6=U&VKW2;;U/948K9)7=V]>;I\K/\]]]?R&\"?\
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M.HU=IS=VN9W:6BTT5AJ*CLDO3^OG;9-NP4445D,**** "BBB@ HHHH ****
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M'' '^>,^]/I KW=U:]OOM9_E_D?RZ?\ !;W]M3X-:;?^'_@)XBU+4/!7Q;\
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M26.-1SN=@B_FQ H6NVM]K"NNZ):*8DD<@#1R)(IZ,C*P/T*D@TI=1U./P/\
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M11N_^OST/';OR<<4E*2:LW?I:_\ 6NF^_F"45?5?/E=MO+;UOJ?(1_9,F/\
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MIQ5H)R=TD>G"E"G"-."]V"48W;;2222;>^B7376^Y^&W_#WWXP_](TOVE/\
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MM5NM>J[!==T24444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ]*M5"O;73MY+L4G<****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=+@2[3'M)YZ5],?L\?'?6?B5XF^*/@GQ-;16VN>!];-UI\T0 CO/"FKW%P-
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MQ>\':+##+!X(^*7A6\U?P?%>6ZV^J:=J6@6]L-:LM3@Y>)Q=7<4:AI&/R-@
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MG.3M;>4I-M[ZZ60[/77=I_))*WKIJ_GNPHHHJ!A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img117602972_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_9.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "V <H# 2(  A$! Q$!_\0
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M1]1U?26NXH+E$G;3-5U*P:0,UI?74!29^JK\@/VM/V,?V9?A)\!/V4]1\/\
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M+>$I0<9.GI*I%WO3J5*4KIJ\J<W!M7W3:TO9KX9*,U******D HHHH ****
M/#_VE/'L'PN^ _Q3^(5U\/&^*]OX2\)7^L3?#[[/+<6WB6. QJ]MJ:V^@^*K
MN'1+4.=0UZ\LO"WB6^T_1;._OK'P]K5W;PZ;<^'_ /!/GX]^'OVC?V>M/^(G
MA3X)Z3\"M ;79M*L?"_AF&9?!VJR)X?\.:MJ6M>$;RY\"_#>XU32;35M8O\
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MZGK.H_8;&?[%I6G7VHW/E6=I<31_EK\6OA+^UCX3_:Q_;'\6>$_V-_C+\8?
M7QA^,GP[^(?@3QW\._B)^R1I6BZEHNE?LD_LT?"35[6ZTGXN?M,_"WQMINJ:
M;XU^%WBNQG@OO"<-I<6D-EJ&GWU[:WL<BGPF^$O[6/BS]K#]CCQ7XK_8W^,O
MP>\!_![XR_$/XB>._'?Q$^(G[)&JZ)INB:I^R5^TQ\)=)M;72?A)^TS\4?&V
MI:IJ7C7XH^$[&""Q\)S6EO:37NH:A>V5K922-C[2I[3D]B^2]O:<VEN]N7]3
MQ?[2S'^T?J?]BUOJGM>3^T?K4/9\G+S>U]C["]K^[R^UO?KT/VS\<?%'X?\
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M-?XW?\$^9_B1XT^+7Q'\!?%/0_AOXP\<^./V;_B7X.2[^%?_  D_A?PKXT^
M$_Q"DO+WQ5HFF>/O!=UX\L?B%%\1]9;5(;35_!FI:5J21ZL=6UBX=XQAB)5X
M13H4XU9.IAH.+:BXTYXW"0Q-:\IP4U0P#QE6-*\95:\:*4TE*G5THQHR<E6F
MX6A6E!J_+.<,/7E1HMQIU94_;8I8>$JRIU%2I.K/V<Y**.K_ &W?%'AWQO\
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MK\'_ (<?%IWC\(67[-_Q$BTN#2XOB'#H2LWBO4)+^32Y=1,5BMTEE G[%/\
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MW;W_ .\WK_5LK_*3_P";4O\ NWO_ -YO7Z7X<;\2?]B:I^<S^?\ QVW\/O\
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M .">/[$/B'Q#XI\<>-_$_C?]ECX&?$CQ?XO^)'CWQI\3/&GB3QI\3/AUX?\
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MC?L7_P#I_P#VQZ_K1K^2[_@V5_Y*7_P4 _[$;]B__P!/_P"V/7]:->MXK?\
M)Q.+?^QK/_TS1.?(/^1-EW_8-#\V>5^/OCI\$OA1XD^'?@SXI?&+X5_#;QA\
M7]<;PQ\)O"GC[XA>$O!WB3XH>)$O]#TIO#WP[T+Q%J^G:IXVUQ=4\3^&]-;2
M?#5KJ=^+_P 0Z'9FW%QJUA'<>J5_$=_P5A_;N_;3\(?\%)?BWX!\!_M'^)/
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MVC3P:SH.GRRRZ>]S;)/8SVMU/_E]?\VI?]V]_P#O-Z_OU_X(3?\ *,#X%?\
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MQ_IAU_.I_P '+/\ R:+^R_\ ]GO^&?\ UEO]K*OZ*Z_G4_X.6?\ DT7]E_\
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M_O\ @K[_ ,I4OVY?^QY^!?\ ZQK^S/7]GW_!,K_E&Y_P3Y_[,@_90_\ 5#>
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M>SH6=?\ (YX9_P"PC'_^F\*?Z#M?R7?\'-7_ "4O_@G_ /\ 8C?MH?\ I_\
MV.*_I]^$7QT^"7[07AN^\9_ 7XQ?"OXW>#],URY\,:EXK^$7Q"\)?$GPWI_B
M2RL-,U6\\/7VN^#-7UK2[37+32]:T?4KG29[J._@L-6TR\EMTM[^UDE_F"_X
M.:O^2E_\$_\ _L1OVT/_ $__ +'%?*>%?_)Q.$O^QM2_]-U3OS__ )$V8_\
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M_P#)T.&/^ZU_ZSV;'?Q3_P B',/3"_\ J;AC]2O^#:;_ )-&_:A_[/>\2_\
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M3O\ E)_^W7_V4?X(?^L7?LO5_7Q_P4&_Y(-X!_[/?_X)E?\ KR3]E"OY!_\
M@J=_RD__ &Z_^RC_  0_]8N_9>H"7\.7]?:@?TP?\$)O^48'P*_[*/\ M??^
MMH_M"U_ 5_S:E_W;W_[S>O[]?^"$W_*,#X%?]E'_ &OO_6T?VA:_@*_YM2_[
MM[_]YO7Z7X<;\2?]B:I^<S\ \=M_#[_LK:'YT#^Q_P"-7_'O\"O^SW_^"=W_
M *WK^S?71?\ !RS_ ,FB_LO_ /9[_AG_ -9;_:RKG?C5_P >_P "O^SW_P#@
MG=_ZWK^S?71?\'+/_)HO[+__ &>_X9_]9;_:RKY/PV_Y+/@[_LK^'O\ U:X
M^[X8_P"22SO_ !9K_P"JO#G\Y_\ P3A_Y/ '_9MGQ@_]6A^SI7]3'_!,/_D\
M#]M3_LVS]A'_ -6A_P % Z_EG_X)P_\ )X _[-L^,'_JT/V=*_J8_P""8?\
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MG3+&*"RT[3=.LH(+.QL+."&UM+6&*WMXHXHT0?S+?\$I?^24?'O_ +.3OO\
MU0GP K^GO_@D=_R9'HG_ &<I^WS_ .M\_M,UP>+-*E#&XVI"E3C4J<5\3\\X
MPC&<_P#A5QOQR24I?-LZLDE)X'!IMM++\OLFVTO]EI[+H?I91117XT>R%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PS_P %&?#_
M (&U#]DWXF>*_&W@?X9>.O\ A6FGQ^-?#EG\8=6GT7X=Z+KL4JZ(/$WB:\A\
M7^ A)IVAZ7K6I7T^G2>,?#@U=8SI46M:7<WD-];^;?\ !*.+Q?'^R[</XO\
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M*_P7^.NH>&/"7C#XH_ SXG^#[OXNV/B*R\>^#[\VGP[^"_B'PEXKL?C#X/\
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M_19/&OC+7/#O@G0H]'U_5?$7B'2M(T#5[VS!;V2]-K-^NMOZU-[XG_'7X<>
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MMOQE\6OC#>_L>_LU0?&'1]7\%_$^V\)?&SQ7\-;OX5^'_B+XHLHO 4WCB_\
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ME^#]%U_68-%L;B]AN-;UMM/_ +)\/:4EWKFO7NFZ+I]_?VW\^_QA^(7[3?\
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MN&PCKX:-.ICI>-:)H'_!,[5O#,GB:]_; _:%\*)IOP_\$_$WQ7H?C#_@KO\
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C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img117602972_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_10.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &\ MT# 2(  A$! Q$!_\0
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MCADC2;8\J*[9V1-(N_ X)5"=Y&>_/)Q4N5FE9N[2OT5UN^J[;6OI>^@:?/\
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M.I=T7.>F,XZ=_P#]9JXTYV2W>UW;6WX;?UM=<K[?KV[>J/HN2145BS!<8Y)
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MQ$U[X;>&?#]CH^F?#/1?B-%\3O&!O(!-J=UKMM;7%M%'I\RLK0;EE5F8HRD
M\9/'U$\\X?S+$\F<9?*E"5;&U7B*V'6&KTJ-2MB*]&E!T^24W"DZ%&G#D<54
M3BI).3,(TJL*:<)OFY*?NIO6T;72:ERJ4K-VZ.5]D?,J_P#!1+]HRSD\>SZK
MX/\  D%KX4\2:9X*M+9H;Z*=]>U:]L;6&]O9GN1#!I]M%J5O<2I(T<CK&ZKE
MBH/(?%O]OWXG^"/&^@>$?B'I.@ZMXJ\"ZGX@O=7O_ 4[KX<UVRBM$;3X8A<7
M$L@E5XW^T)(PV@@[5SS^JVK?LI_!;6;3XA6.J>$+:ZM/B7=0ZCXF\Q%9I-4M
MTM4MKVS(7,-S;M:6\T4H.5EC5ATKR^P_8@_9@\+Q:!I>JZ+#?7L=]J=Q:W_B
M:^@GU;7;G4X5AO(;N:?;)?J$VA40$INR3SD\^&SS@Y252KDE6ZYHNCAZ/+.5
M\/23J0K_ %AN$*<EBE*$HOVGM:=3F7LN56Z==WM43332NURN\7:Z<='S6LU*
MUHMVU/ECX*?'/XY?$?\ :M^$L_CK6?"UOX)\:> /$7B70_#_ (0N6)AMY[*S
MN[:W\102W$S'4;".98V9%6/S0Y7*XQYSXC_:D^-/@KXI_MC^&M!^&/Q ^*FC
MZ59::FCZSX?UC0K/3_!7G:4CO.\6IW,%QM#L9G\A'8X/'//Z$?"_]D3X _!C
MXFKXS\+1SV_C6YMM2ATBSU+5H9I++3KL#[5::/8MB6*QA38BQQ@I'&$!.,5U
M%WX1_9[\$Z_\0;35?$?A7P_XB^+L<%OXGT_5=?TNSU'50D MX4@M;B:.?/E$
M*N$;.>!BL/[9R+ZXYX?)I8O#RRK"X>EAGA7AU[6AF4,5.JXX>M*K=8=.#JQF
MU4G%J2C!N*%"HHU.:HHWJ*<9<SEIR16K=E"S;LKZNVY^67PT_;H^..G_  SN
MT\.1>$KZ'X->$Y/%7Q$N?'D[MKOBDW>O6\']D>&I(+F"-KFTM]3C1I)D:'S+
M1U5CE0>PN?\ @HK^T-KNC^+_ !KX+\,> H?"]CXSTSP-X8TO7+;4?[9FO[_^
MS=]_J#PSI"+:+[:Y$8V2%8P0K;LG[-U']A;]E[QC>:/''I*3S>%XELM3TW1M
M1@$6KV5Q<C5HK/Q/;P[OMEL\S0W,<<H3(CA89 &?3I/V2?@I]DU+3H_"YALM
M7\2VOBR[MH=J(NLV2VJP2(JIA8D6SA&T<_+UZUMB<]X0=6=;^Q).K6Q'M73J
M8=05.G*M1G4@[8B+K2JQYZE*:4%3I3C1@FK234*WNI5;1C!)RNG>3A:[7*]>
M>R;4G=]+IW_/2Q_X*$?M'>&+3Q)XL^(O@_P)/X.\"^-_&OP_\00^'8KU-7U;
M6?!]C%<2WND-<W3PPV=S),FV.X42J@.X X-27O\ P4:^-_A2Q\.:UXH\*> ]
M1TWXN^"/%/C7X7VGA^XDFU'08=#L8K^TT[QHGVV3-S=)<PQ.UNB(DB2%B@Z?
MHW/^R9\%]0L]3LKOPXMQ8:UXMU?QMJ=A,5>UNM<UY8DU666(IAH[I(5CD3NN
M03FO/O#W_!/W]G+PYJ/B'4K;PS/=3:Y!>V=G'?SBY@\,V&I!EOK#PU$R;=,M
M+F,K')%'N!2- .!BIIYOP=-2E6R24)-M.-*F^6I#D:@H-XK]Q4C6:JSJ-3]I
M2C]7Y8IW:Y,3=M5(M:\B_P"WM.9I:WBWIT:6KV/@;Q7_ ,%-?C/\*GN_ _Q&
M\+>#;GX@:W%X&NO"FM:%!?+X8TVV\:Z%'K2'7[::9KR1M.$T<$OV8 2%69"P
M()^H?@U^U1XZ^./P%^-6H>)M-T_1O%/@;2[NV37?#ADAT?4W>T%S%>Z=%<2R
M7=MY.]8F6Y",75F VX->_P#BS]BGX">-9]1O-?\ "L=WJ%_HNCZ(NHDI]ML8
M-!TZ'2]*N;&8HQ@O+2T@1(IARIR0.37:?#G]FOX8_"_P!K'PZ\-Z;,=&\0PS
MP:[=WLPGU355G1HRUY=;%,KQQ-Y<;%1A%4<XKEQV:<+5<!3^IY//#9E[;!U:
MLTOW3=*=*6(=*]:2ITYTX3@J+C*,I34TH-7C485E./-44H<MIWU;?(E=7CK[
MUW]E;]['P[\/OVK[SX1_\$_M%^-.O7J>-O%EAIQC,$M[;W-W<7U]XADTNWEO
M8DD\T0V_GQR3856,49"G=BO&= _X*6_&33-+U/Q'XT\*^$=4\,>#+C2+_P :
M:]X;BN[>R31?$E['IVFP6D-Y,;I+RPG<RWT\B&!XQB-N#7V=X,_X)R? 'P7%
MJFG6S^+-8\-:K;7%M/X1US63?^&XDGGDN0UOISQ".)X+EQ/ P),<J(W.VNW\
M*?L-_ 3PKX)\7> AX?GUS0_&T*6VO?V],M_<W-G#+Y]K9^:T:XM[27Y[9-O[
MMN0<@5T/-.#J<\=4GE]?&U,7F<L3&<Z"H>SP5>I2Y\/14:[5.>%I>WY)6<:U
M2<')+V9/LZ[Y4YJ%HV?*V[RNGS6:U=^EUMIHS\W?&O\ P5$^+5GJ5IHOAWPG
MX4T^[OH/%'B^PN_$%O>S6.M^!].C6^\/1Z:]I* -1UC3SM:>5A;I(RM(8TK@
MG_;U^,/AW6/&WQ!\.Z3:2'Q-/\.;?^S/%<ZW.A^"(M8T$W.KWXL[*87=S$+@
M>9 EGY\AC.2K9K]6/&_["?P \=:-X,T:_P##DFFQ>!=*@T#1;O1Y$L[UM!A@
MCM6T>[G$;&:QGMHUAFBX#QY4\&H/%'[!7[/?BC2[W3)_#DVF_;%T)$O-*F6T
MO+-?#MD+#3OLDHC/E%;< 2<$,W.!730SK@FG""60U(JI%TL0I1]I>FL52J*7
M,ZZ<N>E!2Y4KTVI4_>A*494X8AI_OK<T=DE93LFMU\*DE;=KK=),[_\ 95^,
MU[\=_@_X<^(-_)H\UYJ7VV&[FT)9DTN2:RO)[1GMH[AFGC#F'<4FPZDE2 1@
M?25>9?"/X1^"?@EX*TSP#\/]+CTCP[I7G-!;I@O+/<S27%S<SL -\]Q<2R32
MO@;G=FP,G/I3L4&0,\X_0_X5\)C9866,Q=3!PE2PD\16GAH224HT'-NDI1BV
ME)0LFDWL;1YE%<WO2LKVMO9+RN//((]:A\B/K@YP0#QD ]AQQ3#.P&0H//3(
M_P <_IZ>M2B08Y!_+_'!KD=FD[<RZ.WIW]=?G?0KFMI=KKU7EZ=;'/:S>IHV
MEZIJIBFNET^TGNC:P<W$OE(7\J $<NV,+_7D'\M=&_:V\8_M.Z%\?/!_AG1_
M'7P3UWX52SW.E>+$B2V_M&WM+8LUO-)-#(I,[L'7:H_=CK7ZR/&&?<#C/4$
MYX(YYQCGT]JY*\\!^%[NQU^P&E6=K#XHC:+7C9V\<#ZDK1B+-RR &1Q$-@+=
ML<<5I0J4Z7M'/#>UG+V;HU'-I4)0J1E)NF_=J<T;JT[K>ZM=$N[M:5EJI)6]
MZ/NV2EO&VFVVEM-_P+UOXQ?M-Z#^S=\*?&0^*_B_QE>_$+Q+JC^*8])U;1].
M\3:9H]@NH6T)T&74U@MI(8Y[&&XN(0)IC&)]J],=%\/O^"A7Q/T'4]'TV*/Q
M!^T#8P^!KUKQ/"GDVFLZ+K%I97DK?\)*VJ+;PW-[;LD?VB:R!@8KF,D#G]2/
M&?[$GP)\;?#[PW\.K_1;W3]+\(7,]YX8U/2;D6>M:)/=/.UPUA>A6\H2K<SQ
MN-ARDKCC-;7PW_9 ^"/PHEM[KP9X;33K^/09- O+_$;7>KVTT,L,]UJDNW-S
M>SI,XEG(!?C@8KUI8W 2A4OA>9NK5G"*IQA:,KJFI24DTTFE>%G&S3NE=Y\L
MO=4965H73E=736S;>R>UK2TN]K_@]XY_;^^.-_K5_=:GXK^('A72[#X>CQ18
M:9X/6&:YT_6KK3YKBVM_$H^S72_9X+A$2>2+8BKO;>!T^^?C3^T9^TIX7_8-
M^"WQ7\/W.D1_&+QEXR^&^FH(94N+77-)\0QRS1P3O#)(@OM3M5B>Y7>FR;<K
MJA!6ONWP]^R'\#?#>K>(M8L?"EM-<>*M"E\-ZW%=Q0SV][I$\,MO+:R1,F-K
M0S2(<8X;'2M"V_9<^%5O\/?"OPO;3[NZ\'^"_&-IXV\.:?=SB?\ L[5=/NY;
MO3X82RX6QL&F:*UMP (H0J \9,U<9E\WAN3!*,:5:C4J)TXM5*<5)U*37,K*
M7N1;YI<R2OR\FK@I*[E*]XM64M;M0M+56TDV]._7F5OQ_P!1_P""G?B_5K+X
MXM8:I!H6KZ)IFA^#_#ND74,TMYX>^($FB6D]_))9VZM<2QW%[;W\L"PH[-%(
MI'&37FK?\%//C!/I'[+OB2#48IH?#VNW.G?M,:%/"\$^K6LB:C';2065PB30
M1CS=.F(NHUX0^H-?LG+^PC^S1)\3]4^+*?#W3(O%&LZUIOB+5$2"(:;?:SI5
MC_9]I?W-GMVR3);%D9B?F+,3R:I:S^P/^S1KGC7Q)XYOO EHVI>*T UFSCCC
M72[APD<0E^R!-@E"1J%8$8VBNB&-R92BW@)VY(MW49/VCI^SE%+FTC><YQE=
M24E"5KQT.63ZJUFO==FUTL[737NO:W>]V?-G[!'[4GCS]H;X^?M(Z1K3Z='\
M._#DUE??#FRT^VAMU31[N[CB2=_)1%D9_G1I/F+%>O&3^LHB0=,]_3O^'\\G
MDU\^_!C]F?X2? :^U'4OASX?71KK5-)M=%O&3;^\L;.Y>Z@C("KRLLC'//&!
MVQ7T)O'H?T_QKR<;4PU6NY8:C*G15.E346E=NG",92E[SUG).;U>K?;2H)Q5
MI--\TI6O=*[NELMKI+1;+38C-M$3D@YR"3GJ1T_^O4XX 'I49D 'I[GI^)SQ
M6=/JUE;W,%E->6L%W=?\>UO-/%%-<'N((W<-*>/X W)XKE5ME%J[;:2]&Y.W
M175WTVZ%76]][7=].B6NUWI;_AC5HJ RLH!*Y'0D=CTS@'D9ZXYX/%3*P89%
M-MV5NM[/=*V]WK;T"_DUZJU]$[KRU7Y;GXS_ /!57Q-XGTOQU^RKH.AZ7XP\
M4:=XA\2>,EUOP7X+U.STO5O$D%EI5K-# D]]+#;DPL690\@Y;(KXO^&7[:GQ
M#^!_A?QIK7ANPUC18/&7Q)TWX;^%/AS\3;Q-0U/X:7L>H7.FZGJ^O'3Y2'MK
MB8)/8FV=Q)%&V XYK^AKQM\(/ OQ!\3>"/%_B?1X-0U[X>7=]?>%;V559]-N
M=1A2WNY(R0<&6)%4X[#ZY\C\:_L8?L_^/M8\6:]XB\#Z;/JOC%K*?5KJ*".-
MQJ.FK(+'5K;Y2(M2MFD>2.X W"0[B">:_0,KXFR2CE.7Y3F>65<32P])_6:D
M&I.K6>9U,2HJE*:IV]A.%\0HQK_NY8?F=&;.>I2J.;G3DE=6L[IW46D^9.^_
MV;6?796_.31?^"F'Q2\-^'-,\2?$KPKH2:(Z:OX5DUS3-WV'5/'1U$V_AZ*Q
M4SO*MO=VL,TLD<H$A88XQ@\;XF_X*<_'[0O&^L^&T\(^$R_PT&GMXRT>Z2X@
MU/Q4NM16M_9-X;EDN$MX4@L-2MA-]I89E@DV_>7/ZEK^Q?\  !_ >B?#F]\$
MZ?J/AK0=>MO$]I#>Q)--)KMH9&@U&XD(_>SHTLA#D _,:3Q?^Q=\ ?''C33O
M'FN^#+*77+..WBO/+C1+;6HK.!+:UCU>(+_I:P110K&&(V^3'@X7!JGG?!BJ
MSE4X>DTUB-8I>SMSP>&<:;KIQE4I2Q$*JNHTY2H3@_W9/LL1:RJ\ONI)[^\E
MKI9JVD;-MOXKIWU_-#Q3_P % /VH[3P?XB^(6DZ/\.[?PQ+XTN/".E6]^EV-
M1\.166F6NK2ZKK)%PJWD3I*]J8;!9+@.-Y0)EJ/&'_!2[XC1^#/!^L^&/%GP
MH.JV_A_^WO%,<UCK;Q:VUK;&XN++28U;?:--Y31QM>B-<N"3PU?I=XC_ &/?
M@3XI\*:EX+O_  =;KH]]K$FOL;=%CN+;5)H([6:>TDVXB>6UC6WD)5LPY7C-
M<)?_ /!/?]EN]M=&A7X;Z?:PZ-IC:4_V**. ZO:M"86_M;*'[4Q5B=V ,ECT
MQ4T<\X,GR>WR:I"5/$R<8TL-1E&5!4H0BJW/6M-WTNE=37M&N9\XW3K6TJZ<
MCB]7\5T[MK9V35TTNECYM_8F_:)\1^.[C]HGXIZ[/>7MA;>#_"OC:R\-Q3++
M'IYNM*O=2NK*P7<P192HCC!<DX&<UX9\2OVX?VA=5^#WBKQ)/>^ =-T?XI>%
M?'-KX%M/#\EQ)XJ\"W>B:I_8]K>:^!<3(IF0//*\2#86YP<5^K?P]^"?P/\
M@:EYH_A?3-$\-GQE96FDOI=U/;0MK-EID+06UE;V[,CW,<$,IC\N-7PKX(P:
M\*OOV<?V*/ASXA\3Q>(6\">&M1\8:?J-M<:'K^NZ3IZ6EEJ\JW&I/I6GWMQ$
MUJ+RXQ/,ZJ=TC;NXSG1SKAZ>:XK%_P!C8FM0E_9TL#1^JQJ-8?!48T:M)0C5
MM1E*O"E5E72J<T:52E45JDA>SJJG&,JJBW=R:M9N3BU=R6SC*2M9-NSTL>7?
M"/X,R>)_V!/#]KXW\3ZCJ&L0^'=9\6OKVD7=S#<S:H%OY4E::=O,*JS]"=N5
MX& *^'O#.A^/_ GP _9%\?\ PK\;:G+\3?B;XGUF'5+SQ9?3WFC:@UHNJ@&^
MA@<3201PVJ%5B(;<F<8Z_O%X/\-^ Y/AW8^$O"#Z;?> SI<VF6,>EW$%W83:
M?*)(Y8XIH&>%T(9PQ5B,D^]<E:_L[_"NU\.?#_PQ#X:@&C?#*YN;OP?9[$6/
M3;F[$ZS21?+A2RW,H.,??/K6&%XKI8>KF/UBC4G1Q6>5L<\-*C15'V$\-CZ;
MP]2E-QTEB*^%G5A90_=W5G!%2H<T::C96H3@I7:EK[-0DY+L^9Z]>NJ/S,L_
M^"C_ ,4? \UM%\4-$\-W&FQZ]XL^&DNM:)%<QVESX\\.Z8DFGRIY\C-#9ZSJ
M-S:6D"3!9-S-D#(-+>_MU_M+:>WB;5;S3/ -EINCGX8^';?3+JVO_MMOXD^*
M3RV=G?ZG<)-]FBTK0[J,2WQ9HV,.=AZFOIOXS?L2:+X_U3PKX=T'2_#^E?#N
MX\?CXC^.$N;$3ZK>>(;6YMM0M9=/N$93;F:]M(5G8JX:/*D@'CZ7O/V8_@YJ
MUAXST[4O"-A>VGCRTTRT\11W,22>>=&26/2KB(X'E7%@TLCV\H&8W(*]ZZYY
MOPA"&'K0RBC5K5T_;T(QNJ5.GBL,VU"510I5JN'>*BXPE))*A)2@ZC<9]G7;
M:5248V34NUU.*325VHR]G)ZK3FO?2_Y(?%C]NGXJ^"+^U\.?$BT\)^*?$_PX
M^(/@J6XUOX?2S-H&MV?B&SGU%+2 R7,KO+:*T<$P=\%D?:#P1Z?\$/C1\;_B
M!^U[\-[KQYXN\'77A?Q=\.]7UO2_#'@ZYE8Z9''K9M[>'7()9YA]N6(#S&C
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M*JBYXM2BVU%VLU%Z:ZI-)O=;7&PH(XU15"*H"JHR      >@ X [ 8HDZ#D
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MACJ"BBB@ HHHH **** "O%_BQ^SY\)?C:^BS?$CP=I7B.YT"Y2XTRYO( \\
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M-&K#!'&<X_S]/I[4XJ-NT<#&..PI:*GECHK:+;\P_K^OO$4!0 .@I:**H!"
MPP>E(B! <=SD_6G44K*][*_< HHHI@%(RAA@C(R#^5+12:3WU 0 *, 8%+11
M0DEH@&>6F<[1GU[]<]>O6GT44));(!NQ?3^=*JA1@<"EHHLM[=W]^X!1113
M**** "D(!ZBEHH C>))/O#..F?\ /^!IHA4=>?J/7]/TJ:BE9=E\_P"O(/\
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M 44A8#J<4!@W0YQ1=7:OJM6NJ7=@+1110 4444 %%%% !1110 4444 %%%%
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MA-X@^+_P4M/AGK7@Z?3-#TNXU]M(\27^H6ES:S2:1:P7<Q62&VG4W MBJ>:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** &.@==IZ9S_/_&JWV"T+[VM[=FZDF"(DGU+%2<_C5RD)P">N 3CZ4 1>
M1&&W  <8Q@8Q].*E P /0 ?E41D8#D+DC(7/./\ /;%1_:>2" ,=R<#\/KVH
M271:[:+\ _KY[?Y(M5#*3T&?P&?7OV_SBHS<8P /F(R3V7C/)Y&:_GL_X+0?
M%C]M3X>^+?V>[GX0>*+#P%\!+CXK?#G2_'6K6-T$\4>([K6?$UA9S:-"JB*X
MMK&-6"RR1S,DZ3.KK@4FTW%-VYIQC>VS;5F[JWHGOHNH:N]ND>97^UI>T;;O
MIV3WV/Z#T=QM;!DY()'"K@XQTY/!S_(BE:5RQ*C;MQ@G!!!ZG&. N3D]/Y#^
M/+_@HM\;OVH="_;=T[6-:\7_ !T^'O[*WPZTSX>+K7BGP!9:O)H#7>LVADO9
M]7FL[RUMYH(WM7-R\[,$#-NSDY\>?]M/]HSQ;\2M=_:\\-?'SQ+=>%/AU\?O
MA#\&?"WPTA::/P_XD\">)/"NKWU]J&IZ8MT;:XU;4'T:SN?M$L$DR&:0*YW,
M2DU>.NC;2;3;^)03OM[S>FO7LF4XR5K*]HIWC:UW#G:=[[*^NS<>MS^VZ5Y,
M9RH&,[\@J!P<G@8STZ\U:C.4!Y_'^GL>M?Q(_L__ +:O[5FM_M+_  $_:?U_
MXS>(-7T3X[_M/CX+>(_@BRR?\(YI?A)](UF[#Z=I7VAK:VOQ<:3;N;F*U238
M91NP6!_H#_:=_P""L?A3]F+XH:[\,M8_9P_:1\=OH%@M_<^*? 'PRU7Q#X7E
MA$2RRF#5;9Q"_DH2\G]U5+'&*<4VDU>VUFDFFHQE_P"DR7J[I;$2:B[.ROKI
MK=-\O,^RNO32_4_6ZBODK]C#]L'X>?MM_!RV^,WPUL-=TK0Y=7O=#N=+\26#
MZ9K6GZEIZQ-<VM]92,SV\T7G*KHQW!@00*^M:8PHHHH **** "BBB@ HHHH
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MWNK[6^_R]-7_ %.QOO0-_G/?]:?7XU_'S_@L-X,_9_\ B;XV^&VJ_LQ?M/\
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M<^LYI65W=+1M+F7N;)[OS>NFGZ'C_@X&^)F<'X#:?[D:_98'&<<I_G]*</\
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M\?KWQUXX\?W/AB_UG5/A[X5\7:K?ZIIG@F_UW4GU:]GTV>]O;J60B\EE:%9
M%A1_+C"H !^O-%/6][N^UWJ[62MJM-EM9KI85M&KNV^CZ]_4\G^+FBZ9+\,_
MB7<S:9ISSMX#\7%IGLK>21F_L#4#N9FC))!  ).<8K\L?^"":@?\$_O!6  /
M^$C\2\    :G<8  Z"OUE^+7_)*_B5_V(7B__P!1_4*_)O\ X(*?\H_O!/\
MV,?B;_TYW%)=K[/2_;EBOT7_  +@DKRZ:)^KN_TU]3]I:***8PHHHH ****
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MXQ\*Z+8W+W.M:>]TJN2OVFW#9 )X4N#G@\\C&..F?YUOVE?^"N,VLZG?^'O
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M7VG7$5W8W,:RV]U"V^*:-AE7C;C*GC!QT.>]7: 33V] HHHH&%%%% !1110
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M..5/<YP0>0.0:]W\)?&_]FOXN^-_&WAK]EKP??\ @/X6^&;+39=%T;5-1O\
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M%[PO+]F\;ZN)3)YNE7(2(DOY<AMP% Y(SP> !C/UK[8U,6UF@DEFPGF ,A
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M\<1\#/"OAVW>]_X2[0=0.FZE?KKUSN46[(7TJ6';Y\@"SY,8;!'[5_M(?\%
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MW_TQBCS<;_RY_P ,O_;2T_0?7^AK[Q_X)?\ _)]?P&_[&:V_]">O@Y^@^O\
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MCI\&/VE?%/@_X2>$_B=X;\'?%_X"^.)M0O/!'QTM;/PS\,O%R3:3/:(T&O\
MB.>#26N(I;U)8KA$D=# -HXXFW35)SBW]IV25]^FC]-];:D;--Z;22?S25M5
MK=+J[[):G=_\$>OV.O#7BR.\?XS_  K^!UQ<?#O6(O%_A?5?!FJZ'K?B5]<N
M9(8?MWB(6&J:C<D)$D;6[2PP[9E4@D\5_4I$"[  $*F!T[#&,?0?I7\ZG_!#
MO]G#QYX2U7QE\;/B!\1O@UK6I:OX+TKP/9>$_@EXOT#Q7H@LM,U%[^/7M;O?
M#]Q)!/JESYQMY)9XQ(R1QJ20!G^CD  Y  /J ,_G6E1)RNG>.Z77=I-R2CKR
MI*R22)2WWNK)WO9_#)M)MM)O5:^;NF+1114E'G_Q8_Y)?\1O^Q%\7?\ J/ZC
M7Y-_\$%O^4?_ (+_ .QD\3?^G2XK]9/BQ_R2_P"(W_8B^+O_ %']0_QK\FO^
M""G_ "C^\$_]C'XE_P#3G<4"6\O7]$?M+1110,**** /A_\ X*-_\F6_'G_L
M53_Z<+.O\]JS_P"/:+_?;_T-J_T)?^"C?_)EOQY_[%4_^G"SK_/:L_\ CVB_
MWV_]#:OZI^CK_P B[BC_ +#<M_\ 3&*/-QO_ "Y_PR_]M+3]!]?Z&OO'_@E_
M_P GU_ ;_L9K;_T)Z^#GZ#Z_T-?>/_!+_P#Y/K^ W_8S6W_H3U^P\??\D3Q3
M_P!B7&_^FSDH_P"\4/\ '_D?Z!5)D>H_,4$X!/H"?RKR7Q7\3?"&B6VIQ1^+
M/"G]NV:.$TB[\0V-C<-<#YA!.7EWP,21G<F>Q&.:_P ]?1-Z-V2N_N[+J^GF
M>YK=)+?35V7]6N]+['K=)D#@D ],9'7TK\W]9_;-\2Z#KV@^';KP]X'DOO$+
MW$=D\7Q!T^2WC^S1^:QN)50+'N7 7=U/ Y&*^EOA[\:M$UW3&N?&?B'P/X;U
M/[0T<5A#XPTR_#INQ&_F&2+DC'1<@GKQFC7:SNMUUO:_D+F2W<5=7^)>GYZ?
M=W/HK(]1^=+6=I\]O>1K=VT\5Q!*H>&:"598I8VY5T=25D5E(*NO!!!&:T:2
M=^EO6WZ-HK^ET?S70****8!36 (.>P.*=36'!.3T/';H:&KA=K:^_3I?J?SQ
M_MF6K77[1/C20<K";,(IZ%_L5N1]>^<FOGG1-.N6;,SY8,793G8BXX&<<X&#
M@'&>W4U]:?M;64<OQ^\8Y0']Y9D@8!(^QP=\=2?P_E7S>8G!9(E$* X)# >Q
MWD8)X]>O)QFOD,55?UFK%N[C*45KM9K[].G2W6VOJ85Q5.$4DI<L;NZZQ5M-
M+_+=/0XKQ5+"+.X6&3&08'(4LTDC@KMCQUP6'(ST_+Q#0_AY8#59;MH9&N)G
M/F,Z9>,$D-AR,*#W7@XXKZ%O+&%Y5<J)I ^%"8,2 <^:T6,$XQECWP14\-C#
MO$<:J"[!WD0!68MR<=_\.,>_%;GW5K:-;WZK[KWV_P"!U?#KS.^FM^C:NNJM
M?7OYZ'.Z;X<L]/0PP0(NU0S-M S@<MTQDG)/X=*Z33Q'YK") 0HP2 0., @'
M!'7/?/\ 70>U54>+.'< *>K#L<D =ASGUSWX7ROL42Q(HW97Y\+\Q.3UX]>>
MH["N>K%1E9*VB_)%7O9WW_7_ #O]Y9&,LRJ !G(.0<^O3\/>LF>Y=G#)G$3C
M=CDG&,]!C\#SCMS6E<SK%"<X+''W1V*G/.<GH<^OTK+A E$A3A>N2 O;G&.O
MX]/6L7)12<M/Z[_UY7$WOM==WZ?Y];7_ !'^>)+@'!"L.0",'IU[Y]!QP.].
ME_>S%1C[J@'N,#'.,_3W^HYJ^2ZLKJW&[N>3@@'ICDX/'/?'6K:GR2S[@2<=
M1NX/')QGW&?7WK&-1<\I>]9V[VTM]SM>_3S2%%W6K3ZVLM-?Z9GZ[;YAMT_A
MC^?/?/4C/X].F<UY3KS/-&0  RN0OR\GYL>F/IZ<<5ZQ>2;K=FD.<A@OIS\P
M]<$=AQZ8].&DM$=)'*[MK]=H(7G.#D?CQ@_G6Z:DKZ_=;MY_@3=*4M'JUMWW
M_$^=_B#IGGQ6Y8;LJ=V 3GY<X/!X!YP<8/3V\&N-(FL0DT>2CRY?.2 ,@],
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MDVTT[=OO_'??74I/WDW=I+\7;6SZZ?JB3RHM/TZVLPQ?S"%)!&&D)7=GKT/
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M_8Q^)?\ TYW%+[7R=O\ R7]28JRMU6_]>EC]I:*:S;1G&><8Z?SH#@C.1T)
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MDX)^4#'<=#SG%=A#X/\ %)C#+X8USE0 3I\V1TZC:><=P>_UK\4Q_P %3?\
M@H P\M/CW=._0(G@SP<[<XQA4T,MR/;)';O2C_@J;_P4"49_X7Y>A(Q\S_\
M"&>$1&AR,JS?V'A&&>58J?48S6*^C#QFW9YMP\K6LOK&*6CM9_[C?7[-]V_0
MK^W*>ZH5/7FTTY=O>>J=M%^"1^V$WA3QA<&"U_X1;7#%&2Q)T^4*, G!^7'O
M]<&N7U_P-X[N5B$7A36D\R11O&GRY6WC8$L!MX+)G K\=5_X*H?\% @OF_\
M"_[PQ$X:0>#?"'EJ0/N^:-$VACQP6[]Q4A_X*G_\% RBN_Q]O5C( C9_!W@\
M(<#^%FT,!@!S\I(YSR*/^)8>,[-+->'D[?\ /_%[W2<5? [WO==K:ZC>=Q5K
MX>I;5IW6MK>:LG=:WLWI>Z9^NESX&\:3O#;IX9UXP6ZB1Y'T^8C8HW/U4Y.!
MC'J,]ZP(-%\>2Z)JFJ)X0U\!FN;6PC.G3AI7MY6A5L;>$(3.1U!! Z5^4_\
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MF!XY_P"$-\%YP#G _P"))Q37T7>-$U_PK9 [;?O\7H]-5_L/>[_I72SNDG_
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M_H:^\?\ @E__ ,GU_ ;_ +&:V_\ 0GK]AX^_Y(GBG_L2XW_TV<E'_>*'^/\
MR/\ 0%G_ -1-_P!<I/\ T!J_SE_^"B Q^V_^TS[_ !#O#_Y*VM?Z-$_^HF_Z
MY2?^@-7^<M_P42;/[;_[3 '7_A85Y^EM: __ %O\BOY"\*O^2BK_ /8NJ_\
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MRMYDTJ-]E 5I&PS-CDCI@5EZC^S/^U/J]W-J.K?"3Q_J.H3G,UW=Z7J$]Q(
M,#>WV4$[1D9/;\J]#*\3E^ Q\\36XSRO$86I#$-X+^T,,J:K8G$.LIISQ-2<
MG&,N7FE+FOK>VBFI+VD%35":E%149RBWHG&]FERI.UDK)VZWLCY^Y_OC\A1S
M_?'Y#_&O=/\ AE?]I50,_!7QJ.@&=(O^3TP#]GY/L/>G?\,J_M+\_P#%D_&_
M!P?^)-J/!QG'_'OZ'-?4?ZQ<._\ 0^R?_P .F#\O^G_FK]CF5*H]H2^X\)Y_
MOC\A_C1S_?'Y#_&O=C^RM^TL,9^"GC89.!G1[_K_ . ](?V5_P!I49S\%O&B
MXZ[M(OQC_P E_P#/YT?ZQ<._]#[)_P#PZ8/_ .7^?Y]F/V53^27W'A7/]\?D
M/\:.?[X_(?XU[B?V6_VD$/[WX.^+X@3\I?3+Q V> %+6_)SVZGIUJC+^S?\
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M+Q-]BCN)8[BYL;6UUF;7;BRT^3;Y%KJ6HW %Q-?1X;S#-F0J5)/( _7@@'J
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M,OW&&7_3B@O_ "E#4\ ^HOV(O^3S_P!F3_LJ.E_^DE[7^BK:_P"IB_ZXP_\
MHM:_SJ/V(/\ D\W]F+_LJ&E?^D=[7^BO:_ZF+_KC#_Z+6OY%^D+_ ,E7E/\
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M_P N?\,O_;2T_0?7^AK[Q_X)?_\ )]?P&_[&:V_]">O@Y^@^O]#7WC_P2_\
M^3Z_@-_V,UM_Z$]?L''W_)$\4_\ 8EQO_ILY*/\ O%#_ !_Y'^@+/_J)O^N4
MG_H#5_G*?\%#_P#D^+]IG_LH5Y_Z36E?Z-<_^HF_ZY2?^@-7^<O_ ,%$@/\
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M%$KOB 9U&<H&8?,V?N_*P/.>YKYB^&]_<^('N-:ED,Z[F=+EN$<$_,(5^[M
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MRXD*G )-?K76CVCO\$;WM?NUHEHGIKKH2MFKW2;MU\[]DWN[:)A1114C//\
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MXI_[#LN_],8HYL;_ ,N?\,O_ &TM/T'U_H:^\?\ @E__ ,GU_ ;_ +&:V_\
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MOV,_^38/@M_V(7AW_P!-=K7T[7\:5OXU;_K]5_\ 3DC_ &1P7^YX3_L&H?\
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M^IZSJ?B1]0LF3QAH+WMIXY\$72K]GUC3;=FBN[BPAF^69+J-?-N%WO/O<"
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M08P1C@DYP />OS'^)/[*/A>Z\13^*-.TB6PDCF^U*ECO,,I!RRLN0@.XG@#
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M4K);N6FVUWV[Z:_CTO8E0/;F1  =S<GVP<].>#[9Z_7S#Q%,'&YV;*L58@$
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M/^>G-4=*^$^LK?/-?>/?A@JECM/_  G_ (4PJX.,?\3<D8/U]?IQRP&8)JV
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MQDFFKN]FGMOL<-249SE*,HRBW=2B[Q:LM4[*X4445TD!1110 4444 %%%(2
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MHH&%%%% !1110 4444 %%!X!/I4?FKG!R.O)'&!GGJ>.* &23A"!@DDD=/\
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MC_#FD'QLOP^UK5+N[O/['\27L;3I>Z;9W NI%N+N]C1##%&(Q\IK]9?V$?\
M@GV?V2]>^(OQ-\9_$2Z^+'QD^*4LB^(_&;Z<-#MCH[72WEIIT&DQSW,,0MG2
M,"19/X<;0<U<8\J3NVGS<LE\2D[<U-IZ)+3F;Z*,H-/1N4K:-6UBI*]XRBG%
MQGY:\W*DGHI1DFEKZA^PQ\"/&WPQ_99^!_@?XZO;>)OB3X(\+:?;3ZCJ?EZG
MJ6D3BV1&LUU-]SRS0+B*2>-E63;]U<8K[?AB\H;<Y'Z_Y^GY4^-2B!3G(ZY.
M?QSQUZT^B_-[SW>KTMK9*]N]DE=W=ENQ))=%?9M>M[:=+ZV5EU2"BBB@8444
M4 %4[N,&.1MQR(I3M['Y']OT/H*N5!<,/(G&>?)E_P#0&_\ K_E1_7Z_TA-;
M>37YZ_A]Q_G._P#!1"YNA^V=\=@M[>J4\4(J@74PC"BUCX5%=0/7T':OC$SW
M0QNO;S .?^/F?D\_]-#Z>G\A7V-_P4/;/[9WQZVD-GQ4F,<D8MH@<@<_Y'K7
MQH6<8RO49'!Z?G7]=Y'3A_8V4WITVWEV"NY0BVV\/2;NVKMW;W[OR/\ */Q'
MS+,8>('&L(9ECJ4(<49U!0IXS$4X0C''U%&,8QJ<L4DK));>NMC[1=DG-[>X
MXQ_I<_XG_6?SJ/S+O/\ Q^WF"#G_ $JXZ\=O,]*8&/<'\!_B:7=_LM^5>FH0
M7_+NG_X+A^B/B7FF9NU\RS'R_P!NQ:[+I5]-R9;B[ &;V]_\"Y^/;_6?K2&>
M\)XO[X>WVNX_^."HMX]&_+_Z] 8''49Z9!%/D@M/94[]O9Q\M-OZ^X7]J9E+
M_F:9C9?]1^*TMR_]/?2_JR43W@/-]?'_ +>[C_XY2F>[/_+]?#Z7<X_7?4.[
M'4$ >HZGMCMV/Z4%B.QZCKWSZ8/)I>S@_P#EW3^4(WW79?U=E+-,S2M_:>8_
M/'8I_P#N7R1.;B[/_+[>CZ7<_P#\<J-I[P#/V^^[#_C[N.YQ_P ]?>F!@<<'
MGC)'%-9A@K@@\?X]<T^2&J]E3OU_=QOTWT]/O]+3_:F9.S_M/,>BTQV*7;_I
M[Z+RN/,]VI(:^OMH ;<+JY(.>[8< >Y->A:_\-?B7X2\+>%O&OB+1M=TOPQX
MTA:;POJUW)>1VNKQJ\D9:V>3:KKOAD4!';)7CFN;\(6&EZGXGT+3=;OTTS0[
MO5;1=5U"0@_9;%9!)._++N)";-I('S#T /[C^,_VBOV4?C1HFD_"2&34/[.^
M$>JZ%/\ #&POH&>SUU1;6=I=Z3912-Y>'O9[R_*1+)OVE2!DD>+FV/J8"IA(
MX?+_ *U3G*3Q=2G14O88=1C%37*OXGM9PO#5*G&<]$FX_?\ !V2OB+#9I/'\
M6U\JQ=)4*.34*V:UJ2QV/G4E5K4I.K5<OJ]/!TJGLYJ,)5,55HT5)R^+\(B-
M85D5EU>.24XBCD>Z1Y"<8$:EP7)R,! <YX%'_$V>5[96UG[2GRR6ZF\,Z,#A
M@T>XNNT=<CDY%?T4?%A?A-\.?#'@_6?BAI_A/1=8UGXD^,HO!=S>^#=,T231
MM+F\'1KH0U2P)QJ=A;Z@PE6YN&6,N"X *UX+K/Q^_9R\.Z1>S6%U\/\ 6?BC
M!8_#6QU?Q%!X6T=]$U1[7467Q3+I]FK-;HXM2S2W,;%I0REB,"O'I<3SQ$(S
MHY'.I&4N53@Y2I<RJ^SNYK#6<(O2I+1P;^&45SK[/%^&E3+JM2CC_$>6$J48
M1J5:.)K.EB5"6']LJ3HO.(RAB*J]^A3LZ56G%R=2$GR/\;I/#7BB+0['Q%OU
M)],U"[GL;1DNKEKF6[MY##-";4.90R2@J>/J.U,'AOQB^CW'B(Z?KW]BV=PM
MG=ZDXO1;6ERX9DAFD/R1NRJQ 9LD ]<<?LU9?'#]F"&\\$16,O@^YC76_%-Y
MK-O?V-A:V%JVKZB+B.>-V+1P$ EH648A'"G'3C/VDOC'\']2^$/QG^'GPM\>
M>%)K?4/$?AS7+2V70=/L&U&"+1&CU&TTFZ29FEDBO)FA6>'YIBID(!; VCGF
M*E7HTEDDDJM6FO;5*<E&E2J5H4YN:C1NI4X2YU)^[-*VFIABN!L%0P&)S"'B
M%4JRP^ JU%@<-F<9UJ^.IX*IBJ=.G*IF*3I5:E-490A*I4IN=N:;L?C\BZO.
MOFP-K%Q&HR)(GNY(RV>5+(Q"^V2,].]=MX"^'7Q%^)FK7NA^"M(U_7-8T_3[
MC4[RPM6O)+FULK6*2>>:=%WO"(XHI')=0."..:_3GX._M!_ SP5\*_AMH$T/
M@LZK8_#::/Q,=5\-Z9?7<OBW_A*)9HC/<3GS78:5LQOYV@#%>P^'OVI?V6/A
M1XF\5_$[1;Z,^*/B!#IFBZE;^%K**PAL[-;R&34IDM[-PL$-S:&>UDB "%&8
M'(8BC$9YC$\32H\/UI5(SJ4L)-0YXUITZO)&<XJG#V=.<8NIS.>D7%*^YCEO
M!>75*>5XW&^)D*6&J8?"XG-J*Q]2E5PM#$4/:U(8><L?6E5Q-&K*G0E3=*R;
ME.<6HV?XN7/@7Q[:>%(_&UQ8ZY_PC,VJ7VBIJ4;WDD2ZEINP7UM(5.(V@+KO
MRW&>@YQREJNK7LC06<NHW$ZQ/.(;>>YFD:&, O((XW9MB9^=L87C)&:_=_2/
MC7^S;I7A+4/#_AGXA>$[;PKJOQ*\<^/-8\.>)-&T[4S)HWB-()+?2=,^US!K
M2[4121[H4WAF4[>!G\\/V??C_P#"3X-_&WXC^*=?^&MIXR\':PWBZW\.13LJ
MBPM-0F?^SH(8C!,$1XRHW J(@N%SVWP>;8G$T<=)9/-U,-'GH4G2]C.LFH+V
M;56$8*K%NSY:DU))V232/.SGAK"95B^'Z<N/IT\+FE1T,=768UL=#!3@N9XJ
M,\%B:U2>&JKEM[6CAU2J-*4YQO-?+'@/P9XU^)6OV_A?P=#J>JZW.78VT5Q<
MB."*-PDDMS-N*6\43'$DDF%0D;CVKV*#]E3]H*Y\2:AX7@\,ZA+J&EZ=_:UW
M<+JLC:9'8":.W-R-1!-M)&L\J0DJQ E^0G=@5Z9^SA\8=(T+]I'5_B!IFHZ1
M\)])U9-32TMKZQMM7TAH;RZ65=-O/M#6\,$-PN#)<LI\HK]WFOT<\0?M6_LU
M^"X_B+JFDZO<^)O$NM?">?3=6T+3?$<IT74/%?\ PDUG?P6V@ZC$S1V%I+:0
MBYDBM8BB2B2,C.37/F>:9EA<32I87*Z=2-3#TI<BP[K2IUZDDY1J5(<E&,::
M7*VIR5]Y031Z7"O#F19GE%;'9QQMF6'GA<RQ=)U%FTL'3QF!PM-.E/#X:O.O
MC)5L1-^T2E2I2Y%^[IS29^&_C3P'X^^'WB5O"/BNRUG3O$&4$=@9KMWN/-8*
MC6>"/M*.Q 5XMP9N!SQ7?6W[.WQTN?$6E>%/^$5\16VO:SHEMXBL+"\FO;65
M](O$>2UNI1* 83<+&XB1P"[+M4DXKT_X@?M-Z)\7M;U;Q[XV\)30?$'3H;6R
M^'5U:7CFQ\/V5I*CP)J,<<2QZG/'B0F>?8[$J<945]>Z[\=_!OQ-^,7P$\7S
M_&5O#&I^$?A'\/[/Q7J,JK:Z;J7B#0Q-+JVEWCFZCB6*,!4B1MV]G("C//3B
M,=FF'IX;GRVA"J\/B)8NI[%UH1KTZ"J4?9*AS7I2G:$W)I\RY8\RCSR\W+<I
MX=S#&8V5#C'.:^$EF66T\KH_VF\%B'@,3BWAL1'&U,?4ITX8V$(^WITZ2G3]
MC:<W&<U1C^=-C\!/C3?6WB>\A\.ZU':^$)9X=?EO+JZM5M);8LLJJ92/.(:-
M@NPC=Q7(:UX!^(OASPKI7C37M&\0Z3X;URXFMM(U*_\ M]M%J$L$S02_9C*4
M$J+(A =&92.<\U^U4/[37P0U+1?BOHT_Q TQ_!6KW'B:^UG29[>WM->UW7KI
MYI+&;1-2,QNI=/2X+E88%,2Q.B@8P#^?_P :?CQIGQ)_9?\ A[X(N?$ U#Q'
MX5\7:PUMI/E+%_9WAXZM>-IJA0Y+2&R-N9G*JTDFYVR2166 S/,\37IPJY71
MHTWB,+3JMT9J4*5:A.<YIRC9OVD4K72A3E!MMR275Q%P]D>49=B,1@>.,RQN
M,CEF8XK"T*>:4ZM'$8G"8[#48T^:&(]IR?5Z[E%1BZE:M1KI*%.E>I\-_:[W
M_G]O>?\ I[GX_P#(GX=_ZT_SKS_G_OO_  +N/_CM5<'.-I[=NF?7_P"MFIMW
M ]3TZX)__7ZU]5*E2325*GU_Y=P=G[MK::>EO/>Q^/4LTS::?-F>9-IJR^NX
MI:67:JMTOS\K3"XO!UOKT_\ ;U./_:E(9[PG_C_OA[?:[C_XY41)],8Y.<=/
M;!Z_I1N&0.3D9'T_'%3[.G_SYI::?PX^7EOI\NG2VKS/-&K/,\RM_P!AV+Z6
M6_M?ON[ZMCQ->Y_Y"%]U/_+W.>/^_G^?4T":\SDW][NZ_P#'U/QGL/WF,=<?
M_JJ/=CKS_N]!]<]Z7)P3U';&<XI^SC;^%3U[4X=;-;+TMYB_M/,UK_:68K6]
M_K^+W5O^GO9:^1*;B\*G;?7N2#C_ $N?W_V^.>],\Z\XW7]Z0!DDW=QUX_Z:
M=#[>E-W^S<\]/\^M&[_9;\J7)#;V=/3_ *=QOT\OS[A_:>9-ZYEF3MI_OV+\
MM[5;7VUMIJ^X[S[IL@:A?X]/M<^ !]7I#<705F6]O=R\Y^USC( ]/,Y!'X^N
M::7QSM; Z_*>_3'XTC-E'P#T(Y!ZFFJ=/K3II:?8@KZQW=O-?@3_ &GF2U69
M9G=1E:^.Q<GI%MO^+NE=WLFM>VG]<G_!N-//-\)/C+YT]Q,%\7V&WSY7DV_\
M2Y,A=S$@>W3CUK^EBOYHO^#</=_PJ7XT C&/%]A_Z;8_?^G^%?TNU_+G'"4>
M*\Y44HI8F-DE96]C3>B6B^5O1'^IOA!4J5?#+@JK6G4J5JF18652I5E*=2<V
MY\TIRFW)R;W;=PHHHKY,_2 HHHH **** "F2<HW7MTZYR,8I]-8$J<=<<9H!
M[,^;?VGOVF?A[^R9\+[_ .+GQ1&JCPCI5Q#!?W&D6OVN>V20C-S<1Y4I!&N3
M(PSC\#C^7;]J7]ISQ+^T=\=O'OPY^!W[1.D^,?@G^V5X"L1\&+^WU,6UIX,^
M*.BZ@NO7G@K5?+</;PW^F:>+.0,&9FO"A1@17]>WB+POX>\6Z1>:'XJT33/$
M.C7L307FFZO9PWUK<1O\K+);W*21$$'!.W=C!XK\@OBM_P $+OV'OB#\:? ?
MQW\,^&=9^$_C'P-XCC\3QVW@;4+J#1M8U&)@ZR7&G7%T]I9%R%5_L$,.Y1L(
MP2"DHW7-?E;DI/=\LE9I-Z)Q?O1=KW5MFP4]-%MRV;V;C*+3:5W*^JDMFF[V
MLS\QO^";/_!,+XZZGXNUC3OVI_@=9?#_ .%_VF#6/&OAN_>>6V\4>-[*8W-C
MJW@UKB$?V;I]IJ"0WL5YIRVTEVAVRKM4"OZO_#VD67AO1M+T"PC>#3M&T^VT
MVPCEE>9H[6TB2&!&ED+/(RQHH+L2S8RW/73L8S#:00EG;R8HX@9"3(5C144N
M222Q"Y)[G/>EN03MP?\ @/\ >Z\?X>YIMIM=$Y7MHKN32<FEUM;T22TUO/O+
M5]%MV:6R[+R7SOI:CKNH0Z5I5]JD^Y[?3[2>\F6(;I&C@3S6"*/O$JIP,C)Q
MS7\SO[=W_!43P+\1_!VD^+_V8/C*_AOQ[^SW\1'O/BQ\)]:8:7XB\1>$4BO-
M#U!+:T+9ECANKV"]C='Y6%20 :_0;]L7_@K'\'/V,?C/X;^!'Q,\(^)]3\6?
M$2.*S^'2V'V![;Q;JMT\42:3&LTN8V$DIB)G$,>$)W8QNZS]I;_@EY^Q=^W1
MX'M]3^*'P?M/#/BGQ-X?M[F+Q1X:+:'XDT=]3@BNW6?^R9[>QU"6-Y2'%XEQ
M&6!.20*E:Q4]5%R4E+M).UGJK)QU:::U5]AWM*S2=XV:[QDHMOKU>CNFM>MT
M?S7?!G]@3]KOX@?M 6'Q)\&^&+?XB^!OBOX@M_&'@;]IF;4+J[T=/!.K)$FO
M67BF/;+8WUS/:MJFE1:=>&YMXW,,Z$2@$?V-? 7]GKX:_LV>"1X"^%.AQ^'?
M#LM[+JL^GVTC_8_[2NHT6[FM;?/E6L4CIE;>%%B3^%0.O*?L@?LN^#/V,_V?
M_ 7[/'@'6-;UKPGX#T\Z9I-[K\WGZBULTTDJK*59E7:9B-JX!'J:^J%4!5&!
M@#COBK<OL0TBMFU>ZTT>UW9*\E:]KM78+WFI3LW?6UXZJSVZ+5V5KI.U[)7J
M,Z00O/+(L:1*SRR.0H6-!EF9B0%4 9))P/I7X'?\%+/VSM<^,_PC^)/P9_8+
M^)6B>-/BIX%N6N?C1X;\*7[3>,+/X?6*S+XGA\.)$J&768T\M8UBN(G60$!Q
MUK]H?C7X1O\ XD?"OXC_  _T'Q$/#NL^,/!^N>'=+UJVN(TN=)U#4K*2U@O(
MB&++);RNK\#<".!G%?PG_&WX'_M)_L>>)9?@AK?[0>O>#/CC(VI7?P5\&?!#
MPT-4U#XJ:EJ5['-!??$#7=<T:>25+II0UU!'J(@Q<,HCVJ (2YW:[2M%QT;Y
MI<S]UKJO==U]K572U'%I*VC:T;>BC!*/OWZ23=D^CL_(_0S_ ((\_!>']J2;
M]J:X^&_CCXF^%/V6?'/AB'X=ZKX5\9>)-8G^(<'CMH]-E\2:T8KW4)[K1RFI
M6.K6L8M+E%,4X.1D"OZ@/@'^SS\//V>OA/X7^#'@C2Y)?"/A2'R;%-9EDU6X
MEE+O,]W-/?-/(\[RN6+LQ8$Y#=A\J?\ !/W]CCPQ\"?#6G_%[6/"T7A;X[?%
M7PGHEW\7;?2Y[F'2+[7SI]FKWITH2BQM;^1(@UV;>WC5IWF;DG)_2RM)/644
MX[VGRI6<HO3K>RWBM-&E;1$I-V;<M+6YG=V:6O:[25WKW25RLD8CQ'CY, *!
M^7H !C(QCZ<<59 QP***A)WW6VNEFWIK_7XE:=%8****8!1110 4444 %%%%
M !1110 'H>WOZ5\K?M4?M<_!K]COP1IOQ"^-^MS^'_"6K:Y;: -7C@,\-E=W
MB2O'/=X_U=K&(F,DG.TXX.<#ZH;H?H?Y5P'CKX=^"/B9H%YX6^(?A?1?%_AZ
M]5EN=*URPM[^T975D+".XC=4?:2HD3:ZC(5N34R5]VK>:_X*M;7Y7N"W372_
MEVZ[+Y[G\@_[4'QH^-/[4'Q(_:"_9M^$GQSTSXE^#?CI%9?%_P#9GN[#4Q::
M7KUE:Q:?I][\,KN[LR)X[F1K?4=06W5'=S&JE=K$U]%_\$O?^";?CSQE<^);
M[]J_X):GX!^'6B/I/B+P-X9\0O=VWB+2?BO9:E =6U[P[</_ *3IOA^\TVWC
M2&.RE@AD/F*8L.V?NYO^"$7[(.@?M2_#;]J3X2S>*_A/K?P]UP^((_!GAS4K
MF?PQJ-\\,\<C&#4;BXDM(9!.[&WM?+A#$[4K]NH@!&BX)"*JC=U.T!<X/KBJ
M?)&,5%6F]'II;10GYM*T5?5M*5[MB;E)V;O%6]4_=YDM;)-IO335QLDDBCIL
M L;:WLE#""T@CMK<L[2MY42JB>9*Y+,^U1N8YSCKGKF>,O%.E>"?"VO>+-;>
M5-*\/:9=:KJ#0)YDXM;.,S3&).-S[%.!W/%;T^%&1P>P ^N.GJ:_)+]H+_@K
M-\"?@/\ M"V?[*/Q"\)^)KWXG>+M1T#2O"6@1QZ;-!XLLM? %U=VRS2&/[+I
MXDB%TMR8V*RKL1N14I.]DTVWUO>3:6OWW;_#4-NFBU>FB2MIY>6[OZ'Y[?MC
M?\%3?"GB75OA-\?OV8/CE:ZE\/? /C6;P+^T'\+V,-OKVF:'J$U];7/B.XM9
M"LR+I\T<"*RG;LF#%\X%?GA^SY_P3L_;)O/VD(GUCP!<^+=&\:ZW<ZK=?'*Y
MU"^U+X?>*/@UXMDEU\V^KM-YMGJ&M6KZA;6$=G<0S1PK;[DD#Q(!_0)^UY_P
M1E_8I_;4T"_U?7/A^_PL\?>(["SFG\9>!)9-(U$&6.&<V]_I5M-%HUTRNJK+
M)):.Y=20Y!Y_1']G?X+Z7^SQ\&/ 7P7T+6-5\0:5X#T6#0[+5M:D\W4KJUMQ
M\KW,@X8@8  X4#   XI1CRR3:TGRJ/:.CGO=M1DM%>S4W&5U:R<FK<J^**<F
MUHY:<NJ25VG9II--*[35@^ /P \ ?LX?#+1?A9\,-+DTCPEI";[336N[BZCM
M9Y1NN%MC.S&*!IS(Z1)M1-P"KBO8+^^LM)L;G4-3NH;&SL;>6YN[J9UCB@MX
M$,DLTSL0%5$4LQ)P!S6I$-L:\C@'GH.I/X"OG']JWX7ZY\</@)\3?A7X1\2_
M\(SXD\:>%]2T;2M7M[E8Y8+JYM98HU+(QE6)V<),T8\Q8V)4A@#4RE*R<4KV
M^'9;;>71==-[Z#25]6TG:[W=TU9N_;KMOY'XL?\ !3/]NKQ!\9/@UXK\*_L.
M^/;7QWHGP_\ $EO9_M02?#^X:\^('A[X>I//'XB?PQ:((5GN8[*&X_?1743Q
MNJLC\YKY9_X)&? "Q_;!^%_[2=KH'Q&^*B?L=?$:YTO2?".D^+/$>KR?$&'7
M-,LFLO%4E[-/J<]]IBSZS%=NUO%=B,;\ 8 K\T?B9\*?VH?V=/B%I'[.L'QY
MUK1_VF-!N/!VE>!?@[\$_"D-YX2\::3>((FUOXA:SKNBM=7YOX5BN-95M0E1
M9)I!$@!.?[$/V(OV*_AG^RKH=SXC\&:)-X8\7?%70_"NO_$_0;6YG.A0^.SH
MMN?$UWIMC)*\-D;K69[^:XCMXXHS*YVJ!C&EH04VI)Q:E%.UG=J*O:[O%-+5
MM<LK/6Z24G+FBE\2UE9K:+36B2UE?1[22:TM<^H/A?\ !_P3\)? 'A'X;>%M
M)5_#O@FR@LM"CU,G4KBW,*$/<_:;OS9C<3.9)'EW[RTC#=R2?7!T'&.!QZ>U
M&!Z#\J6HMJWW=WWO]]N_1%!1113 **** "BBB@ K.NE<[E"D"17CR!D_,& 8
MYS@#/]:T:1@,'CL: /XTOVT/^"5?Q+\>?M*_%/QM!\7_ (1:%;>)-934+?3=
M<\02VFIV\301[4G@6TD"L<Y'S'C![@5\P)_P2!^*3J67XZ_ WCU\4W'3_P
M@<9] ?6OW4_;!C0_'SQ>^V*,[[/]Z[/A?]#@R5&2I.?4?7J*^8+F6!$5I96D
M*C(+%53 SRNP@XQZCD<<5]YA_$'BO"T,/AJ.*H1I4*5.C3C+!T96ITHQA%7?
MQ>[%:N[\]S\;S/P&\,<[S/'YKF&05:V/S/%UL=BZL<SS*FJN)Q,_:UJBA#$J
M$.:3;Y8*,.B22:7YB-_P2&^)\99&^/7P,!')'_"47&1GKTL^V/UIC?\ !(GX
MF(IS\?/@9WQ_Q5-R#W/_ #Y@>O;\Z_2F:]MK@>7&@+D8W'.0/7U]!TZ\\\FB
MPCCDD/F*9"I''4=!D>W&!VK*OXH<74E?ZWAFTF_]SHJS5NRMNGZ'+#Z-_A+*
M7*N'*UVXIK^U\S\K/_>O5[WUUOU_-+_AT;\2P.?CU\"]N1S_ ,)3-\WMG[%G
MW_'/T<?^"17Q-5#(_P >/@4D8&XLWBF=< <G@61X[$GUK]15TN":=9'94,8S
MY0'!4]F'3 '!]>/I5+Q2]A8Z>\Y5,[,K"O\ &1P,#K]0<\D=17@XCQGXRI?!
M6P#=];X.%UMV=NU_NUU9Z</HQ^$#46\@Q3;25EFV8]U_U$=.]]-S\L)O^"5'
MC>%@DW[0?P'!92P/_"53\*N<E?\ 0NW.#]*;:?\ !*KQO>QB:V_:!^ TD>_8
MI/BN?)?( Z67J?\ (YK[=6\@O9B]Q"J+#&PGC&"1$SG:,9S\Q8#/!)X]<5/#
MD4%K?:@)XC;1N\DNFV8_U8MS_JI6W9;>3GH>H!KC_P"(W\;-I*ME[T=_]BIZ
M/;OUT_X)N_HN^$,8\[X?Q=[I)O-LQ=]ENZZUOY=3X]'_  2;^()9XS\?/@07
M1&=@WBNX& HR<?Z'RP].>I[4U/\ @DU\0YGC5?C_ / <%BJJ#XJG^<L. <V7
M&37W1'9274EJZ2LTR22R2-D8V,1A3_>"C)Y![G%17VJV.HZC;VA81R6TB(S1
MD+EX?E7.W&,X_P :%XV\;Z?OL!_X107;H_1ZOOH#^C'X01_YD6*OHTO[5S#3
M1+_G^M-.GEH?#-Q_P2<^(%O<RVDWQ]^ Z301B2=#XJN.(R =P4V1SP0>_7TK
M&;_@F/XLTFZM2/VC?@3;74?^E6MQ'XKGCE@:-OEEAD6R#12*PZJ01SS@$5^B
M&L7=I-<+/Y(%Y#$L,C<G[1%M P3WXX_#Z5YUXAT/3KC3YF*/N:.7R94"DP2X
M,@7GD*W(Z\[C5KQKXTG[CK8"UDI7P=-NS2OI=7VU6EUH[HRA]&7P>34GD.+C
M)6:DLVS&-FFGS*V(MN[+2Z6W2WR%XJ_8-^(WBFWL[GQK^UK\'==AL<)8'6O'
M-_?1VXQY8$0N;>4(Q'R[@ <<9P!6##_P3)UJY420?M%? $!P"K?\)3)C#]QB
MR(YSQCKT/>N]UQX-3\-7T#0*TUC)+%?VP+"5&B^9&0+C&6VG.<=!S7/^#O%]
ME)I1@NV)MH ;>$[AYT,\7R[9<'<$W  =>.IQ6U+QBXQC&,:=7+J<$GI3P-*,
M;-IV44DE[VOK\SHK?1F\)\76E5Q&2X_$U:G(Y5:V=YI5K2Y4HQE*I/%.HVH*
M,$W+1))/1'//_P $S=:BCF9OVC_V?_+@#>:?^$G?Y<?>P#8C.>O7O[8KE_\
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MZTNNNMOZ -,_9M_83_X*?:-X0_:]N?#!\9WNM:8D.@ZG>N!J?A'4+(PQWMG
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MO<CI<E_J6I)(C9A5CNZ\?-M*\=NN/TKS_P &Z&C76I&15>9=2D$<SCYE(E<
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M292O:SM!QM=WOJDI-KETD^R;23>ET=[X9T8Z'X>T70!/%(ND:59:<KV]NMK
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M3,/MZ6<EU"KY+@R/)*>O4G>2QZDDD\D&J]C=".],,Z-;W<4Y$RMD(S+U*@X
M! [=#7KY9.]-:W]]JUV[);)6^?F?GV9T8T<=6IQOR1K*W_;W(Y+3;6]DM-4[
M:6/W)_X*5_$=_A]_P2]^"UU#-)%-J/@F:RBEB8H09M(A0$%3GJX'I]!G/\$/
MA9KFSUJ/69)/*E;59-4:<<2-,\QF+E@<Y9B69CSGGIP?] ?]LG]G'5/VHO\
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MNBBFW%=6M97BE>[U<;))7WM>Y&LKR;5VUHG>RTNKZJ^FJ3T>R2*JM\OS#;R
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MK:7W5EIKUM\[=CX^<U4DVMK;K7U5_*VJZ?,S]:O#8V,LCR#:4*CH#R<]N<]
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MLK:=+)+YJXELO))?=^CW7DPHHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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MK7M=WW;>KMHK_=ML):I-I7>NFUWZ_F]?,****904444 %%%% !1110 4444
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M_P"")XK$O_E[MLN6/EV2['XNZ;_P2+T?1;Q[K2OB?J-FK-GRDTZ+R^H/W?M
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:!0@N6,=E=O\ %MLS;E)MR=Y/=V2O\EH?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img117602972_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_11.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %3 C,# 2(  A$! Q$!_\0
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M^)'@CPA\0/"%]%K'A+QQX;T3Q9X;U6)<PZEH?B'3;75M*O8T."JW-I=0R;&
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M/$$<VGZ5<-J)@NO"UQI-OX@L[NYLA/96>H:1+KVCQ7EA=3PWJF_B"Q91@O\
M/W\2O^":W[6=YX1\'7/A>5Y?$U_\1OC9XA^)>F:5\8;D7>IZ]XJ\32S_  E^
M)0\1>.M/\013#P%H3WUC;-!%'XJT5-8>_P!+MYM6%S!+J0_\$V/VFDO=9\*W
M&C:0/#>L?$R\\0^//%NF?%2^TJ;XKV'B;X@?L^>)/$.M:G;Z5'HFLP:L=*\#
M_$%-2>>"TFU"XU&5;..*'52@Z(93E<XJ4LZH2=YI1BJ491Y)<KDXRQ#<TY*,
MH*+3G%Q::3FZ:;E>W*E:^[3V=KWZ*SUW^UT2D_Z.AR ?4#U'Z'G\^:6OD?\
M8Y^$/B[X&?"G6OASXKS#I^F?%3XHW?P_TQ=?O/$$.C?#'5_%M_J7@?1;:\O'
MEN;2WT[2KE4@TWS&_LU/]&B+(@9OK<#  /)  )P!^@X'T''I7AUHTZ=:I2I5
M%6IPE)0K))1J05N6:2E-+F33LI22::YG:[I.ZU5GUCNT^S%KYI^-G[6_[._[
M.VJZ3HGQA^)NE^$-:UVQO=9L=(_LWQ%XCU*+0=.D6+4?$VJZ?X8TC6KS0O"N
MG-(HOO$VM0Z9X?LI \<^I!HG"?2U?FU\7?!/[0WPN_:5^(WQR^$7P9T7]H/1
M?C3\&_!/PNN])U'XA:#X!UWX:Z_X UCQQJ&FW37_ (DTZ[M+WX<>)T\<27'B
M"VT8WWB+3=4T:"\M]"UF*:*&WVP=&A7JN%>?+%4W*$/;4<-[6HIP2A]9KQG2
MHV@YSYIQ:DH.FO>FFE*^EN_?I^OW/T/T4T?5]*\0:1I>O:%J=AK6AZWIUCJ^
MC:QI5Y!J.EZMI6I6T5[IVIZ;J%K)+;7UA?V<T-U9WEO+)!<V\L<\,CQNK'G-
M(\=^#=>\8>+_  'I>O6%_P"+_ UIX;O_ !;H$+NU[H5GXO36&\-W%\I0(B:S
M'H&KFT"NY9=/F+!,KN_GPM?^"9'[2'P_^%?C3PYIVD^$OB;XDG7]FGP;97UW
MX_UVS@E^%O@_PG:7'Q;T/P+X?U/6=&\)P65OX_ALX=$T#Q]:R:'KOAK2H;O5
M=,FOX;"S'O\ ^RK^RM^U3\"?V>OVIK#XC:T^B?$[Q5^S!HG@+P#XK\.>(M0^
M('B32?$O@23]I8>'+S3UT73;;7+^7PQH/C?P'!X>ATS3TOKA;)-)TC3(9-.C
M@'I5LKR^%"I5IYM2JSC4H4Z-+DITYMU9T4ZDH>UJ5)0HPG/G480DITW]F\9)
M2;T<=6EU36O(V^LM%)I)I-M/LT_V.UOQ[X.\.^+/!G@C6]?T_3?%?Q#GU^'P
M3H=PY74/$,OAG1WUW7DTY%1E==+TB*2^O/,:,)"R;26(4]L!@ #L,?E7\D?P
M=_9:^.?[2<?Q6\3_  /^'%Y\&O!VF>%I/#/A2/Q7X^^([:?<>/;S]F;Q5X3\
M1:KX=U+QKX?T?Q,C>(/B#J6E6?BJ_P!/TF.YTV_O7U#55O=>36K.#[:U3]DS
M]L7XA?%7Q?\ %KXE_!G1?$>B^/?B3XY\0^"?@E<?M1>)O"]M\!?%>O>%?V>-
M+\'_ !ME\:>!=-LY]4O?#I^'?B_3+_1_"4 UG15G5O#,MXOBC5;Y-JV18/#U
M%2EFM*$XT[UX57AHU(UY*G.%-0>,4$W3J)2O6<8RIS3GS5*-(7.]?=O9;*UU
MJTHW2MS/ELTI-*2>NJO_ $!45_-MK'_!/?\ ;(O_  OXST>32)[?6Y-)EL_B
MSXET7]HJ]O+W]LGQJWQFT7QQHOQ+U#PKXR\-ZUX+TN'PIX6L-<L+OP-X_M;3
M3]>A\4W/@T:AIN@Z/IFJ';^&O[!O[>FE?'/]F[QSX\\665OIG@FP^!L<][X/
M^*5W%I?PI\)_#NSU"U^(?PS2'Q7I_BGQOKO_  LFT=_[8M_#.O1^&/$5[K>H
M6FIW>F:5X9\.W(AY1@%"<_[<P5X*;4?<;FX04ER<E>;:FV^5M)VM&WM^:A&N
M9MI*+UV;<4NFKN[+1WLVI6U<4K,_HNHIJ#"J,YPH&<8S@#G   SZ #'H*=7@
M+;:WEV\BCD?&'B[PQX \-Z]XS\<:_I7A;PGX;L;K6==\1:Y?6^FZ3I&F649D
MGN[V\N#'%;PQHNXR/DO(T<4;/))&E>4_!/\ :=^!_P"T5!KTOP<\>67BV;PI
M/:V_B/2Y-.UWP]K^C#4;5;W2KN\\.^+-)T77$TS6+0K<Z)K)L#HVKVXGFT^^
MN%B9JY7]LWX-^*_CQ^SQX^^''@:72/\ A+;V]\%^)O#]CXCN9[7PYKNI^ ?'
M7ACQU;^&O$,\5M>/;Z)XC?PXFBW<\5M/]G-W]LDM[F.&6"3X%^,GPH_:\_:,
M&A^+?&?[+?P^\/>!/"GB'PQ!XE_9W;XT6NE_$+X\Z-IOA;Q79^=XK^*O@^-_
M"]CX0\&^+-?TS6_ W@Z[W3S^1K6JZG<:?JDFF:0._!X+"8F@W5Q4:55UI1<G
MB,/3C1A"-!P<L/5G3EB7B93J4XSC6I4Z,H*>(J1C-N$N372]K*UKN3O>Z]UN
MZ2T27*G+7;WOU*'QP^$[?$B3X0?\)WH0^):2W$3^#3--_;4<EKH6@^)+B%HS
M$(RT>A^)M#U3<KLOV;4857<Z2JGJ;,(DW%N.,K\N3R<N257&< R$Y553 !Q7
M\V6K_P#!-W]NB\TO43:^.=&3QM)X'DTV3QNGC^\FU6\@?X=_ 70+SP7%XAO-
M)GUBX_M"R\">*O 8\4:G:2&\L?*O]71K74;E:Z;X<_L#?M9^'8/ /_">>"D^
M*OA.TU+6G\'?"[Q)^T5JG@ZU_9UU6_\ '%MK8\<P2_#71-"TK4K6[T"#[')X
M>\)RZE<6+Q'0[6[ET+5-1^S^A4R;+5"+IYUA;\J52G)T7-S4+\T.:K0A&-TH
MQIU)-J_O57/V=.I%Y6^%MI1VYGK9:I.^FN_6TK)_"_W6O?C9\)++P]X9\83^
M/?#9\.>,/%-EX(\,ZY;WRWNFZYXKU&:[M[#0["ZLS-%-=SW&GWD2@$1J]O(K
M.G?I--\?>#-3\:>(?AYIWB'3;KQIX4TW2-5\1^'(6D;4=(TW71.VCW5W&4V"
M'4!;W#6Y64MMC.X8 S^,5]^PY\6K?]A+X8_L^K\%O"&O:_\ #C]HNV\?>(_
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M+1^6_P"I0Z#_ #_*BD484#.>!R:6O'6R]%MM\BPHHHI@%%%% !1110 4444
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M2ZE":22/T&\%_M3^%_$,DHU2WM+.VCN7M7O-)U.WUJ."YB8+-;7L-M$)+>6
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M_P#"#MO_ )8U]?#_ ((8J/\ FX^3GD_\6TCZ_P#A8_X?2E_X<9+_ -'(3?\
MAM8?_FOKZ+ZUPU_S[P^Z_P"867]SO1]-]=?(^?\ J_$?\]7_ ,*(?_+#Y"_X
M>_\ [9!_YBOPX_'P);\>W_']2'_@L!^V5G/]J_#GVSX#M\_^G&OK[_AQDO\
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M6Y\BT>^U>]DO-0\1^'+:5VATW5+0W,GDPJ_D7]HIL+IPR6UU:_H:_P#P0T5
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MUI^[P_3_ )A9?W/^G/I_2U\WZOQ'_/5_\*(?_+#Y /\ P6"_;''!U7X<\?\
M4AV_Z?Z>:7_A\#^V2>1JOPYP1W\!V_3_ ,& KZ^_X<9+_P!'(2?C\-(_Z>,1
M_*D_X<8IW_:0F_#X;1@?E_PF%"Q7#7_/NAT_YA)?W/\ ISV7])7!8?B+K.M_
MX41?X>T7]>K/CF\_X*Z_MAWUK<6=QJ/P\>VO+:XM9Q'X'@1C#/&890I%[PS*
M7VD!]I[DUS7[#O[?7B[]F/QG-I/BR6Y\0_![Q9K$EYXDT1"_F>&KZ_N&EN/$
M7AR)Y"(6C>0R7VG "&[@YC_T@ O]M:G_ ,$1(],T_4+]OVBYI1IUE>7IA_X5
MS&IE%M;R3;%V^+&*,_E!?,&]@3GRV.*\]_X)\_\ !-:Y^(&MVWQB^.FE30?#
MG1M5EE\&>$M1MFM[GQQ<:=>.EOKFKV;EI(?#QDB26ULY27U$X9C]E!::Y8C(
M7A,5R0I1H^XIQA1G2J3D^=4O9WA!NJN7W7'X4VVU%,SC0SR.)PW/*K[6\G&<
MJD*E.$(JBJBJ\KG'DDMXRL[Z?$T?T<>%/$^A^-/#6A^+?#5]'J>@>(M,M-6T
MB_B5T2[L;V)9H)E215==R,,JZAE;((R*XSXR_%'PY\%/AAX]^+/B^4Q>&O '
MAO4_$FJE&"O+'I\#/%:1LRN$GO;EH;2&0 A))P6&T$5Z7:6UM9VMO:6<$5K:
M6T,<%M;01I%#!!$@2*&**,!(XXT4*B* %4  <5^<?_!6W0]8\0_\$_?VC[+0
M6=KRW\(0ZA<00D>;-866J64UXH QD+%F1E.<B,GI7S&686CC\TR[!59NC0QF
M/PF&J5&U>E1KXBG2G-R5E>$)WYE;WDK6N?39CB:N#RW&XNG!5:V%P6)Q,*:Y
ME[6K0H3JP@ES<WOSBDHMRO>S9_.IX!NKK_@I7\5/&'[<W[='CK3O!'[*'PD\
M2Q>'? W@G5K^YL/"4EW+>"71_":!8YGAL2WE2>)-12WDO]8O6E26;['%,1]_
M7_B=O'6JKJTS:=%IVBP#1/"7AW15CM_#OA'PO&B_V3I^@VL;M#]EO;-8;MM5
MCR-51U(/DJ OY'VEM>_$G_@B?<:=X#4S:G\'/C;=:G\0M.MXVDG;3M1NII[/
M4[R),![2U2XBEEFE953S0P[5QO[&/Q-U/2/@%KFF_M&_%2X^$7@WQ!$WA7]G
MSQA/<:E;^*=9OI)GAU6QTLZ=#?ZI9^"])E,<MGXFN'DTGP_JV8;=I;=[JT3]
MDXVX8Q694,UQ& KJC0X4XAQG#&5<*T:$^6C@,/&BZ=;!PI.=7$YEC)<V/QLZ
MM+VF)IR=>-6?L:D%^1<%<18? U<IH8W#^VQ/%?#F!XHS;BJKB(\U;,,1SJ>&
MQDZL84,/EV$TP. IT:WLL+*,,/.C2>(IU*GWC+\>OC2GQNU_2/@[H?P]9?@[
MKGAF#Q%)J?C*\TCXA2Z7KT!GU77--TMK--&A\,VEN LMMK#WMGX@19HH)K6>
M*(CQC]N#]B;P3^TSX:\2?M+_ +-.FZ!'\3- 2ZU3XV?"#PU>6%SIGBB&U5FU
M+Q]\/WL)6ADF.UIM:T2,QNK>89$2[4QR> _&FT\8^$-0\5>'O$WQ2UWQ,/'/
MPNLO.U?Q!X&UKQC=>/+;0[ZS30O >@1_#FWT'1].M]8B8:IXEU0W\NI:];7+
MWL%^;,7$8_1_PK=?!C]A?X07G[2_C3P]9?"R;QKX=D'A'X4>'9+FPU/XC^-]
M2\+KI%S-;:!<W+P:-X8LUD"7UREI$+U85FU":>41LWYQPAG&>Y'G^ K\/1JU
M\PK5Z>%67*DZ]/,E6G"+P.(PJ:=:G5:7,KQ=&:C7C.FZ7M(_H'%V3Y%G>0XZ
MAQ#.%#+Z%"IB_P"T776&JY74HP;AF&&QC:5&K0O)IWY*L)SH5%4IUIPE^*O_
M  3K_:U^)W[(7[2'@/7? >HSCPKXP\1Z#X.^(O@5&E?1?$6B:IJ,6G^7<V8.
MQ=8TV283Z?/ HN;62+:C*&85_HTV<JSVEM.@<)/!%.@D012*DR"1%>, ;&56
M"LI (((;G-?QV?\ !(C_ ()8>(_C5X[TO]L?]H/1KGPK\-;3Q/<>,_AIX#N+
M8P7?C;69+^74+/6[V&1-]MX3TZ>0-81N$FU:2)70K A>O[&DQL7  &!C P./
M09.!Z<].M?>^.6=<.YSQ7AY9+2P_UW"Y?##Y]BL)R/#ULQBXOV,:L$HXF>#C
MS4*N)CS1J<L8.<G23/@O W)>(,EX4Q$,ZJXAX/%9C6Q.08;%N?M\/EDHQY:L
MJ=1*IA88Z?\ M<,'-1='VDI*%-5/9P_*7X^_\$T+/XV?&+QC\59?BJ_AW_A-
MM>T!_$>C6_AI[E]7\"V'A35]!U;P'J5\->M1)INL:C?6>L_:OLP-O+IX@\AU
MD,R?.?AS_@C/>^%]7T^_TKX_2QQ6<6B:TVHR^%O$%[JVG^.=#T.^T+3K[0M)
MD^(Q^'L.B&&ZANI+;6/ 6N:];212VUCX@B@NF:+V_P#X*._M0?&'X#:_:6W@
MCQY<?"[1+7X7:_XTTK5K+X76WQ27QYXYT[Q!H^EV7@G6A<Z/JZ>$-$_LN]N[
M^75G331/<Q10IK5L<12?!OP[_:O_ &L_A!X)\9Z+8:'X^N];\;ZI<>*?A3:W
M'PE\1>*HM;\6:W\0-,_X2V :NGAZ_M=,T>/P_=-+ NL75GI]II[-=Z=M:$LO
MP^#7$%3 TJM#'T84YQI4*%*=.#;I0?):3E1E"7LERSE9U&HQE[1Q<7%_L;Y$
M];VN]=59^[>VCV<FEVT35MO>4_X(\>/Y+'6KJ\_:(T2?QEK&J^%K]?$,GA#X
MC3:EH;>'O".J>#Y[W1?$=S\:I?&46H7MMJ/VY])N?$=SX%DVG1[WP;=Z(8;.
M/N-:_P""3_C?6)!H%Y^T)I=_X TK4?'.NZ18WWPN0>*;G7_B+X8T?0?$5YK^
MM6OBRTTB]M8;C2GOM/L=-T#28T_M&6&[DN%M8&/DTW[8?[78LK3^V/B7\1/#
M<>H^)KNV^,FJP?L@W&HQ_LURV^I:Y'I/A;P[J(T.[@\=+XA-KHMC+?7WAKQF
M;:SO#KT?B"UBEB@3A[;]NO\ X*-67B6XAN? _B#Q+KMU\+-=U;P]\/M,^".J
MZ3"=0L?#^O3:%XQ\7#5/!Z7UI'KL]II&LEM ^(NH6NGW=T_A>X\ "Y99EV4.
M))WE]?R]N"DXWIQBERQC#W74PL5I"#]]27[N<9\RIU:<ICY-4D[-+163>EM6
MTMD]+V6CUU4G]]^"/^"<5IX*_:RN/V@8_B"-1\,+\2/$/Q:T[PK=6OC)]?L?
M%'B+PE#X4GTL7TOC^;P#%X>LX8C<VLUA\-K'Q*Z,--GUN6QV*OGWQ,_X)B>*
M/B?J_P 2;+5/C1X=TOP/XN^(WQ)^+?A^RTGX9S6?C72O%GQ \!V7P_EL-=\7
MGQ>\>O\ AC3M/AGOTLHM&TB[O;R2&*YOY;.!+<\#\.?C-^U)\<_V#OVM[[XG
M6NKZYKVE:%=V'PY\0Z5X4U_PSXG\0?:_#-O<ZQ8PZ>O@#X9K>OHVN![&TGT;
MPE') 99;2ZO=5O+-[F3QCP;^V#_P48E\4_$VR?PI*++X8:5XJ\4:I\.KOX<:
MU<:C8>'/AUX@TEM#\/:+JDGPUT<WNL_%#P?:7L4$\WCSQI>75]JQO-%CT6:P
M:V7EI4L\=6O*.88-8C"*G@9RJ.ER^QIPIRIRISE2F^:^(E&<G3A*$O=O>2BV
MU'W7RR2O>]Y:-M-73MM9VL[ONE<^DM3_ ."6/B;4;OP>'^-_AR*P^"FM>*O$
M7P-23X4+?W#:KXI^*6E_%2Y@^-_VGQ<UG\3=+M-3T[^S([:QM?",MU;2I=WM
MQ-J-K;7(S)_^"4GC4S^,M1T_XY^#8]2^-/B?P_XO^-:7WP>2_P!/CU3P[\3(
M_B780?!VW'C&VG\!:>\L:Z-J$&KW'BZ2^D8^(9)8]8C1J\.\7?M=_P#!1*#Q
M]\.](?PU=:?H'Q,\.^'/&WAKPK>_#V_,^O\ ASXB^-_$/VWP?KEYH?PO\12Z
M;KWPY^&J>&9]59_&'@&^TG5M3O\ 4-:EUBWM%L8-G]A7X_\ [5VC_&7X$? G
MQM;^.;OX5W?@5+=]#G^&>K6E]H, \):OK(\1^-O$OB7PAI]]]GN?$HMK:T\1
M:5\1=6M"3%X=N_ UO>NNJG:=//Z>'JUEF. E[*$J_)"%";J14JE:=I+#N+FZ
M\.=IMQE7E*7M(3BXR5X7MRM73L_>?*VE%Z/1-1T5XKMN[+^@R, 1J VX ?>X
MY_+CCI@8 Z  <4^F1_<7@#CH""!ST!'4>A[C&>:?7Q:V771:]S8****8!111
M0 4444 %%%% !1110 5YGXU^%W@CXA:KX-USQ/HT>HZM\/M:O=:\+7Z236]S
MI=YJ>CWV@:M"7MY(OM6FZMI.H75GJNF71FL;M%B\Z!Y;> Q>F44TY1DI0E*$
MDFKQ;3M)6DO22NFNJ=MFTS_@_CIT\KI^IR0\#^$%OEU1?#&@?VDD-O;"^_LB
MQ-T+:T26&VA$I@\S;!%/+%$!TCS'PIVE+;P+X-LK6RM+/PMX?M;73);NXTZV
M@T>PB@L9M01DOY;:*.W"027@9UNFC&9%^5MPXKKJ*.:>GORTLE[TMELK\U]F
MUI;?[U;^\_32W;:UCBV\ >!I++3]*?PCX9?3-(F:YTRP?1=.-KILTBG=):6Y
MM_*MW=6(=XAEB=S$G!&9X&^&7@_X;P>((_!VCKIS^*_%&K>,_$=T\]Q<WVLZ
M_K=P]Q?:C>WMR\L]Q(<K!;0-+Y=I9QP6ENL-M%''7H]%'-5<91]K/ED[N/-)
MQ;W]Z+DU)<UY)-63MVU>G]=/3[@HHHI %%%% !11103*/-;6QX-\3?@Y?>,=
M?T3Q3X6\3_\ "&:[HQD9KRVTR*\-^Y.8Q=+YT&]$&4(8DD'G->SZ9;7D&FVE
MOJ-TE]?QP1I=WD<'V9+FX50))E@W.(M[ G:K$#/%:5%9*E&,Y5$Y\TK73G*4
M--O<;LGTNK75KWL;2JU)TH4I<CA3ORM0BIM.VDJB]^23V4I22^RD%%%%7&-K
MZWN9A1115 %%%% !1110 5$\,,CQ2211N\+%X7=%9HG*E2R$@E6*L5R,'!(J
M6B@ HHHH **** "BBB@ HHHH " 001D'@@]"/0U'%#%!&L4,:11(,)'&H1%&
M<G"J !DDDGJ223DFI** "BBB@ KE/%WB?0?!/AGQ%XQ\3ZC#I7A_PSI6HZWK
M>I7$L<4-EIFFV\EU=3$NP&(X8WQ&"KS./+C!DDP>KK\N?^"O?AGXK^*?V+/'
M.E_":SU?5;PZ]X>N_&>D:%%-/JFH^!+22[FURW@MK5Q<WD,5PFE7EW:VX>XD
MMK:5T4!"*BH^6-[7[+Y/5^25W+5>ZG=VN?6<!\-4N,N-N$N$Z^84,IH<2<0Y
M3DM;,L34A2HX&EF6.H86>(G4J2C2C[.-5N#G*,74Y4Y13<EZ/^Q'^W5X(_;1
MT?QC=Z!I!\+ZOX1\07=HFAW5^M[>:AX8GN)O[!\1$^3 8OM\$9%Y:K$ZVE]#
M- ;B160UZO\ M<?M/>$?V4/@QX@^+'B> :I-8M;:=X<\+I=_9+OQ+XCU%C#I
M^EV]P!+]D1-LM[>W!BD$%K;O+D.R$_S6_P#!&;3/B!_PTSHTWA;PSXLM="T[
M1-?MOB5KMSINJZ5H=II'V,II^EWD]]%##+JMUJ_V:6"SB$DT*VES*"JH"WU'
M_P %[?"_Q:U/4/@;X@T_1_$6K?!S1K'5XM9?2;&]U33M'\:W-Z2+S68K,220
M+>:*MK#97LJM$LEK)!]\8&E6=#VW[E5%1<J49<Z]_P!Y0]JU&-FE*4JC@K)W
ME%6LU?\ M;BSZ,7 F7_3$X5\'LOS2EA.!L_GE^=5\NQ69<^-P>!P^%QF(QO#
MT\9/$/$+&9M_9,Y9<YU:>-J8/,L/*C!S]A*I^ZG[.'Q]\+?M&_"3PK\5?"XC
MM+/Q!9Q/J.G?:ENI=$UF("/4]%NI/*A'GV5WNB,IC3SHMLVQ=Q ^>OVP_P!O
MWX=_LC^-/A-X(U[3AXBUSXB:PIUN&"_CLW\'>#1/]FG\3W?^BS"?_2G"6UDS
M0M-%;7,OF856'PU_P0_L/'MO\//B;?7^@>)-$^&EY?Z-_P (W-X@M+ZSAUGQ
M!'#*FMZEHMC?QK-)9^7]DMKB\1$CGGA;RQ\I)_)/_@J)X6^+NF?MU_$OQ!\2
M?#OBO4O#FOZCI_\ PKG5+;3;_4M.OO!JPI%I>E:4UK#<QN]J +>YL[?R[N"Y
M+AL[\!J>%^LPTJ+"NK-<DFE4=*.G(YJ[]I)KI[UKMQ4K*.7A_P#1CX%SWZ6/
M'/A-FF;4\3P=PM@<[SG"X&&:4Z&:8R%7"86>6Y+2KTL5%U<PR.OFU!XZ%.I.
MM)Y5B(XJ$5+$0I_VBZ/J>G:]H^G:OIEQ!?:7JUA;7]E<PLLEO<VEW"LT,D;
MLK1R1N",$@@UHQQQQ(L<2)'&@"I'&H1$4= JJ % ]  *^&O^"=UAX\L?V1_A
M=9?$73-8T36(M-NVL-&\0^<FM:;X=DN96T&WU**9C/!<1Z<8,6\V9+<$1M@@
MBON=0 J@<@  'U %0FGJKVUMS6YDNG,E=<W=)Z=+WT_B;C+(J7"_%O$W#=#'
M4,SH9#GN:Y11S'#3A.ACJ>7XVMAH8FE*E*=)PK0IQG>G4G"[:C*44I-:Y;Q;
MX8TCQGX:\1^$O$-K'?:#XFT75-"U>SE562ZT_5;6:RNHB'!7<89G"$YVL PY
M KJ:*>J:<7RN+4DU>Z::::::LTTGUUM=/8^::3T>J:::>J:>Z:ZKYH_AX\1Z
M/\2?^"-G[6?C7P;XZ\'3?$;]D?XUBYTV]TV:P%SH/C'P7>SN\!B6X22P'C#P
MW#,]M=Z;<,6OK90F#&R3Q.^/?_!/KPG^W-XC_P"%U?L9?M3?"_Q/H6H:=:VV
MG_"#Q]JMMX.U_P"%NGVD<?V?PMH6B6]K,-/T?2PK16]F=+LTA8L(=4O=Q8_V
M-?&[X$?"7]H?P/J_PX^,?@;1?&_A/5@5EL-5MA+);S@8BO\ 3;R-4N]-U* D
MM#>6<T%S%C]W*<D-_/I\5O\ @V^\ 7^NW6L? /\ :(\7?#73;EGD30?%.AP^
M+5LR[EC#9ZM8:GX<U%;5%.R,7C7TY"CSKB1LFOW#)^.\GS&OALUS/-,1PMQ=
M0PL,%C<ZI913SO*,]H4H1ITL3F. YHXS"9HH4J-.>-P;G*O[/7D?-;\4S3@G
M.LJP]?*LKRS#\5<)5L;4Q^#R2KG%;(<WR.M7E.K6PF6X]0J8+&95.M5K5(X#
M'1HQPRG*,958."7SM\+]!\,_\$W?@9KE[^VM\3?AK\6_%FCF!_@G\&? WBF]
MUKQ)97.#,=+UV\26RDD\,R76RZ:UURRGTG2QN:S:25A"/2/V'/V&_B[_ ,%%
MOBY9_MQ?MQVES:_"NSN8KGX/_!RYCFM-*U32K242:0(M-?9'IW@NQ"(RJB1S
M^()U\V;%N1GZ3_9I_P"#?7X(_"_QIIGCOX]_$O7_ -H#4=(N[>\TSP[<:-_P
MC7A#[9;.LL<NLVAU#6-4UE(I45TM[G4DLVP!/;2(=M?T+Z;866EV%EINFVEO
M8:?86T-I965K%'!;6EK;QK%!;V\,0$<4,42JD<<85$0!54 8'@Y[Q5EF75LS
MJ\-XV69Y]GCJ/-N*5E=/):=##UDHUL%D&7P]_!K%*4_K^.FJ6)K*4J=*%.-2
MM.M[F1\,9EF%/+*7$6$AEN1Y%&BLGX76:5,YJ5:]!J=''<09A.$%CI822A_9
MV7TW4P>&Y8U:L\14AAXX0TZQLM,T^RT[3;6WL=/L;6"TLK.UB2"VM;6WC6*"
MWMX8@L<4,4:*D<: *B*%4 "KM%%?ENO5MOJWNWW?F^I^H+16_+1'BWQ._9^^
M"WQDUCPUKGQ2^&WA+QQJO@VX-SX:O?$.D6NI3Z8[ND[QPO/"Q%N\T,5P;60R
M0/<11S&,R1JR^P16MLD<2+;P(L*A8E$:$1* %"H=OR@* /EP.,=!5FBFYU'&
M,)5)RA34E3@Y2<::D[RY(MM1YGK*R5V*VM_T7Z+O_P &[U(C! 0ZF&(B0AI
M8T(D8="X(PQ'8MDBE\J+>'\N/>$\L/L7>$_N!L9"?[.<>U244AD:Q1(GEI'&
ML9SF-454Y.3\H 7D\GCD]:!%$&=Q'&'D $C!%#.!P [8RP X 8G%244 1F*(
MLC&.,M&"(V**6C!&"$)&4!'!"XR..E AB5@ZQ1JX3RPX10P3.=@8#(3/.T'&
M><5)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4UT216215=&!5D=0RLI&"K*00002""""#@TZB@-MC-L-*
MTO3/.73].LK#SI&EE%I;0V_G2.2S2/Y2+O8DDEFR<YZ5/=V-GJ%L]K?6MM>6
MTH_>6]U$D\+YY.Z.574]3C*\#C@5;HI679>6FR+]K5=1575J.JFFJCG+VB<;
M<K4[\R<;:.]UI9JQ7M;2UL8([:SMH+2WB4+'!;1)##&H[)'&JJH^@%5K[2-*
MU-H'U'3;&^>VD$EN]W:P7#0NI)5HVE1RC#.<J1SS6C13&JM6,W4C4J1J-MNH
MIR4VY7YFYI\S<KN^NMW<:BA550  % &,8P!QC';TIU%%!F%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?GY\??\
M@I-^S!^SC\4M;^$7Q&U7Q\?&7A;PAI7CSQ;'X1^&WBWQEIOA;P9K+7R6?B'Q
M'J>@:=>0Z3IRKIM[//=7:B&"WMIR7R"!]K>#_&'AOQ_X3\,^-_!^K6NO>$O&
M.A:9XF\-:W8N9+/5]!UJP@U+2=3M'98Y##?6=S!<0;E#;6&X*X(KJQ& QV%P
M]#%8G!8JAAL5%3PU>K1J0I5XN$*D?93<>6;E&:<%!RYE9Z)D*<'*4%*+E&W,
ME)-QNTES):K=-WM9.^JU.MHHHKE+"BBB@ HHHH **** "BBB@ HHHH ****
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ML2S,S:3:%F8G)+,2223DDY-=34&@4444 %%%% !1110 4444 %%%% !1110
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MW39/35VO?KH?*W_#?G[)'_17;?\ \([X@_\ S)T?\-^?LD?]%=M__".^(/\
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MZ=/PH_K[PO?_ (9K\PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#\3/^"NL5E=ZI\$[C6OB#I'@_3O!_ACXR^,=(\+>+_A[XN\9^"?BEXM
MM=,\-Q:%X.U"\\,WD26.O7 @NK70K*YMVNKH:M>SZ;,+BU('QO\ #/Q?XCN/
MC'X.\8>)](\4^ /VH%_:=\"ZHO@R:+Q48/"?['7_  HFXO\ 6]/7$,VCMX"T
M6&'3EN#/,UT/%R)$R/J;.A_IKU#2-*U=(8]5TS3]3CMYDN((]0LK:]2"XC.8
MYX5N8I5CF0\I*@5U/W6%5KOP_H5_+<3WFC:7<W%U82Z7<74UC;/=RZ;."DU@
M]R8C.UG*I(:W\P1'NF>12E9)-)[:[7U5[[[V2TLN]WJ39WW>[?FKN^GZWOY6
M/YTOVCO'P\;?M%>-?&WP_P#$7B76OC5XA^(?[*^J_L:7VBQ^*AHNK_"35/#>
ME3>.+O1 MLFDMX=N9I_&3>.5O5C(E$*WJ!EM,_,)U/68]%^'B>![WX@'2;KX
M?_#)O^"CC"+QD9[;Q*?C/CQ*OBI+FW68:H8&O8M>&CAV3P@J//\ \2\QU_6!
MI'@[PGH-IHEEHWAS1-.M?#=A'I?A^.UTVTC_ +%TV)/+CL=,D$1DL[54^40P
M.B$<$&KZ:%HD8U$1Z-I2#5V9M6":=:*-39UVNVHA80+UG7Y6-SYI9>#D4<W=
M+\U;LM-K[>B6M@4;;-_C;ITOV6U]VVC\<_V;=1_:?M/@!\3F_8STSX<>)/"<
M'[2WQ#M_@:GQSN?&ECX7;X%)JMR;"7P_+:R6.ORZ:M[N7P\+S;;MIFPQJ8PE
M>T?L,?M3?M+_ !@^,'[3_P #/VG?!OPD\->./V>]9\$V"7_PAOO$=YH.KV_C
M#PS:^(4,G_"1W5S=+-:)<K _E[59E./?],+2SM+"VAL[&UMK*SMT$<%I:016
MUM!&.D<,$*I%&@[(B*H["OR3_8V_Y2._\%/O^QI^!O\ ZK;2:3UNDDN9JSLK
MK1+>W=)W5NPFFK.[=E:U]--=/N:[:WMI8_74=!SGCKZ^]'6BD.<$#&<<9Y'X
M]._4 ]/K2+/D3QG^PQ^SCX_\4ZWXR\3^$]6O-?\ $-])J.J74'BWQ+91374N
M-[I:VNI16\(.!\D4:( ,!:Y<_P#!.C]E,_\ ,DZY^'C?Q;_\MJW_ !AX0_;<
MNO$FMW?@WXT? [1?"4U]+)H>FZ[\,M>U'5+#3B1Y,&H:A!X@MH+JX0</,D,2
M,<$*._%ZAX=_;QTJ&2YU3]H?]FW3K>.&>ZDFO/A;KMO$EM:Q^;<3M)-XI0"*
M%/WDLA.V-<EB!0DV[*3OO9>J\M%I^#^:;M?1Z6_&WW[_ (>A:OO^">G[)UA:
M75]<^"];BMK*VFNKB3_A-O%I*06\;RRM@:L2P5%)P.2>,9KY3L_ 7_!-O4]&
MT76M/TCQE.NO^-T^'NEV+:QXZM[R7Q)(66..?[3JL-E96<T2O<0W=_>VT5Q&
MN+<2S$1'V75=>_:J;2[?^U/VN/V18M(\1Z/?7EE-<^#+R"#5M'CC>&_O+.=_
M&"I<6D09DEN+=VC1SC<&R*X+X9_#/XU^#]#M_ _PX_: _8OCTM]9BFATJQ^'
MD^JS7?B+50^I6[L)?&$]U<:O<!GN+?!>X:+#1*J* *4>]V_)I]K;)]'?;M8G
MF>C;LKJZL[V>^Z5WVL^C['AVMV'[!VCV7BZZ;X._$::3PQXEAT*W@3Q[J\4F
MN6&^]%]K=MYOB +9P68TZ]8V-T5O;CRD6%1YJD</H_BC]@3699UM_@)\79HK
M?2DUEWM/&VH75P]IJ=I)?>&&ALH_$R/)-KEC!-/,GF!M&\HI>EF9<?9NI?LA
M?M(ZO)JLNI^)?V2[R77=3CUK5GF^!6N,U_JT0W)J%P#XF DN5.2'PJ@%MRG<
M<MTK]D#]H_1+Q;_2?$G[)&GWJ1:A EQ;? ?6XG$.K)LU%/E\1X*72#8RG*JA
M9(PBDBC2S3OLE>_IV5[6U2O;MT87UNKO;3;HN\FE>_1.S?5:/T_PQ^P-^R5X
MJ\-^'_$]IX"\0P6OB+1-*URV@G\;^*A/#;ZK8P7T,4VW6"OFQQSJDFTE=X.T
MD8-;O_#N?]E+_H2-;_\ "W\6_P#RVJM9?#[]OG3[.UL++XX_L[6MG96\-I:6
MT/P>\21PV]M;1K#!!%&/$P"10Q(L<: 85% ' JS_ ,(5_P % _\ HO'[/7_A
MH?$O_P T]+E?23\M_*WV7Y=>WD"EWU^<?+^]Z_>'_#NC]E,<#P1KOX>./%G_
M ,MQ1_P[I_94_P"A(UW_ ,+CQ9_\MZV_"_A#]N*U\2:-=^+OC+\#=8\+P7]M
M)KVEZ/\ #'7].U._TQ7!N;:PO9_$4T=G<2Q[@DTD3*&P<$ FOLE?NCG/'7_/
M?U]Z+6VDWM^2ZV\K=_PL[MOLM^GE\^^NW76Z/AS_ (=T?LI_]"3KG_A<>+?_
M );4G_#NC]E3_H2-=_\ "X\6?_+>ON6BIU_FE]_IY>2*_K^MSX9/_!.C]E7'
M_(E:X 1_T/'BT'OQG^U>F"W?K[=/KOP-X+\/_#OPEH?@KPK:S6?A[P[9"PTJ
MVGNKF]FAMA+)-MDNKR26YF8R2NQ>61FYQG  '5T4]>[?D[6[=NP!1110 444
M4 %%%% !1110 4444 %?SV?\%B/!6I:?XN^$7_",O\<_C)XO_:+\577A#PK^
MS=X?B^''CCX<7>L_#_P;-KMUXJG^'WQ4L+W1[>"VTRS1]:U#29[*Z0F.1I-]
MPV?Z$Z_GP_X+[:WX5M/A[^RQX?\ $&A_#;2]5\6?&/Q-8>%?C?\ $7XE^*OA
MA:_!G5['P)>:A++I?B'P//%XH-QXWTX7N@R6MNLNG.D"'4BBM;,;@[/=JZMI
MZIM/R=B)=+JZ3O\ A:]ULU>ZZ]G>U]S_ ((V?MXZC\5+/4?V1?B=\%+KX+?$
MKX;:/XTUGPY8Z9X/\+^"_"NK>%_ _P 0[OX<^*]-7P[X5NY[+0/%?@OQ2D&E
M>(;)H(DO)KE;^T:2!@3^^=?AO_P1L_9Q^"/ASX70_M >%M/^#.M_%2\L/$7P
MGOOB!\&/'/C/Q]X:U#PS8>,]4\7WQNM9\:33:G<>,==\2:Q=:MXWU&0&;4]2
M^QO-(ZVT2C]R*4K<SM?SOU:WV25^FB[#C?6_DUOV6S?3\>]MEX-^TEKOQG\.
M_ ?XIZQ^SQX7TSQI\;K/P?J;_#'PUK=_'INE:CXJF46^G27][+')%';64DXU
M*1'C83FT:V8%7(/\4-M\+/VFO#?PY\7:/^U9\ _CYK/PITC]L_\ :BUWXHC4
M+C7?B5K/C'XB?$/]FY=,^&NK_P!G^'[*UN-3T72OBC'._A_7=+@DT"TU;5+$
MVZ6PM-P_O7ICQQR#;)&CKE6VNBL-R,&0X8$95E#*>JL 1@@4D[7T6][[/RO;
M339:;:=6#CYZZ+7Y7:[/2Z?=]M#^(_X._"/]J32?VE_V8+'XG^ ?C#>_M+KX
MP_83U?P1\0)=(\27.C>%_P!G_P )? W5['X[>'M8\5B1M$TA5UZ8VGB?1;^4
MWFJZW+;S,DS(DE?I[_P61\'_ /!06/\ 9F_:;U^_^-?P$G_9>;Q!X NH_A[#
M\,]8C^):^#I/C!X$&EZ4?%QU=K$ZQ;W36<EQ?"R\F1+>9 B^8 /Z-"B%@Y12
MX!4.5!8*WW@&QD ]P#@]Z_+C_@M !_P[4_:7X'_'M\,?_5U?#C_$_F:?-K&T
M8Z^[K?L]?TUOTO>R%;?5WNG?35*4%9Z62VV[75FS]'O F/\ A!_!N.G_  BG
MAW&>N/[(LZZNN4\!_P#(C^#/^Q4\._\ IHLZZNI+. ^(NH:UIOA;69-(T2'6
MF?2M4%R)]7@T>.UA^P3_ +XS3VUPLN.R80Y'W@.:R?A)JFN:GX.T4ZMH5MHT
M::99K:36^NVVL_:T\D;I0;>U@6(CH1OD(XY Z?"W_!5<_$RX_9ULM.^&]SK-
MM/J?C33+#78-%D>"]U+3YHI1!ID4L,T4[FZN,?Z/#O,ZQL6 2(FOGO\ X)^?
MLZ?M)W7PSU72_BS\1/C)\+O#7]J0W7ACPQ8:E;6D^IZ7>VR-=3-J,DEUJEFA
MEWJ;-&A5!\X )(JERRIJ/)"]W>7O.6Z=TD^5MOO%+F_'*TE-OGER*UH_NN3;
M9MT_:=4_=F]-_+]K-7U[1- MS=ZYK&EZ-:@'-SJM_::?!QUS-=RPQ_7YA^%?
M&/[1'[<WP;^#OP^\6>(O#GB[P[X[\9:+8DZ1X9T:\FU*&ZU!Y!'%]MOM-CGL
M;:WA9M\KO>1LRJ50ELX[K2?V-/@/93?;-:\/:IXZO6(=KOQ[XBUKQ0YE."TH
MCO[HP!BW( B"@<8XKV$?"#X6KX?NO"B^ ?",?AZ^M)+.\TI-!TU+>YM904DC
MF MP[*<\%F+ \@YYJ59O9NS[6=M>K3M\OG<OUMJM/5->:3OKT5NEC\C/V&/^
M"EUAXWF\4>$/CA!HW@R.P,NM:+KVE66K7%A(NHW;M/I]_';0WS6IA+AH;J0)
M'(GWV#"OUC\-_'+X/^+T1_#/Q.\#ZJ7(1(8O$FF173-C.W[%<W$%X"!US#G/
M!QTKR[]G'X#?![X<^$]3_P"$-^'WAK1O[7UK55U!H]-M[A[E(+V6.&&62X21
MS%$@P(LB,<?+Q7H?B;]GCX(>,&:;Q#\+?!][.PQYZ:-:VEP.>JRV*V[@]R0<
MYSR:;Y&TU?6S;OHFVFE;3;II=_@UJM[MZ).T6^BWM;5W>K:UT/8XI8IXTEAD
MCEBD4,DD3K)&ZD9#(ZDJRD="#@U)7R+-^QM\-+)WNO!/B#XE_#J]W;H9?"7C
MS7;6U@*G*[--N+BXM2%Q@(4V@ #&.C#\%/VA/#0\SP5^T_KFIKC_ (\_B5X3
MT7Q-!CL/M=O';WX('!82;CR2<T:=TGYW\O+7?I>W4J_EVOJK)?-W[[I;'U[2
M'&#NQC!SG&,8YSGC'KFOD+^U_P!M+PP"ESX7^#GQ-MHOF-WIFJZUX-U2>,#G
M;;7OV^R$AZA=JC<0. *8_P"TAX_T..0_$+]FCXHZ1:1(5O-3\,3:/XST\( 1
M*\:6D]C=M'MW''D,YX[G%+M_7YVV_P"&"^WG:WSZ:7NWT2_ ]:L)O#8^+&N8
MDT0'_A&--55#V&_[3]O?=M526,IZ,<!\]>AKV88P,=,#'TK^?_P#_P %#/A3
MX@_:NB\-7?P8L?#W@O6_$$/A.P\27US-::_IFIQ:C(D6K:O8SSBVMD>^++=V
MS-O@0?,^X$U^_P!$Z2QQR1NLD<B(\<B,'1T=0R.CJ2K*RD,K*2&!!!(-:5(T
MHN"I2J2O"\O:0A!IIV5N2I4YDUKTMMK>X*^MUUWU\KK5)IK9KY]1]%%%9C"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **_//\ X*%?MPV?[&/P
MP&K>'])TGQE\5]?"W?A;P5J>K0Z;:P^&M,UC1[/Q9XRUM_/BN(M%T2VU6&&V
M6$>;J&L75I:1%D%T8O(=/_;Z^(U[\6[*Z@\+^#7^ "_M%:#^RKJ-TMQJDOCR
M;Q]K7@6;Q2/&6GSI<-HTGAF/7+:Y\/+8& W;6BQZD)V#E::3>MM/^&2Z6WOU
MTMYDN5MT[Z=FEM>[3Z7735W71GZU45^4OQZ_;K^)7PJ^+?Q$CT;PAX1U#X&_
M OQS\'?AY\4[S49]47QYJ6J?%_2M-U*/5/"HAF33+>R\*G7M#AN+>\AGGU)K
MB]:%T6VC6O"Y/^"FOQRT:P^'A\0> ?ATVI?M0>%?!_BK]F^'3KG7A!H$7C#Q
MVGA(6'Q,,MR7OI=)TF:'Q%)/HILDN9V?355=H>GRNU]/2]GH]=UT#FULTT]N
MF^GGY_T]#]SJ_(_]C3_E(Y_P5 _[&;X&_P#JLM*KTWP/_P % / _@SX7>./$
MO[6.O^&_AKK_ ,*OC5XH^!/B[5O#NG>)]3\*ZWXK\.W$XMK[0[6TLM8U>VLM
M6L(UN_)O5;[+(WD/*2HS\L_\$V?C/\-OCQ^W#_P4J^)/PF\31>+/!FL>*/@Q
M'IVMPV.J:?%<R6GPYTF"X46NL65A?J890Z;I+=48@F,E<T).TGIT2U5WLV[7
MOIML%[VLGK9[/1;KRUMWNNQ^Y Z#Z"EI%Z#(QP..N/Y5QOB?X@^ _!DMM#XP
M\;^$_"DMZK/:0^)/$>C:')=HAV.UK'JE[:-.B-GS#%N"D')Z"IWVU_K39/=V
M7S'LEULO+IUU9\"?MA?&.V\=>#O'OP1TCP-\?],UHZA8:>_C#P_\+)]>\.S)
M8WUO=W9TZYAU^Q?4;2Y@C:)7*0Q,Y'F*4!KP&;4?A)<:9 EW\/OVT;S7T^%I
M^&%SK5[\.KJZM[FS6-&AU)=%F\2/86]W'<1CSI(8LW5J!;3LR5^J4/QQ^"UU
M-#;6WQA^%]S/<2K#;P6WC[PG-+-/(X2*&**/5FDEE=F"1QJC2.Y"@$X%>KQL
MKHCHP=64%74@JRD AE(X(88((X(P13NU_,K>37X[=?Q%HW:VCNWM=_"ELV^E
MNVA_.QK?PN^'^M:!X8T2YT3]K91X:@@>*8? #0Y%EU*QU-]:L&AA?662WTHW
M\A%_I, 2VO[4""92HKL_@SX/^$7PGUO1]=?P!^UGXCOO#7BS1_%>@S77P2L+
M>2SGLKRZU+4+>:2#6U,Z7U[>RQ0R.3)9Z<L5C!MC0"OWWHIN3=O)66_2W^0T
MK==+[)+_ "/G_P"$/[0&C_%_4]4TO3?A]\6O"#:19Q74MY\1?!B^&+2\6:41
M+#8S'4KTW-P"=SQA4VI\QXZ_0 Z>GMTHP.N.?6BI$HV;?>UO)(****"@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OYS/^"RGBG0]9^(GP/T;Q
M%?\ Q$^!VJ? CQ-JOC_P1\;K_P#9ND_:(^$_C*T\<^#9/#7B#PW)IMI!JD.F
M7^FRS+!=KJVEAY9K:WGL)E')_HSK\D?^"M?[??BO]A#X8_#K4_!O@GP+XBU;
MXEZUXVL1K_Q5U*ZTCX;>%['X?>!]0\<WEKJE[:PR^=XK\6QV!T+P+I,[P0:I
MK(:W>0,JJ:BWS)+K;OT:MM=[VVZV)DD]6F[:Z?CIMM=7W735G/\ _!*'XW:O
MXQ\ :G\.'@\;_$"Q\/SZMXDF^/$_[/-K^SA\.-;FUS58FT[PIX>\(""PN=4U
M&UTYC>76LIID$$B#$LDCJN/V.KX"_P""=?[75[^V?\"M:^)>H^%="\-2^&?B
ME\0_AK!?>$-0GU7P'XPL/!6N3:;IOC+P-JEQ# ]]H&L6(A(E2,PQ7\%_;0NT
M<"&OOVE)ZV>]E?Y[>>G6]_4(VLW?=ZK7LM=[:KHDK;!17G/Q6O/%=A\-O'%[
MX(U;PUH'C.V\-:PWA;6?&KO'X0TSQ UI)'I6H>(BDT+MH]K>R0SW2B:/=&A3
M."17\Q-U_P %0OV]X;?5OV?9O&/PUTC]H73?V@/CKX5D^(/B;X9#1VM_AG\&
M/@!;?&?3;K4_AM]JEL-/_P"%@W$YM/#VK+>3&X\-(NLA5N)70$5S1YEHM=_E
M;:^[=M;+N[#;M)+1[7=]D[?E?:]_P/ZO*_+;_@M!_P HU/VE_P#KV^&/_JZO
MAO7Y5_"W_@L-^U1\5OB=\&/&MM8> M#^"UWX\_9 ^#GQ$^&DV@2R>*O$?BO]
MI[X4ZCXXU#QKH?B5Y!<:5IGAG5(+>"PTM8I(;RP6:29A(,U[5_P6/_X* ?!O
M4?V8?VFOV7XO"/QV7X@0^(O 7@^77I_@YXK@^&QU/2_C#X$N)[A?'KP_V*^D
M,EI)';:H)/(N9&@16)E&7:S6SLKZ/MK^/3YZ62O+=[7T::5M7NX=;+7NM=-;
M]OZ"/ ?_ "(_@S_L5/#O_IHLZZNN5\"#'@?P:/3PIX>'_E(LZY;XS_$S2_A!
M\,O&/Q"U>6&.V\-:/<75O%,P5;O4G @TJRRS*!]KOYK>)R#E(F>0_+&U3U2[
MNW5[M*RLG=MM)+J4W97M?OJEMJVVVDDE=MMI*Q^&?_!:7XL^*+KP)JMAX)^(
M^D^ =,^#_B3PJ+Z\N=?&BZEXK^(GB)V-OX:\+W'G1)<ZMH>@N+RYM9,I +R8
M,\<@7/S3_P $RO\ @H1XR^"VF:W\-_CCX?\ '7Q=O/%6O6WB#0?&&A^-])\:
MZI8Z7>6,8AT%=,?4Y83>VT8\P:/;W]MJ<A)(LY2<G\QO^"NWPE^-W[7?P0_9
M[U3P>=8U.?QS^T)K%Y\,_!.GVLEQXB^*-_IVFW7B3XC_ !2>T2XM9_[!CDCD
MTO1;VY*V-GHUA:;F!G0-Z=_P28^"/Q!_X)_?"_X[V_[??[(GQ/U#]G7X^>.=
M#\36OQ=TK1U\1?\ "L9(M)2QM=9U32=&O+[Q'I>F@@W0\5:(5_LR1&-S$44&
MOM,)FF"RK O(<SR?"9A2G/VN,K*I6HX[#UJRH2C3IUJ,J?[W".$54A*<Z;G*
MK1GS64E\!5RC$9QG-+C'*,RQ5"M0P,\NP6 Q,IRRG'X:EB:[EC9TXU).F\9&
MI_L>+5'GAAX4ZSHUJ=107]<WP\_;A_9K^(=U%HUK\1K/PEXGD)5_"?Q)M;OP
M!XC@<9!1[+Q)%8PN_& EK<W /520>??_ !5?:O<>'6O_  A=S3W,JQO:W&DP
M:9JAN(G(*RP"]\RRFC9?XLD8^8'-?D-8^'-*M_ >G>,] M/!_P#P4%_8^U6W
MMY]/O84T?Q1\:/ASI17<39ZW&!J'C'3-,MR1+IMY-:>)+1(Q$P:0%*T-1_9Z
MTCQW\'/$WCO_ ()L?'SQKX#\97%G<1Z?X.;QSJ%SX/M-1PRW.B>(/"'B,W5Y
MX6NK4%X(H D$EO<*K1AE7)SGE7#N(E2JX7,<7EE"I4C3CB,;0CFN7TISDKQQ
M6)PT,/C,)*-W>E4RJM*T7*G6K0O->Y@\YK5YO!8K#>PS&,'.IE\ZOL,34IPT
M=;!2C*='&X9NS]MA\2N13A'$TL-7;I1^_OV=+[QG=Z?<_P!M3:U)I7V_5R@O
M]-T"TM_M8U"42A9M,43LV[)*,=@)QVKZFK^<+_@F7X3_ ."K/PZ^&_BV[UB+
MX;>*?"-_XO\ $+:?X8^*_B;5IO$=OKEIJ4UOK5[IVKZ6&>TTK5;L27$$-R9(
MLD3(B [:_4%/V@_VP_"B^7XY_8XN?$K#'^E_"GXEZ'K<97H7%EK%M:W1/&1$
M9@Q]1R:SS'AATL=B:&6YUD&;8>C-0HUJ.9X+ SJKEAHL/CZF#FY1<G&3A[2#
M:]V<MST,'C)2P]*IB<+B\-5G%2JTJD)UG3G*UTYPE6T>GQ26O1:GWY17P./V
M^?".BXA^)7P1_:+^'-WO*2#4_ACJ.M6$&!EG?4O#]Q?IL5N-XA((&>G3MM#_
M &]/V2M=:&W'QG\/Z'?RG8-.\4V^K^&+V)AQB:/7-.LHT8=#F7@YST->=4X:
MX@IQ<_[&Q]6"5_:X6A/&46E:[5;">VIM:[J7*[/71G6L7AG;]_2C>]E.:IR=
MK;1GRR_#MW/L*@@$$$9!X(/0CT->?:!\4?AKXN2,^&?B#X,U[SD5XUT?Q5HF
MH2.C8P1':7LLF3GD,H([C-=\6 0N,N A8;?F+ #(VXX8D=,=2>*\BK1JT9<E
M>C4HS7V*L)0EI_=DD]_Q1O&49J\91DN\6I)W[-=#X%'[$'[,FI?M >,?&&I?
M#+2K_5-4T--9O+>Y>>32SJNJ7$D=[J$>FAUMXKF8$R"2,!A,6E7#G-=+)^SC
M\1_AC+)J'[.?Q9U;0+)':4?#'XA27'BSP), V7@L+BYD;5]$$@VQ1&TN3% @
M&$(7 ]*TOXCZ-<?&;7M'CL-?.H?\(MI8ELSIZ"6W@;4Y($O)X_M)ECLI9 5C
MN&CV/VY-?1HZ#CL.#U_'W%0U4A:,XSC>,9QYUR\T9Q4HR2LFXM:QDU:2U0)7
M=TT[::=&K:;Z;OMO9WL?%MK^U1KW@&XCTC]I#X7Z]\,Y6D%NGCC0([CQ;\-K
MM\A3.^K64;W^CV_1B-2M2J [6ER"U?5OA3QAX6\;Z5;Z[X2\0:1XDTJXC1H]
M0T:_@O[8AU#JK/!(_EN5(/ERA9%Y#*""*W;NSL]0MY;2_M;:]M)T,<]M=P1W
M%O-&W!26&97CD0]U92#Z5\H>*/V2?!3ZK<^*_A/KOB'X(>-9'DF?5/ 5V]KH
M^HS,Y+G6?"\A;1[Y)&($V+>)RA.T@&DTGTM;LVM[=%9=-E^C86MUNKWLUMLK
MW[]6WJWHK'UQ17Q+_P ++_:7^#)$7Q4^'UM\8?!]H"'\?_"N/R/$4-L" ;O6
M_!-RVZ5XHQF4:3,/,<,RQX(%>Z?#7X__  H^+*-%X,\6V-SJT( O?#>H!](\
M3Z?+QNM[W0=1$%_%+&=RR;8W161@'(&26MYKYM[==]5ULW;N-._9O3;2][6:
MO;1WZV/9J*/UHH&%%%% !1110 4444 %%%% !1110 45CZUJVF:!IFI:YK.I
M6FE:/H]A=ZIJNHW\\=K8Z?IUC!-<WM]=W$S+%%;VUO$\DTLC+'%&A=V"UY7I
MG[0_P7U;4OAOHVG?$;PY<ZI\7O#U[XJ^&5J;F:%O&^@Z?%!+=W^@27$,4-Z(
M8KFWN#;HXO&M7-Q% \22.A9]%?\ K^M.OK85]WLE;7UZ^2?3ON>9?M3_ +$?
M[/'[8?AZ[T7XU> ]-UW4VT1_#VE>+E5X?$N@:3+JUIK-Q::1J$4B-;0W-W:K
M]HB=725<D@'!'D1_X)T?"O3?B"?&7A+Q5XVT#0[/5K;QOI/POM=4S\/;/XNZ
M9X(F\!:)\36T\JURVM:7HLS2QQ>>;?\ M+?J6TW39/Z**=RJQ!!(!P>HR,X-
M.H3DMI=M'JM-K[-Z7T;Z@U?TL^KZVV6W3^M3\X'_ ."=OA3Q-XK\(>-/B7\3
M?B#XLUB.V^'NH_%G1$U%;?PA\9?'7PPTU--\*>-/%FFF-G6^T^."T>2&!EAO
M9+&P:Y5S;@G!MO\ @EM\&8;/6K&]\<?$W5FM]*TC0?A!=:CK<<EY\!]%\/>*
M/^$QT*Q^'<WE@VXT[7@LIFO1-+=6:)839MQBOT]HP/2FG)/65UKHUIJDGZZ*
MWEWNKB<5Z:)::;6MY=/TVT/FSX)?LU>!O@QX)U#P<[7GQ#NM?\4ZQXY\9>+?
M'\5GKNN^,?&WB*YEOM9\1:J;B![87ES-(1&D$:16T6+>$!%%?"?[$>FZ?I7_
M  40_P""G5CIMA8:;9P^)/@:(;/3K.WLK2(-\,]*8^7;VT<<2Y;YFVJ,MDGG
MFOU_K\C_ -C3_E(Y_P %0/\ L9O@;_ZK+2J$])>B_!H7+:WDU;OK)7U_X;30
M_0GX]_&[PQ^SS\+M?^*_C&UU*]T'P[]D6YM-(A6?4)Y+VYCM(4B1W5,;Y 68
MGC &,FOR7\<_\%2/V*/B5-93^/\ X'^)_%TVFI)#82Z]X7TC4GLXW??)'"UQ
M+)Y(D?D[>!DDYK[ _P""I/\ R97\4?\ KOX;_76+0G]>:_D7;J?J:<(IOJG=
M]MU9]O[WX/OI#D[1M;;?6]MM+-6V;O9[VVW_ & _9X_;*_8D^&FA^(X?%_[.
MUQ?:[=?%+QKXNT.]A\):+=2V&B:MK9O_  _ D[.'MI+&#;LB0XA95"8 K]8_
MV;O^"C_P=_:5^)-I\*O!'AGQGI&MW&BZEK%O/KEC!!8"TT9(FN(B\,[.CB.5
M?*&W:0,'%?R-<9/KZ>G [?3O^M?IQ_P2,_Y/+T/_ +$#QQ_Z2V56X*S;ULM+
M]+)6?JK?UU%)MI=WK:^S=VM]MON/ZP <@'GD=Q@_E2T45D;!1110 4444 %%
M%% !1110 4444 %%%% !17G_ ,3+SXCV/A*_G^%.D^&=;\:++9C3M.\6WMYI
M^B30M=0)>FZNK#_2(Y([1II8=O#O&%/6OA6W^/?[;UW\8M:^#,?PG^ J>(-%
M^'OA_P"(D]\WC/Q3]@DTGQ!K^O\ AVVMXT"^:MU%=Z%<3SL<+Y$D2@!J:5_^
M#H3?6UNMM^FFNWGMZZGZ545R'@*Y\:7GA#0[GXB:=H>D>-);:0Z_IWANZNK[
M1+6[6YG6./3[J] NIHC;+ [&;YEE>1!E5!KKZ104444 %%%% !7X._\ !>+7
M_P!H'0O@/\+O^%2^&?#7B;P-J_BKQMX?^)4?BK3O!E[H6G>(?$O@>]\-?!W6
M?$,GC:2.QL?"7AWQKJ\WBC7KZQ;^T8W\/Z<$1X7N%;]XJ_$7_@L=X#'C2\_8
MC%F/A1\0?$\7Q_U[1O"7[,GQLU/5]*^'W[0OB'Q+\/-:MXK&]NM)258-5\ 6
M]I=>*=)N=4AETR%_/CF7SKF AQ^*+]>]^_3I9._W+5HF6VGWZ6MMUMKJN756
M>KT1ZM_P1JT7XM>&?V.+#PY\3M0EUG0-!^(_Q!TCX*Z]?0^&H-5U_P"#-AK<
MEIX.UG4QX2_XD@DU/R[Z\L9+;,LVE3V+77^E-+7ZR5^/W_!$W1M'LOV-[_5]
M#\4>#=4LO%WQO^,WB9_ ?P[GU>X\"_ V]OO&E_%J'P7\+C7O^)G%I_@:_M9[
M0Q3+'']LDGEMD6U>$#]@:'\4O5=;_9CU&MD[:VUT2>[W2Z_-]UHT</\ $/P#
MX4^+'@?Q9\-?'>DQ:YX-\;:!J/ASQ)I,LDT*:AI6JP/:W4'FV[Q31%HG+1S0
MRI+%*%=2"M?GA>?\$>_V&[_X87/POOOA_P")[^QO/&;^/;WQ?>>//$=S\2[O
M79O#Q\&S)+X[ENCKCZ7+X/QX6FTPS?99-!4:>4\OFOU'HH3:V_)?U;RV%R[W
M;>NCOJM%^.F_4_/VU_X)G?L;VGQ@^'/QST[X50:9XR^%>D>&-)\)66G:KJ%I
MX6B_X0319_#7@O5-4\+1RC2]5\0>%M"N;C2M$U>ZC>ZL[5BD;;N:\>_X+-7T
M[_\ !/7]H'P_;Z3J]Q/K%C\-BFH06X?2K3[-\8? 5TR:A>F0"!Y4MR(4$3F6
M38I(!)K]8L#T'Y>G3\LG\Z_++_@L)J=Y!^P?\:M*@T:]N;._M_ ;7&L120BS
MT\V_Q0\%2(ER&S*S3;?+C**<,WK6F'C&=>E&:YX2DE).:IVC)QBY*5MXZ/E^
MTM'LB:DXTX2E)J*26O(Y6U72*;ULVVK6['Z"_"G6)-7^'_A.9M)UC26B\.:'
M;^3K-H+.=_*TJT7STC667='(5!C;<,@YQ7Y@_P#!0?4Q\;_''A[]G:X\2Q>%
M?@W\.=+E^-G[5/C62]^PV.@>!-#MYKRR\.SWNY$BO]9MX9Y8X5<2BVN)2!YJ
MP"OJSXK?M.:9^SQ^RW!\6O%6CWFGZA;>'O#_ (?\)>&;F2-K[Q'XNU+38;7P
M_I]NL3',=Y< W;X^9+*&4M\R@5^4%CX'\7_M9?%/0/V,=0O_ +;8Q2^%_P!H
M[_@HSXTME/F:S=:U,FO_  P_9MAND<%;*[MDLK_Q%8HYBCT"SL[.1,WTN>BF
MI86I#&JG"$83DL-%R]HE5IPA:JI7]]4*DZ<M;J4X\NL5*_G8KV&8QQ&6>TG:
M=&B\8J=H-87$5&O8.S7*\91I5:;M:2HSF[PDX-=%\"?!WBKXD:1XS_;UUGP_
MX=\&^'M4^'_B+X2_L>_#3QS?:?X?M?AI^SCI^DWT47B>RL]0,:1^-/BC/"FN
MWGDA;V+2S96F0 0?U:_9*UW7/%_PAT'3_%<G@K5M.A\,Z5:1VFB:KI>OQ/:S
M6>R:WU>TMVF6 2IE9+>Z0^8N596&17E?_!0GXL?!']G/]F75]0\;R:7IC:;H
M=[HOPL\&6PL8&U?7UTHZ9I.F6%C/:7"BRL(Y(I9]B1+%;0LHDW,!7@O_  2R
M_;'_ &>_C'\,/#?A?3-?TWPY\;9M,@M_%_@>[^RV,MU?Z:GE27.@>59VL=[9
M2+B4(LLT\>[#"O<I\.YMB^%\3Q'3P%6M@Z6.>&JXJ.%KSJW:=6=?V_M.5T*2
M]RK7]C[.E.3I.7/>W9"%.G.%.'[M0A&,*49M4HJ,;1BJ4;122BDHVLURG:?$
M[_@G+=>"_%NJ?&[]@CXAS?LM_%^_F?4=?\'6]L^J? /XG70R[6OC3X<;Q8:;
M=7K##ZYX>2SOHW;S"K%:_,']JC]H[P5\)_#GC?6OVO\ 2/B+_P $W?VG;'0[
MJWM_CA\'(=3U[X&?&Z2$[()K+5=*MI;&YEU"\"L^GZ_;6NO6,<CF.XG"'/\
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M \<?^DUE5M7^YK[[?Y"3LT^SN?U@T445SIW2?=7.A;+J%%%%, HHHH ****
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M&_T>3P+\7=/?PO?FXR5*Z5JEYMT36E#8*RV5X1*I#*N&P/D/P9_P4/\ B7\
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M"+YK6]A)-@ED0GC/H7P__;F_9P\>:A%X=F\:R_#_ ,822FT;P7\4]+O? 'B
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M ,%2?^3*_BC_ -=_#?\ Z>+2OY$I"=[<GKZU_7;_ ,%2?^3*_BC_ -=_#?\
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MLF^U81PS;H_=_P#@F!\)?VA_@]^RGX1\+?M&>,O^$F\074C:OX1T:65K[4?
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M5]A5O0PM2K3<:G+-QM4C%M6U5TR*\W3IRG&UTXI75]93C%/RM>]UJ=)\1O\
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M7P__ ,%VB3_P3Z\;$]?^$R\ ^G./$]@,\=CU'IT/-+_P0E_Y,+T3_LI?CO\
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M\,?^RA>#/_4CTVN"7[H^H_\ 0J[WX6?\E4^&/_90O!G_ *D>FUH4?[:'P_\
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M*,/P1B\<7UW\-[?Q'/XFBAUZ[FL] NX;9+G4PTS(@BW%(U _8FD  &  !Z
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M_P $U<#_ (RX^%@]O[5DX]N;;/YTK2_EE]R_S']W3JNMN]MK_J?IC17YF_\
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M /+MZT6E_*_N]/\ /\&%UW7I=+MWLNM].A^F=%?F=_P^)_X)J?\ 1W/PL_\
M!K)_\C56G_X+'_\ !-.W5I9OVOOA)#"I8F2?6VAB508U_>220*J#+JH<LJ[V
MVY+<4K2_EE]R_P P^:^^_;M?NKGZ=45^9O\ P^*_X)J]_P!KCX6 ]P-4E(SW
MP?LO(]#2_P##XG_@FI_T=S\+/_!K)_\ (U.TOY9?=_7])^5U==&OOCY>?G^#
M/TQP/0?YS_B?S-%?F.__  6,_P"":T4<TLG[7?PF6*(.\KOK4B>5&J22;B3;
M@85(R6Q]S@L0!FOT2\%^,?#/Q#\'^%O'W@O6;'Q'X/\ &WAW1O%GA;Q!IDRW
M&FZYX=\0Z=;ZMHNKZ?<+\L]EJ.G7=M>6LR_+)!-&XX84M>L6O6W^8SIJ***
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M5_(NW4_4_P ZNG]I?WG^$8_YF;^&/_;WYC3CC)^G.,_XU^G/_!(O_D\K1/\
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M /R=_P#$C_LANM_^I5X5K^R_5_\ D%ZM_P!@R[_])[BOYF\1O^2NS#_!E_\
MZ8PA_I9]'3_DT?#W_85GW_JYS _S O%W_(W^,/\ L;O%'_I^U"N?KH/%W_(W
M^,/^QN\4?^G[4*Y^O]$LJ_Y%>6_]@&#_ /4>F<.(_P!XK_\ 7ZK_ .ER._\
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MP#U /.>G?U^M3=]_+R^[;HAWO9WTT?GTMUTM9?<>9+\$_@TJJO\ PJ7X9':
M,GP'X5R<#&3_ ,2JC_A2?P9_Z)'\,?\ P@O"O_RIKTZH7#,&",5;G:Y!8 C?
MM)4%0P1R"4W(SJN"Q'4N^[_K_AE]PUIMH?+7QY_9E^'?Q"^"7QG\ >$?A?\
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M7GPEU/X,_$[XZ?L+V7A75]1TC4KJX\+^!?C'9:JMUHNH0ZE:+%-=->P)$\D
MCF#0,Q#8&":_E+'9M@\3QIBL[IRF\!5XBJ9G";@U5>%GF#Q,6Z3LU/V33<+Z
M/2_4Y.*,NQ.;<+<093A%!XS,LAS++L,JL_9TWB,7EU7"TN>=GR0]K4BI2:?+
M&[MT/XR5Z#Z#^5+7[RW'_!N)^VK;0SW)_:/_ &:BD$,LVU-!^)AR8D9F0?\
M$B/RA5.&<XSU(P:^</V2O^"*G[6_[6?PFN/BQX9^./[/_AC3H?B#\3?AZVF:
MQH_Q N;HWOPU\<ZWX)OKX2V6C3P&VU&?1GO;8*Y9(9XT<"1& _9EXF\+-7]K
MC?\ PCGUZ?%HS^!/^)9?%'7_ &?(O_#S3M;36_L-KMI6O>USZ@_X-W_^3O\
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MM;2W@M;:WB2&WM[>*."""&)52.&&*)5CBBC155(T541555   J>BB@ HHHH
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MIVGP1V\( ^Y/%7BK1/!'AG7?%GB:_33/#_AK3;K5]:U28DQ6.G6<337-U.4
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M:38SW>M:SK=[!INDV%C'&S3SWU[=-';PP)$&:1WD# 8"C)KC_@M\.OA/\,_
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MO*/5-I]+)Z:<U]+.UM'>^JLG)?TP!5P,J.F.1DX/4$G).<<YZ]Z<  , 8 X
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MI:QX#U:X6T^)'PK\0,+UO"]X=2TYI/LHNTM? 7_@E[\:/B/\)[>7X]?%'0]
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M8_"_X*ZU\;M>?P/JWQ,\3V.B>*_#_AR_A\%:#J=OI>J)X)LM;GA'CKQ7;3W
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MUMK2VMK6VMK>UM[:"&WM[:VACAM[:"&-8H;>"*-5CBAAB58HHXU6-(U5455
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MS2O)]3(@5%4\[0HR0/X>5XYQM/W<DD8SDGD_G'_P]Y_X)C]?^&Y?V;.N<_\
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M%_#UG8^#K_P;J%YH>OV\2S^'S>2VPGB?4?.I>*?@I^U3>W>G^)?@]\*/VRM
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M+^T-\.?B1X,L/&?@_P#;4\7_ +)&N>$/@]XO_:/\/>$_&7QP\:>.?$OQ)O\
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M035[?/\ 'RV=_/1;V;L?E%^R1\ /B]JGQ-^'7[2WC7XH^#/&OA/1O@]<>!O
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.10 ;V]?T'^%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img117602972_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_12.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #Z <,# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"W[;W[)L/[=/QITN7X\> H]4\1_![]EOX0Z'IC7]P-1U3XG^%/C!^U];^(_
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M;J&EPVNK:;;1_P!@R30ZW;>F?#GQ1JWBC2]7?7-"US0M3T7Q+J^AW*:SIO\
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MPOK6B6Z._B+4K#3A*L&E"&XNO$^AK+H=I"_BS2OAOK'A/B?V?/CWX?\ AQX
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M->+H4:\:].-.:K.NK0C4A6M%T*]%J]2G3DVVW[B2:BYJ7GYCECS">"J+'XW
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MM/T_PS"1%;?M(_#BQU.Y^$5Q$#M2Z^)WANYN-5\4? NZDR&N=0UJ]\5_#&V
M$ES\3=.N;F'1X_K'3M2T[6-/LM6TB_LM4TO4K6"^T[4M.NH+[3[^RNHEFMKR
MRO+:26WNK6YA=)8+B"22&:)UDC=D8$]T9QE=*Z:WBU:2]4^G:2O%[Q;6I_ V
M;\/9EDT:%?$0I8G+L8YK+\XR^M'&91F"IJ,IQPV-I7IK$4X3IRQ.7XA8?,\
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MLK6UMK*VM[*S@AM;2T@AM;6VMXUB@M[:WC6*""") J10PQ(L<<:*%1%55
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MS_?^"2%OXVN_^"A/[/UO\.=8\*Z#XRD_X6M_8VK>-?#FK^+?#%KL^"/Q)DU
M:GX?T+Q5X*U6_P#M&E+?6MFUKXFT[['J$]I?SK?VUK-IMY_:Y_9?[;,/_,\?
MLLZEC_JEGQ:T3=_YF+7]F?\ @>/>OJ:BLL'@5A*4J?M9S;J.?-'FIK6,59Q4
MY)_#ONT[=$?IWTA/I,XCQUXSRSBR' F1\-TLNX7P7#CR[,Y9;QA7K2PF;9UF
M;QD,XQ'#^38O#T:BS>-".7PIRI49X>IB857/%U(0^6=_[;,'_+O^RSJ6/^GS
MXM:'N_\ )'Q!L_\ (GZ<_P F?_!>"?XHS_M=_#EOBWIG@'2O$:_LX>$4LH/A
MUKOB+7]$FT0?$[XP-;7-U=>)O#OAJ_MM5>_;4HY[*&SNK2.TBL9H[^6:XN(+
M;^W*O&?B+^SC^SS\7];M?$OQ:^ WP8^*/B.QTJ#0[+Q!\1?A=X'\;:W9Z);7
M=]?VVCVNJ^)=#U._M]*M[_4]2O8-/BG2TBN]0OKF.%9KN=Y'C,)+$T'2C5DF
MY1=YOF6COVO?MKW[F7T>OI 95X.>(^&XWS?@K+LPP]#*,URYTN'J*RS,G/,*
M5.G"4:E?%3P2HIP;JQEAG.2:]G*+U/Y@?^#?GQSX\\$_\-;3^#?@MXN^,5K>
M_P#"A?[;@\%^*/AMH&LZ']E_X7.=/,5G\3/&/@72=7&IBXOL"#7[=K-M/Q.I
M%W"R_P!'O_#5FDZ7QXY^!G[47@(KQ*9_@5XK^)<$![F:]^ G_"W;!8E/W[A;
MI[6-09'F6(%QZK\-?@;\%/@Q_;7_  I[X/\ PM^%'_"2?V=_PD7_  K7X?\
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M\-OBK?3-Y>G:!XAM'FN(?A=\6;T (OA/4;R3PSXQNLS_  \UN\O)KOP?X?\
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MS)X;OO%'C70+[P>-(\WX?>'O#6M7&A7-O=6/ANP@ALAR]_\ LJ_%[PWX:O\
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M_>:'XN@\-]4O;Z>QR_-\=K[[RO)LVS>-!?9EBY99@L7'!TYOW:=3%.C"K/\
M=TY2G[ICE628S.(XN6%Q&34%@Z=*I56;\1</Y!*I&K4]G%8..>YGETLPJ1EK
M5I8!8FK0I_O:T*=+WSVO_@H""?@1X$QS_P 9L_\ !-(_>*\#_@HY^RH3RH).
M "=O1_N,0K$U[3XB^+>O:7\8-.^%6B?#V\\31W/A&V\4ZEXBM-7DM$T5=2@^
M(/\ 945]:RZ'-ID-A=ZIX$BT234;OQ#9W$>H^)=)%KI5]!#?S6_F/[<.DV&M
M?!?P99ZEXFT7PE;P_M>_\$^=6CU77X/$EQ8W5_H'[?'[-6NZ5X9@C\*:!XEU
M1=:\::IIUGX.\-S76G6WANV\1:]I5QXRU_PIX0BUWQ3HWUN+2U6Z>^6VMQ>R
M01VLEX(8Q=26L,DDL5L]P%\YH(I9II8X6<QI)+(ZJ&D8EV;E'5J*]IS)6N^:
MC5A3LVFDZ=:5.KLU)4W!KEDSRFU[*:27M).E[.;NXT^7$X:I6O%-<_M<-"OA
MU=KDE655>]3BG\N>+/BY\;]"\2>#+/3_ (/7.HZ1K&GZW-XCBM;#7-5GTC5+
M>R\0OIVE#Q%I7FZ/:I!?:=X>AFU2ZL9[/78_$Q_LH6@T34)SXMX>_:$_:]UB
M^L[*[^!.GZ/%+K<MJ^H:GX(^)EJE[H%AJW@?S-4L+9;F>*PUCQ#I>L>.K#1-
M#\4:EH.GZ9?^"8==U_Q);:1XATRQD_12BG2_=RBY?O%&<9<LK\MHU\36Y%NW
M%PKTL._:NJW1P\.9RJN-6FJK]I\"]E[G(^37FE]6=#VDN:[4W4?UIJDZ4%72
MC"$*%Z+****!!117PI^VOI_[:H^%'Q*U#]F3Q9\/99GT1(].\)6WP]\1V_Q>
MMM,%DB^([OP=\0V^)MUX9OO%+E+J;0M.;X8:==I:7!M=+U23Q'::==WWF9QF
M,LIR[%9A'+\?F?U6C5K2PF6TZ-7&5(TJ4ZC]E1K5J#JR;@H1ITG4K2G./)2D
MN9Q^EX0X=I<6<0Y7P_5X@R+AG^U,9A<%3S;B2OC,)E%"KBL50PT7BL7A,%C5
MA*<%6E7J8C%QP^#IT:-5U<33DZ<:GW717Y-_\$U-/_;ONO@9X)NOC1XN\(:+
MX*MM1M7\+Z-\2OA[XN\4_&G7?A]O1V@O/$\7Q.\'VGA2%X5>'PA=>)?"7C36
M$LIDNK^TDTB#1[&X^[/VB+[XAZ1X'TS5?AKJWBO3]=C^('POTF]MO"'A/3?&
M.H7GAKQ-\2_"'AOQA=7&FW_A?Q7+;V6A>$-4U_7+C5+:RMXM(2Q.K:E=+IEA
M=1R<O#N=SX@RC+\U>59CE7]H4L+4IX3,84*>(3Q3A%/DA7E.-*,Y^[.O##SJ
M4DJT:/).-_4\1."Z7 '%^=\)0XHX>XKGDF88W 5LTX<JXW$8"4L)5E!)UL1@
MZ-"5>4$G6I8+$8^CA:_M<+5Q3JT:EO>**^";/]HCX]:7=ZEX>E^!WC+7#I'B
MM?#%CXGUSPY\1#/XFBG^)/Q5\/S^(YO^$6^#.D^'-*\-:5X$^'NG>-CJ5I]N
M%W!XP\(:%IZZSJGB+0+WQ!R]M^V=\:;C4UL$_9HUB22/PS8^+-3T>W@^,'_"
M<:)I6KVOQ'BMUU#P7J'P2TRYEN]'\3>!;;PU>"PU*YTSQ+_:\6K>$-7U)/+T
M]O<34FU%J5G.VCCS*$(U'*/M%"\?9SC4<MHPO.?)&,FOB)QE3A6J37+'#JFZ
MSNI.*JUWAJ:BH.3JRG77LX0I*I.<W&,(RE))_H]17YDM^UA^TE?:3J&H7'[.
MGQ,\.S:OX9U)M"CL_AW\1KP>#M3O_!/P*U;3I_$]A<?#35M2\0:CIOBWQYX\
MT&S.B+:6N?"&KIKOA:>TTC6M;\/>I^#?V@/C'KWPV&K^(_AIJ_@S6K3X@?"#
MX>WMYXB\/>--%UM;3Q7XWTGPEXR\8WFA>)_ ?AC0/LL6E74?B;1;WPMJ_BK1
M+(Z]#8>(8-+E\.ZA;7]44Z]-5(?#*>6TXJ;4).IFF)J86C&496=*-"M&DL95
MKJE1PT<30E.I95_8S5_<^PYM?K%/&U(.'OJ,,%"E4GS.-USUX5)RPM*#G6K+
M#UOW<;T/;?<=%?G'\/OBK^TQJ_B>P\,?$*S\>^'/"US-X]BOOBKX<^%MYJMM
M<ZU%HW@.X^&=AH?AW4_AE8:_X6T36+;6?'&H^*=/\:>$M7D\->,?"UIX(M?B
MAXFMKZRU'6OI;XA^/O&B67PRO_A9::OXD:^^)7B7PEXLM_\ A$]46WF@\/>
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MX@_X)E?\HW/^"?/_ &9!^RA_ZH;P#0/H_5?E(^WZ***!!1110 4444 %%%%
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M\6+;Q=/X)73].>XTVT^[/VE/#7Q"\9?L_P#QD\*?"?Q[-\+OB7XA^'/BO2?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ#)]3^9HR?4_F:
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9!/14&3ZG\S1D^I_,T 3T5!D^I_,T4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img117602972_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117602972_13.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %1 SH# 2(  A$! Q$!_\0
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MT_TQ?^'NW_!.C_HZ3X?_ /?6J_\ ROH_X>[?\$Z/^CI/A_\ ]]:K_P#*^O\
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M\ ;7_P"-4?\ $HW!'_13<4?^ 95Y?]0OK_6Q_K%BO^?%#[Y^7GZ_UM_IT?\
M#W;_ ()T?]'2?#__ +ZU7_Y7T?\ #W;_ ()T?]'2?#__ +ZU7_Y7U_F+_P!C
M:/\ ] K3?_ &U_\ C5']C:/_ - K3?\ P!M?_C5'_$HW!'_13<4?^ 95Y?\
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MQ8K_ )\4/OGY>?K_ %M_IT?\/=O^"='_ $=)\/\ _OK5?_E?1_P]V_X)T?\
M1TGP_P#^^M5_^5]?YB_]C:/_ - K3?\ P!M?_C5']C:/_P! K3?_  !M?_C5
M'_$HW!'_ $4W%'_@&5>7_4+Z_P!;'^L6*_Y\4/OGY>?K_6W^G1_P]V_X)T?]
M'2?#_P#[ZU7_ .5]'_#W;_@G1_T=)\/_ /OK5?\ Y7U_F+_V-H__ $"M-_\
M &U_^-4?V-H__0*TW_P!M?\ XU1_Q*-P1_T4W%'_ (!E7E_U"^O];'^L6*_Y
M\4/OGY>?K_6W^G1_P]V_X)T?]'2?#_\ [ZU7_P"5]'_#W;_@G1_T=)\/_P#O
MK5?_ )7U_F+_ -C:/_T"M-_\ ;7_ .-4?V-H_P#T"M-_\ ;7_P"-4?\ $HW!
M'_13<4?^ 95Y?]0OK_6Q_K%BO^?%#[Y^7GZ_UM_IT?\ #W;_ ()T?]'2?#__
M +ZU7_Y7T?\ #W;_ ()T?]'2?#__ +ZU7_Y7U_F+_P!C:/\ ] K3?_ &U_\
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ML93BJG(Y*U//<=&,9RPM)1ERVE^\M[R3CL].97:O:ZV\O](7_A[M_P $Z/\
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MA'",58@5#>^!;W3;)M3U/P->:;IJ7+V<E_?>''MK9+R/87MG>2U4K*HD0X(
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MT_TW/^'NW_!.C_HZ3X?_ /?6J_\ ROH_X>[?\$Z/^CI/A_\ ]]:K_P#*^O\
M,7_L;1_^@5IO_@#:_P#QJC^QM'_Z!6F_^ -K_P#&JK_B4;@C_HIN*/\ P#*O
M+_J%]?ZV/]8L5_SXH??/R\_7^MO].C_A[M_P3H_Z.D^'_P#WUJO_ ,KZ/^'N
MW_!.C_HZ3X?_ /?6J_\ ROK_ #%_[&T?_H%:;_X VO\ \:H_L;1_^@5IO_@#
M:_\ QJC_ (E&X(_Z*;BC_P  RKR_ZA?7^MC_ %BQ7_/BA]\_+S]?ZV_TZ/\
MA[M_P3H_Z.D^'_\ WUJO_P KZ/\ A[M_P3H_Z.D^'_\ WUJO_P KZ_S%_P"Q
MM'_Z!6F_^ -K_P#&J/[&T?\ Z!6F_P#@#:__ !JC_B4;@C_HIN*/_ ,J\O\
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MC_HZ3X?_ /?6J_\ ROK_ #%_[&T?_H%:;_X VO\ \:H_L;1_^@5IO_@#:_\
MQJC_ (E&X(_Z*;BC_P  RKR_ZA?7^MC_ %BQ7_/BA]\_+S]?ZV_TZ/\ A[M_
MP3H_Z.D^'_\ WUJO_P KZ/\ A[M_P3H_Z.D^'_\ WUJO_P KZ_S%_P"QM'_Z
M!6F_^ -K_P#&J/[&T?\ Z!6F_P#@#:__ !JC_B4;@C_HIN*/_ ,J\O\ J%]?
MZV/]8L5_SXH??/R\_7^MO].C_A[M_P $Z/\ HZ3X?_\ ?6J__*^C_A[M_P $
MZ/\ HZ3X?_\ ?6J__*^O\Q?^QM'_ .@5IO\ X VO_P :H_L;1_\ H%:;_P"
M-K_\:H_XE&X(_P"BFXH_\ RKR_ZA?7^MC_6+%?\ /BA]\_+S]?ZV_P!.C_A[
MM_P3H_Z.D^'_ /WUJO\ \KZ/^'NW_!.C_HZ3X?\ _?6J_P#ROK_,7_L;1_\
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M]J3X?X )/SZIT'_</K_,7_L;1_\ H%:;_P" -K_\:IK:-I 5_P#B5:;]UO\
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MM"_\'^F__)5'_#A3_@I%_P!$VT+_ ,'^G?\ R51_Q$[PZ_Z+?AC_ ,/&#_\
ME@?4<;_T"XC_ ,%3_P O/\^S/QPHK]A+3_@A%_P4:OC<BW^&^B$V=R]G<!M<
ML$V7$:H[I\]UDX61#D<<U;_X<*?\%(O^B;:%_P"#_3?_ )*H_P"(G>'7_1;\
M,?\ AXP?_P L#ZCC?^@7$?\ @J?EY>?Y]F?CA17['_\ #A3_ (*1?]$VT+_P
M?Z;_ /)5'_#A3_@I%_T3;0O_  ?Z;_\ )5'_ !$[PZ_Z+?AC_P /&#_^6!]1
MQO\ T"XC_P %3_R\_P ^S/QPHK]C_P#API_P4B_Z)MH7_@_TW_Y*H_X<*?\
M!2+_ *)MH7_@_P!-_P#DJC_B)WAU_P!%OPQ_X>,'_P#+ ^HXW_H%Q'_@J?\
MEY_GV9^.%%?L?_PX4_X*1?\ 1-M"_P#!_IO_ ,E4?\.%/^"D7_1-M"_\'^F_
M_)5'_$3O#K_HM^&/_#Q@_P#Y8'U'&_\ 0+B/_!4_\O/\^S/QPHK]C_\ API_
MP4B_Z)MH7_@_TW_Y*H_X<*?\%(O^B;:%_P"#_3?_ )*H_P"(G>'7_1;\,?\
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MJ4E26!KQBE346X3;BH1A'I"-W*VM]$KV2=V?C917['_\.%/^"D7_ $3;0O\
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M3BLKG4FF?4)K>+1K2-'OFN"9VNR%_?F4ES+N+,3R?8J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#@_ \CO+XO#N[[?%E^!O=GQ_HMETW$X& !@>@KP
M7X@?MP?LX_"_QPOPX\:^-;K2/&4UR;2QT;_A&_$=U-J5RL'VJ6+3I+72YH;U
MH+8/<3?9I)!%%'([D*C$>[^!?]=XQ_[&V^_]);.OB']IGP'%K7[:/[!^N1>#
M;35;'2_%_P 5I]>UC^QK6YBL$F^$/C6VLY-1NFB+(DEW)!# 9-P,[QJ.3B@#
M[A\ ?$SP/\4-)?6_ WB"SU_3XI!#/);&1)+:?!W07-O,D<\$R%61XY8U975E
M(R"*[D21MO*NC"-BKD,IV,O+*^#\K*.2#@CO7\Q0^'/[27P4TSQY\9OV?]3^
M(J_%#Q;^U-XY\-VWPZGAG'@F[\)7C^-[N.9-)^UR644:FRLGL[P6(82^4H*"
M3</GWP3\1/VYO%?A7Q3X5M]?^,_ARUU?0-%M/BKJS2:GJ6NZ3\0+K[6L_P!B
MO;R^CN/#]W--]H^U:=H\SV68X@9V5$( /Z]A-"61!+$6D4O&HD4M(@ZN@!RR
MCNR@@>M/#*2RA@2N-P!!*Y&1N'49'(SU'-?RU?M1_%[X^_#G]HJU\&_!BU^/
M%OJ?@'XK_!W0;SQ#J^JZWJFA:E\/=6OO"J>-=1T_2)]1N-+E\,OI]YK/VO5)
M#%>P3)?$6A$$;2>=^$?C)^UKXG^%-]XW_9&\?_&/XM?&^^M_C /B'I'BBVGN
M?!5CH>D_&SQ)HBRZ.]WJ=W!::EIOA*VB@TEK*T60Q00R[X7)50#^MA71QN1U
M=<E=RL&&Y259<@D95@5(Z@@@\@UR'BGX@>#/!=KJ%UXD\1Z7IITS2KK6[NSD
MNX7U,:591F6ZO8M+C=[^XAA12S/#;N.,#)K^8/\ 9]_: _:H\)^,OASXU\27
MWQ9_X9O\)?$/P5>?%J;4EU/7O[,OI?"'B,>(83J&HW)U*>RN=>:)M7LA$;6S
MOUMH8!/&!*OG?B6?XN^-+[XB?M"ZZGQ>3QGK'P&^..C_  976K2]^RWMS9Z%
M;OI-I+HBWMQ:/(TEU +43KF0LR@#!H _KGM+VUOK>VN;:59(KNU@O8.JN]K<
MHLD,IC;$BJZL/O*"#E3A@17GOB3XR?#'PAX^\%?"WQ)XST;2/B#\15O)/!?A
M2ZN"NK>((M/BN);R6Q@"MNB@6VG#R.R+O3RP2Y53^*G[+'C'X@WWQUTBU^-_
MB/\ :"'Q]N/&.C6%EX&TNSF@^'.G?#'_ (5YX9FAO]2M?[;M]*3PZ-8DU=H[
M\6<EZ-32Y@:S5(4F;S;]J;X7_M._M%?'?XP?M4_#/P_I-KHG[-VK>&_"'P9U
M/5;5X/'%UH/A_4=&U'XH+X43['*\;:GK>G:[917$5] \MC=O&2$E9" ?T>F2
M-259T4JAD8%E!"#JY!.0@[L>!W-(9HE19&EC5'**CEU".TA"QJK$X8R$@( 2
M6) 7)(K^7CQSX]_:O\9_!?XS?M)>";[XQ23>.OVD/!,.I^"YKG5-,;X?_ J_
MM_&$_B#2=+@@OG>PMM/9=#@U'4[&(7<4D< CCE\QBOD7C7]H/]J&#]GR'1-:
MTGX]WNJW=K\:]2^"_BFPU#6]-TVW.C>$]'NO!-C<7MEJ/V_Q5J46L/.?#YUZ
MVA%_>R20SRVR R$ _KHHKYD_8R\0^.?%?[+7P0\0?$N34Y?'NI>!M.E\4OK-
MN+753JB2W$,G]H6X>01W0BCB$HWMEOF)R37TW0 4444 %%%% !1110 4444
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MK\\5R]KX=\22^';;6[.S@L;B";1M1F6 )=?:E<3W=O$D;JY<>UP_MS_LCS^
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M5Y[%]Q%U"GEN6DC&T!6)/%?/J?L0>%X(=6M;?QQXHBL_%NBVGAOQS!LTAO\
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M;MH.,C.*SY9::/6[6CU2W:[VL[]NH'GW]F?$C_H8-$_\!9/_ )"H_LSXD?\
M0P:)_P" LG_R%767/B+0;.=[:ZUC3;>XC8+)#-=P)(C'&%=&<%#R.& /-:T<
MB2HLD3I)&X#(\;!T92,AE9258$<@@D$<BJE2J0C&4Z<X1FKPE*$HQFK)WBVD
MI*S3NKZ-/J!Y[_9GQ(_Z&#1/_ 63_P"0J/[,^)'_ $,&B?\ @+)_\A5Z+14
M>=?V9\2/^A@T3_P%D_\ D*C^S/B1_P!#!HG_ ("R?_(5>BT4 >=?V9\2/^A@
MT3_P%D_^0J/[,^)'_0P:)_X"R?\ R%7HM% 'G7]F?$C_ *&#1/\ P%D_^0J/
M[,^)'_0P:)_X"R?_ "%7HM% 'G7]F?$C_H8-$_\  63_ .0J/[,^)'_0P:)_
MX"R?_(5>BT4 >=?V9\2/^A@T3_P%D_\ D*C^S/B1_P!#!HG_ ("R?_(5>BT4
M >=?V9\2/^A@T3_P%D_^0J/[,^)'_0P:)_X"R?\ R%7HM% 'G7]F?$C_ *&#
M1/\ P%D_^0J/[,^)'_0P:)_X"R?_ "%7HM% 'G7]F?$C_H8-$_\  63_ .0J
M/[,^)'_0P:)_X"R?_(5>BT4 >=?V9\2/^A@T3_P%D_\ D*@:9\2/^A@T3_P%
MD/\ [9UZ+10!Y#H_A7XC:2VJLOB;19O[4U2?4WW6;+Y;SQPQE 5LAD 0@UL_
MV9\2/^A@T3_P%D_^0J]%) &20 .I/ 'XTQ9(W.%=&/HK*3^0)H \]_LSXD?]
M#!HG_@+)_P#(5']F?$C_ *&#1/\ P%D_^0J]%HR#T.: /.O[,^)'_0P:)_X"
MR?\ R%1_9GQ(_P"A@T3_ ,!9/_D*O1:,C.,C/IW_ "H \Z_LSXD?]#!HG_@+
M)_\ (5']F?$C_H8-$_\  63_ .0J]%HH \Z_LSXD?]#!HG_@+)_\A4?V9\2/
M^A@T3_P%D_\ D*O1:* /.O[,^)'_ $,&B?\ @+)_\A4?V9\2/^A@T3_P%D_^
M0J]%HH \Z_LSXD?]#!HG_@+)_P#(5']F?$C_ *&#1/\ P%D_^0J]%HH \Z_L
MSXD?]#!HG_@+)_\ (5']F?$C_H8-$_\  63_ .0J]%HH \Z_LSXD?]#!HG_@
M+)_\A4?V9\2/^A@T3_P%D_\ D*O1:* /.O[,^)'_ $,&B?\ @+)_\A4?V9\2
M/^A@T3_P%D_^0J]%HH \Z_LSXD?]#!HG_@+)_P#(5']F?$C_ *&#1/\ P%D_
M^0J]%HH \Z_LSXD?]#!HG_@+)_\ (5']F?$C_H8-$_\  63_ .0J]%HH \Z_
MLSXD?]#!HG_@+)_\A4?V9\2/^A@T3_P%D_\ D*O1:* /.O[,^)'_ $,&B?\
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M_H8-$_\  63_ .0J]%HH \Z_LSXD?]#!HG_@+)_\A4?V9\2/^A@T3_P%D_\
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MT6HJ[]DHJ3M?F3M?79\ORV6JT/DKXW?%'XT:_P"+_P!F+3?&'P8U#X5:+/\
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M  K_ ,&?]"]IW_?K_P"RH O?\)AX2_Z&CP]_X.=._P#DFC_A,/"7_0T>'O\
MP<Z=_P#)-4?^%?\ @S_H7M._[]?_ &5'_"O_  9_T+VG?]^O_LJ +W_"8>$O
M^AH\/?\ @YT[_P"2:/\ A,/"7_0T>'O_  <Z=_\ )-4?^%?^#/\ H7M._P"_
M7_V5'_"O_!G_ $+VG?\ ?K_[*@"]_P )AX2_Z&CP]_X.=._^2:/^$P\)?]#1
MX>_\'.G?_)-4?^%?^#/^A>T[_OU_]E1_PK_P9_T+VG?]^O\ [*@"]_PF'A+_
M *&CP]_X.=._^2:/^$P\)?\ 0T>'O_!SIW_R35'_ (5_X,_Z%[3O^_7_ -E1
M_P *_P#!G_0O:=_WZ_\ LJ +W_"8>$O^AH\/?^#G3O\ Y)H_X3#PE_T-'A[_
M ,'.G?\ R35'_A7_ (,_Z%[3O^_7_P!E1_PK_P &?]"]IW_?K_[*@"]_PF'A
M+_H:/#W_ (.=._\ DFC_ (3#PE_T-'A[_P '.G?_ "35'_A7_@S_ *%[3O\
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M$O\ H:/#W_@YT[_Y)H_X3#PE_P!#1X>_\'.G?_)-4?\ A7_@S_H7M._[]?\
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M_0T>'O\ P<Z=_P#)-4?^%?\ @S_H7M._[]?_ &5'_"O_  9_T+VG?]^O_LJ
M+W_"8>$O^AH\/?\ @YT[_P"2:/\ A,?"7_0T>'O_  <Z=_\ )-4?^%?^#/\
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MU3X%:3X#T2X\7>&8-*NXH[OQ<+RX6\OO#VG213>?J5G:+97.J/'N9EC=2(P
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MT_PSX>TB!@LD\UW<007-[,W+1V=@MQ%+<R*K%4;.*^;?@UX>ET3]K?X[_9-
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M<MN&6KO_ *&J\G_T +S/ZZ_[9T?_ *"NF_\ @=:__':/[9T?_H*Z;_X'6O\
M\=K^/V;6=<(_Y#NL="?^/^?G'_ OS_\ UUC2ZUKO/_$]UCIG_C_G[9_VO_K^
M]=</H<N?_-?Q6E_^2<EZ/_F<'?2\:?:_\TZU_P!U-/71/_F"\W_6_P#8U_;6
MC?\ 06TS_P #[7_X[1_;6C?]!;3/_ ^U_P#CM?QD76MZ]N8?V_K.!_U$)_7K
M][K_ )-8USKFO_,!K^M<#/\ R$9QUQWW>WM^===/Z%_M+?\ &PXJ_P#U34GV
M_P"ITNCN>E1\655M_P (;BWO_P *"=MK_P#,(NY_:?\ VWHHZZOI8_[?[3_X
M[2?V[HG_ $&-*_\ !A:?_'J_B2N-=\0?]#!K?)(_Y",_8Y_O?6N>O-?\0]!X
MBUP$\G&HW XX_P!KW/'^3WT_H1<]O^-CQ5[:_P"K$NO_ '6_7\#TZ/B/[9I?
MV.XWM_S&IVVO_P P_9L_N._M[0QUUG2A_P!Q&S_^/4G]OZ%_T&M)_P#!C9__
M !ZOX4+O7_$>&QXCUWOP-3N,YYQG# ?U Z8KF+GQ!XCR<>)-=&,_\Q.XZ^H^
M;TZ]/ZUWTOH*^U6GB9%/_LE9/U_YGJZ?=IZ'KT.,_;VMES5]/]Y3Z)_\^5W[
MG]\EM>6EZADL[JVNXP=IDMIXIT#==I>)G4''8G-6*_C8_8I_;R\=_LI>.8HM
M;U#5/%/PK\07D*>*-"O+J:YFTY6<*^KZ67+E)H$=WD0)^\"(I8+FOZ[/AM\2
M?!OQ:\&Z+X\\!ZU9Z[X<UVTCNK.]M)HY0I909+>X$;-Y5S ^8YHF.Y6!Z@@G
M^:O&GP*XF\&LSP\,=4><\.9CIE7$F'PL\/AL16C!2K8+%T'4KO XZD[R5"=:
MI&M2M5HU)I5(T_J<OS"ECZ7/%>SJ+XZ3=W'^\G9<T7?>RL]&EI?NZ***_#CT
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SKFRT
MF]S+>6FG79@)4RW,%M<>25^\I>5'\LJ>H)&.X%:-?@IXI^)GQ#^#6J_MC^-]
M<\3:[J_P<^(7Q1\?^ )YFO;V63X4^*K'4)K;P]J.GR(YFT_1KL75ZU\+=A'"
M+6WV1#BJC*4'S0E*,ELXMQ:^::8'[O2V.G7L4:3V=E=P( 8DEMX)XE'8QJZ.
MBC XV@"F0Z3I5MO^SZ9I\'F8$GDV5M%Y@4AE#[(UW8(!&[." 1R*_$GPY^W?
M\6?"MIHAT7P==>(O"'@:W\.^'M3\.RSV!\2>+(M4O?)N/$UO-J-RFIR?8[:Y
M2Y6*&4";R-OE2%BK>M67[8'QBTK6?#.J^*/%'PMC\)_$GPOXEUO1[-)ICJ'@
MBZT[4]4L;"SUM+>S,^\QV4(F,YF47LIA+; <4JM51Y54J*-[\JG)1O>][7M>
M^M[;Z[@?K7\JKV55'L%50/P   ^@ J%)+:\A)C>"Z@D#(Q1HYX7'1D)4LC#L
MRG/H17X5S_M:_M#^/]=T7PMIOCWPUH)\(_%KP#I^M^(/(T];#Q=H/C+P1XG\
M12Z8YM[5X+>UB%E%!%(%AN21&TA\S)'K?@#]L+Q_X;T6W\(2^'M'BUOXB:M9
M6WP9AAEU*^AN5O)'CU5;Z>Z62>>31-]A)>C,HC6Z3;NW5G=WO?7>_6_<#]=H
M+&RMHWAMK.UMXI,F2*"WBBCD+##%TC15;(X.X'(X-,@MM.L6\NVM[*S>=B=D
M$4%NTS 9)VQJAD8 9)P3@9[5^5O[/W[:?Q@^)7Q4\+6&N^$(W\'>.K[5M*CT
MJS?2XM3\(3Z,L]N]Y>PM/'JDD-Y>6TC!9UE9(75PBK@UYS^TI\<O%B?M0Q^/
M_".D_$36/#'[.EQI&AS2^%Y[=_AYK<OB06?_  DMUXJ5KZ*6XF\/VFK:E;@0
MVTRQRV"L.4W"G.;YKSD^9IRO)OF:V<M=6NE[V _9Q'L_.?RVM?M#\/L:+SFV
M\8?:=[;>F#G'2N ^)'PO\/?$RUT*/63<VM_X8UZP\1Z!JUBRQW^FZEI\\=Q&
MT$CJZ^7*\40G1D8.J <5^(L'[0NM^%?CCXB\?>%->O?$NE:]XC\1+X2@U#5]
M0E\.16NMZH)M*U6]A$[00Z9;6X!;]ULC615V -BOHGX@?M8_M'>!+/QGX%MK
MCP%XT\5>#'\'ZWJ/Q"\+W>FOHQT/Q?=WT$=A;0WXM=/GOM*739GOHXX'N46:
M#@EQGHPF-Q> Q-'&8/$5,/BJ#;HUJ<K3A>+@TGJG&4)2IS@TXSA*4))QDTTT
MFK-73Z,_6Y+*W6%89(891^[:1GAB/G3(%_?R*$"&4LH?=M!# $8P,2/;VI\Q
MY((#O4>:SQ1G>J8(\QF7YE7:"-Q(7:",8%?B7K'[9WQG\.ZWXP^)-EXJT/Q7
MX2OO"O@?1M \&65JD3:3X@\0^*K;P[>Z^7NK.V:6+3VNGNY3YLEGBW>,YB!%
M=SX;_:V_:+\<ZYX0^%-I9^&M%U[59O$RZCXVU0V5SIVO:3I>FZQ>,^GPZ.E[
M#;70^QQ6I!@MF4L\J990]<_/*]^:5[WT;6NG;_"ON79#/UY'V.]@ 7[-=VS\
M #RIX&QV &^-L?CBH;JUTNY:&&]MK"=B&%O%=0V\K84#<(8YE8X48W!!@#&:
M_)/X/_M,_%3QE8OI/AG6OAQ\-M*^%UAX>U+Q<WC.^OY_^$\?Q/#-<BW\,374
M%Y>RK8?8)X[@6_DM&]S IY85K_MU>)O%7AWXS?LK>/O#NOZGIUAX)OM9\;^,
MK*POKVWTW4_ NFVMAJ'B_P"V6*.D=Z(M'MIWM!<02/&S%D",Q)(SG&SC*46F
MVG&35F[)M6:LVDDVNR _5A8M/&VR2.S'D 2+:*D(\D9^5U@ _=C/1@@&>AS5
MI]A5A)MV8.[?C;CONSQCUSQ7X)Z;^T-X_L?VD_&_Q/\ "VN&73?V@H_#_ASX
M42>)=1NU\)^#_"\;Z;!+KU[I\C-96TS:G:WT7G26I\TNJ,65B#[OJ'[47QT\
M8:IXF^ FG>)_ASX<\:^$/#/BKQ!K_P 6KNY$?@WQ3IVBZK'HZZ/X=N3;-:_V
MW>1WT4[QP0Q-$;:;RV158E-MN[;;NW=MMW>K?JWJWU _7&-+<P[(EA-N5("1
MJAA*D<C:HV%2.HQ@BHK6WL80S64-I$#\KFUCA0':20K&)1G:6)P>A)..37Y"
M_!S]K'QKX6^!?B*'5-3\/3:SX)TGPS#H<NJZCYEYK4VJQ:@+B9!=LUW?Q;K2
M-H)8A,#O)9@2,^=6'[6'Q ^&GPYNY?#7BS1+G6-)UW6/%_B/0-:G^V:YJ.EB
MQMKI[.UEU:.2"WL7-O-&GV2YCG3+E5!VFGS2LUS2M)WDKNS>]VMF[ZZ@?M[-
MING7!9KBPLIV=MSM-:P2EV VAF+QL68* N3DX&,XKS_XA_"GPS\1O#$W@_4X
MVT[0K^^M+G6;728K:S_MBTM&:3^S;UDAW-:33>5)*JE78PIAP 0?R<^&W[4G
M[1&N^,_%FGMXY\%V\GQ7\9>'](\$#Q%&EOH_PNC;X;6'B^XNK]Q9EI+&\CMK
MBPB,ZW$<M_>Q",%F1J]T^$G[2WQS^*_QDT_X36MWX,L(O EQJ,?Q \2V\<MU
M9^,HM+NELS/X6D%I+"8[HGSBZ"W1,JH*@@5U83'XW XBABL)B:U#$8:K"MAZ
ML)OFHU:34J=2%[J,Z<DI4Y)7A)1E%J232LNRUW\S]-+2TMK"UM[*SACM[6UA
MCM[>")0D<4,2A(XT48 55   JQ0.@SU[T5R-N3<I-RE)MRDVVVV[MMO5MO5M
MZMC"BBBD 4444 %%%% '@/[3O@CQ;\0O@QXL\,>";AH=>NHK6XB@6;[.=4M;
M*=;F]T<S;X_+&J6R/9EMZX$O6OF77ET[XF^"[WP]H_P(\5QRZ#X!T?0?$>OR
M6]QX5U2TN--OK9[G1]!BU".V.O/8R1G6X+ZUAOH+QXQ;@R2,T9_0Z]OK/3;2
MYO[^YAL[*TADN+FZN)%BA@AB4O))([$!555)/?C !/%>9>'OCE\)O%2:O)H?
MC?2KJ/0EWZH\Z7VG"WC\P1"9/[3M+/[7 966,3V?VB)G(4.3Q0!^:UOX,^+6
ML:1I^HVUEXJ\;> ?AAX_\#>,-/\ $?BG0I_#WQ+U'3]!\-ZCHVH>'?[%%CI$
MVK6^DS7ZP6LMMHTC74%HDHEFW>8WTQ\*M(;6OC)\7OC+JV@^*M-\)?$>X^%^
MC^#(KW3-7L=6?4?!C>(QJ-WJ6CRPQ7FEZ<\FK69CGO[:""9!*?,?RSM^N_#'
MCSP?XT;4$\*^(=.UM]*D@BU%+*5G>TDNHC/;K*KJC#S8@70@%2H/.1BNF^TV
MVQY/M$'EQL5=_-CV(PX*NV[:K \$$@^U 'F/B;P1XRUCQ-::YHWQ)UWP]IEO
M;&"7PU:V^FR:7<N0X^TS&>QENQ.NX%=ERL>47*$9SX!I?PTE\'?M5:_\1K71
MM5DTO6/A_ OB#Q#B[O/M^K6\]I"(H8(_,0.T,(E:"WB!+*2%ZY^SGN;>,(7G
MA028\LO*BA\\#9EANR>FW.:3[5:^69?M,'E!MAE\Z/RP^<;2^[:&SQM)SGM0
M!^8GQ1T?QS;^._B%K7P6T/XAZ=\3?';Z)>:IJ6JVA?PMJ/A6PTZZMK>.TO'L
M(XM/NK>&YMXSI[7::@'X928I*\UMO@9\5=#C75]*D^(\NIZ5\+O!/BK35N=0
MN)4/Q-FDUJ7Q LL1C D97M]-\VT8%54J-@W<_L)-=VMNI>>Y@B41-.3)*B_N
M4&YY1E@3&HY+#('KS6=HOB+0_$6F1ZUH>J6>IZ3+O\O4+64/:L(_]81*=JX3
M/S$X ]: /R!T+X$_%BZT[P/JVM2?$AM:U/P7XC\2>+8VU&XC0>.;"76[KP^C
M1B-?*'VFVTK%N-JRH0I5@^#^LWP]?6I/ _A-_$8E&NG0-*_M43KLG%\+.$7/
MG+A<2>:&W\#+9)&:ZL7%N1$1/"1.2(")4(F(&2(OF_>$#D[-W'-<3X>^)_@'
MQ9K$N@>'?%&FZMK,%OJ=W+I]J9C/';:-JS:%JDS"2%%V66KJUA-\V1."%#+\
MU '>45R&O>/?!WAC4+32M=U^QT[4[^SO=0L["0RRW5Q9Z?);Q7MQ'!;Q32&.
MWDNK=')4'=* H;#8ZB.ZMI1^[GB;$8E($B[EC8;@[H3N1<<Y8#'?% $]%0?:
M;81+.;B 0L<+-YL?E,=VW"R;MA.X%< GYACK3O/A\Q8O.B\UUWI%YB>8R?WU
M3.YE_P!H CWH EHJ'[3;[9'^T0[(21*_FQ[8B.")&W80@]0Q!%2*RNH=&5T8
M95E(96'J&!((]P: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7YY_\%&?^24^&?\ L;K#_P!#CK]#*^5/VL_@IXF^.'@C1_#OA>\L+*\L->MM
M3FDOS((F@A9&95\M'.X[3CC'OS7WWA=F6 R?Q X7S/,\52P6 P>91JXK%5FU
M2H4U2JISFXJ344VEHGN?$>)&7XW->!N)<NR[#U,7CL7ETJ6&PU))U*U1U:34
M()M*]DWJUL?@E2'H?_K?UK[R/_!/?XO<_P#$^\-?7==?U@_I2'_@GM\7_P#H
M/^&_^^KD?K]GK^]O^(M^&W_18Y/_ .#*W_RG^K/RO_%$?"_Q 2L^%,TW_DH^
M7_3[^M>Q\#U5?[I_#^8K[_/_  3S^+V.-?\ #8/^]<__ ".:@;_@GA\8#D#7
MO#6/7?=<_G;_ -*I>+?AKI_QF63Z._\ $K^7_3CR9M3\,N/UOPKFBU3^"CY?
M]/OZLS\_)>GX'C_/^1^-4G^Z?P_G7Z$O_P $Z_C$V1_;_AG'/\=SW_[=_P#Z
M_N*K-_P3E^,A! \0^&.?]NZ''X6Y/ZUTT_%[PS5K\9Y,M;ZU*ZMMO^X_JWD=
M4/#7CSF_Y)?,TK;N%)?^YOZ^X_.Y^@/O_G^54)ASUZY_#./Y?RK]%F_X)O\
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MG6-=?Q?3\.@[]!_];W%?JI-_P2G^/$A.WQ/X/'UDO#TP>/\ 1?R]?4UG2_\
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MBXU&YCN8(5N+H-Y9A1TE1&C)P 2#^UZJJ*J(H55 554!555& J@8
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M#_XJ@#CKW]GOX.7>K6?B ?#[PO!KVFVD-KIFJ)H]F9[$6@)L9(QY:[FLWVO
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M.+--4O+_ %7PM?6>O176NS:G'-=Q?9[:ZTY9HS&LT@\IN=V2*VOV5O@?\7/
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M?_ @?_%4?:O''_0-TW_P('_Q5 ';45Q/VKQQ_P! W3?_  ('_P 51]J\<?\
M0-TW_P "!_\ %4 =M17$_:O''_0-TW_P('_Q5'VKQQ_T#=-_\"!_\50!VU%<
M3]J\<?\ 0-TW_P "!_\ %4?:O''_ $#=-_\  @?_ !5 ';45Q/VKQQ_T#=-_
M\"!_\51]J\<?] W3?_ @?_%4 =M17$_:O''_ $#=-_\  @?_ !5'VKQQ_P!
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M]/\ BSJ1U7QDFF2S75U+<"\NOL%S>7-SI,=[>!I/M5VFFRVHEF,TY/"F5BI
M^B*_)\XP$,JS;,\LIXW#9C3R_'XO!0Q^#DY83&QPM>I1CBL-*23=&NH*I3;W
MA):M:O>+YHQE9KF2=GNKJ]GYK9A1117G#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /GS]J;XX2?LY_ SQU\7H-#7Q'<^%---Q9Z/+=16
M-O>7<I,=NEU>SS6\-I:B4J;BXEGACBBW.\B*"P^4_@5^VI\0]=TO5O''[0VG
M_ OX=_#/3_#&CZ\VN>!_BEX<\<ZI87&NW-I!IUIJ^F^'O%GB.[LUE>^MK;S'
MLHU-Y((%8R$)7T;^V9\%?$7[0O[.?Q&^$OA2YTFVUWQ5IBVUD==>:/1[AHW\
MQK34'MX+F9;6Z4&&4QP2,%8D*>E?G9!^P=\3M6^$B_"6T^"/[.?PK^UO\,H_
M$7BGPC?:Q=7?B&R\#>*O#FOWUI?6]UX?ACFBU$:+)(J2;D-Q,H8*,L #[YD_
M;M_98'PXU7XIQ?%?29O"FDZQ<^'KF2/3]:?6#K=LEVQL8?#8T\:_<>9]BG,5
MS#IS6DB)YHN!$1)7EGPH_P""DW[/7C7X?>%/'/C3Q7IO@4^.O%NO>'/"FFRK
M?:G/>V6CS644.N:@NFP7S:#IEVM[%)]LULV%M$NXR2(%8CY;\:_\$Z?B]HO[
M0.I_M"_"F/X/:H;&:*TT+X2^,+>ZL? 6I6%UI-S:W^J:G9Z?H=[;Q:[9W3Q)
M8S):.7M9;H-.C.4?Q_P/_P $S?VI?AOX<^(UEIJ?L[^*-3^/?AW6O#/C6UUQ
M=6&E?"4:E&8[>_\ A:$\+RNL2"YN6N86BTX,;6R^1R!L /UVU_\ ;*_9I\,>
M-;SX?ZS\5O#]MXCT_1)_$-\L8O;K2+/2[:TDOI9+GQ%:VLV@P7 MHGD6QDU%
M;Q\HJ0,TB!O--&_;\^ &KZWXEOH_B-X7C^&_A[2K>63Q+/;ZO97TFLSO;E+*
M&SNXHYKVUEMYO,M[NSL7BGE,5O'*TKA#^>ND_P#!-']I3P!\'O'7[,W@O7O@
MMXD\"^,;34;B7XT>/+"YU7XMF:^TY(9-&E2[\/:A;);2W$;6B7<>IF>SL9$F
MMBLJ%!W_ (Y_X)C^-?$7B3P%=Z5=_#JQ\.^&_"?PVT/6M'-GY4.J7OA"Y\/7
M&IW,EM%I1@NOM;Z3<-')<?/(9%$FT,Q !]]7/[=O[*EK\/\ 3?B;+\6]'/A/
M5M<F\.64L-AK4^M-JUO-+;SP3>&8-.D\1VL4,T,B2W5SI<5JF S3!64GA4_;
M]^#^G^._B9H_BG6-*T3P#X"\/>%=>T[QY;WG]KP>*5\42:JD%IHVF:4;W4[Z
M[A_LPE[6TL9;E6FC1X@SJ*^,=1_X)X?'+P!^TM\0?VCOA79?!#Q?:>+;35O#
M.G_"7X@17UIX-TC1]?N4N;WQ-86>GZ!?6UKXEM);6W\GRH$6:.XNEEG*,ROY
M9X#_ ."47Q]^$/BCPG\2_#OBWX8?$'Q%X(OX-<MO OC9M4;P/KESJD_FZYIE
MPHT6[>.UT1+6W_X1=S9@QRW5V2MMD,X!^L_B']M[]ESPOX8\(>,-9^+>@P:#
MXZ@N[GP]<P0:E>SRP6$$ES>S:E865E/?Z)':PPRO.^LVUBL8C<,05('6Z-^U
M+\!/$'@]_'FC_$C0[_PM'J^E:"VI0&Y8C5M;2*72;,6GD?;#)?P317%N1 4D
MMW$X;ROGK^=OXQ_ ?XI?L=ZU\6-=U+2_AI\2_B+^U?X3\>27_P -[O0]>U;P
M+\-]5\3^&]1\+:5HGPFN+?PS=#3]US!;7,HN;?18WNKJX9RT;[W^AOV8/V8?
M$=Y^U1\"- ATV]T+X<_#KX&>"_BM\?/"^HZ8R:#>?'O3/#.C>"/"OAVU@DB:
MPN[:V\*:H=:D"C$=[8*\B><F0 ?T/4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !117BWQN^-_AOX%>';#Q)XEL-3O[34-3A
MTN*+2TADF2:<J%=UGFA78"PSAB?;I7?E>5X_.L?A<KRO"U,;F&-JJCA<+12=
M2M5:<E"',XQO:+>K6QQ9CF.!RC XG,LRQ-/"8'"4_:XG$U;^SHT^91YY\JE*
MUY):)O78]IHK\^F_X*+?"1?^9;\8_P#@/I_'U_TWU_SZTY/^"D/PBC)SX:\8
MGTQ;Z><\>OV[I[U]XO!WQ-=K<'9L[]HT.MO^G_G_ %I?XV/BGX?2^'BG+7Z2
MK>7_ $Z\_P &?HC17YP2_P#!3#X.Q9W>&/&9P,\6VG?_ ">*RYO^"HOP7@^_
MX5\;GUQ;:8?_ '(<UM#P5\4YM*/!6;N_:.'\O^G_ )_AZ7Z:?B-P15M[/B/
M2OV=7R[TEW_!GZ9T5^65Q_P5@^!UN</X2\>' ).VUTOMGN=1 [?Y[8%W_P %
M@?@):!BW@WX@OMR<+::3DX[#.ICG\?PKKI^ WB_5:5/@+.Y7LE:.&ZV[XCS_
M  9Z-'C'AFO;V.<X2HWTBZC?_IOS1^ME%?._[.?[3OPP_:<\(MXJ^'FI/YEK
M+]GU;0-0,4.MZ1/R MY;1R2+L<JX22*21/E(+ E<_1%?FN;Y/FF09EC,GSK
M8G+,TP%:5#&8'&4I4<1AZL;-QG"7=-2C)-PG!QG"4HR3?T-&M2Q%*%:C4C5I
M5(J4)P=XRB^J?YIZIZ-)A1117FF@4444 %%%% !1110 4444 %%%% !1110
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MTH2;;3=[Z7?+=JS:2=DVNN^_<X[XN_!IOBA>?"FZ&MG2Q\-?'-CXR*"V$_\
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MMRQC>0!@U13XW_!]O#VI^+H_B%X5/AS2KZ/3M4UM=1A%C;:@^$CM9I\#=.>
MJ*'.T=E''YT3?L,_%1/&NBF77=-UWPKHOC&^\2M>W]V$EO\ 2+KPM8:,/#KV
MPN$OU=[JUF,MS)*;4PSC;"I5F.AJW[&?QBU:P%]#XCFTBV\)^.KKQ/X+^'MI
MJVEFWFL[[0-2\/7%I<:MY3:>EK&NK3:A!;WD,LJM;1Q^:)0K, ?IYI/BSPUK
MTD46C:UI^I23:?:ZK$MG.LWF:=>QB6UO%*Y4PSQD/&V>5(.!4'B'Q9IN@:-J
M&L;+G5QIZ'.GZ+&E_J,\V#LMX+9)%9Y78!0N01G.#TKR']GKX6Z]\'O ^C^
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M/$'@#XE>'_&+76CQ:?I>H?$FYNH+&(Q336_C"]TBYTV$8F;*6J6$JLC*RIO
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M?I[CFO,=7/#YPV,X&!UR1CG_ .MQ7I6IR1Y_UD??JRG^O'^>M>9ZO)'\W[Q
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M9D\(W3:P+RW$UM=R3R.E@JR6P!P?V:^W67_/Y:_^!$7_ ,71]NLO^?RU_P#
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MU2P\ 3Z]K4>IVGBJ*XGU6/1GOK>&V,-RFGWTY$EY*+:(1CC]B?MUE_S^6O\
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M &#XST[5]5\-ZI9Z%XBN_"NJ/;N]KKEC:V-Y<V3Q@ON2WU&WNK23<!@^; X
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M  (B_P#BZ +5%5?MUE_S^6O_ ($1?_%T?;K+_G\M?_ B+_XN@"U157[=9?\
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M .3:IO\ L,_LQR9W_#>T;/!SJ6K#CTXO17U=]NLO^?RU_P# B+_XNC[=9?\
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M21U 921QWYI] &#K?AC0_$0@&L6$-[]F),/FC.PGKCZU@?\ "LO!'_0!M/\
MOFN]KYF\<?M)V&A^/;WX7^ _!6O_ !1\<Z-8V^H^(=,T"6&QL/#]M=AS:KJ6
MMWD+Z;#>3K%-Y=B\R7),3C9D$5ZF59-F>=UZN'RS"RQ-2A0GBL1)U*.'P^%P
MM.4(3Q.+Q6)J4<+A:$:E2G3=;$5J=/VE2G3YN><8M2DHV;=KM)=;M[)):ML]
M<_X5EX(_Z -I_P!\T?\ "LO!'_0!M/\ OFOGJ7]LKP1:_#O7_'%_X9\2Z9J?
MA'QUX8^'WBSP;J-O)9:UHFN>*=7L=(LG+W-M%%>V22W\<K7=K&T,B)(J/N6O
M;_BG\5=*^%7PLU[XJ:II]YJ.F:%I5CJ;Z;9NB7EU_:%Q9VMM;1.ZLBR//>PJ
M692HY)&*[\1PCQ)A,5@L%B,IQ-+%9EF<LFP%*3I7Q69*. G]6HR51PES4\SR
M^I3K<WL*M+%T:M.K.G+F4JI!W:DGRKF?DM=?P:?9IIZFM_PK+P1_T ;3_OFC
M_A67@C_H VG_ 'S7S'IG[8[V<O@.\^)/P?\ %WPV\*?$6?3+/P_XNU'4;#6=
M*2\UBU:\TZWU+^RX&:P^TPHY$MPT2*5VD$D5]D:KJVF:'IMYK&KWUMIVEZ?;
MR7=[?7DR06UM;Q(7DEEED*HB*H)))%99QPQGF15<+1S/ NE+'.K'!SP^(PF/
MH8JI0K+#UZ5#$Y?7Q6'JUZ%=QI5J$*KJTJDH1J0BYQNXSC*]GM:]TTU=73::
M3LUJGU1R?_"LO!'_ $ ;3_OFC_A67@C_ * -I_WS7@>@_MD?#?Q7\(/B7\:?
M"]EJFL>%/AQXDU/PS-L M[C7+S3+;3IWFT\3Q#RX)Y-2B@B:16!9&D!*%37-
M7G[8NI^&?#WAOQQ\0_@?XS\$_#[Q%+HR#Q;/JVF:M;Z9%K[V\>E7.H6.GP-=
M107$MW:Q^8XC56F7<1W]:GX><95*M?#_ -B5:6*P^/>5SP>)Q6 PF.GF<<-1
MQ<LOP^"Q6*HXO%8U8>O1J/"X6C6K)U(0Y/:24"?:T]^9-6YKJ[2C>UVTFDO-
MV779'U#_ ,*R\$?] &T_[YH_X5EX(_Z -I_WS7;V]Q#=00W-O(LL%Q$DT,J'
M*R12*'C=3W5E((]C7SU\3?VBM'\#>--,^&/AKPSK?Q%^)6IV(U4^%?#^(1IF
ME,66/4-9U:>&33]+AG,<PMUO)(6N##)Y9.TX^=RO)\RSG%2P66X2>)Q$*-;$
M58\U.C3P^'P\>:OB,57KSI4,+AZ*LZM?$5:5*G=*<TVKU*48J\G97MYMO9)+
M5OR2N>G?\*R\$?\ 0!M/^^:/^%9>"/\ H VG_?-> V_[7OA:'P=\3M>\0^$?
M$OAGQ/\ "2U2\\7>!M4C*:BEK(85AN=,U(VZ6&IVLC3!1<6GF1JZLFXLK8H:
MS^UQ/_PF/ACP-X%^$OB?Q]KGB/X;Z-\362PU?2],BTW1=;M-,N[:"X>_CVRW
M*IJENC>6P!8-A>0*^@I^'_%]2I5IK)IT_8>W=6M7QF7X;"0AA\)A,=5K?7<1
MBZ6#>'^IX[!XBGB8UWAZ]/$4I4:E3F)=6FK>]O:R2;;NVDK)-WNFK6TZGT;_
M ,*R\$?] &T_[YH_X5EX(_Z -I_WS7RG<_MS>&8?#<ES#\//%DWCVS\?Z=\.
M=5^&LLL%GK6G:YJS7R:?*U]<VZV=Q8W1T^Y,-S C12*A99""">XTK]J">R^(
M/@WX>?%#X7^)/A?J/Q":]@\&:CJFHV.L:9K-_80Q3W.G?:--B\NUNE2XM]JS
MR*6,R@#/%56\/.,</"K.ODLZ<J5/&UO82QN7?7*U#+\/'&8S$X/ K&/&8["T
M,))8J6)P5#$4)8:^(A4E23FA5:;VEV5[2M=NR3=K)MZ6;O<]T_X5EX(_Z -I
M_P!\T?\ "LO!'_0!M/\ OFN]KY3\1_M1VJ^-/$O@7X9_#[Q+\5M7\$HI\8W6
MA30Z=I&B7#()#IXU6_@:RO\ 4UCWE[&TF>Y1XY8FBWHP'@Y3D>:YY4KTLLPC
MQ#PM'ZQBJLZU#"X7"T'4A1C5Q6,Q=6AA<-"=:I3HTW6K0]I5J0I4^:<HQ=2E
M&-N9VN[+=MO?1*[>FK[*[>A[?_PK+P1_T ;3_OFC_A67@C_H VG_ 'S7C5M^
MUM\+G^%%Y\5;TZUIEOI^M?\ "*7OA>\TJ^3Q/'XP+-%'X:ATLVRW=S>S3HT,
M#PV[1RLK% 0M5/"W[4<%[XW\->!?'_PX\5_#+4/'$<LG@J^UMH[_ $W7&BC\
MYK66\LK98-*O?)*.+6_ECF)EC78"PKU?]1^+%3QU2628N"RZ>,IXF%5T:5?G
MR^C'$8]8;#U*L<1CE@L/.&(Q<L%2Q$</AYQKUG"E)3:]I#3WOBLUH_M:1N[>
M[=Z+FM=Z'N'_  K+P1_T ;3_ +YH_P"%9>"/^@#:?]\U\]7_ .UO;:AJ?BN#
MX:?#'Q?\3M!\#7ES8>*?$^C/%I^FVMY8Y_M&VTH7ML6UV:R*2I*FF-,WF0R1
M;0ZE1'K_ .V+X;CT3X5ZGX%\%>)?'U]\6;^^TK0]#M6CT+4K'4=*D,&J6>IQ
M:K;J;>:QN5>"5'5#N4GC! WCX?\ &$I8>']BU8RQ#LHU,5@:4L-+ZC5S-1S%
M5,5!Y5*67T*^,A',_JDJF'I5*D%*,)-+VM/7WEIV3=]4O=LO>U:3Y;V;29]$
M_P#"LO!'_0!M/^^:/^%9>"/^@#:?]\UXUX*_:636/BA8_"#Q[\/?$/PQ\:ZW
MI%[K?AJUUF\L]4LM?LM-1)-0^QZAI\8M4GM$EA,D#2M(?.0!1FOJ*O"S;)<S
MR.O0P^9X;ZO/%86GC<+.%;#XK#XK!UI5*=/$X7%X2K7PN)H2J4JM+VE"M4BJ
MM*K2DU4ISBJC*,DW%WL[/=-/1V:=FG9IV?<X+_A67@C_ * -I_WS1_PK+P1_
MT ;3_OFN]HKRBC@O^%9>"/\ H VG_?-'_"LO!'_0!M/^^:[VB@#@O^%9>"/^
M@#:?]\T?\*R\$?\ 0!M/^^:[VB@#@C\,O XZZ%9CZKBD/PR\#@9.A68'')''
M/ _,]*^1?^"G$.IW_P"Q1\;-#TCQ+J?@^_\ %'A\>%H?%&C71L]4T+_A()/[
M,?4[&Y )AN;-;@SQ. 2'0'!Z5_/?\:OVBOBAKO[)?[-_@R;QCXPTKQY^Q9XK
M^%?C+XPW.FZG*FM^-;6[\>:3X5\/>$_$CHK%KK7="U?1_$#03)')=6MY ZJ5
M=2P!_67_ ,*R\$?] &T_[YH_X5EX(_Z -I_WS7\POQ6_X*V_M-?%'X:_&CPW
MX0TW2O!5_KWA;QQJ_@_Q#:>"/&NB:C\+XO _Q?\ #'@RWCU75]9N6TS6KO4K
M"_DFNI[&/R8U,Q"1D@K]/_%S_@J#\5/A%XO\$>#8?%OPM^(UE%%X#\&^.X=
M\)^+GGDUWQ%#=V^LWMMXT75)?#%M>1R6P:TMY&9D<R&6-QP #]VA\,O YY&A
M69'J!F@_#/P,HRVA68'J0 /UK^<GX._MZ_M%_LQ?![X:G7]7^&/QKT/XPZQ\
M7K3P=!I4^J7OBWX8WOA?0)O$^GZI\3[]-<FM/^$<EGGBM)ECM].D2*VG(N(]
MRL)OVEOVO/CIKVH_#[X<_$7Q/X"U35_"WBC_ (6(OBOX-76HZ?X8UK1-6^"&
MJ>(CX&\1BXUC4Y&EBN=4;+0W-JS00),IRB2  _HP'PS\#L 5T*S(/((&01Z@
MC@U%-\.O %OM\_2-.AWG:GFND>YCV7>1D^PK\8?V6_VXOC%\3M+T:71=<^ W
MP?\ AG\-M!^$EEK/A?X@OK,WB_QA+X]\,MJ\@\*7DGB6 /!:/;/!8O/#>22Q
MRQN9)BI:O5/CQX,^'7Q8_P""A]CX)^,?BF>S\$V7P!AU33]%G\8MX6TLZC=3
M:PEU?IB]L_.N$2*%_,WN(Q&I; .: /U/_P"%9^!LA?[#L]Q&0,#)'J!U(]Z7
M_A67@C_H VG_ 'S7\T?PF_:U^-'PMUKQ5X1\ V&A^/4^'7B3Q[X=_9_\7_$'
M6[CRM8^%&FZ'-J<UVEQ_:VG6OB*.UUF?7[.PDB%S=7,UJEI#)+(JI7=ZK_P6
M6^+Z^'OAUX5TBS\)W?Q&U&QU_7O'7B2+X6?$FY\.Z>FCWE];6_A"WT2&Z.J6
M^LW@CMI4U2>9]/F@66:)#')$P /Z(?\ A67@C_H VG_?-'_"LO!'_0!M/^^:
M_GY\?_\ !9/XD:9X;\!^/O#<'@2U5M*\.2^.OAIJO@WQE/K5KJ-];1C4?/\
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MT?\ "LO!'_0!M/\ OFN]HH X+_A67@C_ * -I_WS1_PK+P1_T ;3_OFN]HH
MX+_A67@C_H VG_?-'_"LO!'_ $ ;3_OFN]HH X+_ (5EX(_Z -I_WS1_PK+P
M1_T ;3_OFN]HH X+_A67@C_H VG_ 'S1_P *R\$?] &T_P"^:[VB@#@O^%9>
M"/\ H VG_?-'_"LO!'_0!M/^^:[VB@#@O^%9>"/^@#:?]\T?\*R\$?\ 0!M/
M^^:[VB@#@O\ A67@C_H VG_?-'_"LO!'_0!M/^^:[VB@#@O^%9>"/^@#:?\
M?-'_  K+P1_T ;3_ +YKO:* ."_X5EX(_P"@#:?]\T?\*R\$?] &T_[YKO:8
M\D<8!D=(P3@%V503Z L0,^U"3>B5WV0-I:MV7=G"_P#"LO!'_0!M/^^:/^%9
M>"/^@#:?]\UVWVJV_P"?B#_O]'_\52?:[7K]IM\>OG1__%57)/\ DE_X"_\
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M* ."_P"%9>"/^@#:?]\T?\*R\$?] &T_[YKO:* ."_X5EX(_Z -I_P!\T?\
M"LO!'_0!M/\ OFN]HH X+_A67@C_ * -I_WS1_PK+P1_T ;3_OFN]HH X+_A
M67@C_H VG_?-'_"LO!'_ $ ;3_OFN]HH X+_ (5EX(_Z -I_WS1_PK+P1_T
M;3_OFN]HH X+_A67@C_H VG_ 'S1_P *R\$?] &T_P"^:[VB@#@O^%9>"/\
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M8T[0M*U'P=97-AX:TZXTG1K=I+@)9:?=7<-]<6T068'9)<V\4O))4H-I XH
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M]C>:M+;E6,M\]G,(4D+KM\J,X.W!];HH **** "BBB@ HHHH **** "OD?\
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ML**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .;\0ZOJVE"W.EZ!>:X9682BU>W3R .C/Y\
MT.0?]G-<U_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;
M1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_
M *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\
MO_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>
MDT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\
M)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A
M!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V
M'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PE
MWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'
M5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?
M_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4
M>;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM
M_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_
M +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;
M1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_
M *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\
MO_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>
MDT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\
M)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A
M!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V
M'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PE
MWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'
M5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?
M_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4
M>;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM
M_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_
M +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;
M1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_
M *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\
MO_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>
MDT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\
M)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A
M!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V
M'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PE
MWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'
M5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?
M_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4
M>;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM
M_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_
M +_V'_R;1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;
M1_PEWBW_ *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_
M *$'5_\ O_8?_)M>DT4 >;?\)=XM_P"A!U?_ +_V'_R;1_PEWBW_ *$'5_\
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M:&\M1/&Y+$S(%1LG'H=?F5^UA\%-=^+'[4/P6U?PY!JFE^*?A_\ "SXM>(O
M?C6VMYO[.T3QG%)X6;2-/O[M"J1KJDJL!"TBF1;=F&0AJHRE"49PE*$XM2C*
M+<91DG=2C)---/5---/5 ?>/@"?X8&WUBW^&UOX5L[;3=3DT[6X/#.FV6EPP
M:K J-);WD=I:VJ-<QI*A)97(#C#<UT5EX2\)Z9<F]T[PUH%A>&XDNS=V6D:?
M:W!NI@RRW)G@MTD,\JNXDF+>8X9@S$$U_.];>+_VHK[39-;U#PQX\^%7AO5M
M?\1R^)+72[B\\/7D_P 2K>SAMUE$YM6-_HLRP:7=6P$<:RS37"AOXJ^@[OXP
M?M"^%? 7C+PGX]NOB?<_%CQ-I7@^]\%S>&=+O[S3?[/77-#BEGMM0B;;9SR:
M3'.=24+(92US(Q7>0-I8S%SE5G/%8B4\1;V\Y5ZLI5K)I>UDY-U+)M+G<K)M
M+<5EIHM-M-O3L?M%=>'/#-Y::C87FAZ'<V.JR&75;.YTZQFM=1E8DF34+>2%
MHKN1B6)>X21B2237)Z;<?"JSUMOACI-MX2M-9T&WLO$W_"(66EV-M_9<%RTI
ML=9BLHK2.TMW=[>4PW,6V8&)CD8%?D5IUE\2-*\(>%O%_P 6?&O[1MIX2\2>
M.O%=KXVN/#^K:E_;6FSZ=>ZC!X7M;*U6V,FFZ)-;J#/*S2)<.D##;D"O/-#E
M^.P\6Q>+/&\'Q8T[PO?Z%X3TSQGXVT>RU"+Q\?AC;R:B-+D2_56F&J_99;UM
M2?860F$LG(!/K>*Y/9_6<1R.:J.'MJG(ZD8>SC4Y>:W/&'N*=N90]U.V@S^@
M#>@ .Y0IZ'< #]#G!_"J,&EZ7;/>RVVGV,#ZDV_4)(+6")KY_+$6^\=$4W+>
M5B/=,7.S"YV\5^"GB'QS\1[73?%2^+?''[0&C_ '3M/^(NH_!CQ'I]YJ-K\1
M=4_LWP3+>Z9=>+;ORO/ET^TUJ*9[5Y8D1Y(V7Y""1Z3X/^(/QA1_@QX"?Q[X
MWU'PO\=/!VC?$[5_'=S>W$^K^ /#_@F&V@U&!YB R#Q'=:.?MP+Q"1]4F1BS
M,:Q4I14E&4HJ22DDVE))J24DGJE)*2OLTFM4@/UT\3:G\.?!EIX>@\4'PYHE
MCJ/B2RTOPU#>V-NEK+XHO$N9;&#3XDMWBAU*9(KIXI56)R%E_> DYX.3Q[^S
MK-XG\<ZS+J?P^E\7_"J6U@\>:Q)IMD^N^$)[HRBTBU+4VL3>022F"41)#<2-
MF,\#BO.?VFDL?BI^S7J/COP1:W?B2_\ #,-C\3O %M80.]WJ&NZ-;W']F1PP
MIND$KPZA. J!F#$ #J1^;0^%GQ/G_P"%1ZW#X*URWO\ ]L^2Y\0_'Z.?3;AA
MX8\5V<5D_A^+Q!D+]FLX[F]N/-,X0 +(.0IK:.+Q4')PQ.(@YQG";C6J1<X5
M7>I"34ES1J-)SB[J;5Y)BLNR^[MM]Q^XUA8^&K[3)6T^PTF?2M>A6]N4ALK8
M6NJPWD*D3W</E*MR+F!EW-<(QD0@/D<5QFN?"/P!JGA?5_#&E^'/#OAN'5[*
M:Q%WH.BZ9IUQ;":1996MGLH+=D=V4E]CJ6W-NSDY_'V^\1_&BQMKJR\"Z]\=
M9_B_9:3\1-+^)VBZDFI_\(7H>@:5X/U>T\)W/@^S9!#:W;7]OIDNG3Q2NTEP
MP554[&.TG@#XTZ%:^,KW3/B#^T+?7O@_X-?"KQYX0M=1\1:C=PZC\0]=T[P<
M?$.GWR&U0:E;K=:QK NM(!B>U:-M\K?9SNUP^8X_"5(U</C,32G"M2Q"<:T^
M5UJ#3I5)P<G"<J=DH\\967N_#H#BFK-)Z-?)]NWR/UU^'GPS\'_#?1=+TGP_
MHFAVE[I^DV>E7>L66D:?8ZIJD=G$D8GU&ZMH5N+F60KYDCSRR%G)8G)IFIP_
M"SP!J$'BG4-,\)>&M6U_5K/0HM>BT:QMM3U/5]8G2SL[&34;.S-Y+->SRI"/
M.EV,7 D8*<U^&3>,OVR9/$VNS'6/'=AXQGU'7F\9:7#?W=U:6WA9[J+[.OAK
M1!%&=/O(HF9;2=)YMHSMC-?:_P %O"/CC0?&&O>%]>U;XE^+/#6I_ /PQ\0H
MK_XA3W7B5]#^*$VH^)_M$_A^2:*V%GJ%D+#29HM-3=-"_E-YV9%P5\RS#$UL
M5B*^-Q56OC>;ZW4E7J<V(4I<SC6M)*<.;54VG".BC%)) HI))))*UEZ;?\.?
MHFG@CP0NJSZW'X2\,+K4\JS7&K)H>EC4Y9E "RS7JVWVIY%"KM=Y2PP,'@5Q
MUOXF^"]SI?B+Q_;3^#I=-T;6+[2O$OB=-,M=UIK6A7SZ1?6NH7GV,7+W6G7\
M<ED[,7\N12J/MP:^"OV#_$?Q+E^(_P 2= \6W_Q$\6Z2EM<W,7BGQ;J5U<Z=
M'=_VP^+."QF@"Z==1PXB6#[3*WV8(>C8'EUC\(OCG>_ _P#:#N],\=ZIX=\.
MWOQI^*U_:_#67P'=7NIZM;/\1M3FA>TU(:O;O)9ZV[1:C#,FGO&("#\V58YO
M&8R7Q8K$RM35%7KU7:E'E<:6L_X:<8M0^%<L;+1!9=EWVZ]S]=+#0/ ^IZC:
M^-M/T+PW=:S?6D<]KXGBTG3SJ]Q9S*&B=-4-N+\PNA! ,H7'&.U1>)M:\#>"
MXI/&?BBYT30U62QTB7Q%>00I.'O[I;6PL'O8X7N=L]U.L44);R_,E/ W$U^&
M/@WQ;^UOHOQ$T?[:WC2T\0Z9JM@D_@^*_NI-#E^&D)D%S:Z=H @79JK6PC6"
M=9G,;9_=MG%<;_PD/QE\?^()?#*V?QBU/P!XI_X1^_UC3/$5Y?:Y+INKV7B6
M\E,L8:UMQH=[9"*":,.LS)&L+#C%1/$XB=N>O6GRTE0CSU9RY:"VHJ\G:DNE
M->XND1V7;S^?<_>2Y\0_"3Q/KNAZ=>7?@_7M?U.TDN- BNK:QU*]GM+:5YI#
M92S03&-(IH'D,8D1A+&6";P#78:YX5\,>*+6&R\2>'=#\06<#K+!:ZUI5AJE
MM#(HPLD4%[!/%&ZCA610P' .*_!7X-_ O4]2U'3=!%Y\=?#NJ^%/^$]U/4-2
MM]2O],O;+4"-?O-$M=.U5K5\VEW%)8S20+%B>:9U# L"/UA_9L^)4WB+P/H?
M@#Q3JFIR_%#0O"UM-KEMK4,L6L+:-!#%87^H/*Q>6XN(IH)))F53+(S/M'=P
MQ6*INC*GB:\)8=MT'"M4BZ+>[HN,DZ;?7DY;]1679:[^9H^-/C#^RUI>O6'P
MQ\<Z_P##TZQI=U:V6G^&-6T6/4;72;R9A%:6T*G2KK3--G+1A%C$L#1;%#A
M%KVJ7P9X%U'2CI$_A;PM>Z)=-'=MIDVBZ7<:;.Q2,Q7+64ELUM(VQ(RDK1%@
MJ+@X Q^9_@+QEX9^$&E_$KX/?$KX.>)/&7Q*\3?%SQ+J]CIH\,RZQIGCVUUZ
MXM4T;7WUN2WD2*TN&AG,R^5,MD &#.)"P^7_ !E\4OCPWQ.>[\&Z7\9_"U];
M7WB31M7\*3WU_<Z;H]BWAM8]+.GZ%]C@\NRBN90MA<B4)'=*656*8-QQV-@H
M1CC,5&-.HZM-1Q%5*%64N>52"4THU'+WG.-I.6K=]0LNR^X_>#/ASP=H4KQQ
MZ7X>\.Z-;2SR):P6]AINGVL0:69E@MHXX88T 9V6.,<YP":X3P=J?P;^(.I7
M'C;P;!X0\0:Q:16,DWBJST6U_M1(=1A>>Q==8GL8;QX[B&-WC,<[#:I#;<@'
M\E/'6@^)="\*Z-HOQ1\8_M(S>#?%7PXU?4]'F\/ZEJ6J:KJ/Q)N;QL:+XD6*
MW1H='^SR7B0V,N<11P$/A>?/OAKJ7Q7T31O#^B?$Z]^.7A#X(:=I/@*UNYO!
M<&H:=XALM430;P6MDDD<;M!I\DJ,-4#(P69(%;!(%1'$XF$ZM2&(KQG7C.->
M<:M2,ZT:CO4C5DI)U(S>LU-M2>LDV.R[;;'[[VVGZ=92W<]G96=K->S&YOIK
M>WA@DNYV'S3W4D:*T\K #,LI9R!RU4I= \/7,U[)-HVCSSZB(!J+RV%G++?"
MV=);<7C-$S7(@DCCDA\XOY;HC)AE!'XZ>&=9_:OT_3?AEH5Q=_$G4[7X^SVW
MA]-4O#>G5O 'A[0;D3:UX@U*9D+:1J6IZ9JL"V$DH5IY[%MI.SCRQ_B-\;Y_
MBM+!X8OOCGH5G*GB/PYXCDU6YU'6&TU=.TJ]M+;5$T(6]F]J;IXH;RWO#<L-
M\J3*K<9A5JT9.<:M2,FHQ<E4DI.,'%P3:=VHN$'%-VBX1:MRJP?O))I6C33)
M=RZ=ILMQ!:/I\=S):6SS0V,A'F623-&7CM7(7?;AA$Q RA(%8=SX \!7NEP:
M+=^#/"5WHUK/)=VVE7'A_2)]-M[F4AI+F"RDM&MHII& 9YHXU=R 68FOP^\'
M^,_C(/#YT7Q-JGQRE^$MG\2;-?B9\0M*U?4+OQ+)X<7PQK#11Z#<16@ETT2^
M(!I2WUNC7#))YL>2P%=QK_QB^(G@S2OC%I^D2_M"?V1XT^#5K8_ &;6]-U34
M_$4OB%($235)[O9 ^G:A(9;=A,8Y&.Z1OX<'2GC,71<72Q6(I.$HR@Z=>K!Q
ME#GY91<9+EE'GGRM6:YYVMS.ZLNR_K_AE]Q^P'A?5?A]XE>[N?"DGA_49/!6
MJWW@ZXGT^TMU?P[JMG!;2W^A12&"-K-XK>]MFFM[8B(QSH/F!(&G=^#?!U_K
M4'B&^\+^&[SQ#;A/L^MW6C:;/K, C&(_)U&6W:]C"* $V3#:!A< 5^!OCSQ'
M\5_!OA7XE>'])T7XQ>'_ !!JGQ ^*?BW1]9\/W-_H6G:QKB?#WPM)I4EW,MK
M<+J5W=:G:^5:QAHVGN@T2$,21]X?L86'Q.\:>-/&OC_XJ:_\4(K_ $.S\(Z/
MH?A[7+Z[L?"LL5UX(T*XU*[&D31,E[>#4;F\$MT)DQ<JY*;EI1Q6*A)SAB:\
M)RISI2G&M4C)TJC<ITW)23=.<I.4X-\LFVVFVPLNR/>]:^/?[(L?Q"N=/UWQ
M7\.7^(V@ZK#H=W=7VA^?K6DZNP:."PEUQ]'D^R3XB9$'V]$7:4W*<"O=O#]Y
MX"US6-:UKP]%H=WKEC<MHNMZQ:Z?#%J(GMBP-C<:DUO'/<QQ$D*%FE@&?D/-
M?D5+XLT+2M'_ &O/A+K'P\\7:WXY\>_$F]7PMI">$+J2UUM[W5KJYT^[M-6
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MV\)F#?WA+LW@^^[-++96<^/.M+:;#^8/-@BDP_\ ?&]#A_\ :Z^]<!_PKO\
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M!@!%8H2J@  *" ,#CBN!_P"%=_\ 4S^(/_ G_P"O1_PKO_J9_$'_ ($__7H
M[]+.SC>62.UMDDF!$TB01*\H/42LJ!I >X8D'O3H+6VM5*6UO!;(S%F6"&.%
M68]6*QJH+'N2,FO/O^%=_P#4S^(/_ G_ .O1_P *[_ZF?Q!_X$__ %Z /2**
M\W_X5W_U,_B#_P "?_KT?\*[_P"IG\0?^!/_ ->@#TBBO-_^%=_]3/X@_P#
MG_Z]'_"N_P#J9_$'_@3_ /7H ](HKS?_ (5W_P!3/X@_\"?_ *]'_"N_^IG\
M0?\ @3_]>@#TBBO-_P#A7?\ U,_B#_P)_P#KT?\ "N_^IG\0?^!/_P!>@#TB
MBO-_^%=_]3/X@_\  G_Z]'_"N_\ J9_$'_@3_P#7H ](HKS?_A7?_4S^(/\
MP)_^O1_PKO\ ZF?Q!_X$_P#UZ /2**\W_P"%=_\ 4S^(/_ G_P"O1_PKO_J9
M_$'_ ($__7H ](HKS?\ X5W_ -3/X@_\"?\ Z]'_  KO_J9_$'_@3_\ 7H ]
M(HKS?_A7?_4S^(/_  )_^O1_PKO_ *F?Q!_X$_\ UZ /2**\W_X5W_U,_B#_
M ,"?_KT?\*[_ .IG\0?^!/\ ]>@#TBBO-_\ A7?_ %,_B#_P)_\ KT?\*[_Z
MF?Q!_P"!/_UZ /2**\W_ .%=_P#4S^(/_ G_ .O1_P *[_ZF?Q!_X$__ %Z
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MO_J9_$'_ ($__7H ](HKS?\ X5W_ -3/X@_\"?\ Z]'_  KO_J9_$'_@3_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
*%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img222063773_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img222063773_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"!&8#YD# 2(  A$! Q$!_\0
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M'/\ A5G_ %'?[7_MW_F%_P!E_P#$Q_?[_B!C_P"LHO\ YI-_^5Q1_P &,?\
MSE%_[LF_]^XK^_R@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK
M^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_
M .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_
M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_
MRB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q
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M "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_**
M/X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_
M^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^
M5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\
MUE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#R
MN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#
M_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_
M .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\
M0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\
M-)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\
M** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/
M_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW
M_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_
M]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF_
M_*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH
M_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\
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M -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\
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M^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\
M647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\
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M_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\
MX@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_Y
MI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0
M,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF
M_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH
M _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\
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M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_
MRB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q
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MM=+U">VLY-;T(Z3KZ6=M;ZK!&/MF@#^6#XR_\';G["7[.OCW4_A;\>_V//\
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M_%!;V\$2I%###&JQQ11JL<:*J(H4   _T!_^(TW_ ()6?]$2_;T_\-3\ _\
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MKX;\5P_&SPQX'\,WU]?>,-.U?5-,ET"+P1\2/B+!=VD-OHMVE])?W.ERQ3/
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MT'XC\06VDZ7:P6.GVEUXTT_2?&FK"TL[9([>VBEU?Q!?W AAC2*,RE415 4
M']T'_$:;_P $K/\ HB7[>G_AJ?@'_P#1.T?\1IO_  2L_P"B)?MZ?^&I^ ?_
M -$[7\#_ /P1PM+6^_X*N_\ !.>ROK:WO+.Z_;+_ &>[>ZM+J&.XMKF"7XE^
M'DEAG@F5XIHI$)62.1&1U)5E()%?[3<GPR^&TR%)?A]X'E1@0R2>$]!="#U!
M5K @@]P10!_*)_Q&F_\ !*S_ *(E^WI_X:GX!_\ T3M'_$:;_P $K/\ HB7[
M>G_AJ?@'_P#1.U_1-\</^"=?[!W[2?AZ_P##'QR_8_\ V=?B+INHPR1/=:U\
M)_!T/B*Q,J-&UUH?B_3-*L/%GAS40C,L>J>'];TS4H59A%=(&;/^</\ \''?
M_! 'PQ_P3 NO"7[3_P"RM=^)-4_9%^*'B]O!&K^#/$U_<>(=?^!'Q#O[&_UK
M0=#3Q+<E]4\1?#WQ3INEZQ#X:U;7S=:[H6I:*=#\2:]K=[K6B7]Z ?ZEV@:S
M:^(M"T7Q#8I/'9:[I.G:S9QW21QW,=KJEG#>VZ7"12S1).D4Z+,D<TL:R!@D
MLB@.=:N#^%G_ "3#X<?]B'X0_P#4>TZOQ_\ ^"W_ /P6?^%W_!(?]GZSUF.Q
MTGXB_M1?%BVU73_@#\';R[ECL;B>P$4&J?$CXA-8S0ZAI_PW\)3W5L)X+2:T
MU;QEK<EMX7T*ZL$;7?$GA@ _2+]J?]LS]EC]B3X>O\4_VK?CI\/O@?X*9[B'
M3K[QIK*P:KXDO;2$7%QI7@SPK81WWBSQOK<5NPN'T/PAHFMZN+?,_P!B\I6<
M?S,?%S_@\N_8%T7Q7'X*_9R_9W_:G_:6UFZU%-*T?4+'P]X8^'6@^*+RXD$-
MA#X7M=7UO7_B%?37DS+%%::E\.]&OBSHL5K,YV#_ #I_VG_VKOVG/V]?CGJO
MQF_:,^(_B_XT?%SQMJ$&FV#7S2W$.G07=XRZ1X+\ ^$]-C32O#'AZVNKLP:+
MX4\+Z;96"7%Q))':2W]Y<SW'^J3_ ,$&O^"'WP?_ ."7W[/O@WQ[\0?!?A[Q
M3^W/\1_#-EK?Q?\ B;JME8ZOJ?PUDUZR2YE^#7PSOY$N$\/>'O"]O.-(\5ZO
MHLR7OQ \10:AJFI7TWAZ+POH6@ 'R+??\')G[7^C>&U\<>(?^#?7_@I+HO@5
M(!?7?BRZ\+_$6/2;33-JR'4YKJ[_ &?+.RBL3$ZO#>75Y:V4X(V76#N$O[/7
M_!XG_P $O/BGK=IX8^-7A7]HG]EK59;D6EYKOCWP)IOCKP#I]P9O(\FXU?X7
M:YXG\;1/%*"+N2[^'%G:VJ@O+<A5E,?]8M?R2_\ !S1_P0^^%/[67[-?Q._;
M@_9\^'FC>%/VP?@3X<U/XB^-YO".E6VFM^T-\,?#5K+J7C?2_%]AI\<*:W\1
M_"_AVWO?$G@WQ3]GN_$VMPZ-)X O6U2#4_#<OAH _J!^"7QY^"O[2?P\T;XL
M_ #XJ^ OC)\-?$ <:5XV^'/BC2?%GA^XN(50W6GR7^D75U'9ZMI[2)#JFCWW
MV;5=+N=UKJ-G:W*/$OK-?X@'_!/7_@I7^UC_ ,$ROC3I_P 9/V8?B%>Z(D]U
MIZ_$#X9:S->:C\+?BUH%G,7D\._$#PDMS!:Z@C0274&F>(+%[#Q7X9>[N+OP
MSKFDW4LLLG^O)_P2X_X*7_ S_@JC^RSX:_:.^#<C:'K$,Z>%_B]\*M3OH+WQ
M-\(_B79V5M=:MX6U2:*.W&J:/=17$6K>#_%,-I:6OB;P[=6MX]GI>KPZSH6D
M 'MO[6/[4>J?LL>%?#?BC3/V6OVKOVISXAUB[TFX\-_LG?#WP?\ $7Q5X8BM
M+!KX:SXDTKQ=\1OATEOH]TR_8;2;2[K5KR6_986L8XSYP_ #XK?\'=_[ ?P)
M\<ZU\,/C9^R/_P %,?A%\1_#CPQZ]X#^)?[/GPA\$>+](-S"MQ:MJ'A[Q)^T
M=INJVL5Y;21W5G/+:K#>6LL5S;22P2)(W]5M?Y^/_!\;X \-6VK_ /!.;XI6
MFD6%OXOUG3_VF? .O:[%:PIJ>K^'/#=Q\$?$/A/2KV]""XGL?#VI>*?&5WIE
MM([PVL_B;598EC>[F,@!^CG_ !&F_P#!*S_HB7[>G_AJ?@'_ /1.TH_X/3?^
M"59(!^"?[>8]S\*?@)@?7'[3A/Y U_E\5_MS?\$F+6VO/^"4O_!-JVO+>"ZM
MI?V"OV2%EM[F*.>"5?\ A0O@+Y9(I5:-U]F4CVH _$_P]_P>4?\ !)+6IXX=
M2\*?MB>$8W95:Z\0_!SP%<P0@XR\B^$_C+XGNBJ]6$5M*_!VJQQG]+/V6_\
M@X%_X)&?M>>(=+\%_"W]L;P/H'CW69H+/3?!7QDTGQ5\$M7U#4KJ1(K/2-'U
M+XG:)X:\*>(]9O9G2&RTGPSXCUF_NYV6"WMY)F"'0_X*/?\ !#S]@?\ X*-_
M"[QAX?\ &OP4\ ?#+XUW^D:BW@/]HWX:>#M#\*_$KPEXL:&232-2U^^T&VTI
MOB+X9CORO]L^$/&$NH65[IUQJ TBYT#79K/7[#_'A^.?P<\;?L\?&GXL_ 7X
ME6,>F_$'X,?$?QI\+O&EE"[36T'B;P+XAU#PUK/V*X*)]JL)+[39I;"\51'>
M64D%U%F*9"0#_>DZ]**_SV_^#3[_ (+;?%#5/BEX?_X)>?M1^-]3\<^%O%.A
M:L_[)?COQ7J,VH>(O!NN>$M&N=;O_@CJ6MZA.T^H>#-3\+:5JE_\.8[V>2[\
M,:OHX\$Z7]LT?Q!X>TWPU_H24 ?AA^U)_P %UO!?['-CXV\2_'+_ ()L_P#!
M5[0_AKX#US5]'UCXQZ5^S7\*]:^$[V>EZG<Z9!XI7QA;?M#K!I7A36VMTN]$
MU7Q1;>'WNK2\L1/:VEY<K:#\W/\ B--_X)6?]$2_;T_\-3\ _P#Z)VOZW];T
M71_$FC:OX=\0Z5IVNZ!K^F7^BZYHFKV=OJ.DZQH^JVLMCJ>E:II]W'-:7^G:
MA93SVE[9W44MO=6TTL$T;QNRG_$X\;?L):P?V._CW^V#X&CO[SPS^SU^W#JW
M[,GQ'TQ0US%HOA3Q7X=&H_#/Q8S;=UI96OB30]8\)ZU=W$TWVO4_%O@ZWA2)
MEN'G /\ 0&\+?\'F?_!*7Q+XG\.>'+GX8_MK^$[;Q!KVD:)<>*?%/PO^"EOX
M8\-0:KJ%O82Z_P"([C2/VB]9U6#0=&CG;4=7FTS1]5U"+3[:X>RTV^N5BM9?
MZSX)X+J"&YMIHKBVN(HY[>X@D2:">"9!)%-#+&6CEBEC97CD1F1T8,I*D&O\
M RO]>?\ X-F/V^/^&Y?^"77PJT[Q3K7]I_&/]E=X?V;?B=]JN/-U/4+#P7I=
MB_PK\6W(E9KRY3Q!\,[GP_I]]K-T\KZQXO\ #GB^8S/-#.J ']"-%%% 'YK_
M /!3O_@JG^S%_P $FO@WX,^-'[3%K\1M?TOX@_$"W^'/A#P=\(]$\,>)/'VL
MZLVAZOXAU'58-(\6>,_ FE+X<T&PTD)KFJR:ZAL[W5M"LH[>>XU2W2OPU_XC
M3?\ @E9_T1+]O3_PU/P#_P#HG:_(W_@O%K6M_P#!6?\ X*7?M=_"+PMJE]<?
MLT_\$;OV!OVHOB;XSU/3;B3^S)_CKX>^&>H^(M9AMKD$0QZQ<_&!OA9\.-:T
M>8+<3Z3\'_'%Q:"6&*:5/X:Z /\ 5$^&'_!WQ_P3[^-OCC0OAE\&_P!D[_@I
M7\5OB-XHN'M?#G@3X<_ #X/^-/%^N7$4,ES/'I7AWP[^TAJ.K7QM[:*:ZN3;
MVDBVUK#-<SM'!%)(O[Z_LE?M9ZO^U5IWC+4M4_9(_:__ &5$\)2^'DM+/]K7
MX<^!OAUJ/C5-?BUB22?P;9>#OBA\2)KN+P__ &3''XA76AH,]E+K&CK;0WPN
M+AK3^'7_ (,>O /AC5/C'_P4&^)U[I%A<^+_  7\./V?O!7A[7)K:&34=*T'
MXB^)/BKK/BK3[&Z=3-;6^L7OPT\*2W\<+(MRVDV?FAO)3'^B30 4444 %?E=
MXJ_X*Q_ 3PG_ ,%7OAU_P2AOH5?XH>/_ (#:W\51XU77+=--T7Q_ 9?$/ACX
M,WNB-8;_ /A(?$GPMT3Q7\1_[2DU> 6EE;^%-+MM+U*X\5K<:7]^?'3XS> O
MV=/@Q\5?CW\4M670_AU\'/A_XL^)/C34SL:6W\.^#M$O-=U-;.&22(7>I7-O
M9/:Z7I\;B?4=1GM;&V#W%Q$C?XI'Q-_X*#_'KXA?\%#]?_X*31:U)H_QUO/V
MB;/]H3PU(;F>\L?#-[X=\26>J^"/!4;%H)K[PEX5\.:3HG@2#3[A@E]X4TQ-
M-O!)%-,K@'^X917SI^R-^TMX"_;'_9C^!G[4?PRG$G@OXX_#?PUX^TNU-Q'=
M7.AW>KV*?V]X4U.:)5C.M>#O$,6J^%==2-0D.LZ-?0KD1@U]%T %?D-_P56_
MX+3_ +*O_!(#_A0__#37@CX]>,?^&A_^%H?\(3_PI#PIX!\3_P!G?\*E_P"%
M=_\ "2?\)/\ \)Q\3_AQ]A^V?\+,T#^Q?[+_ +9^T_9=6^V_V=]GM/MWZ\U_
M"=_P>;?"+Q]\?OBY_P $;O@=\+-#E\2?$GXO>._VK_AQX%T*)UA_M/Q3XRUK
M]CO0=%MIKF3]S96C7]]"U[J%RR6FGV:SWMW)%;02R* ?7_\ Q&F_\$K/^B)?
MMZ?^&I^ ?_T3M'_$:;_P2L_Z(E^WI_X:GX!__1.U^FO_  3(_P"""?[!W_!.
MOX/>#=$E^#'PR^.?[0\>DV-U\2OVB/B=X'T7QAXHUOQ=+%%+JP\ P^*K35X_
MAMX,M+M?LF@Z#X833[J;3;2RNO$]_KNOM>:K<>-?\'.'@/P/H/\ P0S_ &W[
MO0_!GA31;JRMOV<EL[G2?#ND:=<6BR?M:_ :"1;::SLX9(%>"62%Q$R!HI'C
M8%'8$ ^+_P#B--_X)6?]$2_;T_\ #4_ /_Z)VC_B--_X)6?]$2_;T_\ #4_
M/_Z)VO\ +YK_ $J/^#+'PIX6U_\ X)^?M0W.N^&M UJYA_;&U6"*XU;1M.U*
M>* ?!3X02"&.6\MII$B$CN_EJP3>[MMW,20#U[_B--_X)6?]$2_;T_\ #4_
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MH6IZ9:Z3_;NJ3/H4^A6&A:CIU_<:TC274%I^&O\ Q&F_\$K/^B)?MZ?^&I^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='
M?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\
MY1?^[)O_ '[BO[_* "BBB@ HHHH *_P+O&W_ ".?B[_L9]?_ /3K=U_OHU_@
M7>-O^1S\7?\ 8SZ__P"G6[H _K*_X,LO^4JGQL_[,,^*W_J^OV8Z_P!0>O\
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MO/:7<$-U:74,MM=6MS$D]O<V\Z-%-!/#*K1S0S1LT<L4BLDB,R.I4D'\E?\
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M^4G_ (/'O^41>B_]G<?!C_U$OBO7]6U?RD_\'CW_ "B+T7_L[CX,?^HE\5Z
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MR$EU/P1XQLM!\7Z2KYC.IZ):>8K)N4_W9U_';_P:$?\ )._^"G__ &?5J_\
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M>*[73-&T_P 46.DV?]W7_!O-_P H7?\ @G]_V1S4/_5A>-*R/^"N7[%?C?\
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M\1/BUXWOETSP9\+O OBWXB>+M2<J$T_PQX)T#4/$NOWK%RJ!;72M,NYR695
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MN]8\-6&G>(+SP_XADL7\)6_AJSU#5].U?3OY_O\ @TD_Y31?"/\ [(Y\?O\
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M*_&C_@G%_P ',/PU_90^.MO8R^+/ G@WX^WNC>*-$%RWACX@^!]=^ /CR_\
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MW0)I?@3XN3+>:WHY53IVA^.$\0^'P^EV&L^"=(E_D$TG5M4T'5--US0]2O\
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MM" JQJH /'_^"P?_ "BC_P""DG_9CG[47_JF?&%?XD5?[;O_  6#_P"44?\
MP4D_[,<_:B_]4SXPK_$BH _OD_X,:?\ D/\ _!3+_L#_ +(7_I;^TO7^@I7^
M?7_P8T_\A_\ X*9?]@?]D+_TM_:7K_04H *_F9_X.E_VX=>_9O\ V +7]EWX
M1RWU]^T5_P %!_%7_#.W@3P]H)>7Q+/\.[U]-B^+EWI5G$?-O'\0V&M^'?A(
MMJB^=-+\4EGM,RV3-'_3-7^>3\8?@M^T[_P<9?\ !:;]I;XG_LG_ +1%E^SU
M\'/^"8__  A/PT^!'QTFT35/%%C:^/O"WC759K37_!5OI&H:7#)X@\8>/]$^
M)'Q T;QC:W)N-/\ "/A?X?P7$;ROI%S  ?V8_P#!+']A_0?^"=G[!G[.W[*.
MEQ6,GB#P%X)M=1^*&LV 1XO$WQA\72/XG^)VNK= >;>6,GBW4]1T[P_)<O+-
M:>%M-T+3!(8+"%5_G=_X/'_V!/\ A=O['7PY_;E\$Z+]I\?_ +)/B%?#/Q'F
ML[?=>:G\!OBAJMAICWEV8E>YO%\ _$E_#E[8P!!;Z9HOC3QQK%S+%!;RL>I_
MX<D_\%]_^E@_XD?^$Y\1?_FWKCOB'_P0'_X+??%KP)XP^&'Q,_X+R>+/'7P\
M^('AO6/"'C7P;XF\&>/M5\/^)_#.OV,VFZSHFKZ=<^-7@N[#4+&XFMYXG7E'
M)4JX5@ ?YFU?ZG?_  :,_M__ /#47_!/:\_9=\::W]N^*_[$>M67@:S2\N/,
MU'5O@1XQ;4M8^$NH@R,K2Q>%KFQ\5_#9+>UB:#2= \)>$1<R^?JD0;_-<_;)
M_99^(G[$O[4GQS_92^*BQ/XW^!WQ UGP5J.I6MO/::?XDTVW:.^\+^,](M[H
MFZBT+QOX5OM%\7Z$EUBY&CZW9?:%6;>H_2+_ (-[?V__ /AWI_P4W^"7C[Q+
MK?\ 9'P8^,=S_P ,]_'1[BX\C2[/P/\ $G4M,MM(\7:B\C>1;6OP]\>V7A+Q
MKJ-]Y,MU'X=T?7]/M=G]J3;@#_8^HHHH *_ C_@Z%_Y06?MT?]</V;__ %KK
MX!5^^]?@1_P="_\ *"S]NC_KA^S?_P"M=? *@#_'^K_3'_X,F_\ E'M^U+_V
M>7JW_JD?@[7^9Q7^F/\ \&3?_*/;]J7_ +/+U;_U2/P=H _LQHHHH *_R;/^
M#M__ )30?%?_ +(Q\ O_ % K:O\ 63K_ ";/^#M__E-!\5_^R,? +_U K:@#
M^?W]G;_DX'X%?]EC^&/_ *FVB5_O*U_@U?L[?\G _ K_ ++'\,?_ %-M$K_>
M5H _B+_X/=O &I:E^R=^Q-\488)'TGP;^T-XZ\!W]PJYC@O_ (D?#=M?TN*1
M_P"%IX/A9JK1@\-Y#\Y !_S>Z_V??^"['[#.I_\ !0C_ ()B_M'? GPAI9U?
MXKZ+HMC\8/@K911B6]OOB=\*KEO$NF^'=,5E*#4O'>@1^(_AU9R.8XX9?%XF
MDFBC1I%_QAYH9K:::WN(9;>XMY9(9X)HWBFAFB<QRPS12!7CEC=622-U5T=2
MK $$4 ?Z>_\ P98:W;7O_!+OXZ:*L@^V:'^W-\2'FAR"RV>J_ S]G6>TF(SD
M++<0:A&N1R;=B">@_K\K^ ;_ (,@?CYIXC_;O_9=U&^CCU5W^$_Q\\(:;YF9
M;S3XU\0?#SXCWPB+ K'IMS+\+(#(BMN;50LK)LA$G]_- !7->--9M_#G@[Q9
MXANY4@M="\,Z]K-S/)]R&WTO2[J^FE?K\D<<#.W!X!KI:_.W_@KA\>-._9G_
M ."9'[=/QFO[Y-.N/#7[-/Q1T?PU=2%53_A/?'_AVZ^'7PXMV+$ B]\?^+/#
M5EM!+M]HVQAG*J0#_$9K]K_^#=#X?:E\2?\ @M+^P7HVG023'0_B?XA^(-](
MBYCM=-^&GPT\;^/;N>=S\D4;#P\EM&SD;[FXMX(]T\T2-^*%?W>?\&6?[!VM
M:K\2/C__ ,%%/&>BS6_A7PCX<NOV=/@G=7MNRPZSXQ\27&B^)/BKXETII(T8
M_P#")^'-/\->$XK^!Y;2[?QUXET[/VO2+E80#_0\K^0W_@I'_P K4_\ P15_
M[('\1_\ TW?M-5_7E7\AO_!2/_E:G_X(J_\ 9 _B/_Z;OVFJ /Z\J_(K_@LQ
M_P $FOA5_P %:OV4]5^$WB$Z5X4^./@-=4\5_LX_%^YM&>Y\">.Y;2-9M#UJ
M>VBEO[GX<^/4L[+1?'6DPI<[8H=*\3V-C<^(/"VA^7^NM% '^##\=_@9\5?V
M9_C#\1/@)\;_  ;JO@#XK_"OQ/J'A'QMX3UB-4N],U;3W4B2">)I+74M)U.T
MDMM6T+6].FN=)U[1+[3]:TB\O-,O[2ZF^U?^"47_  4V^,G_  2J_:S\)_M$
M?#-[K7_!U[]G\*_'#X3R7[VFB_%CX77=[#-JVA7!8/!8>)M)9!KG@7Q(899?
M#_B2UMVN(K[0;[7M%U;_ $)_^#E3_@AE:_\ !1;X/3_M3_LW>%[=/VV?@?X8
MG']C:7;1Q7/[1?PPTA)[Z?X=7HC53=?$/PVC7=_\+M3??-J3RWO@+4/-MM7\
M/:AX6_RL;NTNK"ZN;&^MKBRO;*XFM+RSNX9+:ZM+JVD:&XMKFWF5)H+B"9'B
MFAE1)(I$9'564@ '^D#_ ,$4/VB_A/\ M;_\'(G_  5)_:3^!OB+_A*?A3\8
MOV0OAMXP\':P]N]G=FRN[/\ 90M[S3-6L)&:33-?T#5K74- \0Z5*SRZ5KNF
M:AITKM);,Q_MOK_,[_X,FO\ E(+^U/\ ]F;ZE_ZNSX0U_IB4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM$TC1M/@N;;3_P"V/%%SHOAS5OY1/AE_P0/_ .#GE].LO!NN_P#!7+5/A?X
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M(H55 554!555& J@8        &!2T (S*BL[L%5069F(5551DLQ.   "220
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M*:):*<-=:OXA\07NGZ1IMN"<&>\O(8P>"U?YY?\ P<@?\'(7P]_:5^'GB?\
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M#NK1$VOB+P7XJL8)KA=)\7>$-:AO= \1:9YTT=OJ5C,]I<WEA+:7MQ_$S_Q
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M!J4VL:>LMA;WS>*K4Z5+*MZMM>F/[._\P_[?7_!MY^W3_P %,M7\*W_[7O\
MP6NN_'FB^ Y+Z?P-X$T/]@7PWX'^'_A6[U.&"#4=2L/"WA/]J32K._UN\A@6
M&3Q!X@;6=>CM&?3[?4X=.86@ /\ +PK_ %2?^#.;6;#4_P#@D1J%C:7$4USX
M=_:P^-&D:I$CJSVE[<>'/AEK\4,R@DQN^FZW87*JP!,4\;@88$_EE_Q Q_\
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M9TN^B@O=-U72]0MKBQU"PO(8;JSNX)K>XBCEC=!_M4U_-G^W7_P09T7XQ?\
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M>AA?0KGXT:5^T1JFL6^L7,(B27QIK_ASQAX@N)$:[U275+V::X< _86BBB@
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MX?M]7L-.UE-*&K:=8WMO^.W_ ! Q_P#647_S2;_\KB@#D_\ @QOU>Q@\<_\
M!2+0)+B-=2U+PG^RUJ]I:EU$TUCH>L?'NRU&XC3.YH[:X\0:7'*X4JC74(8@
MR*&_T**_BD_9$_X-,OVG/V#_ (PV'QW_ &3_ /@M!X@^$'Q,LM-N]"N=7T?]
MB#2M4TS7_#E_/:W-_P"&?%OA;Q%^U1J_A?Q;X=N[NPL+Z31O$6CZE8Q:EI^F
MZM;10:KINGWMM_2M\*O@-_P4,\,_!_XV^#_BU_P4'^'/Q4^+OC'P]8:;\#OC
M+H7[$7ASX:6?P3UZ&SUJ'4?$GB+X:0_'7Q=HOQ>-[=7FB7MMI%WK/@BRL3HL
M]N[WL6K2&S /AG_@XD_X*?Z1_P $V?V /';^$_$T&G?M-_M&:9KGP?\ V>M*
MM+Q(M?TF]UG3Q9^./BS;Q(_VFULOA9X9U&34]/U7R9K1/'NI>!=)NT\G5I'C
M\I_X-3/V?O _P9_X(X? SQSX:6QN_%7[2/B[XJ?&3XC:U:^7+)=Z[:^/]>^%
M^B:2;H;IO)\.^$/AWH.GS6#OY-GKS:_-%%'+>W+2_FO^U7_P:1_M+_MO_%G4
M?C?^U5_P6E\6?&;XEZC:1::FN^)OV+;2"ST71K>:>XMO#_A3PUHW[5NF>%_!
MWANVN;J[NX/#WA71M'T:.]O+V^%E]LO;N>;[!_89_P""!_\ P4H_X)T>#KCX
M:?LM?\%T-1\,?"JZUF\\02?"[Q=_P3X\#_$GP1;:OJ+(^HWFA6'CK]I?7+[P
MDVI3)]JU.+P?J6@0ZG>O)?:A'<W<CSL ?U445R7@#2O%^A>!/!.B?$+Q;8^/
M_'VC^$?#>E>./'>F>&(O!.F^-?%^GZ-96GB7Q;I_@R#5M?@\(V/B36H;W6;3
MPQ#KNM1:!!>QZ5'JVHI:"\FP/C'X=^*'BSX8^,?#GP7^)>C?!WXI:MI8MO!G
MQ-\0_#V'XKZ+X/U7[5;2G5-0^'=QXH\%0^*X#:1W-K_9LGBG15$ERES]K)MQ
M#* ?P"?\'JO[$6E^%?B3^S7_ ,% ?"=C;V8^*=G=?LZ_&$0QK#]M\8^#=-OO
M%?PK\12[5+7NJ:QX+C\8>&M1N)&C^S:5\/\ PO;Q)(&E:+^$ZO\ 4U_X*#?\
M&\O[?/\ P4[M?!NB?M;?\%I+3Q5X*^'NJWFO^#OA[X3_ .">GA7P'X+T?Q#?
MV3:;<^()M.\-?M26=[KVM#3I)M/LM1\2ZEK,^D65WJ-MHS:?#JNJ+>?F-_Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU_\ HJJ/^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%57X _\05/_  5-_P"B^?L
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M (@J?^"IO_1?/V /_#I_M%?_ $*M '[_ '_$:M_P2R_Z('^W_P#^&L_9U_\
MHJJ/^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%57X _\05/_  5-_P"B^?L ?^'3
M_:*_^A5H_P"(*G_@J;_T7S]@#_PZ?[17_P!"K0!^_P!_Q&K?\$LO^B!_M_\
M_AK/V=?_ **JC_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /155^ /_$%3_P %3?\
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M!_X=/]HK_P"A5H_X@J?^"IO_ $7S]@#_ ,.G^T5_]"K0!^_W_$:M_P $LO\
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M ,.G^T5_]"K0!^_W_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1
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M^B^?L ?^'3_:*_\ H5:/^(*G_@J;_P!%\_8 _P##I_M%?_0JT ?O]_Q&K?\
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M_P"A5H_X@J?^"IO_ $7S]@#_ ,.G^T5_]"K0!^_W_$:M_P $LO\ H@?[?_\
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M-9^SK_\ 155^ /\ Q!4_\%3?^B^?L ?^'3_:*_\ H5:/^(*G_@J;_P!%\_8
M_P##I_M%?_0JT ?O]_Q&K?\ !++_ *('^W__ .&L_9U_^BJH_P"(U;_@EE_T
M0/\ ;_\ _#6?LZ__ $55?@#_ ,05/_!4W_HOG[ '_AT_VBO_ *%6C_B"I_X*
MF_\ 1?/V /\ PZ?[17_T*M '[_?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ/\
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M  2R_P"B!_M__P#AK/V=?_HJJ/\ B-6_X)9?]$#_ &__ /PUG[.O_P!%57X
M_P#$%3_P5-_Z+Y^P!_X=/]HK_P"A5H_X@J?^"IO_ $7S]@#_ ,.G^T5_]"K0
M!^_W_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^S
MK_\ 155^ /\ Q!4_\%3?^B^?L ?^'3_:*_\ H5:/^(*G_@J;_P!%\_8 _P##
MI_M%?_0JT ?O]_Q&K?\ !++_ *('^W__ .&L_9U_^BJH_P"(U;_@EE_T0/\
M;_\ _#6?LZ__ $55?@#_ ,05/_!4W_HOG[ '_AT_VBO_ *%6C_B"I_X*F_\
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M_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^SK_\
M155^ /\ Q!4_\%3?^B^?L ?^'3_:*_\ H5:/^(*G_@J;_P!%\_8 _P##I_M%
M?_0JT ?O]_Q&K?\ !++_ *('^W__ .&L_9U_^BJH_P"(U;_@EE_T0/\ ;_\
M_#6?LZ__ $55?@#_ ,05/_!4W_HOG[ '_AT_VBO_ *%6C_B"I_X*F_\ 1?/V
M /\ PZ?[17_T*M '[_?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ/\ B-6_X)9?
M]$#_ &__ /PUG[.O_P!%57X _P#$%3_P5-_Z+Y^P!_X=/]HK_P"A5H_X@J?^
M"IO_ $7S]@#_ ,.G^T5_]"K0!^_W_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_
M (C5O^"67_1 _P!O_P#\-9^SK_\ 155^ /\ Q!4_\%3?^B^?L ?^'3_:*_\
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MLZ__ $55?@#_ ,05/_!4W_HOG[ '_AT_VBO_ *%6C_B"I_X*F_\ 1?/V /\
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MLO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^SK_\ 155^ /\
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M!_X=/]HK_P"A5H_X@J?^"IO_ $7S]@#_ ,.G^T5_]"K0!^_W_$:M_P $LO\
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M ,.G^T5_]"K0!^_W_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1
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M^B^?L ?^'3_:*_\ H5:/^(*G_@J;_P!%\_8 _P##I_M%?_0JT ?O]_Q&K?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO
M^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC
M_P"<HO\ W9-_[]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_
MX.CO^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /
M_@QC_P"<HO\ W9-_[]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K
M_7Z_X.CO^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\
MK^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?@#_P='?\H*/VYO\ NV;_ -;#_9]K
M_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)O_?N
M*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?@#_P='?\H*/VYO\ NV;_ -;#
M_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)
MO_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110 4444 ?B;^UU^W_ /\
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MBBB@ HHHH **** "OR*_X+6?\%3])_X)'?L:R_M%K\/T^*7Q \9?$+0_@_\
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M^LV>B:-%X;?3M-:XAUN?5#J\$>DR6MW_ "U_MA_\'3O[6_[ GC:S\ ?M>?\
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MUFQCN(9[GP[K3Z3XBCLY([\Z5]@EANI/>?V%O^"W?_!2;_@HE\-U^,_[.?\
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MK)+D6T72T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVTJS\4Z1::MI.CN$FN6U3Q+>"\BT_3O#^@KJFK:UJA73]$M-1NI8(I/\7_\
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MT02:9K%B\6J^']2U?1[BVU";^<7_ (*Q?\&N_P#P3CN?V(?CE\1/V,?@G?\
M[/\ ^T'\$OAEXL^*7@B[\.?$7XG^+]%^(2?#[0[SQ-J7P\\5^'_B-XP\96ES
M)XIT?3-1TO0M=TE]$UO3_$]UH]_J6JZCHUO?Z1>_R^_\&E_[67C'X!?\%9/
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ML]E<QCR=3O+74(I#MEME(8+^IE?Q-?\ !D9_R9U^V=_V<OX8_P#56Z+7]LM
M%6^OK+2[*\U/4[RUT[3=.M;B^U#4+ZXAM+*QLK2%[B[O+R[N'C@M;6U@CDGN
M+B>1(884>21U168?SL?'_P#X.A/^":'PI^)US\%?@FGQ\_;H^*5K<W=A+H/[
M&OPPA^)FC?;[%F^UQ6'BW7?$7A#1/%MG!&OFOK'PYE\;Z25=0EXS+.(/Y[/^
M#H7_ (*\?%C]HO\ :,M_^".W[%^M:O-X;M?&/ACX;_M 7'@V]>#5_C7\</%>
MJ:=IFB? *UO+29&E\'^$-3U/3--\7Z49UC\1?$6XN= UBUCM?!*?VM_7K_P2
M6_X)4? 3_@E3^S)X3^$OP[\/>'M7^,6LZ'I5]^T!\<4TN)?%?Q5\>M;QSZJ?
M[6N8VU2Q\ :%?O/8^ _!R31:;HNDQ+?7%M<^)M5\0ZUJH!^>WP9_X.GO^"=G
MC'XM:=\#_P!HSP+^U%^P=X_U.>RMK9_VM_A/9^"?"D4^I2&'3_[7UOP_XG\3
MZEX4L;B=6CDU_P 9^'O#?A>Q0&YU#7;6UCN)H?\ .A^+VHZ?J_\ P6E^*&K:
M3?6>IZ5J?_!4+QKJ.F:EIUS!>Z?J&GWO[5VIW-G?6-Y;/+;7=G=VTL=Q:W-O
M))!/!(DL3O&ZL?\ 67_X*B?\$T_@-_P4_P#V6_'?P*^+7A7P^_C?_A'M;O/@
MA\5[C3;<^+/A#\2_L+R>'/$>AZW' VJP:%/JT%A;^-?#MO.MAXJ\._:]-O83
M-]BNK/\ QQ?V>_"^N^!_VT/@?X*\46$FE>)?!_[3_P -/"_B+3)61Y=.UWP_
M\5M%TG5["5HV>-I+/4+2XMW:-V0M&2K,I!(!_NLU!=75M8VUQ>WMQ!:6=I!-
M=7=W=31V]M:VUO&TL]Q<3RLD4$$$2/+--*ZQQQJSNRJI(GK^''_@OK^W1\;?
MV[O^"A7P3_X-_P#]CSQY>^ ]"^(WB_P7X<_:\^(.@2W!OM4?Q1ID7C76? <\
MNGS1377@+X8?"A;CXA?$+1K6[0^,-9DC\'ZJ+.U\+ZI:ZP ?K)^TY_P="_\
M!+O]G_QUJ_PN^'FO?&']LOXAZ%)=V^LZ/^R'\/;7XD:!IEU9OY<^[Q[XA\1^
M"O!6OV$#L@N=5\"ZUXQL;=G\EY3=)+;I\M?"#_@\@_X)=>.O&$'A#XI_#_\
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MTWP=\=-:@&F?"WQYX9M9Y5BTW5/$VO)I/PX\51V;01Z[I&N:3?ZG%J-[X/\
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MXCT2QU2U9)I;>X%EK%C%=P%+BVDCF@F$%PI6:WE26*3#Q2*ZJP_@U_X.3O\
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M'P?X':]MWM[C3K/Q[XP\,:AJEG=V^H:79WNGL]U'_ 7_ ,&O7_#:?B/]H_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._
MY04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^
M<HO_ '9-_P"_<5_?Y0 4444 %%%% !7^'E_P5&_Y29_\%%/^SZ_VN?\ U?\
M\0:_W#:_P\O^"HW_ "DS_P""BG_9]?[7/_J__B#0!_LL_L"_\F*?L5_]FE_L
MX_\ JG?!M?6E?)?[ O\ R8I^Q7_V:7^SC_ZIWP;7UI0!_C??\''4:Q_\%L?V
M^548!^(_@B0_[TOP9^&LKG\6<D^I.:_UU?V:?^3<O@!_V1/X5?\ J":#7^1;
M_P ''W_*;+]OC_LHG@3_ -4K\,J_UTOV:?\ DW+X ?\ 9$_A5_Z@F@T =9\6
M;6"^^%?Q,LKJ-9;:\^'_ (SM;B)@"LD%QX<U*&:-@P*E7C=E((((."".*_QT
M/^#?N1XO^"S'_!/EHV*L?CK;1DCNDWA3Q-#(OT:-V4^Q-?[&_P 3O^2;?$+_
M +$?Q9_Z8=0K_'%_X-_O^4RW_!/C_LO%E_ZC'B2@#_9RK_&\_P""M/\ P3U_
M:D_X(W?M^>(=>\-)X\\ _#^[^*NN?$_]CW]HOP5<ZKH]K=^'VUR?Q#X;T_1_
M&>DM =&^)GPZMKJUT/Q;H+7%EJUO=62:[:V4WA;7M#U+4?\ 9#KY1EL_V0O^
M"D7[,\;ZEHOPU_:B_9A^+MOJ\%O!XB\/KKOA'Q"_AO7]7\+:C=6MEKUA;:AI
M6N>&O$^BZO86NJV\&FZ[H.M:;)<Z;=V=Y;Q7"@'\./\ P38_X/+_ !IX5MO#
MGPO_ ."F?PMG^(FEVZ6FEC]I?X)Z9IFE^.8XU"0+J?Q'^$DDVE^%_$DK.YN=
M4UWX?:CX0FMK*W*V/@#7]2E9I?[6?@E\;_V#_P#@IS\._AE\;O@SXS^%'[3G
M@_X6?$;0?BCX"UFR/VO7_A)\6]'T;6M.T+6=4\,:M#IWB[X<>/=/T+Q%KEM!
MIOBG1M%UC^R]7N9/L4EE=I*_\>G_  5!_P"#-W3GM/$WQ=_X);^.+FVO85O-
M5D_9/^+_ (@^TVEVJK)-_9/PC^,.K2BZLYP$CMM+\.?%B>^BNII9;C4/BGI\
M4<-H_P#(#^R?^U?^V7_P1]_;)7QWX(3QC\'_ (R?"?Q2WA+XQ?!KQK:ZMH.G
M^,=&TW4(F\2_"OXK^$KD6[7VBZI%&?)DF@^W:->-I_BKPM>V.L6.E:K" ?[=
ME?Q5_P#![<BG]B/]C^0@;T_:HU-%/<+)\)/&3,,^A,2$^N!Z5_75^S;\=/"7
M[3W[/GP0_:-\!K<1>#?CK\*? /Q9\-VMX\;W^GZ3X^\,:9XFM=+U(Q8C75-)
M34O[-U2)0ODZA:W,)560J/Y&/^#VW_DQ_P#9!_[.KU#_ -5%XUH R_\ @R,_
MY,Z_;._[.7\,?^JMT6OZZ/VK?C9;?LU_LO?M'?M$W<$-W;_ CX$_%KXPO97!
M80WY^&W@+7_&,>GN$99'^WR:.EFL<;"65YECB_>,HK^1?_@R,_Y,Z_;._P"S
ME_#'_JK=%K^EG_@K=X0UCQY_P2X_X*'>%/#\,UUK>J_L8_M'_P!EV5NK-<:A
M>V/PH\4ZE!IENB\O/J3V8L(4X#RW"*Q"DD '^6-_P0CM+_\ :#_X+E?L2:[\
M3+^?Q9XD\3?M(Z[\9_$NM:O*);W6O'7A3P]XU^,@\0WLS "74IO&'A^#67<
M&2] *@,PK_9%K_% _P""+WQOT/\ 9U_X*K_L&?%GQ/>VNE^&-'_:,\"^&_$N
MKWTPM[#1/#OQ(N9OAIKFO7\Y($-AH>E^+[O5KV0DA+6SE8JP&T_[7] !7^*G
M\;$2/_@ME\7(XT6../\ X*F>/41$4*B(O[6FK*J(J@*JJH 50      *_P!J
MRO\ %4^.!"_\%L_B^Q. /^"IOQ ))Z #]K35B2?H* /]JNO\@S_@G=!\9_\
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MX8\?^$_#'COP3KVE^*?!OC3P]HWBSPEXFT2[BO\ 1O$7AKQ%IUMJ^A:YI-]
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M5[VSTJ.]N(_\O3]B#_@HU_P4"_X(R_'SQI#\(M5U[X9>(['75\/?'/\ 9O\
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M_!#_ )(M\(?^R7^ /_44TFOQ!_X.FO\ E!A^V?\ ]A#]FK_UJ[X(4 ?RX_\
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M'=(\):*]_)9_'^TMW;3_  YH.CZ3 T=O&3;6$/F%Y=\C_P!+O_!*3_@GTO\
MP3 _8Q\$?L>P?&"\^.&G^!?%'C_Q#IOCF^\%1?#^9[;QYXJU#Q;-I(\-P^*_
M&44":?J.J7VVY36W^UF=I6MK=LJWZ-RRQ0123321PPPQO+++*ZQQ111J7DDD
MD<A$C1 6=V(55!9B ":^6?V-/VO_ (5_MT? ^U_:'^"4'B1_A=K'C_XL^!?"
M6O\ B*QT^RB\;6OPE^)?BGX87OCGPN=.U358KWP5XIU7PG?ZGX6O[F6SU*XT
MN6+^T]*TN_2XLH0#ZIHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;N31-?M[/]EM;'7]&:\MK6]_LK6K6_L%OK6UO5MQ=6T$L?\ 29\/?"=UX#\
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M'[07P0\&Z[+I=U)#+>:/?7FB?LPV;ZEHM]);V[7^C:B+K2[XP1"[M)A&@']
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'X _\ !T=_R@H_;F_[MF_];#_9]K_(%K_7Z_X.CO\ E!1^W-_W
M;-_ZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_ '[BO[_*_@#_ .#&/_G*+_W9-_[]
MQ7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]ABES,=][&@N[A/+@F=H;: * ?VV45_$[_PZ>_X.P_\ I,M\$_\ PY?Q<_\
MH5*/^'3W_!V'_P!)EO@G_P"'+^+G_P!"I0!_;%17\3O_  Z>_P"#L/\ Z3+?
M!/\ \.7\7/\ Z%2C_AT]_P '8?\ TF6^"?\ X<OXN?\ T*E ']L5%?Q$WO\
MP2._X.P;N^TJ[/\ P66^#N=.FN)5\CXS?'/38/W\!A/VO3+#]EI-/UQ,?ZNW
MUB.6"T?_ $FV"W #5J?\.GO^#L/_ *3+?!/_ ,.7\7/_ *%2@#^V*BOXG?\
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M]Y^RN[P19;]U90D6EDFVWM$2"-%%K_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4
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MVWY_?:5=E].OAB.\C= !0!_;M17\3O\ PZ>_X.P_^DRWP3_\.7\7/_H5*/\
MAT]_P=A_])EO@G_X<OXN?_0J4 ?VQ45_$[_PZ>_X.P_^DRWP3_\ #E_%S_Z%
M2C_AT]_P=A_])EO@G_X<OXN?_0J4 ?VQ45_$M=?\$F/^#L.XM;FW/_!9;X+X
MG@FA/E?%3XRV,N)8V0^7>VG[*R7=I)\WR75JZW%NV)8661%(EC_X).?\'8:(
MB?\ #Y;X*?*BK\WQ.^+\K?* /FDD_95,DAXY=R7<_,Q+$T ?VR45_$[_ ,.G
MO^#L/_I,M\$__#E_%S_Z%2C_ (=/?\'8?_29;X)_^'+^+G_T*E ']L5%?Q._
M\.GO^#L/_I,M\$__  Y?Q<_^A4H_X=/?\'8?_29;X)_^'+^+G_T*E ']L5%?
MQ$Z-_P $CO\ @[!TNQ6T7_@LM\'<+-<2_P"F_&;XY^(9_P!_.\QSJ>M_LM3:
M@Z9?]W;M(8+1-MM;!;>*-1J?\.GO^#L/_I,M\$__  Y?Q<_^A4H _MBHK^)W
M_AT]_P '8?\ TF6^"?\ X<OXN?\ T*E'_#I[_@[#_P"DRWP3_P##E_%S_P"A
M4H _MBHK^)W_ (=/?\'8?_29;X)_^'+^+G_T*E58?^"2W_!V%%/>3#_@LM\&
M,W4L4AW_ !8^,]S'F.WB@_<VL_[*[6^GIB,;X;%4BGDWW<P-S/,Q /[;**_B
M=_X=/?\ !V'_ -)EO@G_ .'+^+G_ -"I1_PZ>_X.P_\ I,M\$_\ PY?Q<_\
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M'+^+G_T*E ']L5%?Q._\.GO^#L/_ *3+?!/_ ,.7\7/_ *%2C_AT]_P=A_\
M29;X)_\ AR_BY_\ 0J4 ?VQ45_$7J_\ P20_X.PM3TV[L&_X++?!S;<HJ'['
M\8OCAH%S\LB/^ZUC1?V68=4L6^7F6SE21EW1,3'(X.A'_P $G/\ @[#1$3_A
M\M\%/E15^;XG?%^5OE 'S22?LJF20\<NY+N?F8EB: /[9**_B=_X=/?\'8?_
M $F6^"?_ (<OXN?_ $*E'_#I[_@[#_Z3+?!/_P .7\7/_H5* /[8J*_B=_X=
M/?\ !V'_ -)EO@G_ .'+^+G_ -"I1_PZ>_X.P_\ I,M\$_\ PY?Q<_\ H5*
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MQ._\.GO^#L/_ *3+?!/_ ,.7\7/_ *%2C_AT]_P=A_\ 29;X)_\ AR_BY_\
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M:I^RQ)J.H2<?/=WLCW,YR\S%R35W_AT]_P '8?\ TF6^"?\ X<OXN?\ T*E
M']L5%?Q._P##I[_@[#_Z3+?!/_PY?Q<_^A4H_P"'3W_!V'_TF6^"?_AR_BY_
M]"I0!_;%17\3O_#I[_@[#_Z3+?!/_P .7\7/_H5*JVG_  26_P"#L*V291_P
M66^#'[VZN;@^;\6/C/?'-Q,\IV/>?LKN\$66_=64)%I9)MM[1$@C10 ?VV45
M_$[_ ,.GO^#L/_I,M\$__#E_%S_Z%2C_ (=/?\'8?_29;X)_^'+^+G_T*E '
M]L5%?Q._\.GO^#L/_I,M\$__  Y?Q<_^A4H_X=/?\'8?_29;X)_^'+^+G_T*
ME ']L5%?Q$V__!([_@[!@U74=1'_  66^#NZ^ALXF\SXS?'.[M/]%5U'V?0[
MG]EIM'TE_F_?7&FQ1SWYP]Z7>-"-3_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4
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MW_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4?\.GO^#L/_I,M\$__  Y?Q<_^A4H
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M ,.7\7/_ *%2C_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4 ?VQ45_$[_P .GO\
M@[#_ .DRWP3_ /#E_%S_ .A4JJ/^"2W_  =A"]DN_P#A\M\&,O:PV_/Q8^,[
M08BEGD&W3F_97^PQ2YF.^]C07=PGEP3.T-M % /[;**_B=_X=/?\'8?_ $F6
M^"?_ (<OXN?_ $*E'_#I[_@[#_Z3+?!/_P .7\7/_H5* /[8J*_B=_X=/?\
M!V'_ -)EO@G_ .'+^+G_ -"I1_PZ>_X.P_\ I,M\$_\ PY?Q<_\ H5* /[8J
M*_B)O?\ @D=_P=@W=]I5V?\ @LM\'<Z=-<2KY'QF^.>FP?OX#"?M>F6'[+2:
M?KB8_P!7;ZQ'+!:/_I-L%N &K4_X=/?\'8?_ $F6^"?_ (<OXN?_ $*E ']L
M5%?Q._\ #I[_ (.P_P#I,M\$_P#PY?Q<_P#H5*/^'3W_  =A_P#29;X)_P#A
MR_BY_P#0J4 ?VQ45_$[_ ,.GO^#L/_I,M\$__#E_%S_Z%2JMY_P26_X.PKJ
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MW_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4?\.GO^#L/_I,M\$__  Y?Q<_^A4H
M_MBHK^)W_AT]_P '8?\ TF6^"?\ X<OXN?\ T*E'_#I[_@[#_P"DRWP3_P##
ME_%S_P"A4H _MBHKX-_X)K?!S]L;X#?LB^ ?AG^WG\<M!_:,_:8T;6?'5UXS
M^*_AK5=:UK2-=TK6/&6LZIX0L[?4/$'@_P ":I,^B>%KK2M(G6?PU9I%-9O'
M#+>1*EU+]Y4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^
MMA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_
M<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]
MVS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-
M_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?
MMS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_
M '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._
MY04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^
M<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\
M@Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X
M,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U
M^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_
M@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R
M!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO
M[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V
M?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?O]_P0Q_;Z_X*F_L.?\-1
M?\.T?V*_^&P/^%H?\*2_X75_QCC^T5^T!_PKO_A"O^%N?\*X_P"2!>,O"7_"
M)?\ "6_\);X\_P"1L_M#^WO^$9_XD7V3^Q=9^T_O]_P_T_X.FO\ I"O_ .<Y
M/^"BG_SY*/\ @QC_ .<HO_=DW_OW%?W^4 ?P!_\ #_3_ (.FO^D*_P#YSD_X
M**?_ #Y*/^'^G_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"
MO_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\ ?_#_ $_X
M.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?
M_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^4
M4 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\ .<G_  44
M_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\
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M_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\
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MG_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\
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MBG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\
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M/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\
M?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]
M_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_
M )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\
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M $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E%
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M_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\
MSG)_P44_^?)7]_E% '\ ?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-
M?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'
M^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_
M #Y*/^'^G_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YS
MD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\ ?_#_ $_X.FO^
MD*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3
M_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P
M!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\ .<G_  44_P#G
MR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_
MP44_^?)7]_E% '\ ?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5
M_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!
MTU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*
M/^'^G_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X*
M*?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\ ?_#_ $_X.FO^D*__
M )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:
M_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\
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MG_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\
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MBG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\
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M/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\
M?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]
M_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_
M )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\
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M $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E%
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M_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\
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M_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\
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MG_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\
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MBG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\
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M/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\
M?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]
M_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_
M )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\
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M $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E%
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M_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\
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M_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\
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MG_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\
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MBG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\
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M/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\
M?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]
M_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_
M )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\
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M $_X.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E%
M'\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E
M?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\ .<G_
M  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(
M5_\ SG)_P44_^?)7]_E% '\ ?_#_ $_X.FO^D*__ )SD_P""BG_SY*/^'^G_
M  =-?](5_P#SG)_P44_^?)7]_E% '\ ?_#_3_@Z:_P"D*_\ YSD_X**?_/DH
M_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^44 ?P!_\ #_3_ (.FO^D*_P#YSD_X
M**?_ #Y*/^'^G_!TU_TA7_\ .<G_  44_P#GR5_?Y10!_ '_ ,/]/^#IK_I"
MO_YSD_X**?\ SY*/^'^G_!TU_P!(5_\ SG)_P44_^?)7]_E% '\ ?_#_ $_X
M.FO^D*__ )SD_P""BG_SY*/^'^G_  =-?](5_P#SG)_P44_^?)7]_E% '\ ?
M_#_3_@Z:_P"D*_\ YSD_X**?_/DH_P"'^G_!TU_TA7_\YR?\%%/_ )\E?W^4
M4 ?P!_\ #_3_ (.FO^D*_P#YSD_X**?_ #Y*/^'^G_!TU_TA7_\ .<G_  44
M_P#GR5_?Y10!_ '_ ,/]/^#IK_I"O_YSD_X**?\ SY*/^'^G_!TU_P!(5_\
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M5/B]X=@T/Q[X"UR:"R;6O"VM/8WMO')<65CJFEZI8ZIX?\0:9I/B#2=4TNS
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M.]*NX$GT^:]%[>Z@9+R2!K:&W /]AZBO\!+[???\_MW_ .!,W_Q=?Z3V@?\
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M7=^$O_!7KX?ZYX4UWP_IGP>_:[^%VBVNK_$_X0VFHSWOA[Q+X<>XMM-/Q/\
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M6=16RMWDB-]JEU#:&TTG3(I!<ZIJ=Q::=:A[FZB1O5:_DY_X/%OVCM6^$/\
MP2V\._!SP]J$UG?_ +47[0/@CP+XCCAD\E[KX=^ =-UOXJ:[$)%83;9/&'A7
MX>6MQ"@$=Q8W=W!<.89&@N #_/,_X*9?\%#?C-_P4W_:U^(G[3OQ?O[NVMM9
MO9M$^%OP^%]+=:'\)OA3IEY<GPCX"T*,E;<-96LS:AXDU2WM[9O$OBW4-=\2
M7$$,VJ-!%^Z'_!GY^Q-H7[1__!1/Q=^T;XWT6#6O!_[%?P]L_&V@P7=NEU91
M_&SXDWVH>&/AC>7<$R- S:'H.D?$KQ9H\Q_TG3_%/ASP]JEF%GL5FA_DPK_2
MD_X,D?AU9Z9^Q)^V!\6DMT6_\;?M4:7\.[FZ"J))K/X7?"7P=XEL8&;&YDMI
M_B_J,D:DE5:ZE*@%FR ?VJ4444 ?SQ?\'/W[%VA?M;_\$F_CEXKCTF"X^)?[
M)EM_PTS\/-86W0WMAI?@:"0?%O2Y+I4-T-&U3X3W/BK4;NPCD6UN==\/>&-0
MO(Y#H]NT7^17:W5S8W-O>V5Q/:7EI/#=6EW:S26]S:W-O(LL%Q;SQ,DL$\$J
M)+#-$ZR1R*KHRLH(_P!X/]IGP+:_%']F_P#:"^&=] MS9?$7X(_%?P+>6SJ&
M2XM?%W@/7O#]Q ZGAEEAU!XV4\$,0>M?X.M '^M?_P &SG_!6;6_^"E7[&5]
MX$^-/B ZW^U3^RG+X>\"?$_6KV96U3XE^!=7M+T?#+XL7N]VFNM=U:TT35_#
M/CBZS-)=^*O#4_B6[:U_X2ZRLH?Z2:_R6_\ @T[_ &B]6^!__!8GX1^!H[^6
MV\+?M-?#[XJ?!'Q5;F3_ $.66'PE>_%3P?</;N?+:]'C/X;:)I-G<HOVFWAU
MN^AC<6]Y=QS?ZTE !1110 5_A@_\% @%_;S_ &VU4 !?VNOVD@ .  /C+XS
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M:-:[OLVE:#H&CVUIIFE:=;[V\FSL;:&"/<VR,9- '95_BV_\%V@!_P %A?\
M@HA@8_XR8\='\3):DG\3R?>O]I*O\6W_ (+M_P#*87_@HA_V<QXZ_P#1EI0!
M'_P0I_Y3!_\ !.[_ +.<\ ?^E-Q7^TM7^+3_ ,$*?^4P?_!.[_LYSP!_Z4W%
M?[&O[0'Q\^$O[+OP:^(GQ_\ CGXSTGP!\*OA;X:O_%/B_P 3ZS<1006MC9)B
M&QL87=)=4UW6;U[;1_#NA6(FU37]=O\ 3]&TJVN=0OK:"0 \>^"?[9?@3XY_
MM4_MI?LI>&?#^NV?BK]B2^^ .E^/O$][/ILOA[Q+J'[0'PTN_B?HMKX<2UN)
M;Z-_#>DVR:?KO]HPV_\ Q,YC%:B18)BO\]__  =;_L5^'OBA\$_V3/VV-$T2
MV3XD?LO?M._!_P %>+=?@MDCN;_X)_&#Q_HWA\Z?JMU%'Y]XGA_XKS>!I?#<
M-Y(;72AXM\7M:>5<:U<"X\D_X-2_VG->_;._:#_X+7_M4^([673M0^.O[0_P
M+^(-KHT\HGD\.^']8'[0?_")^%O/5Y!,GA;PM%HWAV*4._F1:8C[FW9/]CVI
MZ5IFM64NFZQIUAJVG3O!)-8:G9V]_93/:W$5W;/+:W4<L$CV]U!!<P,\9,-Q
M#%-&5DC1@ 7Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H
M[_E!1^W-_P!VS?\ K8?[/M?Y M?Z_7_!T=_R@H_;F_[MF_\ 6P_V?:_R!: /
M[_/^#&/_ )RB_P#=DW_OW%?W^5_ '_P8Q_\ .47_ +LF_P#?N*_O\H ****
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M\H1?V"O^Q(^)O_J^_BO7[CU^''_!ME_RA%_8*_[$CXF_^K[^*]?N/0 4444
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MR^*OB*[9A;V]E;)Y>E?"3X@ZE,TGA"2-4TKPAXIN)O F-+T[4/ 5A? '1_\
M!KK_ ,%SO^&//B-I/[ 7[4_C#[-^RQ\7O$Y7X.^./$5^5TW]G[XL^)+WYM+O
MKZZD$>D?"CXEZK< :P\CII/@WQO<P^+)ETW2?$/CK68_WE_X)R_\K7W_  6<
M_P"S;_ O_I#^R77^8+7]MO\ P9P_$SQ]\7O^"F/[6'COXG>+-9\<>,KW]A_1
MM!OO$_B&Z:_UK4-,\$?$#X#>!O"\.HW\@^T7\^F>%?#FBZ3]OO'GO[U+%+K4
M+J[OI;BYE /](NBBB@ K_,+_ .#UC_E*)^S[_P!F#_#3_P!:&_:@K_3TK_,+
M_P"#UC_E*)^S[_V8/\-/_6AOVH* /X^Z_P!\3X;_ /)._ 7_ &)?A;_TQV-?
MX'=?[XGPW_Y)WX"_[$OPM_Z8[&@#M**** "BBB@ HHHH ^!_^"K'_*+O_@I)
M_P!F#_MA_P#K//Q%K_#_ *_W /\ @JQ_RB[_ ."DG_9@_P"V'_ZSS\1:_P /
M^@#^\C_@QQ_Y*)_P4<_[$O\ 9C_]/GQPK_0PK_//_P"#''_DHG_!1S_L2_V8
M_P#T^?'"O]#"@ K^%O\ X/A+74'^!G[ %[$KG2K?XL?'&UO7"GRUU"\\'^ I
MM,5VZ!VMK'5S&IY94E(X4U_=)7\P/_!V_P#LN:M^T%_P28\0_$/PSILFH^(O
MV4OB[X%^.MQ':0F:_F\"S6NN_#'QW%$H!(L-+T_Q_8^-=9<8,.G>#9KDMY=N
MZ. ?Y0M?ZA__  9<O W_  2G^,"Q8\R/]NOXLI<XQGSS\$/V;9%W8Y!^S/;]
M>=N#TQ7^7A7^D/\ \&17Q1LM5_9*_;6^"R7*-J/@+]HOP9\4;BSW?O(K+XM_
M#2S\)V=R4S]R>?X*7T08#[UL0QX6@#^W&BBB@#,UMX(]&U>2ZP;:/3+][@$
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MZ\0^(;V.".)-L5EHVC64<&C>&M(T30K.RTNV^S** "O\AC_@Z=_Y3F_ME_\
M8,_9K_\ 65/@G7^O/7^0_P#\'45O+!_P7)_;"DD4JEYHO[-MQ ?[\2_LN_!N
MT9A[">UF3ZH: /R:_8'_ .3ZOV+/^SL_V<O_ %</@VO]T6O\+C]@EU3]N?\
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MPZAI6K:5J-G)#=Z?J6FWUO!>6-[:S17-I=0Q3P2)+&K#_7P_X-]?^"P&B_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M36NGV<4ES<1H0#XJ_P""K3*G_!+G_@I*[$!5_8&_;$9B>@ _9X^(I)_ 5_B
M5_J._P#!8#_@J[^T3\>OV*OCO^RU^QA_P2=_X*Q>,O'O[1'P]\1?"+7OB!\1
M?V"_COX"\">"O /CFPDT#QS=VMH_AO4_%7B3Q-J7A:]U;0]&T[^Q=&TFPN=3
M77;W6KH:6N@:O_GP_P##IW_@J;_TC3_;_P#_ !#?]HK_ .=S0!_61_P8XLH^
M(W_!1M<C<?!7[,K =RJZ[\;@Q'L"Z@_[PK_0QK_+S_X-_?%'_!2G_@D%^TM\
M1?&'Q1_X)'?\%)?B/\#?CKX)TCP5\2+3P'^QY\=QX_\ "][X8UF76O"GC#PQ
MINN^"=(T+Q)_9YO]=TK4_#>HZUX?-W::V-2M-<@N-(73-7_T1/V2?VS] _:\
MA\;2:+^SQ^V1\ I? L7A>2^MOVMOV8/B7^SE-KY\5'Q"(8O!,GC_ $ZSM/&<
MNB?\([-_PE'_  CUS?)X?&J^'C?O&-;L?, /LBN3\>^!?"/Q0\#>,_AIX_T&
MP\4^!/B%X5\0^"/&GAG58S-IGB'PIXKTF[T+Q#H>H1!E:2RU72+^[L;I%96:
M&=PK*2".LHH _P 6G_@L=_P2R^*7_!*3]KWQ9\%_$MEJ^L?!CQ9>ZMXM_9N^
M*MU;,VG_ !!^&,MZK6MC=:A'#%9_\)[X%%Y:>&_B#I"I;3VVJI:Z[;6:>&_$
MOAN]O_T6_P"#3_\ ;MT']D+_ (*96'PK^(.N0:'\,?VR_"*_ ZZO[^Y6UTK2
M_BO;ZO;Z_P#!G4KZ5Y%7?JNN)K/PVTX,K(FH_$>VFF:&WBFFC_TL_P!NW]@7
M]F3_ (*.? 77?V>?VH_ D7BWPAJ,C:EX<\0:=)!IGCSX;>+([>6WT_QO\.?$
M[VMY-X=\3:>DTD9=K>]TC6+"6ZT/Q+I&M^'[_4-)N_\ -W_X*#_\&H/_  49
M_9$\2ZOXT_95TN?]L[X+V%[/JWA_6/A>L.D?'CPQ96\_GZ?!XC^$T]]'J^N:
MY:L(HK:^^$UYXSDU"6 ZG+H_AOS4TZW /]56BO\ /^_8<_X.P/CO^R!X,\._
ML]_\%??V2/VB+_Q?X%LK;PW:?&O1/"#^$/C)K]EIL*6UI#\4/A7\6Y?A[I^N
M>++:",#5/&>E^+]%O-:2-;C5?"]WKC:AK6J?:?QC_P"#TG]AZP\-W-G^S-^R
M]^U1\9?BG?020^&_#WCO2?A_\,?",VIRQXM8]0UOP]XX^*'BJ7RY3OEL]*\$
M737*1-#%?6[2+/& ?3'_  =I_MVZ#^S#_P $TM;_ &<]&UN"+XP_MK:U:?#3
M1-)M[G9JNG_"7PQJ6D^*/B_XK>%3@Z3<V-OH7PUN$FPURWQ$>2T24:=>26O^
M6-X'\$>,/B7XR\*_#SX?>&=;\9^.O''B#2/"G@_PEX;TZYU;7_$OB37KZ#3-
M&T31M,LXY;J_U+4K^Y@M+2U@C>2::5$49-?T0^./V)/^"['_  <!_M3:E^TC
MX_\ V<?'^D0^+$L-&T#QO\5O#^L? C]G?X3_  UMKNYDT7PU\.YO'\<.J:YX
M0\/R7]U=74'@2P^(/C'6-4O=4\0:S'K.N:CJ5]-_;M_P19_X-T?V=/\ @E8+
M/XS^/M7T_P#:'_;*O=+GLI?BM?:,++P7\*;74H'@U71/@KX<U 3WNFW5Y:S2
MZ3K'Q$UJ4^*]<TPW-GIEGX-T76-;\/7P!]$?\$&/^"5ME_P2G_8=\/\ PT\5
M1:;>_M&?%N^M?BE^TCK^GRP7EO#XTO=.BM=%^'>DZE"TJ7OAWX7Z&5\/VMQ!
M<3:?JOB6X\7>*=.%O;>)5M8?VPHHH **** "O\,#_@H"ZR?MY?MM2(P9'_:Y
M_:1=&'1E;XR>,V5A[$$$>U?ZQ7[7_P#P6/\ $O[/Q^+7@OX,_P#!,#_@JA^T
MU\6? FK>*O"/A=O W[$OQAM_@=XM\3:!>WFEVFM6WQC&C7MMJOPVU.[M1?:?
MXN\%:!XN.LZ/-;7NDV,\%VEQ'_ET_$'_ ()J?\%:OB9X]\;_ !(\4?\ !-C]
MOF?Q-\0/%_B7QOXBFM_V,_VC(;>;7?%>LWNO:O+!$_P\E>*&34+^X>*-Y9&1
M"JM(Y!8@'ZS?\&?C*O\ P6&T@,0"_P"S5\<%0'^)A_PB3D#WV(S?137^K+7^
M1=_P21^$O_!5O_@F#^W7\)/VMU_X)/\ _!03XB^&_"D'BCPKX_\  ]K^R1^T
M-I&I^(/ GCK0+WP[KJZ)J4_PUEM;?7M':ZL_$>B1WJ"POM3T:VTV_FM+.\FO
M+?\ TQ/V/_\ @HEHG[8'BR[\&6O['O\ P4+_ &:]7L/!=[XTNK[]K[]C_P"(
MOP%\(F*PU;0-'E\-67CO7!?^#-5\933>((KVQ\-Z7KMY?W^D:5K^JVJR6>C7
MDB 'Z&T444 %?YA?_!YI^S+K_P -O^"B?PL_:6ATR<>!?VEO@1H6F#7/)VV\
MGQ,^#%_=>%O%.C-*FY3):>!=5^%VH1/,4DG&HW$42-'8N]?Z>E?G[_P4N_X)
MP_ /_@J+^R_XF_9H^/%M=Z?%-=Q^*/AM\1]$@MY?%GPG^)&FV=[9Z)XV\.K<
MLD%ZL=O?WNE>(/#]W+%8^)/#NHZEI4L]A<S66JZ> ?XJ'P<\>R?"KXN_"OXH
M10R7$OPW^(_@?Q[';Q%1+/)X/\3Z7XA2&(LRJ))6TX(A9E4,PRP'-?[PW@3Q
MQX3^)O@CP=\2/ >NZ?XH\#^/_"^@>-?!WB72IUN=+\0>%O%&E6FMZ!K6G7"9
M6>RU32KZTO;65>'AG1N]?X]G_!0G_@WV_P""E'_!/GQ7KB^(?@?XJ^/'P9M;
MJYD\/_'WX!^&]=\?^"[[15DD-K>^,-%T6SOO%/PPU$6XA74K'QGIEGI,6H/)
M::%XC\26B1:E<>]?\$K_ /@Y+_;A_P""6O@VU_9^U7PQX>_:0_9U\.W=U_8'
MPC^*>HZWX9\6_#-[B[DN]1TCX=?$.QM]1U#PUHEY>33W5QX7\1^&O%VAZ=>2
MS7/A_3="GO-4;4 #_7$K\RO^"P7[<W@G_@GM_P $]_VBOV@/$VNVFE^+'\">
M(/A_\%-(>YBBU+Q;\;O'6B:GHOP\T;2;9G6XO!IVIR/XL\0_8TEGTWP?X;\1
MZT8VBTV2OY;=$_X/*/C[\>$_X0O]E/\ X)%>,OB#\6-16.UTO3]'^-'C+XQP
MVNIW6Z*T1O!7PZ_9VT3Q%KT<LY39!#KF@33@/&DJ,PD3TOX"_P#!'W_@IG_P
M67_:)\!_MC_\%X]<7X8_ /X>7CZO\)OV$_"4I\.M<VT]Y:WLVAZKX6TO5=8/
MPP\'Z\]I:1>+]3\2>)_$'QX\8:=81>'-4O?"EC9Z%J]D ???_!H_^RSXH_9W
M_P""3ND>/?&NCW&C:[^U7\8_&?Q\T>UO[>2UU)/AS)HGA3X<^ IIX)41Q8:]
M9^ ]1\;Z#/\ .E]H/B_3M1AD:WO(0O\ 4#69HFB:-X:T;2/#GAW2M-T'P_H&
MF6&B:%H>CV5MIND:-HVE6L5CIFE:5IUG'#9Z?ING64$%G8V5K#%;6MK#%!!'
M'%&JCC/B[\2;/X/?#3QG\3M0\(_$;Q[9>"M$N-<N?!WPB\"Z[\3/B7XBCMVC
M4Z;X,\ ^&+>[U_Q5K<QD!M])TJVFNYE61D3:C$ 'XV?\',3JG_!#S]O!G8*#
MX:^#* GIND_:3^#4:+]6=E4>Y%?X\%?Z/?\ P7U_X*%?M<_M[?L<>*OV)/V.
MO^"27_!56XT;XK^(?!-]\6/BI\5OV&_CCX,T^V\+_#_QCH?Q"TCP]X&\.Z;X
M;\0ZWJ>I:QXN\,>'IM6UCQ GAZUTO2-.N]/M-,UN?6_MNA_Q!_\ #IW_ (*F
M_P#2-/\ ;_\ _$-_VBO_ )W- ']]W_!E*RG_ ()B?M#H"-Z_MX_$-F7N%?\
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M1D)*^=\4!;Q$+;,D?^I;\8_B?8_!?X8^,?BCJ7@[XF?$"Q\&:6-5N?!OP<\
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M;7&B^'-+M%D%ZOA_3+BXM=7\>>(8(I(?#'A:*[O2MQJ<^CZ7J?\ ,/\ &_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^
MU_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E
M!1110 445\ ?\%8O^467_!2S_LP#]LC_ -9U^(U 'W_17^ /10!_O\45_@#T
M4 ?[_%%?X ]% '^_Q17^ /10!_O\45_@#T4 ?[]EAI]AI5I%8:78V>FV,!D,
M-G86T-G:0F:5YYC%;VZ1PQF6>66:0H@WRR/(V7=B;E?X ]% '^_Q17^ /10!
M_O\ %%?X ]% '^_Q17^ /10!_O\ %%?X ]% '^_Q17^ /10!_O\ %%?X ]%
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MS7^!;10!_O\ %%?X ]% '^_Q17^ /10!_O\ %%?X ]% '^_Q17^ /10!_O\
M%%?X ]?Z??\ P94_\HLOCY_V?_\ %/\ ]9U_95H _K]HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='
M?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\
MY1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='
M?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\
MY1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='
M?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\
MY1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='
M?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\
MY1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[X3? NQO%W0&9?$7B/2+CQ[XM^PW(,C6NB>!-/T'6K>,'3/'$<5Q%>)_5/\
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MX6^'O@^S;^T_$FM/&4DNGB%OH^AVC_VIXDU;1='BGU&+[/K_ "Z-)_:YNO\
M@M+_ ,'._P"S=>_$"[/B[]F_P3^TS?>&_@'\/;]_MGA&U^#WP"@\3_$#1;^7
M19?,LKBX^*FJ> 8_'/CI+M;S^TGUS_A&[FYN_#NC:/9V@!_0I^TA_P '"_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P &SG_*<3]@_P#[&3XS_P#K-?QFH _V'JX#XG?%?X7_  4\&:O\1OC'\1O
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M*/YE/V!?V'?CY_P<<SW'_!1O_@K5\0/'=M^QSJ'C'Q%9_LC_ +"?PT\6>(O
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M.FZU;6,?B6[\">'],\>MJ7B738KR/PO'XF&A33PR>+9(R ?Z)E%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'X _\ !T=_R@H_;F_[MF_];#_9]K_(%K_7Z_X.CO\
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M=<U_C$_\$*?^4P?_  3N_P"SG/ '_I3<4 ?[2U?YB_\ P>M_\I-/V=/^S$_
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M5D9@/]7BHYIH;>&6XN)8X+>".2:>>:18H888E+RRRRN52..-%9Y)'8*B@LQ
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MS0O$GP!AC^&EM9:HJ$F&[U7PEH7A?Q9;)(3++I'B33+N3YKDBOVAH _R]_\
M@H7_ ,$'_P#@N_\ \%!/VQOC5^V%XC_8*^'7PNU[XU:CX3U75O _A3]J#]GG
M5=!T>^\,_#_PGX%GGLM0U3XJQ7]P^MOX7.OWIN$!CO\ 5+J)"T4:,W]NW_!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?@#_P '1W_*"C]N;_NV;_UL/]GVO\@6O]?K_@Z._P"4%'[<W_=LW_K8
M?[/M?Y M ']_G_!C'_SE%_[LF_\ ?N*_O\K^ /\ X,8_^<HO_=DW_OW%?W^4
M %%%% !1110 5_"C_P &M'BC1]7_ ."JW_!<0V-Y#./$_P 3M9\4:/Y<@;[9
MH\'[1WQG,EY#C_60K_PD&EYD' ^U1?WQ7[Y_M=Z#_P '!_Q&L?BWX"_90U#_
M ()8?!+PKX@UGQAH?PV^+_BSXD?M3>(OC5H7P_NM2U&V\)^(G\.Q? "^^'/A
MOXH?\(\VFW.J!CX_\,Z-KK7T>EC588;'4E_F]_X)V?\ !NG_ ,%Z?^"8W[2'
M_#37[.?[2W_!.*[\7:KH&J^$/'OACXA?$']I?Q+X,^)?A#7-3TS6]3T#QA:6
MG[-.CZX^_7-&TG6[36=$U[1]?LM4T^*2'5/LESJ5E? ']_M%?&W[)6H?\%![
MY?&J_MV>$?V-O##P0>&1\.I_V2OB+\;?'2ZG<N==_P"$R;QK:_&+X6_#LZ%!
M;JGAD^&5T*\\127AN-=757L19Z>U]]DT ?,7[8_[(7P/_;L_9S^)7[,'[0OA
M>/Q/\-OB5HSV%TT/DPZ]X7URV)N?#OC?P?J<T%Q_8WB_PEJR6^KZ%J0AGA%S
M ;/4;34-(O-0TZ\_QK_^"G7_  3@^.'_  2Z_:L\9_LT_&:TDU*QMFD\1?"?
MXF6EA-9>&_B[\+[^\N8?#WC70UD>=+6Z;[/+I7BG0#=7<_ACQ38:KHTEU?6U
MO9ZG?_[=M?DQ_P %C/\ @E#\)/\ @K1^RIK'P<\6?V9X5^,O@M=3\5?LZ_&&
M:S,M[\._B!):(C:?J<MM%)?7GP]\;):6>B^/M"B6<7%G%IWB"QM7\2>&?#US
M: 'S7_P:Z_\ *"G]AG_<_:5_]:__ &@*_?NOR/\ ^"%'[*?QN_8B_P""5G[+
MG[+W[1OA>R\&_&7X7/\ '*+QAX=T[Q'X?\66-DOB[]I#XP>/?#<]KX@\+:EJ
MVB7\.J>$_%.A:LHM;YY[/[=]@U&&SU.UO+*W_7"@#_&N_P"#B3X>ZK\-?^"T
M/[>VBZK:RVS:[\5]*^(5@\B,L=WI7Q-\ >#_ !]875O(0$FB,7B(P.\998[J
M"XMG(F@E1?\ 6T_8N_:'\!?M8?LH?L^?M$?#77]-\1>%/BK\)_!7BF"[TR\A
MO5T_5KO0K)/$GAO4C"\AL]?\*^(8]3\.>(M+N-EYI.MZ7?Z=>Q17-M+&O\_?
M_!P[_P &]M]_P5,F\+_M+_LR^(O"G@G]KKX?^%8_!6L:)XSGGTGP3\;_  'I
MMW>ZGH>DZGKUC9WTGAKQYX7N=1U.#PWX@O+"ZTS6M-OXO#GB2[TO3],T;5]&
M_EO_ &3O^"$7_!SK\$?$>I_#7X%7WQ:_8U\&>)=3(\5>*_#'[<?A3P!\,9YI
M%2T'B'5]&^!_Q;\2^*-:F6TC0Q7^E>!=8UVUMT6)8K>8+!0!_=#_ ,%B_P#@
MH]\"/V/?V=/B/\&=0;4OBS^U%^T%\)OB5X*^"O[,?PR,>N?%7Q6VO>"/$5CJ
M'C?6]*M$O)O!7PM\':8FJ^)/%OC_ ,0VT&DVFCZ#JZZ8FK:E:/8#_,__ .#=
M?QGHG@/_ (+4?L!Z[X@U&UTO3[SXJ>)/!\-U>3)!"^L?$3X5^/\ X?\ ARP$
MDA5?M&J^(?$^EZ79QYW37EY!"@+R*#_H._L-?\$(/!G[!G[,O[4'BO7?%>L_
MM=?\%%?VB?@/\5?"?CW]HWQW>7%]KM]J_BSP+J^FV?PZ^&VH^--3O-2T'PW?
MZM)IUMK7B?Q%K8\0^-[RWMM3\2WNDZ)::/X8\._RB_L)?\&>/_!0'XMZUH_C
M']KKX@>$?V*?"6FZG!>+I&D:KI'Q?^.D\FGW2W%O<Z-8> O$1^'OAH3F%6LM
M<O\ XD7>L:1<-#=R>$+LPF!@#_3MK_+M_P"#T2Y@G_X*M?".**17DLOV%_A-
M;7*J03#._P ;/VC[Q8W .58VUW;R@'!V2HV,$$_W(?"K_@GE\3?^"?/P7\5'
M]@#Q1<?M'?M2_$*]\"Z3\1?BG_P4O_:C_: \5V'BSP?X.MO%+Z<TM]X&\+>.
M;30K[PYJ'B.\/A[0O"'PZ\,V=W9ZUJZ:UK\LMK8F3^57]OW_ (-E_P#@N%_P
M4A_:>\<_M6?M"_M#?\$XAXZ\90:1I%CX?\(_$3]I72O!O@GPEX<LET_P[X/\
M):=?_LRZMJ%OH^EP":=Y=2U74M3U+5;[4]7U*^N;_4+B5@#^H?\ X-VYX;G_
M ((L?L R02+(B_";78&92"!-:_$[QY:W$9(_BBGADB<=0Z,#R#7[2U_+/_P2
MB_8:_P""_'_!,WX$^%/V4KOQ3_P2V^.GP"\'^)]5U3PDOB3XK?M5Z+\0_ .A
M>+?$=UXE\7Z#X>UC2?V;;?1=:TI];U77?$6C:;KVDK>6NL:Q?VK^(4T9[&RT
MO]G_ -LZY_X*@B72K#_@GQH'["%Q:7GAJ^37_$W[8'C?X^Z/J6A^+'NYH[!_
M#_A+X._#;Q/8>(-$BT\PW,TNK>+-"N_[0#V_V*:T F< _P G+_@O5*DO_!8S
M_@H8T;!E'[1GBB(D$$!X;+2H95XSRDD;H1U!4@X((K_9:\!31W'@7P7/"ZR0
MS^$_#DT4BD,KQR:/9NCJ1D%65@P(X(((K_-W^,'_  :!_P#!8[X]_%;XC_&W
MXK_M/_L%>+OB9\6?&WB7XA^//$MY\3_V@X)]:\5^+=7N];UN_%K:?LH065C!
M-?WDQM=.L+>VT_3K40V-A;6UG;P01_V"?\$Y_AS_ ,%Q?@7HOP3^"G[:VM?\
M$XOB_P#!SX=^'[7P7X@^+WPK^('[2$'[0]_X7\.>%[K3O"=Q/X=\1_ _PY\-
M?%WB9-1M-"T[6M6FU'P4MYHJWVJW,>I>(EDEU4 _8WQ@Z1>$O%,CL%2/PYK;
MNQ( 5$TRZ9F)/   ))/ %?XPW_!#"XAMO^"P'_!.V2>18D;]J+X;VZLY !FN
M]1>UMXP3_%+<311(.K.ZJ.2*_P!/3_@HS\/?^"X'QPT;XT_!;]B'6O\ @G5\
M'_A#\0?#TW@[P]\8_BM\1?VCW_:(TWPYXB\*6>G^+[FS\-^%_@=XC^''@[Q0
MNKW6OZ?X?UJ#5_&OV30_[.UB"#2_$CHVD_QU_"C_ (,^O^"P_P $/BA\.?C-
M\,/VFOV!_"_Q(^$_CGPI\1_ 7B2V^)W[05Q/H7C'P5KECXC\-ZM';7G[*%Q9
MW7V#5].M+EK2\M[BSNEC:WNH)K>22)@#_2\K_,7_ .#UO_E)I^SI_P!F)^ O
M_6@/VD*_T /V*Y_^"E7]E>(+#_@H=HW[$D&JV&E>'(?"'B/]CWQA\<M:C\2:
MLIU./Q5=>+_#7QB^'GA./PO;^7'HL^C)H&O^(Q<W%SJT=U#IL%K9?:?A_P#X
M+ _\$&?V5O\ @KU:Z#XS\?>(O&'P>_:/\!^#QX'^'WQQ\'O_ &[;VWA:#5]9
MU^Q\)^./AUJU]:Z%XN\+V6N^(M=U>!-+O_"'BN&]U.=8/%T>GM+ITP!4_P"#
M:C5M*U7_ ((E?L,)IFIZ?J3Z5X4^)NDZHMA>VUXVFZK;_''XFSW&F7ZV\DAL
M]0@AN;:::RN!'<Q17$$CQJDL9;]TZ_SI_@3_ ,$9?^#E/_@C5\3?$&N?\$[O
M''PQ_: ^&_B'45O?$?@GPU\2?!MC\//'UM;HMO:7WC[X._M :I\.K+2O%<=G
M#%;MK/@+Q#>^)["T!TS2O&LUE)/#+^I^LZU_P=V_MN>#9_@UX@^$/[&G_!-K
MP[XGM#I/BWX\>&O&4%Q\1XM(NHWM]8_X1$^%_C7^TGKOA?4+BT>1=.O-(\,^
M&_$EG?F*XTOQMH!\O4;4 _$#_@Z@_::UC_@H_P#\%./V>O\ @GK^R;IMY\9/
M$'[.J:Q\+(-'\'"/4'U_]I7XRZUH$OCSPM8W4,QTZ:S\":!X-\":1XAU>]N+
M6S\)Z_:>/[36IM.MM U&ZK^[[_@E=^PGH/\ P3>_80^ 7[)6EW=CK&O^ O#,
MVK?$WQ/IZ.MMXL^+/C*_N?%'Q$UNUDGCBNIM(7Q%J=UH_A@WL:W=OX3TG0;&
M=5>TVK\9_P#!(/\ X()?LM_\$HK&]^(5EJ5]\?\ ]K7Q9IMQ8^-OVC_'&E06
M5_86NI$2:QX?^%OAEKS5U\!:!JDV7UJ]EUC7/&'B9VD37/$L^D_8M#T[]UJ
M/\^W_@]*_8%\4S^)/@%_P4=\#Z%<ZCX4@\+6G[./QXNM/MWD3PS?6.O:SXD^
M#_B[5E@1V2R\1OXF\5>"K_6KLP6EEJ&D^!=$,LEWKNGPG\Z/^#='_@X9T_\
MX)M+<_LC_M<MX@UG]C?Q9XDN_$/@_P ;:)8WGB'Q#^SKXNUZ=9/$-VGAZS6?
M5-?^%OB:[/\ ;7B+0M AN=<\/Z^VI>)?#FC:W>Z_KFFWW^G-\6OA+\-OCO\
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MVGZA=V]L/$?C/6#;^(/%<=A9QQZ9X6TIKK0IP#]LOV;?@;X5_9C_ &>_@?\
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M-%M]7\$_VSXG^+6N:K=6:W!L/"_PO\8>+OB*/&6JE&@TW3?!NMZH=]O&K/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /_
M  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04?MS?]VS?^MA_L^U_D"T
M?W^?\&,?_.47_NR;_P!^XK^_ROX _P#@QC_YRB_]V3?^_<5_?Y0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M /SOZ /[8J*_B=_X?^_\%_/^E?;XV?\ AGOVK_\ YW]51_P7^_X.!/ML@/\
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MMY&T4%XZM<06]O$ZQ):_X?\ O_!?S_I7V^-G_AGOVK__ )W] ']L5%?Q._\
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M ,%_/^E?;XV?^&>_:O\ _G?T ?VQ45_$[_P_]_X+^?\ 2OM\;/\ PSW[5_\
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M/^'_ +_P7\_Z5]OC9_X9[]J__P"=_0!_;%17\1.C?\%__P#@X-:Q4ZK_ ,$
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MJ_\ ^=_0!_;%17\3O_#_ -_X+^?]*^WQL_\ #/?M7_\ SOZJW/\ P7^_X.!
M]IY'_!OY\9XE-THN1)\$OVMKLS6_DSYBA>'P/ ME*91"XO+A;F!4CDMS;F6X
MBEA /[;**_B=_P"'_O\ P7\_Z5]OC9_X9[]J_P#^=_1_P_\ ?^"_G_2OM\;/
M_#/?M7__ #OZ /[8J*_B=_X?^_\ !?S_ *5]OC9_X9[]J_\ ^=_1_P /_?\
M@OY_TK[?&S_PSW[5_P#\[^@#^V*BOXB]7_X+_P#_  <%KIMV=+_X( ?&.SOP
MB_9KF\^!'[7FNVT+^8FYI=)T[P=I=[>J4W*([>_MG5F64NR(R-H1_P#!?[_@
MO]L3?_P;\?&MGV+O9?@W^UC&K-@;BL;^ 7:,$Y(1G=E'RLS$$D _MDHK^)W_
M (?^_P#!?S_I7V^-G_AGOVK_ /YW]'_#_P!_X+^?]*^WQL_\,]^U?_\ ._H
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M5]OC9_X9[]J__P"=_0!_;%17\3O_  _]_P""_G_2OM\;/_#/?M7_ /SOZ/\
MA_[_ ,%_/^E?;XV?^&>_:O\ _G?T ?VQ45_$F/\ @O\ ?\' GVV0'_@W\^,Y
MM/LL)2 ?!+]K99UN/-G\V5M0/@<VTL3Q"%$LTM$G@>.2>2XECN(HH;7_  _]
M_P""_G_2OM\;/_#/?M7_ /SOZ /[8J*_B=_X?^_\%_/^E?;XV?\ AGOVK_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^
MU_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"M
MA_L^U_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7
M]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML-/M+>UA\V223RXEWN[98_,_[ BA?V$OV*E4!57]DK]G%54#  'P=\&@  <
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MXG6^DW+O'%KNL>%/#&HZGX>\.&2-E9'\1Z]#INA0N'C"S:A&3)&H+J ?B?\
M\%6?^"W'Q"^"?[17@S_@F3_P3/\ A;I'[3G_  4C^*DUGI]S8:D_VOX;?L_6
MFKZ6VM0ZGXY$-_IL&I>*;/PP)/&-YI>J:QHOACP1X42'QAXYU&?3VM_#FK_-
M7B/_ (()?\%:/VD/"DOC#]J;_@OU^TIX>^-FMVAO[OP9\ =!\6>$O@#X1UJ6
M/>=-TSP[X+^*GP<TWQ%86TQ:&/6+/P%X#NC;MM73,H6G_F;_ .#=_P#X*A_L
MG?LD?M6_MJ_ML?\ !0/6_BOXQ_: ^-&FZ5IW@[QEX1^&.L?$W4[J]^(WC'Q-
MXZ^.FN:S<:8%3P_J&LZQHWP_ATUHBC7-A)KEC L%C')#+_75_P 17_\ P29_
MZ"'[3_\ XC9XT_\ CU '\D/QP_;:_P""^?\ P;S?M<:;\(?C;^T_XU_:!\#W
MMO%XK\%VWQK\6^*?CQ\#_CK\-4U![*6;PSJOCZ]G^(/P^O;*[@?3_$.A^&O$
M/@[Q/X9U40O/_:?AS5M)U'Q#_H%_\$J/^"G'P5_X*L_LJ>'OVC?A/!)X6\16
M5\WA#XQ_";4M1AU+7_A1\2;&TM[K4/#]W>Q068UK0-3L[FVUSP=XIALK.#Q!
MH%[ US9:3KUEKN@Z/_$-_P '+O\ P5D_82_X*F?LT?L]>&?V7M.^-&M_&GX/
M_'.]UUIO&WP4\2^#K:S^%_BWP#XBT_QE%8ZU?K.LD]WXKT3X;/)I<>UKJ.T^
MUG(T_CEO^#,?XL_$3X<?\%!_CA\";^S\06'P]^./[-^L>(=0T^\M=1LM.?Q_
M\)/%_AF]\):LR7$*VLES:>%O%OQ$TY1A9RFJAEE\N%XI #]]_P#@L?\ \%MO
M^"IO[(7PU^)WC;]F_P#X)@>.?A?\$_ /C*_^'NL_M@?M+7/AGQ-ID%Y_PDTG
M@O3_ !3X;^"OPY\97=[I/A+7]=^R'P#\1O'?B.]\+^(AK7AY;KPLLNJVEA=_
M@)_P0/\ ^"PG[47QG_X*E^,_CK_P4-_;;^(>K?!KP7^RS\=O'WCR+QSXTNO#
M?P2\):?X>3PW<6^HZ;\)_"ZZ1\.M*O;::Z:UT6S\-^#DUK4]3O+;3=+@OM5O
MK:WG_MQ_X+IZ+9Z__P $?O\ @HC8WT$5S!!^S!\0]:2.5%D1;SPW9Q>(M.G"
ML"!+:ZAI5K<PN!NCFACD0AE!'^;;_P &RW[*?P._; _X*J?#SX;?M#>#;?XB
M_#CPQ\-OB#\5)? .K3.WA/Q9XB\!MH-[X7T_QQI !A\4>%;+6;FUUR[\+:@6
MT?6K_2=-MM<MM2T;[?I5\ ?TB_M2?MV_\'!__!8<:Q<?\$A_V<?BQ^S#^PT9
M;J#P;\===\0> /@9\6_CQI4;O%;^,=(\>_$WQ/X:U30O#6HR1B31+'X)&YN=
M.=+B'Q)X^U.1Y-*TG^:;Q5^WC_P7S_X(\_M26WA3X]_M!_M5^#OBIHJZ=XJO
M_A=^T3\5O$/Q\^$_Q(\,7MY<1?VC%9>(_%WCCP#XS\-:[+8ZGHLWC'P)K2ZM
M8WEKJEGI7BC1O$.ERO8_Z_UK:VMC:VUE96T%G9V<$-K:6EK#';VMK:V\:PP6
MUM;PJD4$$$2)%##$BQQ1JJ(JJH _AU_X/>/A/X=O_P!G/]B+XY'3[=/%GA3X
MU^/_ (3KJL<*)=W'AWX@>!5\7R:?=W"J)+BWLM2^&<=SI\,SNEG)?ZF]LL;7
M]V9 #^I#_@E]^WQX)_X*7?L3?!K]K?P;IL7AR]\<:7>:/\1/ \=X;Y_ 'Q2\
M*7DFB>.O"?VEU2>XT^WU6W.J^&KVZBM[O5?".K>']7N;6UEU!K>+] :_BW_X
M,EO%NI7_ .PM^UKX(GN))-+\,_M76_B33X'8LEM<^,?A'X%T_4?*!^XDR^#+
M%V13M,@=]H=W9_Z/O^"JO[;=A_P3N_8"_:2_:RDCLKSQ+\.O!#6'PTTC4 );
M76_BSXUU&R\%_#2PN[4,LU[I<7C#7M*U3Q#;VY$R^&M.UFY#1);O-& ?BI_P
M7(_X.)KS]B3XE:9^PA^P7X.TGX[_ +>/C&]\/^&]5FGT^Y\5>%O@WKOCB6SM
M/!_A6#PMI,T5UX_^,_B(ZIIUSHO@UKB#1O#ZZEHE[XCCUZ6]/A2;D/@W_P $
M*_\ @J+^TQX+L/BM_P %)?\ @M'^VQX)^-/B^SBUZX^"_P"RQ\1I_ OP\^%6
MH7\?VN/1[M_#6I:5\/=8UK3WDA@UF#P'X!\.Z!I]Y:3V&A^)/$FG)9ZY+_.]
M_P &E?P,O/VP/^"M/Q6_:V^.-[?_ !$\2? CX=>-_C?<>)_$LRZKJ&M_M ?&
M'Q1!X5TWQ3KSW:R+?:BVD:]\3_$MO>,HGLO%%EH^JVAAN;*&2+_4%H _SEO^
M"LMI_P %HO\ @B[\$_BO\%OBM^UCXE_X*(?\$[/VROAG\3/V=;+XB?&V/6M<
M^(/PO\5^/?!.O6&EV&K^(=>UCQ-XT\)>+M.T]KW5?#$2>-_%'PY\=Z/H6N6T
MF@^&];AMDT;\[?\ @T._Y3)^"?\ L@'QV_\ 3%IE?WZ_\%^_A#X5^-'_  1W
M_;X\/^*[&VNXO"/P'\1_%[0;B>$23Z9XJ^#4EK\3- OK"4%9;6YDO?# TV::
M%T,NG:A?64XEL[NY@E_@*_X-#O\ E,GX)_[(!\=O_3%IE '^KW7\V_\ P59_
MX+<?$+X)_M%>#/\ @F3_ ,$S_A;I'[3G_!2/XJ36>GW-AJ3_ &OX;?L_6FKZ
M6VM0ZGXY$-_IL&I>*;/PP)/&-YI>J:QHOACP1X42'QAXYU&?3VM_#FK_ +8?
MMG?M%Z5^R+^R5^TC^T]K%M!?VOP(^"WQ%^)UOI-R[QQ:[K'A3PQJ.I^'O#AD
MC961_$>O0Z;H4+AXPLVH1DR1J"Z_YJW_  ;O_P#!4/\ 9._9(_:M_;5_;8_X
M*!ZW\5_&/[0'QHTW2M.\'>,O"/PQUCXFZG=7OQ&\8^)O'7QTUS6;C3 J>']0
MUG6-&^'\.FM$4:YL)-<L8%@L8Y(90#^F3Q'_ ,$$O^"M'[2'A27QA^U-_P %
M^OVE/#WQLUNT-_=^#/@#H/BSPE\ ?".M2Q[SINF>'?!?Q4^#FF^(K"VF+0QZ
MQ9^ O =T;=MJZ9E"T_\ -/\ '#]MK_@OG_P;S?M<:;\(?C;^T_XU_:!\#WMO
M%XK\%VWQK\6^*?CQ\#_CK\-4U![*6;PSJOCZ]G^(/P^O;*[@?3_$.A^&O$/@
M[Q/X9U40O/\ VGX<U;2=1\0_UO?\17__  29_P"@A^T__P"(V>-/_CU?S9_\
M'+O_  5D_82_X*F?LT?L]>&?V7M.^-&M_&GX/_'.]UUIO&WP4\2^#K:S^%_B
MWP#XBT_QE%8ZU?K.LD]WXKT3X;/)I<>UKJ.T^UG(T_@ _MY_X)4?\%./@K_P
M59_94\/?M&_">"3PMXBLKYO"'QC^$VI:C#J6O_"CXDV-I;W6H>'[N]B@LQK6
M@:G9W-MKG@[Q3#96<'B#0+V!KFRTG7K+7=!T?](+V]LM,LKO4=1N[73]/T^U
MN+V_O[VXBM+*RLK2)Y[J[N[J=XX+:UMH(Y)KBXFD2*&)'DD=44L/\SW_ (,Q
M_BS\1/AQ_P %!_CA\";^S\06'P]^./[-^L>(=0T^\M=1LM.?Q_\ "3Q?X9O?
M"6K,EQ"MK)<VGA;Q;\1-.486<IJH99?+A>*3][_^#N__ (**>(/V5?V(?!_[
M*'PPUZXT/XF?MLZEXF\.^*]3TVY>#4M'_9^\$6^E2?$FRBE@8364GQ"U7Q'X
M8\$.TV(-5\(W'C_3D#R!Y+< ^2OVHO\ @O7^W%_P4Y_;57_@FW_P0DCT'PQI
M O-8L_&O[9/B+3;+49KKPSX>N8;#QE\1_#DVMZ3KVB?#GX-:(;M+>R\8S>&_
M$/Q%\;WU[X?3P':>'];U31M*UW[:?_@W+_;"UCP@?$7B;_@OM_P4JG_:2DLQ
M=KX]TKXD>/+/X8Z;KK+YWV>Q^'Z_%2+Q*-!MK@1V\,%E\0-'5[:$2QV%DKK8
M0>#?\&7G[*GASP!^PW\;_P!K:_TF$_$+]H;XU7_@'2]9EBBEFM_A1\&M*TZV
MTVRT^9T,]D-3^(?B7Q[)KD,#I#J2Z'X:DN5EDTJU,/\ 9C0!_DH_\%R?V@_^
M"KOPL\,:+_P2L_X*>^)=#^-=U\(?BIX<_:$^!W[226A&O_$;X>S>$?B%X!LI
MX?$L&GZ,?&_A[49]>OA->^+-(B^('ACQ3X=US0-=U;6[5[!M/_HQ_P"#(;_D
MUG]N'_LO_P ._P#U75Q4'_![I\(?"NH?LQ?L7?'M[&VC\;^$?CQXM^$-OJ4<
M(2\N_"OQ%^'VI^,[NQNKA"IN+;3]7^%UE/80SB46DNIZD]H8/MU[]HG_ .#(
M;_DUG]N'_LO_ ,.__5=7% ']OM%%% '!?%-?B>_PU\>)\$YO EO\8'\):\GP
MQN/BC!K]U\.(/'3:;<#PQ-XZM?"D]KXFN?"D6KFTDUVWT&YMM6FTY;B.PN(;
MEHY%_P N7_@XZ_X)R_\ !2OX&WW@G]M[_@HE^UO\*/VE/$'Q?^(4OPB\):'\
M-(_&NF:1\-]/M?#^O>,+/P_X2\*Z[X4\.>'/"O@JQM],O(X[+1C-J.HZM=RZ
MSKDVJZS?ZIK%S_JKU_%E_P 'MG_)C7[(G_9U]W_ZJ#QW0!^)?_!N1^S5_P %
MD?C?^SS^T#K7_!-/]O+X3_LE?#C1OC-IFE_$3PI\0O &@>+]0\4^-I/!&CW=
MKXAL+O5_@S\3);2SAT*6RTUK:+4M.C:>W>4V+LQN'_L5_90T/_@L7^P=\)/V
MDOB9_P % ?BQ>?\ !57Q/JLOP>TO]G;X-_LH^ ?AYX2\<:%J\NK^,M(\=7.K
MW6L>!_@3H4/AS59?$/@*_P!:UW4M2\0_\(OH7A;6]6@TU0D]OJ/Y'?\ !D=_
MR9?^V1_V<_H/_JJ?#5?VNT ?YJ7_  6:_P"#B#_@MW\-_B?JO[-^O_!(_P#!
M+JWU?P_;^(M,T#1'TKX@_&?Q)X)UF>^L;/6;3X\W"7WA:>PEO=,O;.+7?A!X
M?\)ZGI.L:;JFDSZ_)=V=U;P_</\ P3A_X+"_M-_!W_@C-\!/A_\ "*U^)W[=
M7_!4[]K3XW?M&^'?V?/ OC3Q#XG^+7BK3O#OA;Q A\0_&+XF:EXAUNZU>/X=
M_#^V=TTR#6]<TG1]3U9;@3ZC9>&O#_C#4=*^?O\ @^&TJUA^-7_!/K6TAC6]
MU#X7?'G2KBX"J)9;71O%GPXN[.%W W-'!-KM\\:DE4:XE*@%VS^D_P#P9N?L
M?_#;PA^Q'XP_;6O5E\2?&GXQ>.?&'P@TG6=40SGX;_!WX=:[%?#P%X0:XEN'
MTRR\6^/]2USQQXO;3S8VNMWP\-I=6+7.@"^O0#^,_P".'_!3C_@N;^S+^UOK
M^L?M!?M9_MG_  F_:1\%>)(M5U_X=^/O&GBO0?"%H\DPO[2S_P"%(3RQ?!S4
M?AYJT>R[TS2--\&77P_UO398;W2[>[LIH;AO]3FU_;^\/?!G_@ES\/O^"B7[
M9.E7'PHBA_96^$GQO^,'@[3]/G35M,\>^/\ P7X5O6^''AG1-6NH+I?$&O\
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MKQ5XKB^$NM6,-RI62.RU#1OB#<7%Y:L7MKFXTS3IY86N+*SF@ /P(_X,AO\
MDZ?]N#_LW_X>?^K%FK_1)^(WQ#\%_"/X?>.?BK\2/$-AX2^'OPU\(>(_'OCG
MQ3JK2)IOASPCX1T>\U_Q'KE^T4<LWV32M(L+N]G$,4LS1P,L44DA5&_SMO\
M@R&_Y.G_ &X/^S?_ (>?^K%FK^YO_@I7^S#XL_;0_8)_:N_9;\!^(K'PKXW^
M-7P;\4^#_"&M:M)<0:-%XFDACU'0[#7;FTBN+JTT#6M2L+;1->O+:UO;BST?
M4+VZAL+^2%;.< _BYTW_ (+0_P#!3G_@O=_P4%M?V)O^"<'Q6?\ 8(_9H:W\
M3^)M7^)EAHNGZE\98/A!X,N+2WU;XG>-?$*22ZSIFOZI=ZEHFG^%_AU\,=:\
M)6]OK?B32M"\2^.-3T^&_P#%MG^JWQK_ .#<_P#;57X?ZIXB_9Y_X+O?\%*W
M_:(TW2IK_1;[XP_'OXFW'P_\4^(K:)IX=*O+CPAXWL/%/@C2]5NU6W_M:.X\
M<OHD<GGMHFMK&;>3Y(_X-D/^"$O[>'_!/?\ :^^,/[47[9?@KPW\)-)3X(^)
M?@MX"\':?\0_ OQ U[QGJGB[QQX$\1WGBXW'P[\0^*='TCPMI.E^ Y;:*SUO
M4-/\0ZAJ&O6$PTFU@TR[\S^U_P :^.?!/PV\+ZQXW^(OC#PMX!\%^'K5K[7_
M !?XU\0:3X5\+Z'9(0'O-8U_7;NPTK3+5"0&N+V[@A4D N"10!_FL?\ !+[_
M (.5OV__ -CS]KW2OV3?^"F'CG6/C/\ !VR^+%U\#/BQJ?Q.MM*N/C+^S[XL
MT[Q1+X(UKQ+_ ,+ TR"'5/&6D>#?$=O/)XXT;QC/XKOKK1K'4)_"VJV&H11V
M^I_Z9%Y]K^R77V#[/]N^SS_8OMGF_9/M?E-]F^U>3F;[/YVSS_*'F^5N\OYL
M5_BG_P#!:;QW\(_BA_P54_;D^(_P*\9>%OB%\*_'7QSUWQ7X7\;>"=2M]9\*
M^)WUW3]+U'7M6T35[-Y+/5+.Y\37&LL-1LY9K.]E$ES:S36\D<K_ .SW\*M4
MNM<^%_PWUJ]E>:\U?P#X/U2[FD):26ZU#P]IUW<2NQ))>269W8DDEB22: /\
MZ[_@Y!_X)Q?\%;]6^$7B7_@H!^WS^U]^SK\3?AO\*?$7A?POX'_9_P#@9:?%
M#P[X*^'47Q)\3Z9X:4>!?"WBGPW!9/=275U:3>(O%7BKQ'KGC/5[&SM;.[UR
M\LM-TG3[/\Z/^#;WX%?\%._CC\4?VH-/_P""9O[7OPZ_9'\5^'_ /P\O/BKK
M7Q#\&Z/XPMO&?AZ]\1>(8/#FEZ9!K'PO^)R64^E:E#J-W<2P6FDO-'=1H]Q<
MA!%'_:O_ ,'9O_*%/X[_ /94/V?/_5M^&Z_GQ_X,??\ DOW[?/\ V1_X+_\
MJ:>,Z /ZDO\ @FE^RY_P6V^"GQY\3^*_^"D'_!0CX/\ [5OP+OOA1K^@>&OA
MSX ^'7AWPEK.D_%.[\6>!]0T+QE<:EI/P0^&US-INF^%=+\:Z--9/KMS#+<^
M(+.9M*G>WCN['[=_X*+_ /!0_P#9[_X)D?LS^*/VE_VAM8N5TC3YX_#_ (&\
M#:&UK)XT^*OQ!U"VNKC1/ G@VRNI889-0O8[.[O]3U*ZDCTSP]H-AJ>NZI*E
MI8LLGW;7^8A_P<H?MI^#/VB_^"X?P?\ V<_C5J^O3_L<_L8>-O@KX#^(V@^&
M[.\UR?4(/&NJ>"?B%^TEXCT70+,BZU/Q;<>%-3T_X<PV,6PSW/@&TAM3$+RX
MN9P#]WO@C\*?^"[W_!;OP79?M+_%?]L_7?\ @D=^R'\1K==?^ _P,_9LT#5)
M/CGXL\!WRF70_&'BKQ_:^(/ 'CG3-.\1Z9+:7>EZUJ7B^*W\46\<FN:/\)/"
MGAW6='U'4_RX_P""GW_!,W_@MS_P2*\":C^V1^S+_P %6/VN/VF/@IX'N+74
MOBD^H?%#XI:1XW^'6GSW<%I;>)/&'PS\1?$?XB>"/B;X"MKZ>VAUW6 DEQH@
MNX]0U?P=%X<L]6\06'[\67_!UE_P2,TVSM-.TZ7]I:PT^PMH+*QL;+]F7Q?:
MV=E9VL206MI:6L$D<%M;6T$:0P00HD4,2)'&BHH XSXJ?\'/O_!'OXM?##XC
M_"KQ3)^TOJ/AGXF> _%_P_\ $5A>?LS^,I[2^T+QEX?U#P[JUI=0O(R36]S8
M:C<0S1NK*\;LI4@D4 ?,G_!O3_P<K^(?VZO'ND?L4?MV-X6TK]I35M.NI/@U
M\:="TZR\*Z!\<[K2+.2_U3P7XM\,Z?';Z#X9^*0TVVO=9T.[\-VVD^$_&5G9
MWVCVFA>'?$=EI5MXQ_LNK_!L^$FO_%[X)?%3X;_&3X>Z5XJT/QY\*?'?A/XB
M^#=8MM(UB&?3?$_@O7;'Q%H=XDD,$<J^1J.G6[L$=2R!DSAC7^[7X'\46WCC
MP5X/\:V<#VUGXO\ "_A_Q1:VTC;Y+>V\0:3::M! [[(][Q17:QLWEIN92=BY
MV@ _SEO^#L+_ (*7?M]?#3_@H5:_LL?"_P"-WQC_ &=?@9\.OA3\./&GA.R^
M$7C7Q5\+[CXIZQXULKO4];\>>(?$7A+4-&UKQ/9Z3K=M=^"-'TJZU&Y\/:)?
M>#;^\L=/@UN\U6[F_I._X-;/VT_VH_VV_P#@FK>^,/VK-?\ $/Q \6_"WXZ^
M,O@[X-^+GBSSI_%'Q,\!Z#X1\ >)+#4?$FL7"K<>+-=\.ZQXKUKPG>^+YFGN
M]:BT>TCUF]U'Q-8:]J-U^NW[6_\ P3Q_8F_;OMO"L'[7/[-WPW^.$W@B2Y;P
MCJ_BK3KRU\2^'8+V2.:^T[2_%?A^^T;Q-:Z+J$\,%QJ.A)JW]C:A<6]O<7EA
M/-!"Z?1/PG^$GPO^!'P[\*?"/X,> /"7PN^&/@?35TCPCX$\#:'I_ASPQH&G
M^=+=20Z=I.F06]K$]U>7%S?W]R4:ZU'4;J[U&_GN;ZZN+B4 ]$HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@&=1<'3-'\6?$FTU8Q1D[GA%UKNBB=P"L;FV5B#(H/\ HF5_C_?\&V'_  4
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MM7>)E^W:&^O_ !3_ .$JFTJ<O;2:YX2\.ZD\9N-+M'C .X^(_P#P<'_ME_\
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MD;W5PMO/=M!;([!IYEM+6ZNFBB#.+>VGF*B.&1E /\0#_@J;XPUCQ]_P4O\
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M-2^'6D!9(K6']G[X8:V#$IP#$-<OM3=@#@RF7G)-?Z&G_!OM?PZE_P $9?\
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M"#X]_#:]UV7P'X<ENIY([;35\?\ AWQAXST"TE+&75_&%KX&\/PQ37&HVQA
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MWQP\<W@L]"^$_P#P6!D\7>([V\<1QVW@7P%^U+;/>222OQ%;Q>#-)(24@K%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!
MT=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?
MW^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444
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MA^U3I/\ P2W_ &_?$]Q\!OB_X*^(]UX8;]D+]HK3SXGT;0-9MY_$/AN/4?\
MA6=P--FU_0#J6D0:BUM=+83WD=V]K<K"8)/]E2B@#XC_ &-?VW]*_;*TWQ-=
M6G[,7[:_[-&I^$=/\,WNK:%^V%^S'X^_9\NKV;Q+_:ZC3_">I>*H)/#_ (VN
M]$DT:9?$7_"+:OJD>CI>Z/->/''JUD9/Y2_^#MO_ ((^?M(_M4>+/A)^WI^R
MO\.O$?QFU7X>?"M?@S\;OAAX#TJXUWQ_:^%= \5>)/&'@GX@^%O"FG+<:SXT
MAM[OQOXGT/Q?I^@V5[KNDV-KX:U2#3K[18==O="_N0HH _R^O^".?[8?_!Q[
MX4^%FE_\$\OV(/@/?7/@*RUG7+7PS\3OC]\ _$EAHO[,MKXIUB]UCQ'=)\3/
M%CZ'X%TK2+/7=3UKQ5#X:\;>'_B%K%QJ,^HV'A/PSJLDL&@2?Z$7_!.[]C"R
M_83_ &8_#?P9O?&VJ?%CXI:[XA\4_%O]H;XV>(&G?Q%\;?V@_B;J7]O_ !/^
M)>LO<R37).J:HT&DZ'#=2SWECX4T3P_IU[<WEY:3WEQ]QT4 ?PE?\'#W_!LQ
MX^^._P 2O&W[=_\ P3J\,6.O^/\ QQ=7?BC]H+]FBUN;#1M1\7>*I=T^L_%+
MX0RWTUGI-WXD\1,'U+QOX#N[JQO/$&NF]\1^%[C5?$.MW/A^Y_AZ\%?$W]NO
M_@G-\4]6C\%>+OVF?V,/B]!C3_$NCV=Y\1?@EXKO8+&:0#2_%?ANY&@7&LZ?
M;SO(?[,\0:=>V"RL7^S[SFO]SJJEW86&H+&E_96EZD4@EB2[MH;E8Y5^[)&L
MR.$D'9U 8=C0!_DO_LX_#G_@X,_X+L:AHOPAU/XU_M6>+OV<-;O+*+Q[\3?B
MWXF\9^"OV8-(T198S<ZCX@6Q@T7PS\4-7L(L3Z=X3T/3?%GBB>>2*=+*QL)+
MS5;;_3,_X)V_L$_!7_@FO^RE\.OV5/@=:RS:%X1@EU;Q?XQU"VAM_$7Q/^)&
MLPVI\8?$;Q.(7F5=4U^ZM+>&SL%N+BW\/>'=/T/POITS:7H=B%^WZ* /Y5/^
M"]W[>WQT^*'[(O[4W["/[)7_  3C_P""EOQ@^*OQ+NM3^">O?%32/V*/C>?@
M9I7A'2_%MM;>.?$OA/QU9^&;_P#X638>*]$TF_TCP1J/A6PG\-ZKI^NIXH/B
M 6EG::=K/\@7_!&+X5?\%-/^"8'_  4 ^$_[5GB__@E)_P %&?'7P[TC3/%_
M@7XF>'/#'['7Q\3Q7/X(\=Z'/H^H:GX675/ EAI5WKOA[4/[+\0V6E:G?Z=9
M:V-*ET6;5='_ +075['_ %J** /ASX._MV>&/C)\$OBK\<+7]FK]N/X<6'PD
ML+N^U;X9_&+]D;XN_#GXV^,/L>B/KDEG\*_A9K&BGQ)\4;^6)#IMI;^"HM7-
MWK932;9Y+MU0_P 6_P#P<H?M _MF?\%4?#'P&^ /[*?_  2K_P""G\?PK^$W
MC/6_BAXP^('Q)_8:^/OA:_\ %7C6[T&X\*^'-+\*>'+;P?JU_:Z!H>B:KXBN
M-4U37FT^_P!5U+5K2UM='LK71FO]9_T*Z* /\Z'_ (-K_C)^VS_P2@U/]HCX
M7?M1?\$K/^"G^H?"#X[W?@;Q9H?C/X;_ +#_ ,>_$NJ^!_''@RUU_2;Z'7?#
M5YX/T:YU'P[XIT76;(-J6C7%YJFC:EX=M(1HNHV>M7-[HO\ H*>$]<\-_'/X
M1Z%X@U7P1XDT_P (_%GP%9WVJ?#KXP>!=2\)>*[?P]XST-7O_"'Q)^&_BVSA
MU30-7&G:A-I'BGPAXBL([NQN#>Z5J=J'2:*O2J* /\M+_@MG_P &QW[2/['?
MQ*\9_'+]A[X<>,OV@OV/?$>HW_B&U\)>!M/U+QE\6?V?TNYI+RZ\)^(?"MBE
M]XH\8^ ='5I3X=\?Z-:ZO<Z=H5L;7XAKI][I\?B3Q-Y]_P $XO\ @Y]_X*2?
ML)>#?#W[+OBWP%H/[6W@CP<EMX2^'_@WXKP>,-,^,_@BTT]19Z9X$T+QEH+7
M&L:GH>F(OV/3=!\8>%O%.KZ/:0V6B:%J>DZ%IUGI$7^K=546-D+LWXL[47YC
M\DWHMX?M9A'2(W.SSC&/[A?;[4 ?P2?M?ZW_ ,%M/^"M7_!/[]K']HC]L7PM
M#_P3=_8.^"?[.OQ3^,GAW]G7PIHOB'P_\9/VIO&/@3P9J7BCP18_$<^-[F?Q
MC:?"G3M?L;/6=2;5](\$Z'XHLXM+CT/P3XAOVLO'_A/^<'_@BW^PU_P6$\7_
M +2GP@_:Q_X)T_ [Q'I&J_#;7+R_T+X\_%+28?"/[/QT[6-)U+PKXKTK5O$O
MB_\ LZP\>Z)JOAS6M4T/Q'X>^'Z^)?%D.GZFUQI]E9WR6E];_P"P]/!!=0RV
MUS#%<6\\;Q3P3QI-#-%(I5XY8I%9)(W4E71U*LI(((-+%%%!%'!!''###&D4
M,,2+'%%%&H2...- $CCC0!410%50%4  "@#XX_8M\$_MR^$O NOWW[>?QS^"
M?Q?^*?B;5-/U/3M!_9^^%&K?#CX9_"S3X-.6UO\ PMH.M>)O$&L>,/B)!?7Z
MG5?^$D\3Z?X=OH'D>QATI+9(V'\BO_!P]_P;,>/OCO\ $KQM^W?_ ,$ZO#%C
MK_C_ ,<75WXH_:"_9HM;FPT;4?%WBJ7=/K/Q2^$,M]-9Z3=^)/$3!]2\;^ [
MNZL;SQ!KIO?$?A>XU7Q#K=SX?N?[M:* /\,7P5\3?VZ_^"<WQ3U:/P5XN_:9
M_8P^+T&-/\2Z/9WGQ%^"7BN]@L9I -+\5^&[D:!<:SI]O.\A_LSQ!IU[8+*Q
M?[/O.:_8_P#9Q^'/_!P9_P %V-0T7X0ZG\:_VK/%W[.&MWEE%X]^)OQ;\3>,
M_!7[,&D:(LL9N=1\0+8P:+X9^*&KV$6)].\)Z'IOBSQ1//)%.EE8V$EYJMM_
MK07=A8:@L:7]E:7J12"6)+NVAN5CE7[LD:S(X20=G4!AV-6Z /B#_@G;^P3\
M%?\ @FO^RE\.OV5/@=:RS:%X1@EU;Q?XQU"VAM_$7Q/^)&LPVI\8?$;Q.(7F
M5=4U^ZM+>&SL%N+BW\/>'=/T/POITS:7H=B%Z#]N_P#8D^"?_!0[]E[XF?LJ
M?'O2Y[OP5\0M-B;3]=TP6Z>)O 7C+2I#>>$_B!X/O+B*6.R\1^%]56.[MQ*D
MECJMB^H>'M:M[[0=8U73[OZ_HH _QN/V[O\ @CQ_P4I_X(^?'"#QR_A/XC:A
MX,^'WBNW\5?!_P#;'^ VG^))O"$;Z-?"^\-^([SQ!X>^TZG\(/&MJT$<MQX;
M\77.F7EO?VM\= U'Q-H4$&O7O[<?L9?\'<7_  51\8Z%H'P.B_8P\#?MM_'$
M6EKI&@>)?A[X8^(VE^/_ !1<86"'4_%_@+X9V6O:-K.ISRY-W<>$M(\!Z6Z
M-]@MW6:XE_TCZJVMC96(E%E9VMF)Y#-,+6WAMQ-,WWI91$B>9(W=WRQ[F@#_
M #$_^#@;X _\%2O'7[(_P'_;L_X*C?$73]"^+7Q/_:(T;X2_!+]AGX36D47P
MN_9Y\!>(_AQX_P#%VK7NJ6EIJGB675_BYXOUGPKX?M92_B7Q;KNE:+;C2=>\
M6:M<SZ=X7\">F_\ !N]^PA_P<(_L_P#B#QW\0?V9?A[X"_9;^"7QYT7PS9>/
M=>_;@\):U:Z'K\'A>;5KKPKXM\'?"#3KK2_C#?\ B71;'Q)KS>&-5N-/\.^!
M/$%GKTT&I:W=VWV6>P_TH+BRL[LV[7=I;736EPEU:M<013&VNHP1'<VYD1C#
M<1AF"31[9%#$*PR:LT >8_!CPY\3_"'PL\#^&OC3\2]-^,?Q5T?0K>T\=?$_
M1_ ME\,M*\9Z^KRO=:QI_@+3M8\067A>UD5XX8=,@UG45181*UPSRL%].HHH
M *_"O_@X?_X)K?$'_@I[_P $[]<^$OP7CL;SXZ?";XC>&_CQ\)/#^HWMEI-K
MXWU[POH?BKPIK?@)];U&>VT_2+GQ'X0\;>(&T.YU*>WTF3Q5IWAZWU>\TS39
M;G5K#]U** /\A'_@F#\9?^"W_P#P2H_:!^(WPY_91_9'^-=_\0OBLNC>%OB-
M\ ?BA^S+\5?%6AZ[JGAFZU1/"WB.]TC3(/"VMZ/>^&1KFNM8^*-/\3:9H;Z1
MJU]/K$VH:.()+?\ O5_83^#G[6'[)/@#XZ_\%3O^"J%E\3/VB?V[_C+X6\!>
M [SX-_LN_"O5/C+XA_9Z^ %KXOM#X7^ /P<^&/PKMM6GUN8^+O$A\?\ Q>O?
M#,FLZ7$VD1ZYJ.OZY+X>\1>,_$/]#-% '^8U_P '$7B?_@H-_P %=/VC_A-K
M_P #O^"37_!3#P;\$/@#X$U_PCX/OOB+^Q?\==/\;^,_$'C#6[35O%WB>_T3
M1/!^NZ=X?T1XM%\.Z7X?TIM7U'4WATZ[U?4Y;&?5ET+1_N__ (-TOVQ/VX_^
M"9/P:\=?LC_M<?\ !)[_ (*AZG\(]:^(^J?%+X;?$WX9?L1_'CQ1JW@W6O$V
MD:#I/BGPGXK\*:AX1T&XN/"EU)X<MM?T?6?#]QJ>L6.M:EK-G>:+>V%_:WFC
M_P!^U% ')^ O%UM\0/ O@OQ[9Z'XL\,VGC;PGX<\76OAOQ[X9U7P7XZ\/6WB
M31[/68-#\:>#M=@M=;\)^+-)BO5L/$?AG6;:WU70=8M[S2]0@AN[6:-?P7_X
M.//^"37C3_@J?^QCH-C\$(].N/VE_P!G+Q7J?Q'^$6B:K>6FEVGQ TG6](32
M?B#\+DUG4)8-/T/4_%-I8:!K/A[4]1F@TN3Q)X1T?1]6O-)TK5[W6]+_ *%*
M* /\:S]AG]HG_@KG_P $8_VD/$H^"OP6^,?@/Q_XF%KX5^)7P ^+/P,^(>L>
M$/B=%HUW=/HEMK_@F.TT36M0N]*N[N\G\,>*_!>M:1KL%IJ6HV^C>(6T/7]5
MM=2_LH_9\_9U_P""X?\ P7&T?3]8_P""I_C"\_X)]_L$WYAGUW]E#X#>%->^
M"_Q;_:2L P+:%XU@\6Z_XR^*'@CX<:@F^'7+/X@^)O,UJ&.(Z+\-U-YIOC?1
M_P"RNB@#_&$_X*#?\$T_VLOV)/\ @HQ\7?@S\,OV>?C5;6.B_'?Q'XD_94U'
MP'X#\=>,XO%7PWE\97.O_!K5O &LV.GZ]-XIU'3=!?0;'4(;:^UC5M)\4:=J
M.B:S(^L6%XE?Z*'_  28_9F_X*<?&SQYX%_X*%_\%@_B'=Z;\7?"'@+5_"'[
M,G[)7A73].\#^$?@YI?C72UTOQO\7OBIX2\+RC2[SXU^/-$>;1;71]4GU&Z\
M#>&]1U*SU*/3-6N[+POX'_HKHH _!/\ X+R?\$3?!7_!7?X$Z+<^$]4T3X>?
MM;?!>UU:Y^"/Q(U>&9-!U_3=2V76L?";XCS6%O<Z@?!GB"\MX+W2-;MK74-1
M\"^(@VL:997FFZIXHT/7_P#-C\++_P %6O\ @@A^U1'X]'@GXL?LM_%70Y+C
MPY?W/B;PQ+K/P>^+WA9[N.6^\/7.JJFH?#;XM^!=5FM(IHKG0M9U+^SM2M8-
M4T35-%\3:3:7]A_M$5%/;P74,EO=00W-O,I26">-)H94/59(I%9'4X&592/:
M@#^!G]F/_@YB_P""U/\ P4%L-/\ A#^QG_P33^$_C'XR:LD>CZK\:=,L_BG?
M_!7P1<W.RWN?$_B%=>UW3?"?@BTL-TMS:_\ "9_%74+,W@MK7[%KTK)I-_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB/$/_P L*/\ B+O_ ."-?_0]?'S_ ,,1XA_^6%?LE_PZ]_X)H?\ 2.[]A?\
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M,1XA_P#EA7[)?\.O?^":'_2.[]A?_P 1)^ /_P [^C_AU[_P30_Z1W?L+_\
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MO^'7O_!-#_I'=^PO_P"(D_ '_P"=_0!^-O\ Q%W_ /!&O_H>OCY_X8CQ#_\
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M/^D=W["__B)/P!_^=_1_PZ]_X)H?]([OV%__ !$GX __ #OZ /QM_P"(N_\
MX(U_]#U\?/\ PQ'B'_Y84?\ $7?_ ,$:_P#H>OCY_P"&(\0__+"OV2_X=>_\
M$T/^D=W["_\ XB3\ ?\ YW]'_#KW_@FA_P!([OV%_P#Q$GX _P#SOZ /Q>;_
M (.^_P#@CFNIQ6 \2?M%O:R6<ER^M+\#+T:9#,DHC73Y8G\1)K!O)4)GC>'2
M9; 1*1+?1S;86O\ _$7?_P $:_\ H>OCY_X8CQ#_ /+"OV-/_!+;_@F29EN#
M_P $Z/V$C<+&8EG/[(O[/YF6)F#-&LO_  K[>(RP#% VTL 2,U+_ ,.O?^":
M'_2.[]A?_P 1)^ /_P [^@#\;?\ B+O_ ."-?_0]?'S_ ,,1XA_^6%'_ !%W
M_P#!&O\ Z'KX^?\ AB/$/_RPK]DO^'7O_!-#_I'=^PO_ .(D_ '_ .=_1_PZ
M]_X)H?\ 2.[]A?\ \1)^ /\ \[^@#\;?^(N__@C7_P!#U\?/_#$>(?\ Y85!
M/_P=Z_\ !&^)K=8_%_[0=R)IQ#(\'P*UA5M(S%+(;JX%SK-N[0*\:0%;1;JZ
M\V>(BV,(GFA_9G_AU[_P30_Z1W?L+_\ B)/P!_\ G?TUO^"77_!,URA?_@G7
M^PJYC;>A;]D?X ,4<*RAT)^'QVL%9EW#!VLPS@F@#\;_ /B+O_X(U_\ 0]?'
MS_PQ'B'_ .6%'_$7?_P1K_Z'KX^?^&(\0_\ RPK]DO\ AU[_ ,$T/^D=W["_
M_B)/P!_^=_1_PZ]_X)H?]([OV%__ !$GX __ #OZ /QM_P"(N_\ X(U_]#U\
M?/\ PQ'B'_Y84?\ $7?_ ,$:_P#H>OCY_P"&(\0__+"OV2_X=>_\$T/^D=W[
M"_\ XB3\ ?\ YW]'_#KW_@FA_P!([OV%_P#Q$GX _P#SOZ /Q@U+_@[Z_P""
M.5C97%W:^)_VBM8GA0-'IFF_ S4(KZ[)=5,=O)J_B#2M-5U5C(3=:A;)L1@K
MM(41[:?\'>/_  1L958^-_C]&656*/\  C7RZ$@$HQ34G0LIX8H[ID':S#!/
M[(3?\$M_^"95Q&\,_P#P3I_83GAD&'BF_9%_9_EC< @@/&_P^96 (!P01D ]
M13Q_P2\_X)G@ #_@G;^PL    /V2/@"  .  !\/\  =!0!^-W_$7?_P1K_Z'
MKX^?^&(\0_\ RPH_XB[_ /@C7_T/7Q\_\,1XA_\ EA7[)?\ #KW_ ()H?]([
MOV%__$2?@#_\[^C_ (=>_P#!-#_I'=^PO_XB3\ ?_G?T ?C;_P 1=_\ P1K_
M .AZ^/G_ (8CQ#_\L*/^(N__ ((U_P#0]?'S_P ,1XA_^6%?LE_PZ]_X)H?]
M([OV%_\ Q$GX _\ SOZ/^'7O_!-#_I'=^PO_ .(D_ '_ .=_0!^,UK_P=Z_\
M$;[BWAFE\7_M!V,DL:N]I=? K6'N+=B.8IFLM9O+1I%Z,;>ZGB)^[(PYJ?\
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MO_H>OCY_X8CQ#_\ +"OV2_X=>_\ !-#_ *1W?L+_ /B)/P!_^=_1_P .O?\
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M_P#B)/P!_P#G?T?\.O?^":'_ $CN_87_ /$2?@#_ /._H _&W_B+O_X(U_\
M0]?'S_PQ'B'_ .6%4+K_ (.^_P#@CG;W>GV\7B3]HN^AO9)H[F_M?@9>I::2
ML47F)-J"7OB*SOI([A_W$(TJSU.99>;B*"#]]7[0_P##KW_@FA_TCN_87_\
M$2?@#_\ ._J)_P#@EM_P3)E>*63_ ()T?L)220,S02/^R+^S^[PLZ[7:)V^'
MQ:-F7Y6*$%EX.1Q0!^.7_$7?_P $:_\ H>OCY_X8CQ#_ /+"C_B+O_X(U_\
M0]?'S_PQ'B'_ .6%?LE_PZ]_X)H?]([OV%__ !$GX __ #OZ/^'7O_!-#_I'
M=^PO_P"(D_ '_P"=_0!^-O\ Q%W_ /!&O_H>OCY_X8CQ#_\ +"C_ (B[_P#@
MC7_T/7Q\_P##$>(?_EA7[)?\.O?^":'_ $CN_87_ /$2?@#_ /._H_X=>_\
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ML\RHLLR_LB_L_K+*L8(C620?#X.ZH"0@8D*"=N,U+_PZ]_X)H?\ 2.[]A?\
M\1)^ /\ \[^@#\;?^(N__@C7_P!#U\?/_#$>(?\ Y84?\1=__!&O_H>OCY_X
M8CQ#_P#+"OV2_P"'7O\ P30_Z1W?L+_^(D_ '_YW]'_#KW_@FA_TCN_87_\
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M,1XA_P#EA7[)?\.O?^":'_2.[]A?_P 1)^ /_P [^C_AU[_P30_Z1W?L+_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\ ?\ @Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\ !T=_R@H_;F_[
MMF_];#_9]K_(%H _O\_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\
M?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\ ?\ @Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\ !T=_R@H_;F_[
MMF_];#_9]K_(%H _O\_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\
M?N*_O\H **** "BBB@ HK\2_B-_P<6?\$=_A#XCO_"7Q0_:OUWP'XBTV_P!1
MTVYTSQ/^RY^V%I4K7>E7;V5^+.6Y^ "6VI6\%S&R"]TZ:ZLIU*2V]Q+#+'(_
M ?\ $4!_P0N_Z/IM/_$=?VM1_/X#4 ?OG16/X=\0Z'XN\/Z%XK\,:M8:]X:\
M3Z/IGB'P]KFEW,=YIFLZ'K5E!J6DZMIUW"S0W5AJ-A<V]Y9W,3-'/;S1RHQ5
M@:V* "BBB@ HKA/BC\3? ?P5^&WC[XO_ !2\36'@SX:_"_P?XC\?>/?%FJ"Y
M?3_#GA'PEI-WKGB#6;J*S@NKVXBT_2[*YN?LMC:W5]=-&MM96MS=2Q02?B/_
M ,10/_!"[_H^FT_\1U_:U_\ G#4 ?OG17X^?!#_@O9_P2J_:1\8>$? GP-_:
M/\5_$CQ'XX\9^'?A]X=30/V6_P!KPZ)+XM\5ZMI^AZ'IFK>*[[X"V?A3PU#<
M:CJEC'=ZMXFUK2-&TFVG_M#5]0L=.BFNH_V#H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBOR/_X*%_\
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M44 %%%% !1110 4444 %%?E3^W1_P6M_X)M?\$\(M5TS]H;]I'PK+\2M-CE
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MA$X!_4[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%KWQ)\7:/X8BU2Y@C$KZ;X?M-0N8M1\2ZTZ,OV?0_#]GJ>L7;ND=K8S2.B,
M>\T5_--\&/\ @Z&_8<_:B_;W^"'[#G[+O@/XN?%B'XQ>+-3\)#X]ZMIMK\.?
MA_I]U8Z!K/B""^T#PSXF5OB%XAL+B#19[>9M=\.>![BWEF@>"WOHB[I_2S0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\8O%-TVVW\)_#CX[?#+Q=XLE. 1L\+Z+XFO-?(((VDZ< W(4D@X^NZ "BBO
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MS\_X2+]JS_@H?_P4"_;<^/>KW7Q-^.MG\-?#SW/C[Q,([[5(O$?QV\<ZO?\
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M".K:QIGF,JLRQ_:MS*I(! )KTZ@ HHK,UK6]&\-Z3J.O>(M7TS0="TBTFO\
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MU;6?$_B&\M[.QM+C6M7OI;*PL+1H+.#T#XL?&3X1_ ;P5JGQ)^-WQ/\ A_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *\%_:I=X_V8/VCY(V9'3X"_&!T=&*NCK\/?$3*R
MLI!5E(!5@000"""*]ZKP/]JS_DUW]I+_ +('\8O_ %7GB*@#\A/V$O\ @CU_
MP3(^(G[$'[&WQ \;_L8_!KQ-XT\=?LJ?L\^,?%_B35=*U2?5/$'BCQ/\(O"&
MMZ_KFI3_ -K+YU_JVK7UW?WDNU?,N+B1]HSBOJO_ (<D_P#!*#_HQ7X%_P#@
MEU3_ .6]>^?\$WO^4=_[!7_9E_[+?_JCO M?:% 'Y9_\.2?^"4'_ $8K\"__
M  2ZI_\ +>C_ (<D_P#!*#_HQ7X%_P#@EU3_ .6]?J910!^/'Q2_X(M?\$KM
M'^&7Q&U;3/V'_@A9:EI?@3Q=J.GWD&C:HL]I?67A_4+FTNH6_M<[9;>XBCEC
M;!PZ XXKZ(_X)/32W'_!+7_@FS//+)//-^P1^Q_+--,[22RRR?L^?#UY))9'
M+/)([DL[N2S,2S$DDU];_&3_ ))#\5?^R;^.?_48U2OD3_@DQ_RBP_X)J?\
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M"_B;1/'/@CQ1:V-Q+;PZHF@>,_#.@ZI>Z-+=V4>N:=:W>C27]C'?M=P_9-%
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MG74%[97"*[1LT%U;22P3*LB/&S1R, Z,I(92  7:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?\ =LW_
M *V'^S[7^0+7^OU_P='?\H*/VYO^[9O_ %L/]GVO\@6@#^_S_@QC_P"<HO\
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M7XF_$+P?XE\,'1?%IUT:I(^F:)\-/"U\;]/[-M_LDXU4119D\RWFW+M^ O\
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M-+\->#_#^L^*?$6IR)))'IVA>'].N=6U:^>.%))9$M+"TN+ADB1Y&6,JB,Q
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M?HNGZEJ%I_$U^PK\+OVL?^#JCX\_$W]I;]O/XB>._A?_ ,$S?@=XY3PW\/\
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M1_$M]9B>WTSQ?H=S,+Z/^DI$2)$CC18XXU5(XT4(B(@"HB*H"JJJ JJH 4
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M_@VM_P""O/PPU.;]J37-?U3_ (*/^,OBE<KX@^-WB#X,Z;XT\:_%_P />/\
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MI;X=>(M,D34/"^E:!:WUE9^/M;T&YMO$VM>)KJ]\#176CZ3H/B"W\6_T._\
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M4$UE:_L_:SXD@2Y!:,:QX-UO0O%_AV50/^6\'B#0],GM3T6ZCA8\ U_G\?\
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MQ/X_\;>(;TE;30_"7@[1;WQ#XBU>Y(RWD:=I&G7=W*%!8I"0H+$ ]K7\F?\
MP=O_ +;.M_![]B;P!^P[\)YK[4/C?^WOX\LO!)T#0-]QXAD^$/A#5M#OO%%E
M96]H7O$O?'WC74? ?@"PLWC6+Q%HFI^-M/A>5K2YAH ^*/\ @VP^'?C#_@H[
M_P %)/V^?^"Y/QNT2Y6WNO'/B/X5_L\V>K#[4OAS6/%FE6%OJ-AI5V22)_@[
M^S_%X#^%5K<QRS0:AIOC[6 ^;FU+CL_^#SS]@O\ X6/^SK\%O^"@G@O1?.\4
M?L\ZW#\'?C'=VEONN+CX._$G6/,\#:UJ=QM)6Q\#_%2[.AV42E2UQ\7KN:3<
MELIC_IL_X)8_L2:)_P $\/V"?V<?V4M.AL3XA^'_ (%M+_XGZM8^7)%XB^,'
MB^67Q5\4-:6[4>9>V+^,-6U33] DN'EEM?#&GZ'IJR&WL($3Z-_:@_9[\"?M
M8_LZ_&O]FGXFVWVGP+\</AKXM^&_B%TACGNM-M_$^D7.GVVO:8LI"1ZWX;U"
M6T\0:%=;D>SUG3;&[B>.6!'4 _SP/^#-']O/_A4?[6?Q7_81\9ZSY'@S]J;P
MW)X]^%UM=W&+:R^.'PJTF\O]5TVPB=HX8)?'7PM37)]2N&9YKJ[^&WA;3;>(
MR7!-?Z6U?X9 /QW_ ."9_P"W0#_R+/[07[%G[1G(_P!(&G2>-/@]XWY'_+%]
M3\)^)'TC!ZV7B#PMJO\ RWL-0_>?[87[,7[07@3]J_\ 9W^"O[2GPRNOM/@3
MXX?#7PE\2?#JO-'-=:=:^*-'M=1GT+4VB 2+6O#M]+=:#KMJ522RUC3;ZTEC
MCE@=% /=:Q/$WB7P]X+\-^(/&/B[6]+\,^%/">B:KXE\3^(]<OK?3-%\/^'M
M"L+C5-:UO6-2NY(K33]+TK3;6YOM0OKJ6.WM+2":>:1(XV8;=?R5_P#!X7^V
M5XC_ &>_^"<_@S]GGP1J]QHOB3]LGXGR>#/$US:3M;7<_P &OAMIUOXN^(.F
MVT\+I<1C7/$E_P##;0-6C4_9[_PSJVOZ1>A[;4GAE /B+Q;_ ,%2_P!OK_@X
M*_;=\2_L*_\ !*SXG>)/V.?V)/AW!=ZI\:?VNM'T_5-/^*_B/P'::C_9#^++
M?5;6YTC7_!4'C+4?]!^$WPR\+ZUX2\;^)H([W7?'?BG2-#@\1Z'X,^]==_X,
M]_\ @F?XL\(ZG;^,?BU^V7XP^+FL64CZC\<O$WQA\-ZSXNO/$4D3,VL76D7O
MP]E\/WMH;M@S:=?6EU>O8H+5];-X6U-N*_X,R_@5X<\!?\$T/B?\;HK"W_X3
M3X^_M)^+(M5UI8!'=S^"_A3X=\.^%_"&@32\F>VT?Q'J/Q$U>V;(5)O%%Y&%
M!5F?^O&@#_(F\&_M[_\ !1W_ (-X_P#@H!\7OV8/"_QV\0?%CX=? 'XI3^$/
M%GP4\=ZSKNI?!CXK> '73]:\/ZYI'A/5K[6&^%/B+Q=X&U'0-:LM?\%S0:UX
M?N[FVTW4+SQ1H=G=Z7JG^I[^QC^U;\-OVXOV6O@C^UC\(S>)X"^-W@FS\6:7
MI^IF$ZKX?U&.YN]&\4^$=8:V9[5]:\&^+-*USPIK$EG)+9R:GHUV]I--;-%(
M_P#/9_P5Z_X-</A;_P %/?VJM0_:Z\%?M/ZU^S7\1?'6D>%-)^+VE77PEM/B
MYX:\8W7@S0--\(:%XHT6"/XA_#74/#6O1^$=%T31-3MY[[7-,U5='L+N*#2;
MQM0GU#][?V!/V,?AW_P3V_9!^"7['GPLU?7/$7@WX,>']6TZW\2>)?LRZYXE
MUWQ3XJU[QWXR\1W\%FJVEDVN^,?%.O:I;:9;F6#2;.ZMM+AN+B.S2>0 YG_@
MHG_P4)_9^_X)F?LR^+?VF_VA=8GCT7298]!\$^"-&>U?QE\5/B%J-M=3Z!X!
M\&65U+%%/JFHK9W=[J%_<,FG>'M T_5O$.JRQ:?ID['^1K]E3P#_ ,%9_P#@
MYJOO$W[0W[0W[3/Q _8+_P""9*>)=8\.> /@W^SKJ-YX?U?XN)I-[/I^K:/I
M^IF2PN/'=EX?N(%L/%?Q0^)\/B'PJ_C*UO\ 2/ 'PUM/LFOV?A3\:_\ @ZN_
M;4\9?M@_\%3=4_9@\+ZI<WWPP_9'&C?!/P/X=@NBFF:I\7_%UMHFK_%;Q-+!
M(P2+6G\1WVD_#:>21O*CL?AY9S0+";R\:?\ TZ_V7_@'X/\ V6?V<_@=^SAX
M L[>R\(?!'X6^"?AIHJV\:Q_;(O">@6.DW.KW15$:XU/7;ZWNM:U>^F7[3J&
MJ7]Y?73/<W$KL ?R[?%/_@S._P"">VI^"YQ\!_CW^UC\(?C'IT4EYX5^)?B'
MQGX,^(6F)XA3=+::CXI\+V?@;P1J%_$ESME;_A%/%7@N]20":.\)4Q/_ !S?
M\%!/VS_^"S_['+_%3_@D9^T]^V'\6M3\&_"/Q!/H^M6UGXJFU*\^(O@7Q)HF
MEZKX51/C!>:?:_%CQ5\(/$?A*_T_5-%\#>(O$G]D65AJT_AW7/#UM-I?]BZ5
M_L,5_E??\'C^FV5C_P %<]$NK6WCAGUG]D;X,ZEJ4B*%:[O8O%WQ7T>.XE(
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M?3SW=]>7$US<S232N[?=_P#P4K\:?\%JU_X2/P=_P3#^"W[*L.BV/@"'7O\
MA>'QP^)EYJ'CS6?%%P=7%[X&^&/PB;P]9^$-)\4:2NGZ=-9>)?B=XCUCP1K
MUVWMY+&RDLKZ2V]M_P""8/\ P3_TK_@FY\#?B=\ O#/B/3-?\#^(?VG?CK\9
MOAS9Z7I5QI*>#/AW\3?$=MJ7@WX?WD<\\ZWNH^#=#M+71;O5+46]GJ+6ZW-O
M9VB/Y"?H]0!_BH:'^VC^V-^V1_P4#_9:\3_M@?'GXK_&+Q?I7[5/P7ACTOX@
M:[>+HG@Z_7XK^&;?4=.\+^ +5-.\'^ HHYUFBN=(\+>'=#M(YO-#VBR&3/\
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MQ2W8\-^#_B+86GA;QC\.O&FHE5BT36M:\1:]X8N]0AL-,U2'PU:W=YXIT_\
M./\ X(N_\'07[1G[._QCT3]D3_@JCXM\2_$/X17'B9_AV?CE\2H+I/C;^SSX
MKMM1;198OBQJU[#'K7CSP3INLQ3V?C&Z\7QW?Q$\'EKO53KFL:=HX\+'_20K
M_*2_X.W_ -C[0OV:O^"IE]\5?!>D0:3X1_:_^&6B?'"^M[*!+;3X/BG9:KJW
M@?XH+;Q(JAKS7+SP_H?Q!URX+.UWKOCO4KER&E90 ?ZK4U_)<Z-+J?AY;#6Y
M9],>_P!#7^TA;:7J\DMJ;C3%_M>VMM26"POV: ?VE;V>H"*WE^U16UT%6*3^
M#C_@OO\ MK_\''O[/?P+T/XO>+8/@M^Q1^S+X_\ %MM\/+G3OV2OB--\1/C;
MX/UK7M+U75]"T7XG_&;6O#VCZSI5]?0:-JL%CXM^"-IX1T9;VQATS4+^&ZU+
M3(]4_8?_ (-4/VS_ !)^UM_P2G\&^%/'NKW&M>//V3/'FN?LVW>IZA<-<:IJ
MG@30-$\.^+/A7>W+,S$VVC^"_%=E\/;!V(EF@\!&6</.TD\R_P#!VA80WG_!
M%7XXW$J*[Z5\5/V?;^W8@$Q32?%70-+9U)^ZQM]2GC)&#MD9>A(H _D:_P"#
M;'_@I/X(_8C\;?\ !0O]HKX]:CX^^-/Q;^(_P\^#WA'X3_"_1[S5?&OQS_:9
M^./B7QSXE7P]X%\+)<C6=?UO6M6N56?7=?N(-3.C:5'->/;ZGJ+Z7HVJ?J%^
MU#_P2/\ ^#D#_@M+#??%;]JOXT? _P#9,^&6MF34OAQ^Q=XE^*OQ#TGPWX+T
M:X/VG1+?Q3X+^$_@CQ_H6I>(1:/&VI^)/B)XAUSX@VE[/=6,^B^&[2*/PYIO
MR7_P92_"CX;>,?VQ?VK?B3XK\%>'_$7CKX2_!3P=)\,O$VL:?%J&H^!;KQKX
MJU;1_%&H^&6N1)%I6KZQHUC'HT^L6T2:I'H]QJ>E6UY!I^L:M;WO^E30!_BY
MSZQ_P4G_ .#?S]NC4?!MKXLU_P""/QO^&NHZ#KFM:%H7B*[U[X-_&SP-J 6^
MTB?5],MY[30?B9\,_%^GI- J:G96^KZ->Q7EL4\*>.O#TJZ-_KL_L)?M9^#O
MVZ_V/_V?/VM_ MH=,T'XX_#G2?%D^A&X%X_A?Q1#)<Z'XZ\'2WHCB6^F\&^.
M-)\1>%IKY8HDO)=(>Y2.-)50?PC_ /![[X&T?3_VD?V$OB5!:0IK_BWX(_%?
MP1J=\J*)[G2?A[X[T#7=#MI7'SO'9WGQ-U^2%6X1KV8KR[8_H0_X-*-=O=7_
M ."+7P:T^ZF>6#PO\7?V@-"TU'9BMO97'Q*U7Q-)#$"2%1M1\1:A<%5"KYD\
MC8W,S, ?TMT444 ?/?[4WPK^+GQL^!?CGX8? []H;7_V5_B/XLMM/L-(^.7A
M7P3X;^(/B3P;8KJME/KPT3P[XLFM]'&HZWH<6H:%;:SY\.I>'9-1&N:+/;ZO
M864\?^5%_P '!_\ P2+'_!*SXO\ P2GU#]J'Q_\ M4^+?VG]+^*'Q"\9^.?B
M3X971/%'_"0>'-?\.6][?:IJLGB_QCJ/B?4O$%QXEN+_ %'5=4OH[QKF'?(U
MP\[R+_KPU_G9_P#!\-_R6G_@GS_V2_X]_P#J5_#:@#/_ ."%/_!%S]HS]M7_
M ()X^ ?CU\./^"NO[9_[(/A;7/'WQ2T.V^"7P6UWQU8> ]&N?#7BV[TN\UFQ
MMM"^,_@K3EOO$,\3:EJ31Z#!(]U*YEGN7S*?[2/^"9W[#GQ,_8%^!WB_X1?%
M3]LKXX?MOZ_XG^*^L_$>R^*?Q\U#7]2\7>'-'U3PAX(\,P> -,F\1^./'UZG
MAS3;WPE?^(K6*+5[6U&I^*-6=--BE>:ZN_RU_P"#2;_E"Y\'O^RP?'__ -6-
MJ-?TO4 ?Y9'_  >3_P#*6[PM_P!F>?!O_P!3SXQU^TG[%W_!2']K;QE_P3&_
M8<_X)O?\$<OAU9_&#]M33_V:O#-S\?\ X]ZR-*7X'_L3>'?$>J^()-)D\8>(
M]?27PG??&+5[$R:KH'A#4(M:?3+*!KG_ (1/QEK F\-V7XM_\'D__*6[PM_V
M9Y\&_P#U//C'7]O/_!N9\*_AQ\,?^".G[%MWX \%^'_"=[\2OANWQ)^(-_HV
MGQ6VH>-/'FOZWJL.J^*O$U_AKS6-8GM+'3]-AN;Z>8V.CZ;IFC6 M=*TVQL[
M< _BS_X*"?\ !L'_ ,%EM.^'WC[]K[XP?'_X<?MM?$/P[H6I>,?B3HNC?%+X
MN>./C%)I&FV]QJNN3>$9?BCX%\/VWBVTT*QAN;E/#VF:KI>KS6\*Z?X4\,ZG
M<?9K!NG_ .#6G_@LW\=OA!^UW\,_V OCO\3?$WQ!_9J_:%NY/ ?PNLO&^MWN
MO7'P5^+DEE/<^!K;P5J.JW%U?Z;X.\>ZC:KX'O\ P3:R?V+#XDU[0?$6EV^E
MS0^(#K?^G&0""" 01@@\@@]01W!K_% \"V<'P,_X+,^#M/\ "T::5:_![_@I
MQX?LO#L-HH@CTZW^'_[5-I;Z3%;)&%6&.TBTFW2)$"JBQJH  Q0!_L^?%K7?
MB+X8^&7COQ%\(O &E_%3XH:+X7U?4? ?PWUKQG;_  [TGQMXHM;2272/#>H>
M.;O1_$%KX5MM4NUCMI-;N-%U&"Q#^;+;L@9E_P \'_@X<_;:_P"#B;]G=/ >
MD_M&>/\ X<?LN?L__'5?$>G>#],_86\8:U%975]X?BL9=7\'>/OB]JUEI?QD
M7Q-'H^KVLM]::;J'AGP'XMLI]1?2])O$TW4[33/](&OXNO\ @]JLXG_80_9*
MORBF>V_:W:SCD(^98K[X.?$::9 >H5WT^!F&>3&N>@P ?CI_P;\?\% _BS^R
MY^PC^TY\)_V7/!DOQY_X**?MF?M:Z-\/_P!E?X8WLT>H"37;;X46NK?$+XY?
M$2XU.[M[:'X??"?2KR/Q#XFU37=0M--NM5O=*BUN^L_#Y\1:SI/XU_\ !6G]
MAO\ X*R_LG?M!CXL_P#!0^/XE^.?'OQ#U6UUOP[^TUI_BW5OB-X(\2:W]H%W
M;:-X6^(.G1V]OX0U;P]>'[/I'P_EL?"%]H-G;VDGAKPY!X;.D74W]0?_  9'
M_L\?"^[\+_MF_M4ZAH46H_&'2?%/@SX&>&O$%XL4I\+> K_0QXV\36>A+Y0D
MM;KQ;K2:#_;UTTLCRVGA;1K6U%K&VI"__O@(!X(!&0>1GD$$'Z@@$'L0".:
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M1X3\$ZGJ_P *=*CCM8+>QLO%&BZ7;O;VT45K)_9M_P /[?VM?^E?_P#X*O\
M_AIM5_\ F2H _D&_X*S?\$GOVO/^#>#XI^ /VGOV*/VH/C+#^SW\0/%'_"-^
M%?BGX;UV^\&_$3P#XXM+2YUFQ^&WQEM_"HTWP=XTTWQ+HUAJM[H&J'2(/#WB
MVVTCQ/HNO>#-'6RM5\0?UX?\&Y__  7-NO\ @JQ\*O%?P>^/R:)H_P"V=\"-
M$L-8\83Z%90:/H7QF^&UQ=VNC6OQ7T30[;;:Z%KFFZW=6.A_$?P_IT,.@V6K
M:QX>UOP['8Z9XG'AKPQ^8_\ P6+_ &Z?VR_^"G?[ _Q3_9'\,?\ !"__ (*=
M_#[QGXO\0_#+Q-X/\;^+?@GXEU?0_#>J^!_B'X=\1ZG<75EI7A(:B\FI^$[3
MQ'H%L]J0T=QJ\;3?Z-Y]?C;_ ,&\O["__!3O]D3_ (*W?LM?%/X@_L0_M;?"
M[X4ZE<_$/X??%?Q;XV^ WQ.\,>#;'P9XU^&OBO3H9?$VNZGX>LM.T_3K'Q<G
MA;689[VZBMDU32].,I91L8 _L8_X*[_&'_@O%X0\'_'_ %;_ ()Z?"/]E_P)
M\'/A!X)NO%\7QD\4>.S\1OVC?B/HNC^"[7Q7XNO_ (5_"37?"4'PT\):GX9N
M3KNA1Z#X];QGJ/B>;P^M_P"&QYNL:;I[_P">+_P3O_;@^+?QC_X+"_L/_M(?
MMN_M+^,/'4'@O]H'PMXI\6?$WXW_ ! OK_0_ OA+2I;G5=;N8+C7;X:'X+\*
MZ7:6LERVF:+;Z5HEA! J6UE"B(@_V*O&&FP:SX2\4:/=(LMKJOAW6]-N8W 9
M)(+[3+JUF1E/!5XY65@>""0:_P 5S_@C+X%\&?$S_@JM^P-X%^(7A?0_&O@O
MQ%^TS\-;3Q!X5\3:;;:QX?UVRAUA+P6&LZ3>QS6.IZ=+<6T)NM/O89[*\B5K
M>[@FMY)(G /[R/VH-3_X+3_\%RWU32/V"M?D_P""<O\ P36F66U\+_'?XKZG
MXR^%_P >OVO-*D$D$GC7P[X<\+:-?_%/PK\(M<MI8[CP?HEXGP]T_P :>&+P
MZWXA\1^(&U*/P?X6_CK_ ."H_P#P1!_X*!_\$=-0\&?'_P =>.=(\?\ @+Q)
MXOCLM _:4^!WBCQE::EX5^(US%=ZK8Z=XSDU>P\/^+_!WBK6$L=3U'1=:M+G
M5M(U,VDT<7B1-:\S3$_V#U5454151$4*B* JJJ@!550 %50       !BOQ*_
MX.-_!>B^.?\ @BO^WCIVMVD-TFB_#CPKXTTUY8T:2RUKP1\4O GBG2[NUD*L
M\$PN-+%N\D11Y+6XN;5V,%Q*K 'X%_\ !#G_ (.:])M?V)OC[X?_ ."D7Q%U
MCQS\7OV6-/\ "5U\(-?A6/6_C5^U/X?\:W=UX<\+_##2M(\R*[\=_&'0O%EM
MIVD3^([B2*;6/#/B73?$?C*[5_"WC#Q??\_^T1_P3A_X.*O^"Y\.H?%+]H+X
MI> /^"?G[-GB1)+SX6_L8>*?B!\0M(O--\+W2F30I_B?X'^'/A35)?$GBBXL
MV677-3^+^IV'BO2M2NKZVTGX>^#=*F7P]9?CM_P9Z_#OP!X^_P""MFIWOCKP
M7X;\87?PZ_99^*/Q$^']QXCTNVU5O!GC_3/B!\'M!TWQIX?2[22*Q\2:=H?B
M3Q#ING:HB&YT^+6+N>S>"[$,\7^JI0!_C*?M;?L;?\%*?^#?W]J;P-+JGC_5
M_A%X]U:RG\5?"#X]? #QOKC^ _B7HV@W]I#KEE8:A=:;X?NM5BT>[O+"Q\;_
M  Z\?>%X,V6K:>=8T#4O#'B/2;W5_P#3U_X(?_\ !29O^"I?_!/_ .'/[17B
M*TTS2_C!X<UG6/A!\?=(T6'[-HUM\6?!-II%YJ&KZ/:%F-EI7C3POK_A7QU:
M:8&DCT0^)9O#\=S>#2#>3_AA_P 'M7A/2;S]A#]DKQU-:POKOAS]K=O">G7K
M(IGM])\:?!SXC:QK5K'(5+K#>7G@+0)9T5E61[&W9E8QH4X7_@R%UN]N/V7/
MVX_#<DSMI^E?'WX<:W:P%F,<=[X@^'EW87\R+G:'G@\,Z<DC!0S+;Q!BP50H
M!]Z_\%J?VN_^"^7P-^#'[07Q5_9"_9V_9^^#7[//P5/BJ_UOXSO\1-#^-W[1
M^J_##PY=SI-\9?#WPUUS0=,^&_@?P\-#!\1:SX<UG3OB;XMT#2()]0N!8BPO
ME@_C3_X(>?M[?$#Q;_P6N^!7[6_[=W[2?CKQUI?PU^&W[6GC?QQ\3?C!XRUW
MQ5_PBWA'0_V5/C1JVJ0:/;ZA<7@TO3HHK<0:/X3\+6-O!/=&RTC0](>YFL[1
MO]-C_@II;PW?_!-S_@H-:W"+)!<_L0_M7V\\; %9(9O@/X]CD1@>"K(S*0>"
M"0:_R@O^#?3]F7X.?M>_\%;OV4?@5\??"X\;_"C7KSXG^*/$_@NXNIK;2?%<
MGPS^#WC[XE:!H?B.* AM4\+WOB7PGHX\1:%*RVFO:0MWH]^)+&]N8I #]UOV
MQ+C_ (."/^#B*[U_XB_LQ_!#XG_!K_@G'>W%]%\$OA]KOQ,\(? KP[\4_"D$
MMQ!IOC7QP?$WBWPUK/QEUGQ.MN;H7%I9Z]\+O"<K+HOAR[-S;ZGXAUW^8#XP
M? K_ (*$_P#!)/\ :$TO1_B/H?QM_8Z^/6CQ)K?A3Q-X8\4WOARXUG3+>Z5/
M[8\#_$?X?ZY<^'/&>@+=Q_9+VZ\->(M8TI+I9M,U+9<I<6B_[?&GZ?8:386.
ME:58V>F:7IEG;:?INFZ?;0V5AI]A90I;6=C8V=LD5O:6=I;Q1P6UM!''#!#&
MD42(B*H_&S_@O3_P3M\'_P#!1?\ X)T_&OP/-X>M+[XT_!_PKXD^-7[.OB*.
M&%-<TGXD>"=#N]7D\*V5^T;2)H_Q/T:QN_ VN:?,YTZ674M(UR:'^T_#FC7E
MB ?GA_P;7_\ !>'7O^"F'@KQ'^S#^U+J.DC]LCX-^&8O$UIXNL[2QT2U^/\
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MA_X+W?MO:W^P)_P2X_:2^-/@G5I=%^*_B?1]-^"OP=U.VF>VO]*^(/Q:O/\
MA&4\3:5<QG-OK/@7PI)XJ\?Z.[*\;:GX5M8I4:.1A7\97_!E5\(=&\8?MZ_M
M-_&K6K6+4=4^$7[-::'X<FNU$TFFZ[\5_'^A07>N6TC@R1ZC_P (]X-U_1//
M#Y:P\0:G"X;SPR@']"?A/_@TP_8P\<>&DU[]N#]H[]L+]L;]HS7;-)O&OQJ\
M7?&34-*)UR94:^D\(:1J5GXJUBTTPS#,4?C/Q1XWO9F!FDN84>.SM_YV/^"G
MG_!,W]OO_@W&\3>%_P!K'_@G3^U[\>YOV2]<\5V6B7UV=:C.I?#3Q;>.9M$\
M,?'?P)9VJ?"KXG^#_%DMM*FA>+-2\ VF@2ZY$GAK7_#FD:O/X6OO%/\ IK5\
MV_MA_LS^!_VR?V6_CS^RY\1K6VN?"?QP^&?B?P'=7%S;K<G0]5U.PD?PQXML
MHW5U76/!GBB#1O%NAS[6:UUG1;"Y12T*@@'XH?\ ! 3_ (+V^$O^"LG@36/A
M+\7]-\._#?\ ;5^%6@1:UXQ\*Z$\UKX2^+?@J&>UTZ;XH?#FQOKFZO=,;3]1
MO+&P\<^#I[S4&T"]U+2M4TN_N]'UDV>@_;W_  5(_P"":GCG]O?P,FI?!C]M
M;]K/]CKXZ>"/"&NZ;\-=9^!GQQ\<?#_X4:_K=U(VH:=!\8_ 7A.\L9?$^G27
MRI9-KVCW^E^)]%LIC-:SZI;6O]BWO^2-^QM^T?\ %'_@FW^W;\(_CUHXU#1_
M''[-OQG2W\<>'K6<Q2ZWH.CZS<^%/BQ\/;Y@T8DL_%7A:3Q-X2O@2I2/4&GA
M>*XAAFC_ -PK1M7TWQ!I&E:_HUY#J&CZYIMCJ^DW]N2T%]INI6L5[8WD#$ M
M#<VL\4T9(!*.I('2@#_%*^-_[9O_  5N_9S^+_Q(^!/QC_;>_;M\&?%'X3>,
M-;\#>./#.H?M7?'<SZ7K^@7LEE=K#/'X^:WO].NO+2]TG5K*2;3M8TJYL]4T
MVXN;"\MYY/\ 53_X)0?L,Z#^SE\%_A1\:Y?VO/VPOVL_'?QA^ /@/5/$?C+]
MH/\ :5^(_P 6/A[J_P#PG&E>&?'EQXA^'WPY\0ZQ=^%/"=M+<B&W\-:E;VU_
MXEM?"T[Z9?\ B/5GOM1O+W^37_@\Z_X)U#PUX]^#_P#P4L^'6A!-(^(J:9\!
MOVBWL+;Y8?'.@:7=77PA\=ZD8EDEDD\1^#M-U7P#JFHW!M[*Q'@7P+IR&2^U
MM0_ZV?\ !HQ_P477]J/]A/4?V0_'NN"[^,'[$UQIWAG0EO;C=J'B']GKQ1+>
MW'PTOH1*RO<CP#J%KKGPWN8;.%K?1/#FD_#Y;N7[3K4>\ _K/D02QR1DNHD1
MD+1LR.H=2I*.I#(X!RK*0RG!!!%?YPO_  7N^"_[3G[(/[?W[&?['O\ P3Y_
MX* _\%&+[QU^UGX:T.$?"SQO^V]\>O%ZZ!XG\6?$Z7X<>!-6L-<G\6IKNG^'
M?$E[:ZW_ &HVMS:K%I@\,:EJ<-Y'9^?;6O\ H[W%Q!:03W5U/#;6MM#)<7-S
M<2)#!;P0HTDT\\TC+'%#%&K2222,J1HK,S!037\,G_!':UN/^"OG_!??]MK_
M (*R^(X)M9^ 7[*,D_PK_9<>^B=M,DO=4TW5OAK\,-1TNWNEDM]UO\*M)\=?
M$OQ'IT7FRZ'X[^)^@ZO%/%)):R2@']0'_!-K_@GWJW[ _P ,=2T+QI^UI^U3
M^U[\4_'>D>"3\2_'_P"TC\9_&7Q*T6'Q'X5M]?:Y;X2>$/%&I:G;_#/PWJ%[
MXFU!;FPMKW5-:UBQT_PZGB77M8N=%LYX_BW_ (+C_P#!:C2_^"7_ ()\!?"+
MX*^$+3XU?MW_ +2$D.C_  !^#S0WFIV.CP:IJR^&-/\ B%XVTC1YH-9U+3;O
MQ-*OAWP3X1T^XL-2\?\ B>"_T^QO[.PT/7KVT_?.O\I*?]N[Q5\??^#FS7_V
MP)/V??C!^V?9_"7]H7XJ67P8_9\^">DS>)O'^N>"_P!G[P?XW\'?!K4/!^B0
MVVI):1>%;OP[HOQJ\1K96DT2:C:^(]59C<7D]_0!_45\.?\ @V^^*/[;_A;3
M?C/_ ,%NOVX_VH/CY\>O&5O%XBNO@9\+/B+H?@WX$_ ^74T6Y'@_0M(3PSKW
MAZ\U710RI?W?P]T?P+X0M]4?4+6RL_%4$,'BK5?P%_X+,?\ !OO\7/\ @C1H
M%C^WM_P3L_:'^.,WP9\):]HVF>.;I?%-UX7^._P*N]>U.#3_  YXJ3Q[\-;3
MP?:>)OA]J'B"XT_P[<WJZ5X>UKPUK&I^'K>\@\2V>J7VL:/_ %#?\/[?VM?^
ME?\ _P""K_\ X:;5?_F2KY._;O\ ^"K'[6W[8_[&/[4'[+,7_!!/_@J7H6H_
M'CX(?$/X;:!X@UOX-Z[?Z1X<\5>(O#M]:^$?$FI6=KX2^UW%EX>\3_V3K-Q%
M:?Z6T=BWV8B?RZ .:_X-HO\ @X/\>_MTZY)^PK^VOKUEK?[2^C>&K_Q!\%/C
M"ME9:3=_'#PQX7L9+[Q/X3\9V&G16NFGXH>$]$MYO$5IKFE65K!XT\):=KEY
MK-K:>(_#=WJWC#^RPD $D@  DDG  ')))X  Y)/2O\?S_@G'_P $YO\ @K/^
MS3^WU^QM\=D_X)^_MH^%['X9_M)_![Q%XDUS4?V<_BSI^EV?@I?'&C67CR/6
M+Z3PS#':Z)?>"[O7M/UJ>2:*./2KJ\9Y8U!<?Z)__!Q'^UGK_P"QU_P2._:K
M^('@K59]%^(7Q T'1/@+X$U.TG:UOM/U3XRZW:>#_$6J:;>1.EQ8ZOHGP]NO
M&FNZ+>VI^TVFKZ98W$+0M']HB /R+^.__!37]M?_ (+0?MP^.O\ @FU_P1Z^
M*B?L\?LV?!L7*_M5_P#!072K>6_\1S:7::G)H>HQ_!W4K*YL[K2M,U#6(+W1
M_A[<>%M5T;QG\3-2TR]\1Z9XR\&?#C2M8UF\]/\ ''_!G=^P%\1?".J3^-/V
MEOVW?&'QXUBS>?4OCSXV^)W@OQ?JVI^)GC9SJ.K^&]7^'DBZEHC7CEWT>77T
MUM[/_1O^$O%X6U-OQ _X-GOV\_B?^PU^R7\<%^%?_!*C]MS]L[4OBM\?I[WQ
M)\;OV</ -YXA\%6NF^#O 7A&R\-_#'4-4MM#U-6U_P )WFN>*?$]S;-<(8+3
MQ_9D6Z"4RS_TA?\ #^W]K7_I7_\ ^"K_ /X:;5?_ )DJ /X@?B+XZ_X*I?\
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MXGCE19H)9(RT;I(H8E'5@" #^OW]O']MC_@L/_P7'\;>/O@C_P $7_A_\1?
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M4%_:6_92LM3U2?3O@U\2_-^'6OW-SMUN[^'/BK2])^(?PHU:]OK2.UC;Q /
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MD)X9U[P]>:KHH94O[OX>Z/X%\(6^J/J%K96?BJ"&#Q5JO\NL_P"W=XJ^/O\
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MOX@T'5/!NI/(O@?Q=$T=S;6WB_P[9:5XKT'4(_*N)+[33J>B:A_M15_FQ_\
M!Y)_P3M\'_!+X]_!W]O?X6>'K30-'_:AN==\!_'*QTR&&TTQ_C7X0TVSU7P_
MXU^R11HB:Q\2?!?]J1Z^]N%CO=6^']UX@OEDUKQ#J=[>@']]O[#_ .V-\(OV
M^OV6OA%^UA\$;Z:?P+\6/#BZF-)OW@.N^#O$FGW,^D^+O OB:*W=XH/$/@_Q
M)8ZEH6I&%GL[U[--4TR:ZTF_L+RX]/\ VA?^2 _''_LC_P 3/_4+UNOXC?\
M@R(_:/UW4O!O[;_[)FL:C-/H'A/7?AG\?? 6GR2M(EC>>,K37/ 7Q,,2N28(
M+C_A$OAE+'#"1";E[^=D6:=WF_MR_:%_Y(#\<?\ LC_Q,_\ 4+UN@#_()_X-
MW?\ E-+^P!_V5S6O_5:>.J_V5J_QJ?\ @W=_Y32_L ?]E<UK_P!5IXZK_96H
M _)?_@L3_P %9_@]_P $COV89/C%XVT^+QU\6?'=YJ'A/X ?!N'41IU[\0_&
M=I9QW5]?ZK>)'/<:/X!\&V]U9:EXU\016T[VZ7ND:%8H^N>(]&AF_$[X!?\
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M:_\ #7@#0]/N-5N-.CEA76M?N?#7AVXN;&TUJ?4+3V7_ ((EW<U[_P $C/\
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M\&>"_"NF6VC^'O#?A_2;=+73]+TK3K1(X+:VMX4 X4R2R&2>=Y)Y9)'^9_\
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M\,>#;'P9XU^&OBO3H9?$VNZGX>LM.T_3K'Q<GA;689[VZBMDU32].,I91L8
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MWO\ \%'?^#>/_@H!\7OV8/"_QV\0?%CX=? 'XI3^$/%GP4\=ZSKNI?!CXK>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6YN=&U;3]1AC>UNHI6_%/_@I9_P<(_\ !/K_ ()__"CQ5J'A_P"-GPU_:/\
MVB'TF\M_AO\  /X-^-=%\>ZEJ/BJ:%X]*;XC:]X1O-6TCX;>%+2[:"\UNZ\0
M7UIX@NM)6<>%="U[4F@M'] _X(4?LV_&WX'_ +$LWQ8_:HDO9OVL_P!N#XM^
M.?VT_P!HF+4[=[74-!\6?&*/2$\+>#)+&8"XT)/"WPXT#P?;7/A!TBA\&Z[<
MZYX<M84AL T@!\(_\%]/^#BOPG_P2XD_X9I_9WT+P[\5OVU/$7AVUUO4HO$3
M3W?P]^ /A[7;;S]!UWQY8Z==6E[XC\;:]9.NJ^%/A_!?Z:D.D2V7B[Q5>PZ+
M>^'M&\8?.'_!.?\ X(2?$;]N;3_ '_!0G_@NY\5OB9^U?\8OB)H^G^//AA^R
MUXR\2:EHWPI^$'A/Q+!;ZWH<7B_PEX<DT/3;'6=1M9+#5;GX2^#['PEX#\-"
M6;2O&>C^+=8NM1L=$_AH_P""Q/B#Q@W_  6 _P""@^N?$:WFUG5]*_;8^-L<
M-AK7FE+[P/X;^)6K:?\ #W3'\]6<Z0WPYTWPQ8:?\C1_V.+7RD,.Q:_V0OV;
M?VA?A1^U;\"?A=^T1\$/$^G>+OA?\6?!^D>+O"NKZ=<6\_E6VH6ZF[T74XK>
M23^S?$/AS4%N] \2Z)<^7?Z%KVFZCI&H007ME/"@!_.U_P '2OPT^'7PA_X(
M5_$?X>?"?P%X,^&7@'PY\5_V?[/P_P""?A_X8T3P=X3T.T7XC:<1;Z3X=\/6
M6G:1I\.?F,=I:1*S$LP+$FOQ'_X,>?\ DM/_  4&_P"R7_ 3_P!2OXDU^E/_
M  =W?M[_ +*NG_L+>*OV%+'XK:'XH_:C\:?$+X6>*I_A?X0EC\1ZGX"\,^#O
M$]GXAU'6/B?=:?+)9> Q?6XM+;0='UN>'Q'KD^HV=WIVBS:,M[JMG^7?_!D!
MK^FVW[1G[>/A>6[MTU?6/@I\)-?L;%I46ZN=-\-^.O$FGZK=PPDB22WLKKQ5
MHT-S*JE(9+^T20JT\88 _P!&>O\ %5\<?\IM?%__ &E.\0?^M:W=?['7P*_:
M0^"G[3&D>.O$7P*\?Z)\2_#/PZ^)OB;X0>(O%'AF9K[PV_CWP9:Z//XJTG1-
M;1?[/\06VAW&M0:5>:MH\]YI3:O:ZE8VUY.]C,P_QM_&.I65Q_P6B\5:Q%<1
MOIT__!4#7-2BN@ZF%K*7]JVZNDN X)0QM PD#ABI4Y!(YH _VN*_,C_@M)_R
MB3_X*._]F<?'O_U7VM5^F]?F+_P6GD2+_@DE_P %'&D8*I_8[^.T8)( +S>
MM8BC7GN\CJBCJ68 <F@#_/&_X-!_^4QWA7_LWCXZ?^FS0J_U<Z_RA?\ @T-N
M8(/^"R7@N*614DO/V?\ X[6ULK$ S3IH>E7;1H"?F86UK<2D#)V1.V,*2/\
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MKKP#9QWTJ K"VJ:>DA4SQ;OW$_X.0?\ @G-XB_X*+_\ !-KQOX=^&&B3:_\
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MX=\-^']/N-6US7-8U*[>*UT_2M)TRTNK_4+VYDCM[2TMYIYG2.-F&]7X;_\
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M_P#!X7_RF!N?^S8/@C_Z6^.:_P! S_@A_P#\HAO^"=/_ &:A\)?_ %';>O\
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M4M/T#4/B'K&DVD%G<_%#X26=Y<1+XI\,^*V4:KJ>A:,;G6O NL7-YHNK6/\
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MH6 FGL=)^([VNH7")G+1VL^M:9'*P&$:[A!(+KD _P!'^BBB@#_*P_X/%/\
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MG.J:3%9ZE\5OB';_ !8^,FA:\ES:7VG^&]*CMU*W]G8,/ZI_^#AW_@H5;?\
M!/3_ ()G_&3Q5X=U]-)^./QTL;K]G_X#PV]SY.L6WBOQ]IE[:>)O&VG>4QN;
M9OAQX$3Q'XKLM4\F2RM_%5KX4TN\:-];M1)Y1_P;"_L+6?[&'_!*[X1>)]9T
MR.V^*W[7"6O[3?Q O)(0M[%H7C?2K(?"#P[YSJMRMCI/PNA\/:T^FSJ@T[Q/
MXJ\5A(PUS*\@!\1?\0J/C_\ Z32_M_?^#?6O_GIT?\0J/C__ *32_M_?^#?6
MO_GIU_7]10!_DE?\'"O_  12\9_\$K_&GP3^)X^/7Q(_:A\"_M#VOB;3-?\
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MU7],W_!JK_R@[_9+_P"QD_:/_P#6E/BQ7\?/_!WC^V+^S_\ M5?MP_![PS\
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M@O['/Q)_X6 $65M+>T/Q-^#@\-I='_CV34O[?^SR::S8NS:1ZPEM_H[7X/\
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M/CMI\EXESJ]C\3OA9H^FZ#-KFK(&+H_Q$\-1^'OB3;,!Y*Q>*WL4<SV%U'$
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M%>ZY\/?^%B:3>:]X'A\5VL.X:1=>)]#L+K6-(L[ITN[G2TCOQ"+6>WEE /\
M,3_X/)_^4MWA;_LSSX-_^IY\8Z_NX_X(#_\ *&S_ ()[?]D TC_T^Z]7\(O_
M  >2NK?\%;_#*JP)C_8^^#:. <E&/CGXPR!6]"4=&Q_=8'O7]W/_  0%96_X
M(V?\$]RI! ^ .E+D'/S+K^OJP^JL"I'8@B@#]@*_Q2?B1_RFE\>_]I0O%/\
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MVU'3/@QX4MKAHV!U>QUM=0^)>8N+6V^'ZQ74D#ZKIXN?]6Z@#_%A_P""YO\
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MWQ!\1>/?A7\0/#4FOR>)]1O+K5;*&VU"XT+2+*XM=+\/PVNDV-E!']&? ?\
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M]>/]GK_D@/P._P"R/_#/_P!0O1*]@KP7]EGQ#I/BG]E_]G+Q5HE[!?:%XC^
MOPA\0Z1J,$J26MYI.K_#WP]J5A>PS*=CP7%G<13QRJ=C1N'!P<UV/PB^,7PN
M^/GP^T/XK_!?QUX<^)?PU\32ZU#X<\<>$=0CU;PUKQ\/:]J?AC69-'U6#-MJ
M-M8Z_HVJ:8]W:/+:RW%E/Y$TL8#D ])HHHH _DI_X/-_^43OPY_[/8^$/_JJ
M/CY7YZ?\&-7_ "+G_!2__L-_LC?^D'[2=?H7_P 'F_\ RB=^'/\ V>Q\(?\
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M_!/$J0P'[-W@]20<C<DNH(X^JLI4CL017ZVT ?XJOQ9_Y3:_$O\ [2G>,O\
MUK74J_VJJ_Q4OBW)&O\ P6P^)LS.JQ+_ ,%2_&<C2$X41C]K/4F+D] H7YB?
M3FO]JV@ HHHH _F)_P"#NS1KO5/^"-/C^^MDE:'PY\>/@/K-^8U)2.TG\37G
MAY'G(!"Q&^UZR0,V!Y[PKG<R@_R7?\&<FHPV7_!7;4[:5U5]7_9,^-&G6ZMU
MDFB\3_"[5F1/]H6^ESR''\*-VK^^'_@NM^S[??M._P#!(S]N_P"%.DV<NH:Z
MOP/U/XG>'K"VA,]]J.O_  +UG1?C?I&E:=$BM(]_K-[\/8M'M8HP'GEOQ;Y"
MS-7^<5_P:P?$:W^'_P#P6S_99LKVY2TL/B/X?^.?PYN9I&VH;C4_@IXZU_1+
M8]R]]XC\-:-80J <W%U%G"Y( /\ 7;HHHH _@J_X/DO^1,_X)L_]C/\ M5_^
MFK]GVOO/_@R^_P"44?Q7_P"SY/BW_P"J8_9UKX,_X/DO^1,_X)L_]C/^U7_Z
M:OV?:^S?^#*SQ5I.H_\ !,KX_>$8;RW;7?"_[;?CK4]1TY95:ZM]'\3_  2^
M JZ)J,T(.^.#4+[0O$-I;.RA99-)N@C,8G"@']A%?RD?\'CWAW3=9_X)&Z+J
MM[';M>>$OVM?@UKFCR2J#-'>WGA3XI>&)Q:L1N61],\0WXD (#0"7.=HQ_5O
M7\2__!Z_^TQX>\,_LE_LM_LDV>IP-XW^+/QPNOC7JVF0O'+=6?P_^$?A#Q%X
M6BDU&(.9+*VU_P 7?$O3GT>9XU_M";PAK<5M*5TZ]0@'YV_\&0WAK4[K]J7]
MN'QA%%*=&T+X _#KPU?S -Y,>I^*_B)<ZII$4C ;!++:^#-;>(,P9DAF*A@K
ME?\ 0:_:%_Y(#\<?^R/_ !,_]0O6Z_FS_P"#1S]@WQ#^RC_P3JUCX^_$/0[C
M0?B+^VWXNTGXGV.GWMN]IJ-K\$/"&EWFB_!K^T()$$F?$+:UXX^(>D3"1H;C
MPOXZ\/S+'#,UP'_I*_:)=(OV?OCI)(P2./X.?$YW=CA51/!6MLS,>P5023V
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MCQZ99+HUPU]J5[-#;0.=3B&GPQ-)YUQ?RPV5O')=310O\_\ _!83_@HAJ_\
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M9)J/AOQ?X>UKPMX@T]R52_T3Q!IMSI.JV3D<A+JPNYX&(Y <D4 ?Y7W_  :
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M%+(L,M[X=\%^&]>\=:MX$UA(HK?7!H'CO5-][X;\0^%+C4 #\D_^#Y:WU/\
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MM0Z??6MY+I&K):6E^^EZI';RR/8:BMCJ%A>M97:Q7*VE[:7)B$-S"[_S?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^R;\'+;[9H?CKQ3\'OBJ?%7Q8^(/@J_=(];\*^!K/PBJ:/8Z?XJLX38WU_\
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MQ9_P50^!_P (_A9\%?!7_!33]EY_!OP@^'/@CX7>$GUG_@F3XCO]8;PS\/\
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MYHNH^+_">IZ/X7\>^(+#16A_MKPG\-/"G@@>&#XN@LM3\:?$64VGAG4?#O\
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MYV&6#PYX*T&Q\/Z4;N6-(Q<ZA/:V$=QJ-ZR"6^OY;F\G+33R,WJE !7X\?\
M!8[_ ((X_ C_ (*\_ BQ\$^-KX?#CXZ?#@:KJ7P)^.VG:5'JFI>#=2U2.'^U
M/#/B;3/.LY/$_P .O$\EG8G7M!%]97MI>V5AK>B7UI?6DT-_^P]% '^-G^U?
M_P &]'_!7#]DOQ=JF@:W^Q]\3_C9X;M;N:/1_B3^S)X<UKX\>#_$6GQNR1ZO
M#9^!=-U#QOX:MI=I)M?'7A#PIJD0&^6Q6!X9I>N_9T_X(W_\%TOVR[K1OA#9
M_ ;]K'P)\-9I[6TO-5_:DO/B5\%?@YX9TI)8T;4YM/\ BD=,FUK3]/(5VT_P
M)X5\5:V_ED6&C7,D3*G^P]10!^//_!&?_@CY\&O^"0_[.MS\//"VHVWQ$^.?
MQ(FTW7OCY\;9M*33+KQCKFGP31Z3X7\-6<CW%YHOPY\&K>7\/AK2+F[GN[R^
MU#6?$FIM'?ZT]E8?L-110!_#5_P75_X-6-<_:(^)'C7]L'_@FQ#X4TGXD>.;
M_4/%'Q=_9?US4].\'^'_ !IXNU"62[U?QG\(/$^I26GAGPSXA\27\CZAXC\&
M^++S1/"U]JESJ&NZ5XGT66;^P+S^-2Y_X)8?\%?/@=X]%EI?["'[>/A3QQI\
M\EE9:[\-?@5\9]5$DC.$D70O'/PWT#5-'U2!V5=T^B:[=VTBA'\QD*L?]L"B
M@#_,0_X)L_\ !K__ ,%!?VW/BSX4^+7_  4O?XD_ G]G_1[NROM?T[XI^+;O
M6OVC_B?I5K.MS)X/\.>'M1U/6M:^&VGZBRRV>K^)?'IT;5M(AG^U>'_"FOS2
M&XLO]+WX=_#SP/\ "3P%X-^%WPS\+:-X(^'GP]\-:-X.\%>$/#UG'I^A^&O#
M'AZP@TO1M&TNSB^6"SL+"VAMXE)9V";Y7DE9W;LJ* "BBB@ K^#;_@LS_P &
MF?Q;^._QT^-7[8_[!/Q7TGQ5XR^-/Q"\:?%_XB?L]_&'4K/POJ#^.?'.O7_B
MGQ+-\*/B9!:P>'6LM3UW5;J;3?"?C^V\.0:%;!]WQ#U)6M[*#^\FB@#_ #_O
MV-/^"IG_  <<?\$V_#VE?L]?M@_\$L/VG_VWO _@JWM_#_A3Q7;>!_B3J'Q)
MTG3K%%L[31I?V@OA3X'^-/@3XD:;8PQK_9USK^EZSXJND!BF\:75@MG%9_5O
M[1'QC_X.%?\ @MMX%O/V9_@Y^PEJG_!*']E_XAVYT+XW?%7]HKQKK>F_$[Q)
MX.O"8]4\+P6VK^"O /Q(L?#?B'3S-!K/AWP7\)+F[U^)?^$=\0?$32O"FLZQ
M9:G_ &J44 ?D9_P2/_X(X?LS?\$C/@]>^#_A2L_Q ^,OCJWT]_C/^T%XGTRT
ML?%WCZ[L<RVVB:/I\$U[%X*^'FDW4DTVA^#+#4+XK*XU#Q!K'B+6A_:E?KG1
M10!^/'_!8[_@CC\"/^"O/P(L?!/C:^'PX^.GPX&JZE\"?CMIVE1ZIJ7@W4M4
MCA_M3PSXFTSSK.3Q/\.O$\EG8G7M!%]97MI>V5AK>B7UI?6DT-__ )G7[5__
M  ;T?\%</V2_%VJ:!K?['WQ/^-GANUNYH]'^)/[,GAS6OCQX/\1:?&[)'J\-
MGX%TW4/&_AJVEVDFU\=>$/"FJ1 ;Y;%8'AFE_P!DRB@#_'A_9T_X(W_\%TOV
MR[K1OA#9_ ;]K'P)\-9I[6TO-5_:DO/B5\%?@YX9TI)8T;4YM/\ BD=,FUK3
M]/(5VT_P)X5\5:V_ED6&C7,D3*G^DQ_P1G_X(^?!K_@D/^SK<_#SPMJ-M\1/
MCG\2)M-U[X^?&V;2DTRZ\8ZYI\$T>D^%_#5G(]Q>:+\.?!JWE_#X:TBYNY[N
M\OM0UGQ)J;1W^M/96'[#44 ?F]^W5^TE_P % ?@U]H\-_L0_\$X];_;%US5O
M +:II'Q&O_VDOV>/@M\-O"/CJ\U#7--M_#WBCP]\3/'OASXA^(1H=M8Z1XGO
MAX=TJUTC6['6(-#L_%>EZG#J-QIG^;#)_P &WG_!P7-\39/C%)^QG,_Q$E\=
MO\2Y/$3?M*_L;-<-XT?Q ?%#:TT3?'\VYF;7";XQF,PESM*%/EK_ %OZ* /R
M[_8=_:A_X*0_%>]\*^#/VV_^"8VN_LJ:E%X/FG\9?&/0_P!J#]FCXM_#"^\8
M:7:6J&WT3P7X"^(FO?$[2+?Q7>&YNM-L;G3->M/#D0^P:GXGU#RH]2N_S&_X
M+'^,?^"T?[7?[-7[0/[%O[)?_!*7Q#HGAOXLW6L_#;7_ -H7QQ^U[^QQ''K_
M ,)K;7VBO[WP/\.C\8;'6=-E^)NA6,, N/&=YINJ^&O#VLZA9W7AE?$,L-UH
MO]/M% '^7S_P3-_X(S_\'"'_  31_;/^$/[8'@3_ ()Y:=X[N_AS<Z_IWB/P
M!J_[5?[(6BZ?XX\$^,?#NI^%?%7AU];MOCMJ,VB7\NF:K)?Z%K2Z=J<6D^(=
M/TG4;O2=7LK:YTN\_P!&O]E7XO?'_P",W@'5?$?[1?[)/BW]CCQMI_B271[+
MX<>+OB[\&OC/<ZYHL>D:1?)XMT[Q3\$_%/BGP_!ID^IWVI:)%IVL2Z7KXGT2
MXOI]*AL+W3YI_INB@#^2G_@OE_P;5:%_P48\1:I^UI^R#JOA3X7_ +7TNG6\
M7Q!\*>)6DTGX<_M"0Z191V>F7^HZO96UT_@WXHVFFVUOI%MXFGLKO0/%%I::
M7IWB<:++;/XJB_@D^(7_  1W_P""N_[.WCH:7K/[!'[8>G^*="OV6P\3?"?X
M3>._B;HL=]"[1I-H/Q'^#5CXO\+74K9)MY](\1S/)&V^)BI)K_:QHH _RE/V
M(_\ @W'_ ."NG_!1'X@^$K_]KRQ^,G[-_P !]*O;>3Q'\0_VH]4\1W'Q,@T?
M?&=0TCX<?!SQEJK^.I/$=W;!([6Z\4Z9X1\)6REI[G6[NYM$T>[_ -.;]E3]
MEOX+_L7?L_\ PS_9F_9^\*0^#_A7\*O#T.@^'].#1SZEJ-PTDEYK/B;Q)J*0
MV[:SXL\5:S<7WB#Q-K4L,4FIZUJ%Y="*"-XX(OH6B@#X2_;"_:+_ &Q_@E<:
M5I_[*W_!/#QM^VO<:KX;O]2GUG1/VD/V<_@)X8\-^(H;N6VL/#?B";XQ^,=)
M\3S_ &V%8M0?5O#7A7Q!8V]M(87)O%,%?YU/[=G_  0\_P"#BO\ X*!_M8?&
M3]KOXS?L*Z19>._C!K]EJ-QHGA[]I7]D2'P]X6T#0-#TOPGX/\):''=_M$7%
MTVF^&?">A:-HT5W=S27VIRV<VJZA)+J%]=2O_JAT4 ?R:?\ !(7QC_P77_8+
M_9*\!?LA_M(?\$A_$GQF\/?!JTU#1/A7\2?AQ^V=^Q-H7B9?!EWJU]K&G^$?
M%_AKQ+\<7TV_?PS+J-QIFB>(]*UW3RWAV#2=)O/#\M[IL^MZI_2EX>^)GQ?U
M7]G:X^*VL_LW>+?"_P :XOA]XH\4P?LMWOQ$^$^I>,[KQGHUCJUQH'PQ3XFZ
M-XMO?@Y%K'B^[L=.T^P\2S>,U\(:3+K=O<:[J]A;6>H26_O-% '\$G_!>/\
M94_X+V?\%B]5^"OA+PC_ ,$M+SX&_!'X'3^*->TK0]>_;#_8R\7>,/&OC?Q;
M!INGW7B3Q!=:?\;=*TG1K'0]&TQ=+\/Z%IPU*6.34]>U'4-:O1J%AI^BU?\
M@@]^R=_P7O\ ^".6N_&GPUXI_P""6ES\<_@E\=6\*:OKF@Z)^V'^QGX0\8>#
M?&?@Z+5K+3_$OAR]O_C9J^E:O9ZOI&LW&E^(- U&/3GN'L=!U&PURP_LR^L-
M:_OEHH X_P"'NO>)O%7@'P1XG\:>!=2^%_C'Q%X2\.:YXK^&NL:WX<\2ZO\
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MH6EK?V-S!>V-[;PW=G>6LT=Q:W=K<QK-;W-M/$SQ3P3PNDL,T;-')&ZNC,K
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MM+/5[K3KW4[>UU#QCXNO;+2;SQ;>Z;HUO'HVE:;HL$=[_1510!X5^T[^SO\
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M.**6]\4Z_J'P^UW5BR/XB\!V/B :E?ZA\U?MN?M0_P#!<;_@M=\/M4_8U_9
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MCIGP]T+6?$^G:K?06$WC#Q =/L]2\%ZG_=G10 5_%I_P7.\!_P#!=;_@JS\
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M;P]\2]?M]!TY9]4GE\7:=J)^$OA"VMX4U#5_$?C.XN]"6]E\*ZM%;@'\.?\
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M[P+XMMM?M? 'BBTTWQ!#X>\$:3X/U6!/$^K:/807U[XN@LO"]YJ=NOBA+/\
MOSHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]"8KF1>.<,1T)K^<3_@R&_Y.G_;@_P"S?_AY_P"K%FK^D+_@Z]_Y0D?M)?\
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MU*\T_P T6>JN;GXC:;!=Q2C2_$.O6L<%_< ']0]%?Y^W_!2[_@LM_P '$?\
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MI-4632&D-ZUU:Z?JT\<3/9+!/]OT4 ?Y ?[??[ W_!8C]NO]LS]HO]KC7/\
M@F)^UYX1N?CG\2=7\7V'A2/X-^.=3/A?PVD5KHWA'PY/JAT.U&JWNA^%-*T;
M3+_5([.QAU*]M;B]AL+&&=+2'^_7_@E+_P %%?VDO$7P>_9;_9?_ &K/^"8O
M_!0;X%_&3PSX)\#_  >\3_%G4_@5YW[.D[^"O#-KX=M/B!K?CG4_$FC^(_"%
MGKUKHL.I:UIVH>#;NVT/5-0_LZQU?6K94O*_H'HH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *^<OVM/V4O@E^VY^SU\2_V8?VA_"W_"
M7?"CXIZ+'I6OV$%TVGZMIUY8WMKJ^@>)O#FJQI))I'B?PMKUAIVOZ!J2Q3QV
M^IZ?;_:[6]L7NK*X^C:* /\ ,6_;9_X-!/\ @H/^SKXVNO'7[!GC70OVI? 6
MEZI%K7@^UB\5Z+\&?VB/"4MI<B]M&N[7Q)JN@^!-7O=#VP&S\2>$O'>GZSK%
MY;27=IX(T*5K6R;SGP'\5?\ @\$_9EA@\&^&-"_X*4:Q;:5_Q+;;_A+/@9_P
MU%:PQ0';'%!XH^('P_\ B[!<6<2J(K:>/6)K1(%2&WE$"H@_U+Z* /\ .V^%
ML_\ P>I_M>36_AN^\9?$WX'>%]1:*#4O&WQ2\!_LJ?LS0Z%#+A#>7">'?AEH
M?QAE5=YDE'A7POK%_'@D6RE$4?O_ /\ !,7_ (-[/"W[+OQ;T[]M/]O;X[^+
M/^"@/[>\8MKW2/B7\3M7\2^+/ _PDU*WW26UUX!3Q[?:MXG\5>)](FFN!HOC
MSQ:]A_8B-;W'A#P7X.U2WDU&Z_I*HH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#Y>_:L_;._9M_8C\#:+\2/VG/B)/\./!WB+
MQ$/"FBZI;>!_B)X]N-0\0G2=2UM=-AT;X:^$O&.NB1M,TC4+E9I=-CMF-O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME]9G[?H]J)_(\^V,UM)#-)[7110 4444 %%%% !1110 4444 %%%% !1110
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ML-+UO3C>6-S#/]BU;3;'4+;?Y5W:03*\:]S110 4444 %%%% !1110 4444
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MNQN4\,>,/$5I=2SO-I-[J5E!-=1_I7110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB='UC7=6\1:;%HNLZ)IU_>?IQ_P>S_\ )@'[*G_9X=G_ .J6^*]</_P9$_\
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M1Y?'6DV2W#K;77Q%UB=PEQ=S1I_1?_P_T_X(W_\ 20K]GS_P>:Q_\I*_+O\
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MWU3PE^SSXQUCPY\.8[B?4XC+:W/C;P?X-T"R\+W$%T9/B5/J%J?!FN@'\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /P!_X.CO\ E!1^W-_W;-_ZV'^S[7^0+7^OU_P=
M'?\ *"C]N;_NV;_UL/\ 9]K_ "!: /[_ #_@QC_YRB_]V3?^_<5_?Y7\ ?\
MP8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _ '_@Z._P"4%'[<W_=LW_K8?[/M?Y M?Z_7
M_!T=_P H*/VYO^[9O_6P_P!GVO\ (%H _O\ /^#&/_G*+_W9-_[]Q7]_E?P!
M_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_ )04?MS?
M]VS?^MA_L^U_D"U_K]?\'1W_ "@H_;F_[MF_];#_ &?:_P @6@#^_P _X,8_
M^<HO_=DW_OW%?W^5_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO\ E!1^
MW-_W;-_ZV'^S[7^0+7^OU_P='?\ *"C]N;_NV;_UL/\ 9]K_ "!: /[_ #_@
MQC_YRB_]V3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBOQP_P""O_[+G_!4
M;]ISPG\$--_X)C?M=^#?V2_$GA+Q%XTOOBWJGC#Q%XJ\/0^--#U73= @\*:?
M8R>%OAA\2Y;F31K^RUJYG2\MM)CC6_C:*>Z9GCA /V/HK^)W_AT]_P '8?\
MTF6^"?\ X<OXN?\ T*E'_#I[_@[#_P"DRWP3_P##E_%S_P"A4H _MBHK^)W_
M (=/?\'8?_29;X)_^'+^+G_T*E'_  Z>_P"#L/\ Z3+?!/\ \.7\7/\ Z%2@
M#^V*BOXD[S_@DM_P=A74!A/_  66^#&#+;R?N?BQ\9]/DS!<13C_ $JR_972
MX"9C'F0AO*NX]]I<AK:>93:_X=/?\'8?_29;X)_^'+^+G_T*E ']L5%?Q._\
M.GO^#L/_ *3+?!/_ ,.7\7/_ *%2C_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4
M?VQ45_$[_P .GO\ @[#_ .DRWP3_ /#E_%S_ .A4J"Z_X),?\'8=Q:W-N?\
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M3_\ #E_%S_Z%2C_AT]_P=A_])EO@G_X<OXN?_0J4 ?VQ45_$[_PZ>_X.P_\
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MXSQ0XN# 3YMA%^RN+.\?]R/*FND:6S_>"U*BZN-UK_AT]_P=A_\ 29;X)_\
MAR_BY_\ 0J4 ?VQ45_$[_P .GO\ @[#_ .DRWP3_ /#E_%S_ .A4H_X=/?\
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M/?\ !V'_ -)EO@G_ .'+^+G_ -"I1_PZ>_X.P_\ I,M\$_\ PY?Q<_\ H5*
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M6:Y=I7ZN2:M?\.GO^#L/_I,M\$__  Y?Q<_^A4H _MBHK^)W_AT]_P '8?\
MTF6^"?\ X<OXN?\ T*E'_#I[_@[#_P"DRWP3_P##E_%S_P"A4H _MBHK^)W_
M (=/?\'8?_29;X)_^'+^+G_T*E9>F_\ !([_ (.P;&74Y%_X++?!W_3[^2];
M[3\9OCGK"9D1%/V6#5/V6I8=&M_D^72M*$6G0MNDBC#RR$@']NU%?Q._\.GO
M^#L/_I,M\$__  Y?Q<_^A4H_X=/?\'8?_29;X)_^'+^+G_T*E ']L5%?Q._\
M.GO^#L/_ *3+?!/_ ,.7\7/_ *%2C_AT]_P=A_\ 29;X)_\ AR_BY_\ 0J4
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MKG_A\M\&,V\5S&-OQ8^,\4.+@P$^;81?LKBSO'_<CRIKI&EL_P!X+4J+JXW
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M-L(OV5Q9WC_N1Y4UTC2V?[P6I475QNM?\.GO^#L/_I,M\$__  Y?Q<_^A4H
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MRWP3_P##E_%S_P"A4H_X=/?\'8?_ $F6^"?_ (<OXN?_ $*E ']L5%?Q._\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!
M1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\
MG*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H
M[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,
M8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^
MO^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@
M#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!
M:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[
M_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?
M:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W
M[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6
MP_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_N
MR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF
M_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.
M47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_
M +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q
M_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\UFQM=<UGQ3<_#O2-9\77L6AZ)-?ZO:Z+I$-G/K=U9Q:7_:NF?:A=Q_Y@O\
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M:K?:)XE\+ZQI^O\ A_6+)V9%O-*UG2KB[T[4+5G1T6XM+F:)F1E#DJ0-ZOR
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MN/"^NQAS)HOB*'1K^]DT35D$;E].U-;6\4(Y:$!3CM:_B"_X,AO^36?VX?\
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M:,NOVB[/X.>,)OV3M'^#NN_'YH](M_ %C\?M:\8Z!\(TN;O7=,M-8U+QE?\
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M1/\ @DQ_RBP_X)J?]F"?L>?^L]?#R@#] Z*** "BBB@ HHHH **** "BBB@
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MVGQ1^(2:I\)O@I:SC<L.HZ9HU]9GXJ^-H(I$(N-+OM!^&44\4D<UEXCE7<*
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MUL/#^NW5C>::GC&SDCN+JR /]!:BOD']AS]NC]G#_@HC^S[X9_:3_9@\:_\
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M\=LXK;_@KIH\T:A7U']DCX,7DY P7E3Q9\5=/#,>Y$%C"F3_  HHZ"O]"_\
MX)G?M;?M._MD_ [Q?\2_VKOV(O'7[!?Q T#XKZSX&T3X2_$#7M8\0ZQXF\':
M?X0\$:_8_$6UO-:\"?#ZZBTW5-;\2:_X:BMH]'NK=;KPG>2KJ4LDTMK9_P">
MY_P>3_\ *6[PM_V9Y\&__4\^,= ']W'_  0'_P"4-G_!/;_L@&D?^GW7J_7^
MOYDOV$?^"CG[+G_!,G_@WU_8&^/7[4'C-]&TN7X"V.E>!/ >@16VJ_$CXK>*
MX=4UZYC\*?#[PU->60U*_$;12ZGJM_>:;X:\.6DT5_XCUK2K.2*63^<G]H#_
M (/./^"AMSXMBUOX'?LF?L]?![X2:C/)<^$;+XP^'OBK\3/%?B'3$D(BGOO&
M.D>./A3X;O(KB$)++!X>\+6YLY)'A36+U$2=P#_2CHK^8G_@A/\ \'&W@?\
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M-3\8CPQ;ZSIT$P!_6717\@_[<O\ P4Z_X."O^"2OA_2_CC^UM^S+^P)^U?\
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M?P/XNT.X^U:/XE\*>)],MM9T'7--G*HTEGJ6F7EM=P&1(Y524)+''*KHO9T
M%%%% '\!7_!\S9Q&U_X)BWX4"9)_VR;-G &YXI(_V6ID5CU(C>*0H.BF5\8W
M'/Z9_P#!FO\ \HDO%7_9XGQC_P#4"^#5?FQ_P?+_ /(&_P""9/\ V$_VP_\
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MD77AM;#P_KMU8WFFIXQLY([BZL@#_06HKY!_8<_;H_9P_P""B/[/OAG]I/\
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MRUCQGXI&FR:EI<&J7FD:)<Z;HTNJZ:=9O=/BO8)7_C1_;A_X/6KA+J_\*?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'X _\ !T=_R@H_;F_[MF_];#_9]K_(%K_7Z_X.CO\ E!1^W-_W
M;-_ZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_ '[BO[_*_@#_ .#&/_G*+_W9-_[]
MQ7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/AUX<TSXBZC_ &G%)+%J1O?%]KK%P=1BD:*^,ANHR$E4#^$O_@^,_P"2G_\
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M\9?&VCW(OI_$.CZ5<>$;]K[PIH%G;6G][7[>_C;4_AK^PM^VC\1M$FDMM9\
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ML'Q__P#5C:C7X(_\'PW_ "6G_@GS_P!DO^/?_J5_#:OWN_X-)O\ E"Y\'O\
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MW&K^,D^'^A6'BW5IY&+,TNI^([/4[Y][,X:<JSNP+'_.N_X/'T5/^"N>BLH
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MLZ/K)TA[G_0:_;T_X(,?\$U/^"@W@CPGX3^)7P.T_P"$.O?#_3++0/ ?Q/\
MV;+#PE\(_B#X6\+Z?"MO:>$89;?PGK/A#7O"=G"BQZ7H'B[PAXAL/#^Z>3PW
M'HT]Y>RW'\D'_!D'_P G,?MT_P#9"_A=_P"I_J]?Z.% 'Y]?L?\ ['/[(O\
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MW_X+$:)%>*AN+[]FWXXVNEEBH9;](_"M[(T>1DO_ &99ZBI"8;RV<D[ P/\
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M#QWKQ-QXDN=)U6^^WS?#OP,]S(UKHG@+PG=VNFVFD6NG1:U<^(-7MYM9N?\
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M_9+N^N-/^SQ7$[VC7,-M-" ?ZG _:K_9<  '[2/P"    'QA^'8  X  'B+
M '05_+G_ ,':7AO]D;]I+_@F5>_&7P[\3O@KXQ^.7[,7Q)\ :_X!O/"GQ#\%
MZ[XTF\(_$OQCH'PT\?>$[2RTG6;O4K_0=1;Q#X<\5ZG:16\@M[KP9I^H[X(+
M:\,OZ7?\0S?_  0[_P"C$/#G_AZ?VEO_ )\]'_$,W_P0[_Z,0\.?^'I_:6_^
M?/0!_$9_P:*_MH>+_@%_P4ZTC]FB;6KO_A4_[9'@_P 5^#M>\/S33MI%I\2?
MAWX4\0?$;X=^+XK9'V1:PMOH'B;P-%.(W2:U\;2+=*?LMI<6?^J=7Y!_ /\
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M\ >!O'5O"+>#QIX/\,^+(+<,6$$/B/1;+6(X0S ,PB2\5 S $A<D U_C^?\
M!R6JK_P6X_;U"@*/^$Y^&K8  &YO@-\*F8X'=F)9CU+$D\DU_K=_LL\_LQ_L
MY9_Z(/\ "'_U7WAZ@#WBBBB@#D/$?P]\ ^,=2T76?%W@?PAXIUCPU#JUMX=U
M7Q'X:T77-2T"WUX6"ZY!HM]J=E=76E0ZTNE:8-6BL98$U$:;8"\686=OY?\
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MN>'?BY>6VI^(-1US7+W5?$-OXV_X2?1O$>KZU>6EKXBU\ _7S]C7]B[]G/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /P!_X.CO\ E!1^W-_W;-_ZV'^S[7^0+7^O
MU_P='?\ *"C]N;_NV;_UL/\ 9]K_ "!: /[_ #_@QC_YRB_]V3?^_<5_?Y7\
M ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTT<ZFNK^"O[ -Y!:^)K;Q39:3=>&]0+Z=K<-C>QO H!_+-_P>S_\F ?LJ?\
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M!*C*2K+)$ZNI4D$$$$CFO%/VP^/V2/VI<_\ 1N?QN_\ 59^)Z_B@_P"":_\
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MOQ(NM5_MIO$\3_";1==U7QGX$L/#45KX?FT_5/%UO9Q^*X]?G.G6]J-%F-V
M<A_P5V\6?L!>$/V#?C3?_P#!2O3]!US]F&[TV#3]3\+WT;S^+_%/C203W'@W
M0_A'#9WFG:XOQ9FU&V>Y\(W^@ZEI=WHC6M]KNIZOH_AK3-=U2S_CV_X)$?\
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MBZ0/$UWX6\=V_A74=2@TZRMK>34-.\(Z*UUY?GWL5S>237,H!_4[^T[^P/\
M\'#/_!1+X9ZG^SI^U%^V=_P3P_90^ GC:S.A_%5/V(? 7[1'B[QM\0O"\[*F
MI>&]=N/C)<>';Y=!UB$21:QHOASQMX4L==L'ET+Q NJZ'>ZC87/Z7_\ !+#_
M ((X_LA?\$EOAWK'ASX!:-J_BKXG^-[6RA^*7QZ^(#6-_P#$?QREE*UU;:+
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MX2UA?)FN-VE>)+_5;?1M0'V>VN)\VE[,/)MYI?N12,H!_F&?\'D/_*7+0?\
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M"#Q1H5S>Z)J>N:)I/P_L[[78-+O;R+29=:M=,O9HM7MM1L++]B/^#0?]O?\
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M=;\+_%[1]!&A:SX=TR349]0$6C^*M(TK4M<\*:((_P#,>_X)5?\ !3OXX_\
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MPU^]>ZUCP?XHL+")VTGX6WVKW4D_PY\5^5#HVCVUY;_#_6Y;/4].T#4/%O\
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M>)-8TVSNM/MH;FVEGO8)I+>*.X@=Y%6:,L ?Y$W_  <F?\IN?V]?^QX^&?\
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M>J^*_$NL>(M>^)?Q9\0"*VC\*^&+S6[CPOX5O9(?B5<>"+2+P_#-* ?W*?\
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M[OQ%XFLM"MM+T[2;"#PEX8U'59O"?@Y8=+L)7\*Z'H\U[;I?R718 ^EJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEQ2Z9H26%E)'INGH\!6SMA'],44 ? '_  Z=_P""67_2-/\ 8 _\0W_9U_\
MG<UZ#\+?^">_[ WP-\=:'\4?@G^P_P#L@_![XF>&1J8\-_$7X6_LT_!CX?>.
MO#XUK2+_ ,/ZR-#\7>$O!6D>(-)&K:#JNJ:)J8L-0MQ?Z1J5_IMUYME>7$,G
MU]10!P'Q1^%'PP^-W@7Q!\,/C)\//!7Q4^''BNT^P^)? GQ"\,Z-XP\):[:A
MUECBU30->L[_ $R\$,R1W%L\ULTEM<Q17-N\4\4<B_FAX!_X(.?\$??AGXX@
M^(GA3_@G_P# )?$]I>KJ-FWB31=9\=>'[&^CD\Z"ZL?!GCG6_$?@RREM9@LU
MFUKH$/V.5(I;40O%&R_K=10!76SM$M%L$M;9+!+86:62P1+:+:+$(5M5M@HA
M6V6$"(0!!$(@(PNSBOS@^%W_  1X_P""7WP6^,[_ +0GPO\ V'?V?O"7Q=76
M9/$6F^*K/P9#>0^&-?><W2ZUX(\,ZI/?>$O 6J6\[-)97_@O0=!N; LPL9+=
M6*G])Z* .8\;>#/"_P 1_!GB[X>>.-%M/$G@KQYX8U_P9XO\/7_F_8=>\+^*
M-*N]#\0:+>^1)#-]DU32;Z[L;GR98I?)G?RY$?##X-\??\$AO^"7WQ/\ ^'O
MAIXU_8+_ &7=4\*>$M#L/#?AA;3X1^%- \1Z!HFFVL=G:V&D^.?#MAI/CBQC
M$,2&XE@\1)/>W"_:[V6XNR9C^C-% 'X&6'_!L%_P0XT_Q%'XDA_8BM)IX;A+
MN'2K_P"/7[3>H^'5N4<2;I=!O_C-<:==V[,"'TV^ANM*9"8S8^7A1^SWP7^!
M?P9_9S^'^C_"KX"?"OP#\'/AOH(8Z5X)^&_A71O"'ARVGE2)+F^;3-$M+.WN
M=4OO)CDU+5KM9]3U.=3<ZA=W-PS2MZK10 4UT21'CD19(Y%9'1U#(Z,"K(ZL
M"K*RDAE((()!!!IU% 'XT_M!?\&^?_!';]IKQ5?^.?B9^P]\-[#Q;JMU+?:G
MK/PIU[XA_ Q=2O[AS)=ZAJ>B_!GQCX%\.:GJ-]*SSWVHZCHUU>WES)+=W%Q)
M=2/,WM7[(/\ P1W_ .":'["'B"'QC^R[^R)\-/ 'CRVCDBLOB+K,GB;XG?$;
M2EN(FANQH7CWXJZ_XV\6>'$OHG>*^A\/:OI=O=PMY$T+P*D2_I910 4444 %
M%%% &)XE\,^&_&GA[6_"/C'P_HGBSPIXETN]T/Q'X8\2Z38:[X>\0:+J=O):
M:EI&MZ+JEO=:;JNEZA:RRVU[I]_;3VEW;R20SPR1NRG\^OA)_P $?_\ @E]\
M"?B=;_&7X3?L+?LX>#/B78:D-8T3Q18_#O2KV?PMJZ2B:'5/!>GZLNH:/X)U
M"UD&;*\\):?HMQ8J6CLY((V93^D%% 'D7QI_9^^ W[2/A2S\!_M$_!+X1?'O
MP/I^NVGBBP\&?&GX;>#?BEX4L?$VGV.I:98>(K/P[XYT77=(MM=LM-UG5]/M
M-7ALTU"VL=5U*TAN$@OKJ.7Y=_X=._\ !++_ *1I_L ?^(;_ +.O_P [FOO^
MB@#X0TG_ ()9_P#!,?0-5TS7="_X)S?L(:+K>BZA9:MH^L:3^R'^S]IVJZ3J
MNG7,=YI^IZ9J%G\/8;NPU"PNX8;JRO;6:*YM;F*.>"2.6-6'H_QD_86_8D_:
M+\71_$#]H/\ 8Z_97^.WCR+2++P_%XV^,G[/?PD^)_BZ/0--FN[G3M#C\2>-
MO".N:RFD6%QJ%_/9::MZ+*UFO;N6""-[F9G^J** /@#_ (=._P#!++_I&G^P
M!_XAO^SK_P#.YKO_  '_ ,$]/V!/A6OC5/AA^P[^Q_\ #A/B5X"\0?"KXBIX
M#_9H^"_@]?'_ ,+_ !8UD_BGX;^-5\/>"M.'BKP%XE?3=.?Q!X/UT7_A[66L
M+)M1TZY-K 8_L"B@#X _X=._\$LO^D:?[ '_ (AO^SK_ /.YH_X=._\ !++_
M *1I_L ?^(;_ +.O_P [FOO^B@#@?A?\*?A=\$? NA?"_P""_P -O /PA^&?
MA9=13PS\._A?X.\.^ / OAU-7U:_U[5ET+PCX4T[2= TA=4UW5=3UK45T_3[
M<7NK:C?ZC<B6\O+B:3OJ** .<\7>#_"7Q \,ZWX+\>>%O#GC;P=XEL)M*\1^
M$_%VB:9XD\,Z_I=P +C3=;T'6;6]TK5;"< ":SOK6>WE  >-L"OQ.^)/_!M/
M_P $2OBCXBN?%&N?L->%?#^J7EPUQ<V_PV^)OQP^%GAUM[;VAMO!WP[^)GAK
MP?IEN3D+%I&A6 B4[(C&H '[J44 ?G3^R9_P21_X)M_L-:O;^)?V7OV0/A)\
M-O&5G&\5A\0;K3]6^(/Q,TV&6*2&XATKXE_$W5O&?CS2H;N&1X[Z'3O$5K%?
M)M6[281QA?T6HHH *\B^.?P"^"G[37PUU_X._M!?"WP1\8?A?XG2)=;\$^/]
M L/$6A74ULQ>RU"&VOHI&L-7TV8_:=)UK3I+35](O%2\TR]M+J-)E]=HH _#
M'P%_P;6_\$3/ASXW@\?Z'^POX0U75[2]&H6>D^._B5\;_B7X)@G$GG&.;X?_
M !!^)GB7P3JEFT@&=/UO0=3L4C_<16\=N3$?V5UGX:^!M;^&NK_""X\-Z=8?
M#;6O!.H_#FY\):##_P (YI-KX*U30Y_#=QX?T>#0CI_]AV,6B7$FGV*:.;(Z
M= (A8-;F&(IW-% 'Y[?L9_\ !*?_ ()[?\$_HFF_90_9<^''PT\22K<1W'Q#
MN[?4_'?Q5G@N]XN;%OBE\0M1\4^/H-)F#LK:)9^(;;157 33T &/T)HKEO'.
ME^(=<\$^,-%\(ZXOACQ7J_A;Q!I?ACQ*\'VE?#WB'4-)N[31=<:WP?M"Z3J4
MUM?M!@^:+<QX.Z@#^2;_ (*-_MR:A_P5I_X*&>'/^" _[*7BU=#^"+:SJ=__
M ,%&_C]H+6-[JUQX(^%C1>)O'OP+^&EU-%>6^F36^IV&E>!_%?BJ.WO+IOB-
MK%CX7DMK?PQX;\8Q^*?V;U3_ ((2?\$>]8T/1O#][_P3Q_9H2RT+1M,T.SNM
M+\"0Z!KES9Z38P:?;7&L^(_#]QI>O^(-9G@MTEU/Q!KFI:AKFL7S3ZEJNH7F
MH7-Q<R_Y=GPG^*7[??\ P0'_ ."D?_"?>-?A]>>%_P!H'X;:AXFT3QOX3^)U
MIJNH^#OC;\/O%D\MKXBGM/$T4MM/XL\(>,S;Q:]X;\?^'-2GVZW8Z9K EN+F
MPO=+D_N8_9G_ .#R/_@F=\4?#^EK^T1X.^.?[+OC<P6PU^VNO"+?&+X>6]W(
M@\__ (1_Q=\/#-XRU:S@D#;I=5^%_AVY*&/RK6<E]@!^B.L?\&TW_!$#7&=[
MW]@WPE 7))&C_%O]HGP\HSG.Q- ^+^F(@YX"*H7C &!CYZ^)_P#P:6_\$6O'
MNCW^G>$O@G\5/@GJ%U!+';>(/AK\?OBGK&IZ;,Z,([FVM?C#K_Q5T.9X7(=8
MKW2;J%MNUXRI(KTF\_X.F?\ @AC:V#7L/[:%_J,XC=UTNS_9L_:L34)'1=WD
MJU_\$;'3TD<X1&FOXH2QSYH179?@3XI?\',OC/\ ;>\33?LD_P#!#C]ECXN_
M'K]H[QK;/IL7QT^+'A;3?"'PC^"^D:@PL[CXGZAHD^I:Q/<:?H!G#PZC\46\
M ^&++6/L2SZ=XU+P^%]9 /GO_@V8_9>U/]FC]N+_ (+>?\$\-?UG3OCU^S'\
M,=3\%?#?Q8/%&@6.J>"/&=[?:O\ %#PG::?XI\&ZFNK>'5U#QK\.9?$7A_XC
M^&Y%OM,U5O#LFC7_ /:>G:79[/ZC?^'3O_!++_I&G^P!_P"(;_LZ_P#SN:\R
M_P""2/\ P35T?_@FE^S9J/@;7?&D_P 7_P!H[XT>--6^-G[5_P =M1>\N=2^
M*GQJ\6$W.N75M?:H/[8F\,:"\LUAH!U0QWNIW,^M^+M1L[#6_%>L6J?J90!\
M ?\ #IW_ ()9?](T_P!@#_Q#?]G7_P"=S7L_B[]BS]CCX@?"[P1\#_'G[)G[
M,_C;X*_#*X2Z^&_P@\7? CX6^)/A=\/KJ*VO;*.Y\$?#_6?"M[X3\*7$=GJ6
MHVB3:#I-A(EMJ%[ K"*ZG23Z8HH ^ /^'3O_  2R_P"D:?[ '_B&_P"SK_\
M.YKH?"7_  3+_P"";O@#Q5X:\=>!/^"?7[$/@KQOX+U_1_%?@[QEX2_90^ _
MAOQ5X3\4^'M0M]6T#Q+X:\0Z-X"LM7T+7]#U6TM-3T?6-+O+74=,U"UM[VRN
M8+F&.5?MZB@ HHHH *^)?VL?^";W["?[<TFE7?[6/[+GPF^-6M:':?V?HWBS
MQ)H!L?'6EZ7YCS_V18>/O#EQHOC2UT;SY)+C^QX=>33/M+M<?9/.8R5]M44
M?$_[*7_!.#]A/]AV34+O]E']EGX0_!;6]6M&T[5/%WAKPU'=^/=2TMY(Y6TF
M_P#B#X@EUCQO>:.9HHYSI-QK\FF_:$6?[+YPWUZE^TU^R=^S=^V7\-)_@]^U
M'\&O _QM^'$NIVFN0^&O&^E"]CTO7;&*XM[/7O#^IV\EKK7AO7K>UO+VRBUK
MP_J.F:HMA?W]A]K^QWUW!-]#44 ?+?[+/[$G[)7[$GA/4/!/[)_[/WPS^!6@
M:U<077B!? WAZ"RUGQ/=6BR)9W/BOQ3=M>>*/%4]C'--%83>(M9U.2QAEDAM
M&AB=D/U)110 4444 %?FC^U1_P $<O\ @F)^VGK=_P"*OVCOV,?@]XU\::M)
M)/K'C[0M.U?X7_$/7+B0Y-QKWC_X3ZQX'\8Z].ISY<NLZW?/&"50JC,I_2ZB
M@#\-OA5_P;:?\$4?@_XCM?%7AW]ACP7XCU>RN$N+:/XJ>/\ XQ?&'P\#&XDC
MBN?!?Q/^(?BOP5J$"L/FCU+P]>"9<I.94^6OVN\-^&O#G@W0=(\*^$/#^B>%
M?"_A^PM]*T'PWX;TJPT/0=$TNSC$5IIND:/ID%KIVFV%K$JQV]G9V\-O!& D
M4:J *VZ* &NB2(T<BJZ.K(Z.H9'1@5965@0RL"0RD$$$@C!KX"_X=._\$LO^
MD:?[ '_B&_[.O_SN:^_Z* /@#_AT[_P2R_Z1I_L ?^(;_LZ__.YKZA^"W[/O
MP$_9M\*7O@3]G7X(_"'X!^!]2UZ[\5:CX-^"WPU\&?"SPI?^)[^PTS2K[Q'>
M^'? VBZ%I%UKU[IFBZ-IUWK$]G)J%S8:3IEG-</;V%K'%Z]10 55OK&RU.RO
M--U*SM=0T[4+6XL;^POK>*[LKZRNXG@NK.\M9TD@N;6Y@DDAN+>:-XIHG>.1
M&1F4VJ* /Q4^-O\ P;L?\$8_C]XDO?%_C?\ 86^'6A^(=1N)+N\NOA+XG^)O
MP.TV>YG=I+B=_"WP=\;^"/"+37$CM+/,V@-+)*S2L_F,S'U/]F+_ ((>_P#!
M*+]CWQ+IOC7X#_L3?";1/&VC7,5_H?C3QP_BOXS^+/#^IP2I-#JOAK7_ (S^
M)/'^I>&-5AD0-!J/AVXTN[ME+Q6\L43O&?U8HH *\U^+7P9^#_Q\\$W_ ,-?
MCK\*/AK\:?ASJMUI]]J?@#XM>!?"_P 1O!.HWND7<6H:5>7_ (5\8Z7K.A7E
MUIE_##>Z?<7%A)+97<45S;/%-&KCTJB@#X _X=._\$LO^D:?[ '_ (AO^SK_
M /.YH_X=._\ !++_ *1I_L ?^(;_ +.O_P [FOO^B@#POXI?LO\ [-'QQ^'_
M (9^$WQK_9W^!?Q@^%G@J\TC4?!OPT^*7PD\ ?$#X?\ A+4/#^BWWAK0;[PS
MX-\6>']7\.:#>:)X<U34M TBYTK3;2;3=%U&^TJR>&QN[B"3YT_X=._\$LO^
MD:?[ '_B&_[.O_SN:^_Z* /B#PE_P3*_X)N> ?%7AKQUX%_X)\_L0>"O&_@O
MQ!HWBSP=XQ\)?LH? ;PYXJ\)^*?#NHVVK^'_ !+X:\0Z/X!L]7T+Q!H6K6=I
MJFC:SI=Y:ZCIFHVMM>V5S!<P12K]OT44 ?G=^U]_P29_X)R_MY:F?$/[5?[)
M7PN^)WC!K>&TE^(4%OK?@'XFW5G;1+#9V5_\3/AIK'@[QYJ5C81J$L+#4?$-
MU962EUM;>)990_S'\#O^#=;_ ((R_L^>+;#QSX$_8<\ ZUXGTNZCO=.N_BQX
MM^*'QNTJRN8'$MK/!X3^+WCGQKX.6XLY56:UNV\/M>03I'.EP)8HG3]K:* (
MK>W@M((+6U@AMK:VACM[:VMXTA@MX(46.&""&-5CBABC58XXXU5$1555"@"O
M _CG^R7^RM^U _AB3]I;]F?]GW]H=_!*ZRG@Q_CG\&?AS\6G\(IXB.EMX@7P
MPWC[PWX@.@+KIT/13K*Z4;0:H='TLWHG.GVGD_0-% 'P!_PZ=_X)9?\ 2-/]
M@#_Q#?\ 9U_^=S71>$?^"9G_  3>^'_BOPUX[\!?\$^_V(O!'CCP9KVD^*O!
M_C+PC^RC\!_#7BOPGXGT"_@U70O$?AKQ%HW@*RU?0M>T74[6UU'2=8TN\M=0
MTV_MH+RSN(;B&.1?MVB@ HHHH **** *M]8V6IV5YINI6=KJ&G:A:W%C?V%]
M;Q7=E?65W$\%U9WEK.DD%S:W,$DD-Q;S1O%-$[QR(R,RG\7OC;_P;L?\$8_C
M]XDO?%_C?]A;X=:'XAU&XDN[RZ^$OB?XF_ [39[F=VDN)W\+?!WQOX(\(M-<
M2.TL\S: TLDK-*S^8S,?VKHH _*?]F+_ ((>_P#!*+]CWQ+IOC7X#_L3?";1
M/&VC7,5_H?C3QP_BOXS^+/#^IP2I-#JOAK7_ (S^)/'^I>&-5AD0-!J/AVXT
MN[ME+Q6\L43O&?U8HHH X+XG?"KX7_&WP-KWPO\ C-\-_ 7Q<^&GBE+"/Q/\
M//B=X/\ #WC[P-XCCTK5;'7=+37O"7BK3M6T#5TTW6],TW6+!=0T^X6SU73K
M'4+<1W=I;S1_'O\ PZ=_X)9?](T_V /_ !#?]G7_ .=S7W_10!\ ?\.G?^"6
M7_2-/]@#_P 0W_9U_P#G<U[5\7OV,/V//V@K7P78_'K]E#]FKXW67PWTFXT'
MX=V?Q>^!7PN^)5KX"T.ZCTZ&ZT;P7;^,_"VM1>%M)N8M'TB*XT[0TL;.:/2]
M.22%EL;81?2M% 'P!_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S7=_#/_ ()W_P#!
M/_X*^.=!^)WP;_89_8[^$OQ*\*RWLWACXA?#/]F7X*^ _'/AR;4M,O=%U&70
M?%GA;P3I6OZ/+?Z/J6HZ3>R:?J%NUUIE_>V$YDM;J>*3[$HH **** "O#_V@
M?V:/V??VK?A_<_"O]I/X,_#CXX?#VYNXM1'A7XE>%-)\5:99:K!%-!;:UI U
M.VFGT37;2&XN(K/7-'FL=6M([B=+:]B6:0-[A10!\9_LM_\ !._]AW]B>;5K
M[]E3]EOX.?!'6M>MC8ZUXH\&^$+&+QGJNFF6.?\ LG4/&VHC4/%MUHRSQ1W"
M:/-K3Z7'<*+A+19LN>P^-G[$W[&7[2OB;3?&O[1O[(_[,7Q_\9:-H4'A?2/%
MOQL^ GPJ^*OB;2O#-KJ&HZM;>'=-U[QUX4U[5;'0K?5=8U?4X-(M;N+3X=0U
M34;R.W6YOKF27Z<HH ^ /^'3O_!++_I&G^P!_P"(;_LZ_P#SN:]0^$/[!G[#
M7[/GC*#XC? 3]C']E#X(?$*VT^_TFV\=_"']G7X0?#7QE;Z5JL:Q:GID'BCP
M9X/T76XM/U&)$CO[*.^6VO(T5+B.15 'U?10!\+^(?\ @E]_P30\6Z_KGBKQ
M5_P3O_87\3>*/$VKZEX@\2>)/$/[)/P"UK7_ !!K^M7L^I:QKFN:QJ7P_N=1
MU;5]6U&YN+_4M2O[BXO;^]N)[JZGEGEDD;(_X=._\$LO^D:?[ '_ (AO^SK_
M /.YK[_HH \@^"O[/GP#_9L\*WW@7]G3X(?"#X!>"-4U^[\5ZGX-^"OPT\&?
M"SPKJ/BF_P!/TO2;[Q+?>'O VBZ%I%WK][I6AZ+IEWK%Q9R:C<:?H^EV4UR]
MMI]I%#ZZZ)(CQR(LD<BLCHZAD=&!5D=6!5E920RD$$$@@@TZB@#\:?V@O^#?
M/_@CM^TUXJO_ !S\3/V'OAO8>+=5NI;[4]9^%.O?$/X&+J5_<.9+O4-3T7X,
M^,? OAS4]1OI6>>^U'4=&NKV\N9);NXN)+J1YF]J_9!_X([_ /!-#]A#Q!#X
MQ_9=_9$^&G@#QY;1R167Q%UF3Q-\3OB-I2W$30W8T+Q[\5=?\;>+/#B7T3O%
M?0^'M7TNWNX6\B:%X%2)?TLHH **** "BBB@ K\T?VLO^".?_!,G]N'7[SQA
M^TQ^QU\*?'?CG4COU7XA:)%X@^&'Q$UJ15VQRZ_X^^%&N^"/%WB&2!<+ VNZ
MQJ/DH!'&%B&ROTNHH _#KX4?\&W/_!%+X.^(;3Q3X;_85\#^(M8LIX[B!?BI
MX\^,/QDT M%)YL4=SX,^*?Q#\7>";V%6X:.]\.W"SI^[N?.3BOVK\.>&_#O@
M[0=(\*^$= T7PMX7\/Z?;:3H/AOPYI5CH>@Z)I5E$L%GIFD:/ID%KI^FZ?:0
MHL-M965O#;01*L<4:( !M44 %?R4_P#!YO\ \HG?AS_V>Q\(?_54?'ROZUJ_
MD _X/3/&&@Z5_P $Q?@=X-NM2LX_$OB_]M+P%J&C:*]Q$NHWNC>%?@]\<)/$
M.KVUHS":?3]'N]9\.6.H7,2&.UNM?TJ*9E:\B#@'YK_\&8?P@^%7QY^#O_!5
M#X5_&OX<>"?BQ\-?%>I?LB6?B/P+\0_#.D>+O"NLPQVG[2,T'V[1-<M+VPEF
MM+A([NQNO)%S87D,-Y9S074,4R?T<:Y_P;#?\$.M?\12>);K]B"PLKJ>Z>\N
M=-T/XZ_M+Z!X=GF=Q(%C\.Z/\8[+2-.M4882PTBTT^P"9C-L8SMK^>/_ (,;
M_&?A^WU3_@I%\/;G5+*#Q5JUA^RSXST?19+F)=2U3P_X?N/CWHGB35+.S+B>
M:RT+4O$WA6TU*Y1&BMI_$>E12NKW<(?_ $"Z /F/]F#]B_\ 90_8M\(7'@7]
ME3]G_P"%_P "O#E^UO)K,7@'PO8Z7J_B6>T5TM;SQ=XGD2X\3^,+^UCD>*VO
M_$^L:M>P0MY,4Z1 (/IRBB@ KYK_ &F_V.?V6/VS?!D/@#]JCX!_##XZ^%K-
MYYM)M/B#X6T_6-0\.75TB1W-_P"$O$)CB\1>$-3N(HTAFU3PQJVDZA+ # ]R
MT+,A^E** /P1T+_@V(_X(>>'_$T?BBT_8BT^]NH+D7=MI6N_'']I+Q#X9BG#
M^8?,\-ZW\8+[2-0MB<@Z?JMK?Z=L/EBT"!57]K?A9\)?A=\#O N@_##X,_#K
MP1\*/ASX7MC:>'? OP[\+Z+X.\)Z+;LYDD33M T"RL-,M6GE9Y[F2*V66ZN)
M)+BX>6>1Y&]!HH X+XG?"KX7_&WP-KWPO^,WPW\!?%SX:>*4L(_$_P //B=X
M/\/>/O WB./2M5L==TM->\)>*M.U;0-733=;TS3=8L%U#3[A;/5=.L=0MQ'=
MVEO-'\>_\.G?^"67_2-/]@#_ ,0W_9U_^=S7W_10!\ ?\.G?^"67_2-/]@#_
M ,0W_9U_^=S7M7Q>_8P_8\_:"M?!=C\>OV4/V:OC=9?#?2;C0?AW9_%[X%?"
M[XE6O@+0[J/3H;K1O!=OXS\+:U%X6TFYBT?2(KC3M#2QLYH]+TY)(66QMA%]
M*T4 ? '_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<UW?PS_ ."=_P#P3_\ @KXY
MT'XG?!O]AG]COX2_$KPK+>S>&/B%\,_V9?@KX#\<^')M2TR]T749=!\6>%O!
M.E:_H\M_H^I:CI-[)I^H6[76F7][83F2UNIXI/L2B@ HHHH \)^./[+?[,O[
M3MGX>T[]I3]G3X$_M"Z?X1N=0O?"EC\<?A%\/_BS9^&+S5HK6#5;OP]:^/?#
MVOP:+<ZG!8V4.H3Z:EM+>Q6=K'<O*EO$$^=O^'3O_!++_I&G^P!_XAO^SK_\
M[FOO^B@#XK\#?\$V?^"=7PP\8>'/B%\-/V!?V*_AYX^\'ZK:Z[X2\<>!OV6/
M@9X2\8>%M;L7\RRUGPYXET#P)I^M:)JMG)^\M=1TR]M;NW?YHID;FNB^+G[!
M'["_[0'C2Z^)'QY_8N_9-^-OQ$OK+3],O?'OQ<_9S^#_ ,2?&EYINDP"UTO3
M[KQ3XR\':UKEQ9:;; 6^GVDU\\%G !#;QQQ_+7UE10!\ ?\ #IW_ ()9?](T
M_P!@#_Q#?]G7_P"=S7K7P9_8:_8G_9Q\6S^/OV>OV//V6O@/X[NM%O/#=SXU
M^#/[/OPE^%_BVY\.ZC<V-[J&@S^(_!'A'0]8FT6^O-+TR[O-+DO&L;JYTZQG
MG@>6TMWC^I:* /ASQ/\ \$Q/^":WC;Q)XA\9^,_^">G[#GB[QAXNUS5O$_BO
MQ7XG_9,^ FO>)/$_B37K^XU77?$/B'7=5\ 7>J:UKFM:I=W6I:MJVI75S?ZC
M?W-Q>7EQ-<322-A_\.G?^"67_2-/]@#_ ,0W_9U_^=S7W_10!XS\$OV<?V>O
MV:/#VJ^$?V<?@/\ !G]G_P *:[K+^(];\,?!+X7^"/A5X>UCQ#)8V>F2:]JN
MB^!-#T'3=0UE]-T[3]/?5+NVFOFL;&SM&G,%K!&GA?[6/_!-[]A/]N:32KO]
MK']ESX3?&K6M#M/[/T;Q9XDT V/CK2]+\QY_[(L/'WARXT7QI:Z-Y\DEQ_8\
M.O)IGVEVN/LGG,9*^VJ* /B?]E+_ ()P?L)_L.R:A=_LH_LL_"'X+:WJUHVG
M:IXN\->&H[OQ[J6EO)'*VDW_ ,0?$$NL>-[S1S-%'.=)N-?DTW[0BS_9?.&^
MO4OVFOV3OV;OVR_AI/\ ![]J/X->!_C;\.)=3M-<A\->-]*%['I>NV,5Q;V>
MO>']3MY+76O#>O6]K>7ME%K7A_4=,U1;"_O[#[7]COKN";Z&HH ^6_V6?V)/
MV2OV)/">H>"?V3_V?OAG\"M UJX@NO$"^!O#T%EK/B>ZM%D2SN?%?BF[:\\4
M>*I[&.::*PF\1:SJ<EC#+)#:-#$[(<+XG_\ !//]@+XW>.M=^*'QH_8<_8^^
M+OQ,\4MI[^)OB)\3_P!F?X+>/O'7B)](TFPT'2FUWQ;XK\%:MK^KMIFA:7IF
MBZ>VH:A<&RTG3K#3K8Q6=G;PQ_8-% 'P!_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^
M=S7L7P4_8D_8Q_9J\3ZCXV_9S_9&_9A^ /C/6-!N/"NK>+O@I\ _A5\*_$^J
M>&+O4-,U>[\.:CK_ (%\)Z#JM[H-UJNBZ/J=QH]S=RZ?-J&DZ9>R6[7-A:RQ
M?3M% 'BOQN_9L_9U_:8T+2/"_P"T?\ _@K^T#X:\/ZL=>T#P[\;OA9X&^*VA
M:'KK6<^GMK6D:1X[T+7M/TW5FT^ZNK$ZC96\%X;.YGMC-Y,TB-\U?\.G?^"6
M7_2-/]@#_P 0W_9U_P#G<U]_T4 ?!NF?\$L/^"8>BZEI^L:/_P $X_V#=)U?
M2;VTU/2M5TS]D']GRPU+3-2L)X[JQU#3[ZU^'D5U9WMG=117-I=VTL<]O/''
M-#(DB*P]Q^.?[)G[*W[4#>&'_:6_9G_9^_:'?P0NLKX+;XY_!KX<_%MO"*^(
MSI1\0KX8;Q]X;\0'0%UXZ%HAUD:4;0:H=&THWWGG3[3R?H&B@#X _P"'3O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _
M\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y
M M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/
M]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_
M -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_
M %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\
MNR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^
M[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y
M1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/
MVYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'
M_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?
M\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G
M_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\
MP='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M
M']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?
MY M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?
M[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?
MW^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45^;'[3?_  6&_P""8G['>KZAX:_:&_;5^"/@OQ=I$LD&L^!=
M&U^[^)7Q!T2XB=HWM];^'_PMT[QKXST><.CJ(-3T*UE8JVQ&VG'PCI__  =/
M?\$.K_5$TUOVP-8L(I)5BCU;4/V=/VF(=+9G8JK/)'\(IKNWB)QNENK."*-6
M#RO&BNR ']"M%?(O[+_[?'[%O[:>GS:A^RM^TY\&_CA):6JWNI:%X(\:Z5=^
M,]$LWV!+GQ#X#NYK/QKX=A<NJI)KF@:>KOE%)96 ^NJ "BBB@ HHHH **^3/
MVK_V[OV/?V&_"7_":_M8_M$?#+X(Z1-:S7>EV'BW7XF\7^)8K<L)D\&^ -)3
M4_'7C6YB*.)+3PGX<UFZ38Y:%51B/R,_8/\ ^#D/]D__ (*.?MX0_L7?LT_"
MCXO7>BS^!O&WC&U^./CU-"\(Z-JI\$6L-W=P:/X#CNM8\3-IFIPW$/\ 9^HZ
M]<^'=55_-6]\-VH1&E /Z)J*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HKX&_;3_P""D_[+W["[>$?#'Q1U[Q+XY^.7Q.E%G\&OV7/@CX9NOBC^
MTE\8]2DDFB@M? OPPT25;[[#+-;743>*/$UWX<\'PSVMQ:S>($O42U?[-\!>
M(-7\6^!O!?BKQ!X2U?P!KWB;PGX=\0:WX$U^XT^[UWP5J^LZ/9ZCJ7A+6[O2
M+B\TJZU?PW>W,VC:E<:9=W6GS7EE-)97$]LT4K '64444 %%%% !117Y1?MU
M?\%M?^":_P#P3PCU;2OV@?VC_"]Y\3=+25?^%&_"MD^)WQDEO8U+IIVI>$O#
M=Q-;^"9[E5<VMY\2=6\%:/.49$U/S-J, ?J[17Y%?\$A?^"NOPV_X*^_#'XT
M_%GX7?"+QQ\)/#7PD^*R?#2WM/'VM:#JNN^)(;GPYIWB:SUV:T\.^?I^AR/9
MZE%!<Z2FJZTMO<QR"+5;N+;*WZZT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'
M[<W_ ';-_P"MA_L^U_D"U_K]?\'1W_*"C]N;_NV;_P!;#_9]K_(%H _O\_X,
M8_\ G*+_ -V3?^_<5_?Y7\ ?_!C'_P Y1?\ NR;_ -^XK^_R@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[M[B;3[HH)!;7L4,CO:W!C8.(9UCD*$-MVD&@"]15*?4M.M;JTL;F_LK:^U
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MM>'?'&DZ#I.J:DDNC?#_ ,*V_CO1(O%5V(+#56^(JV_AFYUB&'6I=-_N<HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_
M ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+
M0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1%Z*TT7@^Q5R/O"%,]*_97_@XC_:SU_]CK_@D=^U7\0/!6JSZ+\0OB!H.B?
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M^U\<>*;/X2ZYXY34U&J2>*M;^%%OX+U35K[6&DUW59KH:MX@?^W;[4D3]6R
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MK,;B\GOZ /ZBOAS_ ,&WWQ1_;?\ "VF_&?\ X+=?MQ_M0?'SX]>,K>+Q%=?
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M!2^.-&LO'D>L7TGAF&.UT2^\%W>O:?K4\DT4<>E75XSRQJ"X_P!@2@ HHHH
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M/C /&'BK1M&G1[*/QG-8^!M)T?2O$S(VI:)I-WK=II<EM_;%Y(X!\=_M;_\
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M%/%6DVFN^'M<TZ5E1I+'5M(OK2_M79$9H)T+(K$J/\E+_@J5^Q9_P4A_;O\
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MX\(7-SKZVBK:W'B'Q1X@UMDEN+^XDF_UQ0 !@# '  Z >E '^</_ ,%U/^"
MG@C_ ()(_ S0O^"@W_!-_P".7[0?PSB\!>/?"?A7XE^'+WXCW<7B3PM:>,=0
M_LKPMX[^'GQ&\(6?A+Q3I:V/B[^P]$U?0M8NM9FNIO$%GJ^FZSIJZ5-IM_\
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MBW6E^'O'7@6;Q/>)X^N?$T-[;>(O$&F^*;ZY\-7_ (8UK0])'AR/9J-]J_\
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MK;QQP6]O"B10Q(D<:*B@  MU_)#_ ,'EWP9@\>?\$N? /Q5M[,/K'P)_:A\
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M*U&YT2Y,L,4AGTV6VE,D4;E]R*1Z;TZ4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!^ /_  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^
M#H[_ )04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_.47_NR;_P!^XK^_ROX _P#@
MQC_YRB_]V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^#0]E'_  63\$ D M\ ?CNJ@G[S#0--; ]3M5FQZ GM0!_J^5_%]_P>T_\
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MM<VUN]W<>6T=C80-+?ZA<%+6QMKBYDCB;^=?_@EM^TKXC_X*Y?\ !3S]I/\
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MZM;RTO=&UA+2RB\3^$-=L]1\.>(8;*PN+FR@UK2-!UG2/\TW_@IK_P &T/\
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MW[0VD:Y>0PDAWM],O-;\/07,JJ5CDU>U1RID0, ?Z ]?B/\ \''7AW3?$_\
MP10_;WL-4CMY(++X<^"O$5O]I4,L>I>%/C%\./$NE21$@[;A=1TJV%NRX/G,
MBYPQ!_;BOYEO^#M#]ICP]\#?^"0OQ*^%]QJ<$'C;]JGX@_#3X0>#].5XWU";
M3]!\7Z1\6/'.JK:LXD_LJT\,^ 9M U"_$;PV=]XKT6W9H[G4+-J /X[_ /@T
M,\-:GKO_  62\&:I812R6O@S]G[X[>)=;>,,5ATRZT32O!\4LQ4$+$=9\5Z1
M""Y5?.EB4'>RJWU5_P 'L2:D/^"BG[,$DHE_L=_V+/#Z6).[R3J4?QR^-K:L
M(\_+YHM9=&\W'S;##NXVU^DG_!EK^P;XA\$?#G]H7_@H9XZT.XTM/C'!;? +
MX%3WEN]O<:MX!\*:_%X@^+/BBS:1"+O0-<\?:1X1\+Z=<PN@&L_#?Q1#-'(J
M6TB]C_P>F_L6>)/B+^SY^S;^V_X+T:YU*+]GCQ'XC^%/QADL;=YY=/\  'Q:
MNM"N? _BG4G Q;:)X<\?:'-X8EER2VJ?$[2E9#&KR1 ']"G_  0I^.6A_M!_
M\$B/V O&VB7T-ZWAW]G+P'\'-=V2*UQ;>*/@+IX^#'B&*^C#&2"[GU+P+-J(
M254:>UOK:]B3[-=0._ZS5_E@_P#!M+_P7=\-?\$U_&?B3]EC]JC4M1@_8^^-
M'BJ'Q3IOC>WM;W5Y?@%\4[JSL=&OO%%UI5A%<ZE??#OQEIFGZ39^,[72[6]U
M#0M1T;2O$FDZ=*D_B:+4/]0;X<?$WX<_&+P7H7Q'^$WCWP=\3?A_XHLH]1\.
M>-O 7B31_%OA37;&4!DNM*U_0;R_TN^A.<,UO<R;'!1]KJ5 !W%9.JFYN]%U
M=='G0W[V&J6UC-%*I$>I1Q7%M&OF*P"26]ZGER@LK12QNC[&1@/R)_X*^?\
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ML]SIVJZ1JNGW%O?:=J-C<3VE[:3Q7%O-)%(CD W:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!;5KZ'_@H!:17NI-I6DVAOKN*TM8[BZ,LR6\"N(E]&_X9]_X*[?]),OV3/\
MQ5]XG_\ IA%?J710!^6G_#/O_!7;_I)E^R9_XJ^\3_\ TPBC_AGW_@KM_P!)
M,OV3/_%7WB?_ .F$5^I=% 'Y.>(OV8?^"M/B?P_KOAK4O^"F7[*0T[Q#H^IZ
M'J!MO^"87B6*X%EJUE/871@E;_@H-(L<P@N)/*D:-PC[6*,!M/W%^R9\"O\
MAEW]E?\ 9J_9G_X2G_A.?^&>/@#\'O@;_P )K_8?_",_\)A_PJ?X>^'? ?\
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M&VW%_-I/[-5_?75G:MMEFBG705EA5Q)J%@/WR_UX44 ?P$_&'_@G=_P<4?\
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M+X@T%?B9H^F6Z&?QW>V&M^'?#VK:AIUYX2BU^>*]T7^7K_@F;_P1K_X.%/\
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MGP/<2P*3.+/PY/.D9A@N7B_T2J_ST/\ @JG^QE\2/^""?_!5OX1_\%F?V5?
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MX-JM"_X*,>(M4_:T_9!U7PI\+_VOI=.MXOB#X4\2M)I/PY_:$ATBRCL],O\
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M[2VOKMIO]:"B@#^5+]CO_@@U\??VAM:T;]J'_@O5^T/XA_;0^/5MI=^/AO\
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MJZ* /Y*?^#S?_E$[\.?^SV/A#_ZJCX^5_(W_ ,&]OP#_ ."ELWBOX]?MT_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'X _\ !T=_R@H_;F_[MF_];#_9]K_(%K_7Z_X.
MCO\ E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_ '[BO[_*_@#_ .#&
M/_G*+_W9-_[]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %<)\3_AA\//C3\/?&/PG^+/@SP]\0_A
MK\0-!O\ POXT\%>*],M]7\/>(]!U.$PWFG:GI]TCQ312*1)%(H2>UN(X;NUE
MANH(9H^[HH _F'^#W[)G[87_  0:\<^*/^&4O#7Q&_;D_P""3/C?Q+J'BWQ%
M^S'HD[>)_P!K;]C36-9N&N=;\4? G2KZ:W/QW^'$TO[[7/A_IUW;>/+QY8-6
MM=+O_$-KXL\7^-/K/]KK_@X(_P""?/[+7@WQ<]MXJ^)WQ4^-&F>"-)\3>%/@
MAX-^ GQQ3Q'KNI>+_!6G>-?!&FZSK^O?#[1?!GA&'4=.US0I]<.O^([35/#\
M-Y<6UQI,NM6,^D+^XM% '^&G^RAXF^+/[-O[6W[.'[3]S\(?B-XEF^!7[0OP
MD^.5]H<'A77K2X\1K\-_B+H'CJ^T6.ZETQHK:36X]'FT\3NI2$W7F,"JD5_L
M _L3_P#!7#]AO_@H!K=IX,_9W^(?C.[^);>";GQ[K/PR\??!OXM_#CQ1X8T7
M3KK1K#5XM7U+Q9X-T_P->WVDZCK^EV-RGACQAXBM+J6=YM)O=2LH)KJ/]*Z*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-_J-Y<7$S.?=J* "BBB@ HHHH **** /S<_X*H?\%(/"'_!+/]E^']I[QO\
M"OQI\8=%F^)?A+X:CPCX#O\ 2].UQ;SQ98>(;Z#5C<:NCVGV&R7P_+'<1[?-
M9[J$H0%:OYP/^(UC]G+_ *,&_::_\*WP)_\ (U?VQ44 ?Q._\1K'[.7_ $8-
M^TU_X5O@3_Y&H_XC6/V<O^C!OVFO_"M\"?\ R-7]L5% '\3O_$:Q^SE_T8-^
MTU_X5O@3_P"1JS=7_P"#V+]GZRTV[NM/_8!_:(GO(45H(M7^('@G1M-=C(BD
M7>IPZ+J\MH@1F*R)IUT6D"1E%#F1/[=** /XFX_^#UK]G-D1F_8&_:8#,BEA
M'XP\"R(&(!(20VB%T!SM<HA888JN<!W_ !&L?LY?]&#?M-?^%;X$_P#D:O[8
MJ* /XG?^(UC]G+_HP;]IK_PK? G_ ,C4?\1K'[.7_1@W[37_ (5O@3_Y&K^V
M*B@#^)W_ (C6/V<O^C!OVFO_  K? G_R-56R_P"#U[]GB>TMYKG]@/\ :0CG
MDB5Y4LO&_@>^M$<CYEM[R33;)[F('[LK6EN6')B7I7]ME% '\3O_ !&L?LY?
M]&#?M-?^%;X$_P#D:C_B-8_9R_Z,&_::_P#"M\"?_(U?VQ44 ?Q._P#$:Q^S
ME_T8-^TU_P"%;X$_^1J/^(UC]G+_ *,&_::_\*WP)_\ (U?VQ44 ?Q$Z;_P>
MQ_L_W4NII>?L ?M#1):W\EO9MIOQ#\%:G+-:JB,DNIPRZ'IPTN_+,PDTZ*74
MHXD".+^0R%$U/^(UC]G+_HP;]IK_ ,*WP)_\C5_;%10!_$[_ ,1K'[.7_1@W
M[37_ (5O@3_Y&H_XC6/V<O\ HP;]IK_PK? G_P C5_;%10!_$[_Q&L?LY?\
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M!/\ Y&H_XC6/V<O^C!OVFO\ PK? G_R-7]L5% '\3O\ Q&L?LY?]&#?M-?\
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M_P"(UC]G+_HP;]IK_P *WP)_\C5_;%10!_$[_P 1K'[.7_1@W[37_A6^!/\
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MP+(@8@$A)#:(70'.URB%AABJYP/[9** /XG?^(UC]G+_ *,&_::_\*WP)_\
M(U'_ !&L?LY?]&#?M-?^%;X$_P#D:O[8J* /XG?^(UC]G+_HP;]IK_PK? G_
M ,C4?\1K'[.7_1@W[37_ (5O@3_Y&K^V*B@#^).R_P"#U[]GB>TMYKG]@/\
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M^SE_T8-^TU_X5O@3_P"1J/\ B-8_9R_Z,&_::_\ "M\"?_(U?VQ44 ?Q._\
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MWM$:%IY_M0:!89[7_$:Q^SE_T8-^TU_X5O@3_P"1J_MBHH _B=_XC6/V<O\
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MP'^TA'/)$KRI9>-_ ]]:(Y'S+;WDFFV3W,0/W96M+<L.3$O2O[;** /XG?\
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M\C5_;%10!_$[_P 1K'[.7_1@W[37_A6^!/\ Y&H_XC6/V<O^C!OVFO\ PK?
MG_R-7]L5% 'P;_P36_;O\,?\%)OV1? /[7'@_P"'/BOX4Z#X^UGQUHUKX*\:
MWNGW_B'39/ WC+6?!UU/=W6EJED\6HW&C27UJ(U#);3QI)EPQK[RHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H
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M_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\
MSFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;
M_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_
M *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\
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M (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\
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M_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\
M**_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN
M@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\
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MK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ
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MYT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\
M@Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_
MPX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13
M_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\
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M_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\
MG-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW
M_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\
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M#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\
MX**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\
MX.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S=
M'_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\
M!13_ .<W1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH
M_P#.C?\ P44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7
M_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#
M_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /
M[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_ *34?^=&_P#@
MHI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU
M'_G1O_@HI_\ .;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@
MZ:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?
M\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %
M%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_
M ,Z-_P#!13_YS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_
M  =-?])J/_.C?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_
M (<%_P#!TU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O
M\HK^ /\ X<%_\'37_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\ I-1_YT;_ ."B
MG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\ @Z:_Z34?
M^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#I
MK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_P
MX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44
M_P#G-T?\."_^#IK_ *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\
MSHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\ **_@#_X<%_\
M!TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\
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M^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\
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M ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX
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M1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\
MP44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2
M:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\
MP=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_
M .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_ *34?^=&_P#@HI_\YN@#
M^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@H
MI_\ .;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^
M=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK
M_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='
M_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!
M13_YS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J
M/_.C?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!
MTU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\
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MOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\
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M=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^
M/_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ
M /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI
M_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\
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M^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H
M_O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_
M ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=
M&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:
M_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_
M  X+_P"#IK_I-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C?_!1
M3_YS='_#@O\ X.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\
MZ-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_\'37
M_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_@#_X
M<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P YN@#^
M_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\
MSFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;
M_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_
M *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\
M#@O_ (.FO^DU'_G1O_@HI_\ .;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/
M_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SH
MW_P44_\ G-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?]
M)J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP
M7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ /[_
M "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI_P#.
M;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_
M (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\
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M_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\
M**_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN
M@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\
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MK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ
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MYT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\
M@Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_
MPX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13
M_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\
M.C?_  44_P#G-T?\."_^#IK_ *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU
M_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\ **_@
M#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_
MRBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\ @HI_
M\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G
M1O\ X**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#
MIK_I-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#
M@O\ X.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_
M )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z
M-_\ !13_ .<W1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_@#_X<%_\'37_
M $FH_P#.C?\ P44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /
M_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ /[_*
M*_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_S
MFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_ *34?^=&
M_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.F
MO^DU'_G1O_@HI_\ .;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."
M_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\
MG-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW
M_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\
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MZ;3_ ,1U_:U_^<-0!^^=%?@9_P 10/\ P0N_Z/IM/_$=?VM?_G#5]K_LG?\
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MR*WD\IM6^''P*\7VNERLI*R&WD^)K?#>\GCC8$>='9&&88DMI)XF5SQVF_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%%$BQQ111J$CCCC0!$C1 %1% 55 50  *_R:_\ @TD_Y31?"/\ [(Y\?O\
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MA_P15_X-5/V9?#_P \ ?M#?\%*?A[J/Q?^.?Q.T+2_&NE? 76]=\2>&OA_\
M!CP[K=G%J'A_1?%VC>'+_0-7\7?$J33;J.Y\86'B2_F\+^'+ZX_X1B#PW=:C
MH=SXBU/^AO\ X*L?\$]=5_X*,^%?V*_AZ-2\$VW@3X#?\%!/@)^U/\9M%\;2
MZND7CCX0_"SPM\5-&\6> O#UOI6AZU%?>(O%<WC;2]-CM-9DT/1SHSZU//KE
MM=V]E:7OZHT ?SX?\%&?^"1'_!+WX5_\$Y/V]/'/P\_8'_96\)>-?A_^Q7^U
M+XQ\$^,-(^#?@V'Q1X7\5^%_@;XZUOPYXCT;7WTR35;+6M$UBQL]3TS48KL7
M5G?6L-S#*DL:L/\ (6K_ ' /^"K'_*+O_@I)_P!F#_MA_P#K//Q%K_#_ * /
M[-O^#/K]CK]E3]KGQU^WC8_M0_L[_!_X_P!GX%\)_L]W?@VU^+?@+P]XY@\+
MW/B#6/B_#KD^AQZ_8WJZ;+JT6D:7'J#VHC:Z33[192P@CV_V"?M&?\&Z'_!'
M[]HOP%KG@V?]CCX<?!C6-1LIXM%^(O[/EB/A+XT\)ZDZ%;?6-+7PZ(_"VKS6
MK'<-,\8>&?$N@W&3]ITJ5UBDC_F-_P"#''_DHG_!1S_L2_V8_P#T^?'"O]#"
M@#_+)_8U_P"";?Q2_P""5W_!S/\ L:_LN?$?4D\5Z1#\3+OQQ\)/B5:Z?)I=
MA\3OA1XB^'OQ*M_#OBJ/39)KEM*U6VOM*UCPSXIT<75Y#I7BO0-:M+&_U32E
MT_5K_P#U-J_*C]M?_@G9??M,?MP?\$SOVSO!^J>#M"\2?L1?%3XDZCX^'B"7
M5K35O&/PE^(G@*]TMM#\/2:5HNJPZCK^@>-;+1-0TBPUVXT72K?2]:\77,6K
MQ7LD5AJ/T)_P43_;)\*?\$_OV*?VA_VNO%MO;:C;_!WP!>ZKX;T"ZE>&'Q7\
M0M;N[3PM\-/",LL3I<0VWB?Q]K?AW1;^ZMM\UAIUY>:BL;K:,* /Q=_X+^_\
M'"/@_P#X);: ?V>OV?8/#GQ)_;A\:Z!%J<.FZKC4_!O[/_AC5H0VE^-?B)86
M\T3ZMXMUJW<WG@3X>M/;"XM!%XN\6/!X;;0M)\;?YM'AY/VT/^"NW[;'@'P7
MXB\?>-/V@_VG_P!HOQOI_A#2O$?C_7+W4(].@N9;K4+Z[E\J&6R\'?#?P%H<
M>L>([_2_#>E6?A_PEX5TG4I-(T6"TM$M:^9/C;\:/B5^T7\7?B-\=?C%XIU#
MQK\4/BOXOUKQOXW\3ZG(7N=4UW7;R2[NC%'GRK'3K0.EAI&E6BQ:?H^DVMEI
M6FV]M86=M;Q_V4?\&3_[+6D^-/VEOVLOVN_$&F174GP*^&G@_P"$OP_N+R%9
M([3Q3\;-3UO5/$^M:4Y4F'5M&\(_#DZ!/,K(RZ3X_O+<+(MXYB /Z^/^"8/_
M  1&_8C_ ."8?PR\+Z7X ^&?A3XD_'V'3;*7Q_\ M,^/O"^DZO\ $OQ-XF,*
M-JDOA.ZU*/4I/AEX/^U[H]'\'>$;JTABL+>PD\1:AXF\017?B"]_2CXU?L_?
M S]I#P7J'PZ^/_P@^&_QG\#:I;SVUWX7^)?@W0/&6D;;A K3VMMKMC>BPOHR
MJ36NI6!MM0LKF*"[L[F"Y@AF3U^B@#_*(_X.1O\ @AWHO_!+/XL>"_CQ^S3;
MZY_PQW\>=>U#1] TC4;_ %#6+_X%_%:SMKC7'^&DWB*^>;4-5\,Z_HEKJ&O_
M  TU/5KZ]\1_8_#WBG1==N[ZX\.VNO\ B#Z/_P""&?\ P=!_&?\ 97\7>#/V
M9_\ @H)XW\2_&G]E76+NP\-Z!\8_%%SJ'B;XL_L]BXEBM-/OM1UN8W>N_$7X
M4:=N$>KZ%JKZGXM\*Z2J7?@R^O-/T:W\#:I_;9_P7H_9DT;]J[_@DI^VS\/[
M_3(=0USP9\&O$GQU\!RF%9+^Q\<? BTD^*6DC2)&4M;7^O6?AK4_!\LB%#/I
M?B74;&1U@NY37^,'0!_OQ:!K^A^*M"T7Q1X8UC2_$7AKQ)I.FZ_X>\0:)?VN
MJZ+KNAZQ9PZCI.L:1J=C+/9:CI>IV%Q;WNGW]G--:WEI/%<6\LD4B.=:OXE_
M^#.3_@I9K_QI^"OQ-_X)U_%;Q!<:SXK_ &;-'@^)7P$O=2N9+K4[GX%:UK<&
MC>*_!AFGD>9]/^%WC?6=!?0O,:0V^A?$*ST"S6VTCPMI]O'_ &T4 %%%% 'X
M-?\ !PI_P5AO_P#@E3^Q,WB?X92Z=+^TW\?-:U#X7_ &+4K>WO[7PO>6^F"_
M\;?%F]TJ\1[35K3X<Z1=:>NG:?=175C=>-?$O@R'5]/O]!DU>W/\3'_!M+_P
M3L\$?\%;?V[?CQ\?OVW-3UGXY^$/@)I_AWXH^/\ P[XZUK4=<O?C9\8/BIK^
MO)X3E^)6J7US+J?B/PM:+X3\7>(?$FESW>SQ%JEIX?TC63>>&KK6M(U'[9_X
M/>]4\23?M.?L,:+=-<GPA8? CXFZIH:,9/L:^)-7^(.FVGBIH ?W7VE]+T3P
M:+HI^\,26?F?*(J_#+_@A!_P5RO_ /@D;^UU>?$?Q-X=U3QM^SY\8O#]C\._
MCYX2T)H?^$DM]"M-535/#OQ \'PW5Q:65]XL\!7\M_+::1J-U;V.O:#K7B70
MOM>EW^I:?K>E '^POX0\"^"?A]X8TWP1X"\'>%?!'@S1;--.T?PCX0\/:1X:
M\,:3I\<8A2QTW0-&L[+2K&S2)5B2VM;2*!8P$"!0!7X+?\%8/^#=#]B'_@HY
MX$\4>)/ ?@'P9^S/^UE%8WM_X-^-WPV\-V7AK1_$WB%8GEM]+^-?A'P[;6FE
M^.=#U><16U]XH^P#XA:$BVUUI.N7=A:77AK6/V(_9>_:U_9O_;1^%.C?&O\
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M/_!H;_RAM\%_]G ?';_T^:57]/U !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_#6JV4B>/?&<RV8T/4M;@UJZU.X5HULM)L["XU2_FEA@LK2XGFBC?_(\K_0
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M?#OC?0ED>!KJVC-S-I7BC03=6D'B?PMJ&K:))=6,]U:ZE8_@M_P4C_Y6I_\
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MOVH*_P!/2O\ ,+_X/6/^4HG[/O\ V8/\-/\ UH;]J"@#^/NO]\3X;_\ )._
M7_8E^%O_ $QV-?X'=?[XGPW_ .2=^ O^Q+\+?^F.QH [2BBB@ HHHH ****
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MBZ7PK\1_!MQ<9-QH7B"WM9DFMC+)=Z!KMEK/A?6!!K>AZE;0@'^JQ_P;9?\
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M4O\ U=GPAH _TQ**** "O\PO_@]8_P"4HG[/O_9@_P -/_6AOVH*_P!/2O\
M,!_X/4KRWN/^"IGP)MH9$DEL?V"OA?#=*K F&>;X_P#[3MTD,@'*O]FFMY\'
MK'/&W0T ?R"U_OB?#?\ Y)WX"_[$OPM_Z8[&O\#NO][KX4WEOJ'PN^&U_:2+
M-:WW@'P?>6TR,&26WN?#VG30R(PX97C=65AP0010!WU%%% !1110 4444 ?
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M_#[5+B K!J'QC^*\%M_;LFE71#++-X/^%EOJ]EKULH22&/XF^'9O,V2M&_\
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M;_P62_X*^>'_ /@L]_P4%_8R_P""?G[,5[?ZG^QOHW[6?P;\)S^(I[.YL/\
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M** "BBO/_BS\4O GP.^%GQ+^-?Q2UW_A%_AE\'_A_P",OBE\1?$W]F:QK?\
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MP-YIU]HFMZ/JVF7O[*,MGJN@>)/#VJ:MX=\0:7<H8M1T75;ZT+1F82I_:_\
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M#<?K_P#\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\
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M */F_P#-9OVP_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#[0!_-9^R/_P;$?\
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M&W6?&E^/";3ZKH\7A_3?$W[//A'0KJ\37X-*F9=1\2:5#';1SS).\T<<$O\
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MZ M^P[_P>,,A0_\ !6C]A8!E*DKX7T-'P1C(D7_@G(KJWHRL&!Y!SS7Z*_\
M$4=_P0H_Z/F_\UF_;#_^A]H_XBCO^"%'_1\W_FLW[8?_ -#[0!_/I^U9_P &
M]/\ P<I?MO:<NA?M3?\ !3']F/XN>%!<PWW_  @FJ?';]HG0?AP]_;RB>UU"
M3X;^$/V3/#W@274;24!K._E\//>6G*VTT2D@YO\ P36_X-,/V^OV2?V\_P!E
M7]IOXU?&+]C3Q%\,O@3\7_#?Q.\3:+\//B!\;=9\:7X\)M/JNCQ>']-\3?L\
M^$="NKQ-?@TJ9EU'Q)I4,=M'/,D[S1QP2_T._P#$4=_P0H_Z/F_\UF_;#_\
MH?:/^(H[_@A1_P!'S?\ FLW[8?\ ]#[0!^_U%?D#^RY_P7J_X)/?MH_';P-^
MS1^S1^U9_P +*^-OQ*_X2;_A"O!7_"C/VDO!W]M?\(=X.\0^/_$?_%1^/_@[
MX5\):=_9WA+PKKVK?\3;7K#[9]@^P6'VK4[JRLKC]?J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCS_Z(*O]?JB@#_(%_P"(7'_@NO\ ]&,_^;,_L>?_ $05'_$+C_P77_Z,9_\
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MCS_Z(*O]?JB@#_(%_P"(7'_@NO\ ]&,_^;,_L>?_ $05'_$+C_P77_Z,9_\
M-F?V//\ Z(*O]?JB@#_(%_XA<?\ @NO_ -&,_P#FS/['G_T05'_$+C_P77_Z
M,9_\V9_8\_\ H@J_U^J* /\ (%_XA<?^"Z__ $8S_P";,_L>?_1!4?\ $+C_
M ,%U_P#HQG_S9G]CS_Z(*O\ 7ZHH _R!?^(7'_@NO_T8S_YLS^QY_P#1!4?\
M0N/_  77_P"C&?\ S9G]CS_Z(*O]?JB@#_(%_P"(7'_@NO\ ]&,_^;,_L>?_
M $05'_$+C_P77_Z,9_\ -F?V//\ Z(*O]?JB@#_(%_XA<?\ @NO_ -&,_P#F
MS/['G_T05'_$+C_P77_Z,9_\V9_8\_\ H@J_U^J* /\ (%_XA<?^"Z__ $8S
M_P";,_L>?_1!4?\ $+C_ ,%U_P#HQG_S9G]CS_Z(*O\ 7ZHH _R!?^(7'_@N
MO_T8S_YLS^QY_P#1!4?\0N/_  77_P"C&?\ S9G]CS_Z(*O]?JB@#_(%_P"(
M7'_@NO\ ]&,_^;,_L>?_ $05'_$+C_P77_Z,9_\ -F?V//\ Z(*O]?JB@#_(
M%_XA<?\ @NO_ -&,_P#FS/['G_T05'_$+C_P77_Z,9_\V9_8\_\ H@J_U^J*
M /\ (%_XA<?^"Z__ $8S_P";,_L>?_1!4?\ $+C_ ,%U_P#HQG_S9G]CS_Z(
M*O\ 7ZHH _R!?^(7'_@NO_T8S_YLS^QY_P#1!4?\0N/_  77_P"C&?\ S9G]
MCS_Z(*O]?JB@#_(%_P"(7'_@NO\ ]&,_^;,_L>?_ $05'_$+C_P77_Z,9_\
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MCS_Z(*O]?JB@#_(%_P"(7'_@NO\ ]&,_^;,_L>?_ $05'_$+C_P77_Z,9_\
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M/ 'QB\5>+=1_M'Q;XJT'2?\ B4Z#?_8_M_V^_P#LNF6M[>V_^CY110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,'1
MW_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?
MY_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_
M ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+
M0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[
M7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH\"ZIJ%DCJAU'2H/$?[1FG_VOI;,Z"+4],-WI\P=&BN75U)]/_8:_P"#HO\
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MF^(="\-ZK80?%CQ]I4SPN/LUYH_POMKN)A/I_B.X5&6OMK_@VE_X*F_M7?\
M!5#X/_M7_$S]JK4_ EUJ_P //C-X7\-^"-*^'W@RW\':'X=\/:]X3GURZTB&
M+[;JFJZG#;W@1+2[U[5]6U1;=%2XU"YD+RL ?TQT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW
M_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\
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MZ/J_ 3_@UU_Y04_L,_[G[2O_ *U_^T!7ZE?'G]O']B?]EKQ7I?@3]I3]K/\
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M;#;75Q\,OA]8>)O&NEZ;.K[HM9UG1M-T5E23&H91@ #]&J*^?/B=^U9^SO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._
MY04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^
M<HO_ '9-_P"_<5_?Y0 4444 %%%% !7\.7_!KW_RE8_X+R_]EOU3_P!:._:"
MK^XVOX<O^#7O_E*Q_P %Y?\ LM^J?^M'?M!4 ?HS_P ''G_!#C3/^"F/P2?]
MH'X >'K"T_;A^!GAJZ_X1B.V2WLV^/GP[T\W.IWGP@UR[;RHSXHL)9;W4_A5
MK-[(+>VUJZO_  IJ<MKI'BC^VO#G^<U_P35_X*'?M _\$F_VP/#_ ,>?AQ;Z
MG'-H.H7'@?XY?!K7Y+[0K#XD^ AJD<7B[X=^*[*X@-QHVNZ?=V7VWP]JMS82
MW_A#QCI=AJ$MC>6]OJ.CZA_MLU_!3_P=4?\ !"/_ (2&T\8_\%1_V0_!O_$^
MTZVFUO\ ;(^%WAJPR=:TRUBS<_M%^'-*M(\_VKI<$8_X7):VD3#4=-C3XE30
MPWNG>.]6U8 _L^_8^_:W^"/[<W[.WPU_:>_9Z\4Q>*?AG\3=$CU*P:3R8=;\
M.:Q QMO$/@OQ;IL4]Q_8WB_PEJ\=UHOB#2VFFCAO;5I[&ZOM,N+&_NO@3_@X
M0_Y0Q?\ !0/_ +(I%_ZG'A&O\ZW_ (-]_P#@M9XH_P""4G[17_")?$K4=8UW
M]BSXY:WIEC\;/"< N=1D^'NNN(=,TOXY^#-+B$LHUOPY;+!9^-=*TV%Y_&O@
MJW-DUI?^(/#_ (-DTW_0P_X+Q>+O"_C_ /X(;_MO>.O!'B'1_%O@SQE^SMHG
MBCPGXI\/:A;:MH/B/PYKWBGP5JFBZYHNJ64DUGJ.EZKIUU;7UA>VLLD%U:SQ
M31.R.I(!YS_P:Z_\H*?V&?\ <_:5_P#6O_V@*_9GXM?L\? /X]Z7?Z)\;_@I
M\*/B]I6IZ/+X?OK+XE?#[PIXUBGT28W+/IA_X2+2M0=+,27EU-'#$R+#<7$U
MQ#LGD:0_C-_P:Z_\H*?V&?\ <_:5_P#6O_V@*_?N@#_#R_X*>? 7P1^R]_P4
M/_;0_9^^&=G-IOPY^%'[1OQ3\)^ =)N+JXOYM%\&6GBF_F\,Z&]_>237E\=$
MT6XLM)%[>337EXMF+B[EDN)9';_;U\/?\@#0_P#L#Z9_Z105_B\_\%S?^4O_
M /P43_[.D^)7_IS%?[0WA[_D :'_ -@?3/\ TB@H _+G_@J__P $_?V2OVK/
MV+?VL_\ A:/P$^%&L>/X/@3\6?%_A'XK-X"\,P_$WP=\0/#/@36M<\*^+]#\
M=P:;%XGM+_3=9TS3Y;R%=4^R:WID=SH>M07VCWUY93?YG_\ P;.?\IQ/V#_^
MQD^,_P#ZS7\9J_UDOVPO^32/VI?^S<_C=_ZK/Q/7^3;_ ,&SG_*<3]@__L9/
MC/\ ^LU_&:@#_5K_ &R/V=_BG^T[\*[+X8_"S]K/XQ_L>3W7BBUOO&7Q#^!&
MF^"9?B/XA\%)H^MV5]X*T+Q-XQT+7+CX?W5[J][HFMQ^-/"B6OB2Q_L%M,MY
M39ZM>%/\DK_@N_\ L%:]_P $[/\ @HC\0O@EK'QG^(7[0-CXK\(>#/C!X8^*
M_P 6M1DUCXH^)M#\;07]E<#Q[K,DTRZUXATKQ+X>\1:1)K,1@CU:RL;+4#8Z
M=+<R6%M_LT5_EW?\'HL$<7_!5GX0R(H#77["WPFGE(_BD7XV_M(6P8^I\JWC
M7Z*!0!^OO_!,[X/_ +>7_!4[_@D_^R!^QM\*/&7BW]A/]@;P%\-]3\(?M$?M
M)Q6;'XZ?M8ZRWC;Q5J&O?"?]G?1(KZS7P]\%=(@O_P#A'OB!\4=?O[2/Q?XG
M74?">E:%XE\+^'O%VC>(OH?XU?\ !F+_ ,$[-?\ @WK/AWX#?%;]H[X=_&NS
MT6X/@_XC^._&GACQYX:U+Q'%;O\ 8A\0O!UCX#\-QW6A7D^$OO\ A#+KPIJ%
MEO6[M6NDMWTR]_6[_@WA_P"4+?\ P3__ .R0:M_ZL?QO7[/T ?XGG[%_[27Q
MZ_X(\?\ !2CP[XXN+C5O"OC7]F_XX:U\)/VB?!&F7DDMGXN\%^&_&DG@_P"-
MGPUU.!&CM-:L=0M-*U4:+-<PS16'B/3_  ]XJTY(M4T?3;F#^\WQ_P#\$[?V
MR?\ @X@\5:7\<OVYOB#\5OV'/^";%AJ":Q^R_P#L6^#H]-TWX_\ Q+\/D2#2
MOCG\>)-<MM<\*^!?%_BC39Q=^&]%UWP[XUU+PIH=]/HVCZ)X?6;4/&?Q _AG
M_P""[]A:Z;_P6'_X*'6]G"D$,G[2GC6_=$555KK518ZI?3$* "]Q>WEQ/(V-
MSR2,[$LQ)_V:?!DDDW@_PI+*[22R^&M"DD=CEGD?2[5G=CW9F))/<DF@#^&/
M_@IO_P &@?[+WPX_9/\ BQ\:_P!A;XD_'#3_ (P?!CP'XB^(Q^'/Q7\2>&?'
M7A3XI:#X+T>YUWQ!X;TNZTGP;X5UWPQXXO\ 2;"^F\-7YOM7T#4=9BL] O=&
MTJVU1O$6C_CQ_P &D/[>'C_]GG_@I#X>_9.N]?OY_@=^V1I7B;PUK/A:ZO)&
MT30OBUX-\'ZUXS\ ^/=-LV8I:ZYJ,'AO4/AS?O:+$-6L?%.G/JHNCX<T5K#_
M %'O'=E;:CX(\9:=>1+/:7_A7Q#974+JK)-;76D7D$\3JP*LLD4C(RL"I!((
M(.*_QFO^"$%S-:_\%A_^">$L#LCM^TKX*MF925)AO!>V=PF00=LD$\D;#HRL
M5(()% '^T?7^8O\ \'K?_*33]G3_ +,3\!?^M ?M(5_IT5_F+_\ !ZW_ ,I-
M/V=/^S$_ 7_K0'[2% 'M'[ /[,__  4T_P""T_\ P3:_91_86^$GB:Z_8J_X
M)L? 'PQXFT'XT_'7Q1I^I:AK/[5GQ.U'XJ>-?&%[HW@?P=H^J:'?_$#X>?#B
M+7M.TH:+>^(O"W@6X\9:?KNI>(_$6L^)-%\.^&O"_L7[2/\ P9(>(-"^&6J:
M[^RG^VD/B!\5=&TV2ZM/A]\8_AG9^"?#OC:\MX7EDT_3/'7AOQ7KK>$;V[9/
M(TN/6?#>M:9+=30Q:IKNCV8FU*+^EO\ X-M_^4)'[!/_ &(GQ(_]7M\5*_<.
M@#_#\_9^_:#_ &S_ /@D3^V7)XP\$3>*_@9^T1\#?%UYX0^)/PZ\3P7=MIVN
MVNFZA$OB;X9_$WPW'<Q6?BCP;X@CMX_-B6>2"6-M,\5>$]6M-3M=!U^V_P!D
M']@3]LKX>?\ !0+]D#X&?M=?#*%]/\._&'P?%JVH>')[J.\O?!?C+2;V[\.^
M/? ^H7,<<(N;KPCXRTG6]!%_]GMDU6VLK?5[:".TO[<'^%;_ (/7?V2/"O@C
MX[?LH?MF>$]&M=.UCXZ^$_&WPB^+5S96T%K'JWB3X0CPQJ7P^\1ZHT:K)J&O
M:IX0\7:KX8FOIR\D>@_#[PY8;O)M(%7]-/\ @RC^*VL>)?V#?VG_ (1ZC=2W
M=A\+/VGT\1Z LSL_]G:;\3OAQX7^TZ7:@G$5D-:\$ZKJRQ* /MVL:A,23,0
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M/[6'Q3\.:SJ.CK)H7C7Q7HVIZ/X*T6.72O%%UX*L8H+/4_"]I#/K'Q!_-_\
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M)_Q[E>SU+3+J*]L;I8I_BM+!(UO=012K'-%)$Y0+)&Z%E/[<444 %%%% '\
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MCTQOA;\ [/7=*TK[;JMG>V=_XQFU5M%@U2]O(-:^'?YJ?\'DD:I_P5P\-LH
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MM=0^$?#4UW"BFWLV73]3\5^+KVTA:YT_PAX>\2:AI]K=7MM:V-Q^D%?YXO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=VEW!+;75K<Q1SVUS;3QM%/;W$$JO%-!-$[1RQ2*T<D;,CJ5)!FHH _RO?\
M@Y;_ ."%ES_P3U^+-U^UO^S-X5G/[%7QJ\3R#4_#VD6LDEK^SA\4-;EFNI/!
M-S%$K+9?#'Q9<?:+OX::B0EGH=R+KX>WPM'L_"5SXG^1_P!D3_@M+XN\!?\
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M^F:'H8^)/@+QA\,].U'6M4NY(;+2](@U;Q?8'4]4OIH+'3;(SWU[/!:P32H
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M &DO&-D[QNKJMSIT=AI]Y"2I($EO=VL\$J'YHY8WC8!E(K_99^'%]:ZG\//
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MOB/X.\9Z/<% \^FW.A7_ (09M3O+5LQ/-X9N=?TRX=2VGZC>PE)6_$?]O_\
MX+4R_P#!:'Q_X7_X(\?\$A5\9Z[I'[2^K)X6_:4_:UU?PIKOA;P_X9_9_@N(
M9/B:_A'PWKEOI7BV#PE)X=-Q%XW\3>+].\*SZSIC_P#"N/"^B:OJ7CJRU*V
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M+\(:;#/<7WAY;F\\2Q73Z>FN6'AS1[]->B /Y9_^#.C_ )2\WO\ V:A\:?\
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M,TVV^,&C:'96ZF>_UK1/^$9\(>/K6T4RSW.D^$/$.F:7:7>L:M8V\H!]7_\
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M],G_ *9/^">G[(/AW]@G]BK]G+]D;PW>V^K1?!;X<Z?H7B#7[6*6"V\4^/\
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M*WHMM1AAE+P#6_C'\0_#6G7T%M<JJPZEH^@_#&WO!#)+_9WC*TG$=PO]^]%
M'Y8^#O\ @EY\/?V0O@#??"/_ ()22?!S]@+QWK>L>'IO%'QGU7X!K^TSXH\8
M^']#MM7C;2/&,OC/XF^#/%GBW4/MFIK?:)JWB7Q]J]AX:8ZG!IOA_P K6)_)
M_G,_:<_X- ?CK^V1\;O''[1?[2/_  6&U3XG?%_XB7MK>>)O%6J?L/Z=8"6/
M3[&VTK2=+TK1]&_:LT[0] T+1=*L[/3-&T/1-.L-+TVQMHH+6UC 8M_<#10!
M_-)_P3P_X(H_\%%O^":G@*Q^#'P*_P""R.AZU\![7Q7/XJ3X3?$+_@GQX?\
M%.EZ5/JU_'?>*;?P=K]]^U3)XC\(P^))1<75W96-_<:#!K5W>>((M";5=0U6
M?4/UB_;.^ G[>/QLETJT_9#_ &_/"G[%FACPU?:5XE-_^Q_X5_:1\6:GKMU=
MS-;^(O#_ (B\7?%SP1I7AC['I\D=FFF3>$]?#7,7]HK?1.PMT^^:* /X(O%7
M_!D9XE\=>*/$GC;QG_P5BU;Q3XP\8Z]K'BGQ7XGU_P#8UN=5UWQ'XD\0:A<:
MMKNO:UJEY^UY->:EJVKZI=W6H:C?W4LMS>7EQ-<3R/+(S'^CG_@GQ_P3X_X*
M-?L4VGPA^&OQ&_X*O:9^U/\ LV_"G2_^$:MOA7XT_8C\.^$O']UX.T[P]>Z1
MX6\+Z7\=;;]H3Q1XGL++PS?-I%W97/B/0O&EZ='TE?#$$UGITEI)IW[244 ?
MC#_P4+_X)^?\%%?VU[+XN_#+X:_\%5M)_95_9L^*VD+X8N_A=X-_8ET#QE\0
MK?PAJ'AFPT;Q=X8U3XZW7[0OA;Q%?6'BK44UF^N[CPWX=\%7\6BZP?"L]S?Z
M=#=SZG_-[X8_X,B?$7@KQ+X>\9>$/^"L&J^&/%GA+7-)\3>%_$FA?L:7.EZW
MX>\1:#?V^JZ)KFC:G9_M>17>G:KI.I6EM?Z??6LL5S:7=O#<02)+&K#^^"B@
M#X7_ &*_@7^V[\#]*\0:/^V!^W5X;_;8CDTKPYI_@K6;#]E'PS^S;XFT"YTL
MZFFNZEXGU#PG\5/'FE>-;CQ!!/I"1B/0?##:9-IEU<O+J4FJN+3SS_@HK_P2
M3_8?_P""HO@ZR\/_ +4_PL74/&'A[39]+\"?&KP1>1>$_C-\/[6>>>Z-IX?\
M81V=[%J6B)=W5W>CPCXQTKQ1X,-_=W&I-X>.ILMXGZ5T4 ?P*P?\&G__  4A
M_8D^,DOQB_X)6?\ !2SPOX.U5?,AM+GXBGQ_\%_%#Z$\XG7PMXKE^'N@_%[P
M9\3--5TAEN+7Q'X6T?P]J5U''<3>';-H8BOW%J__  2:_P"#C_\ ;.\'S?!;
M]OW_ (*_?"'P!\ ]?M?[,\=:'^R_\.]/?QWXWT&5'@U30O$&H^%O@O\ LTO<
M:=KUF\FG:CIMUXPUCPS<VTS2:IX8U9/.L+C^PBB@#\T?^";'_!)G]C7_ ()7
M?#:\\#_LQ^!+C_A*_$MM9Q_$GXU>.+BT\0?%WXES61WVZ>(?$D%AIUIIN@VD
MV9M-\'^%M,T'PI83F2_32)=8NK_5+S]+J** ,S6]$T;Q+HVK>'/$>DZ9K_A_
M7],O]%UW0M:L+75=&UK1M5M9;'4])U;3+Z*>RU'3-1LIY[._L+R":UN[6:6W
MN(I(I'0_Q&_\%%/^#-'X5_%OQMX@^*/_  3U^-6C?L]3^(KRZU.\^ /Q9TS7
M=?\ A+INI7DCS3#P)X[\/C5/&G@?P^LF6B\,:IX7\?Q6KW$D>D:IH^D6ECHD
M7]PM% '^95\.?^#*3_@HEK'BFUL_BI^TI^Q[X#\&"Z2/4O$/@S7/C!\2?$B6
MI<"2ZT?PEJGPG^&^G:DZ1[F2WU+QEX?,C[(S)&K-)'_;+_P2>_X(S_LH?\$C
M_AKJ_A[X+6FI>._B]XZM;*'XL?M ^.+:Q'CKQLEDXN8- TFTLE:P\$> ;&^+
M7FG>#]'EN#+.MM>>)M:\3ZO96NJ1_KA10!\2?MF_!3]M?XT:1X5TO]CO]M_P
MO^Q7/9VGBFV\;Z]K/[*7A?\ :;USQ++J@T-?#%WX;/B_XG^ ]%\&3^%UL_$!
MN1=:)XNBUY]<LW=-,_L0+J/\AGC_ /X,H?&OQ5\<^,/B9\2/^"MFM>-OB!X_
M\2ZUXQ\:^,/$?[&DVIZ]XG\4>(M0N-5US7=8U"X_:Z>:\U'4]1NKB[NIY&)>
M65B !@#^\ZB@#^>?_@F]_P $B_\ @HE_P3ET3X:?"/PW_P %@K?XO_LM^ _%
MNCZG<_ 7X@?L+Z!/<#P6NO0ZIXM\"^ /BC>_M*Z]XO\ AS:>([$ZA9:9)''X
MD\/>$;^_DUG2O"$TS7=K??T,444 %%%% !7QQ^W+^P3^S!_P47^!FK_L^_M4
M?#VW\;>#+V?^U?#^L64XTCQO\//%45M-;6/C3X>^*8H9KOPYXDL([B6+S!'=
MZ5JUE+<Z+XCTG6M!OK_2KK['HH _@=LO^#4[_@I1^PM\=I?C=_P2<_X*0^#?
M!M_$+BUT^?XK#QE\+?%;>')[B*Y'A'QG%X*\&_&#X>?%?2UF@MKBZM?$_A#1
M/#FI7UI:WS>%[*XMK;RONSQ'_P $I/\ @XW_ &UO"-Q\&_V^?^"NGP6^&?P&
M\16O]F^//#_[*'PWA?QIXWT*:,1ZIH6OZGH?PB_9OF-AKMOYNG:GI;>+M5\*
MW%G<R_VCX:U>V:73)OZ]J* /S=_X)M?\$IOV/?\ @E?\++WX<_LP>";N/7?$
MZV$OQ+^,'C6ZM->^+/Q0OM-$WV"3Q5XBMK#3;.UTC3#<W)T7PGX;TO0O"NDO
M<W=[;:/_ &MJ.JZEJ'Z1444 ?SE?M_\ _!'S_@I9_P %#OA]XI^"/Q1_X+,:
M3X'^ /BK6)KS5_A3\,/^"?VA^%HO$6CP:J-2T#P]XX\7V?[5,?BGQ9INC&*T
M-QIQOM*\/:Y?6D&IZIX>EN+:P6Q_%CPG_P &1WB?P'XI\->./!/_  5EUCPG
MXR\&Z_H_BKPGXI\/?L;W6D:_X;\2^']0M]6T+7M$U6Q_:]AO=,U?2-3M+74-
M.O[2:*YL[RWAN()$EC5A_>Y10!^57[/G[+G_  53^&?B3X;_ /"ZO^"JGPO_
M &B/A[X5U#3?^$YT&]_X)W>%_AKX]^(^@6:^7=:;)\0_#'[2]]I7AG5[Y N[
MQ#:?#[4FCD#32Z9<R2,Q_56BB@ HHHH _DC_ ."F_P#P:Z0?\%.?VY/VB/VO
M?&/[74WP9M?B+X:^$.A_#'PQX9^%2>/9](O? GPXT7P7XAU'QV=5\8>#X[ZU
MO;S0K:YT;3?#]_:2BVN)WOM3CE2.W9/@-_P3Z_X.<?V&O">F_"+]GO\ X*%_
ML1_M.?!CPO;0:/X)TO\ :VT+XK?\)5X8T:U1+:PL=.U/2?AYXK\61:/I]E#;
MVNGZ!J/Q8UW2="LX8;#0;"VM$\L_UNT4 ?R4WW_!OO\ MD?\%$/CGX$^./\
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M>U\1Z%X?\1:Q?>+;3PC>:I>:LFJ^X_\ !9K_ ((<?L^?\%@_ GA2?Q3XFO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#\ ?\ @Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\ !T=_R@H_
M;F_[MF_];#_9]K_(%H _O\_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[L
MF_\ ?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:?V9?_!]^R%_\_\ K^V*B@#^)W_A:O\ P>M_]&T_LR_^#[]D+_Y_]'_"U?\
M@];_ .C:?V9?_!]^R%_\_P#K^V*B@#^)W_A:O_!ZW_T;3^S+_P"#[]D+_P"?
M_56\^*/_  >P2P%(/V</V;[:3S;=A+9ZY^QJTX1+B)Y(P-0^/,]MY4T:O#<$
MQF86\DIM'BNQ!*G]ME% '\3O_"U?^#UO_HVG]F7_ ,'W[(7_ ,_^C_A:O_!Z
MW_T;3^S+_P"#[]D+_P"?_7]L5% '\3O_  M7_@];_P"C:?V9?_!]^R%_\_\
MH_X6K_P>M_\ 1M/[,O\ X/OV0O\ Y_\ 7]L5% '\2UU\4O\ @]?DM;F.']F[
M]FR"62"9(I[77?V.#=0R-&RI+;"]^/<UF9XV(>$7<,MJ9%43QR1;U,.F_%#_
M (/8H+"SANOV<OV<KRXBMXDFN]2US]C%+^XD5 'FO%TCX[VFEK<2'+2BPMH+
M0.3Y,2)A1_;?10!_$[_PM7_@];_Z-I_9E_\ !]^R%_\ /_H_X6K_ ,'K?_1M
M/[,O_@^_9"_^?_7]L5% '\3O_"U?^#UO_HVG]F7_ ,'W[(7_ ,_^C_A:O_!Z
MW_T;3^S+_P"#[]D+_P"?_7]L5% '\2=I\4?^#V"-)A-^SA^S?<%KJYD1KO7/
MV-5>.*29WB@A^P_'F%#:P(5BMC.KWIA5#>337'F2-:_X6K_P>M_]&T_LR_\
M@^_9"_\ G_U_;%10!_$[_P +5_X/6_\ HVG]F7_P??LA?_/_ */^%J_\'K?_
M $;3^S+_ .#[]D+_ .?_ %_;%10!_$[_ ,+5_P"#UO\ Z-I_9E_\'W[(7_S_
M .LNW^)O_![,FJZC<2?L\?L\S6D\-FMM87&M_L3C2K-XE<32:>]K\<XM<::X
M)5KP:M>W5NK*GV!($\Q6_MVHH _B=_X6K_P>M_\ 1M/[,O\ X/OV0O\ Y_\
M1_PM7_@];_Z-I_9E_P#!]^R%_P#/_K^V*B@#^)W_ (6K_P 'K?\ T;3^S+_X
M/OV0O_G_ -'_  M7_@];_P"C:?V9?_!]^R%_\_\ K^V*B@#^).3XH_\ ![ U
MW;2+^SA^S>D,<5RLMO'KG[&IM)WD,'E27+2_'EKX2P;)!;"SGAA(EG^V),1;
M&.U_PM7_ (/6_P#HVG]F7_P??LA?_/\ Z_MBHH _B=_X6K_P>M_]&T_LR_\
M@^_9"_\ G_T?\+5_X/6_^C:?V9?_  ??LA?_ #_Z_MBHH _B=_X6K_P>M_\
M1M/[,O\ X/OV0O\ Y_\ 67JWQ-_X/9KF*U6S_9X_9YL'CO[2:632=;_8G>6>
MWC<F:TNAKGQSO8%L+A<+=M9)#JBH!]AN89,L?[=J* /XG?\ A:O_  >M_P#1
MM/[,O_@^_9"_^?\ T?\ "U?^#UO_ *-I_9E_\'W[(7_S_P"O[8J* /XG?^%J
M_P#!ZW_T;3^S+_X/OV0O_G_T?\+5_P"#UO\ Z-I_9E_\'W[(7_S_ .O[8J*
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M]^R%_P#/_H_X6K_P>M_]&T_LR_\ @^_9"_\ G_U_;%10!_$[_P +5_X/6_\
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M_P#!ZW_T;3^S+_X/OV0O_G_T?\+5_P"#UO\ Z-I_9E_\'W[(7_S_ .O[8J*
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M.Q0N!3O^%J_\'K?_ $;3^S+_ .#[]D+_ .?_ %_;%10!_$[_ ,+5_P"#UO\
MZ-I_9E_\'W[(7_S_ .C_ (6K_P 'K?\ T;3^S+_X/OV0O_G_ -?VQ44 ?Q._
M\+5_X/6_^C:?V9?_  ??LA?_ #_Z_IP_X)K:Q^WAKO[(O@'4O^"D_A7PIX,_
M:YFUGQTGC[P_X*N/!5UX>M-&A\9:S%X%DM)OA]XC\6>%FENO!R:-<W0L=;N9
MEN99%O8[:[$T$?WE10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,'1W_*"
MC]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8
MQ_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,'1
MW_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?
MY_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGN=1DM52R1U:[N)9=SL"Q  'V[7Y ?\ ! ?_ )0V?\$]O^R :1_Z?=>K]?Z
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MY%AN_&/Q0\;>&O 'A6UE='D2*Y\0^*]3TG2()&CCD=4EO%9DC=@"%8C\X_\
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MWPRD\+W&LRW&K6_@G6?#_CF/Q5X1TF_N9I= T7Q#:Z%"+6TTZWL;4 _UB?\
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MM#L)EM]0\276@:9-/HWA;3[J2*>&TU#Q3K;:=X>L;RYB:UM+O4X;F[Q;12L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI>;+_LU#X+?^I%\3*_U2Z_RM/^#Q?_E+S9?]FH?!;_U(OB90!_?9_P $+/\
ME#]_P3M_[-@^'G_I%+7KG_!5G]I#6/V1O^";_P"VA^T1X9OGTSQA\.?@#X[G
M\":I&Q1]*^(?B33CX.^'NJ*0"6_LWQKXAT*^,8*M*(#$LD9<2+Y'_P $+/\
ME#]_P3M_[-@^'G_I%+7B7_!RGI&IZW_P1#_;SL])222ZA\&_"K5Y5B!+#3-
M_:"^$FO:TY"\^7'HVFW\DQZ")'+84$T ?Q/_ /!K_P#$?_@I-\*[[]L_QO\
M\$]?V(_A3^V#KFM1? _P]\4M?^)_QP\)?"34/AW9>=\5=7\/Z?H9\3^)_#MS
MKL/CJ\75;W79;5KV.VG\&Z-]H\B26,S_ -:O_#:/_!S-_P!(9_V8/_$U_A;_
M //-K^;C_@R@_:1T#P'^UW^UA^S%K>HV^GW_ .T/\'?!GCWP='=3)&-9\2_
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M'QV_],6F5_HF?\%FO^43'_!1_P#[,P_:&_\ 5:>(:_SL_P#@T._Y3)^"?^R
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MH_\ P5TT?4=.M([:\\5?LD?!C7]>F0?-J&K6_BSXJ^%X;N7UD30_#>C6 /\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\
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M?B'XPDAE\0ZG\3OVF[KXZ^.OA?X=\70>(?!>B>+3;?L^:SX,\%7>KC2="O\
MQYI/A9_$*W%W;3:%IWBR?P]/J,>L?@1^P_\ \&O/_!;G_@GW^TY\,_VK_P!G
MW]HS_@G1:?$GX97VHR6FG^)OB'^TCJ_A/Q/H>O:3>Z!XF\)>+-*MOV8M-NK[
M0/$.AZC>Z?>"QU+3=4LI)(-4T74],UFPT_4+4 _T2:_C'_X/9I$'_!/_ /94
MB+ 2/^V)92*F1N9(O@K\6%D8#J0K31@GH"ZYZBOZ5?@[JG_!2B7X)?%6X_:
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MWQUX<\$CXA_LX_%7X4^ X=>U&&TN_&/Q'\?>"]9T+PCX,\-6)+7FLZ]K&H7
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M%\:?&T5O(DLOA[_A)/"DFM_#7P)I-^G[FZ\36?B;QEK4*+/;67ANWEG@UBT
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M8_ZCD4L4\4<\$D<T,T:2PS1.LD4L4BAXY(Y$)22.1"&1U)5E(9200:_SCO\
M@I5_P9Q?'_PIX\\1?$+_ ()G>*/#/Q7^%.MWUWJ6G_ 'XG^,++P;\4_ 374C
MS)X=\,^._%$EKX(\>^&K([XM.U3Q?XC\'>)K&S:QL-2/BN\AOO$MUS_[%O\
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MT&A:S\1DTPOF7R+G5O*PGFY_N:\!2>.IO O@N;XH67A/3?B7+X3\.2?$33_
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MZ]U*U#6EXGQ$^+OAVV:SFN6U!-65I-)OO O^"F?_  :H_M%>+_VP/@A\)?\
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M<1Q;C:PKX?MK.[G,<3ZE:Q&6Y@ /Z?O^"A7_  4M\%_\%JOVC?A#_P $5_\
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M&UOQ)X0\.Z#IFI7EC?PZ79W.OMX@U)+&ZN['1;BRC^TM]Z?L=_MC_L]_MY?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P '
M1W_*"C]N;_NV;_UL/]GVO\@6O]?K_@Z._P"4%'[<W_=LW_K8?[/M?Y M ']_
MG_!C'_SE%_[LF_\ ?N*_O\K^ /\ X,8_^<HO_=DW_OW%?W^4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLI>2#S(XYA,$M9'2ZFCGAAD@D /[;**_B=_X?^_\%_/^E?;XV?\ AGOVK_\
MYW]'_#_W_@OY_P!*^WQL_P##/?M7_P#SOZ /[8J*_B=_X?\ O_!?S_I7V^-G
M_AGOVK__ )W]'_#_ -_X+^?]*^WQL_\ #/?M7_\ SOZ /[8J*_B6NO\ @O\
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M?Q._\/\ W_@OY_TK[?&S_P ,]^U?_P#._H_X?^_\%_/^E?;XV?\ AGOVK_\
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M+"4@'P2_:V6=;CS9_-E;4#X'-M+$\0A1+-+1)X'CDGDN)8[B**&U_P /_?\
M@OY_TK[?&S_PSW[5_P#\[^@#^V*BOXG?^'_O_!?S_I7V^-G_ (9[]J__ .=_
M1_P_]_X+^?\ 2OM\;/\ PSW[5_\ \[^@#^V*BOXG?^'_ +_P7\_Z5]OC9_X9
M[]J__P"=_67>_P#!?_\ X.#1?:4+3_@@#\8H+-IK@:E!/\!?VOM0GNXA 3 E
MIJ-KX0M+717CF_>23W]GJ4=TG^CPQ02GSJ /[=J*_B=_X?\ O_!?S_I7V^-G
M_AGOVK__ )W]'_#_ -_X+^?]*^WQL_\ #/?M7_\ SOZ /[8J*_B=_P"'_O\
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M>^"K^[L(W;)2UN;VZFA!"23R,"QN_P##_P!_X+^?]*^WQL_\,]^U?_\ ._H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _
M\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y
M M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[
M/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\
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M'CR\T:6.:VU.#X=Z/XIU'QRUGJ%M=:/*WA]!KMM+H@U%:_C$_P"#;3_@MO\
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M *U9^P-7ZET %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;=%2XU"YD+RM_3'7\07_  9#?\FL_MP_]E_^'?\ ZKJXK^WV@ HHHH ****
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MGPKLM"U'QWX<2:V>.ZLXO&OB?Q=X!T74G\P6VL>$X?%_ARZ@NK+5KU(_HO\
MX-'? .C^#_\ @C)\+_$FFV%O:W_Q5^-/QZ\=>(+J*)$FU/4]+\<3_#*VN[J1
M0&FDAT3X>:381LY)2"SBC7"J!0!^$?[8/_!>C_@XR_X)5?&[PSX6_;G^!W[,
MMUH7C"*YU;PE&OP\GO/AE\0M!TZ>V@UU/ ?Q*^''Q"M+J'6M'^UVR7VEZ]=3
MZ_X>?4-(U#7_  K)INJ:8-1],_:Y_P"#S:X\1_L??"_4OV,_@]:?#/\ :_\
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M6TATO(GTK4X;B*2._P!->/4+^-[&Z66U9+Z\0Q%;F8/_ (DWPO\ !VE?#O\
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M74/#^I^+?!MI9^)IM7^&WB#0;^[\>6=]9V/A2>'Q#;VMO=_HW10!\(?L _\
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MPQVY>\T:ZN8+S2=2>SL4\2>%M2\/^*K2SM[#7+6-0#[KHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\+O"VB^(H@#)]L\+1ZY\8HGU:VE@ G@6[FTFZ>,DS6UN!D_.W_!O-^Q%??\
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M&M67BJWU'0]6TS2;O0-'\1V.IZ+J6J7VEZCIP!_:;^S7^TU\"/VP/@UX/_:
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M"Y.IZHWA[3;58;'0-!^)GAS41X@TSPWIUNMCIVO^&/'$UDMEI=YI>EV7]U-
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M_P!NNM+O+472VDKJ_P#8I0 4444 %%%% !1110 4444 %%%% !1110 4444
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M*S@\4^&+B2WT_P"(/PR\1W-N9YO!_P 2O"!N9[_POXAM&2=(O--QHVN6T/\
M;'A?5]=T"XL]5N?XD?\ @X^_X-OOB?;_ !-^)'_!07]@#P%?^/\ P=X^U'5/
M'?[1'[/'@[3Y+[QIX-\8ZA)+J/BGXH?"_P .V4;WGBSPCXIOGN-<\7^#]'AN
M?$?A;Q#=W^LZ%I^J>$-1NK3P/_&G^S!^UI^TM^Q)\6],^,_[,/Q=\:?!7XG:
M$QM9-7\,7ODP:K8QW"2W/AWQAX;U&&[\/>,/#EQ<01/?^%_%ND:OHES/!#)<
MZ>\]O"\8!_NTU^%O_!QS^QMXJ_;;_P""4'QV^'7PS^'^O?$WXT> M?\ AO\
M&#X-^$O"NBW/B'Q1J7B_PGXQT[2=?MO#^CV,4VH7VJ7_ ,+_ !-\0=+MX+%&
MN'-^0$E3?%)^+'_!+_\ X/$O@W\5#X<^$G_!2SP;9_ CQY/]DTNV_:,^'.GZ
MMJWP7\07;;+>*Z\>^#$;5O%WPRN[J3ROM.K:-)XR\(O=375_?)X$T2W$<?\
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M:10C5-.LKSS;6W@N=\"H9C$SHU+_ (-3/^"6O[ O[>W[+G[3OCK]KO\ 9O\
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M=3/K'QT^*T.J:[IEMX5N] TI8M*TJ6ST_P 3:Z?[0E2Y:V;\]?\ @]G_ .3
M/V5/^SP[/_U2OQ7H \[_ .#(;_DUG]N'_LO_ ,.__5=7%?TA?MF?\%EO^":'
M[ 7B)O!/[4/[5W@7P7\1(XH)KCX9>&]/\5_%'XC::EW"ES9-XA\&_"_P_P",
M-;\)1WUK(EU87'BZUT*UOK9EGM9Y8W1F_@]_X-N_BM^WMXO_ &>?VH_V&/\
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M'NA7Z#/]F^)_"OPE\/\ C;5O"&H.-KK;>+8-#81/'.Y2"1)&^=O@O_P<J?\
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M'P3IO[:^E:+?7EZMCI^M^-OA#\>/ O@V[F:3RQ+-XQ\6_#'2/#VAV0/S-?\
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MWBZ>TT^/Q3;64(!_K+?!W_@HY^P#^T+X^TGX5? C]M/]EWXQ_$S7H-4NM$\
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MO:+\/[3Q]%K^G6%AHU_=7EC+XZDM)/'7C>Z:_P!:UO6XM/O].\.:& :WP_\
M^#H#_@B5\0_$EMX7M?VQ!X3O;ZY2UL-0^('P:^.7@WPW<22,%#W/BC5_AU%X
M?T2V&=SW?B/4=&M8U!+S*>*_=#P)X^\"_%+PAH'Q!^&?C/PI\0_ ?BO3XM6\
M+^-? _B'2?%?A/Q'I<Q98M1T+Q%H5W?Z1JUC(R.J75C=SP,R.H?<K ?S.?\
M!<C_ (-Y?V/?VK?V6_BO\8/V9O@?\._V?OVM/A'X*\1?$+P9JWP@\*Z+\/\
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MX'^*LEO=Z'<>%X5.GV7Q!O/#^MZ3%I)UGQC/K']G?_!2K_@EO\6/^"BG]NZ
MO_!1O]JO]FGX27OP^A\/:?\ !+X&1^"_#7@G4O&HEUIM0\4_$O6[+2[#Q_\
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M-(T%AXR3QKX8\5_V1;F&PL]3\->)=9A@%_XAU:XN0#_0EI"0H+,0% )))
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MXM^+93!X5^%O@'QC\1?$TZLJ-#X?\$>'M1\3:S*'?Y%,>G:9<N&;Y5(RW -
M'^;?_P '@'_!2#6/C]^UQX7_ .">WPUUJYN?A3^RN=-UWXE6&E2RRVWC+]HW
MQGHL=S%:W$5NTD.I)\,/ ^M6/A[25B47-AXJ\6_$/3+N-YK6V$/]]_\ P38_
M92TK]B']@[]E?]EO3;&&QO?A/\'O"FE^,?(CCC2_^)>M6A\4?%/6BL7RAM<^
M(VN>*-7P7E9%O%B,TVSS&_R(/V*G\3?MW_\ !8']FK6?B>QU[Q!^TS^WS\.?
M'7Q3=V><7MOXW^-VG>-?B,R><79H4TFXUTP12'8L,<<1VQKQ_M?4 %>2?&KX
M^?!']F_P-J'Q-^/_ ,6_AS\%_A]I>5O/&'Q-\8:#X+T!9_+>2.Q@U#7[ZQAO
M=3N0C)9:59-<:E?S;8+*UGG=(V/CMX(^)7Q'^$_C'P1\(/C-JG[/?Q$\06EA
M:>'?C'HG@KPE\0]8\$&+6=.N]5O=+\(>.[6^\(ZK?ZAHEOJ6BVDFMV5[:Z7/
MJ::PMG=SV$-O+_E[?\'0O_!-_P",G[#WQQ_9^^*'Q*_;.^.?[9^B_M(Z'\2U
MT;Q-^T'JKZMXZ\">(_AC>^"G\3>';1[*Z'AJR\(:E9?$#PW>>&M.\.:)X;LM
M.:TU;31I9@L;2ZG /]+']CC]N3]EO]O_ .&GB/XQ?LC_ !1A^+OPU\*_$77_
M (4ZQXKM?"OC?PE9IXX\,Z3X>US6-,LK7QYX;\+ZEJEG#I7BK0;RWUS3;*ZT
M+4([\#3]2N7@N5A^+/VJ/^"^?_!)3]C?QYJ7PM^-?[8?@U?B1H=Y)IWB'P;\
M-?#7C_XRZGX9U&W<Q7NF>*+SX5>%/%^A^&=9T^13'?Z#KVK:?KMK)F.730ZL
MJ_Q!?\$7OC7^W!\>/^";WB/_ ()*_P#!-"#4/"?Q[^.O[4/Q6^*'[3/[3%[<
M:MX;\'_LP_LO:U\-O@GX,TV[;QKIUC=W6E^,_BSX@\,^+M#TH>&TO?&UKHGA
MG6(_#.DG4-;@\2>%?O3Q7_P8]:Y#\,+J[\&_\%"=-UGXV1:9)>0:5XI^ -UH
M'PRU?6V@#KHUQXBTSXH>)?%>AZ<;LO$_BA?#?B&Z:$+<_P#")K([6R ']B?[
M&7_!4G]@#_@H*M_!^R+^T]\/?BUK^DV1U+5? R?V[X+^)>G::CI%-JMS\,_B
M%H_A3QY_8UO/)';3ZY#X>ET6.XEAA_M O/")/ORO\,KXD?#S]KC_ ()>?MAZ
MEX-\12^+?V?/VJ?V:_'%G>6.M>'-5-MJ>BZM;PPZGH/B?PQKMDSV6O>%?%.A
MWMKJ>F7D?VK1?%'AC5Q!>VUSI]_=V3?ZX_\ P1-_X*6Z=_P5/_8,^'O[0VH6
M^F:1\7_#FH7OPI_:#\-:2OD:=I'Q<\)6.F7.IZGH]HSR2VGA[QMH.KZ!XYT2
MT9YUTFW\0R>'3>WUUH=W=2 'ZW5_BDP\?\%I(@.G_#T)/_6KA7^UM7^*3#_R
MFEB_[2A)_P"M7"@#_:VHHK\./^"]O_!7'3_^"2W['P\:^$+?1]?_ &F/C7J6
MJ> /V=?"NM*MSI=IK%C80W7BOXG^(M/WQOJ/A?X:6&H:7<SZ:C8UGQ1KOA'0
M;HV^F:MJ&H6(!^@/[6O_  4'_8I_83T6RUS]K;]I3X7?!%-5MI;W1-"\4:Z;
MOQQXBLH':*XO?#'PZ\/V^L^/O$]G;3(8;FZT#PUJ4%M.4AGDCEDC1ORST/\
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M]-@WOB/Q/\)/B!XK^%TOBS560+$^M>,=.\):=XNUIX$BMVU77+PP06\6V",
M_6^OR^_;#_X+/_\ !,;]@SQ1/X"_:<_:V\ ^#?B+:)"]_P##?PSIWB_XJ^/]
M'-S&)[6/Q+X2^%/ASQIK'A&2[MV2ZM1XLMM#6XM9(;J)G@FAD?P[_@X+_;_\
M;_\ !.3_ ()E_%KXS_">^&C_ !H\>Z]X9^!7P?\ $1BBG/A3QE\1$U6XOO%]
MO#/%/;R:KX4\#>'O&/B#PZMU#-9?\)+IVCF^@N;,7%M-^<__  :R?L*?LGW/
M_!/'X>?MS>(_!/A3XU_M9?M(^,/C!X@^*OQG^)NG6'Q \>^&]2\._%KQIX-@
M\(Z'K'B>/5-2\-_;+#P]9^+O$][!)!KOC'7/$<VL:YJ.IZ9'X;@TT _3+X#?
M\'"'_!&_]HS4H=$\"?MV_"?P[K<SI"FF_&:U\8_ $/<R &.UMM6^-GAGP'X>
MU&YE++'#%I6L7QFG9;>(O.1'7W=^SG^VU^R]^UOXK^./A#]F_P"+GAKXP7G[
M.WBGPWX+^*&M>"99M:\&Z?XD\4^'_P#A)--T[0?&UI%)X6\8>18+-;:M=>%=
M5U>ST?6+6]T349[?5;*ZM(ODW_@HS_P1L_8>_P""D'P<\7> _B;\&O /@_XH
MW>BZ@OPY_:"\$^#M"T'XI_#KQ5]F?^QM577](M=.U#Q1X;AOA VO>!_$%Y=^
M']=L!+'Y-CJL>FZSIOX0?\&?/P4\>_LW:+_P5-_9_P#BEIJZ1\1?@Q^U5X-^
M&?C.PC,LEK'X@\&Z'XVT+49].N)8H&O=)O9[)KW2-16)(M2TNXM+^#,%Q&Q
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MQ39Z#\0/#5C<S.(+6]UWPSI]K=7"R06\TDT4B)Y?\7O^"0W_  3%^-WPJO\
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MX;_$35O"VN>)HY+Z6>^>VUJ\T>XU>&6[FFNG@ND>>624LY_O/^.7["/[=?\
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MU?QCHVEV7B?QAHWCWP[X>L89]4\4M9W?A[7=%TJ*74;;0=8TZSU2]T_\[_\
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M_P >Y7L]2TRZBO;&Z6*?XK2P2-;W4$4JQS121.4"R1NA92 ?9WQ&_P""G_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&W+Z!;V^E0> =+MM4EAU/7M \7>!?"&M6\$;VUCKOB& !;SG?^#'@G_A<_\
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MT'V[1KQM/\5>%KVQUBQTK58?]H+]FWXZ>$OVGOV?/@A^T;X#6XB\&_'7X4^
M?BSX;M;QXWO]/TGQ]X8TSQ-:Z7J1BQ&NJ:2FI?V;JD2A?)U"UN82JLA4 'M5
M%%% '\0__![5^T3KG@_]F+]C?]F'2+Z>TTSXX?%OXA_%+Q=':R21&_TSX$^'
M?#6D:)I&H%&59],NM<^,4>M+:2J\<FJ>&-.O,++I\35+_P &1.C:7!^R7^VS
MX@A2(:UJG[1/@C1M0D 'G-I>A?#6"^T=)&QDQ)=^(M<:($D!Y)B -Q)\@_X/
MA_A3KE]X(_X)[?'&SM9G\->&/%7[0'PI\17FQC;VNN>.M(^&'B_P;:[P-L<U
M]8?#OQW+L<[I4T[,8 AD)X7_ (,?_CKI<.J_MZ_LS:C?11ZUJ6G_  =^.OA#
M3,KYUUI>B7/BOP!\1KXJ2&,5A=^(/A9;@J&4-J1#E"4W@'^@97RW^V_\"]*_
M:;_8X_:D_9\UBRBO[7XP_ /XJ^ ;>.6-9#;:QXA\%ZQ9>']4M@V0E_HNO/IN
MKZ;-UM]0L;:=?FC%?4E5;Z]M=.LKS4+Z9+>RL+6XO;RXE(6."UM8GGN)I&/"
MI%$CNY/ 5230!_AU_P#!-CXU:]^SK_P4"_8P^-/AV\GLKWP%^TM\'M2OOL\C
M0M?^&KSQOH^C^,="F="&%GXC\(ZEK>@7ZJ07L=2N$!&[-?[CU?X@/_!,#X':
MM^TS_P %(_V+?@SX<L)K@>-_VF_A9+JD,"%Y-/\  _AWQA8>,/'FJ[%#[D\/
M^ ]!\0ZS*I^0Q:<X9U3+C_;^H _EM_X/ O\ E#QK'_9RGP._]"\65^//_!C5
M_P C+_P4O_[ ?[(__I?^TC7[#?\ !X%_RAXUC_LY3X'?^A>+*_'G_@QJ_P"1
ME_X*7_\ 8#_9'_\ 2_\ :1H _P!!BBBB@ KS/XU?"OP]\=/@W\6O@EXN:X3P
MG\8OAGX\^%?B=[39]J3P]\0O"VJ^$M::V\P&/[0NFZO<F'>"GF!=P*YKTRN5
M\=^-_"OPS\$>,OB1XZUFW\.^"/A]X5\0^-_&/B"[CN9K70O"OA32+S7O$.LW
M,5G!<WDMOIFD6%Y>S1VMM<7+QP,L$$LI6-@#_%P^-_P5_;]_X(9?MS'36UCQ
MQ\!?CO\ "K7-1U'X6?&#PG'-;>&/B?X)>YFL;3QAX.O;^WNM \<_#WQAIO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR^&O$"W'@GQIX?\ 'FARZ9KEO\&+B:P==<\-:>MV4A?[3I[WEDVU+EG7^O\
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M+^'FJ^)DC5C#9:-X@^%/QH\*VVJW!&558O$6JZ%I,9< &76E4."=K@'XX?\
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MA>6Y35+/PWX4T/73K^JVMIHFIZEX>T^[N]:L?@;_ (-T_P#@V^^+?[//Q?\
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MK5O^05J?_8/O?_2:6@#_ !=?^"%O_*8'_@G;_P!G0?#K_P!+I*_VFJ_Q9?\
M@A;_ ,I@?^"=O_9T'PZ_]+I*_P!IJ@#\;/\ @X0L+74O^",7_!0.WO(4GAC^
M"D5^B.JLJW6E>./".J6,P# @/;WMG;SQL!N22-74AE!'\.7_  9C22)_P5A^
M)*H[*LW[$OQ=CE .!)&/BU\ )0C#NHEBC?']Y%/:O[F?^#@+_E#1_P %!O\
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M>"Z@FM;J&*YMKF*2WN+>XC2:">"9&CFAFAD5HY8I8V9)(W5D=&964J2* /\
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M+PR6YUK1_P!G'QEK^H1*V;I-+\2?$V^T[1Y)DS\MO)=^%-<6V;'S2178R=G
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M?Z&G_!:3_E$G_P %'?\ LSCX]_\ JOM:K_/#_P"#0?\ Y3'>%?\ LWCXZ?\
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M\9?#7B!;CP3XT\/^/-#ETS7+?X,7$U@ZZYX:T];LI"_VG3WO+)MJ7+.O]?\
M10!_!O\ \$H/^#6O]OO_ ()]?\%"/V:_VOO&?[07[*>O>#?@[XG\2WOBW0_
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M*P7>J^-O%/B_Q5<6UM(5VS2Z?9_#^VEODC<FV34]/:90+N D _T1Z_Q28?\
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M?[??_!/K_@H1^S7^U]XS_:"_93U[P;\'?$_B6]\6Z'X!\3_&.7Q;K'AOQ7X
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MZG\1OVG?C1XI\1SH0T\VH:79>"? ME'.Q^9%AT;PAIIAM\^6@F>=5#W4K/\
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MJJ +% !7^2!_P=>:##I'_!;?]I34(E"OXI\"?L[:]<$* 6FM_@3X"\,AF/\
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MBBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y
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M^\-Q^.#\-_".D:?I_AOP)_:GA^32]$LY);SQ'XON]3U76-=O-+_@EQ_P7=^
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M$7?PY\(:%HES+<7GA/2_%@ET[5X/"UU=7MW:^$?#/P[O=;NY/%UYXG9O)/\
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M/BKQ'>6]C"+?3['^T=6_9>N9;?3-,ME6UTO2K4P:=IEHB6MA:V]NB1@ V_\
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M^(K[XT#4K6_TJU_9^TR[AOM1&I:W#8:G:^)+/4Y?".N:)HD7Q1U:P_)'5/\
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MR+]HTJTU[XB^"OASX:\'WEU'O$.N-HWCV"R.QWT&]+-'& ?I9^RU^UE\1/\
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MXAM[RT>3Q/K_ (F\)_&#QSI7B07.FPW-E-I$'A'0$-W=#4OMY,'V64 ^9_\
M@X.O;:P_X(Q_\%!)[J:.")_@DMDKRNJ*USJ/C7PGI]G"&8@&2XN[J"")/O22
MR)&H+,!7\,7_  9HWUK:?\%:?&UO<3)'+J?[&?QAL;)&8!KBZC^(_P $=2>&
M,'EG6RT^[G*C)$<$C=%-?UJ_\%$O^"*?_!1;_@I5X)U7X-_&[_@LGI7A_P"
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M_B@VN:5>QWUS>S7=I\+_  QJ+7D\D\CL ?V<*JJJJJA54!550 JJ!@*H&
M   , <"EHHH _P VG_@\8_X)L>+OAW^TIX:_X*2_#_PY=ZC\)_CUHOA7X>?'
M'4M.M))X_!7QH\$Z+!X9\):SKSPJ$L-%^(GP]T?P_HVD7;(8%\2^"=7@U&[C
MO?$.AVUY\Q?\$"_^#DO7/^":_AZT_90_:PT/Q9\4OV/9-6O+_P ":]X5\C4_
MB+^S[J&N7LM_K4&B:1J5Y8VWBWX9ZKJUU<:WJ7A6/4=/UCP]JE[J^N^&GU:6
M^N/#5_\ Z=_Q:^$OPS^/'PU\:?!WXR>"/#OQ(^%_Q$T*\\->-?!'BO3H=4T'
MQ!HM\H\ZTO;28962*5(KNQO;=X+_ $S4+>UU+3KFUU"TMKF+^$[]M_\ X,I[
MG6/&.M>+O^">W[3/A;POX5U>[N+RQ^#'[3,'BAK;PD)I&F.GZ)\8? ^C>+M;
MUG1H3(;72K+Q'\.YM;L;2WA&K>+?$5Y+/?  _H_TW_@XW_X(J:GX.3QQ'^WK
M\-[32S:"\DTO4O"/Q9L/&,($?F/;OX$N?A\GC&2[CP8S;VVB3O+(-MOYP9"W
MX7?%G_@H7?\ _!RK^VC\'_\ @G1^QWX1\<:1_P $W?A9X^\*?';]N/XR>+]'
MN?#UW\9/ OPX\06VMZ#\/AHOF/<>%_!OC+Q#IMKI'A/3->D'B_Q-XHN[/QAJ
M/A?0-&^&>J17OYM_ [_@R=_;<U[Q;8)^T7^U/^S+\,_ *W49U2]^$I^)GQ=\
M;S6D;AIX]/T+Q1X%^$?AZ"2YC!BM[RZ\53_97?[1-IERL0M9_P"[+_@G5_P3
M8_9<_P""8'P&M?@/^S'X3N;"RO;J#6OB#\0O$T]MJOQ(^*WBR*V^R_\ "2^.
MM?M[.PAN9;> O;:-H>E6.E^&O#MI+/!HFCV37FH37@!K?\%)OV--$_X* ?L+
M_M(_LA:K=66E3_%_X=W6G>#]:OHW:P\-_$?PW?V'C'X8>(;U((WN#IFA^/\
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M?]^*** "BBB@#_(8_P"#IW_E.;^V7_V#/V:__65/@G7^F]_P2A^+OPQ^-/\
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M@?LI?\%%]$_8B\ ZUX!;PKXFL[#]D;0/CC\2;GQ!>:AKG]K>*_"_Q/UOXT^
MG\%&\\/W^D:-8V>E>%9M9T&^TF?Q%I'BFVU'4+==* /\E3Q7XIT2_P#^"Q'B
M7QM;WUO)X<O/^"EFL>*8-365#:/HEQ^U'<ZM%?+/D(;=K!UN!+D(8SOSBO\
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M/".@/'J.C:]H6OZ-<60DM[Z_TFZUCP]K/]:P^ G_  =G>&]$_P"%?Z+^VO\
M\$O_ !S9)$^G6'QL\8> _'NC_$]+2./R(-7U7PUH_P  +CX?#6Q'MN1;IX?U
M^REND O;B='E:0 ^<?\ @\=_;K\(?";]AOPI^PQHFNV=U\6OVJO&GA3Q3XJ\
M-07&^]T+X&?"KQ'#XO?Q!JD4#E[+_A(_BGX?\&:1X;2]1(-:M]"\:O:M))X?
MN%7V;_@T]_X)A>*/V)?V,/$W[27QF\-W/AOXY?MGS^%_%5IX<U>T>UUSP1\"
M?#%KJ$OPRTK5+6YC%QI6M^,[GQ!KOCW6+%6CD_L34_ ]CJ]K:ZUH=W:V]O\
M8S_X-G]#T[]I:7]NO_@JQ^TEK'_!1']JNZUJP\46VC:[HTVG?!/0O$&E")=&
MGU/2M7EGO_B%8>%UM;2/P=X:ETCP)\-_#UC#%I7_  KF_M++3C:?U4=.E !7
M^,I_P<$ZK8ZQ_P %FO\ @H+=Z?/'<P0_'%]*DDB=75;[0O!_A;1-3@+*2!):
MZEI]W:S)]Z.6%XV 92!_K0_MB?![]LGXP^'_  QI'[('[9GA/]C;5+1?$D?C
M/Q/X@_9;\/?M,ZGXBBU*#28O#DGART\4?%#X>Z-X0N_#<MMK,\TU[IOBV#6V
MU6T26SL5TK_3_P"/3QM_P9+^+/B1XR\6?$/Q[_P5FU;Q=XX\=^)-<\8>,?%6
MO?L92ZAK?B7Q3XEU.YUG7]>U>_G_ &N6FO-3U?5;RZO[ZZE8R3W,\LC'+&@#
M^VG]FK4[+6_V<O@!K.FSQW6G:O\ !/X5:GI]U$RO%<V5_P"!=!N[6>)U)5XY
MH)8Y$92596!!(-?YU/\ P>R^&O&=I_P4!_96\8W\=\/A[KW['ECX;\+32"0:
M:_C'PG\:?BOJ?CN&T)_=-?PZ-XS^'<FHE,2"WN=+$@VB(G^P'_@G3_P3:_X*
M(_L':'\'?A#XE_X*O:1^TA^S!\([>'0;#X0>,_V'O#_AOQF/ EAIUU9Z+X'\
M.?&R+]HKQ+XFT+2-!F>Q_L0ZWHWC+^R-%T^#PSI4%CHL.GV^G_17_!5/_@E5
M^SK_ ,%9OV>HO@C\<FU3PMXC\*:K<^*/@_\ &'PK;64_C+X6^+;FT6RO+JQ@
MO@MKKOA?Q!:Q6UEXQ\'7T]M8^(;2ST^YAO-)\0Z+X>U_1@#\</\ @TS_ ."A
M?P"^,G_!.KX9_L53>-O#7AS]I']F+4/B%HE_\-M6U2RTOQ%XY\!>*_B%XJ^(
MWAWX@>"]+N9HYO$6DV4/B^;PKXG&D_;+W0]:T+[=KEMIUEXD\/S:C^A__!5#
M_@L/^R#^R)\.O'GP&L?$ES^T7^UQ\4/!OB_P-\.OV4/V?C%\0_BWJ.NZ]X<U
M.PBN_&%CX>&J1?#OP_ID4[ZMJ5[XF6+6;G2+/4+KPSX=\1S65S;1_P GL7_!
MD/\ M2CQR+&3]N/X!1_#A;[:OBV+X=_$5_'(T\2X6['P_:ZAT$7WE?O/L ^)
MI@$O[H:F5_?5_7-_P2T_X(<?L4?\$K? U[:?##PP?BE\;?%FAS:'\2?VB?B7
MINFWGCSQ-IM]$%U3PSX:L8DETSX=^ ;N3/F>%/#S/<:K#'8CQAKWBV]TVROX
M0#_,#_X(2_%#P5\&_P#@KO\ L&_$'XB>)-&\'^#M-^-MKHVK^)O$.H6NDZ%H
MY\9^&?$7@K3KO5M5O98;'3=/&J^(K&.ZU"]G@L[.*1KBZGAMXY)%_P!;KX1?
MM^?LX_M ?M1?$_\ 95^!GBQ?BYXK^"'P]TOQQ\9/'G@$V_B3X3_#S5_$NN6^
MD>$OACJWC[3+BYT2Z^)>O6<7B#Q _AG3;BZFT?2?#>HKJLMMJ*36-M_%YXS_
M .#(_P 7ZI^T7K\_@G]M+P9X7_96U'Q3>ZIH4.J?#SQ'K_QM\-^$KN^DO+;P
M@^FC5=.\&Z]J6DV+KHD7C&;Q1IJ:BT":Y<>%+9Y'T4?UU_L]_P#!-OP7^P?^
MQ+=?LE?\$Z?%.A?LW>+0=-U6V^/'Q!^&MG\>-<U_QPVJZ')XM^(/Q/\ "G_"
M4?#&'X@>(_$_AS3+WPY:11^)/#6C>$H+K24\/:7;:%X<L/#<@!_&O_P?":UI
M\_QU_8!\.Q7$3:KI?PF^.&M7MH'!F@T_7O&'@.QTRXDC^\L5U<^&]7BA<\2/
M9SJ.8VK]W_\ @T3O[6\_X(T^ +>WF26;2OCQ\>+"^1&#-;W4GB:SU1(90#E'
M:QU*SN K8)CGC?&UU)^,_P!MC_@U+_:>_P""AGQMN_V@OVL/^"QMQ\2/B-+H
M6G>$]+N$_80T;PYH/A;PAH]S?WFE>%/"OAKP]^U5IVCZ)HEE>ZKJE^8;>U-U
M?ZIJ6I:OJUWJ&K:A>WT_TM_P3S_X-_O^"@'_  3!T7QAX0_92_X+.Z9HWP\\
M>:W#XH\2_#7QQ_P3UT#QYX*N/%4-C;:6?$^FV.M?M7G4?#VMW>EV=CINJW?A
MW5=*77+/3M)BUN+4/[&TAK$ _JLK_'#_ .#D"]M=0_X+9_M\3V<\5Q%'\0O
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M_ _]BGXSW7[9/[4GQ<\3?MT_MQ:KKE[XQ_X6Y\2;"XA\*>"_&FKS/>:EXO\
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M/"W@S1+>TT'0([Z_NA%?:]JVO:[JX!X)_P %_/\ @G;K7_!2K_@FU\5?@YX
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ML5G]G .L_9(_X.G?^"2?[2/@32=8^(_QJN?V4?B4UE _B;X7_&_0/$B1:5J
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M^\(>&?"?AW2L236_C+7Y+HV[:+H>LWEG_5-\>?\ @DO_ ,%_O^"F.D0_!_\
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M]O\ _P""F/AOQ_\ !KQY_P %<-(^&?[+7BSXB7WB[2_@1X*_80T(31^&M/\
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MW.G>./BFNG>&VM+6.WMM-N?@^UG96EK8^1&;?_!X-X@\.?&3P+_P3[_X)_\
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M5CI/A?Q%KPT;PSI>BZK-?:OJ&G:O?:UI0T)M)U?^U^@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXD^W^"=,TO2]#T/Q3XIM['0M.\/S2/<:Y/<W^M7OV:RBM@#R'_@QID0^'_\
M@IC$&!D36/V0Y&3/S*DEE^TLJ,1U 9HI I[E&QT-?WR5_GU_\$5O^"<?_!P-
M_P $;?BY\3_&'A?]A[X1?&_X8?&_P_X8T/XJ?#'5OVKO@QX&U+4+KP->:Y>^
M"O$GACQM:ZYXH70]9\/GQ3XGLWAU#PQKVEZIIFO7]M-9VUZFG:II_P#=3^SU
MXX^,GQ&^%'AWQ=\?/@8G[.'Q2U*?6H_$'PA3XG^&/C$GAN&QUJ_L=(N%^(/@
M^PTW0-:77-(M[+7!':64,FF_VA_9MV&NK29B >UT444 %%%% !1110 4444
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M9_$R..V1FFM-"^%7CO2=!^(7C?4-Z^1;6G@+PYXHDU"X>&'33>/<0"3\UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#7C6V\-_%+]F7QQXKUWQ-\'/&_@VYBL]3T_Q3\)+O789+WX>MXO\)WVF>*?
M_C;PMINC7$]O=Z*/&?AO6;"WU'PJ_P#JE?LH?M._"?\ ;._9S^$7[4/P/UB;
M6OAA\9O"%EXM\-3WD4=OJFG,\L^GZWX;UZTAFN8;+Q)X2\0V.K>%_$MC#<W4
M%EKVCZA;075U#$EQ)_F>?\%R/@W_ ,%"_P#@JM^V=H_[4WPG_P""07_!0GX.
M:</@AX'^&WB?P_XT_9\^(&L:QK'BKPAXC\<W1\2)>:!X3%H;*?PQKOAC1H8I
M_P#2TDT.?<?(:WK^J_\ X-,/A9^UO\ /V!?B_P# G]K'X'?&/X&WW@S]I/Q!
MXB^&&A_&7X?^*_A_JEWX*\<>!_!5[J4>@6/BG3M-DOM$M?&FE^)-0DGLH7CB
MU77+]9I2TD:* ><_\' W_!6+]HWP+^TI^S-_P2 _X)_>-K;X8?M/_M:>(OAI
MH'Q"^.ZW#6VI_"30?C)XUC\!>!?#GA74HH9YO#GB37)FO?%'BCQ;91-XA\)^
M#X='D\)!->\10:IH?M/@K_@TX_X)AS^$TD_:0OOVB_VI_CCK%G'/XZ^/_P 1
MOCIX^TGQ;XA\330@ZEK&GZ3X=UBUTJQL3>-+)I6G^(CXQU&SM?)M]4U_7;E)
MKZX_D@_X.C+3XV?LO?\ !>'5/VF- NM2\,ZOK&@_LP?M ?L^^,!;":VL=1^$
MGA/PEX1MKW3GFC>SGNO#_P 3?A;JU_=Z?+YCQ_:+26ZA%MJ%L9OZ]O\ @E9_
MP<[?L,?MZ>'?"'P_^.WBWP[^R1^U9<VMAI>M>!?B/JT>B_"OQWXC\N.":^^$
MWQ/U>9-"-OK-XT1TSP1XUU'1/&L%[>#0M(B\9I9?\)#?@'\U7_!>[_@FQ^W)
M_P $BO@I+?\ [+O[=7[8'Q#_ .":WQPNY?A+\0/@[XU^,?C'4E^%FI>(+*ZF
MLO!WBS3-*OM/\):_\-_'FG66HZ/::[:>&?#QD>VC\#^,[?5'U31[_P 0_P"@
MY^Q9_P F<?LF?]FS_ ?_ -5;X5KB/^"A?[('AK]OW]B?]HK]DCQ#J&GZ5;_&
MSX;ZEH7AOQ-?V!U>P\*>.["6U\2?#;QI+812PS7UOX4\=Z/X<\0S6MK<VUQ>
M6VGRVUO=6[SK,GO?P*^'EW\(_@C\'/A1?ZE;ZS??#'X5_#WX>7FKVD$EM:ZK
M=^"_".D>&[C4K:VF>2:WM[Z;37NH8)7>2*.58W=F4D@'XB?\'/WBW]I_P7_P
M2$^.6L?LO7GB_2]1D\4> ].^-.M> Y-0M_%6C?L_7U_>0_$"\L[S2"NK6.CS
MW_\ PC.F>-;RQ9$A\!ZAXH.K21: =6E3^);_ (-)?%O[4&F?\%:?A]X4^"]W
MXOG^"GB3P-\2[C]JK1;*34)? (^'VE^ ?$LW@WQ#XOM4+Z9:ZQIWQ5?P3IW@
MW6'B75EU/5Y]$M;A-'UO7X9O]7.>""Z@FMKF&*XMKB*2"XMYXTF@G@F0QRPS
M12!HY8I8V9)(W5D=&*L"I(KSSX<_!OX0?!VVU>R^$?PJ^&_PLL]?OAJFNVGP
MY\#>&/!%MK>IJ) -1U>#PSI>F1:E? 2R@7=XDUP!)(!)AVR >D4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:SL=(\>_%*_N-&\+V]S=2:>FO7>BS>*O&'B[^CFB@#^##_@NU^S3_P %^O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%
M'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+
M_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.C
MO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/
M_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_
M (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _
M^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO\@6O
M]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^XK^_R
MOX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/]GVO
M\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_ -^X
MK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_ %L/
M]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\ NR;_
M -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^[9O_
M %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y1?\
MNR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^
M[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y
M1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/
MVYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'
M_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?
M\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G
M_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\
MP='?\H*/VYO^[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M
M']_G_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_$(_^T;_ -)S?VFO_#4>._\ Z+RC_B$?_:-_Z3F_M-?^&H\=_P#T7E?VQ44
M?Q)C_@T4_:'6]DOA_P %QOVD!<R6L-H]R/@_XX%Z\$,L\T<$EW_PU[YCVL<D
M\LD-L5V12RSRJ2TS 6O^(1_]HW_I.;^TU_X:CQW_ /1>5_;%10!_$[_Q"/\
M[1O_ $G-_::_\-1X[_\ HO*/^(1_]HW_ *3F_M-?^&H\=_\ T7E?VQ44 ?Q.
M_P#$(_\ M&_])S?VFO\ PU'CO_Z+RLN]_P"#0C]H"_OM*U"Y_P""WW[0US<Z
M/-<3V-U>_!;QK>7UA)<P&"632KR3]K]9-,FFC/E7$L*NT\&86 7FO[=J* /X
MG?\ B$?_ &C?^DYO[37_ (:CQW_]%Y1_Q"/_ +1O_2<W]IK_ ,-1X[_^B\K^
MV*B@#^)W_B$?_:-_Z3F_M-?^&H\=_P#T7E'_ !"/_M&_])S?VFO_  U'CO\
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MC_[1O_2<W]IK_P -1X[_ /HO*/\ B$?_ &C?^DYO[37_ (:CQW_]%Y7]L5%
M'\3O_$(_^T;_ -)S?VFO_#4>._\ Z+RJMI_P:*?M#V:3)!_P7&_:0@6:ZN;N
M1;3X/^.+9))[N9YYIYE3]KTB6ZGD=I+FY;#W$S/,X#,17]ME% '\3O\ Q"/_
M +1O_2<W]IK_ ,-1X[_^B\H_XA'_ -HW_I.;^TU_X:CQW_\ 1>5_;%10!_$[
M_P 0C_[1O_2<W]IK_P -1X[_ /HO*/\ B$?_ &C?^DYO[37_ (:CQW_]%Y7]
ML5% '\1-O_P:$?M 6VJZCK$7_!;[]H:&^U*&S@N[^W^"WC6#5;R.R5TMX]1U
M-?VOS-?PVZNRV<4J*MJK.J%@YK4_XA'_ -HW_I.;^TU_X:CQW_\ 1>5_;%10
M!_$[_P 0C_[1O_2<W]IK_P -1X[_ /HO*/\ B$?_ &C?^DYO[37_ (:CQW_]
M%Y7]L5% '\3O_$(_^T;_ -)S?VFO_#4>._\ Z+RJLG_!HI^T/)=VUX__  7&
M_:0>>UBN8H;B3X/^.)+N%+HP&9+:Z/[7H>WBG-O$;F- 1<&* N1Y*Y_MLHH
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M_::_\-1X[_\ HO*/^(1_]HW_ *3F_M-?^&H\=_\ T7E?VQ44 ?Q._P#$(_\
MM&_])S?VFO\ PU'CO_Z+RC_B$?\ VC?^DYO[37_AJ/'?_P!%Y7]L5% '\2</
M_!HI^T/!/>7$?_!<;]I"*6]EBEN)8?@_XXAGN'AMXK9'O)E_:]+7<J0PQPQ2
M.%,=O'%  5B4FU_Q"/\ [1O_ $G-_::_\-1X[_\ HO*_MBHH _B=_P"(1_\
M:-_Z3F_M-?\ AJ/'?_T7E'_$(_\ M&_])S?VFO\ PU'CO_Z+RO[8J* /XG?^
M(1_]HW_I.;^TU_X:CQW_ /1>5EO_ ,&A'[0#ZS#KC?\ !;[]H9M1@L)=.CU%
M_@MXU?68[6699WM(=6/[7_GQ6#R*)9;%4,<DP68L&7%?V[44 ?Q._P#$(_\
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M:VZ* L4",RQH H) K^V^B@#^)W_B$?\ VC?^DYO[37_AJ/'?_P!%Y1_Q"/\
M[1O_ $G-_::_\-1X[_\ HO*_MBHH _B=_P"(1_\ :-_Z3F_M-?\ AJ/'?_T7
ME'_$(_\ M&_])S?VFO\ PU'CO_Z+RO[8J* /XD[3_@T4_:'LTF2#_@N-^TA
MLUU<W<BVGP?\<6R23W<SSS3S*G[7I$MU/([27-RV'N)F>9P&8BK7_$(_^T;_
M -)S?VFO_#4>._\ Z+RO[8J* /XG?^(1_P#:-_Z3F_M-?^&H\=__ $7E'_$(
M_P#M&_\ 2<W]IK_PU'CO_P"B\K^V*B@#^)W_ (A'_P!HW_I.;^TU_P"&H\=_
M_1>5EV__  :$?M 6VJZCK$7_  6^_:&AOM2ALX+N_M_@MXU@U6\CLE=+>/4=
M37]K\S7\-NKLMG%*BK:JSJA8.:_MVHH _B=_XA'_ -HW_I.;^TU_X:CQW_\
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M_P"UZJF6&:%)K>3.8+B.*=06C -K_B$?_:-_Z3F_M-?^&H\=_P#T7E?VQ44
M?Q._\0C_ .T;_P!)S?VFO_#4>.__ *+RC_B$?_:-_P"DYO[37_AJ/'?_ -%Y
M7]L5% '\3O\ Q"/_ +1O_2<W]IK_ ,-1X[_^B\J"Z_X-%_VB+NUN;2?_ (+C
M_M)SPW4$UO-!=?"+QQ<VLT4T;1R17-N_[7H2X@D1BDT+$++&61B Q-?VTT4
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MW[2#SVL5S%#<2?!_QQ)=PI=& S);71_:]#V\4YMXC<QH"+@Q0%R/)7/]ME%
M'\3O_$(_^T;_ -)S?VFO_#4>._\ Z+RC_B$?_:-_Z3F_M-?^&H\=_P#T7E?V
MQ44 ?Q._\0C_ .T;_P!)S?VFO_#4>.__ *+RC_B$?_:-_P"DYO[37_AJ/'?_
M -%Y7]L5% '\1.K?\&A'[0&L16L-]_P6^_:&OTM+^TU&"/5O@MXUU.*"ZLW+
MP7=K%-^U^@MK^!B6M+Y"9+5R716)Q6I_Q"/_ +1O_2<W]IK_ ,-1X[_^B\K^
MV*B@#^)W_B$?_:-_Z3F_M-?^&H\=_P#T7E'_ !"/_M&_])S?VFO_  U'CO\
M^B\K^V*B@#^)W_B$?_:-_P"DYO[37_AJ/'?_ -%Y4%U_P:+_ +1%W:W-I/\
M\%Q_VDYX;J":WF@NOA%XXN;6:*:-HY(KFW?]KT)<02(Q2:%B%EC+(Q 8FO[:
M:* /XFX_^#1S]HR-$C7_ (+E_M,*J(J*L?PF\=(BJH"A40?M>$(@  50<*
M.E._XA'_ -HW_I.;^TU_X:CQW_\ 1>5_;%10!_$[_P 0C_[1O_2<W]IK_P -
M1X[_ /HO*/\ B$?_ &C?^DYO[37_ (:CQW_]%Y7]L5% '\3O_$(_^T;_ -)S
M?VFO_#4>._\ Z+RLO1O^#0C]H#1+%=/T_P#X+??M#:=;+-<3K:Z-\%O&NDV*
MR7,[SRR+9P?M?O&LTTDC2W$H;=/.SS, SD#^W:B@#^)W_B$?_:-_Z3F_M-?^
M&H\=_P#T7E'_ !"/_M&_])S?VFO_  U'CO\ ^B\K^V*B@#^)W_B$?_:-_P"D
MYO[37_AJ/'?_ -%Y1_Q"/_M&_P#2<W]IK_PU'CO_ .B\K^V*B@#^).'_ (-%
M/VAX)[RXC_X+C?M(12WLL4MQ+#\'_'$,]P\-O%;(]Y,O[7I:[E2&&.&*1PIC
MMXXH "L2DVO^(1_]HW_I.;^TU_X:CQW_ /1>5_;%10!_$[_Q"/\ [1O_ $G-
M_::_\-1X[_\ HO*/^(1_]HW_ *3F_M-?^&H\=_\ T7E?VQ44 ?Q._P#$(_\
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M;_TG-_::_P##4>.__HO*/^(1_P#:-_Z3F_M-?^&H\=__ $7E?VQ44 ?Q._\
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MWDFF_!;QKI\M[=2HB/=ZG+%^U^QU&_=8U62^E"22(J(5 0$ZG_$(_P#M&_\
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M(1_]HW_I.;^TU_X:CQW_ /1>5_;%10!_$[_Q"/\ [1O_ $G-_::_\-1X[_\
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MH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^0+7^OU_P='?\H*/VYO\
MNV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5_?Y7\ ?_  8Q_P#.47_N
MR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\'1W_*"C]N;_
M +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=DW_OW%?W^5_ '_P &,?\ SE%_
M[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_!T=_R@H_;F
M_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]_E?P!_\ !C'_ ,Y1
M?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^0+7^OU_P='?\H*/V
MYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5_?Y7\ ?_  8Q_P#.
M47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\'1W_*"C
M]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=DW_OW%?W^5_ '_P &,?\
MSE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_!T=_R@
MH_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]_E?P!_\ !C'_
M ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^0+7^OU_P='?\
MH*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5_?Y7\ ?_  8Q
M_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHKXS^,/_!1C]@']GW7[KPG\;_VV/V5?A3XNL96
M@OO!_CKX]_##P[XOLI4)61;OPKJ/B:'Q!;>6PVR--IR+&Y"NRLR@@'V917SA
M\$/VQOV2?VF'EA_9U_:?_9]^.US;PO<75C\(OC%\/OB)J-E#'GS)+[3?"?B'
M5;^Q$>#Y@N[>$H.7 %>H_%'XJ?#;X(^ /$_Q6^,'CKPK\,_AIX*T]=5\7>._
M&VMV'ASPKX;TU[FWLDO=9UK4YK>QL+=[RZMK6.2XF19+BXAA3=)*BD [ZBFH
MZ2HDD;*\<BJZ.I#*Z. RLI'!5E(((X(((IU !1110 4444 %%>._'']H7X$_
MLS>!;_XF_M#?&#X<?!7X?Z=N6X\6_$WQAH?@[1GN%C:5-/LKK7+VS&IZM<A2
MECH^FB[U34)BEO8V=Q/)'&WP]^P=_P %A?V'O^"E/Q1^-GPM_9"\;^+?B+=?
M C3/#VL>*_%^H> ]>\'^#-9T_P 37^I:7I]SX2NO%,6E^(-4C6^TJ]AF>^\.
M:4C)&ES:-=VLT,[@'ZAT444 %%%% !1110 4444 %%%% !117Q)^V)_P4>_8
M?_8%\.MXA_:T_:2^&WPBEELGO]*\(:EJSZW\3/$ELNX"7PM\+O#$&M?$'Q%
M95$$E[I/ARZT^UE>,7MW;(X>@#[;HKXP_8+_ &\O@+_P4=_9^L?VE_V;YO%]
MQ\,=2\6^*?!EG-XX\.#PMKDFK^$+N&SU5SI'V_46CLFEGC:TFDN%DFC),D$+
M I7V?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'OB6WA+K(_A#X;:!#J_Q \7;'C:.4^&_#6J+ ^!.T0YK"_X)_?\ !0G]G?\
MX*7? _5?VAOV8KOQE??#;2OB-XE^&$EYXW\,/X2U6Y\1>%=.T#5=0GM=)EO;
MZ<Z5-9>)=+EL[FY:VN9&>:.>SMY(64@'W%1110 4444 %%%% !1110 4444
M%%%% !17Q;^V!_P44_8E_8)\-'Q-^UI^T?\ #7X.B:SDO])\+ZQK#:M\1O$M
MM'O4R^$_ACX;@UGX@^*(A*GDRW.A^&[ZTMI607=Q;JP:F_L#_M\_ '_@I%\
MX_VDOV:[CQA=?#.;QIXH\"07'CCPW_PBFM3:UX2>R75)%TDW^H.M@XU"V>SG
MEFCFE5F$EO Z%* /M2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***CFFBMXI;BXEC@@@C>:::9UBBA
MBB4O)++(Y5(XXT5G=W8*B@LQ !- $E%?BS^T)_P<%?\ !*K]GCXN>#O@/J'[
M2>E?%SXM>,?&VA> H_"?[/\ I\GQ;M_#FM^(-6M]"ME\6^,O#\Z^ -$>SU6Z
M@L]4T=_%<_BC3Y#(9] "03M%^TU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117Q;^V!_P44_8E_8)\-'Q-
M^UI^T?\ #7X.B:SDO])\+ZQK#:M\1O$MM'O4R^$_ACX;@UGX@^*(A*GDRW.A
M^&[ZTMI607=Q;JP:@#[2HKXK_8'_ &^?@#_P4B^ <?[27[-=QXPNOAG-XT\4
M>!(+CQQX;_X136IM:\)/9+JDBZ2;_4'6P<:A;/9SRS1S2JS"2W@="E?:E !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /_  ='?\H*
M/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04?MS?]VS?^MA_L^U_D"T ?W^?\&,?
M_.47_NR;_P!^XK^_ROX _P#@QC_YRB_]V3?^_<5_?Y0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5^+W[4/PT\0?M(?\%2?A9^S[J_[0G[5/PB^%EA^P
M'\4?C'-X=_9O_:)^)GP&36O'^D?M$?"SP3INM>(I/A[K>E?VV]IX=\4:O8P)
M?I+Y8FC9&7RE%?M#7Y9ZO_RFR^'O_:+/XQ_^M:? J@ _X=1^ /\ H]3_ (*F
M?^+&?VF/_FQH_P"'4?@#_H]3_@J9_P"+&?VF/_FQK]3** /RS_X=1^ /^CU/
M^"IG_BQG]IC_ .;&C_AU'X _Z/4_X*F?^+&?VF/_ )L:_4RB@#\2/@U\'=<_
M9:_X*Q?"KX.^&OVDOVO_ (K?#+XE?\$]?VI?B5XB\%_M&_M.?%;X\^'X?'7P
M_P#VC?V-O#'A;Q/HFE_$'7M5L=%UC3M \?>+=*6_LK=+IK+6[ZW\Y8;B9)/V
MWK\M/&W_ "FN_9J_[1>?ML?^M6?L#5^I= !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%?.'[8_C+Q1\.OV0_VJ?B#X(E
MN(/&G@3]F_XX^,O"$UIN^UQ>*/#'PQ\4:WH$MML^?[1'JUC:/#M^;S NWG%
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MZ;XCT,V>NZ%H_C/PO?:;I'^Q/7\BG_!XC^Q3X<^-/_!/'0?VO=*T2W'Q/_9
M^('ALZAK]O;(=0O_ (,_%W7]+\ ^)?#MV\2K<7=OI_C[5OA[XET][AYX=#MK
M7Q/);0P+K>I7- '];>D_\@K3/^P?9?\ I-%6A6?I/_(*TS_L'V7_ *315H4
M%%%% !534+5[ZPO;*.\N]/>\M+FU2_L&A2_L7N(7B6\LGN(+FW2[MBXFMFGM
MKB%9D0RP2H&C:W10!_GB_P#!SI_P15\(_LZ?LE^'?V[;7]J[]K_]I'XR:%\5
M_"7P]^)NL?M4_%/2/B;'K'A/Q]::ZD-]X1MM,\'>%H/ 9T3Q7I^BVFG^&-!C
MA\+1Z#J=Q;Q6$-UIMI-<8/\ P8^?\EX_;\_[)'\$O_4R\<5^^_\ P=N1J_\
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MS2J_I^K^8'_@T-_Y0V^"_P#LX#X[?^GS2J_I^H **** "BBB@ HHHH ****
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M35(O!OB?7/#_ (HL=!O=>TRRN_#MSJZ:+<:CIVGZM=W>D3V.JPV5];_Y:/\
MP<V?\$K_  !_P36_:C^#NM_"_P"*'QE^*7A7]IOP!XE\8:OJWQ\\:)\1_B3#
M\0_ ^O6.D>+)[[QT=*TB^U_3=6TS7O"NH6K:S#>:O:ZBVL)+J5Q8R:?;V?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M^ /_  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04?MS?]VS?^MA_L^U_
MD"T ?W^?\&,?_.47_NR;_P!^XK^_ROX _P#@QC_YRB_]V3?^_<5_?Y0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5^6>K_\ *;+X>_\ :+/XQ_\ K6GP
M*K]3*_+/5_\ E-E\/?\ M%G\8_\ UK3X%4 ?J91110 4444 ?EIXV_Y37?LU
M?]HO/VV/_6K/V!J_4NORT\;?\IKOV:O^T7G[;'_K5G[ U?J70 4444 %%%%
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M^";_ ,0O^"QW_!Q[XT^-/QF\<?\ !0#XB_L"_L:_"KQ9;^"[7P=^Q]'/\/\
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M@!_ZL;3J_ 7_ (,?/^2\?M^?]DC^"7_J9>.* /\ 18K\'?\ @LE_P6P\-?\
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MPO.HCQ4NJ^!A8"X.MBT/AV],0TW[3(;_ /DV_P"#XS_DI_\ P3J_[$/]I/\
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MT7_90^$_BF?QS\+/AIXVNBIN?&'@#P;XIN"JA5,_B#P[INK3%54!54R7;$*
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M2^/_ (/>+;C3K.ZU/1[+P/\ %.U@UW0[&_N?#7BR^;2/%.D:+_7M_P $:?\
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MU\9^#M!M/A[$/C#H]G8ZU?ZMH&O^(/$D1T2\^U:=;^$[G[7;20WT4L/YZ_\
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MT(2XC\,^/]<U[PMK,-O+I5NWA6]U$^)[#_6#(!!! ((P0>00>H([@U_F5?\
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M_P"#/W_E#QH__9RGQQ_]"\)U^-O_  ?(_P#(Z?\ !-K_ +%?]JK_ -.W[/\
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MIQB.6Z\,^!-%L_@M#J7Q*\:VUM*ES=:-I%S8:+HR26B^+/%/AIM4T<:A]O\
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M'POJKI&JHK76N_";X>ZW?3$* #)<7NH7%Q*Q^9Y97=B68D_ZD?\ P2._8_\
MAM^Q3^P'^SW\+?A^LNIZMXI\#>'OB_\ %GQ]J2%O$OQ3^,7Q1T+2_%/CWQ[X
MGOII;F^OKV_U"\CTK25U"]O[K2?"VD:!H/VZZBTJ.9P#_.'_ ."*?_!7/_@J
M-X+_ ."G'[,GPLUC]HG]H_\ :#\,_'/X_>!_@]\8O@Q\;/B'X^^*]E=^'?&G
MBJS\.>-/$MKIGCS5-<O?!7BOX>Z=<W_C23Q'H\FAW%F/"\MIXJN9_"PUBPE_
MUH*\-T;]F']FKPY\8-8_:%\/?L]? [0OC[XAMKFSU_XX:-\)_ 6F?%[6[2]C
M$-Y:ZO\ $JRT"#QEJ5O>0A8KN&\UJ:.YB58YE=$51[E0 445DZ_KNC^%M"UK
MQ-XAU&UT?P_X=TG4==US5KZ00V6EZ/I%G-J&IZC>2G(BM;*RMY[FXD((2*)V
M/2@#\7/^"TW_  6X^!?_  2!^$^C3:QI$7Q9_:8^*%AJ$WP:^!5EJPTO[58V
M4K65Y\0_B'J\,%Y/X8^'>DZAFSADBM)=:\9:S#<:#X:@6+3_ !-K_A?\H?V:
M_P!A[_@N5_P5E^&WA[]J/]N?_@IM\7_V _AO\5M)M?%_PL_9:_8WT>]^%OB;
M2O OB"&/4?#]YXSU[1/$OA[6]#CU*QD@U73O#?CC6?BOXN?2=0M8_$NJ^&M2
MAN/#]M_(IX7^,>K_ /!;G_@X"^#OC7XOQ76K?#WX_?M>^ ]+T_P-J^)[?0?V
M9? 7B6/4M)^&2VH+6=N#\*_#EU8Z]-:PI;ZEXFU;7_$=Q;R7FJWAE_V $1(U
M5$541%5$1%"JB* %55  55  50    !B@#^ [_@H;_P3N_X+J_\ !(7X?ZS^
MV#^QA_P5:_:M_:N^"_PU@;Q'\4/!/Q)\3>*O%WBOX<^'++RY+WQE?_"WXB^)
M?BO\,_B3X)TF*.6[\9ZS::+HFK>&M(/]IWWAN\\-Z;KOB'2?T*_X(,_\'-'A
M_P#X*$^*]#_9(_;+TCPE\*?VLM2M7A^&WCGPSYFC_#+X_P!QI]L\]SH4.D:A
M=W;^!OBH]E!)?P:##J%YX;\9O#J(\,_\(]J(TOPA=_UNZCIVGZOI]]I.K6-G
MJFE:I9W6G:GINHVT-[I^HZ?>P/;7EC?6=RDMO=V=W;2R6]S;7$<D,\,CQ2HZ
M.RG_ !;/^"M?[+&I?\$RO^"J7[0_P:^%.H:QX,TOX4_%O1?BI\ -=T>^N[/5
MO"W@[Q?;:)\6OA4^AZTDHO3JG@"VUO3O#B:S'*MT-<\+7-SNCN$;: ?[$/[3
MGQG\7? 'X->)OB=X$^ 7Q8_:;\6:1<:)IVA_!WX+1>%G\<>)-1\0:S9:%9S)
M-XP\0^&M&TWP]I5U?PZCXKUN2\NI= \/6^HZW_9=_!I\\0_SR/\ @LU_P</?
M\%N_AY\4=7_9L\1?!D_\$NHM5\/6GB33O#7AV;2O'OQI\0^!]=GU"RT_6K?X
M]2B_\.S6$U[I6H64&O?!_0O!VHZ9K&EZMI%SKDEW97EM#_=/_P $H/VS'_X*
M _\ !/+]EK]J_4!:1^+/B7\.8K3XCV]E%';6D'Q4\":OJGP]^)S6=C&!_9^F
MWOCCPMKNIZ-9,-T.B7VG;7EC9)I/XL?^#X+1;.#X_?L#>(D@B74-5^#_ ,:-
M%NKD(HFFL] \:>#;ZQ@DD W-%;S^)-1DB0DK&]U,R@&1B0#[,_X)<?\ !;2_
M_9*_X(M_ O5?B%>_&;]NS_@H!^T'\:?C[X:_9T_9]'B;QG\5_C;\5M0TWQE/
M:6NL>(M3NV\6^,M-^''AR4&VEOX[34]0U*Y271?"VEW<UOK%WHOYW_MF?!C_
M (/"/VG-$\0_M'_$#2?VAOA;X'M+2[\46'P*_9B^/O@3X4S^%_#<,;WD-CI?
MP7^$_P 7(_B?XPU"PBW+;:;XK'C?XHRRYBEBGF58T_:7_@SW_9)^ GA;_@GS
M%^V!9^!;#4/VBOBE\0OB?X!UGXFZWC5M=T+X?>#/$OV/2O G@B6Z1E\(>&+V
M^-UX@\16>CB"X\3Z]>?:]>N]0@TS0;32/Z^Z /\ ,,_X(._\''_[77P7_:G^
M%O[,O[<OQL\9_'S]FKXR>+]'^&<GC#XS:W>>*_B7\$/&/B;4(=$\,^+X_B-X
M@EN/%FL>"TUVYT_2_'&@^,-8U6TT+099_$7AV32[K1[[3?$'^GG7^+K_ ,%V
M?A9H7P._X+!?M\^"?!]G%HFCQ?'_ %?QWIMCIZ"SM],G^*6D:'\5KJ#3H8!&
MEE:VNI>,KE;"WMECAL[=(8;98XHHU'^QY\$_%%[XX^#/PC\:ZG(9M2\7_#'P
M%XHU"4XS+>^(/"NE:M=R' 49>>[D8X51SP!TH ].HHHH _*W_@J?\#_^"GO[
M1'PMTGX4?\$Z/VCO@7^RY!XIL/$NG_%_XG>/M.\=R_%NWL;I=,M]#T[X/^(?
M"^D>(-,\'&\M)?$2>(O$<FD+XOT^;^P[GP9KF@7D%W>/_D(_MX_LI>/?V'_V
MNOCC^RO\4?&&@>/_ (@?"'Q3::1XJ\9>&)M9N=#\0ZIK?A[1O%KZC97'B&RT
M_6[@R1>((DNIM2LX;B6]2XD(=661_P#= K_&U_X.,/\ E-9^WY_V5#PK_P"J
MD^'E ']FWPI_8)_X.EM1^%WPVU#PE_P6/_9NT3PI?> ?!UYX9T6Z^"_@R>YT
MCP]=>'=.GT72[B>3]E>\>:?3]->VM)I7N[IY)(6=KB<L96_JU_9\\._%OPC\
M!O@KX4^/OC?2_B9\=/#7PH^'N@?&7XC:)80:7HWCWXIZ1X3TG3_'_C+2=-M=
M(\/VVGZ;XF\56^JZS8V5OH6BPVMM>Q0Q:5IZ(MI$G[/7_) ?@=_V1_X9_P#J
M%Z)7L% '^*3\7O\ E-+\4/\ M*%XV_\ 6KM3K^_G_@H-_P %;?V_OVJOB7\0
M?V+/^" _P5U'XU^+?AOJUQX1_:"_;@%IX0_X4W\+_%4 (U'X>?##QG\2[W3/
MA'J?C/3%R=8\2:Y?ZZH2.]L_ WA37+I8/%6G?Y[W[2OA+3?'W_!7'X_^!=9G
MU"UTCQI_P4:^*OA+5;G2;D66JV^F^(_VF=>T>^GTR\:*=;34(K6\EDLKDPS"
M"Y6.4Q2!-A_V=_V>_P!GGX,?LJ?![P/\ _V??A]X?^&'PG^'6CPZ-X6\(^'+
M7R+2VA3,EUJ&H74C2W^M:_K%X\VJ>(/$>L75]KGB#6+J\U;6+^]U"[N+B0 _
MRIOVZ/\ B)/_ ."9_C#PO\9/VM?VCOVX/ ,7B_7S;^&?B;I/[5OB3XE?"G5=
M>C2XU!/"EZO@SXA>)? >D2S6UI>W-C\/_%6C:3!J>EV%]+IN@7>EV-R\/]L'
M_!MC_P %I/&7_!5'X"_$'X=?M$S:*_[6/[-[^'$\9>(=&T^RT*Q^+GP\\4K?
MVWAKXD1^']/BMM-TKQ)9ZKI&HZ#X]T[0;2VT""]D\/:UIUII4'BB/0]+^QO^
M#A/X8>'?BM_P1K_;ST?Q%I=GJ0\+?!N;XGZ)+<P1RS:5XB^%WB#1/'6EZII\
MS*9+.\C;0Y;1Y[=XY);"\OK&5GM;RYAE_AE_X,V?&5_X<_X*S^*O#MO<2)8?
M$#]D;XN^']0M=[>1.=)\:?"GQC9S-%G89[:7PVZ0S%?,CBN;J-&"7$H8 _U-
M*_!W_@LE_P %L/#7_!-T_#O]GGX&?#MOVF/^"@?[0LVF:5\#/V>M*-]=VVG'
MQ)JS>&_#OC#XB6^AR)KDFEZOXA$FE^$O!^CS6.O>.M1LM0M;75?#^F6%_P"(
M++]R_$.O:1X5T#7/$^OWL6FZ%X<TC4M>UK49]WD6&D:/93ZAJ5[-M#-Y5K9V
M\T\FU6;9&< G K_*?_X)N?\ !5?]GW6?^"Y7QK_X*F?\%!G^(6HZ=?Z5\6_%
M?P8TKPGX&U/XFZKX,\5>(+W0/AY\*_#2Z/IY?[#H'PZ^!NH>)/#NEZJSEK35
M-,T6Y1Y-1N#>* ?U/VG_  1K_P""UG[:?A./XD_MX?\ !:OXS_LX?$/Q79C4
MH_V=_P!CS1[_ ,,_##X9+>I]ILO#>N:O\/OB/\+-(\;WVA)+#8:C&=+UY4O;
M.>2V^(WBU98]<F_G0_;JUS_@OM_P;M_'/P+JEY^WK\8OC[\!O'E_>_\ "L/B
M%XY\6>*OBS\'O'<FBB&XU[P)XW^%7Q=UKQPOPU\9G3IXKJZL=%U1+F_TFXDU
M+P3X\O[W1]8ET'^K#_B*_P#^"3/_ $$/VG__ !&SQI_\>K\8_P#@OE_P7"_X
M)P?\%)/^";?Q+_9U^"MK\>-<^-T/CSX3?$#X4P>+O@+XJ\.Z/:Z[X9\<:99^
M)[MM>O#-#I=P/AEKGCNV@D*!KMKDZ<K WN" ?T8?\$._^"TOPV_X*_? 36M8
MN=$TKX8_M.?"$Z3IOQU^$5A?3W6E*FJQS)HGQ)^'LVH22ZE>?#[Q7/9W]NEC
M?SWFM>#=<L[KP[K=YJ5NWA_Q-XG_ '#K_(Y_X->OBG\2O@)_P63_ &;+&TT[
MQ)IGA+XXZ;\2?@C\0[:2RU.QLM3T'Q#X#USQ+X>BO7>!;9TT_P"(WA'P1K$:
MW"L&;3S%$T4LJRI_KC4 %%%% 'YJ?\%3/^"I'[/'_!*']G&Z^._QQFNO$/B'
M7KRZ\-_!SX/>'[RVMO&7Q=\<0VGVLZ/I<UQ'<0Z'X<T:!X+_ ,9^-;ZTN=,\
M+Z;-;(MKJWB'5_#?AS7?YU_V1?"W_!=#_@O5X+'[5/Q6_;=\1_\ !+O]BCQE
MJ&J?\*5^%G[*N@W^A_%?X@^'=/OKG2IO$,?C>+7?#GCVR\/74MO+90>+_$OC
M:_M/$NH:9?ZGX8^%FA^&=2TS5;O^7'_@N[^V)XL_X*C_ /!8GQ5\//#_ (AF
MF^%?PV^+FE_L<? "PCE^TZ/:66E>.8?!/BKQO9PPNEM?3?$'XCSZYXHBU/RX
MKZ[\+'PEHUU-)#H-D8_]:CX8_#CPA\'?AM\/_A+\/M(@T#P'\,/!7A;X>^"]
M#M51+?1_"G@W1+'P[X?TR%8TC01V6E:=:6ZE44'R]VT9Q0!_%?\ MK?\$5O^
M"TW[%?@#Q!^T=_P3P_X*^_MM?M*:KX L;OQ1XF^ GQ,^)'Q#O?&OB'2-*CGO
MM0O?!FF:EXY\:_#[XK>((+=3/'X#U[P1HVH:M#!>0>'[S7]=O=/\-WN'_P $
M0O\ @ZXUSXX_$GP;^R1_P4U_X1+0?&_C34K+PK\,_P!JC0M,L/!7A[7?%M]-
M'::7X6^-GA6R6T\,^%M1U_4)!I^E>//"=IH/A6'4)].TO7_"FBVSWGBH?W2U
M_D:_\'17[#_A[]B__@JI\0M2^'^C0:#\,?VI?"ND_M+^%M)T^W6#2]#\1^+]
M8U[0/BCHMDL82" 2?$;PSX@\70Z;;1PVVD:5XPTG3[6)+2"W% '^M%XX\3GP
M3X*\7^,U\.>*/&#>$?"^O^)QX2\#Z4FN>-?%)T'2KO51X=\(:))=6,>L>*-;
M-I_9N@:4][9IJ&JW-I:-=0"8RI_#[_P6;_X.,_\ @JW^RM9Z#H'PQ_X)Z^+?
MV%/!/Q,75+3X??'G]IW2M!^)/Q!\1-80PW,__"/^%/#>HZS\'O /B[3K:ZM;
MB^\*>,-4^*EXEH[7+V$"-O@_;O\ X-L_V]/$W[?/_!+CX6>*/B1K5SXB^,/P
M#\0:S^S9\4-?OYVGU/Q-J'P^TO0-4\%^*M2EG9[N]U/6_AEXH\%'7]8NI)I=
M;\66GB/4))C-+-%%\$_\'H.FV=Y_P2H^$U]/!&]UI/[;_P *9[*<HIEA-U\&
M_P!H2QN$23&]8YH9_P![&#LD:.%F4M%&5 /S0_X-_P#_ (+:>/?AG^S'_P %
M9_VVO^"E'[3GQ@^.&F?#76_V6D\!>&_&OCC4/$-_J_CSQS8?M#K9?#/X)>"]
M2OH?"GA'4O'5YX?TPWVF>$=)T'0+#2/#\WB778;;0?"]Y>V/YN?MB?MT?\',
MO_!1&VUG]H'P+\'OV^O@3^R]<K<ZSX$\%?LJ_#CXW_#WP79>"29;BSOKOQGX
M+T;1?'?Q@@6RB6YUGQ;JVH:GX;DO(KB]TC2?#.F&'2K/W+_@T"_8 ^!G[7OQ
M5_:1^,_Q_M+WX@Z!^RAXC^ WBCX>?!76_+O/A3K'Q6\9V?Q?@T'XJ>-_#<YD
MLO%7B#X9Z7X8U>S\!V6JVUQIFEW?C#6-6>&6\@LO*_TQ: /\=O\ 8E_X.(O^
M"JO[$'Q'TG5+_P#:/^)?[1GP]L-4C@\:?!+]IWQ?XE^*6CZUI4%P(]1TC2?$
MWC*[U?QW\.-6A19AI]_X4UJQMK'4ECDUC0]>T]+O1[S_ %4/^"?7[=WP3_X*
M0?LK_#G]JSX$7UQ_PB_C6VGT_P 1>%=4EMW\3?#?Q_HPAA\7?#OQ9%;,8XM;
M\/7DT317,:K::YH=[HWB;2O-T;6].GF_BK_X/%/^"6/@/P$O@'_@IM\$O"=C
MX8N?'/C2T^%'[4>C^'M-@L]+UKQ7K6GZGJGP_P#C)>6UHD45KK6KG1]3\%^.
M=59-FNZG-X%O)E76[O6;[5_'?^#*;]JWQ!X5_:G_ &F?V--4U2=_ WQ?^$4?
MQP\,:9<3.]IIWQ)^%/B#0?#6JG2[8MLMKOQ5X(\;SSZW<(FZ\M_A_H<4S#[%
M " ?Z+'Q%^(?@?X2> O&7Q1^)GBG1O!'P\^'OAK6?&/C7QAXBO(]/T/PUX8\
M/6$^IZSK.J7DI"06=A8VTUQ*V&=@FR)))61&_D1\(?M^_P#!57_@OK\5?B5X
M4_X)=>,K+_@GO_P3K^%WB2Y\%>*/VTO&7@R+Q/\ &SXKZRD44TNF_#[0+\HN
MCZF]A=:?K\?AGPQJ7A36O"FBW-C>^-/BMI>J>(](\$OPG_!Z)^VKXC^%G[+_
M .SU^Q5X*UFXTR3]ISQ;XB^('Q9^P3O#/>?#+X-S>'7\/^%=24$!])\5?$+Q
M)IOB JF7>Z^&:02LMM/+%<L_X)4?\' '_!)#]A'_ ()Y_LI?LP2#]H33_%7P
M^^$OAVY^)[^'OV=O%FI:7J7Q@\70GQA\5]2L]:MFB77;&?QYKFNQ:3J[@FZT
M6WTQ8A';100Q@&/^V!_P;R?\%>_ ?@'6_C%^R-_P6U_;2^/_ ,;_  S87&M'
MX;_$;XN_&+X7ZQXXFLXS<S6'@;Q_8_'3Q%I.DZY<K$;70_#GB;3]/\/W<SPV
MMYXOT:U7S#^8_P#P20_X.I?VKOV>?C5H/[.'_!43Q#J_Q<^"EWXH'@'7_BUX
MQT%-+^._[/FM0ZB='N-2\93Z?IUA??$+PKH.J+<1^.M,\4Z;>_$C2K=+O4M)
MU[4Y=%C\&:Q_2O\ \17_ /P29_Z"'[3_ /XC9XT_^/5_G2?\%>_B5\*OVI/^
M"DG[5W[17[+?ACQU)\$?C-X\TCX@>&9]>\ ZSX3UBYUWQ#X'\*7GQ&N]0T&X
MMWFLKB[^)K^,;EI)'9K]95U'<1=@T ?[$_[1/QZUSX.? G5OC-\+/@C\2_VL
M-5$/AEO!WPQ^ DO@_4?$_C?_ (2_4=.TW1=6TW4_$_B7P_X=A\(VW]JVFL^(
M/$L>HWRZ1X72]\00Z?J5K92I7^>K_P %FO\ @X>_X+=_#SXHZO\ LV>(O@R?
M^"746J^'K3Q)IWAKP[-I7CWXT^(? ^NSZA9:?K5O\>I1?^'9K":]TK4+*#7O
M@_H7@[4=,UC2]6TBYUR2[LKRVA_K9_X-J_C9XS^-_P#P1L_9(OOB$^IS>+?A
MGIOCCX(W=SJYNA>RZ#\*O'GB#PUX B=+Q1<QIIOPY@\(Z/&LC.&73A+&RQ2)
M%'_+_P#\'P6BV<'Q^_8&\1)!$NH:K\'_ (T:+=7(11--9Z!XT\&WUC!)(!N:
M*WG\2:C)$A)6-[J9E ,C$@'V9_P2X_X+:7_[)7_!%OX%ZK\0KWXS?MV?\% /
MV@_C3\??#7[.G[/H\3>,_BO\;?BMJ&F^,I[2UUCQ%J=VWBWQEIOPX\.2@VTM
M_'::GJ&I7*2Z+X6TN[FM]8N]%_._]LSX,?\ !X1^TYHGB']H_P"(&D_M#?"W
MP/:6EWXHL/@5^S%\?? GPIG\+^&X8WO(;'2_@O\ "?XN1_$_QAJ%A%N6VTWQ
M6/&_Q1EES%+%/,JQI^TO_!GO^R3\!/"W_!/F+]L"S\"V&H?M%?%+XA?$_P
MZS\3=;QJVNZ%\/O!GB7['I7@3P1+=(R^$/#%[?&Z\0>(K/1Q!<>)]>O/M>O7
M>H0:9H-II']?= '^89_P0=_X./\ ]KKX+_M3_"W]F7]N7XV>,_CY^S5\9/%^
MC_#.3QA\9M;O/%?Q+^"'C'Q-J$.B>&?%\?Q&\02W'BS6/!::[<Z?I?CC0?&&
ML:K::%H,L_B+P[)I=UH]]IOB#_3SK_%U_P""[/PLT+X'?\%@OV^?!/@^SBT3
M1XOC_J_CO3;'3T%G;Z9/\4M(T/XK74&G0P"-+*UM=2\97*V%O;+'#9VZ0PVR
MQQ11J/\ 8\^"?BB]\<?!GX1^-=3D,VI>+_ACX"\4:A*<9EO?$'A72M6NY#@*
M,O/=R,<*HYX Z4 >G4444 ?)G[9'[0_Q5_9L^%=EXP^"_P"R9\8OVR?B+K_B
MBU\(>'/A5\(-4\$>''M;Z\T?6]8C\1>/_&'CK7-+TWP3X!M_[$;2M0\4V^G>
M);BSUK5M"L?[$E74?/A_S??^"N7_  </?\%LM0^+OQ&_9=\>Z5>_\$V9?"TT
M%AXC^$/PE$MC\5X=-UG3;;6-%N=9^/,UU?\ B741J&CZE:WVG^(_A->^ O#N
MN:;=6UQ%9W49$S?ZFM?Y:O\ P>8Z%9Z1_P %9_ FH6T$<4_BG]B_X/Z[J,B*
MJM<WEO\ $WXY^&4GF( +R+I_AVQM@S$L(K>),[44  _HN_92_P""P_C[X ?\
M$B_^">GPN^$'@GXC_P#!07_@J+^T)\$]:UWX?? ^#5?$WQ \5QZ1'\1O&>D2
M?&[]HCQ6]Y?:YX;^&.AM!#:Q:AK^L:5=^*);%M+LM;T#0M-U_P 6^&/Q2_;Y
M_9C_ .#N_P 4^$/$_P"U%\:?B)\==,\-:!8WGBOQ!\)?V3/VD_#OA!?AWX?L
MHS>2&S^#_P  _&^E?\)8GAVVA56NM%;XB^+DMXI]2U#4;X+J>IU_4S_P;)_L
MW_!;X/\ _!)C]F7XJ> O FD:1\3?V@_!U[XT^,/Q!EC:_P#&/CC5-,\8>*?#
MWAZQU/7KUIK^/PUX4T#3++2?"WA:SEMO#^AP+=W5EI\>IZMK%_J']"% '^95
M_P $%?\ @Y1_:S^&O[3GPG_9:_;H^,7B?]H/]G7XU^+="^&NE_$;XJ:I+XD^
M*7P8\:>+-0@T7PGXEG^(VJ/)XB\6>!+S7KS3]+\::=XWU35Y] TFY_X2?P_J
MFGIHNI:'XD_I$_X*4?\ !8S]L3XB_&CQM_P3X_X(:? Z_P#VE_VH/ DK:1^T
M%^T;:Z3H.K_!O]FO6)9+BU'@VU\1^-+S2_A+/\3+6ZMYTU;4?B#K;^#O#=[8
MWOAB+0?&'BJ#Q!8^#/\ .^_X*^_"_P /_ ?_ (*H?MY?#KP%9P^'?#/A;]J;
MXJ7_ (3TO24%C:^&]+U[Q3=^+=)TC1X[8H+*RT&'68=.TJ.$J;6UL[=$(:,&
MO]BS]C']EKX!_L>?L[?#OX*?LX_#O2/AQ\/-)T/3]5>RL5-UK7B/Q!JVGV=Q
MK7C#QMXBN=^K>+_&>O3A9];\2ZW<W6HWK)#;K)#8VEE:6P!_F?\ [?7P,_X.
MC_V-/#UW^UA^U'\??VTK#P1IVHV,NO\ Q(^%/[86L^)_"/P^N]3O(+>SBUWP
MC\(_B.;+X?\ AVYU.ZM],2\'A/2O TFI7MKI OFN]1M+6Y_H8_X-BO\ @OW\
M9/VWO&>M_L)?MM>*+3QK\<=)\'ZCXU^!?QGGL=-T?Q!\3O#_ (62)_%O@#QQ
M:Z3;V.G:KXW\.:*__"4:'XELM/M[SQ%X8TGQ1)XH:?6]&35O$']<_P"T?\-/
M#OQF_9[^.GPB\7:?;:KX7^)_P@^)'@#Q!IUY"D]M>:1XN\'ZQH-_#+%(-C!K
M>_DVDX*.%=65E5A_C]_\&^WBO4?!O_!9K_@GWJ^EW$EM<WGQQC\*2R1,49].
M\=^$/%/@C5[<D9S'=:3XAO;:53P\4SH<!B: /]FNOX:O^"UW_!R;^T#X<_:N
MG_X)I_\ !*F+0X/C!9_$G1_@;X[^/VI:1H7B;59OC5KVOVGA%_A3\(=#\40W
MOA"PN/#GB:_C\*^*_&_B[2]6(\41ZKI?A_2]*@T*'Q5K/]RM?YRWPG_X-AO^
M"CGAG_@M)X;^,WB33/!K?LF^"?VTM,_:9'[1<GQ'\&W-[XM\"^'?B['\7+'0
M(/AY!KD_Q-L?B1KMK9V_AK4!J/A2+POI/B&[NM1B\2ZMHUK#=WP!^W.@_P#!
MO1^VQ\0?A[8:U^TA_P %X_\ @H_=_M!ZGIL%_K-Q\)_BSXQT+X*^%/$=Q;"6
M?3/#?@NX\6V&H:MHVD7CM;PZG9WO@*37(83>C0?#LEU]BM?YFOCI_P %(_\
M@N'_ ,&^_P"W7J7[-OQH_:U\4?M>^!="MO#OCC1-.^/>J:[\2_!WQQ^#?B*X
MNX-'U[1?$'CB\UKXJ_#?4VFT?7?#=]:Z#XT,'AOQEX?U>Q9_&7A^RM[G6O\
M43=TC1Y)'6..-6=W=@J(B@LSNS$*JJH)9B0  22 *_S(/^#R3XX_LX?&[]KW
M]EZ;X'_%_P"%_P 6?%OP^^#'C3P'\6/^%;>,="\:-X-OK3QY_;7ASPUXGO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOV@+:R>#RAJTOPUCT_X82ZFNI^6/.?3H/%$NDG0_MA\J.YN/$/\ 9HWRZJ:
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M_P"%BZ><#U. 3@=@3T%?@-_P8^$?\+Y_;\&>?^%1_!,X[X'C+QQD_AD9^HH
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M>?MH:<DT;7MK^TKX5O;BW# RQ6M_\+M(@LYG3.Y8[B73;Z.-B ':VE"DE&
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M"#W!H _D^_X/9_\ DP#]E3_L\.S_ /5*_%>N'_X,B?\ DTG]M?\ [.+\$_\
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M!X@\6V_BBQMHF.D>'=;\&W<?FV\U[_9_[$_\%O\ _@L!\)_^"2G[,L?B?6M
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MHLME?>.O%VK37WB+0M \1Z1+:W-N?B%>^+(->\J34K7X->%-'U+2]0N_RO\
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M ()D_P#83_;#_P#27]F&OTG_ .#-?_E$EXJ_[/$^,?\ Z@7P:H _K"K^7/\
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M4WGB3QYX[TJ12(;WPEXJ\+7BJ'EDK]AO^"U/_*)'_@HW_P!F>?'7]? FKXH
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MK0+J#SU=7_L2]U76;SPT5#\^2?#EQI1MF'R-;F)H_P!V5K_./_X*^^%_%?\
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M^U=2K'XF^$9 ",$I+\(?AU+&WT>-U8'N&!H _P!>?]GK_D@/P._[(_\ #/\
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M+2]AEUWX:?"7XS?%+6K**16EM+#XR^+O!/A?0GND4GRVN)/@AK30I( XB!D
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M'\;U^S]?C!_P;PD'_@BW_P $_P#!S_Q:#5AQZCXD>. 1^!X/O7[/T ?XOO\
MP7N_Y3'?\%"_^SB/$?\ Z;=(K_9:\#_\B7X0_P"Q7\/_ /IIM*_QI?\ @O:0
M?^"QO_!0O!S_ ,9$>)!QZC3M(!'X'@^]?[+7@?GP5X0Q_P!"OX?_ /33:4 6
M/%O_ "*OB;_L7]9_]-US7^,3_P $*?\ E,'_ ,$[O^SG/ '_ *4W%?[.WBWC
MPKXF)Z?\(_K7_INN:_QB?^"%) _X+!_\$[LG'_&3GP_'/J;F< ?B>![T ?[2
MU?SF_P#!7_\ X.+_ -F__@FAX@F_9Y^%WA>Y_:H_;7U%=/LK3X+^$=1D@\-?
M#S4M?2W'AY?BKXETVUU2_AU_5!>V=]HWPT\+Z;J7C'6;66T_M27P=8:WH>MW
MO[+?ML?&3Q!^SK^QI^UM^T#X3MHKWQ3\#/V9?CQ\8?#5I<0+<V]UX@^&?PM\
M5>--&M[BW<,D]O-J.BVT<\3J4>)G5P5)%?Y3O_!NO?\ ACXS_P#!=S]DKQ=^
MTAK3>-M<\5?$;XP?$J37O'-X=3N?%/QSB^%?Q*\;>#?$.N:EJ+22WGB:7XDP
M:?XDT>[FF^UW?C6VT?RVEN9TBE /[&?A?_P2K_X*I_\ !6+1=.^*W_!:?]L+
MXA_ /X*^+XH-9TG_ ()R_LF7,/PPT>V\/WH6\LM&^-6NPRZVCS8.+OPKXFD^
M*OC2PLKUK6X\>>#->M;G1=/_ )SO^#KO]@[]D?\ 8 \;_L'_  K_ &1?@AX3
M^#7A/5/A1\7-0\1-HO\ :6J^)O&&J6'BOP?:6>J^-/&GB2_UCQ=XMU"T@EGB
MLI]>UJ_&GQ7-S!IR6D$TD1_U%J_SCO\ @]YUW1+S]I3]AKP_::QI5UKVB?!;
MXJWNM:);:A:3ZOI%GK?C7PT-&N]4TV*9KS3[;5SI>I#3)[N&&*_.G7PM7E^R
M7'E@']$?_!IE_P H4_@1_P!E0_:#_P#5M^)*_H2^*?\ R3#XC_\ 8A^+_P#U
M'M1K^>?_ (-+IXY?^"*WP0C1@S6OQ6_:"@F .2DC?%/7;D*?0F&XB?![,#T(
MK^A+XEW-M>?"CX@7EI<075I=?#SQ7<VUU;RQSVUQ;3^&[^6&X@GB9HIH)HF6
M2*6-FCDC971BI!(!_CI_\&_7_*9G_@GS_P!ETM__ %$_$]?[-U?XR'_!OVRK
M_P %F/\ @GR6(4'XZVRY) &YO"OB95'/=F(4#J20!R:_V;Z "O\ /;_X/D?^
M1T_X)M?]BO\ M5?^G;]G^O\ 0DK_ #VO^#Y$C_A-?^";0R,CPM^U22.X!U;]
MG_!QZ'!QZX/I0!^#>L_L&?M4?&7_ ((-_!C]LCX8^/\ QQX[^ '[._Q_^/6F
M?&']G:UD5O#WP[.IZCX=,/[1NB:-IUM#+K;>3J">$?B)J&K-J>I>$M!@T/6-
M):S\*MXVGTW][O\ @U$_X+CQZ%<>%?\ @E?^U9XM2/2-1NY+']C7XC^(+Q43
M3M4OKB2YF_9VUS4KEPIM-7NYIKWX/3W<BO!JDMY\.(+B>/4? .BV/ZZ_\&C&
MB:+XF_X(O#PWXBTG3-?\/:_^T#^T!H>O:%K-C;:GH^LZ-JMMX8L=4TG5M-O8
MI[/4--U&QN)K2^L;N&6VN[6>6">*2*1E/\=__!PO_P $8O$__!*#]IFR^+WP
M,LM=C_8Y^-OBFZUSX+>)=/N+][OX+>/X))==OO@QJ^NI(;VTO-"%O-KOPOUJ
M\N5U'7?"%J\ OM4\0^#?%&HD _UMJ*_F%_X-NO\ @N#IW_!2KX&1?L\_'_Q+
M9P_MO_ ?PU:)XDGOIX;>Y^/OPWT[[-IEA\7M(@)C\_Q7ISR66D_%?3+5&CBU
MNYT[Q=9+;Z;XK;2/#_\ 3U0!_C]?M$?&:#X-_P#!S!\1OCAXYO!9Z%\)_P#@
ML#)XN\1WMXXCCMO O@+]J6V>\DDE?B*WB\&:20DI!6*!4D *J,_[ O7I7^1C
M_P '2?[*'B#]FC_@KS\=?%DNEW%MX!_:BL?#7[0WP_U4PO\ 9-0E\1Z1:Z!\
M2+,W2K]F;4]/^)_A[Q9=7-DK_:K;2=7T"[NHU34[:6?^T'_@W _X+B?##]O;
M]G3X>?LK?&[QSIGAW]M[X(>$--\&76D^)M3@L[S]H3P5X2TV.QT/XE>"Y[V5
M#X@\7PZ#901?$[P];27&M0ZO8W_C."T7P]K!32 #^HVBBOYZO^"Z/_!0G6?A
MQX5^'O\ P34_9#\>3K_P42_;Y\6^$_@M\/K?P/K%U'XM^ 7PV\<ZS:Z;XV^.
MGB2\T"YAUGP0MEX9.K6WA'6/M6DZG9DZSX^TJZ6Q\!:G/& ?T*U_C:_\'&'_
M "FL_;\_[*AX5_\ 52?#RO\ 8XT733H^CZ3I!OM0U0Z5IMCIIU/5KI[[5=1-
MC:Q6OV[4[V3]Y=ZA=^5]HO;I_GN+F265OF<U_CE?\'&<;Q_\%K?V^U=2K'XF
M^$9 ",$I+\(?AU+&WT>-U8'N&!H _P!>?]GK_D@/P._[(_\ #/\ ]0O1*]@K
MQ7]FR]M=2_9T^ 6HV,T=S97_ ,%?A7>V=Q$P>*XM;KP+H4]O-&ZDJ\<L4B2(
MRDAE8$$@YKU?1];T;Q#8KJ>@:OIFN::\]Y:IJ&CW]IJ=B]SI]W-87]NMW92S
MV[3V-];7%E>0B0R6UW!-;S*DT3HH!IT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W
M_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M '
M]_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5^5G[3?P(_;BM/VX_AY^UY^R'X;_92
M\=66C_LH^.?V;_%OA+]I#XP_%[X2W4%UXJ^+W@?XG6OB/P[=?#'X ?&R'4[>
MWB\&)IEQ;ZF^C2"2^>2-95A!?]4Z* /RT_X3'_@MC_T;E_P2T_\ $T_VL_\
MZ >C_A,?^"V/_1N7_!+3_P 33_:S_P#H!Z_4NB@#\M/^$Q_X+8_]&Y?\$M/_
M !-/]K/_ .@'H_X3'_@MC_T;E_P2T_\ $T_VL_\ Z >OU+HH _);X'? O]O_
M ,6?M^^#?VMOVM_"7['GP]\&_#K]D'XY?L[>'_#W[.?QO^-7Q;\3:YXE^+WQ
ME_9Q^),&LZS;_$S]G#X*Z5I.A:3I?P5U>RFFLM8U34);_5=-1--:W-U=6GZT
MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5YO\ &3_DD/Q5_P"R;^.?_48U2O2*:Z)(CQR(LD<BLDD;J'1T<%61U8%6
M5E)#*0002""#0!_DS?\ !/C_ ((6_P#!;F+X4? S_@IW^P@WA+P?XHU&&Y\<
M_!C3]*^+^@>#?C)JGAT7%]I2:I-H?C.RT_X;WGA+QK80W<+>&?%WC![3Q5X8
MO_LVN^'YM)U7[/<?TF>"/^#G[]K?]C+3=/\  ?\ P6/_ ."6G[1?PJ\6Z0L6
MG7?QH^#_ (4ETGPIXYE@"6S:AI7A3XCW>A^!;NXF:-Y[O5/!OQMUCP]?WTLT
M6F:5H=K"EJO]HME8V6F6=MI^G6=KI]A9PQVUG8V5O%:6=K;Q*$B@MK:!(X8(
M8T 6.*)$1% 55 &*GDCCFC>*5$EBE1HY(Y%5XY(W4JZ.C JZ.I*LK JRD@@@
MT ?QB?%#_@]1_8Q;1'T[]F?]D#]K7XM?%#44-MX<\,?$6S^&/PT\/WNJSQXM
M()-4\$>/OC3XENBDQS-:6'A"26X"-%;W"^8)T_)'X5_\$F/^"M'_  </_MDV
MW[9?_!2'0?%/[*?[.<PTK3H#XE\-ZCX&\06'PITB]N-1TWX4?LW?"3Q:;OQ1
MI]E?'4;R\/Q)\>V:Z!/>ZWJOC1[_ ,?:T)/#M_\ Z1>D^$?"F@W,UYH?ACP]
MHMW< K<76DZ+ING7,ZL066:>SMH9902 2'9@2 3R!70T >7?!/X+_#+]G3X1
M_#OX%_!GPEIO@7X6?"KPGI'@KP-X4TI9/LFD:#HMLEM:QO/.\MW?W]RRR7NK
M:MJ$]SJFLZK<WNK:I=W>HWES<R_RS?\ !T__ ,$8OC'_ ,%!_A]\*?VJOV4O
M#$OCS]H']GC0-=\&>+_A7IY@3Q+\4?@]JFHMXCLAX*^T211ZEXN^'GB*;7=1
ML/":O'=^*])\6Z[%H\EQXATO1M"U[^NJB@#_ !__ /@F!_P4%_X+(?\ !*+Q
MSXP^#/[-'P(^)7BV+QWKR7?B?]E3XQ?L\_%[QCI5QX\B@@T=?$.E^"?#C^#?
MB/X:\9O96UKI.HOX<UO2EUZWL=*MO$FG:P=$T0:=_8/\%O\ @FQ_P5._X+&:
M+8_%3_@N/\5[_P"!W[/3VYUKX;_\$X_@;#=?#31=:UXP&?0?%O[0*:5KFK>)
MH]/T:\^R:KI'@7Q/XV\4^/K6]62.[U/X:RVVH:/KW]?-% '^*9\+_P!D[_@I
M]^Q/^WUX+\-?"C]FWXZ67[87[/\ \7K#4O ^D>'_ (1>*?&<&I>(O"^M%+#6
M],ACT*ZT7Q;\.?$-O&T_]O+)+X4UWPCJ$E\^H#2KE[E?]1'_ ()4_LA_MJ>%
M=4\9?MO_ /!3KXLGQ_\ MO\ QT\$Z-X&B^%_A.ZL[+X.?LL_!FPU&#Q%:_"/
MP-X?\/SR>&+OQ7KFOP66O_$OQ79RZLM[JVF:7I>GZ]KBZ=J?BCQ1^T5% '\-
M?_!QQ^V!^U#_ ,%"/V6="_8V_8]_X)>_\%1M>T_4?BOH'CSXI_$SQQ^PE^T!
MX2\/_P!C> X=7_L+POX.T\^$-0UG6KK5_$=]9:UJ&M7UEI.G:=I^A6MM8+K4
MNN3S:)^2G_!O-J?_  4+_P""2/[5OQ!\;_&S_@E%_P %+O%_P/\ CA\-H?A[
MXYE^'W[%_P >-0\9>$=6T;7[3Q#X2\7Z;HNL>#-%T_Q!I]E*-7TC7-(_M;3K
MX6&N-K&FS7MYI$>AZQ_I_P!% 'AW[.WQVTO]H_X7:3\5-'^&WQQ^$UEJU_JV
MGKX*_:)^$/C'X'?%'3Y='O9+&6XU;X?>.[#3O$%A87KQFXTF_EMOLFJV31WE
ME+-;R*Y_F,_X.*?^#=:\_P""BMY+^V+^QU#H&B_MB:+H%EI'Q ^'^KWMEX>\
M/?M&^'O#]DEGX?DC\07CP:7X>^+'A[3((- TC5]?GMM \3Z!;:1H.O:OH*:#
MINI'^N2B@#_#(UCPK^W9_P $VOC.MUJFD_M+?L6_'+P[+=:?::S"OQ!^"WC$
MP"1#<II'B&Q?0YM<\/ZB(8Y1/I5_J/A_7+'RIXI;ZQEC=_U,^ OQC_X.(_\
M@KK):_ #X4_'3]M3XR^ ?$C1Z#XOUW_A,_%7@;X*Z;HEPWV>_;XM?$S34\/^
M&)M$2W,TUWHWB+5]6U+71;R6NE:'KFJ_9[&7_7CNK.TOH6MKZUMKRW<@O;W4
M$5Q"Y4Y4M%,KQL0>1E3@\BI8XXXHTBB1(HHT6...-52.-$ 5$1% 5450%55
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M316UM;127%Q<7$B0P000HTDTTTTC+'%%%&K/)([*B(K,S!030!_"Y_P>,?\
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M4U*:RT'3?B7>VT4:^,?#FL7FEZ7XZE@_X2.PU&V\<2ZI:^-?[::* /\ -O\
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M-/'.H>&]*N/AH#IMO9:I\2[WQ+H\7A+0&AU/Q#;^(AI4LFG:1_3)10 4444
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M''= 7UE\/_ EI=W>C>"],N1#+(+G6?$U]9V>M^*-8A'ZY444 %%%% 'X*_\
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M^Q-'T_7AKGVB\U'3M-_H,_;._;ZTO]C:72M.?]DO]N_]I[7==\-7WB+2=/\
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MZ1^T#X(_X1WP1\(O@+^SWXU^)_QN\'?$K6O!&N>-OAEXTU[P=I&G3:S\+9O
M'BO0M*?5O%'B*VAM/#'B=M.\-ZQ:7T^K_P!BW_[ 44 ?XM'[/W[#G_!:O]EK
MXS?#S]H'X#?L%?\ !17X=_%KX6^(K7Q-X-\6:-^QU^T.+BPO[=9(;BUO+6?X
M;2V6K:)K&GSW>C>(= U2WN]'\0:%?ZAHNKV=YIM]=6TO^E!_P3\_X++_ !P^
M/F@?";X?_M@?\$M/^"DW[,W[07BC7_"?@/Q3XBC_ &*OCM>_LUMKFOZG8:"/
M'9^(>J^'K74/AOX%6ZNCKGB<^/K%-.^'^CBY>[\8>([#3KC6G_?>B@#\@_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?Y M?Z
M_7_!T=_R@H_;F_[MF_\ 6P_V?:_R!: /[_/^#&/_ )RB_P#=DW_OW%?W^5_
M'_P8Q_\ .47_ +LF_P#?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M']D7]E#X)ZA%JWP:_9B_9Y^$FJPDF'4_AC\%OAMX"U"(D8)BO?"OAK2KF,D
M E) 2!7T-0!\S?L??LB_ O\ 86_9Y^'7[,7[.GA-/"7PP^&^EM9Z?%-*EYKO
MB'6+R5KSQ!XQ\7ZNL-N^N>+O%.JRW&JZ[JCPP1/<SBTTZST[2+33]-L_IFBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y
MM?Z_7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]
M_E?P!_\ !C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^
M0+7^OU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5
M_?Y7\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA_L^U
M_D"U_K]?\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=DW_OW
M%?W^5_ '_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/
MM?Y M?Z_7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[
M]Q7]_E?P!_\ !C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^
MS[7^0+7^OU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?
M^_<5_?Y7\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA
M_L^U_D"U_K]?\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=D
MW_OW%?W^5_ '_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K
M8?[/M?Y M?Z_7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W
M9-_[]Q7]_E?P!_\ !C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_
MZV'^S[7^0+7^OU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_
M]V3?^_<5_?Y7\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "OBW]I/\ X*$_LF_LD>.O"OPS^.OQ!\4Z#X^\:^$]3\=>
M&_"O@[X)_';XPZM>^$-&UBT\/ZGX@N(/@U\-/'ZZ3IUIK5]9:<\NL/8%[FZM
MTB5Q*A/VE7Y9ZO\ \ILOA[_VBS^,?_K6GP*H /\ A\[_ ,$^?^B@_'3_ ,0=
M_;J_^AMH_P"'SO\ P3Y_Z*#\=/\ Q!W]NK_Z&VOU,HH _+/_ (?._P#!/G_H
MH/QT_P#$'?VZO_H;:/\ A\[_ ,$^?^B@_'3_ ,0=_;J_^AMK]3** /A?]GC_
M (*2?L=_M3_%6Y^"'P7^(OC'5_BG;?#_ %WXIGPAXT^ G[0WP>O+GP!X8\1>
M$O">O^(]-O?C)\*O .DZM;:5XA\=^$M,N[72]0O-0276[:46;6T=S-!]T5^6
MGC;_ )37?LU?]HO/VV/_ %JS]@:OU+H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *_*[_@H%_P %H?\ @GA_P32C
M?2?VEOCG8#XGO91W^G? OX;63?$'XRZA;W$:SV<UWX3TF>.T\'V6H0%IM+U?
MXB:SX.T/5%CD33]3N9E\H_B)_P '(_\ P<,ZA^PG'J7[$'[%_B"P;]K?Q%H5
MM<_%?XIP+9ZI#^SCX8\0V*W.E:3HEK,+BSF^,OB;2KFWUBR;4H);;P+X:O=-
MUUK*\UG7M$FT;\WO^#:G_@A+X<_:STZ3_@J;_P %%]%U'XT:9XX\6:UK/P'^
M&GQ5N+WQ3:_%'6+'6;J'Q-\>OC&FORWEWXZT^^\36^H:=X0\/^)I+O3O$MU8
M:SXL\266M:3=^&7N@#](M%_X.A_VH/VB8YM;_8*_X(;?MG?M*?#IYI8[#XF7
M]_XGTC195BE>(I=+\.?@I\6/"4%V70JULGQ(E>-XYD4S>4[+S7B'_@ZI_:5_
M9NN[*Y_;Y_X(C?M:_LS^"+F[@MI/'KZYXLCM93.P01Z/8?%#X&_"[PQK%R7(
M2**'XC1"65C S12(2W]DNGZ?8:3866E:58V>F:9IMI;6&G:;I]M#96&GV-G"
MEO:65E9VR1V]K:6MO''!;6T$<<,$*)%$BHJJ*>O^']!\5Z)JWAGQ3HFD>)/#
M>O:?=:3KGA_7]-L]8T36=+OH7M[W3=6TK48;FPU'3[R!W@NK.\MYK:XA=XIH
MW1BI /S$_P"">W_!:#_@GO\ \%-;<:;^S1\:K9?B?!82ZEJWP(^)=DO@'XSZ
M7:6\0GO;FW\*7]W=67B_3]-A9'U76_AYK?C'0=+,D<>H:K;3.L9_5*O\WK_@
MY,_X(<Z7_P $]M7\.?\ !3G_ ()VVVN_![X8V'CW0F^*G@?X<ZEJ?A]OV=?B
M-J>JPKX(^*OPHU32KFWU'PCX&\0>)9+70KC1+&[MH? 7C2_\/1>%&C\.^([;
M1?"'[9_\&WG_  <"7'_!1/0D_8^_:VUC3+/]L_P#X;GU3PCXU$-GI%C^TIX&
MT"V5M5U5=/MDM]/LOBUX4LT.H>,-$TJ"WL_$F@I<^,]!TZVM]*\56>C ']:5
M%%-DD2)'EE=(XXT:2221@B1H@+.[NQ"JBJ"S,Q 4 DD 4 .KPS]I#]I;X&_L
MB_"#Q1\>OVC?B'I7PN^$O@W^S4\0^+]7M-8U&&UN=9U*VT?1M/M-*\/Z=J^N
MZOJNL:M>V>F:5I.CZ7?ZEJ-_=06EG:S3RHA_-S_@DE_P4WO/^"F?BO\ X*!^
M*M!'AN7X'? ;]K&Y^"G[/6K:%9S1WGBGX<Z!X)T,R^-=8U*6^N4U;_A-_$4>
MK>+=#DBM=-_L_P .ZUI>E36SW%G+<2_LA/;V]TBQW,$-Q&LUO<+'/$DJ+<6E
MQ%=VDZI(K*)K6ZAAN;>4 /#<0Q31LLD:, #^%W_@H'_P><>$/A_J'B'X;?L%
M?LR^(/%?BG3VELC\7/VH;'5? _AFQN#&'@O=&^"^B7UIXZUVRNK>>&[LKGQ=
MXK^'-_ 53[7X8NX)A7[U?\&^'[<W[07_  40_P""='AW]I+]IG6_#^O_ !1U
M7XN_%7PG<W_ACPQIGA'25T/PMJMC;:-:PZ/I*+:J]M!<2))<MON+CY6GDD<;
MC_)]_P 'NGPY\,Z+^U)^Q-\4M.T>QL_%'C_X'_$CPEXEU>WMXX;O6;'X<>-M
M%O\ PZNH2QJK7<NFK\0=6@MYIB\R6LL5MO\ (@@CC_H!_P"#0W_E#;X+_P"S
M@/CM_P"GS2J /Z?J*** "BBB@ HHHH **** "BBB@ HHHH **** "O$OVBOV
MD/@=^R7\(/&'QZ_:,^)7AKX3_";P+8B^\1>+_%%T\-K$TC>79:7IEC;17.JZ
M_P"(=7N2ECH7AO0;'4M>UW498=/TC3KR\FCA;KOBM\4_A_\  _X:>//C%\5_
M%.E^"/AI\,?">N^./'7BW6I6BTSP_P"&/#>GSZIJ^IW)C26>46]G;2-%:VL,
M][>SF*TLK>XNYX8)/X:/V-M=^(7_  =#_P#!3WQ3^T)\?]&U?2O^"5W[ ^O6
M&I?"3]G+5W4^'?B+\0M6GNQX!@^)&F*SZ5XH\2^)-/TB_P#''Q6C+:K8^'O#
M$/AWX2VXGT'Q=?ZYJX!_21^PW^VM^V?_ ,%"?B7X=^/G@?\ 9]T?]F;_ ()I
MI8Z_<>#/$/QYMM5D_:K_ &KUOM&O;7P=XY\$^!-*O(_#7P8^#@U&[M?$5MJ?
MBBY\3>)O'-AIVDW'AUK?0M=O9K']CJAM[>WL[>"TM((;6UM88K>VMK>)(+>W
MMX$6*&""&)5CAAAC58XHHU5(T5410H $U !1110 4444 ?GO^WK_ ,%0?V/?
M^";WA_P]J?[3/CK7['Q/XWT[Q!J/PX^%W@#P1XF^(7Q,^(L/A9;)M?/AGP_X
M?L)K*VM=*_M&Q6_UOQ3J_AOPW8O=VT5[K5O)<0))_$'^VW_P>D_M'^.=1N_#
MG[!7P#\(? KPA#=@0_$CXWQVWQ.^*6LVD4HDBFMO!VF75I\.O!#7*?Z/?Z=>
M7/Q08QAI+'6[.9U:'_1^:WMVN(KMH(6NH89[>&Y:)#<0V]T]O)<P13%3)'#<
M26EI)/$C!)7M;=Y%9H8RO^+5_P %SOA[X:^%W_!7?_@H#X/\(Z18Z#X?A_:*
M\6^(;/2-,MX[/3K&;QO#I_C?48K*SA5(+2U;4_$5Y)!:6\<=M;1NL%O%%!''
M&H!_LM?"7Q#J?B[X5?#/Q7K4D<VL^)_A]X,\0ZM-#"EO#+J>M>'--U*_DBMX
MP(X(WNKF5DAC 2)2$4!5%>@UY'^S_P#\D'^"?_9(_AO_ .H;HM>N4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'AG[3_P ;]/\ V9OV:_V@_P!H
M_5M!O_%.E_ 'X)?%3XT:CX8TN46^I>(K+X7^!M=\;76AV-RT-Q':W6K0Z(]A
M!=RP2PVLDZW$T;11N*_@6_X)M_\ !V3^WI\=?^"BGP,^#W[0W@?X,^(/@1^T
MQ\;?!/P7MO!?P]\$ZEX=\1?"N[^*GBS3_!O@_7?"OB>77M5U77[?P[K>M:5<
M>);+Q9'KTVMZ'#JB:4^C:E)9SV_^B5K.C:1XCT?5O#WB#2].US0=>TV^T;6]
M%U>RM]1TG6-(U2UEL=2TO4]/O(YK2_T[4+*>:TO;*ZBEM[JVFE@GC>)V4_BY
M^R]_P;R_\$K/V0/VFX/VL?@M\ ]2L?B=H>IW^M_#[3_%'C[Q9XP\#?"S6=12
M>*75O ?A77M0NX+74;.&ZN(]#O/$%SXAG\-,\=UX<?2KVUL[JW /VUHHHH ^
M%O\ @H/_ ,%%OV7_ /@F9\!-1^/_ .U!XQET71&N9-&\$^"M @@U;XB?%+Q=
M]EDNK?PCX \.2W=DNI:D\,9GU#4;^\TSP[X?LO\ B8^(M9TJQVSM^!?C?]MG
M_@YY_:J^%47[0G[%W[!7[-7[.7P9\2:(GB_X8>!?C/XVTCQA^U#XX\(WUJU[
MHFLW6G>)O%W@[P/X?EUW36MM0L?#/B+PKX7UN%YXXUN]3M)K2YN/Y??^"R'[
M6&K?\%)/^#A#P/\  WQ!J,FM? ;X*_M<_"?]B_X?^"YIC<:#'9Z?\8?#'@?X
MT:P;-6-A>7_COXA_\)-]KU:. 7&H>%--\'Z-<SW=KH%A(/\ 5=55151%5$10
MJ(H"JJJ %55  55        &* /\YO\ 9=_X/%?VS/@C\9;WX4?\%*OV:?!_
MBGP]X:\57W@_XC7/PS\*:W\(OCY\,]9TG49=+\11:KX*\4>(+_P=XFU'P]>6
ML]K<>#;FR^'&HK=1W*7/B='CCMJ_T#O@3\<?A;^TM\'?AQ\?/@GXML/'7PI^
M+'A32_&?@;Q5IRSQ0:KHFK0^9%Y]G=Q6]_IFIV,RSZ=K.C:G;6FJZ)J]G?:1
MJMI::C97-M%_-'_P6]_X-E/!G_!3SXRZ5^U'^S[\4_"W[._Q_P!6LM-T'XQQ
M>)O"NH:SX$^+-CI$$.GZ)XQO'\/W$&K:'\0=#T6"'0KN]6RU:P\6:-I^@VEV
MNAWFCS:IJO[L?\$X?V*/#7_!.O\ 8G^ ?[&OA3Q?JOC_ $SX+>&]:LKSQKK-
MHNFW7B?Q-XQ\8^)/B)XTUF#2$N[]=#TF]\8>+M=FT+0O[0U)]%T5M/TN;4]3
MGM9+^Y /MRBBB@ KXT_;@U_]MKP9\)],\>_L)^#?A#\6/B;X&\50>(O&/P.^
M+NIZKX6A^-7PTM]$UN+7/ ?P]^(.G7"V7P^^*%QJDVB:EX0\0^*+'4_",D^G
MW.E>(+6.UU 75O\ 9=% 'Y@?\$ZO^"L7[-7_  47LO&'A/P?%XH^#/[3?PBN
M;O1_CU^R-\:+%/"OQQ^$VOZ1>+I&NBYT&Y,3>)_"UAK9_LU?%>B1-%:SSV%E
MXHTWPMKMZFAI^G]?R6_\'(7_  3N^(7A_2=#_P""SO[!&J:I\)?VVOV-8+7Q
M9\4M<\ P_8]4^*OP5T&*.UU77]>LX(I+#Q'JWPNT#[2WB*WUZUN-.\7_  5;
MQ7X5\4C6=-\/>%M#7]2_^"*7_!6CX>?\%;?V3-/^*UE;:1X0^/7PYGT_P9^T
M?\*M/NWDC\*>-9+22;3O%/AV"[EEU)OAY\1+2TN]:\(7-V]R]A<VNO\ A"YU
M/5=4\)ZEJ-R ?L/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!^ /_  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04
M?MS?]VS?^MA_L^U_D"T ?W^?\&,?_.47_NR;_P!^XK^_ROX _P#@QC_YRB_]
MV3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^6>K_\ *;+X
M>_\ :+/XQ_\ K6GP*K]3*_+/5_\ E-E\/?\ M%G\8_\ UK3X%4 ?J91110 4
M444 ?EIXV_Y37?LU?]HO/VV/_6K/V!J_4NORT\;?\IKOV:O^T7G[;'_K5G[
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MK_4;.+7/ 7BWQ+?>,]6\/3ZAI%[I^L6UI<6/Q0O].1[/4+6[MK-DAM)X(HH
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M?L__ +16F>'9I'?RXVDOI?A8UQIUNY(8W>KV>G6MNAWW<UNJN5^7_P#@C?\
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M6GR:AHUW=PVFK6!E2+4]'O3;ZII=P3;:A9VUPK1+ZS7^,A_P2]_X*1_M'_\
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M;2_$^GV^I>'K:"VOUCU.]U[6H+J"+2?#%A977B+4[Z5--L-,N;]EMS_BJ_\
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MT'B7Q1IVIQ6>OSZ,GA;7OV*M_P#@R8\;>-/".K^,/B__ ,%)9=2_:)\5/?\
MB3Q+?VWP/U;QKX0NO&.J2W%_JK:OXT\3?%C1O''C!]5U.9Y[[QA?:+HFJ3RW
M%Q?7'AZZN,Q2@']6G[''_!9__@F1^WMXGA\!_LQ?M9^ _&/Q&N8Y7LOAIXGT
MWQ=\*_B#JYMXFGNH_#?A+XJ>'?!NK>+WL[9'NKP^$+?78[6UCEN;AXX8I73]
M0J_P_?V[OV$/VJ/^"5'[4US\#?CE;2^$/B/X3?2/'GPU^)7@'6-33P]XR\.K
MJ4[^%OB;\,?%<<.D:O'!'JVDW,44KV^D^(O#?B'2;S3M1L].U33W1?\ 3&_X
M-J?^"MWB+_@IU^QSK'A;XVZS'JW[57[+=]X>\#_%?6W$4-W\2O!^OV5])\-?
MBS=6\2QQKKFOP:%K_A[QFMLAAF\4>&+OQ#Y>GV_BFPTRU /Z/*_QI?\ @X=_
MY31_\% /^RP:7^OPZ\$YK_9:K_&E_P"#AW_E-'_P4 _[+!I?_JN?!% '^O\
M?L__ /)!_@G_ -DC^&__ *ANBUZY7D?[/_\ R0?X)_\ 9(_AO_ZANBU\A_\
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MOX@\-P:MJFJ>(;'5]5O #_7BHK\%_P#@WA_X*I:U_P %2_V%K3Q5\4[BQ?\
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MAVVT7[3KE[KEQ=)81::DM_+<+;JT@_UJO^'P_P#P2@_Z21_L0?\ B3GP?_\
MFMK_ "*?V?O@]\-O&'_!5+X)? #Q)X7M]4^$'BG_ (*!_#;X/:_X+DOM5@M-
M1^&VM_M&:+X*U3PO)J5K?P:Y#;W?ABZGTE[ZVU.'58XI#/#?QW86X'^I5_Q#
M6_\ !$/_ *,+\&?^'3_:!_\ GM4 ?=OQ(_X*7_\ !/#X.ZSI?ASXL?MP_LI?
M#;7]<\*^&_'.C:+XX^//PT\,:IJG@SQCIL6L>$_%6GV.L>([2XN_#_B329H=
M2T/5X(WL=4L98[JSGFA=7/GW_#X?_@E!_P!)(_V(/_$G/@__ /-;7G'_  4
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M49&92 ?G;_P^'_X)0?\ 22/]B#_Q)SX/_P#S6U]9_ ?]I3]GO]J3PCJ7C_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"JI\-5_:[7\47_  9'?\F7_MD?]G/Z#_ZJGPU7]KM '^>/_P 'QG_)3_\
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MB?PAJ7B8S:EI>CZ;I_B.W\'^-/"-AXBCMY;S5K2ZU34=6O[_ .N/VY_^"O\
M_P $\O\ @G/:SV7[3/[0_A71/B EI'/IGP3\$B7X@_&C5?/B633XD^'GA47V
MJ>'K74T(73=;\:-X7\,7#*R#6T*-C^3?_@N)_P '$?[2/Q7_ &H[O_@EM_P2
MFUS4/"VM7GQ0TO\ 9Y\:_'SPA=QVWQ%^(OQD\0>);;P-+\,O@MX@+@>!O#ND
M>++Y/#6I?$?3)+?Q3KOB&WN7\(ZOH'AC3X]9\8_T)?\ !*/_ (($?LE_\$Z/
M#V@_$OQWH&D?M+?MNZPL7B/XD?M,_$ZR/BW4M+\;Z@1?:Q'\(+/Q*EY_PA.G
M6NHS7<<7BY(A\1_$XFNKWQ'XA%K=VV@:2 ?R(_\ !RM_P47_ &A_^"@O[-_[
M.?BO4O\ @GK\</V3OV2M(^->KW_PB^,W[1M[I_AGXD?&3Q)J?@355CMM/^$B
MP1WOAWPQ_P (ZESJZ>(+#5_&F@:I-%:1VOB.)VCMKG]B_P#@R4=C^PO^US&2
M=B_M8VSJO8-)\'_ *N?JPC0'_=%9O_![C_R9?^QO_P!G/Z]_ZJGQ+6A_P9)_
M\F-?M=_]G7VG_JH/ E ']%?_  5\_9'\4_MU?\$U?VN_V6O GD/X^^)?PQ2[
M^']G=7$-G;:OX_\ AYXG\/?%'P/H%Q?7+QVVGP>(O%7@K2-"FU&Y=;;3X]1:
M\N#Y,#U_E&?\$Z/^"G7[:_\ P18_:-\;WWPUL)M)EFU=/!7[1/[-?Q<T?6+#
MP]XKN?!VHW]G)H_BK0W?3=?\'^/O"%Y<:Q;Z'XDT]K/6O#]W=:A8:A;:MH.H
M:SH&I_[.WBCQ7X6\$:'>>)O&GB70/"'AO3WLH[_Q!XHUG3M T.QDU*_M=*TZ
M.\U;5;FTL+9[_4[VRTZR2:X1KJ_N[6S@$EQ<11O^//\ P5#_ ."#O[!__!4^
MUN_%/Q6\'WGPN_:%BTU+'1?VD/A-'IVB^/Y%L[98-+L/'VGW%K-X?^)^@V2P
MVMM':>*;-_$&GZ5 VF>%O%7AB*>64@'S1_P3B_X.?/\ @G%^WC_8'@?QWXL/
M['OQ^U7[+9GX:_'36=-L_!6O:S/L3['\/OC2(].\&Z\LUS+!9:9IWBV'X?\
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M\#_^"-?QMTKP_?S:9JOQ[\??"OX"B^MI6BN$T;Q'XAD\:>+K"-E9=T.O>#/
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M[LR6WAOP5H-CX>TG[5)&D8N;^6SL(I]0O&02WM]+<7<Y::>1CZE0 5_F?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,'1W_*"
MC]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8
MQ_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7Y9ZO_ ,ILOA[_ -HL_C'_ .M:? JOU,KX
MH_:3_P"">?[*G[6GQ \*?%7XU>$OB/=_$7P5X.U3X?>'?%WPS_:._:4^ &L6
MW@K6M;L_$>J>'+Z?X _%WX8IKFFW>N:=8:F\6NQZDR75G;/"\8AC50#[7HK\
MM/\ AS5^PE_T#/VL_P#Q9-_P4D_^BSH_X<U?L)?] S]K/_Q9-_P4D_\ HLZ
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M;/'=:=K'[._P4U33[F)@\5Q9:A\-?#-W:SQNI*O'-!-'(C*2&5@0<&OX\/\
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M.B1?E?\ #G_@RD_X*):QXIM;/XJ?M*?L>^ _!@NDCU+Q#X,USXP?$GQ(EJ7
MDNM'\):I\)_AOIVI.D>YDM]2\9>'S(^R,R1JS21@'ZI_M_\ _!:F7_@M#X_\
M+_\ !'C_ ()"KXSUW2/VE]63PM^TI^UKJ_A37?"WA_PS^S_!<0R?$U_"/AO7
M+?2O%L'A*3PZ;B+QOXF\7Z=X5GUG3'_X5QX7T35]2\=66I6W]G_PB^%W@_X'
M_"CX9?!?X>:>=(\ _"+X?>#?ACX(TIG$K:=X2\!^'=.\+>'+%Y0J>:]KI&E6
M<+R[%,CH7*@L17YI?\$GO^",_P"RA_P2/^&NK^'O@M::EX[^+WCJULH?BQ^T
M#XXMK$>.O&R63BY@T#2;2R5K#P1X!L;XM>:=X/T>6X,LZVUYXFUKQ/J]E:ZI
M']*_MF_!3]M?XT:1X5TO]CO]M_PO^Q7/9VGBFV\;Z]K/[*7A?]IO7/$LNJ#0
MU\,7?AL^+_B?X#T7P9/X76S\0&Y%UHGBZ+7GURS=TTS^Q NH@'^4U_P<=WMM
M?_\ !;']OF>TFCGBC^(W@>R=XG5U6YTWX,?#33KV$LI($EO>6L]O,A^:.6)X
MW 92!_K5_L8>*-&\;_L??LI>,_#E[#J.@>*_V;O@=XCT6_MY$E@O-+UKX9>&
M-1L;B.1"R,LMM<1N"">N.H-?QC>/_P#@RA\:_%7QSXP^)GQ(_P""MFM>-OB!
MX_\ $NM>,?&OC#Q'^QI-J>O>)_%'B+4+C5=<UW6-0N/VNGFO-1U/4;JXN[J>
M1B7EE8@ 8 _;;_@F]_P2+_X*)?\ !.71/AI\(_#?_!8*W^+_ .RWX#\6Z/J=
MS\!?B!^POH$]P/!:Z]#JGBWP+X ^*-[^TKKWB_X<VGB.Q.H66F21Q^)/#WA&
M_OY-9TKPA-,UW:WP!_0Q1110 4444 ?XF?\ P55_9VUW]A3_ (*B?M:?!RRL
M6T&'X;?M#^(?&OPR01LB0_#SQCJ\/Q3^$-U"5")(8_ _B3PR+AH"(H[V&Y@4
MHT+(G^TG\,/'ND?%3X:_#SXG^'W630?B/X&\)>/=$D2194?2/&&@:?XATUUE
M7"RJUEJ,)611M<$,.#7\,_\ P>9_\$W-2\1:#\)_^"FOPQ\/-=-X(T_3?@9^
MTS_9UN3+;^&+[6)9?@Y\1K](46,VVF^(=:U;X=>(-5N7DNW;Q#\-M.B7[#I\
MKV_[\?\ !MM^U9I_[5O_  1__94OVU2._P#%_P !O#EQ^R_X]M%F6:?2-3^"
MGV?0/!EK=/G>9]0^$<_PX\0,95#_ /$YV%I2AFD /W9K^2G_ (/-_P#E$[\.
M?^SV/A#_ .JH^/E?UK5_)3_P>;_\HG?AS_V>Q\(?_54?'R@#\=?^#(S]H#P'
MX1^.7[<'[-WB'7;'3/'7QK\"_!;XC?#C2KVXBMI/$,'P3O\ XJ:?XZT[2?.9
M!?ZO;:=\4]#UO^S+;S;UM$T?7-52$V.D:C/;_P"C!7^4]_P;G?\ !);0_P#@
MI;X'_;!\=^#_ (^?$K]E;]J[]E;QO^S7XJ_9K_:!^'%U>SR>#M7\66/QO?Q#
MI_B#P[9ZOH%SJ>F:O)X1T!X]1T;7M"U_1KBR$EO?7^DW6L>'M9_K6'P$_P"#
ML[PWHG_"O]%_;7_X)?\ CFR2)].L/C9XP\!^/='^)Z6D<?D0:OJOAK1_@!<?
M#X:V(]MR+=/#^OV4MT@%[<3H\K2 'SC_ ,'CO[=?A#X3?L-^%/V&-$UVSNOB
MU^U5XT\*>*?%7AJ"XWWNA? SX5>(X?%[^(-4B@<O9?\ "1_%/P_X,TCPVEZB
M0:U;Z%XU>U:23P_<*OLW_!I[_P $PO%'[$O[&'B;]I+XS>&[GPW\<OVSY_"_
MBJT\.:O:/:ZYX(^!/ABUU"7X9:5JEK<QBXTK6_&=SX@UWQ[K%BK1R?V)J?@>
MQU>UM=:T.[M;>W^QG_P;/Z'IW[2TO[=?_!5C]I+6/^"B/[5=UK5AXHMM&UW1
MIM.^">A>(-*$2Z-/J>E:O+/?_$*P\+K:VD?@[PU+I'@3X;^'K&&+2O\ A7-_
M:66G&T_JHZ=* "O\93_@X)U6QUC_ (+-?\%!;O3YX[F"'XXOI4DD3JZK?:%X
M/\+:)J<!920)+74M/N[69/O1RPO&P#*0/]:']L3X/?MD_&'P_P"&-(_9 _;,
M\)_L;:I:+XDC\9^)_$'[+?A[]IG4_$46I0:3%X<D\.6GBCXH?#W1O"%WX;EM
MM9GFFO=-\6P:VVJVB2V=BNE?Z?\ QZ>-O^#)?Q9\2/&7BSXA^/?^"LVK>+O'
M'COQ)KGC#QCXJU[]C*74-;\2^*?$NIW.LZ_KVKW\_P"URTUYJ>KZK>75_?74
MK&2>YGED8Y8T ?VT_LU:G9:W^SE\ -9TV>.ZT[5_@G\*M3T^ZB97BN;*_P#
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MA\$=>DLH[G6_AS\<_"'B[P;XN\.7+1AY+">^L-'U[P1K\T9)43>#O%_B.V?
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M4=6O+*/P?K&CAFM_$.A>)_[)UGP]?P7.GZU8V-[;3P1_S7?\%C?^#5OX5_\
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M=6<:>(++1O%?ACQSJ.LP^"KV7SM.NO#OBCP-XLM/$>D2&+7;4P2S:<_Z61?
MO_@[0OO#K_#G4OVR_P#@EII<,]J-/N?CSI7@CXBW7Q1@MI%,,NKZ;X7D^ 5C
M\-G\0I&QG2TG\'V.D+<+B*YC4*Y /XGO^"\7['?@ZS_X+O?&_P#9;_8Y\):;
M+J/QB^(OP7B\/?#'P;:HNF:#\8/CCX+\$:SXA\-Z;8:;"\.E6=_XN\33^)Y]
M.M8$LO#MOK\UC!;V>GZ=';6_^N'X+\/'PCX.\)^%#=R7Y\,>&=!\/&^E+&6]
M.BZ7:Z;]KD+%F,ES]F\YRQ+;G.23DU^#O_!*W_@W]^"/_!/WXH>(OVMOC9\4
M/$W[9O[>7CF\U_6?$7[1'Q*L&MK3PMK'C$S3>,+_ .'WAS4-4\1:A;>)O$#W
ME_8ZY\1/$6O:MXIU/2[B[L=)3PGI6LZ]H^I?T$4 ?Y%G_!U9_P IPOVL/^Q8
M_9P_]9O^%=?Z.'_!#']H#P'^T;_P27_8.\5^!-=L=:_X0;]F_P"%7P-\:P6U
MQ%)>Z#\1O@;X+T3X8^,=&UFT5C/IM\VI>&_[:M+:[CADN]!UC1M8MDDTW5+&
MXG_SC_\ @ZL_Y3A?M8?]BQ^SA_ZS?\*Z_IV_8B_X(H_MS?LX_L^?LQ?M??\
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MOQOX \8:9%/;S7?A_P 3://K?A+Q):VEY#_:6@:O>'3=0B,]K?)_J*_L/?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_ ';-_P"MA_L^U_D"
MU_K]?\'1W_*"C]N;_NV;_P!;#_9]K_(%H _O\_X,8_\ G*+_ -V3?^_<5_?Y
M7\ ?_!C'_P Y1?\ NR;_ -^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*DEE^TLJ,1U 9HI I[E&QT-?WR5_GU_\$5O^"<?_  <#?\$;?BY\3_&'A?\
M8>^$7QO^&'QO\/\ AC0_BI\,=6_:N^#'@;4M0NO UYKE[X*\2>&/&UKKGBA=
M#UGP^?%/B>S>'4/#&O:7JFF:]?VTUG;7J:=JFG_W4_L]>./C)\1OA1X=\7?'
MSX&)^SA\4M2GUJ/Q!\(4^)_ACXQ)X;AL=:O['2+A?B#X/L--T#6EUS2+>RUP
M1VEE#)IO]H?V;=AKJTF8@'M=%%% !1110 4444 %%%% !1110 4444 %%%%
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MX<^#8TAA?PUXBT*[\2:9H.GZ>-'&M37.K7H!_2Q1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'R3^VC^W/^RW_P3X^#<WQX_:T^*FF_"SX=
M_P!MV7A?2;J;3-;\0Z[XH\5ZE;7MYI_ACPGX6\,Z=J_B'Q#K5S9Z=J%])!I^
MG2PZ?IEA?ZOJUQ8:38WE]!\+?L__ /!PK_P1U_:-TK5M1\*_MR?"7P#=:%97
M.H:MH?Q[NM2^ .KQ6]K&9I1IG_"VK#PGI?BFX\D&1+3P?J?B"Y?#1B+SD>-?
M'_\ @X?_ ."1WQ%_X*T_LF^!O!_P1\9:!X8^./P)\?WOQ%\!:/XTO+O3O!/C
MZRU?0+C0?$W@[5=6LK6^D\/ZU=0#3=1\,>()[&\TZ"_TZ;1=433]/U^X\0:)
M_%W^S3_P9]_\%4/BI\0[#1OV@;;X3?LM_#6WOXQXB\<ZU\1/"GQ7\03:2LNR
MXE\%>"?A=K>NQZUJK1XDM;+Q7XE\"6+(2UQJD$J"WD /U]\+_$ZQ_P"#CK_@
MOW\)O&/PZLM6\1?\$V_^"7-C:^-['Q#JVEWUCH7Q&\;0Z_%KFC:U+I&KPQ2V
M;_&3XG>&O#-OI_A[6+6"ZUGX,_!Z_O\ 5=+TK5;S4=*M_P"\:OA+_@G;_P $
M[/V</^"9'[.6@_LX?LW^'[FUT:WN3K_CGQQK[V]YXZ^*GCNZM+6TU3QOXVU2
MWM[6&XU&ZAM+:ST_3;"VL]%\/Z1:V>D:-8VMI;XD^[: "BBOE']K^;]LF?X;
M:7X;_8@L/@K9_%GQCXG@\.ZM\2_CSJ6OMX(^"_@J?1]8NM7^)-IX'\,:==:O
M\4_%MA>VNEZ1X4\!OJ?AK1+S5]8@U;Q+KL6@Z3?V&H 'XH?\'%?_  4)\7_#
M?X-Z5_P3,_8ZT[5OBA_P4"_;^TZY^%WA7X>>!2E]XH\!?!KQ4EWH_CSQQJ_D
MSQ?\(W/XIT1-:\*^%]5U6XTJRTK3CXR^(5QJ^G:?\/[F:;ZV_P""&_\ P2)\
M%?\ !)+]DVW\ WDVC^*OVDOBS)I/C']I+XDZ7&[6>I^)K2UN$T/P!X6NKB**
M\?P#\-K;4-0TW0I;F.";7-8U'Q)XNFLM+;Q$FBZ7[1^P1_P2P^#/[$OB+Q]\
M<_$'BSQ9^T[^VO\ &QVN_CQ^V5\9TL[SXH>.)IA;&7PYX1TVV,VC?"GX9V9L
M[*UT;P!X0*VUMI.EZ!I6KZKKUMX;T#^S?T_H **** "BBB@ HHHH **_F7_X
M*8>//^#F/0?VMO&>F_\ !-'X*?!'QK^R7%X=\#OX-U_QMJO[/-IXAN?$,WAC
M3Y/&\-S#\0_BUX2\4+#:^)VU""U-WHD%NT"(;.6XMRDS? O_  M7_@];_P"C
M:?V9?_!]^R%_\_\ H _MBHK^)W_A:O\ P>M_]&T_LR_^#[]D+_Y_]'_"U?\
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M:?V9?_!]^R%_\_\ H _MBHK^)W_A:O\ P>M_]&T_LR_^#[]D+_Y_]'_"U?\
M@];_ .C:?V9?_!]^R%_\_P#H _MBHK^(F]^)O_![-+?:5-!^SQ^SS;6]M-<-
M=VMEK?[$[6-^CP%(X]5;4?CG<:DD,,G[VW.AW%E<&? NGEMLQUJ?\+5_X/6_
M^C:?V9?_  ??LA?_ #_Z /[8J*_B=_X6K_P>M_\ 1M/[,O\ X/OV0O\ Y_\
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MX?LWW!:ZN9$:[US]C57CBDF=XH(?L/QYA0VL"%8K8SJ]Z850WDTUQYDC6O\
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M0O\ Y_\ 1_PM7_@];_Z-I_9E_P#!]^R%_P#/_H _MBHK^)W_ (6K_P 'K?\
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MXG?^%J_\'K?_ $;3^S+_ .#[]D+_ .?_ $?\+5_X/6_^C:?V9?\ P??LA?\
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M?_/_ */^%J_\'K?_ $;3^S+_ .#[]D+_ .?_ $ ?VQ45_$[_ ,+5_P"#UO\
MZ-I_9E_\'W[(7_S_ .C_ (6K_P 'K?\ T;3^S+_X/OV0O_G_ - ']L5%?Q)C
MXH_\'L O9)3^SA^S>8&M88UMCKG[&OV))5EG9YXV7X\C43=2(\<<PEN&LA%%
M 8(8YS<O):_X6K_P>M_]&T_LR_\ @^_9"_\ G_T ?VQ45_$[_P +5_X/6_\
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MC:?V9?\ P??LA?\ S_Z/^%J_\'K?_1M/[,O_ (/OV0O_ )_] ']L5%?Q._\
M"U?^#UO_ *-I_9E_\'W[(7_S_P"C_A:O_!ZW_P!&T_LR_P#@^_9"_P#G_P!
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MU"2>87$DH@=+001):_X6K_P>M_\ 1M/[,O\ X/OV0O\ Y_\ 0!_;%17\3O\
MPM7_ (/6_P#HVG]F7_P??LA?_/\ Z/\ A:O_  >M_P#1M/[,O_@^_9"_^?\
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M?\(S_P -0_\ "2?\(M_PG_B/P_\ \)!_PC__  D&@_VW_9/VO^RO[;TC[?\
M9_[2L_._M]_X>Q?\$LO^DEG[ '_B9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L
M?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$L
MO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7
M_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^
M /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#
M[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B
M9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P
M!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2
MR_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q
M?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\
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M$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\ HKX
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M>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\
MHKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQ
MJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L
M?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7
M_!++_I)9^P!_XF1^SK_\\:@#[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D
M?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++
M_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#[_HK
MX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ
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M1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L
M?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$L
MO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7
M_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^
M /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#
M[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B
M9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P
M!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2
MR_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q
M?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\
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M$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\ HKX
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M>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\
MHKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQ
MJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L
M?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7
M_!++_I)9^P!_XF1^SK_\\:@#[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D
M?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++
M_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#[_HK
MX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ
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M1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L
M?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$L
MO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7
M_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^
M /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#
M[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B
M9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P
M!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2
MR_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q
M?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\
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M$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ /O\ HKX
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M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?
MR!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;
M_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G
M_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B
M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?
MR!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;
M_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G
M_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B
M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?
MR!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;
M_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G
M_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B
M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?
MR!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;
M_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G
M_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B
M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?YX?_  69_P"#7[]@7_@G;_P38_:0_;%^"GQ=_:_\4?$WX/\
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MYX>T.RGU+6=<UO5M0FM['3-)TK3[:XOM0O[R>&UM+6"6>>5(HV8?PP?MB_\
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M'G\$ZSJ<<3SR:3I7CO0_VH=6\&ZAK$=O&]S)I%IKLNI1VJ_:7M5@(D/[V_\
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M!X*\,EIO'OC#QAJ5LVFC[)?VZW-VL_\ 6U7^?W_P8R_\??\ P4^_Z]_V+_\
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M9S6UY-IZ7GDM>Q6MQ!<R6PE2":*4HZ_S4_M^?M.?\'&_[#_P \=_M*:-\/\
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M29;W2YYH()9[">WEDAC9RB_U(?\ !E?_ ,I4OCC_ -F$?%7_ -: _9>H _U
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MOIFKW&G"XBL+ZVN6CE7^27_@J/\ \%0/^#B[_@E;X$M?C1\4/V??^"8?QA^
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MWBB\U'Q7HFE>#-,UA9O#XFCUS5]:L]4M]%CT/5_Z5J_FD_X.2O\ @BS\1O\
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M]C8V-O/>7M[>3Q6UI9VEM$TUS=75S,R0V]O;PH\L\\KI%%$C22,J*2/X./\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N%^)_Q-\ ?!;X<^./BY\5?%>D>!?AM\-O"VM^-?'/C#7K@VVD>&_"_
MAVPGU/6-6OI5224Q6EE;RR"&WBGN[F0);6EO/<RQ0OW5?YT7_!V'_P %MM(^
M+^JZM_P2\_9>\41:G\/_  3XFL;S]K/XA:#J GTWQCX[\,7BWND? _1[JTD:
MUOO#_@+78+37?B#=!YQ=_$#2='\.PFQ;P7KB:R ?Z%_P_P#'GA+XI^ O!'Q/
M\ :U!XD\"?$?PCX;\>>"O$5M!>6UMKWA+Q?HUEXA\-ZU;VVH6]G?V\&J:-J-
ME?107UI:WD4<ZQW-O!,KQ+UU?%?_  39_P"4=7[ W_9E?[+'_JC/ E?:E !1
M110 4444 %%%% '@O[3"?M02?!SQ,O['%S\!;7]H'[1H1\&S?M,67Q"U#X."
MT&N:>?$R>)K;X6W^F^-FN)/#8U5-"DTJ[6.'7&T^74(Y[!+F%_X</^"A_P#P
M<E?\%S/^"8O[1NI?LR_M-?LT?\$YH?&47AK1_&_AKQ+X(\(?M'Z]X%\?>!M?
MNM4T[2_%_A#5-2_:&T'6)M)EUC0M?T.X@UO0-$U:RUC0]3M+K38A#%+-_H$U
M_FB?\'M%O$O[?/[*%VJ*)YOV0(+>20#YFBM?C/\ %&2%">I6-[NX91V,C'O0
M!]0_\$X?^#LC_@H3^V%^W;^RK^R]\2/@C^QIH/@/XY_&;PC\.O%>L^"/ OQN
MT_Q=INBZ_>&WN[OP]>Z]^T!XCT:VU2)!FVFU+0M5M%;F6SE'%?Z#5?XL/_!#
M+_E+_P#\$[/^SI/AK_Z<S7^T]0 4444 4M2U&QT?3K_5M3NHK+3=+LKK4=0O
M)VVP6EC8P27-W=3, 2L4%O%)+(V#A$)P:_RMOVYO^#LG_@IC\9?V@?%FN?LB
M_%>U_9?_ &>M#\1W]I\+O!6C?#?X8>+/$^N^&]/O)(=(\3_$O7OB/X/\97=[
MXDUZU1=0U'P]H[Z7X4TA+J/1TT[5+BPEUW4O]4C4]-L=9TW4-'U2UBO=,U6Q
MN]-U&SF!,-W8WT$EK=VLP!!,5Q;RR12 $$HY (/-?Y5_[<?_  :=?\%-?@O^
MT!XLT#]DOX2V_P"U#^SYK7B._NOA;XZT+XC?#'PMXDT?PU?WDDNC^&OB7H'Q
M#\7^#;S3O$VAVDB6&J:_I,6I>$M5%LFK0ZGITU[+HFG ']D/_!N'_P %G/'7
M_!6?]G[XIZ)\>M%T#3/VEOV:=6\&:7\0=>\)Z>-&\,_$GPC\0+3Q$_@GQW:Z
M"LCP:#XBFO/!WBC2?&&C:4?["AO++3=:TB'2K/Q#%X>T;^CVOYO?^#<#_@C'
MX]_X),_ #XJZ]\?=9T#4?VE?VE]6\%ZGX^\/>$]176O#7PU\(?#ZU\1IX*\#
M6^O(B6VO>)$O?&7B?5O&&L:3G09+N[TO1=(GU:T\/Q^(-9_I"H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "OS=_P""BOB3_@J9X)\#6WC?_@FMX9_8
MV^(6H^%/#/BW6_'GPS_:<TKXQS^,O&][IT5E>>'M'^$&J?#;QMX0\.6^L7=K
M!K-I)IOC>>UL]3U.?1XH=>T>%;IY?TBHH _S$#_P>L?\%0 2#^SS^P8""00?
MAQ^T*"".""#^TUD$'@@]*_JR_P"#=/\ X+"_M(?\%>?AE^TWXT_:,\!_!#P)
MJGP6\=_#[POX8M_@IX?\>:!8:A8>+/#_ (@U;4)M>B\=?$;XB7%S>07&DVZ6
M;Z?=:9"D,DRSP7#LDD?^4+\6K>&T^*OQ,M;:-8;>V^(/C.W@B0!4BAA\1ZE'
M%&BC 541550    !Q7^@U_P8^_\ ) _V^O\ LK_P6_\ 4+\:4 ?W.T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P='?\ *"C]
MN;_NV;_UL/\ 9]K_ "!:_P!?K_@Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,
M?_.47_NR;_W[BO[_ "OX _\ @QC_ .<HO_=DW_OW%?W^4 %%%% !1110!_G?
M?\'OOP@\46WQ:_85^/D=G<W'@O6OAU\4OA!=7\<;O9Z5XH\,>)M'\9V%G>RC
M,<%SX@TKQ=J,VF1MA[N+PSJS)N6R?;_%]^S1^TO\;OV/_C;X#_:(_9V\?:O\
M-OBW\-]6&J^&?$VD&&0 2Q26FI:/K&FW<<^FZ]X<UW3I[G2?$'A[5[6\TG6M
M*N[JPU"UFMYF6O\ :"_X*;_\$\OA%_P4^_9#^(7[*OQ:E?1?[=-KXG^&OQ!L
M[&+4-8^%GQ6\/P7@\(^/-*LYI;=;U+3[?J&B^(M(%W8MX@\'ZYXBT!-1TR34
MTU&T_P >;]OG_@GC^U+_ ,$V?CEK'P)_:A^'M]X7U:*>^G\%^-K"*[OOAQ\5
MO#-M.L4'B_X;^*WM;>TU_1[B.6V>\LV2UU_PY=7 T?Q3H^B:U#<:?$ ?Z$'_
M  2__P"#N/\ 9#_:<L_#/PO_ &ZK33OV/OCI/%9Z;+\09I[N]_9J\;:JP2)K
MZ'Q1<O=:O\(9+R7S;B73?B$UWX2TFW1?,^)MW/,EI'_7#X>\1>'_ !;H>D^)
M_"FN:/XF\-:_86VJZ%XA\/:G9:UH>M:7>Q+/9ZEI.K:;/<V&HV%W Z36UY9W
M$UO/$RR12.C G_ ?K]3/^"<__!9']O/_ ()A>)K.Z_9R^+M_>?#"341?>)OV
M?/B*]]XO^"/BE99O.OBWA*>^MIO".L7[!6N?%7P_U+PIXHN#%##>:M=V"R64
MH!_K*?M=?\$^M%_:D_:M_P"">_[5\?CB#P3XP_8/^*?Q%\:VUFWA7^WI/B)X
M1^)O@N#PSX@\$MJD>O:+)X<=-3TK0-;M-7EM/$,,*V=_9II*OJ3W<7Z,5^'/
M_!'G_@N[^RQ_P5O\)3:!X;1O@U^U)X3T5=6^(7[.OBG6+?4-1?3X6AAO/&'P
MO\1"WTZ/XA^!HKF>*"^N8=-TSQ)X9N9H(/$WA_3[.]T35M;_ '&H _&C_@X5
M_P"4+_\ P4"_[(Q:?^I[X.K_ !GJ_P!F'_@X5_Y0O_\ !0+_ +(Q:?\ J>^#
MJ_QGJ /]%_\ X,?O^3?OV]_^RQ_!K_U"?%]?T ?\'!/[2^A_LN?\$A?VU_%>
MI:E!9:U\3?A+K?[._@BT>7RKW5_%/Q]MI?AF\&D@%6>_T;PQKWB7Q>^Q@\&G
M>&M0O%R;;:?X,?\ @@!_P6[\+_\ !(_X(_M4:1XA_98^,7[03_$_QOX$\56^
MM^ -1T_0O"7A5/"_AO7M->Q\6:_?:5K)TR6_?44N+:5+"X"VT,\AC8J%;X>_
MX+&?\%Q_VD_^"P7C+PC#X[\.:)\&?@#\,;Z^U3X:? ;PEK-]XALK+7]2MWLK
MSQIX[\6WUEI$WCKQO_9TLNC:=JD>@>&]%T'1);JST+PYIUWK'B74=> /]73_
M ()L_P#*.K]@;_LRO]EC_P!49X$JSX>_8E^&7A?]O+XB?\% ='U;Q!:_%#XH
M_LW^#OV;_%WA91I8\(7^D>"?&]]XQTOQH2+ :V?%DEO/I_ABX+ZF^E'0]$TT
M16$=VLUQ+6_X)L_\HZOV!O\ LRO]EC_U1G@2OM2@ K_+1_X.[?V_=9_:1_X*
M#Q?LD^&-;FD^#O[%NBVOAVYTZTN"=-UWXY^.-)TOQ'\1?$-PL;(ES<>&-(N?
M#/PZM8+R*271-4\/>,6L9DB\07BR?ZEU?X3_ .VE\1]4^,/[8?[5GQ8UNXEN
M=6^)7[1WQM\=7\TK,[&X\4_$GQ+K31KN)V10"]$$$2XCA@CCAB58T50 >(^!
M/!NN_$;QOX-^'OA>W6\\2^._%7A[P;X=M&8HMUKOBC5[/1-(MV<!BJSZA?6\
M18*Q4-G!QBO]VO\ 9X^"7@_]FOX"_!G]GOX?VRVO@KX)_##P/\+?#,8C2*27
M2/ _AS3O#MI>W03/FZAJ*:?]OU*YD9YKN_N;FZN))9YI)&_Q:?\ @E!HUCXA
M_P""HG_!.31M2CBFTZ__ &Y_V4(;ZWG&Z&ZM%^.G@66>SD7^)+R)&M2O?SL9
M&<U_M\T %%%% !7Y)?LS_P#!-:Z_9M_X*F_MZ_MV^&M8\&V_PR_;1^'/P9MW
M\":6NJ6WBG0?BSX*6YMOB%K]]:'2(M";1O&4EO8^*#?V^MW>K7OBG6?$<E]I
MUK#]GN+K];:* /$X_P!G3X+Q?M&WG[6R>![0?M#W_P $]-_9TN?B2VJZ^]\W
MP7TGQUJOQ+L? \6B/JS>%K:T3QQK6H:]/JMMH4.OWLTEO:7NK7&G6&GV=K[9
M110!_(3_ ,'J/_**[X&?]G\?"K_UG[]J*O\ +]K_ % O^#U'_E%=\#/^S^/A
M5_ZS]^U%7^7[0!_KC?\ !J1_RA$_9A_['3]HO_U?_P 1:_HRK^<W_@U(_P"4
M(G[,/_8Z?M%_^K_^(M?T94 >*Z'^SM\&?#7QY\??M.:%X&LM-^.?Q1\!>"_A
MCX^\>V^I:[]I\3>"?AWJ&NZIX-TB^T635'\,QS:)=^)-7\O6;31;?7;NUFMM
M/U#4[O3]-TRUL_:J** /\6W_ (+M_P#*87_@HA_V<QXZ_P#1EI4?_!"G_E,'
M_P $[O\ LYSP!_Z4W%2?\%V_^4PO_!1#_LYCQU_Z,M*C_P""%/\ RF#_ ."=
MW_9SG@#_ -*;B@#_ &EJ_DG_ .#PG]MC6OV=O^">/@O]FKP7JTVD>+OVT_B%
M>>$_$$]M,8+M_@K\++;2O%7Q(L[6>)UN(CK?B76?AEX;U.-?]'O_  QK?B+2
M[LM#>M#+_6Q7^;C_ ,'NGBK4;S]K[]BWP3+*YTGP]^S;XN\56,)W>7'J/C'X
MGZEI&J2H<[=\MMX%T=), -MABW$@K@ _B5K_ %+?^#-_X)6'P\_X)6>)OBNU
MG&-=_:!_:4^(_B234S&%GG\+^ -+\,_#30M++C!DM--U_P .>-+ZWW99+G6[
M\9VE0O\ EI5_L!_\&OVEV^E_\$,_V'E@10]];?M!ZI<R #=-<7W[5'QOEWR$
M?>:.#R+92>1'!&IY6@#]]:*** /PL_X.4?@_8_&3_@BW^VKI\]I'<:GX \*>
M"_C!H%TR!Y=+OOAC\2?"/B?5;NVR&V27/A&T\2Z/,^,K9:I=@%20R_X[5?[;
MO_!8/38=5_X)1?\ !22UN%5DB_8<_:AU)0P! FT;X->,-7MFP>-R7%C$ZGJ&
M4$<@5_B14 ?Z'G_!E+^VIK7B;P#^U#^P-XMU::]M?AG<:3^T3\&[2XF,\NF^
M&?%VHQ^$?BYHMJ)'W6FBZ=XM;P%X@LK.W1H#K7CCQ1>R^5/>9N/[O*_RE_\
M@S_\4:CX?_X+$:'I-E*\=MXX_9M^./A?6%0-MFTZTB\+>-8HI<$ (-6\(:7,
M"V5\R*, ;BI'^K10!_(%\++"QU7_ (/$/VN=,U.RM-1TW4?^"=6BV&H:??V\
M-Y8W]C>>#OV<+>[LKVTN$DM[JTNK>22"XMYXY(9X9'BE1D9E/\Q__!R3_P $
M-K[_ ()M_&B3]I3]G;PU=R_L0_'/Q-<C2]/L(9KB']GKXE:F;C4;KX6:G* Y
MB\$ZTL=YJ7PJU6X<-%I]MJ'@K4F>_P##VG:MXG_I[^#O_*X]^U9_VCU\._\
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M2]U9Z)X_T*)8&MKZ33]?L;5?#7B;P[=7GYI?#3XE>/?@Y\0O!?Q7^%OBO6O
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MFN=7U_6;LO?:UKE_J&K7\DMY>SRN >Q5_ M_P?+_ /(&_P""9/\ V$_VP_\
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M?]ASXY_^LP?&RO\ 86K_ !Z?^#9+_E.1^PE_V'/CG_ZS!\;*_P!A:@ HHHH
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MX+:_\I=/^"C'_9W'QF_]2V_K^A;_ (,C_P#D]']L?_LU_0O_ %:_AFOYZ?\
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M7=*S:=K_ ,3/%-Z+K2_AIX;U+;C39KRQUOQ3J\;"]T'PAJ^F0WM_9_AK<?\
M!=W_ (.(_BM^R]XD_;\_9_\ ^"5?[.>A_L9Z#I&M>,AXD\?WGC?QUXWNOA_X
M>:Y?7?&>CZ#I_P =_@_XW\6^$M$M;6XN=0\8>'OA+)HCV%IJ&LVGFZ3IFJ7-
MC_!YH6H_%']O/]M#P@_Q<\<:WXS^+'[6'[0W@KP_XQ\<ZM/'-J^H^)/BQX[T
M?PW-?H&C%G:063:Q%!I&EVMO!I.CZ=:66E:=96NF6=M:Q?[AFC_"GX?^'OA1
MIGP/T+PSIFD?"S1/A[9_"K1_!MC;QPZ/IG@'3O#D?A*P\-6EKM:*/3K/P]#%
MID$!1D6VC5"I P0#^(G]A#_@]*\'^.?'7A_P#_P4"_9TT?X0:%KUY:Z?-\=O
M@5JOB+Q!X2\+W%R_DB^\6?"KQ(-9\76WAN!V26_U?PUXQ\5ZQ9P;C!X4U':S
MK_<UX4\5^&/'?A?PYXV\%>(-&\6^#O%^AZ5XG\*>*?#FI6FL^'_$GAS7;&#4
M]%UW0]7T^6XL=4TG5M.NK:^T[4+.>:UO+2>*X@E>*16/^$-^T'\$O&_[-GQT
M^+O[/_Q)TJ[T;QW\&_B+XN^''B>PO;:2UD&I^$];O-'DO($E \W3]32UCU/2
MKV(R6NH:9>6E_9S3VES!-)_J<_\ !I7XF^+GB/\ X(V_#&+XH#69-#\-?&'X
MR^&?@M?:U]H=[_X1V6N6%[;G3;FY'FW.C:7\0]1^(GA[3,22V]E;Z,-*LS%9
MZ?;VT !^_?Q__:$^"?[+'PE\7_'7]H;XE>%_A+\)O E@-0\3^-?%M\;/3;))
M)%@L[&T@ACN-1UG6]5O)(=.T+P[HEEJ.O:_JEQ;:7HNFW^HW-O;2?RZI_P '
M,7Q]_;1^(?C#X6?\$9O^"8OQ<_;!;P:T<>M_&7XK^(++X6_#G1VN7NH=+N=3
MTE&73-)T[Q";6YN_#J^.?BM\/?$FI6=E>$^%X)[>]CL/PL_X//?VJ_BUXM_;
M>^$/[($^HZMI'P/^$'P7\+_%;3_#*R7%OI?B_P")GQ(U7Q=8ZEXZO8E,=OJP
MT+PWHNG^$/#CW$=RV@7(\;"PN(3XBU."M'_@S9_;\\9_#+]J[QO_ ,$]-1T2
M#6OA?^TKI?BKXL^'=4M[4)JW@?XK_#+P9]NU*]NKR-1]H\+^,/ 7A^;2;^WO
M#*UCXBT3PK)I+6B:EKB:@ ?47[7W_!R1_P ' G_!/KQMX=T3]L[_ ()S?LJ?
M!K2?%C7,OA<ZCX-^+^JZ/XGATYXGU/3_  Y\6/!_[3GC+X>:OK.G07%LVIV>
MGF]O=,CN[*[O=*@@N[<3_KE_P2'_ .#I']F?_@HM\0_#O[./QU\!?\,H?M*>
M+)X=+\ 6E[XKC\5_"'XMZ[(JK#X=\*>,+O3=!U/POXWU:42C1/!7BG39K;5Y
M1;:/H'C+7_$E_9:+/U7_  =T>$M$\1?\$:/B-K>IZ?:W>H^ OCA\"/%'ARZG
M@CEGTO5;_P 8'P3=7=E*X+VTT^A>+M8T^62(JSVMY/"V4D85_E#Z7JFIZ'J>
MG:UHNHWVD:QH]_::II.K:9=SV&I:9J>GW$=W8:CI]]:R17-E?65U#%<VEW;R
MQSV]Q%'-#(DB*P /]^JOY/?^#RC_ )1)>%?^SQ/@Y_Z@7QEK^B+]B'XJZ[\=
MOV+OV0_C?XHNA?>)OC)^R_\  'XJ^(KT1Q0B\UWXA_"CPGXNU>Z$4*1PQ"XU
M#6+B41Q(D2;]L:*H '\[O_!Y1_RB2\*_]GB?!S_U OC+0!_EDU_IU?M3?\'0
M'P!_8L^%OP2_9B_9*^%FJ?MM_M1^&O@?\+M)\9Z=X2U2[M/A/\,-=L/ &@0Z
MCH6O>(] TKQ#K?C?Q=H=P!#K_A3P?IT.GZ-<BZTC7/&VB>(M/OM$@_S%:_VK
M?^"1'_!/[]E_]@O]C7X+>'OV?OAUI6B>(/'_ ,+? /C7XH_$S4;.QO?B5\3?
M%?B?PSI7B#4]1\7>+%M(;^[T^VO[Z:/P_P"&[=K;P[X;L%CM=(TVV+7,UP ?
MQ+>$_P#@]?\ ^"@.B>-B?BA^R3^R/K_@ZSU)X=2\(^%+/XU?#OQM'#!<>7<Z
M?_PE_B'XG_$72[+48@DD$EQ<?#Z=8;@%I-.(0P'^S3_@D[_P6K_9&_X*W^!M
M6O/@W>ZI\/?C9X(TVUU'XG_L\>/KBP'CGPM97$L5G_PDWAV_L7&F^/O $FIR
MII\/BO1H[:ZL+B?3K?Q;X?\ "FH:QI5A>?S)?\'HW[ _PUT+P=^S]_P4-\ >
M$=(\->/==^)+?L^_'74M#L+>QD\?+KGA+7O&'PP\5^)(K2.*.[USPW#X%\6^
M&;GQ'=)+J6I:9K'AC1KZ[DM- T2W@_BG_89_;"^*?[!/[5GP8_:L^#^HW-KX
MK^$_C#3]8O=(2[FM-/\ &W@^>067C7X?:^8L^=H'C;PQ/J?A[4U*M+;1WR:C
M9-!J5E974 !_NBU_"5_P?$_\DB_X)Y?]E'_:&_\ 48^%5?V]?"WXC^%?C'\,
MOAS\7? M\=3\$?%3P)X0^(_@[4F54;4/"OCCP_I_B?P]?%$>1$-WI&J6<Y59
M)%4R85V #'^(7_@^)_Y)%_P3R_[*/^T-_P"HQ\*J /X&_P!GO_DOGP/_ .RO
M_#3_ -331:_WF:_P9OV>_P#DOGP/_P"RO_#3_P!331:_WF: //\ XK?%;X;?
M WX<^,?B[\8?&_AOX;_#+X?:'=^)/&GCCQ=JEMH_A[P[HMD%\Z\U"_NG2-2\
MKQ6MG;1^9=ZA?7%KI]A!<WUU;V\O\>GC3_@ZE^-/[6W[3>G_ +)'_!%_]AM_
MVEO&^L76JQZ#\2/CQJVH^%?#VN:;HJ,^K>+6^'^F:MX/F\'_  ^LH46]7Q;\
M1?BCX0O'@N[&RU/POH>L75OI\_XW?\'<_P#P5,\7_'G]JZZ_X)X?#/Q/=V/P
M"_9?N-'N?BK9:5>/'9?$S]H'4=*M]8N_[;:&0+?Z-\)=(U:S\,:3I,Z(EEXY
ME\<7MVM[);:!-IGZ7?\ !D=^S5X:LO@Q^V5^V'>Z7;77C#Q+\3_#O[-?AS6I
MH86O-"\-^!_"GA_XH>--,TVXV^?#;>*M3^(?@*ZUJ$L8KF3P=H+J%>U<L =1
M\=_^#C3_ (*^?\$N_C-X#\$_\%9_^"<OP%LO GQ&M[K4_"WB;]FWQ;XET!->
MT73;FSMO$5SX3\4ZU\2OCIX/\1>(/"CZA92:KX)U>;P;K(CO=(DOKK1M-US2
M]:N?ZPOV&?V\/V:?^"BOP#\/_M%_LN>.H_&'@?5IGTK6])OX$TKQK\/O%MK;
MV]QJO@?X@^&C<7,_AWQ3I275O+)!Y]YIFJ6%S9:[X=U36O#VI:9JUY^&W_!W
MO\'O#WQ"_P""0'B?XAZCIMM/K_P$^.GP:\=^'-5,2_;=/'BSQ#)\(]8M(KD
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M9>L?V.M1^ T^A_&OP=\7O^$VN_CQ:_$N.X3PIX7\>>&VT%?#\/P@\"/"]_\
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MBSQ/X4O]7\)7_B#Q;KM[I9M=-\-:UK-AHND^'8;BXUBYO]>N--T, _IH^/\
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M7=[I4$%W;B?]<O\ @D/_ ,'2/[,__!1;XA^'?V<?CKX"_P"&4/VE/%D\.E^
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MZ<\3ZGI_ASXL>#_VG/&7P\U?6=.@N+9M3L]/-[>Z9'=V5W>Z5!!=VXG^7?\
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MH88(!K_6]A\,^&[::*XM_#^B6\\+K+#/#I5A%-%(A#))%)';J\;HP!5U8,I
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M_B(^-OB!X[T?QKX?TO4K^R/B:UTS2_"&HPZ0U_J^F->75C!H&H_Z"%?YA_\
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M6TJ/)X9\*^&[K1O'VOZ9*9;/6O$/B+PN+J&&Y\%K]H_.O_@T)_94\.?M ?\
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MNEZ=]FL9]6_L#3KB]T[PQHP*"UCUKQ9K1L?#NB(Z"*;6=7LTD($C-0!\<_\
M!4'_ (+!_L=_\$G_ (=:=XH_:(\3ZAKGQ&\7V=W/\,/@-X 2PU;XI?$ VKM;
MR:G%I]Y>V.G^&/!MG>*T&J>-?$U[I^D1R0W-AHXUWQ D&A77X"_L^_\ !;?_
M (. _P#@I)X/\9?'?_@G)_P3"_9>LOV?/#>LZIHFDZM\?/'_ (@UC6?%VKZ0
M%EO?#_A'Q#=_%_\ 9UTWQ3JEFCI;ZG?Z5X6'AS3=39](NM:BU.%[8?Y^/[9G
M[7WQJ_;M_:2^*'[4/Q^\23^(?B%\3=?N=2DMUFN&T7PCX>B=X?#7@/PC9SRR
MG2O"/@[1Q;:)H5@KO+]FMC>7\][JMY?W]U_M3?L)?LU>&OV._P!C;]FC]F3P
MII=MI6G?!KX.>"/"&H1VT,,']I>+8-&M[SQWXDO%@587U;Q9XVO/$'BC6KB-
M56YU?5[VX 'FX !_+Q^P-_P=O>#O&GQSG_97_P""GWP!M_V,OBK8^,+[X=ZG
M\3=$O]<_X5AX7^(&FZK+H6H>%_BQX-\8I+XQ^$45AK-M+I=WXCN?$7C/1],O
M7,GBD^%=%L;[7(_[,K>XM[NW@N[2>&ZM;J&*XMKFWE2:WN+>9%DAG@FC9HY8
M9HV62*6-F21&5T8J03_D]?\ !W!\'O#WPL_X+&>//$'A_3;;2Q\<?@?\&_C#
MK<-I$L%O<^(9+'7/ACJ>I"&,+$MSJ9^&45]J,J*&O-3GO+^X,EW=W$LG]8?_
M  :)?\% ?%7[5W[!/C#]F[XG:_=>(_B)^Q)XF\-^"="U;4KEKK4[WX$>/--U
M6_\ A/9WMQ.[3W,OA#4/"WCKP188!AL?"6@>$+ ,9(F9@#^K^]O;/3K.[U#4
M+NVL+"PMI[V^OKV>*UL[*SM8GGN;N[N9WCAM[:WA1YIYYG2*&)'DD=44D?Q6
M_P#!2'_@\<^!WP)\<>(OA'^P+\(M+_:@UKPU>W6DZM\=O'6OZCX=^"#ZM9.\
M-Q'X#T/08E\6_$[1XYU: ^)CK?@+1;QX'N_#5QXGT2[L=9F[O_@\(_X*0>)?
MV</V6/AQ^P_\)_$5QH7CS]K\>(=3^+.I:5=&WU32_P!GKPA+9V.H>&3)$8KJ
MS@^+7BO4(=%N+FWF,6H>%/!_CKPUJ$,EEKT@/^?G_P $[?V:+;]L;]NK]D[]
MF'4FN8_#_P :/CM\//!OC">RD>&^M? 5SK]K=^/[RQEC*NE]9>"K/7KNR97C
MQ=0Q9EB&9% /['?@+_P=:?\ !7 >&[/]H?X_?\$KM-^(G['(F>;7/B_\!O@[
M^TQ\.O#>F:+;W+VVI:G9?&#QIKOQA^%NHS:08YW>SO!H]K>7-L]A<:OH^][R
MV_)?_@Z"_;L_9O\ ^"BOQN_8E_:2_9A\:#Q7X%UW]DR72M9TG488M-\9_#WQ
MA9?%SQ]/K/@+X@^'4N;M_#_BS15O+66>V6YO--U/3KO3M?\ #VJ:SX<U;2=7
MOO\ 52\,^#?"?@SPAH/P_P#"GAS1?#W@?PMX=TSPCX<\):1IUK9>'M%\+:-I
ML.CZ5X>TW28(ULK71]/TJW@T^UL(H5MH;.)+=8Q&H6O\G[_@Z6_X)]_!/]@O
M_@HO82?L^:39>#OAQ^TO\+K3X[?\*RTFQBT_PY\.?%][XO\ %/A/Q=H_@^T@
M/D6'A+6-1\.IXITO1+=(++P[=:YJ6@Z-:6/A[3]&L;8 ^!_^"&7_ "E__P""
M=G_9TGPU_P#3F:_VGJ_Q8?\ @AE_RE__ ."=G_9TGPU_].9K_:>H **** /S
M9_X*+_M?_M>?L<^"(/B9^SG_ ,$^]9_;A\$:!X6\5^*_BQ-X4_:%\(?"7Q;\
M/M/\-QVMW$^C^!-=\$>,?$7Q+%]IIU2^FMO!L%QK-D--$,6C:@UVKP_RB?\
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M\7?@E_P3TU7]LWX-^"/ &M^/?B_XN\,?M'^$/A7XF^'-EX?DO+G5FA^&VK^
M/&7BCQOI>G:!:_V_J6J>%EN[FQM#<F72#;6%W>I^(O["7_!T3^T9_P %'OB]
M_P *<_92_P""/7C7XB:UI=O9:OXXUR']L'PQHWA/X>>%[J]%H_B+Q;XG\3?
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MG\(RV]O"D/VG6=.\%Z./$FKW2HB"34]>\1/JNN:O<LJR7FJZC>7<O[V9R?\
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M W_9E?[+'_JC/ E?:E>%_LO?"*]_9^_9H_9W^ NI:U:^)-1^"/P+^$GPBO\
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MOFL8QEF70-09L!5S_H5U^,W_  7J_P""=EY_P4M_X)P_%OX+^#=.AO\ XV^
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M_B1X>1I]4U7X&>,=4E,4/]DZ_<M<7O@;5M3F2W\&^-;@W/VS3?#_ (C\8F]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _P "[QM_R.?B[_L9]?\ _3K=U_3A_P &
MB_P"^!/[1G_!2OXO^!_VA/@K\)?COX*TW]BGXF>*-.\'_&7X<>#OB?X6L/$U
MC\;/V=M+L?$5EX?\;Z-KFDVNNV>F:UK&G6NKP6D>H6]AJVIVD-PEO?W4<O\
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M*OPEUNZLSXP\"ZHX$D,,]S#:6VL>&=4GM[I/#_C'1_#^O_9+Q=->SN/]G_\
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M07PH_P#F@H _KU_XC&_^"1/_ $"_VM/_  R_A?\ ^>E7\5W_  <8_P#!2?\
M9T_X*E?MO_#3]H3]F2#XAV_@'PG^RWX'^#^JI\2_#%AX4UX^+?#WQ5^-7C+4
M&M=.T[7O$4$VDG2/'^A"WO6OHI9+M;Z!K5%MTEF]<_XA,/\ @M5_T0WX6?\
MB07PH_\ F@K\BOV]_P#@GI^T]_P34^,7A[X$?M8^%= \'_$?Q1\-]&^*^CZ9
MX<\8>'_&UC-X+U[Q+XO\):;?2ZMX;O+VQ@NI=;\#>(H)-/EE6ZABMH+B2,17
M4#, >Q_\$9/VO/A/^P;_ ,%+OV8OVLOCE%XKF^%?PBU/XF7?BR+P1HUMX@\4
M-%XM^"WQ(\ Z5_96D7FIZ-;7CC7?%6EM="74K40V(NKA3*\*PR?ZU7_!-O\
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M[2K2/JH 'QIM[./E?*^)UQ;@K\0M;;^ "@#_ &,?^#;+_E"+^P5_V)'Q-_\
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M7]D<#I_PUG-_ZI[X@T ?YJ%?[^L9+1QD\DHA)]RH)K_ *K_?TA_U47_7-/\
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MV8_X0_\ 5\_'^OQI_P"#?[_E,M_P3X_[+Q9?^HQXDK]EO^#U_P#Y22_LU?\
M9C_A#_U?/Q_K\:?^#?[_ )3+?\$^/^R\67_J,>)* /\ 9RK_ #@/^#WCP[:6
MO[5G[$7BU(E%]K?[/GC_ ,.W,P4!Y+3PO\1UU.RB9L9*PS>,+]T4L0IG<@#<
M2W^C_7^;Q_P>[>)[.[_:V_8H\&)*AO\ 0/V=/&OB>YA!'F1V?B[XEW.E6,K+
MG(2:;P1J"(2 &:"0 DJ0 #^4#]@GQQJ?PR_;E_8U^(FC3RV^J>"/VJ/V?_%-
MG)"[HQET/XK^%-0\EBGS/#<I;M;W$1#)/!+)#(CQR,C?[HU?X?W_  2Q^$&J
M_'K_ (*2_L+?"C2;26\?Q5^U1\$FU9(5=WM_"F@>/=%\3>-=2VHK,4TCP?HV
MN:K+T416;EWC0,Z_[@- '^*;_P %M?\ E+I_P48_[.X^,W_J6W]?T+?\&1__
M ">C^V/_ -FOZ%_ZM?PS7\]/_!;7_E+I_P %&/\ L[CXS?\ J6W]?T+?\&1_
M_)Z/[8__ &:_H7_JU_#- '^DY7^"%\4O^2F_$;_L>_%W_J0:A7^][7^"%\4O
M^2F_$;_L>_%W_J0:A0!_H4?\&/\ _P F\?MZ?]EG^#__ *@_BFM__@]U^*>L
M:)^RI^Q/\&+6YEAT;XC?'OX@_$35X(W*)=W/PD\ V>@:5'/M(,L,1^,%].(7
MW1&>."<KYMO"R8'_  8__P#)O'[>G_99_@__ .H/XIKO?^#V;X,:UXH_8U_9
M&^.NG6<UWIGP@_:"\3^!O$$D"-)_9ME\9/ WVVRU.[VY\FP_M;X5V.DM<.!&
M-0U?3;;<)+J)6 /X#_V"_%VF_#_]N;]C#Q[K4L<&C^"/VL/V=?%VK3S%%BAT
MWPU\7_!VLWTLK2$1K'':V4KN7(0*"6(7-?[I%?X!4<DD4B2Q.\4L3K)')&S)
M)'(C!D='4AD=& 964AE8 @@BO]N'_@D]^VQX?_X*#?\ !/[]FO\ :<TO5K74
MO$_BKX?:1X?^+=I#+&UQH/QI\&6L/AOXHZ1>VZ[9;/S/%5A>ZUHZ7,4$M[X9
MUC0M8CC^R:E;22 &_P#M(_\ !+K_ ()Y?M?>/K#XJ?M*_L@?!#XN_$G3X+&T
M'CGQ/X0ME\4:E8Z8B1:;IWB/6-+?3KWQ7ING0HMO8:;XFEU:QLK4M:VUO%;N
M\;?:7@_P=X1^'OA7P]X&\ ^%_#O@GP5X2TBQT#PKX0\):+IWASPQX:T+3($M
M=-T;0=!TBVL]+TC2K"VCCM[+3["UM[2VA1(H8D10HZ.B@#\F_P#@I]_P1=_8
MD_X*RZ/X2_X:5\/>+_#_ ,1OA_976E>!_C5\)=<TSPM\3M"T"]N7O[KPK=7F
MMZ!XI\->)/"LFI22:C!H_B?PUJ_]CWMSJ=UX;N=#NM:UF>__ !]\#?!+_@A)
M_P &L9\5_%;Q3\6_'GQ _:D\=^$9]&T/1O%VN>%_BG^TKJ/@V\N;?4)_#WP^
M^'7@G0? 7A?X>^%O$=]I5H]WXU\<6_AZQU:?2QI,GCV2%3I$D7_!R[_P7T\8
M_P#!.ZQT;]C?]D/4K"Q_:P^)/A&+Q;XY^)UQ:66L)\!?AUK4M[8:&= TR]CN
MM,N?BEXQ>RO;O2I-9MKNT\(>&K:'77TF\O\ Q)X<OM-_D!_X("?L-V?_  5Y
M_P""IBV_[5WB?Q-\4O!7@3PIXG_:?^/UQXR\1:MKOBCXR-X=\2^$O#>E>%/$
M?BC4[RZUN_B\5>-/&GAZ;Q;=373W]_X0TWQ!IEK?:??7EG?VH!^J7_!8+_@I
M9_P4S_X*K?\ !-CXO?'S1OV5O"W[*'_!*C0O'GPRAL==^(E]<:W\;?VAO$+?
M$?1M'\*W'A34KFQM;.3PUHWB.2QUO5[KPMX9TCPW97&GZKX;B^)_CB^L;S1U
M_B>K_6:_X.KM$T7PS_P0W^,OAOPWI&E^'_#OA_QS^S9HF@Z#HFGVFDZ+HFC:
M5\5O"-CI>D:1I=A#;V.FZ9IME!!9V%A9P0VMG:PQ6]O%'#&B#_)EH _V]O\
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M;_9^_P#53>$J /J2BBB@ K_-#_X/9_\ D_O]E'_LS^V_]71\4Z_TO*_S0_\
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MH_B6V\.^._!FHR:1XN\&:[-H]Y>1Z3XJ\,ZI&]AKV@7[6^JZ3= 0WUK [*"
M?X=W[>GQJUC]HW]MG]K/XZZY=S7=[\5/VB/B]XQA:9MWV32-6\<ZW+X?TF#Y
MFV66B:"--T>PBW,(;&QMX0S! Q_LG_X,;-!MKCQ;_P %*O$[QJ;S1_#O[)V@
MP2D?.EMXCU/]HC4+N-6[+)+X5LF8=S$A_AK^*/\ :O\ AIJ_P8_:C_:0^$.O
M6SV>M_"WX\_%WX>:K;.CQF&_\&^/_$'AZZ4*X#;/-T]FC8C#QE7!*L"?[1O^
M#'+QC86/Q*_X*,?#Z2:-=3\3^!_V:/&-G;E@)9;#P+K_ ,:M$U&9$ZM'!<?$
M72TD8<*US$#RXH _T-*_Q1/^"U2JO_!6_P#X*-A0 #^V#\<VP!CYF\<ZLS'Z
MLQ))[DDU_M=U_BB_\%K/^4M__!1O_L\#XX_^IQJM ']$W_!D;_R>/^V;_P!F
MS^&?_5I:)7^DI7^;7_P9&_\ )X_[9O\ V;/X9_\ 5I:)7^DI0!_C4_\ !Q%_
MRFE_;_\ ^RN:+_ZK3P+7ZM_\&5/_ "E-^/G_ &8!\4__ %HK]E6ORK_X.*K:
M6U_X+4_M^Q2J59OBKX;N0&!!,5Y\*OA_=PM@]GAGC=3T*L"."*_5/_@RI('_
M  5.^/>3C/[ /Q3 ]S_PT3^RL<#\ 3] : /] C_@JG_RC _X*/\ _9A?[8'_
M *SW\0Z_P^Z_W!/^"J?_ "C _P""C_\ V87^V!_ZSW\0Z_P^Z /]9;_@TC_Y
M0O?"3_LLGQ^_]6#>UE?\'=?Q)U7P)_P1M\=>'=-N9;>#XP?'GX&?#;61$Y0W
M&E66NZG\4S;.5928I-1^&6G&1.1(J%'4HS5J_P#!I'_RA>^$G_99/C]_ZL&]
MJS_P=H_"C5_B7_P1E^+>OZ1;27C_  7^+?P1^*^H6\$+SW']D+XO'PUU&YCC
MC!<1Z=#\2/[3OI@I2VTVSO;F8I!#+(@!_DSVL[6MS;W*I'*UM/%.L<REX9&A
MD60)*@92T;E=LBAE+*2 P)S7^I5I'[4'_!W?KVDZ7KFE?L)_\$M[O2]9TZRU
M73;M/&'B4)=6&HVT5Y9W"!OVS@P6:WFCD4, 0&&0#Q7^6=7^U%_P1)_:\\/?
MML?\$OOV0_C%I>K0ZGXFTCX3^&?A'\5H!)%]MTSXM?"#2;+P'XWCU*UC=VT]
M]=O='A\9Z5:S$22>&O%&AWR[H;R)V /XNO\ @IQ_P1K_ .#B?_@JY^T#X=_:
M1_:)_95_98\&^.?#7PI\/?!^QTSX+_&;P=X<\*S^&O#/BCQKXLL+^]L?&WQF
M^(FKRZ]+J'CO5K>[NH=<M["2PM=,BATR">"YN;S]4?\ @V+_ ."/?_!1C_@F
M+^TM^T;XJ_:Q^''A7P1\*OBQ\#-+\/Z;=^'OBGX%\<37OQ!\,^/M#U'0;>YT
MGPMK>HWMO''X<U3QG*FHW%NMK$V;8S)+=Q)+_:57%P_$CX>W'Q"O_A);^.O"
M$WQ4TKPAIWQ U+X;1>)-'?QY8>!-8U?4/#^E>,[OPDMX=>M_"NH:[I.IZ-9Z
M_+8+I4^J6-S81W37431  _S5/^#MS_@E9\2?@A^UMX@_X**?#CPMJ6O?L[?M
M*/X<;XHZOH]E+<VGPD^.&FZ/IGA2Z@\3K;QN=,\/?%"TTK3/$6@^(+N3[+>>
M-[OQ5H-R]C<2>'(-8_CIBEE@ECFADDAFAD26*6)VCEBEC8/')'(A#I(C@,CJ
M0RL RD$ U_N9^&OC[^S)^UU\0_VQ_P!B^^TS3_'VO?LYW7@;X<_M*_"OX@^%
MM/U'PUJFA_&_X<6GC[PHS:7JAU#3O%7@[Q3X9OKRQDEN[2.,ZII.L6$UKBVA
MGN/X:?\ @M#_ ,&E?BKX:CQA^TM_P2YL-7\>> (1?>(/%W[(=[=76L?$+P?;
M)ONKV?X&ZU>R3W_Q#T*VA$C0_#W7+F;X@6B0+;^&]6\>W=_;:+I@!Y/_ ,$1
MO^#JKXJ?L\ZKX,_9C_X*1^(]?^,'[/D\NG^'/"?[1NH?;-?^+_P8MY&CM+/_
M (6!<J+G5?BQ\.K E&N[^Z%Y\2?#=B;JXL[WQE8VNE^%K/\ TE?#/B;P[XT\
M.:!XP\(:[I'BCPGXKT72_$GACQ+X?U&TU?0O$/A_7+&#4]&US1=5L)9['4])
MU73KJVOM.U"SGFM;RTGAN+>62*1'/^!5>6=WI]W=6%_:W-C?V-S/9WME>02V
MUW9W=M*T-S:W5M,J36]S;S(\4\$J)+%*C1R*KJ0/]3'_ (,\/VD/'/QI_P""
M77B7X8>.=2O=93]F3]H+Q;\,/ 5]>RRW$EK\-O$'A;P?\1M&\/M=3L\LJZ#X
MD\5^,+6PB,ABT[0)-#TJTC@L["WB4 [W_@[U_P"4-_B__LX3X%?^G?6:_P H
MFO\ 5W_X.]%8_P#!&[Q@0"0G[0?P*9B/X5.LZPN3[;F4?4BO\HB@#_<D_P""
M;/\ RCJ_8&_[,K_98_\ 5&>!*_%S_@[K^).J^!/^"-OCKP[IMS+;P?&#X\_
MSX;:R(G*&XTJRUW4_BF;9RK*3%)J/PRTXR)R)%0HZE&:OVC_ .";/_*.K]@;
M_LRO]EC_ -49X$K\>O\ @[1^%&K_ !+_ .",OQ;U_2+:2\?X+_%OX(_%?4+>
M"%Y[C^R%\7CX:ZC<QQQ@N(].A^)']IWTP4I;:;9WMS,4@AED0 _R9[6=K6YM
M[E4CE:VGBG6.92\,C0R+($E0,I:-RNV10REE) 8$YK_4JTC]J#_@[OU[2=+U
MS2OV$_\ @EO=Z7K.G66JZ;=IXP\2A+JPU&VBO+.X0-^V<&"S6\T<BA@" PR
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M?A);PZ];^%=0UW2=3T:SU^6P72I]4L;FPCNFNHFB !_E?_\ !WM\1M4\:_\
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MQ_9+_P"S1S_ZN3XD4 ?@K_P0R_Y2_P#_  3L_P"SI/AK_P"G,U_M/5_BP_\
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MS>)OA+XHBA\4_"_Q$]P%$%S>W_@K5]'CUS[*\L-EXCM]9TII3<:?.J_TD?\
M!FS^W_\ \*<_:P^)W[!?CC6_LW@7]JG19?'7PK@O+C;9Z;\=_AGH]S=ZEIUF
MCM';VTOQ"^&%KJRW]Q([S7FI_#GP=I%I$TUZ ?T2_P"#T7]@/_A+/A;\"_\
M@HUX&T3S-:^%5[:_ #X[W-G;[I9?AWXMU2\U7X3^*=1D14CALO"OCZ_U[PA<
M7,K2W%Y>?$WPU:(%M]/^7^ #X(?&/QW^SS\9/A9\=_A?JS:'\1?@[\0/"7Q*
M\%:J-[1VGB3P;KEEKVE&ZA22+[582W=C'!J-B[B&_L);FRN T$\BL ?Z8O\
MP6:BF_X*<_\ !6K_ ()X_P#!&W09)=6^#7PKU$?MP_MR6]H[S:='X/\ #D-Q
M;>$/!NO& B73KO4O#$FK>'(FEBN(?M7Q\\#ZCB/[(S#^MZ&&&WABM[>*."W@
MC2&""&-8H888E"1111(%2..-%5$C10J* J@  5_+;_P;7_#7QY^T#;_ME_\
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M(DOH=!EUS4_&GPJUI+,.TR:+>>!/$%CX7L;^0".^UKP3XEBB.^QF1 #\&/\
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M4?\ 1C/_ )LS^V'_ /1!4 ?RJ_\ !HC_ ,%-?V1?V-+_ /:W^ W[5GQC\)_
MAOC+J7PJ\=?#'QM\1=0C\/?#W4K[P=8^-=$\7^'=;\8WQBT3POJOV76_#FHZ
M(^OW=AIVJP0:S E_#?VEG::A_<=J'_!8'_@E'IELUW<_\%)?V&Y8DY*:?^U)
M\&-7N3P3\MEI7C&]O'X'1(&.>.I KX;_ .(7'_@A1_T8S_YLS^V'_P#1!4?\
M0N/_  0H_P"C&?\ S9G]L/\ ^B"H \(_;3_X.Q/^"67[-'A?6H?@AXWU[]LG
MXLQ6MW'H7@SX1Z+K>A>!EU9%(LSXK^+OC'1=-\.V6A3R*PFU'P-8?$;5(5"D
M:"Z2I(/X:?AY^V%^T9_P6B_X+@_L4?$3]I+5;;4I_%W[5WP$\/:#\/M!BG@\
M#_"[X,^'/BII7BO5? _@S3+B6XE2PL= @U_4-1U349KK5O$&L7%[K&M7D\UQ
MB+_0-_XA<?\ @A1_T8S_ .;,_MA__1!5[;^SE_P;^?\ !(K]DOXV> /VBOV?
M_P!D>+P'\8OA?J=YK/@7Q?+\=/VEO&"Z%J=_H^I:#<W@\.>._C)XG\*:E*=+
MU:_@A&KZ%?I:S2QWUJD-_;6MS" ?LC7A'[37[-/P8_; ^!7Q'_9P_:"\&6'C
MWX3?%/0)M \4^'[W,4RKYL5YIFM:+J$8^U:+XE\.:M;6.O>&M>L'BU#1-<T^
MPU*SE2>V0U[O10!_D"_\%@O^#?']KG_@ESXM\3>.-#T'Q#\?/V.'O9+OPM^T
M%X4T5[N?PAI5S.PM="^./A_2A<S^ M=TXM!8OXJEA3P!XGDGL9]'UBRU>]O/
M"FBI_P $)/\ @N?\0_\ @D+\4O$/AWQ7H.M_%7]D+XO:K8ZA\6/A=I%Y!'XD
M\+^)+2VCTVV^*GPM&J7=IHT7C"#3(K;2_$6AZC<Z=I?CO0]/TO3-2U72K[1/
M#VM:1_K[3P074$UM<PQ7%M<1207%O/&DT$\$R&.6&:*0-'+%+&S))&ZLCHQ5
M@5)%?B'^U5_P;F_\$A/VMM5U/Q1XQ_9/\/?#'QSJUQ+=WOC7]GS6=8^"]]<7
M=R2]W>7?A?PC<V_PWU._O9S]JN]2U?P/J&HW%T9)Y+LR7%TTX![O^S9_P6O_
M ."5W[5GAG3O$7PL_;?^ >GWE_;)-+X(^*?CS1?@U\1]-FVI]JM+SP)\4;KP
MIXAN&L9G^S7&H:19ZIHDTH$NGZK>VDMO<S>O_%;_ (*@?\$Y/@AH=UXA^*/[
M<W[*?A6QM(9)_LDGQT^'>J^(;Y8E#O'HOA/0M?U3Q3K]T$(86>AZ-J%VRG<L
M!'-?SJZ__P &4W_!->^O9+CP[^T7^VQH-K+,9/L%YXP^!^N1P1LV3;VLY^!.
MF7(C0';$]U)>3*H'FR3N"S>V?!K_ (,\/^"1OPTU2TU7QW+^TW^T$+>199]"
M^*'Q?TSP_P"&[IE<,$:#X+^"/A5XA2 A0K1-XFE9P7#2%6"J ?)G[7__  <2
M_'__ (*%>-[W]@[_ (("_"#XC_$[XE^,X9=(\7_M>:SX9N_"FC_#OPK>S-IU
M_P"*O ^F^)K>T_X0'31'/$O_  M[XNKX6ET"X,ECX8\%7OB:]\/:[9?N?_P1
M3_X)2V__  2E_9F\0^ O%'Q/U7XS?'WXW>,O^%M_M$_$6YO-0N- U3XB7FGQ
MV4FF>#UU:--:N="TB'SDE\2>(RWB7QCK%SJ?B75(='BU"Q\-Z'^B?[.W[+?[
M.?[)'@"W^%O[,WP5^''P/\!02+<R>'OAUX7TSP[!J=^L8A.K>(+RS@74O$NN
M2Q )<:[X@O-3UBY4 7%]+@8]ZH ***^>OVF?V6?@I^U_\.(OA/\ 'O0O%?B+
MP-!XCTWQ7'I_@_XK?%KX.:K_ &WI-IJ5C8S2>+/@QXY^'WB^:R2VU>_2?1IM
M=?1;UY(9[[3[B>SLY+< _D;_ .#U_P#:$^%MM^QY^S)^RS%XQT.Z^,VO_M.:
M-\<9O MGJ-M=>(=)^'7@;X3_ !:\$S^(==TVWDDN=&TW5_$/Q-TFST"?4X[5
M=>ETW6_[(-X-"U<VG^;A7^P7J_\ P;$_\$/O$&I7FLZ]^Q=J.MZQJ,QN-0U7
M5_VI_P!LW4M2OKA@%,]Y?7G[0\UU<S%553+/*[D* 6P!6=_Q"X_\$*/^C&?_
M #9G]L/_ .B"H ^5_P#@T+_:&^%?Q!_X)2^%O@/H/C3P_=?%CX!?$[XMV?CW
MP -2MD\6:-HOCKQWJ?C[POXGFT*21=1?PSK5MXHET^PU^&WDTJXU?2=8TI+H
MZAIE[;P_U35^#OAS_@V8_P"")G@_5K;7_"7['6N>%M=LM_V/6O#G[5_[:6B:
MM:>:ACD^S:EIG[15K>0>8A*/Y4R;T)5L@D5^P/P#^ WPQ_9E^$_A;X)?!S2_
M$&B_#GP8VN-X>TWQ3\0/B'\4M=MCXC\1ZOXKU?[=XZ^*OBKQKX\UL3:YKFI3
MVPUSQ-J0TRSEM](TL6>CV&GV%J >PUFZSK.C^'-)U/7_ !#JVFZ%H6BV-UJF
ML:UK-]:Z7I.DZ98PO<WNHZGJ5]+!9V%C9V\<D]U=W4T5O;PH\LLB(K,-*ORF
M_:5_X(F?\$U_VP/'?C/XC?M'? _QY\2_$GQ U.VUCQ5;W?[5/[7?A_PA?:A9
MVEC8VTUE\.O"'QX\/_#W0DB@TVR(MM \+Z7:FYA-ZT#7LLUQ( ?Y,G_!5[XU
M>"/VBO\ @I5^W%\:_AGK-KXD^'?Q _:6^*NK^!O$MBQ?3_$WA.#Q/>Z9H'B3
M378*[Z;X@TNPMM8TYW1)&LKV!I(XW+(J?\$HOC1X'_9W_P""E7[#GQJ^)NMV
MGACX=?#[]ICX4:SXZ\3W[,NG>&/"<OBFPT[7_$NI/&KR)IGA_2[ZYUC47CCD
ME2RLIVCBE<+&W^GO_P 0N/\ P0H_Z,9_\V9_;#_^B"H_XA<?^"%'_1C/_FS/
M[8?_ -$%0!^].A:]H?BC1=*\2>&=9TKQ%X=U[3[35M#U_0M1L]7T76=*OX$N
M;#4]*U33YKBQU'3[VVDCN+2]LYYK:Y@D26&5XW5CJU^4?[-G_!$?_@FI^R#X
MZ\&?$7]G+X'>//AGXD\ :M-KGA:WLOVJ?VO->\(V6IW%O>VL]Q??#OQ9\>-?
M^'VO)+%J%XSVOB#PQJEH;B7[7Y'VJ.*9/U<H _A__P"#B?\ X-IM?_:4\5^,
M?V\/^">OA>PG^-FNM<Z_\?\ ]G&P:STE?BYJOSS:E\4?A?+<S6NF6_Q-OE!N
M/&7@Z>2T@^(=RLOB'1+@>/[C4--\<_Q@?\$UOVYOCA_P1^_;U\(?'9?!GB?3
MM6\!ZCJGPW^/_P $_%%EJ'@[7_%?PWUJYLX?'?P]UW3=:M+:_P! \1V-QI^F
M^(O#QU6R0:/XU\.>'KW4K*ZLK6[L+G_:_KX,_;&_X)@?L"_M^6BI^UI^R]\,
MOBQK<-G'I]EX]GT^]\)_%/3+&'<;>PTWXJ^![[PU\1+/3(';S4TB+Q*-(>0
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M.?Q(DMIOB)^R[XZ\>RV1<V<OC3]L?]N/Q3):&0 2&V?7/VDKYH"X #F(IN
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M-4\(:=KO^O!%%%;Q10011PP0QI%##$BQQ111J$CBBC0*D<<:*$1$ 55 50
M*X_X=?#?X>_"'P3X<^&OPI\#^$OAM\//!^G1Z1X4\#>!?#VD^%/"7AS2XF>1
M+#1/#^AVECI>FVHDDDF:*TM8E>:669PTLCNW:4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD0V=C:001Y)6,$DD ZJOX2O^#US]D/XG^-? 7[)O[9G@SP]?^(/A[\&QX_\
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M7W@_Q%I6OZ.7OO#_ (J\+2ZWX@M-,U&2RUG3)-*\2:]97VB74UQ87NF_KO\
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M#=SI$E[K&JW+--J7B#Q%J?D0R:SXF\07VI^(-:GC6YU74[RXS*?;J /\R/\
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M>ZSX3UN32[JRU2RVZMHF@^(M&U33KJ.?3/$>@:/>SP:EI\5[I.H?[#/[<?\
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M:1J5G)-:7^G:C8W$%U9W=O+)#/!*DD;LK U^$'_$+C_P0H_Z,9_\V9_;#_\
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M$G@DTVYT6YTV233[C2YK9[&:Q=[22!K=FC/\]/C[_@U3_P""+GCWQ_>>//\
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MC^3_ -M+_@CQ_P $[/\ @H=X^T/XF_MB? 75OC%XO\->&K+PCH-S+\=/VBO
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M(JNC*Z.JNCHP971@"K*P)#*P(*L"0000<5^ ?_$+C_P0H_Z,9_\ -F?VP_\
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M1AJ"7*C_ %C/^"?W_!O3_P $R/\ @G/XLTOXG?"7X3:[\3_C3H4BS>'OC/\
MM ^(+/XC>-O#%PJD+?\ A'3++1/#'P]\(ZTFZ18O$OAKP/I7B>*&::U36A:2
MR0-_F _\%K/^4M__  4;_P"SP/CC_P"IQJM ']$W_!D;_P GC_MF_P#9L_AG
M_P!6EHE?Z2E?YM?_  9&_P#)X_[9O_9L_AG_ -6EHE?Z2E '^5%_P=T_LE>.
M_@E_P53\5?M$W>@7R?"S]KOP+\/?&/A#Q1%;2'0V\9?#?P%X7^%'C[P@;PH(
MU\0:=_PB6@>+]0LRS'^SO&^E74;MYLT5M\(_\$"?^"EWP]_X)7_\% -*_:"^
M+^@>)M>^$7C7X6>-/@C\2I/!MI:ZGXH\/>'O%VK>$_%.G^)])T:\O=-@UI=(
M\6>!?#;ZMIRW]O=OH,NJW&FI?:G;V>FWO^ME^UK^QU^S9^W/\&M;^ ?[4_PI
M\/?%KX9ZW-%?C2=9%W9ZGH&N6L4\-AXG\(>)=(N;#Q%X0\4:?%=74-IK_AW4
M].U%;2[O=/EGETZ_OK2Y_FVMO^#,/_@E5!XR;Q%-\4?VT;SPY]M^V)X F^*7
MPJCT+RS)O.ER:O;? V#Q<^E!?W2;/$$.L! "^M229D(!\ _\%4O^"]7CC_@J
MO\!?C[^QY_P2(^''Q4O_ (::)\ ?BQ\7OVU_VE_'.@'P)IOAS]G'X<^!M=\7
M>.O!7AVW:[U&]T>S^(.D:/=^$M2U/Q,-%U7Q7)>R?#WPYX?O;;Q%?Z]8_P"?
M/7^XA\%?^":G[#_[._[+7C_]C+X-_L_>%/ ?[/?Q:\%>+? 'Q7\*:'?>([3Q
M!\3/#_CKPQJ'@WQ8_CCXDQ:TGQ*U_7=6\,ZK?Z1'XGNO%I\0Z-92Q0>']2TF
M.RL$M?SI_P"(7'_@A1_T8S_YLS^V'_\ 1!4 ?*__  9\?$[PAXO_ ."2-MX!
MT?7-,NO%GPD_:"^+FB^,?#\5[;MK&CKXJN]*\;>']0OM-#_;+?3=9T_7)8]+
MU"2(6E_<Z7J]K:SRW&EWT5O_ $E_'SX)^ ?VD_@C\6OV?OBGIKZO\.?C1\._
M%WPR\:6,$B07DGA[QGH=[H.I3:;=/'-]AU:S@O6O=(U%(VFTW4[>TO[?$]O&
MP_-/]FW_ ((&?\$GOV0OB_X2^/7[./[+^K?"_P"*W@>^_M#P[XGTS]H[]JK5
MX8I_*DA:'5?#GB;XX:WX5\2:<Z2N9=(\2:)J^E2R".62R:6&)T_8>@#_  \?
M^"B__!/WXZ?\$U/VI?'_ .S+\<M#O(;G0-1N[_X>^.DL+BV\,?%KX;7-[<Q^
M%_B)X1NY \%UIVL6<(CU.QBN)[KPUXAM]5\,:OY.K:3>0I]C_P#!&3_@MU\?
MO^"/OQ,\2W'A;P_;?&#]GCXHW.FS_%OX$:UK4V@PW^J:6AM=/\=> O$B66K#
MP=X]L+!WTVYO'TG5-%\3Z-Y.E>(M*N;C3/#.L>&_]9/]L+]A7]DO]OGX;+\*
M/VM_@?X.^,OA&UFN;O0FUV"\T_Q/X/U&[BCAN=6\#^-] N])\8^"]4N8H88;
MR\\,ZYIDFH6\*6>H_:[/=;M_.3XK_P"#+W_@EAKWB";5M#^+G[:_@?2;B=Y6
M\+:#\3OA#J6EV43,S+;:5?\ BSX#^(M>BC0$(LFJZMK4Y507D9RSD \%\>_\
M'I_[.?B#P9:Z!^R]^Q)^TQ\0_P!HWQ4UKX?\%^!O'S>!=)\&3^,];DCT[1;.
MUOOA[XL\?>.O&A;5;FWCM?#NE>#?#^J^))/+TNTU#1[F\2\M_P!N/^"-?[%'
MQ^^"O@SXL?MD_MXZNGBK_@HA^W-K&A^/OCO,5MWL?@YX#T*TGM_A1^SGX0B@
MEN;71M#^'FB7DCZWINDW$EBFO72Z(U]XAM_"6E>(;_IO^"?_ /P0A_X)K?\
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M]F3XAZ/\3/$6D?&C]J'6O#U_;ZKH7AW]H[QEX2UWX=V&I6<JRV=U>>!?A_\
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M+< '^)'XYUV'Q1XU\8>)K>-XK?Q%XI\0:[!%( )(X=7U:[U"*.0 D!T2X56
M) 8'!-?WU_\ !C[\4_!L?AW]OOX+76NZ9:>/KG7O@=\2M&\.7-Y;PZMKOA6+
M3/B%X:U_5M)L7D%S?V7AO5/[!MM<GMXWCTZ7Q+H:W#(=1@W_ +S?\0N/_!"C
M_HQG_P V9_;#_P#H@JV?#_\ P;*?\$2/">L6/B'PK^QOK/AG7],E,^FZYX?_
M &K?VT=&UC3YRC1F:QU/3OVB;:]M)2CNADMYXW*,RYPQ! /WEHJM96<&GV=I
M86JR+:V-K!9VRRSSW,JP6T20PK)<W4DUS<2"-%#SW$TL\K R2R/(S,;- '^.
MG_P<2?L!_P##OW_@I[\:_"/AG1?[)^#/QSN#^T5\$EMK?R-+LO"OQ(U/4Y_$
MOA&P2-3;VMOX#^(=EXN\+:9IJRR7-OX7L?#5]<K&-3@#?Z+/_!NC^P1_PP+_
M ,$O/@EX9\2Z+_9/QB^/, _:/^,ZW%OY.IV?B/XE:9ID_A3PI?I(IN;2?P1\
M-[+P?X<U/2Y)7@M?%-KXFNX$B?4KA3]'_P#!17_@D9^R?_P4[\4_LP>+?VD+
M/Q4=2_99^)3>//#,7A2[T"RM?'6@W]]X>U'Q-\*OB(NL^'M<FU7X=^++KPKH
M9U>STF;1=;@CM[I-(UO36U&]>;]0P         ,  <  #@ #H* %JIJ&GV.K
M6%]I6J6=KJ.F:G9W.GZCI][!'=6=]8WD+VUW9W=M,KPW%K=6\DD%Q!*CQRQ.
M\<BLK$&W10!_C0?\%P/^"4/Q%_X)6?MC>,_ P\.ZS/\ LT?$K7=<\8?LP_$:
M2*ZO=(UGP%>7AO1X"U'6W0Q-X]^&0O8/#/BBQNGAU&_MX-*\71V<6D>)M,=_
M$/\ @EI_P5(_:(_X)0?M&P_'CX%OIWB+1/$&F1>%OB[\(O$UQ=0^#/BOX*6[
M6\32M4EM ]UHGB'1;O=J7@_QCI\,VH^'-1>YBDMM6\.ZOXC\.ZY_LO?M#_LU
M? /]K/X7:Y\%?VD_A-X*^,WPN\0F.74?"'CG1X-5L([Z!)H[/6=)N3Y>I>'O
M$6FK<3MI/B30+W3-?TF25YM,U*TE8O7\T'Q-_P"#-/\ X)0^-_$=SKG@WQM^
MUY\&].N;AI5\'>!_BMX$U_PS80.X;[-IUQ\4/A-X_P#& $:Y2*74_%NJ2!2#
M-YS#<0#YNN_^#V_]C;_A6[:CIO[&O[3ES\8FT[?!X&N]?^%EM\-VUEHOELF^
M*5OXCO?%/]G?:2(_[13X.FZ:+]Z-*60^2/TW_P""-7[//[67Q[^)OCW_ (+#
M_P#!230_^$4_:4_: \$VWPX_9?\ V?Y+*]L=*_90_90DOXO$-MHUCH6L&34=
M"\:?%#5%MM;UYM3_ .*IBT> 7&MW%CJ'C/7_  KH7H?[#7_!MO\ \$K/V#?&
M6B?$[P3\(?$GQL^+'AB[M]0\+?$G]I3Q+9?$K5?#&I6KB:VU?0/">EZ!X1^%
MVG:]9W20WFF>)(O )\1:+>017.BZKI\H9F_>:@#^'O\ X/&_BI\2?V<?B!_P
M2%_:B^#NO3>%?B?\#?BK^TEXD\%^((4\U+/7K?\ X9OU^P@U"V++%J6D7P\-
M7%AJ^CW9>QU?2+O4=+O8I;.]N8G_ '>_X)+_ /!<3]D+_@J=\+/#$GAWQMX6
M^%W[3]MI-I#\3?V9_%7B"ST[QCIGB*"!$U74_AS%JDUK/\2/ %U<AKK2M>\/
M)>WVF65U96/BZPT+6G-D_P!5_MJ?\$U/V6/^"@?C+]F;Q3^U)X5U#XB:+^RW
MX\\4_$+PG\,K^71+CX9>/-7\4^'[;0IM,^*_AW4]!U.[\6>&=-GT_2]=M/#U
MGJVB:=J6J:9;VGBB+Q#X;N-1T"^_-G]J?_@UM_X(^?M.ZC=Z_I_P-\1_LS>*
M;YV>ZUO]EGQ:GPWTUF)+1BU^'6O:-XU^$FCI"Q8JN@_#_26D!"S/(J1", _
MW_@]J\7?LO:Q>_L:^&=&U?P=JG[7GA>^^(8\5V>@76G7?B_P]\#M2L-'N=*T
M[XA?87>]L+.^\:;]0^'VG:Z5=0?'E]HL,4-]JLMUV7_!F#_P3P\=^$S\<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '\(/\ P72_X-W?C!X!^. _X*D?\$D-
M&U'3_B=X6\<:=\:_B)^S[X M8H_%6A_$KPWK,7BP?&/]G_2(XV@UBZN=:LTU
MOQ-\)[:VEOY]8%S?>"+'68=7D\):;_0Y_P $<O\ @LM\#?\ @J=\&;"UDO\
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M_;=_X);_ !+^+6O7?A7XO?!KPW9^ ?CY^RAX?\:^*K^[\'?"[Q]H\4UOX/\
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M -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\
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M^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\
M647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\
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M_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\
MX@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_Y
MI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0
M,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF
M_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH
M _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\
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M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
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MH:GXR\+QS2M=>)M>\)Z;"]W7]EX(8!E(96 *L"""",@@C@@CD$<$4 +1110
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MVU_5Q_P2;_X*)6G_  5)_8T\)_M=V7PDN/@E!XI\8^/?"2^ ;KQO'\0IK%O
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MOA_I"RM+)]G\2^'OLOQ'T[3+86UAIMSX0\?ZJZRW_B.9V /]#*BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\ ?\ @Z._Y04?MS?]VS?^MA_L^U_D"U_K]?\ !T=_R@H_;F_[
MMF_];#_9]K_(%H _O\_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\
M?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^B3WVN?#[X=Z?I[WWA+1O&&O:8?[/U#0?"\?Q-OO#GVK3=1UKXA> TU*Q:X
M/\_VO]F?_@WU^-/C#]H#_@C=^PA\2/'FM7OB+Q1_PJ_Q#\/K[6]2G>ZU+4;7
MX,_$_P >?!O19]0O)2T]]?C0_ 6FQWE_=/+>7URDEW>3374TLK_XS%?Z^_\
MP:WDG_@A3^P\#_"_[3('L/\ AK_X_'^9)H _H!HHHH *_P Q/_@]7TNRM?\
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M  F/A+1(&%O9:I8?$'2]*M--\/:-HMA#_GZ?LL?M;?M&?L4?&#0/CO\ LO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /\ P='?\H*/VYO^
M[9O_ %L/]GVO\@6O]?K_ (.CO^4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_P Y
M1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ=%\<ZWI]HD5BOCF'Q+X<U?4;*SMI?$FG^(O$,^I>)+X _TEJ*_AET;_ (+
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M:2S#M,FBWG@3Q!8^%[&_D COM:\$^)8HCOL9D3^E6O\ $Q_X):?\%2/VB/\
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ME?LH?LH27\7B&VT:QT+6#)J.A>-/BAJBVVMZ\VI_\53%H\ N-;N+'4/&>O\
MA70OZ*: /Y4/^#QG68M+_P""0^GV,CA7\1_M8_!;1H%) ,DL'AOXG>(2@R<D
MB'0II,#)PA., D?Y;G@KPEK/C[QEX2\">'8#=>(/&OB;0?"6A6H#$W.L^(]5
MM-'TR !06)FO;R",!06.[@$\5_H[?\'N'Q/M=(_8P_8Y^#+7*)?>/_VG=?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /_!T=_R@H_;F_P"[
M9O\ UL/]GVO\@6O]?K_@Z._Y04?MS?\ =LW_ *V'^S[7^0+0!_?Y_P &,?\
MSE%_[LF_]^XK^_ROX _^#&/_ )RB_P#=DW_OW%?W^4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\U?M7?L>_LT?MQ?"/4_@9^U7\(?"WQD^&6IW<.I+H?B)+ZUOM%UJV
MBG@M/$/A3Q-HEYI?BGP=XDM;>ZN[6W\0>%M9TC6([*\O;'[8;*]N[>;Z5HH
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MDE8(K7FK:3K6E:=;@L0#)=ZA>VUK"O5YID1068 _[/\ 0!_,;^S#_P &D_\
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M)_C=\>H2'M5^(1UF]FU[PO\ #R1&E\):S+#K_BV.T\66-IX=\._W%T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!
M1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\
MG*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%?S!?\ !:O_ (-O?^'P?[4_@']I?_ALO_AG?_A!_P!G
M_P *_ O_ (0K_AG?_A;?]J?\(S\1?BKX_P#^$I_X2/\ X7G\,OL7VW_A9O\
M9/\ 8G]@W?V;^Q/M_P#:]Q_:7V.P /Z?:*_@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN* /[_**_@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KB@#^_RBOX _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KB@#^_
MRBOX _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N* /[_ "BOX _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KB@#^_RBOX _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XH _O\HK^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XH _O\HK^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MB@#^_P HK^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XH _O\HK^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN* /[_**_@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN* /[_**_@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XH _O\ **_@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN* /[_**_@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KB@
M#^_RBOX _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KB@#^_RBOX _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN* /[_**_@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN* /[_**_@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XH _O\ **_@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M* /[_**_@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KB@#^_RBOX
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KB@#^_RBOX _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N* /[_ "BOX _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KB@#^_RBOX _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XH _O\HK^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XH _
MO\HK^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KB@#^_P HK^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XH _O\HK^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN* /[_**_@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN* /[_**_@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KB@#^_P HK^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XH _O\HK^ /_B!C_ZRB_\ FDW_ .5Q1_Q
MQ_\ 647_ ,TF_P#RN* /[_**_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P T
MF_\ RN* /[_**_@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XH _O\
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M ,TF_P#RN* /[_**_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*
M/[_**_@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XH _O\ **_@#_X@
M8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN* /[_**_@#_X@8_^LHO_ )I-
M_P#E<4?\0,?_ %E%_P#-)O\ \KB@#^_RBOX _P#B!C_ZRB_^:3?_ )7%'_$#
M'_UE%_\ -)O_ ,KB@#^_RBOX _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__
M "N* /[M?B_X8^(/C3X8^-O"OPI^)[_!?XC:]H%YIW@[XK1>#-!^(<G@/6YP
MHM?$2>"/%#Q^'?$SV6&*Z5K#BQN"P\[*KM/\@G[3'_!HMXM_;&^,/B;X^_M-
M?\%8_C%\7OBWXN%G'K7B[Q)^SCX.@D^QZ=;K:Z;I.D:/HWQ4TSP_X;T'3+=?
M*TWP_P"'-)TK1-/5Y3:6$+32E_D7_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_
M\TF__*XH ]@\)?\ !E#X4\ ^*O#/CGP3_P %,_BMX3\9^#-?T?Q7X2\4^'_V
M?]&TK7O#?B7P]J%OJVA:]HNJ6?QDBN].U;2-3M+74-.OK66.XM+NWAGAD22-
M6']7G[&_P _:_P#@5;>*;']J3]O+5_VV+:_T[PY8^"YM=_9R^$WP*U7P;+I+
M:J-9O;W4OAC<.?&-QXB@NM)AE?6;>*6Q?1S<QS7%QJ=X]?QQ_P#$#'_UE%_\
MTF__ "N*/^(&/_K*+_YI-_\ E<4 ?W^45_ '_P 0,?\ UE%_\TF__*XH_P"(
M&/\ ZRB_^:3?_E<4 ?W^45_ '_Q Q_\ 647_ ,TF_P#RN*/^(&/_ *RB_P#F
MDW_Y7% ']_E%?P!_\0,?_647_P TF_\ RN*/^(&/_K*+_P":3?\ Y7% ']_E
M%?P!_P#$#'_UE%_\TF__ "N*/^(&/_K*+_YI-_\ E<4 ?W^45_ '_P 0,?\
MUE%_\TF__*XH_P"(&/\ ZRB_^:3?_E<4 ?W^45_ '_Q Q_\ 647_ ,TF_P#R
MN*/^(&/_ *RB_P#FDW_Y7% ']_E%?P!_\0,?_647_P TF_\ RN*/^(&/_K*+
M_P":3?\ Y7% ']_E%?P!_P#$#'_UE%_\TF__ "N*/^(&/_K*+_YI-_\ E<4
M?W^45_ '_P 0,?\ UE%_\TF__*XH_P"(&/\ ZRB_^:3?_E<4 ?W^45_ '_Q
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M0,?_ %E%_P#-)O\ \KB@#^_RBOX _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\
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M_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN* /[_**_@#_P"(&/\
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M -91?_-)O_RN* /[_**_@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XH _O\HK^ /_B!C_ZRB_\
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M-]J,-O86]W%86P!^J]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQJ_@;0M0U/4;R8\RW5]>W$]S<2'EY978\FO:J "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "ORS_X+9?\HK/VT_\ LE=M_P"IEX7K]3*_
M+/\ X+9?\HK/VT_^R5VW_J9>%Z /U,HHHH **** /RX_X+;?\HB_^"C'_9I'
MQE_]1.^K]0X?]5%_US3_ -!%?EY_P6V_Y1%_\%&/^S2/C+_ZB=]7ZAP_ZJ+_
M *YI_P"@B@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_#5_P""CWA[
M3?"/_!0W]O+PIHUM#9:/X8_;._:B\/:59V\:Q6]IINB_'#QSIMC;01( D<,%
MK;1111J J(BJH  %?[*/_!-3PMI/@C_@G7^P=X3T.UAL],T+]CK]FJPMX8$6
M-69/@YX.>YNI-JKYES?73SWMY.P\RYN[B>XE9I978_XY?_!4;_E)G_P44_[/
MK_:Y_P#5_P#Q!K_99_8%_P"3%/V*_P#LTO\ 9Q_]4[X-H ^M**** "BBLCQ!
MX@T'PGH6L>*/%.MZ1X:\,^'=,OM;\0>(O$&I66C:%H6C:9;27FI:OK&KZC-;
M:?IFF:?9PS75]?WMQ!:VEM%)/<2QQ(S  UZ*_G#^*7_!T;_P37\.?$G4/A%^
MSUH'[4G[=OCW33<I<V'['/P.N?B'I>^QE\F]GL=6\6>(O 2^(M)M96B4^(/!
M]KXET&Y$\$EAJ5Y#)Y@\,TK_ (.\O^"=^A>/U^&_[0W[/_[=?[+7B!6MWOY?
MC#\#_#4,&B6=RSB*]UG0O#GQ(UKXA0P,$9D^P>!M2:54D$(D9-K ']5]%>&?
MLY?M,? /]KKX3^'OCE^S5\5O"/QC^%/BCSX])\8>#M0-W9K>VGEB_P!&U:QN
M(K75_#OB+3&EB35O#?B'3]+U_29)(XM2TVUD=5/N= !17XN?MV?\' '_  2\
M_P""?_\ ;.@_$[]H32OB=\6-'\^&7X(?L^K9?%?XC1:C;[A+I6ORZ7J5KX&\
M!ZE$P3S+#XA^,_"E\8Y$EM[6X4XK[@_9+_;7^$W[6?[&GPT_;ATM;WX3?![X
MC^!-7^(KR?%K4O#7AVX\%>&-"U36M,U74/&FK6VM7_A?2+2P70KS4+R_.N2:
M?:6&V>YNH@LHC /L.BOY9/VC_P#@[Y_X)/\ P,\;7_@?P(G[0'[3CZ5>266H
M>,_@CX"\,P?#P36TBQ7D>F^(?BCXZ^'6H^(%C?S%M-2T#0-2\/:F(FN+#7)K
M*6VNI_TP_P"":_\ P6S_ &!_^"J*:OHO[-GQ U[1?BKX<TMM=\0_ KXN:':>
M"OBQIV@)-#;2^(+'3++6/$/AKQ9HEK<W%O;ZGJ/@GQ3XEBT.6ZL(]?&E/J>F
MK=@'ZUT5\\?M0?M8_LY?L7_";6?CC^U%\7O"'P9^&&B2QVLWB/Q9>2K+J>J3
M13SVN@>&-"TZ"^\1^,/$U[!;74UAX9\*Z3K&OWL-K=36NG2Q6UP\?\S7B?\
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M8V]UI>B:I9Z;HJW9O=8N8;?_ $:G=(T:21E1$5G=W8*B(H+,S,Q 55 )9B0
M 23@4 .HK^?O]I;_ (.7_P#@F#^S_P#%"?X'^!O%'Q<_;&^,EKJ5UHEQX _8
MT^&P^+]PNN6A=9](L?%&HZ]X/\"^);VW\J<WD/@SQ1XFDL#;7,-ZD%W"UM7R
M?K/_  =S?L0_#;QAIW@_]HK]C[_@HO\ LW76K[I;"Z^*_P "?!&AL+%)HXI=
M2NM#N?BS;>)Y+* R#SWT31-<D1RL:QR.ZY /ZM**^1?V-?V\/V3/^"@7PP?X
MO?LC_&GPO\7_  ?9W<&F^((]*74=)\4>#=9N(#<Q:+XW\%>(;+2?%GA'4YH4
MEFLX==T>RCU2VBDOM(FO[#;=-]=4 4=4U.PT73-1UG5;J.RTS2;&[U/4;R8D
M0VEA86\EU>74I4,PCM[>*260A20J' )XK_)U_P""7O[0WB?_ (*(_P#!S7\!
M_P!I7XF37.J:C\6_VG?B7\4-)T_4W-R/#/AKP+\,/B'XC^%GA.S\TR&.Q^'W
MAGPCX4\/Z,"S20V^@VLCRR7 >9_[)/VGO^#F_P#X(V:]\#OVAOAMX7_:KUZX
M^(>L_"GXL^!_#NF?\,^_M&6B3^,]1\(:_H.DV']J7/PL@TVV637)K>W^WW%[
M#8PAOM$MU';JTH_SW/\ @AQ^U!\$_P!C'_@J?^RC^TO^T7XKG\#_  9^&&J_
M%.Z\:^*;;P[XD\63Z3#XE^!?Q/\ !>B/'X?\(:3KGB+43=>)/$>C6)73=*NV
MMUN3>7(BL[>XGB /]I>OYL?^"E7_  ;"_L1?\%'?VF;;]J75/''Q,^ 'CSQ+
M<Z4WQOL/A1:^%9M$^+RZ7'#:#7WM/$&EWB>$?B#?:7;P:7JGBRQ35--U1+2U
MU+4_"M[KS:CJVI>C:!_P=%_\$3/$VNZ+X;T7]K+7[K6/$.K:=H>DVK?LZ?M)
MVZW.I:M>0V%A UQ<_":*W@$UU<11F:>6.&(-OED1%9A^@_[>7_!4+]B?_@FA
MIOPSU;]LOXL7_P ++#XOWWBK3O $UC\.OB3\03K5WX+@T&Y\1Q21?#KPGXIE
MTL6,/B;1G635DLH[LW3+9M.UO<B( _EK_P"#O7XYZ?\ LB?L!?L3_P#!-;X#
MK+X*^&OQ$,.G:EX>TR]NY/LWP*_92\.^!?#_ ,/OA]J,]S++/>Z-?>)?$'A/
M6EEN99KRYU#X9VLEQ.5:X6Z_4;_@TR\+6/A__@BI\"M6M+>.&?QQ\4?V@_%.
MIR(BJUW?6GQ9\1^"H[B9@ 9)%TWP?I]H';+"&VBC!VHH'\;_ /P=%_\ !2W]
MD3_@I3^T'^R_XR_8\^*5_P#%'P7\,?@WXJ\,>*;V^\!?$/P"VD^*-;\;2:JM
MK'8?$/PQX7O;X7&DV]C,UWI]K<VJE!#).)D\M?W%_P""!W_!?/\ X)8?L/?\
M$L/V=/V:/VEOVB-7\ _&;P#JOQKNO%GA:T^"GQQ\80:=#XP^.GQ'\:>'G7Q!
MX,^'>O\ AV^-[X;U_2+YEL=5N6M6N#9W8@O()X(@#^PK]LG]CSX$?MY?L[?$
M+]F#]H[PJ?%/PR^(FGQ079LYX[#Q'X8US3YEO/#WC3P9K3V]T="\7>&-3CAU
M'1]1^S75J[I-IVK6&J:'J&J:5??B'^P1_P &LO\ P3E_8VM?C2GQ0TJ\_;2N
MOC!I-OX0C7]H#PMX4ET?P+X&L]<L/$D6G^%-(T2TB:Q\7WVLZ3H]SJ_C^VO[
M/5VAT>RLO#UKX9L[G78-:_6/]@__ (*<?L7?\%+-"^(OB3]C;XJW_P 4M'^%
M.K>']#\=75]\/?B/\/VT?4O%%GJ5_HD$=O\ $3PIX6N-2%W:Z1?R--I<5Y#;
M&$)<R0O+$KP?MI_\%2_V!O\ @GSI,][^U;^TM\/?AUX@6S%[I_PTM;^7Q=\7
M=<BDCWVCZ1\+/",.M>-Y;.\<QPQZW=:-9^';>2:)]0UBRMRTZ@'T;^SO^S+^
MS[^R5\-K'X0?LT_!_P !?!/X:V%]=ZM'X2^'^@6>A:==:SJ"P1W^N:M) AO-
M<UZ^BM;2"\US6KJ_U:YM[.SMY[QX+2VCB]SK\L_^"6?_  5J^ '_  5L\"?&
M/XD_L\>"?BOX/\)_![XDV_PWO)OBQI7A;1M4\1W-YH=OX@M-;TG3O"_BSQ:E
MKIL]E<QCR=3O+74(I#MEME(8+^IE '^<#_P>\^'M/MOVJOV(/%<5K FJZU^S
M[\0/#U[>K&@N;C3_  S\1H]2TRUEF \QX+.Y\6ZO-;QLQ2*2^N60!II"W]$G
M_!I3_P H6O@S_P!E<_: _P#5EZM7\_O_  ?!?\E^_8&_[(_\:/\ U-/!E?T!
M?\&E/_*%KX,_]E<_: _]67JU ']+5?+G[4G[$W[)G[;/AC0O!_[5_P"S_P##
M3X[:#X6U*?5O"T/CWP]!J.H>&-0O(X(K^X\-Z[ UKKV@_P!J0VMK#J\.DZE:
M0:M#:6D6I174=K L?U'7Y3_MT?\ !;#_ ()L?\$\8]5TO]H3]I'PK/\ $O3$
ME'_"C_A>Z_$[XR2WD:EH]/U'P?X9FN(_!<UTJO\ 9+WXCZGX,T:=D9%U3S,*
M0#]%OA3\)?AA\"_A[X6^$WP9\ >$?A=\,O!.G#2?"7@/P)H.F^&?"WA^P,TU
MU+#INCZ5;VUG UU>7%S?WTXB-SJ&HW5WJ%[-<7MU<3R>A5\%_P#!-O\ X*"_
M"W_@IQ^RWX?_ &L/@[X.\?\ @7P-XD\6>-/"5AX?^)=OX=M?%D5UX)UF31;V
M[NX/"VO^)M'CM[R:/SK58=7N)!&<3!&&#]Z4 %%?DO\ M_\ _!;O_@G+_P $
MU]6'@S]HWXWI=_%V2SMK^'X'?"O1+SXC_%9+.]C2:RGUK1M(>+1?!27]M)'=
M:6?'WB'PI_;%K(MQI OHB6'Y>^-_^#LG]EKX::98>,?B-_P3Y_X*E> /A?JD
MMJFG?$7QO^SOX \*:'J$=]($LYK"ZUWXRV.BWB7:E7M5@U]Y+C(6)&8@$ _J
MJHK\G?\ @GO_ ,%L_P#@G9_P4SU&;PE^S3\:63XLVFF3ZS>_!#XFZ'>?#[XJ
MQZ7:1B:^O])T;4GN-%\96FFQ'S=7N? 7B'Q5!HT($VK264,D+R?J!XO\7^$_
MA_X5\1>.?'GB?P_X*\%>$-%U+Q)XL\7^+-9T[P[X8\,>'M&M);_5]=\0:]J]
MQ::7H^CZ78P3WFHZEJ%U;V=E:PRW%Q-'%&S@ N:_KVB>%="UKQ/XEU;3M \.
M>'-)U'7O$&NZQ>0:=I.BZ)H]G-J&JZMJFH73Q6MCIVFV%O/>7MY<RQP6UM#+
M-,Z1HS#\$_\ @A)_P4G\=_\ !3O4?^"CGQKU7Q!>W_P>\-_MBR^"?V:/#=W8
M66GCPC\$]+^'WAZW\,H8H;*VOQJ?BR.U'C?Q'%JMQJ%Q:>(O$&J6EM<)8PVT
M,?\ +Y_P<:_\')7A?]J;PCXH_8,_X)_^)[Z^^!6M.^E?M!?M!6D%]I'_  MZ
MSM+F.1_AG\,DNDM-3A^&,MS /^$R\575M9S?$-(QH&CPCP"^I7WCK._X->/^
M"Q'_  3Y_P"";7[,W[2?PZ_;$^->I_"_Q=\0OCKI/C7PGIEC\*_BSX^34O#E
MKX T30I[Y[_X>^"O%&GV+IJ=G<6XM+^YMKQ@@F6 P.DC '^DM17YV_L%?\%5
M_P!AG_@IE)\5(OV,OB]J'Q4D^"R>"9/B,M_\-OB=\/O["3XB-XM7PD8C\1?"
M'A4:M_:3>!_$H<:.;XV/V!#?BV%Y9?:/T+NKJVL;:XO;VX@M+.T@FNKN[NIH
M[>VM;:WC:6>XN)Y62*""")'EFFE=8XXU9W954D $]%?SJ_M.?\'0O_!+O]G_
M ,=:O\+OAYKWQA_;+^(>A27=OK.C_LA_#VU^)&@:9=6;^7/N\>^(?$?@KP5K
M]A [(+G5? NM>,;&W9_)>4W22VZ?+7P@_P"#R#_@EUXZ\80>$/BG\/\ ]JO]
MGE);\V-SXO\ 'OPW\*>)_"6B,LWD2MKT/PU\?>+_ !W:26\F?M$-AX$U5H0D
M@=@Z;& /ZSZ_.3_@J/\ \$S/@9_P5:_9?O?V:?C?J?B/PI'I_BO2OB'\.OB)
MX/\ L3>)OA[\0=#T_5](L-=M+/4HIM.UK2[S1M?UO0O$'A^_6.#5-)U2X:TO
M-)UJUTC6],^T/@]\9OA1^T%\-_"OQ@^"'Q$\(_%7X7^-M/75/"OCGP-KECXA
M\.:S:>8\$WV;4+"6:)+NRNHI['4].N/)U#2M2MKK3=2M;2_M;BWBB^-?Q;\+
M_ 7X2_$+XR^-++Q3J?A?X;>%=5\6:SI?@CPQJ_C7QCJEII5NTPTOPOX3T&WN
MM7\0:]J4OE6.E:790F6ZO9X8V>&(O-& ?YF?_!;?_@V]^#G_  24_8:\'?M)
M^&_VI?'OQB^(VL?M ^%?A/J.C^)O!7AGP3X2U30_%GA#Q]XBB?P_H^G:GX@U
MNT\1Z1+X+^T7,EWXFU.PO]*>_=+#3YK2.2;_ $5O^"=O@_QE\//^"?W[#/@'
MXBQWL'Q \$?L>_LT>$?'%OJ7F?VC;>+O#GP8\%Z/XCMK\S?OFO+;6+.\@N6F
M_?/-&[3?O"U?A?I7[*G[77_!;S]J[X(?M.?M[_ CQ#^R)_P3B_97\6M\2/V:
M_P!B_P"*'V8?'K]H7XD1/;_V/\3OVE/"D+W%KX#T"U2TC3_A76MJ=5MM,.I^
M$(;'4=%\5:]XUUK^I:@#^.G]H+_@S5_8R^-7[3'C_P"-'AC]I+XR_![X7_$7
MQ'KOC'4?@AX3\*^#M6/AO7_$=[<:IJ5IX)\>Z[+<#2/",6IW4\NE^'M6\&>(
M;S3;)ETZ+7I((8&B^-/^#-GX)^*_AA^TE_P59M]-UB?7_A7\.M;^''P3C\50
MQ/:Z+XX\5^%?'GQ?CTG6-/C66>UFGLO#FF7NHW$4-Q<OI5IXQT]7E,>IPO-_
M0I_P4-_:U_;G^*GCSXA?\$\O^"8W[/GQ!C^-]SI^C>&/C)^W1\5-$U+X?_LO
M?LMZ#\0?"6B>)&UCP3XVU&V:;XR?&+3_  AXKTS4;#P]\/K'7&\&ZGJ%C?WE
MKKNHZ3K&@Z;]C_\ !,;_ ()U_!__ ()??LE^"OV7OA+<7'B&>PNKSQ?\4?B3
MJ=G#8Z_\6/BMX@@LH_%/CK6+6&2=+&*:+3].T/PYH_VJ^;0?"6B:#HT^I:M>
M65UJ]^ ?H-1110 4450U75=,T+3-1UO6]2L-'T;1[&[U35M7U6\M]/TS2],T
M^WDN[_4=1O[N2&UL;&RM8I;F[N[F6*WMK>*2::1(T9@ 7Z*_G6^/7_!T!_P3
M%^%7Q O_ (3_  ;O/CO^W#\1=,>ZAO\ 1/V-/A4?BAI%O+9R)'<26OC#Q!K_
M ()\*^*--B$D<CZWX"U3Q?I&UU1+QYPT2_/OP\_X._?^"8VL>.O^%??&[X<?
MM@_LM:M#=P6VIZI\8?@WHE[HNA?:!&T;ZUI_PX\=^-_B!:%8Y%GD2/P%/BW9
M)8VEW;0 ?U5T5Y)\#OCU\%OVE_AIX>^,?[/_ ,4/!/Q@^%_BJ%IM"\;> =?L
M/$6A7;Q;5N[&6YL99&T_6--F;[+J^B:E'::QHU\DMAJMC9WD,L">MT 4=4U.
MPT73-1UG5;J.RTS2;&[U/4;R8D0VEA86\EU>74I4,PCM[>*260A20J' )XK_
M "=?^"7O[0WB?_@HC_P<U_ ?]I7XF37.J:C\6_VG?B7\4-)T_4W-R/#/AKP+
M\,/B'XC^%GA.S\TR&.Q^'WAGPCX4\/Z,"S20V^@VLCRR7 >9_P"R3]I[_@YO
M_P""-FO? []H;X;>%_VJ]>N/B'K/PI^+/@?P[IG_  S[^T9:)/XSU'PAK^@Z
M38?VI<_"R#3;99-<FM[?[?<7L-C"&^T2W4=NK2C_ #W/^"''[4'P3_8Q_P""
MI_[*/[2_[1?BN?P/\&?AAJOQ3NO&OBFV\.^)/%D^DP^)?@7\3_!>B/'X?\(:
M3KGB+43=>)/$>C6)73=*NVMUN3>7(BL[>XGB /\ :7K^;'_@I5_P;"_L1?\
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M<#0?A/\ %'X<?"*V@\&W>G+! ^B?\(1XF\+^(/"VG6,AG:XTC3+#4Q<2B^R
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MEX@\$77BGPYITES;6][J\%S,D) /TWHHK@_B7\4_AE\&/!NL?$7XO_$/P/\
M"OP!X?A^T:[XW^(OBK0O!?A/1X<,1)J?B'Q'?:;I-DK;6"?:+N,R,-J!FXH
M[RBOY\="_P"#E[_@FI\2_P!L[X)_L3?L^Z]\2_VA/&WQI^(NE_#2U^)OP_\
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M!=R-%(%\'7_@ZD_X(=NRHG[6_B)W=@J(O[-O[33,S,0%55'PB)9F)   ))(
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M.*)2$BC"_P",'_P1=B>'_@KE_P $Z(9!MDB_;(^!<3KZ/'X_TA6'X,"* /\
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M#;"QL]2\5^*-4=KFZCTRQW6FCZ-I\.F>'M&2:^FTO2+2[U35;B^ /NRBBB@
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MQ!^.]MXFEO[CQW\9=:\Z/5(_"_BK[;IOP_\ .23Q!8ZAX_ C\$ 'W_\ "?\
MX+M?MF_MCI;>(_\ @G[_ ,$1?VIOC1\)]5*S:!\8?VB/C/\ #3]D/P7KFF.>
M-:T/5/%.@>/?#GBBQ5&61D\*>*];F?YX8]URAA/[S_LW^,/CSX\^$/AKQ1^T
MO\%_#/[/OQBU&76?^$E^%/A'XK6WQJT3PW;VVL7UMH;P_$2R\*>"[36;G5-$
MBL-4OH+;088=+N[N;3$NK\6OVR;W&**.&..&&-(H8D2***)%CCBCC4*D<:*
MJ(B@*B* JJ    !3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2;2_$GB*XO/$%SI&M:9JWAF_^QZSJ.JWEKK']LRQ:@-/N['3]._UFJ_SO/\
M@^)C4?%W_@GE*!\S_#C]H6,GN5C\3_"IE&?8ROCTR?6@#,_X(;_L9_MF?\%3
MO^":GP^_9 UGXA>(_P!D[_@F!X#^*7Q1U7XW^-OA[J%L/C;^V=XV\0>*_P"V
M9_A5X3DO+6XT[PC\(_ &GR6*>*-:UNPUO2=?\8W)L6\/>+GT26#P?_19K?\
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MBO+;3O$/ASQ/X3U?P_XM\+ZY;6>HZEIZZOX<UW2]0DTO4]3TN6XDT[4;VVG
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M7[9W_9R_AC_U5NBU_;+7\37_  9&?\F=?MG?]G+^&/\ U5NBU_;+0!_G1_\
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M%\'6\4#31XE;X6?#;P;\/CXB&BF_.CC73X2T72#JPTDZKJATT7_V@6!U*_\
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MR?V#XINM/N)!)O<?[8&F:C9:QIVGZMITZ76GZI96FHV%S'G9<65]!'<VLZ9
M.R:"6.1<@'##(K_'#_X.,;.&Q_X+6_M]PP(J(_Q/\)WC!1@&;4/A%\.[^X?_
M 'I+BYE=CW9B>]?Z[G[,]W+?_LX?L_7\[%Y[WX(_"F[F=CEGEN? F@S2,Q/)
M+.Y)/<F@#^6+_@Z _P""J_QF^#]Y\&?^"5_[%.O:CHW[3O[7P\/6?C_Q9X9O
MY;#Q3X3^'WQ$\4-\/_ O@#PIJUFXN="\6?%WQ*FIVFIZO;RV^K^'_!NF;;&-
M9?&FGZKIG[C_ /!++_@E%^S-_P $LOV?_"WPS^$O@[P[JGQ;O= TUOC;\?;O
M2+63X@_%?QD]O#-K=S/KUS"VK:5X'M=3\^/P=X%M+F'1= TM(I9H+[Q%>:YK
MNK?YS7[?_BSQW^UK_P '0/BO0=!^+FK?!KQE?_\ !1/X,?LW_#?XNZ5I-MXC
MU'X/ZU\-/&_@/X'^"O&7A_P]?7VEV-[?>%_$GAJU\3VNGR:AIT%YK?G7,UY#
M/<S79_M1_P"'-'_!6;_I8Q_:?_\ $8O!?_SYZ /K#_@MS_P2=^ __!3']D/X
MIVNN>!M L_VF/AQX \3>+/V?/C)8:5;P>-M#\7>&M+N];TWP3J6M6JPWVL^
M/&T]HWAO7_#NJ/J.FV*ZJOB;2;"+Q+H^DWL'^:/_ ,$,/^"GWC__ ()B_MS_
M  U\<P^);^']GSXK>)/#7PV_::\%2W+MH&L_#K6M6CT\>-CITDL=HGBSX6SZ
MA+XO\,ZLAMK[R+;6O#+7T.A^*=<@NO\ 0&?_ ((R_P#!621'CD_X.+OVG7CD
M5D='_9@\%,CHP*LC*?C,0RLI(92"""01BOQ__P"(&SPC_P!)*?$?_B)^F?\
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MD@T^/4_&7A'3_C9XGU>. L8O[3O;KXF6&B:C=HBR3VWAC2[20LFGPD?Z /\
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M+Q[JFI#Q/.T_BW4/"VD^*M7UF^OO\Y#_ ((6_P#*8'_@G;_V=!\.O_2Z2O\
M::H _@(_X.3O^#>3]C[]G;]C[Q+^W=^P]\/G^!^I_!?6?",?QF^%>BZ[XCUW
MP)XP\"^-/%&D^!HO%6@:9XGU;7+WPOXI\+^(_$'AV2]M-"O+/PSJ'A>36KZY
MT>#5K 7]Y^2G_!MK^US_ ,%'K#4OVE/^"=O[ =IH%WXS_:8\/:-X\T3XE?$7
M6$7X??L?#PQ?V7A3XG_M''PW-::C_P )%JMYX6\1^&/#%CH5I87KZMXSL/AS
M<7FFZQ8:/=:/J/\ >M_P<$017'_!&;_@H+',BR(OP-EG"L,@2VWB[PO<P/\
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MQ\.Q_9-+TJ^L$\&>$].L;"#1-$\'QZ#8:>6_E1_X-7/^4Y/['_\ V!/VDO\
MUE_XQ5_KOT ?Y3/_  7G_P"#</Q)_P $K_#.F_M+_L]>.O%GQJ_9$U;Q#8>%
MO$TWC2RTUOB=\$_$.M2&W\-IXVU'PWIVE>'_ !-X.\37JC2M+\:V.@^&%T_Q
M'=:;X7U?1DN]6T/4M:^F_P#@T4_X*H>,?@A^U);_ /!.;XH>)[S4?@-^TI)K
MM_\ !VTU>]>6T^&/QZTS2KK7_LFAO<.5T[0/BSHVE:EHVI:/ &AN?'\'A&]T
M^&TNM7\1SZI_H??M?_LZ^%?VM_V6OV@/V9O&MI;W?A[XW_";QM\.[AKA5/\
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M1M'^'NC>$M2UG2? NEZ%:Z9?^&O[-\/K)JNHV5IJ%IJ?[F_\$0"3_P $A_\
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MBB06>HZ?:+:Z=8_Q[_\ !G]_RF(T7_LVSXX_^@>%*_U9Z /\K'_@YY_X(M_
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M!\(/V;/A5K\6F_$;]KOQ5X:EN5U/XZ_%WQ)-9W5MX8^'YU@76D?#;PX=+O\
M7)M#M;S7]#/A2YU6U\:>)/U#_:2_X-1O^"2/Q/\ @'XN^'WP-^!5_P#L^?%\
M>&=1C^&WQDT+XK_&/Q3J.B^,(;&5]$NO%^B>//'7B[0/%?AN\U9+5?$^GSZ/
M%JLFDR7L/AO5O#U^UM>V_P!\?\$'O^4._P#P3Q_[-L\&?^AW]?K70!_C-?\
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M+X7\>Z-IVLI:W5BFK6&F>*M+U:RM-32RO;RS2_MX([I;6[NK<2B&>5'])HH
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M=[/YES<32O\ X_'_  <C_P#*;?\ ;V_['SX<_P#JBOA97^QM7^.3_P '(_\
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MZ_VN?_5__$&@#_99_8%_Y,4_8K_[-+_9Q_\ 5.^#:^M*^2_V!?\ DQ3]BO\
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MB'V2;4?!6G7T,4%Y=ZE-?@'^B[7QM^UW_P %"?V*_P!@[PS_ ,)3^UI^T?\
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MZ_LT_M'?"7]KGX%?#C]I#X%:_=^*/A)\5]$F\0^"/$%_H>L^&KO4]*M]4O\
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MMV5Y9W2/:W,$5PC1B?\ 9W_X.!_^"/?[4'B33_!GPR_;>^&NF^+M5N([+3M
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M>.M$NYM/\0>%_A'X,T.QU'XH2>&-3M]MQI/B'7Y_$W@[PE'JMM)#>Z=H6O\
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MV6NG:9JGQC\*>!_#VKZE>R%(;*PTC6;^[N[B2*UMX9+J183Z=^Q;_P $;?\
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MPXM=<GU+S7UZ'PS-I.O_ !.\0R27-S,WB#1_!EKKD%UIOB2XCG_U/*_SN_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZSX>NO#NO:EI4^IZ#%X:U#P_+KETWB&#10#^RG]H0!?@!\<   !\'OB6  ,
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MC2-+FNO#5G:_:;/7-,U34@#ZF_;-_P"3/OVKO^S:_CI_ZJ_Q37^3[_P;)?\
M*<C]A+_L.?'/_P!9@^-E?ZG_ /P4F^)7A;X/_P#!/C]MKXC^,M7L=$T#PQ^R
MS\=)Y;S4+F*UBGU*^^''B'2?#^CVSS,JS:IXA\07^EZ!HMC&6N-2UC4['3[6
M.6YNH8V_R>_^#>7XD^'/A1_P6?\ V!?%GBO4K32-'N_BQKG@,7U]/';6J:Q\
M6/AEX[^%?ANWDGE(C1K[Q'XSTFQAWLH::YC3<I8$ '^RW1110!_FW_\ ![I_
MR>#^Q?\ ]FU^*_\ U:&K5_3M_P &K?\ R@W_ &0/^PY^TE_ZT_\ &&OY1O\
M@]4^)7A;Q+_P4'_9R^'&BZO8ZEK_ ,,?V6;&?QE9V5S%<2^']2\<_$?QIJVE
M:/JJ1,S6.J3>'].TS7Q8W 2X_L?7-&U#R_LVHVLDG].G_!I/\2?#GC;_ ((P
M?!WPGHVI6EYK'P>^+'Q[\!^+;&&>.2ZTG6-:^)NM_%2PM[V!3YENUUX<^(VB
M7T'F*!+#<*Z,0&"@']+]?Q7?\'MO_)C_ .R#_P!G5ZA_ZJ+QK7]J-?Q#_P#!
M[OXOT*T_93_8F\!3:A:IXFU_]H3QQXOT[2C,@O;C0O"/PXFT;6M0CM]WF-:V
MFH>-]!MI9MNQ9;V%"VYP* -/_@R,_P"3.OVSO^SE_#'_ *JW1:_MEK^'7_@R
M$\6:'=?LU?MR^!HK^U;Q)HGQR^&OBR_TL31_;8=#\4> =0T?2;]K?=YHM;F_
M\(:U;I-M\LRVLD>[<,5_<50!_G1_\'P7_)?OV!O^R/\ QH_]33P97] 7_!I3
M_P H6O@S_P!E<_: _P#5EZM7\Z__  >[>+=#O_VK?V)O ]K?VLWB'PS^S_X^
M\2ZQIT<R/=6.E^,OB'%IVA7%S"K%X8[^X\%ZZML9%7S?L<Q7(7-?T!_\&AOB
MW0O$/_!'#P7H>EZA:W>I^ _CW\<_#?B6SAGCDN-+U34/$%CXSL[:\A5C);R7
M&@^*M(OH5E53);W4<B95LT ?T_U_G7_\'PO_ "6[_@GY_P!DK^.W_J7?#RO]
M%"O\X?\ X/>?%^A7_P"T_P#L.^!;74+6;Q'X8^!/Q*\4:SIL<R/=V.D^-/'V
MF:9H%U<PJQ>&+4+GP/KZ6S.J^:;&<ID(< ']"7_!I!_RA@^%7_9:/C[_ .IW
M<5^L?_!4'_@H%\/O^"9'[%_Q7_:T\?:5)XHN/"-OI_A_X>> H+P:=<_$/XH^
M*K@Z;X,\(IJ!BG_L[3YKOS]9\2ZHEO=W&D>$M&U_5;.PU*\LK?3KO\=_^#07
MQ9H?B#_@COX:T33+^UNM3\"_M#?&_P .^)+.&:.2XTS4]0U+1?&%G!=PJQD@
M>XT/Q/I5[")%7S(;A73*G-8G_!X=\(O&OQ-_X)&6?B?PC8WM_IOP+_:F^$?Q
M;\?1V22RFV\%7'A3XH_"5]0N8859WM++Q5\5?"LMS(P,-K#OO)RD5NTL8!_/
M)_P2'^!'QH_X.8OV_P#XM?M0?\%,?B3XC^)7[/\ ^RW:>&=;N/@QH^J:IX8^
M'DNO?$C4]=;P!\&_ WA_3[^,>#/AM!I_@KQ!J_CN_P!#NSXT\2#1]#M?$7B&
M_P!6\3WOB6'_ $D/A_\ #SP%\)_!GASX<_"_P7X5^'7P_P#"&F0:-X5\$^"-
M TOPOX5\.:3; ^1IVB:!HMK9:7IEG&69E@M+6*/>[R%2[LQ_RZ?^#5[_ (*V
M_ K_ ()R?M _&[X/_M1^(8_ /P3_ &JM,^'XM/BM>VUU=:%\.?B9\-+CQ7%X
M</BT6,,]WIG@_P 8:3XYUG3-6\2""ZMO#^KZ7X:N=5CL/#T^NZYI7]R/[5'_
M  <'_P#!,#]G#PU9'P3^T-X1_; ^+GBR6TTGX7_ 3]CC7-&_:!^(7Q#\5:O)
M%:Z%X=MKKP!?:SX6\-7&H7US:PX\2ZYI^HRK(T6BZ1KNK?9](N@#_-;_ .#A
MW_E-'_P4 _[+!I?_ *KGP17^P5\$/^2+?"'_ +)?X _]132:_P 7+_@KAXZ^
M.WQ0_P""C?[5/Q'_ &E_@RO[//QK\=^.=(\6^,?@G_;":_<?#B'7_ _A74_"
MOAS4M9C<KJ&M6_@RY\/3:[.8=/?^V9[Y)-'T216TBR_TV/V4?^"Y'[+/[0$/
M[ _[,W['S:O^U%\>_C)X'^&-S\7O#/@RQU33-&_97^&'AGPMH/\ PM_Q_P#'
M#Q%J^FVVF:+?^$YUN?#6@>%+.XNK_P 3^+KK2+*WN(;75]"EUP _+?\ X/;/
M^3&OV1/^SK[O_P!5!X[K/_X,CO\ DR_]LC_LY_0?_54^&J]*_P"#U'P#KOB#
M_@F_^S_XZTNRN+W2_A[^U[X:3Q+);Q/(NE:9XN^%/Q3TNRU6\905@L?[=M-*
MT8S2$ ZAK6G0+EIP*_)[_@T/_P""GW[(?[(_A/\ :P_9O_:I^-?@3X W/COQ
MAX+^+OPV\7?$_7+3PGX(\1&P\.W_ (6\:^'[CQ?JSVWA_1M<TV+3_"M_I.GZ
MM?VDOB"#4-232_/N-*FA< _T=*_Q/?V5OC7JO_!,;_@K-\/?BMXHL]0B;]D[
M]KS7?#_Q-TNWA=M7?PAX<\;ZY\./BYI%I;G#'5KGP9<^*].M(G4@7\L2R(R[
MD/\ JW_L6?\ !3SP9_P4(_:7^/'A+]E+0K/XB?L>?L]>$= \/^(_VLEEUG3]
M#^(/[27B+56OI_A=\)]-O]+M+?Q3X2\$^ H!K/C#QRETJ'6M;\.6FD:?=>'M
M5TKQ)K'\)O\ P=D_\$I?&O[-7[7?B']OKX9^%KW4/V;_ -JW6[?5_'VJ:39/
M+8_"[]H6YM$@\4:=XA,*/]ATWXKRV;^/-!UF\E$>I>+-0\:Z*1:FPTA-2 /]
M./PAXN\,>/\ PGX8\=^"=>TOQ3X-\:>'M&\6>$O$VB7<5_HWB+PUXBTZVU?0
MM<TF^@9H;S3=5TR\M;ZQNHF:.>VGBE0E6!KHJ_RHO^")O_!S7\8/^":'A#2O
MV:?VB/!>O?M&_LD:9=3/X-M='U>TL_B]\$8+VYDO-0T_P#=Z[-#H7BWP9/=3
M75W#\/\ Q'J6@)IFHW<ESH/B[1=/%SHM_P#U2>(O^#QS_@DGI7@V7Q%H>C?M
M5>*/$ALFFM? %I\(?#VEZX;UH\PV5_K&K_$2U\)6L8E*I=W=GK^IB&(22VT-
M\ZQP2@']!G[6_P"V)\)OV,_"?PM\3_%)/$&J7?QI_:!^#'[-/PP\(>#[33=1
M\6^,?B?\;?&=AX3\/Z=HNG:IJNC6MU!HMG/JOB_Q"POEN(/#7AW5Y+"WU#4_
ML.FWGU;7\5__  2Z^(W[3_\ P<"_\%&/"/\ P4U^/_P]E^#W[ W[!-_XFL/V
M0O@M]NFUK2?%7[0>N6$5E-XMU?6;FRTQ/&GBCP-IUQ9^*?$/BRPTW2-)\.>(
M]-^'/A3PU83FW\;WMW_:A0 4444 %%%% !1110!\5?\ !23X4ZY\=/\ @GK^
MW%\'/"UK->^*_B7^R7^T'X.\)V5NC237OBO7/A7XILO#-FD: O+]JUV2PMVB
M0;Y%D9$(9@1_CE_\$O?CKI?[,_\ P47_ &)/CKX@OHM+\*_#K]IKX0:OXTU*
M8JL>G^ [KQEI6C^.[UBQ" VOA#4M;G4LRKN1=S*N6'^X37^1O_P<??\ !(OQ
M=_P3@_;+\6?%+P%X5NS^Q]^TUXMU[QU\(/$6F63G0/A_XMUVXN==\8? W5I8
M4\G1KWPS?S7^H> ;6Y*IK?P\?3_[/NM2U3PWXM32P#_7(HK^<W_@W'_X*\>
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MQ';:A:>;]GO8$GF2&YCEC6615#MI444 %?RE?\'=?["6M_M2_P#!.K1OVA_
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M\4L4J%DDCD1E=)$8JZD,I((-?PY_\'@?[??A+Q3\-?A!_P $K/@5J4GQ*_:
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MB%TOASP]K&NZ?I6O:$^NW5I;W4FGV.I:AX6CT:.^DA-K;W^HV1O);:U::YA
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M":QHEG>:9I=]<W^FZK=6D^E7AC_K5H **** /\K3_@\7_P"4O-E_V:A\%O\
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M% !1110 4444 %%%% 'X _\ !T=_R@H_;F_[MF_];#_9]K_(%K_7Z_X.CO\
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M_L^O]KG_ -7_ /$&O]PVO\/+_@J-_P I,_\ @HI_V?7^US_ZO_X@T ?[+/[
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M?:1IOCG7-%D/V?Q)XV\0:AI^IQ^!/"5]OTBW32KOQ1XPM[K1ET7P]XQ^/_\
M@B/_ ,$1=._:U\'> _\ @K%_P5YU[Q-^V5^T#^T)I.F_$OX/_#CXVZI=>+O
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M_!Z+!'%_P59^$,B* UU^PM\)IY2/XI%^-O[2%L&/J?*MXU^B@5_J(U_EZ?\
M!Z3_ ,I5O@S_ -F(?"C_ -7K^TO0!_;9_P &\/\ RA;_ ."?_P#V2#5O_5C^
M-Z_9^OQ@_P"#>'_E"W_P3_\ ^R0:M_ZL?QO7[/T ?XN/_!=^PM=-_P""P_\
MP4.M[.%((9/VE/&M^Z(JJK76JBQU2^F(4 %[B]O+B>1L;GDD9V)9B3_LT^#)
M))O!_A265VDEE\-:%)(['+/(^EVK.['NS,22>Y)-?XT7_!>[_E,=_P %"_\
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MH_Z*W_!/?_@L]_P3W_X*8:99V_[-_P ;M,M_BA)8M>ZM\ ?B8EMX#^-VBB&
MW%\(O!]_?7%MXPLM-AVR:CK_ ,.=8\9^&K$21QW>LPW!:%?R7_X*B?\ !I_^
MQA^V?>^)_BW^RKJ%K^QG^T#K#W6JWMAX:T--1_9[\<ZU,7GEE\0?#6R:RN/
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M69F=V8DDDDY))KW"O!_V6/\ DV+]G+_L@_PA_P#5?>'J]XH **** "OXPO\
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ML HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_%S]JO\ X(PZ=^V%+\4M,^*7_!3+_@JO
MHWPS^+/B'Q1J^N?!#X<_M!?!KP;\)=,T'Q1J=[J$OPYTO0K;]FZZUJ_^'&D6
M]Z-%TKPUXN\1>*2VC6EG;ZQ>ZO<Q/=R_M'10!_(%_P 05/\ P2R_Z+Y^W_\
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MCFDT+Q5HD>H7T-K=/;WNG7]A?:CH>O:9K'A_5=5TF]^O** /XX_A#_P9;?\
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M$)I9=!^V^3^[.H?\*R$!D_>C30O[FO[>Z* /AG]@_P#X)P_LA?\ !-SX2?\
M"G_V4?A3IO@O2M1%K/XU\8ZHZZ_\2OB;JMK%)&FL_$/QM>0KJ>OSQF>Z>PTJ
M,6/ACP^M[=VOAC0-$L)WM#_.9XS_ .#,+]@[Q9^T7K_Q/L?V@/COX.^!^O\
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M(:7^S]X9UK2-.MM4UB7Q7:6/@_Q1X8MSXJM;?5+U+Q)=1M;_ /96B@ HHHH
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ME\,-)U*6[GN; VG@NT_9=CTJ].@).]EX>OM=36-8TNR+QQ:FTEQ=2S_ \/\
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M[&RL6T6-#?->_I910!_(%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5K]R/V$O\
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MQ=WM[=W'[+$EQ=7=U<223W-S/))-/-(\LKL[,Q_KRHH _%/]AO\ X(E^"/\
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M;C@F4',<C:;K.GW01L,8KF*3&UU)_P!"67]C#7O@1^R/X#_94_X)M?$;X?\
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M?'=OI]YIL6K6MG?>7;:]X=U6QO9M-\6^$;NZLK7Q!IIB>WU#1M>TW0M?T?\
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MZSX=\1:99S0O:R1RZG9S7WA^X%SIVL7UE=?S[_LY?\$'O^"V7_!+>\UC1_\
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M[V=IY]%\,^,_#VK;_&6AV3R20Z#;^(M)T36;#38K6QU;Q#XBOHY]:N?Z"_\
M@CA_P08_9C_X)#:)KWBKPUKVI?'']IGQUHJ>'_&_Q]\5:'9^'Y+3PY]IMKV?
MP9\-/!]M?:S'X%\)WM_9V6H:TD^O>(?$/B+4+*SEU;7I--T_1]'TH _&O_@\
M*_X)<>*?CO\ ";P!_P %&?@OX;NM?\9?LX>%KOX?_M":-I-H]WJU]\!I-5OO
M$7AWQ_#;6Z&>>T^$_B;6/$C>*C'%<2P^%/&<_B*\DLM#\%:C./S7_P"#._\
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M\<>(]-F^S7FEWGC&T\,ZS8VVK^%[E!_3=110 4444 ?P#_\ !Y!\7O'?[/\
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M7M8N-0\.6.G:LNWS/$?PXGD/@?Q3&KP7D&MZ$-7CMHM*UG1;J[_K2_X([_\
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MV\%I:00VMK:PQ6]M;6\206]O;P(L4,$$,2K'###&JQQ11JJ1HJHBA0 /D?\
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M$_\ !*#Q/X_TWPO_ ,%0O@;X8N=:O/ 'A73_ (<?M7:'HMFUQJ$?@C2KJ<^
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M'\YO_!S9\2O%7_!5/_@KK^S;_P $Y/V/+(?%KQI\"M%U/X57,>BW#7.BZ?\
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M)['PUX2\+0ZUH%OK&K1Z?KFI_P!I>(]!L[#0;Y+J[N=/\C_X(U?\%W?V>_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!Q7Q&^(_@#X0>!/%?Q/\ BIXS
M\-?#SX=>!=%O?$?C'QOXQUFQ\/\ ACPUH6G1F6\U36=9U.:WLK&TA7 ,D\R[
MY&CAC#RR1HW@W[+'[='['_[;FB:]K_[)_P"T5\+OCM8^%+FWM?%-OX%\26][
MKGAF6\,PL'\1>&;H6?B30[74S;77]DWNJ:5:V>J_9;HZ=/<BVG\OQ/\ X*R?
ML'7/_!2O]@KXY?L?:;\1)?A=KOQ'M/"VJ^&/%[VUQ?Z);>*? /C#0O'?AW3O
M%FFVKI=7WA36-6\/6NFZU]D\R]TZ"Y76K"UOK[2[:QN?\_\ _9X_X-[?^#C;
M]@']I+0_C!^R3X7\'Z!X[\)74^GV7Q3^'W[0WP;7P/XDT&YGB_M#2/$GA/XC
M:_X=U?Q7X+U@6]O/?^&O%GP^G@N&@L[M]*BU.QLY;8 _<3_@]O\ $=A:_L3?
ML>^$9+B)=3US]J;5O$=G:EU$TUAX5^$OB_3-1N(XR=S16UQXQTN.9P"J/=PA
MB#(N?TZ_X->?V/?$G[(7_!)'X0CQQH]SH'CO]I/Q9XI_:A\1Z+?0/!?Z;IOQ
M#L?#WA_X=1W23!9HI=1^%/@KP-XAEM)8X9+"YUNYLY81<0SO)\X_#G_@B=^V
M;^W_ /M!?!K]K'_@O/\ &KX1_%FW^ 5I(_P8_8I_9]T*>S^"ND:E?W>F:EJV
MI_%/7;^RL'\1OK.IZ)I%WXK\*Z6FO6/BH:1H.E:GXVF\&:7+X*O/ZIHHHH(H
MX((XX888TBAAB18XHHHU"1QQQH B1H@"HB@*J@*H  % $E%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M433,YC0J ?V^4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8V]S>VMKXA\(^*]%UKPUK4=C?:AIKZCI5Q-I>HZCILMI?7 !].45_._^W_\
M\')'[&/[&?QI_P"&4_A+X*^*/[<'[6[>(H/!DOP6_9TL+;5++1O'-S=K8P^
MM?\ &A34C/XX>];[!+X3\!^&?'^NZ7JJRZ1XAL=%U.)K6OE+XS?\%Z/^"NO[
M/W@34/C;\6O^#>SXO>%O@MHFG/KOB/6H?VFX?$^L>%_#L*&XO-;\66OA+X"Z
MYJGA+3].LU:XU:]\2>%]-L='C2275+FTA1Y% /ZS:*_G._X);_\ !S#^PO\
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ML+RZJWP]\"^.=#T:.WU*'6]<TS4-*OK"+YY^)G_!P;_P4L_93T2#XK?MJ_\
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M4 %%%% !1110 4444 %?S8_\'9O_ "A3^.__ &5#]GS_ -6WX;K^DZOYL?\
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M)X@%C!KFGZ=J<NH>#_$6G"_2_D_N9_X)L?\ !X?^S)\>+GPY\,/^"@'@6/\
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MCEI'P\^'5[\2OB]\&-=\!?''X::%H>CRZSXL\SPEXGL=,^(C^&+2S@GU.[U
M?"37_'DYTO3HIKO6%M5L;>VN+R2U2OXJ_P#@T.UW]I;PY_P5GT?P[\,=(\7S
M_!;Q/\+_ (H:+^U8D%EJ9\):#X9T3P=XBUOX;ZKXJS&=-T[Q%:_&#3_"GA[P
MS/>JFKI%XB\2Z9IYCL]2UO/^JG445O! 93!!#"9Y6GG,4:1F:=PJO-*44>9*
MX50TCY=@J@L0!@ EK_%5U;_E-KJ?_:4Z]_\ 6M9:_P!JJO\ %5U;_E-KJ?\
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M/PSUBVC9_)O]"^)O@'Q;X'O[>\B4[9X+8ZW#JL2RAD@OM.L[U0LMK$Z_[)%
M'^&58^!?$_P-_;_L_AG\,;"U\6>,_@]^V';^!?A[IGB.[2QLO$OB?X??&I-
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MAX_TG2[#58;KP5%!X=A_T)$1(D2.-%CCC54CC10B(B *B(J@*JJH"JJ@!0
M !7^7!_P:\?\$R?@C_P4BM_VU=/^*7Q]_:S^"VL_!Z;]GZ\T.R_9D^,]E\)H
MO%&F>/$^,L&HW7BV"Z\'^*7\02:%=>#[&+2IHVLETE=:O4D$YU*,Q?UE?\0O
M7[)7_1\W_!5__P 3$TK_ .=%0!^(O_!Z-^P7\)O!EA^SS_P4%^'_ (6TSPGX
M_P#B+\0KOX!?'"ZT6PM;"V^(6HR^#]:\:?#?Q=KD5I# MUXOTO2?!OC#P]J6
MO71N-1UK0H_#.G74XM_#-BIZS_@R\_X*"^-O$O\ PO?_ ()P?$'Q#>:YX;\#
M^$9?VA?V?H=3O7F?PGHY\5:5X;^+O@G2C<;V&BWVO^,?"7C/2-&M9(H=/U2[
M\=ZJEO*VL74MO^KOC?\ X--OV"OB9I5OH7Q(_:L_X*7?$'0[34(M7M-&\;_M
M.^#_ !7I5KJL%M=V<&IV^G:]\%;^SAU"&SO[ZUBO8X5N8[:]NX$E$5S,K_3W
M_!.C_@W5_86_X)A?M%)^TW^SKXX_:8UGX@#P-XG^'LFG?%'X@> /$7A.X\/^
M+)=*N-2,^F^'?A/X/U)KV&XT:PGLIEUE(8I(R9;:<$!0#\BO^#U_]HSQWX _
M9._9*_9M\-:G>Z5X2_:)^*WQ"\7?$5;*62!/$&E? ;2?!%QH'AC52@V7.D3>
M)_B9IGBEK&5PCZSX1T2]".]@I3][/^"$'Q-^ ?Q/_P""2G[#5W^SQ+X;A\,>
M#?@'X!^'?CC0/#S6D<_A?XT^$/#VGZ?\9=,\2V5N5N+7Q-J?Q#.O>*[^ZU*"
M"^\26_B.R\7A9K/Q%:7=Q\V_\'%W_!)CQ?\ \%5OV,M$T3X+2:4O[2O[/7BS
M4/B5\'=,UJ^MM*TWQY9:KHS:1XZ^%LNM7TD>GZ#>^+K.UT34] U?4I+?2T\4
M>%=#TW6=0T?1-3U/6M._S,_V;?VQO^"C/_!&W]H;Q;I_PN\4?$W]FGXJ:!JU
MOH_Q;^"OQ \/W4?AKQ*^F,7@TOXD_"OQ;:-I&L*;2XF_L3Q +&#7-/T[4Y=0
M\'^(M.%^E_( ?["O[=W[%_PA_P""@/[*_P 6_P!E?XTZ-9:AX9^)/AF_L]%U
MR:QM[S5OA]XYM[6X?P9\2/"TLRE[+Q)X-UM[?5+*6)XTOK=+S1-16YT;5=3L
M;K\9?^#5+X9^+?@K_P $S/&_P<\?V TKQU\)_P!M;]J#X:^--,#.PT_Q7X%U
M[P_X7\0V2M)'$[K:ZOI=W KO%&SJ@8HI.T?#O_!-C_@\/_9D^/%SX<^&'_!0
M#P+'^RI\2M0>UTQ/C%X2?5/%'[.VN:E,4B6YUNWN6O\ QW\)([NZECAB&JGQ
MYX7T^!)]3\0^.]#LD(C_ +#?!=QX'U3P_9^*/AW-X4U'PKXW5?&]AXB\%R:1
M=^'_ !>OB>&'4T\76>KZ&TFG:^OB&WE@U!=?AN+L:M#+#=B[N$=)" <U\;_^
M2+?%[_LE_C__ -135J_Q]?\ @WB_Y31_\$__ /LL&J?^JY\;U_L%?&__ )(M
M\7O^R7^/_P#U%-6K_'U_X-XO^4T?_!/_ /[+!JG_ *KGQO0!_LM5^ W_  <:
M?\%0]?\ ^"8_[ NIZW\)]6BTO]I/]H;7YO@Y\#]2 AEN_!;SZ5<:GX\^*MO:
M3JT5Q/X$\.)':Z&[K/#:>.?$_@V[OK.^TR*^M)?WYK_-N_X/<_B7JNJ?MA_L
M8_!Z6YE;0_ _[-7B?XEV-F7;R(M5^*GQ1UKPOJMRL>[:)9[3X.:-$[A0Q2VC
M4L0 % /Z0/\ @V5_X)R^!/V6?V#/AQ^UEXPT:/Q3^UI^V_X5M?CI\2OBYXE#
M:UXT3X?_ !&N!XM^'G@S3O$.I/<ZI!I.J>&KK0_'?BYO/2]\3^-]=O+S7KC4
MHM%\.)I?]$OCOP'X*^*'@SQ1\.OB/X3\/>.O 7C71-1\->+_  =XLTFQU[PU
MXET#5K=[34M'UO1]2AN+'4=/O;:1X;BUN89(I$;E<@$?R3?L'_\ !NO^R=\?
M_P!B']CWXY3_ +:?_!3?0[OXO_LP? ;XDZCH/@C]K'2M$\'>']5\:?"[POX@
MU;P]X7T0_"V^;1-!T'4K^ZTC2M&>]NY-)LK*'3Y+F=[9I&^KO^(7K]DK_H^;
M_@J__P")B:5_\Z*@#_.<_P""FG[/MY_P3'_X*H_M%_!GX%>)_$_@\_LZ?''2
M/%_P/\3V.K74'B_P9HNLZ;X:^+OPIGM=?B=+U]=\*:%XF\/6\>M[DN;R\TX:
M@ZI),R#_ %J?^"3O[9T__!0/_@GA^RW^UAJJ64/B[XE?#W['\1[;3UBALX/B
MCX#UO5OAY\2)+2RB1!INGZCXS\+:SJ^D:<RYM=&U'3D62XB\NXF_%?Q5_P &
M>7_!,GQUKU_XJ\;_ !R_;]\8^*-5^R_VGXD\5?';X:>(=>U'[%9V^G67V_6-
M7^ ]YJ%Y]DT^SM+"U^T7$GV>SM;>UBV001(OZ?>&_P!GGX3_ /!$/_@DW^T=
MX:_9QUWXA:]X,_9F^"/[3'QZ\&77Q7UK0/$WBA_%L'A+Q3\0[?3)K[0?"WA'
M2)K&X\56\,-A;-HL93[8R75Q.K%P ?Q1?\'&W_!2;XL_\%/O^"A/@W_@E3^R
MUK\TWP5^'OQU\*? BWTO3=1DM](^-G[5.O>*K/P)?ZWXBN;8F.[\)_#;Q/JL
MO@CPK;RI/80:C8>*_&:S7L.KZ(=)_P! []@;]AOX(_\ !.S]EWX:_LN? C0K
M2P\.>"-(MG\3>)VL+2T\1_$[Q]=6ELOBSXE>-+FV7?J'B7Q3?P>?(9998-'T
MN'2_#6D"UT#1-*L;7_*!_P"#>K3(?'__  6V_8.;Q7<-JUQ<_&7Q-XSN[[6)
M9+VXO?$7AOX;^/\ QMIVHW-Q<-)-<:E)XBTBSO([J5WF?4/+G9S)EJ_V2* /
MEC]M7]D'X/\ [=W[,OQ9_9=^.'A^PUOP5\4/"^HZ3!?7-C!>:EX,\4BUF;PG
M\0?#$DV&L/%7@K6S::[HEY#)'FXM6LKKSM.O+VUN/\67X.?#_P 0?";]N_X5
M_"OQ9%'!XI^&G[6_@?X?^)88O,,4/B#P;\8]+\.:S%$98XI?+CU'3;E$\V*.
M3:!OC1LJ/]T&O\57XW_\IM?B]_VE.\?_ /K6NK4 ?[55%%% !7GWQ:U_Q3X3
M^%7Q,\4^!M#;Q/XV\-?#[QGK_@_PTL$URWB'Q3HWAS4M1\/Z&MM;LEQ<-JVK
M6UI8""!UFE-P(XF5V4CT&B@#_(*_X( 6WC7]JG_@O?\ LK^.OC%9:K\8O%^M
M?%OXN_'7XHZ[XKM9-8NG\7^'_AG\2?'L7Q \233Q-%97FC_$:WT#5].NKE;>
M*W\3)HEE9".[EL;=O]?6OSU^-WC3_@F;_P $P]*\>_M8?%G2?V6_V2K_ .(-
MQ?#QK\4M)^'/@CP=\4/C#K$DJ:Q?:4I\$>&E^)7Q?\27,\::M<:+IMIXGUF9
MXCJDUJ4@DN8_Q>L/^"V'_!1+_@I1?:AX<_X(I?L 7LGPI_M"[T.?]N_]M^>?
MX?\ P5LY+>=]/U&_\'>!M'ODO?%D^F7 \^)-(\2>-?$EAYEJ?$WPIM4%Q:4
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M\DR_X*+?]CW^S7_ZC_QFH _>"#_@V<_X(GP?#D?#<_L5:%/;_P!GFT?QE/\
M$WXRO\1GO&A,;:T?&B_$%-434#.3>"UA,6@I-B"/14TX"Q'^?W_P7T_X(:>)
M_P#@D3\6?"_BOX=Z]K_Q(_9 ^->I:G9?"SQOXAA@D\5^!O%FG6YU&_\ A3\1
M[W3+*RTB[UQ=+$NL^$?$5I9Z5%XQT.QUEH](M+_PSK0K_7EK\%?^#F;X)^'_
M (U_\$7_ -KY=6L;:XUCX3Z7X&^-G@S49H!/-H7B#X?^/O#LNJ7UEGF*YU'P
M)J/C+PO+.,&.Q\0WIY!((!^37_!G;_P4K\9?'_X%?%/]@/XO^)+OQ'XJ_9;T
MC0_&OP,U;5KJ2]UB?X"Z[J)T#5O!4MQ,SW$VF?"CQ;+HEMH$EQ)(;/P]X]T?
MPQ9"VTCPOIMM'_3!_P %,/VY_!7_  3B_8G^.?[7'C*VMM8F^''AE;?P)X1N
M+@VY\=?%'Q-=P^'OAWX/#12)=BRU3Q/J%A+XANK%9KO2/"MIKVNI!+'I4JU_
MG ?\&@?BC5= _P""Q?AS2M.DE2T\;_LY?'/POKJQE@DVE6EGX<\:0QS@<-$-
M;\(:-,H;*^?%"P^8*:_<#_@]_P#C9KFC?!S]@S]G6PNYH_#_ ,0OB-\9OC%X
MGLXWV1S:E\)O#G@GP=X.:=00TJB'XP^,F1&_=K)$LA5I%B9 #X5_X-D_V>O$
MO_!6#_@II^TO_P %+?VWK^3XWZ[\ I?"_C2P_P"$RMTU#1=0^/?Q/O\ 7D^'
MMY9:/>"?2H?#/P=\)>"?$,G@[PG96T>F>"]1/PZNM(CL(_#^G0R?Z3%?Q*_\
M&1<&FK^R#^VE<1(@U>7]I+PC!?.% D;3;?X8:;)I2,V<E$NKG62BD85I)""2
MS8_MJH _BM_X.YO^"2_@7XK?LZ7_ /P4M^#GA"QT7XY? F30;']H)]"LDMI/
MBI\%]4O[/PW9^*==MK6/&I>+_A5K%_H\BZZ\:7DOPXN]?@UR^N[#P?X7MM-^
M ?\ @T/_ ."O/C'P_P#%*'_@EG\=O%=YK?P[\>:=XB\1_LGZIKEX]Q/X"\<Z
M'8WWBCQ=\)+2[NG)A\(>,] L];\4^&-.,T=OHOC#1M1TW2[6XN/'82S_ +V_
MVHOA!I?[07[-7[0?P(UJTBOM*^,WP4^*/PNOK:5!(LD'CSP3K?A@E058K-&V
MIK+!*@\R&=(YHBLB(P_Q+OV#/B7KOP9_;?\ V0/BMX;N)[;6_A]^TS\#O%5F
M8&=6N/['^)7ANZNM/E5"#-::G:)<:;?6K9CN[.ZN+657BF=" ?[EOB/P[H'B
M_P /ZYX3\5Z)I7B7POXGT?4O#_B/P[KNGVNK:)KVA:S9S:=JVC:QI=]%/9:C
MI>IV%Q<65_8W<,UM=VLTL$\3Q2,I_P 6O_@L-^PW?_\ !-/_ (*0?'S]GC2;
M"XM? &A^,+?XE? B[U!'O8=1^#?CF0^*? $/VB^$AUE_"L4MUX UV]N$V7_B
M/PAKA:,QG!_VK:_BD_X/-?V"?^%H_LQ_!_\ ;]\%:+Y_B[]FG7H?A;\7;JTM
M]UQ=_!3XG:Q%'X6U;49PKNUKX$^*UU9Z9IUN@C11\6-;O)W*6J!0#^K;]B3]
MJ3P=^VQ^R3^SY^U9X$>W'A_XX?##PWXUDL+:7SQX>\1W-K]B\:^#[B7=(&O_
M  5XSLM?\):GMDE5=1T6Z5995 D;ZEK^$+_@RT_;U_X2#P!^T!_P3H\;:SOU
M3X?WDO[17P+M[RXW2R>#/$E[IOAWXO>%]/61D2&S\.^+[CPGXOLK&!9KBZN_
M'_B[4'V06+$?TK?\%P/VZD_X)Y?\$TOVCOCWI&KKI7Q/U7PT?A'\#&280W[_
M !A^*,5SX=\,ZKI@8JLUWX&T]]<^)<UNSKY^F>"=0C4LY5& /PJ_8E\'^'?^
M"MG_  <?_M?_ +?6K:19>)_V</\ @FGI?A_]G;X ZA=6\=[H_B+XQ>'9_$/A
M[2_$^GSRJUAKEEH6OK\:?B9H5[:HTVB76O?"K6HI(KE;*[G_ +/*_%K_ (-_
MOV$G_8!_X)@_ /X;^(](;2OB]\5=/?\ :%^.8N83#JD?Q&^*]EINIP:!JZ./
M,CU/P)X&M/!OP_U*,R2QMJ?A>_NXG*W9S^A_[:'Q)U3X-?L=_M8_%_1+B2TU
MKX4_LT_';XDZ1=1,4EMM4\#?"[Q3XHL+B)U*LLD-WI<4B,K*590001F@#^&7
MQ3\3I_\ @Y!_X.#M._9@\5ZWJ.K_ /!./]AZ[^(WC"/X;Z7J=S;:!\2_#_P=
MUC2O!OB7QYJK6-Q;F_E^-'Q5UWPOX9MM5CDM=2T7X,W\-AHITO7+K6=0U#_0
M5\->&O#G@SP]H?A'PAH&B^%?"GAC2=/T#PWX9\.:79:)X?\ #^AZ3:Q6.E:-
MHFCZ;!;:=I6E:;900V=AI]C;P6EG:PQ06\,<4:J/\D;_ (-I_P!AOX5?\%"/
MVW_BU\#_ (K_ !A_:)^#5MI/[,/B[XEZ%K_[-_Q0M?A7XRUS5M ^*/PCT"XT
M#5]<N_#?B<:GH4NG>+KO6)M'2RAEEO=(M-0-R$T]XY/[??\ B%Z_9*_Z/F_X
M*O\ _B8FE?\ SHJ /D3_ (/#?V"_A-\3/V$[?]N_3?"VF:/\=OV;/&?P_P##
MFN^-]-L+6VU/QC\'_B5XJL? 3>$O%5U##'<ZS%X<\;^)/"^M>$;B_GG/AU+G
MQ19:='''XFOFK\+?^#/+_@H+XV^#O[;FJ_L%^)/$-Y>?!?\ :K\/^+?$/@_P
MY?7KG3?"GQW^'7A6Z\71^(-'CGWP6#>,_AWX7\1^'/$-O;?9Y-?U+2? IEEE
MDT6UMY_Z;/%7_!J;^P_XZT&_\*^-_P!K_P#X*?>,O"^J?9?[3\-^*OVJO#'B
M'0=1^PWEOJ-E]OT?5_@S>:?>?8]0M+2_M?M%O)]GO+6WNHMD\,;KV?['O_!K
M=_P3J_8B_:6^$?[5?P=^(7[6E]\2_@QXBN/$OA2R\:_$OX::OX4N[V[T75-
MN;;7=-TCX+^']2O+"?3M8O8I(;/6M.F+,A%P%#*P!_2+1110 5_&O_P=G?\
M!8'Q1^R9\(_#G[ ?[.WBNZ\-_'#]I#PE=^)/C)XQT*]>UUWX>? "[N[[0(?#
MVDWELZ3Z7XB^+^IV&N:3/J$,JWND^"= U^)((9_%FBZK9?V45_BV_P#!=7X_
M:W^TC_P5Q_;T\>ZQ?37MOX=_:$\;_!OPT'D9K:V\(_ :_/P;\.+I\))2VM+[
M3_!$>LO'$L?G7VJ7E[.GVN[N7< _T%_^#6[_ ()@> OV,_V!OAW^U!XG\+6-
MQ^TW^V5X.TKXH^(?%VH6=K<:QX3^"_B8QZW\)OAUX:OFC^TZ9H>L^%#H/Q$\
M5VT7V>YU7Q1KT5EK#7UMX0\-BP_IMU/3--UO3=1T;6=.L=7T?5[&[TS5M)U.
MTM[_ $W4]-O[>2TOM.U&QNXY;6]L;VUEEMKNTN8I;>YMY9(9HWC=E/FGP#\.
M:7X.^!7P6\(Z'';PZ+X6^$WPY\.:/#9J$M(M+T3P?HVF:?':H  EO':6L*P*
M  L04 8%>LT ?XTG_!?O]A7PC_P3W_X*@_'OX*?#+2XM#^#OBI?#WQI^#^@P
M+*EMX;\$?$ZQ?5)_"=@DNXKH_@WQE:^+?".@#S[E_P"P-#TPW,[7AN$3_3<_
MX(#_ /*&S_@GM_V0#2/_ $^Z]7\*?_!YA_REG\"_]F8?!_\ ]67\<J_NL_X(
M#_\ *&S_ ()[?]D TC_T^Z]0!^?7_!T5_P %:_%'_!.[]DGP]\$?@+XGG\-?
MM0?M:CQ'X=\/^*=(NC;Z]\*OA#H4%I;?$+X@Z/=6\HN]&\6ZM<:QI?@WP'J@
M2"XL[B_\3^)]#OK?6_!=LP\ _P"#0?\ X)Z^!_A%^Q+<?M^^,?#UGK'Q\_:S
M\1>,[7PQXOUBU2ZUWPC\$/!'BO4?!T&A:3<WBS7FFS^.O'/AOQ-XM\37UK-
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MO\HW_@T&9A_P6-\+@$@/^SO\=%8 \,HT[06 /J-RJV/50>U?Z7O[?/QGU?\
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MY\:R:EXA$[WNJ:+XLM+KQ)I=[X;OY+CP]IUOJRS:+I>FW.EZ1-8?T7?LW_\
M)N_P%_[(O\+?_4'T*OB+_@MHH;_@D9_P49##('[(WQH;\4\(:@ZG\&4&@#_,
M+_X-]? O[7'Q5_X*"VWPG_8P^)'ASX)_%3XH?!/XH^"/$7QUUZVFU&_^"GPG
MU9-!D^(_Q#\"Z/;W5G-J_P 2[/1+7^Q? -JD]N+;Q)KECJLFH:'%ITGB#2?]
M*O\ 9(_X(*?\$N_V2?!D&B67[+?PU^/GCZ^C>Y\;?&W]J#PEX:^.WQ1\=>(;
MQFEU?Q!?:EX^TG5]'\-3:M</)+=:;X'T;PUI4NXR75I=7DMU>W/\$W_!G]_R
MF(T7_LVSXX_^@>%*_P!6>@#_ #1?^#N?_@E;^SC^QOXM_9P_:J_97^%_A;X+
M^$OCKJ/C;X<_%;X<> -)M?#7P]L?'WABQTGQ%X2\5>%/"FFQQ:-X8G\4^'[O
MQ+I_B#1_#]II.@"7PEI>J6NEIJNK:[>WG[V?\&<?[0WBGXM_\$O/&'PG\6:I
M<:H?V:?VB_&?@3P4;F5IGT[X<^,_#GA3XEZ5I0DD9I2EGXS\3?$ VJ,?*MM/
MFLK*V"06J1IXK_P>S11G_@G_ /LJ3%098_VQ+*)'_B6.7X*_%AI%'L[0Q$^Z
M+7!_\&1#,?V3?VV5).U?VB/ S!<\!F^&L08@>K!%!/<*/2@#^UOQ'X=T#Q?X
M?USPGXKT32O$OA?Q/H^I>'_$?AW7=/M=6T37M"UFSFT[5M&UC2[Z*>RU'2]3
ML+BXLK^QNX9K:[M9I8)XGBD93_BU_P#!8;]AN_\ ^":?_!2#X^?L\:387%KX
M T/QA;_$KX$7>H(][#J/P;\<R'Q3X A^T7PD.LOX5BENO &NWMPFR_\ $?A#
M7"T9C.#_ +5M?Q2?\'FO[!/_  M']F/X/_M^^"M%\_Q=^S3KT/PM^+MU:6^Z
MXN_@I\3M8BC\+:MJ,X5W:U\"?%:ZL],TZW01HH^+&MWD[E+5 H!_5M^Q)^U)
MX._;8_9)_9\_:L\"/;CP_P#'#X8>&_&LEA;2^>/#WB.YM?L7C7P?<2[I U_X
M*\9V6O\ A+4]LDJKJ.BW2K+*H$C?4M?PA?\ !EI^WK_PD'@#]H#_ ()T>-M9
MWZI\/[R7]HKX%V]Y<;I9/!GB2]TWP[\7O"^GK(R)#9^'?%]QX3\7V5C LUQ=
M7?C_ ,7:@^R"Q8C^E;_@N!^W4G_!/+_@FE^T=\>](U==*^)^J^&C\(_@8R3"
M&_?XP_%&*Y\.^&=5TP,56:[\#:>^N?$N:W9U\_3/!.H1J6<JC 'X5?L2^#_#
MO_!6S_@X_P#VO_V^M6TBR\3_ +.'_!-/2_#_ .SM\ =0NK>.]T?Q%\8O#L_B
M'P]I?B?3YY5:PURRT+7U^-/Q,T*]M4:;1+K7OA5K44D5RME=S_V5:SK&E>'M
M(U7Q!KVHV6CZ'H>FWVL:SJ^I7,5GIVE:5IEK+>ZCJ-_>3LD%K96-G!-<W5S,
MZ100122R,J*Q'XV?\&_W["3_ + /_!,'X!_#?Q'I#:5\7OBKI[_M"_',7,)A
MU2/XC?%>RTW4X- U=''F1ZGX$\#6G@WX?ZE&9)8VU/PO?W<3E;LYJ?\ !Q;\
M;-<^ G_!&']NCQ?X:NYK+7?$WPY\.?!VUFMW\J;^S?CG\1_!OP@\5+'*"&C;
M_A#?&GB)MZ$2 (?+97VNH!_#+\1?VA?'7_!S!_P7<^!_P7U_7O$NG?L=P_%'
MQ#H?PQ\ 6]U?:5:^&_V:OAEI^L>._B%XKGM$E$6C_%#XS^%?!ET^J^(9EGU#
M2M9UWPKX5AN;W2O"FAVH_P!1[P'X#\%_"[P7X5^'/PY\+:#X(\!>!]!TSPOX
M/\'^&-,M=&\/>&O#NBVD5CI6C:-I=C%#:6.GV%I#%!;V\$:HB(."22?\L+_@
MS_@TV7_@L3H<E\B-=6W[-OQQGT8LH+1ZDT7A:WE>,DY5SI%QJJ%ER3&[KC#$
MC_5IH _)7_@LK_P2T^%O_!5/]CSQQ\(]=T/1+3XZ>$=&UKQ7^S3\4+B"&VUC
MP-\4+2Q:XTW2)]9"&X3P'X]FM;;PQX]TF;[382Z7=0>((;(^)/#?AW4-._S.
M_P#@B/\ \%3OBO\ \$A/VWM.7QE>^(=/_9Y\=>,;/X8_M;_"?4%NS'I^F6>K
M3:%<>/;70GW?9/B)\(=1DN]5MGA@34-5TFV\0>"IIH+?7FN+3_8NK_&0_P"#
M@/X0:9\#O^"RG[?W@?1[2.QT_4?C6OQ1BM84$4,4WQU\&>%/C?>B&)55(H6O
MOB'<O%%&JQ1HRI& BJ* /]F6PO[+5+&SU/3+RUU#3M1M+>_T^_LIXKJSOK*[
MA2XM+RTN8&>&XM;F"2.:">%WBFB=)(V9&!/\U?\ P=L_\H7/C#_V6#X ?^K&
MTZOT1_X(B_$S7?B[_P $D?\ @GUXV\2W$]YK;_LS?#WPI>WMTSR75^?AU8R?
M#NWU"[FD)DN+N_M?"L%Y=74C-)=7$TEP[,\I8_G=_P ';/\ RA<^,/\ V6#X
M ?\ JQM.H _ 7_@Q\_Y+Q^WY_P!DC^"7_J9>.*_T6*_SI_\ @Q\_Y+Q^WY_V
M2/X)?^IEXXK_ $6* /\ ,M_X/$O^"=ND?L__ +5_PV_;B^&'A:UT3X>_M:V&
MI:#\58]&L4M=+L/VA_!,,=Q>:]=QV\<-G9WOQ4\#W-AJ[1Q1-<ZSXE\%>/?$
MNHS3:AJMQ+)_1S_P:)?M8>%/CE_P2GT'X!6KV=IX^_8Z^(OCCX?>*=)B\M+N
M[\+?$_Q?XG^,/@3QA+;Q'9'::Q-XJ\6^%()6"37>H> M7N)D9Y/M$_Z<?\%M
M_P!@^+_@HK_P3:_:(_9^TK2H]3^*&G^'O^%K_ EO*62\A^,WPSANM>\*:;I[
MN&2VF\<60UKX:7EVR.;;2/&VIRHOF*C+_G4_\&NW[=\O[$W_  5'\!^ /&.J
MR:/\)OVO+>+]F_Q];7\K6UEI?CC6=4BN?@SXCNK>4Q1QZAI_Q%CM?!3W=X\4
M6DZ#X_\ $UW*"8PM '^MO7\;W_!?NT7_ (*7_P#!3O\ X)E?\$7?";S7WABS
M\7S_ +5W[65_ILCE_#'P]LM.U:TMK%K^W*C0?$$?PNT;XG&S^UN#<:G\2/AT
M(0KW\"7?]>_CKQMX6^&G@GQC\1O'.LVGASP5X \*^(?&WC#Q#J#F.PT+PMX5
MTB\UWQ!K-ZZABEII>DV%W?7+A6*PP.0"1BOY1O\ @VU\#>*?VPOCO_P4+_X+
MA_&'1KNT\3?M@?%[7_A!^SM:ZPHDOO"WP!\ ZEI@OK"PN<RQ7>F1#0?AO\,(
M;J"5'2_^#.NJZM'?;F /ZR/#7AKP_P"#/#GA_P '^$M%TSPWX5\*:)I7AOPS
MX=T6S@T[1]!\/Z'8P:7HVBZ3I]JD=M8Z9I>G6MM8V-G;QQP6UK!%!$BQHJC^
M"+_@M!^TMX\_X*_?\%H_V>?^"&_PM\<:SX8_9B\"?%C0M+_:&G\+7HAG^('C
MCPQX;O?BC\8=1NG!\B^B^"_PXT77?#OA'1-2A:QL_B=9^)M7U"'4?(\/2Z9_
M?Q7^._\ \$POAKX4_P""E'_!<O2?!WQI^)GQA^&]A^U)\8OVK_'>M?$+X*>.
M8?A]\4+3Q+JG@CXQ?%FVCT;QA>:1XACT\:]K&G+HVIQ/IMR^IV&HW.EQM%)>
M+,@!_KF_!/X)?"?]G'X5>!_@A\#O ?A[X:?"KX<:%:>'/!W@OPO8I8:5I&FV
M@)+$#=/?:E?W+SZCK6M:C-=ZOKNKW=[K&L7U]JE[=W<WX?\ _!R[^P7\)OVP
M/^"8'[0/Q-U_PMIG_"Z/V2OA[XF^/OPE^(D%A:KXET/3O 5F?$?Q'\(RZH(?
MM]SX0\7^"-.UN/4M!:Z73CX@L?#?B-X)+[P_9UYW_P 0O7[)7_1\W_!5_P#\
M3$TK_P"=%6?J_P#P:Q_L:>(-)U/0=>_;2_X*GZWH>MZ?>Z1K.C:O^UOH.I:3
MJ^E:E;26>HZ9J>G7GP>FL[_3[^TFFM;VRNH9;:ZMI9()XI(I&4@'\0?_  ;0
M?\%!?&W[$G_!3?X,>!?^$AO(?@?^UWXN\+_L]?%WPG->O%H=WK'C34FT+X2>
M-G@DWV=KK7@KX@ZSIBKK,D0F@\):YXQTD7%M;ZS<3Q_Z\=?RO?"__@T'_P""
M7WPC^)?P[^*_A/XE_MGGQ3\,?'/A+XA>&AJ7Q7^%-QIQ\0>"]?T_Q)HPO[>W
M^ ]G<3V7]HZ;;?:H8+NUFE@\Q(KF!V65?ZH: "BBB@#^;'_@[-_Y0I_'?_LJ
M'[/G_JV_#=?SX_\ !C[_ ,E^_;Y_[(_\%_\ U-/&=?T'?\'9O_*%/X[_ /94
M/V?/_5M^&Z_GQ_X,??\ DOW[?/\ V1_X+_\ J:>,Z /]%ROXQO\ @]G_ .3
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M  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04?MS?]VS?^MA_L^U_D"T
M?W^?\&,?_.47_NR;_P!^XK^_ROX _P#@QC_YRB_]V3?^_<5_?Y0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRRVOAKQ?;>,;;QE;Z.K1:5H^M^'/$-_90Q7_ (LU)[K](/\ @ZQ_X+*_%O\
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M@/\ ^#<;_@X]_9=_8X_9;T[]AC]O+7/$7PR\)_"W7?%FL_ _XUZ1X.\5^/\
MPV/"GC;Q%J7C+6_ 'C70? ND>)/'%AJVE^,M=U[4_#>NZ7X>UO2+_1]:;1M3
M'AS_ (1NQN-?_8CXS?\ !<GXK_\ !3BR^)W[)W_!#+X!^)_C9J=]X-U[2OBY
M^VI\;?">M_#_ /9Z^"OA36]%OK:XFT/P]KUA'XM\6^/]<TYK^V\(Z#XCT+1M
M1;5(DO;'P)XZTFTUC^RP#^'W_@W0_P"4UG[ ?_94/%7Z_"7XA@?K7^R'=6T%
M[;7%G<H);:[@FMKB(D@203QM%*A(((#QNRD@@X/!!K_$-_X)8_M3^#_V)/\
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MHNI67A'Q5\./ _BOPIXHT.YU(31Z!J5UJNAZI/I[6UYXAT+PW*]Q;6WY9?\
M!3O_ (* ?M9?\%C?^"=W[9WQ<_9?\&^,OV5_^"5OP(^'^I:MXC^*OQ*T>VM/
MC'^W/XYT+Q/HNG6/PZ\$:+:7UW8^!_@KX=UN5-7\<ZW:ZGK.H:]>:18>$[N]
MM;FZ\6>%-! /R9_X,QW5?^"L7Q(!(!D_8F^+J(/5A\6/@$Y ]3M1CQV!/2O[
MG_\ @OW\)]8^-7_!&_\ X* >"=!M);[4[+X'3_$F.T@1I)Y[7X*^+/#'QEU)
M8(D!>:8:;X"NVBAC5I)758XU9V53_F@_\&^W_!0[X2?\$S_^"C7A+X^_'H:]
M;_!OQ-\-?B!\(?B!KOAK2+GQ#J_A33?%Z:/K.D^)(_#]E_Q,-8LK#Q3X4T"'
M6+334N-3BT:ZO[[3K'4[ZT@TV[_U??V4_P!J_P"#W_!0'X-^)_B#\/O 'Q?L
MOA%J^J:IX(LIOCQ\%_%_PGLOBSX7O_#FE7=WXJ\%Z#X^T[3]0\5_#36K?7KO
MP[%K<VGVL-]JFD:_8M9_9K>"YO #_,6_X-:_^"@WA#]AC_@I/I?ACXL>(+3P
MS\&OVLO"#? ?Q/XAU6[2RT'PGXZN-<TW7OA-XLUNZE:."UL!XELKKP+=:C=R
M1:=HUCX_O-<U.:WL--N+F'_6LK_&V_X+A_\ !(+XI_\ !*/]JGQ+H46@:UJW
M[*GQ/\0ZSKW[-7Q5,-S>Z5>>&KJ>74!\,O$VL;7AMOB/\/K>7^R-5L[R2&Z\
M1Z5:67C.PMTL-7DMK#],/^"8G_!VU^U=^QA\./#7P)_:B^&L'[8_PJ\&Z?::
M%X)\6WWC6X\$?'+PCH%E$EO8Z+J/C&[T3Q7I/Q'T;1[6*.VT>#Q+I.G>*((2
M;:[\<7FGVVG6%D ?ZC-? \W[>'A?4/\ @I)I7_!.;P9X5_X2[Q7HO[+?BG]I
MOXV>.K3Q D%E\(+ >./ W@SX7>#-1T=-*NX]3\1_$1?$>N:_)8SZUHVHZ'X?
MTW0M9BT[6-.\0-<:?_'Q^T'_ ,'L.N>*_"<W@[]C3]AS4]*^+'B<1Z-X;\6?
M&3QW#XNL-%UG4RME8_V7\+_ >@VM]XTU62[N(UTJTF\:Z/ U\MNEQIFK13/8
MM^_G_! ;_@GG\<OV6?@W\6/VM/VW=9UGQ;_P4#_;Y\3Z3\6OC_JOBEXYO$7@
MCPS96UW+\/?A;?1QPPVFD:QHL&M:IJOBG1=%MM-T?0+S4-)\ V6GKIGP]T>9
M@#]<_BC^U5\)/@_\??V9/V;?&]]J]E\2/VN+KXO6'P=6WT^*;0;_ %'X)^";
M7X@^,M/UK5'O(7TN\E\-7+7.AQI:78U.XM+JU+V\HA$_B/[=W_!+_P#8A_X*
M1>"QX2_:Q^!OAOQSJ=A836/A3XFZ6A\,?%[P()&DEC;PA\1]'6#Q#9645W)]
MNE\-ZA<:GX/U2[CC;7?#NJQ+Y1_FE_X.^OV@/B)^RIXV_P""0G[2/PFU"+3?
MB-\$_CS\<?B-X3GN5EDT^YU/PS:_ S4/[)UBW@F@DO=!UVVBN-%\0:<)HEU+
M1=0O["1Q'<N:_HR_X)G?\%3OV5_^"I'P,T+XK? 3QII-OXWM]'L)/BS\#-6U
M>R'Q.^$'B5XH8]2TOQ#H9:"^U#PX=0>2+PUX[T^R/AOQ19[)+2XM]3BU/1],
M /\ .E_X+5_\&TWQX_X)B:#KO[1GP4\57_[1?[&]EJ-O%K7B>YTZWT_XK_!:
M+5;^*PTB/XIZ)IB+I.N>')[R[L=*@^)/A:&QTZ75IU@\0>%/!JW6DG5/U<_X
M,RO^"B?Q2U'XC_%O_@FW\0_$>I>)?AC:_#76OCO\!H]7NI[U_AYK/A_Q1X=T
MCXA>!]!DF>66U\->+[;QC;>,K?1U:+2M'UOPYXAO[*&*_P#%FI/=?UQ_\%F_
MV@?@)^SO_P $R_VR_$'[0FO>'[#POXX_9\^+?PI\->&-8N;1=1^(_C[XC> /
M$/A;PAX#\,:9.WVG5M;UC5]1MY&^Q0S'0]+M=1\3Z@UGI&B:A?VO\B7_  9@
M_P#!/WXH6OQ.^,__  4;\=>&]3\._"UOAGK'P"^"%YJ]I/9)\1/$'B'Q9X<U
MKXA^+?#BSPH]_P"'_!5OX)M?"#ZS"[:9?Z]XCUO2;2:YU'PQK,.G@'][WQO_
M .2+?%[_ +)?X_\ _44U:O\ 'U_X-XO^4T?_  3_ /\ LL&J?^JY\;U_L<>+
M_#\7BWPGXH\*SRFWA\3>'=;\/S3A=YABUG3;G3I)0F1N,:7)<+D9VXSS7^)=
M^Q[\8/%G_!,'_@I1\&_BK\5/ ^MKXE_9#_:/AM?BW\/4CCL_$HMO!_B&]\(_
M$_PSIZ:D]I;Q>(/[&;Q!9:0U_);V9U/[(]S+':EY  ?[>=?YP'_![K\)]8TO
M]JS]BKXZ/:2GP_XZ_9\\9?">WOE1F@76/A3\1[[QA>6DL@!6*5[+XRV,T".5
M:=$N&B#BWFV?T%:K_P '%'PB_;<\8_"+]DO_ () V_BWXS_M6_''Q)X9CU?Q
MQ\0O@_XOT'X2?LN?"JQU73-0^+?Q2^*MMXE'ARZ\3W?A/PE_:%CH>B>&;B[\
M/ZIXGO=.@'BB[OGT7PWXJ^V?^"Z__!+F'_@JM^PGXH^#7AF;3-.^/GPVU>'X
ML_L[^(-7EBLK%_B'H>F7^GW?@W7-1")]B\._$;P]J&I>&KVY9DL-)UN;PYXI
MO+>ZB\-I:2@'YV?\&E7_  4&\(?M-?\ !.[1/V3M=\06B_';]B^?4/"%[X?O
M+M%UCQ#\%/$&NZAKGPT\::;;.RM=:3X?.JWGPQU!;-)/[&D\+:#-JIMV\3Z0
MU[_5?7^&7\)OB]^V%_P2]_:R'C#P'J7CO]F[]J#X$>)M2\.>(-&UC3&T_5=-
MNX)%M]?\%^./"NL02Z;XB\,:U D<>IZ'K-G?Z)K5B]I?VXF4:??)_:!\ _\
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M3^-'TB/2M,O-&T_Q)J>C?&O_  :I_P#!%;QO^Q;X"\2_MU?M3^#KKPC^T/\
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MGJ=EX7^(FJ>#YK4:Y%_PB=WJ?B'PM\1M MM.3Q!_86JRZG%8ZKJ_A#2M U
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MX:_''XF?#;5[F-&=+.Z^,/@;1?$6DM<%0?*AG_X4Q?PB9]L8G:"$L)9XE?\
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M'C[X<^+_  QX^\#>*M.@U?PQXR\&:]I?B?PMXBTJY!-OJ6B:_HMU>Z5JEC,
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MA</&-2UNWT3Q/)KPTFU,M_)HNC:UJ<<#6>DW\T'^E;0 5_D*_P#!R5^PS?\
M[ '_  56^)^L^ [*Z\,_##]HJ[A_:D^#6HZ.9=/BT'4O%^M7MQ\0-!TB[L_*
MBTN[\(?%;3_$=WH^FV#PRZ'X5U3P<\<<$=Q:LW^O57\M'_!VG^P3_P -6_\
M!-NZ_:"\(Z+_ &A\5_V(=<O/BQ:26UOYVHWWP7\0Q6&B_&W1XR%_=VFDZ?9>
M&?B=J$\D@6WTWX;W\<2M+=[6 /@7_@H;_P %@?$O[</_  0C_8F^%GP.OH=8
M_;*_X*J^+O"/[('BGPGH]Q'::K:>*_ VO^'_  K^T4R6ML'.EZ7X[\877@C0
M+73[FW=&^'?QGCO!(1$LK?U[?L8?LO\ @K]BS]E+X _LJ_#Y8G\,? WX9>&O
M L6HQVZVK^(M:L+,7'BSQA>6Z'9'J?C7Q;=:WXMU8)A#JFM7;(JJ0H_SH_\
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M4M7U?5+^Y>.VLM.TW3[:XO;V[N)$@MK:&6:5UC1F'\$?P#_X/>K*#P18:?\
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M]BB]TO4]/N(KRPU+3OVH_P!LJRO[&[@<2075G>6W[0T5Q;7$,BJ\4\,B2QN
MR,K &OWQHH ^(K3_ ()V?LH6'[+]]^QQ:^$_B;%^S_J.N)XBNO#I_:6_:<D\
M:G5(]=LO$B-!\:9?C"_QNL[ :MI]K(=&L_B+!HS62RZ2U@=(N;FQF_.[5?\
M@V'_ ."'FNZE>ZSKG[%FH:SJ^I7,MYJ.JZK^U-^V9J.I:A=S,7FNKV^N_P!H
M::ZNKF5B6EGGEDED8DLQ/-?O=10!^%O@W_@VN_X(P_#K5_[?^'W[)OBSP+KO
MD/:_VUX-_:\_;;\,:O\ 9I&1Y+?^TM$_:.L;SR'>.-WB\[RV9$9E)52/MC]L
MG_@F3^QO^W]J_P ![[]K+X82_%K1_P!G6Y\<WG@'P9JOB37K'PC=W7C_ $30
M]"U>;Q;8:7>V=_XE-E;^'=*N])CO-46&WU*W^V74=ZS;1]]44 ?S1?$3_@U
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M+/@2'4'$E]9:%XJBM;ZVO]%NY1]HG\,>*](\2>%7OMFI_P!B#4X8+R+])J*
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MPO\ "F+X->'O&UCX+^%&O:%X3U_Q3X@TRYUZ7PYX>LOB6+EY_%NI6US'X?\
MB'X?MY+>"R5(X_+G%S^I7[/?[+W[.G[)W@2V^&?[-/P3^&GP/\#6XA:3P_\
M#?PEI'AB#4KJ",Q+J>OW6GVT6H>)-:D0L;G7/$%WJ6L7CO)+=WT\LCNWN]%
M!7Y+?M^?\$0/^";W_!235)O&'[1GP'M;;XM26D-E_P +O^%NK77PW^*L\%M
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M *V'^S[7^0+7^OU_P='?\H*/VYO^[9O_ %L/]GVO\@6@#^_S_@QC_P"<HO\
MW9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO[_* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^
MU_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0LLFCVK.H.&,*$@[1C6_X,D/^3*OVQ?^SH]&_P#53^%:C_X/<?\ DR_]C?\
M[.?U[_U5/B6I/^#)#_DRK]L7_LZ/1O\ U4_A6@#^UFBBOD/]M3]N_P#97_X)
M[_!Z\^.'[6'Q8T3X8^#$GDTW0;2X6XU7Q=XY\0+ UQ%X7\!>#]+CN=>\5Z]-
M&OFRV^F6<EKI5GYFJZ[>:5HUM=ZC;@'UY17\DOB;_@X[_;A^)?A>X^*7[$W_
M  0>_;7^-GP%EMGU7PW\8?'\7BWPB_B_00AECU?PYX&\"?"7XE0ZYI\\.)X]
M0\->//$5L LD6&D20Q^-_LG_ /!YE^S#X^^(MO\ #']M;]E[XD_L?7K:R_AS
M4/'>C^*9/C+X/\+ZO!=&SO6^(.@GP1\/OB'X1M+&Y2:VOH]&\,>.M0L+F/;>
MVD,"W,]J ?V?45S/@OQIX0^(_A'PUX^^'_B?0/&O@?QEHFF^)?"7B_PMJUCK
MOAOQ+X>UFTBOM*UK0]9TV>YL-3TO4;.:*YL[VSGEM[B&1)(W92#734 %%%%
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M2\\:>-Y]-M)-=O+"RTZPM=+\-Z#H&A:3_6K_ ,$TO^#GG]EK]E#]@?\ 9/\
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M+#?:;?+"UGJ5A/!?6$]Q:3Q3. ?UHT5\5?\ !/7]N?X8_P#!2#]D[X<_M?\
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M6=3GMK&PLX%P#+/,@:1DBCW2R(C '9T5_+1XP_X.7-0^,OB3Q9X=_P""5/\
MP3._:[_X*0:)X*U&XT77_C-X>T'Q'\+?@M'J42)*G]CZ\/A]\0M>O!+!+%/;
M:9XMT+X>ZU?QEY;.RDLQ'>R_"<'_  >*>,O@7\87^$7[?O\ P2M^,_[-VI6,
MUM+X@L]/\?Z@?B5H.EW4C)!J$?PI^*WPN^%QUJTN(XY9[*_7QSI-EJ$<1:R>
M:-Q(H!_<'17RE^QI^VW^S-^W[\$]%^/_ .RM\3](^)GP]U6=]-U!K9+C3?$G
M@_Q);003ZCX0\<^%]1CM]:\*>*--CN;>:;3-4M8A=V-S9:SI,^I:'J6FZG>?
M5M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?@#_P='?\ *"C]N;_NV;_UL/\ 9]K_ "!:_P!?K_@Z._Y04?MS?]VS?^MA
M_L^U_D"T ?W^?\&,?_.47_NR;_W[BO[_ "OX _\ @QC_ .<HO_=DW_OW%?W^
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7^=3_P 'L7[2'C*?]HS]C;]DV:\OQ\*/"_PDO?VCM;\.VUU-:6'B
MCQAXT\=^+OAOIUUJ)12DM[X8\._#O7;+0[G]Y+ID7C;7C&BC4&,G^BM7\DO_
M  =+_P#!&#XO?\%$/AK\+_VHOV5M /C7]H7]G#P]XC\+^)?A9:/%%X@^+'P@
MU2^7Q%%:^"VN'2&_\;> ->_MG5-'\*^9;W'BW3/%/B"STF6[\2V/A[0=; /Z
M7OV6/B5\"_B_^SA\$?B1^S+>^&;SX ^*?AGX1O/A*GA".RMM TGP5!H]K8Z-
MX:M=.L&,&AW'A2WM1X:U/PXRPW?AO5-*O-"O[:UOM.N+>+\_O^"X/_!.3P;_
M ,%*?^"?WQF^%4_ABPU/XV> ?"WB#XH_LU^)5LXF\0:!\6O"FE3:KIOA_3-1
M\J2YM]&^)D%@W@'Q19 3VMQ8:S!JOV.75]"T2YLO\N']@C_@K3_P41_X)'^/
M=<\/?!#QYKGAGP_9>)KI/B9^S)\9="U36/AIJ/B+3YA9:Q:^(OA[J\VDZYX&
M\6++9Q6&LZWX.U'P7XS<6%OINIZK+:6OV*O[Z_\ @F5_P=A_L/\ [9NH^&?A
M1^T[I[?L6_'G6Y+32K&X\8ZY#K/P \8ZW.R6\,&A?%62WTQ_!5YJ,PDGCTKX
MEZ3H.CV1FM-(L?''B35)HUF /T:_X-[ 5_X(P?\ !/X$$$?!F[!!&""/'OC$
M$$'D$'@@]*_F0_X/>/C#\9K'4/V'?@/:SZWI7P!\0:5\4/BAJB6OVJ'0?&WQ
M5\/:AX?\-6%OJT@/V6]OOAYX7UF:ZTFU.'M$^(FH7,JRF:S>V_OPT31]$T'2
MK+2?#FEZ5HNB6<1&G:9HEE::=I5K#-(]P1965A%#:012RRR3D01*CR2O(<L[
M,?.?C'\ /@1^T3X=L?"'[0/P4^$GQT\)Z9JUOKVF^%_C%\./!WQ-\.Z?KEHD
MD=KK-CHOC71M;TVTU6VCEEC@U&"VCNXHY9$CF578$ _"G_@U0^&L'P^_X(J?
MLWZJW@^/PIK/Q0\8?'+XBZ[=OI_]GZEXP>Z^+_B_PMX=\6:F'CBN+K[7X+\*
M^&=-T:]F#+=^&]+T:XLWDL)+61_2?^#E[X >#OCS_P $;?VMIO$>CV-[X@^"
MVA>&_CK\/-9GMXY;[POXG\ >*=(DU2_TN9XY'MIM8\"7_C#PE>LFWS-+\0WJ
M%D)22/FOVO/^#A']@S]D'Q=I/[*/[,'A;Q7^W%^U#:/#X$\#_LN_L9^'H/$F
ME:)JVD6QL[#P;J?B_P /6&H>%- 32(;";3+OPWX!TOQ[XG\*&P:UU;P;IEO"
M7C_([_@IE:_\' W[6W_!//\ :\^./[4VJ_L__P#!.;]DSPK\$/%_B_5/V1_
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MK/3K.YOKN3&?+MK2%[B=\9&=D4;MC(Z=: /\YC_@[>_X*R^._BK\>4_X)7?
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MA[HWB+0/!=Q\3_#5OXJM?#NE^+)]+NM>AL-+U)I=*$][<:+ILL=_+92ZA8M
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MSWQW_P &C_\ P3T^*7]E?\+._:9_X*._$;^POMW]B?\ "=_M(>!O%_\ 8_\
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M+>V9(X=?\7Z[%;VEGIZ6$1_KL_X-#?\ E#;X+_[. ^.W_I\TJOQ1_P"#X_\
MY'__ ()P?]B?^U#_ .GKX%5^UW_!H;_RAM\%_P#9P'QV_P#3YI5 ']/U%%%
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M^OZI:6YL++Q)=_#O3OAM?68U":"ZUZV6]ELUNWTG4Y(?ZG/^#3CQ)^T?K_\
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MO5=(OO"NIZ]=WJP?#K7].U71O['D%S>37'CJ6Z\<3?Y\W_!OU_RF9_X)\_\
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M90^%VL?"GC+0M$BN-<T2R\-Z#X@L-*U/2KCQ1?>'_P"8+_@FA_P7U_X*$_\
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MTV7_ (+$Z')?(C75M^S;\<9]&+*"T>I-%X6MY7C).5<Z1<:JA9<DQNZXPQ(
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M_P#*%/X$?]E0_:#_ /5M^)*_H1^*H#?"_P")"D9#> O& (]0?#VH@C\J /\
M$L_X)G^*/V@?"'[>/[,FK?LI^'+#Q5^TE<_$:#PU\$=+U9-^C6WQ(\::/JW@
M[POXBUQ6@N8#H/A#4M>A\6ZX;V(::-)T2\.IS6VGBYN8O]+NY_X-;?\ @G'X
MW_9%'P2^,.A^)_&G[3GB,WWCCXD?MU6^O:FGQ^\6?'3Q))+JOB_Q[+?:Q=ZK
MI%]X5U/7KN]6#X=:_IVJZ-_8\@N;R:X\=2W7CB;_ #YO^#?K_E,S_P $^?\
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MLJ_U0T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!^ /_!T=_R@H_;F_P"[9O\ UL/]GVO\@6O]?K_@Z._Y04?MS?\ =LW_
M *V'^S[7^0+0!_?Y_P &,?\ SE%_[LF_]^XK^_ROX _^#&/_ )RB_P#=DW_O
MW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^%/AS49DDG\/^$?".A:GHMEK.F:5.MMXG\766H>(]2EO$_L6VTGZZ_X+I_\
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MZ1I\KK<:EIVA:UX?M;+7;FR2:/2)]=T%-0:W.L:?]H /Z+/^"_?PGUCXU?\
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M(X7C77-6L[W5A$T41C^V;#&FW: #_-)_X/%_^4O-E_V:A\%O_4B^)E?WV?\
M!"S_ )0_?\$[?^S8/AY_Z12U_#U_P>D_!?Q=X5_X*+? SXWSZ1?#X?\ Q<_9
M;\.>%]&\1M;R+IMQXX^%_C_Q^GB[P[%=;?)>]TKP[XN\!:O-%O\ -$/B&$[
MB[C^F?\ P1I_X.<_^">W[+__  3%^#GP"_:IUKXG>$_CA^S3X4U;P!9>$?"?
MPTU[QFGQ9\.Z9K6L:CX)O?!&NZ6J^%]*U ^';[2O#VJV7C_7_!\,6NZ==W<%
M[+I-U#<1@']V-?XY/_!R/_RFW_;V_P"Q\^'/_JBOA97^I[_P3@^,'[47[0'[
M,MC^T-^UIX'TOX/>(_C5XP\7?$KX6_!=--FTWQ'\&_V>-8N8!\'_  A\3;Z[
ME,FL_$NX\+VB^,/&.IO:Z*+6X\3P:)-X?T*[T:[L(O\ )U_X+T?%WP!\=/\
M@KY^W7\2OA?XFTGQGX'U/XN6?A_1_%&@WD.HZ'K4W@#P+X1^'VLWNC:G:O+9
MZKI3:]X6U--/U6QFGT_4[1(K^PN+BSN()Y #_8/_ &7O^39_V=O^R%_"3_U
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M"X9962"/5OB7X+U)'TIKAU^W:O\ #[2?#U@)=7U[3[2Z_NS\!_!+XI_M8_\
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M=0US2;&1UN-1T_0=:T2QLM<N;1)8])GU_04OF@.L6'G_ -V] '^-K_P<8?\
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M2SNOC#X&T7Q%I+7!4'RH9_\ A3%_")GVQB=H(2PEGB5_W'_X-S_C!X%^+_\
MP1O_ &)Y?!?B'2M:N_AS\-IOA-XWTZQO(9]0\+>-/ .OZOH^HZ'KUFCFXTO4
M)[!-,U^SMKR.&2\T+6](U>V62PU*TGE^SO\ @I5^PQX&_P""CW[%GQO_ &1O
M'-W%HH^)'AV.?P5XP:U-W+X#^)GAJ\@\0?#[QE'"A2XFM=(\2Z?8KKMA:S6T
M^M>&+G7-!%S!%JDL@ /Y//\ @S#_ ."@WA#5OA+\8?\ @F_XZ\06FF_$'PAX
MOUGX\? FRU*[2"3Q;X%\46.EVOQ,\)^'XY&1)[_P/XDTJ+QK-IT6_4;[3?'6
MN:I!#)IWAG59[/\ NNK_  TOBS\)OVO_ /@EK^U]<^#O&$/C3]GK]I_]GSQE
M:ZUX=\2:#>W>FWMO=6-Q*^@>.O GB*%(K;Q'X-\2V:/<Z/K%H+C1O$.BW5Q8
MWT$D4NH:>O\ 7G^R1_P>Q^//"W@32?"O[:?[)%M\5/&FD64%I<_%OX(>-=/\
M!2^*FMXEA6]U[X8>(=!U+1+#6KS8+K5+_P -^+=*T*>[FF&E>$-$LUAM$ /]
M#JO@?]A;]O#PO^WA>?M9:U\-?"OV;X2_L[?M2>+/V9/ _P 4(O$":OIOQKO_
M (>>#/ VJ>//&>@V4>E64.G^'--\:>*-6\+Z#?66J>(M.\2Z;H\&O6NHV[WE
MQI=C_%3\>O\ @Y._;W_X+#>)]%_X)Y?\$NOV9[WX >)/VA9)O ^O?$F^\;W'
MC;XIVG@O4HS!XNUNWUK1?#>A>'?@IX1TG09KV?QGXW">+M>TG0X[B\\-:SH&
MM-9L?[>?^"=W[$_P_P#^"=_[&WP,_9%^'4XU/3/A3X4%OXB\4O;"UNO''Q!U
MZ]NO$?Q"\;W<)>66#_A)?%^J:OJ&G:?-<71T/17TS0(+F6STJV( /1?AO^U5
M\)/BI^T3^TI^RYX6OM7/Q;_93M?@W?\ Q6TS4=/BM-.33OCMX1U'QGX!U#P[
M>K>3R:Q9SZ9I&HVNJR/:V9T[4[5K5DE26">7\MO^"F/_  ;Q?\$\_P#@I5'X
M@\:>(? 2_ +]HW58[FYA_:%^"FGZ;H.OZOK,JL\=[\3_  <(X/"7Q3BFN! =
M3O\ 6[2Q\<W%E NGZ7X[T2$[U_FY_;<_X*GS?\$H?^#IOX_?%[Q7:ZOK?P ^
M)WPJ_9Z^%/[0WAW18VN]57P1J?P5^&&IZ7XX\/Z<TL<%[XF^'GB&PLM<M+9A
M]IU7P]+XI\,64]E<>(Q?6_\ >#\"OC]\%?VG/ACX:^,W[/OQ/\&_%WX7^+[.
M*]T'QGX'UFUUG2;D/#%-+8W?DM]JT?6]/\Y(-8\/:S;:?KVAWHDT_6-.L;Z&
M:VC /\;_ /X*H_\ !(K]JW_@D3\9M&\%?&N*P\2> O&4^I:C\%/CYX%^W1>#
M/B%9Z'/;2744:7&W4_!_CK0$O--F\0^#]4D>[TN6Z@O-&U3Q#H4UAK][_HY_
M\&Q/_!0SXE_\% O^";6GWGQPUV]\6?&;]F[XBZI\ ?%GC;5II+K7/'_A_1_#
M?ACQ3X!\9>(+R0N]_K\WAOQ-'X5UO5+F674M=U7PE>>(]5DFU#69[B;\[O\
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M1M1^%OBGP]#++C EU6#7?$[P1ELE-&N& P"3_H-U_-K_ ,'5W[(5_P#M2_\
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MC0M&T^#+$16\"A[F]O)VEOM5U6^DNM5UG4[B[U35KV]U&[N;J7_/P_X/@O\
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M7PG>WD:Q3ZMX%\:Z5-I_C#P-K4D<:1R:MX4US2+Z>!?LMS--:O) _P#GJ?\
M!9G_ (-1/B1^QYX.\=?M0_L(>*?$?QV_9\\':?J?BKQ_\(/%D=K<?&[X5>%K
M"&2^U7Q!HFIZ5:66F?%;P9H%I'<WFK-;Z7H7C3P[H\,5S-I?B^UM=:\0V/\
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M7A_QI)XT\0C3II(]!M=#T"/59+8^*=#BU'_4,H **** "O\ %5U;_E-KJ?\
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M[G3]2TZ_MX;RQO["]A>VO+*]M+A)(+JTNK>22"YMYXWAGAD>*1&1F4_Y!O\
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M^L/%_P 4?&VJ>&+NYM7DMQJVD:1XZT)=7LUD:;3-0FGTN^6#4+*[MH?[>/\
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MG?!J6^-[-':-=:1\4]7LY26:PDOY L#_ ,='_!RI\5O^"AG[2'C;]D?]IO\
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M^VZKJ,V9;_7-?U-XTGUCQ'KEYJ.O:S= W>JZC>7+-*?:J** /Y_=9_X-@O\
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M?\)!!XBTKX,?$[X>V'C**Z'AO25M%\86^NC2%BO%T;^SUU75A??FS_Q"X_\
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M[KWBSQ#J!1K_ %[Q-^UC^VIKVLWK1H(XS=ZIJG[15U?7)CC58T,T[E44*N%
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M$X/B9\&)+%%W[A80ZK=?L_W&MKI^,1D37UQJ1CW8U192)5_KRHH ^ /V#?\
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M[X?TSQ/X7URS+I-''?Z/JUM=6<LEM<1PWEC<B-;JPOH+>^LIK>\MX9X_1**
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M=X6EQA;SPA97T%AX*\(ZR@,D:>)?#7A+2O$R6\]Q9C6?L<TENWU9_P %"_\
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M/_\ !;+_ **W_P $L_\ Q'?]K3_Z*&OU,HH _+/_ (1__@ME_P!%;_X)9_\
MB._[6G_T4-'_  C_ /P6R_Z*W_P2S_\ $=_VM/\ Z*&OU,HH _,7]C']H']L
M/Q3^U3^US^RU^UY/^S5K>L_ +X5_LH?%+P?XL_9O\$_%'P/IFJ6?[0^J_M)Z
M7J^D^)=/^)WQ+^(]U<W.AO\  [2Y=-N-+FTJ+;J]^MTEX?LYM?TZK\M/@#_R
MEY_X*4_]FB?\$Q/_ %+O^"A%?J70 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?D?^U+_P %V/\ @E/^Q7\</%_[-_[3/[5MK\,_C3X"@\-W'BWP4WP;
M_:$\7OH\7B[PQH_C/PZSZ]X"^$WBGPO=MJ/AK7](U01V&MW4ELEZEM>I;WD4
M]O%\^?\ $4#_ ,$+O^CZ;3_Q'7]K7_YPU?SV?$O_ (([V?\ P61_X.1_^"D^
MO?%O7?$/AC]E7]F_5_V=H/BO>^%9HK#Q/XY\33?LZ?"[PYX/^%GAG5KJWNH-
M&CU.+P9X@UCQAX@MK6^OM&T338M/M(;#5_%6CZWIW],OA7_@W@_X(N^#])M=
M'TS]@/X1:A;VD,<"77BK5/B'XUU:81J%\V[UGQ=XTUK5+J9\;I)9KMV9B3P,
M  'EO_$4#_P0N_Z/IM/_ !'7]K7_ .<-1_Q% _\ !"[_ */IM/\ Q'7]K7_Y
MPU?S1_\ !VG_ ,$Y?V'?V)?V<_V2_%7[*/[-/PU^!?B+QM\:_&?A_P 6:MX&
MT^^L[O7=%T_P*NHV>G7SW=_>*]M;WQ-S&J*A$O)8CBOE?_@T@_88_9&_;=^*
M/[;&C_M8_ 3P%\=M+^'W@'X+ZGX+LO'5E=WL/AR_U_Q%\0+76;K3A:7MF8Y=
M1M],L(K@N9 R6L04*020#^P3_B*!_P""%W_1]-I_XCK^UK_\X:NZ^%__  <;
M_P#!&/XS_$SX=_![X:_MGVGB3XC?%?QUX2^&O@#P[_PH?]I_1O[>\:^.M?T_
MPOX5T7^U]?\ @II6A:5_:FNZI86/]I:UJ>FZ38^?]JU*_L[.*:XCZG6O^#?/
M_@C'K^G7.EWW_!/OX(P6UW$\,LNBGQIX;U%$<8)MM8\.^+-*U>RE ^[-9WT$
MR'YDD4\U_([_ ,%3O^""7@'_ ()2_MI?\$__ -M3]D?4/$\O[+>O?MQ?LX>&
M?&/P]\6:M<>)=:^"?CP?%#0/$OA>31O%%WOUK7?AWXGLO#^K6-O/XGEOM=\,
M^(-/L[+4?$>O#Q5I<>E@'^CE1110 4444 %%%% !1110 445^:?B;_@HUX3T
M_P#X*H_"_P#X)B>&M L/$'BOQ!^S'\0/VCOBCXN76G2;X?0Z7KNAZ1\._"4>
MD06<T-WJOBFT;Q+KVL)?7]C<Z3HP\*7MO:W<&OK)& ?I3))'%&\LKI%%$C22
M22,J1QQHI9W=V(5$1069F(55!)( K\&?V[?^#D;_ ()8_L*_VSX<U+XVQ?M%
M?%S2_/MS\)OV:!IGQ+U&UU*'=$UGXE\=Q:G8?"[PK+9W>V#6--U+QFWBK3U$
MS1>&+Z>!K8_O%=6MK?6MS8WUM;WEE>6\UK>6=U#'<6MU:W$;0W%M<V\RO%/;
MSQ.\4T,J-'+&S(ZLK$'^-S_@Z<_X)R_L6_"W_@DO=?%/X(?LO_ GX(^,O@1\
M7OA*WAGQ!\(?A7X(^'.JGPUXRUR3P%K_ (7U2^\):)I-SJ^A:E)XBL-9N;+4
MY;I9-=T?3M4+?:XY9)0#Z_\ ^"&__!?CQW_P6*_:,_:;^'NH?L\>$O@9\-OA
M!\/_  WXV\#BS\9ZQXW\<:B-:\3OX?DMO%>L3:7X=T&7=#']N2/2/#MC]DEE
M^QM=7Z0_;)_Z:Z_S@_\ @R&_Y.G_ &X/^S?_ (>?^K%FK_1\H **** "BBB@
M HHHH **** "OSS_ &U_^"K'_!/_ /X)ZZ9<S_M5?M+> / 7B>.S%[8_"W3+
MV;QG\8=9CFA$MDVG?"[PA#K/C&.SU M'%;Z[JNE:;X:B>5'OM:L[<23I^AE?
M"_[2'_!-K]A_]J+1OCA_PM?]E?X ^*_'OQZ\(7?ACQQ\5]8^$O@6^^*M]-%X
M0@\&^&=:B^(USH4OC"RUGP;I>GZ.OA+4[/6(+OP[-I&GW&DR6L]M'( #^9_X
M5_\ !W1HO[5O_!0;]ES]DW]E[]E.\TOX._&SX[^ OA1X@^*_QP\4+:?$"XTC
MQGXDL="FU;P[\._!,NH:%X:NK"*XDO+236/''BL7XDBCN=+TMX9%E_M(K_%#
M_P""+2LG_!6__@G*C@JZ?MC? I64]59?'VCA@?<$$&O]KR@ HHHH **** "B
MBB@ HHHH **** "BBB@ HK\T_P!KS_@HUX3_ &8?VP/^"??[&=GH%AXO^)O[
M<'Q.\8Z%<02ZT]A+\._A?X'\%ZOK&J>.YK2WL[R2]O=5\6?V!X<\.Z=>MIUG
MJ<$7BZZBO6G\/O;O^EE !1110 4444 %%%% !1110 5X)^TQ^U!\!/V.O@WX
ML^/_ .TK\3?#GPG^$_@NW276?%/B.>4":[N-ZZ?H>A:590W6L^)O$VL3(UMH
MGAGP]I^I:[K%S^XTZPN) P7WNO\ +[_X+_?MI^(?^"D?_!;/X5_L&)KVH/\
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MWBKQ'=>,]$T*R\0:A>>,H+G7]+\3G4+^Y35=/UJ[AG3?'9R6P!X1_P $G/\
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MX4O;>UNX-?62/]+* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?Y M?Z
M_7_!T=_R@H_;F_[MF_\ 6P_V?:_R!: /[_/^#&/_ )RB_P#=DW_OW%?W^5_
M'_P8Q_\ .47_ +LF_P#?N*_O\H **** "BBB@ K\L_V9/^4J?_!5#_LE?_!.
MC_U#?VCZ_4RORS_9D_Y2I_\ !5#_ +)7_P $Z/\ U#?VCZ /U,HHHH ****
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M1M8U$:-:VMIXQ\)6^H^(4TNRU#PQXBO-4_K\H **** /S-_X*E?\%3OV;_\
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MSP)X^UK1K0R)$MWJ^B^&M<U'5=+M'DD1(KJ^L[>"5G41R,6&?INO\6+]M/\
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MB#PAXM@@?2OAO=:G<W6L>&?% TGP3:R7OAS7M&M?" !_H<445_(E_P %B_\
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M^/7O?^$LU'P7KSZ3?V=A?:Y>7/B7P?XGL-,AN?%&NCQ3IJ:* ?Z@%%?QZ?\
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M\7?$FB3K);ZYJM_K%I?:+\./#6H(=&U36-)U[6M?6]TCPO-X<\3 '[\?&/\
M:#^ G[.^@1>*_C_\;?A)\#_#$[RQV_B'XO?$?P?\-]$N98$#S0VVJ>,=8T:R
MN)HT96>&":24!E^3YES\X_#W_@J+_P $V?BQX@@\)_#;]OG]CSQGXIO+A;6P
M\-:%^T;\);S7]3N&?8L6DZ./%:ZAJS,^%']FV]T"63!PZ;OYQO\ @D]_P;[^
M _VH?A7X+_X*%?\ !934_B/^V5^U/^T?X>TKXF:+X$^+_CSQB_A/X6^ ?$T
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M:K_LE:GIOAKQ_P"$]0TC4[:P\2>#O&OAV[TW4+27%QI>O^&O$FFR6MW;2;&
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MV?%7]MOX1^$O'VC_ +-_P#^._C;P9XRUBYU+2O%7PWEF\&)K6J7?@;7M(O\
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M8&G_  ;^#'BC]I3]K?\ :$^'?PP^%O[*?[/_ (7LKQT\<?$2/Q)XHUC4M?\
M&VMPM;V?A7X8?#W18W\4>/=?O]2TN*#2H$M3J>CV]U=:_HW[R?$/_@UG_;[_
M ."D'B*^_:2_X*?_ /!32QT_X^^*+>:?3OAO\/?A1J'Q8^'WPBTV_;[9:^"O
M"UYJ?Q(^&/A_0M&T4M':WGASP3X5CTFXU"&YU%O%OB2]N9]>U  _L%^ ?[:W
M['O[5-QJ=E^S3^U)^S]\>M2T6W^UZUI'PD^+O@3Q]K>C6?F)"+S5]$\-:[J.
MK:99O+)'''=7UG!;RLZ".1BPS].5_BR?MO?L@?M=?\$*OV_M+\"0_$VY\/\
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M;\'O"EUXH\27<$:7&IZA()H-/T/PUH%E)+;IJ/B?Q;X@O=+\,>&=->XMTO\
M7=6T^UEN;:*5[B/^#3]C^7]K_P#X.P_VP_BMXD_:D^)OC_X'_P#!,7]G6_T;
M4;K]G/X2^(KC1=!UO5==O;Z;X=_#FYU,VD-GXV\=76GZ-J?B3XA?%'Q#I6KZ
MCX;LHQI'@G1? ]MXRT Z( ?VE:[_ ,%9_P#@ESX9\02>%M?_ ."BG[$VEZ]!
M<&UN]/NOVG?@VK6%TK!6M]3G7Q@UKID\98"2+4)[9X^3(J@$C[,^'7Q1^&?Q
M@\,6GC;X2?$7P+\4O!E^S)8>+OAUXN\/^-_#%ZZ*CNEIK_AG4-3TJY94EC=E
MANW*K(C$ .I/XX:__P &VW_!%;7OAP?AH/V'O!6BZ?'IIL+/Q7H'C7XIZ?\
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M&:.3P8-6TRXUB^U#4+WX<>(-<U:R\+>)O!/BJ_UZUT3Q'X@\*:]X-?1X-/\
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M/]>_X1'PCJD6F:BD^CW?Q(\;:VUQ%X1M-?AGT3PQHVGWOC/Q/92V,WAZWU8
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MM?!?X4>!?BE^V5I?@#5=3FT?P[J6FZ=::YXF\->!+S4KK4X_#5[XX3QG\)_
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M/:A=-J:?P[?LN_\ !0O_ (*-?\&W_P"W+XZ_94^)FK:SXZ^$WPQ\?)HGQ?\
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M>,_B3H/B3PWJ.G7<RS?$2]\(WXFFB/AK2;I;[3+;_0C_ ."#VLZOXA_X(_\
M[ >M:_JNI:YK.H_ ;2;C4-6UB^NM3U._N#KFNJ9[R_O99[JZF*JJF6>5W(4
MM@"@#];:*** "BBOGK]KC7OC)X5_93_:8\3_ +.ND-K_ .T!X<^ 'QBUWX'Z
M&EC%JLFL?%W2?AYXBO\ X<:9%I4Z20:I-?>+[?1[:'3)U\C4)9$LYF2*9W4
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M_#RZE:QRS):Z@NDZU:+>VRS2K!="6(2.$W'U:@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?\ @Z._Y04?MS?]
MVS?^MA_L^U_D"U_K]?\ !T=_R@H_;F_[MF_];#_9]K_(%H _O\_X,8_^<HO_
M '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\ ?N*_O\H **** "BBB@ K\L_V9/\
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M/H_AW]MOP'/KR1*S+;)J7P3^/>G:9J5Q@82"*]E_LT2,1BYU:VC )ER/Q/\
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M$QC;!&\H?NU_EM?\$"_CS_P4'\7?\%.?VCOVI/V4?V9OA_\ MJ?M4>-_A/\
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M:W\%^-OAIXR\&7XF\/>&_B1J^MZS%'>:[874=KI^F7MS%=VUM?0Q"6T26/\
M2;_@]8_9H^(OQ)_9._91_:3\(Z1J.M>#_P!FSXG?$7PW\3ETV">Y'AS1/CII
M?@2TT'QAJ\<2E+;0[+Q-\-]-\*SZC-A;?5O&>B6N0+]F7^R?Q1\0_ 7@C4_!
M.B>,O&GA;PIK'Q*\4-X(^'FE^(M>TO1M0\<^,5T#6_%1\*^$[34+JWG\0>(?
M^$;\->(-=_L?2TNK\Z5HNIWP@-O9SNE_Q=X1\*>/_"WB'P/XZ\-:#XR\&>+M
M&U'PYXJ\)^*=)L->\-^)- UBUEL=5T37=$U2"ZTW5=*U*RGFM+[3[ZVGM;JW
MEDAGB>-V4@'^:=_P0P_X.D;K]AGX7^!_V-_VW?!OB;XC_LZ>" =%^%7QA\")
M!J7Q,^$7ANYO)9X?"7B7PQJ%U90?$#X?Z)/=22:)<Z=J=AXO\'Z+')HFG:?X
MQTR'P_HFA?Z&7[*?[:G[*G[<'P]A^*/[*/QU^'_QM\'E;8:C-X1UA6UWPS<W
M<;2V^F>-O!VHQV'B_P #:S)$K2KHOB_0M%U1H0)UM#"R2-_'1_P5$_X,X_"7
MC.]\3_&'_@F%XYT[X=ZS=O=:O=?LL_%?5+^;P'<W#EYY[+X5?%&;^T=9\)B7
M;Y>F>%?'UOKVC/>W17_A//"FBV\%E!_%!K&A?M]?\$FOVGH[?4H/C=^QG^TW
M\/I5N+2YMKK4/">L7FE/=E?M.G:IIT\_AKXB_#S7I;&2"2:RNO$_@#Q;:0SV
MLK:M8F:(@'^R7^Q#^Q+\-/V#_A[\4/A?\)M3U>\\&_$?]HGXS_M"6FE:I;Z?
M;P^#+KXQ^(T\0W/@70$TZ&!6\+^%/+CTOP^]V)-1_LZ*)+V>>9#*WOGQO_Y(
MM\7O^R7^/_\ U%-6K\!O^#=G_@N)<?\ !6'X/^,/AK\<;+0_#W[8?P"TO1;W
MQ\?#]M'I?A[XN> M3F_LK3?BQX>T2,^7H6IP:O''HWQ#\/6 _L32]:U+0]6T
M(6&E>*;7PYX>_?GXW_\ )%OB]_V2_P ?_P#J*:M0!_CZ_P#!O%_RFC_X)_\
M_98-4_\ 5<^-Z_V6J_QI?^#>+_E-'_P3_P#^RP:I_P"JY\;U_LM4 %%%% !7
M^,%^VU^T-??\%0_^"ROC/XA>)]3GU3P;\<OVNO"'PB\!VYG?R=+^"%I\0=&^
M%?PYTNS2*0Q6KMX$M=-U#5&L?*BO/$&HZQJ^#=:A/*_^S-K]I>:AH.MV&G3B
MUU"]TC4K2PN22HM[RYLYH;6<D D"&=XY"0"0%R >E?X/GPB\5W7P3^/?PP\<
M:W87=K>_"/XO>"O%>KZ8Z-'?6]UX"\9Z9J]_8/'@LEW%+I,MNR8++,I7!(H
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MDU&WMY8X;V33;![E)6L[<Q_Z/%?YR_\ P9 ?\G&_MX?]D3^$O_J=^(J_T:*
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M(4U.S\0S^$-4U;3;FYTR^\:^.-=TS0-<\9PV%Q?6&A6_AGPQHMG>G4(O$0F
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M3JFLZG8Z=9QS75S%$W8T %%%% !1110 5_'=_P 'KG_*,S]G/_L^OP'_ .J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0V^"_P#LX#X[?^GS2J_DB_X.4O\ @JY^RO\ \%8?#7_!/OXK_LVZAXHTW5?
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MXP^)OC#0?!>@K.(WECL;>_UZ^L8;W4[E49;+2K(W&I7\VVWLK6>=TC;^4/\
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M^.M!^%G[3WPS\4?L3>+O$U];:5H?C'Q'XQTWXF? U]3N95MK:T\2_$6U\/\
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MZF\>DOXIM=7OM(T_4@#^LVBBB@ HHHH _E!_X/)-(LM2_P""2'AN]NH4DN-
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M9+#\,_!\>K^*-,M=1)6*TUWQ)9:'X9#L6NM;MH8Y98_R:_X)K_\ !R]\/?\
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MT7QAX+\7>'KV+4=#\2^%_$6GV^JZ)K>DWT),5U8:EIUU;W=M*I&Z*5=P5LJ
M#KJ**_)#_@H]_P %J/V*O^":-[H7@'XJ:[XL^*O[1GC2.Q/@+]EWX$Z'#X\^
M-/B-M8F^QZ'=7^C_ &_3]*\)Z5J]\\=OI=QXDU6QU3Q !='PAHOB>XL;JTC
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M9K4_V>*:YC_L34M0M-6BGM8I+NWFLH[BU0W$48H ^>/^"17_ "BI_P"":_\
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M>3]G_LP>+/L']O#3_(_<?8Q?_9O)_=>7L^6NVK^.CXG?\'A_[+.L?M'?"+X
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M\+ZC';ZUX4\4:;'<V\TVF:I:Q"[L;FRUG29]2T/4M-U.\ /JVBBOYU?VE/\
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MY;/ KEEAW31RQRVTL27,4D2_Y['_  <)_P#!QOXP_:1^&_C#]D']A+PG\6?
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M6?A;1_C)X.\'ZCXAA\-6OCWP@^KWFD07EO8GQ!IB74D37EN)/V2HHH ****
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MJ%M_;O[-FOZ_J_B;Q0^C:%_PD>N:KK$PNUT32[;3K'2--LK>PB\O_P""<?\
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MUGQ!JFFZ7; SW48/^8[_ ,$)_P!ASXI?\%CO^"N'C/\ ;A^+OA::'X$?#O\
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M'VHZC:Z1KGQ"U?3[#UC_ (+[?MUG_@G=^V?_ ,$4_P!HW7=7U:Q^%6D_&_\
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M%/1OC'^UCX)\6^*-(LWM[;4=?OO"MK^S%=>$YO&=W9)-=W!TI_"WAN]U5O\
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MVM[>TNKK^-?_ (*7?\&Z_P#P79_X*H_M&2?M&?M&?M ?\$U],U73?"VF^ O
MO@3P%\0_VFM*\#?#[P1I-]J>JVVAZ#:ZO^S3K>KW=S?:QK.K:WKFMZSJVH:G
MJFIZA*B2V>CV>CZ/I8!^Y'_!J?-')_P1 _971'5FM_%G[1L,R@@F.1OVB?B=
M.$<#[K&&>*0 X.UU/0@U_157\C/_  2@_P""<?\ P<&_\$I_A!JG[/'A#QW_
M ,$J_CE\#KGQ3JOC/P_X4^(WQ1_:NTCQ!X'UW7A VOQ>%/%GAG]FFV\O0=<N
MH!JE_HNN:)KB0ZO)<7^DW.EF_P!3BO\ ^@?]KB^_X*1P:)X-@_8/\+_L1:KX
MBN](UX?$+4OVMO'WQW\.Z/H&NB/1!X8?P7H_P=^&GBJ\\6Z5)*_B-M=77=;\
M%W<"6VB+8&Y-[?FP /\ +!_X.9723_@N)^W>R,& \1_!9"001OB_9I^#$4B\
M=U=&4CJ""#R*_P!7O]AZXAN_V*_V0+JWD66WN?V7?@!<02H0R2PS?"?PE)%(
MC#@JZ,K*1P0017\"?[2/_!I?_P %HOVL?CO\4_VD/C?^T[_P3_\ %'Q5^,7B
M_4O&GC/68_B3^T)86DFI:@R1P6.EZ=;_ +*@M],T31=/@L]%T+2X,PZ9HVGV
M-A$6CMU8_P!4_P#P2I^ /_!;?]D3P#\!?V8OVM_$G_!.OXQ?LX_![PW:?#VU
M^(_PX^('[1B?M$Z/\./"WAFYTOP#X?M=(U[X&>%_AQXSN/#LEGX=\-P7VIWO
MA&]7PE:R7&H7NO:]:B?4@#]YZ^;_ -K_ /9A^'G[:'[,/QQ_98^*EN)O _QP
M^'FO>!]3NUMX[JZT"_OH!<>&_%^E0S,L+:[X*\3VNC>+M :4^5%K>B6$L@*(
MRGZ0HH _P_\ PWX__:V_X)&_MC?&SPQX2URY^&/[0/PIM_CQ^S-XYGMQ<R6<
MNG^+O#OB+X:^(-0TX%[0:C:"&_L?B!\.]:=9;)-:TOP;XOMH+R*TMHY?]0S_
M (-K_P!A+_AAG_@EA\%K;Q)HW]E_%S]I)3^TQ\5?M%OY.I6EQ\1],TQ_A[X9
MNQ,HO+-_#'PML/!]MJ.C7!4:9XKN_%3K!!/>W0;^=3_@J3^QC\"_^"DG_!T[
M\$_V;/AKX;:[AT/X=?"'QM_P4"U6T>*31-0L_AII]WXVU:SU!((7EL]6U_X,
M/\'OA//J[7,T*ZUXH\-6$FG6ESI>HW.H?Z#<,,5O%%;V\4<$$$:0PPPHL44,
M42A(XHHT"I''&BJB(BA44!5   H DHHHH ***\0_:'NOVD;/X6ZS/^R=H7P0
M\1?&L7FD+X>TO]H?Q7X\\%_"V33WU"%=>FUG7?AMX,\>^+8;RWTHW$ND6UCX
M=G@O-06&WO+NQMGDN8P#^$/_ (/C[F!O'O\ P3?LUD4W,'A#]J*YEA!&](+K
M6O@1%;R,N<A99+.Y5"1AC"X!)4X_93_@SYGAF_X(]Z=''(KO:_M-?&^"X52"
M8IFB\&7*QN!]UC!<0R@'!V2*W0@G\R/^"HW_  ;]_P#!=_\ X*R_'?1/C?\
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M/6OV>_&D.ER^.=6BA@1Y[^7X9:WX>T+Q>T!58=-\'W?Q"UAI%:U$4_\ //\
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M$#5VC>ZUK6M3U2::67N+/_@@G_P4&_X*E_'WP5^TC_P7A_:4\&2^ / #R2^
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MO4I#+J]BCL!A6GC!Y89_TOJ_SQOV%O\ @V4_X+L_\$Z/VAO#G[3/[,'[4_\
MP3S\,_$30M-U/P[J%GKGC[]H;7O"7C/P=KC6CZ[X*\9Z#+^RU;_VMX<U:73]
M/NI8[:\T_4]/U/3=,UK1-4TO6M+T[4;7^TS]D34/^"FUSJVMV_[>GA+]A+1-
M"A\.6Q\-ZO\ LB?$/]H#Q1JVI>+OM\*WB:WX=^,OPP\(6>B>'#IAN);:6P\4
M>(-3%^(;>6$V[27*@'W;1110 5_CA_\ !R!<0W/_  6S_;XD@D61%^(7@*W9
ME(($UI\$OAC:7$9()&Z*XAEB<=5=&4@$$5_JU?MF77_!1*'P_P"%K?\ X)[Z
M%^QAJ?B>[C\3Q^-]4_;&\7_&[P]HN@NL6BCP;<^$M%^"W@3Q7>>*/.FD\1MX
MDMM:UOPFMFEMH8TVXU WM_\ 8/X,_C]_P:._\%F/VF_C7\4OV@_C'^TW^P#X
MG^*/QB\;:_X_\<:V/B5^T'8P7FO>(KZ6^NDL-.M?V4TM-,TJS$B6.D:59I'9
MZ7I=M::?:1I;VT2  _T&OV2)H[C]E+]F.>%UDAG_ &>_@O-%(I!5XY/AOX;=
M'4C(*LK!@1P0017??&%UC^$?Q3D=@J)\.?&[NQ. JKX9U-F8D\   DGTK\8?
M^"9WP5_X+H_LM>!O@)^SE^U9K_\ P39^,_P'^$VD>'OA[<?$WP+\1/VE;/\
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MM+>-(H+>&.-%"J*Z>@#_ "+O^#FK]A2Z_83_ ."I_P 1O%G@C3KCP_\ "O\
M:D;_ (:<^%M[I:R65MHOB;Q+K%S_ ,+4\.Z==6ODQ65]X?\ BA:ZQXAT_3[
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M:=K%BL[B?4F^'_CO7M<\(:TEJCV^@:!J7PXMY&3^TX47^I3]I;]FGX)_M?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYR?^#E#_@K=JW_!,?\
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MBWPK\ ,Q_%B3^- '^O/^S?\ \F[_  %_[(O\+?\ U!]"K^='_@O!_P $=O\
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MAB?Q3X?N_$NG^(-'\/VFDZ )?"6EZI:Z6FJZMKM[>?O9_P &<?[0WBGXM_\
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MOBWPCH \^Y?^P-#TPW,[7AN$3_3<_P"" _\ RAL_X)[?]D TC_T^Z]7\*?\
MP>8?\I9_ O\ V9A\'_\ U9?QRK^ZS_@@/_RAL_X)[?\ 9 -(_P#3[KU 'Z_T
M444 %?BQ_P %'?\ @CQ_P3T_:.^!_P"VG\2_%O[*_P *KK]H/XH_";XB>+9?
MCJFA$?%'3/B1X:^&L]KX+\6:+XI:=K[2)]&N_#V@3SZ3IS6VA:[]CN(O$&EZ
MI%JFJ+>_M/7E7QV4-\$/C(K#*M\*OB&I'J#X1U@$?B* /\?+_@WL_P"4S_\
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M-R.%="KJK#Z1\/?\@#0_^P/IG_I%!7A?[87_ ":1^U+_ -FY_&[_ -5GXGH
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MWAWPAI7B+Q-+9W5OHTT$GWO7^:/^UI_P5J_8@_X*0_\ !970O%'[?_Q,\0^
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M=%K@_P#@R(9C^R;^VRI)VK^T1X&8+G@,WPUB#$#U8(H)[A1Z4 ?V5_&3XM^
MO@'\)OB5\;OBGKL'AGX;_"3P-XH^(OCG7K@;TTOPOX0T:\UW6;J.$$275RMC
M93+9V,&ZYO[MH+.U22XGBC;_ #"_V7;[XF?\'/G_  72TC7_ -H^37(?V:?
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M\?Z3I=AJL-UX*B@\.P_Z$B(D2)'&BQQQJJ1QHH1$1 %1$50%554!550 H
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M?\62Z5<:D9]-\._"?P?J37L-QHUA/93+K*0Q21DRVTX("@'S!_P70_X(Y_\
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M70+'PWC1KCPOX'\#V]K97&G:=9_:(;JTOIGGA5TN8T_=5^FE !1110!^$_\
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M/^&;>T2"#3/#EC\0/!?BN[\,:59106OAW1;K3]!L$6TTJW8_Z#/_  ;>?\%
M/&/_  4(_P""8GPY\:?%;7;CQ/\ &KX&^*M>_9U^*OB?4+HW.K^+]3\#:7X?
MUOPEXRU=Y1]JN=7U[X=^*_"0\0:M<O/)KGBNQ\1:H\YGN)X+?Y!\;_\ !H1_
MP3?^)FK6^O?$C]H7_@H;\0-<M-/BTBUUGQO^T'\/?%>K6VE6]S=WD&F6^HZ]
M\#+^\AT^&[O[ZZBLHYEMH[F]NYTB66YF9_UU_P""8G_!*3]F[_@DW\-/B/\
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M;]0/0#]JZ4 ?@!7^UO0!_-C_ ,'9O_*%/X[_ /94/V?/_5M^&Z_GQ_X,??\
MDOW[?/\ V1_X+_\ J:>,Z_H._P"#LW_E"G\=_P#LJ'[/G_JV_#=?SX_\&/O_
M "7[]OG_ +(_\%__ %-/&= '^BY7\K/_  7K_P""/'_!/33O^"8?[<'QS^&O
M[*_PJ^'7Q[\&Z5K7[1.G_&'PEH1T[X@3^,E\=V'BWQPVJ^(O/EO]7T7Q5IM_
MXFTV\\.ZE+=:#I\6J1W&BZ;IMWI>D3V/]4U?E7_P7&4-_P $A/\ @HH",@?L
MJ_%)OQ71'93^# '\* /\_#_@S[_Y3#:7_P!FT?'#_P!"\'U_JQU_E.?\&??_
M "F&TO\ [-H^.'_H7@^O]6.@#^ ?_@M!^TMX\_X*_?\ !:/]GG_@AO\ "WQQ
MK/AC]F+P)\6-"TO]H:?PM>B&?X@>./#'AN]^*/QAU&Z<'R+Z+X+_  XT77?#
MOA'1-2A:QL_B=9^)M7U"'4?(\/2Z9_=+\$_@E\)_V<?A5X'^"'P.\!^'OAI\
M*OAQH5IX<\'>"_"]BEAI6D:;: DL0-T]]J5_<O/J.M:UJ,UWJ^NZO=WNL:Q?
M7VJ7MW=S?Y&7_!,+X:^%/^"E'_!<O2?!WQI^)GQA^&]A^U)\8OVK_'>M?$+X
M*>.8?A]\4+3Q+JG@CXQ?%FVCT;QA>:1XACT\:]K&G+HVIQ/IMR^IV&HW.EQM
M%)>+,G]Y/_$+U^R5_P!'S?\ !5__ ,3$TK_YT5 'HG_!R[^P7\)OVP/^"8'[
M0/Q-U_PMIG_"Z/V2OA[XF^/OPE^(D%A:KXET/3O 5F?$?Q'\(RZH(?M]SX0\
M7^"-.UN/4M!:Z73CX@L?#?B-X)+[P_9U_!?_ ,&T'_!07QM^Q)_P4W^#'@7_
M (2&\A^!_P"UWXN\+_L]?%WPG->O%H=WK'C34FT+X2>-G@DWV=KK7@KX@ZSI
MBKK,D0F@\):YXQTD7%M;ZS<3Q_V^:O\ \&L?[&GB#2=3T'7OVTO^"I^MZ'K>
MGWND:SHVK_M;Z#J6DZOI6I6TEGJ.F:GIUY\'IK._T^_M)IK6]LKJ&6VNK:62
M">*2*1E/"_"__@T'_P""7WPC^)?P[^*_A/XE_MGGQ3\,?'/A+XA>&AJ7Q7^%
M-QIQ\0>"]?T_Q)HPO[>W^ ]G<3V7]HZ;;?:H8+NUFE@\Q(KF!V650#]/_P#@
MN?\ M%^.?V4O^"2_[;_QO^&>I7NB>/="^%%GX0\+^(--ED@U3PWJGQ=\;^$_
M@]'XFTFYB5I+35_#<?CR37-*O4 :RU#3[:Z#H8=Z_P ^/_!DY\3_ ("3_LH?
MM6?!_3)O#EA^TY9?'R/XB^-[25K2+QCXI^"^H^ _!7A[X?:I;O*4U#5?#7A/
MQE8?$.PNK:U%S9>&-6\4P75ZUK<^-;1;O^LC]M_]E3P?^W#^R1^T!^R;XZOI
MM(\/?'/X;:YX*_M^WMEO;GPOKLR1ZCX1\76UB\L$=_<^$?%NGZ'XEM["6:&&
M^FTI+666..9G'^/-^T?^RS_P4-_X(F_M::;;>+!\1?V>OB]X+UC4+_X2_'3X
M;:KK&G>$_B'HEK)]G?Q'\-?'EC':V'B?PWK&GSPP^(O#&H*M_9VFHR>&?'_A
MC3[J:^T>@#_:NUK1='\2:/JWA[Q%I.FZ]H&O:;?:-KFAZS8VNJ:/K.CZI:RV
M6I:5JNF7T4]EJ.FZA93S6E]8W<$UK=VLTL%Q%)%(Z'^1+_@CQ_P3]T;_ ()O
M_P#!?/\ X*;_  /\"Z9+I7P8\9?LP^ ?C?\  FQD:5TTWX9?$CXJVDJ^&K5Y
MMTLFG>!/&ND^,_A_I4T]Q=W=UI7A:QN[ZZEOKBXQ^8O_  3B_P"#S7QQX;_L
M#X;?\%,?A./B!I"?9=.;]I'X%Z5INB>-8%^2$ZG\0?A#)/IOA/Q$S22-<ZGJ
M_P /-1\%O96-N4TWP!KM_(!)_=)^S#^TE^R]^V9\/-$_:6_9?^(GP_\ C%X.
M\2:;_P (];_$+PHD+:Y90VDJ:K/X)\3P7UI9>+?">JZ7<W\=_?\ @CQ38Z1J
MNEW%['=W>D0/=QRR@'TM1110 4444 8/BKQ1X>\#^&/$?C3Q=K%CX>\*>$-!
MUCQ1XGU_4YA;Z;H?A[P_I]QJVM:QJ%PP(@L=-TVTN;V[F((B@@D<C"U_#/\
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M_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /CCX]?\%#OV$_V6O'6C?#+
M]H[]KS]GCX)?$+7K2VU'3_!OQ+^*_@_PGXA72KUWCLM8U+3=6U6WN-#T6^DB
MF2RUG6TT_2[Q[>Y6VNY6MYQ'S7[7W_!1K]E+]C;]DGQ;^V/\0?BSX$UWX8:;
MX:U#4_AZWA3QEX>UJ7XU>*1:3/X<\!_"V[TR]O[3Q3K_ (FU%(;*"32FO;+2
M+-[SQ#K<UCH&DZIJ-I_G]_\ !Q!_P1"_X*4>(/\ @I!\>OVH/@Y\!_BK^U7\
M'OVC/$FD^-/"WB?X0Z#J?Q'\4>#YD\,Z'H-W\/?&7@[0DU#Q5H47A&32%T[P
MYJRZ9/X6OO"*Z&;;5X-4@UC1-'B_X)/_ /!IS^UQ^T3X_P#"WQ'_ ."A/AG6
M?V8/V:="U*VUC4OAKJFJ647QW^+$$;Q3/X<T_0-,NK^3X5Z'J30?8_$7B+Q<
M^F>,+>U18/#WA:>2\A\0Z. ?T _\&K/[-OQ*\>:%^UY_P6#_ &D=/=OC?_P4
M&^*OBF3P1>7MK-!+9?";3_&&H^(/%FI>'UN<3V7A?QI\2I%T32=+;=:P>'OA
M%X4N=+(TVZMR_P#7I7*^!? W@_X8^"O"7PX^'OAO1_!O@/P%X;T3P?X,\)>'
M[*'3="\,^%_#FG6^D:%H6CV%NJPV>FZ5IEI;65G;QJ$B@A1!TS754 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7Y=?\%E/V_+W_@FE_P $\_CK
M^U-X=T:W\0?$31++1?!'PETJ_@:XT=OB=\0M6M_#/A;5]>A!5;C0?"LEY=>+
M]6T]I;8ZU9Z!+H4%U:W6J03Q_J+7SE^UI^RE\$OVW/V>OB7^S#^T/X6_X2[X
M4?%/18]*U^P@NFT_5M.O+&]M=7T#Q-X<U6-))-(\3^%M>L-.U_0-26*>.WU/
M3[?[7:WMB]U97 !_%W_P9O\ [17P7\?>./V]M4^,WQ2L/$'_  4 ^/WQ#\+^
M.-2U3XA:S _Q!^*7PWM;'7=8UB]\)WNJ3+<Z[=67CG5]=U7QYI.A+YUM:2^#
M[Z_M&TZPTYM/_O1K_,6_;9_X-!/^"@_[.OC:Z\=?L&>-="_:E\!:7JD6M>#[
M6+Q7HOP9_:(\)2VER+VT:[M?$FJZ#X$U>]T/; ;/Q)X2\=Z?K.L7EM)=VG@C
M0I6M;)O.? ?Q5_X/!/V988/!OAC0O^"E&L6VE?\ $MMO^$L^!G_#45K#% =L
M<4'BCX@?#_XNP7%G$JB*VGCUB:T2!4AMY1 J( #_ %+Z_('_ (+9_M[_  $_
M8A_84^-]I\3M0TGQ-\4/CU\+_B!\&/@/\!8!!K/C'XS>/?B)X:O_  7I^EV/
MA*-;C4+[P?I5UK]O>^.-8:SDT^RT@'2XC>^(M9\/Z'J_\FGPMG_X/4_VO)K?
MPW?>,OB;\#O"^HM%!J7C;XI> _V5/V9H="AEPAO+A/#OPRT/XPRJN\R2CPKX
M7UB_CP2+92B*/W__ ."8O_!O9X6_9=^+>G?MI_M[?'?Q9_P4!_;WC%M>Z1\2
M_B=J_B7Q9X'^$FI6^Z2VNO *>/;[5O$_BKQ/I$TUP-%\>>+7L/[$1K>X\(>"
M_!VJ6\FHW0!]A_\ !!C]B/QK^P!_P2Z_9O\ @-\4K*32OBY?:?XC^*WQ4T.4
MKYOAGQC\5/$%]XM_X0^Z1"\<>J>"_#M[H'A+7A#-<6TGB#1-5GM)Y+6:$C]A
MZ** "BBB@ HHKYL_:M_95^%_[9?PENO@=\9K[XB1_#/6->T;6/%FA?#CXD^,
M/A;>>-M,T=[AY/!?BCQ'X$U31/$UUX)UMIU_X2#0K#6--_M1;:U26Z1(BK '
M\X?_  6"^,OB#_@LA\1/#W_!%?\ X)_:U'XZ\*S_ !%\%>,O^"CG[47AA5U[
MX.?L^_#7P-XB@U_2OAC)XIM';0?%/Q3U'Q5I%EXB'A'2]3^TQZ_X1T?PI)-Y
MDGC^Y\ _U&?"+X6>"_@;\*?AG\%?AOI8T/X>_"+P!X/^&?@;1_,,QTOPCX%\
M/Z?X8\.6#SE5:>2UTC2[2&6X=0\\B-,_SNU<O^S_ /LX? ;]E7X:Z/\ ![]G
M'X2> _@O\,]"S)8>$/A_X>L= TR2\DBAAN=7U1K6);O7?$&H);PMJOB+7+G4
M==U>:,7&IZC=W!,I]KH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ>HVKK);$>'=*UJROIT!TB]U&WFMIY@#^8G_ (/C_P#D?_\ @G!_V)_[4/\
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M\5-;Q+"M[KWPP\0Z#J6B6&M7FP76J7_AOQ;I6A3W<TPTKPAHEFL-HF7\>O\
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M*]+@N;FVT6[\?>()?%]_I6F6;2:?%X:@T.XTO4O$NF7-GXMU_P#K;_X-W/\
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M(C!T=' 971E)5E92"K D$$$$@T ?Q@?\'M/_ "87^R;_ -G=I_ZIKXF5R_\
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MU6^EM[&TN_$E[\.#X>T..ZFC_M/Q#JFDZ-:"74=2LX)0#_63K_-*_P"#KO\
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MV@&WNK\7EQ]C /R;_P"#MG_E"Y\8?^RP? #_ -6-IU?@+_P8^?\ )>/V_/\
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MT_\ !*:4@$A(VLO'-N&;T!EGB3)XW.!U(K\A/^#&J6,>)/\ @I?"7 EDT/\
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MC(ZW&H6'A[6-*TNSUVYM8Y8M*G\1: EZT+:O8B< ]%_X/=_A/K&N?LP_L/\
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MBTEK@J#Y4,__  IB_A$S[8Q.T$)82SQ*_P"O'_!NA_P24UG_ ()7?L8W]O\
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M_'6CSVMPC;BACD#[N:_UJ_\ @EQ^VQX6_P""A/[!_P"SG^U+X?U.RO=:\<>
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MK_\ !*WX$?#_ %+5O$?Q5^)6CVUI\8_VY_'.A>)]%TZQ^'7@C1;2^N['P/\
M!7P[K<J:OXYUNUU/6=0UZ\TBP\)W=[:W-UXL\*:" ?DS_P &8[JO_!6+XD D
M R?L3?%U$'JP^+'P"<@>IVHQX[ GI7^I#7^-_P#\&^W_  4.^$G_  3/_P""
MC7A+X^_'H:];_!OQ-\-?B!\(?B!KOAK2+GQ#J_A33?%Z:/K.D^)(_#]E_P 3
M#6+*P\4^%- AUBTTU+C4XM&NK^^TZQU.^M(--N_]8[]CO]L?X9_MP?#+4OC!
M\(?"'QK\-_#V'Q--H'AG7/C1\'_&GP=?XC:9'HNBZQ#X[^'FE^.-/TS5O$7@
M"]?5Y=&L?$9L;-;C6M$URU6U$%K;W5X ?YO7_!Y/_P I;O"W_9GGP;_]3SXQ
MU_>)_P $%?\ E#G_ ,$\_P#LW3PO_P"EVJU_GV?\';_QA^'OQ:_X*^>)K+X?
M>*='\6#X2? ;X4_"7QI=:%?6^I6.D^/-(U'QIXKUSPW)?6DDMK)JF@VWC+3+
M#6[6*5Y=(UJ._P!%U!;?5--OK2W_ +A_^#9G]IOX6?M ?\$A_P!ESPGX+\6Z
M'J/CW]GWPMJ/P>^+7@FVU"VD\2>"-<\/>*O$:>'9=<TI9#=VMCXN\)'1_$V@
MZB8C8ZA;7UQ:P7#7^EZK:60!^_\ 116)XE\2^'O!GAW7O%_B[7-)\,>%?"VC
MZEXA\2^(]>U"UTK1- T'1K.;4-6UG6-4O98;/3M,TVPMY[R^O;J:*WM;:&6:
M:1(T9@ ?XLFN?\II=8_[2A:A_P"M735_M;5_AMZG\=/"5S_P45U#]I>.>5O
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MO+?3;FUMKT* ?ZX5?E9_P7%_Y1"?\%%?^S5/BI_Z8Y*^;_V*/^"NE]_P5/\
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M]SXT\1Z!;ZQX8T/[9<O';QZAXDO_  X- T.VDD635-=U+3-(LUFO]0M()?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@=^W;_P;7?\
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MV\7^*?$?C/6-0\1?M5?MA+I<'B#Q;J<^L:]-X=\*Z;\?;#PGX.TZ[O[B1X-
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M+3[/1?#7P^\(:R%:5%\2>&/ ^D>)D@GGLUU@64SVQ_;>BB@#\9_CM_P;\_\
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M'*VKK-%%XH\?>(;B^UVXTN.Z!O;7PSIL^F>$M-O));G2M L))9"WW_110 $
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MOA/P??ZA.[/)/#\//'7@_P"(O@CPU;-D*=+\"Z)X2TM0N^*TCGDFFD_I0HH
M_F1_9>_X-*_^"2/[.7C'2_'7BGPU\9/VH]7T:[AU#3-%_:.\=>']:\!VU_;R
M+)!+=^!OASX(^&VB>)K-=N)M%\<1^*]"O SK>Z9<)L2/^F#2]+TS0],T[1=%
MTZPT?1M'L+32])TG2[2WT_3-+TS3[>.TL-.TZPM(X;6RL+*UABMK2TMHHK>V
MMXHX88TC15%ZB@#YR_:V_98^$G[;'[/'Q)_9>^.MCK>I?";XKV6AZ=XRT_PY
MK=QX<UF\LO#_ (JT+QA96]IK5HCW5@)-6\.Z>MS);!9WM#/#%+"\HE3\:?C?
M_P &L?\ P1F^,<%N^B?L]>*_@)KMM####XF^ _Q9\<^';]5ME5;:7^Q/&6I>
M//!!O(642G4/^$3_ +0N9CYE[=73!=O]$=% '\Q*_P#!JS^QQK]OIWAKXP?M
MH?\ !3SX^?"G2;JUN++X+?%;]J;1=2^&LL5DZ/:VM_I6A_"S0;]4MC'%]FFT
M+4O#]Q;[%,4JLJ,G[X?LQ?LG?LX?L8_"K2?@G^R[\'_!OP7^&>CRR747ASPC
M821R:EJ<R1Q7&N>)M=U">^\1^+O$=W%#!#>>)/%6KZQKMW!;VT%QJ$L-M D?
MT-10 4444 9VKZ58Z[I.J:'J<<LNFZSIU[I6H107=W83RV.HVTMI=QPWVGSV
MM_92O!-(L=W97-O=V[D36T\,R)(OX/ZE_P &PG_!#G6;^[U75_V*;W5=4U">
M2ZO]2U+]J3]LN^O[VZF8M+<W=Y=?M#2W%S/*Q+2332/([$EF)YK]\:* /P4T
M?_@V+_X(@>'M2M=9\/\ [%^IZ'J]C)YUCJNC_M4?MFZ9J5G+@KYMK?67[0\%
MU;R;21OAE1L$C.":_;SX?>!/#/PM\ ^"/AEX*M+[3_!OPZ\(>&O GA*PU/7=
M?\4ZE9>&?".BV7A_0;34/$WBO4];\4>(KZVTK3[2&[UWQ)K.KZ_J]PDFH:QJ
M=_J-Q<W<O7T4 %?&O[9/[ '[*/[?_A;PQX)_:Q^'GB'XD^$_"%YK-]HNA:/\
M8/C7\*+%I]?M;.RU5=:3X.?$7X?OXHMI[:PMHXK'Q.^L65D5EDL;>VEN;EYO
MLJB@#\ ?^(7'_@A1_P!&,_\ FS/[8?\ ]$%3D_X-=?\ @A7$Z21_L.-')&RO
M'(G[3?[8J.CH0R.C+^T&&5E8!E92"I (((K]_** /%_V>?V?/A1^RM\'O!WP
M%^!^@ZQX9^%O@&/6HO"NA:]XZ\??$G5-.B\0^(]7\5ZI%/XS^)_B?QEXXU>)
M];UW4Y[./6?$FH)I5E+;Z/I2V6C:?I^GVL/[0W[-OP&_:Q^%FO\ P3_:1^%/
M@SXR?"WQ,L;:KX.\;Z3%J=@+N!9%L]7TNX!BU+0/$.F&:632/$F@7NF:_H\[
MFXTO4K2?$@]NHH _DL^('_!F=_P2B\7^+;CQ#X8\>_MB?"K0[JZ>9O G@OXK
M_#O5_#EA;LQ9+/2-1^)/P<\>>,8HTR(_-UCQ1KMPT:@&7S=TS?KO_P $^?\
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M *V'^S[7^0+7^OU_P='?\H*/VYO^[9O_ %L/]GVO\@6@#^_S_@QC_P"<HO\
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M/\1^%-<\!ZEXNT:RU[3/!VD:/8:H_AJ^\$W0\/SW5O)/IEOK6L6UO(L%V8U
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M++N=@6(  _S#O^#I+]F#X/?LL?\ !6;QYX;^!O@#PO\ "[P-\2?A#\*?BV?
MW@C1-.\,^#]%\0Z]9ZQX8\12^'_#FD6]II6BVVM:GX.FU^^L]/M;>U?6=4U.
M\2)&NF4?Z)__  0'_P"4-G_!/;_L@&D?^GW7J /U_HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "ORH_;G_X*6:K_P $[/BAX4\1?M$_LZ^/+W]@
MWQ3HGAW3M?\ VR_A;+)X]C^ _P 3M2U[6--NM)^._P (],T]O%^B?#2^L/\
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M!\-=&^U2M/<_V5X%_:%7POIWVB=\O-/]CTJ'SI6^:23<[<L:_P!P*@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[>._'OBCXC:W_:>KV&DZ':W87Q#XNU5;$1:7;?9]/6TMG\Z2%[B4 ^L:***
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M;X9?&;X?^,/%D-O"C22W-QX5T;7KKQ#;VR1H\AN)]-CAV([ARJ,1^07[/O\
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MLA),VE^)/#FKVVH>'?$^C2R/<:+XATO4]*N3Y]G)7N5 !1110!_EC_\ !Y,
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M<.Q'<.51B/R"_9]_X-<O^"47PQ\"BQ^.OPH\2_MA?&3Q!"][\3/CQ\</B/\
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M2L+E!);7NGW]O):WEI<1GAX+FVEDAE0\-&[*>M?XGG[,WQ<U_P#X)>_\%6/
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MJL;PZ?/XC^%GQ=\#ZAI&KV]MJNG6>IV^FZQIFJI::'XKTFTETP _VKZ*\F^
MGQC\*_M$? SX-?'[P,9SX+^-_P *_A_\6_":W10W<?AWXB^%-)\7:-#>",E%
MO(-/U>WAO(Q_J[E)8R 5(&1^TM^T-\,_V3?@#\7?VD_C'JTFB_#/X+>!->\?
M>+;RWCCGU">PT.S>:'2-&M))8%O_ !!K]^;30?#NF>=$^J:[J6GZ?'(LERI
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M6_=IOQ;\>?"_2M=\(3S> O$L48U3PAX3\9^-?#'ARTTNXT/7+'0/'MR8?%J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !17YA_\% /^"Q'_!/[_@FGHUT_[37QTT6U
M^(?V 7VC? GP (/'7QP\0K+#Y]D+?P)IEW&_ANQU*,-_9_B/Q]J'@_PE<NCP
MKX@$P$9_BX^+_P#P=S_MD?M5?M7? 3X4_LD>"_#G[*'P)\2?'WX5>%]8U#6=
M-\-_%3XT>/?"VN>/]"T;5;'7]6\3:-J'@;P9IVM:5=2K-I'A'PU=>(-)FEDC
MMOB+J$822@#_ $@Z*** "BBOYC_^"KW_  <0Z3^R=\==(_8(_8'^#J?MG_\
M!0'Q5K6G^$#X.L7U*_\ AS\,?%VLA#IGAGQ/%X:N;77/&_CE8W2[UCP7H6L>
M&;#PKIK3WWB[QKH=WIUUHK '].%%?R7-^S)_P=R_$?P@/B5=_P#!1?\ 8N^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /P!_X.CO^4%'[<W_ ';-_P"MA_L^U_D"U_K]?\'1W_*"C]N;
M_NV;_P!;#_9]K_(%H _O\_X,8_\ G*+_ -V3?^_<5_?Y7\ ?_!C'_P Y1?\
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M  K_ #[O^#PO_E,#<_\ 9L'P1_\ 2WQS7^@9_P $/_\ E$-_P3I_[-0^$O\
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M^+7AW]HS0-*GF07>K^&_B+X0T+X:^*KW3H23+):>&=5^&/A&'5GP(K:?QAI
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M -F0?M.?^J?\6U_G#_\ !I)_RFB^$?\ V1SX_?\ JO;Z@#_55^+GQ%TGX/\
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M2=_P=9_\H0OVH_\ L</V<_\ UH7X:U_-C_P9#?\ )T_[<'_9O_P\_P#5BS4
M?Z/E%%% !7\V/_!V;_RA3^.__94/V?/_ %;?ANOZ3J_FQ_X.S?\ E"G\=_\
MLJ'[/G_JV_#= '\^/_!C[_R7[]OG_LC_ ,%__4T\9U_HN5_G1_\ !C[_ ,E^
M_;Y_[(_\%_\ U-/&=?Z+E '^0W_P<]_MAZY^U=_P5P^/OA[^U)KCX>_LL3VG
M[,OP]TGS3]FTZY^'_F2?%&[>"-S;MJ>I?%O4?&D4]Z(UNYM&TSP_IUV[KI%N
ML7^J'^Q#\.-'^#_[&7[)GPJT"UAL]'^'7[-GP0\&6$,*!%\GPY\-?#6EF=\
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M\/[Z2=59GMDNK<R!5NXR_P#HKT %%%% '^61_P 'D_\ REN\+?\ 9GGP;_\
M4\^,=?W4?\&^VDZ7H_\ P1H_X)_PZ3INGZ7#>?!"#5KN+3K.VLH[K5-5\4>(
M[_5-2N8[:.)9]0U*^GFO=0O)0US>7<TMQ<2232.Y_A7_ .#R?_E+=X6_[,\^
M#?\ ZGGQCK^[C_@@/_RAL_X)[?\ 9 -(_P#3[KU 'Z_U_BC6L2?#+_@M!;P:
M$HLH_A[_ ,%/X8M&6 >4+1/"?[5BIIRPA,>6+=;"$1A<; @QT%?[7-?XI/Q(
M_P"4TOCW_M*%XI_]:NOJ /\ :VK^9;_@L!_P;2?![_@J]^T[X-_:D_X:/\6?
ML\>,+;P?X?\  GQ3TK2?AOIOQ(T[XB:#X5N[]]!U+2);_P :>#Y/!/BVWTO4
M7T&ZU::+Q;HUWIVG:&Z^&;>\L[^YU?\ IIK^73_@OI_P<5^$_P#@EQ)_PS3^
MSOH7AWXK?MJ>(O#MKK>I1>(FGN_A[\ ?#VNVWGZ#KOCRQTZZM+WQ'XVUZR==
M5\*?#^"_TU(=(ELO%WBJ]AT6]\/:-XP /WCT67]F;_@G=^RM\-/!?BOXE>"_
M@G^SU^SM\,? WPH\.^+OB[XXT'PQIMEX;\!>%['PUX?AUCQ-K]SI-EJ7B._T
M[1XY)_+ O];U1[B2VM)+B<1'^*[_ (.,_P#@M[^QY^WA^P=\5/V9/V/?#7QQ
M^/FD>'_BC\*M=\<?M-:#\*O$6A?LW_#ZYT#Q1&]IH^H^-/$\&E:W/KGB6YF.
MBZ!O\,V.A:L]VMSI.O:DCP17'V__ ,$Y_P#@A)\1OVYM/\ ?\%"?^"[GQ6^)
MG[5_QB^(FCZ?X\^&'[+7C+Q)J6C?"GX0>$_$L%OK>AQ>+_"7AR30]-L=9U&U
MDL-5N?A+X/L?"7@/PT)9M*\9Z/XMUBZU&QT3Z&_X.E?AI\.OA#_P0K^(_P /
M/A/X"\&?#+P#X<^*_P"S_9^'_!/P_P##&B>#O">AVB_$;3B+?2?#OAZRT[2-
M/AS\QCM+2)68EF!8DT ?B9_P8[S2+\8O^"A5N&(BE^&G[/TSKDX,D'BGXH)&
MQ'0E5N90"1D;CC&3G_1'K_.S_P"#'G_DM/\ P4&_[)?\!/\ U*_B37^B90!_
M#!_P>C_L$_\ "7_"/X#_ /!1/P5HOFZY\(M1@^ /QPNK2WW32_#;QIJEYJWP
MK\1ZC*JJD.G^$OB'>:[X5>61Y)KJ_P#BIHD"*(;0E>E_X,P/V]?^%A?L_P#Q
MM_X)[^--:\[Q-\ =8G^-/P9M+NXW7%Q\(?B+K"V_Q T/3+?<=EAX(^*5Y;Z_
M=R,JM)=_%^.-"\=L1%_79^U_^S1X&_;)_9>^._[+?Q(B0^$/CE\,_$_@"_O3
M;I=3Z#?ZO82?\(]XLT^"1EC?6/!OB.+2?%>B,[!(]7T:RD;(0@_Y"'_!.S]H
M?XD?\$:_^"MW@'Q3\4;>\\-W7P ^.7B?X"_M-^'H#<313_#V[UN^^&OQ>@CM
MUCC;6DT.S-QXU\*+L6WU#7/#OAO4(75/)E !_LQ^)/$6A>#_  [KWBWQ1JME
MH7AGPOHNJ>(O$6N:E.MMIVC:%HEC/J>KZKJ%R^$M[+3M/MKB[NIW(6*"&21N
M%-?R0_\ !O!X9US]O/\ ;2_X*/?\%R?B9I5[';?&WXF:K^SA^RA9ZW"RW7AS
MX+>#?[ ?4I;6WG#0K+;^%-"^$G@G^V-,2V677M#^)MN^7U/481]5?\'-W[8F
MN?"G_@G=HG[-?P(O#XD^/?\ P4I\<^&_V8?@_I/AF]AN=3\1>"?&4VEO\1M0
MT)X9OL^I:=XET/5_#_PN:2&9T=OBWIES"6C!EC_8O_@G]^R/X5_80_8Q_9S_
M &2_"/V2:R^"WPTT3PYK>K641A@\3>.[T2Z]\2/&"Q,B/&WC#Q_JWB3Q,8I%
M#0?VH(/NQ*  ?0/Q<^(ND_!_X4?$[XM:\C2Z'\+OAYXT^(NLQJXB:32?!/AO
M4O$NHHLA5Q&SV>F3*'*.$)W;6Q@_Y3__  0+^//_  4'\7?\%.?VCOVI/V4?
MV9OA_P#MJ?M4>-_A/\7O'OC_ $/XH?%3P]\*-.T"U^*7Q>^'^J>./B5I6N^*
M-?T*&ZUMM>U"T\+P:7;7\UPNC>+M5;[,]O"\D/\ IJ_\%'=(U/7_ /@GG^WE
MH.BI))K.M_L9?M0Z1I,<(+2R:GJ7P0\<V=@D07+&1[J:)4"\EB .:_S+_P#@
MTU_:1T#]G[_@L#\/?#GB?4;?2=)_:9^$OQ)_9S@O[R9(;./Q)KDWAKXE^#;*
M1G./M?B'Q;\+=&\)Z0B RSZOX@L;1<+<N: /[1O^&T?^#F;_ *0S_LP?^)K_
M  M_^>;7P=_P4L\.?\'&'_!2[]CGXF_L>^/_ /@DS^SY\/-!^(^H^ -5'CCP
MS^V)\&]8U[PY?> OB!X:\=6\^G:?J_Q/2PF?4T\/S:!=&9T,5AJ]W+$3*B*W
M]I%% '^<#_P1&_X(*_\ !8?]A+_@I[^RY^TQ\6?V>-*\$?"3P5KOC72OBCKU
MC\=O@-XD:W\%^-OAIXR\&7XF\/>&_B1J^MZS%'>:[874=KI^F7MS%=VUM?0Q
M"6T26/\ T?JX[Q1\0_ 7@C4_!.B>,O&GA;PIK'Q*\4-X(^'FE^(M>TO1M0\<
M^,5T#6_%1\*^$[34+JWG\0>(?^$;\->(-=_L?2TNK\Z5HNIWP@-O9SNG8T %
M?XF7_!97PW#X4_X*Q_\ !1O2+>-(89/VS?VA=<CBC 6.-?%/Q+\0^*-B*,!$
M4ZP0J* J#"J H '^V;7^*W_P7&O8-0_X*]_\%%)[<HT<?[57Q2LF,9!7S],U
MM].N@2/XUN;259!U60.IP010!_KD?\$T/'][\5?^"='[!GQ(U20S:OXW_8Y_
M9J\2ZU(SF1GUO5?@[X.NM:)D/S2$:I)=@NV&;&Y@&) ^W*_.[_@D5X<O/"?_
M  2O_P""<VA:@C17UM^Q-^S+=7<#AA);7.J_!_PCJTUK*&Y66U>^:WE7[JR1
M,JDJ :_1&@ K^0'_ (/-/VE=<^%G_!.GX3?L_P#AW49M.F_:@^/>FVGB](96
M0:M\./@_H\_CC4]'E1-I9)/B%=?"_4V9G*;-)>%XG%P&C_K^K^#7_@^/TC4Y
MOA]_P3AUZ))#HVF^,OVG](OY #Y2:GK>B? R\TE'/W1)):Z!K31 G)6.8KPK
M8 '_ /!##X[_ /!;SX-?\$Q/V=?"_P"Q=_P2Y_9_^./[/^H7'Q5\3>%OC)XL
M_:C^'GP^\4_$34=7^+_CH>(M4U[PGJOCG1M2TNYT/6;6Z\%V*WNFV\LVB^%]
M+G4S121SR?KA_P -H_\ !S-_TAG_ &8/_$U_A;_\\VO-O^#0/]I'0/B[_P $
MF=)^"<.HV[>+OV4OC%\3? 6LZ*TR-J,'AKXE>)M2^-/A37Y(03(FEZOJ/CKQ
M?HFFS28\V[\):O!&!'9K7]4% '^;/_P5J_X)'_\ !?/_ (*R?M.:!^T[XY_X
M)W?"OX-^(M&^$'A;X2W7A[P3^U3\ ==TS5X?"OB;QOXAM/$=W>:W\5(;Q-2G
M@\8IH\ENH:!+/1+)T;?+(J_TE_\ !L7^PI^V[_P3P_8Y^-?P!_;3^'EO\.=1
MU#]H?4?B5\,M)MOB!\/OB%#)X?\ $WP_\$:'KQ@OOA_XG\3VFEPKKGA(W']F
MW]Q:R-=7EU?06[?:YY7_ *3:X[PY\0_ 7C#7?'/A?PGXT\+>)?$GPQUZP\+_
M !'T#0M>TO5=9\!^)-4\.:/XOTW0?%^FV-U/>>'=6U#PKXAT/Q%96&K0VMS<
MZ-JVGZC#&]K=12L ?QR_\'M=K&_["_[(UZ5!EM_VL;BU1\#<L=W\'_'TLJ@]
M<,UE$2.A*+GH*Y'_ (,B-(TJ/]E3]MG7H],T^/7+S]H/P-I%WK*65LNJW6E:
M=\.(KS3],N-16(7D^GV%YJFIW5E92S-;6MSJ-_/!%'+>7#R=Q_P>T_\ )A?[
M)O\ V=VG_JFOB97+_P#!D7_R9_\ MH_]G)^$_P#U5^ET ?VTU_E6?\'B/AS3
MM#_X*^KJ=C;Q0W/C']ECX*>(]8DC4*]WJ-KJ_P 0O",5Q.0 7E72/"VEVH9B
MQ$-M"F=J!5_U4Z_RS/\ @\J_Y2V>$/\ LSCX.?\ JP?C10!_>7_P0BU&YU3_
M ((\_P#!/"YNY&EEB_9I\$:<C.=Q%MHXO-)LXP?[L5G901(/X415[5\,?\'9
MMSXLM_\ @BK\=$\.-=+I-W\4?V?K;QV;<N(SX3_X6OX>GMEO2G M6\:P>#U
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M6STWQQI.C:IH_B=?!/B.\M]3\'>.M.\*7.NV]YX<GT[5-9_T5?A__P %V/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/<L2>(OC/?7-O\.+:Q,R207K^#M2\>Z[ITJ$7/ASYDW ']'5%?CY_P $G_\
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MMF+7QAX/N+E?DGO?!OBZTUSPK?RH2CWNCW#(2I!/U'0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+GPW\2M7U+5;&6W2X6T\!W(N1$^GK&P!_H_5^&__  <FZEXUTK_@B-^WG=>
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MDS@=2L;W,"L0, R*#U&?U\_X*[_\$S/^"^G_  5J^&?A7X#^+_&O_!+;X(_
M_P +>-[;XAW'A7P'\6/VK-6\0^,_%.E:?JVD>'[KQ=XFU[]F>6.32M#L=:U*
M>PT#1](TRT;5;LZCJMSJ\^GZ(=+^$?\ @F#_ ,&\_P#P75_X)1_M$7'[0G[/
M?QT_X)I>(+KQ!X1O_A_\0/A]\0/B+^TYJ'@OQWX-U'4--U<V&HKHW[-.C:QI
MNJZ5K&D:;J^@:[I.I6UYI][;/;W*:CHNH:QH^I '][]?YY'_  ?&2(?B;_P3
MIB# R)X$_:3D9,C<J2^(/@RL;$=0&:&0 ]"4;'0U_:U::K_P4A_X9?OK^_\
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MXB?$I].N+UY&NK_4? _@B?6KIE22Z62XCB50#^F[_@[;^+WPP\%_\$?OBO\
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M8);:;1?$7BK4EEDGADM=D4<LOX%?\%:?^";?_!P%_P %8?A+X=_9^\7>-_\
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M7<D"7WBSQ=X5T1Y(9;[<G]37Q;^!_P#P=%_\%5/!%_\ L_?M"67[)W_!+O\
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MW?#?0[GQ!\0OV+/&E_\ %F_TNPMY+O4KWX+>(]&&A?&'^SK>)=Y?PZEAX/\
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M\%<?#\<4BN]I^R%\&K>X52"8IF\9_%R[6-P#\K&WN8)0#@[)%;&""?[NO^"
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MV\&B>%O!3:WH=[JFF7L/@_P#H?ANSNXM,U2_T>/Q3=^*KS3+B6+4I)YOW.H
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MK<%UH=I=:%#+K5G>:6MW:S '\3G_  0N_P""@?[)G_!0#]N']J[]MK_@K?\
M'SX$6'[3=O8^'O O[(_PL_:!\1>&O"/P1^$7P>\2IXG;QKHGP/T_XDW\7@J7
M7RO]C>&[[=<R^/+G3+C7];U"XUR[\<>)+]?ZHK+X'_\ !!WQ)K0\4:=\(O\
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MA/\ %S7O%*W8V@Q+I]M]L+X5(]^!7]6'_!L!_P %>?VOOB_\9_BM_P $O?\
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M)GA@SAG.D>)M+3P[XY\+73;C)INI6$LBK+YD:_[GE?@Q_P %J_\ @@U\ /\
M@KOX0TGQ7_;47P4_:P^'^BRZ/\//CEI^C+JUEK>@)-<7T'P\^*VAPSV5SXF\
M'"_N;JYT34K2\@\1>"=1O[W4-&DU#3KW6_#6N@'TW_P2._X*E?!;_@JM^RGX
M0^-'@/6="TOXMZ'I.CZ)^T/\';>^4Z]\+/B4+/R]3B_LVXE;49_ OB6ZMKS5
M_A[XF*S6>LZ(QL9[F+Q)HOB/2=*_3#Q/XG\-^"O#FN^,/&/B#1?"GA/POI&H
M:_XE\3^)-4LM$\/^']"TFUEOM4UG6M8U*>VT_2]+TVR@FN[Z_O;B"UM+:*2>
M>6.-&8?Y6^A?\&Y__!Q#^P_\;(O&7[*7@O4O^$LT:6XTW1OC;^S'^U+\,_ E
MKJNG33(9[.3_ (3CQ_\ "CQN= U-886U#2/%7A*VTF]A"P:E:S*K15_09^S#
M_P $-?\ @KO^W)?>&+[_ (+K?MS?$;6_V=/#VHZ9K=W^QEX#^*Z:G<?$[4='
MN+>\L=.^+&K?#.+1?AEI>B07-O [ZAH%[X]\874)U"'1==\#:C/#X@(!_"Q\
M;_B_X$U;_@J-\7OCYX:\0VFM?#+4_P!OGQ_\7] \5VJ7*6&K>!+S]H?5O&>E
M>(;:.Y@@O%M+_P /R0:E"D]M#<K#*JRP1RAHQ_M[V=Y::A:6M_875O?6-];P
M7EE>V<\5S:7EI<Q+-;75K<PL\-Q;W$+I+!/$[Q2Q.LD;,C G_,DC_P"#2G_@
MH'^TC^VG^TM?W?AOX4?L9?LJ7/[17Q>O_AGXF\2:]X<\77=U\(M2^(GB"[\"
MCX8_";X7:UJUP+2T\)7.CC3=#\;ZY\,K>TL46R^UPW5J]HO]I_\ P38_X(M?
M!;_@G6O@WQ,?CW^U%^TS\6O!/@V[\"^&O&'QO^,OC6^\"^!?#.IVMM9ZMX<^
M%GP1T[74^'?@SPU=P65DEK9:K:>,-:TI;9$T[Q'!&2E '[*4444 %?YU'_!\
M'<P/\=_V K-9%-S!\)/C=<RQ C>D%WXQ\#16\C+G(662RN50D8)A< DJ<?W\
M?'JY^/EG\)_%EQ^S!HOP@\0_'.,:)_P@VD?'KQ-XS\'?">[9_$>CQ^(SXL\1
M_#WPEXZ\8:>+;PB^OW>B+H_A;4S>^(X-'T^_;3],N[W4[+^(+_@J#_P;T_\
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MRU\>S6N[]R-0GT71OAS'J/E_O/LUMI)E.WR@/],6OQ!_X+B_\$8/A]_P6$^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ?%O]O;XB_MB:UI,I\"?LE_#/5M&\-ZO+"RPS?&3XV:=J/@W3+.RED"Q7/\
M9OPO'Q+GU<6YEFTV75_#;7"PIJELTG^G10!PGQ/\=I\,?A]XO^(+^$?'?CY?
M"&AWNN'P7\,?#4WC'X@^)OL4>\:/X0\+V\]M-KFN7AQ'9:>EQ!YTA^::- SC
M^&G_ (+8?\'(?_!0KX<>"M;^%?[.?[!'[57[!OA;Q?%<^'W_ &H_VK?A1X@\
M&_$:\M;^*2":W^$ND)97_P ._"&N21B6.V\6'QQX]UJUBGDET;2O"OB&QM=7
MMO[T:P?%/A7POXX\.ZSX0\:^&]!\8>$_$=A<:5XA\+^*='T_Q!X=UW2[M/+N
MM-UG1-6M[O3=4L+E"4N+.^MI[>9#MDC8<4 ?Y#O_  1R_P""_P#^T?\ \$HO
M%&K>&&\(^$/C7^SE\2_';>-/C)X(U;0]$T7XIZIKNI"WM=6\;>'?C#9Z?'XJ
MU+Q9%9P)]DTSXBWOB_PK+&MW9V5AX=O-6NM?A_U=?V3?VJO@G^VS^SY\-/VG
M/V>O%<?B_P"%?Q3T)=9T*^>-+75=+O()Y;#7?"WB;3%FG;1O%GA36[6_T#Q)
MI#S3"QU:PN8X+F[M3;W<_P#GJ_\ !T9_P0A^$7[$FE^&OV[OV,O"'_""_ OQ
MMXU@\#_&[X.:09YO"WPL\;>(HKN]\*>,_ =O*TTN@> ?%UU97^@ZKX9:9=&\
M)>*)?#MGX72VT;Q+;:'X?^P_^#(G]H_Q5>6_[;O[)6KZE=7O@[15^&_Q_P#
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M1O!_B;P)XMTIG:-=3\,^+]%O?#^O:>TB_-&+W2M0N[8NOS()-PY H _SXO\
M@S%^/OPJU[]K+]O?3_C+XCT[5OVO/C]X=\"^/? WC/QA=V\_C3Q_H^F>)?B+
MXD^/NFZ1JU^4N;S6M5\0>(/ 7C?Q+I-C)-?Z_9Z)-KUQ:M9>#KJYM?\ 1-Z]
M:_QE?^"F?_!*K]M'_@C%^TI'>ZE'X\L/AUI_C=]8_9J_:Y^'DVL:)I.OPV-W
M+J/A>Y@\7^'I;>X^'GQ=T:U@236O"=S?:=K6GZE8W>J>&Y=9\,/I?B&__;'_
M ()P?\'BO[3GP/3P_P##;_@H'X"7]JCX<68MM/\ ^%P^"DT;P?\ M":)I\6V
M+[5K&GO_ &;\/?BJ]K;11PPQ7R_#_P 1WLSSZCKOC?6KQRL@!^TWA+_@G'X.
M_8<_X.H/@E\5O@]X7L?"'P2_;(_9P_:4^*&D>&]'LXM.\/>%_BWX:\+_ -E_
M&/P]X=T^WB2VL='O)]9\(>/X[*W9;;3[_P ?:CI>G6=AI&GZ=;)_8G7PS^Q/
M^WC^Q9_P4D^'VE_'7]E;XD^$/BI'X6#V.IV=UIR:7\4OA+J?B*U5;[0?%GA7
M6[>'Q5X*NM7BT^2W%RL*Z%XKM]+EN="U;7M*MH[RON:@ HHHH _CZ_X/.?C#
M\9OA_P#\$[_@O\// ,^MZ1\,?C5^T-9^'?C7K6D_:HK;4M,\+>$=:\7>"_ &
MNW4)$(TCQ)XCTYO%+64VUKZ_^'UB$<P074$_*?\ !E'\-8-"_8 _:9^*5SX/
MCTO6/B%^UA?>'+;QG/I_V:_\6>$_A_\ "OX=R:9IUO?21I+J&@^&O$OB[QDE
MG)"\ME!K6J>(K5&%Y!?1Q_UX_$[X4?"WXV>"]6^&_P 9OAMX!^+?P\U\6ZZ[
MX#^)O@[P]X]\&:T+2>.ZM1JWA?Q5IVJZ'J(MKJ**YM_MEC-Y-Q''-%MD16'X
MU_ME?\%IO^"8?_!*"QTC]F?PNFF>,?C!H+0>%_ 7[%'[&_@;P_JOB30=6U.Z
M(TSPQ?>'?"BZ-X!^%\U]JFH6\G_"-ZI>V'BZ\BU(:CH/@[7FF$<H!]U?\%-_
M@!X._:A_X)\_MB_!'QOH]CK.E^,?V>_BA)I2WUO'<C1_&GAWPIJ7B?P!XILE
MECE$6J>$_&VCZ!XCTN=49HK[3(&VLNY&_P OO_@UT^*WB7X8?\%KOV3K#1-4
MO+'1OBM9_&'X5>.-/MIY(8/$'AO6?@]XV\1:;IFH*A"SVEEX[\+>#?$B0R*Z
M?;M!LY %>-'7^Q?XD>.?^#BG_@HW\)OB7XH@\&?"#_@CE^R?-\//&>L76F>-
MM/'QI_;'\;^#X_#6IW5]H]UHFK6%IIW@Q]6LH);"YBU70O@GXST%[F66VGU>
M(PR5_$7_ ,&Y_P#RFL_8#_[*AXK_ /52?$.@#_7G^/G[/OP7_:C^%GB'X(_M
M!_#KP[\5_A/XLN?#]WXD\"^*[>:YT/69_"WB/2?%F@M>PV\]M-(ECX@T33+_
M ,D3+#="V-G>QW%C<75M-_FQ?\'=?_!/K]E[]BGX^?LB^-/V7/@[X,^!GA[X
MY_#/XEZ9XM\$_#K28?#O@RY\1_";Q!X0$'B2R\.V>W3-*U34M'^(ECIVK'3+
M>TMKX:-8WL]NVHRW]Y=_Z@%?Y^7_  ?+J!J__!,AL?,=._;%4GN0MU^R^5'X
M%V_,T 2?\&Y/_!.CQ;_P4<_X)QZ%X(_:D^)M_8_\$Z_AW^TC\0_$$'[+_P ,
MM7UKPIK_ .TW\7(8_!^HZAJO[1'CG2[FSU>'X1> ECT:'P1\./!UWI5_KWBQ
MM3\6^(M;M/[!\+03?V-W'_!+S_@G!<_"NX^"<G["O[*"?#"YTE]'E\+6_P "
M?AS:1^0\'D&^BU6T\/PZY;^(5.+J+Q5;ZG%XFAU-5U:+5TU1%O!^)_\ P9Z?
M\H?K?_LZ#XV_^D/@6OZGJ /\5K_@LE^Q1I'_  35_P""F/[0G[-GPPU37(?
M/@;Q+X5\=_!O5;G4;E]?TKP5X_\ "^@?$3PKIW]M!X[^ZU+P-/K4WA(:Z[I?
M7]YX:.K/(+BX+U_?G^PI_P $P]8_X*N^&?V>/^"G7_!8[Q-HW[2VK^,_@S\/
M?$?[+W[)>B76JVG[-OP=^&_B3PMH6KV?C+QKX>2Z@;XB?%OXHJMGXO\ 'UEJ
MS-X5LKZ^'A[5+#Q'8:)X8TSP9_)9_P '=2JO_!9CXAE5 +_ KX#,Y  +,/"M
MP@9CW(1$7)YVJHZ 5_HO?\$;O^43G_!-[_LRC]F[_P!53X8H ROVD/\ @C5_
MP3._:;^"OB3X(^+OV-/V>?!ND:MH%WHWASQ?\)_A!\/?AE\0?AQ?/:R1:5X@
M\ >+?!WAS2-4T*_T2[:&^@T\2S^'M5-NNF^(M&UC1;B\TVX_RD_V"/'/Q"_X
M)W_\%@?@%/9:Y+9^)_@'^VCIGP9\?75@9+.+7/"L?Q-F^#GQ;T5XGD8QV7B;
MP??>*-+,<[2_9A?),=TMNC5_M45_BD_M4?NO^"TO[1_E_N_+_P""H7Q?\L)\
MH39^U=XBV;0,;=N!MQTP,4 ?[6U?PV?\'3?[?_Q<^*7Q\_9U_P""(O[+7BB?
MP_XC_:,\1?"RQ_:#U;2KR6VN-;O/C-XSL/"/P@^"VHW-K)%=6F@7<MS!X^\?
MZ>N%U_2=4\"V+7 TMO$&G:C_ ')U_D5?MO3:5^UM_P '-WQ&\%_%#QAXU\*>
M&O'W_!33P#^S7K?C3P)XA3PSXY\)>%?"OQ.\'_L\:=K'A'Q-<VFIP^'M9\.Z
M)X=LI]'U:2PNX=+FLX;HVDB0F(@'^H]^P]^Q1\!_^"?G[-WP\_9E_9[\)Z?X
M<\'>"-)M$U?6([*V@\1_$3QC)9VT/B3XC>.=0A7SM:\7>*KRW^V7]W<2R16%
MLMEH.D1V.@:1I.FV7D7_  51_8+^$W_!1;]BCXU?L^_$OPMIFL:[<^#/$?B/
MX.^*9;"UF\0_#CXP:)HM[>>!_%OAC4I87O--E&L16VE>(;>QFMAXB\*:AK?A
MJ^D-AJMPM?EY_P 0O7[)7_1\W_!5_P#\3$TK_P"=%1_Q"]?LE?\ 1\W_  5?
M_P#$P]*_^=%0!_F]?\$H?V_/'W_!-K]N3X)_M+>$=:U&S\*:;XGTOPK\;?#=
MI<3)8^//@AXDU73[;XA^&-4M$$D-Y)%I<8\1>&WN+>Y72?&.A>'M<AA>XTV)
M3_L-_M%?L(?L4_MI:QX!\:?M-_LY_"+]H74/ >A>(=,^'^I?$;P[9^+M/T?1
M/&SZ+>ZS_9UE>/-H]TNHOHFDW-G?W%I=7.GF.671[FS%_?&Z_GF_X@Q?^"3_
M /T4S]MS_P .[\(__H?J_JX\(>&K+P7X3\+^#M.N;^]T_P )^'=$\-6%YJDT
M-QJ=W9:%IMMI=K<ZC<6]O:03W\\%JDMY-!:VT,MP\CQV\*,L:@'^*5_P5^_9
MO\ _LC?\%,_VSOV>/A5I;:%\-/AW\:=;C\!>'S<W-XGAOPEXGL=-\9Z!X:MK
MN^FN;ZYLO#NF^([?1;"XO[FZOYK*QMY+VZN;II9Y/]%S]B/_ ((E>'/VH;/X
M4?MR?\%?6T/]J[X[:U\*?A]9_!O]G*[N;V\_9:_98^$5KX<TR3P7\/M#\$_:
MSIGQ)\5MI#1:A\0=:\5?VMX2U7Q3J.I36VB:U?6D7C/5?X.O^#CQ0O\ P6Q_
M;Y"C /Q&\#-^+_!?X:.Q_%F)_&O]=3]FG_DW+X ?]D3^%7_J":#0!^+O_!7+
M_@AY^P/^T;^PC^T!9?#']D_X"_!;XX?#;X3>-OB#\$?B%\%?A3X)^%7B/3_&
MO@/PY?\ B70_"VK77@31=!CU_P '>*Y-+/A76-$U^#5M/L+'69]9T>SM/$&G
MZ9J%M_"%_P &KW[0WBGX&_\ !9+]GSPMI6J7%KX0_:)T'XF?!'XA:8DK"WU;
M3;_P'KOC?PCYD#-Y+7.G_$?P3X/N8;AE-Q#:'4;:W=5O9DE_UD/BG%'-\,?B
M-#*H>*7P)XOBD1ONO')X?U%74^S*2#[&O\<G_@W]9E_X++_\$^2I*D_'>T4D
M'!VOX7\2JP^C*2I'<$B@#_9QK_,G_P"#C;_@I-\6?^"GW_!0GP;_ ,$J?V6M
M?FF^"OP]^.OA3X$6^EZ;J,EOI'QL_:IU[Q59^!+_ %OQ%<VQ,=WX3^&WB?59
M?!'A6WE2>P@U&P\5^,UFO8=7T0Z3_H:_MP?&Z]_9I_8Q_:R_:&TMHQK'P0_9
MP^-?Q5T))421)_$'@3X<^(_$F@6ICD!CD-YK.G6-JJ2#RF:95D(0L1_DM?\
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M_:&_]5IXAH _SL_^#0[_ )3)^"?^R ?';_TQ:97^KW7^4)_P:'?\ID_!/_9
M/CM_Z8M,K_5[H *_SNO^#X;X;V^G?%__ ()]?%Z*V'VKQA\-OCU\-[V[4 L;
M?X;^)_AOXGTNVE8#("R?%36)8 QPQ:Y*#*/7^B+7\*?_  ?#:9#+\%_^"?.L
ML@-Q8?%#X]Z9%)W2'5O"GPVNIT'M(^BV['WB% 'U7_P9B_M"WWQ'_P""<7Q=
M^ NKWDUU>?LW?M$ZVOAV%YB\6F^ /B_H&F>-=,L88F9C#O\ ']I\3]2DV!(9
M'U'<J><+AW_L!K_/I_X,;=;NX_$7_!2CPX7E:QNM%_90UL1DL8(;O3[[]H:P
M9U4G:DMS#J2*Y4!I4M8PY(A3;_H+4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P=
M'?\ *"C]N;_NV;_UL/\ 9]K_ "!:_P!?K_@Z._Y04?MS?]VS?^MA_L^U_D"T
M ?W^?\&,?_.47_NR;_W[BO[_ "OX _\ @QC_ .<HO_=DW_OW%?W^4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7\(W_!=C_@G-\8_^";7[<?P__P""^G_!/WPB=2T7P5\1K'XC_M9?"[1(
M[B)-'U[4GN-'\??$![73X9)U^&/QO\+ZOK/A?XQSV41OO"WB'7]1\;.\^G>)
M]3N_"G]W-4M2TW3M9TZ_TC5["RU72=5LKK3=4TO4K6"^T[4M.OH)+6]L+^RN
MHY;:\LKRVEEM[JUN(I(+B"22*6-XW92 ?.?['?[6WP8_;F_9P^%O[4/P#\1Q
M>(OAQ\4_#MOK%DK/ -8\,ZS%FU\2>"?%5G!+,NF>+?!VMQ7N@>(=/\R2.+4+
M*66SGN]/GL[VX^F:_G1@_P""8G[1'_!+?XW>-OVD?^"0$6B^,OV?_BGK7_"3
M?M%_\$M_B!XK3PCX&\1:L46*Z\>?LE?$G6'GT7X2?$>*VB@MK;PCXQ2/P)J>
MFH=%GU^RT/1_!7AWPY_0/X)\1W'C#P9X1\77GAGQ'X*N_%/AC0/$=UX-\86M
MG9>+O"5QK>E6FIS^&?%-GIU]JFGVGB/09;IM*UNUL=3U&SM]3M+J*UOKN!$N
M) #IZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY=76I:CKOC'Q+.)+BWTE=5U#4;S1O"UC-_9NG2WMYJ5]+K/B?5->\2:Q^CM
M!1110 4444 %%%% !1110 4444 %%%% !7^?E_P>-_\ !4+XD:1XN\&?\$O?
MA5J>I^%O!%_X*\-_&+]I'6;&>:SN/'[ZYJFI'X=_"YI(VB=_">B1:$/&_B:
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M6Q\8^*KGPFGAK7M+LIKB'2/%^M^"K"]2XU'P_P"+[3PQ\4_"?_@FE_P=+?\
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MC22R*H)K^3[_ ();:9HG_!2#_@N?^V__ ,%A/A5X=O-/_9(^&OPSTO\ 9&^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^+/[)'[$WC30_P!GOP#^SGK>F^#O$7C)_AU\/OB#X[^)OC7^Q-+UGQ'>7O\
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M_P#MQ_%;XT^'-5LHW*ZUX,U7X]Z]XYT?4+2*18Y"NHZ)/;W,$;HCD3(K*K9
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M5[:?XEW6B_'CPCK=D[#RYOLTGBJQF5T+(EU;2V[XEAE1?]8;_@GE^VU\,?\
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M\1R6$MO>'PUI/B+QEINL^(;>SO-/OK_1]/O--T_4;'4+RUN8@#]$**_SF?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\:V=] PD@O\ P[H]UH^F?#CP5J%I+YAM-7\&>!=!UY(I#%<ZO=A58?M\  ,
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M5_#GB;PWK'B[PMMMFU'6[3Q%I^JWE[;MH[:+/;7G]/E?A5_P2!_X(&_LN?\
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M-()8XKF[L?"^D7.I1Z/I@E(6XUO7[N&WT/0K)0TVH:SJ-C8V\<D]Q'&WF/[
M?[3>I?MG?L7_ +-G[56L>$K'P'JGQY^%/AOXC7W@W3=5N-<L/#EQKT#S/I5I
MJ]U9:=<:C#;;=JW4UC:O)G)A3I0!]>T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17YI_ C_@HUX3_:
M"_X*._MC_L&^!] L+W3_ -C?X8_![7?&OQ(M]:>ZDU+XH?$B[URY\0>!+;2H
MK/[%'9>"]#3PU;ZAJ*ZE->+XJG\1:%=V5H^B[I?TLH ^,_\ @H1^VGX#_P""
M>'[''QR_;%^)&A:MXJ\-?!GPYIE_%X3T.XAL]4\6>)_%7B?0_ O@CPQ;ZA<0
MW,.E0Z]XS\3Z#IFH:U)9WZ:'IMQ>:RVGWZV)LY_YQ?\ @C'_ ,'2M]_P4D_;
M(TK]CKXY?LV^&_@UXC^*FG>,M1^"?BWX>^,=9\3:7/JG@GPQK/CG4_!GC?3_
M !!IMI-'<W7@[P]K^H:=XMTN\M;2?5=*AT:7PQ =8@O;/^G_ /:P_9=^$'[:
MG[.GQ8_9;^/6B76O_"CXQ^&3X;\4V6G7O]FZO:-;:A8ZYH/B#0=1,-RFG^(O
M"OB72=&\3^';V>TO;6UUO2+":[L;ZU2:TF_$C_@EG_P;0?L??\$OOVC;K]J7
MP[\3OBK\=OBKHVE>(M!^%-U\1;?POH^D?#'3O%>G76A:_JMGI_AG3K:37?&>
MH>&;_4O##Z_=W5II<&BZQK45KX:M[N]BO+0 _H^HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /XA/V_/^#P.7]E3]NOXG_LU
M_"3]DO0_BI\)/V??B?K_ ,)/BCXT\4_$+5?"_C7QCXK\"ZY<>&_B&/ -EI^@
MZEHGAS3M"\0Z?J^C:)>Z['XF_P"$D&FIJ[PZ+:ZA%;6_]DGP'^,O@S]HOX(?
M![]H#X=2WTW@#XW_  P\!_%OP5)JELMEJI\*_$3POI?BW05U2R2:X6RU./3-
M6MH]0LQ/,+6\6>W\V3R]Y_G$_;3_ .#3_P#81_;+_;#\5?M9:A\4?C7\)4^*
MOC";Q]\:OA7\/Y/"4OA[QIXOU2[%_P"*]=\-ZYKNB:AJW@B]\;Z@UUJ_BG,7
MB2";6]1U+4='AT;[2EO#_3!\.?A[X-^$GP]\"?"KX=:#9^%?A]\,_!WAGX?^
M!?#&GF8V'AWP?X-T6R\.^&="LC<237!M-)T73K*PMVGFFF:*W0RRR2%G(!V5
M%%?FGXF_X*->$]/_ ."J/PO_ ."8GAK0+#Q!XK\0?LQ_$#]H[XH^+EUITF^'
MT.EZ[H>D?#OPE'I$%G-#=ZKXIM&\2Z]K"7U_8W.DZ,/"E[;VMW!KZR1@'Z4R
M21Q1O+*Z111(TDDDC*D<<:*6=W=B%1$4%F9B%5022 *_!G]NW_@Y&_X)8_L*
M_P!L^'-2^-L7[17Q<TOS[<_";]F@:9\2]1M=2AW1-9^)?'<6IV'PN\*RV=WM
M@UC3=2\9MXJT]1,T7AB^G@:V/[Q75K:WUK<V-];6]Y97EO-:WEG=0QW%K=6M
MQ&T-Q;7-O,KQ3V\\3O%-#*C1RQLR.K*Q!_C<_P"#IS_@G+^Q;\+?^"2]U\4_
M@A^R_P# GX(^,O@1\7OA*WAGQ!\(?A7X(^'.JGPUXRUR3P%K_A?5+[PEHFDW
M.KZ%J4GB*PUFYLM3ENEDUW1].U0M]KCEDE /K_\ X(;_ /!?CQW_ ,%BOVC/
MVF_A[J'[/'A+X&?#;X0?#_PWXV\#BS\9ZQXW\<:B-:\3OX?DMO%>L3:7X=T&
M7=#']N2/2/#MC]DEE^QM=7Z0_;)_Z:Z_S@_^#(;_ ).G_;@_[-_^'G_JQ9J_
MT?* "BBB@!DDB1(\LCK''&C22.Y"JB("SNS' 554$L3P "37\&S_ /!Z_P"&
M5_:Y/AA?V2K9OV+1XZ/A<_$@>-M4_P"%W-X,&J_V;_PM1?"_]C?\(OG[%_Q4
M8^&ID^WFT_XDY\;"^/VH?WF=>M?R>2?\&?\ _P $X)/VNS^T1_PFGQ@7X/MX
M[/Q#?]E$2^&/^%=G43JO]M'P6OBO^R?^$K7X5F]_T0^%-QUX:$3HZ^-%3%P
M#^K^*6*>**>&1989HTEBE0ADDBD4/'(C#AE=6#*1P0014E(         !@ #
M@  <  =!2T %%%% !1110 4444 %%%% !7(>//B#X"^%?A/6O'WQ.\;^$?AS
MX%\.6K7WB'QIX[\2:-X1\*:%9*0K7FL^(O$%[I^D:9:AF53/>WD$09@N[) K
MX"_X)_?\%&O"?[?_ ,0OVZ-$^'F@6%M\/?V1OVG+O]G'POXXLM:?51\3YO#G
MA/1[KQ9XM2$6<%G8Z4/&<GB#3/#;V%WJ5MK'ARSTO7!=(VH-!%]Q?%KX-?"/
MX^>";WX:_''X8> ?C!\.]2U'0]6U+P)\3/"6A>./!^I:CX:UBR\0:#=ZAX;\
M26.I:1?2Z5K.G66HVGVJSE6.YMHVVD;E(!_,A^W;_P '=G_!.?\ 9F_MGPE^
MS19>*?VVOB=8_:+:*;P'(_@3X)6.H0[D,6I?%GQ+I=U>ZW$&:.:WN_AYX(\:
MZ'J$0EC7Q#9R!6/ZE_\ !$[_ (**>/O^"HW[#6B?M7?$GX?^$/AGXEU?XF_$
M;P0?"O@>\UJ_T.WT[P;J5I9V%V+K7KBYOY+VZBN2UV2Z0&1 888E)0?Q#_\
M!XQ^R!\ /V;?VJ?V4?'WP&^$O@#X.P?&CX,>,[+QKX>^&?A+0O _A?6->^&G
MBW3H;'Q--X>\-V&FZ0OB"ZT;QG::1J6IQ6B7%_8Z)I"7+2/:!V_IH_X-#?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6_A?X9_#RSOH]/UGXJ_%;7K:]D\)^ ]*O)(+I=/BNQ87^L^(M:-I>_\ "/\
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M#,,;^*?AMXRU:[=[WQ)XW\$:7CQ+X?\ $5Y)>:QXB\%VGB(:_<M>^$8]0UL
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M7BO[RTNE\&>&M4T*\TBPOO$WB?3=2\(^_P#_  3W_P"#9#]DSP9\.]'^,?\
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M>(O^$@\4ZMXRLM34:GINA>';<:>(=!L?LMM_9YDB<SLT\HD4)_4M_P $R_\
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MAX^+]!TJY3P_XU\*7VHQVMGXGL-=TF[U232)[V;0=6T3719ZO; '] .@>(-
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M\_\ !";]GF']FSX1?\%)?VI_ARWC_P"/'CSQE8_%3]FG2/$E[K%GH?P;\)^
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M/#J_A7Q';-I]Y9-J^@ZC9WMCJ41LM0M&O]/F7[/>6YE29 #K20 22  "22<
M <DDG@ #J:\"^&7[5G[,OQJ^(/C[X4?!W]H#X._%7XD_"N&SN/B5X)^'7Q$\
M*^,_$?@2._N);2T'BS3?#NJ:C/H4LMW#+:_9]16WGCN(WAEC252M?PJ?\'*G
MP%_X+8_"_P#99TK]HS]H[_@H;X;^(_P)\1>/=&^''Q)_9M_9D\'>*O@!\,/
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MS_$K3O'[:I9WG@CQ7XPO=4::'PCH&HS:_?:WIL-Q>ZK?ZA>RW0EN3,CS3&8
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MGQ.FL+9(((_%>@:L+?PO\2/L5O%I\^H:CX5\1Q>5<>+;K3-+]&_X+(_LR_\
M!:WXR_#']I3QA^RQ^WY\-_V>O@Y\/O!>O^+OA_\ !+X/?#CQ-X-^-7Q.\.^%
MO!\>NZ]I?C']I&7Q)J/B+PGXVO[^U\0Z?X9M?AU8>&/"^I6[Z!;^(;NQDGO]
M1L@#]O\ Q?\ M5?LS^ /BYX(^ 'C7X__  >\+_'3XDW(M/ /P<UKXB>%;#XG
M^+9FMGNT&A^!9M47Q+?1R6T4DT4\6FF"54;RY6(Q70?&K]H#X%?LW>#G^(7[
M0?QE^%WP/\"QW<=A_P )?\6?'GACX?>'9-1F1Y(--M]7\5:GI=E=:G<I%(;;
M3K::6]N=C"""0@BO\9?_ ()1_M->$/V>_P#@IO\ LS_M7?M ^+-9G\)?##XB
M^(?BE\1_$^HW-UK_ (GUB/2?!/BW4;M8I;^Y:]U[Q3XBOO*TS2K>XNS<ZOKF
MH6=J9_-N0]?TU_\ !1K_ ((P?\%K_P#@KE\.9_\ @I;\3M;\)1^./$%A=>)?
M@C_P3BNM9U?2O%WP8_9]U()?^%O#.@ZAK*Z?X(C^,&J:0MAX@\<>&M670]=\
M07SL=6URT\60V7PVT8 _O\^"?[0/P)_:4\&)\1?V>?C+\+_CCX"DO9M,_P"$
MP^$WCOPS\0/#D6J6R1276E7.K^%M3U2RM-5M$GA:[TRZFAO[42Q_:+>,NN?7
MJ_@1_P"#1#]@3_@HS^R_^T]^TS\3OV@/@M\:/V<?V=]:^##?#_4O!_QG\)^)
M?AO=_$?XPVWCOPKJW@S7O#W@GQ99Z3JFKVO@CPO9_$.T?QS!I\FCP1^+CHVF
MWM\^KWIL/UU_X+Y_\%F?BM^R1XH^$/\ P3N_8$TZU\7_ /!0_P#:NO/#>@^&
M]02UT_68_@MH/C_7O^$1\(ZI%IFHI/H]W\2/&VMM<1>$;37X9]$\,:-I][XS
M\3V4MC-X>M]6 /WX^.?[67[+?[,-G::A^TA^T=\#/@+:ZC$\VF/\8?BMX&^'
M,FK1HS(W]D6_BW7-)N-6?S$>-8M.BNI7D5HT1G!6O)_@W_P4H_X)[?M"^);3
MP7\$/VV_V6/BCXUU"=;;3?!?@[XZ?#C5_&.J3,P14TOPK!XA.OZF&<A%>PTZ
MX0LRJ&W,H/XW_LG_ /!L%^Q'X>\-?\+'_P""AX\8?\%"?VQ?B!!%KOQC^,/Q
M@^)OQ/N?#X\57\,;ZGI7@O1M-\4:'>:EH>F.(["R\0^/9O$'B;4OLKZE:CPM
M8WT?A?2_P;_X.(O^#:OX&_LH? +Q'^WA_P $^=,\0>!?!GPON]*NOCG\ +[Q
M%KOB_2-%\*:OJMMI,7Q,^&?B'Q1JFK>,;'_A'M<U#3AXL\*:KJVO6:Z'?3>(
M]#O?#MEX7O=+U4 _T3:RKS7M#TZ;[/J&LZ587&Q9/(O-1L[6;RV)"OY4\R/L
M8JP5MNTD'!.#7\#G_!J__P %WOBU\0?BAH?_  30_;'^(&L?$?\ X2?1M2D_
M94^+7C75I-3\8:;JWA?2;K6=2^"GBWQ'J<KWWB32-1\.Z=J&I?#?5-8O+C6=
M&O\ 2)O R7.JZ;K7A+3O#/\ 39_P4\_X(<_L,?\ !4K1_$GB'XR>!)_"O[1<
MO@J'PGX#_:1\':GK-EXV\&G1SJ-UX9BU+0UU6'PIXV\,Z?J.I71U#P[XCTJ>
M6ZT^\OH=(U?0-4DL]9L #];/^$L\*_\ 0S>'_P#P<Z=_\DU?L=7TG5#*-,U3
M3M1,(0S"QO;:[,0DW",RBWED,8<H^POC=M;&=IQ_A#_'OX#>-?V8OVA/BG^S
MG\9K&71?&WP7^)OB/X:>/(K!&G07GA779](U#5-">Y2V&HZ7J=M;C5_#M\5C
MM]5TN\T^^B;[/=(Y_P!HO]@+]@+]@_\ 8C^&]E>?L._!_P &^ _#?Q.\$^ +
MC4_B!H5UJ6M^(_BQX<TG3+K4O!?B+Q5XLUB]O=2\1S3VWB34M7MKN62*$2:Y
M=O:VUM!,D$8!]\SW$%K#)<74\-M;PH9)IYY$AAB1>KR2R,J(@[LS #N:Q/\
MA+/"O_0S>'__  <Z=_\ )-87Q2^%OP\^-OP\\8?";XL^#]$\?_#7Q_HEWX;\
M:>"_$EHM_H/B30;]0MYI6JV;%5N+.X55$D989P.017^=-\>_^"+W['G[7?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@
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M[G5/"?[,&IZ/J>DQ1KO9[J_;3+O3HX@3OFG5"WS;J /\SC_@EGXK\3?MW?\
M!>[]E/XK_'"Z3Q)XO^,7[:UI\?/&K7 >:PN=?\/ZWJWQBBTR"UG:1(] L+[P
MW9Z5IND$&QM-$M;72HX5L85A'^QU7^*7_P $3OB9IOPC_P""M7_!/?QKK$Z6
MNEC]J/X7^$K^\FE6"WL;;XD:W'\.)+^ZF<A(;.Q'BO[7>2N5CCM89G=E0,1_
MM:4 %?X\?_!R?^RWHO[*G_!8/]J7P_X3TR'2/!7Q?O\ PW^T5X6L+>)8+>!O
MC#HT.O>.$MH(PL%O9K\5(O'R6%M;JEO:V"6MO%'$L7EI_L.5_F!?\'J-G96_
M_!4GX$W-N$2[O_V#_AC-J"IC=))#\?/VE[2WN)><[WMH([<$@#R[5 ,X- ']
MJO\ P;T?M5^(OVP/^"1G[(_Q(\;:I/K/Q \'^%=:^"'C?4[N9[F^U'4_@MXD
MU3P!H6K:E>2EIK_5]>\#:/X3\0:S?7!:XNM6U6]FG>65FFD_SMO^"Q>B_M-?
M\$PO^"\?[0?QX\&ZAK'@/XAW'[2.N?M@? 3Q\]F;C2O$'AGXL^(=1\<VLMFE
M[&UEXB\.6M]K'B7X8^+]'N$FTZ]?1?$OAJ_AELFE23^YG_@TM\ :UX*_X(O_
M  >UG5X)K>'XG?%OX[>/]$CG5T=M%C\>WG@*&=8Y K)#=7O@6_NK=@-D]O-%
M=1EHYU=OU8_X*&?\$R/V0?\ @IY\)(_A/^U5\.4U]M&^WW/P^^)7ANXAT#XK
M?"O5]1BCBNM5\!^+Q:7CV<=V;>TDU;PYK-EK7@_Q"]AIS>(?#NJ-IVGM:@'X
M<?\ !,G_ (.SOV(?VL=-\,?#K]L6:P_8P_: N8;/3KW6?$MY/<?LX>,=894A
MDOO#_P 2;AY9OAQ%>R)-?2Z1\5%TS1M"ADM]-@^(?BF[S._[T?ML?L??!S_@
MI#^S9IOPD\6^*9(_"-[X\^#_ ,:O ?Q&\#3Z+KMQIVN?#7QKH7CO0-=\,WTX
MO]%O[#Q+I5EJ/A>\O(3,EQX9\4:J]A/'/);W$?\ G ?\%./^#4S]NG]BF+Q)
M\3_V;?._;2_9]TI;K4I[KP#H4]A\=O!FCQ;II'\6?"."?4KGQ/:Z?"R12Z[\
M--0\337$5O=ZUJ_A;PEIL;)%^?7_  2K_P""W/[9_P#P2F^(FBQ> ?&&M?$/
M]G5];5OB1^R[XYUB^N? .LZ?/=9UV[\%QW@NY?A;X]96EN+7Q1X7M[>.[U."
MR3QCH_BK2+=](E /]F.OYH_^#M>UBN/^"+?QDFD4,]C\7O@!=0$@$I*_Q)TN
MQ++Z$PWDR9'.UV'0FOWC_9>_:/\ A?\ M??L]?"']IKX,:M+K/PR^-/@C2/'
M'A6YNHDM]2M+?4HF2_T+6[2*6XCL?$7AG5X-0\.>(]/2XN%T_7=*U&R6>80>
M:WX3?\':'_*%7XX_]E4_9]_]6MH% '\]O_!C_P#\G$?MY_\ 9%_A!_ZG'BBO
M]&2O\YO_ (,?_P#DXC]O/_LB_P (/_4X\45_HR4 ?Y6G_!XO_P I>;+_ +-0
M^"W_ *D7Q,K^^S_@A9_RA^_X)V_]FP?#S_TBEK^!/_@\7_Y2\V7_ &:A\%O_
M %(OB97]]G_!"S_E#]_P3M_[-@^'G_I%+0!ZY_P59_:0UC]D;_@F_P#MH?M$
M>&;Y],\8?#GX ^.Y_ FJ1L4?2OB'XDTX^#OA[JBD EO[-\:^(="OC&"K2B Q
M+)&7$B_YZW_!K_\ $?\ X*3?"N^_;/\ &_\ P3U_8C^%/[8.N:U%\#_#WQ2U
M_P")_P </"7PDU#X=V7G?%75_#^GZ&?$_B?P[<Z[#XZO%U6]UV6U:]CMI_!N
MC?:/(DEC,_\ ;!_P<IZ1J>M_\$0_V\[/24DDNH?!OPJU>58@2PTS0/V@OA)K
MVM.0O/EQZ-IM_),>@B1RV%!-?R6_\&4'[2.@> _VN_VL/V8M;U&WT^__ &A_
M@[X,\>^#H[J9(QK/B7X :[XD%WH&G(QWS:I-X0^*_B;Q&88A\VD^%-4N)3BT
M04 ?TC_\-H_\',W_ $AG_9@_\37^%O\ \\VOR>_X*^?LV_\ !PW_ ,%>O@'\
M._@3\2/^"6OP,^$5O\./B_IWQ:TKQ=X,_:[^"6O:Q<36G@SQGX.NO#DUKKGQ
M1BMHM-U%/%L.IW%Q$_GK=:'8QA6CDD*_W<44 ?P>?\&U7_!&K_@J=_P3:_;[
M\6?%C]ISX'Z=\./@?X]_9X\=?#7Q)JMA\9/@SXW27Q!<>*O 7BSPD)/#W@GQ
M[XBUMIDO/"UY!!J46FF.RAO+N&:XA@O91)_>'7':A\0_ 6D^./#7PRU3QIX6
MT[XC>,]!\3>*/"/@2^U[2[7Q?XG\-^"[G0+/Q?KV@>'9[I-6U?2?#%UXJ\-6
M^O7]A:3VVE2Z[I27LD)O;??V- !1110!_*S_ ,'<_P"Q#_PTQ_P32'[0?AG2
M/M_Q)_8H\9Q?$R*6W@\[4+CX/^-FTWPA\7M+MP%REK8.O@KXB:K.TBI;Z3\/
M+\A7>0"OQZ_X,I/VV/[)\8_M0?\ !/SQ5JVRR\6Z?:?M-?!ZRN9_+A7Q%H*:
M/X$^,&E6@E8BXU#6O#\OPWURTLK?RWCL?!OB2_9)D$TD']^OQ*^'GA'XN_#G
MQ]\*/'^DPZ_X$^)W@KQ3\/?&NA7/_'OK/A/QGH=]X<\1:5/P<1:AI&I7EI(<
M$A920,BO\;_X-^)OB'_P0^_X+/Z%<^*9M2-]^QI^U)J?@SQY-;P20W/C?X)W
MNH7GA+Q;J.GVB#+0_$CX(^)+S7/#HDA<1C7M*NS;&2)8@ ?[.Q( ))  &23P
M !U)/8"O\6S_ (+8?$[P+^TC_P %(OVP/VI_@9X'N=$_9W^)?[0OC+P/X$\<
M6%K=2>#_ (D>-/A+X6\ Z)\3?%NAZTT8L+N^\:ZIJFE_%>^TZ!UO+'2_B7H%
MW?V\4FIH\O\ I0?\'"?_  4);]D/_@F;XGG^"VM-K?QT_;-.E_LZ_LSIX2F.
MHZSJEU\6M*=?$/CCPJNG&6]N'T3X>W.I3^&=7TU)1#XWU[P)"KB34[;?^3O_
M  40_P""%FD_"K_@VI\(? 3PMX>L=0_:,_8KT.#]L7QAK&E00W%]XH^(]WIU
MUJ?[4FFKJ=LKSZGHNG^!=9UZU\.I&DDNJV/PG^'=H\2O:0O" ?M__P $"OVY
MO^&_?^"7?[.?Q7US6/[8^*?P]T0_ /XVRS3_ &C47^)?PEM-/T236]7EW'=J
MGCOP;-X/^)%Y@(B2^,6B1$$6Q?DW_@Z0_:WU_P" G_!-G4/V>OA@UY?_ !V_
M;Y\>Z%^RU\/?#NBL7\0ZEX7\1SPW?Q2;3[,,AO;;6O#JV7PMNXE8N+OXHZ9M
M0AF>/^8G_@S._;F_X5)^V#\6_P!AWQ=K'D>$/VJO!S>-OAM:W4_[BV^-?P@T
M[4=5O-/T^%V2*WD\8_"R;Q5=:I< M-=W'P\\,6,<3,X9/VS\11_\/5O^#H3P
M_H&/[?\ V9/^"+OPV37M1ZW7AW4/VG=8O;*_A2)SO-GXETOXDWOAZ.:%XXHY
M9OV9]3C#'<CS@']''_!.G]D30/V#OV(?V:OV3- 6S=O@Y\,-$T7Q5J-@H6U\
M0?$?5O.\3?%#Q1 -JN(?$WQ$UKQ-KL"2;I(;>_AMVD<1!CR__!33_@GU\-/^
M"G?['WQ%_9(^)WB/6O!%AXON_#WB+POX_P##MI;:EK'@7QQX1U6'5_#OB.#1
M[V>ULM<LPR76DZWHMS=61U30-5U2TL]3T?4I;+6+#[[KXV_;W_;J^ G_  3E
M_9E\=?M2_M$ZY<Z=X*\(+;:9HN@:/'!=>+?B)XXU=+@>&/A[X(TRXGM8M2\3
M>(9K6Y>,3W%MI^D:38ZOXDUR\T[P_HFK:C: 'P#_ ,$3_P#@B'\,/^",W@7X
MSV.A_&37?CW\3OCMJG@^X\>?$;5O!MI\.='M_#OP]@\2#PCX<\-^"H/%'C:3
M2(;2Z\8>)=0UG4KKQ9J=QK4]W8J\=G;Z3:PUK?M??\' W_!-7]DGQ*WPNMOB
MOJW[4/[0-S?-HVC_ +/?[(>@GXZ?$74O$.6B'A^XOO#]Y#X"T/7(KD+!=^']
M:\967B>',C0:#=O#+$O\QO[,GQ-_X*8_\'5WQR^*&G^./C+XH_8G_P""6WPF
MU6PTSXB?#?X%:G/8:GXW.MB>[TGX5W?BNXM[:Z^*WCK5M#MTU/Q?K/BZWG^&
M/@:W.E:Y8_"V/4=:TC2-6_LT_8G_ ."9O[#O_!//PI!X9_9/_9Z\"_#>_;3X
M]/USXAOIX\1?%KQ>BJAG?Q;\3]?.H>,M7@N;A7O!HQU6#PYIT\TJ:+HNF6I2
MV0 _R$?@KXHNO$__  5R^$OC23PMKO@*]\0_\%&_ ?BA_!7B:VEL/$W@NZU;
M]IG2M6;PMX@LY8K>:SUWPY-<'2=6MI(89;?4+.XB>*-T*+_MNU_BJZ3_ ,IM
M=,_[2G67_K6L5?[55 'P=_P4U_8B\*?\%$_V'?V@?V3/$XL;6_\ B1X,N9?A
M[XBOXR\?@WXL>&I(_$7PS\6&6.-[J&TTOQ?IVEKKT=D8KG4O#%SKFB^:(-3G
M5O\ +3_X(<?MO^+?^"2/_!5?PK_PN4:AX#\!:YXNUW]E3]K7PSK;_9!X1TG4
M/%,7A_4-<UV!G>&TO?@]\2-&TCQ/JUS'%/?)H6A^*-%L& UJ?S/]AVO\PK_@
M\!_X)U_\,Z_MG^%OVW/A_H7V3X5_MD6<T7CHV-MLT_0/VA_!&GV=KXC:<0JM
MO9?\+*\(+HOB^T#_ .E:UXHTKXD:I(79)&H _P!/-'215=&5T=5='1@RNC %
M65@2&5@058$@@@@XK^(W_@YE\>>+?V^OV[O^"=/_  0\^#&LW*77Q#^(>@?&
M?X^W>DD71\.6>LKK6C>'+_488\D-\,OA+I_Q>^*NMZ3=).EWIFJ^$M1C@66&
MV:3](?\ @W(_X*G>%OVK/^"4T>M_&WQM:6/Q&_8'\+W7PY_:"\0:W=E[E?AA
MX!\*WFO?#OXLZR[&:Z>RU/X8Z'=:5K.KWDDU[K'BWX?>-=4EXGC#?F[_ ,&U
MW@?Q3_P4)_X*$?\ !17_ (+B_&#1KM(O&'Q U[X*_LZVFLH+A_#MGJ]OHUYJ
M]G93,2$N_AA\%=-^$_PNL-2M))H+ZR\3>++5S'-#(& /[1/AWX \)?"CX?\
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MCJWC#Q?JUAIFAZ3<:S=:5H>A:.D>BZ#H>D6>E:+IEE9:7;1VYW_DA_P=F_\
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MA/*_^S-K]I>:AH.MV&G3BUU"]TC4K2PN22HM[RYLYH;6<D D"&=XY"0"0%R
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MYL_$NE_$F]\/1S0O'%'+-^S/J<88[D>< _HX_P""=/[(F@?L'?L0_LU?LF:
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MECCO&L;,W"R&U@V?Z1E?YP?_  9#?\G3_MP?]F__  \_]6+-7^CY0!_G0?\
M!\#H%G;_ +07[!'BA(474-8^#GQDT"ZG"@226?AOQMX1U&QA9^K)!/XJU%XU
M/"M<2$<N:_H%_P"#2G6;G5/^"+7P9L9Y&>+PY\7/V@-&LU8DB&VG^)>K>(7C
M0'A5-YKUU*0,#?*[=6-?@S_P?%?\E9_X)X?]D[_:)_\ 4E^$M?N5_P &B?\
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M99?,']H__!S!_P H/?V\/^Q8^#G_ *TA\'*_CV_X,H?^4E7[2/\ V8WXS_\
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M1[Z<J.@+MCJ:_P!%JO\ .O\ ^#X7_DMW_!/S_LE?QV_]2[X>4 ?O5_P:0?\
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MMY-CI]MI^CV.FZ;9 'TS7^(#^PE\2O#7P;_X*@?L@_%GQIJ=KHO@SX;?MT?
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M%/IWC;0)4CU>W_3;_@CY_P $)_V9/^"2GA[6/%.A:K??'+]J7QYI?]F_$?\
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M!\<?\(YJ?BBY\1^&?%R>,O _@SQ)9^$M<ODOY+*'P]>QSAA%/#KUY865VR,
M?Z =?YOO_!YK^PO\!O@A\6OV9OVO/A+X8T'P%XZ_:7N_BKX8^-FA>'[2UTK3
MO&WB?P%#X*UC1OB;_9-HD4 \4ZC:>*]2TGQUJ\42G7)K;PSJ-\'UF;4[_4OW
M5^&'[6O_  =0_!?PW9> ?C1_P2Q_9W_:Y\1:9;II=A\:O /[3?P5^$)\42PI
ML76?%GA^[^(XT[[=.Y$MS-I/@WX<:2\8"0Z5:2"20_/=W_P0[_X*'_\ !7[]
MJWP'^U9_P7$\:_#/X3_!OX60?8/AM^P]^SKXAN==>RT.74++5=6\,:[XVT_4
M]8T7PW:^,+NSL6^('C'P_P",O&_CCQ;!IT6C:1?^ -,TSPI/H0!^E/\ P:Z^
M!?&W@+_@B;^R1:^-X;ZRE\377QE\=>&-,U#<LMAX)\8?&CQYK'AF:"-B1'8^
M(;*<^+M/V_+/9^(8;H &X('EW_!VK<P0?\$6?C/%+(J27OQ;_9_MK96(!FG3
MXF:1>-&@)!9A;6EQ*0,G9$[8P"1_1YX7\,>'?!/AGP[X,\'Z)I?AGPEX1T+2
M/#'A?PWHEE!INB^'_#N@:?;Z5HFB:1IUJD=M8:7I6FVEM86%E;QQP6MI!%!"
MBQHJC^2#_@KC_P $Q_\ @OW_ ,%:_AGX-^!OCGQS_P $M/@A\%O"?C"W^(-[
MX/\ AU\6OVKM6U;QGXPT[3=1TG0[SQ;XG\1?LRR-<Z5X>L]7U632=#TK2=(M
M&U'4)-2U=]6NK#0VT@ _)'_@R!N(5_:0_;NM&D47$WP1^%%Q%$2-[PVOCS7X
MYY%7J5B>[ME<C@&9 ?O#/^C57\#G_!,/_@WC_P""Z?\ P2E_:,D_:(_9\^.G
M_!-3Q!>:YX1U'X?>/_A_X_\ B-^TY?\ @SQYX+U34-,U>33=231OV:-'U?3=
M3TS6-&TO6= UW2M1M[S3K^S,%PFH:+?ZQH^I_P!P7P$N?C]>?"?PK<?M0Z+\
M'O#WQS?^VAXWTCX">)_&GC'X3VI3Q#JT?AUO"OB+XA^$? OC"_\ M/A1=#NM
M:35_"^G?8O$,^K:?8OJ&FVMGJ5X ?YDO_!Y)IEY8?\%</#=W<PO%!K?[('P;
MU/3Y&4A;BTA\;?%[1I)HR>&1;_2;V D<"2%UZJ:_ND_X-\/B'X6^(W_!&K]@
MK5?"^K66I6_AOX+P?#[7!;7$4DFE>)_AWX@USPCXATO4(U<O9W=M?Z1)-Y%P
ML<CV5Q:7J*;6[MY9/DO_ (."_P#@@S_P]U\*?#KXH?!GQOX7^&G[6'P4T35?
M"WAN_P#'":FG@+XG?#[4M1;6E\!^+]6T:RU?6/#%UX>URXU76_!_B/3M$UJW
M@N==\0:3K.DS6VL6FL^'/YR_V&/^#5;_ (*Y6.MZO\+?CK^UJ_[(O[)WBK5%
ME^,7A#X'?'GQGXEUCXKZ8(TL[RRL/AWX5;2OAQJ%SJ^EPG2FU_XC7LAT6VFM
M[EO"GB:*VDT60 _MXU+Q=^S?_P %9/V1?VN/A!\-_%%UXK^$7C8?'K]C_P 0
M_$2WT6Y3PY?^+-.T&;PAXG\5?#35;H1V7CCP_P"$O$6KK_8?C70)KGP[J?B+
MP]>IH^I7:Z=)/7^.]#<?M3?\$K/VY6EM9+_X3?M3?L??&&X@61HI)[6V\1^&
M+N6VE#0SI!#XE\!>.= N74JZG1_&W@'Q)D&XT?6@9?\ :^_9R_9Z^$O[*'P-
M^&/[.?P*\*VO@KX3_"+PK8^$?!GAZV=IW@L+5I;BZU#4KV7-QJNO:[JES?:]
MXCUN\9[[7-?U/4M7OY9;R]GD;\7/^"UG_!OQ^SY_P5LTNS^)FC:]!\!?VO?"
MFB)HWASXS6&B+JV@^.M#L1(^F>#/C#X>MIK*ZUW2[)WDM] \6:9=P^*/"D5P
M45?$>B6L/AF0 H?\$Q/^#DC_ ()^?M\?#CPU:?$[XL> /V3_ -I>#3[2U\=?
M![XR^+M,\%>'=1U]8D2YU#X3?$+Q5<Z9X:\:^']5N%FFTK1&U2V\>Z;&LMMJ
M_ATP0VNL:I^AW[2G_!6/_@G'^R9X#U7X@?&G]L7X#:78Z=8S7EGX8\+_ !%\
M->/OB)XF>.)I(K+PE\._!6HZYXP\0W5R_EPK)8:0]A:/-%-J=]869>Y3_-*^
M+'_!J7_P6L^&WBB[T+PU^SCX+^-NC0W+V]IXX^%?QV^#T'AO4E5RL<\&G?%+
MQ?\ #/QM:0RKB0-JGA&P$:G;*4<;:_1O_@G;_P &<7[5WQ"\>^'O&'_!1;Q-
MX7_9_P#@]I%_:WVO?";X>^,M#^(7QI\;16\B2R^'O^$D\*2:W\-? FDWZ?N;
MKQ-9^)O&6M0HL]M9>&[>6>#6+0 _H=_X(H_$GXM?\%2_VT?VH?\ @M#\2O"&
MN?#OX$+X&?\ 8I_8"^'OB!D:]M/A)I'C&T\:?%[Q_J$$3RZ=+XD\0^+]$\-V
M.I^(=&N-0M/[:F\;^ +;5KW3/ MG/<_U%UY_\*?A7\._@=\-O WP>^$GA#1O
M /PR^&OAG2/!W@?P;X>MOLNC^'?#FAVD=EING6<;-)-)Y4$0:XN[J:XOK^Z>
M:^O[FYO;B>XD] H **** "O\W7_@]'_8B_X5]^TI\!?V\O"FD>5X=_:#\)M\
M'?BM>6L&(8OBO\*K))_!NKZK<%1NU#QC\+[F+0M.B5G L?A)<NRQD@R_Z15?
MDG_P7#_8)O\ _@HY_P $U_V@?V>O".C6VM?%^QTRP^*WP$MY[G3[&67XP?#:
M:76?#^BV6HZO<6>DZ7=>.]&?Q%\-&U/5;RSTW3[3QK=W=[>V5O%)=0@'\>7_
M  0!?XZ_\%EOVR/V(/%'[1MH=6_9T_X(D_LW>'O#WA**:2XO](\7?&.Z\2ZS
M:? _5M4CNH\V_BNV\.>&O".J7LT-Q<QS)^SAX;N+O8_B.X@/^C5JNE:9KNEZ
MEHFM6%IJNCZS87FE:MI>H6\5W8:EIFH6\EI?V%[:S*\-S:7EK-+;W-O,CQ30
MR/'(K(Q!_%W_ ((!_P#!-G4?^"9/_!.SX<_"CX@Z#::+^T+\3M2O_C-^T3%#
M=Z9JD^F>/_%,%I::7X';5])NM1T^\A^'7@O3/#GA2Y_LG5=2T&X\2V?B;6]%
MNIK77&FF_;&@#_%P_;"^%7Q3_P""+7_!7CQWH'PRFFTKQ'^R;^T9HGQ4^ ^I
MZL+NXL]>^'3ZGIWQ(^$IUMHKBW?6=-USP'JFD>'O&]G!>>5>3/XDT&XG#I<J
MO^AY_P &N7[*_BKX2_\ !/S6?VM/C!]IU']H3_@HS\4O$O[4OQ%\1ZK"$UW4
M_">LZGJD/PU&H2A56YMM?M[WQ-\6-/F!<E/BM.K,I'E1?+__  <6_P#!";XI
M_P#!2W]JC]A;XW_L_P#AN&:2Z\0:7^S_ /M;>)+?6/#.BW?@SX&#Q9;>)-"^
M+,=IKNIZ9)XBN/ UCK?Q*L;W3](M]<\2:HU_X/TZSTV6RL9#!_6;X+\'>&?A
MWX.\)_#_ ,%Z/:>'O!W@7PSH/@[PGH%@ACL=#\,^&-+M=$T'1[*,EBEIINEV
M-K96R%B5A@123C- '35_!S_P?&ZEXUB^''_!.?1[&:^7X<WWC;]I?4O%$$9E
M_LV7QKI6A?!6U\"37@'[C[=!H6L_$9-,+YE\BYU;RL)YN?[QJ_-?_@JU_P $
MS?A%_P %6?V2O$G[,WQ0U.Y\'ZS;ZQ9>.OA'\4=,T^+5-6^&'Q/T6SU&PTCQ
M%'I<MQ91ZYHE]INK:MX>\5>');VR&L>']7O5LK_2=<MM'UO2P#^<W_@RK_:2
M^$>K?L;_ +1'[)L6M:/IGQQ\%?M":]\;[SPM+<6]MK'BGX:^/? ?PR\(6'B[
M3;:1H[G5XO#_ (A\#7_A[Q'+9QW$6@Q7O@\:A);GQ!IR2_UD_M4_M>?LW?L2
M_"/7?CC^U%\6_"7PA^'.A13?\33Q+?A=2U_4HX)+B'PYX-\.6JW'B#QIXJOH
MXI#I_AKPQINJZU=JDDL5F8(9I8_\UFV_X-3O^"XW[/OQLL-9_9_UGX<0:IX:
MU>9_"'[0GP?_ &DF^%][I$$OFV\>L6=S?'P9\4?#UX]E*R7]OI.C7<T)DN+6
MVN=1AVSS_P!2_P#P3;_X-Q[CX>>/?#/[5_\ P5L_:!\3_P#!1;]K3PWY%SX&
MT3XF>.?'WQ;^#7PBN()DN;>[M;SXLSW'B+XH^([.XC2[TZ]\2:3H7A+0;MA/
MI_@R^UO3=)\56X!_G3>!OBUX4\4?\%3?!WQUM9;K1_ WB+]O_P /?%JVG\1Q
M0Z7>Z7X4U?\ :*M/&,,NO0?:+BWTZZLM(N%?5(OM<T-G+%.GVB1(_-;_ &B?
M%O[2'P4\#_&[X3?LW^(O'^B6OQR^-NG>,-=^'?PTAF:\\4ZMX9\!Z)?Z[XI\
M6WFG6JRR:-X5TZ&P?34U[5OL>GW^NW%OHNG376H&:&'_ #V?^"D/_!IO_P %
M!OB3^WO\=?B/^RH?@WXO^ /Q\^+WC/XM:#XD\6_$>V\$WOPO'Q*\27_BO6_"
MGC+P]=Z9>:[=6GA76=7U'3]'U'P99>,)-5\-VNEWUS!::S/>:1:_UJ_\$</^
M"+W@G_@F'X0U;Q]\1_B/JW[2W[:/Q*\,Z1X8^*'[0GBRYUC5&T/P;I(M9=+^
M$'PH/B:[U#7-$^'&CW%G9RW=S>7$.K>,M0T[3M2U2STC3=+\.>%_#@!^X-?F
M'_P6)_8#TG_@I1_P3Z^/'[,OV2Q?XAW>A?\ "?\ P+U:],,0T'XW^ X;K5_
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MVH:)8ZKK'AK5_#.L:IJ][X4\8:=HNM[8-9U70=>TB^LIM%U/PO\ RT_LK?\
M!M'_ ,'"_P %?B%JND?!_P",-E^QIHOBAH-+\9?%+X=?M@^)/!6DZ]HEM)*
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M/%%O-;M<:7<ZCICW]G!+?Z==S>%_%5EI&OC39M2T*WA'^W)X*\%^$?AOX/\
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MT^.XNF@TW3+..*RTS3XK:PLXHK6WBC7^N+_@EQ\%_P#@M7^R_P""_@+^S?\
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M:XLXM6\&ZC:7<\*/':3S64=RT;7MJ)?["-(_:M^"GB']J3Q7^QSX>\27&O\
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M8TWP%H%[J7]AM?G]_P $V?\ @FW^SI_P2Z_9NT7]G7]GK2KR>%[S_A)/B/\
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M5O\ M"?M ?'+_@FGX;G\/>$-/^'_ ,/OA[X ^)'[3MEX-\"^#M.U#4M7^PV
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MX=7T22XV&>UN_!+&> -YL45Q:RNJQW,+/_JI5^!O_!>G_@B7X;_X*_\ P/\
M"#^#O%.B?#/]J;X'/KMW\&_'?B&WNW\)>(='\1)9OXB^&7Q#DTJUO-7M_#6L
MWFF:9J>D>(=/L-7U#P?K-K-=66D:A8ZSKNGWX!ZM_P &^G[0_@+]HK_@D+^Q
M'J?@K7]-U:_^%'P7\*? 'QYI-K>0SZGX3\:_!;38/ 5YH^O62.UQI=YJ&DZ-
MI'BC38+M(GO/#GB#1=6MU>RU"VE?Z[_;L_X*#_LY_P#!/?X70>/_ (W^(KJ^
M\5>*;V/PW\&_@?X(MU\2_&SX]?$"_G@L-"\ _"?P!9R'6/$>LZMJUYI^FS7Z
MPQ:%HCW]K/KFIV$,T)E_S@?@/_P0 _X.4_V7_BAJVF_LV>%_B/\ L_RZU/#I
M>N_%7X/?MH?#3X;>#]>T>VED6VO]:D\'_&'2O&&LZ/ TTMQ;Z7J7@^ZUFW\Q
MI4T&.8D5_8K_ ,$B/^"![_L>^/T_;0_;Y^-6L_MN?\%#-4L3;V'Q+\<^)_%W
MQ&\,?!2TG@E@N;7X>^(/B3)/XM\5>+[F&YN[6[^)&OVFCW5AIEW-H?A/P]X?
M@GUW4_$P!_FE_ /XDQ>&O^"H_P %OB_\0=/'P]AT#]OKX<_$GQOI6LWT4P\#
MQ:5^T/HWBCQ+I^JZD8K6&4>&4@O;:^OC!;1/]BEG\J%#L7_;]!# ,I#*P!5@
M0001D$$<$$<@C@BO\Q'X;_\ !I5_P4F_:H_:8^,_B[XWS_#S]D'X.ZY\9?B%
MKEGXK\8>(=!^*?CSQ%X;USQAJVIV&K>#/AW\,_$6I6-SYUE=Q2FW\<^./A],
M@/R),PV'^X?_ ()R_P#!(3X-?\$[_P"R_%&G_'']J/\ :1^,%A\/9/AA'\2?
MV@_C?XV\5Z7H'@:\N]!U'4?!OP^^%D&KVWPY\%^$Y=1\,>'[FQLFT37=?TV/
M2+*UB\42P+,)@#\T_P#@C)_P4)T34O\ @IS_ ,%D/^"<_P 2?%[KXTTS]NKX
M_?'K]GVTU_5)IYM>\*7/B(^%_B?X$\-M?3>7$O@E_#/AGQAIGANP,EQ<:;XD
M\9ZQ;6L>G^'M3FB_J4K_ #_/VH_^#8K_ (*B?%?]O/\ :P_X* ?LZ_M"_ _X
M#_$+7OVO?BC\9?V>[.]\?>/]!\<?\(YJ?BBY\1^&?%R>,O _@SQ)9^$M<ODO
MY+*'P]>QSAA%/#KUY865VR-^JWPP_:U_X.H?@OX;LO /QH_X)8_L[_M<^(M,
MMTTNP^-7@']IOX*_"$^*)84V+K/BSP_=_$<:=]NG<B6YFTGP;\.-)>,!(=*M
M)!)(0#\*O^#S7]A?X#?!#XM?LS?M>?"7PQH/@+QU^TO=_%7PQ\;-"\/VEKI6
MG>-O$_@*'P5K&C?$W^R;1(H!XIU&T\5ZEI/CK5XHE.N36WAG4;X/K,VIW^I?
MT]?\&NO@7QMX"_X(F_LD6OC>&^LI?$UU\9?'7AC3-0W++8>"?&'QH\>:QX9F
M@C8D1V/B&RG/B[3]ORSV?B&&Z !N"!^:UW_P0[_X*'_\%?OVK? ?[5G_  7$
M\:_#/X3_  ;^%D'V#X;?L/?LZ^(;G77LM#EU"RU75O#&N^-M/U/6-%\-VOC"
M[L[%OB!XQ\/^,O&_CCQ;!IT6C:1?^ -,TSPI/H7]BGA?PQX=\$^&?#O@SP?H
MFE^&?"7A'0M(\,>%_#>B64&FZ+X?\.Z!I]OI6B:)I&G6J1VUAI>E:;:6UA86
M5O''!:VD$4$*+&BJ #=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_
M (.CO^4%'[<W_=LW_K8?[/M?Y M?Z_7_  ='?\H*/VYO^[9O_6P_V?:_R!:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2M6.NZ-HECXG\66FI>&F.J_V9'J\&J&.35]-U6S6,BT$TOU!0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W
M_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M '
M]_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXBL9?$.AV.KR6<4[I$\\=J]X8$F>.-I50.R(6*CM* /X_/\ @L__ ,'25_\
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M;6._\1^*_$VK:SXG\0WEO9V-I<:UJ]]+96%A:-!9P 'T31110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\
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MX@BT^:VO]<U;5?#?A.SOM'?Q#)K^C?SX_P#!('_@D=XM_P""R_A>T_X*J?\
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MF^S'Q;\6?'WA7X=^&S=%&D6SCUKQ;JND:=+>.BEHK2*X>YEQB.)B0*_RT?\
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M*2Y-YH6NVT$MQI>HQ6]Y"AEA6O\ -J_X.6O^"(G['G_!,K]G[X+_ !X_9_\
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M\:?"GQUX8^(7A::[A5'FM$U_PGJFK:6;N!9(S<6INA<0;U$T:$@5_"M\8?\
M@RQ^+?CGP=XN^)5U_P %*KKXM?M4^(8]1\4ZU=_%#X0:XOA?Q[XVO$-S/9^(
M/B3=_%CQ=XZMVOKPO%<>-M1\/^(;VY.RZG\,P;WAA_F?_P""6/[</[0/_!&7
M_@I1HL?BV^\1>!_#'ASXPGX$?MG?!^_OI?[&U/PEI'BZ?P;X_CUK2(IGTZ[\
M5_#&[&J>)?!FM0D3VFLZ2;.'4#H&N:U:ZB ?[+-%("" 0000""#D$'D$$<$$
M<@CK7\HG_!TG_P %C_BU_P $YO@K\+OV>/V7]:D\'_M#_M/V/BW4;_XI6B*^
ML_"3X3>%Y=.TG4=2\(^>AAL_'7C?6M6;1_#OB(+=R>%M,T'Q1J-E!9>(YO#&
MM:: ?T4?&_\ ;+_9#_9GN(;/]HK]J3]GCX$W]S#'<VNF?%[XS?#OX=:K>03!
MC#+8Z7XM\1:3J%ZDP1S$;2VF\Q4<IN"L1YE\,/\ @II_P3H^-.NVGA7X3_MV
M_LB_$#Q5J$Z6VG^%?#'[0_PIU/Q1J,\C%(XM.\.0^*CK5^SL-J_9+&8%BH!R
MRY_E"_X-J_\ @B_^QC^U7^QM;?\ !0W]MGP'!^UY\</V@_B'\3/L(^->J:WX
MQ\/>$M#\$>--7\#WL^I:'J>I2VGC/QOXL\0>']7\0:UXJ\9#7;B'3KC0[#1;
M?29X=;O==SO^#E/_ (-_?V+_ (4_L3>.?VY?V,/A%I/P!^(/P%U#PIJ7Q,\"
M^ I]1@^'OQ$^&OB7Q1I/@S4[R#P=>WMUI7A?Q3X-U'Q#I7B.'4_#"Z-87_AN
MS\2V>M:5J^HR:'?:2 ?W7U%<7$%K!-=74T5M;6T4EQ<7%Q(D,$$$*-)----(
MRQQ111JSR2.RHB*S,P4$U_!7_P &<_\ P4Z^.OQ8\6?&'_@G9\;?'&O_ !(\
M*> ?A(WQN^ .M>+M5N]9UWP+H?AGQ;X4\$>-?AG::OJ4MSJ%[X5N#XY\+Z[X
M1T26X^S^$TTCQ+;Z:HT[4H+33O[ /V]OV$OAI_P4/^"!_9\^,'Q)^/?P^^'-
M]KL.L>*+/X"_$V7X97WCS3XM+U33&\&^/+A-(UJV\4^!;EM375+SPMJ-F^GW
M>L:9H]_.KOIT2D _@S_X.CO^"\GA+]K*>X_X)X_L<^,X/$O[/W@_Q-::G^T+
M\6_#M[%=>'/C3XW\,7T-[H'@+P7J%J[P:U\,_ FNVR:WJGB*)YM.\:^-M/T>
MZ\/LWA[PI8ZUXL_LL_X(:>)?#EK_ ,$A/^">5O=:_HEM<0_LQ?#V.:"?5;&&
M:)ULY<I)%).KHX[JR@CN*_S1/^#@K_@GG\ O^"9/[?%M^S9^S?<^/KKX=2_
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M;PW<316]OXAT.>>:1(H88=6L)9I99&"I'%&EPSR2.Q"HB*69B  20*_R+_\
M@XT_X),>$?\ @E9^V=H6E?!*TUJV_9?_ &AO"5Y\0_@U9:W?WVM7'@K5M#U)
M-(^(GPJ'B+5)9]3U^'P?>WOA_6](U#5+B[U:/PKXU\.:=K.I:QK%AJ&L7_\
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M/%_P]\126Z1++>Z-<75M>Z7J0MK2/Q%X7U30/$]K:6UEK=M"@!YK_P %2O\
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MI'\N&&=Y'V1H[MM4[45F.%4D;%?SY_L2_P#!M)_P3F_8%_:>^&'[6WP+U/\
M:+N/BK\))/%\OA6'QU\3O#OB#PJ[>-O 7BGX<ZS_ &KI%C\/M$NKP+X>\7ZL
MUF(M4M?(U!;2Y?SHX7MY?Z#* "BBB@ KY7^.W[<_[%W[+]\FD_M&_M8_LY_
M[7)88[BW\._%/XR_#[P3XFN[>95>.>R\-:_K]CKU[$\;+()+33ID\HB3/E_-
M7\W7_!8O_@J]^T_\9/VVOA]_P1 _X)2^)XO"G[2OQ+U*ST7]H?\ :1L+B59_
M@GHU]H4GBOQ!X=\):O91W,_A[5O"/P^AO/&?Q(\;:7%/XA\-6ALO"G@EK;Q^
MU[)HWU]^S[_P:Y?\$HOACX%%C\=?A1XE_;"^,GB"%[WXF?'CXX?$?XEKXI\:
M>)]1#7&NZO8:'X4\:Z+H?A>VNM2GN[FP,2:IXJ@MY(8];\9>([^ ZK, ?K[\
M"/V]/V)/VH=4;0?V<_VN/V</C=XC2&6XE\+?#+XS?#_QAXLAMX4:26YN/"NC
M:]=>(;>V2-'D-Q/IL<.Q'<.51B/K*O\ +_\ ^#B?_@@=X<_X)7'P#^VW^PYX
MA\<:%^SWK7Q TWPOKOA"[\2ZMJ'B[]GKXDW,5UK'@C6O!_CU[W_A+-1\%Z\^
MDW]G87VN7ESXE\'^)[#3(;GQ1KH\4Z:FB_OK_P &MW_!<7XA_MW^&O%7[$O[
M6_BN;Q?^TK\'/"*^,_AK\5M9N(O^$@^,WPDTV\T[1=8L/&$[^6VL_$GX?7VI
M:0UWX@!EU7QMX6U1=8UF&;7/#'B;Q%KX!_7G=^(= L)WM;[7-'L[F/:9+:[U
M.RMYXPZ+(A>&:=)%WHRNNY1N1E89!!-?_A+/"O\ T,WA_P#\'.G?_)-?C_\
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MC:9?^*?B-\1?%%S::)X4\+:;>W9:[U&73].O #_4S^*/Q?\ A-\#_"5YX_\
MC3\4/AY\(? FG.L>H>-/BAXU\-^ ?"=C(Z22I'=^(O%>I:3I%O(\<,LB)->(
M[I%(R@A&(\0^!G[>O[$/[3GB&Y\(_L[?M>?LU_&_Q=:17%Q<>$OA;\:_AUXW
M\4QVEH&-Q?\ _".>'_$-]K3Z=$JLQU&.Q:Q**SK<%037\LGQ6_X-F/VU/^"G
M'B.Z_:+_ ."K/_!1Z]LOC+KT5U-X7^!WP+^'S^*O@U\ =(OW^TV?@KP7>>*?
M%VA:>]EID3066KPZ)X4M+O5=0LIM3U;QYXWU*[F\177\;'_!5'_@EY^TM_P1
M)_:O\%^$M3^)-SK=CJ]LGQ-_9Q_:/^'']L^ =0UV#PWJT5O<WEM;6VJW>K>
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M+ZTN(]J%2H /;Z\>T#]H;X!^+/BSXD^ GA;XV_"3Q+\<?!F@2>*O&'P<\/\
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MZAX?\6>$M?L[O3I+RR\3>"_$-GJMG;WJ77]U\'_!6K]OC_@LY^S]\%OV>/\
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M:&1)8I422*6-U>.2-U#))&ZDJZ.I#(ZDJRD$$@@U_&Y_P74_X-T/^">&B_\
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M6:6WGA=)(I'1@Q_S.?\ @I=_P:)?%+]BK]E+XC?M1_ O]JBV_:4@^"OA>_\
M'7Q3^'6M_!Z3X7>(E\ >'[<WOB[QAX-U*Q^(OQ!L-7?PKI27?B/6/#FJPZ-*
MGAO2]6O-/US4]4M[31;_ +3_ (,]_P#@IC\2O '[5-S_ ,$W/B!XLU;Q#\%/
MCOX:\:>*O@GH.KWT][;_  U^,/@30]1\>>(+/PO]ID9-'\->/_ NC>+[[7]'
MMR+.7Q=H.@ZCI]K;7^K^(9]4 /\ 2EHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=>^$_A6QNY%7H&EB\.6:N1RPA0'[HQL?\'M/_)A?[)O_ &=VG_JFOB97%_\
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M'_!3']B'_@HIX0_X2O\ 9+^/O@[XD7EI8Q7WB3X?RW,GASXK^"DD,<;CQ?\
M#3Q FG^+M)M8KMVL8M=&F7/AC5+F*4Z'KFJ6X6=NC_9S_8E^&G[,GQ\_;/\
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MC&1\@H ^P*_D^\ _\&GG[,_@/_@IG8_M\6W[0WCB]^&WA[X^1_M)^$?V86\
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MXJT;4+W7?A;"]]J+ZOX7T"7R[:ZOKJXM=2CNM6AAU#1M+DV)/_:]_P $^?\
M@W._9*_9FO+/X[?M@2W7_!0?]M[Q#):^(_B!\=_VCKC4OB3X=T_Q<\<<MP/
M7@OQO<ZQ97*:7<QPC3?&WCZ+Q-X\ENK-=7TV_P#"<%TGA[3_ .<'_@][AAMO
MCQ^P#;V\,5O;V_P:^,D,$$,:10PPQ>,O!<<4,4485(XHT54CC151$4*H  %
M']#'_!IM-)+_ ,$4/@"CL2MO\2_VA88@23MC;XP^*K@J,] 99Y&P,#+$]22?
MSP_X/6/V:/B+\2?V3OV4?VD_".D:CK7@_P#9L^)WQ%\-_$Y=-@GN1X<T3XZ:
M7X$M-!\8:O'$I2VT.R\3?#?3?"L^HS86WU;QGHEKD"_9E_0K_@TR_P"4*?P(
M_P"RH?M!_P#JV_$E?T6>+O"/A3Q_X6\0^!_'7AK0?&7@SQ=HVH^'/%7A/Q3I
M-AKWAOQ)H&L6LMCJNB:[HFJ076FZKI6I64\UI?:??6T]K=6\LD,\3QNRD _S
M3O\ @AA_P=(W7[#/PO\  _[&_P"V[X-\3?$?]G3P0#HOPJ^,/@1(-2^)GPB\
M-W-Y+/#X2\2^&-0NK*#X@?#_ $2>ZDDT2YT[4[#Q?X/T6.31-.T_QCID/A_1
M-"_T,OV4_P!M3]E3]N#X>P_%']E'XZ_#_P"-O@\K;#49O".L*VN^&;F[C:6W
MTSQMX.U&.P\7^!M9DB5I5T7Q?H6BZHT($ZVAA9)&_CH_X*B?\&<?A+QG>^)_
MC#_P3"\<Z=\.]9NWNM7NOV6?BOJE_-X#N;AR\\]E\*OBC-_:.L^$Q+M\O3/"
MOCZWU[1GO;HK_P )YX4T6W@LH/XH-8T+]OK_ ()-?M/1V^I0?&[]C/\ :;^'
MTJW%I<VUUJ'A/6+S2GNROVG3M4TZ>?PU\1?AYKTMC)!)-977B?P!XMM(9[65
MM6L3-$0#_9+_ &(?V)?AI^P?\/?BA\+_ (3:GJ]YX-^(_P"T3\9_VA+32M4M
M]/MX?!EU\8_$:>(;GP+H":=# K>%_"GEQZ7X?>[$FH_V=%$E[//,AE;[,K^;
M;_@W9_X+B7'_  5A^#_C#X:_'&RT/P]^V'\ M+T6]\?'P_;1Z7X>^+G@+4YO
M[*TWXL>'M$C/EZ%J<&KQQZ-\0_#U@/[$TO6M2T/5M"%AI7BFU\.>'OZ2: "B
MBB@#_.U_X/A[6-/C+_P3WO0H$MQ\,?C]:N^!N:.T\5?#.6)2>N%:]E('0%VQ
MU-?NA_P:(Z1I6G_\$;? E_8:9I]E?Z[\=_CI?ZW>VEE;6UWK-]:^)K;2;:]U
M6YAB2;4;NWTK3M/TR"XNWFFAT^QL[*-UMK:&-/PY_P"#XK_DK/\ P3P_[)W^
MT3_ZDOPEK]UO^#1S_E#%\+_^RV?'S_U-GH _IJK_ !K?^#B;PYIWA7_@M1^W
M]IFEV\5M;77Q8T#Q'+'"H1&U'QC\+_ 7B[6+@A0H,MWJ^N7UU.V,O--([%F8
ML?\ 92K_ !S?^#DS_E-S^WK_ -CQ\,__ %0OPIH _P!<G]FW4;G6/V=O@)JU
MY(TMYJGP6^%FHW<KG<\MS>^!M"N9Y';NSRRNS'N237^<'_P>7?MAZY\5/V]_
MAK^Q_I>J3)X _95^%6C>(-;T5)2D5Q\8/C9:6OBW5-2O8HG$=RMC\,8OAI;:
M+]J1I]-DU+Q(UJT<.LSB7_1M_98_Y-B_9R_[(/\ "'_U7WAZO\G3_@Y^T+6]
M$_X+B?MLR:U'-C7+GX$Z[H]U(K".]T2[_9K^#]M926S,!YD-D]G<:0[ ;5NM
M-N(@3Y>2 ?Z,?_!O'\.-'^&'_!&+]@?0]'M8;=->^$-W\1]1DC0+)>:Q\4O&
MWBKXAZE=7,F-\\WG^)3;1O(S&.TM[:UC*V]O#&G[05^(W_!N/\3--^*?_!%K
M]A/6-/G227PS\.O$_P ,]4MQ*LD]CJ7PP^)?C7P(\%R@.Z![BTT*SU.WBD 8
MZ?J%G,H,4T;-^W- '\<'_!Y]^RWHOQ%_8(^#'[4]CID)\;_LW?'#3_"U_JRQ
M*LW_  JWXUZ9<:-K=E<3(!).(?B#X=^&LFGQSEXK07FKFW\J2^F\[\>?^#*_
M]JOQ%X,_;#_:)_8^U'5)W\ _&_X,R?%O0M+FF>6WLOBA\(==T733-IULQ\NS
ME\0> O&?B)M<N80LE\/!WAR"Y$J6-LUO_5+_ ,'1EG97?_!##]MQ[P)NL6_9
MQO+*1\;H;U?VL/@9;QF/)&'FBN9[4]3Y=Q( ,FOXJ?\ @SS\ :UXM_X*]1>*
M=/@F;2_A;^S-\9_%VOW*JXMXK76;GP?\/+&"64#RS-<:GXUM9(+=V#RI:W$\
M:LMK(4 /] ?_ (+@?\HAO^"BW_9J'Q:_]1VXK_/S_P"#/3_E,#;?]FP?&[_T
MM\#5_H&?\%P/^40W_!1;_LU#XM?^H[<5_GY_\&>G_*8&V_[-@^-W_I;X&H _
MU6Z*** "O/?BY\1=)^#_ ,*/B=\6M>1I=#^%WP\\:?$768U<1-)I/@GPWJ7B
M74460JXC9[/3)E#E'"$[MK8P?0J^,O\ @H[I&IZ__P $\_V\M!T5))-9UO\
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MY9=6U1O&-_: ']=5?GY_P59_:0UC]D;_ ()O_MH?M$>&;Y],\8?#GX ^.Y_
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MG<7$3^>MUH=C&%:.20K4_P"#:K_@C5_P5._X)M?M]^+/BQ^TY\#].^''P/\
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M;F_GMK6"WFU&[7]HCXF6:7FHRQ(DE]>)8VMGIZ75TTLZ:?8V-DKBVL[>*/\
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M/XJL?B-<^!KLP:LVO?%*%K5/#]QX,EDT\6I<3'7K\S!3%&6_2#_@UH_X)?\
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MLY4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !117E7QQ^-WPO_9N^$OCOXY_&GQ0G@KX6?#30Y/$?C;Q4^D:]KZZ+HT4
M\%J]W_8WA?2M;\0ZDWVBY@B6UTG2;^\D:0>7;L 2 #U6BORS_P"'SO\ P3Y_
MZ*#\=/\ Q!W]NK_Z&VC_ (?._P#!/G_HH/QT_P#$'?VZO_H;: /U,HK\L_\
MA\[_ ,$^?^B@_'3_ ,0=_;J_^AMH_P"'SO\ P3Y_Z*#\=/\ Q!W]NK_Z&V@#
M]3**_)SQ!_P6^_X)M>$]$U3Q+XI^+OQ=\->'-#LI]2UKQ!X@_8P_;>T;1-'T
MZU0RW6H:IJNH_LYVUAI]E;1@R3W5W/#!"@+R2*H)K]8@0P# Y! (/J",@_E0
M M%%% !1110 4444 %%%% !1110 4444 %%%?D?^U+_P78_X)3_L5_'#Q?\
MLW_M,_M6VOPS^-/@*#PW<>+?!3?!O]H3Q>^CQ>+O#&C^,_#K/KW@+X3>*?"]
MVVH^&M?TC5!'8:W=26R7J6UZEO>13V\0!^N%%?@9_P 10/\ P0N_Z/IM/_$=
M?VM?_G#4?\10/_!"[_H^FT_\1U_:U_\ G#4 ?OG17X&?\10/_!"[_H^FT_\
M$=?VM?\ YPU'_$4#_P $+O\ H^FT_P#$=?VM?_G#4 ?OG17XC?"__@XW_P""
M,?QG^)GP[^#WPU_;/M/$GQ&^*_CKPE\-? 'AW_A0_P"T_HW]O>-?'6OZ?X7\
M*Z+_ &OK_P %-*T+2O[4UW5+"Q_M+6M3TW2;'S_M6I7]G9Q37$?[<T %%%%
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M/T/0M*LH;K6?$WB;6)D:VT3PSX>T_4M=UBY_<:=87$@8+_-=\3_^#@__ (*
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MB)X 3PKX(OM:U'18=+\'OH_V"\:[UZ>XOI;^Y34W6\8&*W9HE:&WA#%!^O-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*=*T_5M(\/W7B[Q-KW[,\L<FE:'8ZUJ4]AH&CZ1IEHVJW9U'5;G5Y]/T0Z6
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M;/3Y?^%):;\&_BE\?]0^"'B+5!I$C0GXJ:YXV^#VF>//!NGR:\(HI1X2\/\
MCNYATAI+A#/>HMLX!_--_P 'M+J/V#?V3(RPWM^UR'5<\E4^#?Q)5V ]%,B
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MR6EK;1:=HVFZ3I.G_97_  23_P""7O\ P<#?\$D_A_XO^"WP\^(O_!+#XT_
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M;2]&TV$PZ9HFDVH6TTK2+.RTZU5;>UC4 '^@U^R?<P7G[+/[-5W;2+-;77P
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M<]K9GQ)X0U3P_P")H;2V@U>."+W_ /:G^ /AG]JK]FKX]_LU>,I3:^&OCO\
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M_A#2QI/PI\?W$,KF]NK'Q[X TK3FNM<E00W_ (XT+QS9122/I<K']-/V^OV
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M$0/V5T1U9K?Q9^T;#,H()CD;]HGXG3A' ^ZQAGBD .#M=3T(-?AO_P %+O\
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M8NM>U[60#^Q%'21$DC=9(Y%5XY$8.CHX#*Z,I*LK*058$@@@@D&OBC_@H_\
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MWP^ATO7=#TCX=^$H](@LYH;O5?%-HWB77M82^O[&YTG1AX4O;>UNX-?62/\
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M6DV-P%5S!>:C9VTP1\[7,4\R.%;!VMMP<'!-5?\ A+/"O_0S>'__  <Z=_\
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M2OB#X4U7X;:'X<T2Q?4]7US4O&NG:K=>';33--T^-[R\O)=06&&W'FNP4@D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOPUX-T_7+6ST71(;?3K*:-8S(W]B-?EA_P %P/\ E$-_P46_[-0^+7_J.W%
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M_$;X>Z;9^'M%\T6L_A[PAX5T?36U&*\U27Q/XIU"_N]>OOX\?VT_V1OVPO\
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MERZ_:COK8IX4L/@%/\?;RS6;#)X>M?AVWQ$N+9;@HV"NFQO$)C&V"-Y0_=H
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MCJWGT[3]7^)Z6$SZFGA^;0+HS.ABL-7NY8B9416_,G_@B-_P05_X+#_L)?\
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M(5\/WLTMMJ$NCSV<6I!+E]-EA4VK?Z*O_$&C_P $EO\ H=?VS/\ P\/PX_\
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M30^" N=:^./[?_Q@\+Z/>^%](F!U74/AWX2\6>'X- \./'&R36DOQ$^,FK>
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M.X5+FR\5?$;66B&K_#CP+JUN4?1=!TN*S\?>)["X_ME=5\%Z8FD77B3^Z/\
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MA:-HI:.UO/#G@GPK'I-QJ$-SJ+>+?$E[<SZ]J'\@O[;W[('[77_!"K]O[2_
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M/!'P_CO/%WB'4]&TS3YOAI\)-!TOQ#H^;^R:]UWPK8BVC::<6TG]H7_#:/\
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MC_%5_P '&'_*:S]OS_LJ'A7_ -5)\/*_UZOV>O\ D@/P._[(_P##/_U"]$H
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M_P %F?\ @V(^*W_!+OX#/^U7\+_CO#^TK\"_#VM:'HGQ26_^'K_#KQU\,?\
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M]S%<M90(;R5M2D6:;=(D<2G8/Z?_ (4_\$FOB3_P3Q_9,U?]EC_@D'\>]!^
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M#_"?A/4;N3P]I2Z!HVI6=OK'B"6PO/%&N^)6UC4)];CTM]'T;1_QA_X.D_\
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M9J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._P"4%'[<W_=LW_K8
M?[/M?Y M?Z_7_!T=_P H*/VYO^[9O_6P_P!GVO\ (%H _O\ /^#&/_G*+_W9
M-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ'X\\;>)=2E6&QT/PMX4TF[UO7-4N78C]W9Z=97$VQ<R2LJQ1*TCJI_RIO\
M@AY^QOXO_P""O?\ P6;\1?M)>+/"UY_PH[X?_'[Q1^VC\?=2O;=[C2!J^O\
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M1TZ&[ /Q2_X.O?\ E"1^TE_V/G[.W_J]? =?S>_\&0W_ "=/^W!_V;_\//\
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MXL(?'W@>&]:\LM1T>ZE62TTSQ]X*O)[K5O!>M7$+QQM=ZSX?O7CT3Q-K&_\
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MY*6T]S,4XP&NY,GD"O[_ *O\U/\ X/"?C9-^U!_P4=_97_8F^"UG>_$GQ_\
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MS5-,U"WCN[#4=.O[22:UO;"]M9HKFTN[:66WN;>6.:&1XW5C>K_/S_X-5?\
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M-"U/1O FJ8W:9K*VU]<?#SP'<Z3<2#4+.QO_ ([6:1;M-OD'\.OA[Q;\<?\
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M%\;K>V5B 9IENO!-VT: _>86]K/*0,G9$[= 30!_JNU_C*_\$?/CU9_L7?\
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M T5DVH#Q7=_M ?"H:'<VJQ^8KV&H)XK>#4I)UPMI;Z>US<7DKQP6D4TTL<;
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MXE^$GC2$:+XVTZWMY9+99]<\/$6/C3PSI]Y/:VEQXP\)Z#!J,T5D;EA_LV?
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MWX*?'?XL_M#_  :^%7B2X\7>*?V6O$OA/P1\9-3T[3+M_!VA>._%NA7'B-/
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M'XB_M<^+=3\!6]UN6UU&U\._#+X7^%_$?B/34)*/;7FO:;/X<FN%P7OO"5U
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MFGZK=PPDB22WLKKQ5HT-S*JE(9+^T20JT\8;^V'XK#]G/_@JU^QS^V'^S_\
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M>6(3V.JZ+\)+&>R^)?BO2KVVE@N+<^*-:^$^H(#N;3+F!XW?]G?^#<__ (*
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MM.U72M2LIX;NPU"QN9[2\MI8Y[>:2)U8[E?P$?L&_MG_ !<_X-U?^"E_B?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7]4NWOO$7B#4+TS7[PZ?96EKIVCZ5I6EV7]Y-% '\?7_  2)_P""7G_!??\
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M5OK&H6J)?3?ZR5% '^73^Q3_ ,&>O_!1?XS>-]%N?VPKKP-^R%\);:]MY_%
M_P"$T\'_ !;^+VK:8LBR2V/@WP]\-]9\3^![.^O85>W.J>+/&^GC1&GCOCX?
M\0/;RZ3+_I!_LB_LE? K]AS]GWX>?LS?LY>#X?!GPM^&^EM9:7:-*+W6M<U2
M[E:\UWQ;XLU@Q0S:]XM\3ZI+<:MKVKS1Q+/=SF"RMK'3+:QT^T^DZ* /YHO^
M#B;_ ((\_M&?\%>I/V)? WP,\4_#KP%X>^$GB3X\:O\ $_QU\1-2U%+7P[9^
M+_#GP\3PLFF>']%L+_6?$=WJVI^%+[3GBLTMX-.$L5Y?744& _YW_L8_LO\
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MOK&\@BNK.]L[J)X+JTN[:97AN+:X@D>&>"5'BEB=XY%9&(/\?/\ P1#_ ."
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MMGXF30[C59K/3([N^MO\TOX\?\&[7_!4/]EC]E#XY_MA?M+_  J\ _!7X;_
M9_"AUWP]XA^+O@;Q5X]\76GBSQOX=\ V^H>"=,^%^I>/?#L]GIFL^)].GU'_
M (2CQ3X4NI].6XGT.UUF=8;6;_8RK^3#_@L%\9?$'_!9#XB>'O\ @BO_ ,$_
MM:C\=>%9_B+X*\9?\%'/VHO#"KKWP<_9]^&O@;Q%!K^E?#&3Q3:.V@^*?BGJ
M/BK2++Q$/".EZG]ICU_PCH_A22;S)/']SX! /VE_X(X_$[QS\8_^"6'[ _Q'
M^)-[?:IXW\0_LQ?"Y->UG5)9)]3U^?1- @\/VOB/4[F5WEN]2\16&E6FMW][
M*QDO;N_FNGPTQ _2JO//A%\+/!?P-^%/PS^"OPWTL:'\/?A%X \'_#/P-H_F
M&8Z7X1\"^']/\,>'+!YRJM/):Z1I=I#+<.H>>1&F?YW:O0Z "BBB@#^0;_@X
M1_X-N?&7_!2CXJV/[8G[(7C+P-X2_:+D\+:)X0^*GP\^(]WJ.A^$_BSIWA2U
M>P\+^*M'\7:=IVMOX?\ 'VD:$ECX3GL-8TP>&_$&A:7H+MK'AF]T2ZD\1_F[
M_P $[O\ @U;_ ."AFJ'1/AM_P4-_:MU[X:?L1:'X@A\1:_\ L@_!WX\^/O%U
MI\4KR'48]5N='U+0],N-.^%/@71=:O52?5_%.G?\)+XOG"W<&GZ;HFI7-IXG
MT[_0;HH _+?]L+P9_P %2O#7A?PY\(_^"5NA?\$\_AE\,]$^$NC>"M$\2_M)
M:_\ '#3/$GPQU?21J?A_3=.^''PV^%_PJ\6^ I_#/A;P=:>%&\)S^)-9GMH=
M9BOK#5/!E]H=A;)J?\-5Y_P9I?\ !7#4/%%UXUO?VE_V$KGQ=?:]/XIN_$<O
MQ>_:/.L7'B.YU%]6N-;DOO\ AE<3G4I=3=[][O>)3=,9MV_FO]-VB@#\K_V%
M;'_@LUX:O/"?A'_@H5+_ ,$\?'7@S1?"ESIVN?%G]F_QK^T##\7/$_B.PLX(
M-$U35O /C?X.>$_ASYNKS))<>*K[1-=\.645P[S:%X7MH)$T^#\^O^"JO[(_
M_!>?_@H-\%/BY^R?\./$?_!,;X%?L^_$O7[O3-8\1Q?%?]J34_C+XS^%^F>)
M!JGA[PYKMR_[.=[X5\'OX@L['2)/'NG>'H=<>Z9+SP_I_B9_#]UJ*:M_2K10
M!_G7_L2_\&N'_!;3]@+]IWX6?M8_ ']HK_@G1:_$SX4ZIJ%YIEGXE^(G[2.K
M>%?$6D:[HNH^&O$_A7Q3I5M^S%IMU?:!XD\.ZOJ>DWZV.HZ;JEH+E-2T;4],
MUBRL-1M?[O?V6;S]L"]^'%])^VSX=_9L\-_%R/Q3>PZ;:?LL^,OB?XV^'%WX
M*71M!;3M1OM0^+7@/X?^)M.\4S>('\3PWNC6^F:II-KHUOH-S!KMW>WFH6MA
M])T4 ?SY?\%K/^#?C]GS_@K9I=G\3-&UZ#X"_M>^%-$31O#GQFL-$75M!\=:
M'8B1],\&?&'P];365UKNEV3O);Z!XLTR[A\4>%(K@HJ^(]$M8?#,G\)/Q8_X
M-2_^"UGPV\47>A>&OV<?!?QMT:&Y>WM/''PK^.WP>@\-ZDJN5CG@T[XI>+_A
MGXVM(95Q(&U3PC8"-3ME*.-M?ZX=% '^:O\ \$[?^#.+]J[XA>/?#WC#_@HM
MXF\+_L__  >TB_M;[7OA-\/?&6A_$+XT^-HK>1)9?#W_  DGA236_AKX$TF_
M3]S=>)K/Q-XRUJ%%GMK+PW;RSP:Q:?Z-'PI^%?P[^!WPV\#?![X2>$-&\ _#
M+X:^&=(\'>!_!OAZV^RZ/X=\.:':1V6FZ=9QLTDTGE01!KB[NIKB^O[IYKZ_
MN;F]N)[B3T"B@ HHHH *_%K_ (+A?\$?_"7_  5__9BT/X:Q>,+'X9?'/X0^
M(=3\;? GXDZI876IZ#8:MJ^F1Z;XE\$^,;.R)U >"O'-O9:,-7U'2(;G6="U
M70/#^O6=CK,&F7OAS6_VEHH _P S_P#9-_X-5O\ @MK\-OBIK'AS3?VH/!O[
M'_PU\2O!H?Q*^*OP;_:"^(SWGC#PC;3RAH=+\$?#R#PAK'C4A+BXGTS0/B!?
M^"--;SI_M5_I\DC))_:Q\+_V'_BS_P $VOV(?AS^S'_P2E\(_L[>)/&N@>+)
MM8\?>)_VS?&WQ-\,:;\0-0\0Z/JL_CCXK^)]=^#?@#QKXB\2?$K6_%-IX2M;
M?1I=-T/P_8^#;>31[#6--M?#F@:9/^M%% '^>%^W7_P;$_\ !<7_ (*)?M+^
M//VJOVC/VD?^"<]]\1?'0TFQ&E^%OB#^TAHO@[PCX:\/:?%I7AWPAX/T:Y_9
MCU2ZT[P_HMC#B(7VIZGJNH7T]_K.M:IJ>LZEJ&H7/ZR_\$J/^">G_!PY_P $
MM_A%'^SCH/Q+_P""6OQZ_9^T_7-6U[PEX+^)/Q1_:LTWQ!\.+KQ#J5QK'B.R
M\"^+/#?[-5G]F\/ZYK5[J'B"_P! U[1]>MX]>OKW4-(N-(;4=56__K8HH *_
M$'_@N+_P1@^'W_!83X!^%_#D?BNR^%G[17P9O=<UKX&_%2^TZ?4]$A7Q%!81
M^*/A_P".["R(O[KP3XN;1]%N)=1TU9M:\+:UH^FZWI=MJ=H-;\.>(?V^HH _
MRV_@U_P; _\ !?\ _9\^,@U+X">,?"/P*UL>?H0_: ^$O[6VI?#>R.C7,\?V
MECJ/@@Z5\7VT.Y,,5Q/I[>"?M,Z11^=I;3(L0_KS_P""9W_!O3\(/V4]7N/V
MC/VU_B3XA_;\_;L\4:/-8:W\;_C#J_B/QGH?PZAO[&:SO-.^%4'CO4-9\0SZ
MQ#;W=Q8_\+/\574GBV2 %_#.G> K;4-7TN^_HQHH _R\_$?_  9Y?\%0] _:
M:U'PG\*_%_P4'P5TWQJ]]X#_ &D=6^)MQX?N]/\ "MMJIO?#^LZKX*T;2+OX
M@Z9X^TS3TM9+S3=#TB[T>'Q' T>E^+)--$.LC^WK]BS_ ()B:I_P2W_9"^(7
MA/\ 8[N/ OQ]_;<^)5WX<\5_%'X^?M9>*/&WAJP^.WC^WU6PM=4NO'_BWP;H
M'Q/\>>&?!GA?PM>^)_\ A7/A/2=-\4&QU6:+^V]2O-3\1>*/%US^R5% '\%/
M_!4;_@WM_P""Z7_!6']HBR_:!^/WQM_X)H>%Y?#/@VQ^'GP^^'OP^^(_[3UE
MX0\$^#K#5-5UHVMLVM?LTZQJVK:WJVKZSJ&IZ_K^HWSW&H7$EO:VMOINC:;I
M.E6'VM_P21_X)B_\' '_  24^&WC'X'^ _'O_!++XV_!3Q9XPN/B!:^#/B/\
M5OVKM,U7P=XOU#3M.TG6[[PAXH\.?LSV[VFF>(;/2-*?5]$U?2=:LEU#3XM2
MT<Z1=7VN-J_]@%% 'PC^U'J'_!3:'PYX!B_8K\(?L)ZEXNO/#%^?BE>_M0_$
MCX_Z%X=\.^,_LVC_ -EI\/\ 3?A1\*O$>I>,?#(NWU\WTOB/5/ ^J?9[;1_(
M@,EY>_8?X5/VA/\ @TB_X+-_M1?&_P"*?[0_QG_:;_8 \3_%+XQ^-=<\>^-M
M:7XE_M"V5M<:UKMV]S+;Z;I\'[*HMM+T;383#IFB:3:A;32M(L[+3K55M[6-
M1_I,T4 ?A;_P2W^"'_!;#]E;P)\ ?V:?VO\ 7/\ @G;\6_V??@_X5MOAVWQ1
M^&/Q$_:./[1%OX \*>%+S2OA[I8T+Q+\#?#/PZ\9:IHMS9^&O#EUJU_JGA&Z
MF\)VL^HW\FN^)X);G6?Q+_X*]?\ !MM^W/\ \%&O^"EW[17[8OP;^+WP2^#'
MA>YT'X"CX-7_ (X\4>-;3Q%XD\4>!OAAX9\/ZU>_:? /A?Q%JG@%/#?B+PVK
M:=K,MO>:C=336UYIUBL<#7*_W#44 ?R1? ;XU_\ !UG^R+X3TWX5?&7]A/X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M66@ZAXUUF:ZLHO#?PW\*PV]]XJ\?^(I;JUATKPQHVHS3WVEP&35K'^UC3?\
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MO;#4+"]A>VO+&^L[E);>[L[NWED@N;:>.2&>&1XI4='92 ?G9_P^'_X)0?\
M22/]B#_Q)SX/_P#S6T?\/A_^"4'_ $DC_8@_\2<^#_\ \UM?BS_P7[_X-V?@
MA^V)\!?%?[0'[%GP9\$_"K]LKX7:5?\ BB'PU\,/#&D>#M"_:1\/:= ]YK/@
M;Q!X>T"TL-'F^)SVL4MS\/\ Q@ME'JFK:M%#X-\2WEQI.J:7JOA3^!O_ ((T
M_M _L[_LE_\ !2[]G'XI_M@_#7PUXX^"&B>+-9\(?$"P\>^&K/Q%IOP]N?%V
MAZKX0TSXF7WAC6K.\L[N7X7^(=3L?%&H07.F7FHV%AIFHWFB6J^)K/2)80#_
M &3?B!\?O@?\*/A%<_'_ .)WQ=^&_P /O@=9Z7X9URZ^+WC+QEH'ASX;VVC>
M,]1T?2/".JS^,M5O[70(M/\ $VJ>(="T[0KM[\0:I>ZQIEM9/-->VZ2?'G_#
MX?\ X)0?])(_V(/_ !)SX/\ _P UM>T_M??'+]E_]GC]D'XK?'+]H]? ^I_L
MR^ ?AVGB3Q#I.J:1X>\4>%?%FAPK8MX/\+>'_#NH)/X>\2ZAXLUE] T3P-HZ
M(]KJ>N:AHL%HT8>*9/X4/^#?G_@@W\/?V^_B3X]_X*<?M?\ P3T?P=^R9XL^
M*?CSQ5^R_P#LG0P7%KX+\:+?^+M6OXKW6;0):2W?P+^&DDH\'>#O#F(K?XA:
MIH=T=;B7P7HKZ5XV /\ 0)^"?Q^^!_[2?@B/XF?L]_%WX;_&WX=S:IJ&AQ>.
M/A7XRT#QWX4DUG23"-4TI->\-W^HZ8VH:>;B 7EH+DSVQFC$J)O7/KE<7\/_
M (;_  [^$_A>P\$?"SP%X+^&G@O2MXTOPA\/_"VA^#?"^FB3:'%AH'AVQTW2
M;/>$0/\ 9[2/=M7.=HQ\5?\ !4+_ (*'_"S_ ()?_L=?$;]JKXFVXUZ[T3[+
MX5^%_P /8KY-.U'XH?%GQ'#>#PAX(L;QHIS96TPL=0U[Q+JB6UW+HG@[0?$6
MM06.HW.GPZ==@'TS\?\ ]IC]GO\ 94\!W/Q._:2^-'PU^!_@*VE:V'B;XF>+
M]&\)Z??7XB:9-)T8:K=V]QKNMSQHQM-#T6"_U>](V6EE,Y"G\9]0_P"#I'_@
MAUIWB!] ?]LJ[NEBF-O-KNG_ +/G[2]]X?297",$O[?X0/+=PAB<7EC:W5E(
MBF6*YDB*NWX"_P#!%+]ASXB?\%]?C9\3O^"L7_!6S5]0^.'PK\(>.=1^'G[/
M7P"U&YU72OA%=^(-+6QUK7K73?!T5VMO8_!?X<Q:EHNC:9X8L[JZA^)'C0Z]
M=_$C4O$-UH'B*#Q9_8?\5/\ @EW_ ,$[?C)\)=9^"'C7]BS]FG_A7>KZ+<:'
M#IGAGX-?#_P;J'AJ&:U-I!J'@G7O"N@:1K7@K7--CVOI.M^&;[3-2TZ2.-K:
MX1058 ]3_9;_ &U?V3OVV/!UUX\_91^/_P ,OCIX<TY[>'6Y/ OB.UOM9\,7
M%V)FL[3Q?X5N?LGBKP?>WB0336=EXHT72+N[@C:XMX9(<2'Z@K_$CT7XL_M&
M?\$>O^"C7Q2G_9Y^(6O^$/B;^RK^T#\3_A-+>77G1Z7\0?#GP\^(&K>%M1\-
M?$'P_ ]I8^)?!OC>PT.&35](F1;::.YMM5T>:PU*STG4[/\ V:_V8OC79_M*
M?LV?L]_M%:=HUUX<T_X]_!#X4?&BQ\/7S&2\T*T^*/@30?&]MHUU(T<1EN-,
MAUQ+*:41HLKP-(JA6% '\''_  ?&#_BY_P#P3J/?_A _VDA^7B'X-X_F:_;K
M_@T-_P"4-O@O_LX#X[?^GS2J_$7_ (/C/^2G_P#!.K_L0_VD_P#U(?@U7*?\
M$+6_X*%_MQ?\$T=#_P""<?[$^J:W^R9\%=.^*GQ5UO\ ;&_X* :I8W4FIZ?H
MOCC4K&[TCX"?LTZ=IVIZ7J6N_$75M!5=8\?:[:ZQX>_X1C0M2TNPE\1>''U>
MR'B@ _KC_:J_X+V?\$F/V,_'6H_"_P"-_P"V'X*B^)&B7LNF^(/!7PW\.^//
MC+K'AC4K:0Q7VE^*YOA1X6\8:1X5UG3Y 4OM"\1:GIFN6[_(^G;P5'U3^QE_
MP48_8F_X*$>&=6\5?L??M#>"/C/:^'1;'Q/H>F#6O#GCGPJEZSI97'BCX=^-
M-*\-^._#]C?2Q3P:?J>J^';73-2FMKF/3KRZ:WFV?S<>,/\ @RP_X)Z7WPEU
M#P_X)_:#_:LT7XSC2+@Z3\3_ !/X@^&WB3PO)XG>',5SK_PZT_X<>'I;SPS]
MKW%M(TKQ=I&MI;LJOXHN9HVEF_AV_9:^-'QZ_P""*O\ P5.TG6]5OKK0_&_[
M+/Q^UCX3?'G0-#O+B71?'WP[T;Q<?"OQ8\*8 ABUOP]XL\-VEYJ?A>[NK:6.
M#4%\,^*[*W34M,TZ6$ _VIZJWU]9:997FI:E>6NGZ=I]K<7U_?WUQ%:65C96
MD3SW5Y>74[QP6UK;01R37%Q-(D4,2/)(ZHK,)8)X+J"&ZMI8Y[>YBCGMYXG6
M2*:"9%DBEB=25>.2-E='4E65@02#7^=O_P 'B7_!3GXV1_'+PW_P31^&7B?6
M? _P:T3X;>%OB5\>8]$NY]+O?BUXK\;7.HWOAKP?X@NK:19[[X?^$?#FGZ5K
M2:'YT6G:]XHU^XN->L+Y_"GAJXM0#^IOXW_\'%__  1C^ /B*_\ "7C+]N3P
M!XC\1:;<36MW9_"'PM\2_C?IJ7-N=L\ \6?"7P5XQ\%&6&3]U(A\1AEF62(C
MS(I51OP/_P"#C#_@C'\?_$5AX1\&_MQ> ?#?B/4KB*UM++XO>%?B7\$=-DN)
MW2.WA_X2WXL>"_"'@H2SRNL440\2&1Y"$"990WE'_!OQ_P $ZOV0_@/_ ,$Q
M_P!DSXD^&_@G\/==^*W[0WP.\"?&?XK_ !4\7>#M!\0>/?$VN?$S0;7Q4^@/
MK^KV%W?6/A#PM:ZI!X>\.^&],DL]%CL[!M7FLI]=UC6M4U'\-O\ @[Z_X)8?
MLV_#[]GGX=?M_P#P"^$_@SX2?$;2?B[HGPM^-MI\.O#VF^$?#OQ!\*^/-%\0
M77A_QEX@T'0[6UT9_&/AGQ5X?L-$&OP65IJFO:7XOFA\07VIC0?#\5D ?WEV
M=Y9ZC9VNH:?=6U_87]M!>6-]9SQ75G>6=U$L]M=6MS [PW%M<0NDT$\+O%-$
MZR1NR,";-?Q0_P#!EY^VA\4?C)^SE^T[^R/\2/$VI>*/#_[+6O?"[Q-\&9]:
MO)[_ %#P_P"!/B[#X^MM;\!:?<3N[P^%O"WB/P FLZ%8-N&GS>-M4L[5TTV"
MQL[+^DO]OS]AOXI_MP:-X9\$>&/V[_VG/V/_ (:VND>)K+X@>'/V9)?!/A3Q
M1\2K_57TH>'[K4/B?J7A_4?''AW2="M8-<L=5\,^']2MM)\6VVMQ+J:P-IB-
M=@%/]M#_ (*Y_P#!.C_@GZQT[]J7]J;X>>!O&&8 OPRT.74_B)\5PEUL-O<W
MGPT^'FG^)_&6CZ;.K[XM9UW1]+T:14EV:@6C91]TVWQ'\$3?#NS^+%WXETK1
M/AU=^$+/QZ_BWQ+>0>&]&TWPC>Z1%KJ:[K=[K;V,&B6,&E3)>7TVJ/:)81"0
MW9A\M]O^'[_P4 _9CU_]C+]M7]IK]E[Q+XKN?'FJ?!GXN^*_":^.;V&2VU#Q
MII0O/[3\/^+=3M9;J_DM-5\1Z!J&F:SJMFU_?_9-1O;FW6_O5B%U+_H":5^Q
M/^W#_P '!OPK^#-U\>OB3\1/V"_^"4/@SP#\.M,^$/P/\.6%K'^T+^UL?"_A
MS2-/_P"%W_$>UU)YO#_@[P=KEY:-J_PGLO%=AXNM;71H--US3_ =W+JMMX_U
M, _57QS_ ,',?_!$OX?^.I_A_J_[;F@:QJ5G>M87^O\ @;X6?&_XA>!;6X$I
MB#0^._!/PVUWPKK5FS?,-3\-ZIK6F"(^:]XL>6'["? WX]_!;]ICX:>'OC'^
MS]\4/!7Q@^%WBJ*230O&_@'7K'Q#H5Y);OY5[8R7-C+(UCJ^F7 :TU?1=1CM
M-7T>^CEL=4LK2\BE@3^&K_@J9_P:(?LU? K]C7XP?M!_L1_%GX_7OQ0^ O@'
MQ!\4-;^'_P 9=>\#^-M"^)'@OP/I<^O>,K#1;KPI\/\ P%JOAWQI;^'++5=9
MT1E.NZ7KVH:=;^&4T33)=7CUJP_,O_@T&_;I\<_ O_@HI!^QW?Z[?7'P7_;#
M\,^+[1_#%U=R'1M ^,?PV\&ZSX^\*^-]/MY&:*QU+6/#'A7Q)X"U,6<<+Z\=
M8\,C4GN/^$;T=;4 _P!22BBOX&O^#L__ (+4_%7X;>.I/^"8'[+OC;5? !'@
MW1_$/[6GCWPMJ$VF>*M1MO'FDIJWA?X&Z9JUI)#?Z%HE_P"#+_3/%WQ!GL)(
M[GQ1I/BKPYX7^V6^B)XMTK7@#^G;]H?_ (+M?\$G?V8/&UW\,_B?^V3X!U#X
MD6%]/I5]X%^$N@?$#X]>(]/UBU1GNM%U>V^"7A'Q_;Z#J]IL=+O3==NM,NK2
M:-X+F**=6C'&? W_ (.&?^".?[0/BNV\"^#OVVO 7A;QA=W@TZ'1/C/X9^(W
MP'C;47;RXM/'B#XQ>#O!7A.2_FG_ -%@L8=?DNYKLI:Q0M<2Q1OYM_P;U_\
M!,WX)_L'_P#!/O\ 9_\ &^E>!- ?]H_]HCX3>"?C'\;/BG?:7:7'CBYN_B7H
M-AXRTGX<V^N3P-?Z5X2\ :-JVF^'(O#VF7$.CWFMZ?JWB6>&XU36;N[E^8_^
M#GG_ ().?"+]L']AKXN_M8>"_ 6@Z)^UA^RKX,U3XMV?C_0M(L[#Q#\1OA/X
M)LI-5^)7P]\;WUHD,_B6QTKP9;:MXN\&2:BFHZKHGB'P_'I&@S6&G>*?$4%^
M ?U!6]Q!=P075K/#<VUS#'<6US;R)-!<03(LD,\$T;-'+#+&RR1R1LR.C*RL
M5(-2U_C%_P#!(7]G7Q9_P4:_:P\'?L5ZO^WA\5OV4+WQ?X-\32?"+6;#1_%'
MQ+\.ZUXD\$:.WB)OAZ="@^,GPKA\,1W'@O2?$FIZ+?6UYJ4$MYH4&@1:6DVJ
M6L\?^EU_P1@_X)#_ !#_ ."3^@_M Z/X]_;<\?\ [8I^-VJ?#;4=*B\7>"]:
M\#Z1\-O^$ M?&]M?'0=,UGXM_%E[J_\ &/\ PE]G_;M_!>:*KP>%=!MWM+HV
MZS( ?MU7Y\?M@_\ !5G_ ()W_L$W8TC]J_\ :O\ A?\ "SQ6UK#?#X?+=:OX
MY^)ZV-S&)+/4)OA?\.=)\7?$"VTV^4YLM3NO#<&G7>V3R+IQ%*4_(O\ X.0_
M^"RGC[_@GU\./AS^RC^R3+]K_;B_:PA-GX/U"QMK?4]6^$GP]U+5SX2M_&NE
M:1<I-#>>._&_B<W7A'X81W5O/I]MJ&D^*/$%TK77A[3-/U7VC_@F'_P;Z?LC
M_LD_#32/B!^U5\-_!G[8W[</Q%MX_&?QY^./[06E67QF-IX_U^,:CKVB_#^T
M\?1:_IUA8:-?W5Y8R^.I+23QUXWNFO\ 6M;UN+3[_3O#FA@&M\/_ /@Z _X(
ME?$/Q);>%[7]L0>$[V^N4M;#4/B!\&OCEX-\-W$DC!0]SXHU?X=1>']$MAG<
M]WXCU'1K6-02\RGBOW0\">/O OQ2\(:!\0?AGXS\*?$/P'XKT^+5O"_C7P/X
MATGQ7X3\1Z7,66+4="\1:%=W^D:M8R,CJEU8W<\#,CJ'W*P'\SG_  7(_P"#
M>7]CW]JW]EOXK_&#]F;X'_#O]G[]K3X1^"O$7Q"\&:M\(/"NB_#_ ,-?%I/"
MFF7&MZO\._B%X0\+Z=8>'=:U#Q1I=C=:?X8\7?V?9^)=&\3G0VO=<N/#"ZMH
MU[_&C_P;F?\ !8;XD_\ !.O]KWP#\&?''C#4M1_8T_:+\<:'X%^)_@K6-0NK
MCP_\-O%7BR_L]"\/?&[PK;2/+'H&I:!J<^GP^/O[/A$/BCP,+^/4;*_UK0_"
M5[HX!_K?4444 %%%% !7X+_\'(7[?'_#!?\ P2[^,NJ>&-:_LKXR?M%1M^S=
M\(#;7'DZI9:E\1-+U*/QUXMLC$PN[.3P=\-+/Q9J6F:Q GEZ=XNF\)PR2PRZ
MA;,W[T5_!7_P4)+_ /!;W_@Y%^ '[ &E.WB7]D__ ()[0WVO_'F* F\\/ZAJ
M7AJ^\/>,/C]#J 0YCC\1>)8?A=^S+>))%Y^E:_:ZM=V\OV>YDD4 _.O]L#_@
M@H_P/_X-S/V;_P!K:U\'-;?M4>!/%/\ PTW^T&RV)77S\$_VDK;PMX?TWPA?
MQ!!J7F?"71M*^#FNWNDWA>V\)7U_\9M36"S.IZG(WFG_  :'?MY_\,S_ /!0
MW5/V7?&&L_8?AA^VSX9@\&V,=U<>5I^G?'+P#'JOB+X67[-(S)%)XCTR[\;?
M#Z*WMXUGU77_ !5X4CFE,=A$E?Z>7Q4^%W@CXT?"SXA_!CXB:+;Z[\.OBGX$
M\4_#;QIX?D"I;ZIX0\9:#?>&]>TSA6$(N=)U"YMXY$3,#,LD8#(N/\1G]ICX
M*_&#_@FE^WA\2O@^VL:AX?\ B[^R1\>EF\%^,[:$V5Y-=^"?$-CXM^%7Q+TF
M%P3!!XCT1?"OCO0Q(H866J61D16W( #_ ')Z*^0/V _VM_"?[=W[&G[.W[6G
M@W[)!I_QJ^&NB>)=8TFRF,\/ACQQ:"70OB-X-\UG=Y)/!OC[2?$GAB25V+3-
MI1G!*R*3]?T %07-S;65M<7EY<06EG:02W-U=7,L<%M;6T$;2SW%Q/*R10P0
MQ(\DLLC+''&K.[*JDB9F5%9W8*J@LS,0JJJC)9B<   $DD@ #)K_ #LOV^?^
M"B7[1'_!P=_P4P\*?\$D/V(?B7JOPS_8>3QQK7A_XG?$/PK<7*-\9/"?P]2[
MU+XJ?%SQ==V4D']J?##2=/TJ_LO@_P##RXO+70/'&OW'AG6O%<[ZIXC\.V/@
ML _JA^/?_!Q-_P $:_V<_$M_X-\<_MO> ?$?BC3+B2TOM-^#WAKXB?'&RMKJ
M!BES;3^*?A+X0\8>"X+JTE!@NK.?Q''=P7"R6\D FAF2/TC]E;_@N=_P2B_;
M/\7:7\/?@)^V9\.-6^(6N746GZ%X$\>Z;XT^#?BKQ#JD\D<=OH_A;3/B_P"&
M/ [>+M8N'D46VE^%9-:O;D"4P0R""<Q]_P#LM_\ !(3_ ()O_L@_"_1/A;\)
M?V1?@E=VFFZ7;Z?K/C?XA_#OPA\1OB?XYND@\N\U?QOX^\6:)J6NZU=ZC,]S
M=2:?'/9^'-+:[GLO#NA:+I @TZ'^!_\ X.YO^"<GP%_8I_::_9R^.7[,_P ,
MM!^#G@O]I[PC\08_%O@GP!I%OX=\ :9\3_A-J_A5]0\0>&] TN*WT?PE-XG\
M/_$#P_\ :]#T.WTW2);_ ,/7FM6=A'J&H:S<3@'^H-7X/_\ !:C_ (+J?L[_
M /!*/X3Z]H&EZYX8^*?[9OB?19(_A3\ ;+4TO9]"NM1MR+#XA?&)-,G^U^$?
M &E"1=1M=.NYM/\ $/Q GA31?"RPV9UOQ/X:^#_^#2C_ (*7?'']N+]D_P"-
M'P*_:%U_6OB#XY_8VUOX9:'X<^*GB">XO_$/BKX6_%'3?&A\&Z!XJUFY:6X\
M0>)O!-]\-_$FG/X@OIFU+4O#=]X9AU)KS4=/O=5U#T3_ (+1_P#!&/\ X)C^
M&OV%O^"B'[7>B_LG>#[+]H^#X0_&?XU1?%3_ (2SXG7.MK\4-2BU'Q+>^+OL
M-WXXN-!:]FUR\N;_ .R/I#:7&\GDQ6*6R)"H!_(M_P &WW[;/A#0?^"S?C;]
MK']N']HKP5X(N_B=\(OCSK'CKXR?&_QSX>\$Z-KGC_QKK/A34_LT^N^(;W2M
M&MKW4I8KQ=(T6T>W@MK*S%CI5E!8V44$/^DY\)?^"E'_  3V^/?Q!\/?";X(
M_MN?LK?%OXH>+6U-?"_P]^'/QV^&WC'QGXA;1=&U'Q'K"Z+X;T'Q%?:MJ1TO
M0-(U76K\6EK*;72].O;Z;9;VTTB?Y=O_  ;.?LB?LX_MM?\ !2Z#X)_M2_"W
M2/B_\+7^ 7Q6\6MX0UO4O$6E61\1:!=>$H](U/[5X8UC0]3\ZR34+Q8X_MWV
M=_/;SH9"J%?])_\ 9U_X(H?\$N/V3/C)X-_:"_9W_9#\$_#'XQ_#Y]>?P=XY
MTGQ3\3=1U#0W\3>&-:\&ZZUO9>(/'&KZ1,=1\,^(M:TF7[9IUR(X;^26#RKE
M(9X@#]3**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@EO"VJ^(M<N=1UW5YHQ<:GJ-W<$RGVNB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/P!_X.CO^4%'[<W_ ';-_P"MA_L^U_D"U_K]?\'1W_*"C]N;_NV;_P!;#_9]
MK_(%H _O\_X,8_\ G*+_ -V3?^_<5_?Y7\ ?_!C'_P Y1?\ NR;_ -^XK^_R
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAW\5O@!XSU%@"6M[&[^)^B^ A.  3Q>^.+.-CP%25V)P#7\?'_!GIKD.D_\
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M/XU\/ZQ-'DF.WU+7+WQGIML2%WR>'[LX^7)_K?H _"/_ (.4_P!G32/VC/\
M@C=^UU:7>GPW?B#X+>'=$_:+\%WTD2S2Z'J_PBUNUUKQ+J%J"I,<M[\,KCQ]
MX=EE4J8[/7+IBVT,K?Y^7_!KU^T5X@^ '_!9/]FG3+#4+BV\+_'^U\=_L_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_BOQ]H?AK58M0U^_AT+P=X9CU#2M1GG2PT+PA=ZKI%ZR)#XQU&&$O/\ Z,%
M!17X0_\ !2+_ (.'?V!_^"<&K^.OASXGN?B1\<_CS\/Y-.L?%7PB^#O@[4+J
M/P7J^O:=::IX=M/B/\2O$<>B_#SP@FK6>H6-TMI:ZUXB\5Q65U;W<7A.Z2XM
M5G_GO_8/_P"#H[]MC_@H;_P5@_91_9ZTGX<_"/X!?LR?%'XAZUX;\0?#_2;"
MZ^(7Q UC1H_!OB?7+7^W_BAXA73HC?VU[I%FT,_A#P9X,A\HSPW=O>[TD0 _
MONHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\0)IELM]#)90&VG\(>"?!RQ*\Z72W^Z*2+_0#H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **X3XH?$[P!\%OAUX
MV^+?Q4\4Z7X'^&WPX\-:OXQ\<>,-;DDBTCPUX8T*SEO]7UG49(8II5M+&SAE
MGF,4,LA5"$C=B%/\>O\ P4"_X/'OV=O@G+J/@;]B3X">-_C_ .,Y+/S]*^*7
MQDTS7_@W\'?LUT)/[.\0Z%X4U&SMOBSX^TF=H7!MM0TSX5Q7,;">PUZY5&4@
M']HM%?S:?\&U7_!3[]JC_@J7^SY^TU\6_P!JK5/ ][XB\"_'^U\'>#M/\ ^#
MK7P=H6@>%]0\#:'XC.CPVZ7>HZCJ,=KJ&HW"6U[K>J:IJIMA''=7]RZF5OZ2
MZ "BOXZ/^#E7_@OO^U+_ ,$Q_C;\&?V5_P!DCP]X&T3QCXR^$EC\<_''Q6^(
M'A=O&0CT+7/&OC/P1X;\'>#M"O+RTT2"Y2\^'_B#4?%.KZK::TTEMJ&A66D1
MZ7<0:C<3_J__ ,$!O^"H/C__ (*O_L)/\>OBWX*T'P;\6?AU\6_%'P-^(DOA
M"VO['P9XOUSPUX7\$>,[+QCX:TW4;S4[K1H=4\/^/]&M=7T:35=02T\0Z=JU
MQ9/:Z5>Z;8VP!^W%%%% !1110 4444 %%%% !117PG^W/_P4B_9(_P""=/A3
MPSXE_:?^(.I>'M1\??\ "11?#+P!X1\'>*?'_P 1OB9?>%(-,N/$%AX-\*^%
M-+U&XN#I,>M:/_:>J:O/H_A[2CJE@=5UFQ2ZA=@#[LHK_.>_;E_X/2_C;XKO
M-2\)?\$__P!GC0/@_P"'H[EX(OBO^T(EOX[^)-];1R[EGTWX;>']0A\!>"KT
M[!#<0ZUX@^*4$D#S>6EE<F*6#^]?]D#XC>*/C#^R7^R[\7/'%S;7OC7XI?LZ
M_!/XC>+[RRLX-.L[OQ1XW^&GAGQ-X@N;33[95MK&VGU;4[N6"SMU6"UB=((E
M$:*  ?15%%% !117\T?_  43_P"#I#]@;]AVZ\7^"/AWH/Q)_:Q^,'A#Q)KW
M@36-"^'NC7_@OX4^&_B#X:N;JSUKPAXO^-/C#2%TD:IIEW9W%MJ$'P\\._$J
MXL+J">UU"WLYX+A80#^ERBOXC_\ @AW_ ,'#?[;/_!5+_@J-J/P4^*/A_P"$
M7PR_9[E^!WQ,\:Z+\,/A_P"&+NZU2QU?PKJ'A>+1+[6/B%XCU'4O$.L:BL&L
MW<6I-80^']#O2L,EOX=L&1@_]N% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M@#_P='?\H*/VYO\ NV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^
MU_D"T ?W^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E
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M:_.W_@C3_P &U'[.?_!+;QI;_M#?$/Q[-^TW^U7::??:?X6\<7_A>+PE\/\
MX26NKV<MCJ[_  W\'S:IK]_+XJU#3[J[T:^\>Z_K$M\VC3SV6@:'X534=:75
M>[_X*7_\$?/^"@?_  4KT/XB_!_QC_P5WL?A7^RKXT\;7?B&Q_9^\$_L)^'&
M9?#-AXD/B#P+X1\??$VV_:2T+Q9\1D\(&WTHS7$T7AS0?$6M:39^([[PE;WU
MMIT>G@'\3G_!HM?6MI_P69^'4%Q,D<NI_ OX\V-DC, UQ=1^$X=2>&,'EG6R
MT^[G*C)$<$C=%)K_ %AJ_AD^ /\ P9P_&/\ 9;^,'@3X^_L__P#!837/A?\
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MFW]H7PO\"_C7^WG^VDES'^V1_P %+_B3I?Q]^).E7UA<Z1>> _A1H.CW&B?
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MGQ,\'VK/$ZNJW%C\'_AS97<)920)+>[MYK>9"=T<L3QN RD#_55_:?\ @?\
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M;4]-L=;\.^+BOAW1$\#:9-HFB2:?)H_S'_P6P_X-R?@A_P %8O$NG_'OP/\
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M)<6&JZ1JMG::AI]Y Z36UW;PS1,KHI !_>S7^=E_P=G_ /!6+QYJ/[4VD_\
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M/+,UGI<_E1(K22R;8XU+LH/Z6HB1HL<:JB(JHB(H5$10%5550 JJ  J@
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M&D:UHVIVEUI^IZ;?6\%W8WMO-;7$4<T;H-WX3_\ !2K_ ()Z?'CX@^'OA/\
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M/$WC7QSXBTCPGX3\.Z9$5674-<\1:]>6&D:391LZ*]U?WD$"LZJ7!8 _AO\
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MU+P[I6K:991E);B\2*6*1P#]):*** "BO'_CA^T%\"_V9_ =_P#%#]H7XO\
MPX^"GP\TV18+GQA\3O&&A>#-"-Y(DDEOIEI?:[>V4>H:O>")UT_1]/\ M.J:
MA*/(L;2XF98S^+6N_P#!T=_P0\T'Q!)H$O[95QJ9@N#;76LZ%\ ?VD=8\/P2
M*P5GCU2R^$DB:E;KG(NM'CU*VD56,,LG (!_0+17QK^R;_P4,_8C_;HTR\U+
M]DO]IGX4_&V73+5;_6/#OA?Q MIX[T&PD>**+4/$7PY\00Z/X^\.V$TTR00W
MNM^&["UFN"UO%*\T<B+]E4 %%?('QO\ ^"@G["W[,_C5?AO^T1^V#^S7\#OB
M"^C6'B)?!/Q7^-'P_P# 7BEM!U26[ATW61H7B77M-U(Z9?S6%[%9WHM_L]Q)
M:7"12,T,@7Q__A\/_P $H/\ I)'^Q!_XDY\'_P#YK: /T?HKYJ_9^_;+_9)_
M:OG\4VO[,7[2_P "_P!H*Y\#PZ/<>,K?X-_%'P;\1IO"L'B%]2CT*;Q!'X4U
MC5'TF/6)-&U9-,>^$"WK:;?+;F0VLP3V/XA?$3P%\)?!/B;XE?%'QGX8^'GP
M\\%Z3<Z]XO\ &_C36].\-^%?#&B68#7>K:]KVK7%IINE:=;!@9[R]N88(@1O
M<9% '945^<'_  ^'_P""4'_22/\ 8@_\2<^#_P#\UM?7OP._:&^ _P"TUX+D
M^(_[.OQD^&?QR^'\.M7WAN7QK\)_&WA[Q[X7B\0:7!976I:))KGAG4-2TY-5
ML+;4=/GN[!K@7-O#>VLDL:I/&6 /8J*H:KJNEZ%IFH:UK>I6&CZ-I%E=:EJN
MK:K>6^GZ9IFG6,#W-[J&H7]W)#:V5E9VT4EQ=75S+%!;P1O++(D:,P_$+XV?
M\')7_!%WX$^)+WPCXC_;6\)^,_$&G7$EO=P_!OP3\3?C+H:/$S)(T/CGX<^#
M?$/P_O5212A6P\5W4A/*QL@9@ ?N917Y5?LB_P#!;G_@EK^W)XIT_P  ?LZ_
MM??#[7_B/JTJVVD?#CQKI_BWX1>.==OFY&F^%O#WQ7\.^#+OQGJ(3,IL_!W]
MOS>2DLVTQPS-'^JM !1110 45Y-\:?CS\$_V</ US\3OV@?BU\.O@I\.;/4=
M.TB[\=?%+QAH/@;PG;:KJ\S0:5IT^O\ B.^T[3(KW49U:&RMGN1-<R*4A1V!
M%?'/_#X?_@E!_P!)(_V(/_$G/@__ /-;0!^C]%?)'P)_;Y_8@_:@\8WOP]_9
MO_:Y_9Q^._CS3O#U[XLU#P=\)/C'X"^('B:R\+Z=?Z7I5_XANM$\,:[J>H0:
M-9:EK>CV%UJ4ENMI!>:II]O)*LMW KX_QC_X*-?L!?L\^/M5^%?QX_;2_9>^
M#?Q,T.WTR[UGP!\3?CC\.?!/C#2K76M.M]7T>XU#P[XA\0Z?JMI#JFEWEKJ-
MA)/:HEW97,%S 7AE1R ?9]%?G!_P^'_X)0?])(_V(/\ Q)SX/_\ S6U])_L_
M?M?_ +*G[6$?BN;]F']H[X)?M!Q>!'T2/QK)\&_B9X0^(R>$Y/$BZJWAY/$3
M>%-6U0:.^MKH6M-I2WY@-^-)U$VPD%G/L /HRBO /C]^U=^S'^RII7A[7?VF
M?V@?@Y\ -%\6ZA=Z3X7U7XQ?$7PI\.]/\0ZII]LEY?:?HMWXJU32X-2O;.TE
MCN;FVM'EEA@D261%1@3\O_\ #X?_ ()0?])(_P!B#_Q)SX/_ /S6T ?H_7XE
M_M2_\&\__!*W]L3]IF;]J_XU? 34[WXGZWJ6GZS\0;+PKX^\6>#?!/Q4U;3(
M[>&'4_'OA?0=0M;>ZU&[M[6WAUJ^\/W'AVZ\1^6]QXAFU2\N+JYG_:ZVN+>\
MMX+NUFBN;6ZABN+:X@D66&>WG1989H94)22*6-E>.1"5=&#*2"#7YQ_MG_\
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M\3/_ %"];K_()_X-W?\ E-+^P!_V5S6O_5:>.J /]E:BBB@ HHHH **_._\
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M'Q#X?^#_ ,6_ _Q#UG1-!>]M]-36=5T[PMK>IW=CIC:A=6UDM[<Q1VYNKB&
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MK^'?!EWXSU$)F4V?@[^WYO)26;:8X9FC /U5HHHH **** "BO-?BW\9?A'\
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M *J?PK7]K-?Q3?\ !DA_R95^V+_V='HW_JI_"M?VLT ?F7_P43_X)$?L,_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+;6U_!H4_AS2],_K=_X4I_P=8?\ 1Y'_  2@_P##:?%__P"<]7P/_P %#O\
M@C=_P<)?\%/_ (0>$O@A^U5^UA_P3.U;P1X)^).G?%70!X)\/?&CP=K,'BK3
M/#'BOPC 9M5M?@K=23:9)I'C+5_M.GF,)-=)87)<-:*K 'T/_P &K/\ P5\^
M('[?G[/OCO\ 9?\ VD?%%WXP_:-_96TWP[=Z3\0-;NIKSQ-\6?@EK<\^DZ-K
M7BB]F,DNK^,OA]K-K!X7\3^([J1;SQ!I>M>"]3U1]3\23^(]8OOV%_X*Z_\
M!3_X6_\ !*']D/Q-^T1XXLH/%OCS5[W_ (0?X%_"L7WV*[^)/Q0U*QNKK3K&
MZGCW7&G>$?#UG:W/B+QOKL<;'3]#L6L; 7'B'5]!TW4/P5_X(+_\&Z_[:_\
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M?2;FSM-:UF&]_M6K^77_ (._/^4.?B/_ +.,^!G_ *6>(Z /QI_X,;?^1O\
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MU#0W\3>&-:\&ZZUO9>(/'&KZ1,=1\,^(M:TF7[9IUR(X;^26#RKE(9XO!/\
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M^V%_P2;M[:VABM[>W@^&'Q=BA@@A18X888D^#JI'%%&JI&B *B*%4  "IO\
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MT^*1D35])\8>$]1USPI!*N?+;[#\4/"O@/5MSH[>58SQ1%&GW@ _U!_VV?\
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MQ+!KG@CXB^%-"\:^$M8B4[DCU/P[XDL-2TB^6-OFC%S:2>6_SIM8 U_D_?\
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M'NO7C#S-1\2^,]:OIF:>>5B ?ZD/P;^+7@3X]_"7X9_&_P"%^LQ^(?AS\7?
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M>10#_1DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#\ ?\ @Z._Y04?MS?]VS?^MA_L^U_D"U_K
M]?\ !T=_R@H_;F_[MF_];#_9]K_(%H _O\_X,8_^<HO_ '9-_P"_<5_?Y7\
M?_!C'_SE%_[LF_\ ?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%<MS<:E*I6.'1X()-6FNF6RBLGO&6 @'\5G_  ?&_P#)2?\ @G-_V(_[2_\
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MX;\<?L:>"]*TB^=6$']L^#/B]\9E\0:5 QRK-8V7B'PYJ,P4@J=;3<@R&?\
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M-7Q!:->:#XUTVXD /[;*^#_^"FW[%V@?\%!OV%/VD/V3=92QCU/XG_#[4%\
M:O?JH@\-?%?PS+!XJ^%OB.2;:9H+/3/'6C:&^LBV>*:\T"35M,,JP7TP;[PH
MH _QV?\ @@I^VAK_ /P3*_X*R_"B_P#B:][X)\$>-/%6K_LI_M*:+K1;3O\
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MYU*WAAO](CTGX')*,Z/8W,@!^YG_  46_P""*7A#2O\ @W9C_8;^&&D6>O\
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MDD3JZK?:%^S/\%]$U. LI($EKJ6G7=K,GWHY87C8!E(K_5M_8-U*SUC]AO\
M8RU?3YX[G3]5_91_9VU*QN8F5XKBSOOA#X/NK:>-U)5XY894D1E)5E8$$@T
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M.?$_Q:\0WB1EX-*T7X9?#[Q7XK2ZO&!_=0WNMV&BZ#;R'(.HZQ8Q$?O<C_0
M_P"#HK]MCP/^RG_P2G^-GPUNO$6GP?%W]KC3D^ WPP\)?:XO[8U?1-<U#39?
MBYXB.GHYO1X=\/?#@:SI]]JRPFQMO$?B3PGI%U-'+KEJLGYC?\&>G_!+CQ/\
M#?A1\0/^"C?QH\,W.@>,/VB?#5O\/?V>-(UBS-MJUE\"HM4LM>\3?$*2VN$^
MT6MK\5/$VD>'XO"S21VL\_A7P:OB"T:\T'QKIMQ( ?VV5_#=_P 'O_\ R;G^
MP=_V6OXM_P#J"^&Z_N1K^$W_ (/AO$NE0?![_@GUX.>[@&MZK\2OCSXEMK'S
M%-RVE>'_  O\.-+O;LQ [U@2[\2V$(D*A6D<JI)1@ #Z9_X,H?\ E&M^TE_V
M?'XR_P#5"?L^5_8S7\8/_!DOXITJ[_8'_:O\%0W4+ZWX?_:^G\4ZA9*Z&>WT
MKQA\&/A?I.C74D88ND-W=^!M=BA=E"2/8W"HS&*0)_9]0 4444 %?XJNK?\
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M0Q7-C/\ $K33\2#8W<+*CP7EFOBQ;:[MY%$MO<Q2PRCS(VK^>S_@]Q_Y,O\
MV-_^SG]>_P#54^):_M/TO2].T33-.T71[&UTS2-(L;32]+TVQ@CM;'3M.L+>
M.TL;&SMH52*WM;2VBBM[>")5CAAC2-%55 '\3_\ P>ZZK8P_LB_L5:))/&NI
M:A^T=XRU6TM2ZB6:QT?X97MIJ$Z1D[FCMI]=TR.5P-J-=0JQ!D7(!J_\&2'_
M "95^V+_ -G1Z-_ZJ?PK7]K-?Q+?\&1>IV4O['W[:.C1SQMJ-A^TGX3U.ZM0
MRF6&RU?X7Z5::?.Z9W+'<SZ)J4<3$!7:UE"DE&Q_;30!_G7_ /!\+_R6[_@G
MY_V2OX[?^I=\/*_>K_@T@_Y0P?"K_LM'Q]_]3NXK\!/^#X#5;&;]H7]@K0X[
MB-M2T[X-?&+5;NU#J9H;'6?&_A2STZXDC!W+'<W&@ZI'$Y&UVM)E4DQMC][/
M^#1/4[*__P""-/P_M;6>.:?1/CQ\>-,U*-&#-:WLOB>TUF."4 DI(VG:O87(
M5L$Q7$;XVNI(!X%_P>B^#]4U[_@EQ\'/$NGPRSVO@7]M3X;ZEKNP,8[32-;^
M$/QT\.1WTQ!PH77=2T2P0L,%]1 # D*_Y1?\&27[3FA>'/C!^V9^R)KVI0VV
MK_%'P9\/?CA\.K6XDB@6\NOA=?Z]X3^(EA:M(RM>:I>:5X_\&ZK!8P[ITTOP
MQK=^J&WM;J2'^TW_ (*F_L3:?_P40_8'_:1_9)GN;'3M?^)G@<W'P[UO4=RV
M6@_%3P9JEAXU^&FIWMQ$CW-KI(\9^']'LO$,MHK7,GAR]UBU1)5N'AD_QS?@
MK\6OVF/^"8?[:?ACXE^']-U3X6?M*_LJ_%._M-8\)^*[&>&2RUW0+B^\-^-_
M 'C#3(I[>:[\/^)M'GUOPEXDM;2\A_M+0-7O#INH1&>UOD /]S2BOYX/V'O^
M#G+_ ()8_M:?#/0-<^)'QW\*_LD?%X:;:_\ "=?"7X^:F_A:RT/6EA5;]O"W
MQ-O;.T\!>,_#D]VMP=%O8M6TOQ++8+!-KWA/P]=SK9#Q;_@HO_P=1?\ !/\
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M3O\ RG-_;+_[!G[-?_K*GP3K_4C_ ."=_P#RC_\ V&/^S._V9?\ U2O@FO\
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MB'H_B>.X"20:] V77]$_^"97_!O'^RG^P!\0[G]ICXF>,/&'[:7[:^KZG?\
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M_P!KIIKS4]6U2\NKZ]N96+S7,\DC'+5_>I10!^*'_!-?_@G'^W]^P-I'P?\
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M45]K47@?3-515AUO5[S7/$'BW6X!-92Z[9:#=RZ G[Z44 %?FI_P50_X)=_
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M;*W@L[*RM((K:TM+2VB6&VM;6VA5(;>WMX42*"")$BBB18XU55 %BB@#P?\
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M'\6VO[5W[4?@#]I_6=4U+3;CP?J_@+]FF']FVV\)Z9;VMQ'J>FZCI4/QB^,
M\43ZE=26UU!J#7VBG3X[=[86MV+CSHOJ>B@ HHHH *_DN_X+,_\ !K7\-_\
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M);&59K#QE<P>()I];^(_B[1[B..^\+7>L:;X;T+PQJ&-43PYJNOV.AZ[H_\
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MB&']O3]H022;AM3[-\:?$D<^XYP/+>-P^3\I4@X(('^U[0!_(/\ 'G_@DO\
M\%_O^"F.D0_!_P#X*&_\%%_V7O@A^R_J-[977C3X6?L:>"_&VKW?CF#3KN.^
MCL?$Z>)O"7PPO=8LVGA@DL].\0?$+Q+X4T_4+;3]?F\'ZAJFFVZG^@+_ ()X
M?\$V?V5O^"8?P.@^!O[+O@N;2+&_N;;5O'_Q \27%MK/Q,^*OB>VMVMH_$?C
M[Q+#9V"7T]M#)/#H^BZ78Z3X7\.V]Q=0>']#TU;V^-U][44 <QXWT[Q5K'@S
MQ=I/@7Q-8>"O&^J>&-?T[P=XRU3PXOC'3/"7BJ^TJ[MO#WB;4?"+:OX?7Q38
M:#J\MGJMYX<;7M$77+>TDTPZOIHNOMD/\EO_  4$_P"#:+]LS_@IWX[\(^//
MVN_^"R4'C2;X>:3J6B?#WPMX?_8#T7P=X)\$V.MW-I=Z\^A^'-!_:NMH&U/7
MKG3].;6M=U6;4]=U&#2](L+G4GT[1]*L[/\ KYHH _C_ /V ?^#9O]LW_@F5
MX[\4^/?V0O\ @LT? EQX]TO3M&^('A?6?V!M"\8^!_'&GZ-/=76B#Q!X8\1?
MM5WUDVHZ'<7^H-HNO:8VF^(-+AU/5K&RU6'3]8U:TO?Z8?$OPY_:HU']F"#X
M<^&?VG/ _AK]JA/#_A:PN/VG+O\ 9SMO$'@B;Q#IOB#2+[Q9X@C_ &<Y/BQI
MMK!;>*/#MKK.@Z?HA^*\T?AJ]U>VUT7^L_V4-+OOI^B@#^+C]M3_ (-1?VF_
M^"@_QOU#]H3]J[_@L9<_$GXDW>BZ;X7L+H?L):1X>T+PSX2T66\GTGPKX4\-
M:!^U7I^BZ#H5C=:CJ-^;:SM%FO\ 5=2U/6M5N;_6-3U"_N?IK_@GC_P;^?M^
M_P#!+_2/&7A3]E+_ (+-:5H_P^\?:S!XF\3_  V\<_\ !/;0?'?@JY\506-O
MI0\4:=8ZQ^UA_:/A[7;G2K.RTS5+SP]JNE#7++3M)AUN+41HNCFP_JMHH 10
MP50Q#,  S ;0S8Y(7)V@GD#)QTR>M?S]_P#!83_@WC_9._X*P7!^*G]KWG[.
MW[5UCI5OI5M\=?!V@6>NV'C;3]-MUM=(TCXP>!I;[18O&\&DVJ)8Z/XAL-<\
M.^,-*L8K+3I-<U3P_I=CX?C_ *!:* /\QK5/^#*?_@I5#XJDT_1OVB/V)]1\
M(?:&^S^)]1\8_&[2=7-B) HDNO"]O\"M8BM]1>/,BV-OXAOK+=B-]77.\?TF
M_P#!(K_@UN_9?_X)W>-_#G[0_P >?&2_M8_M->%KFWU;P1J&H^&D\-_!_P"$
MNNV\@FM/$'@SP7=WNL:CXC\::5*-VE>-?%VHO%I=PEKJ_ASPCX:U^SM]63^I
MBB@ K\0_^"S7_!#C]GS_ (+!^!/"D_BGQ-?_  8_:(^%UCJ&F_"_X[:!H-KX
MCE@T'4IVO;SP+X_\+S7^BMXR\$2:FTFK:;:0Z[HNL>&-9N+[4=!U:"VUCQ+I
M.O\ [>44 ?YRO@#_ (,B/VD[GQQ!;_%#]N#X(Z#\-X[P?:M9\ ?#_P >^*O'
M%WIJO^]B@\->(9/!F@Z?>7<&81-)XLU2"R>3S6M]12(V\W]>W[-/_!$?]@K]
ME']B_P",O[%?PF^'-S:^&?VB?A3XL^%7QU^+NLSZ?JGQO^)]CXQ\,ZEX9OM8
MUWQHVFPQ6<^D0ZK<ZCX4\/Z'IFE>#O"^J9U#2/#T%]<ZC=7OZZ44 ?Y[WPJ_
MX,B/&4/QK!^-G[;OA2__ &=M-UPW"CX9?#O6;#XR>,/#L5SE-+FA\3WEYX,^
M'NK7MIA)M9AO?B1:Z?-N,6C:@K*4_NN_9K_9K^"?[(?P2\ _L[_L\> M(^&_
MPE^&NCIH_ACPQI"R/M#R276HZOJ^HW+S:CKOB/7=1FNM7\0^(=6N;O5M<U>\
MN]1U&ZGNKB20^YT4 ?C1_P %./\ @A+^P-_P5-2X\5_&?P-J/P]^/D>FV^FZ
M5^T9\(I[#PW\2FM]/M4M=)T[QG#=V&H^&OB1HMA#!:6=O;>,-&O]9TO2;;^R
M_"_B'PW#*\E?S9_##_@V6_X+/_\ !.OXE:WXQ_X)>?\ !3GX5:!H^L31MJ=O
MXV/C_P"%L?B>WMF8Z:OC+X3KX%_:$^$WC&[TQ)'BM;OQ$UQ]G62XDL8K,74M
MM7]\=% '\>_BK_@B-_P6W_X*%Z3IOPY_X*T?\%:_"J_L]Q7MC?>)/@O^R%X$
MTO2AX[@LKBWN8]/\2:M;?"GX#^'IKB*Z@CU*QN_&'A/XJZ3H^JV\%UIWA\R1
MPSV_]('[#W[ O[*__!.OX,6/P+_91^&&F_#[PDDT.H^)-8DD?5_''Q#\1I;B
MWF\5_$+Q?>*=5\3Z].@9(6N'BTO1K1ETGPYI>BZ);VFF6_V110 5_.]_P4[_
M ."/'[>W_!3?P_X\^#GC7_@K/I/PK_96\5>/I/%FF? 3P;^PMH<]PFAZ5KK:
MUX%\+>/OB9!^TOH7B/XC1>#Y8].N?.EL?#>B:WKVEZ?XDO/"T.HZ?I0T[^B&
MB@#^&?\ 9]_X,Y?C)^RM\9/ 7[0/[/W_  6"UGX9?%_X9:S_ &[X+\::%^Q+
M9RWNE7LEI<Z=>0SV6I?M77VDZOI.K:5>WVCZYH6LV&H:+KNC7]_I&KV%[IU[
M<VTO]>/[*/PR_:L^%W@W7-%_:R_:G\(?M8>+[K68+KP[XU\(_LX:7^S8FC:%
M'IUO;S:1JOAG1OB=\3=/UZ_N-2CN=2.LV]UH,445PM@FD[8!<2?4]% 'SE^U
M=^R7^S]^VY\#_%_[.W[3/PYT?XF_"OQG#']OT;4_.MK_ $C5K02'2O%'A77+
M*2#5_"_BS0Y99)M'\0Z+=VFHV9DGM_-DLKN\M;C^#[]J_P#X,F/C58^+M4U/
M]B+]K/X8>)O =Y=S7.E>#_VF[/Q5X)\8>'+)G;RM*F\<?#/PAX]T3QI<Q(%(
MU9O!7@&*4MY3Z;&8C<S_ .B=10!_G)_LO?\ !DS^T=JWC'2[W]LO]J_X-^"/
MAU;7<-QJ^A?LXP>,OB+X\UVPCD7[1I5IKWQ%\%?#GPUX/O+J/>(=<;1O'L%D
M=COH-Z6:./\ O7_9'_9$_9__ &&O@/X,_9O_ &9_ &G_  \^%O@FWE-IIUL\
MEYJVO:U>^6^M>+O%VNW1?4?$OBWQ!<1K<:OKFI2R3RA+>QM5M-*L-.T^T^E:
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /P!_X.CO\ E!1^W-_W;-_ZV'^S[7^0+7^OU_P=
M'?\ *"C]N;_NV;_UL/\ 9]K_ "!: /[_ #_@QC_YRB_]V3?^_<5_?Y7\ ?\
MP8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC"YUWPU_;WB3Q%?RVD-S+8^'-!TNRTC1=$T^WTZ2[MM0U;5?NO\ X(F_ ?\
MX+Y?\$DO@QXP_9M\6_\ !.?X8?M%_!K7O'NI?$CPK]@_;.^"/PQ\:> O$7B#
M3-(TSQ+:1:A/-XYTKQ-X;U0:!IM_::1-I^A7VE:M/K%Z-;OK>_CTZT_M-HH
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MQ"1H&=V(&%1%9F.%4$D"@!]%?YG#_P#!YA^W0/VOCXU7X5_"+_AD)?'QL?\
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MD\1/H_A]M:73C<_9QJ3:)I1N@GFFQM]WEJ ?4=%%% !117Y2_P#!7[_@J_\
M"#_@D;^R_P#\+T\>Z''\1_B)XN\06_@_X*_!&U\2Q>%M8^)OB4-;W6O2OK9T
MCQ%-X?\ "O@_09)-8\3>)CX?U6VLIIM#T-8'U?Q-HT%P ?JU17XK_P#!$'_@
MKK>_\%B/V?\ XL_'"]^ =K^SY)\,/C%)\*4\-6OQ-E^**:TD?@KPKXO_ +=;
M5YO 7P_;3V+>)#I_]FC3;T 68NOMQ-P;>']J* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX!\#P^*OC%XTT#487"2:7XG\.?!_P]XYU'PEJ:$AGL?%4.C7$<3+-(BQ.KL
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MAM\%_P#9P'QV_P#3YI5?T_5_,#_P:&_\H;?!?_9P'QV_]/FE5_3]0!^&[_\
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MPI\.>--8\(R7=NR75J/%EMH:W%K)#=1,\$T,C@'Z@T5^,_P&_P"#A#_@C?\
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M)-/U.RFBN(8[#QC\._&5I:QSR:5K5A=>'_&/A74;?[?IUS8WHC/^OE_P2/\
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MNB:397>I:IJ5[/#:6-C;3W5S+'#$[K\ _P##X?\ X)0?])(_V(/_ !)SX/\
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M4#M%<7OACX=>'[?6?'WB>SMID,-S=:!X:U*"VG*0SR1RR1HWY9Z'_P '3/\
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M!I_V1/@S+(?[SCQC\6H 3ZGRX8UY[*!TK^]#_@@S_P H=?\ @GE_V;AX2_\
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M)TNO\]/_ (._O^4Q6O\ _9N'P-_])_$U?Z%G_!%+_E$?_P $Y?\ LT#X'_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%
MK_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O
M\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+9_"7B+P]-.][:6-I#(E[+<Q(L*F*.-R[-_6K_P=F_\ *%/X[_\ 94/V?/\
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M_P#M=ZK?:E/=^&?@;XWG_9@\ Z:\S36N@Z#\"Y[KPCXCM+ G[MOK'Q.B\?\
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MXJ\,^+?#^@V<*O<:AKX\!>._%>L:%H]G#/J&OZMI-GH&FV\VHZG:QM_GF_\
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M + >D_\ I!;UN4 %%%% !7^"U\<_^2V_&+_LJ?Q!_P#4MU>O]Z6O\%KXY_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /_!T=_R@H_;F_P"[
M9O\ UL/]GVO\@6O]?K_@Z._Y04?MS?\ =LW_ *V'^S[7^0+0!_?Y_P &,?\
MSE%_[LF_]^XK^_ROX _^#&/_ )RB_P#=DW_OW%?W^4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKXZ#^!=&N?$7B3X.^,->O))=0\5V,/@S3-:\4>!]>UB>XUK1;7PUK'A>\O\
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MEOI7BV#PE)X=-Q%XW\3>+].\*SZSIC_\*X\+Z)J^I>.K+4K;^S_X1?"[P?\
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ME"Q(S7N'_!W]_P IBM?_ .S</@;_ .D_B:O]"S_@BE_RB/\ ^"<O_9H'P/\
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MXI\2:C<:MKFN:K>2_M<;[B^U+4;NXNKB3"KYDI"(B!5']"7_  39_P"";?\
MP4!_8$T7X/?![Q;_ ,%3])_:8_97^$6FW7AW2_@UXL_8GT'P?XTB\'PZ%J6G
M^%_"'ASXWP?M"^+/$>AZ'X3U:XTJ^TFWUK0/%XM= TA/!FE_V3HAT_\ LK]N
M:* .,^(OPZ\"?%SP)XN^&'Q/\(^'_'OP[\>Z!J?A;QGX,\5:9:ZSX=\2^'M8
MMI+/4](U?3+R.6WN[.[MY'1TD3*G;)&R2HCK_")^W?\ \&5\VO\ CC6_&O\
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M (*P?LD>#_!*V@T2]^(?ASPG;>./C$-(\M8#)INNWG[)?@W6;[41#N8:_?\
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MW\/O"EYJGB2;0-?\0QW<\>L^,O$WBGQOX[N4N=1MK+Q1IFEZOJFEW7[[444
M?E]^VM^RI_P4>_:$U7Q7I?[,W_!3KP]^QA\+O$WARQT.+0M#_8L\._%SXI:'
M=-9-:>(M4T?XQ:Y\>/",NFSZR[O+IUQI/@K3-;\+EEET;7DU"&WU&'^4^_\
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M_P -].U)TCW,EOJ7C+P^9'V1F2-6:2/_ $U:* /R/_X)/?\ !&?]E#_@D?\
M#75_#WP6M-2\=_%[QU:V4/Q8_:!\<6UB/'7C9+)Q<P:!I-I9*UAX(\ V-\6O
M-.\'Z/+<&6=;:\\3:UXGU>RM=4C_ %PHHH **** "OA_]L#X*_MQ?%V;PFO[
M(/[<O@W]CFRT[3=:MO&/_"1?LC>%_P!IO4_%.HWL]@^BZGI%[XJ^*_P_T_PJ
MNB6\&H0S64FC>(HM6DOXIY9+460BN/N"B@#^&S]H?_@SM^-G[6'QB\;?'_\
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MC[;=>9F/^A;]BC]F[_ACW]D?]G+]EC_A,_\ A8G_  S_ /!_P/\ "C_A._\
MA'?^$1_X2W_A#-$M=&_M[_A&/[=\3_V#_:7V;[3_ &7_ ,)#K/V/?Y/]HW6W
MS6^GZ* "BBB@ K\2?^"W7_!'+_A\C\(O@K\*O^&C/^&<O^%/_$C6/B#_ &]_
MPJ+_ (6]_P )%_:WAB?PY_9']E_\+/\ A?\ V1]G\_[9]O\ [1U/S=OV?[%'
MN\\?MM10!^,/_!$O_@D/_P .=/@%\5_@=_PT)_PT7_PL_P",$GQ7_P"$H_X5
M/_PJ+^P_,\%^%O"']@_V)_PLOXG_ -IX_P"$:_M#^U/[7T_/VW[)_9P^S?:9
M_P!GJ** /Y1/^#AW_@WD^)7_  5A^)'PI_:5_9I^*GP[\"?'/P%\.[?X/>*_
M"GQAN?$VD^!/&7@+2O$_B3Q?X:U/2_$OA'PWXPU30?%6@ZMXQ\4VMU:W?AC4
M-.\2:=J.F*^J:!)X?QK/V;_P0$_X(SZE_P $>_V>OB9X;^(OQ'\/_$WX]?'S
MQ7X=\3_%+5O \6K1?#SP]IW@G3=5TSP9X.\(W&OV.DZ[KT6EMXA\3ZMJ/B?5
M-$\.W&IW6O+81Z!9V^C0W>H?O=10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!^ /_!T=_P H*/VYO^[9O_6P_P!GVO\ (%K_ %^O^#H[_E!1^W-_W;-_
MZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_?N*_O\ *_@#_P"#&/\ YRB_]V3?^_<5
M_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'X _\'1W_ "@H_;F_[MF_];#_ &?:_P @6O\ 7Z_X.CO^4%'[<W_=
MLW_K8?[/M?Y M ']_G_!C'_SE%_[LF_]^XK^_P K^ /_ (,8_P#G*+_W9-_[
M]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?@#_P='?\ *"C]N;_NV;_UL/\ 9]K_ "!:_P!?K_@Z._Y04?MS
M?]VS?^MA_L^U_D"T ?W^?\&,?_.47_NR;_W[BO[_ "OX _\ @QC_ .<HO_=D
MW_OW%?W^4 %%%% !1110 5^6/Q)_;B_:QD_:N^.G[,7[+_[$G@?X]Q_L^^#O
M@EXI\<>//&W[6]E\"E>?XY:7XRU3P]I>D^&+CX$?$B2\6PA\#ZNE]??VZ@+-
M;$6L7F8'ZG5^6?[,G_*5/_@JA_V2O_@G1_ZAO[1] !_PTG_P5?\ ^D7/P+_\
M62Z7_P#0CT?\-)_\%7_^D7/P+_\ %DNE_P#T(]?J910!^6?_  TG_P %7_\
MI%S\"_\ Q9+I?_T(]'_#2?\ P5?_ .D7/P+_ /%DNE__ $(]?J910!^=W[('
M[8WQQ^.7QZ_:4_9P_:'_ &8/#O[-OQ(_9X\!?L[_ !':/PG^T#;?'[1/&'AS
M]H:_^.6FZ.R:I;?"KX7#0;W0;GX'ZI]KM7M]7^VIK-LRR67V0B[_ $1K\M/@
M#_REY_X*4_\ 9HG_  3$_P#4N_X*$5^I= !1110 4444 %%%% !1110 4444
M %%%% !7G_Q0^+'PL^!_@C6/B9\:?B7\/_A!\-_#SZ;'K_Q!^*'C+PYX \$:
M')K&J6>B:0FL>*_%FI:3H.F/JNM:CI^D::M[?P-?:I?V>GVHEN[J"%_0*YCQ
MCX)\&?$3P[J'A#X@>$?#'CKPGJWV;^U/"_C'0-*\3^'=2^Q7<%_9_P!H:)K=
MI?:;>?9+ZUMKVV^T6TGD7=O!<Q;)HHW4 ^,O^'J?_!,#_I(_^P7_ .)@?L]_
M_/#KU;X/?MN?L8?M#^*YO GP _:Z_9@^.7CBWTB[\07'@WX/?'WX4_$SQ7!H
M-A/:6M]K<WA[P5XLUO5XM(LKK4+"VN]2>S6RMI[VTAFF22YA5_Q1_P""JG_!
MM!^PG^W1\+O%VM_L^_"GX<?LF?M666G76I> ?B%\+?#EMX&^'7BG7K>)YH?#
M?Q:^'GA.UMO#&H:)XBF MK_QIHOAZ'QWH5W+!K<=[X@L[2^\+:Y_E[_##XH?
MM%?\$\/VM;#QY\._$-W\,/VC?V7_ (K:[HTEYIMY:ZG;:9XO\$ZSJ/A7Q?X8
MU1K*XGTGQ-X7U9K76/#/B33#/=Z)XF\/WNH:?,;G3[]MX!_NJ45^6O\ P2+_
M ."I?P>_X*P?LH^'_CMX -CX:^)?AW[!X5_: ^$ OA<ZK\+?B2+/S;BWB65O
MM=_X(\4I#<:W\/\ Q*Z&/6-&\_3[MK?Q-H/B72=*_4J@#EO&_CGP3\,_"/B'
MQ_\ $CQCX6^'W@/PCI=SK?BOQMXW\0Z3X4\(^&-%LUWWFK^(?$FO7=AHVBZ7
M:I\]S?ZE>VUI OS2RH.:^-/^'J?_  3 _P"DC_[!?_B8'[/?_P \.OMSQ!X>
MT#Q9HNI^&_%.AZ/XE\.ZU:2Z?K.@>(-,LM9T75K"<;9[+4]*U&"YL;^TF7Y9
M;:Z@EAD'#H17\J?_  <U?\$L/V,/$7_!,7X^?M,?#[]G;X2?"OX__L[V_@KQ
MWX6^(7PO\">&_A]J^MZ%<?$+PKX8\9>%O&;>$]/TB+Q;HMQX4\0:O?Z7#KL5
M_/HVO6&G7>E3VD<NI07X!^Z'_#U/_@F!_P!)'_V"_P#Q,#]GO_YX=?7WPY^)
M?PY^,/@O0?B3\)/'_@GXI?#KQ3!<77ACQ]\.?%6A>-_!?B.UL[ZZTR[N=!\4
M^&;_ %/0]7@M=2L;W3[B;3[^XC@OK.ZM)66XMY8T_D/_ .#5+_@EK^QS??\
M!-_P!^V7\5?@!\+OC%\;OV@?&?Q5NK/Q?\5O!?A[X@R^"O!?P[^(_B;X4Z5X
M<\$:?XIT_5-+\+K<:EX)UW6M7U?2;.UUW6)M9-EJ6IW.EZ=I5E9_V#^%_"GA
M?P/H.G>%?!?AO0/"'AC2(Y8=)\.>%]'T[0-!TN*>XFNYHM.T?2;:TT^RCFN[
MB>YE2VMXEDN)YIG!DE=F -^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***_G\_X./_ /@I_P")_P#@F9^P%J&K?"#5TT?]
MI']HKQ))\&O@QK">7)>^!HI](N]6^('Q4L[:4".:]\%>'(HM.\/S$R+IWCCQ
M9X/U.ZL]0TZSOK.8 ]P_;I_X+K_L'?L)?$!_@;K^M_$;]HG]IE(RTO[-7[*O
M@EOB_P#%?2F,"7"Q^*X8-3T?PKX0NA;S07LNB:_XFL_%7]ES1:I:^'KNSEAD
ME_&S1_\ @\^_8TTKXCW'@;XT_L<_M>?!^TL=133=7O;RR^'^L^)O#DLGED3>
M(_ NH>)?"FJV$=NDJ7%[;V=YJ6IQVN7L]/OYFBMY?6/^#0+]G3P;X7_X)T^)
M_P!KC5-+CU_X\?M4?'#XH:AXU^*>O9U7QMJOA3P/KR^%-+\.7'B.^,^J7&G-
MXLTOQ=XNU$S7+SZMX@\17=]J<UW);6'V7ZG_ .#@[_@B/X;_ ."JG[/I\<?!
M[0?"^A?MO_!NQEOOA3XLNS8Z#_PM/PQ%YDVK?!+QOXBE$,!T_4]\FH^ -8UV
M4V?A#Q@BQ'4-#\-^*/%]W* ?L9^R5^V1^S/^W1\'])^.W[*OQ;\,_%[X;:K.
M]A-JFA27-KJOAW6X8(+F[\,^,O#&K6]AXE\&^*+*WNK6XN?#_B;2M,U-;.[L
M]0CMY=/OK*[N/INOX8_^#3C_ ()B?\%(OV(OV@OVIOB9^U)\,?%W[/WP/\5?
M"FS^&T?PY\;:CIL>H_$?XMZ5XYT'6O#OCC2=!TG5-2271OA_X5M_'>B1>*KL
M06&JM\15M_#-SK$,.M2Z;_<Y0 445\8?M(_MR?"/]F;XZ_L;?LZ^+X-7UCXG
M?ML_%/Q/\-OAEHVB/IH;2K+P3X+U#Q?XM\<^(1?7EM,OAK191X<\/S#3XKN_
MFU;Q;I9AMVMH+Z:  ^SZ^3/VK_V[OV/?V&_"7_":_M8_M$?#+X(Z1-:S7>EV
M'BW7XF\7^)8K<L)D\&^ -)34_'7C6YB*.)+3PGX<UFZ38Y:%51B/K.OY)_\
M@O1_P0W_ ."?L_[ G[=/[7/@WX1:SHO[5?A;1O$_[1R_&S5/BK\7?&?B74-8
MT[Q+!XG\5^'KZQ\:>.M?T ^#[_PQ)K/AO1O#5KI%KI/A2S.ER^'K:PETR(N
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M8HM5T^]T.*TL+NUTF\U&PNOS(_X,F?\ E(!^U7_V9W??^KJ^$] '^F!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1/\ @F)_ZEW_  4(K]2Z_+3X _\ *7G_ (*4_P#9HG_!,3_U+O\ @H17ZET
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M_B-X$T7P??N/!>GQRZ]K_AC6[!M4_P"$=L]9UK3/%MS>:;:^&]1])_X-NO\
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M 'E7QP^.'PG_ &;?A-X[^.?QR\=:#\-OA3\-- O/$WC/QGXDNOLVFZ3I=F
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M .H'J] '^=__ ,&AW_*9/P3_ -D ^.W_ *8M,K_5[K_'X_X-O_VK?@?^Q/\
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M=Y<06EI;QM-<7-S-'!;P1(,O+--*R1Q1H 2SNRJHY) K\$_^"X__  6HTO\
MX)?^"? 7PB^"OA"T^-7[=_[2$D.C_ 'X/-#>:G8Z/!JFK+X8T_XA>-M(T>:#
M6=2TV[\32KX=\$^$=/N+#4O'_B>"_P!/L;^SL-#UZ]M/@_X<_P#!M]\4?VW_
M  MIOQG_ ."W7[<?[4'Q\^/7C*WB\177P,^%GQ%T/P;\"?@?+J:+<CP?H6D)
MX9U[P]>:KHH94O[OX>Z/X%\(6^J/J%K96?BJ"&#Q5JH!_65HOB/P]XDAEN?#
MVO:-KUO!)Y4T^BZI8ZI##+S^ZEEL9YTCDX/R.P;@\<5LU_F1?\%F/^#??XN?
M\$:- L?V]O\ @G9^T/\ '&;X,^$M>T;3/'-TOBFZ\+_'?X%7>O:G!I_ASQ4G
MCWX:VG@^T\3?#[4/$%QI_AVYO5TKP]K7AK6-3\/6]Y!XEL]4OM8T?]L/^#:+
M_@X/\>_MTZY)^PK^VOKUEK?[2^C>&K_Q!\%/C"ME9:3=_'#PQX7L9+[Q/X3\
M9V&G16NFGXH>$]$MYO$5IKFE65K!XT\):=KEYK-K:>(_#=WJWC  _LMHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^4K'_!>7_LM^J?\ K1W[05?W&U_#E_P:]_\ *5C_ (+R_P#9;]4_]:._:"H
M_N"U#3[#5K"]TK5;*TU/3-3M+G3]2TW4+:&\L-0L+R%[:\LKVSN4DM[NTN[>
M22"YMIXY(9X9'BE1T=E/^4[_ ,'(_P#P0SO_ /@FW\9I?VE/V=O#5W/^Q#\<
M?$UP-,L+&&:YB_9Y^).J&XU"Y^%FJR@.T?@C61'>:C\*M7N'#16%O?>"M4=]
M1\/Z=J_BG_5MKR#X_? 7X3?M0?!GXC?L_P#QS\&Z7X_^$_Q5\,WWA/QIX5U9
M&,%_IEZ%>*YM+F,I=:7K6D7T-IK/A_7=.FMM6T#7;#3M:TF[M-2L+6YB /\
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M[1WPK\.^+/" -U<7MR^_5?BW\/\ 3853QA$[/JOB_P +V\/CS.J:A8>/;ZP
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MB#7=)N= UO7?"_A_6=8T*\M;BRO-%U74])M+W4-)N[*\ N[2YTV[GFLY[6Z
MN+>6%XIP)4:NHHHH *_AV_X/2_VX==^'_P #OV=?V"_!6L3Z>WQ[U;5?C/\
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MOYY?^#5O_E!O^R!_V'/VDO\ UI_XPU_0U0 4444 >7_&_P#Y(M\7O^R7^/\
M_P!135J_Q]?^#>+_ )31_P#!/_\ [+!JG_JN?&]?[!7QO_Y(M\7O^R7^/_\
MU%-6K_'U_P"#>+_E-'_P3_\ ^RP:I_ZKGQO0!_LM5^8G_!:C_E$C_P %&_\
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MV!*CDEBA4/-)'$ADBB#2.J*99Y4@@C#,0#)--)'#$@.Z25TC0%V4$ DHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX?=_\$B?^DB_[)G_ (=_PQ_\EU^I=% 'Y:?\/N_^"1/_ $D7_9,_\._X8_\
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MHV^GP^,=./F:CJGP1\;ZFX1&\+>*[D//X9U2^D"^!O&4T6M03V^B:MXQL=;
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MWP;\.?B!XC^(_AH>*8[S5O$5A;ZKI^K:/X=M=*GT6^\6:C>2Z==:B ?YX/\
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M*(,\&C:-JM^X$%G,Z_R2_P#!F)^P!KWC#X\?%_\ X*+>--#GM_ ?P@\-ZO\
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M'PC:VEG%/I^JZOK/QQ\9^$+'4+/5;IWL4A\.)K6HV;PO<75BL#1L_P#GT?\
M!6?_ ()7_P#!Q9_P5F_:SU']IKXE?\$[]'^'6EZ7X0T?X:?"WX8Z%^U9^R)K
MECX!^'.@:GKFMV&DW?B&Z^.VF3>)_$%_KOB77]<U_P 1/I&D)?WVI&WL=)TO
M2;'3=-M #^J'_@U4O+>Y_P""'G[)L,,BO)I_B7]H^SNU5@3#</\ M)?%:_6-
MP"2K&UOK:8*V"4E1L;64G^B.OXH_^"&G@'_@O=_P2E^"OB7]EWXO_P#!*+4_
MCM\#[OQKK'Q!\":KX/\ VQ_V+_"WCWX>ZSXDMM/B\3:"+/6OCA?Z%XG\*:O>
MZ;%K=E;M>^'=3T/6K[7KA[[7+35;6RT;^N/]G+XF?%[XL?#E/%GQN_9N\7?L
MK>-VUS5--;X5^-?B'\)_B?K2:39"U.G^(CXG^#'B[QKX,:TU@S3K;Z>NM'5;
M0V<AO[2W$L!D />:*** /-OC+;3WOP@^*MG;1M+<W?PV\<VUO$@+/+//X8U2
M**-% )9GD=54 $DD #-?XZO_  0 U_2O#?\ P66_X)\:CK-Y#8VES\>;#0(9
MIY%C1]5\5^&O$?A?0K-68@&;4-;UC3["VC'S2W%S%$@+NH/^SDRJZLCJ&5@5
M96 965A@JP.0002""""#@U_E=_\ !2#_ (-D/^"CW[)_[5/B/QQ^PM\*?&7Q
MW^ E]\09_'GP+\9_!O7].A^)_P )E;7FUWPQX6\3Z#_:VC>+M*\4> ;A+:#2
MO'7AFUO= U&WT_3->35="UJXNO#^D@'^GY\7OC%\+?@%\._$7Q:^-/CSPU\,
M_AKX333G\1^-/%VI0Z3H.DG6-7L- TB*YO)R%^TZKKFJZ;H^F6D2R7.H:I?V
M=C:0S7-S%$_P5_P6ID0?\$CO^"C+L=BO^Q[\<0"X*'=+X&U5(U*N RLSNJ!6
M 8,0I /%?A#_ ,$SO^"8W_!8C]K7XA?!7X\_\%TOV@?&6M_!O]G7Q/H/Q'^"
M?[&NN:SX"NKKQO\ %'PIMG\"_$3X[:;\*["S\(W]CX+NC'K>BZ?XOU+Q9X]U
MG7%FM?$R>'=&;6-.\6?3O_!:GQ%_P6A_:X^ '[1'[#W[(/\ P2RU.'P!\3M2
MU;X=:O\ M->,/VNOV2+/_A,/A3IGB>-Y=2\!?"R_^*VB^(-!7XF:/IENAG\=
MWMAK?AWP]JVH:=>>$HM?GBO=% /Y O\ @T/91_P63\$ D M\ ?CNJ@G[S#0-
M-; ]3M5FQZ GM7^KY7^7W_P3-_X(U_\ !PI_P3,_;*^%7[7WP^_X)WZ/X^OO
MA^?$.D^(? .O?M4_LBZ/IOC7P9XQT#4/#/B?0#K=G\>;VZT+49-/U%K_ $+6
MX]/U.+2=>L-,OKW2-:L(+K2+[_0:^#?[1W[7WCGX(?%3X@_%?_@G7\1O@=\7
M?!&GRW'@+X 7W[1?[,OQ#U?XT7\>D27R:=X4^(W@SX@S_#_PL)]31-$BO/B1
MJ7A&(32K?3)#8+),@!_-/_P>TD?\,&?LFC/)_:Z4@=R!\&OB6"?PR,_45Q7_
M  9#NA_91_;<C# NO[0O@)V3/S*DGPWVHQ'8,8Y I[E&]*\S_P""\G[-'_!>
MK_@L/!\&OAOX(_X)77OP,^!WP9UK7O&4&F^(_P!L/]C#Q=XT\=>/-<TZ/18-
M=UF?3?C9IFE>'M,\.:$=0T[1M#TZ3599[C6]8U'4]8N1)IFGZ3S'_!!S]DC_
M (+U_P#!'#Q+\;=#\4?\$L[KXY?!;X\IX/U'7]"T3]L3]C3PCXO\'>,/ RZ[
M;:5XE\.7E_\ &S5])U:SU72O$5]I?B'0-1CTZ2Z>ST'4;'7+#^RKS3]: /Z:
M_P#@O%^QAXA_;O\ ^"67[4GP.\":3-K?Q2T[PSI?Q:^$^E6D)N-1U?QW\(]:
ML?'%MX9TF <3:QXWT+2M>\":6C%$^V^)X6>2,*77_+,_X)$_\%,_B/\ \$GO
MVS?"G[1OAG2;SQ5X)O;&[^'?QV^%ZW0L'\>_"S6K^PN=;TVSDN"L%AXM\.ZG
MIFF^*/"%_<B..WU_1H-.U&0Z%JFM6MU_M"^ -<\2>)_ G@KQ+XQ\$ZC\-/%_
MB'PEX;USQ5\.-7UKP]XCU;X?^)-6T:RO]<\$ZIXA\):CJ_A37M1\*:G<76A7
MNM>&-6U/P]JES82WVBZC>Z;/;7,O\2__  75_P"#5C7/VB/B1XU_;!_X)L0^
M%-)^)'CF_P!0\4?%W]E_7-3T[P?X?\:>+M0EDN]7\9_"#Q/J4EIX9\,^(?$E
M_(^H>(_!OBR\T3PM?:I<ZAKNE>)]%EF_L"\ /ZUOV,?V\_V4?^"@/PGTGXQ?
MLJ?&'PM\3/#E[96<^N:'9W]O:^// &I748>3PY\1O!$\P\0>#=?M)-\36NK6
M<5K?HBZCHE[JNCW5EJ5UUW[5'[7G[-_[$_PD\0?&_P#:>^+?A'X2?#WP_9W=
MQ]O\2:G##JOB&]M8#.GA[P7X=C:37?&?BJ^ 6+3O#7AJPU/6+V5U$5H8P\B?
MXZ%S_P $L/\ @KY\#O'HLM+_ &$/V\?"GCC3YY+*RUWX:_ KXSZJ))&<)(NA
M>.?AOH&J:/JD#LJ[I]$UV[MI%"/YC(58_NC_ ,$V?^#7_P#X*"_MN?%GPI\6
MO^"E[_$GX$_L_P"CW=E?:_IWQ3\6W>M?M'_$_2K6=;F3P?X<\/:CJ>M:U\-M
M/U%EEL]7\2^/3HVK:1#/]J\/^%-?FD-Q9 ']87_!"?Q_\6?VZ?'W[;__  5V
M^*?A[7/!/@S]KKQIX(^"?[(GP^U]P;KPI^RK^S)-XTT_1]7C,$LMK)/XY^(/
MC?Q=>>)#'+/;CQOH'BFZT:0:'J%C)<?T6UQOP[^'G@?X2> O!OPN^&?A;1O!
M'P\^'OAK1O!W@KPAX>LX]/T/PUX8\/6$&EZ-HVEV<7RP6=A86T-O$I+.P3?*
M\DK.[=E0 5\D_M^_$;QI\'_V$?VU?BU\-Y[BT^(GPN_9+_:-^(G@.[M<_:K3
MQGX*^#WC'Q)X8NK?;EC/;:WIEC-$%!<O&H0%B ?K:L7Q)X=T/Q?X=U[PGXGT
MNTUOPUXHT75/#OB'1=0C$UAJ^AZW8SZ;JVEWL)($MI?V%S<6ES&2!)#*ZY&:
M /\ 'Y_X-MO'WPV\'?\ !;+]BWQ-\9=0L(]-UGQ9\2_#FC:YXEN$EM(OBCX^
M^$'Q"\+?#N>\FO783ZKK/CK7-(T;1KB4R3Q^)=8TJ]C=+F%)X_\ 8@K_ "D?
M^"E'_!KK_P %#/V3/CEXIU?]D+X3^,_VJ/V;=0\17FM?"KQ7\+[FRUGXJ^#-
M(FO6O-(\)^/_  /#=V?BV3Q/X;0K9#Q?X4TK5/#FO16=MK9N?#^IW\WAK2_U
M<_8C_9?_ .#L3]M3PWX=^ G[1?[5OQX_8P_90T^RMM&\6?%#XGV'PXT']H:^
M\-PI';W6B^&-1\.:3I?[37BKQ/=6G[L:MX\\=^&=%GADN7U#Q9>W$2Z5=@'S
M!_P>F?''X0?$G]KC]ECX9_#_ .(WA3QGX[^"7PN^(^D_%SPYX:U:WUB]^'FM
M>*O%'AS4=#T#Q5)9&:TTKQ#=Z?IEU?S>'[BX76=/LFLKO4K&TM]2TV2[_I(_
MX-/O$>B:;_P1&^%>J:KJVFZ3I/A/XF_M&3^(M5U.^MK#3=%L[+XAZUKM[?:K
M?W<L5KI]E9:5=1W]W=7<L,%M9YN9I$A!<?C;_P %U/\ @V6N? _[,?[+.H?\
M$M/@1X@^*.O_  7OOB1IG[1=L-2L_$W[0WQKF^( \'ZAI'Q<U[4[]M,N_'.I
MZ)K7AS7;#4O#'AR!$T>W\764W@_PC8:+9Z_)!Y/_ ,$5?^"#/_!5;XA>"]1^
M#'[</C[XU?LD_P#!,_6_&MO\0OB;^R5)XX?P_P",OVE=>@32HY_"^H^%?#^H
M2ZS\/? 6OKH6DVWQ#O/$5YH>JZ[8Z7I]MH?AF[OY+3QAX8 /Z3/^#E'Q+H'C
M/_@@=^V5XP\)ZO8>(?"WBSPA^S5XE\-:_I5PEWI>N:!KO[3GP$U31M7TV[B)
MCNK#4M.NK:]L[B,E)K>>.1"58&OY1O\ @R9_Y2 ?M5_]F=WW_JZOA/7]]W[:
M?["OP=_;:_8J^)G["OC*76OAU\(/B'X.\(^#K.3X8KH^BZCX)L_AYXC\+^+?
M :^&+.]TS4-$@T[P_K7@SP['_8LFFFRN=%M9](C-FDZ7$'^?7XW_ .#?'_@N
M'_P1]_:'L/VE_P#@G-XGF_: M/"$]X-"^('P,NM)TOQ[?^%KF:,W/A7XJ_L]
M>-]0F_X2W3-;%M =4\)>&YOBSX?G:"QU"6XM-1M;1[$ _P!.:OQ2_P"#A+]L
MKPI^QA_P2C_:K\1:IK5K8>.OC;\//$/[-?PBT@W0M]7USQO\:M$U+P?>W6B*
M/F:Y\$^";WQ9\0KB5ML4=MX4>+>;FYM()_QT^#/_  <-_P#!9E/#MIX%^+G_
M  ;T?M5>/?C3;6\5C/XG\#>%?VA/A!X#U+4MH@_M'4?#GC#]GGXB_P#",Z>T
M@^U2W+_$.]TZ?>8H9["!HYU\_A_X(R?\%0/^"WG[2G@S]J#_ (+7^(-'_9B_
M9O\ A\7_ .%7?L4?"7Q#:ZEXJM?#UY<VUY>Z,]UI&K>(]%\!2^+UMM/D\=^/
MM;\1>)/BOJZ62>'+?P[X$T_3O#3>& #XO_X,T/\ @G!XIUGXI_$K_@IE\1?#
M]UIW@/P7X=\1?!3]G6XU*T> >*_'7B1K>T^*7CK0GF1))M*\%^&(9_A\FIVY
METW4]7\:>*M*CF_M'PEJ4$']:_\ P7,_85U?_@H?_P $S/VB_P!G_P &6"ZC
M\6+'1]-^*_P6M,)Y]_\ $_X77J^)M(\.6;2E8(KWQYH\&O?#NVN;AXK>TD\7
M?:YY8HH&D7],OA7\*_AS\#_AQX+^$/PB\&:!\//AG\.O#VG>%?!/@KPO81Z;
MH7AW0-*A$%G86-K'DX50TMQ<SO->7UW+<7U]<7-[<SW$G?T ?XP'_!$+]MF'
M_@G!_P %0OV>_C;\0);SP[\.E\4:M\&?CS!J"SZ<VB_#OXDP2^#O$>K:[;2H
MEW%%\.->FT7XA7^G-$+J2?P6+(Q>:_EU_L[VEW:W]K;7UC<V]Y97MO#=V=Y:
M31W%K=VMQ&LUO<VUQ"SQ3V\\3I+#-$[QRQNKHS*P)_BZ_P""[W_!K?)^V'\0
M_%_[8_\ P3\NO"'@OX^>,KFYU_XP_ 7Q+=P>%_ WQ>\33[I;[QUX&\2-&=*\
M%?$C7Y_WOBC3-?6R\'>,]5GE\3WFO>%M?DUR[\4_''_!/7_@I1_P7]_X)5^
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ML:=\3?%7@ZYQ_:/A+^R=2\(^!_B-9>&M?M%N+;7?"_A3X3WTWB*(0^'?$GQ
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M_E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_?N*_O\ *_@#_P"#&/\
MYRB_]V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 445X!^U/^T=X'_9%_9[^*O[2?Q)TKQ9
MKG@?X0^&7\4^(M'\"Z=IFK>+]2LEOK/3TM/#^FZSK7AW2KS49KF^@2*&^UO3
M+<@L7NDP 0#W^BORS_X>7^/_ /I%5_P5,_\ #3_LS_\ T6='_#R_Q_\ ](JO
M^"IG_AI_V9__ *+.@#]3**_+/_AY?X__ .D57_!4S_PT_P"S/_\ 19T?\/+_
M !__ -(JO^"IG_AI_P!F?_Z+.@#]3**_'/XK?\%@T^!WPV\;_&#XL_\ !-3_
M (*=^!_AI\-_#>J>+_'/B_5_A-^S@=+\-^&M%MGO-4U>_%G^U7=71M;*VC>:
M7[/;S2[5.R-CQ7[%JP958=& 89ZX(R,T +1110 4444 %%%% !1110 4444
M%%%% !117\Z/[?'_  <Y_L _\$ZOVJOB7^R!\;?AE^UEXG^)WPJM_!%QXFU;
MX6> /A+KO@J4>/? /ACXCZ-%I>I^*OCGX*UNXF@\/^+=*CU%;OPY8I#J N8;
M9[NVCBNYP#^BZBOY#?\ B--_X)6?]$2_;T_\-3\ _P#Z)VC_ (C3?^"5G_1$
MOV]/_#4_ /\ ^B=H _KRHK^0W_B--_X)6?\ 1$OV]/\ PU/P#_\ HG:/^(TW
M_@E9_P!$2_;T_P##4_ /_P"B=H _KRHK^6+X$_\ !W?_ ,$S_P!H/XW_  ;^
M G@[X1?MK:3XN^-_Q5^'GPA\*ZKXJ^&?P2L/"^F>)/B5XNT?P9H>H>)+[2OV
MBM:U2ST"RU/6K6YUB[TW1M6O[?3H[B:STR_N$CM9?TW_ ."BG_!:?]AK_@F9
M+>>&?COXI\;^+/C!#X-B^(%G\#?@]X$UCQO\0KCP==7-_8V?B?5;N0:1X#\&
M^'KF_P!,O;2'5?&WC/P[%<O:W?\ 9Z7S6LZ( ?K-17^<9\0O^#PS]L;]HC]I
MKX+?#C]E[X,_#+]G#X.>)_C-\/?"FK7'C&)OC!\5_%'A[Q!XPTG0;^.^UB^B
MT/P5X8AO].OI9SINC^$M3U32[PQI;^,KZ&%VN?\ 1SH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110!^ /_!T=_P H*/VYO^[9O_6P_P!GVO\
M(%K_ %^O^#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\Y1?^[)O_?N*_O\
M*_@#_P"#&/\ YRB_]V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^6?_!;+_E%9^VG_P!D
MKMO_ %,O"]?J97Y9_P#!;+_E%9^VG_V2NV_]3+PO0!^IE%%% !1110!^7'_!
M;;_E$7_P48_[-(^,O_J)WU?J'#_JHO\ KFG_ *"*_+S_ (+;?\HB_P#@HQ_V
M:1\9?_43OJ_4.'_51?\ 7-/_ $$4 24444 %%%% !1110 4444 %%%% !111
M0 5_#]X-_P""1'PJ_P""I'_!Q3_P5&_:'_:AT:;Q=^S9^R]XV^ 'A*+X=O=W
MEAIGQ:^++_L\?#32]*T#Q#>Z=/;WTW@SP-HGA)M9\4Z);7=A)KFH:UX0TRZG
MNO#\OB+3+S^X&O'/A9^S_P#"'X*>(/C-XJ^&/@Z+PQXA_:#^)]Q\9?C!JBZQ
MXAU>?QE\2+KPOX:\&2^(9EU[5]4AT=!X:\(>'M,AT3P[%I'AZV%@]W;:3%?7
MVHW5V <!X5_8?_8M\"Z3:Z#X*_9$_9B\):+8PQV]II7ASX"_"S1;"WAB4+''
M%:Z?X5MX5"J/[F2<EB223_'%_P 'H7P>^$GPT_9>_8OOOAQ\+?AS\/[[4_CW
MX[M-2O/!/@CPSX4NM0M8?AXLT5M?7&A:9837=O%-^]CAG>2-)/G50W-?W?U_
M$-_P>\?\FJ?L0_\ 9P?C_P#]5PM 'Y[_ /!E?\+_ (:?$SXN_M\V_P 2/AWX
M&^(-OI/PX^ \VE0>-_"6@>*X=,FN_$_Q*CNIM/BU[3[]+*6Y2"%+B2V6)YDA
MB60L(T _OPUK]C;]D'Q)IUSH_B+]E3]F[7](O8GAO-+UKX&_##5=.NX7&UX;
MFQOO"\]M/$XX>.6)T8<$$5_"1_P8\?\ )8_^"A/_ &3/]G__ -2GXGU_HD4
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MX)^)OQET-'B9DD:'QS\.?!OB'X?WJI(I0K8>*[J0GE8V0,P]W_9%_P""W/\
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M'O&GAB_FM;FQEO?#WBG2+/7-%NY;*]B@O+.2YTV^MIGM;N&&YMV<PSQ1RHZ
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MA76?'7Q(\9^%/A]X)\.VC7_B#QCXW\1:1X3\*Z%8H0'O=9\0Z]>6&D:7:(6
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MP_\ P2@_Z21_L0?^).?!_P#^:V@#]'Z*^:_V?OVR_P!DK]J^?Q5;?LQ?M+_
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MH%D&5#=ZSXC\0WNG:/IEOO=(Q->7D*-(Z(&+LH(!VM%?@?X__P"#G7_@B/\
M#SQ%<>&;_P#;1L?$U_97#6][>> /@[\>/'/AV%D=T,EOXJ\.?#.^\-:Q;DH2
MMQH.JZK$Z%'1F1U8_<W[(G_!5[_@G3^W?J"Z%^RK^UK\*OBCXM>WEO(OA\]]
MJO@;XG7%G;Q/-=WMI\,?B/I7A#X@7MC911L]]?6?AN>SLEV&ZGB$D9< _0JB
MBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO\ E!1^W-_W;-_ZV'^S[7^0
M+7^OU_P='?\ *"C]N;_NV;_UL/\ 9]K_ "!: /[_ #_@QC_YRB_]V3?^_<5_
M?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ORS_X+9?\HK/VT_\
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M>OZ38:Q)X<US3_$FB_:;SPUJVBZNJ66MZ5I]^L4.H11326R17*30-)$_N=%
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M^"NNDNH :X_9*^#$TA'5G7Q5\4[<$^IV0(OT ':@#]=OV#/@G_P4%_X+-_\
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MH.NW?BS58;74_#NIW^N_VD_L6?\ )G'[)G_9L_P'_P#56^%:\>\"_&S]@_\
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M$-_P46_[-0^+7_J.W% '^;'_ ,&SG[(G[./[;7_!2Z#X)_M2_"W2/B_\+7^
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M30-336I[O^A+]KW_ ((__P#!.G]MCX7:Y\,OC#^RQ\(]/EU#3)[+0/B1\.?
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MUS6+#X.6%SHZ6.H:Y>:AI]G<:?<:SX7\+1WVB:1JU^%M]2^+GCFUU@^-+O\
MX17PI#X-U/W?_@]7^/6L^"/V&OV9?V?](OYK&W^/'[0>I>*/$Z02LAUCPQ\%
M?"$ET-$NT#!9K!O%OQ \(:\Z,C%=0\/:9*KIL*R>!?\ !#[X/?\ !?W4O^"7
MO[,.L?L._M)_\$ZOA]^S)K-M\5]1^'?A;XQ>!/B3J_Q/L)V^.'Q*MO&3^,=4
MT/X:Z]IE[?7/CFV\1SV#6VKWJVVAOI5BQ@-J;6  _J;^+W_!(;_@F+\;OA5?
M_!KQI^PM^S%9^"[G2I=*TYO OP<\"_#?Q/X41X#;Q7W@KQEX#T3P_P"*?".I
MVJ[6AO="U6RD?;Y5R+BV>6"3_*__ ."@/[.7QU_X(,_\%4/$W@S]G[XP>+_#
MNO\ PGU?P_\ %3]G?XN:==Q6?B75_A?XR@?4?#MKXLM[:UM-(UR:"*/5_A_\
M1-'NM)'A/QA<Z+KT4VA-X=U9-.K_ $!?^%*?\'6'_1Y'_!*#_P -I\7_ /YS
MU?C/_P %!_\ @VQ_X+7?\%-?C;H7[0/[4/[4G_!._4/B-X>^&VA_"JQN_ R?
M&[P;I<GA7P]XB\6^)]-%YIEK\#[J.YU--1\::Q'+J#2*\EDMC;% MHK, ?UD
M?\$DO^"@FA_\%-_V$/@Q^U;9:=I_A[QAXALM0\(_%[PAICSO8>$?B[X*N1I'
MC/3-/^U/-<1Z)JDHL_%OAB&XNKR\@\*^)=#BO[N;4$NFK^2K_@X]_:_U?]K+
M_@K=^QM_P1MUSXBZY\-?V2U^+O[+VF?M-'0=3.CS^,/%OQX\:>&9X[C7;UU^
MRR:1X ^&?B30-1\)1:CYVBZ=XL\1:IXCUBTNY=%T272_Z!?^#>[_ ()7?M'_
M /!)/]FCXT_ 3]H/XE?"7XBMX]^.,GQ:\(2_"+5_&VJ:-H\6I> _"7A#7(-2
M7QKX+\%W%MJ-W+X/TR4"PM+RWFMXHVEN$E01U_(#_P '@?[#WQ<^$/\ P4%M
M_P!NK3-!UJ\^"O[3'A'X<:;)\0-,M[DZ=X.^,WPM\'Z?X"F\%ZQ?VH9=%U+5
M/!G@[POXK\*W%Y+:MKP/B2'2!/+X5U9H #_18^#G[%?[)'[/WPPTGX-?!S]G
M#X-> _AIH^E0:/#X6TCX?^&WM=1MH8%@DN/$=U>Z?=:CXJU>_"F;5]=\2WFK
M:UK5Y)/?:M?WMY/-/)_%W_P=/_\ !"KX!?#[X!ZE_P %&_V-OA5X=^$.L?#S
MQ!HMI^TS\,OAUHUOH'@+Q)X-\7ZM:^'M.^*N@>#M'@BTGPUXF\.>+-3T:Q\8
M0>'M/T_2->T'7;OQ9JL-KJ?AW4[_ %WP/_@E9_P>&>,OA9X=\(? [_@IAX(\
M1?%SPWH=K8:!I7[47PX2UN?BI;:9:QQV=E/\6? NH7-AIWQ#N+:+8=3\;^&]
M7T3Q5<65F;K4O#'CCQ->7FJ7G]LG@7XV?L'_ /!7/]E3XG^%/A5\6O 7[1OP
M"^,G@#7_ (:_$W3/!^OS6/B?1-$\=Z'>Z5>:3XI\/74>F^.OAEXM%A<37VCQ
M^(]%T'Q!IUW!:ZO80J\%O<4 =+^S]\,? OQJ_P"">'P'^$/Q/T"'Q7\.?B9^
MQW\)? WCGPS<7FI:?;^(/"GB;X-^'=(UW1Y[W1[S3M5M8=1TVZN+26;3[ZTN
MTCE8P7$3X<?Q"_\ !UA_P2Q_8!_8*_9+_9L^('[(O[-OA7X*>,?&G[1-SX.\
M4:YH'B#QYK%QJ_AI/AKXNUM=*GA\6>+/$%I%"-4TZRO/-M;>"YWP*AF,3.C?
MZ$'P_P#!&@?#/P'X)^&_A2&XM_"_P^\(^&_!'ANWN[F2]NX- \*:-9:#H\-S
M>3?O;NXBTZPMDFN9?WD\BM*_S.:_C@_X/;/^3&OV1/\ LZ^[_P#50>.Z /SQ
M_P"#4S_@EK^P+^WM^RY^T[XZ_:[_ &;_  M\;/%G@?X^Z/X2\*ZSK_B#QWH\
M^C^';CX=Z%K$VF00^$_%?A^TEADU*ZN+LR75O/<!Y2JS",*@_M]_8Y_X)O\
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MM+2VC::XNKJXF9(;>WMX4>6::5TCBC1I)&55)'^:G^WO^WS^T5_P<A?\%./
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M7[W4YGN+E]-5[/PUI"W4NF^&M!T318[;3(/Y5O\ @Z)_X(@_ KX<?L\>)?\
M@I)^Q5\/-+^!/CGX:WUKI7[27@/X3V*>$/!/CSX8?$BY7P'JOC>R\)>'Q9Z7
MH7B+2]2\266F^-H?#]A8:1XP\%^(O$NJ^*K:>ZTF>ZU'^[2OS&_X+36-GJ'_
M  22_P""CD%];0W4,?['7QXODBG19$6\TSP#K.I:?<JK @36=_:6UY;N/FBN
M((I%(9 : /\ .]_X-#O^4R?@G_L@'QV_],6F5_J]U_E"?\&AW_*9/P3_ -D
M^.W_ *8M,K_5[H **** .$^)/PN^&?QE\':O\._B]\// _Q3\ :_$L&N>"/B
M+X4T+QKX2UB)3N2/4_#OB2PU+2+Y8V^:,7-I)Y;_ #IM8 U_D_?\',G_  2K
M\$?\$T/VW-#U?X#^&I/"_P"S%^T_X6U'XA?##PY')=W.E^ O&?AR_MM+^*GP
MUT:ZO99[F31]%O-4\->+=#@EG<:3HGCO3_#T!>#1$ED_UO*_FZ_X.GOV(?\
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M<DF@#_7K_9O_ .3=_@+_ -D7^%O_ *@^A5[17B_[-_\ R;O\!?\ LB_PM_\
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M;19=2L_%'AF6YU_P_)]JU#_8-_8L_:+L?VNOV1?V:?VG["P@TA/CS\$?AO\
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M<B2$:+KEZ)3M_AD_X-S79/\ @M;^P(R$J3\3O%J$C^[)\(?B+&X^C(S*?8T
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MHMO>?#K4?%^E:%;+HTTVGW-M<ZG));?RO_\ !C;_ ,C?_P %*/\ L6_V4/\
MTZ?M#5_H04 ?X4O@G3T_9A_;/\(Z7\3+Q(H_V>?VGM!T_P"(%_I<%S?1QI\)
MOBM:6WBN\TZV2,7EXB+H%_-:0+"+FX41QB,2N%K^]'XS_P#!#?\ :N_X+]>
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MLO"_C'0M*6&#4M>U:[\[[";N:2\83W$J1P)%^C%% '^(;J7PB^'$/_!5>_\
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M:U;38;$7T$?P^\<+H-CX;OETCQ7HFA>%O]+JOB+_ (*4_LZ:1^UI^P'^U_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M45_')_P3$_X.[?V/_C3\./#7@7_@HAJ,_P"S)^T#HNGVFEZW\2+'PGXC\2?
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M<ZYHLA^S^)/&WB#4-/U./P)X2OM^D6Z:5=^*/&%O=:,NB^'O&/Q__P $1_\
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M&@:GIVHW(!^0W_!VNJI_P1:^+Z(JHB?%_P#9_554!555^(NG!551@!0
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MSJD5M"K233Q>'OA_K7B"[CAC4,\LS6>ES^5$BM)+)MCC4NR@@'^>G_P9Z?\
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MKK^S->T>Z6Y\-_$+X=>*(;>&X%M=P^(O OC+2&M[VU;5-/EMKEO]Q6OXSO\
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MKXENO#-O?7$#ZN?"%YX?TF3Q##:"273[;Q'I5S)'Y$LLD7]>?P8_X*#?!/\
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M/[/'A#Q]HT4LR1+>K\)OB'%HVI6T".0;B\2#XL17B0Q%I19VE_<;##!,\?\
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M %%%% '\^/\ P=-?\H,/VS_^PA^S5_ZU=\$*_EQ_X,C_ /D]']L?_LU_0O\
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M*\LYVMKN*"[MVEMYHY#!=00W$)8QSQ1RJR+HTBJJJ%4!54!550 JJ!@  <
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M? GPQ:ZA+\,M*U2UN8Q<:5K?C.Y\0:[X]UBQ5HY/[$U/P/8ZO:VNM:'=VMN
M?T(?MQ@G]BK]L  9)_9<_:   ZDGX3^+0!7^4A_P;'?\IROV$_\ L,?'C_UE
MOXWU_KD?&?P&?BG\'OBO\,1+'"?B-\-?'7@,339$4)\7^%]5\/B67 )\N/\
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MCX=\7Z9%-&KQW-OH%O<)+)%+&%\O_P"#U?X1ZWXJ_8%_9K^+^E6,]]8?"/\
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M>*];M-)6XTGPS8:3-H^L:C#XF6[T:R^[J "BBB@#_%5U;_E-KJ?_ &E.O?\
MUK66O]JJO\33]IO7'_9X_P""POQ\\5>+[&[1?@M_P4B^)GBO7[*.(M=2V?@+
M]IC6==O!:QL%\[[79Z8TEDZ_N[F.:&2-FCD5C_KF_M$?\%.OV*_V</V4[O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_ISUBOUU95=61U5T=2KHP#*RL"&5E((96!((((()!&*_(C_@@<ZO_P $</\
M@GJR,& _9ZT!"0<@-'JVM1NOU1U96'9@1VK]>: /X+_^"FG_  9P:O\ %/XT
M>+OC)_P3D^+_ ,*?AGX8\?:U?^)-7_9[^-G_  EGA_PIX%U?4[F2]U2#X8^.
M/!'A?QS=)X5N;J>231O!6M^$K6/PO$#867BBZTHV-AI7,?L&_P#!E_XHTCQU
MX;\5_P#!1S]HSP5XM^'7A?48]4'P$_9QO_&]Y9^,B)DN&TSQ)\4_&&@> ]2\
M+:+=O"EOX@L?!W@V77-5LYIHM)\:>&[R*#4J_OWHH _F;_X+P_\ !$7XG_\
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MHVEO]DMM7\9^*M1FO_%GC?6X;3_18];\7:WK6K):A;=;P0JL8^G** "BBB@
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MTTDUUJ.OZ7<^#?'6M7+QMJ_C.]@@BMU_$?\ 9^_X-]/^#@S_ ()N:[K&F?\
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MYK5U:64NMZ[>I?\ B+6DTW2+75-7N[+1=(MK'^PVB@#^13_@G[_P;;?MO?\
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M31]7M;>1[+1OBA:6UW;36L=A);>3=M_51^P1_P $=/\ @GI_P39@M]0_9@^
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MXP"0 ?R[_P#!N=_P26T/_@I;X'_;!\=^#_CY\2OV5OVKOV5O&_[-?BK]FO\
M:!^'%U>SR>#M7\66/QO?Q#I_B#P[9ZOH%SJ>F:O)X1T!X]1T;7M"U_1KBR$E
MO?7^DW6L>'M9_K6'P$_X.SO#>B?\*_T7]M?_ ()?^.;)(GTZP^-GC#P'X]T?
MXGI:1Q^1!J^J^&M'^ %Q\/AK8CVW(MT\/Z_92W2 7MQ.CRM)^4W_  8TR(?#
M_P#P4QB# R)K'[(<C)GYE22R_:65&(Z@,T4@4]RC8Z&O[Y* /Y5_V,_^#9_0
M]._:6E_;K_X*L?M):Q_P41_:KNM:L/%%MHVNZ--IWP3T+Q!I0B71I]3TK5Y9
M[_XA6'A=;6TC\'>&I=(\"?#?P]8PQ:5_PKF_M++3C:?U4=.E%% !7\:'_!9S
M_@U%TC]N#XX^,?VL/V)?BEX#^!WQ@^)^I7/B'XM_"WXH66O6_P )?&WC:^8R
MZK\0="\3^#M(\2>(/ _B'Q%<![_Q;IG_  A_B;2O$>O7=SXABGT&_N=3&J_V
M7T4 ?YU'[)7_  95_M%7WC/2Y/VWOVK/A5X4^$-EJEMJ6M>"?V:;OQKXX\:>
M+8+=@DNG1>(?B)X'\ ^&/ ]W<PETB\0CP]\0);:']V-%+R^9;_TB?\%4_P#@
MB^GQ[_X).^'/^";/_!//PO\ !KX&Z/X/^)GPR\3>&=*\;ZOXD\/^$(='\+7F
MK77B;5]>\0Z'X9\=>*?$/C'7+G4?[3U37-6L-3U?Q%J<MW>ZKJKW4F^3^A.B
M@#^-#]@__@S7_8Z^#?\ 8WC+]N/XH>*OVL?&]O\ 9[NX^''A)]3^$WP-L;H;
M9'LKZ32=0;XG>-TM9T3[/J+>*/ NFZA 98=4\'312^6O[8_M%_\ !._]JF]\
M":-\"/\ @F_^V_\ #7_@E_\ LTZ5\//^$/3X6_"/]AWP+X^\1V.OZCK'B.]\
M4^,/"GQ#E^+WP\/@V\\26&KZ;#-+HWA1?%=EX@T[4?&,/C:37M<,NG?K]10!
M_ 1/_P &-,US--<W/_!4J6XN+B62>>>?]BIY9IYI7,DLTTLG[7+/)+([,\DC
MLSN[%F)))K^E[_@G;_P3^_X*)?L4+\+_ (>_%G_@JU;_ +7?[-_PUT6^\.6O
MPL\;_L9:!X-^(DN@0>&-2TCP?HVG?'R+X_>,?%D%AX3UF71M5A'B?0_&=Y=Z
M+H__  B5M>:5IUQ:7.F?LS10 5_)'_P4W_X-=(/^"G/[<G[1'[7OC']KJ;X,
MVOQ%\-?"'0_ACX8\,_"I/'L^D7O@3X<:+X+\0ZCX[.J^,/!\=]:WMYH5M<Z-
MIOA^_M)1;7$[WVIQRI';M_6Y10!_)%\!O^"?7_!SC^PUX3TWX1?L]_\ !0O]
MB/\ :<^#'A>V@T?P3I?[6VA?%;_A*O#&C6J);6%CIVIZ3\//%?BR+1]/LH;>
MUT_0-1^+&NZ3H5G##8:#86UHGEF>^_X-]_VR/^"B'QS\"?''_@N9^VWX6^.7
MA3X7RSMX&_9._91T77?!'P8L(;Z:"YU.R?QEJ^B^"/$%G9:W)8V%OXIOK'P8
M?B'XBT^"TTY?B9I5IHVDQP_UK44 <QX)\$^$/AMX/\+_  ^^'_AG0_!?@;P3
MH.E>%O"'A'PSIEIHOAWPUX<T.RAT[1]#T32;"*"RT[3--L;>"TL[.UACA@@B
M2-$ %>7?M._LU?!_]L+X!_%#]FGX]^%HO&/PF^+OAFX\,>+=%:9K6[6(SP7^
MEZUHVH(K2Z3XC\-:W9:;XB\-:S IGTC7M+T[485:2V53[Q10!_FQ_M _\&3_
M .V5H_Q'U2+]ES]J#]G'QW\)+K49WT"^^.-]\1OAK\1='TV:9GM;+Q!IO@CX
M:?$OPUK,^G6[+;76N:3JNE?VM-$;V'POH\=P+"U_;;_@DA_P:G_!C]BOXC>'
M?VE/VT?B)HO[6OQ_\)7-CJWP_P#"-EHE_!\#OAGXATYHWL/$PM_$[/KWQ1\4
M:++!%<>%M4\2:5X9T#PY.5OH/!EWK^G:)X@TO^N:B@#^,S_@KI_P;2?M%?\
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MM5:=H^B:)97NJZI?F&WM3=7^J:EJ6KZM=ZAJVH7M]/\ VA44 ?RI_P#!//\
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M'JW5U++J-YI/@#Q$-,O-2NKJ\OH[VYGGGE^N?#G_  ;A?M"?ME?%[P?\=O\
M@N)_P4%\6?MHW?@>5IO#7[._PATN3X7_  0TQI9K>>^M#J6F:?X.^RZ+K8AB
MM=?MO 'PT^&7B?6(K#39-0\;7*6Z6L7]:U% '(^ ? /@CX6>"O"OPW^&WA/P
M_P"!/ '@?0M-\,>#O!OA32;+0_#?AGP]H]K'9Z7HVBZ1I\,%EI^GV-K%'#;V
MUO"D:*O0L23UU%% !1110 4444 %%%% !1110 4444 ?@#_P='?\H*/VYO\
MNV;_ -;#_9]K_(%K_7Z_X.CO^4%'[<W_ ';-_P"MA_L^U_D"T ?W^?\ !C'_
M ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#@OBGXA\<^$_ASXU\2_#/X>?\+:^(.A^'-3U+P=\,_P#A
M+='\!_\ "<^(+6W>33?#/_"9^((+G1/#/]JW 6V_MG5()K*QW^=/&R*17\6W
M_!;K]EO_ (+_ '_!83P/\-?@I8?\$]OA-^SS\#/AMX]'Q1_X1]_VP_@O\2_&
M/B_Q]:^&];\):+K&L^)/M_@G3-+TO0]#\4^*;>QT+3O#\TCW&N3W-_K5[]FL
MHK;^X:B@#_/K_P""*W_!./\ X.!O^"-OQ<^)_C#PO^P]\(OC?\,/C?X?\,:'
M\5/ACJW[5WP8\#:EJ%UX&O-<O?!7B3PQXVM=<\4+H>L^'SXI\3V;PZAX8U[2
M]4TS7K^VFL[:]33M4T_^ZG]GKQQ\9/B-\*/#OB[X^? Q/V</BEJ4^M1^(/A"
MGQ/\,?&)/#<-CK5_8Z1<+\0?!]AIN@:TNN:1;V6N".TLH9--_M#^S;L-=6DS
M'VNB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?Y
M M?Z_7_!T=_R@H_;F_[MF_\ 6P_V?:_R!: /[_/^#&/_ )RB_P#=DW_OW%?W
M^5_ '_P8Q_\ .47_ +LF_P#?N*_O\H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#?!^N^%?$\NO:KJNOV_AW6]:TJX\2V7BR/7IM;T.'5$TI]&U*2SGM_\ 1<H
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MN**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXEC@MX(Y)IYYI%BAAAB4O+++*Y5(XXT5GDD=@J*"S$ $T ?B=^R]_P &\O\
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MA#]H3X7>(?%'BCQ!JLZVNFZ)H&AZ7XFNM1U;5;^Y=(+.PLK>:YN)G6.*-W8
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M31+J2":UDN=(US3[?4]-N'MKE(KBW>:SNH9&@N(HYH68QRHCJRC=H **\?\
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M?$7C/P/%8^$=/GU374_X6QHND77PPO+VSLK:>1K+2_%M_<!X_L\B1W#QQ/\
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M[2"6YNKJYEC@MK:V@C:6>XN)Y62*&"&)'DEED98XXU9W954D $]%?BE\>_\
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MAOCQXP_9O^ WQZ\ _&;XH> ?ACH'Q=\70?"_6;?QUX2T7P;XFUR7P_H[7'Q
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MD='4E71U(964E64@@D&OS'_X+4C/_!)'_@HWG_HSSXZG\O FKD?K0!_G?_\
M!H=_RF3\$_\ 9 /CM_Z8M,K_ %>Z_P H3_@T._Y3)^"?^R ?';_TQ:97^F3^
MUK^W9^R#^PGX,M/'O[6_[0/P\^!WA_5&NH]"B\5ZI-/XG\4RV*QO?0^#O VA
M6NK^-_&4]@DT+WT'A;P]J\UDDT+W*1++&6 /K*BOQ:_9P_X.&?\ @C[^U1\2
M-)^$?PJ_;(\+VWQ \1:C#I/AC1OB7X(^*'P>L_$^I7<RVVGZ=H7B3XH^"O"?
MA6]U?5+IXK32=".MQ:]J=W-!:66ESW,T<3?M+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\
M6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[
M)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?Q9?\'@7_!3GXV?
MLP_"WX*?L3? /Q/K/P\O_P!IKP_XR\8_&KQYX>NY]*\22_"K0+^P\-Z7\.M
MUFUD6\TVP\=:Q=:Y+XWN;"2QU"?1/#UAX=%W/H?B?Q%8W']IM?DS_P %1?\
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M;XN?&C]J?_@Y_NK3X1^)?!>E?%+P-^V]^SU^SS^SQ>?%&"_U3X9>#_&WP?\
M%?@;P7X3/BG3=/M-5O[KPE)\7=/U7Q3XCTRST^_DO)M;U:*.PG^T_92 ?VT?
M\$P_^#?3]D?]DGX::1\0/VJOAOX,_;&_;A^(MO'XS^//QQ_:"TJR^,QM/'^O
MQC4=>T7X?VGCZ+7].L+#1K^ZO+&7QU):2>.O&]TU_K6MZW%I]_IWAS0_ O\
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MQ?KCV=L&@TRUU'6[BPT>":X@TBTL8)YHW /PW_X+1_\ !&/_ ()C^&OV%O\
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ML+B*[L-1TZ^@CNK*^LKN!Y(+JTN[:6*XMKB%WBFAD22-V1@3_'[_ ,%8$/\
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M*SFU);N>-H()!7^UY\68UF^%GQ+B< I+\/\ QE&P/(*OX<U)6!]B":_QO?\
M@@EH>C>(?^"QG_!/?3=>TO3]9T]/VA- U5;+4[2"]M5U+0-)UG7M#OQ!<))%
M]KTG6]-T_5M/GV^9::A96MW"R301NH!_5G^U5_P:]?MN?\%$/A7XE_;A_:+_
M &M+7_AY?\7(U\?:E\!/$FE"/]G_ .'/A>X@:Y\*_LU>'_%ME=:MKOA>]\!:
M/-#I,7B&SLM9\(IKT5WI%Q8ZF+C4/BAJ?L/_  ;!?\$//V_/^"=G[3OQV_:3
M_;$\/:1\&M"UOX,:K\$O"GPOT[XB^"?B!JGCS4-;\=^"/%[>.]1F^'/B+Q5X
M:TO0/#EKX(FL-'@U74[?Q1=WGB6>0:;IEA:W7]I_VW44 ?Q]?\' W_!5/]H?
M4_VE/@S_ ,$4/^"<GBF;PO\ M0_M):QX)\-?&OXNZ)J,^FZY\*M"^)\L"^'?
M V@ZW8[M0\(ZOJ'A2Z;XB?$/QE8K%J_A3X;RZ0_ARX&HZ]>W>B?K/^P;_P $
M%_\ @G%^PU\*=#\(P?L]?##X_?%>;3H9/B1\?_CW\/\ PO\ $OX@^._$]S&L
MFN:EI_\ PF-CX@L_ 7AZ\O"PL/"7A(6-E#8PV9UN[\1Z\M_XAU'_ #U_V,OB
M=^U]^VG_ ,'$_B;XS_LC^/O@_P"$_P!J/XH_'K]K3QQ\'_%G[0>GZWXA^&'A
M_P /VOP^^+0M]'U'3M#TCQ)JMT-#^#-E=^&O!PBTN]&GW=CHUR\D*V?VR'^V
M_P#X4I_P=8?]'D?\$H/_  VGQ?\ _G/4 ?FY_P '+O\ P0#_ &64_90^)/[>
M_P"QS\*/"'P#^*_P%L8/&'Q;^'WPRT6Q\)?#/XH_"[[?;V?BG68/ NC6EMX=
M\,>._!<=ZGBS^VO#UMHMGK_A^P\36?B"QUC6YM!U#3ORZ_X-._\ @L-\2?@S
M^TCX1_X)M?&SQAJ7B;]GGX]W>H:7\"3XAU"ZOF^"_P 9%M+W6--\.^&IYWFE
ML? _Q5DM[O0[CPO"IT^R^(-YX?UO28M).L^,9]8_H1^/'[%G_!SM^T?\$OBY
M^S]\3_VO/^"5M_\ #GXV_#;QK\*O'-IIG@'XQ:9JDWA7Q[X=U#PQKHTO4X_@
MW))INIIIVIW$FG:A''(]E>I!<HCM$%/XD_LO?\&?_P#P4?\ V>_VE_V>?CV?
MVE?V-Y%^"?QQ^%'Q:DBT/Q9\<DUF:+X=>/-!\7S0:4UQ\#K.W_M&>+1WBLQ<
M7=K;M</&L]Q#$7D4 _T8R0H+,0% )))   &223P !R2> *_RM/\ @IG_ ,%'
MOC/_ ,%[O^"IOPE_8:^&?Q$UOP?^Q1K/[3_@KX%?"/PQH%W)'HOB:TO/&UMX
M1U_]I3QK91$1>*M;NM+FUGQ7X-LM5@FMO!W@U;+2=+T^#7+_ ,5:GK_^GW\<
M=$\1^)O@K\7_  WX.>2+Q=X@^%WQ T3PK)#)Y4L?B/5O">K6&AO%+E?+D34[
MBU9)-R[& ;(QFO\ &3_X(U>-M.^$G_!6G_@G[XD\79TBPTO]K;X1^&M:?4HO
MLPT:3Q3XOL_!$MQJ:77E&RCTJZUQ;C4))PC6,=M-,X5H2  ?[&_[,7[*?[/_
M .QQ\%_"7P _9Q^&7AGX9_##P?I5KIEGHNAZ;:PW.LW$-M';7GB'Q;J@B%_X
MK\5ZVR->>(/$NNS7NKZS?337-[<R.^!_ ;_P=T_\$K?AE^RWXM^#G_!1;]F+
MPCIOPHT7XM^/Y/AI\;?#?@*RB\,Z!IOQG72=4\;> _B?X=T[1S;P:!K/C72/
M#?BV#Q=+I-OIEC)XA\+Z/XB*2>)O%.N7]]_H\5_,9_P=TVVC3_\ !&?XB2ZH
M8!?67QU^ USX<\Y8S(=9?Q7/9SBU,A#+/_PCUWKI9H<R&V%PI'DM*0 ?R$?\
M$2O^"4/Q _X++?#_ .-&M:3_ ,%4/C%^S]\3_@;XI\.Z=XK^%]Y\/?&'Q-2Z
M\'>--.OKCP=XWTKQ4G[2GP]DN8=2U3P_XMT74])/AE6T2XT6RFEU*Z37+1(O
M]!?X(?\ !/'XV_ K_@FG\-/V"?"'[?/QDTGXF^ [6_TN_P#VR=&\%>%KSXJ:
MQH6M_%+Q#X[UO2-)\/?$O4OBA8^&0OA?Q%+\._#&JC7]8UKPAIFEZ+JFDZAY
M^GI9-_&G_P &0_A[Q9<?M6?MN>*[.*[/@;1_V?/ 7A[Q#.BR?8$\6>)/B/\
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MH&DZSKVAWX@N$DB^UZ3K>FZ?JVGS[?,M-0LK6[A9)H(W7_:"H _B1_X-@O\
M@AY^WY_P3L_:=^.W[2?[8GA[2/@UH6M_!C5?@EX4^%^G?$7P3\0-4\>:AK?C
MOP1XO;QWJ,WPY\1>*O#6EZ!X<M?!$UAH\&JZG;^*+N\\2SR#3=,L+6Z_M/\
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M?B1]-F\0>$=4G\4>$/''A_6/#>I76D:=>I#?>'I=3TB\@N)M U32?[4UA=1
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M\+^&-8MI6AN]%\3_ !0-I\+/#FMV,JLACO\ 1M:\:6.IV#Y(6\M("4D *-_
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MO%OB?31>:9:_ ^ZCN=334?&FL1RZ@TBO)9+8VQ0+:*S?OQ_P;W?\$KOVC_\
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MOW[?/_9'_@O_ .IIXSK_ $7* "BBB@!&945G=@JJ"S,Q"JJJ,EF)P   222
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M<UR\N? 'PZ^%\5C;_#[1;G0_&4FH>%+T1^');'^OWXV?\$QO^">W[0WPVO\
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M:9J?A?Q(MPVL'POX@\-P:MJFJ>(;'5]5O/[[/^#?3_@J5XD_X*K_ + LVO\
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M"@D"2%+;PS>*C $!E%Q:028;(W(K8W*"/]6N@#^!K_@[/_X+4_%7X;>.I/\
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M 9-6L?[6--_X-;+#]LKQ3K?[3O\ P6$_;'^./[0/[5OQ'MH[G7M"^!FM^'?
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M-_ZV'^S[7^0+7^OU_P '1W_*"C]N;_NV;_UL/]GVO\@6@#^_S_@QC_YRB_\
M=DW_ +]Q7]_E?P!_\&,?_.47_NR;_P!^XK^_R@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,US'%=66B:CXZFUW0K2Q\I;:X\*?#7X?WELS6_D!/\[#]@O4?VI/B7XZU_\
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MP@M-3OM-;QOH/B[Q))=>)8O!WA*6X\9>"M0FU:XT;0+OP)ILMWX4_P!*^O\
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M#;&(Z-X-TN\?SBLFK>([RWM-9\3ZO"/UHKQCX,?M'_L]?M'Z+<^)/V>OCO\
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MA+QI\5?#ER%/B#4M4^$_Q8M+[XAZ,3>/$L?B"[ET;6K*&:Z=!!JSQS3']VU
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M:ZC\,^/O"O@?QKX?UB:/),=OJ6N7OC/3;8D+OD\/W9Q\N3_6_7^3I_P:V?\
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M?1-<U#39?BYXB.GHYO1X=\/?#@:SI]]JRPFQMO$?B3PGI%U-'+KEJLGYC?\
M!GI_P2X\3_ WX4?$#_@HW\:/#-SH'C#]HGPU;_#W]GC2-8LS;:M9? J+5++7
MO$WQ"DMKA/M%K:_%3Q-I'A^+PLTD=K//X5\&KX@M&O-!\:Z;<2 ']ME?XJOC
MC_E-KXO_ .TIWB#_ -:UNZ_VJJ_Q,_%?BG1+_P#X+$>)?&UO?6\GAR\_X*6:
MQXI@U-94-H^B7'[4=SJT5\L^0AMVL'6X$N0AC._.* /]LROS(_X+2?\ *)/_
M (*._P#9G'Q[_P#5?:U7Z;U^7W_!;"]M=/\ ^"1W_!1J>\GBMXI/V0OC99))
M,ZQHUUJ7@S4M.L8 S$ RW-[=6]M"@.Z6:6.- 7=00#_/-_X-!_\ E,=X5_[-
MX^.G_ILT*O\ 5SK_ ">_^#135+'3_P#@LO\ #ZTNYXX9]<^!'QYTO3(W<*UU
M?0^%[;6Y((03F21=-T?4+HHN2(K:5\;48C_6$H **** .>U+Q3X4TW7- \):
MQXB\/6'B3QC%K3>%_#.I:OIMKKGBF#0+6"[\0MH&BW5Q'?ZY%HEE=VUUK1TZ
MVNDTVUN8)K[R8IHV;^6?_@J)_P &G_[&'[9][XG^+?[*NH6O[&?[0.L/=:K>
MV'AK0TU']GOQSK4Q>>67Q!\-;)K*X\!:AJ<XCBGU[X;7>GZ3:&6[U;4/ /B;
M5KB663 _X.6/VS=3_P""?7[5'_!%#]KJQM+W5--^$?QY_:1N?&VB:<8_[0U_
MX9>*?!_PD\$_$_1-.2>6&U;5M1\ >(_$4&AM>2"UM];.G7<V%M]P_J0^#_Q>
M^&GQ^^%_@3XT?!SQEHGQ!^%_Q+\-Z;XM\$>,O#MVMYI.NZ%JL(FMKF"0!98+
MB%O,M-1TZ[BM]1TK4K>[TO4[6TU"SN;:( _Q:/VY?^";_P"W5_P2?^,FAZ#^
MT/X$\1?#36(-9_M7X3_&_P"'^L7][\/O&-YH%S'=VOB#X8_$[1EL)(-:TR1+
M74VT>]'AWQ[X;6:PN]9\/:,]S:-)_?K_ ,&M_P#P6V^)W_!0GP5X]_9!_:L\
M0/XP_:5^ /@VP\;^$?BE>>6NN_&#X,Q:KIOA74;SQIY:HE]X\^'VOZQX9TS5
M_$P2.Y\9:5XHT;4=5BN/$>F^(M<US]M_^"R/P0^"OQ\_X)A_ML^$OCQIVA3^
M#O#O[.OQ8^)>DZ]K<=MO\">//AMX%U_Q=X&\=Z+>3CS-/UGP[XBTRSFA>UDC
MEU.SFOO#]P+G3M8OK*Z_A6_X,N/@1XZ\6?\ !0CXY?M!6FFW\/PT^#W[->O>
M"M>U]8IUT^?QS\5?&?@Q_"?AAIP@MYI[G0?!GC/79(?-:2W&B6DCQ8N(9  ?
MW&_\%P/^40W_  46_P"S4/BU_P"H[<5_GY_\&>G_ "F!MO\ LV#XW?\ I;X&
MK_0L_P""S/AO4_%G_!)S_@HMHVCVTEWJ!_8\^/.J16T*M)-/%X>^'^M>(+N.
M&-0SRS-9Z7/Y42*TDLFV.-2[*#_FL_\ !K=^T9\+?V;O^"O/PCUCXO\ B[0O
M 7A3XG?#OXI?!VT\6^*-3M-%\.Z9XJ\5Z+;:MX3M=5U>_EAL]/'B+7?#5GX6
MTV:YECADUK6],M7D07&]0#_75K^7;_@XD_X+]M_P2S\/:!^SI^S?8Z#XI_;/
M^*OA1_%,&J>(+6+5_"GP%^']]=7VD:;XYUS19#]G\2>-O$&H:?J<?@3PE?;]
M(MTTJ[\4>,+>ZT9=%\/>,?V1^.W_  44^ WP;^/W[-7[*OA_4(OC/^T=^TS\
M1[/PIX?^$?PQU[P]K'BCP)\/;/2=3\1>._CK\2;<7[?\(K\,? GA[2+N_N;N
M]5=6\37(_L_PIIVKR6>KRZ7_ )FW_!UUX:\9Z#_P6W_:5U3Q1'?)HOC/P-^S
MOXE^'3W8D%O/X,M?@5X#\'WDFE[\J;%/'_A3QU;RF(^6=3@U$G$ID  /Z>/^
M"(__  1%T[]K7P=X#_X*Q?\ !7G7O$W[97[0/[0FDZ;\2_@_\./C;JEUXN\!
M>"_AIK#/J?@7Q-XN\,ZB\FB^*[KQ/HUQ#XA\'> )K0?"WP3X-UC2;>'PE<:V
M\8\-?NW_ ,%OM*TO0O\ @C7_ ,% M%T33;#1M&TG]E3QWIVE:3I5G;Z=IFF:
M?9Z;;V]G8:?86D<-K96=K!''!;6MM%'!!"B1Q(J*%'D?_! /_@H?^S_^VM_P
M3D_9H\.^"/'/ABW^,7[/'P/^''P6^-GPHGU:PL_&7A'6_A1X2TGP,OBJ7P[+
M,E\?!/C:QT*V\4>&_$-G%<Z((=1N- EU!=>T'6]/L/A;_@X0_P""P?[(FE?L
M=?M6_L*_!?Q#>?M2?M+?%+X*^.="\5^$/@"$\>Z%\!?!5I:K/XR^)/QL\::"
MNI^'O"6E^$--AGN+[P\MS>>)8KI]/37+#PYH]^FO1 '\L_\ P9T?\I>;W_LU
M#XT_^I%\,Z_U2Z_R8O\ @TX^,7PY^#G_  5W\)W?Q,\:>&? FD^._@/\9? .
MCZUXMUK3O#VBS>)+JTT#Q58:5)JVK7%II]O=ZC:^$M0BT^&>XC:^O1!86HEO
M+FW@E_TU?V6OVZO@'^V=XQ_:"T']G37;SXC^#?V=/&>@?#3Q-\9-$M1=?"3Q
M?\1[_2[W6?$_A+X:^,H9)-.\;R?#ZQ&@KXLU?1GGT:*\\3:;!IU[?0G[5( ?
MYOG_  >+_P#*7FR_[-0^"W_J1?$RO[[/^"%G_*'[_@G;_P!FP?#S_P!(I:_@
MS_X/+?#>IZ/_ ,%8_!.LW=M)'I_BW]CSX2:II-R5;R;B+3OB!\8_#]Y&DF-A
MFM[S29/.B#&2..:WD=0D\1;^R#_@WU_;1_9L\6?\$9/V6-7OOC1\,?"W_#.W
MPLE^&?QL@\5^./#7AM_AAJ_P_P!7UG3C/XW.LZE91^';#6/#UKIOBS2M0U)[
M>SO="U:TNXIVQ.L0!Z=_P<@^%-4\9?\ !$O]O?2-'BEFN[/X??#_ ,5S)"K,
MZZ7X$^-_PP\<:Y*0N2(K?1/#NH3SM]U88Y&;"@FOXUO^#,K]K/PY\'?V]/C5
M^S'XKU:WTBV_:V^$6G/X+:YF6)-8^*7P,O\ 6O$^B>'4#LD?VB^^'_BOXIZC
M:NS&22YT>*P@CDFOT%?WH? SXY?!;_@KE^Q[\>)]*\%>+[?]F#XTWWQ\_9L\
M->*_$D%KIZ_'7X4PVFI?"_Q%\8? -F?,OM.\$^)]3N/%.G>#9]>MK'7I&\/O
MJEWI6GB:VB/^0'^U#^SO^TO_ ,$J/VX?%'PF\1:CX@^'7QR_9N^)>G^)/AU\
M1_#XNM'?5K;1=5CUWX:?%[P'?/N,FC>(K*WTWQ%I$H>9K.5[C1=6BBU33M4L
M( #_ '$J*_CD_P""8G_!W;^Q_P#&GX<>&O O_!1#49_V9/V@=%T^TTO6_B18
M^$_$?B3X&_%"]@B2$>(M.?P=IOB#7_AMK.ILDESK'A[Q%HX\(Z=,1+I/C&6&
M[31M*_0[]I3_ (.??^"//[/W@/5?$WA[]I6#]HCQA%8S3>'?AA\"O"_BCQ'K
M_B*^$3-;VLWB75]'T/P#X9MC,8EO+OQ%XIL;B&!I9;'3M3N(39N ?M'K7[1'
MP=\/_'[P)^R_JOC*VA^.GQ)^&_CGXN>$O 4.GZO>WMY\//AUK7A;P]XH\2W^
MH65A<:/H-G!K/C'1K#2UUW4--G\07"ZK'H46HOHFK+9_+7_!77_E%3_P4H_[
M,0_:R_\ 5%>.J_)#_@@9X?\ VC?VU?BY^TK_ ,%O_P!KSPV_@CQ3^U7X=TCX
M$_L??#!FO'MOA=^R%X,\0'Q',FC37T%K<7VA^/?&=IHU]::S-8:5-XHU?PKX
MC\?V^GPZ)X\T>*']7O\ @L3JMCHW_!*#_@I'=ZA/';03?L0_M-Z5')*ZHK7V
MN_"#Q9HFF0!F(!DNM2U"TM84^])+,D:@LP% '^<)_P &D_\ RFD^#O\ V2#X
M_P#_ *KC4J_UFZ_R5O\ @TRU*SL?^"U?P*M;F>.*;6/A=^T'INGQNRJUS>1?
M"7Q'J[P1 D%Y%T_2KZY*KEA%;R/C:C$?ZU- '\O/_!WS_P H<?%/_9Q'P+_]
M.6O5^,/_  8W?\CI_P %)?\ L5_V5?\ T[?M 5^RG_!X!>VUK_P1WUN">:..
M74?VDO@=96:.ZJUQ<I)XJU!H8@2#)(MI874Y1<L(H)),;48C\8/^#'&^M8_B
M'_P4<TUYD6]N_!G[,5];P%@))+73]<^.,%W,J]2D$NIV22,!A6N(P>6&0#_0
MOK_/C_X/E/\ D:O^":G_ &+_ .UG_P"G']G.O]!RO\]O_@^1N[=_&O\ P3:L
M5EC-U;^%_P!JJ[F@#J98[>\U;]G^&VE=,[ECFDL+M(W("NT$H4DQM@ _8K_@
MSW_Y0^67_9SGQN_])O!-?F]_P?%^%-4O/A5_P3M\<0Q2MHGAWX@_M&^%-0G"
ML88]4\9>'/A#J^CQ2-]T2S6G@37'A4G<R6\Y7(5L?HE_P9UZG97_ /P2$N+6
MUGCFGT7]JOXU:9J4:,&:UO9=#^'&L1P2@$E)&T[5K"Y"M@F*XC?&UU)_0#_@
MOY_P3MUK_@I5_P $VOBK\'/ &GQ:G\;_ (<:KI/QW^ ]BYCC?6?B)\/[+6+:
MY\(0RR-%&EYX\\#:_P",?!>D-<7%M80>(=<T6_U&9+.RE8 'Y@?\&</[6?AS
MXM?\$W?%7[+=QJUNOQ _9,^+OBI%\/-,IN_^%6_&G5-0^(_A?Q%%$S!S;W?C
MZ]^*>D7"0HT=K)I-M+-(KZE"A_KHK_$(_P"">_[??[2?_!*C]K'1OC]\&Q-I
M7B[PK<:EX'^*GPK\86^I:=H?Q \'MJ4">+OAEX_T@BVU&P==0TN"XM;@Q1:O
MX4\5:1INKV\7VO36M9O]+O\ 9(_X.G?^"2?[2/@32=8^(_QJN?V4?B4UE _B
M;X7_ !OT#Q(D6E:@(E%[_8/Q(\-:%JW@+Q/HOVH2II=Y+JF@^(;RT6&ZU+PE
MH<TQLH@#^CRO%?A9^T1\'?C7XO\ CAX%^&'C*V\6>)?V<?B1;_"/XQ6EEI^K
MPVGA/XAS^#O#7CIO#2ZO>6%MI&MWEEX?\6Z,VK-H%]JD&CZK)>:%JDMGK.G7
MUC!_-#_P41_X.M_V+?A1X!U3X;_\$\]9U+]LO]K/QTB>$/AA:^$?!'C"/X7^
M%/&/B&1=)T+5->U/7]%T6_\ B#?V]_>6L^A>"/AWIWB ^*M3%OH6HZ[X<6Y>
MZ3]9?^"+'[$_C[]AS]A3P=X/^.&JW7B+]J#XW^,?&7[4/[5WB34+M+_4]7^/
MWQKN[36O%%OJM]&\L-_J_A?0[/PSX*UG4K6::QU?6/#5_K%@XM-0A1 #^2+_
M (/BO^2L_P#!/#_LG?[1/_J2_"6OW6_X-'/^4,7PO_[+9\?/_4V>OP4_X/A-
M:T^?XZ_L ^'8KB)M5TOX3?'#6KVT#@S0:?KWC#P'8Z9<21_>6*ZN?#>KQ0N>
M)'LYU',;5^[_ /P:)W]K>?\ !&GP!;V\R2S:5\>/CQ87R(P9K>ZD\36>J)#*
M <H[6.I6=P%;!,<\;XVNI(!_3M7^.;_P<F?\IN?V]?\ L>/AG_ZH7X4U_L95
M_CA_\'(%[:ZA_P %L_V^)[.>*XBC^(7@*R>2%UD1;K3?@E\,=.OH"RD@2VU[
M:W%M,A.Z*:*2-P'1@ #_ %Q/V6/^38OV<O\ L@_PA_\ 5?>'J_"G_@[-_P"4
M*?QW_P"RH?L^?^K;\-U^XW[(6J6.N?LF_LOZWID\=UINL?L[?!35-/NH7#Q7
M-CJ'PU\,W=I/$ZDJ\<T$T<B.I(96!!P:_%G_ (.L?#>IZ_\ \$2/VG+O3;:2
MY3PMXP_9\\2:DL2L[Q:8GQU\ Z+/<[%!8QV\VMV\L[ ;8;=99Y"L43L #^='
M_@Q]_P"2_?M\_P#9'_@O_P"IIXSK_1<K_,D_X,R?VD_A-\'_ -MK]H[X1_$K
MQIX=\$ZW\??@EX=@^&DWB?5['1;/Q3XL^'OC(7USX,TFZU":"&Z\2ZCH7B74
MM:TS2DD^T7]GX=U;[,DDT"1/_?1<?\%#?@;JW[;G@#]@WX671^-'Q@UCP%X]
M^*/QBOOAQK6@ZYX8_9J\!>#[?3K;1-2^,6H6U],=*USXA^*M9TGPMX1\(V:7
M'B$R7B:YK5GI.@SZ;?:D ?>=%%% 'X&?\'/7@_5/&?\ P0__ &U[71X9;B\T
M&T^!_C"2WB#,7TOPK^T9\)=8UZ9]IXBL-!MM2U*0D,H6RR0H^=?XI/\ @S__
M &G-"^!W_!5.Z^$_BK4H=/TG]JOX&^-?A3X?>YDBM[5OB3X9U+0?BEX32>ZE
M94234-$\&>,_#NF6VX/J&N:_I5C 'NIK>*3_ $Z?VBO@=X-_:9^ ?QH_9W^(
M<4DO@?XX?"_QS\*_%!@1&N[;1O'7AS4?#EYJ&GF3Y8M4TR/4/[1TNY!5[74;
M6UN8GCDB1U_Q-OVAO@5^TC_P3$_;2\2_"OQ=)K'PW_: _9B^*FF:WX3\8:2D
MUD9=1\+:Q:>)?AO\5?!-U=1'[5H/B"VM]%\8^%KYXW$ME=6T=[!'=17=I$ ?
M[EU%?RQ_\$Q_^#J3]@?]JCX2^%=%_;!^)?AG]D3]IS1])LM.\>:;X]BU+2O@
M]XUU>T@2&^\8_#SXA""]T#1-&UB0)?2>$O'.IZ'KV@7=U<:183^*]-TU?$M[
M] ?MK_\ !SK_ ,$J/V3?AYK>L^ /COX>_:U^*OV"X/@[X3_L^WS^*+;7-4*.
MEG_PD7Q/@L;GX>^#]!CNO)_M:^FU?5O$4%B\EUHGA+Q#/%]C< _: _M+_"0_
MM/Q?L?0ZY=W?QS/P,O/VC+[P[::7=W&G:)\+;?QWIWPXL=6US7(T.GZ7J&O^
M*;ZZMO#FCW,BW^L6N@^([^UB-MH]RX_RB_\ @Z.\#:YX+_X+=_M@7FKPSK8^
M.[7X%^.?#-W,K*-1T.^^ 'PRT.6: MG=!8^(?#^O:(K*2N_27 VD%$_O#_X-
M^O@[^T;\0?"?[1'_  5;_;6L&TK]IC_@I'XG\,>*?"_A"2VOK*V^%?[+7P_T
M^[T_X)>#-!TG4F>ZT#1]7MM4U#7;"T>6YO-9\(P> _$.OWM[XFO]7E'YC?\
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MFI1HP9K6]E\3VFLQP2@$E)&T[5["Y"M@F*XC?&UU) /Z=:_Q5?''_*;7Q?\
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MCBY%UXR\)^&/$4OB?6?#MWJ6@:;JUYI&A>$/"MMJ-]XQO_%XFT&TTG4_5/\
M@W#_ .#?+7_^";*ZI^UQ^URF@WW[8'CGPK/X5\)> =&O[#Q'HO[/G@C7!:7'
MB"TN/$-D;C2M:^*GB;[/%I&OZMX:N[W0O#WA^*^\/:#KNMVWB+7+J7]9=*_X
M+Q?\$=M7,<=G_P %#?V;8-V G]J>,)="11P &;6M/T](P/\ ;*A>^,5]=? _
M]O;]B#]IC5H_#W[/7[7W[-'QJ\2R1O,OA7X9?&[X<^,O%BQ1QM+)++X5T/Q%
M>>(8(TB5Y&>;38U"([$[48@ ^LZ*** "L#Q1XK\+>"-#O/$WC3Q+H'A#PWI[
MV4=_X@\4:SIV@:'8R:E?VNE:='>:MJMS:6%L]_J=[9:=9)-<(UU?W=K9P"2X
MN(HWWZ_#W_@Y'FFMO^")?[>%Q;RRP7$'@SX7303PR-%-#-%\?OA.\4L4J%7C
MEC=5>.1&5D=0RD$ T ;O_!4/_@@[^P?_ ,%3[6[\4_%;P?>?"[]H6+34L=%_
M:0^$T>G:+X_D6SME@TNP\?:?<6LWA_XGZ#9+#:VT=IXILW\0:?I4#:9X6\5>
M&(IY93_G+?\ !5+_ (-X/V[/^"7L.L?$;6='L_V@_P!F"RN<1_M"?"C3-0:R
M\-6DT_D61^+G@2=[W7_AC<3R-#$VJ2W/B'P$+N[L=,MO'=WJUVFGC_2Q_P""
M,O\ P4E\ _\ !3O]ACX4?&S2/$6F77QB\,^'="\!_M)^#8[BW36O!WQDT/2X
M;+Q!>WFE1NTMGX=\?2VDOC;P1=XDMKK0-62P-R=8T;6[*P_4O6M%T?Q)H^K>
M'O$.E:;KV@:]IM]HVN:'K-C:ZGI&LZ/JEK+8ZGI6JZ;>Q3V6H:;J-E//:7UC
M=PS6UW:S2P3Q212.A /\S_\ X-B?^"ZOQK^"/[17PA_X)W_M)>.M:^(W[,_Q
MO\0Z5\,/@IJ'BW4;C5M?^ _Q/U^6/3/ 'A_PWK%]+-?/\,O&NNR6'@V7P7/-
M)IOA?6M6TCQ!X9_L6SC\3V&O_P"FE7^0'\,/V,]'UW_@Y!L/V3_V4K*34?AU
M\./^"F%^WAI=!EN-1M/ _P (O@O\:YO&OC IJ,/VAWL/AIX-\*ZWIT.HW$Y-
MW+H5LLEVUS=K*_\ K^4 ?XI7['P(_P""TW[+8(P1_P %0_@B"#U!'[5_AD$'
MZ5_M:U_B>?M$+K_[!/\ P6!^*FK:WH=V^J?LL?\ !036_']II+(+>;6M(^&_
MQZ;QWX7NK+[08U^R>*/#VGZ3JFDSR%(YK'5+2X)5),C_ &2O@!^T]\ ?VH_@
MWX<^/_P&^*W@SXD?"7Q/HD&O6?B_P_KEA<6.FV[V:7MW8>)HS.MQX6U[149H
M/$7A_P 01:=K/AZ^@NK'6+*SNK::) #\[?\ @X&_Y0S?\%!?^R&3?^I;X7K^
M&O\ X,Q?^4L/Q*]_V)/B[C_P[?P /\J_H4_X+_?\%;OAM\<_V0/VR?V(_P!A
M'1]/_:PUO0/A')X@_; ^./@O5X-0^ G[+_PMLO$VCB2WO_B!I]P=$\;_ !;\
M7:Y:VOA?PKX*\+:AJ,6G74FM:CK=RT_A;6-"3^7_ /X-*?CI\.?@C_P5ST*'
MXD^+M"\%V'Q?^ 'Q7^$7AO5O$FIV>C:1=>,=1U+P3XYT71)=3U":WLK>]UN/
MP%>Z=H\$\Z/J>M3Z?I%DLVH7]I;S '^DO_P5/\'ZIX__ ."9G_!0CP9H<,MS
MK?B/]BO]IW3=%M(0S2WNKS?!CQFVF6**IW$WUZD%I@9.)C\K?=/^5-_P;Q?M
M.:%^RA_P5_\ V.O'_B_4H=*\$^,O&>L_ _Q;?7,D4%G:6OQO\+:U\-_#M_J%
MY,R0V&EZ/XZU_P ):WJM],R06NF:;=RSO' ))%_V%M"\7_#GXHZ;XGLO"_BG
MP7\0M)TO4;[P7XRMO#VNZ)XJL=,U>32K&^U'PKXDCTR[OH+'4VT36]-O;S1-
M2$-W_9>KV%S-;?9;^WDE_P 7_P#X*^?\$[/'O_!,/]NGXM_L^:UI6JV_PZFU
MZ_\ '?[/'C&=+G[)XT^"OB'5+RZ\&:A9:E)@7>L^&(ED\&^+PC^99^+O#VK!
M-]G)8W5R ?[6]%?Q<_\ !%W_ (.JOV9/B1\$/ OP%_X*1_$<_!+]H?X?:)IO
MA.+XY^*-/U:_^&/QQTS2;:*RTKQ-XB\0Z/9:D_@/XC36,"_\)I_PE-OI_A#6
M]2A?Q%H_B*UN==?PEHGZ^_M+?\''/_!(#]FSP%JGC!_VO? /QQUV"QGGT#X;
M_L[78^+7C'Q3J"1>9!I5M<Z Q\'^')9R0#?^-O%/AG2X<.CWIN EO( ?J;\0
M_P!I?X2?##XW?L^?L[>*M<NXOBU^T[<?$V/X3^&=.TN[U)]0L/@_X*E\=^/]
M>UJYMD:#P_X>T72CIU@=7U)HK6Y\0:[H.AV[27NIPI7R!_P6H_Y1(_\ !1O_
M +,\^.O_ *@>KU^27_!#/4/VAO\ @II^U5\>?^"X7[3_ (-G^'/@KQ-X*G_9
M9_8 ^$4]S=WMAX'^"&G>)1KGQ(\8V%Q=6MBFM7_B#Q)IMAH5QX]BM+:;Q+XA
M/Q-LK2QT?PI8>&=*@_5[_@MUJ=EI/_!(G_@HO=7\\=O!+^R7\8-,CDE<(K7N
MM>&+O1M-@!8@&2ZU&_M;:).LDLR(H+,!0!_GG?\ !H=_RF3\$_\ 9 /CM_Z8
MM,K_ %>Z_P GG_@T6OK6T_X+,_#J"XF2.74_@7\>;&R1F :XNH_"<.I/#&#R
MSK9:?=SE1DB."1NBDU_K#4 ?Q??\'M/_ "87^R;_ -G=I_ZIKXF5Q?\ P9$?
M\FG?MM_]G#^!?_5;1UUG_![7=6Z?L*_LCV+31K=W'[6<]U# 742RV]G\'OB#
M#=3)&3N:."2^M$E< JC7$*L09$!X/_@R#U2RF_9D_;GT6.>-M1T_X[_#+5+J
MV# RPV6L?#_4[33YW3.Y8[B?0]2CC8C#M:RA22C8 /[A:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?\ @Z._Y04?MS?]
MVS?^MA_L^U_D"U_K]?\ !T=_R@H_;F_[MF_];#_9]K_(%H _O\_X,8_^<HO_
M '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\ ?N*_O\H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>'[WR=3B_HM_X*2_\$+OV<?VS_\ @G-X8_8$^!%AX3_93T7X,^+]"^)7[/\
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M(0FDS_VSX<\7:1#'!I^F^+;;1$FT>Y_CX\8?\&5'_!273O$TUCX%_:(_8O\
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MQJ\!OX)-[X?O])T>PLM*\+7&LZ!?:3/XBTCQ5;ZC?VZZ5_)2?^#&F8S&X/\
MP5*D-P9/.,Y_8I;SC-NW^:9?^&N=_F;_ )_,W;MWS9SS7]_%% 'Y=_L._LF_
M\%%/V;KWPKH/[2W_  4VT+]L_P"%'A/P?-X8MO#NN?L9>'OA)\3]1N[6TM;+
MPWK.M_&31_CKXTO=<N-(@MV&I3:WX2U/7/%$LGVS6?$,FHFXO;KX=_X*-_\
M!(#_ (*)?\%(/!7CSX(?$+_@KYH?PZ_9H\9^,KC7S\&/ /[ NA6,]YX<T_Q&
MVO\ @CPCXZ^(,/[4-AXE\<6OA-H-):X8+X>T7Q'K6D6?B#4?#,5U;:?!I_\
M1-10!_#)\ /^#.'XP_LM?&3X?_M _ +_ (*_ZO\ #7XO_"_7%\0^"/&FB?L2
M6<U[I&HFUN=/NHY;+4OVKK[2M5TO5=+OK_1M<T/6+"_T;7=%U#4-'U>PO=-O
MKJUE_L _95^''[4/PP\ ZKH'[5_[3GA+]JOQ[/XDEOM%^(/A']GK3?V;[;3O
M"YTC2+2#P]J/@[2/B5\3;#5]3CUBUUC5Y?$=OJ>CQS0:M;Z6FAP)I:W=Y]-U
M\>_\%!?VDM=_8]_8A_:I_:A\+^&!XR\3_ SX'^/_ (A^&_#DL5Q-8:AX@T+0
MKJ;1&UI;5H[I?#=CJ;6NH^)YK>2.>W\/6FISQ2(\:N #^33_ (.1?V*OV3/^
M"@W[=O[,W[*_[,NCZCK'_!6?XG-H5E\2=<\):O;0?"[X8?LRZ#8W.JW?Q"_:
MK@&GZDT.L^'M!?[1\/+;0I-*\;ZGX<DM;'67U6PN_A1H&L_%?C+_ (,?_P!H
M2QFF7X>_MZ_!KQ/;J6\B7QE\'?&_@2:0#.TS0:)XK^(R0EN-P2XN O."^.?D
M_P#X-E/^"HWP$^#'_!2+]I_XP_\ !0CXKP:'\4OVP_!K:9IG[3'Q+NH(/#]A
MXWU'Q[;^,?%N@>-/$TD:67@G1?'<L&BW%GK%ZVE>"]#?P7I>C7DVE64FE"#_
M $^M \0:!XKT73/$GA;7-(\2^'=:LX=0T;7] U*RUG1=6L+A=\%]IFJZ=/<V
M-_9SK\T-S:SRPR+RCL.: /\ ,]U;_@R@_P""D$+.-#_:7_8BU%1G8=6\5_'?
M1F;TWK9_ 77@F>^&DQVS7S!\8?\ @TX_X++?L[:1<_$KP'HGP=^-&I^" /$]
MG'^SE\8=6/C^UFT-AJ,6H^$],\?>$_A5KFI:[8O;BZTNP\-FZ\2W=Y%#!HEA
M>:F]M;R?ZO%?EO\ \%.?^"M7[+/_  3$^$NL^)/B?XNTCQ;\==8TJ:W^"O[,
MOA?5;;4?BU\6/&5]&;;PWI]OX:L/MNKZ!X1N-5EM8]=\<:GIZ:5IMFTD&G+K
M7B.YT;P]JP!\ _\ !L%_P49^,_[?_P"P-XATS]I#6-3\5?'/]EWXGW'P5\2>
M.M=\QO$OCSPF?#FC^(?!'B+QG/,L<]UXULXKS6O"/B"_N8C?ZS_PBUEXAUJZ
MO?$&LZO<-_2-7X.?\&\O[!/Q3_8A_8?UGQ#^T5I2Z#^TW^U_\7?%?[4WQK\+
MFV^R3^ ;_P >V^G0^&/AW=6P=C::AH.A6*:UKVER@W&@^*O%'B#P[)/=)I$-
MQ)^\= !7P#_P5)_8X\1_\% ?V"OVAOV/O"7C/1/AYX@^-FB>#]&L/&?B/3K_
M %;1M!'A_P")/@SQK>75YINF217MZ9;#PU=6EM!#-"'N[B#S9H81)*GW]10!
M_#_\._\ @U6_;:_8'^(]G\<?^"6__!5B?X<?$Q--ATS5M+^*/PJNO#?AKQ/9
MPO'=2:5XPE\.:S\2_#/C+PQ<W\:747AGQ7\*-8L]-N(8+V*XN[^*&XA^[/$_
M[,O_  =7?&GPG>_"+QW^W#_P3?\ @/X5UNSET+Q-\:?@'X5^+%_\:Y='O(3:
MW]WX6AUWX4:)HFCZO<6[2&/5-"O/ &N:7/(MUH.L:5=Q075O_4I10!^+?_!)
M'_@AW^RO_P $E_#^OZ[X%OM9^,_[27Q!T_\ L[XF_M)_$&PM+;Q3K&G/>)J-
MSX:\%:%#<ZE!\/\ P;>ZG%!JFJ:5;ZOK>N>(=2MK*Z\5^*-?72- ATC]I***
M /Y<?^"Y?_!M?\/O^"I?C>/]IKX$_$70O@%^UF-$TWP_XPOO$^CW^I?"_P"-
M.F:#9QZ;X;F\;MH4<WB#POXNT#3(;71K7QOI&F>)6O?#>G:;H&I^&KL:=I6I
M:9_/E\ O^#*G]M_4_&<-E^T=^UA^SE\-/A9+=VZ^(KGX*7?Q/^*7C76M/M9Q
M-):Z?H/B[P#\)?#=L;I5,=GJ>JZ[?'3)Y!>R^'[\0?8[C_2;HH _##XN?\$8
M?A1\,?\ @C[^T9_P33_8#\*>$? 6M_%OX<MHD'C+XEZO>1ZC\0?B#-JF@75_
MX[^,/CG1?#NK:OJ>KZA:Z2\*RZ?X=;2M%M5LM"\,Z!HGAZSL].L_PV_80_X,
MMO@UX,.C^,O^"AOQ\U7XR:["8+J[^"OP"DU/P-\,XYT*F;3M?^*&L6EK\1_%
MVFSJ7#'PSH?PFU&WE5&CU.XCW*_]S%% 'SS^S/\ LF_LU_L:_#:V^$7[+?P5
M\ ? _P"'D%V=1G\/^ ]#@TPZSK#6MM8R:_XHU=S/KOB[Q)/965G9W/B3Q1J>
ML:[<VEG:6]QJ$L-M D?SY_P4=_X)C?LI?\%1_@B?@O\ M.^$+F[DT::]U3X;
M?$_PK-::1\3_ (3^([Z"*WN=:\$^(;FROX$@U".WM8M?\-ZS8:MX6\1Q6=B=
M8T>YO-+TB\T_]":* /\ -5^-W_!DY^V[H?B^\B_9W_:I_9B^)/@"2[<:;J/Q
M<_X6?\(O&EO:2R$PKJ6@>%/ ?Q@T&=K6(B.YN[/Q1&UTR>?!I< E^RP_?7_!
M/C_@S!\'?#WQOH/Q&_X**?'?P]\9K#P_>VNH)\ ?@1;^)]'^'_B.[M9?-6W\
M;?%+Q-9>&?&NL>&YP%2\\/\ AKP?X(U*Y*C=XK6U:>RN/[L** ,#PKX5\,^!
M?#'A[P5X*\/Z-X3\'^$=$TOPUX6\+^'--L]&\/\ ASP]HEE#INCZ'HFD:?#;
MV.F:5I>GVUO9:?86<$-K:6L,4$$21HJC^?O_ (*7_P#!'S_@H'_P4KT/XB_!
M_P 8_P#!7>Q^%?[*OC3QM=^(;']G[P3^PGX<9E\,V'B0^(/ OA'Q]\3;;]I+
M0O%GQ&3P@;?2C-<31>'-!\1:UI-GXCOO"5O?6VG1Z?\ T1T4 ?PR? '_ (,X
M?C'^RW\8/ GQ]_9__P""PFN?"_XO_#75SKG@OQOX>_8HM3J&D7LEI<Z=>126
MNH?M7WNEZKI>JZ7>WVCZYH>LV&H:+KNC7]_H^L:??:;>W5K+_5C\&_@I^WGX
M-^"'Q4\%?&+]NKX<_&GXW^(M/EMOA#\<;']C71OAAI'PQOCI$EI#J/BOX2:+
M\<M<TKXH&/6#'J\MI;^*OA_!-"C:6A@207<?W510!_(I_P %"/\ @VR_;6_X
M*?\ BWP9XI_:[_X+*V_C"V^'%CJUA\/?!OAO]@'1/!?@;P;'K\ME-K]WI/A[
M0OVKK=+G5]<?3=-35->UJYU;6[FUTW3=/.H+IVGV5I!E_P#!/[_@V<_;*_X)
MC>/O%?Q!_9#_ ."RD7@>Z\?Z1IVA?$'PQKG[ FA^,?!/CC3=%N;N\T(:_P"&
M]?\ VK+NV.HZ#=7^HR:)KNER:9K^EQ:IK%C9ZI%IVM:O9WW]?]% ')> -+\8
M:'X$\%:+\0_%FG>/?'^D>$O#>E^.?'6D>%U\#Z3XT\8:?HUE:>)O%FE^"DUK
MQ(G@_3O$>M0WNL67A=?$6OKX?MKR+25UK51:"^GZVBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA
M_L^U_D"U_K]?\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=D
MW_OW%?W^5_ '_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ^;OVL_V1_V??VX?@9XP_9S_::^'FE_$GX5^,XH
M'OM(OI+BRU+1]8L"\FC^*?"NO6$MOJWAGQ5H<\CS:5KND75M=PK)<V<S7&FW
MU_977\&O[9O_  93_&_0?$.K^(?V#/VE_ ?Q!\$7%U/=:;\-_P!HT:GX%^(&
MA6)W>1I5MX_\%^'?$?A#QS>JP7_B8ZCX9^&%N(G*/ \L/G77^BW10!_EU>!O
M^"'G_!U#\#H[;PK\&/&7Q[\ >&[,):VB_"C_ (**>'_ ?AFUMK;$5N(-)TWX
MZ>&;F&U2,#R(8]&5HXAL\E#\E?=_PJ_X-P/^"]W[4TD&E?M\_P#!3_X@> ?A
M7?L8?$7AK7_VH/CS^T_XTN;*8;;RS@\%77B?3/AG+#=6^ZU,UU\1)$A,@9M+
MO(8S"_\ H344 ?ES_P $RO\ @D#^QC_P2F\ 7WAG]F_P7>:C\0?%-C:VGQ)^
M._C^:RUWXM?$ 6TB7"V%[K-M8Z?8>'/"D%VD<]EX,\)Z;HWA])8+:_U*VU77
M4GUJY_4:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^ /_!T=_R@H_;F_P"[9O\
MUL/]GVO\@6O]?K_@Z._Y04?MS?\ =LW_ *V'^S[7^0+0!_?Y_P &,?\ SE%_
M[LF_]^XK^_ROX _^#&/_ )RB_P#=DW_OW%?W^4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%?YTW_!2K_@[&_;T^ W_  45^.GP:_9W\#_!GP]\"OV9
M/C;XU^"]WX-^(7@G4O$?B+XJWOPK\5ZAX.\8ZYXI\31:]I6J:#:>(M;T759_
M#%IX2309]'T*;2QJ<NL:BEW--_?'^RY\<M/_ &G?V:/V>_VD=*T"_P#"NF?'
M_P""7PL^-&G^&-4F%QJ/AVS^)W@?0_&EOH=[=+!;1WEQI,6M+8RWL5O#!>-
M;J"-894% 'NU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?
M:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W
M[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?RK_\ !P)_P<.?"O\
M8"^&OC7]F/\ 94\<:!\0/VZ/&&F:CX8N[KPW?VFM:+^R[8ZC:RVEYXP\9WEJ
MUSIY^*EI%*7\$?#R9Y+S3-0-MXK\:V=MH=KI6B>,@#]#_P!D/_@IU<_M<?\
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M6IRVZVD%[JVG6TDJS7D". ?6M%>3?&GX]?!+]G#P-J/Q,^/WQ;^'7P8^'VE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?\
M=LW_ *V'^S[7^0+7^OU_P='?\H*/VYO^[9O_ %L/]GVO\@6@#^_S_@QC_P"<
MHO\ W9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO[_* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]'#.;C3=5T^XMM2TG48;74M.N;:]M8)XP#_+L_X((> K+_@LK_P6LUOXE?\
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MXH?"/1?%LD:^&?&UK:K:VM]HWQ/^'/V&W\3:;Y2VT4NJ-<Z<]O>6.G7UO_M
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M5IXG^#G@'P-8Z+X3^%]O:>);;3=,O?">EZ5>6M]:>(9+U-5M)M*D@U;\K?\
M@VN_:'_:W^%7Q._:Q^#G[!7P<'Q3_:[_ &E_ACX!\#_#/Q3XGCBA^#?[/^A:
M'XHUF^\;_'SXRZK/'<0P^'/ MEJ>F1Z!HDEE?'Q1XNU71M(ATW79Y(O"^O\
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M^HZ??6\MI>V%]9OX1MKNRO+6=$GMKJUN(Y(+BWF1)89HWCD174@=E_P=&?\
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M<:9'J-Y<:=ILEU?Q:#XGTSX<IKD20C1=<O1*=H!_*A_P:2?MH?%'X&?\%0O
MW[,%EXFU)_@C^UUH/Q \,^-?!5U>3R>'K7QWX&^&_BGXC>!/'NGZ<7\FV\4P
MS^#;CP0]_"JF[T+Q9>07Z7'V'2Y+#_5<K_&W_P"#<UV3_@M;^P(R$J3\3O%J
M$C^[)\(?B+&X^C(S*?8U_LBR2)$CRRNL<<:-))([!$1$!9W=F(555069B0
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M^#0&YF@_X+%>'XHG94O?V</CE;7"@D"2%+;PS>*C $!E%Q:028;(W(K8W*"
M#_5KHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPCX1LTN/$)DO$US6K/2=!GTV^U( _FY_X/9_^3 /V5/^SP[/_P!4K\5ZX?\
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M ,%V/^"T7@O_ ()!?L^:!JFB:!I7Q'_:@^-3Z[H_P'^&VKSW$?AZT308;/\
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M\1O#OQ \%Z7<S1S>(M)LH?%\WA7Q.-)^V7NAZUH7V[7+;3K+Q)X?FU']#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?[/M?
MY M?Z_7_  ='?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\ OW%?
MW^5_ '_P8Q_\Y1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?&7C/4+J+39H+#5?#7A/PMKME'J9_J:HH _C8_X+1_\ !K-XK_X**_MF:_\
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MW7M2TFQ==$B\8S>*--346@37+CPI;/(^BC^T7]@?]@+]FS_@FY^SUX=_9O\
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M  A\;_\ !4K2OVH/V5_A%H^H>&=*^#?BK]BO0?!/CB+PG%X:U;2_!WA7P_\
M'*#]H/Q?XCT;0_!>N7.BZGIEIK?A[Q>4\.Z(G@?3)-%T633Y-'_:^B@ K^4'
M_@JU_P &I/[*W[=OCOQ/\?\ ]FOQP/V0OC[XOO;S7/&^GZ?X5B\4_!#XD>([
MR5[F^\0:IX+L]0T+4_ WBK6[F1IM<\0^$=1GT?4;HS:OJ'@?4/$%_J>L7O\
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MUS0]8L+_ $;7=%U#4-'U>PO=-OKJUE_N;HH ^9/V5?AQ^U#\,/ .JZ!^U?\
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M=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]_E?P!_\
M!C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^0+7^OU_P
M='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5_?Y7\ ?_
M  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA_L^U_D"U_K]?
M\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=DW_OW%?W^5_ '
M_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y M?Z_
M7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]_E?P
M!_\ !C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^0+7^
MOU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5_?Y7
M\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS?]VS?^MA_L^U_D"U
M_K]?\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_ .<HO_=DW_OW%?W^
M5_ '_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[<W_=LW_K8?[/M?Y
MM?Z_7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#^_S_ (,8_P#G*+_W9-_[]Q7]
M_E?P!_\ !C'_ ,Y1?^[)O_?N*_O\H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_W;-_ZV'^S[7^
M0+7^OU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\ YRB_]V3?^_<5
M_?Y7\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBOE?]MW]I@_L;_L
MH_&_]IU/ [_$J3X.>#F\4Q> T\2)X/;Q1.=4T[2X-+_X2>31/$D>B++-J*.U
M\VA:H(EC8?97W94 ^J**_+/_ (:3_P""K_\ TBY^!?\ XLETO_Z$>C_AI/\
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M.K:A:V5I9?$:P\,^#;3Q.E[I$&GZM)=0^&M*6TFU"33&BF>R:ZG]5H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKB/B5
M\2? ?P=^'WC3XK?%'Q7HW@7X<_#KPSK/C+QOXQ\17:6.B>&_#/A^QFU+6-7U
M*Z<'R[:SL[>65EC62>9@L-O%+/)'$_\ *K\-_P#@I-_P5/\ ^"XGBWXOP?\
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M.WOQ!\%66J76HZUX6GT+Q%J^B:/XL\):OJFLQV4OB'P]J>B^(=4@U74-+\-
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M4 %%-=MBL^&;:K-M0%G;:"<*HY9CC"@<DX%?QS?\%6O^#F/]J']E'P%;:_\
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M^U6V_:9^+OA&"ZG95!EF30O"NBV(=RS"&SAB#;(T ^B?^#A#_E#%_P % _\
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M!HMU>Z5JVG7*?-!>6-U/;R ';(2#CJB0 23@#DD] /4T %%?B1^W9_P<+?\
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M\'>.=36)+B:;1O ?C#Q/K%M:VES?75A!8Q?:6 /V2HHK\_OV\O\ @J%^Q/\
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M_M\_LA_\$_/AS#\4OVNOCAX2^#WAG49KFS\.6>JMJ&L>+_&>HVD22W.F^"/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *_+/_ (+9?\HK/VT_^R5VW_J9>%Z_4RORS_X+9?\ **S]
MM/\ [)7;?^IEX7H _4RBBB@ HHHH _+C_@MM_P HB_\ @HQ_V:1\9?\ U$[Z
MOU#A_P!5%_US3_T$5^7G_!;;_E$7_P %&/\ LTCXR_\ J)WU?J'#_JHO^N:?
M^@B@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^'+_@U[_Y2L?\%Y?^
MRWZI_P"M'?M!5^X/_!=C_@C;X"_X*U?LR3:;H<.B^%?VLO@_8ZOKG[.WQ,O4
M2VAN;V:(7.J?"?QO?1QM/)X \=R6T$)NV$T_@WQ)'IOBO3XKFUAU[0_$/X??
M\&O?_*5C_@O+_P!EOU3_ -:._:"K^XV@#_#E_9Y^/G[5W_!*7]M+2OB7X-@U
MSX1_M%_LZ>/-6\,>-? GBNTNK:&\;3+V31_'?PM^(FAQSP?VKX8\0VT-UI&L
MVD=PI:)[;6]!U&SU2RT?6+7_ &'/^":7_!13X'?\%/?V5?!/[3?P3O5LSJ:+
MH'Q-^'5[?07GB7X2?$[3K2UE\2^ _$?E)"TQM'NH-1\/:U]EM(/$_A;4-&\0
MVUK:IJ#6=K_/M_P<]?\ !"5?VT?A[J_[>/[*7@\3?M9_"?PR'^*_@7P]8@ZA
M^T5\+?#EEA+BQL;6/?JWQ=^'FE6^/#HC1]6\:^$+5_!<9U+5M%\":6O\1/\
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M /WY=TB1Y)'6..-6>21V"(B("SN[,0JJJ@LS,0% )) %?YBG_!0+]N#XM_\
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MP.HQ_'^[>P%Y<:1';F]2TNGM1)YZV\QC$;?W#4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!V
MS?\ K8?[/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3
M?^_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M._'$MM&L<GB#6? VI>(-!\3^ -6O0%>[TKP[_P )QHMQ>BZO+%_#UC/:Z)9
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MSQQXN_X-]/VLM9\9>#7\)?$'6?AC^S'XC\<>!=/O4\1+X-\1O^T+\!-;\9:
MFJV"O!JMEX2NUU6UN-9@ M)K+3)=3+);;G4 _E5_X,F?^4@'[5?_ &9W??\
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MC_\ #V7X/?L#?L$W_B:P_9"^"WVZ;6M)\5?M!ZY8164WBW5]9N;+3$\:>*/
MVG7%GXI\0^++#3=(TGPYXCTWX<^%/#5A.;?QO>W?]IDLL4$4D\TB10PQO+++
M(P2..*-2\DCLQ"JB("S,2 J@DG H DHK_/B^(_\ P>S^.-*_:@U.T^&O[(?@
M'Q)^Q]H_C&?2+6ZU[Q1XITWX]>,?!EEJ+69\9:?JD-RO@?PKJ>L6"'6M/\':
MCX2U]+ RPZ-?>*97$NJ1_P!\/PK^)/A7XR_##X<?%_P)=S7_ ((^*W@+P?\
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MD_9A73HU\16NGVVE>([W13H^M:GID<5NVJQ26UG-;?T T4 ?FG^VY_P3;?\
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M^ _ARXUG0YIX;N31-?M[3]EM;#7]&:\MK6]_LK6K6_L%OK6UO5MQ=6T$L?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_ +MF
M_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q_P#.
M47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C]N;_
M +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_  8Q
M_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W_*"C
M]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M ']_G_
M  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _\'1W
M_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y M '
M]_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _
M\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[/M?Y
M M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\ K8?[
M/M?Y M ']_G_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'X _\'1W_*"C]N;_ +MF_P#6P_V?:_R!:_U^O^#H[_E!1^W-_P!VS?\
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MK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ
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MYT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\
M@Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_
MPX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13
M_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\
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M_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\
MG-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW
M_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\
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M#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\
MX**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\
MX.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S=
M'_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\
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M_P#G-T?\."_^#IK_ *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\
MSHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\ **_@#_X<%_\
M!TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\
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M^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\
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M ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX
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M1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\
MP44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2
M:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\
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MTU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\
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MOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\
M.;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^
M"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1
M_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O
M_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_Y
MS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C
M?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_T
MFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_
M\'37_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\ I-1_YT;_ ."BG_SFZ /[_**_
M@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\ @Z:_Z34?^=&_^"BG_P Y
MN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X*
M*?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_
M )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^
M#IK_ *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-
MT?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\ **_@#_X<%_\ !TU_TFH_\Z-_
M\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:
MC_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P
M=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^
M/_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I-1_YT;_X**?_ #FZ
M /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\ X.FO^DU'_G1O_@HI
M_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S='_#@O_@Z:_Z34?\
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M^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H
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M_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\
MSFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13_P"<W1_PX+_X.FO^DU'_ )T;
M_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\ .C?_  44_P#G-T?\."_^#IK_
M *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\ SHW_ ,%%/_G-T?\
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M (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\ !13_ .<W1_PX+_X.FO\
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M_!TU_P!)J/\ SHW_ ,%%/_G-T?\ #@O_ (.FO^DU'_G1O_@HI_\ .;H _O\
M**_@#_X<%_\ !TU_TFH_\Z-_\%%/_G-T?\."_P#@Z:_Z34?^=&_^"BG_ ,YN
M@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\ G-T?\."_^#IK_I-1_P"=&_\
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MK^ /_AP7_P '37_2:C_SHW_P44_^<W1_PX+_ .#IK_I-1_YT;_X**?\ SFZ
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MYT;_ ."BG_SFZ /[_**_@#_X<%_\'37_ $FH_P#.C?\ P44_^<W1_P ."_\
M@Z:_Z34?^=&_^"BG_P YN@#^_P HK^ /_AP7_P '37_2:C_SHW_P44_^<W1_
MPX+_ .#IK_I-1_YT;_X**?\ SFZ /[_**_@#_P"'!?\ P=-?])J/_.C?_!13
M_P"<W1_PX+_X.FO^DU'_ )T;_P""BG_SFZ /[_**_@#_ .'!?_!TU_TFH_\
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M_P#@Z:_Z34?^=&_^"BG_ ,YN@#^_RBOX _\ AP7_ ,'37_2:C_SHW_P44_\
MG-T?\."_^#IK_I-1_P"=&_\ @HI_\YN@#^_RBOX _P#AP7_P=-?])J/_ #HW
M_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\ X**?_.;H _O\HK^ /_AP7_P=-?\
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M#^_RBOX _P#AP7_P=-?])J/_ #HW_P %%/\ YS='_#@O_@Z:_P"DU'_G1O\
MX**?_.;H _O\HK^ /_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS='_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ /[_ "BOX _^'!?_  =-?])J/_.C?_!13_YS='_#@O\
MX.FO^DU'_G1O_@HI_P#.;H _O\HK^ /_ (<%_P#!TU_TFH_\Z-_\%%/_ )S=
M'_#@O_@Z:_Z34?\ G1O_ (**?_.;H _O\HK^ /\ X<%_\'37_2:C_P Z-_\
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M_P#G-T?\."_^#IK_ *34?^=&_P#@HI_\YN@#^_RBOX _^'!?_!TU_P!)J/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img222063773_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img222063773_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ;>#YD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^?W_@AC_P
M0Q_X?1_\-1?\91?\,V?\,V?\*2_YHE_PN+_A-/\ A<7_  MS_JKGPL_X1S_A
M'/\ A5G_ %'?[7_MW_F%_P!E_P#$Q_?[_B!C_P"LHO\ YI-_^5Q1_P &,?\
MSE%_[LF_]^XK^_R@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK
M^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_
M .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_
M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_
MRB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q
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M "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_**
M/X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_
M^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^
M5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\
MUE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#R
MN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#
M_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_
M .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\
M0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\
M-)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\
M** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/
M_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW
M_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_
M]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF_
M_*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH
M_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\
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M -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\
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M^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\
M647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\
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M_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\
MX@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_Y
MI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0
M,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF
M_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH
M _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\
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M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_
MRB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q
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M<\26EN[K%/?Z!<:U9V\Q\J5Q("E?;/[&_P#P>@_L@_%OQ-I'@W]L#]GSQ_\
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MJ2R\#7EY,_EQV-EX[M_VD+KP=>7[N5 L;77)KO#Q,80LL98 _P!"BBOX)O\
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MGKK%A,K1W^@>!= \;ZAI][!<:/XCD\,ZA&ZQ@']-=%?YA _X.9O^"^?_  4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O@#_@K%_RBR_X*6?]F ?MD?\
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MXEUF*VM+AIO*< ^QOV;_ /DW?X"_]D7^%O\ Z@^A5[17 ?"CPG?> OA;\-?
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M_P '0O\ R@L_;H_ZX?LW_P#K77P"K_'^H _TQ_\ @R;_ .4>W[4O_9Y>K?\
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M@H^&O!VO6LVG>(+;X2>$H-3U/Q%-XDUW2+FXTR+QCXH7PK<^$4GN;S1-"O\
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M+_2;RSO8LQ3H2 ?VM4444 ?Y-G_!V_\ \IH/BO\ ]D8^ 7_J!6U?S^_L[?\
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M[HTMQ(TVHJ6_J>H **** /P(_P"#H7_E!9^W1_UP_9O_ /6NO@%7^/\ 5_L
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M&OPLC%@@-UXY\&ZEX)LDR>IDO?$%O&%ZN6"#EA7^*30!_4A_P9_^*-1\/_\
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M1N[B]CTK3M:UO\O/^#8;_D[S_@X#_P"S_I/_ %9W[4=?Y[__  3U_;U^./\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5\ ?\%8O^467_!2S_LP#]LC_ -9U^(U??]?
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MO_!0_P#9W_X*7?LV^#?VBOV?_$]A=1:MIMC!\0OAS<ZI8W/CGX/^.3!_Q.O
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M>E?!7X3^"?V[_P!GSXS>#M7T*/XG_''X%7EM\8O".GW=H^LPS_"[7+/P_P"
MOB!X@L8V:]MI/%WA?5SX-TRZN@EO>6/PK6*T4O97;N ?E;_P;H?\% /^'?\
M_P %//@WXC\4:W_9/P6^/LJ?LZ?&IKJX\G2K#P_\0]4TV+PCXROVE;[+9Q>!
M/B+9^%-?U/5I(GN+/PC'XKL[=XEU.X+?[$%?X ]?Z['_  ;G?\%;O!__  4=
M_8J\#> ?'_CG3)?VQ/V=_#FE_#WXR^%=6U6!?%OCO0O#MM!I?A+XWZ;9W$PO
M==T[QAHT5A'XUU.TB9=)^(=OKT%[;V&GZGX;FU, _H@HHHH _ C_ (.A?^4%
MG[='_7#]F_\ ]:Z^ 5?X_P!7^L=_P=G_ +0GPM^&/_!'SXU?!?Q-XQT/3_B;
M^T=XL^"OA/X8^"I-1MCXG\1#P1\;OA[\5_%FL66BI(VH-H&A^'? -_#JVNM;
MKI-CJ.I:+I5S=QZCK6EVUU_DXT ?Z8__  9-_P#*/;]J7_L\O5O_ %2/P=K^
MS&OX6O\ @R9_:&^%<7P%_:S_ &7+_P :>']-^,?_  NW3/C1H7@74-2MK+Q#
MXG\#ZW\/?#GA'4M;\-:=<R13Z]:^'-5\%K#XC.EI=/H2ZOHDNJ+:Q:M8//\
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MSX?\1JW_  5-_P"B!_L ?^&L_:*_^BJH_P"(U;_@J;_T0/\ 8 _\-9^T5_\
M154 ?T%> /\ @R]_X)>>&=2M]1\9_%_]LCXDQ021.^AZE\0_A;X9T&\1&#21
M7@\+_!O3_$>R7 0M8^);&1$+;7\PK(G[Y_L7_P#!+7]@/_@GS9R+^R7^S+\/
M?A?X@NK)M/U+XA/!J/C'XJ:M92X:YLM0^*'CB_\ $?CI],NI<SS:)!KMOH2R
M[?L^F01QQ1Q_P!?\1JW_  5-_P"B!_L ?^&L_:*_^BJH_P"(U;_@J;_T0/\
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M/[8?_P!$%7\@7_$:M_P5-_Z('^P!_P"&L_:*_P#HJJ/^(U;_ (*F_P#1 _V
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M/^(U;_@J;_T0/]@#_P -9^T5_P#154 ?V<^"?^#<3_@CM\-)+N7X<_LP>//
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MCS]I[X6>//B'KU_X:T[PA?6NF_M+?M1_#;PE>^']+-\;2RN_A_\ "KXS^"/
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MV%I]HL-=TW4=.U"WA%EJ%I=6;26[_LY7^8)_Q&K?\%3?^B!_L ?^&L_:*_\
MHJJ/^(U;_@J;_P!$#_8 _P##6?M%?_154 ?Z?=?,G[3O[%_[*'[:'A&+P/\
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M9G]L/_Z(*OY O^(U;_@J;_T0/]@#_P -9^T5_P#154?\1JW_  5-_P"B!_L
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M0/\ 8 _\-9^T5_\ 154?\1JW_!4W_H@?[ '_ (:S]HK_ .BJH _T^@   .@
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M/^(U;_@J;_T0/]@#_P -9^T5_P#154 ?U^_\0N/_  0H_P"C&?\ S9G]L/\
M^B"H_P"(7'_@A1_T8S_YLS^V'_\ 1!5_(%_Q&K?\%3?^B!_L ?\ AK/VBO\
MZ*JC_B-6_P""IO\ T0/]@#_PUG[17_T55 ']S_[-G_!$?_@FI^R#XZ\&?$7]
MG+X'>//AGXD\ :M-KGA:WLOVJ?VO->\(V6IW%O>VL]Q??#OQ9\>-?^'VO)+%
MJ%XSVOB#PQJEH;B7[7Y'VJ.*9/U<K_,$_P"(U;_@J;_T0/\ 8 _\-9^T5_\
M154?\1JW_!4W_H@?[ '_ (:S]HK_ .BJH _T^Z^#/VQO^"8'[ O[?EHJ?M:?
MLO?#+XL:W#9QZ?9>/9]/O?"?Q3TRQAW&WL--^*O@>^\-?$2STR!V\U-(B\2C
M2'D ,UC*,J?\_?\ XC5O^"IO_1 _V /_  UG[17_ -%51_Q&K?\ !4W_ *('
M^P!_X:S]HK_Z*J@#^B+QU_P9I?\ !+G7M9;7?A]\5?VRO@]<+<//9Z;X4^*7
MP\UO1].+$F-;*3QE\(M?\4J8,A(I9O%<TICR)7DD/FC(\-?\&9'_  37@UE-
M<^(GQ^_;<^)]PI7SK/5_B/\ "G2+&^"MG9?7&F_!AO$+IC*J+3Q!9LNYCO)(
MV_SZ?\1JW_!4W_H@?[ '_AK/VBO_ **JC_B-6_X*F_\ 1 _V /\ PUG[17_T
M55 ']XO[&'_!''_@FO\ L!7MGX@_9E_94^'WA;Q_9H1%\5_%8U;XF_%>"62$
MP7<NE>/_ (BZCXF\0^%TU"-F%]I_@^[\/:1< A#IRQ(B+^FU?Y@G_$:M_P %
M3?\ H@?[ '_AK/VBO_HJJ/\ B-6_X*F_]$#_ & /_#6?M%?_ $55 '^GW7Y9
M_M:?\$6O^";?[<_Q)USXL_M4_ ;Q1\5_&GB*/0H]4DN/VC_VI/"/AAAX:T6Q
M\/Z,]A\/O /QJ\*_#_1Y[;2M.M8IKG1_#%A<:A<K-J.HRW>I7=W=S_PH?\1J
MW_!4W_H@?[ '_AK/VBO_ **JC_B-6_X*F_\ 1 _V /\ PUG[17_T55 ']?O_
M !"X_P#!"C_HQG_S9G]L/_Z(*OL?]DO_ ((Z_P#!//\ 88\=:-\1?V6/@OXR
M^%OB/0+/7+'2K8?M*?M3>-O!UO;^)+&?3M8,GPY^(GQJ\7?#R\N;FUN9Q%>W
MOA:XO;*X<7MA<6MZD=PO\'?_ !&K?\%3?^B!_L ?^&L_:*_^BJH_XC5O^"IO
M_1 _V /_  UG[17_ -%50!_I]T5_F"?\1JW_  5-_P"B!_L ?^&L_:*_^BJH
M_P"(U;_@J;_T0/\ 8 _\-9^T5_\ 154 ?Z?1 8%6 96!#*0""",$$'@@C@@\
M$5^=/[$/_!,+]FO_ ()\_%;]KSXD_LVV>M^%-'_;!\=^#/B'XI^%V_25^'WP
M[UWPG8^*(;BT^&6GV6EV=]H?A[7=3\7ZSK,WA^]O]2T[0YIHM+\,Q:/H%I9:
M3;?P-_\ $:M_P5-_Z('^P!_X:S]HK_Z*JC_B-6_X*F_]$#_8 _\ #6?M%?\
MT55 '^GW17^8)_Q&K?\ !4W_ *('^P!_X:S]HK_Z*JO]/N@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\
M_P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)
M9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_
M .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[
M?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4
M_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7
M[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G
M^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_
MT7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_
M (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X
M=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO
M^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_
M(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]
M"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__
M /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?
M^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M
M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3
M_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?
MM% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .
MG^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5
MH_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\
MX=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!
M++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!
M_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_
M /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]
MO_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J
M?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\
M9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?
MM_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q
M!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]
M?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ
M?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67
M_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6
MC_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_
M (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $
MLO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '
M\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK
M_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V
M_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@
MJ?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]
MG7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_H
MOG[?_P#X=/\ 9U_^A5K^OVBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&K[_KX
M _X*Q?\ *++_ (*6?]F ?MD?^LZ_$:@#\ ?^#*G_ )19?'S_ +/_ /BG_P"L
MZ_LJU_7[7\@7_!E3_P HLOCY_P!G_P#Q3_\ 6=?V5:_K]H _@#_X,8_^<HO_
M '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\ ?N*_O\H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O@#_@K%_RBR_X*6?\ 9@'[
M9'_K.OQ&K[_KX _X*Q?\HLO^"EG_ &8!^V1_ZSK\1J /P!_X,J?^467Q\_[/
M_P#BG_ZSK^RK7]?M?R!?\&5/_*++X^?]G_\ Q3_]9U_95K^OV@#^ /\ X,8_
M^<HO_=DW_OW%?W^5_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M++_@I9_V8!^V1_ZSK\1J^_Z^ /\ @K%_RBR_X*6?]F ?MD?^LZ_$:@#\ ?\
M@RI_Y19?'S_L_P#^*?\ ZSK^RK7]?M?R!?\ !E3_ ,HLOCY_V?\ _%/_ -9U
M_95K^OV@#^ /_@QC_P"<HO\ W9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO
M[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^ /^"L7_*++_@I9_P!F ?MD?^LZ_$:OO^O@#_@K%_RB
MR_X*6?\ 9@'[9'_K.OQ&H _ '_@RI_Y19?'S_L__ .*?_K.O[*M?U^U_(%_P
M94_\HLOCY_V?_P#%/_UG7]E6OZ_: /X _P#@QC_YRB_]V3?^_<5_?Y7\ ?\
MP8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@#_@K%_P HLO\ @I9_
MV8!^V1_ZSK\1J^_Z^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&H _ '_@RI_P"4
M67Q\_P"S_P#XI_\ K.O[*M?U^U_(%_P94_\ *++X^?\ 9_\ \4__ %G7]E6O
MZ_: /X _^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\Y1?^[)O_ '[BO[_* "BB
MB@ HHHH **_$W]KK_@WJ_P""5W[8S?%/Q)XX_9Z/@;XP?%?7O%?C37/CE\+?
M&OC3PK\08/B!XQU"_P!9UKQH;9M>OO!.MZA=ZUJ-WJ5QIOB?PEK6A333,/[,
M3;"T/^0]\?OAKX@^ GQV^-?P+UC7)]5U?X+?%OXC_";5=4A,]I%J6H_#GQCK
M/@^^OXK5KB=K:.\N=&EN$MVGF:%9!&99"N]@#_>3HK^23_@CG_P;B?\ !.2R
M_82_9M^,_P"T[\$D_:*^/'Q]^#GP_P#C1XOUKXC>*_&HT'PC#\4/#&F>-='\
M">%O!>@^(M&\-65MX7T?6=/TO4=6U*PU?7]5URWU2]_MB#2[BPT?3OZOO"_A
MG0?!7AGP[X-\*Z9;Z+X8\):%I'AGPYHUIYGV72=!T'3[?2M'TRV\UY9?L]AI
M]I;VL/FR22>7$N]W;+$ W:**JWUL][97EG'=W6GO=VMQ;)?V+0K>V3SPO$MW
M9M<P7-NMU;%Q-;M/;7$(F1#+!*@:-@#ROXV_M ? W]FOP+J'Q-_:"^+OPY^"
MWP_TS<MWXN^)OC#0O!FA_:!&TD=A:WNNWME'J&J7(0I8Z38?:=3OYBEO96EQ
M.Z1M\(_L*_\ !9#]A;_@I%\8OC'\&OV1/'7BWXD:G\$O#^E^)O$_B^\\!:_X
M1\#ZQI6JZL=$@F\*7WBJ+2=?U3R]222%WNO#FFV\T4?VNQGO+.2">7^2?_@Y
MK_X(F^$O@%^Q[9?MY6_[6'[87[2'QG\&_$SP9X-^)>L?M4?%31OB9:ZUX.^(
M4]]I2W'A'3]+\&>%;7P ^B^+CX=ATSP]X=2W\+0^'[N\LQI0O+2SO#Y/_P &
M0W_)T_[<'_9O_P //_5BS4 ?Z/E%%% !1110 4444 %%%% !1110 4444 %%
M%% !117BW[0_PAU7X]?!WQE\)=&^,GQ=^ %]XR@TJR/Q:^ ^NZ)X8^+7A6RL
M]=TO5-47P9XB\0^'?%6F:%J&NZ78WGARXU<Z%=W^G:?J]Y>:1)8ZO#8W]L >
M1_M<_P#!03]B[]A#PO\ \)9^UI^T;\,_@O:S6DM]I6@^(M;%]X]\2V\)=9'\
M(?#;0(=7^('B[8\;1RGPWX:U18'P)VB'-87_  3^_P""A/[._P#P4N^!^J_M
M#?LQ7?C*^^&VE?$;Q+\,)+SQOX8?PEJMSXB\*Z=H&JZA/:Z3+>WTYTJ:R\2Z
M7+9W-RUM<R,\T<]G;R0LI_S:?^#GO_@D[X!_X)K?'S]G[QY\,_BS\;_BSX>_
M:K\+?$;4_$&K_M"^.8_B;\2E^(WPIU+P;;>*-2O/'AT?1+_6M-US1_B#X2N(
M8=8M[W4[/5+;6'.J36%W86.F_P!6W_!FO_RB2\5?]GB?&/\ ]0+X-4 ?UA44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 45XU^T/\?OA7^RQ\$/B?\ M$_&[Q+'X0^%'P@\(ZIXU\;^(&M;K4)K/2-,
MC'[BPTVQBFOM5U?4[N2VTK1=(L89KW5M7O;+3K.*2YN8D/I/ACQ%I?B_PWX>
M\6:'+)<:+XHT/2?$6CSRPR6TLVEZW86^I:?++;S*LL$DEI<PN\,JK)$S%'4,
MI  -ROQ[_;^_X+K_ /!.3_@FM\4_#?P3_:6^*_B"+XJZ]I>G>(=0\%_#KP/K
M?C_5?!7AG5Y9(]*U_P </I2)9:%!J*0S7=CHRW=YXJN]-2+5;?P_)IM[I]W=
M_L)7\(O_  7P_P"#:+]L[]N7]OWQ;^V1^R-XG^%WBK0?CQI7P[M/B'X1^)'C
M.Y\$ZQ\./$_@'P'X9^&2:CIL\VCZK8Z]X)U/PWX0T35W%A=-XCL-;GUFRA\/
MW-@-/N) #^V[X,_&7X7_ +0WPK\!_&[X*^-=%^(GPJ^)WAO3_%G@;QIX?EED
MTO7M"U*,M!<QI<PVU[974$BRV>IZ5J5K9:MHVIVUYI.KV-EJ=E=VD/IE?GG_
M ,$IOV(+S_@G)^P!^SG^QQJWC2W^(/B#X2>'?$DOBOQ9817<&C:CXP^('CSQ
M5\3/%L'AR&^2&\3PSI/B+QCJ6C^'9;RUL;Z]T:PLM0U&PLM0N[JVC_0R@ KX
M._;0_P""G7[!W_!/;3;&]_:[_:4\ _"74]7LVU#0O!,SZOXM^)>OV(D:!=0T
M;X9^!M,\2^/+W26NE-HVN)X?70[>XS'=ZE;[)&3YB_X+G_\ !3V#_@E5^P?X
MQ^./ARWTO5OCEX\UJT^$?[//A_5XUNM-E^)?B33M4U!O%>N6 )DO/#GP_P##
M>D:UXMO[5D6TUC5+#0_"EW=Z?_PDL-Y#^,G_  :Y?L6?#3]I+]G+XE?\%1/V
MQO#>C_M2?M;?M*_''Q_:V?Q5^.FD:=\2-7\,>#/ DMAX:\OPO#XJM=3L?#^K
M:KXI@\41WVIZ+;6#6_AFQ\->$])CTW1-'-G<@'W3X%_X.O?^"+7C3Q9;>%KS
MX]_$+P'#>W26=KXK\=? [XE6/A-YIG6.!KF_T/1?$%_I=K)(RJ]_K&EZ?86:
M;I]0NK2VCDG3^@;X9_%#X;_&?P+X;^)_PB\>>$/B=\./&.G)JWA7QUX#\1:5
MXK\)^(=.D=XQ=Z1KVB75[IM]$DT<L$Q@N':"YBFMIA'/#)&O\EG_  <8?\&\
M7P]_:C^"^H_M4_L%? [PMX-_:P^%L,NJ^,_AC\*/#&E>%[3]H_P#&C/JUK;>
M%-!M;#2K_P",GAA1_:_AG4K*UBUSQOI<>J>#;X>(-9?P/#I7P?\ \&9_@;]O
M?X:?%W]K3PG\1? 'Q<\!_L;#P!#<7VF?$SPWXF\*:'9_M0V7C#PO8:/#X)TK
MQ596)&O2_#L>.8/B7_8%NKQIIOP_B\6ND\/A:)@#^_VBBB@ HHHH **** "B
MBO&OVA_C]\*_V6/@A\3_ -HGXW>)8_"'PH^$'A'5/&OC?Q UK=:A-9Z1ID8_
M<6&FV,4U]JNKZG=R6VE:+I%C#->ZMJ][9:=9Q27-S$A /9:CFFBMXI;BXEC@
M@@C>:::9UBBABB4O)++(Y5(XXT5G=W8*B@LQ !-8_ACQ%I?B_P -^'O%FARR
M7&B^*-#TGQ%H\\L,EM+-I>MV%OJ6GRRV\RK+!)):7,+O#*JR1,Q1U#*0/RJ_
MX*-?\$AO /\ P4QFU>P^,O[6?[:7@#X<WG@*W\)Z?\#?@Q\6/#W@OX(KXD@N
MM9NF^(?BKP1+X%U2?X@^()Q?Z;:-8>+=;OM"M;+2/+TW3[&XU&ZN@ <5^T)_
MP<%?\$JOV>/BYX.^ ^H?M)Z5\7/BUXQ\;:%X"C\)_L_Z?)\6[?PYK?B#5K?0
MK9?%OC+P_.O@#1'L]5NH+/5-'?Q7/XHT^0R&?0 D$[1?M-7^&-\*/AYJGPB_
M;Z^&OPHUNXAN]:^&/[7_ (-^'FKW5LCQV]SJG@OXSZ=X;U"X@CD+.D,UWILT
MD2.2ZHRJQ+ FO]SF@ HHHH **** "BBB@ HHHH **^?OC%^U!\%_@/X]_9[^
M&/Q*\5_V/XZ_:B^)5]\*/@OX=MM/OM2OO%'BO2O"6M>-=7:1+*&9=+T32-$T
M.4ZEKNH-!IUI?ZCHFG2S"[U>RCD^@: "BBB@ HKR+X[_  %^$'[3GPH\6? W
MX]^ ]&^)OPF\=)HT?BWP/X@-X-'UU/#_ (ATGQ7HRWAT^ZLKS&G^(M"TC58/
M)NHO])L8=^^/?&_\-'_!RU_P01_8D_97_8JUW]N/]C?P5K7P&\2_"_QQX T?
MXC> -%\7^+/$?PY\9>$OB%XELO T6I6NC^,-:UZ^\*>)M%\3:UX:DM9?#FJ6
M'AV[TJ36+>_\.W&IW-GJMD ?WZ45_B@?\$??V+-/_P""C7_!1;]F_P#9'\9>
M)_$OASP!\1-=\4:Q\1-:\.WBPZ[;>!?AUX%\3_$;Q)8Z/=7<5Y;:?JOB*R\+
M'POI>J3V-_#I>HZW:ZC+8WD=LUO)_K)?LF?\$>O^";_[#OC+P[\2/V9/V8/"
MWPZ^)/AC0]3\/:9\0W\2^/\ Q9XR.FZW8'3=;CO-;\9^+/$%Q>2:M:,\=V\X
M8 2,+9;= B* ?I;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%?/W[2?[4'P7_ &2O 6B_$GXY^*_^
M$4\,>)/B3\-OA%X=>#3[[5]2UWX@?%?Q;IO@SP;X?TO2]-AN+V[GNM3U(7E]
M)'$8=+T/3]6UJ]>*PTRZE0 ^@:*** "BBB@ HHK\!O\ @MO_ ,%IM._X)P^'
M_ O[/7[//A>T^.7_  4._:3GTSPY\ ?@O;12:Q!X;?Q3K"^%M \?^.](T^X@
MU"[MM2\1S?V+X!\(13V5[X\\16]W!'=VFC:-K=[" ?IY^U9^W?\ LK?L5V7A
M$_M!_%?2O"_BGXC:Q:>'?A=\+]%LM4\:?%_XI^(=0O(M-L=(^'GPM\(V6L^-
MO$[RZE<6MA<ZG9:.="TBXNK8ZYJVF02K-7U[7XI_\$K_ /@E/+^RPEY^UK^V
M1XON/VH/^"GGQMTN+5?C?^T3XYN8O$ES\.TU:V623X*_ \2)_9?@GX>>$H9G
MT*6X\*66C1^)O(D2WM=)\&P>&_".@?M90 5S?B_QEX0^'OAC6_&WC[Q5X;\#
M^#/#.GS:MXD\7>+]<TSPUX8\/Z7; &XU+6]?UJZLM*TK3X 09KR_N[>WB!!>
M10:_/[]MW]HS]OGP'K4'PE_8)_8<3X^_$35_!D/B>;XY?&;XH^"?A9^R]\.Y
M=0U'6=+L-)U8)XE_X6M\2O&5M/HK7NK>"/"N@>'+6RT75]#U2;QO#]M:TC_R
MOO\ @LQ^U5_P5>^)7[4?Q$^ ?_!3OXD>+K;Q[\*M?M'?X%:+JNFZ5\#_  E'
MJ^E6>O>&=:\"^$/!5TW@K5[/5/#.KZ9>Z1XUO&USQ;J6E74$6NZ_<:A%=0P@
M'^QI\/?B+X!^+?@GPU\2OA;XU\*_$;X>>,M+AUOPCXY\$:]IGBCPEXGT>X++
M;ZKH'B'1;F]TK5M/G*.(KRQNI[>0HP60E3CLJ_)#_@@S_P H=?\ @GE_V;AX
M2_\ 2C4J_6^@#Y?_ &IOVR/V=_V*O#'@;QW^TWX^3X5_#SQ[\1-)^%UG\1=8
MT;7+OP+X:\5Z]I>LZIH9^(/B;2M/OM-^'_AW5#H=SI</B_Q9+I7A:UUBYTVP
MU'5[)[^W9OHO0M=T3Q1HND^)/#.LZ5XB\.Z_IUGK&A:_H6HVFKZ+K6D:C;QW
M>GZII.J:?-<6.HZ=?VLL5S9WUG/-;75O+'-!*\;JQR?'7@3P5\3_  =XF^'G
MQ'\)^'?'?@/QGHU_X=\6^#?%NCV'B#PSXET'4X'MM0TC6]%U2"YT_4M/O(':
M*XM;N"6*13RN0"/XP?VB_$/[1'_!K;^T7X-^(7P@;QW\=_\ @B=^T5X\N-*\
M3? '6M5O?$GB#]D#XAZU+/JM_IGPH\2:Y<33Z797]HFJ^(_ FFZGJ,6B>/;3
M2_$?@WQR]IXSL-!^*6H@']M-%>5? [XW_"K]I+X1_#_X[?!#QKHWQ$^%'Q1\
M-V/BOP3XQT&9I=/U?2+X,N'CE2*[T_4M/NXKG2];T74K>TU?0=:LM0T76+*R
MU2PO+2'U6@ HHHH *_,;_@HM_P %??V&?^"6UEX&_P"&L/B3JVD^*OB2+ZY\
M%?#GP+X8U'QOX]UG1=+GBM=4\2RZ/IY@M-%\.65W,EFFK>(-3TJ'5+U;JRT,
M:I=Z?J,%I^G-?QW?\'*7_! 7]J#_ (*=_&KX-?M3_LE>)? FK>-O!GPFL?@;
MXY^%?Q#\32^#H[CP]H?C3QEXV\->+_!NO3V%_HTUY]M\?^(=.\4:/JUSHN+2
MRT.]TB;4;J74;:, _IZ_9&_:_P#V>OVZ/@7X3_:._9A^(=A\2?A5XO:^M+/5
M[>TU#2=3TC6])F%MK?ACQ/X>UBVLM:\.>)-&N2L=]I6JV=O,T$UGJ=DUYI&H
MZ;J%Y]+U^)7_  0)_P""7OCO_@D]^PFWP$^+'C;0?&GQ9^(OQ:\4?'+XC+X0
MN+^]\%^$]>\2^&/!/@RS\'^&-1U*RTN[UBWTOP]X!T6YU;69M)T\7GB&_P!6
MALX[C2K/3;NX_;6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M'O\ ;^_X+K_\$Y/^":WQ3\-_!/\ :6^*_B"+XJZ]I>G>(=0\%_#KP/K?C_5?
M!7AG5Y9(]*U_QP^E(EEH4&HI#-=V.C+=WGBJ[TU(M5M_#\FFWNGW=W^PE?PB
M_P#!?#_@VB_;._;E_;]\6_MD?LC>)_A=XJT'X\:5\.[3XA^$?B1XSN?!.L?#
MCQ/X!\!^&?ADFHZ;/-H^JV.O>"=3\-^$-$U=Q873>([#6Y]9LH?#]S8#3[B0
M _MN^#/QE^%_[0WPK\!_&[X*^-=%^(GPJ^)WAO3_ !9X&\:>'Y99-+U[0M2C
M+07,:7,-M>V5U!(LMGJ>E:E:V6K:-J=M>:3J]C9:G97=I#Z97YY_\$IOV(+S
M_@G)^P!^SG^QQJWC2W^(/B#X2>'?$DOBOQ9817<&C:CXP^('CSQ5\3/%L'AR
M&^2&\3PSI/B+QCJ6C^'9;RUL;Z]T:PLM0U&PLM0N[JVC_0R@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY2_:R_;E_9&_86\$0?$/\
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M?J/CN;37_P"$8N/$4Y /]-6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_\ 9(_AO_ZANBT >N4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^9++XT_#/X=>&K-4@O\ 3Y-]C\3O#?A+33'?V4VG^.[71;>XT[QWJ^I_:O\
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M%E_P4L_[, _;(_\ 6=?B-7W_ %\ ?\%8O^467_!2S_LP#]LC_P!9U^(U 'X
M_P#!E3_RBR^/G_9__P 4_P#UG7]E6OZ_:_D"_P"#*G_E%E\?/^S_ /XI_P#K
M.O[*M?U^T ?P!_\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7
M]_E !1110 4444 %?X>/_!44!?\ @IE_P4350 !^W5^UP !P !\?_B"  .P
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M=X.T1'2[\2>,?$MXHL-#T.R_>3RF2ZNYK+2[/4-0M #_ %$**_@5_:O^(O\
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M*U/QS\+_ /@OK^V'\0_V@]/LIM3T_1OB)XL^,OPV^'GB+68XFF72=%U?P?\
M';Q/=_#&SEN=RV$EGX:\26%LSI&]G9Q-)=0@']E5%?Y=7[%W_!Q[_P %1?\
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M+>( _A:_X/F(T.E_\$QYB!O2_P#VQXU/<)+;_LN,X^A,*$_0>E?I7_P9K_\
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M:SJ5UI\>D78!_>Q17\2G_!O;_P '-'CW]L/XK>%?V&_V_I/#]Q\;O&<5S9?
M_P#:#T'1]-\*67Q/U_3[*YU&;P!\2_#6C06/AG1?&VI6-K=2^$?$?A?3M#T'
MQ)<6T?AB[T"R\27&FWOB/^VN@ HK^;?_ (*L_P#!;CXA?!/]HKP9_P $R?\
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MZ+%XPO/MNGII7A"WTC6=+T".TURV\4M=ZU%:Z/\ UPT %%?RI_\ !QM\1O\
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M_BK1M)@U/2["^ETW0+O2[&Y>'^V#_@VQ_P""TGC+_@JC\!?B#\.OVB9M%?\
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M'4[;6=$T@ _0]F559F8*J@LS,0%50,EF)P   223@#DU_F^?\%S/^"POA/\
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MFB^,(K34M+NYKK0['Q386VM);7^BW,D]A$(KK2YF:2T8 _W2J*_DI_X=^_\
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MX;_MS?LJ?'']E'XKVJ3>#OC/X%U3PN^H?9X[F[\+^(4\O4_!GC?28Y<1G6_
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M-;_@HC^TOK'B;PWX4_:9^'OBRPUCX?:%X3\!>'OVA/AYKEMK^B^&/$^J>)O
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M+MD%O;?;+VSM?.D3[1=6\.^5 "Y17\//_!97_@X _P""P7[,/P[T/Q1\*?\
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M7$]OH&F?$7P/XATY;CQ#=0V%T/!&O:MX6CU< _T3**_G&_X(4_\ !P5\+?\
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M_@N;^S+^UOK^L?M!?M9_MG_";]I'P5XDBU77_AWX^\:>*]!\(6CR3"_M+/\
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M\8?B'X+\$2>)+ZU\0ZMJ6K>"YO!%UX?UVP\4V$@T/5+F'^6;_@FE_P %G?\
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MTYXUNX0#]0/^"UL:R_\ !(__ (*-*X! _9 ^.$@!_O0^"-4F0_5712/<"O\
M/#_X-#O^4R?@G_L@'QV_],6F5_H@?\%J/^42/_!1O_LSSXZ_^H'J]?YOG_!K
M1\6OAK\"/^"I!^,?QB\::#\._A?\./V7_P!H;Q5XW\:^)[U;#1/#V@Z9X=TR
M6ZO+N8AY))&.RVLK&TBN-0U._GM=-TVUN]0N[:VE /\ 6^HK^&7]JS]L[_@X
M1_X+##5]1_X)'_ 3XH?LK_L(C[7#X%^./B#Q1X$^ _QA_:&TY&D2T\;:+XP^
M(?B+0/%?AWPKJXC\[PO;_"&&.*T7S_\ A*OB!J5U.FD:+_,CXB_;Y_X+V_\
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M^P-^U]^TGI,\5MXC^$7P ^)/BCP9+.56$_$ >';S3?A[%,6##RKCQM?Z!!(
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M$;XJ:I+XD^*7P8\:>+-0@T7PGXEG^(VJ/)XB\6>!+S7KS3]+\::=XWU35Y]
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M7@6R?21::]XLOK^[.F7&HZ9#;Z5J5S>16[?YW/\ P5P_X.6/^"RFF?%3QO\
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M#+7?!.LWOQ0\'ZCXO\/7,LFG7D,L]]!%\/K+X=VD&J%RLBVQL5Q]@P/[+/\
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M+.P66:P_X0)(?'T$,Z":SU;XCZ];NSA5-?EY_P %[-6U7_@JE_P64_X)_?\
M!%OP)J-Y<_#3X9:[IOQH_:IDTBXE1-+?Q#HS>+O$:ZD\;>78ZSX(_9VTF^NO
M"-[));)/KGQJ@T@NUU<6R#^WS1M'TKP]I&E:!H6G6>D:'H>FV.CZ-I.G6\5I
MI^EZ5IEK%9:=IUC:PJD-M9V5I!#;6MO$BQ0P1)'&JJH  -*BBB@ K_*[_P"#
MH[]L'QW^W#_P5GMOV.?".N2-\,?V8]:\)_ 'P'H?VF5=$OOC-\03X=N?BAXP
MOK5=Q&JQ>(]6TGX<SN0XATWX?0S6<<3ZC?&Y_P!42O\ %*_;@^(EUX _X+1?
MM;?%3Q0+F6X\ _\ !3?XY^-M9B$9EN%C\&_M2>)]8N+6&%P Q@M]+-M;6^U4
M"1QPJJH   ?[+7P#^"G@7]F[X(?"7X ?#+3(](^'_P &?AWX1^&OA&Q2..-U
MT/P?H=EH=E<7AC4"XU*_2S^WZK>R;[C4-2N;N^NI);FXEE?,_:7^!7A?]J#]
MG;XZ_LW^-;J[L/"7QY^$7Q$^$/B'4M/2*34M)TKXA^$]5\*W6L:8DY$)U32(
M]4.I::92$6^M;=F( )KV+3M0L=7T^QU72[NWO]-U.SMM0TZ^M)4GM;VQO8$N
M;2[MIHRR36]S;RQS0RH2DD;JZD@@U<H _P _K_@G[_P:&?M;?LS_ /!03X#?
MM _&#]I3]G_5/@7^SG\;O!/QHT.[^&ES\2)?BG\0;OX8>*M/\9>#]#OO".O>
M!]%\-^#K77-5T;3[;Q?)'\0?$S:9IL][::0==DE6\A_MM_;._:+TK]D7]DK]
MI']I[6+:"_M?@1\%OB+\3K?2;EWCBUW6/"GAC4=3\/>'#)&RLC^(]>ATW0H7
M#QA9M0C)DC4%U^F*_"__ (.5[_4M-_X(@_MY7&E-(MU)X1^$UA*8L[CINJ_M
M#_"'2]94X_Y9MI%Y?+-V\HOGC- '\1W_  ;O_P#!4/\ 9._9(_:M_;5_;8_X
M*!ZW\5_&/[0'QHTW2M.\'>,O"/PQUCXFZG=7OQ&\8^)O'7QTUS6;C3 J>']0
MUG6-&^'\.FM$4:YL)-<L8%@L8Y(9?ZZO^(K_ /X),_\ 00_:?_\ $;/&G_QZ
MOP@_X,>?BQHVG?$O_@H-\#;N[A7Q#XQ\#? /XK^'[$NJSRZ/\-]?^)?A#Q?=
M)']Z2*"]^*G@B*5Q@0O<1 Y,XQ_H;4 ?YKG_  <N_P#!63]A+_@J9^S1^SUX
M9_9>T[XT:W\:?@_\<[W76F\;?!3Q+X.MK/X7^+? /B+3_&45CK5^LZR3W?BO
M1/AL\FEQ[6NH[3[6<C3^.6_X,Q_BS\1/AQ_P4'^.'P)O[/Q!8?#WXX_LWZQX
MAU#3[RUU&RTY_'_PD\7^&;WPEJS)<0K:R7-IX6\6_$33E&%G*:J&67RX7BD_
MTS** /RO_P""X.E6NL_\$AO^"BMI>0QSQ0_LH_%C54215=5NM"\/SZW8S ,"
M!);WNGV]Q$WWDEB1U(901_F7?\&XW[(7PY_;6_X*H?!OX3?&$SZE\*?#GA_Q
M5\7_ !SX%*M)H_Q1M/A6=*\4>'/ /BRV,JVNH>#[[QU;>%-:\2:3J%M?V6LZ
M;H,VDR6T4E[%?V7^G-_P6H_Y1(_\%&_^S//CK_Z@>KU_GE_\&@G_ "F,\-?]
MFZ?'/_TA\.T ?ZHWC#P-X*^(?A/6O 7C_P '^%O'/@7Q'ISZ1XA\%^,/#^D^
M)O">O:3)LWZ7K7AS6K2]T?5-.?RX]]E?6<]LVQ,Q':,<[\)?@O\ !WX!>#+3
MX<_ KX3_  U^"WP]L+J[O['P+\)_ OA?X=>#K.^OV1[^]M?#/A#2]'T6"\OG
M1'O+J*R6>Z=%>>21E!'I=% '^-K_ ,'&'_*:S]OS_LJ'A7_U4GP\K_7J_9Z_
MY(#\#O\ LC_PS_\ 4+T2O\A7_@XP_P"4UG[?G_94/"O_ *J3X>5_KU?L]?\
M) ?@=_V1_P"&?_J%Z)0![!7^4G_P=^Z)9Z3_ ,%BO$%_;0QQ3>)OV<?@;K>H
M.B!6N;RWMO$OAM)I2 "\BV'A^QMP[9(B@C3.U% _U;*_RL/^#Q3_ )2]V_\
MV:I\%?\ T^?$>@#^^C_@A'_RAY_X)X?]FT>!_P#T&[K]9Z_)C_@A'_RAY_X)
MX?\ 9M'@?_T&[K]9Z /\V_\ X/=/^3P?V+_^S:_%?_JT-6K^G;_@U;_Y0;_L
M@?\ 8<_:2_\ 6G_C#7\Q/_![I_R>#^Q?_P!FU^*__5H:M7].W_!JW_R@W_9
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MY3A?L'?]C1\8O_6</C'0!_L%Z!X?T'PIH6C>%_"VB:1X:\->'=+L-$\/^'=
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MY@D2:"XMYT66&>&6,LDL4L;+)'(C,CHRLI*D&O\ #R_X*>>%;#P-_P %)_\
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M54DPW5K+!?:;J>GW4=MJ>BZUIMS::MH>LV5AK&DWEGJ5C:W,7^9O_P %5O\
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M^&]5@=0Z3:;KFG7.F7T3H2 ZR6MU*C*2 P8@D9H _P C/_@V=_;T\3?L4?\
M!4?X*>%Y=:N;?X/?M;^(-!_9L^+'A][AUTN[U#QUJBZ7\(_%4D+M]DM]3\'_
M !-U'1 -9FC,MCX3UWQII\4UO#K5W*/]>NO\)']DVPUV7]K7]FC2_#HE/B:3
M]HOX-6&A"U#/.==?XE^'+?3!;"/YWE.H&#R1'\S/M"\D5_NW4 ?PW?\ ![__
M ,FY_L'?]EK^+?\ Z@OANO>/^#*'_E&M^TE_V?'XR_\ 5"?L^5X/_P 'O_\
MR;G^P=_V6OXM_P#J"^&Z]X_X,H?^4:W[27_9\?C+_P!4)^SY0!_8S1110 5\
M/?\ !2O]F'Q9^VA^P3^U=^RWX#\16/A7QO\ &KX-^*?!_A#6M6DN(-&B\320
MQZCH=AKMS:17%U::!K6I6%MHFO7EM:WMQ9Z/J%[=0V%_)"MG/]PU7N[NUL+6
MYOKZYM[*RLK>:[O+R[FCMK6TM;:-IKBYN;B9DA@MX(4>6::5TCBC1G=E520
M?P__ /!LA_P0E_;P_P"">_[7WQA_:B_;+\%>&_A)I*?!'Q+\%O 7@[3_ (A^
M!?B!KWC/5/%WCCP)XCO/%QN/AWXA\4Z/I'A;2=+\!RVT5GK>H:?XAU#4->L)
MAI-K!IEWYG]K_C7QSX)^&WA?6/&_Q%\8>%O /@OP]:M?:_XO\:^(-)\*^%]#
MLD(#WFL:_KMW8:5IEJA(#7%[=P0J2 7!(K^23]K_ /X.6/'OQL_:/LOV /\
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M6:,KK:>)M L/$5CINM7/AK6$NM"U>ZTRSM]:L-0T[[18W'^GO_P5U_Y14_\
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M^R7_ ![_ /4K^&U?Z)E?YV?_  ?#?\EI_P""?/\ V2_X]_\ J5_#:@#][O\
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M /R0?X)_]DC^&_\ ZANBU_D _P#!P[_RFC_X* ?]E@TO_P!5SX(K_7^_9_\
M^2#_  3_ .R1_#?_ -0W1: /7**** "O\Z/_ (/@M%LX/C]^P-XB2")=0U7X
M/_&C1;JY"*)IK/0/&G@V^L8)) -S16\_B349(D)*QO=3,H!D8G_1<K_._P#^
M#XK_ )*S_P $\/\ LG?[1/\ ZDOPEH _47_@SW_9)^ GA;_@GS%^V!9^!;#4
M/VBOBE\0OB?X!UGXFZWC5M=T+X?>#/$OV/2O G@B6Z1E\(>&+V^-UX@\16>C
MB"X\3Z]>?:]>N]0@TS0;32/Z^Z_F5_X-'/\ E#%\+_\ LMGQ\_\ 4V>OZ:J
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MO>!_$ZVLZ>'/B%X)O[F&9M%\9>$=0F34]%U&(;'=)M-U*&]T;4-2TZ\^J**
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M_P"SQ/C'_P"H%\&J_K"H _S*O^#M[_@DS\-OV0OB]\-/VX/V=?"&G^!_A/\
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M.KT ?X^/_!O9_P IG_\ @G[_ -EHN?\ U!/&%?[,5?XSO_!O9_RF?_X)^_\
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MD?\ *6/XB_\ 9E'Q>_\ 5K? 2@#_ %(E5454151%4*JJ JJJC"JJC "@
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M;EUP3%/*F=KL#_3?7\UO_!VA_P H5?CC_P!E4_9]_P#5K:!0!_/;_P &/_\
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M%[_LE_C_ /\ 44U:O4*\O^-__)%OB]_V2_Q__P"HIJU '^/K_P &\7_*:/\
MX)__ /98-4_]5SXWK_9:K_&E_P"#>+_E-'_P3_\ ^RP:I_ZKGQO7^RU0!^8G
M_!:C_E$C_P %&_\ LSSXZ_\ J!ZO7^9O_P &TO[*WP/_ &O_ /@JU\*/AC^T
M-X,M?B+\-] \#?$3XGW'@/5Y7;PMXJ\0> -/LM6\,6'C/2@/*\2^%[76VM-7
MO_#%\3I&N7&FV=EKEMJ.C/?Z7??Z9'_!:C_E$C_P4;_[,\^.O_J!ZO7^=_\
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M\?:+\FM^!/%WASQAI.YFBVZKX8UFSUJPW.H+Q[;NQBRP4LF,@$C% '^^517
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M9X2NMC%1-IOC?X3?$'PAJ5O*HR)(Y;/6IOE8$"0)(-KHCK_LBU_C&_\ !O\
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MW2;"[O;B*%_Y$] _X+)?\%2?^"X_QG\:_ '_ ((U?#S1_P!DC]F;P3=P:?\
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M[0!_ '_P8Q_\Y1?^[)O_ '[BO[_*_@#_ .#&/_G*+_W9-_[]Q7]_E !1110
M4444 %?X=W_!4&5)_P#@I=_P40FB8/%+^W/^UM+&XZ,DGQ]^(#HP]F4@CZU_
MJU?M9?\ !8O5O@$/BQX3^$O_  3*_P""J7[2_P 5/ .N>+/!_ARU\ ?L0?&B
MV^#_ (R\1^'-0OM(MM;L/C++X>N](U'X::M>60O=-\:^#M(\8-JVB7-IJ>BZ
M3J$%U&Z_Y<_Q0_X)P?\ !6_XN_$SXB?%CQ?_ ,$V/V^)_%OQ/\=>+?B'XHFM
M?V,_VC(K:;Q%XUU_4/$FMRV\3_#R5XH)-2U.Y>&-Y9&2,JK2.06(!_L$_L!.
MLG["/[%$B,&23]DG]G!T8'(96^#G@UE8'N"""#Z5];5_)Y_P2>_X*[?M'?"3
M]D#X%_LV?MJ_\$E?^"L'@?XA?L__  O\%_"#3?B+\.OV$?CQ\0O _P 0/"?P
MZ\/V7A3PIK>HVB^%])\6>&_%LGA[2M+MM?L!HVNZ3?ZI!=ZW;:W9IJ*Z)IW]
M4WA;7XO%?AGP[XH@TS7=%@\2:%I&OPZ-XIT>]\.^)M)BUC3[?48],\1>']2C
MBU'0M=L$N%M=7T>_BBO=,U"*XLKJ-)X)% !NT444 ?SB_P#!UZ0/^")'[262
M!GQ[^SL![G_A>G@0X'J< GZ GM7\WO\ P9#?\G4?MP?]F_\ P]_]6+-_B*^]
M?^#B#]MG]J'_ (*!?LDG]B[]C[_@E=_P50UJS\4?$?PCXM^)WQ1^('["GQY\
M'^'$\/> KRYUG2?#G@[24\*ZIX@UG4M5\40Z-J-_JVK6&A:;INF:3]GL8];N
M-8:?1?QY_P"#>ZZ_X*%?\$D?VMO'/Q'^-/\ P2<_X*7^-?@Q\9_A>_PR\;/\
M/OV,_CM>>,_"%]9^)='\3>&_&&EZ+K7@O1=-\16=E/I^H:3K.C/K.E7G]GZT
M^K:=<W=YI,>B:P ?ZAM?YW__  ?%?\E9_P"">'_9._VB?_4E^$U?VO67[=OA
M6]_9@O?VIC^S=^W'::)8^((_#DGP7O?V0?C+#^T_-<R:O9:-_:-E^SZOA^3X
MA7WA])KY+Z3Q!::9-I"Z1;WNK&[^PVDTR_P#?\'%WB#]OO\ X*V_M*_"77/@
M)_P2E_X*7^&_@A\ /A_K?A'PIJ_Q"_8H^/6D>,?&OB7QCK=MK'B_Q'/H>E^#
M=9MM#\/B+1_#NE>'M/N-1N-5F33K[5]26PDU6/1M+ /Z9?\ @T3(/_!&GP#@
M@X^//QX!]C_PDUF<'T."#]"#WKR3_@\2_90\0?'+_@FIX0^._A#2[C5=8_9(
M^,VE>-?%$5M"]Q<6WPH^(NF7'@'Q??PP0J\[C3/%ES\-]5U&55,%CH-AK.I7
M9CMK*2>+XG_X-R?VO_VHO^"<O[+?C#]D+]L'_@EO_P %3=*TJV^+'B'XF?#'
MXE?#[]A#]H#QGI TOQGI7A^UU_PAXJT9/"&G:YI=WINN:)<:WI&K:79:U9ZI
M;:_>V5_%HLNBVLVM_P!P'CGP1X1^)G@OQ;\.?B!X=TKQ?X%\>>&M<\'>,O"N
MNVD=_HOB3POXETVYT?7M"U:RE!CNM.U72[RZL;R!QB6">1,C.0 ?Y7/_  ;)
M?\%G_"?_  30^/GC#X%?M':U/I/[)7[3.HZ%)K/BQUN+FS^"WQ:TJ-]*T+XC
M7MI DTO_  A_B+29T\,?$6:UMY+RSM=/\)^(]WV#PMJ%G?\ ^JIX;\2^'/&7
MA_1?%OA#7]%\5>%?$FEV6M^'?$WAO5;'7/#^OZ+J=O'=Z=J^BZSID]UIVJ:9
MJ%K+%<V5_8W,]K=6\D<T$LD;JQ_RQ/\ @L?_ ,&Q'[5W[$WQ"\7?%7]CKX?^
M./VG?V/]6O[[6M$@\#Z;?^,_C'\&-/N)9+IO"OQ \&Z5!=>)/$^A:% 9([#X
MD^&]/U2PFTFS-YXU@\+WVPZC^)_[.O\ P4(_X*+_ +&:W'PS_9R_:A_:0^"E
M@-3F@F^%7ASQCXIM?#MOKMU.?M)3X9:J]YH%GKUU<2$7$\/A^'5+B4A99'8*
M  ?[1?[3G[3GP0_8[^"'CS]H?]HCQ[HWPY^%?PZT>XU;7==U>YBCFO)TBD.G
M^'?#NGM(EUXA\6>(;I$TOPUX:TM+C5=<U6XM[&QMY9I0!^9O_!#+XN?M$?M5
M_LV_&7]NC]H*]\8:99?MJ?M,_$3XP?L]?"KQ+K.I7MA\'OV8]!TKPQ\*_A+X
M5T/2+R9['1O[6M_ 6K^+=3OM#MK#2_&DVNP>.([5I_$$UY=_QM?\$[/^"/G_
M  59_P""U?QG^'7QQ_X*J_$7]IVQ_8[\#:K:>(9I/VB?%/C73_&'Q.T^.2.Y
MF\%_ [X<>(KBTN?!VA>+(ECMM>^)EEH/A[0XM&N[J[\+W?B/7XQ;VW^D!J]S
MX0_9Z^"VHW/ACP%KS^ O@G\,[A_#WPR^#_@G4O%?B8^$?AWX8;^R/ _PR^'7
MA>UN-6\0ZR-'TBWT+P?X.\/V<U_J=X-/T?3+:2>:&,@'\C'_  >S_P#)@/[*
MG_9X=G_ZI;XK?XC\ZX;_ (,B64_LE_ML+D;A^T5X(8KD9"M\-( I(Z@,58 ]
M"5..AKXY_P"#D?\ :&_;4_X*L>'/@7\!/V6O^"3W_!4+3OA/\(?&FN?$SQ1\
M0/B?^Q!\=_#6K>,/&=YH,WA?P_8>%?#.F^$]<N;#PWHFC:GX@GO]3U^YL]4U
MC4M5MK>'0]+M-%-[KGB?_!NI\9?^"BO_  2*\?\ QJ\%?'S_ (),_P#!3+QM
M^SQ^T&/!NI:SJGP[_8Q^.VH^-OAOXY\#IK]EI?B'3?#NM>#=!T[Q%H&OZ7XD
MGT_Q99?VU9:M:+H^AZGHJW\EI>:/JH!_I25_)=_P>)?LH>(/CE_P34\(?'?P
MAI=QJNL?LD?&;2O&OBB*VA>XN+;X4?$73+CP#XOOX8(5>=QIGBRY^&^JZC*J
MF"QT&PUG4KLQVUE)/%_3I\!_C#IWQ]^$_A+XN:5X#^+OPQL/%\6KRP>!OCQ\
M,O%'P<^+&@G1]?U7P]-%XM^&_C2SL/$OAN6]GTF74](74;2-=5T"]TK7+%IM
M.U.TGD[3QSX(\(_$SP7XM^'/Q \.Z5XO\"^//#6N>#O&7A77;2._T7Q)X7\2
MZ;<Z/KVA:M92@QW6G:KI=Y=6-Y XQ+!/(F1G( /\KG_@V2_X+/\ A/\ X)H?
M'SQA\"OVCM:GTG]DK]IG4="DUGQ8ZW%S9_!;XM:5&^E:%\1KVT@2:7_A#_$6
MDSIX8^(LUK;R7EG:Z?X3\1[OL'A;4+.__P!53PWXE\.>,O#^B^+?"&OZ+XJ\
M*^)-+LM;\.^)O#>JV.N>']?T74[>.[T[5]%UG3)[K3M4TS4+66*YLK^QN9[6
MZMY(YH)9(W5C_EB?\%C_ /@V(_:N_8F^(7B[XJ_L=?#_ ,<?M._L?ZM?WVM:
M)!X'TV_\9_&/X,:?<2R73>%?B!X-TJ"Z\2>)]"T* R1V'Q)\-Z?JEA-I-F;S
MQK!X7OMAU'\3_P!G7_@H1_P47_8S6X^&?[.7[4/[2'P4L!J<T$WPJ\.>,?%-
MKX=M]=NIS]I*?#+57O- L]>NKB0BXGA\/PZI<2D++([!0 #_ &B_VG/VG/@A
M^QW\$/'G[0_[1'CW1OAS\*_AUH]QJVNZ[J]S%'->3I%(=/\ #OAW3VD2Z\0^
M+/$-TB:7X:\-:6EQJNN:K<6]C8V\LTH _,W_ ((9?%S]HC]JO]FWXR_MT?M!
M7OC#3++]M3]IGXB?&#]GKX5>)=9U*]L/@]^S'H.E>&/A7\)?"NAZ1>3/8Z-_
M:UOX"U?Q;J=]H=M8:7XTFUV#QQ':M/X@FO+O^-K_ ()V?\$?/^"K/_!:OXS_
M  Z^./\ P55^(O[3MC^QWX&U6T\0S2?M$^*?&NG^,/B=I\<D=S-X+^!WPX\1
M7%I<^#M"\61+';:]\3++0?#VAQ:-=W5WX7N_$>OQBWMO]+'PEX3\,^ O"OAG
MP-X+T+2_"_@[P9X?T;PIX3\,Z)9PZ?HWAWPUX=TZVTC0M#TBPMU2"RTS2=+L
M[6PL+2%%BMK6WBAC540  '\&_P#P?+_\@;_@F3_V$_VP_P#TE_9AK])_^#-?
M_E$EXJ_[/$^,?_J!?!JO?O\ @XV_X(N?%O\ X*[_  A^!6H? 7XE^$/"/Q;_
M &8[OXKZIX:\#^/K:]L_"WQ0LOBC:?#Y=6TB3QGIPOI_"&NZ:WPXL/[ GN]!
MU/1-4N-4GM-9OO#]M&-7A_D:_8(_;I_X*X?\&U_BCQ3\%_VG?V,/B7KG[*7B
M7QA<>)/%G@/QAHE]IOABR\4W%M8:1JWCKX'_ +0WA?3O%/P^N]1O].TG28-:
MTO\ M+Q=X5UB'3+2(6_AW5YY->0 _P!2FOXJ/^#U;]J+PYX1_8]_9M_9%L-6
M@/C[XS_&X?%_6=)@GAEN;3X9?"'PSX@T7S=4M5<SV5OK_CKQYX>DT*ZF1(M1
MD\&^(H+5I7TZ\$'KMK_P>#_LN?%;PQ_8/[*'["_[=WQ]_:/U6Q$/AKX-Z?\
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M)?%[1/JWC_QD\)5#%<^-?'6I^(_%EW&439=:S,H1%4*/K.@ HHHH *_R O\
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MQS502 686'A]L#U.U6; YPI/0&OZQ?\ @NC_ ,%$_CO\2OV4/VJOV&?V2O\
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M\;C_ (.,XWC_ ."UO[?:NI5C\3?",@!&"4E^$/PZEC;Z/&ZL#W# U_LCU_G
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M0U'P;=^"+R[?1- \1ZK!!X?\6:';Z/J.GZJNNRZUX?T0 _UK0         ,
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M'MTEJ)OASYDMK:ZSJ,@A$IWO#&OF'<2:_P!3;]A/_@J!K'[7<_@'P/\ $?\
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M?^"##!O^".O_  3R*D$?\,X^%%R/5;K4U8?4,"#Z$&OUPK^/'_@BA_P4S_:
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M-\;_  <L/#E]XAOIKG<UQJGB;0KY=<O;B3*7%[J,LVT)(%'\B7Q&_8D_;/\
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MZ5X4AC\/3:;>^*=3%IH=CK6J>']*NKR*[UNQ27_+Q_X+1_"[_@IM_P %0O\
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MYI'@KPGI&JVB7EC-/;-<Z9JUC>Z9J$ D,MEJ-G=65RD5S;S1)_L)_ _4+,?
MSX,7TES!#:W?PO\ AFL$\TT<44DFI>&="M["))'95:6\N+FWMK6-27GN)HH8
ME>21%/\ DO\ _!=7_@CY\1_V _V[O%G@/X"? /XLW_[*WC?1_A]J7[/7BO3-
M$\8?$2VUX?\ ""^&]*\:Z%JOBNWM-4$_C^V^(MCXHO-6T*>>WOVL=3TC6;'2
M+#0]9TBW3^P/_@B]^R__ ,%<OVN=%_9/^,W_  59\:>+OA3^S=^QO8>$-0_9
M<_9:/AU/AA\1/C)X]\"Z+;Z'\/OC)^TOI=A'9>)+C3?AY86UM=>#_#OC)=/U
M7Q+XJM8?%6H^'--TQ;J]\? 'UM_P=B$#_@B;^T,"0"WQ%_9Y"@D L?\ A=/@
MYL#U.U6; YP">@-?SM?\&0)'_#1W[> SS_PI/X2G'? \=^(LG\,C/U%?;W_!
MQ=^V5^T[_P %!OV2]+_8V_8[_P""7W_!4W7+77_BCX7\;_%/XD^.?V#_ -H#
MP=X<7P[X$&IWFC>%?"VFR>$+[7M9U+5?%,VD:S?:K?:?I&F:;IVA16]F=9N-
M9DDT7\B_^#>.^_X*"_\ !)3]K'X@>._CA_P2C_X*7^*_@E\;?ADOPZ\:7/P^
M_8M^/.I>,?!^K:3XAL/$?A3Q;8:)JW@S1;'7],MIH=4T?7-*75;"_2QUK^V-
M-DOKK2$T/5P#_3^K_/+_ .#XW_DI7_!.?_L1_P!I?_T_?!7_  -?VKVG[='A
M6[_9?OOVI_\ AG+]MVVT.PUQ-!D^"]W^R)\9(/VH+BX?7;+0!?V/[/9\/M\1
M;[0UGODU%]<MM+DTM-"M[W6S<_V?:33K_ %_P<7>(_V_O^"MW[27PDUCX"_\
M$I/^"E_AKX&_L_> M>\*>$M5^(7[%/QZTCQCXT\3>--9LM6\9>);C0]+\&ZS
M:Z%H'DZ'X;TGP]IUQJ5SJLL>FWNKZD-/EU5-%TL _ID_X-$R#_P1I\ X(./C
MS\> ?8_\)-9G!]#@@_0@]Z_IVK^%'_@W,_;!_:F_X)Q?LN^,OV0_VP?^"6G_
M  5.TW1K;XJ^(?B=\,?B5\._V$/V@/&FEKIOC+2M MO$'@_Q5H:^$=-US3;K
M3M;T2?6]&U;2K/6[75(-?OK&_AT:31K2?6_[J+:<75M;W*QSPK<013K%<PO;
MW,0EC601W$$H62"= VV6&10\4@9' 92* ,+QCX0\,_$'PCXJ\!>-=$L/$O@W
MQOX<USPAXM\.:K"+C2]?\,^)=,NM&U[1-2MR0)[#5=*O;NQO(20);>>1"1NK
M_&?_ &L/@[\:O^"&O_!6W7=#\!W]_:>*/V6/CAH/Q5^!'B?4O-$'CKX5W=]!
MXL^'=UJ\EOY4.IZ?XI\$7J^#_B'86CR63ZC_ ,)?X9F=_LUS&/\ :#K^%W_@
M]@_98^%>H?!/]E?]L]-8T;0?C5X=^(D_[.,^D2*PUCXF?#GQ-H?BKXAZ:L)A
MBGED_P"%6^(= UF[M3*+33X[;XDZREU?&_DT.PNP"C_P0JN=>_X+%_\ !:O]
ML7_@LU\1/"FJ:+\*O@3I5A\,?V:?"WB%X;M_"^N^*?"\O@GPI8030>=I<FK>
M#_@_8>*=<\:VE@6@M_''Q<L-<L;I_,267^["OQ]_X(1?L)C_ ()[?\$R/V=O
M@OK>CC1_BIXOT(_&_P".<<L'V?41\6/BK;6.N:IHNKH%4-J/@+PW'X7^&4LB
M@K+%X*AE#R%S(_[!4 %%%% !1110!^=__!74@?\ !*G_ (*3DD ?\,(_M8CD
MXY/P+\<@#ZDD #N2 .:_S=/^#2<C_A])\'>>OP@^/X'N?^%;ZF<#\ 3] :_L
M>_X+I?\ !07XW>)?V4_VM/V'?V4?^"<G_!23XX?%[XIZ!XJ^ .I?$SP[^Q?\
M:[GX!Z5X2\0[_#_CWQ7X<^(FF^&]03XA6^I>&)]4T_P?/X3T^[T/4;G48M6N
M=;@L[$6>I?Q8_P#!(3X)_P#!3W_@FC_P4#^!/[7?B'_@E/\ \%%?'7@GP+<^
M+/#_ ,0O"GA_]CSX_0>(=4\#_$#P;KO@G7KCP\VH^ +/3I]?T"/6X?$VC:?J
M%]IUAJ^HZ+;Z1>ZII=K?3:C; '^N77\O/_!WR1_PYR\4\]?VB/@6![G^T=?.
M!^ )^@-?MK^SC^VSX>_:2^'?Q'^(FG?LY_MH_!J+X9:>M_JG@O\ :._98^*'
MP6^(GB;.CZGK)LOAQX2\4Z8EY\1M02/2Y-/:W\'RZOG6+O3=+1WNM1M4D_D7
M_P"#B_\ ;&_:O_X*0_LS>$/V0?V0?^"4_P#P5+O?#DOQ1\/_ !-^)?Q1^)?[
M"GQ]\&V<MMX.TW7+;P[X2\%^'HO"FK:U?2ZAJVN+J^N:WKMMH46FP:)9:=IM
MCK#:S=WFB@'BG_!C=_R.O_!27_L5_P!E7_T[?M ?XBO]"2O\RW_@W2\6?M]?
M\$C/V@?C/J7QZ_X).?\ !3;Q7\%?VA?!7A3PWXFU?X<?L7?';5/&'@KQ)X$U
MC5]1\*:_%X=UKP;H5EK^@R0>)O$6GZ[:0:Q9ZM:)<V>I:9%J<EG+I-]_H#1?
MMK>&9/V5G_:Q/[/G[9D6@I=BR;X(R_LI_%P?M4F4^,T\$^8G[.:Z$WQ)DM!=
MN-?-]'I+68\&*_BWS_[$1KH '\5__!\I_P C5_P34'?_ (1_]K/_ -./[.G^
M!K]@O^#/8C_ASY9<]/VG/C<#['[-X).#^!!^AK^<[_@XQ\8_M]_\%<_CW\%+
MGX"?\$G/^"F7A;X)?LZ^#_&.@^%]:^(W[%?QWTGQEXW\3_$+5=!OO%VNS:!H
M_@_7+/0O#L-MX0\,V'AVSN-5N=7N1!J.IZI%ILE]#I&G_H%_P;B_M<?M8?\
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MIFH2( ?Y37_!PX0?^"T?_!0 @@C_ (7#I@X.>1\.O!((^H((([$$'FO]?_\
M9_(/P&^"1!R#\(_AL01T(_X0W1>:_P A3]NW]D'_ (*O_ML?MC?M(?M7ZG_P
M2V_;_P#"TGQV^+'BOQ[8>%S^R#^T3?R>&?#^HWS0^%_#UQJ"_#2%-1O-$\-V
MVE:7>ZA';VT5_=VLUW%:VT<RP1_Z*G_!*3_@IU\4/BK\(OV8OV=/VE?^"=__
M  4@_9R^/ND>!?"7PM\8^,/B+^QK\9-$_9\O-;\$>$X],D\;O\6]3T&RT[PE
MH'BBWT1=0>W\:6.B/H^N:E_PC<%WK<<=EK.I@'[YT444 %?YWW_!\21_PMK_
M ()XKD;A\.OVB"5R,@-XE^$X4D=0"58 ]"5('0U_?/\ '3XO:=\!OA5XL^+.
MK>!OBU\2=/\ ",.E37'@GX%_#+Q5\8OBKKO]K:[I>@11^$_AOX)L=2\3^)9K
M.?58]2U5-,LIO[+T*SU36KPQ:?IMW-'_ )M7_!Q-J?\ P4"_X*U?M4_#7Q=\
M"/\ @E9_P4S\-_ SX%?#2Z\!^#KGXA?L5?'G2?%?B[Q%X@\0W6O>,?%\VAZ5
MX,UFVT+2+Q(?#NC:)IMQJ5UJ<EKH3ZMJ2Z?<:K_8NE@']0O_  :.$?\ #F+X
M8<]/C9\>P?8_\)LYP?P(/T-?TU5_#!_P;J_ME?M0?\$ZOV4?$?['_P"V!_P2
MP_X*GZ5IND?$_P 2_$3X9_$KX<_L'_M >-=)FTCQK:Z2^N^%?%FB#PEINNZ7
MJ.EZ]IUWJNDZKI-EK5EJUEK<]E>PZ+<:+!/KO]6/[4?[>OA_]EOPYX!U^\_9
M;_;L^/5S\1O#%_XGTCPS^R]^R3\4/C=XBT);"VT>X&@_$"'P]80Z9\.?$UZ=
M:A@L='\;:IHDUQ<6.L1AE_LF^,0!_E=_\')G_*;G]O7_ +'CX:?I\!?A3G\J
M_P!;K]E@@_LQ?LXD$$'X#?" @CD$'X?>'L$'N#7^2?\ \%$_V6?^"K/[>G[;
MG[2/[7=W_P $KO\ @H!X-A^-_P 1KWQ+HOA23]D']H>_NO#OA33M/T_PSX,T
M?4;^+X;107^KV'A+0]%M]9OK:&"UO-52\N;6WM[>6*%/]#+_ ()"?\%(?BC\
M3_@K^RM^R]^TE_P3[_X**_LX?'WPM\,/#/PK\6^-OBE^QY\8?#'[/6H:G\+_
M  "UH?&DGQ@UC0;#2/"FG>,[#PPEQ;Z=XPM-$GM/%VL0^$;"?6O,TW5=3 /X
M*_\ @Z+_ &*O$7[)G_!5[XS>.TT>>W^%W[7<B_M&_#O6U@?[#>ZYXF$-M\8-
M%DNU46S:YI7Q0@U[6KVP1OM-KH'BSPK>W2*-6@DF_N;_ .#7+]M71?VM?^"4
M'P;\#W6L)=?%#]D,/^S;X_TJ65!>6OA_PJINO@WJL%J6,ZZ'>?"JZ\.>'K.]
MD ANM=\(>*+6W.--DCC^Y?\ @KA_P2M^"W_!6?\ 9;U'X$_$FY'@[X@>&+RY
M\6_ KXQV6G1ZCK7PM\?FS-J;B2T,MM)K?@SQ-;)%I'CGPHUY;1:SIR6=_9W&
MG^)-"\.:SI7^>7\#/"7_  6%_P"#83]K[6_BEXA_9S\4>-/@SK$2^$_BG<^'
MK;Q%XH_9F^/_ ,/+&_DNM,N[+XG^'=(O[3P+XQTIYI]8\#ZIXITK2/''A&>]
MO[77?!MYX>UKQ'X<UD _U?J_B?\ ^#V[XO:+H_[&G['OP%>]A7Q'\0OVFM8^
M+=IIXD7[2^A?"#X6^*O!^IW3Q@[UMEU'XW:-&K.H228_(6:%]OM_A+_@\A_8
M0\?>%;&U\"_LH_MR>-/CEJ5B(]/^#7A+X??#GQ&+_P 0F-0+*R\5:/\ $V\U
M"[T,W3K"NL0>"GUDQ%9?^$3$K"V/Q)X$_P""3'_!0W_@OO\ MP:#^WE_P5I^
M'.L?L@?LB>#+?3=)^%7[)U]>:AIGQ3UCX=:5J5UJ]C\/8M&NH-.\2^"+#Q#J
MUQ=:A\5?B3XXTOPKX^\3/<FP\$>$M#T-_#FH>" #[Q_X,^?V'=;_ &<?^"??
MC7]IOQQHTVC>,OVUO'.E^*?#MO>6[6]Z?@A\+[76/#WPUOKB*8">)?$7B+7_
M (D>*-,?:D&H^&-8\-:K;F6"\BE;]E_^"V9"_P#!(S_@HR6( _X9%^-(R2 ,
MMX/U!5'/=F(4#J20!R:_2KPWX;\/^#O#N@>$?">BZ7X:\*^%=%TOPWX:\.:'
M8VVEZ)H'A_0[&#3-&T71],LXX;/3M+TK3K6VL=/L;6**VM+2"&W@C2*-5'\M
MW_!>[]O;XZ?%#]D7]J;]A']DK_@G'_P4M^,'Q5^)=UJ?P3U[XJ:1^Q1\;S\#
M-*\(Z7XMMK;QSXE\)^.K/PS?_P#"R;#Q7HFDW^D>"-1\*V$_AO5=/UU/%!\0
M"TL[33M9 /Y0_P#@S^(_X?$:+SU_9L^.('N?+\*G _ $_0&O]6>O\E?_ ((Q
M?"K_ (*:?\$P/^"@'PG_ &K/%_\ P2D_X*,^.OAWI&F>+_ OQ,\.>&/V.OCX
MGBN?P1X[T.?1]0U/PLNJ>!+#2KO7?#VH?V7XALM*U._TZRUL:5+HLVJZ/_:"
MZO8_Z8OP=_;L\,?&3X)?%7XX6O[-7[<?PXL/A)87=]JWPS^,7[(WQ=^'/QM\
M8?8]$?7)+/X5_"S6-%/B3XHW\L2'3;2W\%1:N;O6RFDVSR7;JA /YK?^#V;_
M )1]_LK_ /9X^G?^J3^+G^(KS_\ X,B"/^&3_P!ML9&1^T/X$)'< _#9,''H
M<''K@^E?)/\ P<H?M _MF?\ !5'PQ\!O@#^RG_P2K_X*?Q_"OX3>,];^*'C#
MX@?$G]AKX^^%K_Q5XUN]!N/"OAS2_"GARV\'ZM?VN@:'HFJ^(KC5-4UYM/O]
M5U+5K2UM='LK71FO]9XS_@VO^,G[;/\ P2@U/]HCX7?M1?\ !*S_ (*?ZA\(
M/CO=^!O%FA^,_AO^P_\ 'OQ+JO@?QQX,M=?TF^AUWPU>>#]&N=1\.^*=%UFR
M#:EHUQ>:IHVI>';2$:+J-GK5S>Z* ?Z+U?XGO_!7J[2P_P""N_\ P4/OI 62
MR_;H_:&NW5?O,EM\8/$<S!<]R$('O7^T;\-O'%I\3/A]X*^(ECX=\:^$;+QQ
MX7T/Q5:^%OB3X1UGP#\0?#MOKNG6^I1:+XU\#^(K:SU_PCXHTU+A;37/#NLV
MMOJ>CZC%<6-[#'<02(/\6S_@L#:2:A_P5P_X**V$+(DM[^W%^T5:1-(6$:R7
M/Q=\2PHTA578(K."Y5&8*"0K' (!_M@6EW;7]I:WUE/%=6=[;PW=I<PN)(;B
MVN8UF@GB=<J\4T3I)&X)#(P(X-6*_C@_9._X+??''_@E%\/O#'[$O_!<#]F/
MX_?#[7_@;I6F?#GX:_ME_#7P3>?$[X,?&7X?>&[9-(\(:CK'B*SFLO[3UVUT
M*SL;,^(O#,GB/6=?6(-XZ\,>#_&-MK,>I7_VL/\ @Z%T7]H+P)XA^ O_  1>
M_9V_:6_:L_:F\?Z;<^&O#GQ!M/@OXAMO _PD.L1264GC7^PC'?\ B?7_ !'H
M<,C7^DVWB+0?#7@72KC[/XA\3>(+_2]*OO#>J '\G?\ P79U'Q#_ ,%"_P#@
MX ^/GPG_ &?[-/&GB3Q#\8_A1^R;\/;+3VDFBO?&W@;PKX-^%7BB*[NHTDCM
M[#2OB58^+O[4U+8MEIFDV$]]<R?9K2>Z;_5M_9Q^"OAW]FW]GSX&_L\^$I#-
MX8^!GPB^'/PBT&Y>(0RWNE?#KPAI'A*RO[B,-)BZOX-)2\NV:2622YGEDDEE
MD9I&_F%_X-X_^#>WQ-^P?X@O?VY?VY9=/\5?ML>,K#6%\'>#CK$'C"#X#6/C
M"*X'B_6]<\6Q7%_8^*?C/XPMKZ\TG7-;T>^U#2?#NAWVM:7IVNZ_<>)=5O+7
M^N&@#_-^_P"#WCP_>VW[5W[$?BF2)UT[6?V>O'GA^UG*D1R7OAKXD'4;^)7Q
MM9X8/%FFNZ@Y59XR0 ZY_I"_X-/O%VC>)/\ @B7^SGHVF7D%S>_#_P"(/[1'
MA'Q%#$ZO)I^LWOQN\;>/(+.Y4,3%._A_QMH5^J,%8VU];R;=LBLU/_@YE_X)
M*_$'_@IY^R%X+\1_L_Z9;Z[^TS^RQX@\3>,_AWX1GN;6QE^)'@CQEINEV?Q,
M^'>D7UY+;6=KXHU)O#'A#Q)X7>_NHK*^U#PM)X==K>7Q#%J%E_G^_P#!/C_@
MJ_\ \%*_^")OQ ^('PE^&GALZ-;^*/$=O<_$;]EK]I'X:>+WTAO'5M!#HD.O
M+X3CU+P-\0O"/C1["UM]'N;G0=;TD:];6&DVOB'3]<CT/18[  _V0[V]LM,L
MKO4=1N[73]/T^UN+V_O[VXBM+*RLK2)Y[J[N[J=XX+:UMH(Y)KBXFD2*&)'D
MD=44L/\ %!_X+)_%?X<_''_@J7^W/\5_A'XOT?Q]\-_&?[0/C'4/"7C/P].U
MWH'B33+=[;33JNB7QCCCU+2;FZL;@Z?JEKYEAJEH(M0TZXNK"YMKF7^VK]EG
MP-_P6Q_X+^-I6J?\%&S/^PC_ ,$S/.L[_P 6? 3X0^$?%OP3\>?M<V<,B7%O
MX/NG\9>(?$WQ>MOA7JL2QOXJ\1ZSXAT?PEXAT^Y@B\#^&=9U1U\3>#/Y)?\
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M0!_F[?\ !O80/^"S_P#P3]R<?\7HN1SZGP)XP 'XG@>]?[,5?XVG["W['_\
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MKO7\E7_! ;]O3X]_ O\ 8[_9N_8/_:Y_X)J_\%-?A7\1?AGKO_"J?"WQ6?\
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M3^*?BYJWP_\ C'\4K#PJ=%$W@7X _"WQ5\:/BQKC:YK^E^'H1X6^&_@JSO\
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MNL7&DVMQ!:76J0Z891>RZ=;7=S;6L]ZD#6T-Q<00R2K)+&K?S?\ _!V@0/\
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MT]IHOV\_X)??\$W?@K_P2T_90\(_LR?!UIM=NX;J7Q;\5/B7J=G#9>(/BO\
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M_P""V?BYPP*G_@J;K[!@05*G]K2[(8$<$$<@YQCFO]8K]NK_ (**2_L7_:-
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MXI:@8XSI\5OX'&M"?5VCTV&22XD16_B]_P"#E+X_?MD_\%4?#7P#^ O[*?\
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M?P]\+Z7X3T3SEC^3SSIVDV[3E2=TI=B222?\T7_@])(/_!5;X- $$C]A'X4
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M_P""]I!_X+&_\%"\'/\ QD1XD''J-.T@$?@>#[U_LM>!^?!7A#'_ $*_A_\
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M_0=>\27$/CC6_P";O_@ASX5_X+6_"3]J3Q9I/_!-KX/^+_"WCGXE^%IOA/\
M%;QA\7_A)>I\'/AYH#ZS8ZFOBCX@:[XWT1/#_AK6?!FHV#:IH]NR:CXCU%DU
M/0M*\*>*I-2GT&] /]>2*YMYWN8H9X9I+.9;:[CBE21[6X:W@NU@N41BT$S6
MEU:W2Q2A7-O<P3!3'-&S?XXW_!QX0W_!;+]ODJ01_P +%\"C(((ROP6^&:L.
M.ZL"I'4$$'D5_I.>!-2L/^",G[+?@/P'XW\$?M^?\%"OC-\5_$7Q)^+/QG^*
M/[/G[//Q*_:4\=_$OXYZFGAF]\<^)/%<'AHW.B?"O0]::^T?PU\+-!\0ZSI&
MF#PQX4-A#>WU]H6NZE-_FS?M^?LD?\%7/VX?VT/VD_VLK_\ X);_ /!03PNO
MQT^*OB3QKI'AB?\ 9!_:'O[KPUX6FF33O!_AZ]OXOAK%#?W^B>%-/T;2[^^@
MA@M[R\M9[F"W@AE2% #_ %T/V:2#^SC\ "#D'X)_"H@CH1_P@F@\UVGQ.X^&
MOQ"S_P!"/XL_],.H5^(/_!*G_@IS\2?B5\'/V6_V<_VC_P#@G=_P4D_9U^/6
MC>!?!/PE\8>*OB#^Q?\ &?1_@!-K?@OPO;:(WC>3XM:CH%IIOA/PSXCM]&CU
M29?&EGHCZ%JNH/H"W6KPV]IK6I]A_P %./\ @J#\0_@/\/\ ]HGX(_L[_P#!
M/G_@HQ^TM^T"G@O6_!7@+Q!\+_V-/C+XF_9\?Q3XP\(1G2_%,WQATO0+K0_$
MWA?PP=<CN=6M_!<.NWU[K.E7?A1VTF?[9JNF '^:E_P;_D#_ (++?\$^,D#_
M (OS8CGCD^&?$8 ^I) 'J3BO]G.O\:O]B+]C?_@K!^QE^U[^SA^U3I/_  2W
M_;]\3W'P&^+_ (*^(]UX8;]D+]HK3SXGT;0-9MY_$/AN/4?^%9W TV;7] .I
M:1!J+6UTMA/>1W;VMRL)@D_U>/V-?VW]*_;*TWQ-=6G[,7[:_P"S1J?A'3_#
M-[JVA?MA?LQ^/OV?+J]F\2_VNHT_PGJ7BJ"3P_XVN]$DT:9?$7_"+:OJD>CI
M>Z/->/''JUD9 #[<K^./_@\-_P""=7_"_?V0O!?[=GP^T+[7\3OV0[O^P_B2
MUC;;]0U[]GGQUJUO;W=S<>4LES>#X8^/;K3-?M(55;;2O#?BSXBZU=RI#:DC
M^QRN-^(OP_\ !_Q9^'_CCX6_$/0K+Q1X!^)'A#Q)X#\;>&M20R:?X@\)^+M'
MO- \1:+>HI5FM=3TC4+NRG",K^7,Q1E8!@ ?X[/[-W_!53]H+PE_P2W^/W_!
M(3P+I'B'Q3-^U#\=/AB?A=?Z3/YFH^'O#/BO4R_Q;^&&D1&4WDA^)_C#P[\+
M[+1M'LHDT^2W\2_%5K^1;K7[=+G_ %=O^";'['&@?L!?L,_LV?LF:&EE)=_"
M;X;Z59>-=4L% MO$?Q0U]Y_%/Q2\31.565[;7?B!K7B+4-.6=I);72IK&P\U
MX[2,C_/O_P"#?O\ X)6>&O%'_!>/XZZ7;Z[9?%C]G[_@E[\5OB7KMI\0(8//
MT;QIX^\*>/?$7@#]GQ)I5MXH8M;76=(U3XGPS66_2I-3^%M\FFWU_ILMI<WG
M^GE0 5Y)\9OC[\"_V<O"0\>_M!?&?X5? WP0U[%IJ>+_ (O?$'PG\./#4NIS
MI)+!IL&M^,-6T?3I]1N(XI7M["&X>[G6-S%"^TX];K_,B_X/.?#/[2X_;_\
MA+XK\;6'C&Z_9DD^ OAK1O@7JR6^HR_#G3O%IUOQ%/\ %+1H;B-#HMK\1+S4
M8M'U#7HI&37+_P )CP293/IFGZ<EJ ?Z3/PM^+WPG^.7@W3OB+\%/B?\/?C!
M\/M7>:/2O'7PN\:>&_'_ (/U.2W*K<1V'B;PIJ6K:+>26[.JSQV][(\+,JR*
MI(%>B5_E5?\ !LW^T-^U3^P;_P %4/@%^SG\1/"_Q5^&OP=_;I\/SZ;K_P -
M?B-X8\4^#].\76.I^&_%E]\'OC7X/T/Q/8Z;%J(A\9>%I/#6G^-])@GL=3\-
M7_B_1X+VZDB5+7_55H **** /\XK_@]F_:3^)-]^T]^RG^R#'J^HV7PA\+_
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M _ '_@RI_P"467Q\_P"S_P#XI_\ K.O[*M?U^U_(%_P94_\ *++X^?\ 9_\
M\4__ %G7]E6OZ_: /X _^#&/_G*+_P!V3?\ OW%?W^5_ '_P8Q_\Y1?^[)O_
M '[BO[_* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J-I]@UX
MFH-96C7\<9B2^:VA-XD1!!C2Y*><L9!(*!PI!((Y-6Z* "BBB@ HHHH ****
M "JC:?8->)J#65HU_'&8DOFMH3>)$008TN2GG+&02"@<*02".35NB@ HHHH
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M1Z9J'C:#0;^7PI8ZE))+!''87>O)86]X\D\*+;R2,TL:@N/\7/Q%_P %1?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54FL+&YG@NKB
MRM+BYM3FVN)K:&6>W)SDP2R(TD).3S&RGDU;HH **** "BBB@ HHHH ****
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M-K:6EK#';VMK:V\:PV]M;6\*I%!!!$B10PQ(L<4:JB*JJ )Z "BBB@ HHHH
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MGQM%I]E:6,3NTKQV=M#;1O(WWI&2%$5G;^)R"Q[FK=% !1110 4444 %%%%
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MO4_C-I']N^(O$NAZ%'%*UK=Z?X^\7ZY\27MY-:T72=%^%]IJ]UJ6I@'Z#?\
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M074$5Q"Q7H6BF5T)'8E21VJS10 U$2)%CC18XT4(B(H1$11A555 554  *
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M"VY\1:-XS^+_ (\^)_ACQ)X*N_&VJZ+IOBS3#HWC:#1M1BT.]O=2TG5M%O\
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M$/PPU/4(O"5AIFBZA'-IZ^ [SPI%X<T6.VCTVUT.TM;2&WB_HY_X)M?L._\
M!4/_ (.&OCQ\$_VJO^"KGQ"^(WB;]A;X%W5IK?AJT\:^&?#WPST'XYRV\UI=
M3>$OA3\.O!7ACP=X;N/#OBZYTW3[3XK?&&VT"*;5_#]I+X5T3Q)?Z[!"_A8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGI?M<+9M?7C6XC-S,7]DHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 > ?$O\ 9/\
MV6?C1XC7QC\8OV:O@!\6/%R:=:Z.GBGXE_!OX=>._$::1927$UEI:ZYXI\.:
MKJ:Z=:2W=W+:V(NA;6\EU</%$C32%O/O^'>O[ G_ $8[^Q__ .(T?!?_ .8J
MOL"B@#YK\#?L8_L>_##Q5I'CKX:_LH_LU_#SQOX?DN9M!\9>!O@7\+_"7BK1
M);RRN=-NY=(\0Z!X6T_5]-DNM.O;RPN7L[R%I[*[N;64M!/+&_TI110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% %>[M+2_M;BROK:WO;*[ADM[JTNX8[FUN;>52DL%Q;S*\4T,J$I
M)%(C(ZDJRD$BODGQ'_P3W_8&\8:E+K'B[]A_]D'Q3J\\[74VJ^(_V:?@QK>I
M37+DE[B6^U/P5=74D[DDM,\ID8DDL<U]?44 >8?#3X)?!CX+V$VE_!WX1?##
MX3Z9<*B3Z=\-/ /A3P)83I'CRUFM/"VDZ5;RJF!L5XV"X&T# KT^BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_@]TO+JT_LSQAHOAOQ)XNT/3]3=;87B0Z=XDU: V=U:R&Y$CO#& >FT444
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M*L+W4]1N(K/3].M+F_OKN=ML-K9V<+W%U<3-SMB@@C>61L'"*3VK^2W]OO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\]?^"K'[;E__P $Y_\
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M++_@I9_V8!^V1_ZSK\1J^_Z^ /\ @K%_RBR_X*6?]F ?MD?^LZ_$:@#\ ?\
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MU?0]=T>YO-+U;3+V!DFM+^PNKBUN8F62&5T() /[S?\ @@/_ ,H;/^">W_9
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M971_ /BYE92&5E;P[J!#*1P58$$$'!!R* /\</\ X($?\IDO^">W_9P&C_\
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M?\&K/[&VC?LM_P#!)[X5_$6ZTFWMOB7^UYJFJ_M ^-]3,'^G3>&M0NKCP_\
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M6EZ9+K_B2^T[3([_ %&2*1+*U:Y$URT;K"CE2!\=?\/A_P#@E!_TDC_8@_\
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M\":;>M)IGA_1_#EKI-Q?Z796.H>*)M8\02WFHR_JJO[*/[+:@*O[-GP"55&
MJ_!WX=@ #H !X<  'H*]]HH _P (+]JNTM;#]J']I&QL;:WLK&R^/?QAM+.S
MM(8[:UM+6V^(?B*&WMK:WA5(8+>"%$BAAB1(XHT5$554 ?[77P<_99_9CN?A
M%\*[BX_9S^!%Q<7'PX\#S3SS_"'X?2S332^&-+DEFFED\/,\DLCLSR2.S.[L
M68DDFO\ %-_:V_Y.K_::_P"S@_C/_P"K'\25_N4_!7_DCGPF_P"R9^ __46T
MJ@#\\OVT/^"*7_!-K]N'X9>(_ 7Q+_9:^$G@WQ)JNF7=MX=^,?PC\!>$_AM\
M7?!&KO ZZ=K6C^+_  MI&FW>JQZ9=&*[/AGQ2-=\):H8_(U;0[R%V4?DK_P:
MK_L^^-?V-O"'_!3[]C'XA7EOJ/BO]G3]N^\\-WNK6<$MK8>(K&[^&?A:QT#Q
M?IUI.\EQ:Z9XQ\/>']*\2:;;W#&YAL=1MX;@^=&X']8=>,^ /V>_@]\+?B?\
M<_C+X"\&0>'?B1^TGKO@GQ+\;/$<&L>(;P>-]=^'?@G3OAUX/U*71M2U>]T#
M0I]*\':3I^D2CPQI6B1ZL;<:EK,>H:M+-?2 'LU%?-_[2_[8/[+G[&_@I_B'
M^U)\>OAC\#?"A2X:QO/B!XJT[1]0U^6U4//8^$_#K2R>(_&.K(A#C1O"NDZQ
MJTBY:.R< D<S^R-^W)^S-^W)\ Q^T]^SC\0F\5_! ZQXNT5O&_B#P[XC^']M
M#<>!KA[?Q+=7FG^.]+\/:KI^F:?L>=]1U"RM;;[*K7!=8T<J ?6U%?B2O_!Q
MG_P1@D^-4/P'C_;E\ 2>+9]<3PU'XFC\+?$MOA"=;DN1:I;GXVCP7_PJ@:8\
MA##Q6?%__"&B/YV\1+D _ME%+%<113P2QS031I+#-$ZR12Q2*'CEBD0LDD<B
M,'1T)5E(9200: )**^#OVNO^"GW[ '[!\D-E^UE^U5\*?A!X@N;--1MO ^H:
MK>^)_B5<:;*C/#JD'PP\#Z?XG^(4NEW 1EMM3C\,M87,H\F"XDFPE?G%I'_!
MTO\ \$.M7UA-('[8NHZ8LTJPP:MJ_P"SS^TM8Z/([\*7NV^$3R6<1. T^H6]
MG!%G=-)&@9@ ?T'45X-^SQ^U)^SE^UKX$C^)G[,WQM^&GQR\"M.MG<>(/AMX
MMTCQ/;Z5J+1B;^R=?MM/N9+_ ,.:TD1$LNBZ]::;JT,;*\MFBLI/O- !117Q
M1^UY_P %'/V&OV"]-L=1_:Y_::^&/P5N-5M&O]'\,:[JEUK/Q!UW3DDDADU+
M0/AGX2LO$/Q#U[3(IXGMYM1T?PQ>V4-R%MI9TG=(V /M&6VMYWMY)H(9I+.9
MKFTDEB21[6X:WGM&GMW=2T$S6MU<VS2Q%7-O<3PEO+FD5O\ *3_X.]?AQX8\
M!?\ !87Q!K7AS1['2+GXK?L[_!GXC^*6L;>.V75O$_F>+O -QK%TD2HDE]=:
M3X"T>*ZN"/,N9+;SYV>>221O[>O '_!SW_P1*^(?BJU\(V/[9$/AB]O[I;/3
M]6\?_!WXY>!_"MS([!5DNO%?B'X<V>@:#:G)9KSQ/?Z):Q*I,LT? /\ %7_P
M>">+?"GCW_@J%\*?&O@7Q-X>\9^#O%/[#OP4UOPUXL\)ZUIOB+PUXBT:_P#B
M-\;Y[#5]#UW1[F\TO5M,O8&2:TO["ZN+6YB99(970@D _O-_X(#_ /*&S_@G
MM_V0#2/_ $^Z]7ZVZSHVD>(]'U;P]X@TO3M<T'7M-OM&UO1=7LK?4=)UC2-4
MM9;'4M+U/3[R.:TO].U"RGFM+VRNHI;>ZMII8)XWB=E/Y)?\$!_^4-G_  3V
M_P"R :1_Z?=>K]>YIH;>&6XN)8X+>".2:>>:18H888E+RRRRN52..-%9Y)'8
M*B@LQ !- 'XG?LO?\&\O_!*S]D#]IN#]K'X+? /4K'XG:'J=_K?P^T_Q1X^\
M6>,/ WPLUG44GBEU;P'X5U[4+N"UU&SANKB/0[SQ!<^(9_#3/'=>''TJ]M;.
MZM_VUK\Q1_P64_X)JWW[57P[_8K\)_M4^ _B5^T5\3M?NO"_AWP=\*8=<^)F
MC6FOV5C>:A<Z3XD^(/@K2M:^'GAO4X(=/O4N-+U?Q3;:G:7%M);WEG;R@*?T
MZH **XWX@?$7X??"?PCK/C_XI^.O!WPU\">';8WOB#QIX^\3:+X/\)Z'9J<&
MZU?Q%XAO=.TC3;<$@>=>7D,>2!NR0*^)OV0O^"J7["7[>GQ2^+GP@_9(^.EA
M\:?%7P1TO2-8\?WWASPOXSL_"%O8:W?W.EV%QX?\9Z[X?TKPWXO@>^M)X3>>
M%M0U>Q8)YT-U- PD(!^A=%?"'[9G_!3C]@W_ ()]6.GW/[7G[2_P^^$&I:S:
M-?Z)X-NGUCQ9\2-;T\.\/]IZ3\,_ FE>)_'U]I!N8VM6UN'PX=&BN@8)[^*0
M$#PK]CS_ (+D?\$M/V[O'EI\*?V<?VL?">O_ !3U(RKHOPY\:^&O'GPF\6>)
M98HWG>U\'V/Q1\+>$8/&FH+:Q37DFE>$KK6]4@L[>YN[BSA@MYY(P#]9****
M "BO _VB?VIOV</V2/ C_$S]IKXW?#7X&^!Q.UI;:_\ $CQ9I7AJ'5M051)_
M97A^TOKA-1\2:R8V$J:-H%GJ6J21!I4M&C5F'Y"WW_!SS_P10T^Z@$W[6^NO
MH=Q?3:9%XRA_9J_:FD\'27]O*89[>WUS_A2ZQ7OE,KLT^GQ7=J8D:99VBVNP
M!^^U%?+?[+G[;?[)'[:_A:Z\9?LI?M#?"WXZZ)IHM_[;C\!^*++4-?\ ##79
MD^QP^+_",[6OBSP?<W@BD>TM?$^B:3<74:&6"*2/YZ^I* "BBB@ HHHH _GW
M_P"#HOX;>&_B%_P1,_:YOM<TNSOM6^&MS\%_B/X,U"YMXI[CP_XBTSXX?#W0
M;W4M->0;K:[O?!WB3Q7X;FGB99#IVO7\.625D;_/1_X-O?AC\-OC%_P6D_8M
M^'?Q<^'W@CXI_#_7;KX^7.M^!?B-X4T+QMX.UFX\/?LN?&WQ-H,^J^&?$MAJ
M>BZC+HGB/1](U_29+RRF;3M:TO3M4M##>V5M/'_HY_\ !R1_RA(_;V_[$3X;
M_P#J]OA77^>)_P &NW_*=7]AC_KI^TI_ZR#\?Z /]7'Q!^QY^R1XL\+2^!O%
M'[+?[.OB/P7/;/93>$=<^"?PUU7PU):2(8WMFT.^\-3Z9Y+(2GE_9MH7@ 5_
MG_\ _!SA_P &^_P=_8W^'T/[?G[#_A6?P-\&1XJTCPS^T%\$K*YOM1\,_#>^
M\7WZ:9X5^)7@*34I[J\T7P=K/BBYLO"7B'PG+>W%CH6O^(/"\GA2VLM!N[[3
M=&_TC:_,?_@M+X:\->+/^"2?_!1S2_%D-O/I=K^QS\>?$MJERB/&OB7P7X U
MGQCX,F4.& N+?QAH6A3VK@;X[J.%XRKJK  _@4_X-G/^"X_Q1_9!_:(^&7[#
MWQ_\;ZGXK_8\^.GBW2O '@M/$^HRWK_L[?$SQ;J":;X4UKPIJ%_-C2/AIXG\
M27MGI'CSPS+/#H&B/J0\?Z6--N[#Q-;>*O\ 4CK_  $M/N[[3[^QO],N+FTU
M*RO+:[T^ZLY)(KRVOK:9)K2XM98B)8[F&X2.2"2,B1)55D(8"O\ ?2\,S:K<
M>&_#\^NQ>1K<^B:5-K,  40ZK)86[ZC%M  7R[MIDP  ,8 '2@#;HIDDD<,<
MDLLB111(TDLLC*D<<:*6>21V(5$1069F(55!)( )K\:?VAO^#@__ ((\?LQ>
M);_P9\2?VWOAQJ_BW3+B6SU#0_A'HOCOXZ&POK=GCNM/U'6O@]X4\;>&=*U&
MSFC>WO=/U36[*\L[I'M;F"*X1HP ?LS17XV_L[_\' __  1[_:@\2:?X,^&7
M[;WPUTWQ=JMQ'9:=H'Q9TCQU\#)K^_G;9:Z=IFJ?&/PIX'\/:OJ5[(4ALK#2
M-9O[N[N)(K6WADNI%A/[((Z2*KHRNCJKHZ,&5T8 JRL"0RL""K D$$$'% #J
M_E:_X._OAKX3\0?\$@)O$MUH.EG5OA)^T)\&-9\&7R64$5SX?76WUSP'J5GI
MDT4:/::??:1XA-O=6$)2SG-II\DD+2Z?9/!_5+7\T/\ P=L_\H7/C![?&#X
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M1_L0?^).?!__ .:VOM_X6?%CX8?'+P#X=^*OP9^(7@WXJ_#/Q?!>77A7Q_\
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M;-')&RNC%6!/^MC^R;_R:Q^S1_V;_P#!K_U77AR@#Z HHHH *X#XK?%/X?\
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M4%F( )H ?17YZ^%O^"K?_!/'Q[^U=X5_8B^'7[5'PW^)G[3'C*'Q9-H_P_\
MAE)K?Q$L(7\#>&M8\7^*K#7OB#X,TC6_AKX8UG2- T#6+NXT+Q%XOTO6C-8R
M6$=@^H/%:R>I_M<?MY?L>_L'^#;/QY^US^T%\/O@AH.JO<1Z#;^)]0NKSQ5X
MIDLPC7L?@_P'X=L]:\<^,)+%98FOT\,>'-6:Q6:%KL0K-&6 /K>BOPZ^"?\
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MOIGB>#X>R2:A=VT3KXYNO#\JQSQSI$\)W@ _3VBN!^)_Q4^&?P3\"^(?B?\
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MOQQXBLH':*XO?#'PZ\/V^L^/O$]G;3(8;FZT#PUJ4%M.4AGDCEDC1ORST/\
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M0W C:5+"TO-=O;)-0U6Y"%++2-/^U:G?S%+>RM+B=TC8 ^>?V!_^"<G[)/\
MP32^$FH?!O\ 9*^&[>"?#_B'7/\ A)_&>O:QK.I>*?&_COQ$MJEC;ZKXK\4Z
MQ-->7HT^Q06>DZ39)I^@:-%)=MI6D6<^HZE->?<M?#_[$/\ P49_9"_X*+^'
M?B5XP_8_^*$_Q6\*?"CQLGP_\6^(#X,\;^#K!/$4NFQ:O"FDKXX\/>';S6-/
MN-/FCN(-4L;26RE5ALE.5S]P4 %%4-5U72]"TS4-:UO4K#1]&TBRNM2U75M5
MO+?3],TS3K&![F]U#4+^[DAM;*RL[:*2XNKJYEB@MX(WEED2-&8?B%\;/^#D
MK_@B[\"?$E[X1\1_MK>$_&?B#3KB2WNX?@WX)^)OQET-'B9DD:'QS\.?!OB'
MX?WJI(I0K8>*[J0GE8V0,P /W,HK\JOV1?\ @MS_ ,$M?VY/%.G^ /V=?VOO
MA]K_ ,1]6E6VTCX<>-=/\6_"+QSKM\W(TWPMX>^*_AWP9=^,]1"9E-GX._M^
M;R4EFVF.&9H_U5H ***_'C]J#_@OM_P2._9 \;ZM\,_C-^V5X'_X6)H-Y/IV
MO>#_ (:>'/B!\9]2T#5+1C'>Z1XBO?A-X3\9:%X<UJPE!@O]%U_5]-U6SN%>
MWN+..>.2-0#]AZ*_)?\ 9_\ ^"[/_!(G]IEUMOA?^WG\"K34W#"/1/BMK.J?
M /7+B5.9(-/TGXZ:1\.KW5YD 9BND17X>)'GB:2!&E'VI^RU^UW^SY^VEX!\
M1_%/]FCXA6/Q0^'?AGXE^-_A/=^,='LM2M]!U+Q=\/;^+3O$9\.:AJ%I:P^)
M/#QGG@FT;Q5HC7OAWQ#8S0ZCHFI7UC-%<. ?2E%%% !1110 45^=O[7G_!6?
M_@G)^PAJ,F@?M4?M;?"OX9^,(8([J?X=VUYJ_C[XGVMM<0B>TNK[X9?#72?&
M'CW3K.^C.ZPOM1\/6ME>8;[/<2!'*_$OP]_X.<?^")'Q'\00>&M/_;3TWPQJ
M-Y<+;V=S\0OA#\=? 7A^8L^P2S^*_$WPTT_POI%N/E9IM=UC2U5&W-@+)L /
MWLHKCOA_\1/A_P#%CP?H7Q"^%OCGPA\2? /BBS&H>&O&_@+Q+HWB_P (^(+!
MG>,7NB>(_#][J&CZI:F2.2/S[&\GB$B.A;>C =C0 5_E0?\ !9#]K#5O^"DG
M_!PAX'^!OB#49-:^ WP5_:Y^$_[%_P /_!<TQN-!CL]/^,/ACP/\:-8-FK&P
MO+_QW\0_^$F^UZM' +C4/"FF^#]&N9[NUT"PD'^C7XZ_X*F_\$U?A?XS\4?#
MKXC_ +>_[(/@3Q]X(UW4O#'C'P7XM_:%^%OA_P 3^%O$>C74ECJVA:_H>I^)
M[;4=)U;3+R&6UOM/OK>&ZM;B-X9HDD5E'^15\"_BGX0_X?&?!WXV>+_&GAW3
M_ /_  \O^'OQ3\4?$35]<L+;PG9>$/\ AJ32/%NM>--4\2W5Q'IEOX=MM%^T
MZY>ZY<726$6FI+?RW"VZM( #_;'55151%5$10J(H"JJJ %55  55
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M'/B"'1_'WAVPFFF2"&]UOPW86LUP6MXI7FCD10#[*HHHH **_,+]H7_@LO\
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MLY?M:^!(_B9^S-\;?AI\<O K3K9W'B#X;>+=(\3V^E:BT8F_LG7[;3[F2_\
M#FM)$1++HNO6FFZM#&RO+9HK*3[S0 45Y-\:?CU\$OV</ VH_$SX_?%OX=?!
MCX?:4"+WQA\3?&&@^"] 2?RWDCLH=1U^^L8+S4KD(R66EV;7&HW\VVWLK6>=
MTC;YW_8D_P""C7[('_!171/B=XG_ &/_ (IR?%GPQ\(_&<'@+QAX@7P=XV\(
MZ:GB&ZTX:K;IHY\;>'O#MSK>GSV1\Z'5=.MI["9<-%.ZO&S@'W#17XN_&O\
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M7PA^V9_P4X_8-_X)]6.GW/[7G[2_P^^$&I:S:-?Z)X-NGUCQ9\2-;T\.\/\
M:>D_#/P)I7B?Q]?:0;F-K5M;A\.'1HKH&">_BD! \*_8\_X+D?\ !+3]N[QY
M:?"G]G']K'PGK_Q3U(RKHOPY\:^&O'GPF\6>)98HWG>U\'V/Q1\+>$8/&FH+
M:Q37DFE>$KK6]4@L[>YN[BSA@MYY(P#]9**** "BBB@ HHHH **** "BBB@
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MZT^#/Q?L?$]SX9\&QSW#RW%U9>"?%7@/QI#IFZ1H](\/:[X>\.VD5MIFDZ;
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M +KW[&?@2R^%O[('[*GPSTZ*.&P^'G[-WP.\#V4448BCCM?"GPQ\+Z% J1J
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M (FM_B+^TAXC/B_XLV'BCP-KUMIGBOP_J?B9!#:ZMH45MXB\-ZIH)M]/TO\
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M2T9YUTFW\0R>'3>WUUH=W=2?A!_P>!?\%.?C9^S#\+?@I^Q-\ _$^L_#R_\
MVFO#_C+QC\:O'GAZ[GTKQ)+\*M O[#PWI?PZT#6;61;S3;#QUK%UKDOC>YL)
M+'4)]$\/6'AT7<^A^)_$5C<?"7_!C]\6=8M?BC^WM\"Y;J6;0-=\ _!SXLV%
ME(Y,&GZQX3\0^+?!^K75K'G;'+K%EXTT6&_?!,R:'IJD@0#/]:G_  5%_P""
M,'[&O_!6_3/A=%^TW'\3/#7B?X/W6M'P7\0_@WXGT#PIXUAT/Q(^FS>(/".J
M3^*/"'CCP_K'AO4KK2-.O4AOO#TNIZ1>07$V@:II/]J:PNH@'XR_\&F'_!/C
M]E#2_P#@F]X(_;#USX/>!_'G[0?QT\<?%6/5_B'X[\+:/XHUOPCX8\ ?$+Q!
M\.M$\&^!+C6K.\3PSHL\?A>;Q%K<^C)::AKVL:Q)#K5[?V6B:#::5T/_  =(
M_P#!*+]F#XE_\$]/BU^V-\-O@WX"^''[2'[-'_",>.&\:_#_ ,+:1X1U#XA?
M#N\\5Z+X8\<>$_'HT"RL[;Q-;:3HNO2^,= U36+:\UG1-0\,C3=+U/3](UW7
MK>]_<.S\3_\ !//_ ((L?L??#+X5>*?BI\//V8_V=?A)H%]H/@6U^(7BX3^)
MO$]U+J5]XE\3W>D:2HNO&'Q'\;>(O$&M:OXI\06GA+0=4U.[U/5KZ[M])MK0
MI!#_ #4_\%2O^"YWB+]OS]@7]LOX<_L ?L"_M'?&/]F&\^#_ (TTGXO_ +</
MQ4TM/@U\$_!_A*P\N37==^'MEKUO<7GQ$UBUBA3[)X=O=7\(^+[:Z(=_!M^B
MQQS 'PI_P97_ +:'Q1MOV@/V@OV#/$'B;4M7^#>M_!S5_P!H7X?>'M3O)[NS
M\$?$'PAXW\#^%/%,'A6"1RNF6GCW0O'JZKXBM8A]DFU'P5IU]#%!>7>I37_]
MSG[:/[-/Q4_:H^&FD?#3X8_M??&_]CF"7Q']L\=^-?V?K/P3#\1_%O@]M&U6
MSD\(Z)XR\5Z#K6J?#J[.LW.D:W%XN\'M::Y''I5QI),EOJCS6G^;O_P9S.R_
M\%=]0520)/V3OC0CC^\H\2?#&0 ^V]$;ZJ*_U2: /\73_@M]^PKKW_!/'_@H
MI\7_ ( ZS\7/&WQWLKW2_!_Q.\,_%CXEW<FH?$?Q=H'C[0X=0\WQUJ#W%R-3
M\2Z1KEMK?A^]U>.5(]:CTF#6%LM+^WG2K+^KS]@SX)_\%!?^"S?_  3>_9$_
M8]^'/C;Q3^PC_P $R_@U\%?#7PX^./QN;2Y9_C%^VAX^T=[E?%_@GX6:%#J.
MF>5\#/"MVTWA75=?U75K+P]XD\21:JVH6'CM-(N?!OA_\B?^#QR%(O\ @KKI
M+J &N/V2O@Q-(1U9U\5?%.W!/J=D"+] !VK^]K_@@]_RAW_X)X_]FV>#/_0[
M^@#\"/VDO^#+3]CA_@'XN7]E3X[_ +2.F_M&:)X9U'4/ MW\7_%'PV\4_#OQ
MKXHL+&6ZL_#GBK2?#OPQ\#ZEX?LO$=[#'I-OXATC7"/"XO!JMYH_B9+-["Y_
ME*_X-XOVV?B1^P=_P59^ .B#4M6TCX??M!_$KPW^RY\>/ ]Y-/::9?V7Q%\2
M0^#?#&L:UI\I$-MJ_P ,OB%JFC^);?4G@_M&PTZT\2:)#-#8^(=7AN?]A>O\
M4SQO:0^%O^"U'BZQT=1:0>'/^"HNOVFEI"/*6VATC]K"[AL5B"',8A2WB"!3
M\@48/ - '^SO\2_A9\,OC/X.U;X=_&#X=^!OBIX UZ-8M;\$?$;PGH7C;PEJ
M\:$E%U+P[XDL-2TB]$9):(W%I(8V.Z,JW-?Y47_!RY_P1ST+_@F1^T_X?^*7
MP$T*;2_V0_VG)-;U7P!H<3W5Y;?"/XCZ+]FN?&OPH^V7#W$P\/R0:A:>*?AV
M]_.MT^A7>L>&XA>_\(/=ZI>_ZS-?E-_P6H_X)]V'_!2K_@G?\<_V=;/3[2Y^
M*5CI0^*7P U"Y\E'TSXV_#^UOM1\)6L5W.1#86_C6SGUKX;:SJ$@<6/A_P :
MZM=QQF>"%E /PY_X,Z/!7[(_B_\ X)Z^*_%6@?"OX:7?[3W@#]HCQ;IGQ;\>
M:OX6\/ZK\3%CN-/T/Q!\++_3_$6H65SX@T;PC!X<NI=/\.V>G7EII:>)M$\9
MW]K NJ7&K7,_]C]?Y(W_  ;,?\%";_\ X)[?\%,O#GPW^)6H7?ACX,?M5W5A
M^SM\7]-UKSM-MO"GCV36I8/A'XRUFSNQ;"PO?"?C^[F\(:Q=ZH]O!X?\*^.O
M&6H7BB2S15_UN: /X[O^#R%_V</"?_!/KP/!K?PU^'FH?M+?&7]H7P5I'PP\
M81^$M"_X6A::3X-T/4M5\?:U:>)X[)/$4^AP:)!X;\$ZK9"^GMY9?%OAN![-
MQ;VLUG^H_P#P0X_X)$?!#_@F[^Q_\$[C5_A'X/\ ^&PO%_@K2?'/QW^+.M^'
M=+U+XDZ5XY\9Z*+O6?ASHOBJ\M)=6\/>%/ -AJC^!8=%T&YTW2]4DT_5==O[
M2?5-?U2XN/PE^.2_\/HO^#HSX=?!"+_BI?V3O^"46E3:_P".H1_I?AS5/'WP
MWU[2->\;VUS!-OLY;[Q'\?[[X?\ PC\2Z/*ZKJWA'X6ZQ=Q6T\5I=E_[I* "
MLC0_#^@^&-.CTCPUHFD>'M)BGO+J+2]#TVSTG3H[G4+N?4-0N([*PAM[9)[Z
M_N;F]O)5B$ES=W$]S,SS2R.VO10 5\+_ /!3+]KIOV#OV"?VI/VM;73K35M;
M^#?PMU/5_!^EZBLC:9J'Q!U^^T_P;\.;/5EA*S-H]QX\\1^'8]76%TF;36NE
MBDCD*NOW17YN_P#!7S]D?Q3^W5_P35_:[_9:\">0_C[XE_#%+OX?V=U<0V=M
MJ_C_ .'GB?P]\4? ^@7%]<O';:?!XB\5>"M(T*;4;EUMM/CU%KRX/DP/0!_,
MI_P:B_LQ_ S]M+P5^U/_ ,%,_P!K:PT7]J3]M;Q+^U!XB\#WGB_XRV&E^.;S
MX?:58^ _A_XRA\1^&]"URVNM,T/7O%>H>,M3TNUU^QTZ!="\,>%=.\'^"VT+
M2;77]/OOZH_VN_\ @FE^P]^W'\,M=^%W[17[.?PS\5Z?J^F7%CI?B_3_  IH
M6@?$OP/>20O%:Z[X!^(&EZ=#XD\+ZQITC+/ UG>-IMZ$.GZWINK:/<7NFW/^
M2I_P3H_X*=?MK_\ !%C]HWQO??#6PFTF6;5T\%?M$_LU_%S1]8L/#WBNY\':
MC?V<FC^*M#=]-U_P?X^\(7EQK%OH?B33VL]:\/W=UJ%AJ%MJV@ZAK.@:G_HL
M_P#!.+_@Y\_X)Q?MX_V!X'\=^+#^Q[\?M5^RV9^&OQTUG3;/P5KVLS[$^Q_#
M[XTB/3O!NO+-<RP66F:=XMA^'_B[6;Z86VD^%+[;YK 'Y#_\&UG[$GC3_@G9
M_P %FO\ @J-^R)XVO)=9F^%7P3\,Q>%/%<EH;-/&_P .?$?Q#\,^)OAWXQ2!
M=UO#<:[X0U?2;C6;*TFNK?1_$"ZOH8NIY=,E<_W:5\\Z7^S!\&M,_:A\2_MD
MZ5H-Q;?'+QK\$O#/P"\1^([;5+D:5K/PX\*>,-8\=>'X;G1$;^SI=9M-9UV\
MC'B#8=0FTE+'2Y)7L["TCB^AJ "BBB@ K_'Q_P"#G;_E.9^W7_V%/@#_ .LK
M? VO]@ZO\?'_ (.=O^4YG[=?_84^ /\ ZRM\#: /]%O_ (-RO^4*'[ O_9-/
M&/\ ZN'XCU]0?M^?L-_%/]N#1O#/@CPQ^W?^TY^Q_P##6UTCQ-9?$#PY^S)+
MX)\*>*/B5?ZJ^E#P_=:A\3]2\/ZCXX\.Z3H5K!KECJOAGP_J5MI/BVVUN)=3
M6!M,1KOY?_X-RO\ E"A^P+_V33QC_P"KA^(]?MG0!_AC_P#!0#]F/7_V,OVU
M?VFOV7O$OBNY\>:I\&?B[XK\)KXYO89+;4/&FE"\_M/P_P"+=3M9;J_DM-5\
M1Z!J&F:SJMFU_?\ V34;VYMUO[U8A=2_Z FE?L3_ +</_!P;\*_@S=?'KXD_
M$3]@O_@E#X,\ _#K3/A#\#_#EA:Q_M"_M;'POX<TC3_^%W_$>UU)YO#_ (.\
M':Y>6C:O\)[+Q78>+K6UT:#3=<T_P'=RZK;>/]3_ ([_ /@XWA2#_@M?^WTB
M !6^)7@R8@<?/<?!SX;W$A^K22LQ]22:_P!=C]FG_DW+X ?]D3^%7_J":#0!
M_#W_ ,%3/^#1#]FKX%?L:_&#]H/]B/XL_'Z]^*'P%\ ^(/BAK?P_^,NO>!_&
MVA?$CP7X'TN?7O&5AHMUX4^'_@+5?#OC2W\.66JZSHC*==TO7M0TZW\,IHFF
M2ZO'K5A^9?\ P:#?MT^.?@7_ ,%%(/V.[_7;ZX^"_P"V'X9\7VC^&+J[D.C:
M!\8_AMX-UGQ]X5\;Z?;R,T5CJ6L>&/"OB3P%J8LXX7UXZQX9&I/<?\(WHZVO
M^FW\9=+M-<^$'Q6T74(DGL-8^&WCG2[V&10\<UIJ'A?5+2YB=#@.DD,SHRGA
ME)!ZU_CO?\&^MS-:?\%FO^"?4L#LCO\ '!;9F4E28;WP=XJL[A"00=LEO/+&
MPZ,K%6!4D$ _V:J_SROVP?COH'_!8W_@YI^$?_!.C]HGQ/JL?["W[-_Q9^(?
MPWT[X/VVMWNA:#\1?B?\'?A7XR\7^.+GQ1)9SV<D^L^._B7X4N/AG#>QW,>H
M6GP^LUT7PI<Z3KWB/4[_ %#_ $-:_P C3_@X1_95_:*_X)U?\%@?BY^T-X<D
M\7^"-$^./QKU3]K;]FSXX>&WO=-3_A*O$?B"W\>^*;70_$-J!%IWC/X:?$K4
M=1M+S2OM(U.WTL^&O$,UJFE^)-,>< _U4-(_94_9@T#X?V_PGT3]G+X%:5\+
MK73DTBW^'-C\)? 5OX'CTR.(0+8#PM'H"Z(UKY0V-"]DR.N=X8DD_P "_P#P
M<,_\$2OA!^Q!^TM^R)^V]^R#X%L_AU\"?BS^TO\ #/X=?%[X4>'()(O!_P -
M/BE?^)[/7_"OB/P1ID8EB\->"_'>F:1XALK[PY;_ &3P[X4\2:-IUKX?BMK'
MQ78Z+I'T[_P3)_X/)O!6L:;X8^%/_!3_ , 7OA/Q'!#9Z2_[4OP>T&;5_">L
MM&J0'6OB?\(=+B?7O#-VT<9NM6U?X7Q>*+#4-1N672_AUX7TV,)'_6_XJT/]
MBK_@K%^RY!I>F>.O!7[1/[//BWQ1X!\8V'BCX5^.+6]CLO%WPP\:>'/B+X;\
MK7= N7U#PUXBT7Q!H.F1:]H-^MAK$-E-J/A_7=/AAOKVT8 ^V-5M;N^TO4K*
MPU.XT6^O+"\M;+6+6WLKJZTF[N+>2*VU.VM=2M[O3KFXL)G2ZAM[^TN;*:2)
M8[JWF@:2-O\ ._\ ^#G;_@D9\9O@G^RUX2_;@^)'_!0C]IW]L?Q7HOQ7\,^!
M?B'X8^.\WAJP\!:#:>/-.UU;3Q1\'/ G@>QT7PG\+[.U\1:;9:7?>$=+TJ[M
M+VV\1&^CU:UFTJ6WU?\ T3Z_FH_X.U(4E_X(L?&IW +6_P 6?V?IHR1RKM\3
M]&MR1Z'RYY%SZ,1WH _GR_X,?_\ DXC]O/\ [(O\(/\ U./%%?Z,E?YS?_!C
M_P#\G$?MY_\ 9%_A!_ZG'BBO] KX^_%S0_V?_@5\:?CQXGC,WAKX)_";XC?%
MOQ#"LHA:70_AOX/UGQCJT2S,K+$TEAHTZ+(58(2&*D#! /XR/^#H/_@NA\3?
MA/XO'_!+O]A;Q7K.C?&'Q)9:-:_M(?$WP#<W*>-O#:^-K>UD\*_ CX=ZAIA_
MM+2O&7BG2]3T[6?&>MZ,\6L:=I&L>'_#&B7T6I:KXEATW]<?^",G_! #]ES_
M ()X? GP5XG^,_PI^'OQI_;5\7:)8^(/BW\4O'FA:/X]B\">(=4MDNKOX>_"
M--=L[[3_  UH'A=IY=(O_%6DV]OXD\=Z@FH:OJVIKHMQH?AS0/\ /C_X(^W?
MB+]MK_@O'^R/X^^--])XL\9?%']KZ]_:(\<W]RIF35O&'A.7Q-\>;B5X+AYE
M&FG7_"\06P9G@ATU%LD7R(U2O]CR@#\%_P#@L%_P0C_9+_X*-?L_?$&?P;\(
M/A[\*_VO/#_AG5M:^"_QI\">&]%\%ZWJGC'2K.:]T7P5\2KK1+;3K?QAX)\4
M7<*:#=R^)(]2OO"*:C)K_AJXL[NWN+>__P HK]G7_A(_^&RO@5_PF#ZQ)XM_
MX:;^&/\ PE,GB&6[FU^3Q'_PM31/[;?7)M09[^76&U/[4VIRWKO=R7IG>Y9I
MBY/^Z[7^*7\8;&STS_@M/\4M-T^VAL[#3_\ @J)XWL;&SMT6*WM;.T_:OU."
MVMH(U 6.&"&-(HD4!4154# % '^UI7\PG_!R'_P64\??\$^OAQ\.?V4?V29?
MM?[<7[6$)L_!^H6-M;ZGJWPD^'NI:N?"5OXUTK2+E)H;SQWXW\3FZ\(_#".Z
MMY]/MM0TGQ1X@NE:Z\/:9I^J_P!/=?Y0G_!3;XN?&C]J?_@Y_NK3X1^)?!>E
M?%+P-^V]^SU^SS^SQ>?%&"_U3X9>#_&WP?\ %?@;P7X3/BG3=/M-5O[KPE)\
M7=/U7Q3XCTRST^_DO)M;U:*.PG^T_92 ?VT?\$P_^#?3]D?]DGX::1\0/VJO
MAOX,_;&_;A^(MO'XS^//QQ_:"TJR^,QM/'^OQC4=>T7X?VGCZ+7].L+#1K^Z
MO+&7QU):2>.O&]TU_K6MZW%I]_IWAS0_ O\ @N1_P;R_L>_M6_LM_%?XP?LS
M? _X=_L_?M:?"/P5XB^(7@S5OA!X5T7X?^&OBTGA33+C6]7^'?Q"\(>%].L/
M#NM:AXHTNQNM/\,>+O[/L_$NC>)SH;7NN7'AA=6T:][G_A2G_!UA_P!'D?\
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MVA\2?A=XGUWX8^,M?:SMT2WL!XNUGPE<>,+>P@18+.SU^V@@40H@'T;^W/\
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MYND@\N\U?QOX^\6:)J6NZU=ZC,]S=2:?'/9^'-+:[GLO#NA:+I @TZ'^!_\
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M&OBW0==U#X<SKJ]QINLCQ5X0CM=?":;)I:SK;:A+)%_E0?\ !LY_RG$_8/\
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M77AS3_CW\$/A1\:+'P]?,9+S0K3XH^!-!\;VVC74C1Q&6XTR'7$LII1&BRO
MTBJ%85\%_M*_\$,_^"5/[7OQVD_:5_:"_9"\'^-_C)?7.G7OB'Q/9^+OB=X*
MLO&EYI$-O;Z?>^//"O@/QOX9\)>-;V.WM+2UNKWQ+H>IW>K6-M!INLSZAIL:
MV@_5/1M&TCPYH^D^'O#^EZ=H>@Z#IMCHVB:+I%E;Z=I.CZ1I=K%8Z;I>F:?9
MQPVEAIVGV4$-I965K%%;VMM#%!!&D2*H /\ /9_X/C/^2G_\$ZO^Q#_:3_\
M4A^#5<I_P0M;_@H7^W%_P31T/_@G'^Q/JFM_LF?!73OBI\5=;_;&_P""@&J6
M-U)J>GZ+XXU*QN](^ G[-.G:=J>EZEKOQ%U;0576/'VNVNL>'O\ A&-"U+2[
M"7Q%X<?5[(>*.K_X/C/^2G_\$ZO^Q#_:3_\ 4A^#5?MU_P &AO\ RAM\%_\
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MV9K=KN9H(F:(R$K_ +L%?XI_C"%+?_@M;XHMXP%2#_@J1K<**. $B_:RND4
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M8/\ @D/\0_\ @D_H/[0.C^/?VW/'_P"V*?C=JGPVU'2HO%W@O6O ^D?#;_A
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M@?XK^&VJZ--H<>@-\./"VDR:!:R6[6\%WX-U;1=-T_6/!6LZ8&$NC:YX4O\
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MXE_"CPW\!_\ @GA\+?%^I> ='^/WA;4OBM^T3K^D3W-KJ6N?"Z+Q+/X/\%^
MVN+,I=-X5UW7]$\9ZQXUTZWFBEUR#PUH.BSM)HU]K6GZC_<G7\ G_!Z=^PO\
M5?$VO_LY?\%!/!/AO5?$_P ./!?PXF_9X^-%]I-G->#X<I:^-]<\9_#/Q+KJ
M6Z2R6GASQ/JGCWQ=X<N-<N%ATW2]=M/#NE7=RM[XHTF&8 _L#_8F_P""='[$
M_P"Q7\!? _PF_9T^"WPRB\-6GA;1X]3^(,WA;PUKOC3XLW4VG0/<^./'/C66
MQN-1\6:GXE9VU'S)KR32+&UN(-+\/66F:!9Z=IMK^ W_  <>?\$%OV;_ (\?
MLE_%K]L+]EKX,^#OA)^U/\ ?#&J_%'Q);?"[PWI_A31/CE\./"UK+JOQ T;Q
M3X5\.VEKI6H^/=&\,V^H^)O"?BJSTP^)M9N]&'@[5)]2M-6TN;0OYZ?^"/?_
M  =:_&O]AWP/X&_9G_;%\#ZQ^TI^S?X(L-.\,>!O&OAS4+.R^/7PH\'Z?'':
MZ?X=M6UNXMO#OQ3\*^'[&&*P\-:!XBU/PIKVB6&S3X/&]SH6F:-X?L?] G]B
M[_@I)^PE_P %+_ &H:K^R_\ &_P1\5X9M$D7QQ\+=4)T/XF>%]-U&(6%_9^.
M?A;XDBLO$]CI4LEQ+I3:S_9EYX3UF43QZ-KFJVQ$S@'S-_P;U?\ *%__ ()^
M_P#9&+O_ -3WQC7'_P#!>W_@KCI__!);]CX>-?"%OH^O_M,?&O4M4\ ?LZ^%
M=:5;G2[36+&PANO%?Q/\1:?OC?4?"_PTL-0TNYGTU&QK/BC7?".@W1M],U;4
M-0L?U/\ V8OV;_A9^R%\!OAK^S9\$M+U+1?A5\)=#F\.^"M*UC6+WQ!J5AI,
MVJ:AK!M[K6=2>2^OV2\U.ZV374CRB(QQL[; 3_FF_P#!X%\<=9^*_P#P5I\-
M?!*34HX_#/[//P+^%G@_3],O)I?[(L_$_P 39[WXG^)->N8XV9X9M4T7Q1X+
MT[4Y80CR:=X:TW:A>(.X!_3Q_P $;_\ @AI\,?$/PS\,?\%"_P#@J1X=A_;1
M_;M_:FT;1_C#K<G[1EI;_$;PM\(O#OBZQM];\(>%['P+XCBO/"UWXRM=!N=)
MN=8O=7T6:V\!74=IX(^'VF>&=,\.W5[X@^X?^"E/_!O[_P $_OV^?@=XM\*^
M&_@+\)/V>/CW:Z%?S?";XY_![P#X;^'.K:#XNMK25M M?'EGX,TC3;3Q]X#N
M;U8;'7]#U^QU&^M='N+Z?PG?:#KHM-3@^<[?X&?\'5-I;P6MK^V%_P $F[>V
MMH8K>WMX/AA\78H8((46.&&&)/@ZJ1Q11JJ1H@"HBA5   J;_A2G_!UA_P!'
MD?\ !*#_ ,-I\7__ )SU '^?/_P2]_X*1_M'_P#!%S]M^XU.*\UU_ 6C?$.[
M^&'[67P$_M*67P]XXT'PSX@N_#?BM(].,PTZ#XA^![B'4]0\!>*HDBN[#5K9
M]*NI[GPMKGB+1]4_V3/!WB[PYX_\(^%O'G@[5K;7O"/C;PYH?B[PMKED7-GK
M/ASQ)IEKK.AZM:&1(Y#;:CIE[:WD!DC1S%,FY%;('^<G\9?^#/3_ (*E?';X
MO_%;XW^._P!IC]A ^-_C)\2?'/Q5\9'1-:^.FDZ,?%7Q#\3ZIXN\0G2-*C^!
M,D>F:8=7U>\^P:?')(EG:^5;([K&&/\ :1\,].^)7_!,S_@CKI]E\6=?\+>-
MOB3^PE^P=XCFUW6_#5WK&I^$M?OOV>/@]K%YHT>D7'B'2] UF[TR>P\*Z786
M\6H:5I]RP MQ HV%@#^7#_@O9_P6$_:/_:S_ &SO#W_!$C_@FAXMO?#.I>+/
MB5H7P*^//Q9\+:M>:3K7C#XE>)-1@TC7_A/IGB?25DU'PC\,/AM'<72_&K7]
M.\O5=7O=+\2>&[EK/PCX;UN#QI_25_P3]_X(7_\ !/']@3X.^%O GA_]GSX6
M?%_XHP:/9#XB?'SXO_#WPOX[^(GCKQ.T$3:SJ%C=^*;#6QX&\,3WB8TCP3X3
M?3]'T^QM[(ZB=:UU=0U_4?X O^#4[2O^%L_\%POAM\0?'U]-XC\6:%\/OVC/
MBL=9UJX:[U#5?&^O>"=7\-ZIK=W+,6:]U2YA\>:[J$LTNZ3[2[WRD3PHZ_ZQ
M- '^?%_P>$_\$Q?V:/@9\*?V?OVW?V>/@QX+^#7B/7_B[/\  _XR:?\ "WPM
MI?@_PAXO'B;P=XC\:>"?%>L^&/#UI8Z#8^)-*N/ GB72KOQ%:6%I>^(H]?LK
M?7KG4)]-T<P>H?\ !F__ ,%,?CI\6=6^+W_!.7XO^(M<^(7@OX3?"!_C;\!?
M$6O7-SJ>J_#OPIH7C3PAX#\6_"YM7N7FN;GPG)>^/_#&L>!=+N9 GA=++Q+I
M=A*=(N=)TW2?[7?VC/V:_@3^UQ\(?%7P&_:1^&/AKXN_"3QI%:Q^(?!GBF"Y
M:SN)K"YCO=-U*PO]/N;'6="UO2KV&*\TC7]!U+3-;TF[C6YT[4+68!Z^:?V&
M_P#@E=^P1_P3?'C2;]C;]GO1/A+JWQ#CLK;QEXFF\4>/?B!XNUO3M.GDN;#1
MF\5_$OQ5XPU_3] MKAQ<C0-)U"PT>>\BAU"[LKC4(EN@ >(?\%=_^"?W[)G[
M4/["/[7Y^)'P(^%U]XYT;X$_&3XE^"_B=;>"/#FG_$7PE\3?"?@?Q#XO\.^,
M-)\:66G6_B.*\7Q%IUM-KL!U(VOB739M1T?78K[3M1NX)?\ -B_X-CO^4Y7[
M"?\ V&/CQ_ZRW\;Z_P!6[]N3_DRG]L'_ +-;_:!_]5-XMK_*1_X-CO\ E.5^
MPG_V&/CQ_P"LM_&^@#_8,N;:WO+>>TNX(;JTNH9;:ZM;F))[>YMYT:*:">&5
M6CFAFC9HY8I%9)$9D=2I(/\ %?\ \'>?[ W[*7AW_@G]X8_:H^'7P,^%WPP^
M-G@'X^> /#%YXX^'7@?PYX*U?Q?X'\<Z3XLTW5O"_B^3PWIVFIXEMK?6+?0-
M;T>[UE+V_P!#GTZ[M])N;.TUK68;W^U:OY=?^#OS_E#GXC_[.,^!G_I9XCH
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M/AS]J+XK>%%\3_$_XHZ1/&^M_ GX6ZPUW8Z/8^%9XW;^Q_BKX_:VO;G3]7F
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MN?$/_",VNA)\1?""WDI76?!?BN:[L[JQN;Z31+OP[XA:Q\0:?^SE% '^/_\
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M "8!^RI_V>'9_P#JE?BO7]G-?QC?\'L__)@'[*G_ &>'9_\ JE?BO0!^'?\
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M;6'_  5\CNX(U276_P!E?X*:I>,H ,MS%K/Q$T59'(&686FD6L0)R=D2#.
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M50  * /HS_@I3_P;^_\ !/[]OGX'>+?"OAOX"_"3]GCX]VNA7\WPF^.?P>\
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M[[0_AUH\<7AKPC:7D%EK/Q%^(.N3+I?@CP!H4LZS>7>^(M<G@CO;]+6]70-
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M\4?VKO&&I6'B/POI/Q8URR83/\.]*\/^*+GX;:)J3>%]/\2^%O%$?B^ZU_\
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M_P ?O!$"L4+^,O">D^(FBC4DD1QG42B DD* ,FOQE\)_\&WW_!-#P9^W\?\
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M2/Y9/^#1[]DGQ5X;_9:^.O\ P49^-7VO6?CE_P % ?BSXC\20^)]:B#:U?\
MPU\(>)_$(N]?D>5$N+2[^(OQ;U;XA:_JJQHEMK6E:/X+U9&GA^R-'_7/0 44
M44 ?%'_!0[]N;X4_\$Y/V1?BY^UI\7B]]H?PZT>.+PUX1M+R"RUGXB_$'7)E
MTOP1X T*6=9O+O?$6N3P1WM^EK>KH&@0:SXFN[2;3M$O0/X<O^".G[,WQ4_X
M.1OVS_C3_P % _\ @J'X@UGXG_L[?L^:W8^&OA[\"+34]:T/X2W/CSQ(IU_3
M_A=X6T2RU$R:)\,_AOX9@TK6_&FFVM[;^(?'^MZ_X.NO&.O>)(KOQ8FJ=?\
M\'M_[4VN7?Q*_8Y_8ITO4I[;PSH7@CQ#^T_XVTJ*9C;:UKWBK7M=^%GPVN[V
M#[JW'A;3O!WQ1CL6SN:+QC>%UVB%C^V/_!H1X0TGPU_P1P\)ZSIT,,5Y\0/V
MAOCIXNUYXU0/<:K9:IHG@*&:X*\M*NA^"=&@4O\ ,((85'R*E '[=:__ ,$Z
MOV _$_PX/PAUS]BG]E:]^&8TTZ3;^"A\!/AA::%I]F45$_LBULO#-M_8UU;E
M(YK34=*>SU"RNHH;RTNH;J*.9?\ -I_X+R?\$J/'7_!#7]KGX3?M4?L.>-OB
M'\.O@+\3?$&HZO\ !3Q7X?\ $NMP^,_@#\5=!B6]USX5S^,ENI-3U70]0T:Y
M?6/ U]KUW/J7B+PNOBCPKXB37G\*:KKOB#_5@K\(_P#@Y3_9TTC]HS_@C=^U
MU:7>GPW?B#X+>'=$_:+\%WTD2S2Z'J_PBUNUUKQ+J%J"I,<M[\,KCQ]X=EE4
MJ8[/7+IBVT,K '(?\&]G_!9FV_X*Q_LRZOIWQ2.CZ-^UW^S\-#T#XWZ1I<-O
MING>/-'U:&XC\*?&;PSH\(2#3['Q4^G:AIWBO1-/3['X;\7Z?=_9K;3- U_P
MO:-]#_\ !2K_ ();_%C_ (**?V[H"_\ !1O]JO\ 9I^$E[\/H?#VG_!+X&1^
M"_#7@G4O&HEUIM0\4_$O6[+2[#Q_\2O"VLV]UH-K>_#?5?%=CHML=$N;O3;Z
MUGU=A9?YS7_!KU^T5X@^ '_!9/\ 9ITRPU"XMO"_Q_M?'?[/_CW3XI&1-7TG
MQAX3U'7/"D$JY\MOL/Q0\*^ ]6W.CMY5C/%$4:?>/]>F@#_"?^&T,O[-G[8_
M@&#X@P7=S/\  +]ICPM#XWM?#ULVJ7\\OPL^*=@GB6#0[1VMGU&[E?0KV/3+
M9FMVNYF@B9HC(2O^C/XT_P""1G[9?_!>7Q=I?[27_!4_XN?%#]C[]E5;M]8_
M9G_X)Y?"*XT>'XC>"_!UY&XT;QK\<O$OB72]=\*:)\8_$&E.MSKUE=^"O%_B
M+1[;5I_#T=Q\.TL;GPHG\)'C"%+?_@M;XHMXP%2#_@J1K<**. $B_:RND4 =
M@ H ]J_VL* /\VW_ (+M?\&O'P5_8(_9%\0_MF?L8_$WXP>)?#GPFU/PTGQG
M^&7QCU/PKXKOE\(^*M?T[PC:^-O!'B/PIX1\%7$#^'_$6LZ&GB'P[J^DZRMQ
MHNHZEXAM]=TF'P])IFI^V_\ !E?^W3XYE\??M#_\$\/%^NWVK^ !X!NOVD_@
MU8ZE=R30>"];T7Q5X;\(?%+PYH2S-(T%AXR3QKX8\5_V1;F&PL]3\->)=9A@
M%_XAU:XN?ZW?^"W&EVFL?\$BO^"C%I>Q)-##^R3\8]41'4,HN]#\*7NM:?*
M>CP7^GVT\;=4DC5QDJ*_SW/^#0&YF@_X+%>'XHG94O?V</CE;7"@D"2%+;PS
M>*C $!E%Q:028;(W(K8W*" #_5KHHHH *_C@_P"#A_\ X)!?''XN?L@_M<?M
M=^*O^"C7[4OQ0G^#4'BOXW>$/V9/$@\&^&?V:-!^%V@Z^VLS^";+P!X$TCP_
M#>>*_!'@-YH]+^)NO-K/B#Q'>^'X6UVW6?5[B_L?['Z_.K_@KY!'<?\ !*;_
M (*31R*&5?V%OVJIP#_STM?@EXUN8F^JRQ(P]" : /\ +@_X-W_CAX_^ '_!
M3GX<>-OA'\#_ !?^T=\7M3^&OQB\$_"GX.^#I[+3)O%GC[Q?X'O])T%O%'B?
M4Y(M*\#_  ]T*227Q%\0_'&IF2T\*^#M*UG5_LUY/;PV<_\ ;[+_ ,&T4'[<
M?CO5_P!J+_@LG^U;\5_VA_VD/&<),/PT^ FOQ?#;]G3X$^'YG>>S^&'PQAU[
M0=?\6ZIX=\-,^VRU:"3P2NKW<E]JWB/1-?\ $-_J'B74OY&_^#2?_E-)\'?^
MR0?'_P#]5QJ5?ZS= '^4I_P<0_\ !O\ ^&O^"3<'PR^/W[.GCGQIXZ_9>^+'
MBZ?X<7>E?$B;2M1\<?"WXF-HNI^)]'T6Y\1Z'I.@Z=XF\+^+="T/Q-=>'[N3
M0[#5M&D\,WFFZS<ZQ+=V6IW'Z"?\$*/^"JO_  4J^-G[">J?\$N/V-?!>J?$
M7]JWPSXO;1?A=^T_\2CYWP=_8_\ V4_$.E1"^\3_ !"U^^AU:?5?$/@3Q-%K
M&E?!3PA-I>MFZLM6M=,TW0];TKX?:=X+UO\ =7_@\"L+6\_X(\:Q<7$*23:5
M^TI\#[^Q=E5FM[J0^+=+>:,D$H[66I7D!92&,<[IG:S _CA_P8VR2#QA_P %
M*(@[")_#7[*,CIGY6DBU3]H58W([LBS2A3V$C#O0!^E'@3_@SL_8L\2:5K/B
M[]L/]J+]KG]I#]HOQY=7>O\ Q)^+>G>-/"W@JSU7Q=JTC7>KZWIFD^(?!_Q&
M\27=[<7TLTD^H^,O&?BF74"$G>TLRSV]?Q6?\%JO^"5WB_\ X(Q_MG^&_AWX
M,^)GB/QA\._%_AW2OC-^SS\62!X:\>:;:Z;XBO-/FT;7KK0FM+>R^(7P^\1Z
M/!,VO^&_L%IJ-A?>&O$]A::!>ZC<:!HO^R97^>S_ ,'R-E;1^-_^";FHK$HN
M[KPK^U/93S!5#R6UAJ_P"GM8F;&XK#+J5XZ*254S.5 +,2 ?UD?\$0_VU_$_
M_!0'_@F-^R_^T?\ $"YCO/BEJ?AC6? 'Q7O46*-]6^(7PJ\3:O\ #[6_$]S#
M;I';6UUXXAT"Q\=7%I:10VMG)XF-I;0PPPI$G/\ _!=7]OKQI_P3>_X)K_&_
M]HOX6P6S_%^ZG\,?"WX27^H64&H:9X<\<?$?5DT:'QC?65VDUG>-X,T%->\4
MZ5I]_:WNF:IK^D:1I>K6DVEWMXH_.K_@S\N9I_\ @CQI$4CLR6?[2OQPMK=2
M21'"Q\)7C(H)PJF>ZGDP,#<[-C))/[T_MJ_L9_ K]OW]F_XA?LL_M&Z!J&N_
M##XBP:8;Z30M1&B^*/#VM:#JEIKGAWQ5X3US[->#2?$.@ZO8VUW9SS6=]87<
M0N=*UG3M4T34=2TR\ /\^[_@TT_94^$?_!0/]L[]L7]J;]M'1!^TQ\2?@UH?
MPX\4^'C\:%/Q$TK6/B/\8=?\=-J_Q*\76GB;^T;?Q1XJT*U\!_9O#;>($U&S
MTVYUVZUJULTUK1]"U#2O[HOVX_\ @EA^Q=^WE\ _&_P2^+'P*^&%I>ZWX9U3
M3? GQ+T'P+X;T?X@_"CQ0]A+#X>\7^"?$^EZ?9:QIMQH6HBTO)]'2\_L/Q#8
MV\NA>(=.U/1+V\L9O)O^"?\ _P $S/V!_P#@A[\$/B[<_"_Q=J7@_P )^,+[
M1O%?QJ^/?[2GQ'\'P:I>:?X3M]2L_"UIXG\71:+\// F@>&?"W_"0:^^D6UK
MH>D1K>>(=4N+VXO;F[5T^+/BI_P<B_ OQKX]U3X%_P#!+[]FO]H#_@J1\=;%
MQ;7/_"D?"^K>$?@1X9GDD>U2]\9_&;Q)H=T=-T1+D Q^);'PC?>![^*.7R_&
MMJ&AF< _@,_X(<?M3?&G_@GQ_P %=?V>_#6D>(-0T71OB%^T/X3_ &4/VA?!
MD=[<_P#"->*?"OCKXA6OPQU8ZWI^8H[ZY\!>(=3B\:^&;QXH[RQUC08DC86=
M]J=E>?Z^OQ:\*^-/''PR\=^#_AU\3-4^#7COQ+X7U?1O"7Q6T7PYX:\7ZM\/
MM>OK22#3O%>G^%_&-EJ'A?7[G1[ADNX]+UVRGTZ[,?E3J P=?\6;X.ZEXPU'
M_@KG\+-8\>>&[7P3X^O_ /@HYX(U+QGX0T_4+;5K+PEXPNOVFM,NO$7ANRU6
MSN+NSU.UT'6I+S2[;4+6ZN;:]AM$N8+B:*1)&_VW* /\P'_@Z/\ ^"4GQ!_8
MS/P!_:D\3_MJ_M'?MB1?&+Q/XH^&_BB]_:;\06?B3Q3X,\5V&CP>*=*'@F[T
M:VTO0=(\$:YIMMKD2>$--T#2K;PS-H=FMG<:G;:D(=)XC_@WU\2_M3?M&?L\
M?'O_ ()6_L:>(]8^$/C7]J7XOV?Q!_:=_:EMK&\EM_V=/V0_"G@C1O#'BM_#
M4MM<Z;+??$_XP>(M7B\!^#]/T_5+2^CL8/$+37?A^VO!XQ\-?OQ_P>T1J?V!
M?V492!O3]K^WC4]PLOP7^*3,/H3"F?H*\W_X,A=#T:']F3]N3Q)%I>GQ^(-1
M^._PWT._UM+2!=4O-&T;X?WM_I.EW-\$%S-I^G7NNZU=V5H\A@M[C5;^:)%D
MNIF8 _+7_@H-_P &<_[8_P '_%.C:M_P3X\16G[7/PVUL6]MJ'ACQSXF^'7P
MC^+G@;4 $CN;C4KSQ=K_ (4^'?B_PS,<W<&J:+J^C>(;5I7TR7P==1V::WJ/
M]KO_  2__9_U_P#X)._\$COA+\+OVJ_B#I5]?_LO_"3XK_$_XS^*=-O+K5O#
MG@S0Y?$WC[XU>)-"T>^N(HKG4](^'/A_69O#\5W'&D&H-H<UQI<-OIT]E:P_
MKE7Y;?\ !;CPUXL\6_\ !(__ (*':)X)BNY]?D_98^*>I"VL5D>[NM$T#0Y=
M?\56D$40,L[W?A;3-9MC;1J\ERLI@1':0(P!_GV_#W]H#XQ?\'-?_!;?X$_#
M+]HO7_$^A_LGR^._&GBCPU\!]*UR[LO#?PT^ OPW\-ZUXWU/0(QILJ))\0_B
M=IWAG2_"?C;XD0+_ &Y<:SXE1M)NM)\.:)X=TC1?]1#P/\&/A%\-/ACI7P6^
M'WPQ\!^#?A#HF@_\(OI?PR\.^%-$TOP-:>'3;FTET=/#%K91Z1)87-NSQWD$
MUI(M[YDKW?GO+(S_ .4+_P &IOC_ $7P-_P6L_9RL-;N(;1/B)X)^.G@#3+F
MX,:0KK5[\)?%/B33+<RR,HBFU*?PQ_95F%S)<7U]:V:*6N0*_P!<6@#_ "H?
M^#G_ /X)H^%/^"9?[;WP\^-_[+&GW'PE^"O[5F@^+/&'A/PWX'GN?#>G?"[X
MK>#;G2],^*OA;P2=)N(9?#_A+5-/\7^%?%.B:1:2V=AI3>*/$/AG0;&R\,Z'
MI]A;>Z_\$A?^"%_Q"_X*U?LF6?[37@G_ (*\_&/X4>(-&\>^)OAK\3/A3>?"
M/QCXUO/ /C#P^-/U:S@MO%4/[57A,^(=+UWPAK_AGQ'I^JMX:T,+-J=[HYMG
MN-&N;B7]=_\ @]VMM&?]DK]B>\G,'_"0P?M%>-[;2PRQFY.C7?PTN)==,+$^
M<(!?67AS[0L8,;2&U,I#+#FC_P &0OA[Q9:_LO?MQ^*KV*[7P-K7QZ^&^@>'
M)I%D%C+XJ\-?#V^U#QFELY;RFNHM)\5^!3>A$#K%+8^8S!H@@!_5!KG[*?Q<
M;]B#X9?LE?#W]L'XK_"CXB> /A9\&_A7J?[5GAOPWX/\1?%GQ59?#?0/#GAK
MQCXCDLOB';^,-+TKQ5\3M-T;4I[SQ"MSJ&N^&=9UHZSIVJ7MY99N_P#,$_X.
M2/\ @F[XF_X)X?MG^"(=7_:2^-/[5.D_M ?"Q/B/8_%#]H?Q"_BSXO1:]I/B
M;6/#?B?PUXE\4$K#XAM;)H-(UK2-2AL]*\NV\0/I#Z8&TG^TM3_UVZ_SJO\
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MHH *^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&K[_KX _X*Q?\ *++_ (*6?]F
M?MD?^LZ_$:@#\ ?^#*G_ )19?'S_ +/_ /BG_P"LZ_LJU_7[7\@7_!E3_P H
MLOCY_P!G_P#Q3_\ 6=?V5:_K]H _@#_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C
M'_SE%_[LF_\ ?N*_O\H **** "BBB@#_ !Z/^#FG2-7TC_@N#^W/'K"3"6_U
MWX,:O8RRAMMQI&I?LX_!^YTMX)#\LD,-HT=D2A98IK66W.)('1?]('_@WO\
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M#+.Z1H^J^.?@C\3_  5H5JK.R@S7VM^(-/LK= 2\L]Q''&K.ZJ0#_8[HHHH
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M>);VZ_:]BO;>V+J)I;73_@S\3H+R>.,G>\5O+J5C',Z@K&]S"K$&5 0#B?\
M@R(_Y-._;;_[.'\"_P#JMHZ^N?\ @\C\*:IXB_X)'^'=7T^*62T\"?M??!KQ
M7KCQJQ2WTN\\%?%[P/#+.1PL3:WXRT> ,V%,TT*_>90?C;_@R#U2QF_9D_;H
MT2.>-M2T_P"._P ,=4N[4.#+#8ZQ\/\ 5+33YW3.Y8[F?0]3CB<C#M:S!23&
MV/ZH_P#@I1^QMHO_  4"_88_:3_9$U>[L]+N?C#\/+O3_".N:@DDECX<^)'A
MR_L/&/PQ\17RPH]RVFZ)\0/#WAO4-6AM0+FZTJ"]M(F5KB@#^/K_ (,D_P!K
M/PY'X>_;!_8=UO5K>Q\32>(_#W[3_P .=)FF59=?T^]T;2?AC\6);2-V4&;P
M^=!^$LCQ1"2:XMM9N)RJPZ;*]?WSU_AH_#CXB?M8_P#!+/\ ;0L_%OAO^WO@
MA^U-^RY\2-4TC5='UFT)>PUO2)+G1?$WA/Q+IAD6T\1>#O%>CSWVD:K;1SRZ
M5XG\*ZNUQIU[+9W]G?'_ $DOV"?^#L[_ ()M?M)_#_0K?]J7Q;<?L:?'6WL;
M:W\5^&O&FB>*O$?PLUK5XHU6]U7P#\2?#&BZW;6VA7+XN(M-^(4'A/6M.>63
M3(7\1160UR^ /ZG*\5T#]HCX.^*?CU\1OV9?#_C*VU3XV?"7P#\/_B9\1/!M
MKI^KR'PMX1^*.H>*M-\#W>I:W]@'AY-2UJ7P;K=TOA]-5?7[72QIVL7>FP:7
MJ^F7=U^ W[;/_!U=_P $M/V:?AQK]_\  OXI-^U_\9WTZ[7P;\-_A5HWBBP\
M+RZP\+KIMUXU^*'B/0-,\*Z'X;6ZQ_:3^'9O%OBE(5)M/#,XE29?:_\ @@#^
MS;^T+X7^!?QK_;S_ &TDN8_VR/\ @I?\2=+^/OQ)TJ^L+G2+SP'\*-!T>XT3
MX!?#%]%NY)[C0[;PSX6U/6=8T?09YOMOAKPYXIT/PEJT,>L>'+\N ?Y</_!3
MC2-7T'_@I'_P4!TC7DF36+#]M;]J6#43.&$DUR/CAXX9KH,W,D=V&%U#,,I/
M#-'-&S)(K'_9_P#V+_BII'QR_9 _99^,N@W*7>D_%/\ 9X^#7CZSE29)V1?%
M7P\\/:S);3NA(6\LI[N6SOH7"RV]Y!/;S)'-$Z+_ )MO_!V__P $Y?%W[-?[
M>=_^V?X6\/7<OP#_ &RO[.U>]UVRM7;2?"/Q]\/Z#:Z5XY\(ZK-$CI97?C73
M=&M/B9HDU_-%)X@O=4\<P:9#)#X3OS%^H'_!JG_P7/\ A+X2^%.@_P#!,K]K
MOX@:+\.M3\):SJK_ +*'Q,\9:E;:/X2\0Z%XIU>[UW4?@KXC\2:C-%9Z-XHT
MSQ/JFJ:A\.;O6+J'3O$6EZQ_P@EE/8:KH/A;2_$H!_?37^6I_P 'F'_*6?P+
M_P!F8?!__P!67\<J_P!1W4-3TW2--O=9U74+'3-(TVRN-2U'5=0N[>RTVPTZ
MTA>YNK^]OKF2*UM;*VMXWN+BZGEC@AA1Y9)%12P_R1/^#HK]L7]GK]M+_@J%
M?>./V:?'^G?%+P%\,O@9X"^">J^/?#^+CP?X@\:>$O%GQ&U_Q#+X*UM'>W\4
M^&K$>+['2[?Q/I^='UC4+'4I]#N=3T5;#5]0 /\ 1*_X(#?\H;/^">__ &0#
M2?TU[7\U^O\ 7\\W_!NE^UE^S]X@_P"",_[&UM>_&/X:Z#K/PST'6?@YXWT;
MQ%XW\-:#J?AGQOI?Q)\3Z9HGA_5[/5=3M9K34?$NE7GA[6?#EK(HFUC3M>TJ
M6R25[I8Q_0S0 4444 ?S6_\ !VA_RA5^./\ V53]GW_U:V@5_/;_ ,&/_P#R
M<1^WG_V1?X0?^IQXHK^@'_@[=U6QT[_@B_\ %FSN[B.&XU[XR_ +2M+CD=5:
M[OH?']IKDEO"I.9)%TW1M1NBBY80VTLA&U&(_GN_X,A-3LHOVG/VY]&DGC74
M;_X#_#/4[6V+ 2S66D?$'4K6_G1,[FCMY];TV.5@"$:ZB#$%UR ?Z.E?Y8'_
M  >0_P#*7+0?^S1/@S_ZF/Q:K_4_K_*K_P"#Q#6M/U3_ (*_?8;*XBGN?#?[
M+/P3T75XHW#/9ZA/JOQ!\116\RCF.5M*U[3+L(W)ANHI/NR+0!_?3_P0>_Y0
M[_\ !/'_ +-L\&?^AW]?K77Y$?\ !!"_M=2_X(X_\$]+BSF2>&/]GCP]8.\;
M!U6ZTK4]8TN_A)4D![>^L[BWE7JDD3HP#*17Z[T ?XJOQ9_Y3:_$O_M*=XR_
M]:UU*O\ :JK_ !.OC#XBT>U_X+(_%/Q9+?6PT"W_ ."F?C?Q%)J0F0V@T>']
MJ;4]2>^%P"8C;"R4W F#;#%\X.WFO]L6@ HHHH *_P 575O^4VNI_P#:4Z]_
M]:UEK_:JK_$T_:;UQ_V>/^"POQ\\5>+[&[1?@M_P4B^)GBO7[*.(M=2V?@+]
MIC6==O!:QL%\[[79Z8TEDZ_N[F.:&2-FCD5B ?[9=<'\4_\ DF'Q'_[$/Q?_
M .H]J-?'O[1'_!3K]BO]G#]E.[_;"\3?'7X?>*?A7J'@\>)_AC#X'\6^'_$'
MB3XW:EJ%C]H\+>"OA-HMOJ/VOQ7XN\5WDEMIEAIUM&J:7+-/?^(YM&TC2]7O
M['W_ ,0^.KS6_P!EK7OB7XS\*:K\,;[5_@%JWCGQ3X(\47-E+KGP^N;_ .'M
MQK^M>%O$=U8R2:<VK^%9);G2M9FLIIK'[=87+6T\UN(Y7 /\@3_@@1_RF2_X
M)[?]G :/_P"F/7J_V>J_Q>O^""M]:Z?_ ,%C/^">=Q=S)!%)^T7X7L4>1@JM
M=:G8ZKIME"">"]Q>W=O!&O5I)%49)%?[0M '\WO_  =A_P#*$W]H?_LHG[/'
M_JZO!M?SF_\ !D)_R<[^W-_V0?X9_P#JP=2K^BK_ (.R;JWM_P#@BC\?(9IH
MXI+[XF?L]VMHCNJM<7"?&#PM>M#"I(,DBVEG=7!1 6$4$LA&U&(_G%_X,B-4
MLH?VLOVVM%DGC74=0_9W\#:I:VQ8"6:RT?XE16FH3HF=S1V\^N:;'(P&$:ZB
M#$%UR ?N1_P>1^%-4\1?\$C_  [J^GQ2R6G@3]K[X->*]<>-6*6^EWG@KXO>
M!X99R.%B;6_&6CP!FPIFFA7[S*#^:G_!DG^UGX<C\/?M@_L.ZWJUO8^)I/$?
MA[]I_P"'.DS3*LNOZ?>Z-I/PQ^+$MI&[*#-X?.@_"61XHA)-<6VLW$Y58=-E
M>O[!?^"E'[&VB_\ !0+]AC]I/]D35[NSTNY^,/P\N]/\(ZYJ"226/ASXD>'+
M^P\8_#'Q%?+"CW+:;HGQ \/>&]0U:&U N;K2H+VTB96N*_QL_AQ\1/VL?^"6
M?[:%GXM\-_V]\$/VIOV7/B1JFD:KH^LVA+V&MZ1)<Z+XF\)^)=,,BVGB+P=X
MKT>>^TC5;:.>72O$_A75VN-.O9;._L[X@'^Y=17\L?[!/_!V=_P3:_:3^'^A
M6_[4OBVX_8T^.MO8VUOXK\->--$\5>(_A9K6KQ1JM[JO@'XD^&-%UNVMM"N7
MQ<1:;\0H/">M:<\LFF0OXBBLAKE]W/[;/_!U=_P2T_9I^'&OW_P+^*3?M?\
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MS_M5_P#IJ_9]K[S_ .#+[_E%'\5_^SY/BW_ZIC]G6O@S_@^2_P"1,_X)L_\
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M*2&5@058$@@@@X- #J*** "BBB@ HHI&945G=@JJ"S,Q"JJJ,EF)P   222
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MY_:3\->)I8Q)_9L7C/Q7H'P:U3P-'>,/W1OKC0_!GQ#;3@X$@M[;5#'E3+@
M^;O^"7O[-G[4G_!S]\=_B)^V+_P4]^,?C'5?V*?@'X_@\->$?V</AWJVK>!O
MAEXC^)$^F6OB*X^'?@_1]*OF/A;PUX1\)ZSX?E^('CA[N\^+7BJS\2^'=(A\
M;"=KW6]%_OZ^"7P%^"G[-GP\T7X3_ #X5> O@Y\-_#\2QZ5X,^'?AC2O"VAP
MR>7'%-?3VFE6UN-0U:]$22ZGK6HM=ZMJMSON]2O;JZDDF;^)3_@S3_X*%_ +
MPY\#_B__ ,$^?B+XV\-> OC-=?&W5_C;\(K/Q-JEEH<7Q6T#QIX-\$>%]?\
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M[$5%%% !7X%_\'//@;7/'G_!$3]M&S\/0SW5]X;M?@OXYNK2!68SZ'X.^/\
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M/0?^"V_[2NJ>*([Y-%\9^!OV=_$OPZ>[$@MY_!EK\"O ?@^\DTO?E38IX_\
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MNO:#K>GV'PM_P<(?\%@_V1-*_8Z_:M_85^"_B&\_:D_:6^*7P5\<Z%XK\(?
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MN8 @'^0%_P '*O\ RF]_;S_['#X4?^L]?".O]:K]DWG]E?\ 9HQ_T;_\&O\
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M<R>+OBOJ*0S*"3'(UG?VEP$<!C%/%(!M=2?[K?\ @WO\4:-XN_X(Q_\ !/\
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M]U)?>'=22&0#E7:RU"TG"G!,<\;=&% ']1-?XX/_  <??\ILOV^/^RB>!/\
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MZ7XL^)^G17?AO6_%'C#Q(UEX:TC3?#M[>:5:WLE_;:GX@M=>TY?#MX ?+?\
MP8\_\EI_X*#?]DO^ G_J5_$FO]#O6-8TGP]I.J:_K^J:=H>A:'IU]K&M:UK%
M];:9I.CZ3IEM+>ZEJFJ:E>RP6>GZ=I]G!-=WU]=S0VUI;0RSSRQQ1NX_S6O^
M#,?]H3X,_!?]HS]MS0?BY\4/ /PO'BWX#^!/%&C:A\0O%N@^#-)OK#X<^,-9
M;Q.T&J^(K_3M.>72;'Q;::G=P"Y\^+3(K[46C^Q6%[/!_9]\4/VR/A%^W/\
M\$J_^"AGQL^ I\2:M\(++X"?MI?#CP3\0=;T.\T+1?BQ;> _@SXJTK6OB#\/
M5OTBN]6^']UXH;7/#FAZ]+!;_P!JW7AK4[B.".'RQ0!V_P#P4(_X)0?L'?\
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M8R7/V;SG+$MN<Y).30!_GJ_\'PO_ "6[_@GY_P!DK^.W_J7?#ROWJ_X-(/\
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MO5X<_;A_9I^)'[%O_!&;X4?M$_MG?&+]I/PMJ?PH\2_%;P%\!?BWX?\ A_\
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M%M[=.8XP^E:7-I]A'(+[6+_3=+BN;^  _P G;_@X=_Y31_\ !0#_ ++!I?\
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MY9VD/QR\+QE%+M#8:#I6D_$Q =\I?X=2Z=9()=8E$G\[/_!F_P#\%&?^%/\
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M96=$AN!X9LO%W@J SPO,%FU^ZMR8Y()5;T;_ (/*/^";'B[XJ> /A'_P4?\
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M44 %%%% '\V/_!V;_P H4_CO_P!E0_9\_P#5M^&Z_GQ_X,??^2_?M\_]D?\
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M_@\A_P"4N6@_]FB?!G_U,?BU7]Y'_!!#_E#C_P $]/\ LWCP[_Z<]8K^"_\
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M/_!U/_R@Y_:Y_P"Q@_9N_P#6FOA'7]#U?SL_\'5MW;V__!#[]JZ&:6..2_\
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MXA\3>$-/NG\;2W]WK4'@OP[_ '6_\%$O#7C/QI_P3^_;G\'?#F.^F^(7BO\
M8\_:9\-^!8=,$C:E/XQUSX+>-=,\-0Z<(OWOV^;6;JRCLS'^\%PT90%@ ?\
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MB/1]+^(VAPVY5-6U7P7I<,<QLKZ0R?U_?\'2OQO\5?M<?%3_ ()Y_P#!&?\
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MX*6:QXI@U-94-H^B7'[4=SJT5\L^0AMVL'6X$N0AC._.*_VS* /S(_X+2?\
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MNK?PO^U5=S0!U,L=O>:M^S_#;2NF=RQS26%VD;D!7:"4*28VP ?L5_P9[_\
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M]*NFU2S&L7[PZ?;^(?$YT'PM%>30VDVM+?7%I:7(!_D\Z3_RFUTS_M*=9?\
MK6L5?[55?X>.C?%N/3/^"F6E?'?XB^'M3^%T.G_MU6/Q;\=>%/$ZSIK/PZCM
M/C_%XQ\3^'O$*S65C<IJ?A%8[[3=6673[.=;K3[@/96\@,"?[$MA_P %&/V5
M_%?[5?PR_8Y^%/Q$TGXW?&/X@^!O%/Q4UR+X/ZAIGC_PI\)OA?X;T@7EGXU^
M*?BSP[>WVB>%K3QAK=YH/AGP9IL]T^JZY?Z_I]ZEI#I<]I=W@!_-?_P>S_\
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M0?$[1O$4MO"IYDE72M!U.[*+R(;6:3[L9K^>+_@R$O[6/]IW]N;2WF1;Z\^
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M"OA_XY0?M!^+_$>C:'X+URYT74],M-;\/>+RGAW1$\#Z9)HNBR:?)H_[7T4
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M?#[2/&GBNSTZWM]>\4:9X%CU_P 4IX0L=;U*.XU&U\-IXEUY=&AN$L%U?4!
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MM'\2M\2O$L-U/X0U*\;P]$OBMK70_P"5_P#:._X,\/C5^UO\:_'W[1'[0_\
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MC=17,>G>(==D^&7P0TF::.9$U"RN?&?A/XJ:/H^K6EG>6/AV2>""Z@_KZHH
M^0?V)/V$OV8/^">7P0TCX ?LJ_#;3_A_X'L9_P"U-<OGE?5?&'CWQ1+;06M]
MXR^('BJ[!U+Q/XFU"*VAB:ZN6CL=,LH;71M T_1]!L-.TJT]N^-/ASXJ^+OA
M?XO\.?!#XGZ'\&/BKJMA;P>#OB?XE^'$7Q=T/PC?IJ-E/<W^H?#B;Q;X%B\4
MQSZ9%?:?'92>+-&6WGO(M0,\WV/[)<>H44 ?QE?MP_\ !JY^U3_P47^,H^.W
M[6O_  61N/B/XZM= L_"7A](/V#]&\,^&?"/A/3[F\OK3PYX4\+>'?VJ].T;
M1].6^U"^O[J2.VDU'5=1O+G4=8O]0OIGN&]Y_P"">7_!O7^WK_P2^M_&NB_L
MF_\ !9S3_#_@GXAZE9Z[XO\ ASXS_P""?&@>.O!&I^(["T33K;Q+:Z9K?[5S
MWN@Z\VFQ0:;?ZEX<U+2)M9L+/3;76O[1BT?1Q8?U>44 ?%G[1?P>_;:^(?PP
M^''AC]G7]M/P)^SA\3=#T^*V^*'Q3UO]DO1?CC:?$*_&A6-E/J7AGP#KGQB\
M':5\.C)KT.H:[%:7&K>.8(;:^AT9S.EE]NNOY,/CM_P9L?%W]IKXO>/?CU\>
M?^"P&M_$SXN_$[79/$?CCQOXA_8IMCJ6M:F]O!908M[']K"STW3--TW3K2RT
MC1-$TBRL-%T'1;#3]%T73[#2K"SLX?[HJ* /YV_^"=7_  2$_P""C7_!.?PE
M\//@OX&_X+#:9\2_V9_ WBRPU<?!/X@?L$>';^6W\*W'B)-;\8^#/ _Q&NOV
MF]3\6>!;3Q-%+JD-BP;Q!H?A;4]3GUK2_"\DTEY;7WWY^V_^S'_P4)_:$OKW
M2_V4_P#@I'H'[$GP\U?P/;^&]7TO3_V.?#?QP^)(\0RWFM_VWXJ\/?%/Q#\;
M/!/_  B_]I:-?:1IFGV>F>#O[7\.WFDS:YI/B>/4+^#^S/THHH _@,O?^#&^
M\U&\N]0U#_@J?<W]_?W,][?7U[^Q;+=7E[>74KSW-W=W,_[74DUQ<W$SO-//
M,[RS2N\DCL[$G^JC_@G]^Q[^W_\ LH0Z!X._:4_X*76'[;7PB\)> G\'^&?#
MOB+]D30?A+\3;6_LY='A\-ZUK?QETWXW>.]6\6Q:)H]CJ.F74'B3PYJ&O:_+
MJ%OJ6J^*Y+NP?[=^I=% '\%7_!\E_P B9_P39_[&?]JO_P!-7[/M?#?_  ;^
M?\$<_&7[8'[$,O[=G['_ .UMX_\ V*OV]O@K^U=\4OAOX5^)VD6\OBCX>>-/
MAW9?#+X*^(;;P1X[\'/=0*MG_:OBC7?M5XD.NZ%K.EZC<Z1XO\#^++9-*DT?
M[A_X/DY$'A#_ ()KPE@)'\2?M7R(F1N9(M,_9Y61@,Y(5IHP2!@%U!(R,_>?
M_!EY(C_\$I?BVJL&:+]N?XM1R ')1S\%?V<I0K>A,<B/@_PLIZ$4 >IZY\ _
M^#M/Q'H4GP[;]M3_ ()>>$K.YMFL+OXV>$_!GQ#;XE"SD_=2ZA::#K'[/=YX
M*MO$#P!G$=GX<T^RM9I6:QU*VEB@N(O1_P#@F!_P;A_ _P#8I^,]U^V3^U)\
M7/$W[=/[<6JZY>^,?^%N?$FPN(?"G@OQIJ\SWFI>+_#'A[6M7\3ZUXB^(/VJ
MXG$?Q'\:Z_J.H6[);ZGX9T#P?J@EG?\ I+HH *_$/_@LU_P0X_9\_P""P?@3
MPI/XI\37_P &/VB/A=8ZAIOPO^.V@:#:^(Y8-!U*=KV\\"^/_"\U_HK>,O!$
MFIM)JVFVD.NZ+K'AC6;B^U'0=6@MM8\2Z3K_ .WE% '^<KX _P"#(C]I.Y\<
M06_Q0_;@^".@_#>.\'VK6? 'P_\ 'OBKQQ=Z:K_O8H/#7B&3P9H.GWEW!F$3
M2>+-4@LGD\UK?44B-O-_7M^S3_P1'_8*_91_8O\ C+^Q7\)OAS<VOAG]HGX4
M^+/A5\=?B[K,^GZI\;_B?8^,?#.I>&;[6-=\:-IL,5G/I$.JW.H^%/#^AZ9I
M7@[POJF=0TCP]!?7.HW5[^NE% '^>]\*O^#(CQE#\:P?C9^V[X4O_P!G;3=<
M-PH^&7P[UFP^,GC#P[%<Y32YH?$]Y>>#/A[JU[:82;68;WXD6NGS;C%HVH*R
ME/[(+W]BSQ1\#/V3/AM^RM_P32^*'P\_87TSX9WVGVVC>(=9^ 5M^T;I\WA-
M-/U[_A(;*Z\*ZU\2_AM)J'C?Q5XGU+3?%FL_$;7?$NN:G?:C8ZH-3TS5)]?E
MOK'] :* /X<?VCO^#/#XU?M;_&OQ]^T1^T/_ ,%@=4^)?QA^)NK0ZQXR\8ZM
M^P_I]G/J%Q::?9Z/IMI::;I'[5FGZ-HVCZ-HVG:=HNAZ)HVGV&DZ/I&GV6FZ
M=9VUI;11+^IO_!.S_@C3_P %%O\ @FWX#\,_!+X1?\%B=$\7?L[^'O%S>)(O
M@_\ $#_@G]X?UVWTVRU;6EUGQEH?@GQA=_M277B7P7:^*9I=0NF@M[C4]"TK
M7=3O_$5IX=?4M0U4ZC_2#10!^:?[;G[,'_!0O]H6^U?2/V6?^"DOA[]BKX<:
M]X(A\,ZCI.G?L<>'_C5\3+;7+B35HM=\4>'?BQKGQQ\$-X:EU'3+W3K/38=,
M\')K'AJ\TV36=(\21ZA=6\FG?R:S_P#!C5/<SS75S_P5+FN+FXFDN)[F?]BI
MY9YYY7,DL\TTG[7+22322,TDDCLSN[%F8L2:_OVHH _,7]@S]D[_ (* _LQ?
MV-X8_:>_X*3:1^VS\+?#'P_;P?X=T36?V0= ^#GQ-BU>RN-$B\/>)/$7Q>TG
MXW>.[WQ>=)T/3]4TJ_@UWPO<:[XDNM4@US6?%<VHV$[:G^G513SP6L$US<S1
M6]M;Q23W%Q/(D,$$$*&26::60K'%%%&K/)([*B(I9B%!-?@U9_\ !S3_ ,$5
MKOXMZE\('_;&TRRU#3M7GT%/'=]\-OBM%\)M2U6UG>UN$T[XD)X,E\-OI*31
MR"'Q7=7-IX/OX%2]TWQ!>V,]M<S@'[H^(_$6A^$/#VO>+/$^JV6A>&O"^C:I
MXB\0ZWJ4Z6VG:-H>BV,^I:MJNH7,A"6]EI]A;7%W=3N0D4$,DC$!37\,G_!K
MO^S/X"_:9_;]_P""CO\ P5X\/_#2T\ _!^^^,_Q8^''[*OA-+.2*Q\/7GQ9\
M57/Q"\=WVGPS,1IFK>$_AOJ?@GPP8]/*Z3'%\2O%6E:=9:=96%K9P?2'_!PS
M_P %N?@7XW_9A?\ X)Y_\$[/B_X/_:E_:;_;=N] ^#UY/^SSXITGXDZ)X5^&
MWCW4;/2=7\.1>+?"5]J?AO4_'GQ=6\A^&VF^#+'4;S4K/P]XB\2:MKJZ%,GA
MM=:_H<_X)6_L0:/_ ,$Z_P!@C]G3]E"Q%C/XC\ >"H=2^)^M:>$>#Q'\7O&-
MS/XK^)FL170437NGCQ9JVHZ7X>FN6>>#PMIFAZ?N$5E$B 'Z$4444 %%%% !
M7P#_ ,%2?V./$?\ P4!_8*_:&_8^\)>,]$^'GB#XV:)X/T:P\9^(].O]6T;0
M1X?^)/@SQK>75YINF217MZ9;#PU=6EM!#-"'N[B#S9H81)*GW]10!_#_ /#O
M_@U6_;:_8'^(]G\<?^"6_P#P58G^''Q,338=,U;2_BC\*KKPWX:\3V<+QW4F
ME>,)?#FL_$OPSXR\,7-_&EU%X9\5_"C6+/3;B&"]BN+N_BAN(?NSQ/\ LR_\
M'5WQI\)WOPB\=_MP_P#!-_X#^%=;LY="\3?&GX!^%?BQ?_&N71[R$VM_=^%H
M==^%&B:)H^KW%NTACU30KSP!KFESR+=:#K&E7<4%U;_U*44 ?BW_ ,$D?^"'
M?[*__!)?P_K^N^!;[6?C/^TE\0=/_L[XF_M)_$&PM+;Q3K&G/>)J-SX:\%:%
M#<ZE!\/_  ;>ZG%!JFJ:5;ZOK>N>(=2MK*Z\5^*-?72- ATC]I*** "BBB@#
M\N/VLOV6_P#@IO\ &;QGX[F_9N_X*D^"_P!DGX5>)K'2;'POX-M/V"O!?QF^
M(/@E8O#>EZ9XBG@^*_BSX\:#;ZK=:YK]OK.OV%U_PK_3+OPY;ZM;Z58SSSZ1
M!K$_\M7BS_@R.\3^//%/B3QQXV_X*RZSXM\9>,==U;Q1XL\5>(_V.+O6?$'B
M3Q)K]_<:IK>O:YJ^H?M>SWVJ:OJ^I75S?ZCJ%Y/-=7EY<37$\LDLC,?[W**
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M0 4444 %?A5^U]_P3G_X*M?M6>&OBG\,K#_@L[HGP.^#OQ*O/%6FOX5^%_\
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MS+)X;\?>!]7N+6]BTGQ1X?GGG%O+-:7FGZEIEYJGA_7+#4_#^LZMIEY]@T4
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M;:=XBTZRFAEAT)=8^*.C^#/"'@* -!$TEUI?PY\92)'$(=/^PW#0ZG:>Y?\
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M5B^V?V%K%W9:A9:IX=U5[>V_M_P=XBL-5\.ZMY%O>K9V>NV&D:UIO\J_P?\
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M/%5V#J7B?Q-J$5M#$UU<M'8Z990VNC:!I^CZ#8:=I5I]?44 %?RO?\%&O^"
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MJ%WX,^%7A:6V_:CT#34T+P=I=XE@;RP\/:(_B/5O[3\6:O8G7]=U6YG^+_\
MB!C_ .LHO_FDW_Y7%?W^44 ?P!_\0,?_ %E%_P#-)O\ \KBC_B!C_P"LHO\
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M-]?V_P#_ ()AZ=XL\-?LH?\ !:2TT'X?>.=8C\2>*/ACXT_X)\^'_'G@._\
M$\5E:Z9_PD]EI>O?M62WWA[7[C3+*QTW4M1\,ZGHTNMV.GZ7;:W_ &C'H^D"
MQ_JUHH ^#OVG_@?^WM\3_#G@#2/V9/V\_ '[+6M:1X4N])^)?BK5_P!C3P]\
M?;_QSXJGMM)BMO%OA73O$OQK\'Z+\/8;.>VUBY7P]>V'CRUG_M6UAEO2FEYO
MOY)?B'_P92>-_BUX]\9_%'XE_P#!6S6/&WQ"^(?B?7/&GC?Q?X@_8Q>_UOQ-
MXI\2:C<:OKNN:K=R?M<;I[[4M1N[BZN'PJ^9*5C1$"HO]Y=% 'XH_P#!-/\
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MB-%T<V']5M% 'YN_MT?LQ?M^?M&K-X?_ &5/^"C&B?L1^ ]9\ 'PIXHM=/\
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MA:ZKHVM:-JMK+8ZGI.K:9?13V6HZ9J-E//9W]A>036MW:S2V]Q%)%(Z'3HH
M_AZ_X**?\&:/PK^+?C;Q!\4?^">OQJT;]GJ?Q%>76IWGP!^+.F:[K_PETW4K
MR1YIAX$\=^'QJGC3P/X?63+1>&-4\+^/XK5[B2/2-4T?2+2QT2+\K_AS_P &
M4G_!1+6/%-K9_%3]I3]CWP'X,%TD>I>(?!FN?&#XD^)$M2X$EUH_A+5/A/\
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ML?@>X\?Z3IVB?$'POKG[ FA^,?!'C?3]%N+J[T/^W_#7B#]JR[MO[1T*YO\
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M;I?Q[\8ZGJ4V@21VD]]>^(/"FOZ]XGCMF35]=-[<SZFWZN44 ?A-_P %%?\
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MU>VM>)=1L+.^O(-+3Q%K6J6&C_:KN;2;*QN;R[FG_J7HH _B@_9"_P"#2O\
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M>Z;>2Z7J=TEK?6LBSVLYCFC.Y #_ *)'PP_X)3_\%UO^"<>GW'PF_P"":?\
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MZAH6I^!O%6MW,C3:YXA\(ZC/H^HW1FU?4/ ^H>(+_4]8O?ZOJ* /XI_V;?\
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MMXK\+_$_6_C3X"?P4;SP_?Z1HUC9Z5X5FUG0;[29_$6D>*;;4=0MUTK](:*
M/X!S_P &-,QF-P?^"I4AN#)YQG/[%+><9MV_S3+_ ,-<[_,W_/YF[=N^;.>:
M_JT_8=_9-_X**?LW7OA70?VEO^"FVA?MG_"CPGX/F\,6WAW7/V,O#WPD^)^H
MW=K:6MEX;UG6_C)H_P =?&E[KEQI$%NPU*;6_"6IZYXHED^V:SXADU$W%[=?
MJ)10!_.S_P %&_\ @D!_P42_X*0>"O'GP0^(7_!7S0_AU^S1XS\97&OGX,>
M?V!="L9[SPYI_B-M?\$>$?'7Q!A_:AL/$OCBU\)M!I+7#!?#VB^(]:TBS\0:
MCX9BNK;3X-/_ "*^ '_!G#\8?V6OC)\/_P!H'X!?\%?]7^&OQ?\ A?KB^(?!
M'C31/V)+.:]TC43:W.GW4<MEJ7[5U]I6JZ7JNEWU_HVN:'K%A?Z-KNBZAJ&C
MZO87NFWUU:R_W-T4 ?,G[*OPX_:A^&'@'5= _:O_ &G/"7[5?CV?Q)+?:+\0
M?"/[/6F_LWVVG>%SI&D6D'A[4?!VD?$KXFV&KZG'K%KK&KR^([?4]'CF@U:W
MTM-#@32UN[SZ;HHH *_GX_X*9_\ !)/]O[_@I-X<^)7P7US_ (*S:5\&?V5/
M'OBI=8C^!/@O]AG0K[4W\-:;J\.L^&/"'CKXKQ_M)>'_ !/X[LM#O;6RN[GR
M;#PMH^O:A96=]JGAYWM+2.W_ *!Z* /X7/@5_P &:_Q:_9F^+W@#X]? G_@K
M[K'PW^+GPOU^#Q-X'\::%^Q/:MJ&BZM!%-;2$VU_^UA>:;J6GZA8W-WI>LZ+
MJUE?Z-KFCWU_H^L6%]IE]=VDW]:7[./P@_;9^'GP[^(_AW]H_P#;1\!?M(_$
M+7-/6W^&'Q'\/_LF:1\"K;X>WRZ/J=H=1\2^"M&^,OCC3?B)OUFXTO6&M(-2
M\$0_9]-N-*0HNH_;+/[1HH _E"_X*%?\&]?[?/\ P4^MO!VA_M9?\%HK3Q%X
M&\ :K<^(/"/PU\&_\$^O#_@3P'I?B2[LYM-F\37.DZ#^U9#=^(/$$>F7%UIN
MG:IXGU+6KG1-/O\ 5;30VTV#6M82_P# OV)?^#5C]JS_ ()W?%\_'']DC_@L
MSJ'PP\=7>B7'A?7\?L):+XD\->+O"UY=6M[<^'?%OA/Q+^U1JN@:[IK7EE:7
MEJUU8F_TJ_MX-2T:]T[488KM/[.J* /C.+X2?ML)^RL_PSD_;)^'$O[61NQ)
M'^U.?V2[)/ ZV/\ PF::L;9_V:T^. LGN3X($G@[[8/BS'&-5=?%WV(E/^$?
M;^9/]MS_ (-6?VJ_^"B7QA'QR_:V_P""R]]\3?'5KHEMX7T!1^PCHOAOPUX0
M\*V=U=WUKX<\)>%/#?[5.EZ%HFFI>7UW>7+V]D=0U6_N9]1UF^U'49I;I_[.
M** /Y/\ _@GG_P &\_[>O_!+]/&.E_LF_P#!9^S\/>"OB!J-KK?C#X;>,O\
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MOA[1?$>M:19^(-1\,Q75MI\&G_D5\ /^#.'XP_LM?&3X?_M _ +_ (*_ZO\
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M_$NKII?[5YU?Q)K=AH^I:AI>F76NZK?6^DVNHZK_ &/9Z<^KZHUW\H_L7_\
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MM;QW4R7-RD$27%Q'#]G2>=8U6:9+?S)?(260,ZP^;+Y08)YC[=QFHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)7[>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#XG?\$[?C-IO[/\ J>M7%[J4_P  ?C#:Z[XB^$-OJ5W*TPA\$_$'0HM6\=>
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M?X)\'>'+-+#0_#?AK0;*+3])TG3;6/(CM[2T@CC#.TD\SAY[B6:XDDE?MZ*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)GUSP[.EMK-A"=6L--NI'L9Y8TDE6W-O)O5H)I4.Z@#W^BBB@ HHHH ****
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M'@<ZL/%AU/&F#1_MY%M0!]UT444 %%%% !1110 4444 %%%% !1110 4444
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MT/1_$-S:R7MK90ZW]DATK68;NSC>ZM-2T&\U/2[JWVS6][+&Z,WU)0 4444
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M!JMN)%M]3T76[&#4M*U"!9HXIEAO;&Y@N8A+%'($D421HV5 !M4444 %%%%
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M$]O;N[:5JM[X7UW2-;ALKC;/]@U"VE=%WX'H-?Q]_P#!H/\ &KQ]^TA\&O\
M@H_\?_BGJIUKXC?&7]N"^^)/C/40)$@F\0>,/ >C:WJ$5A!))*;+2K.:\-EI
M&G1N8--TRWM+"V"6]M$B_P!@E '\_O\ P<I?L!_M*?\ !1+_ ()P2_"7]E:,
M:[\3?A[\:_ _QIG^&G]MV/A^7XM>&?"WAGQYX:U3P78:AJUYINB/K%G=>,].
M\:Z38:WJ-I8:C>^$8[.W9M;FT<#\6/\ @U _X)$?M\_L7?M$_'W]J#]JOX;^
M(_V?? /B3X)7GP6\,_#/QAJ.FQ^*OB!XFU3Q]X)\7GQA=>%],U'49-)T7P3I
M_@W4-*L=1U^'3K[4[KQE*/#XN=-@UJ1_[J:* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#^+3_@Y0_X+7_&OX3_ !A\#?\ !*']
M@KQE/X(_:"^*TO@?1_CA\8M!O7L?%/P\3XMW>GV'@#X5^"-7MM]]X6\7^)]*
MUG3?%?BGQ?811:SX=\*ZYX7C\)WT&L:QJ-YHOZH?"O\ X-GO^"1W@WX%V?PG
M^)'[-6F_'+QQJFAJGQ(^/WQ \5>/'^,/COQK>VY;Q#XXA\4Z;XKL[SP=>ZGJ
MLMQJ-KIGA233-.LMT23Q:A<?:KR\_P [B^^*6J_M(_\ !Q'H/Q+\27,NH2?$
M;_@KIX#6V6Y=I#:^%H_VL- \/>%-$0R,[?9-#\(V.C:'9HSMLL[""/)"U_LA
M4 ?XZ/\ P5Y_X)D?M ?\$/OVW],G^&/B_P").E?"O5M8D^(G[(G[2.@:CJ'A
MSQ3'8V4XDF\,WWB[PU_9D>E_%;X<7$Z:5XA&ER:;)K&E3Z-XPM=+TO2_%$.E
M67^G[_P1P_:(^/?[6'_!,G]D#]H+]IW0[G1/C?\ $;X:7-[XRDO-(30;CQ5!
MHOBWQ)X8\)_$E](A@M;6Q_X6MX+T3P[\2UBT^SLM)<>+!+HUE:Z3)90)^@7C
M?X>^ ?B9HH\-_$?P/X0^('AU;VUU-=!\;^&M%\5Z*NI6+,]CJ TO7K*_L1>V
M;NSVMV(//MV9FAD0DD]9'''#''##&D442)'%%&BI''&BA4CC10%1$4!410%5
M0    * 'T45\1_\ !0_]O'X,?\$WOV4?B;^U1\;-2A&D>#=,>R\&^#XKVWM?
M$'Q0^)&IP7">#?AQX5BFWR3ZMXAU"(M>7,4%S%X?\/6FM^*M3C31M"U&>$ ^
MF_"/Q7^&OCWQ1\2/!7@KQQX:\4^+/@]XATOPE\4M T/5;74=3\!>)];\-:3X
MQTK0?$]O;N[:5JM[X7UW2-;ALKC;/]@U"VE=%WX'#_M+>"?CU\1?@[XG\'_L
MT_'+1/V</B]K,VBP:#\8M>^%.E_&JU\'Z>NLV+^)+JR^'FN^(/#>AZSK<_A]
M=2MM"?6;^?2K'5Y;.[U#3=1M(I;63^73_@T'^-7C[]I#X-?\%'_C_P#%/53K
M7Q&^,O[<%]\2?&>H@2)!-X@\8> ]&UO4(K""224V6E6<UX;+2-.C<P:;IEO:
M6%L$M[:)%_L$H _R1/\ @Y9_8T_:T_8[_:Z^'%G^TQ^VK\4?VXM+^,'PXN_'
M_P /_B-\3HK[0;WPO<V7B"ZT+QAX%TSP)'XE\1>$_"FGZ7<PZ-J]FG@N/0]#
MN;/7[:!=$L[JPN7G_L]_X-#?^4-O@O\ [. ^.W_I\TJOP^_X/BH(U^+'_!.^
MZ"@2S?#S]HJ!VXR8[;Q)\))(U)ZX5KJ4CL"QQU-?N#_P:&_\H;?!?_9P'QV_
M]/FE4 ?T_4444 %%%% !1110 4444 %%%% !7YB?\%0?^"L_[*'_  2A^#D'
MQ*_:$U^[UCQIXJ6_M/A+\#_!TMA=?$OXHZQ91J;@Z987=S!;Z'X2TF66V_X2
MCQQK3PZ)HD=Q;VD U7Q%J&B^'M6^K_VN?VH/AA^Q;^S3\9_VIOC)?RV/PZ^"
MG@C4_&.NI:^5_:6LW,+0V'A_PKHB3M'!+XA\9>);[1_"?AV">6&WGUS6=/AG
MG@A=YD_QV_B/\4_VK_\ @NE_P4S\+S^+M6&I_&7]JCXL>&OAKX&T8275QX-^
M#_@.^U>2#1O#F@V199+#X?\ PM\,S:EKVK20HM_J:6/B'Q5JSWWB/6=5OKP
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M6/&WAUIV*PVC7-P\<#_U5_\ !$3_ )1$_P#!.C_LTSX0?^HQ:5^I= '\//\
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ME>=XXHXWGE""29D4*TL@C5(P\A!=PB(@8G:JK@"2BB@ HHHH **** "BBB@
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M_&/B3X3:QXKU65G?S=6\9/X,C\7ZE*A6.2\UV9XX;=&%O$ ?K!1110 4444
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MTWPT;GQW8:SXPN(M:MM8;Q-N@OK*;_0AK^<K_@ZY@CF_X(C?M,R.H+6OC?\
M9UGB)Q\LC?'OX?6I8>A\JYD7CG#$=": /YN/^#(;_DZ?]N#_ +-_^'G_ *L6
M:O\ 1\K_ #@_^#(;_DZ?]N#_ +-_^'G_ *L6:O\ 1\H **** "O/K+XK_#74
M?B?KWP5L/''AJ]^+7A;P9X?^(?B3X>6VJVLWBO0O _BS5M<T+PUXGU72(W:Z
ML=(US5_#>O6&FW5PB+=3Z7=B(,L88\S^T/\ M _"7]E7X)?$K]H;XZ>+]/\
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MD-_R:S^W#_V7_P"'?_JNKBO[?:_B"_X,AO\ DUG]N'_LO_P[_P#5=7%?V^T
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M9TC0]:U6?7]'M]4\1VGC2_\ $4MN_A.*+PK;+8ZK)KESI 7_ $<:* "BBB@
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M>\\4:QIMC;:AX@NH!-,(;C5KB[FB$LNQU\QL@'94444 %%%% !1110 4444
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M7]E6OZ_: /X _P#@QC_YRB_]V3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\
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MS_\ M?\ A_1)M8U7X.ZEKBZQX;^(FCZ9$'UCQ5\'/$UQ;V%UK<&G1K_:.O\
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M?$7PAX9\<>-;70(?LUFEK9:1X_\ $'BK1C8PVMO;6$^GS6=K"EM!$H_U'?\
M@WI_:A\5?M;_ /!(?]D#XE^/=3N]:\>^&?"?B#X->+=7OY!<7VK7?P7\7Z[\
M.=!U>_O"3-?ZGJ_@S0?#&JZO?W7^EWFK7E]/<O/,[W,P!_,?_P %,/\ @\ _
M:;\%>*?$OP4_9*_8Z\2_LO:]90HDWCS]LKPEJ$/QHM+'48//TW5M+^!#_8O#
M?@R\EA,5YI]UXNUWXEZ9J-I/N?0H2%>OTW_X)Q?\%X--^#'_  1'\'_MV_\
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MP^/?!GC"#4M$OE60V/B_^P/@U;:]IKV6K^%= UG2+V#6I_Y._P!HG]HK6?\
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MT-M*@.NW/B  _-#]M/\ X+2_\'/'CW1=<_:&^'O[+'Q\_8>_98T^&YU_3O\
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M6?PIX+_:JTOX6:]X:N/#_CBZL+N;1M)\?^'/AUJOPLT;PKKD\=M<ZG9Z7?\
M@O4?#OB2.RDM-#\92WMKJMA;?TK_ /!&/X[_ !9_:<_X)??L<?'KXZ>,+GQ_
M\6_B;\,;KQ!XX\8WFG:+I-SKVKKXP\3Z<MY+IOAW3=(T2S*V5C:6ZPZ=IMG
M$A4^5O+LWT-^W=^RAX-_;C_8^_:%_92\<VEC/I'QG^&?B+PMIE]?P).GAKQF
M+4ZE\/\ QI;*\<H34/!7CBP\/^*M/D\N3;>:1#NCDC+QO\X_\$6/@E\4_P!G
M#_@EM^QI\#_C;X-U+X??%7X<?#"[T'QKX,UB2RFU+0-6_P"$R\47PM+J73;J
M]L96>SO+6Y22UNYXGBGC97.2  ?J'1110 4444 %?XQ/_!?S_E,I_P %"/\
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M+^'_ /P5E\.^ ]#M(-/T3P3_ ,%$=(\(Z/86T:Q6UEI?AO\ :4M]&T^TMXD
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M>%O$-BL(USP5XVT&1WN_#?C#P[/-'!JVD71=6CEM-4TNZU+0M3TK5;[\9?\
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M^)M,UCQOHFC_  9\'37UK>:3H,FJZOI&OV5M_,W_ ,% /VH_&'_!?C_@M_\
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MG@3PAIFK?\(U++'YL.A>)OB)>_!KXUZC:ZG"6-M+_9/Q(\>:.6"3-?%BP@_
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M.V2Z;3]8TO2]8L[_ $ZU_P!'6O\ )U_X.YHXT_X+-_$ID15:;X'_  %DE90
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M2_X*>?\ !S;\/OV(M+\7:=\#?V-_VF?CSJWAKQ=KGPWN_C'\0OAEX_\ @/\
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MM"_'?X)_M0>)=.^&OPQ_:TT_X8QZ'\8-<80>%O GQ(^%]WXU@T#3?'.I !=
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MG_!/7X#_ +4UE\;?VB_V@[34?BII_P"S9\8/"@^#_P #_%,HU'X+Z)\3]?\
M"#7=Y\:]>\%7+3:3XM^(&D:18Z=H/@V?6K.6P\+1B_U>&UO-;?1;[P__ *-0
M  P!@#@ = /2@#_-&_X)7_\ !VS^V+X ^/7@KX8_\%)/%7A_XW_ #QKXDT_P
MKXE^*TW@;PCX ^)_P6;4[R/3[?Q?,?A[H?A;PYXL\'Z#<3?:?&.CZSX:F\5_
MV3'<:EHNOO>:8N@:W_I:03PW,,-S;317%O<11SP3P2)+#/#*@DBFAEC+))%(
MC*\<B,R.C!E)!!K_ "-O^#IW]G[P/\ ?^"Q7QO7X?:!8>&-"^,O@KX:?'2]T
M72K>.TTV+Q9XTT6?2O&VJ6MM$JI%+XF\7>&=:\5:H5RLVM:WJ=PH19A&G^EI
M_P $@OB/JWQ9_P""6G_!/OQ[K]Y-J6O:O^R/\#+/7-3N9&FNM4UGP[X!T7PS
MJNJ7<KDM+>:E?Z/<7MW(3\]S/*P !P #W']M3]LSX$?L"?LX?$+]J+]HSQ-)
MX<^&_P /K&%GM]/@CO\ Q-XM\1ZE,+/PWX'\%Z,\]L=:\6>)]2>.QTNS:XM;
M*VC^U:QK>H:3X?TO5M7L/Y'OV2_^"I__  7._P""\7Q6^*J_\$^M1^ __!._
M]E'X3:C9Z7KWQ>\9^!],^-'CE+O7!-<Z+X8^U^-O#WB;P]XU\?W6EVSZS?Z7
MX7\$>"- \*:1-#_;7BAK_4?#4FN_:/\ P=N_L9_M<?M?_L2? N/]EGX<^.OC
M3%\(_CS+XU^)/PE^&FCZIXJ\;ZKINJ>!]=\->'O&6B^"M&ANM7\6'PE>ZAJ.
ME7=AH5CJ>N6EMXQDU*#3WTJTUJ\LO0_^#4;]B/\ :1_8H_X)V_$#2_VGOAMX
MB^#_ (V^,_[2'BCXJ^'?ASXSTZ71?&VB^"!\/?AKX(TR^\7>'[Q(=5\,:OJ^
ML>$M>N(?#VLVUMJ=KI$6EW]U;P-JGD1 'YW?\%$K7_@Z#_X):?"/6?VLM(_X
M*-?#W]LSX&^ 9;.^^+6DQ_LX?!GP]XC\(Z)>7]M9+XDU;P5-\,Y+ZZ\#VUY<
MVMMKNJ>"/B!!K>@077]J7FDVWAVSU?6],^Z?^" 7_!Q?!_P51\2:]^S+^T;X
M#\)?"G]K'PSX3NO&GAV_\!S:G;_#?XT>%=$DM;?Q+-H&C>(-0U;5_"?C7PXM
MY::GJ7A=]>\06NLZ(=3\0Z-<V%IHVJ:78?O[^V[H'A/Q9^QG^UCX3\=3Z5;>
M#O%?[-_QL\+^))M<N;2STI-)\1?#?Q)HUW]MNK]DM((FCO2@DG8*LC)CYMM?
MY.W_  ;5^(;[PW_P6Y_80O+"=X7O_&'Q1\/7(1B%GL?$OP$^*NA7D$JCB1&A
MU!F"N"%E2.48>-&4 _UIOVIO&O[0WP^^!?CGQ3^RK\$] _:%^/-E;:?;^ /A
M9XJ^(^D_"CPWK-_J.JV6GWFI:WXTUFWN;.TT[PUIMS=^([G2T%M>^(8],.@V
M&HZ7=ZC#J-K_ ),?_!>_X8_\%8-"_:;\)?&;_@K%%X?L/B1\;=!\0R_";PWX
M,\;>%/$W@+P5\/\ P9JME#/X,\#:#X3U[7[;P?X<T6]\1V[Q6^HWEQK>OWU[
M?:_KNJ:[KMWJFJW/^Q!7^=G_ ,'PW_):?^"?/_9+_CW_ .I7\-J ,_\ X(4_
M%3_@XG\*?\$\? .C?\$Y_P!FO]C#XE_LO0^/OBE-X:\5_&G7HK#QY=>);CQ;
M=R>,;6^MF^/WP_*V-EK9G@TUO^$:MM]JJM]HN_\ 7-_:1_P3.\7?\%*O&7P.
M\7ZG_P %2?A?\#_A-\>K?XKZS8^#/#WP#U!=2\(WWPBC\(>"+C1-9U.=/B)\
M2PGB.?QG<^.[&ZB_MRS(TS3])<Z5"'%Y??EK_P &DW_*%SX/?]E@^/\ _P"K
M&U&OZ7J "BBB@ HHHH H:KJ5IHNEZEK%^;A;'2;"\U*]:ULKW4KI;2PMY+JY
M-MIVFV]WJ-_<"&)S#96%K<WMU)M@M;>:>2.-OXXO^"EO_!V;;_LU:+8V/[)_
M[$/QS\4_\)C%?1^ /V@OVL?AO\0_@/\  _Q0;6..;^V?A[X/U33-'^('Q2TA
M89[62YAO-5^%=[:B=)'62(Q&?^RROY>O^#O?P=H_B7_@CGXKUW4;&VNK_P"'
MO[0?P-\5:!=30H\^FZCJ.KZOX%NKFTE8%X))]&\8ZG92M&5+P7,D;95L4 ?(
M_P#P; ?\%;OV[?\ @IO^TI^VL/VN/BW8^,O"_@[X<_#?Q+X \ >'O W@OP;X
M1\!7VN>*]>TW4(O#ZZ!HEMXBN[>6QL[:W+^*/$/B*^<1^;/>S7#/,W]>?QGO
MOB?IGP>^+&I?!'1]#\0_&C3_ (:^.[[X1:!XFE2#PWKGQ/M/"^JS^ ='\0S2
M:IH<<.AZGXKCTFRU:636M'2.PGN';5-/4&[A_P ^7_@Q_P#^3B/V\_\ LB_P
M@_\ 4X\45_HR4 ?P+?\ !4_XV_\ !S[XC_X)\_M2:)^V;^R!^Q'X!_9>U'X=
MI!\9?&'PX\3:+>>.-!\*_P#"1Z$ZWOARUMOVH_&D\U\=5338"D?A;6F^SRS'
M[)@&6/\ G$_X-[_&/_!1_P $?MN^-M7_ ."7?PI^#GQA_:(F_9O\=6'B'PM\
M<-1L],\(6OPGF^(/PHG\1ZW9W%[\2?A9"VOVGB>V\%6=G$/$=P[6.H:FRZ1<
MA&NK'_21_P"#A#_E#%_P4#_[(I%_ZG'A&OX>_P#@R_\ ^4KGQ5_[,<^+?_JY
MOV=J /ZJ?V6OCC_P=+:]^T5\&M&_:P_8X_8:\%?LV:EX_P! M/C9XL\!^*-$
MN_&?A_X>37:KXAU3PU;0?M4^+9I]7M;3<]G''X9UQVD  TZX^X?Z;J** "BB
MB@#\[/\ @KS_ ,HI_P#@I-_V8I^U;_ZH_P ;U_DR?\$1?^4NW_!.C_L[3X/_
M /J46=?ZS?\ P5Y_Y13_ /!2;_LQ3]JW_P!4?XWK_)D_X(B_\I=O^"='_9VG
MP?\ _4HLZ /]JZBBB@ KY[_:F\:_M#?#[X%^.?%/[*OP3T#]H7X\V5MI]OX
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M_P""J/B37OV9?VC? ?A+X4_M8^&?"=UXT\.W_@.;4[?X;_&CPKHDEK;^)9M
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M@$$$ @@@@C((/!!!X((ZB@#_  ]_^"F?[9=I_P %!_VW_C?^V+:>!KCX:_\
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MALK"UN;VZDVP6MO-/)'&W^*I^R(^H?LC?\%COV?=-\.ZC>6[_ ?_ (*(^ _
MYNFF*7-]H'A+]H.P\%Z[87LL8C+PZ[X<@U'2]350@GM;^ZCPH? _VNJ /XT_
M^"EO_!V;;_LU:+8V/[)_[$/QS\4_\)C%?1^ /V@OVL?AO\0_@/\  _Q0;6..
M;^V?A[X/U33-'^('Q2TA89[62YAO-5^%=[:B=)'62(Q&?._X-@/^"MW[=O\
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M8@L?%7A#3_$U]I,R:B_P^TWP?\6K[2[2XT+4O%7B[P=9Z]913?D)_P 'C/\
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M16J>*X_$&K>#9M5O'BUBQ\ Z7:K=2_VNU_EC_P#!W/\ \$^O#/[)O[?/A?\
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MS(+.[_?B@#\+_P#@M)_P6@\/?\$O?#GPN^%GPL^'/_#0G[<'[2NI6^@?L]_
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M_"'A32O"OA^.WTBREMQK7B*XL-.T'PWI\]M-K.H_:[W2;+4?Q _;(_X+;?\
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M=+\0Z'=[K+5],LKN.2%0#^#_ /;)_P""['_!>[]CCXV> /\ @G_^UO\ #_\
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M-4^.FDZO92PZQH&N:'K&CZOIEG?Z9J^D7B1B]TN73-6U+^L#_@BA^VS\7/\
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M_8H_X)9?LF?#[1-&M-.\8?$;X8>%_C[\7]32VAAU37?BC\9] TOQKK(UJYA
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MTZ.7[.G]^O[4O@[1OB'^S+^T3X!\16%MJN@>-O@9\6O">M:;>1)/:7^E^(?
M6OZ3?6EQ#(&22*>VNY(W5@058U_C*?\ !)3X$K^TY_P4<_9-_9^N/B%XW^%F
MF?%OXDR^"_$/CCX;:@ND^.M+\)ZKX8\0)XOLO#&KN&72-4\1>%TU?PU%J[0W
M:Z6FL27YL-0%O]BN #^^C_@I'_P<7?'75?BGXW_9!_X(D_LU^+OVU_C/X"GG
MTCXK?'_P7\,?&OQF^&/PYU6*:>SN]+\#^'? EI/;^,-0TZY@N8;CQ[XEU.T^
M'-GJ%DUMI>G^/+26>ZL?YA_%7_!P]_P<4_L8?'&UL?VIO''C#P_XC5K?Q#J'
MP(_:9_92^'GPXT7Q'H$]S(MNT.EZ5\,_AGXZM/#MVT$]M:ZQX,\4Z0;GRI?+
MU6>2-VK_ $^OV:_V8O@)^Q_\(?"WP(_9L^%_A7X2?"SPA:I!I7ACPM8+;+<W
M1BBBN]=U_4I6FU;Q/XHU8PI<:YXH\0WVIZ_K5V#=:GJ-U.=]?S6_\'BW[/7@
M[XD_\$M](^.E[HUB?'W[-_QU^'VI>'/$_P!FB.K6OA/XGW,_P[\7^%H[QE,J
M:/KNK:IX+UR_MD($NH^$=&ER! P< _9/_@DC_P %,_AK_P %6_V._"?[3/@?
M1QX,\56NK7_@#XS?#&341JL_PX^*>@6FGWFL:-;ZCY-L^J^'M7TO5M'\4>$]
M7>VMY;SP_K=E!J$%IK5EJUA9]E_P4J\7_P#!1;P3^SWIFL?\$POA9\'_ (O_
M +1LGQ*\-V.J^%?C=J-IIG@^'X83Z+XHE\3:Q;W%[\1_A="=<M-<@\*6]E%_
MPDDKM:WM^RZ7=!#/:?QL_P#!CQ\0]8@\??\ !0?X4/=S2Z!J?A#X!?$.UL9)
M&:WLM8T+6OB7X;O[NUB+;8IM4LO$6G0W\B)NN$TC35D;%M&*_P!"N@#_ "TO
M^#CCXE_\%M_'?PF_9FM?^"KG[/?[-'P6\$:?\1/'4_PAU#X#ZUINJZGKGBJ;
MPUI,?B.R\0)8_'#XLM#8VFD+8SV;R6.CJUQ)*%N[D@PIZ9_P;N?%/_@O+X&_
M9#^+NE_\$L/V;?V5_C+\#+K]I#Q!?^.?$?QTUW2]+\4:=\6'^&/PLM]3T32X
M+[X^?"J5] A\'VW@R^@E30K]#J-_J2#5Y61K.R_5#_@]_P#^3<_V#O\ LM?Q
M;_\ 4%\-U[Q_P90_\HUOVDO^SX_&7_JA/V?* /UE_P""7WQ/_P""Z'CKXI?$
M6P_X*J_LZ?LO_!CX467@"&[^&NM? G7-,U37M6^(9\1:7#-I>LQ6/QV^*[QZ
M0OAN35;M9'TG3$^VPVZC46)%M-^JWQZ^/7PA_9@^#_CWX]_'KQYH?PT^$OPR
MT*?Q%XS\9>(9WBL-,L(Y(K:W@A@@CFO=4U?5M0N+32- T'2K:]UKQ!KE_I^B
MZ-8WVJ7]I:3>O5_FM_\ !XS_ ,%(/$7Q1_:<\)?\$Y? 'B"YM?A7^SGI?A[X
M@?&BPL+F6*V\7?'/QSH,6N^&M-U=(I&M]0T[X;_#?6]&N])4%?)\1^//%$&H
M6[W>BZ;+; 'Z]_#K_@L;_P %;_\ @M%\3_B!X,_X(T?!7X7?LP?LO?#?6QX?
M\4?MH?M6:?\ \))K<NIO&E[9V>C>&(+'Q5X0T_Q-?:3,FHO\/M-\'_%J^TNT
MN-"U+Q5XN\'6>O644U;]IK]GK_@[7_96\&ZO\;_A)_P40^%'[:=OX5LY=;\5
M_!WPY\!?@WH?CG6--LHTNM0C\(^"]7^"%A8>)%MX(KF1](\*^-- \::BL45I
MX7T75]4O4T\?OE_P1@_98\+_ +'?_!,+]C3X.^'M)MM,U6X^"7@GXE_$6>*%
M$N=7^*OQ9T2R^(7Q!O[^YVB>_>V\0^(+K0],N+LM-!X>T?1=-C6"TL+:V@_4
M"@#^*+_@D5_P=M^%/VB_B+X8_9I_X*/>"/!OP"^)OB?5+7POX0^/O@MM3T7X
M/:WXGN)ET^R\/?$WPQXFU'5M4^%FJ:C>B*U3Q7'X@U;P;-JMX\6L6/@'2[5;
MJ7^T_4]1M-(TW4-6OWE2QTNQN]1O'@M;J^G2TLH)+FX>&RL8;F]O)5AB<QVM
MG;SW5PX6*WAEE=$;_+5_X.Y_^"?7AG]DW]OGPO\ M(?#/0;;P_\ #;]MWP[X
MC\=ZQI6G6R6NF:?\>/ ^HZ78_%V:Q@@00V\/BZT\3>"/'M\TC^=?>+/$WB^Z
M5$@$:I_5_P#\&J?_  4=\4?MR_\ !/J\^$_Q8U^Y\2_&S]C#7M!^$NMZ_J-U
M)>ZUXH^$NNZ1=7_P7\2Z[=S,9KG5[>PT/Q5\/[BZF\VZU*#X?6NMZC=WFJZM
M?S$ ^6?^"EW_  =D:=^S'HUC8_LJ_L1_'CQB_B^.]B\ _'[]JSX;?$3X _ O
MQ.UM$LRZS\/_  MK6D:1\1/BGI2PRV[W5K=7OPJO($G67SI(O+,WS9_P0;_X
M. /VD/V@_%W_  4<_:+_ ."EW[0FAVW[/7[.OP'\'?%*P\,Z%X$\'>$_"?@"
M?4/&=[H8T?P58Z%I$/BWQ'KGB6=],\,>&M'U_P 2^)M<U_7M1TW38+FXU"\A
M)_4W_@[>\)Z-XB_X(P_%?6=3T^TO+_P'\9/@'XH\.W5Q!'+/I.JWWC^S\$W-
M[8RNI>VN)M"\7ZSIDDL15GM+^Y@8F.9U/\>W_!JO^PSX?_;A_;5\=:=\6]43
M5?V=/@)H'@?X[_$7X,W0\_0?C7\0_#'B+4=*^">A^-M-:'[-K7@;PEKNM^(?
M&^L:)J,\VDZUJ>BZ#I&K:-JNG7]S)8 'HO\ P4!_X.F?^"O7BWXUKJOP2DUG
M]@[X+7]O:^*/A#\.]5^#7@K6_&OC+X?WTLDGACQUXS\3_&'P)XF_X2=_$-O&
M]RI\$6ND> C"XT^UAUV2Q?7;_P#I5_X)N_\ !R<WQ5_X)R^&/CI^U)\!?CY\
M7?VGK+XI?%#X)VG@/]C[]GOQO\2+WXW7OPH\(_"SQGJ?Q!L[31K4>!/ARD&D
M?&+P;I_B_3]=\7:3 VM+J6L>$-#;2+B/0-'_ *$_VQ/V OV.OV_O 6F_#7]K
M[X">#/C3X7T*\DO_  VVLMK.@>*/"EW.D4=W-X0\>>#=5\.>.O"8U"*"WBU2
M+P[XCTR#5H;:VAU**[BMX43TC]FG]F#X!?L=_![PQ\ _V9_A?X<^$/PD\'B\
M;0_!_AI;Z6%;O4;AKO4M5U;5]8O-3\0>(]>U.Y8S:GX@\1ZMJNN:BZQF]U"?
MRH]@!_G"?MX_\'@W_!0KXN:UKO@C]E+X?^$_V(O"VF:I=:=/J&H:7I_Q7^/!
MFTZZ>UN[+6]7\>^'H_ WAF1W@=+W1M,^&IUS1;HSV:^++MH5G/\ 6U^U7_P6
M[T#]B[]EC]D/PMX?\!>,_P!M/_@HU^TM^SI\)/&GP]_9B^%6E7FM>-?$6K>)
MOAWHNJ:O\3/B)IO@K1=5U/PQX.NM;DU*>RL-%\.S:UXMOX+W3O#&F6FD:;X@
M\1>&?\]G_@X[\&:/X#_X+8_M\Z'H=A;:=97WQ&\#^,YK>UA2"*35_B/\%_AI
M\0_$%\R1@*;C5-?\4:EJ=Y*1OGN[N>>0M)(S'_3;_P""0?[#?P*_98_9/^#/
MQ)\(Z1>^+_CO\>?@=\'?&OQK_:#^(-ROB?XO?$*^U?X>>%[[3O#=YXKO$:\T
M?X<>![ :?X9^'GPXT-K'PIX3\.:+ID%M87&J?VAJ^H '\.O[</\ P6$_X.I?
M@E)#\</C=X5^*G[&'PDU+5;=-&LM&_9)^'UI\)/#U]J$S'3-!U3Q7\2? 7Q*
MUV+4+U76VL]&\>^-[B^OVMY3:V+3Q71'[D_\&\__  <H^-O^"@/Q4M/V*/VV
M]+\'Z7^T3K.A:OK'P:^+O@S3$\,:'\8I/#&F7&M^)?!OBOPE#++I6@?$.U\/
MV.J>*-)U+PRFF^%O$>DZ3K&G#0?#VL:;IJ^*OZV_C+\(/AY\?_A/\1?@E\6?
M#6G^,/AK\5/!^O>!O&OAO5((KBTU3P_XBT^?3K^(+-'((+N*.;[3I]]&HN=.
MU""UO[.2*[MH94_Q./V3?AQXIT7_ (*._ +X':!\3O&OPJ\27O[7O@3X!/\
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M2L&K:9X@?0;NTT^Q\6:-\'-'\/V\6DZG<0)XHNO&6L:)HM]I7\KG_! KQ/\
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MXI\2Z?*(;G9X&\(H6FTK6KV"?]9O^#5?]ECPO^SO_P $A?@KX\M-)MK?Q_\
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M;V_:=\8^-OA#_P $&OV1OBS\;_ W@/4[O0/%G[8^D?L_>-OC%9ZGK%H,2_\
M"L_"D?AZ_P#!?AS1U;RWT[7OBE:ZUJ/BFVGWV7@;1;=+34=3_E5_X-V/V./
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M\(_9MUSX2_\ !5D_'-].G'A/]JSX*?#GQCIVMB)ELKCQ?\+-$L_@WXJT!96
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M?\$^;[47ACMY_CK;:)&T[!$-_P")?"OB;PYI:*20#-)J>JVD=NN<O<-$@!+
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M:%HO[6WQSN=#L0JI'I^B^(/'VM>)=)T^!5  MK#3]8M[.U)&XV\$1<LQ)/\
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M-%_[-L^./_H'A2O]"3_@ME_RB-_X*,_]FB?&K_U#M1K_ #V_^#/[_E,1HO\
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M4\4^.AXX\+>-X+-9"ZP1>++/P?X1O?LT/E01W7AV_NQ&]QJ-S)0!_>Q1110
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MBUK2+FSUC3["\M_YV/\ @R-^!/PJ\5_%;]N/]HKQ%IVF:U\8/A+X<^"_P_\
MAY=7T<-S?>#_  Y\6Y?BCJ'CO6]-6X$CVVH^)6^'^@Z"NKVH@O+;2;?Q!I/V
MAK+Q#?V\H!^R_AS_ ():?\%>O^"F5G;^+_\ @KS^WEXD_9I^#OB2-;R;]@7]
M@VZL_ UA!I%X/-?PM\4_BM!<:_!K@B8>3J.@ZG>_&^TEBD673/&FC7D"QP?Y
M\?\ P6'_ &<OA-^R/_P4M_:T_9N^!?A^[\+_  F^$?C[2/#'@K0[_6]9\27U
MGIW_  @OA/4KA[S6]?O=0U;4+J]U*_OK^XEN;ID2:Z>&TBMK..WM8?\ ;,K_
M !I?^#AW_E-'_P % /\ LL&E_P#JN?!% '^P5\$/^2+?"'_LE_@#_P!132:_
MR9/^#I#XDZS\0_\ @MI^UK9:C<32Z9\-;#X)_#;PM;3.S#3M&TKX(?#_ %_4
M+>+)PL-UXO\ $WBC5E1%50=38D,Y>1_]9CX&.LOP3^#TB$,DGPL^'SHPZ,K^
M$M(92/8@@BO\L#_@[4_9]U[X._\ !8GXI?$:\L)X/"_[37PR^$'Q=\*7HB8V
M,SZ#X&TGX-^*+**Y"^6U_!XC^&%YJM_:&1KBVAU[3[B1([:_LRX!_HD_\$1G
MTY_^"17_  3H.E@"V'[)7P=27!!_XF,?A:S36#E>,G5EO21U!.&^8&OU)K^6
M3_@T@_;5\*?M$?\ !,+0/V<KK6[1OBW^QGXJ\2> /$6@S78?6KSX:^./$FN_
M$#X7^,1;$_+HKQZWXB^'EF8LF*?X>3FY2(75I)=?U-T ?YZ?_!\?_P C_P#\
M$X/^Q/\ VH?_ $]? JOVN_X-#?\ E#;X+_[. ^.W_I\TJOQ1_P"#X_\ Y'__
M ()P?]B?^U#_ .GKX%5^TW_!H-<QS_\ !''PM$C M9_M$?'2VF .2LCZCH-X
M%;T)ANXFQ_=8'O0!_4-7^*3KG_*:75_^TH6H?^M735_M;5_BDZY_RFEUC_M*
M%J'_ *U=-0!_M;5_-[_P=A_\H3?VA_;XB?L\X_\ #U>#:_I"K^;W_@[#_P"4
M)O[0_P#V43]GC_U=7@V@#^=G_@R _P"3C?V\/^R)_"7_ -3OQ%7^C17^<O\
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MQ]H.O?"GQEXAO(K9)FUC1O"VF^*X_B+I=UI0O+7Q#IVC:9J6ARW]K?6,L_\
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M!XHT^**#3M>MOAG:B^MM6N-*@A@M="TSQWXC\;^'?#=K8:.GAO1=(GT;3KF
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MX>? ;0+S2?B#\;+"*2QM=79OC3\0/$]Y-+#JSBXT6W\&V/AI[*UO=$O[B_\
MXB_^#R7]G#7?AC_P4T\%?M #3IQX,_:=^ OA&[M-;,3);3^/O@_+-\/O%VA)
M)C;+<:1X13X8ZK,P;(B\26T>T>7E@#_04\$_\$_/^"8GQ!\&>$?'OAG]@?\
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MS*.I$+D=#@ ]Z_X,HO\ E&C^T?\ ]GS^-_\ U07[.U?V*U_&K_P9.ZS83_\
M!.S]I_P_'<1MJFE_MI:]K-Y:AP9H;#7?@;\$[+3;AX_O+'<W'AW58XG/$C6L
MRKS&U?V54 ?Y/'_!W1_RF9^(W_9#/@+_ .HE+7^C)_P1S_Y1/?\ !-W_ +,D
M_9H_]5)X5K_.&_X.U==T36_^"SGQ:CT;6-+U>30_A#\#="UI-,U"TOWTC6[7
MP7'=7.CZHMK-*;#5+:VO;.XGT^Z$5W##=VTLD*I/$S?Z./\ P1JN8[K_ ()-
M?\$WY8F#*O[%G[.=L2.TEG\+O#=I,OU6:!U/H01QTH _/#_@Z]_Y0D?M)?\
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M>HB-=0TV/Q%X2\+:1JZ6%^L40O+-;P6]T(HQ/&X1<?2U?B=\"O\ @H+XQ_;
M_P""POQN_9P_9X\6V.L_L>?L+_LZZCH7[2'B71]/T/5]'\<?MA?$_P ?>'H/
M!W@JP\2R65UJ$%K\+/!G@KXB6ES-X?U>RM[GQ>OC30]=L-132='O+8 ^EO\
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M#KRS7/AOQ=H?VNV-[I\LMQ9WEE=6&N:%J&L>'-6TC6+_ /CQ_P"#@+_@V*^
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M\%&?^S1/C5_ZAVHT ?Y[?_!G]_RF(T7_ +-L^./_ *!X4K_5GK_*8_X,_O\
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M</BC]FSXP66H^+OA'-J%O>R#6=.NO 6LW5EJ?@+6)KZ-X]:U/P!J?@?Q5-/
M+;4-5DCC>W/^O#^P5^U5H/[;_P"QG^S7^UAX?33+:'XX_"3PGXSUO2='N)+K
M3O#7C>:Q73OB)X.M[B9Y9I?^$+\>V'B3PG*\TCS&;1I/-8R;C7Q'_P %/O\
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M^,_$]]XN;Q%XK\0:UJCK$=3UAK"T:YM=%L-&T.%X=]CI%HTLYE_V'J_RI/\
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MU_I"4 %%%% '\V/_  =F_P#*%/X[_P#94/V?/_5M^&Z_GQ_X,??^2_?M\_\
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MSCKG[6G_  3*_;9^ /A6PFU?QCXW^ GC&]\#Z-;QF6XUOQYX'B@^(7@;0[=
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M>\<_M>6WCVPM"ZB>YT/X8_!SXG:#KDT<9^9H+74?BMX96>11B.2YME8CS0&
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M^$]AH20W,6GW)\>^._$>G>";N&^MKB7[3J^ER63P.DWF@'^5%_P4)_X(_?\
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M8;:;6O OCWPZ\LUSX;\7:']KMC>Z?++<6=Y975AKFA:AK'AS5M(UB_\ &/\
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MZ?<:IXMU!-+_ &B?"^DJ4A:YT3XHM')#X_DM(WFO9=/^*=AK>MZY/'!IT?Q
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M_9J'Q:_]1VXK_/S_ .#/3_E,#;?]FP?&[_TM\#5_H&_\%OP3_P $A_\ @HL
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MXZ:9XF6-F"2:)%INA:S;I<!>&A'B32?#\BJ_RB>.!A\ZI7^AA_P6R_Y1&_\
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M\KQ9\,/@%\+/ WBF(2$EHX_$?AOPMIVM1Q<X6%+X11K\J(J\5]:T %?Q*_\
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M"+XSD\+W=SI*^'O$_A^[L/"FL^+-&U+1]9NF_P"$>:./58-,UNWU#2+/B/\
M@Z,_8)^+G[=__!,^:R^ GA;4O'?Q8_9V^+WAKX^Z5X#T"TGU'Q5XY\*Z3X6\
M:>"?&_AOPIIEO')/JVOV^D>-4\7V>CVJOJ6M#PE)H^C07VLW]AIUY_1Y10!_
MCS_\$5O^"V?Q]_X(Z>-_C!X2\(_ _3?C[X+^.=UX8L/$_P '==UO7/!/BBP^
M(_@^?6-)\.:GX5UK3O#_ (INM/U:8>(-0T/Q#X>N?"6IRZ]Y.CV\<FFWNE0R
M2_Z)W_!)?P_^W[^T)XQ^(W_!1_\ X*)Z'J'P(\8?&'P)H7PL_9K_ &+M)O\
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MK'5_%WAO5]2L52-0D?V2ZA*( J$*,5H?!#]D3]E+]F87?_#.?[,_P!^ KZA
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M5/XGE6&">^N4/[TTR...&..&&-(HHD2.**-%2..-%"I'&B@*B(H"HB@*J@
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M8==NG:6?7_B;\!/A9XWU^25SEYO[<\1^%M1U99F/WIDO%D8$@L02" ?RQ?\
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M8TK3=0N;5OLUQ>6T\ULJ0/&B_P"Z110!_%S_ ,$"/^#A;_@G7X&_X)Y_ /\
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M'_;4^.O@WP3\<C\(=+^)X^#?@O3_ !7XH\5^-EO'US0XQ\.])BT9[F?1]?\
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M;:3X4U;XB?LB?M)Z!IDWA'QMH6L^'_#>NZ5XJ\)7>HPWULUUH?BW2/%/P_\
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M9^^$=[H/A^+]I;]I_P <^,OA%XRUOX#1^)QJUSX?\)? NU\-:KXZ\0^--/\
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MH=-,C!I#I\?BO1]62S,C ,YMECW, 6R0#0!_&1^SQ_P<8?\ !67_ (*U2P_
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M_!OA3PCHNIZ]I>EGQ1J=];>)O$&KZS>Z-#<:+I,%KH]K'J=]J%]J-GI'!_\
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M2^%_$UWX:TS6+_PW>7=G=:#J.@ZKJ%@OAZY2TUJUU+5M*O4TBWU?^^OXE?\
M!2S]@_X/? 'X9_M2_$O]I[X9^$/V??C+,EM\+/BGJ5]J+^&_'=S)8:IJ<=MX
M<-GIMS?W]S)8:+JMRENED)G2QG"H74*?N2B@#_'0_P"#A_\ ;^^#'_!1S_@I
M5XX^-_[/-YJ.N?!KPC\._ ?P<\$>,=2TO4="E\>6O@P:SJFK^+K30M9M;+6=
M)TB_\1>)]8L]#@U>SL]4NM&T^QU2_L-,N;^33;/^S;_@V^_X+6?L):Q^PA^R
M)^P]\3OC9HWPN_:M\!:C!^S_ *'\-/%^FZ_9_P#"R=1\2?$/4K3X4W'@#Q#!
MI-QX;UB3Q-9>(M \/RZ3/JMEK=AXGMM1@N=-32I=(U;4_P"OFB@#^'C_ (/"
M_P#@ES\9_P!H/1?@Q_P4 ^ G@O6_B1=? _P#JOPB^/?A3POIUWK/BG2/A?!X
MAU7QMX+^(>F:+8Q37FI>'O">N^)?'-IXZ>SBN+S1K'7M%U^2U'A_3/$FIZ3_
M #;?\$9_^#B[]H?_ ()'^#?$WP2N?A9H?[2_[.'B#7[SQCI7PSUWQK??#OQ+
MX!\8:G#;V^L:AX%\?6_AKQO!IVA>(1;6UYK_ (5U7PAK%A/J]LNKZ)<>'[_4
MO$4^N_ZZ%> Q_LH_LMQ>./\ A9L7[-?P!B^))O3J1^(,?P<^':>.#J)D\XZA
M_P )8OAP:]]M,W[TW7V_SS)\_F;N: /Y8_ 0_P""RG_!PK\/]0O/B[IMW_P2
MB_X)M>*M!OFC\"^";O5[C]I?]J:TOK&0Z?H5WXW\3:1HNL:1\(=29HAJWB6+
MP5X+\/>+="O6L;3PG\2],OI=0\/_ .?9^S/\5_CK_P $\/VY_A;\4-'^']Q%
M\?\ ]F#XXVJW7PI\7:5JBW5[XP\,:U<>'/$?PYUW2M/:'68Y]8#ZGX7NH]-9
M=2BDO#)I[-<K 3_N6UY9-\#/@E<?$=/C%/\ !WX63_%R.**"/XIS?#[PE)\1
MXX(+<6D,*>-WTAO$R10VJK;11KJ@2.W A0",!: /RI_X)5I_P4@_:#UWQ;^W
ME_P4/A;X M\4/ >F^!?V=OV#_#*ZA9Z#\$_AK+JFG^)-7^(GQ6BUDR:YJ7QN
M^(FH:9I"FVUG[%J/@OPM9/I=YI>B7FN7/A3PM^.O_!XS_P $_?C/^TO^SK^S
MK^U5\$O!FM>/Y?V4-2^*6E_%SPUX6TV[UGQ+:_##XG6G@O45\?Q:590SW=YH
M'P_UGX?M'XE:RCFN-+TOQ=)X@O(%T+1=9U#3?[,Z* /\G#_@A_\ \' O[5'_
M  3>^&WB#]C7X6_LLV?[86E_$[XBW?BSX/\ @33=;\5Z-\0] ^)'BK3-)T;5
M=*T*T\+>%?&]]XUT#7#H.EZA%X0LM&TS4X-8.K7MIKH759H(O]#/_@E-\&/V
MR/#_ ,/_ (I_M/\ _!0?Q(Q_:W_:^\5Z#X]\6?!SP_JU_-\+OV9/AQX5T,Z%
M\+/@5X T"76-:TK2K_0-*NM3UOX@:OIU[=WOB'Q7KLT.OZSXFU'0O^$EU7]$
M_#'P:^$'@GQ)JWC+P9\*?AMX1\7Z^9CKOBKPQX&\,:#XDUHW$@EN#JVN:5I=
MIJ>HF>51),;RZF,L@#ON8 UZ30!_BC?\%>/VF/VJ/C]_P47_ &H_$'[3/B[Q
MO_PGOPY^/GQ.\$>%_!VKZEJMKIOP>\.^"_&^JZ1X8\&>!-%DF2V\-:1HFFZ;
MI[V]SI4,$^NWGF>*M2O-3UG5KW5;O^Z;_@T:_P""HWQN_;(^"/QP_91_:0\:
M:W\2O'7[+4?@77?AI\1O%=_<ZSXQU_X2^-GU_27\+>*-<O9)M0UVZ^'FO>'K
M>+2]<UBYNM5NM#\6:=HTMQ);>&[9C_2Y\7OV9/V&8?&.I_M@?'+]GK]F*7XA
M?"SP_=^+]6_:.^(WPE^&E[XW\$^'?!.DRW]QXBN_B9KOA^?Q!I=GX4T6PGN+
M?47U9#HEA;S?8Y;:+>#_ #<_\&Q7PEU3XN?'K_@JW_P5>C\)WG@SX2?ML_M/
M>.-/_9MTV]TO^QKC5OA[8?%/XB>.O%?B,69@B2>Q?4_$_A/PNNH6>VWD\6^$
M_'=E,&N;!A" ?U^T444 %?P._P#!T)_P6Y_8._:;_87TW]CW]DCXVZ'^T!X\
M^(_Q7\$>*_&^K>"-/UYO!_@?P+\/Y;[7D:^\3:KI.FZ9J?B#7_$Z:!:Z7H^A
M3:F]OIMIK=_K4VE%-'@UC^^*B@#_ "<?^#77_@IQ^SI_P3?_ &Q_BT?VJ?%%
MQ\/?A%^T#\)+3P2/B2-'UC7M)\'>./"_BBR\0>&)/%&G^'[#5-:@\.ZS87'B
M+29M8L=.OETG5Y]&EU.&VT275-7TO_43^%'[47[/OQS^ MG^U#\)/BMX4\>?
ML_7^B>+_ !':?%70[JXD\*S:)X!U/7=&\9ZB+FXMH+A+?PYJOAG7['4_,MD>
M"XTJ[38VP%O>Z* /X>_^#C+_ (. OV!?BM_P3^^*W[&W[(_QETS]H?XL?M#G
MPAX>US6_ >F:\? OPV\":'XV\/>,O$&J:QXKU?2],TG6M:\0V_AH^%=(\/\
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M_P#1._X(C?'K_@MKXY^ O[*7PG_:)_80^&?P&^!_P>\%^#?AWXJ^.?QW\?\
MBWP7\:_B/\,?!'AN'PUX:;PA^SK:>'M0\3:'\0TTFQT#^UM?^)-[X8\+^(3#
MJ6J6-K#<72VD'[^Z'^R]^S9X9^,WBO\ :,\/? +X-Z+^T!XZBM(/&/QNTWX;
M>$+3XL>)8+'2[70[2WUCX@Q:0OBJ]MX='L;+2U@FU5HFL+.TM71H;:%$]UH
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M_M_^+='\G7?C3X@3X"_""\NH-EQ'\,_AY>VVM?$?6=,G"XFTOQA\1WT;P_<
MONBU/X27"^6JN'E_N.KS[X5?";X7_ SP!X<^%/P8^'G@SX4_#+PA!>6OA7X?
M_#WPWI/A'P=X=M]0U*]UF_AT7P[H5I9:5IT=]J^I:AJEXMK:Q"YU"^N[R;?<
M7$LC^@T ?-O[4_[7_P"S3^Q+\-+;XP_M5?%[PO\ !7X;7OB6Q\&V/BKQ4-3D
ML[[Q5J6E:WKFG^'[&UT;3]4U*]U6]TGPYKE];6EK92RS0Z9<[%+JJM_DK_\
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MI.FZ9J?B#7_$Z:!:Z7H^A3:F]OIMIK=_K4VE%-'@UC\4_P#@UU_X*<?LZ?\
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M1?"7X'_#7X?>(KF"9'BEANM?\*^&M+U>YB>*22%HY[V1#"[18\LE: /YI_\
M@UC_ ."*/Q8_8!\'_$3]L3]J_P ,S>!OVB/CYX.L/ ?@;X5:DD8\3?"CX.-K
M%AXHU;_A.HPK'2O&WQ"U[1?#&H7?A42F\\(Z+X9TNUUYK?Q)JVM:!X=^9O\
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MV'@G4[JS\0ZV^A:/"CW'^ES\%_@[\.OV>_A)\-_@;\(_#=GX0^&7PF\&>'O
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M:C?77@F2YU(%LDI?R7$9)8E<LV0#^)#_ (+3?M"^(O\ @Y#_ &LOV;/V)O\
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M?PW\5;CQ[X@?28?#>@'PIHUEXCT]-..JW.LZEXC;3K*RTZ2P_M/5-+_K4HH
M_P :K_@@%^WC\)/^"=/_  4Q^$?[0'QZN=4TOX-7_AKQ[\+_ (A>)=(TN^UV
M\\':3X\T)[33O%DFAZ5!=:MJ^EZ)XCLM$N->M-'M;S6%T(ZE=:3IVJZC;6NE
M7O\ JY?!W_@I5^PE^T!\$OBK^T?\'?VFOAQXZ^"'P.L+O4_B]\1=,N=5MM$^
M'EC8Z(_B.\G\4IJFEV&HZ9]ET.-]2GCELO-CMU8M&'!6ON.B@#_-N_X.O?\
M@L+^QG^W/\./V<?V7_V0?B99_'"+P!\2]9^,7Q*^(GAW2]=L/!>BWT'A34_!
MOA3PCHNIZ]I>EGQ1J=];>)O$&KZS>Z-#<:+I,%KH]K'J=]J%]J-GI'!_\&H'
M_!7+]D3]@9/VH_@%^V!\2(/@SH/QBUSX??$/X:?$76=(UW4_!S^(?#>F:_X>
M\5^%O$E[X?TS5KGP[=WVG7?AW4_#^IZC:0Z#<KIVNV=_JFGWYT:UU;_3-HH
MXKX;?$?P-\8/A]X*^*WPR\3:9XT^'7Q&\+Z'XU\#>+M%E>?2/$WA3Q+IUOJV
M@Z[IDTB1/+8ZIIMU;WEK(\:,T,R%D4D@=K110 4444 %%%% !1110 5\ ?\
M!6+_ )19?\%+/^S /VR/_6=?B-7W_7P!_P %8O\ E%E_P4L_[, _;(_]9U^(
MU 'X _\ !E3_ ,HLOCY_V?\ _%/_ -9U_95K^OVOY O^#*G_ )19?'S_ +/_
M /BG_P"LZ_LJU_7[0!_ '_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\
M=DW_ +]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1$CRR1Z3H5OJ%ZRQH[N+?"J6(%?ZY_[0W_!%+_@F!^U?\4?%/QG_ &A_V4]
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M)W@_5(]8TG]@;X<W=W%*)EA\4^./C/XYTLN'#A9-#\;?$OQ!HDT6X8,$NGO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **** "O@#_ (*Q?\HLO^"EG_9@'[9'_K.OQ&K[_KX
M_P""L7_*++_@I9_V8!^V1_ZSK\1J /P!_P"#*G_E%E\?/^S_ /XI_P#K.O[*
MM?U^U_(%_P &5/\ RBR^/G_9_P#\4_\ UG7]E6OZ_: /X _^#&/_ )RB_P#=
MDW_OW%?W^5_ '_P8Q_\ .47_ +LF_P#?N*_O\H **** "BBB@ HHHH ****
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M*[.HG5?[:/@M?%?]D_\ "5K\*S>_Z(?"FXZ\-")T=?&BIBX']80
M&  .  !P !T% "T444 %%%% !7Q/^V'_ ,%&OV(?V!O#A\1_M:_M(?#?X0/-
M9/J&D^$M4U9]9^)7B6U0NOG>%?A?X9@UKX@^)8/.3R)+S1_#=W8VLK(+RZME
M8/7VQ7RS\9/V'/V,_P!H?Q#K_B_X[_LJ_L^?&#QCXG\$P?#C6O&7Q&^$?@;Q
M=XPN? UK+J\]IX9@\5ZWHEYX@T_3;.XU[5;JSCTW4;22TN[O[7;R17,%M+"
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M1>#O%WAOQ#;/;ZG9Z+K>JZWJWAF^TW4M%O=*O/$&N"Z?5;6]CM;;[>_X)O\
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M  6&^(G_  6&^&O[2?Q.\=_!KP7\%;3X1_%;0/!GA'P]X2\1:YXIN;G0M?\
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M^J7BV%QXS\)Z9I'AO3UTZ?6I]6O+LZWI\&BSQWG[SU^3_P#P5I_X) ?LW_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?E3_P %C?\ @J)X0_X))?L=7W[3
M.O\ @*\^*7BGQ#X]\/\ PC^%/P]@U<>'K#Q'\0_$VC^)?$=L?$?B%;#59M$\
M-Z-X9\'>)M=U&ZM=*OKJ]ETZST*V6UN-7BU"T_5:OA#_ (*._P#!._X!?\%/
MOV8O$'[+O[0T7B&T\,WVNZ/XT\)>+_!U[9V'C'X>?$'P[!J5IH?C'PU/J=CJ
MFE27D.FZUKFA:C8ZIIE[9:GX?U[6=.9+>>Z@OK0 _'+_ ((+?\'$A_X*Z?$G
MXJ?L]?%;X&Z-\%OCCX \!7'Q;\/W7@?Q%J?B#P)XV^'NG^)/#WA/Q#&T&O6L
M6K^'/$WAO6/%WA;;;-J.MVGB+3]5O+VW;1VT6>VO/Z?*_"K_ () _P#! W]E
MS_@D%KGQ)^(OPY\;^/OC/\:OB=H$?@G4_B7\0;?0](_X1[X>QZM8Z]/X/\)>
M&_#UNEOIUMK>MZ3H>J^)M0U+4M9O-4N_#^AK9G2;6SFM;O\ =6@ HHHH ***
M* "ORI_X+&_\%1/"'_!)+]CJ^_:9U_P%>?%+Q3XA\>^'_A'\*?A[!JX\/6'B
M/XA^)M'\2^([8^(_$*V&JS:)X;T;PSX.\3:[J-U:Z5?75[+IUGH5LMK<:O%J
M%I^JU?"'_!1W_@G?\ O^"GW[,7B#]EW]H:+Q#:>&;[7='\:>$O%_@Z]L[#QC
M\//B#X=@U*TT/QCX:GU.QU32I+R'3=:US0M1L=4TR]LM3\/Z]K.G,EO/=07U
MH ?CE_P06_X.)#_P5T^)/Q4_9Z^*WP-T;X+?''P!X"N/BWX?NO _B+4_$'@3
MQM\/=/\ $GA[PGXAC:#7K6+5_#GB;PWK'B[PMMMFU'6[3Q%I^JWE[;MH[:+/
M;7G]-&MZWHOAK2-2\0>(]7TO0-!T6RN-2UC6];O[32M(TG3K.)IKN_U+4KZ6
M"RL;*UA1YKBZNIHH((E:26144D?A]_P2!_X(&_LN?\$@M<^)/Q%^'/C?Q]\9
M_C5\3M C\$ZG\2_B#;Z'I'_"/?#V/5K'7I_!_A+PWX>MTM].MM;UO2=#U7Q-
MJ&I:EK-YJEWX?T-;,Z3:V<UK=_M/X^\ ^"/BIX)\5?#;XE>$O#OCWX?^.=!U
M/POXR\%^+=(L=?\ #/BCPYK-K)9:KHFN:-J4-Q8:EIM_:32075I=0212QN0R
M]" #^=3]N[_@ZH_X)??L??VSX6^&'C/5/VSOBSIWGVT7A?\ 9^FL;OX<VFHQ
M;O*3Q!\<=4QX&;3961XI+SX>+\3+^TEV+<Z.BOO7WG_@@O\ \%=OB)_P6!^"
MW[0/QA\?_!_P7\&4^%WQJA^'GA?PWX/U[7/$K3^'[WPCI/B>WGU_6=:ALA?Z
MS;/J;64UYIVDZ-972PB=-+M"YB7^<'_@\B_8@_9=^ _PC_8H^,WP$^ OPE^!
M_B&Z\??$/X3>)E^$/P]\)_#C3/$WAN3PMI'B;PS;Z[I/A#2=(TZ_G\+76B:O
M'H5U+;&YL[37=2M/->V-M';_ &+_ ,&2'_)E7[8O_9T>C?\ JI_"M ']K-%%
M% !1110 4444 %%%% !1110 4444 %%%% !7)^.?'O@7X8>%-:\=_$KQIX3^
M'G@?PW:-?^(O&7CGQ%H_A/PIH-@A"O>ZSXAU^\T_2-+M%9E5KF^O((59E!<$
M@5UE>;_%GX.?"7X]>!]0^&?QO^&?@/XO?#G5[[0]3U;P'\2_">A^-O!VJWWA
MG6[#Q)H%QJ?AOQ'9:CH^H/I6NZ7IVJ6:WEG,D=W:0R;3MP0#^93]N[_@[H_X
M)R?LQ?VSX2_9LMO%'[;?Q0L/M%M$_P /I6\$?!.RU"'<ABU/XN^)-,NKC6H-
MQBFM[WX<^"_'6B7T7F1C7K250:_47_@B?_P44\>_\%1_V&M$_:O^)'P^\(?#
M+Q)J_P 3?B/X)/A7P1>ZSJ&AV^G>#=2M+.PNA=:]<7%_+>W45R3>-NC@,B!H
M8(5.P?Q(_P#!XU^Q[^S[^S7^TY^R1\0?@+\)/A_\'(_C1\(/'NF>-?#_ ,,O
M"6@^!O"^L:U\+O%.A1Z;XDF\.^&K#3=(77[C2/'-OI&HZG%:)<W]AHNCQ7+R
M&R1C_2]_P:&_\H;?!?\ V<!\=O\ T^:50!_3]113))(X8Y)II$BBB1Y)99'5
M(XXT4L\DCL0J(B@L[L0JJ"20 30!^$?[9G_!6;XJ_!__ (*V?L+?\$M/V<_A
M=\/OB3XG_:$TN+Q_\??%'BV\\1O>?"OX6_VIKNH7VH>'K7P_?V-G_P )'IWP
M\^'7Q'\526?B!Y8)VE\&*(X+;4F>[_=^OXQO^""$4G_!1/\ X*^?\%6?^"PF
MMQOJW@#1O%;?LN_LQ:G=(TUD_A9?[*L8-3TI2/*TW6-(^#/P^^&AU-+8[97^
M+>NN3-)>7%Q-_9S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5_$)^WY_P '@<O[*G[=?Q/_ &:_A)^R7H?Q4^$G[/OQ/U_X2?%'QIXI
M^(6J^%_&OC'Q7X%URX\-_$,> ;+3]!U+1/#FG:%XAT_5]&T2]UV/Q-_PD@TU
M-7>'1;74(K:W_M[K^6W]M/\ X-/_ -A']LO]L/Q5^UEJ'Q1^-?PE3XJ^,)O'
MWQJ^%?P_D\)2^'O&GB_5+L7_ (KUWPWKFNZ)J&K>"+WQOJ#76K^*<Q>)()M;
MU'4M1T>'1OM*6\(!_1W\!_C+X,_:+^"'P>_: ^'4M]-X ^-_PP\!_%OP5)JE
MLMEJI\*_$3POI?BW05U2R2:X6RU./3-6MH]0LQ/,+6\6>W\V3R]Y]7KC?AS\
M/?!OPD^'O@3X5?#K0;/PK\/OAGX.\,_#_P "^&-/,QL/#O@_P;HMEX=\,Z%9
M&XDFN#::3HNG65A;M/--,T5NAEEDD+.>RH **** "BBB@ HHHH **** /XA/
MV_/^#P.7]E3]NOXG_LU_"3]DO0_BI\)/V??B?K_PD^*/C3Q3\0M5\+^-?&/B
MOP+KEQX;^(8\ V6GZ#J6B>'-.T+Q#I^KZ-HE[KL?B;_A)!IJ:N\.BVNH16UO
M_9)\!_C+X,_:+^"'P>_: ^'4M]-X ^-_PP\!_%OP5)JELMEJI\*_$3POI?BW
M05U2R2:X6RU./3-6MH]0LQ/,+6\6>W\V3R]Y_G$_;3_X-/\ ]A']LO\ ;#\5
M?M9:A\4?C7\)4^*OC";Q]\:OA7\/Y/"4OA[QIXOU2[%_XKUWPWKFNZ)J&K>"
M+WQOJ#76K^*<Q>)()M;U'4M1T>'1OM*6\/\ 3!\.?A[X-^$GP]\"?"KX=:#9
M^%?A]\,_!WAGX?\ @7PQIYF-AX=\'^#=%LO#OAG0K(W$DUP;32=%TZRL+=IY
MIIFBMT,LLDA9R =E1110 4444 %%%% !1110 4444 ?FM^W#_P %>O\ @GA_
MP3PLKV+]I[]I3P1X;\<6UK]HM?@]X4N)/'_QFU%I8A+91K\-_"*ZIK^B6VI
MA++7/%L/AWPRS%C/KD$4<LB?@+^RG_P=?V_[=/\ P4L_9P_8\_9]_95D\'?
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M\'=2^$=]X6UF]\/^%M.TK1Y->6S^*FJZ5<:R;/\ M"]TK3-'L+FXEMM(L(X
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M\1O#FI^$O&_@[7(Y9=(\2>&]9MVM=3TG4(X98)FMKNW=HY##-%*N0T<B. P
M-_\ X2SPK_T,WA__ ,'.G?\ R31_PEGA7_H9O#__ (.=._\ DFO\SO\ X.<_
M^""OP:_X)Z:/\/\ ]L;]B_P]K7A7]GGQYXQ'PX^*GPIN=8UGQ3IGPH\>:II]
M[JWA#Q#X3UG7KS5?$<7@CQG!I.N:9J.G>(-4OX?#'BFUTBSTK4VT_P 6:9H6
MA1?\&C_[!/[!?[;WQ%_;)?\ :Z^%'A?XW>/?A1X9^#FH?"GP#XZN-0N/"]MX
M8\5ZE\0K/XA>*QX9M+ZUL?$6H:?J>C^ ](-QK4-W;:%#K48LX&N=9DFM@#_3
MH!! ((((!!!R"#R""."".AK+O->T/3IOL^H:SI-C<;%D\B\U&SM9MC9VOY4\
MR/L;!VMMP<'!.#5ZUMK>RMK>SM(DM[6T@BMK:",;8X;>"-8H8HU_A2.-%1!V
M50*_FN_X.4_V//\ @GMJ_P#P3X_:X_;'_:%^"?@Z^_:$\)_"32/"7PD^,MK-
MJ&C?$BV^(M[KMIX:^#^B6FHZ;?VQUO1K3Q9XBAEUC0+ZUU"QF\,'7YKFWCAM
MWO+4 _H]@\2^'+J:.WMO$&B7%Q,ZQPP0:K82S2R,<*D<4<[/(['A552Q/ !K
M;K^/;_@VW_X(+_LY?!;]EO\ 9]_;L_:6^%MMX[_:\^*!\/?'SX87WBFZUE;+
MX#>#;TQ:S\)T\,^'8+^TTI_&6KZ$=+\=ZWK^O:;>:KI-WK5GX;TZ/3DT6_N-
M8_7[_@I7^S/_ ,%;?VE?^$C\*?L0?MV?!W]CGX7'P!"-/%G\(=<UWXX^,OB
MYU?^U-&UCXMW.N7]I\-/!DJ1Z =%\4?#CPK%XWTZXN-8^UF]@M[5;L _0SXQ
M_M7?LQ_L\ZSX+\-_';]H'X.?"'Q)\1]9T[P]\/\ PU\1/B+X4\)^(_&VM:M>
MIIVG:=X5T'6=4M-7UZ>ZOY([*,:99W*"YDCA=ED=5/O]?X<?P)U[XI>)/^"B
M'P$U+XU^*/&/C'XK)^UU\'M.\>>(?'_B35?%_C"^\2Z3\7O#>FZJ->\1ZU?:
MGJ>JWUO=VLMO+<W5_<LYB^65EP:_W'* "N>\5^+_  GX#\/:IXM\<^)_#O@S
MPIHELUYK7B?Q7K6F^'?#VD6BD*UUJFM:O<V>FZ?;*S*K3W=S#$"P!;)%?#O_
M  4X_P""B/P@_P""7_[(OC_]J?XN1OK3:,UOX7^&?P\L[Z/3]9^*OQ6UZVO9
M/"?@/2KR2"Z73XKL6%_K/B+6C:7O_"/^$=%\0:ZFGZG-IT.F7G\=W_!+G]C_
M /:(_P"#E[XC_$3]OC_@J[\5OB!KW['WPZ^(5YX-^"?[+/@'Q%KOP]^%>O\
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M(91Y-O-J%Y(@X:=^M?TU_#S]ACQW^P]_P3^\,?L7_P#!,OX@^%/AYK?P]O\
M68?AUX]_:ET75OC#::!I/Q"^*6O?$'XAZGJ.G>#+KP =<\1V#^,/$=QX(ANH
M$T);RWTC3O$%G>6!N[P 'Z'^,/&?@_X>^&M8\:>/O%?AOP/X.\.V<FH^(/%G
MC#7=+\->&M"T^(@2WVL:[K5U9:7IEG&64275[=00(2-SC(KB/@E\>_@G^TGX
M#M?BE^S]\5O 'QH^&]]J6JZ/8^._AIXITCQCX3O=4T.[:QU>QM-=T.ZO-.N;
MC3KM&M[I(;A_*D&TGD9_RF_^#D7X0?\ !27]G/\ :M\'_#C]O#]MGQ3^V/HG
MQ!\!6WQ9^&'B.VAO_ /PUTV*77-;\,Z[H^D_ W3[O_A!/A[X@T34=*;[4?"U
MG/;ZEHFJZ%>R:F]Y/>Z=IO\ :S_P:0?\H8/A5_V6CX^_^IW<4 ?TS44UW2-'
MDD=8XXU9Y)'8(B(@+,[LQ"JJJ"68D  $D@"O\^3]NG_@K5^UK_P6]_X*+>&O
M^"3'_!,3XL:Q\$OV7]7\8ZSX.^(GQ\\$W>H6'B/XI^%O!]M>7_Q6^)VH^(]'
MN=,UC2_@QH>B:9K%MX*\$:-K>B-\69)--C\5:O)'XST7PWX; /[3OC!_P4;_
M ."?_P"S]XBNO!_QN_;9_94^%7C&QF:WOO!WCGX]_##P[XNL)D95D2^\+ZAX
MFAUZS\MF59&N=/B6,G#LO->H_!#]J[]EW]IFUNKS]G/]H[X%?'FWL(1<:B_P
M=^+/@/XDMID3.D>[4XO!^O:Q+II622.)TODMWCE=8G59"%K\BO@/_P &S/\
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MCC12SR2.Q"HB*"SNQ"JH)) !-?CK_P %XOB+INA_\$>?^"A%SH7B327U&_\
MV=O$_AL1V>JV,UQ-9>+[W2_"FJVZ117#2.MQI6M7L$JJI)BD?@BOU&^,?PN\
M-_''X1?%3X*^,I=4@\(?&#X<>./A=XKGT.Z@L=;A\-_$#PQJGA/7)='O;JTO
M[:SU2/2]6NGT^ZN+&]@M[L0RS6ES&C0O_#M_P57_ .#7+_@F[^Q9_P $\OVJ
M/VI?A%XK_:DOOB3\&/ARGBOPC:>-?B=X&UGPM/J;>)-!TDIK6EZ;\)]#O[RT
M^RZE<'RK;5K&3SA$_G;59& /RI_X,S[S3K#_ (*L_%"ZU.]L["&/]B/XM"*>
M]N8;6+SW^,'[/B!%DG>-#(T32D(&W%58@84X_P!0N#Q+X<NIH[>VU_1+BXF<
M1PP0:K8S32NW"I'%'.SN['@*JDGL*_R ?^#>+_@FS^S[_P %3/VXO''[.G[2
M>I_$K2? /AW]FOQW\6["Y^%GB/1?"_B-O%'AOXA?";POI\-QJ.N^%_%MG)I#
M:;XWUA[FT33(KB2ZCL94O(D@EBG_ +Q?V8?^#5C_ ()I?LE_M"?![]I?X7^+
M?VJKSXA_!#QYH/Q%\'6OBWXH^!-5\,SZ_P"';I;RPCUS3=/^$>CWM[IS2J!<
M6]KJEA-(F0ES$?FH _I4HHHH *P?%'BKPQX(\/ZKXL\:>(]!\(^%=!M'O]<\
M2^*-8T_0/#^C6,959+W5=9U6XM-.TZT1G57N;RYAA4LH9P6&=ZO\^[P7\34_
MX.9O^"X'Q6_9L^./Q'\5Z;_P3=_8V\._$?Q_X#_9Z\&^)]2\,:=\<+7X7?$3
MP?\ "RU\5>*[[1;VVO9]2^(/B'QHGBF\\06\D>L^$_A[#;>!_"5YX?U?5]3\
M5W !_8SH/_!53_@F1XH\4+X+\._\%"_V*=:\4RW"V=MHNG?M/?!BYO+^]9V0
M66EB/QF8]5O R,&M-.DNKA2IW1@5]5>*_C5\(/ S?#5/&/Q.\">&F^,OB[2_
M 7PE76/%&CV1^)7C36]-O]9TCPOX'\Z[7_A)]:U'2=+U'4K2PT?[7//8V5S=
M(IAB9Q^:'BW_ ((%_P#!'/QEX#E^'>H_\$^_V?M+T633VTZ/6/"7AZ^\&^/+
M=#"84NHOB3X7U/2?'SZA%Q*M]<^([BXDF427#S$N&_C&UC_@DYXE_P""2_\
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M66L^'GT:;49!;)?V]JMQ_DE?\%P/A]^W)\#_ -OKXH_ ?]NS]IWQE^U7\1/
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M=0\>^*]9\++::KKOAKP?K.K'P_X&U'PQX7N=5U/PUI-]J=WHD]]<0/)<-/,
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M7+Q6]K:VT"/-<7$\D<,,2-)(ZHI(_BP_X-8OV+O^"HO[+7['?[=\WC;P=?\
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MBV?BN+P!X^GU67QG;:)+IWC#P9J^DIJ.O:CK6DZC?:S;)JSZ3)I=E8_V'?\
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M$6J6OD:@MI<OYT<+V\OFO_!:;]FW_@M3\4_A#^U+\1?V:/V__A[\ /@?\+/
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MIWAWQ#H7B[P_H7BOPOJVGZ_X:\3Z/IGB'P[KNDW45[I>M:%K5E!J6DZMIM[
MSP7>GZE87-O>6=U"[Q7%O-'+&S(X)_Q&O^"G?AW]K/X>_MO_ +0'P>_;3^-G
MC+X_?'7X/>/=7\#Z]\1O&'C+Q-XR77=.@:+4] U;PW<>*;B6_P!'\+ZYH.H:
M7K>B:!';Z?!H]A?V]@NGVAMS"G^@%HFL_P#!1;_@L-^RG^SM^S-^P#X^U/\
M8@_8-\'_  $^$WPZ^.W[=_B72==L_B5^T+XH\,_#S0/#/C?X<_LN>"[.\\.>
M*[[X9>%-;L[_ $'Q9\1Y-?\  6D?$'6+'5]!\.^,7\-Z/JVG>- #^BGXJ?\
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M\;;6.UU93AE('^7)^R!_P1T_9>_X*$?\%_OVQ?V>?A9HFJ^'O^">/[*GQ/\
MB!K_ (UTKPMXAUJ:"_TCPAXDM?!&G?"/PWXWNKV]UJSTOQI\2XO$"Z;JMOJ<
MVJ_\*T\-^(I?#VMV^I6^EZQ#_I>_L^?L\_!?]E/X/^#?@#^SS\/M$^%GP>^'
MT&K6_@[P)X>:_DTK1$U[7]5\4ZV\,VJ7FH:E<W&K>(]<U?6M0N[Z]NKJ[U'4
M;JYFF>24F@#V:BBB@#^13_@]( /_  2H^#A(Y'[=OPG(]C_PHW]I09_(D?C7
MQ3_P8Y_\DR_X*+?]CW^S7_ZC_P 9J^U_^#T?_E%/\'?^S[/A/_ZH[]I2OY>?
M^#?_ /;O_:D_9W^"'[8'[*?_  3U^#6O?&G]O_\ :^\;_!ZQ^#H@T:UO/!7P
M:\">"?#_ ,1[3X@_'#QWJ>NM;>#[&'PO<>+O#NF^&X_&-_8^$H]<U2/5_$\U
M[IVDQ^%_%0!_IN?'S]LK]D?]E<:</VEOVG/@)\!)]9A-QHMC\7?BSX&^'^J:
MU KM&\VBZ3XFUS3=2U>)'1UDDTZTN5C*/O*[&QT7P._:>_9N_:;T6[\1_LY?
M'[X,?'G0M.:&/4]5^#WQ-\&?$BSTJ:<.8;?5IO".LZN-*NG\N0"UU#[-<!HY
M$:(,C ?YZ/Q*_P"#0'_@K%\<K?Q/\=OC/^V%^SI\1?VC_&TEQXH\5:?XY\=?
M&/Q1J^NZQ<0^>;#5OBCJ'P\NEFUA56/3HHTTB7P[921Q6=GJZZ1!#=K_ #->
M(= _;T_X(]_MAR:7?3?$G]D_]JKX.ZA;7EM>Z1J44#W^D7DBSVE[8:CI\VH>
M$_B3\-/%L%L8YH]_B+P3XKL$N]+U.VOHXKZQC /]P6BOQ9_X(6_\%9] _P""
MM?['=M\3M8L-(\+?M#?"?5+'X>_M&>!M&+II5IXLDT\WNA>//#%K/-/>6O@K
MXD:;!=ZGHUK=RS2Z/K>F>*O"HO-53PXNL:C]U_MV_MI?!_\ X)\?LK_%C]K#
MXX7LZ>"_AAH:W-KH6G20+X@\<^+=4N(M+\(> O"\5PRQS:]XLU^ZL]+MI)?]
M#TNVDN]<U62VT;2]1N[< ^G?%'BKPOX(T#5/%?C3Q)H'A#PMH=JU[K7B7Q1K
M&G:!H&CV:%5>[U36=6N+33M/M49E5KB[N88E+*"X)%? DW_!7_\ X)40>(/^
M$8E_X*.?L3+J_G_960?M+_")M/2Y#!#!)K:>+&T2*59#Y;I)J*LDH,3 2*RC
M^93]@7]AWX^?\'',]Q_P4;_X*U?$#QW;?L<ZAXQ\16?[(_["?PT\6>(O OPQ
MO-%\.:M>^']4\8:]>:/<:?K<NC6NHVNJ>%XO$]C=:?\ $SQ[KFEZMJEQXJ\-
M>"M*\/>'-9_2?]KO_@U._P""4/Q]^$.M^%/@?\'Y_P!D_P"+=OI-PG@/XL_#
MKQ9\0/$5OINL10L=.C\:>!_&GC'7- \9^'IKI8AK,:KHWBN:T\U-*\6Z3.YF
M(!_1UX1\8^$?'_AS2O&'@/Q3X<\;>$M=MA>Z'XI\(ZYIGB3PYK-FS,BW>E:W
MHUU>Z9J-L71U$]G=31%E90^5('1U_CE?L7?M^?MS?\$ ?VZ_'GPNN=6U>[\.
M_"WXN:K\/?VG?V:;GQ!<W?PQ^)UCX=U<Z1K>J>'XKA9-/TCQ3<Z5 FL?#CXH
M:580:BEO-I1U!-7\)ZCJ_AS5/]=[X$_&KX>_M'_!?X6?'WX3ZROB#X;?&/P%
MX7^(W@K5@$CFN?#WBS2+76-/2^MTEF^PZK:170LM7TR20W&EZI;WFG702YM9
M44 ]7HHHH *\B^,G[0'P'_9U\-1^,OV@/C5\)O@=X1FFDMX/$_Q>^(GA'X;Z
M!<7,:H[VMMJ_C'5]'L+BZ59(S]F@GDG/F1@1DN@/F'[<O[57A;]A_P#9"_:&
M_:Q\86#:OHWP,^&7B#QK#H*W"V;^)_$4$2:?X.\)I>.&6RD\6>+[_0_#D=XR
M2"T?5%N#%+Y?EM_'1_P09_8F\ _\%R[W]H7_ (*N_P#!5/4[C]K+Q]#\=]?^
M"OPK^"7B?5M9M_@Q\*=,\.>%/!7CN]%CX%T_5(;)]!AM_B)IN@^#_ ]])/X<
ML++3-5\2^(['Q5XI\11:YI@!_7_\'O\ @H;^P5^T'KD?A?X&_MI?LL?%KQ5-
M*(8?"GP_^/?PP\4^*IG:0Q1^3X:TGQ/<ZY,DTBE8)8[!HK@C]P\@YKZ!MOBU
M\+[SXI:I\$+3X@>$+KXQ:)X)TWXDZS\,;?7]-F\<Z3X UG6+SP]I'C'4O#4=
MPVJV7AW4]<T^^TJPU6YMH[2[OK2XMX)7>)P/Q:_:Z_X-L_\ @DQ^U-\,]=\(
M:#^S#X%_9I\>2Z;<1^#/BY^SOH\?P[UWPCK@A<6&I7OA;19K+P5XVTY)R@U3
M1O%.B7C7UD9X].U/1-4:TUFR_GZ_X-9_V;_C)^R#_P %<O\ @IU^S)\?;N[U
M+XH_!;X,Z#X*UG6;F\OK^'Q%I%I\1_#-WX-\5:/<ZG))?MX;\6>#+S0/$OAE
M+OR[B+0-6TZ*>WMID>WB /[U;OQ#H%A.]K?:YH]G<Q[3);7>IV5O/&'19$+P
MS3I(N]&5UW*-R,K#(()CB\3^&IY8X(/$.AS332)%##%JUA)+++(P2...-+@N
M\CN0J(H+,Q"J"2!7Y<_MR_\ !$K_ ()P?\%!)?B;XJ^/'[/'AEOC7\3-#M--
MO/V@_"L^J>'/BYH^J:'X:L/"OA'Q#:ZYINH6]IJUSX5TK1]%M;#2?$=AJ_A^
M]LM+M]-U72[VQ:6%_P#)S_X)X>&KKP9_P5<_89\'WTT=Q>^%/^"A?[,OAJ\G
MA5EBGNM"_:0\$Z7<31*Q++')-:NZ*Q+!6 ))% '^W=6"_BKPQ&[1R>(]!1T9
MD='UC3U='4E65E:X!5E((92 0001D5O5_')_P<3_ /!#/_@GMH__  3W_:@_
M;%^!_P !M ^"?[1WPB33_BT?&/@/4_$6FZ5XWAU3Q_H=M\0-(\9>$9M8NO"V
MH'6=)U[6-6L]7M-'L->L?$=IILD>J'29=5TO40#^P>RUS1-2F-OIVL:5?SK&
MTK066H6EU,L2LJM(8X)I'$:LZ*SE=H9E!.6&=2O\N#_@S%_Y2P_$K_LR3XN_
M^K;_ &?Z_P!1^@#_ "%_^#IP ?\ !<W]LP@<G3?V:R?<_P##*GP2&?R 'X5_
MJ1?\$\F5/^"?O[#;NRHB?L<_LS,[L0JJJ_!3P269F) 55 )))  !).*_RWO^
M#IW_ )3F_ME_]@S]FO\ ]94^"=?NG)=?\%9?^"]/[+W[//[)/_!/^,_LP_\
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MQX(UKP?X]>]_X2S4?!>O/I-_9V%]KEY<^)?!_B>PTR&Y\4:Z/%.FIHO[Z_\
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MTETMM/?QA-\0_B[-\2!=-$R?VW'XYE\>/K4.J"X8WJQPS1Z0LH6V&D_V8BV
M_P X/XWZ]^TO_P $!/\ @K#^T#\.?V2_C9XP\-:K\!/B?:Z?HUWJ$[2Z1\4/
MA-X@TO1/B)X&\,_&+PG;&R\/>-M/U/P1XHT*+Q#:S6%M;#5S/KOAG_A']1BT
MJ\L #_93K^5'_@X[_P""]/@G]@7X/>+_ -DO]FCQO8ZY^W'\5?#MSH5]?>&M
M0MKS_AF/P;KUHL5]XT\37-M)(-.^*&K:/=2K\-/"[-'J>E27,'Q"UN.UTNQ\
M.Z?XP_93]C+]I'PW_P %7O\ @FM\,OCUH>I>//@S9_M2_!WQ+H7B*_\ A;XM
MNO"_Q"^%OC2UOO$7PQ^)"_#CQU%;2:AH^K^$?'7A_P 21>"_%JV27Z1V6EZV
M+6&X<1)_"/\ \'+7_!$3]CS_ ()E?L_?!?X\?L_^)/C[XG^(_P 9/V@]3\(>
M.]7^,_Q*T[Q^VJ6=YX(\5^,+W5&FA\(Z!J,VOWVMZ;#<7NJW^H7LMT);DS(\
MTQF !^LG_!D_KFDZ?^QK^V,NJZQIUC//^T]H<RC4-0MK:68'X5^&PTH%S,CR
M OD,XR"V<G.:_M>L-6TK5/-_LS4]/U'R-GG_ &"]MKOR?-W^7YOV>63R_,\N
M39OQOV/MSM;'^9#_ ,&W7_!#+]BC_@JS^SM^T)\4?VH+_P"-5IXF^&/QITOP
M#X;3X8>.]%\)Z8^A7G@;1_$4S:E:ZIX-\2RW5]_:%].$N([FWC6W"1F LID;
M^X__ ()C?\$:_P!D/_@DO+\:YOV5[WXNWC_'N/X=1>.?^%I^--(\7"-?A@WC
ME_#7]A#2O"?AC^SRY^(6O?VD9S>_:@MAY7V;[/)YX!^K]%%% 'DGQU^/'P>_
M9E^%'C3XX_'OXA^&OA;\*?A]I$^M>+/&GBN_2PTO3K2+"PV\*@27>J:OJ5RT
M6GZ'H.DVU]K>O:M<VFD:+I]]J=Y;6LO^53^WK_P5W\4_\%:?^"P7[)GQ%LH-
M6\(?LU_"#]I/X,>#?V<OA_K<D,-]I7A>Z^+_ (*N/$GQ!\60P3365OXW^)%Y
MIFGZGKL-M//;:%H>E>&/"B7NJ'PY)K>J?Z%7_!2#_@B5^RQ_P5-\:>%/%G[4
M'Q/_ &J5TCP3H5IH_AKX7_#OXSP^&?A%IFH6]UJ]Q<>,K?P!J?A+Q'I,7CK5
MH-7;2M7\4Q&/4+[1M-TC379;:P16_P FJ_\ V?/ 5M_P4@O?V5(Y->_X5?!^
MVY<?L^1S-J,!\3_\(%%\=W^'"R-JWV$6IU[_ (1Y0QU'^S! =0_TG["(_P#1
MZ /]OS_A+/"O_0S>'_\ P<Z=_P#)-=!7\I/_ !!P_P#!(O\ Z#7[7'_AY_"7
M_P ZFOZA?'/C?P9\)O 'BWXC?$#Q%IOA'X??#CPEK?C'QGXJUN?[/I7AOPEX
M3TFYUC7M=U2X"L8K+2M)L+J]NY%1F$4#E$9L*0#L&945G=@JJ"S,Q"JJJ,EF
M)P   222  ,FO@_Q_P#\%2O^":OPL\17'A'XB?M^?L=>#_%5E<-:ZCX<UO\
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MO!5Q/%I6G?&3P9I!D8Z<DFJ26^C_ !!\.V?FZ?X8\27^DW=@UGHOBW0])T\
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M4=:T[3_"=OX5EL$U1/$=SX@O;B#2K71#ILB7YU2XNHK-;-A</,L7S5_B+_\
M!23P_P#M7> ?VT_C[\)?VT?C#XO^.?Q\^$/Q UWP#XJ^(7B[QOXE\>'78=,N
MC<:5J?AW5?%4SZG9^%-9TF[L=:\/Z0UKIB:9IFH6UF=*TZ2%[2'^USXW?L]_
MM^_\''?P(TSP+^RS\7_"O[.W_!.3]E_P!X(^%_P[U/QW_P )7;:;^W%^TK\.
M?">BZ7X[\37,?ABUN;I_@Q\._%=C=>#O"GBFZM==T.+7-.N_$6C:#XFUZ;5+
M3P  ?V)_ K]M_P#8T_:@U_7O"G[-_P"U;^SM\>/%'AB"2\\0>'/A%\9/A_\
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MSTWP[IO[0OPN_MG6+N1@D=KHFGW/B:"YUNX=B D.DQWDC=0I'-?A_P#L1_\
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M>JS27%I\)_$VL3V?AKQ#X3N;N/0O"=WJ5EXST)M%@LO%5EXF_P!/6@ HHHH
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M[@N]T@ED94W,%W, NX@9R16D2%!9B H!))(   R22>  .23P!7Y+_P#!-?\
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M_P 2[;5/!#W\MP?#^@^+/#_A3Q+H&O\ A?31;:7JOB#4/#VMK%!J%C=G4O\
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M;7NEZD+:TC\1>%]4T#Q/:VEM9:W;0H ?=%>!>+_VJOV9_ 'Q<\$? #QK\?\
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MCO+"_L[B(M%<6MW:S17%O-&S1RPR)(A*L#6A7B_[-_\ R;O\!?\ LB_PM_\
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M?M*_!Z^UJ]U=IC;#1K"UMO%\AO\ 6A<*T#Z/9F?4DF5HWM5=2!]T @@$$$$
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M_&S_ &9_VK/VH?\ @@=_P5 ^('@WPSX_UZ]\._ G]H;Q#\(OV@OA_97E[;>
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M_8YO+I=:^ G[%%AX<U;XD?$:S\.AS/H'B[XX>#K;Q1\/?#R?$;5K"2WO'O\
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MX.U4,VE^+/ GB;1?%_AG4E4*6:PU[P_>ZAI=X%#H6-O=2 !E)X89_'/XU?\
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MKP_J.L>'[FWUG3[+4H[>XN=.GBNXXS"ZL?Y[O^"B'_!L+_P3L_:F^$GB>?\
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M],>#3DL-)U"TMO[+T]XWM(O[X?$6N_\ !3'_ (+M?"'P!^S[^P/XYNOV(?\
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M5WXF\/\ ASQ#=Z-?:9J=QI,.DZ9XA\1'2;;4;6+6]0T'3]'U%+_2;Z_TJ_\
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M3K'P[JYTC6]4\/Q7"R:?I'BFYTJ!-8^''Q0TJP@U%+>;2CJ":OX3U'5_#FJ
M'^QK17E'P)^-7P]_:/\ @O\ "SX^_"?65\0?#;XQ^ O"_P 1O!6K )'-<^'O
M%FD6NL:>E];I+-]AU6TBNA9:OIDDAN-+U2WO-.N@ES:RHOJ] !1110 4444
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M!.NZ/=2*PCO=$N_V:_@_;64ELS >9#9/9W&D.P&U;K3;B($^7D_Z)7_!N/\
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MGRWVF72RV&IVL<NGZA;W-C<W%O+_ +4U?XR/_!OU_P IF?\ @GS_ -ETM_\
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M#T&[TRTTKQ-XF\,_B/\ \$X/^"87[4__  78T3PC_P %%_\ @M;\>?B5X\^
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M]_P3M_[-@^'G_I%+7ZOU^4'_  0L_P"4/W_!.W_LV#X>?^D4M?J_0!_G2_\
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MP;K-CXC\(>-/#VB^+/"OB'2YA<:9KWAOQ%IMMK&AZSITX $]CJFEWEK?6DP
M$EO/&^!NQ7^4#_P=J_\ *:;XS_\ 9)/V?_\ U6>D4 ?Z1'_!('_E%+_P3:_[
M,8_98_\ 5*>"Z_1>OSH_X) _\HI?^";7_9C'[+'_ *I3P77Z+T ?XJO[-_\
MRFU^ O\ VE.^%O\ ZUKH5?[55?XJO[-__*;7X"_]I3OA;_ZUKH5?[55 '^15
M_P %V?C=K/[>W_!>;XK_  ]UK6+U_!G@;X^^!/V)_!%BEQN7PQX?\ ^+K'X>
M>,8=.:0&.)]1^*&H_$/Q5(S)B.\UMXB7B@C-?ZX.B:+I/AK1=(\.Z!IUII&A
M:!I=AHNBZ380I;V.EZ3I5I%8Z;IUE;Q@)!:65G!#;6T* )%#$B* %%?XH/\
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M [KC0O&7C?0]7@C.%EELDB<A7)'\XO\ P9&?\F=?MG?]G+^&/_56Z+7ZP_\
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M<:JBJ %  K_*<_X.>_\ E.?^W5_V$/V?/_64?@37^K5^Q#_R9=^R'_V:_P#
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MG_@F)_P14CL)_''C7XB1?!B^_:DBBT_5-2\5>,;F]?2]=M?@L^IP7WAWPO\
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M6]O;_!KXR0P00QI%###%XR\%QQ0Q11A4CBC152.-%5$10J@  5_0G_P:9?\
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M/V7->E20:-J7[&6C:182$'RGU/1/C?\ &6\U9$/W3)':Z_HK2@<A9(2W#+D
M_;;_ ()__M(_\'!'PL_89_9 \ ? '_@D-^S7XN^"OAO]FSX+VOPP\::C^U]\
M,O#NJ^.O!EQ\/]!O]$\>ZSH4_P 0[&XTC7/'-I=IXLUS3[BRM+BUU;6+R&XM
MH)E>)?KS_AM'_@YF_P"D,_[,'_B:_P +?_GFU];?\&]G[2.@?M-?\$?OV)?$
M>D:C;W>K?"SX2Z-^SGXRL$F26\T+Q)\ 88_AI;66J*A)AN]5\):%X7\66R2$
MRRZ1XDTR[D^:Y(K]H: /\O?_ (*%_P#!!_\ X+O_ /!03]L;XU?MA>(_V"OA
MU\+M>^-6H^$]5U;P/X4_:@_9YU70='OO#/P_\)^!9Y[+4-4^*L5_</K;^%SK
M]Z;A 8[_ %2ZB0M%&C-_;M_P0._9I_:E_8[_ ."87P,_9G_:_P#"4?@KXM_"
M?7?BKI4.@Q^+O"/CA;;P7K_Q+\3^,_"@7Q#X)USQ#HEQ%'9^)9;6VM1J<ESI
MUI;06,D4$4$$2_LE7'>"?B'X"^)>F:EK?P[\:>%O'6CZ/XH\5>"-6U3PCKVE
M^(K#3/&/@;7[_P *^,_"NH7>DW5W!9^(?"OB32]1T+Q!H]P\=_I.JV5S8WT$
M-Q"Z  [&BBB@#\H?^"Y/[-WQ _:V_P""3G[;/P)^%6F7NN?$3Q)\+=/\4^$O
M#NEQRS:MXHU;X3^.O"/Q>B\)Z/;0@R7FL>*H_ DOA[2;%?\ C^U'4[6T) F)
MK_,^_P"")_\ P7%^-7_!'3XE>,-)7P:/B]^S;\5=5TNY^+_P8OM2?P_KFG:_
MHT<FFV_C[X=:W/;W=OH'C?3]/=M.U?3=3L)]%\9:5:66C:S_ &;>Z;H'B+P]
M_L/U_+W_ ,%;O^#7C]DC_@H;KGBKXZ_ G5[?]DS]JCQ#+>ZSX@\0^']"35/@
M_P#%?Q!<;[B?4?B/\/[.:PET?Q+K%V,ZGX^\$75A?W5S>7^O>*?#7CG6)5>@
M#]-O^"?/_!9O_@GQ_P %+M*L8OV;_CAI4/Q.DL?MNK? 'XE"V\!_&_1#%";B
M]1/!NH7L\'B^STV+:VH:_P##K5O&?AFS\R..XUJ*=C"OT%X9_8E^&GA']O'X
MG_M^:%J>KV7Q)^+W[.W@;]GOQQX7CM]/7PWJMKX \8ZCXFT;QU+<"$:J_BA]
M+N=,\(W*/<MIQT/P]I'E01W,<TDW^0/^WG_P2O\ V_/^"4OQ$TE?VB?AGK_@
MW34U^)OAM^T#\-M3OM<^%?B?6-.E>]TZ[\&_$K2(;&;0_$D1LWU.S\.^);;P
MGX]LH+8:G)X>M;<0W+?UH_\ !MA_P<:_&7XH?&'P%_P3P_;X\:WGQ,O/B$?^
M$;_9Q_:(\3W'VCQX/&-O:23:9\*OBMK<I$OC2/Q7%:RV7@KQQJC3^,?^$LDM
M/#GB*^\2P^(]-OO#(!_?G7^*3^Q[_P II?V6O^TH7P1_]:N\,5_M;5_BD_L>
M_P#*:7]EK_M*%\$?_6KO#% '^UM7XZ?\' W_ "AF_P""@O\ V0R;_P!2WPO7
M[%U^.G_!P-_RAF_X*"_]D,F_]2WPO0!_#7_P9B_\I8?B5_V9)\7?_5M_L_U_
MJ/U_EP?\&8O_ "EA^)7_ &9)\7?_ %;?[/\ 7^H_0!_D,?\ !T[_ ,IS?VR_
M^P9^S7_ZRI\$Z_U%O^";^FZ=I'_!//\ 84T_2;"RTNP@_8]_9K:&QTZU@LK.
M%KCX-^#;FX:*VMHXH8VGN9IKB8H@,L\LDKEI'9C_ )=/_!T[_P IS?VR_P#L
M&?LU_P#K*GP3K_4C_P""=_\ RC__ &&/^S._V9?_ %2O@F@#[$K_ "-_^#HK
M]AGP;^Q-_P %3/&D_P +]"M/#7PN_:>\"Z'^TGX;\.Z5:_9=$\,^)/%6N>)?
M#'Q+T#2XE"P6T$_CSPCK/C.#2K-(K#1--\9Z;I.GV]MI]I:P1_ZY%?YO_P#P
M>\7>FO\ M6_L16,6S^V+?]GOQ]=WV'4R?V;>?$@0Z5OC'SJGVJPUGRW;Y9&\
MQ4YC>@#^G3_@UX^.&M_&W_@B_P#LO?\ "27TVI:W\(K[XF? ^6]GD:21M$\
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M5)]/T/5OC-X2^$GQ(@29UM-2^%_QDU:T^'/C:'4;92(K^+2-,\0_\)5IMM<
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M &BA\4='MX5D*JXOM$M[)(%<^5+%.@;,;'(!_?G_ ,-H_P#!S-_TAG_9@_\
M$U_A;_\ /-K.UC]KS_@Y8UW2=4T/5/\ @C!^R[=:;K.G7NE:C;2?MK?"MDN+
M'4;:6TNX'5OB85*2V\TD; @@AB"".*_I(\)^*O#OCKPMX:\;^#]8L?$/A+QC
MX?T;Q5X7U_3)A<:;KGAWQ#IUMJ^B:QI]PORSV.IZ9>6M[:3+Q+;SQN.&KH*
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MUKP/XKM+*_B_<W+:)XM\.:YH-Y)"SPB^TRY2*21%#M_/C_P=H?\ *%7XX_\
M95/V??\ U:V@4 ?SV_\ !C__ ,G$?MY_]D7^$'_J<>**_P!&2O\ .;_X,?\
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MK7&BREKX@TO1_%/A^^U"PW-):)JEM'/LG\R)/Y"O^#V?_DP#]E3_ +/#L_\
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MAAN8),;X9XHYHRLD:L/]J*O\67_@A;_RF!_X)V_]G0?#K_TNDK_::H _%_\
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MX^#OPGN)6+2S_#3P)-(Q)):27PMI3NQ)R22S$DDDG/-?X^'_  <._P#*:/\
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M\&7XF\/>&_B1J^MZS%'>:[874=KI^F7MS%=VUM?0Q"6T26/_ $?JX[Q1\0_
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MWQS0!_H(_P#!$6:2?_@D3_P3H>1BS+^R7\'X022<1V_A>TMXEY[+%$B@=
M,  5^G6K:5IFO:7J6AZWI]EJ^C:SI]YI6KZ5J5M#>Z=J>F:C;26=_I]_9W"2
M6]W97MI-+;75M/&\,\$LD4J,CLI_,#_@A_\ \HAO^"=/_9J'PE_]1VWK]3Z
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M$7B?2K"V@^,?P^TWS6>1VUCPY8Z5\1M'TNU$%G9CPM\1M5E#WFKL7 /Z /\
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M>/=9T*?XAV-QI&N>.;2[3Q9KFGW%E:7%KJVL7D-Q;03*\2_B3_P>R:1J</\
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M$\6FV_9\UGP9X*N]7&DZ%?\ CS2?"S^(5N+NVFT+3O%D_AZ?48]8_ C]A_\
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M/Q)%:6VK>+?%NN>(?V9[_4/$?B :?8P:3I3Q0:3I.BZ8U['IVDQ7FK:U?:D
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M\*:9I%X^J>'?"7B34+O2/#=MJ/@K0KNZNI;SX8>$O"NF^']>UDW6J>,/&OQ
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MI'V67Q%X.\4&+PA<65T=/U*]OYH&B4 _T;71)$>.1%DCD5DDC=0Z.C@JR.K
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M@SX=_#/Q%J5C<^=97<4IM_'/CCX?3(#\B3,-A_N'_P""<O\ P2$^#7_!._\
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M?]E3X+V20Z+97_Q1_:C^$GB[P-X#TE"(S:>#]*\(>)_C5X]\-Z7:1[I;:Q\
M>&[+3_-9FMS'+-+)0!^D/_![-\7OA@G[)?[*GP'_ .$Z\./\9+O]HZ#XK)\-
MH=1AG\60?#C2/AA\3/"=WXSO]*@,DVF:#)XD\0Z9HVG7NH_94UB^.H1:0+[^
MQM9-AP?_  8^>,]$N/@W^WW\/!J-J/$>D_$SX)^,Y-):9%O6T3Q#X6\;Z'#J
M,5NQ$DUJE_X8GMKB:)72WFDMDG,;75N)>"_X*9_\&POQXM_V,OAC;?L]OX\_
MX*"?\%&/BE^TYX7\8?M3_M/_ !7^(?A[1/$=SX&MOAG\0M%;3-$U/XN>/+>7
M2/ASH_B74_#9OX)/$7B/QGXFO;?3]7UAY-,T3P_H7A?TC_@F%_P:'_$KX&ZU
M9?%K]K7]MSXD_#CQ1J.E-IVL_"G]A[QSXI^'-Y>Z)>/;WEUX7\:_'N6/2-;U
M31KV2&WM_$7AGPOX*L+=Y;8R:5XXN-MM>H ?W2U_E4_\'AUS!/\ \%?FBBD5
MY++]EOX)VURJD$PSOJ?C^\6-P"2K&VN[>4 X.R5&Q@@G_1U\?_"K]H+]G+]F
M?X;?!S_@FKX)_9^O=9^'U]I7A;2M!_:^^+?QWB\'Z3\,X-(\23WU\/'?AGPU
M\8OB?XM\:IXH?PVL%KXEECM;[1[SQ!<W7B6UO+#2[&]_B9_;C_X->_\ @MQ_
MP4&_:>^)O[6'[0'[17_!.>X^(_Q-OM.>YTWPS\1?VDM*\)^%M!T'2;+0/#/A
M+PGI=W^S%J5W8Z!X>T/3K.PM1?:CJ.J7TJ7&JZSJ6I:Q?W]_<@'];7_!!RXA
MNO\ @CM_P3QD@D65%_9N\'V[,A! FM)M0M+F,D?Q0W$,L3CJKHRG!!K](/C7
M>6VG?!KXMZA>2I!:6/PR\>WEU/(RJD-M;>%=5GGE=F(54CB1G9F(4 $D@#-?
MSS_\$A_V+/\ @NK_ ,$XOA1\)OV3?B9XL_X)I_&W]ESP+XZMVBU>#XG?M.VO
MQO\ A]\,/$WC Z_X_P!#\$3O^SUHWA#QC<Z;'JGB/6? >B>+O[%2'6;Y-#U#
MQA9^&$TZ'0_K+_@J!\(?^"T'[2?@SXZ_L[?L6:M_P3U^%GP+^+G@B;X>1_%G
MXP?$/]HJ/]H2#PMXO\'6ND?$BUL_#?A#X(^*/AWX2U6[O[[Q)H>@Z_;ZYXLN
M[?PU-9ZQ;VVA^*9(I=& /\T?_@WVFB@_X+-?\$^GF=8T;XXI"&8@ RW/@_Q3
M;P)D_P 4DTL<:CJ68 9) K_9KK_-6^"'_!H?_P %DOV=?C#\,?CQ\(_VF_V
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M'QMHVN:(]R-2T.[6/_0G_P""._\ P=#_ +)7[7WPQ\(_"_\ ;=^)?@?]E_\
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M?$'C7X.:+X[\'V$OB,1P79\(^&?'%Q;Z(7NH1<WRK9L ?S5?\'LTB#_@G_\
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MEC807>IZQK6M:M>V&B>']"TFSO=7UW7-1T_2-*L[O4+VWMY/P&_9?_X.P?\
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MB35[[7_V;=>\0>*/%>IVFE:992ZEJ.I1Z;IUI:20^'=$T--2U@:C\G_L+?\
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M3]LW5M=LO%]KH,MO>7/P+\%>)=.6!='OI;;7=-TB[^(C>%(K6SMO ^AS>$_
MWPX\%V5M;6.F_#^^.EZ'J&F &;_P:?\ _!+3Q;^Q#^R)XL_:<^.'AJ[\,?'?
M]L@>%];TSPMK-H]KKW@#X#^&H;^[^'^FZM:7"BXTCQ!X\OM<U/QQKFF-Y<\.
MB2>!+'5[:RUW2-1L;7RO_@\6_8%\4_M#?L;?"O\ ;#^&VA7.N>*/V-=?\4+\
M2+#3;=Y[^3X%?$^/0H?$7B=XH$DN;V#X>>+?#'A?4KJ-8_)TCPQX@\9>([N:
MWL-*O'/]B=9VKZ1I/B#2=4T'7M,T_6]#UO3KW2-:T;5[*VU+2M7TG4K:6RU'
M3-3TZ\BFL[_3[^SFFM+VRNH9;:ZMI98)XI(I&4@'^15_P0)_X+C>*/\ @D9\
M8?$/A7XB:3KWQ!_8\^->IZ9<_%GP3H3PS^)O WBFQA33M/\ BY\.[*_N;33[
MK7;72UCTCQ9X=FO--A\9:!::7%+J$&I^&_#\D/\ IW_ /_@J5_P3J_:;\$6'
MC_X,?MG?L[^)M$O;*.^GT_4OB?X7\'>,="CDC$OD>+/ /C34/#_C;PE>1J<R
M6GB/0-,G &]4>(J[?Q]?\%3O^#.KQ#X@\=^)_C-_P2]\8^#=*\.^([Z\UK4O
MV5_BKK-[X?@\+WMU(\T]C\'OB.]KJEA<:#-/*!IWA#X@_P!BCP];1S+#X\U.
MV>QTFQ_!#0O^#6K_ (+AZQXFC\/7?['>G^'+4W(AN?%.N_M!?LVGPS9P%]@O
MI)M$^+6M:O=VP!$AATK1M1U$(>;$.K(H!_<1_P %:?\ @XE_9H_9H^'6K_ ;
M]A?XD^$OVM?V]_BY)#\,O@SX-^!^HZ?\4O#7@'QOXRGC\/:-XF\7^(_#4NJ>
M&+_7M'U*_B'ASX::9J&K>*-?\5#2M+UG2-)T*XO]6M_U>_X)7_L@ZM^PI^P+
M^SC^S7XKU-M=^)'A+P?>>)OC%X@DOVUB;7/C5\3O$.L?$SXM7S:Y(S7&NV\7
MCWQ;KVFZ7K%T[7-]HUAILL@3B-/Q$_X(9?\ !LKX$_X)N>,=)_:G_:I\6^%/
MCK^UOIEG<)X"TOPI:W\WPB^!4VI6DEEJ.K>&;O7[#3-9\<>/Y[&>YL(/&&J:
M)X>L/#MI>WMMH6@2:CY/B9OZP* "BBB@#\5O^#B7Q3XD\$?\$9_VW?%O@_7=
M5\,^)_#_ (6^%>IZ'K^AWUQINK:5J%M\??A0T-W8WUK)%/;S(<C<C@.C/&X:
M-V4_7O\ P34_;@\ ?\%$OV*_@7^U5X#U+39[CQYX/TVV^(_A^PF5YO 7Q>T2
MSMK#XE^!=1MBWVFSET+Q.EX=*-Y%!)J_AF[T'Q':1MIFM6$\WFG_  63_96^
M+/[;G_!-+]J3]EGX&6N@WGQ5^+WA[P-H_A&#Q/K47AW0#<Z-\6/ /BO4I=3U
MF6&Y6RM[?1= U*XW+;SRS21);P0R331HW\HO[)?_  1&_P"#AG_@C+XTU+X@
M_L!_&O\ 9;_:)\'^+TT^7XD_ #5_&/B+1/!WQ O-.B'E/KGA#XDZ7X"T*PU.
MR#-9Z/XW\)?%#PUXP^QF:PNKFUT>YN=-N@#^Z;XQ?!OX6?M!?#/QE\&OC7X"
M\,_$WX7?$'1;GP_XP\$>+M,@U;0];TNZ S'/;S+N@N[698KW3-3LY+;4](U*
MWM-4TJ\L]1M+6ZB_R"_AS^R!J'P6_P"#A#P!^QW\!]0U;7XO@[_P4[\)>"_A
M_K45P+K7--\&?#7X]Z=K,.NZQ>6X16U/P3X*T.?5/%5[$D:PW.A:K<K#$(_)
M7^ZOQ/\ M>_\'1OQ9\)WOPT\ ?\ !*']F_\ 9B\?ZS9RZ+=?M">._P!J?X2_
M$3P?X+GNX3;R>)M \ :)\0M8U*[OK%F>\TD7-K\1-*MKF.#^UM URV62SN?4
M_P#@B]_P;]>$_P#@G%XY\6?M<_M*?$V']I_]OOXFMXEO/$GQ2,>IR^#_ (=W
M/CF[O+_QZ_@*?Q!%!XB\2^+O&]U?W@\7?%#Q-8Z3K>IZ;=7.BZ1H'ANQU/Q.
M?$P!_2#7^)GXOU9OV*_^"P>O^(_&UG>6T?[*_P#P4?O?%'B.U2"5[IM/^#7[
M2SZ[>O:1*OF7 N[#P\T]@\(9;N*:"6W9TEC9O]LROXI/^#@S_@V7^(_[;?QJ
MUS]MW]@R\\'Q_&CQO9::OQO^!?B[6;7P?IOQ%UW1-,MM&T[Q_P##[Q5?*GAS
M2/%^HZ58Z;I_BO0/%-UH.@ZU-8_\)3'XCM=>NM5M=; /[./!_B_PK\0/"GAO
MQUX&\0Z-XN\&>,="TKQ/X4\4^'M0MM6T'Q%X>URRAU+1]:T?4[*2:TU#3=2L
M+B"[LKNVEDAGMY4DC8JP-?S)_P#!R[_P4>^!'@']B/\ :;_81\%MJ7QJ_:?^
M*WPBNKSQ9\//AF8]<_X4#\*M+USPYJOB'XO?';5K-+RR^'WAZV@_L_3_  ]H
M^L-;Z_XKUO7] M;"S@TW4/[8A_F=_8S_ ."%?_!SIH4,7P&\-_%KXR_L*? 2
M]O)H=?DG_;?33/AOIUI>W#2:[/H_PY_9Z^*WCC5+_4;Z*2=F2S\/:5IVNSRK
M:ZEKUK:S7%W!_3IX^_X(0>#?V1_^",_[;?[*W[('A75_VA/VP_VDOA8EO\0O
MC#XMN_#VD?$[X^_$+_A)=%U=[236_%.N6NC^$/!]A(NK7GASPE=>*&L; RW.
MH:UK7B+Q7J.J>(-4 /Y*_P#@SM\9Z)X6_P""O<VBZMJ-K8WOQ%_96^-/@SPW
M;W,R12ZMK=GKGPY\?RZ=9*Y!GND\/^!M=U,PQ[G^R:;=2XV1.1_JHU_G$_\
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MO5+>6:/3+)H?&OA?0?!^J>)+TV]OH/A?Q7K6J:A=1Z?83%?ZE*_D*_X+]_\
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M*]M?:9'\4-0NO!&B;+F&X@\*_&;Q=:01+;Z+:@_ZL]?RZ?\ !K]_P2'^+?\
MP30_9]^.GCK]J;P%:^!?VGOCS\1(-'O= &N>&?%4WACX._#.*YM/!MI%K?A;
M5M=TA)O%WB76O%OBG4(;#4V-UHX\%KJMO!J6EFVM?ZBZ "O\N[_@[^_8%\4_
M 7]ONT_;1\/Z%<O\&OVQ= T!M4UVTMW_ ++\/?'7X=^&=.\)>)_#%\T2-#83
M^*?!V@^&?'.DR74L4WB'4;CQT]G#*/#VHRK_ *B-?-?[7'[(_P !/VY/@'XY
M_9L_:3\#67CWX6^/;)(KZQE<V>L:%K%H6FT3Q=X1UN)3>>'/%WAR\*WVBZU9
M$20RB6UNHKS2[R_L+L _@W_X-UO^#EKX>?LV_#'PC^P9_P %"O$>I:!\+O!:
M)HG[/?[1LEEJ.O6/@3PW+,S67PK^*MIIL%]K</A'1)Y6MO WC2PL]2@\+Z3+
M;^&?$%KIOA/1M/UC2?[I=-_;]_84UCP<GQ#TS]M']E&]\!O:"_\ ^$R@_:&^
M$C>&8[3R_-:>?6CXN&GVZ1QY:87%Q&T!5EF5&1@/\\+]M_\ X,YOV^OA#XQU
MK4_V*/$7@;]K3X3W5W<3>&=&UOQ;X7^$?QKT:R:1I(M-\46'CF^\/?#/6);*
M%X[5?$.@^.+)]<F@GO7\'^&DE@L!\D_ [_@T[_X+-?%?Q;8:)X[^!_@']G;P
MQ-=1Q:CX\^+'QJ^%^L:586P<?:I8- ^$/B?XG>,;^XCBW&UA7P_;6=W.8XGU
M*UB,MS  ?T_?\%"O^"EO@O\ X+5?M&_"'_@BO_P3E\4WOQ,^$OQ1\>:!XI_;
MV_::\(IJ%IX)TC]G/X;:_IGB;QUX,^'WB&2&W?6;;5#86=KJ7C* 6WA7Q#K]
MUX,^'WA[5_$%IXTUN6P_LCL[.TTZSM=/L+:"SL;&V@L[*SMHDAMK6TM8E@M[
M:WAC"QQ000HD442*J1QJJ* H K\@_P#@CU_P1I_9Z_X)"_!?5?"/P]OI_B7\
M;_B,NF77QL^/>NZ3;Z3K7C*YTM96TWPUX9T:*YU >#OAYH,]U>7&D>&X]3U.
M^N[Z[N-5U_6=6O#9#3_JK]LVZ_X*.1:1X5MO^">N@_L4ZCK=Y:>*4\<ZQ^V/
MXR^.7A_3M!O5&AKX+G\(:#\%O /BN?Q1#,9/$S^)8=<U_P *-9FUT%-,DU%;
M[438 '^5#_P<AR)+_P %M?V]VC8.H\?_  ^C)!R \/P/^%\,J\=TD1T8=F4@
M\BO];;]DK4['6OV5/V9=9TRXCN]-U;]GSX,:GI]W"P>&ZL;_ .''ANZM+B)U
M)#1SP2QR(P)#*P(.#7^?/^T!_P &D'_!9S]I_P"-GQ0_:%^-'[3W[ ?BOXI_
M&'QGK?COQQKS?$K]H.RAO-<UV[>YGBL-.M/V4H[/2])L(C%IVC:19116.DZ3
M:66FV445K:PQK_3%_P $L/V7O^"^?[#GP[^"'[,'QZ\>?\$U?C]^S1\,-0\)
M>$+;Q1!\1OVFK;]H#P-\%-.O[*ROO"_A&Z?X :#X)\:S^#O"D<]E\.-(\6PZ
M$\1MM.T'5O&46A6]D=+ /Z.:_P N[_@[^_8%\4_ 7]ONT_;1\/Z%<O\ !K]L
M70- ;5-=M+=_[+\/?'7X=^&=.\)>)_#%\T2-#83^*?!V@^&?'.DR74L4WB'4
M;CQT]G#*/#VHRK_J(U\U_M<?LC_ 3]N3X!^.?V;/VD_ UEX]^%OCVR2*^L97
M-GK&A:Q:%IM$\7>$=;B4WGASQ=X<O"M]HNM61$D,HEM;J*\TN\O["[ /X-_^
M#=;_ (.6OAY^S;\,?"/[!G_!0KQ'J6@?"[P6B:)^SW^T;)9:CKUCX$\-RS,U
ME\*_BK::;!?:W#X1T2>5K;P-XTL+/4H/"^DRV_AGQ!:Z;X3T;3]8TG^Z73?V
M_?V%-8\')\0],_;1_91O? ;V@O\ _A,H/VAOA(WAF.T\OS6GGUH^+AI]ND<>
M6F%Q<1M 599E1D8#_/"_;?\ ^#.;]OKX0^,=:U/]BCQ%X&_:T^$]U=W$WAG1
MM;\6^%_A'\:]&LFD:2+3?%%AXYOO#WPSUB6RA>.U7Q#H/CBR?7)H)[U_!_AI
M)8+ ?)/P._X-._\ @LU\5_%MAHGCOX'^ ?V=O#$UU'%J/CSXL?&KX7ZQI5A;
M!Q]JE@T#X0^)_B=XQO[B.+<;6%?#]M9W<YCB?4K6(RW, !_3]_P4*_X*6^"_
M^"U7[1OPA_X(K_\ !.7Q3>_$SX2_%'QYH'BG]O;]IKPBFH6G@G2/V<_AMK^F
M>)O'7@SX?>(9(;=]9MM4-A9VNI>,H!;>%?$.OW7@SX?>'M7\06GC36Y;#^R.
MSL[33K.UT^PMH+.QL;:"SLK.VB2&VM;2UB6"WMK>&,+'%!!"B111(JI'&JHH
M"@"OR#_X(]?\$:?V>O\ @D+\%]5\(_#V^G^)?QO^(RZ9=?&SX]Z[I-OI.M>,
MKG2UE;3?#7AG1HKG4!X.^'F@SW5Y<:1X;CU/4[Z[OKNXU77]9U:\-D-/_86@
M HHHH _B^_X/*?V!O$_QN_9;^#/[;WPXT*YUG6OV3M7\0^%?B[:Z9;/<7_\
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M:1\0]1\,:KX?L(HH+CQ?XLE?S80#^YKX4_MC?LG?'+P)9?$[X0?M)_ _XB>
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M%=>\/^"?%UK<*]M?:9'\4-0NO!&B;+F&X@\*_&;Q=:01+;Z+:@_ZL]?RZ?\
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M(/V9]0U'Q#XBO[;1-(TRVE6/3-*TG2[ 0Z7I%K=ZCKE]JT'_  21_P""*?\
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MADEAF\!Z#)%(C#(*NC*RD<$$$5_GB_'#_@T0_P""R/[1?QC^)_QY^+?[37[
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M)XF\7^']"UR]A\$>/-.M-;\':EXF\+Z;/JMMIUM;^)?#YLK_ %/290#^(/\
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MZQJ%JB7TWOG[%/\ P9Z_\%%_C-XWT6Y_;"NO W[(7PEMKVWG\4#_ (33P?\
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M8 9) K_9KK_-6^"'_!H?_P %DOV=?C#\,?CQ\(_VF_V _"_Q.^$'CCPU\0_
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M$]I<31/_ 'A_L;7?_!2V6+7K/_@H)X=_8=T][31=%7PKKW['WCGX\>('USQ
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M?Q>U;3%D626Q\&^'OAOK/B?P/9WU["KVYU3Q9XWT\:(T\=\?#_B![>729?\
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M_E6VH6ZF[T74XK>23^S?$/AS4%N] \2Z)<^7?Z%KVFZCI&H007ME/"G\I?\
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MW^L:WXGL7DB@NM<\,7"+)ITH!_E3_L]W5NO_  6J^!]ZTJ"U'_!4;X:71F+
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M9;:RUF>QO+S2/MNCOI^J7W]-?[#_ /P;/?MY?'"Y\'W7_!:O]N+XP_%?X"^
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M;\ /AW^VG_P4X_X):_L>?![3"?VP?B_I&H>$/B'XGL1%<6_A[X$>*?B!:1^
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MTTO[3=7?BO7M*\;>-?$5YX7-O_:*66J?#[4(+>X_MVS*?T8?\&]/_!,O5_\
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M /\ P94_\HLOCY_V?_\ %/\ ]9U_95K^OVOY O\ @RI_Y19?'S_L_P#^*?\
MZSK^RK7]?M '\ ?_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\ G*+_ -V3?^_<
M5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&GZYXJUGQ!K_ (X\26@N+2YUO3?#]\_ABW_=6@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !117XP_MX?\ !4?X\?L\GXN?#']FS_@F
M#_P4$_::^,GAJPN=*\">./"OP-B'[->L>(M0\/PWVE:Z/B3:^)-3\0:YX=T>
M^O[:/4[;1? \UQ>WFGZEHZW6G,O]H( ?Y<G_  2S=3_P6-_8'<,-K?\ !0O]
MGDJ>QW_'SPP%Q_O$@#U)%?[7-?XUG[/7_!,'_@LI^SI^T+\$/VC?"W_!-O\
M:UU;Q?\  OXR?#;XU>'['5?@CX^%AJGB+X:>-=&\<:99:I)!I8N/L.H:CHL-
MO?F(^:UO--M.XBO]2C]B?_@H=XQ_:UUNT\&>/O\ @GU^WK^Q_P"+H?!-SXIU
M_4_VCO@YI_ASX20:KI]UHUC>^%?#'Q-LO$]Q/XCU2YGU=[G04U#P?X8O=6TK
M2M5O[C2]+>U-JP!^E=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7+H&[UK7]3U'4[HF:Z? ![Q1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7P!_P5B_Y19?\%+/^S /VR/\ UG7XC5]_U\ ?\%8O^467
M_!2S_LP#]LC_ -9U^(U 'X _\&5/_*++X^?]G_\ Q3_]9U_95K^OVOY O^#*
MG_E%E\?/^S__ (I_^LZ_LJU_7[0!_ '_ ,&,?_.47_NR;_W[BO[_ "OX _\
M@QC_ .<HO_=DW_OW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7P!_P5B_Y19?\%+/^S /VR/_ %G7XC5]_P!? '_!
M6+_E%E_P4L_[, _;(_\ 6=?B-0!^ /\ P94_\HLOCY_V?_\ %/\ ]9U_95K^
MOVOY O\ @RI_Y19?'S_L_P#^*?\ ZSK^RK7]?M '\ ?_  8Q_P#.47_NR;_W
M[BO[_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 %%%% !1110 4444 %%%%
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MXDU'PU,T.KZLGB2R\1Q6SV.KV8B /]14$$ @@@@$$'((/(((X((Z&EK\F_\
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M\^X_>Q_N_G7/==>E?Y??_!US^R7^WYXT_P""J'B+XF7/PH^-7Q:^ /CKP/\
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M_!_A?PWXK\.ZKIOB#1VT;P1X6O;C2-6M6U32[.]:XM8O]>K_ ()W_P#*/_\
M88_[,[_9E_\ 5*^": /L2BBB@ HHHH **** "BBB@ HHHH ***JWU]9:997F
MI:E>6NGZ=I]K<7U_?WUQ%:65C96D3SW5Y>74[QP6UK;01R37%Q-(D4,2/)(Z
MHK, "U14<4L5Q%%/!+'-!-&DL,T3K)%+%(H>.6*1"R21R(P='0E64AE)!!K\
MCO\ @H_X5_X+1_$(ZYX0_P"":_Q"_8Q^!O@U?A]%?K\4?C"OCKQ/\=-7^(<D
M^M)=>%/"'A^7P#XJ^$7A'0XK"VTEHO%?BFQ\6WES?ZJ$ATW1XM.N+N0 _4#Q
MK\2?AU\-K?2;OXB^/O!7@&UU_5K;0-"N?&OBG0O"UOK6NWAQ9Z+I,VN7]A'J
M.K79XMM.LVFO)SQ%"YKM:_Q"]*^.O[37Q[_;_P#@AXD_:Q^*_P 4OBQ\7-&_
M:6^&7A[7M1^*_B[6O%6MZ!?Z9\5M#L]4\.V*:K>W=MH&G:9?VTUI%H6B166C
MV @6WLK.&"*-%_V]* "BBB@ HHHH **** "BBB@ HHHH ***_&[_ (*O?\%P
M/V./^"3'A.WMOBSJUY\2OC_XET<ZO\/?V;? %Y9GQUKMC)+-:VOB+Q;JERL^
ME_#CP-)>P2VX\2:_'<:AJ?V;45\(>'/%=WI6I6=J ?LC17^?K\$_VY/^#EO_
M (+S:QJWB']CFY\"_L"_LB1ZW?:5_P +4T^R7PWX= LI3%+H]I\6?$/ASQG\
M6_B7XOTU#/!J5U\'_#WA?PM:ZJD=KXDB\+22687]"M#_ .#;C_@H[K%I'KGQ
M._X.*OV\KGQW(CSF?PIJGQN.CZ->2MN:'3[O5?VJH;Z\LX^1']FLO#BA"D<5
MG;QQ!6 /[ **_D \3_LA_P#!S5_P3>T^?Q_^S#^WIX2_X*K?#3PPLFI:]\"_
MVDO"%Q9_%GQ+IEC%YTBZ%?\ B;Q-KWB[5;V.SCN4^P:#^T3I&LZG>&U73O#/
MB.^GCL8OQ?\ ^"F7_!V9\;OV@_V1_%O[)GP[_9F^)W[$_P"U%KFNZ?X4^.'C
MU/B?K6F^)/AG'X-\0VU[XF\.?#R"V\.>"O'WA;Q5XBU71H]"UX^(SIVH>$-!
MF\0>'5CUO4[Z'7M, /\ 2?HKCOAWXE7QG\/_  -XP1E=/%G@[PSXE1UQM===
MT6RU167'&UA= C'&",<5V- !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5;^_L
M=+L;S4]3O+33M-TZUN+[4-0O[B&TL;&RM(GGNKR\N[AXX+:UMH(WFN+B>1(H
M8D>21U12PM5_.+_P=-_!+]KKX\_\$J_$7A']D?1/&_C"^TKXR> /%GQS^'_P
MYM]2U+Q?XZ^!&BZ+XT36](L/#VC+-JWBJQTGQ]>?#KQ?K7A[3K2[N)=)\-W>
MJR0O9Z1=12@']!?@CXA> ?B;H:^)_AOXX\'_ !!\-M=W%@OB'P1XET7Q9H;7
MUIL%U9KJV@WM_8&[MC)&+BW%QYT.]/,1=RYZ^O\ /=_X,S_V:OVX/AC^T!^T
M]\4/'/@+XJ_"_P#9)U[X,Q>$K^Q^(&@>(O"&@>/OCM;^.O"=_P"#=3\*Z+XA
MM=._MW4O!/@NT^)%AKOB'2X+F#1(?%%EHVH2BXUBT6#_ $(J "BBB@ HHHH
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MA:?B)X%_X6:;#^U1\.O^$NT#_A.SI?D?:O[2'A'^T/\ A(#8?9O](^V?V?\
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MR=\"/V??@WX%UOQWHY\*_P#";>(?VP?BEX+\*^"X?$WC_P"S:MXM\ ZM\,_
M6MV@M]>M/"FC^%&@\3:C)I<<]MXYT^\U/3[6( _H*UOXD?#OPSXG\,>"?$GC
MWP7X?\9^-GNH_!GA'6_%.AZ3XG\7/91M+>)X8T"_OK?5=?>TB5I+I=*M+LV\
M:L\H102.TK_'D_X(3_%+XF?&;_@NO^PQ\1?B]\0_&_Q3\?\ B'XQ:U<:[XW^
M(GBK7/&GBW69_P#A6OCLB74_$7B.^U'5KYEW$(;F[DV*=J;5XK_8;H ****
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M\UGP)?RV&J0Q3:AH=OXB^(G@[Q[K=G8W[Z9\.;F&![M/DS]L#_@KK_P<P_\
M!,WPMI_QR_;(_8=_8D\5_L]S:UIFD^(O%OPHC\;ZOIGA:_UBXCM-+TG6==\/
M?'GQ%JW@C^T[Z6#2]-\0^+/!>J>'+S5KNST>VU*YU:]LK.8 _MWHK\)_^"/'
M_!?']E?_ (*Y:9JG@WP[I.H? O\ :>\):*=>\7?L_>,-<LM<FU+0898H+SQ9
M\+O&-O9:-#\0/#.GSW%K!K0DT+P]XE\/W%S"=5\.QZ5<:;K.I?NQ0!_E,_\
M!X%:1V__  6'UB9%"M?_ +-?P/NYB  7D0>+;$,WJ1#91)D\[44= *_T"_\
M@AC_ ,H@/^"=G_9KGPV_]-K5_G__ /!X7_RF!N?^S8/@C_Z6^.:_T /^"&/_
M "B _P""=G_9KGPV_P#3:U 'ZMT5^ 7_  40_P""F?\ P5#_ &"/"GQD^-R_
M\$JOA]\;_P!F/X5:YXDNW^)_@+]M*+_A,;;X5Z9JMU;Z1\2_&WPJD^ 4^O>&
M[2;14L]9\5V6@WOC.U\$Q3WEQJ^KMHNEWNMQ_FW_ ,$O?^#KGQ!_P49_;L^
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M\.:0L;>(=5^&]WJX76]'U_PZDHO]:^'VM7.M:A%X?63Q%HWB+Q!8Z?XE3PV
M?TPT5_.C_P %@?\ @XQ_9K_X)B>(3\ OA]X2N_VI_P!L>]M[9G^#7A'6UTOP
MY\-_[5MXI]&E^*WBVST_7;O3];U*WN8-3T?X>^']&U3Q5J>FF"ZUB3PAIFL:
M#K.I?RK7O_!YA_P5-\)?$<GQQ^S1^R1I?AR&[CDOOAMJ/PY^-_ACQ%'H[R96
M*'Q%JGQCN;ZTU:6!2J:M=^'KW33-OF7P^8MML@!_IKT5^4G_  2*_P""MGP(
M_P""NO[.][\8/A9I5]\/_B'X#U2Q\+_&[X*:]JEMK&N_#;Q/J-I->Z3<6NL6
MUKIZ>)O!/BFVM;^X\(>+5TK23JITO6=.O=)TO6M$U;3;3[]^.OQ_^"?[,7PS
MU_XR?M"?%+P1\'/A=X76W_MOQQX_U^Q\.Z%:3WDHM]/T^*YOI8VO]8U2Z9+/
M2-%TZ.[U;5[V2.RTRRNKJ2.%@#UZBOXK/V[/^#S?]ECX6_VSX._8-^#GB?\
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M!H^J(\<VC:7%HVN^,?$$,MM=Z=X;70KB37[7^0Z]_P"#T#_@IQHWQ&:\UO\
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M@ HIDLL<,<DTTB10Q(\LLLKK''%'&I9Y)'8A41%!9W8A54$D@ FOY=?VD/\
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MQ5\2Y!_9NN+HVJM%I&NW;:WX*\"V6JWEOH\?Q*G\1QW>@P?FY^US_P %+_\
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MO_$?POUG6KV2&P\-7.I^)?&'A_6=0G33K_7/#U[)IT&J@']CM>*?M*6D=_\
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MYX;AEN)[>TU8V-[>^%-1F\/:M]FO7T2\\9>._AEXDU^32=2@\,^#?$*1I=$
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MI(X888WEEEE=8XHHHU+R222.0B1H@+.[$*J@LQ !-?Q<_LB_\%,]"_X*/_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^ /^"L
M7_*++_@I9_V8!^V1_P"LZ_$:OO\ KX _X*Q?\HLO^"EG_9@'[9'_ *SK\1J
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MUQ:R:EX3U?Q#H,\XL-7O$D\3_P"""WA+Q5X#_P""07["?@_QQX:U_P '>+-
M^$=Y8:[X8\4Z/J'A_P 0:-?+XZ\72-9ZKHVJV]IJ.GW(CDCD,%W;Q2;'1]NU
MU)_G&_X)E?\ !Y)X(\<:CX9^$O\ P4S^&^G_  OUB^DM-)A_:<^#]CJ=]\.Y
M;F1DMXK_ .)OPNEEU7Q+X0@8()=3\2^!]1\6:=)?76Y/!'A?18)KFW_N/\)^
M+?"WCWPQX>\;>!_$>A>,/!OBW1M.\1>%O%?AC5;'7?#GB/0-8M(K_2=;T/6M
M,GN=.U72M2LIX;NQU"QN)[6ZMI8YH)7C=6(!_+G_ ,'BUE:W7_!(:SGN((Y9
MM-_:N^"U[8R.JLUM=2>'_B7ISSPD@E)&LK^\MBRX8Q7$J9VNP/Y+_P#!C3_R
M'_\ @IE_V!_V0O\ TM_:7K]<O^#P_P#Y1 -_V=)\$_\ TV>/Z_(W_@QI_P"0
M_P#\%,O^P/\ LA?^EO[2] '^@I7^;9_P>YV-I'^V+^QCJ201+?7?[-'BBQN;
MH(HFFM-.^*6LW%E!)(!N:*VFU2_DB0DJCW4S* 9&)_TDZ_S=_P#@]V_Y.W_8
MH_[-S\:?^K,NJ /Z9O\ @U5_Y0=_LE_]C)^T?_ZTI\6*_3;_ (*C_P#*,O\
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MV$ES/;Z)HVE:>8[*/_-H_P"#4/\ Y3;_ +-?_8B?M$_^J)\>U_K?T ?P\_\
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M)M;3Q'9R>+_&^@>*/B3XAO+ATG\8G6?"VI:HU\NBZ-/%_5E_PU9^R[_T<E\
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M@3\&_#-KXO\ C58R^!/B?\)?#T\]C:7&K^*/ASXTT;7=6T;1[S4IK:SM=?\
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M>H6\/,:W/B#3;3P';7DO#M%X9L4^94^7]S/^#KI5/_!$?]I8D E?'/[.S*2
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MY36?M^?]E0\*_P#JI/AY0!_KU?L]?\D!^!W_ &1_X9_^H7HE>P5X_P#L]?\
M) ?@=_V1_P"&?_J%Z)7L% '^)#^TK:^*[_\ X*X_'^Q\":II^B>.+S_@HU\5
M;7P;K6K6XN]*TCQ7<?M,Z]#X=U34[4V]X+G3[#5WL[N]MS:70FMHI(_L\^[R
MF_UGO^"?O_!*G]G[]A>SU?XB7B2?'_\ ;(^)M]>>*_V@/VS_ (L:=9ZY\9_B
MAX[UXFX\27.DZK??;YOAWX&>YD:UT3P%X3N[73;32+73HM:N?$&KV\VLW/\
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M*J2!+^SK\<XW']Y18>'Y0#[;XT/U H _U;R0H+,0JJ"68D   9))/  '))X
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M5GL;O37NX]+\2_%/6="OM]C?W=L]OJ>EWMJ\<[;H2P5E_7R@ HHHH _Q-O\
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M\\*>$9-)MUUV/3=1TS^H?_@\W_Y1._#G_L]CX0_^JH^/E?GI_P &-7_(N?\
M!2__ +#?[(W_ *0?M)T ?UH>%_\ @D=_P2^\'?#-/A#H?[ /[)7_  @8TX:9
M/I^L_ SP!XGUG48A$\*WFL^,O$VB:OXTUO7$1V:/Q'J_B"]\01RA)X]36>..
M1?\ .8_X.6/^")7A3_@E[\9/ _QM_9LT[5+;]D#]H;4-4TK0_#FHZC>ZU/\
M!?XKZ9;R:MJ/PW76=3FN=4U/PIX@T%)O$?P_O-7O;_6XX-)\5Z'JMU<CP_8Z
MKK'^KQ7\^'_!T=\'M&^+7_!%;]JB^O[6"?6?A!J7PC^,/A&YF@2=M-UGP_\
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M!K:XCN+C^B[]O;X6>'?C=^Q#^UW\)?%5A;ZEH7Q _9M^-/AJZM[F)9A%/?\
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M\#?#S4X)?#^L_$75+Q;CQ?XM^(&O:9=7EKXEU%5\,Q65YIUUXE\0?S0?\'D
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MVW]N:OXS$%W-IKZA/+%<QSW<L$%K'#_2G_Q#-_\ !#O_ *,0\.?^'I_:6_\
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MJ!5_E&?\&@__ "F.\*^_[/'QTS_X+="K_5SH _R$_"'[.G[8'Q?_ .#CC2?
M_P 4_A=X[\3?&Z3_ (*7:'\2_BG8:SX>U.]L[+X=:%^T'9^,M=\=7SS6S6*_
M"73_ (=:9)J^AZO;D^&KGP3;Z9!X>:XLIM-MI/\ 7LKXI_;B_P""AW[(7_!.
MCX7'XL?M:_&+0/AMH]]]KM_"?AH";6_B'\0]4LHT>71_ '@325N?$7B6ZB>X
MM8[^]MK./0M 6]MKSQ+J^BZ=(;U?P \&?\%-O^"SO_!8&*>X_P""5?[,7A']
MAS]DO4;NYL+']N7]LJ&WU[QEXEL8)Y(9=6^%'PRMK'7_  S?7T?EW=FT=CX=
M^,/@^/5[%].U+X@^&[WSHH #\)/^#V+X6>'?#G[;W[*7Q:TNPM[/7?B?^S;J
MOAKQ-<6\2Q'5I_AE\0M6;2M1O2A'VF_CTSQQ%I1NI%,QT[2],M#(T%G;QQ?U
M,_\ !K)XUU;QE_P1'_9.BUF[FO[CP=K/QW\%6MS<RM--_9.D_'CXB7FC6A=R
M2(=+TO4[32;*(86#3[&U@0!(EK^);_@YE_84^*W[%GQ3_92N_CU^VO\ 'C]N
M/XU?&?X>_$CQ'X[^(WQBNELO#N@2^'?$GARRL?#WPG\"_P!HZ^? 'A-3JM[-
M/HL'B*_T^:=;::QL=(1)+:3^S+_@TR_Y0I_ C_LJ'[0?_JV_$E '[_?&_P#Y
M(M\7O^R7^/\ _P!135J_Q]?^#>+_ )31_P#!/_\ [+!JG_JN?&]?[!7QO_Y(
MM\7O^R7^/_\ U%-6K_'U_P"#>+_E-'_P3_\ ^RP:I_ZKGQO0!_LM5YCXQ^"?
MP:^(<WB&X\>_";X:^-;KQ;X8'@GQ3=^*O _AG7[SQ%X.7^T"GA76[S5-,NKG
M4_#L;:OJK1:->2S:=$^I7[QVZO=W#2>G44 ?X@?PZ\":;\+?^"I/@3X9:-&\
M.C_#K]OSPQX$TJ*222:2+3?"/[1%CX?L8Y)I6:65TM=/B5I)&:1V!9V+$D_[
M?E?XI&M@#_@M)JX' '_!4*_ 'H!^U=+BO]K>@ K^=W_@Y:_X*?Z__P $W/V!
M+NP^$?B&3P]^TI^U'K.I?"#X0:Q8W @UGP1H,&F)??%3XIZ2<+(NH>$/#U[I
MGA_0K^VECN]$\9^.O"6O1":/3)HF_HBK_,H_X/5_BCKGB#_@HC^SC\))+J9O
M"WPT_9'T;Q9IMB[N88?%'Q.^*WQ+M?$U[#$?W:F]T7X?>";>61!OD.FJDC$0
MQJH!^HW_  9:_L8^%=-^!G[1O_!0#Q7I,&J?%#XB_$N_^ 'P^UW5(ENM2T'X
M?>#-(\,^+?'>HZ1>R!Y8V^('C+Q/IVFZY*\C7,A^&]FJF*&YN?MG]R-?S*?\
M&CEU87'_  1C^&$5FJ"XL?C;\>[75"I4LU^_C5KV-I,#(?\ LR\TY0'RWEJA
M!V%0/Z:Z /X1?^#R7_@F=X1U'X9>!/\ @IW\+_#-GI/CKPIXC\.?"#]IF;2;
M*.V'B[P=XD!TKX6_$77F@6**;6_"'B2&Q^&]UJMP)]4UC1_%_@[2Y9QIW@[3
MX8^+_P"#.7_@J3XL\0WWC?\ X)>_&/Q+=ZWIFA>&-9^+7[*VH:Q>//<Z'INE
M7T$GQ/\ @]8RS/)++I8CU1/B/X0TV-4CTB*R^(H:9K6?2+*R_J@_X+??#/3?
MBU_P2(_X**>%=5MH[JVTW]E+XL?$B"&5%=1JWP:\/S_&#0IE5N/.MM;\"Z?<
MVY'S+/%&R N%%?Y=7_!O;XOUWP3_ ,%G?^"?^K^'I9HKW4/C3+X0NO(8AI-"
M\>^"?%G@CQ)%( 0&A?0/$&I"93D>7N;&5! !_L+^,/@M\'?B%<:[=^/?A1\-
M_&MYXG\+CP1XDO?%?@?PSX@O=>\&*^I2IX2UB[U73+NYU+PU'+K.L2QZ'=RS
M:;'+JNHRI;+)>W+2_P")9J/PUUKX<?\ !1R_^#WP=U#3O#/B+P'^VS=?#7X6
M:IKT4FIZ3X?UKPM\=I/"_@?4-:@>"]EU#3M*OK'2[G48GMKN2[MK>9&@N&D,
M;_[C]?XJGC< ?\%M/%P P!_P5-U\ >@'[6EV * /]5W]@'_@DI^S5^PU'J7Q
M*O+#_AH3]LGXB:C=^+OCI^VA\8=-LO$?QI^(_C[77:\\2ZCH>J:E_:+_  U\
M(W-]*\>E^#/!]U:6L.F6VFQZ]?\ B35K1M9G^)?^#GG]BOX5?M/?\$JOVA?B
MCK?@[0I_C+^R[X9M/C-\*_B)_9EH/%'A^P\,:[ID_P 0O#2ZU'"NIS>%_$W@
M.?Q)'?>'WN_[(EUZW\/^()[66_T&PDC_ ***_,?_ (+2JK?\$D_^"C@8!A_P
MQS\>6P0"-R^ -993@]U8!E/4, 1R!0!_!K_P9B?&'Q#X._X*9?%KX1PZA<KX
M0^,W[+/C"XU;1EE=;.Y\6?#7QKX'U[PIKDT2_)+=:/H>J^.],M&<?NX?$M]M
M8%R&_P!0*O\ *,_X-!_^4QWA7W_9X^.F?_!;H5?ZN= !1110!_''_P '>/\
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M9O!DWAO1-3U+6I-.;5+K6/#EG:Z7'X;U:6Z?4= .DZ4^DW%H^G69A^IZS]7
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M?$?]E2>;QI\)%OKGS+_7/V??&^MN]_IEL)&EN;I?A=\1=3N+"YGFD2"Q\/\
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M>LM5EL]%U#5O%=]=:=YM_P 'S ']K?\ !,<]SIW[8P)]A<_LO8_+)_.OUO\
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M@>!Y6C=;34O!'C;P%H&B:WH5U87#)>1V0GN=!U&6%+;7M&U?39+BQG_R5?\
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M#M=\#/XIL-"U672K2U;4;#0M2\'/<:!;79FBT5M5UK^SDMQJU^)_Z]?V,?\
M@GU^Q_\ \$]O"/C#P'^QW\&[+X,>$O'WB.V\7>+=&L/%_P 0O%T.K^(K/3(=
M&M]3:?X@^+?%MY9RIIEO!:M#IUS:6TJ1(\L#RJ)*_F'_ .#VD#_A@S]DTXY'
M[72@'V/P:^)9(_$@?E0!^2'_  :W?\$SO#G_  41^%7QE?\ ::^(.N^(OV,?
M@I^T#X9\87/[(^BW5[H?AKXV?'J3P-9IHOC#XRZSILEGJ6M^!O /AF.*'PYX
M(M;Q8=7U[6]6N=5N+/2;>\TKQ3_HZ^#?A9\,?ASX%L?A?\/OAUX%\#?#73-,
MDT73OA[X0\):!X;\$6.CRP&VETJT\*Z/86>A6^G36Y,$MG%8K;RQ%HY(V4D'
M^-+_ (,B_P#DS_\ ;1_[.3\)_P#JK]+K^VF@#_'E_P"#D;]CGX;_ +%'_!6+
MXZ?#_P"#GAG3/!/PJ^)&A>!OCGX*\%:):16&A^$X_B+HS?\ "6:+H6GVR16>
MF:!%\0M&\876@Z-I\%MIN@Z-=6&AZ?;PV>FP(/\ 44_X)/?&'Q#\??\ @F;^
MPC\7/%VH7.K^+_&/[+/P9N/%VLWDKSWFM^+-+\%:5H/B;7+R63+R76LZYI=_
MJ=RS$YFNWPS#!/\ GH_\'E*J/^"MGA(@ %OV.?@XS$  LW_"?_&=<L1U.U57
M)YVJ!T K^[W_ (((?\H<?^">G_9O'AW]-3UC% '4?\%P/^40W_!1;_LU#XM?
M^H[<5_GY_P#!GI_RF!MO^S8/C=_Z6^!J_P! S_@N!_RB&_X*+?\ 9J'Q:_\
M4=N*_P _/_@ST_Y3 VW_ &;!\;O_ $M\#4 ?ZK=%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %? '_!6+_E
M%E_P4L_[, _;(_\ 6=?B-7W_ %\ ?\%8O^467_!2S_LP#]LC_P!9U^(U 'X
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M"'^T=8N8FFO_ !#XKUQ[>.*"?Q)XS\37VL>+?$MU!###=Z_K6HW,,$$4J1(
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M_L\D'X ? T@@@_![X9D$'((/@O1"""."".01UKV&OX,?V)O^#LG7O%?[+OP
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MW#0RZEJ M?,NM8\2:[<P0VT-]XF\6Z]=ZIXH\3ZC';6Z:CX@UC4KU;> 3B)
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MZO%93Z7\0]'LD5;>+0/B%I?B2QL[.2X70VT2^ECU&#_+8_X*V_\ !)OX^_\
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MPF0217$.4_Q^_P#@LO\ \$:?C]_P2:^/VM:'K>BZ_P",_P!E_P 9Z_J$_P
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M-'B36?B?+X?UBV?!MM7\(Z1XGTCP=J5N /*N_#\J,7D#R/\ K_110!_GX?\
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M/_9HGQJ_]0[4:_SS_P#@T'_Y3'>%?^S>/CI_Z;-"K^V+_@X0_;__ &2?@_\
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M]('ANKBS\*^);D^#_%5B[@.]GX@T&/1?%&BWFW%UIVI65VHVRBO]U:OXL?\
M@Z1_X(0^.?VNTB_X*#_L<>"[GQ=^T#X-\+V7A_X__"+PY9&X\3?&/P+X9M/(
M\.>//!>GVZ&XU_XE>!=(B3P_J7AN)+C5?&?@FST.S\.JVN>$+'0_%(!_5M^Q
ME^TAX9_; _9/_9W_ &G_  C<64VC?''X1>!_B$]O8S+/%HVMZYH=I-XI\,3.
MK.$U#PEXH76/"^JP%V:UU32+RV=B\+&OIBO\T7_@VC_X+\^ ?V!]*UG]@7]N
MG6=6\&_ &\\8:OKOP>^*M_I>JWT'P,\::[?,_C+P#X]T>RM;G6-.^'WB77_/
MU^UUBRTZ:3P5XTOO$,_B.T?0/$EYK/A#^Y#XF_\ !8__ ()7_"7X:WGQ8\5?
MM_?LI7_A.UTR35;6#P-\:_ GQ*\6Z[%' TXM/#/@+X?ZUXD\:^)-3<+Y0TW1
MM!O+R*8^7<10D/M /Y#/^#Y#QCIMUXK_ .";OP_@GC;6-"\/?M3>,=3M@P,L
M6F^*]2^ >B:'.R [DCN+KP9XAC5F7$C6SA3F)Q7[)?\ !HS^RKK7[/7_  2C
MTSXF>*]-FT[Q%^UG\7?&/QOL(;N'R+Z'X>6-AHGPU\!1RQD!C9ZM#X*UGQKI
M$K%C<Z5XQM+E#Y4T8'\\T?[.7[1'_!UI_P %4[O]J>Z\ ^.O@K_P32^$W]@?
M"_2_B'XGMFTS4+SX0> M:U+6+GP)X(N0L^E:[\:?B=K^O>(]=\12:(VL:'\)
M;#Q!;6_B'5]:E\/^&+'Q?_HY^&/#7@?X2^ /#_A#POINA^!?AO\ #/PAI7AS
MP]I%J8-*\-^#_!/@[1H--TK3[<S.EMIVBZ!H6G06\;2RK#:6-H#)($C9J /Y
M(_\ @]:_Y1C_ +.W_9]_P_\ _6?OVE*^;_\ @Q]_Y('^WU_V5_X+?^H7XTKS
MW_@\F_;T_9C^*G[._P"S1^R1\(?C+\._BQ\3+/X]M\<O&VG?#;Q=H7C:V\">
M'?"?PZ\<^!-(MO%FH^'+[4=/T;6O$M_\1KJ?2=#NKA=6?3]#OM1N;2VLI].G
MOO /^#-']N/]FSX#7G[97[._QT^+_@'X0>+/BCJ?PB^(?PLG^)'BG1O!FB>-
M5\+V'CG0/&FA:5KWB&\T[2'\2:4NJ^%M0L] -[_:NL:==ZI>Z9:7$&A:H]N
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MM_"?B'7];BOM%EN]-\/>&]:\2 'DW_!E5^S1K?C+]M/]I+]JF]TZ8^#/@?\
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MF\<?##7M>2!))+30O%FH?$3QCX>.MSK'INGZYIN@Z/=W,5_XFT6WNP#]=?\
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M@H^EJ "BBB@ K^:W_@[0_P"4*OQQ_P"RJ?L^_P#JUM K^E*OXTO^#M[_ (*
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M1_X2OQ-K>KI&(=!T+0M(O]6UR[E@M-+M+J>:-&_Q=/A!^T)X<\(_\% OA?\
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M7_!\+_R6[_@GY_V2OX[?^I=\/*_>K_@T@_Y0P?"K_LM'Q]_]3NXK^5G_ (/
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M:>6[@TR))+J( _-W_@^"_P"2_?L#?]D?^-'_ *FG@ROZ#?\ @TR(/_!%3X%
M$$K\4?V@PP]#_P +9\1M@^^U@?H17\<7_!RK\'O^"GL&L?LC?M4?\%+O%O@L
M^,_C_HGQ8TOP9\ /A+IK-\+OV3=$\'W?@35;;X7Q>)HM2U6'Q)XW\1P>+CK/
MBK5IM1UV2\O-$EM-/\8>)]*T>W71OL;_ (-^_P#@L/\ M6^%/V2;3_@D_P#L
M2_LHW'Q9_:Y\0_$?QSK_ ,*OC5XAUI4^!WP5\ >/KO2[[Q/\4?C1I$&F7&I#
M3/AGK%QK&J0PB]M],\23:GH6BQ"\ULVGAKQ2 ?Z*WQO_ .2+_%[_ +)?X_\
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MB3P=<_\ "9_#N_ND>REU./P?XFA5Q;VTE?[0-?YWG_!YY_P3OC\+?$'X-_\
M!2KX?:,D6E?$T:;\ _VA6LX54+X^\/:/>7WPB\;WVP/---XC\$:/K/@75+Z8
MP6=A%X \$V2;[S6?G /H[]GSQ%H?_!=#_@YKU[]HSP]J,'CS]BG_ ()@^#="
ME^%^N6PDNO"?BGQ;X3U"^B^'FKV$NP6\EUXK^.FL>-/BMX9U<0K_ &UX*^$^
MC6TT[QVUHE?W:U_-=_P:N_L)?\,>?\$N_ _Q(\4:-_9WQ9_;*U.+]H7Q7+<V
M_EZC:?#[4K!--^"'A]I2J/)IH\!HGC^UAE02V>I_$G6[8LZJA']*- !1110
M5_G7?\'O'P,UNP^.'[$/[2T%C--X<\5_"KX@? S4]2BB9K?3=;^'_BY/'VAV
M-[,!LAFURP^)GB&?2XBVZX3P_J[* +5B?]%&OS2_X*U?\$W_  %_P5-_8J^(
MG[+OBV_M/#/BN>>S\=?!?XA75H]XOPZ^,/ABVOX_"WB&>")6GGT/4;34M7\(
M^+K:V5KRX\(^)-<73C#JHL+JW /Y^O\ @T%_X*=^"/C%^R@W_!.?XA^)K+3/
MCG^S9=^)]<^$6EZI=QQ7GQ'^!'B;7+SQ5=+H3SN)-3UOX8>*]<US3=9TN/\
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M#MGKFM>--:TYB-UQI6L>*?'VG: TX8QC5? >HVR@26TQ/]Q5?/\ ^RM^S/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M].UG3_LNJZ;,WGV%Y;3A9!^-=U_P;!_\$.KOQ*?$\G[$=I'.UR;Q](M?CO\
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M'5M4LK/58K-;^VM-2U"VAN$AO+A)/6Z* /@#_AT[_P $LO\ I&G^P!_XAO\
MLZ__ #N:U-#_ ."7/_!,SPQK>C^)?#7_  3K_84\/>(_#VJ:?KF@:_H?[(_P
M TG6]#UO2;N&_P!*UC1]5L/A];WVF:IIE];P7NGZA93P7=E=P0W-M-'-&CK]
MUT4 > ?'3]D[]EC]J#_A%O\ AI?]FG]G_P#:(_X0?^V_^$*_X7I\&_AU\6_^
M$/\ ^$F_LC_A)/\ A%O^$_\ #GB#_A'_ /A(/^$?T'^V_P"R?LG]J_V)I'V_
M[1_9MGY/S_\ \.G?^"67_2-/]@#_ ,0W_9U_^=S7W_10!\?_  N_X)Z?L"?
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M1+J-[HWA7X/?'"3Q#J]M:,PFGT_1[O6?#ECJ%S$ACM;K7]*BF96O(@_YY_\
M!C?XS\/V^J?\%(OA[<ZI90>*M6L/V6?&>CZ+)<Q+J6J>'_#]Q\>]$\2:I9V9
M<3S66A:EXF\*VFI7*(T5M/XCTJ*5U>[A#@']#FN?\&PW_!#K7_$4GB6Z_8@L
M+*ZGNGO+G3=#^.O[2^@>'9YG<2!8_#NC_&.RTC3K5&&$L-(M-/L F8S;&,[:
M_5/]F#]B_P#90_8M\(7'@7]E3]G_ .%_P*\.7[6\FLQ> ?"]CI>K^)9[172U
MO/%WB>1+CQ/XPO[6.1XK:_\ $^L:M>P0MY,4Z1 (/IRB@ K%\1^&_#OC'0-9
M\*>+M T7Q5X6\1:;>:-X@\-^(]*L=<T#7=(U"![:_P!*UG1]3@NM.U/3;ZVD
MDM[RQO;:>UN8'>*:)XV93M44 ?D%'_P0*_X(W1>./^%A+_P3V_9^.O?;3J'V
M"31=:E\#^>9/-\L?#*777^&PLMW TT>$_P"SA'^Y%J(?DK]8?#/ACPWX+\/:
M-X2\'>'M#\)^%/#FFVFC>'O#/AG2;#0?#V@Z180K;V.E:-HNEV]KINEZ;90(
MD%I8V-M!:VT*+'#$B*%&Y10!^;'B/_@CO_P2]\8?'S4?VG?%7[#O[/WB+XV:
MQKTGBO6?%>L>#(=0T[6/%<UP;VX\5:OX'N9Y/ &J>*+O42VJWOB*_P#"UQK-
M[J[/J]W?3:D[W1^Y_B5\)OA7\9_ 6M?"KXP_#3X?_%?X7^)(=-M_$7PW^)7@
MWPYXZ\!:];Z-J=AK6D0:UX/\4:;JGA[5(=*UG2M,U;38K[3ITL=3TVPO[58K
MJSMY8_0** /@#_AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\ P2R_Z1I_L ?^
M(;_LZ_\ SN:^_P"B@#YJ^+W[&'['G[05KX+L?CU^RA^S5\;K+X;Z3<:#\.[/
MXO? KX7?$JU\!:'=1Z=#=:-X+M_&?A;6HO"VDW,6CZ1%<:=H:6-G-'I>G))"
MRV-L(O%?^'3O_!++_I&G^P!_XAO^SK_\[FOO^B@#X[^&?_!._P#X)_\ P5\<
MZ#\3O@W^PS^QW\)?B5X5EO9O#'Q"^&?[,OP5\!^.?#DVI:9>Z+J,N@^+/"W@
MG2M?T>6_T?4M1TF]DT_4+=KK3+^]L)S):W4\4GV)17\ W_!8/_@ZD_;?_9$_
MX*$?&?\ 9=_9B^%GP)T;X;_L[>*;/P3JM[\7_!WB_P 7>*?B3XB@T;3-2U[5
M+V31_'7@^V\/^$WN]0:S\-V.BQ+JUWIMM'KUWXA?^UX=)T@ _OY) !). .23
MT ]37\1G_!.AE_X+$_\ !QI^UA_P44OF'B;]F#_@G?HL?P3_ &:+V0_;/#^J
M^)E'BCP+X'UO16F'V:_TS5L_&WXXVTL8-[H.L>*O =Q+%;RM92C\T?C'_P '
M7'[>W_!0WX(VG[#/[+/['&D?#[]J3]H^.;X2:A\0_A5XZ\2^.-?UC3_%=M)I
MVLV/P@\ 7OAC3+OX>:YJ6F2WUO=^,?$'C[QBG@W0CJ>NVMQI.H6MKXET'^SW
M_@BQ_P $U='_ ."6/[!_PX_9UN)M+U?XM:Y=77Q1_:"\5:3B6QU[XP>+;+38
MM9LM*O&A@FO?#O@O1],T3P)X<O)8;9M3TSPY'KLUE97NL7EN@!^LE%%% !11
M10 5\ ?\.G?^"67_ $C3_8 _\0W_ &=?_G<U]_T4 ? '_#IW_@EE_P!(T_V
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M9^&_B-X)U;PUX^T'3KV98[B^TO2O$EIIM_<0P3WMI/+!$R?;%% 'Y,?LH_\
M!##_ ()2?L5>.-.^)W[/W['/@'1/B1HUTE_H/COQSKGCSXQ>)O#.HPMN@U7P
MC?\ Q?\ %GCA?!VKVXRD&K>%8=&U*-&D477[V7?]>_MD?L4_LW?M]_!F;]G_
M /:J\!7'Q)^$UQXI\/>,KGPO;>+?&7@IY]>\+2W$VC7+ZWX$U[PWKZPP-=W
MEM8M4CM[E9")XWVH5^JJ* /GO]G']D[]FC]D'P-#\-OV8?@9\,_@;X,1;<W6
MD_#OPII?A^76;BVC:*+4O$^K6T']M>+-9V,RRZYXFU'5M8GW,9[Z0DFOH2BB
M@#C_ !_\/? /Q7\':_\ #OXH^"?"7Q'\ ^*["32_$_@CQWX<TCQ;X2\1:;*R
MO)8:YX=UZSO](U6S=T1S;WUI/%O1'V;T4C\2O%'_  ;)_P#!$'Q;XKE\7ZC^
MP]HVGWUS=&\NM*\+_&7]H?P?X4FF+^8%B\)>%_BUI/AW3+56X%AHVG:=8%!Y
M3VS1DH?WEHH ^;?V??V//V7?V4OAC>_!S]FSX%?#CX)_#G5(9HM:T#X>>'+/
MP_)XAFN+22PEU+Q/K5JHU_Q1KC64KVO]O^(=4U/6A $B%_LCC5?F_P#8S_X)
M#_\ !.']@&[;6?V6?V5/AUX#\8O).X^).MC6OB3\4K9+G>L]II?Q(^)>J^+O
M&>A:9-&PCFTC0=9TS2IUCB:>SEE025^D5% '/^+/"?A7Q[X5\3>!?'7AGP_X
MT\$^-/#^L^$_&/@[Q9HVG>(_"OBSPKXCTZYT?Q#X9\3>'M8MKS2->\/Z[I%Y
M>:7K.C:I9W6G:IIUU<V-];3VT\L3?$'_  Z=_P""67_2-/\ 8 _\0W_9U_\
MG<U]_P!% 'P!_P .G?\ @EE_TC3_ & /_$-_V=?_ )W-?0/CO]E']EOXI?"K
MP=\"?B;^S7\ ?B-\#_AVOAQ/A_\ !OQW\'/AWXN^%7@9/!^A77A;PBO@[X>>
M(/#FH>$?#*^%O#%]>^'/#BZ+H]B-$T*\NM(TP6NGW$MN_OU% 'P!_P .G?\
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M ((@:XSO>_L&^$H"Y)(T?XM_M$^'E&<YV)H'Q?TQ$'/ 15"\8 P,?G=^S/\
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MT%S?R165G#%:VR101HB^;?\ #IW_ ()9?](T_P!@#_Q#?]G7_P"=S7W_ $4
M?-?P1_8Q_8]_9GUS6/$W[.'[*'[-7[/WB3Q#I2Z%X@\0?!'X%?"_X4ZYKFB)
M=PZ@FC:QJW@3PMH-_J>E)?VUO>KIU[<3VBW<$-R(1-$CKY#J?_!+#_@F'K6I
M:AK&L?\ !./]@W5M7U:]N]3U75=3_9!_9\O]2U/4K^>2ZOM0U"^NOAY+=7E[
M>74LMS=W=S+)/<3R2332/([,?O*B@#X _P"'3O\ P2R_Z1I_L ?^(;_LZ_\
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M_"+Q)K&H:@9=1UJ?6O!%[%XAU.XN-5\00ZIJ4K7=?K< % 50 H       P
M.  . !P!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCT_?Y^F:G]ANOLEPJ2^1)MVGO:* /YK_ (Z?\&N/[#/[3_B:U\9_M'_M-?\
M!1WX\^*["U>PTWQ!\7OVJ+/XAZKI6GR,COIVDW?BKX:ZI)I6G,\4;FPTXVUI
MO16\G<H-<Q\*?^#3S_@G5\"/&VF?$KX(_'3_ (*!?![XB:*MQ'I'COX7_M+Z
M3X"\8:9%=Q^3=PV/B3PM\,-*UBU@O(28;N"&\2*ZA+0SI)&Q4_T[T4 >*?L]
M?!8?L^?"CP[\*5^*_P :_C:OAV?6IA\1_P!H7QZ_Q-^*^MC6=:O]9$'B+QG)
MIND2:K!I/V[^R=%1[&)K'1;.PL2\QM_-?VNBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUOX4WVK:K?2(B*]W?W<\[JBJTA"@#V[]GW_@VD_9%_9.FUF;]F/]KS_@IK\
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M+=87R_#.C7AAMWU'P_X'TWPMX?U.>UMKO4=+NKNWBG7]0*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^ /^"L7_*++_@I9_P!F ?MD?^LZ_$:OO^O@#_@K%_RBR_X*6?\ 9@'[9'_K
M.OQ&H _ '_@RI_Y19?'S_L__ .*?_K.O[*M?U^U_(%_P94_\HLOCY_V?_P#%
M/_UG7]E6OZ_: /X _P#@QC_YRB_]V3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*
M_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5/\ RBR^/G_9_P#\4_\ UG7]E6OZ_: /X _^#&/_ )RB_P#=DW_OW%?W^5_
M'_P8Q_\ .47_ +LF_P#?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J^_Z
M^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&H _ '_@RI_P"467Q\_P"S_P#XI_\
MK.O[*M?U^U_(%_P94_\ *++X^?\ 9_\ \4__ %G7]E6OZ_: /X _^#&/_G*+
M_P!V3?\ OW%?W^5_ '_P8Q_\Y1?^[)O_ '[BO[_* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&K[_KX _X*Q?\ *++_ (*6?]F
M?MD?^LZ_$:@#\ ?^#*G_ )19?'S_ +/_ /BG_P"LZ_LJU_7[7\@7_!E3_P H
MLOCY_P!G_P#Q3_\ 6=?V5:_K]H _@#_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C
M'_SE%_[LF_\ ?N*_O\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^_Z^ /\ @K%_RBR_X*6?]F ?MD?^LZ_$:@#\ ?\ @RI_Y19?'S_L_P#^*?\
MZSK^RK7]?M?R!?\ !E3_ ,HLOCY_V?\ _%/_ -9U_95K^OV@#^ /_@QC_P"<
MHO\ W9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO[_* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX _X*Q?\ *++_ (*6
M?]F ?MD?^LZ_$:OO^O@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J /P!_X,J?\
ME%E\?/\ L_\ ^*?_ *SK^RK7]?M?R!?\&5/_ "BR^/G_ &?_ /%/_P!9U_95
MK^OV@#^ /_@QC_YRB_\ =DW_ +]Q7]_E?P!_\&,?_.47_NR;_P!^XK^_R@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]E6OZ_: /X _P#@QC_YRB_]V3?^_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\
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M\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\
MX**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<W7]_E% '\ ?_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_  44_P#G-U_?Y10!_ '_ ,."
M_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44
M?P!_\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]
M_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13
M_P"<W7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\
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M\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E%
M'\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<
MW7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_
M  44_P#G-U_?Y10!_ '_ ,."_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\
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M:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\
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MC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44 ?P!_\."_^#IK_I-1_P"=&_\
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M\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\
MX**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<W7]_E% '\ ?_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_  44_P#G-U_?Y10!_ '_ ,."
M_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44
M?P!_\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]
M_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13
M_P"<W7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\
M.C?_  44_P#G-U_?Y10!_ '_ ,."_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=
M-?\ 2:C_ ,Z-_P#!13_YS=?W^44 ?P!_\."_^#IK_I-1_P"=&_\ @HI_\YNC
M_AP7_P '37_2:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?
M_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<W7]_E% '\ ?_  X+_P"#IK_I-1_Y
MT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_  44_P#G-U_?Y10!_ '_ ,."_P#@
MZ:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44 ?P!_
M\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E%
M'\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<
MW7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_
M  44_P#G-U_?Y10!_ '_ ,."_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\
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M:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^
M/_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44 ?P!_\."_^#IK_I-1_P"=&_\
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M\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\
MX**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<W7]_E% '\ ?_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_  44_P#G-U_?Y10!_ '_ ,."
M_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44
M?P!_\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]
M_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13
M_P"<W7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\
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M\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E%
M'\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<
MW7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_
M  44_P#G-U_?Y10!_ '_ ,."_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\
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M:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\
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MC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44 ?P!_\."_^#IK_I-1_P"=&_\
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M\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\
MX**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<W7]_E% '\ ?_  X+_P"#IK_I
M-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_  44_P#G-U_?Y10!_ '_ ,."
M_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\ 2:C_ ,Z-_P#!13_YS=?W^44
M?P!_\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]
M_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13
M_P"<W7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\
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M\."_^#IK_I-1_P"=&_\ @HI_\YNC_AP7_P '37_2:C_SHW_P44_^<W7]_E%
M'\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\ P=-?])J/_.C?_!13_P"<
MW7]_E% '\ ?_  X+_P"#IK_I-1_YT;_X**?_ #FZ/^'!?_!TU_TFH_\ .C?_
M  44_P#G-U_?Y10!_ '_ ,."_P#@Z:_Z34?^=&_^"BG_ ,YNC_AP7_P=-?\
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M:C_SHW_P44_^<W7]_E% '\ ?_#@O_@Z:_P"DU'_G1O\ X**?_.;H_P"'!?\
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M\%7_ (=>YC\)3P^++?['I*:[;Z*U?Z.U !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"[=0K ']>U%?%7[$?_!1#]CK_@HI\.KGXF?LB_&SPW\4](TA[2W\6>'XDOM
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M"^(OQ"N_%&@>"/%7A/PE\.M-^'^F6NJ#2?&P^)&E>#/$:>(?$T,E^-)TS0]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OPN_P"#E;PK
MI7BW_@B3^W1:ZK:PW/\ 8WA+X9>*M-DD16ELM5\,?'+X8ZQ:75K(59H)B+66
MTD>,JTMI=75JS>3<2JW[HU^*G_!Q9_RA5_;]_P"R6>&?_5K_  ^H _SCO^#9
MJVM[K_@N)^PC%=00W,0\0_&N<13Q)-&)K7]F?XT75M,$D5E$MO<PQ7$$F-\,
M\4<L961%8?[#E?X]/_!LE_RG(_82_P"PY\<__68/C97^PM0!QWC[X=_#_P"*
MWA35O ?Q1\#>#_B1X'U^ VNN^#?'OAG1?%_A76;9@0;?5?#WB"RU#2=0A()S
M%=VDR<GY:_A:_P""ZW_!JOX @\">-OVN/^"7WA"\\,^(O"=CJ'BGXF?LAZ2]
M]J^A>*="LXI+[6=?^ <-U)>:KH_BG38DN+Z?X4">\T;Q%8A[+X>1:#J^GZ9X
M1\4_WK44 ?X]/_!%C_@NM^T5_P $H/BKHGAO4]8\2_%']C+Q-KZ?\+9^ %Y?
MB\70X=0E$6H_$#X/?VI,+?PCX_TL.=0N],MKC3O#GQ BM_[&\5+!>?V)XH\-
M?ZZ/PB^+/P[^/'PN\ ?&CX2>*M+\<?#+XH>$]$\;^!O%FC2F73]=\-^(;&'4
M=,O8@ZQSV\K03+'>6%W%!?Z=>1W%AJ%M;7MM<01_Y1/_  =&?L">'OV'_P#@
MIQXK\0_#?0K?0/@]^UCX9B_:&\(Z3IULMKHWAOQAK.LZIHOQ:\*:;%%'#;V\
M,/C739_&EKIMG%'8Z-HOCS1=(LU2"R2*/^BK_@RV_;KUGQ[\&OV@_P#@G]XW
MUMKZ;X%7EE\;_@A;74K2W5I\./B!K5SIOQ0\.6:E@D&B>&/B-<Z!XEMD$;22
M:M\5=:+S")+:) #^Y&BBOQ&_;=_X.$_^"9?["OQ"N_@MXV^*?BCXT_'G3M37
M1-3^"'[-'A"3XL^.M)UV206\?AW6+]=2T'P!I'BIKQDL9/"&I>-K7Q7:W4L2
M7FBVZ.LA /VYHK^4WQI_P=K_ +(WPCU'2%^._P"P?_P4X^!OA[Q!.(-#\1?$
MS]G_ , >%(]0W1&?S8++7_C'I+7D<</[^5-'N=5N!;AI8H)0 I_:C]@G_@J=
M^PU_P4M\-:OKO[(WQOTCQWK/A>UMKSQI\.=8T_5/!WQ1\%6]W*+>"[U_P-XD
MM;#5VT>2Z9;.+Q/HJ:QX3N;UOL5IKL]VKPJ ?H563K^O:)X5T+6O$_B75M.T
M#PYX<TG4=>\0:[K%Y!IVDZ+HFCV<VH:KJVJ:A=/%:V.G:;86\]Y>WES+'!;6
MT,LTSI&C,*?B_P 7^$_A_P"%?$7CGQYXG\/^"O!7A#1=2\2>+/%_BS6=.\.^
M&/#'A[1K26_U?7?$&O:O<6FEZ/H^EV,$]YJ.I:A=6]G96L,MQ<31Q1LX_P Y
MS_@XU_X.2O"_[4WA'Q1^P9_P3_\ $]]?? K6G?2OV@OV@K2"^TC_ (6]9VES
M'(_PS^&2726FIP_#&6Y@'_"9>*KJVLYOB&D8T#1X1X!?4K[QT ?U!_\ !"3_
M (*3^._^"G>H_P#!1SXUZKX@O;_X/>&_VQ9?!/[-'AN[L++3QX1^">E_#[P]
M;^&4,4-E;7XU/Q9':CQOXCBU6XU"XM/$7B#5+2VN$L8;:&/^@*O\VG_@UX_X
M+$?\$^?^";7[,W[2?PZ_;$^->I_"_P 7?$+XZZ3XU\)Z98_"OXL^/DU+PY:^
M -$T*>^>_P#A[X*\4:?8NFIV=Q;BTO[FVO&""98# Z2-_<)^P5_P57_89_X*
M92?%2+]C+XO:A\5)/@LG@F3XC+?_  V^)WP^_L)/B(WBU?"1B/Q%\(>%1JW]
MI-X'\2AQHYOC8_8$-^+87EE]H /T2HJ"ZNK:QMKB]O;B"TL[2":ZN[NZFCM[
M:UMK>-I9[BXGE9(H(((D>6::5UCCC5G=E521_.Y^TY_P="_\$N_V?_'6K_"[
MX>:]\8?VR_B'H4EW;ZSH_P"R'\/;7XD:!IEU9OY<^[Q[XA\1^"O!6OV$#L@N
M=5\"ZUXQL;=G\EY3=)+;H ?T545_)A\(/^#R#_@EUXZ\80>$/BG\/_VJ_P!G
ME);\V-SXO\>_#?PIXG\):(RS>1*VO0_#7Q]XO\=VDEO)G[1#8>!-5:$)('8.
MFQOZA/@]\9OA1^T%\-_"OQ@^"'Q$\(_%7X7^-M/75/"OCGP-KECXA\.:S:>8
M\$WV;4+"6:)+NRNHI['4].N/)U#2M2MKK3=2M;2_M;BWB /2Z*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_P"#H[_E!1^W-_W;
M-_ZV'^S[7^0+7^OU_P '1W_*"C]N;_NV;_UL/]GVO\@6@#^_S_@QC_YRB_\
M=DW_ +]Q7]_E?P!_\&,?_.47_NR;_P!^XK^_R@ HHHH **** "BBB@ HHHH
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M:/4Y2MYX7T*V\47>B36LWB#4VNO[]/V79'F_9G_9VFD8M)+\"OA')(QZL[^
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M!?B/1KG2?%^C:SX%O[R[L/&_AF;1M0GL-?USX?ZQXQ\+6L-\EK?:U;74PMU
M/M_]BS_DSC]DS_LV?X#_ /JK?"M?RV_\'!?_  0C_9)N/V(/VP_VZ-&\0?M
M^)?VK?AQ:W?QEL?B'\4_CO\ $'XIV\_AMO'EC?>(_ABGA[QCJFHZ-I'@+1?"
M6L:SI_@?3M M=*OO#C:7H"R:EJ-C:ZA9ZE_8?X:\-Z%X-\.>'_"'A?2[30_#
M/A71-*\-^'=%L(_*L='T+0["WTS2-+LHLMY5II^GVMO:6T>3LAA1<G&:_,3_
M (+D(LG_  2#_P""BBL 0/V5_B@X!Y^:+1FD0_4.BD>A&: /\_+_ (,^_P#E
M,-I?_9M'QP_]"\'U_JQU_E.?\&??_*8;2_\ LVCXX?\ H7@^O]6.@#^7_P#X
M.:O^"S6M_P#!-;]G70/@1^SWXA32?VO_ -IO2M8C\-^(;1XWU'X+?"2SE?2?
M$GQ3MHSO:V\5ZUJ+3>%/AG/+&L5OJMKXG\403M>>"8;#4/FS_@UA_P""0W@'
MX6?LZ>%?^"F7[1?A>#XA?M6?M-_VGX^^%FN^/;1]>U;X3?"S5]1O5TCQ5HL^
MLF];_A8GQA19_'.I^/UDDUL^"M>T#1=.O--_M'QBNO?Q??\ !PK^TUKG[4G_
M  5^_;2\2ZEJ,UWH?PI^*>K?LX>"+%I6ELM&\-? *>;X<7EMI>XMLLM:\9:-
MXM\8R[&:*74O$VH7,)$4Z*O^O-^S-X&TKX8?LW_L_?#30;:*RT/X>?!'X4^!
MM&LX"#!::5X2\":#H&G6T)7Y3%!9Z?#%&5X*(,<4 =/\6_A!\+?CW\.O%?PC
M^-/@#PI\3_AEXXTJXT7Q9X(\:Z-9Z]X>UO3KA<-%=6%]%+&L\#[+FQOH/)OM
M-O8H+_3[FUO;>"XC_P 9/_@LO^P3:?\ !-K_ (*)_'_]EWP[-?WGPUT75M*\
M;_!O4-3N6O=0N/A1\0]*MO$_A/3[^^D"S:AJ7A07M[X(U;4YXX9-4U7PQ?:D
ML2Q7<1/^UG7^6E_P>7HB_P#!6CP0RHJM)^QE\'GD*J 9''Q)^-\8=R "S".-
M$#-DA$1<[5  !_==_P $!_\ E#9_P3V_[(!I'_I]UZOBW_@Y>_X*]^)?^"8_
M[)GA[P#\"=9BTG]J[]J2?Q'X7^'&OH(;BZ^%G@'P];6*?$'XJVUO(LL8\1V;
M:YHOAKP$+V-+==?UF[\21_;AX-N]+O/M+_@@/_RAL_X)[?\ 9 -(_P#3[KU?
MP1_\'<WQ>U#XD_\ !934_AYJNJR6N@? 7X)? SX<:>K(+BTTJ/Q5IMS\8]7U
M06+E()KJ5OB=%]J9_GN[;3K"UFE,-M D0!_:]_P0E_X(_?"C]@?]F_P%\;/B
M=X3L_'W[>OQZ\,:?\4/CW\</'L!\3?$/P[K_ ,0;1/$M]\-?#6OZZMWJF@6.
M@#5/L'C74+&Y35?'_C"'5=?\1:A?V:^']-T/]$/^"A/_  3J_9G_ ."E7[/W
MBSX#_M%>!M&U=M1T?5$^'WQ(CTJTD^('P?\ &-Q:2)I'C?P%KW[C4=/OM+OQ
M;76H:,MZFA^*K&";0/$MEJ.C7MU:2?DFO_!&G_@K(54I_P '&7[3I0J"A7]F
M+P45*D J5(^,^"I&"".",8XIW_#FC_@K-_TL8_M/_P#B,7@O_P"?/0!_F_\
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MX?\ CWP+XI\8_9]1U_2O"OCK7/'VG_&77_ 5E>M<'18M+ND^%7@@W.EI;_\
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M/39 #\X?^"77_!X/\"_C5)X<^$7_  4@\*:9^SC\2;HVFEV?Q_\ !-OJFI?
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M_P#@HHK $#]E?XH. >?FBT9I$/U#HI'H1F@#_/R_X,^_^4PVE_\ 9M'QP_\
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MHW+OJ.MZ7X.M[GQ5\4_'6H:G?Q16&I>.O$+7]C:R)8VVO^)]/L;6!H #L/\
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MU/PAX^\+Z)XQ\+ZC-IMY!J.G2W_A_P 16.HZ3>26&H6UM?63W%I(UK>6\%U
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M ,':O_*:;XS_ /9)/V?_ /U6>D5_I$?\$@?^44O_  3:_P"S&/V6/_5*>"Z
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MMI/::AIVHZ7JMC8:OHNLZ5>6.L:)K%A8ZMI-]9:C9VUS%^?7A_PS_P $D_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$!0,VF>$?''B778;>^N])M;&Y /L[_@IK_P:3_L6_M9?\))\3OV.+ZT_8O\
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M&:*:"ZDCD4U_$#\8O^"I/QY_X.;?V@O!O_!,C]A_X9_$7]G[]AO4]?T3QO\
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M:K^/?QQ\<>+-5^"L'QLOKGX@:;H&F>!O$^H^"[WXK>*+'Q-)?)XG\?:EXO\
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MTBB1$15 !^,7_!=7_@K1I7_!)']CMOBGH.AZ7XR^/_Q8UZX^&_[/O@W6S,=
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MA.;?QO>W8!_:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8L?#'A];V[M?#&@:)83O:'^<SQG_ ,&87[!WBS]HO7_B?8_M ?'?P=\#]?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:A<W6HZA<75_=W-Q+Z%10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E
M!1^W-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YR
MB_\ =DW_ +]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW;-_ZV'^S[7^0+7^OU_P='?\H*/VYO\ NV;_ -;#_9]K_(%H _O\_P"#&/\
MYRB_]V3?^_<5_?Y7\ ?_  8Q_P#.47_NR;_W[BO[_* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._Y04?MS
M?]VS?^MA_L^U_D"U_K]?\'1W_*"C]N;_ +MF_P#6P_V?:_R!: /[_/\ @QC_
M .<HO_=DW_OW%?W^5_ '_P &,?\ SE%_[LF_]^XK^_R@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X.CO^4%'[
M<W_=LW_K8?[/M?Y M?Z_7_!T=_R@H_;F_P"[9O\ UL/]GVO\@6@#]_O^"&/_
M  0Q_P"'T?\ PU%_QE%_PS9_PS9_PI+_ )HE_P +B_X33_A<7_"W/^JN?"S_
M (1S_A'/^%6?]1W^U_[=_P"87_9?_$Q_?[_B!C_ZRB_^:3?_ )7%'_!C'_SE
M%_[LF_\ ?N*_O\H _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_
MO\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@
M8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-
M_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#
M'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__
M "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_**
M/X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_
M^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^
M5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\
MUE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#R
MN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#
M_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_
M .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\
M0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\
M-)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\
M** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/
M_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW
M_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_
M]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF_
M_*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH
M_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\
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M -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\
MFDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?
M\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2
M;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\
MHH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X _P#B
M!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LHO_FD
MW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q
M_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_
M /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#
M^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"L
MHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q
M1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647
M_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^
M_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X
M@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^
M:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$
M#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S
M2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_R
MB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8
M_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_
M^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\
M647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\
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M_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\
MX@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_Y
MI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0
M,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF
M_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH
M _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\
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M^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\
M$#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-
M)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_*
M* /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_
M *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\
MY7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]
M91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P K
MBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^
M/_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*
M+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4
M?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91
M?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO
M[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\
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MB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\
ME<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_64
M7_S2;_\ *XK^_P HH _@#_X@8_\ K*+_ .:3?_E<4?\ $#'_ -91?_-)O_RN
M*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\ \KBO[_** /X
M_P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\ -)O_ ,KBO[_** /X _\ B!C_ .LH
MO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_
M ! Q_P#647_S2;_\KBO[_** /X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
MS2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_
MRB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C
M_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_
M .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?
M_647_P TF_\ RN*_O\HH _@#_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\
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M (@8_P#K*+_YI-_^5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\
MYI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q
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M "N*_O\ ** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_**
M/X _^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_
M^LHO_FDW_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^
M5Q1_Q Q_]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\
MUE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#R
MN*_O\HH _@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#
M_P"(&/\ ZRB_^:3?_E<4?\0,?_647_S2;_\ *XK^_P HH _@#_X@8_\ K*+_
M .:3?_E<4?\ $#'_ -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\
M0,?_ %E%_P#-)O\ \KBO[_** /X _P#B!C_ZRB_^:3?_ )7%'_$#'_UE%_\
M-)O_ ,KBO[_** /X _\ B!C_ .LHO_FDW_Y7%'_$#'_UE%_\TF__ "N*_O\
M** /X _^(&/_ *RB_P#FDW_Y7%'_ ! Q_P#647_S2;_\KBO[_** /X _^(&/
M_K*+_P":3?\ Y7%'_$#'_P!91?\ S2;_ /*XK^_RB@#^ /\ X@8_^LHO_FDW
M_P"5Q1_Q Q_]91?_ #2;_P#*XK^_RB@#^ /_ (@8_P#K*+_YI-_^5Q1_Q Q_
M]91?_-)O_P KBO[_ "B@#^ /_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF_
M_*XK^_RB@#^ /_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*_O\HH
M_@#_ .(&/_K*+_YI-_\ E<4?\0,?_647_P TF_\ RN*_O\HH _@#_P"(&/\
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M -91?_-)O_RN*_O\HH _@#_X@8_^LHO_ )I-_P#E<4?\0,?_ %E%_P#-)O\
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M_B!C_P"LHO\ YI-_^5Q1_P 0,?\ UE%_\TF__*XK^_RB@#^ /_B!C_ZRB_\
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MQ_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,'1
MW_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+0!_?
MY_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_
M ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[7^0+
M0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV'^S[
M7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;-_ZV
M'^S[7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q
M7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W-_W;
M-_ZV'^S[7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_
M +]Q7]_E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?@#_ ,'1W_*"C]N;_NV;_P!;#_9]K_(%K_7Z_P"#H[_E!1^W
M-_W;-_ZV'^S[7^0+0!_?Y_P8Q_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\
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M1KX03PS&TU&QMK@1312>7LD1CR'_  ]3_P""8'_21_\ 8+_\3 _9[_\ GAT
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MX= 'WI17P8/^"J7_  3!) '_  4>_8+))P /VO\ ]GLDD] !_P +#Y)K[SH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_P"#H[_E!1^W-_W;
M-_ZV'^S[7^0+7^OU_P '1W_*"C]N;_NV;_UL/]GVO\@6@#^_S_@QC_YRB_\
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MNYT&ST[0_$V@>)K6QO4T+QQI.B^'X4UBTE\/:YH.EW=UX>O?$OQ/_P $VO\
M@NU_P4"_X)K>-/#3^ OB[XH^+'P(L;RUB\4?LU?%KQ+K'BCX::OX?$@%]9>#
MCJLNI:A\*=>:$M+I_B+P*=.0:A#9/XBTCQ1H\-QH=W_IP_\ !??X>Z#\3/\
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MA7P=HMEX?T'3U*JGF&VTW3[:.29E#SR*\TF9'8GT"@#^"_\ X+T?\&M_P/\
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M1%5$10J(H"JJJ,*JJ  JJ      , 8I0 H"J %       &  !P !P . *6@
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M_JI5_EW?\'HMS#/_ ,%6?A#%'C?9?L*_":VN,'),S_&[]I&\7(['R+N 8/8
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MYJWA[0IYH"TEG:7US?E3':2$?B[_ ,&N/[''B_X1_L5^-/VX/CK]LU;]IO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_ (.CO^4%'[<W_=LW_K8?
M[/M?Y M?Z_7_  ='?\H*/VYO^[9O_6P_V?:_R!: /[_/^#&/_G*+_P!V3?\
MOW%?W^5_ '_P8Q_\Y1?^[)O_ '[BO[_* "BBB@ HHHH *_A-_P"#JKXW?'+]
MM+]I7]F;_@C9^QSX$\1_&KQ]I5I<_M-_'+X=^";RTMK_ %?5+3P_K$WP^\):
MKJ5Y>:=9:+'X;\ )XM\>:O'J]V+&[_X37X=W=F'UBVL+>7^T7]I+]H+X:?LI
M? 3XN?M'_&'6DT'X:?!CP)K_ (^\67Y:+[3+8:'9//#I.E0S21+?>(/$%_\
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M>*U^#_Q7N9W$<%O\-?'4\TC$!4BA\+ZI)([$D !44L22  ,DU_@HT ?W*?\
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M),ZHC:C^T%"&8@ RW/[*7QUMX$R2/FDFECC4=2S  $D"O]@N@#_ W^(7P_\
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M1X6^'=[>RNL<%I;?&>UU+X.37%U*Y5(+.&/QXTEY/(RQP6JS32,$1B/[@_\
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M%;:?%_P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\ $R/V=?\
MYXU '\>W_!<+]DW_ (.'_P#@L=XB^%6AK_P2\TWX"_ KX*7'B'5O!W@)/VP_
MV/\ QUXI\0>+?$]OI^GZGXN\9>*O^%S>&;%WM]+TR&Q\/:!I.@VT&AQ7^MF[
MU;Q!-?P3V7X&_P#$+C_P77_Z,9_\V9_8\_\ H@J_T^_^'L7_  2R_P"DEG[
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M_"]_Q"X_\%U_^C&?_-F?V//_ *(*O]/O_A[%_P $LO\ I)9^P!_XF1^SK_\
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M7=IHOP]^'OC?QGXR^'5U<6LUSK#6NM:MXAT2&.SEMX/$1N+FUL4])_X>Q?\
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M*])T1]7'B.U?1X[H:?JHM>6_X>Q?\$LO^DEG[ '_ (F1^SK_ //&H_X>Q?\
M!++_ *26?L ?^)D?LZ__ #QJ /O^OQ@_;5_:L_X*JZ5:?&OX5_LH?\$?]?\
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M)+/V /\ Q,C]G7_YXU'_  ]B_P""67_22S]@#_Q,C]G7_P">-0!_/6O[6_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
MYW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_
M /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G
M?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_
M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
MYW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_
M /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G
M?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_
M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
MYW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_
M /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G
M?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_
M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
MYW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_
M /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G
M?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_
M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
MYW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_
M /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G
M?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\ 2-/]O_\ \0W_
M &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(-_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\ YW-?[?-% '^(
M-_PZ=_X*F_\ 2-/]O_\ \0W_ &BO_G<T?\.G?^"IO_2-/]O_ /\ $-_VBO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\
M@Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X
M,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U
M^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_
M@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V?:_R
M!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\ W[BO
M[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\ 6P_V
M?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[)O\
MW[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[MF_\
M6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%_P"[
M)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;F_[M
MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_ #E%
M_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R@H_;
MF_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\&,?_
M #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!T=_R
M@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?W^?\
M&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!
MT=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D"T ?
MW^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X
M_P#!T=_R@H_;F_[MF_\ 6P_V?:_R!:_U^O\ @Z._Y04?MS?]VS?^MA_L^U_D
M"T ?W^?\&,?_ #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4
M444 %%%% !1110 4444 %%%% !17@'QT_:Q_98_9?_X1;_AI?]I;]G_]G?\
MX3C^V_\ A"O^%Z?&3X=?"3_A,/\ A&?[(_X23_A%O^$_\1^'_P#A(/\ A'_^
M$@T'^V_[)^U_V5_;>D?;_L_]I6?G?/\ _P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_
M ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?
M\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_
M^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67
M_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0
M!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S
M]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(
M_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O
M^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\
M17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_
M^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67
M_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_
M ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?
M\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4
M??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(
M_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O
M^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S
M]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T
M5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_
M ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?
M\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_
M^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67
M_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0
M!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S
M]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(
M_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O
M^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\
M17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_
M^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67
M_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_
M ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?
M\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4
M??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(
M_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O
M^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S
M]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T
M5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_
M ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?
M\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_
M^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67
M_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0
M!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S
M]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(
M_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O
M^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\
M17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_
M^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67
M_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_
M ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?
M\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4
M??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(
M_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O
M^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\
M3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S
M]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /
M8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T
M5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_
M ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_
MTDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?
M\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_
M^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67
M_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!
M_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0
M!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9
MU_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S
M]@#_ ,3(_9U_^>-0!]_T5\ ?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\ @EE_TDL_8 _\3(_9U_\
MGC5Z!\+?^"A/[ OQQ\=Z%\+?@I^W#^R!\8/B;XH_M/\ X1GX=?"W]I;X+_$#
MQWXB_L31]0\1:S_87A'PGXUU?Q!J_P#9'A_2-5UW4_[/T^X^P:/IFH:G=>59
M65S/$ ?7]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !17R!\4O^"A/[ OP.\=Z[\+?C7^W#^R!\'_ (F^%_[,_P"$F^'7Q2_:
M6^"_P_\ '?AW^V]'T_Q%HW]N^$?%GC72/$&D?VOX?U?2M=TS^T-/M_M^CZGI
M^IVOFV5[;3R^?_\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%?
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??
M]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8
M_P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\
M ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_
M $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8
M_P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%?
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??
M]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8
M_P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\
M ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_
M $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8
M_P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%?
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??
M]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8
M_P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\
M ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_
M )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9
M?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_
M $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=
M?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@E
ME_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8
M_P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_
M ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%?
M'_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU
M 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$
MR/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU'_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TDL_8 _P#$R/V=?_GC
M4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\ #V+_ ()9?])+/V /
M_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC4 ??]%? '_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU 'W_ $5\ ?\
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M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?
MR!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;
M_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G
M_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B
M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT
M_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z
M+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@
M7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_
M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T
M4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%
M\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#A
MT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\
M@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G
M7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%
M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^
MT4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_
MLZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]
M%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/
M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:^O_ -@K_@U^_8%_X)V_M8_"G]L7X*?%W]K_ ,4?
M$WX/_P#"=?\ ",Z%\4O'WP7UOP)??\+ ^&WC'X6ZS_;NF>$_@!X)\07/V;P_
MXVU6\TS^S_$^F>3K%OI]Q=?;;**YT^[_ */J* "BBB@ HHHH **** "BBB@
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MU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\
M\.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"6
M7_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^
MA5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\
M_AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\
M$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M%
M'\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O
M_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/
MV_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"
MI_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/
M]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\
MHOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_
M !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0
MJU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_
M ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\
M@EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z
M%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?
M_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_
M\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[
M10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^
MSK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?
M/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_
MX@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_
MV=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^
MB^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7
M_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"
MK7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\
M_P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)
M9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_
M .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[
M?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4
M_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7
M[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G
M^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_
MT7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_
M (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X
M=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO
M^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_
M(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]
M"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__
M /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?
M^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M
M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3
M_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?
MM% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .
MG^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5
MH_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\
MX=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!
M++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!
M_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_
M /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]
MO_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J
M?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\
M9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?
MM_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q
M!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]
M?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ
M?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67
M_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6
MC_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_
M (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $
MLO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '
M\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK
M_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V
M_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@
MJ?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]
MG7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_H
MOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_
MQ!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0J
MU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\
M\.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"6
M7_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^
MA5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\
M_AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\
M$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M%
M'\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O
M_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/
MV_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"
MI_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/
M]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\
MHOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_
M !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0
MJU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_
M ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\
M@EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z
M%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?
M_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_
M\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[
M10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^
MSK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?
M/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_
MX@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_
MV=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^
MB^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7
M_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"
MK7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\
M_P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)
M9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_
M .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[
M?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4
M_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7
M[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G
M^SK_ /0JU_7[10!_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_
MT7S]O_\ \.G^SK_]"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_
M (@J?^"67_1?/V__ /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X
M=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO
M^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7[10!_
M(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]
M"K7]?M% '\@7_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__
M /PZ?[.O_P!"K7]?M% '\@7_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?
M^"67_1?/V_\ _P .G^SK_P#0JU_7[10!_(%_Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6OU__ ."4G_!%3]EC_@CY_P +Z_X9H\??M >./^&B/^%7?\)K_P +T\5?
M#KQ-_9?_  J3_A8O_"-_\(M_P@'PJ^&7V+[;_P +-U[^V_[6_MO[3]DTC[!_
M9OV>\^W_ *_44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P='?\
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M.S^(_P"V!_P7+^.'P*^(FMPIJ\GPT^%_CCXS?$;2?"=W=*;@:7=Q>#/B_P#
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M=6VBU>Y^#EYX^GL9;OPGX B826]MX@\(>$+Z3Q7\1O%]NEWJWAJV#>&?"?\
M9GCFQU+4-" /ZR?&WQ7^%OPT^R'XC_$KP!\/Q?@FQ/C;QEX=\*?;0KB,FT_M
MW4;#[2!(0A,.\!R%/S$"NJT/7M#\3Z59Z[X;UG2?$.B:C%Y^GZSH>HV>K:5?
MP[F3SK/4+":XM+J+>K+YD$SIN5ESD$5_*;\7_P#@T)_8+^+/PP\0)K?QZ_:V
M\1?M2ZWI,UW>?M3_ !*^*$?Q%\0^(O'AM!LUOQIX/UK2ET[6_#4VI -=:'::
MII?B0Z2?L47C=;]!J[?PK^"?CW_P4K_X-^?VX?'WPL\,>._$7PR^(/PF\;QV
M7Q"^%]Y?:MK7P(^-_AL-;W>D:UJW@Z]DLM*\5^#O'OA>2TU+PMXOM[/2/&>D
MZ1JT=SH>K^%_$$,OV, _V;Z*\1_9G^,J?M%_LX?L_P#[0<7AO4/!L?QU^"?P
MJ^,:>$-69WU3PJOQ-\"Z%XU7PYJ4CP6K27VAC6_[,NY#;0>9/:R.(8PP0>W4
M %%%?C=_P5>_X+@?L<?\$F/"=O;?%G5KSXE?'_Q+HYU?X>_LV^ +RS/CK7;&
M26:UM?$7BW5+E9]+^''@:2]@EMQXDU^.XU#4_LVHKX0\.>*[O2M2L[4 _9&B
MO\_7X)_MR?\ !RW_ ,%YM8U;Q#^QS<^!?V!?V1(];OM*_P"%J:?9+X;\.@64
MIBET>T^+/B'PYXS^+?Q+\7Z:AG@U*Z^#_A[POX6M=52.U\21>%I)+,+^A6A_
M\&W'_!1W6+2/7/B=_P '%7[>5SX[D1YS/X4U3XW'1]&O)6W-#I]WJO[54-]>
M6<?(C^S67AQ0A2.*SMXX@K ']@%%?R >)_V0_P#@YJ_X)O:?/X__ &8?V]/"
M7_!5;X:>&%DU+7O@7^TEX0N+/XL^)=,L8O.D70K_ ,3>)M>\7:K>QV<=RGV#
M0?VB=(UG4[PVJZ=X9\1WT\=C%^+_ /P4R_X.S/C=^T'^R/XM_9,^'?[,WQ._
M8G_:BUS7=/\ "GQP\>I\3]:TWQ)\,X_!OB&VO?$WASX>06WASP5X^\+>*O$6
MJZ-'H6O'Q&=.U#PAH,WB#PZL>MZG?0Z]I@!_I/T5QWP[\2KXS^'_ (&\8(RN
MGBSP=X9\2HZXVNNNZ+9:HK+CC:PN@1CC!&.*[&@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBOSQ_;WTG_@J#XHT?PUX1_X)P^)?V0_AI=:U
MI/B<_$#XN?M,)\1O$'B'P9?V[:4GA2V^&?@3PCX7UWPOK%]J9N=4GU'6?'#W
M^DZ/%IJQ#PQK$M]"T(!]Q>-O'W@7X:>'KKQ;\1_&GA+X?^%+*6WAO?$WC;Q'
MH_A3P]:37<HAM8KK6M=O+#3;>6YF98K>.6Y1II2(XPSD"NEM;JVOK:WO;*X@
MO+.\@ANK2[M9H[BVNK:XC66"XMYXF>*>">)TEAFB=HY(V5T9E8$_XBW_  4M
M^,?[?'CC]JCXO_##_@H+\=/B%\8?C5\#OB5XR^'?B&T\2>+;S6/ _A[7O#6L
M7>D:I)\-/#=K;Z/X/\->%-7>V_M/1U\)^%_#FGZAIE[;7_\ 9T+73(/]I3]G
M_P#Y(/\ !/\ [)'\-_\ U#=%H ]<KA?^%H_#,>.Q\+3\1/ O_"S38?VJ/AU_
MPEV@?\)V=+\C[5_:0\(_VA_PD!L/LW^D?;/[/^S^1^]\SR_FKMY!(8W$3*DI
M1A&[H71)"I",Z!D+JK8+('0L 0&4G(_QK9O^"?\ _P %D1_P4Z;P>?A%^TB?
MVY6_:%/BM?C0OAWQD-.;QO\ \)A_:0^.2?%K^SO^$<'P[^TX\4#Q[_:G_"-)
MX>&3*(%-D #_ &5:*CA$JPQ+.Z23K%&)I(T,<<DH4"1XXV>0QHS[F5"[E%(4
MNQ&3)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M .&GBDVR7-UX-^(WA0W-S<^'?$-HC[XF2>^T36[/R]8\,:SKFA7-IJEQ]HT
M%%%?@'_P7X_X+6Z#_P $B_@!X>L_ .EZ%XY_:V^.B:W8?!7P;KIFN/#WA/1]
M&2WA\0_%KQY8V<]M=W7A[0+J_L=-\/Z MWI\_C#Q'<FUM[I=)T+Q-<V !^[O
MB7Q7X7\%Z3/K_C'Q)H'A/0K5D6YUKQ+K&G:%I-NTA(C6?4=4N;6SB:0@A!),
MI8@A0<5D>"?B7\.?B59W.H_#GQ_X)\?Z?9R)#=WW@GQ5H7BJSM99 QCBN;K0
MK^_@@D<(Y1)75F"L5!"G'\H_[.7_  ;O>!_^"@_[/'PR_:G_ ."O'[1?[5'[
M3'[5OQ]^'VA?$^^MHOBL/!W@+X"V'Q$T>S\2Z+X$^&G@?3="GT#0KSP[I6HV
M-IXAMK6U_P"$,?7H+N'1?"UKI\"SW_\ 'Q_P58_X)P_M4_\ !OU^VCX6\3?
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MO X\2>&;32[S499/&^I:Y96.DO=7%];W2?ZZ] !1110 4444 %%%% !1110
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M//)ZW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?@#^V-^R)_P7'T
M#X;_ !+^(?['7_!8+4/$?CW0K/Q+XK\(_ _XE?L3_L@V^D>)[6T%YJ=CX T+
MXA:5\-+S5-)UDV:)H_A_4?$&@:[!JVI"SAUS4-(ANKK6K3^ \_\ !TK_ ,%T
ME)5OVU;4,"00?V:/V2P00<$$'X%9!!X(/(- '^O=17\.?P>^'_\ P>P_%/1[
M#6]=_:/^!'P5MM2M8+VTMOBOX8_8FGOFM;F(36\D]I\)_@#\4I+1Y8F1S;71
M@O("XBN;>"9)8X_2O&/@O_@]$^$&G3:WIGQD_9%_:;:R1IW\->#M$_9XTK4;
MV./+/'"OB_X2_ **9RBEEA@UF*XER(X%>=DC(!_:%17^=>W_  =D?\%9?V*?
MBB?A%_P48_8"^&@U_2/*FU+PU<^'/BC^S7\2M2TQY6B_MC3=9U[4_B7X+UK2
MKGRW;2]:\/\ @E]$U!5+6U_<Q,)5_J4_X)??\%^_V!_^"I,]GX$^&OBK5?A#
M^T4]A<7MW^SO\8%L-&\8:I'80F?4;OX=Z_975UX5^)-A;0QW-XUKH&HQ^+[3
M2;2XU?7?!^B6$;2@ _;RBBB@ HHHH **** "BBJ,VIZ;;W]EI5QJ%C!JFI0W
MMQIVFS7=O%?W]OIOV;^T9[*S>1;BZAL/MMG]ME@CD2U^UVWGM'Y\6\ O4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P '1W_*"C]N;_NV;_UL
M/]GVO\@6O]?K_@Z._P"4%'[<W_=LW_K8?[/M?Y M ']_G_!C'_SE%_[LF_\
M?N*_O\K^ /\ X,8_^<HO_=DW_OW%?W^4 %%%% !1110 4444 %%%% !1110
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MX?:?+X?31;J#5+7XC'4+K6=%.B06NM_D'^V%_P '9'[7/[!?QQU_]G;]J?\
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M;7/@U\1?#&KV^EW>B>%_&FJ0MX>T#6]5\771M?#.J%[+0+F.5;6!Y;VV /\
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MH"[M](\1?%SQ'=)\._V>?A]JLT@M_&'Q5UNTNIK*[U:VM98;V3P?X)TNUO\
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M1L](T+0]#TFTFU#5=9UC5]0FM]/TS2=,L+>>^U#4;VX@L[.TAFN;F:.&-W4
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M;CN\UQ(['J68D\FO]@G]G_\ Y(/\$_\ LD?PW_\ 4-T6O\@'_@X=_P"4T?\
MP4 _[+!I?_JN?!%?Z_W[/_\ R0?X)_\ 9(_AO_ZANBT >N45^8?[?7_!8O\
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MC"WC&/0O^$M%MF*/7F^$@T#?\S^#SG(_T4OV>OC=X._:6^ OP7_:(^'HU%/
MOQT^%?@'XN>$(M8MTM-7M_#OQ#\+Z7XKTBTU>UCEGCM=5M++58;;4K:.>>."
M]BGBCFE1!(P![#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7^"A\9K.WT[XP?%;3[2-8;6Q^)/CJS
MMHD542*WM?%&J00QHJ@*JI&BJJJ H     %?[U]?X+7QS_Y+;\8O^RI_$'_U
M+=7H _WB?#'_ "+7A[_L!Z3_ .D%O6Y6'X8_Y%KP]_V ])_](+>MR@#XL_;M
M_P""?O[+?_!1OX'ZU\"/VI/AQIOC'P_=V][+X3\66L5K8_$+X7^)+FW$-OXR
M^&OBUK:XOO#7B"SDC@DE1%N=%UZV@_L;Q3I&NZ!<WNE7/^05_P %)?V!?C__
M ,$@OVW=<^!WB3Q'K-KJ_@W4=(^)OP!^-_A234O"UQXV\"RZI<7/@7XD^%[V
MSN4O_#OB32M3TJYTK7;2QU"6?POXX\/ZO9:?J>H6=II^LW_^V17\@O\ P>2?
ML@Z'\6_^">'@?]K+3]*@'CW]DKXK^'[;4=<2!?M#_"/XV:AI_@'Q!H]S+&@E
ME1/B1+\+-0TYKB5X+!5UE((EEU>:0@'UY_P;@_\ !96[_P""I/[,.L>!/C9J
MEBW[8?[-MOHFC?%>XAM[;3(_BIX*U7[3:^#?C'IVFVZQ6L.I:D^GW6@_$33]
M*A73],\66D&LP6NBZ3XTT#1;/^CZO\;G_@WA_:UUG]D'_@KC^R1XFM]2N+/P
MC\9?'NG_ +,WQ)L4N6MK'5O"OQVOK+P5I3:NP=$.G>%_B%=>!_';F4^6D_A2
M"1_D5J_V1J "BOY@?^"H7_!R_P#!_P#8Y^/$?[%/[('P8UG]M_\ ;.NO%&G_
M  \O_!_A76)].^'W@KXD:U?0:3I?P^O=4T72_$'B#Q]\2(]6NK;3]4\!>$=/
MM(M+U"630]8\8:/XELM0T2TY#Q1\</\ @[G/@>3XH:+^R3_P3$L9TTZ36(_@
M-9>(/'&K_$^.!81<+HM]J-]\?+7P'J&NI%F*1-(^(-K!<W2M%;!7>*$@']5M
M%?PZ?L.?\'@TVI?'>V_9O_X*@_LR:3^S1XB7QI<?#KQ3\6/AY<>*M)\.?"WQ
MK9:O+H&HZ9\6?A'\0Y]9\8>$-(T76(9;/Q+KEKXUU[4/#4L$QU#PNUI!>7ME
M_</#-#<PQ7%O+%/;SQ1S03PR++#-#*H>*6*5"R212(RO'(C,KJP9200: %EE
MB@BDFFDCAAAC>6665UCBBBC4O)))(Y")&B L[L0JJ"S$ $U_%S^R+_P4ST+_
M (*/_P#!T7J1^%'B1?$7[-_[,_[(WQU^"_P;U2RF,FB^,-1@U[P3J'Q/^)^E
M#+Q2VGC'Q6L>CZ)JEO(UOKG@?P9X,U=8X9+N6-?,/^#B_P#X*+_\%7/B!\+?
MCY^SM^R[^P?^UA\ /V0?!L'C'2/VBOVN/%7@'5]*O_B;X!\-75YIOB./P;JV
MC27ND^"/@;XAMK2:\O\ Q1+K5SXD^(/A&]M;&\MO!^A7FO:%X@_E._X(%?M.
M_M$?LD?M\0_%K]F']D'QE^V[\3E^#/Q'\-+\$O NLZKH.NOX?UJX\-/JWBT7
M^C^#/'=X+/0'LK..XA_L(Q2'4(R]Y;[5$@!_LDT5_.U^PW_P5I_X*<?M+?M3
M?"SX)?M!?\$2?CG^R3\(?&\GC%/%_P"T)XP\=^+]8\.?#U?#_P /_%?BK0WU
M'3=4^!7@^QN1XG\2:'HW@RU$_B/3?*O?$5M/&;J:..QN?Z%M5U73-"TS4M;U
MO4K#1]&T>PO-5U?5]5O+?3],TK3-/MY+N_U+4K^[DAM+&PL;2&6ZO+RZEBM[
M:WBDFFD2-&8 %^BOY;/B)_P<#?'7]JOXQ^-_V=_^"&_[$6I_MWZ[\.;H:=X]
M_:>^(>O#X<_LM>%=2:6:*%-/U34=3\)#Q9IU[]GO9-+OM3\?_#V\\21Z5J%U
MX&T?QEHY@UEOSA_;(_X+$?\ !S[_ ,$W]-M/C#^UM^PQ^Q^_P,GU*QLM3\5^
M _#'BSQMX!T2?4;E+>VTS6?%/@#]HWQ%KG@*ZO+F:'3='U/QY:)I>H:E/;6=
M@VLW<GV9P#^[&BOYRO\ @C5_P<=?LS?\%5];B^!WB?PI<?LV_M;1Z5>:K8_"
MK6_$,/B3PA\4-/T>SDO-;U#X2^-6L-%GU35-+LK>XUK6/ NN:-IWB+3=&2XU
M#1[GQ=I6B^(-8TO^C6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@Z._P"4%'[<
MW_=LW_K8?[/M?Y M?Z_7_!T=_P H*/VYO^[9O_6P_P!GVO\ (%H _O\ /^#&
M/_G*+_W9-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K^9W_@MY_P &X7P0_P""H\FI_'[X,ZUH
MOP _;5MM)AM9_&MQI\[_  V^-D&EV:6NC:1\8M,TFWFU*RUNQMK>WTK2?B?H
M%IJ&OZ?HZ1:9K^@^,M-TSP]9Z#_25XA\1>'_  EH>J^)O%>NZ/X9\-Z%8W&I
MZWXA\0ZG9:+H>C:;:(9;K4-5U;4I[:PT^QMHE:2XN[NXAMX4!>215!-:<$\%
MU!#=6LT5S;7,4<]O<02)-!/!,@DBFAEC9HY8I8V5XY$9D=&#*Q4@T ?X9O[:
M'[!/[6G_  3[^*5S\(OVLO@SXI^%?B4O=OX>U:_MUU'P1X\TNTE6-M>^'WCC
M3&NO#/C#1R)(3/-H^HSW6E33+I^N6>EZK'<6$/ZG_P#!+[_@Y'_;^_X)OOX=
M^'^J^)I?VHOV9-*-K9-\#OC#KFH76H>%M%A*(;3X2?$YXM3\3?#_ .SP(L&G
M:'>0>*OA_8QF9H/!$=Y.;Z/_ %>_V@_V;?@+^U=\,M;^#7[2'PE\#_&;X9>(
M5_XF/A'QYH5KK6GI=+'+%;ZMI,TJK?\ A_Q!IXFD?2?$F@WFFZ_H\[?:=+U*
MSN564?P,?\%9_P#@S_\ &'PXL/%?QU_X)?:YK7Q,\):?#?:YK'[*'CG4!??$
MS1[&!9+JZ@^#GCB?RH_B)#;1;ET[P1XM2Q\;/:VBV^F^*O'_ (BOK73) #^P
M/_@F1_P6*_8L_P""J_@6?6_V=_'$VC_$_P .Z7!J'Q&_9^\?BRT3XM^!$=X;
M:?46TB*[NK+Q;X0%[/!;VWC7PA>ZOH2O>6%EK$FB:[<OHEO^J-?X/WP*^.?Q
MT_8W^/?@[XT_!SQ1XF^$GQO^#7BXW^DZC#'<Z9J^C:WI-S+8ZSX<\1Z->)%]
MLTR_C6^\/>+O"FMVLEAJ^EW.I:%K=C-:7-S;-_M.?\$UOVUO#7_!0_\ 8?\
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MZCKNHPV*7FKWT5G:1W>H37%PEM L@B3_ &VZ /XLO^#VS_DQK]D3_LZ^[_\
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M'H7@+Q/=2>(/!/V359VDN;^\\ :_8Z[\.M0U"^$J>(+OP=?W5[!+;:C+ _\
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M)O"T]IXA\4>&]+D\%6^HZ9I_B'4[^W_MI_X.FP#_ ,$,?VS_ &U']FHCV/\
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MF^''C'X5_%W4M8\'W,VAZ?8&[T;^WO!OA+5+"SNO.@TN?39O[/CMQJ%[YWX
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MO1), <-&-:T32) #D>;'$V,J"/\ 6#H _P :7_@X=_Y31_\ !0#_ ++!I?\
MZKGP17^O]^S_ /\ )!_@G_V2/X;_ /J&Z+7^0#_P<._\IH_^"@'_ &6#2_\
MU7/@BO\ 7^_9_P#^2#_!/_LD?PW_ /4-T6@"]XQ^"?P:^(<WB&X\>_";X:^-
M;KQ;X8'@GQ3=^*O _AG7[SQ%X.7^T"GA76[S5-,NKG4_#L;:OJK1:->2S:=$
M^I7[QVZO=W#2?XJ/PZ\":;\+?^"I/@3X9:-&\.C_  Z_;\\,>!-*BDDDFDBT
MWPC^T18^'[&.2:5FEE=+73XE:21FD=@6=BQ)/^WY7^*1K8 _X+2:N!P!_P %
M0K\ >@'[5TN* /\ :WK_ #^?^#W3P]\?]3UK]A?5[/1?%%_^S7I&C_%2SFU'
M2;.]NO#&G?&S6M5\+1+;^*);*-[:TUK4O!]GI\7@@:PR2WD,7C.'P]O9-?6O
M] :L3Q)XD\.>#?#^M>+/%^OZ)X5\*^&M+OM<\1^)O$FJV.A^'] T72[>2\U+
M6-:UG5)[73M*TO3K2&6ZOM0OKF"TM+>*2>>:.-&8 'X:?\&SWP5^(/P(_P""
M,W[)_A3XH^"-3^'OC/7Y?BY\0[KPWKVE3:+XB70_'?QB\<Z_X,U;7;"YBANX
MKK7?!5SX>UC3Q=HMTN@WNCQ3)"\9MX>S_P"#B[X6>'?BQ_P1C_;HTOQ!86]Y
M)X/^&FE?%/P_<RQ*]QI/B+X9>-?#/C"RO["4D/:W$MMI=[I-S+$RM+I>IZC9
M2"2WNYX9/AWXU_\ !R1;?&GXS:A^R1_P1@_9;\8_\%&/VAHA<0WWQ(;[7X(_
M9C\#10W L9?$^L^*;Z32=2\0^%=/U'%C>:_JFI_"_P !ZB]U82^&_B/K9O;2
M&X^%O^"F7_!.O_@K%\5_^">?[7G[57_!3_\ X*0:K"?AK\$/%_Q"\,?L._L<
MZ:/ 7[/-GJ>F6T=_I.A_$[Q-/:Z?>_%'2]/NI M_HVO^'_$M]%<P,=)^)MW;
MBWN% /QI_P"#,7QKJV@_\%3OBAX2M[N9=%\>?L=?$NVU33O-86L]_P"'?B7\
M'=<TC47A!"/>:?%#JUI:S,&:&VU;4$3 N'-?Z=?BCP-X*\;KHR^-/!_A;Q>O
MAS5T\0>'E\4>'])U]=!UZ.QOM+36]&&K6EV-+U=-,U34].34K'R+U;'4;ZT$
MPM[NXCD_RW?^#.C_ )2\WO\ V:A\:?\ U(OAG7^J70!_DJ_\'7OP0^'GP2_X
M*_\ Q#7X;^$]"\%Z5\4O@[\(_BMK6B^&M,L]%T9_%>KZ?J_A77M7M]+TZ&VL
M;6[UV?P='J^LRP01OJ6N7FI:O>&;4-0NYY?ZR?\ @@-_P2/^$/Q)_9+_ &/O
MV[?VU[RP_:V^*DOP,\)Z'^S#X"^(FCVNK_!;]E;X+Z+<7H\*^'O WP\U."7P
M_K/Q%U2\6X\7^+?B!KVF75Y:^)=15?#,5E>:==>)?$'\T'_!Y  /^"N6A$#K
M^R+\&2?<_P#"8?%D9_( ?A7]ZO\ P0>_Y0[_ /!/'_LVSP9_Z'?T ?>W[1/[
M-7P4_:K^!_CK]G;XY^ ?#_CGX4?$'PS?>&-8\.:IIEC/'8075C+96.L>'9)K
M>4^'_$OAQY(]1\+>(-+6WU/P[JUI9ZEI5Q;75K#(O^-W^PEK?C']B/\ X+ _
MLU16&KSP>(O@/^W;X-^&/B2^LS):-JVAZ=\88OA;\1M+8(S216?BGPG=>)-#
MO8<N38ZK/"V\$@_[7-?XJGQ7 3_@MG\2E0!57_@J;XQ"A0%"A?VM-1 "@8
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M'K.TT_X2?"VPL%1;&Q^'/@BSLUC&(UM+;PSID-NL8' 00H@4#HH KT:ODO\
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MU3^Q!8R&3^S;?]G[X@W5H"Q\H7UY\1HH=0*+T$AM['3/,;JRB('[HH ^T/\
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M9_%'P!^P_P#!/Q%966M>"_#'C[Q3KMGXG^-_[0WB'PY>?;M-U7QQ=ZC+X<\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.]6C^%?Q(T47WQ%N-<MEN]*\5:C\1==T/3=/CU8KK%SXHU&VN@A\BZNH/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]H+X@:78:9=:)I-]'"FK:#\*_!5E<:C8?#S1-7,.=4N9=7\3>,=3BFN=-O\
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M0S_LXSQ3^EGI>?RK_9>\#RI/X*\(3QD-'-X7\/RQL#D,DFDVCJ0>X*D$&O\
M$P_X*I_ W3?V:?\ @HE^US\"=*\8>-?B';_#3XP:WX>N/B!\2-9?Q#X_\=ZN
MMK87NO>,_&6M2*C:EXD\4ZY>:CKFKW.T*U[?RA!L5:_TT?\ @CA_P5O_ &A/
MV[/A9^S-X:O/^"</[37@SPU8?#O1?#OQI_:N\9W?@SP5^S^M[X4\!SVD'C+X
M4OXJU+2_&/Q;L?&OBG2M*M)M$\(Z%<2>#8?$5U<7VKZO;>'I9]2 ,O\ X.O?
M^4)'[27_ &/G[.W_ *O7P'7\Y/\ P9!_\G,?MT_]D+^%W_J?ZO7ZL_\ !V+_
M ,%#_P!D*^_X)J>)_P!E7P-\?/A;\3?CE\9OB9\*WT_P!\-?''AOQSK?AOPO
MX$\767CW7/%OC&'PUJ6I1^%]&+>';+0],_MF2SO=;U75XET>TOK73=;N=,_F
MK_X-1?\ @H1\ ?V%_P!NWXE:!^TMX\T/X5?#;]I'X/Q?#[2OB5XJNXM,\'>&
M?B-X=\7Z-XA\*P^,]=N6CL/#'AO6M*?Q5ITOB;59X-)TO67T5-5N++3;NZU*
MQ /]6NOYK/\ @[(^!FM_&;_@C=\5M>T"QFU*]^ /Q5^$?QSN;*VB::Y;1--U
MF_\ AQXCOHXT!/DZ)H'Q,U+7]1E.%M])TN_N7.V$@_T/> ?B5\.?BMH"^*_A
M=X_\%?$GPN]RUFGB3P#XJT+QCH#7:6]M=O:KK'AV_P!1TYKE+2]L[IH!<F5;
M>[MIBHCGB9T^)7PY\%?&#X=^._A/\2/#]CXK^'OQ,\'^)/ /CCPQJ2L^G^(/
M"7B[1[S0?$.C7@1DD%OJ6DW]W:2M$\<J+*7BD215< '^8+_P:8_\%._!'[%?
M[8/CG]F;XW^)K+PG\&?VR[3PEH>B>+-;NX[30?!OQW\'76J0_#UM7O+ETMM&
MT3Q[IOB;7O!NHZHQ6)?$;>!#J4MMI%K>W]C_ *F%?XT?_!9?_@C3\?O^"37Q
M^UK0];T77_&?[+_C/7]0G^ 7Q]@T^2XT+7]"N))[RP\%>-=0LX!8>'?BIX=L
M%:SUO1+P6*Z^MC/XF\,P7&AW!%G]A_L$_P#!U1_P4L_8G^'^A?!_Q3<?#[]K
M#X7^%K&VTGPI:_'FV\27'Q$\*:)8QK#8Z%HWQ/\ #6O:3K.IZ39Q+Y%I%X[L
M?&UWI]DEMIFDWNG:596EC$ ?ZS-?EC^QG_P4$U/]M']M?]OWX5?#/3O"NK?L
ML?L:7?P>^#6C?%C38=0NM2^(?[2>IQ^/=8^.FD:1KT>JRZ!?^%/AO9VG@SPK
M+:6^CP7T?B 7FL0ZSJVBZ[IT=E_#QXM_X.+/^"T?_!87Q5I'[#G[$/PE\#_
M_P 2?&19O#VJW_P(L_%E_P#$NU\+WQ2S\1:OKWQ>\4ZQ?:?\+/ VD6-R+G7_
M !QH6@>%M:T.V+O!XJADN(+27^\#_@E;_P $\?A]_P $P?V+OAE^RMX)O;?Q
M%KFD?;?&/Q=^(,=FUE-\3/C#XICM)/&?C&6W<M-#8J++3?#/A>UN7EO-/\%^
M&_#>FWUQ=WMG<7EP ?HK1110!\Z_M??!'_AI?]D_]IO]G430VTOQW^ 'QA^#
M]M>7!VPV-Y\1_A]XA\(V5^[X)C^P7>KPWBR@%HG@61?F45_B>_LO_%7Q/^Q/
M^VQ\!_C%XBT+5=+\4_LN?M*?#[QIXN\)7436FKQ7GPF^(^F:AXO\(7]NQ1X;
MJXCT75?#VHVS,C*TT\#,IR1_NF5_G=?\'2/_  05^(NG?%'QQ_P4Q_8Y\ ZE
MXT\"^/WN/%'[6'PN\':7-J/B+P+XUCBWZU\<M!T/3XI+O5_!?B^.(ZM\3ELK
M>?4/"OBD:IXXOOM?ASQ%K-UX0 /]"CPMXG\/>-O#/ASQGX2UBQ\0^%/%VA:1
MXG\,Z_I<ZW.F:YX>U_3[?5=%UC3KE/DN+'4]-N[:]M)U^66WGCD7AA6[7\"_
M_!MQ_P '&_P)^'GP&\%?L _\% ?B/8_"F[^$]K'X;_9W^/\ XQFE@^'^J_#J
M.1FT?X7?$CQ$5DMO!&I^ XG?3?!WBO6VLO!M]X)MM.\/:KJ.@ZQX<L)?%_\
M4-^U!_P7$_X)9?LI_"O6?BCXO_;0^ GQ#:RTN>_\/_#WX%_%#P-\9OB;XXO/
M)+:=I?AGPEX"\0:S=+_:MPT5I#KVO2Z+X2T]IA=:UX@TRPBGNH@#^$7_ (/.
M?&.F^(_^"K?PTT#3YXY;CX?_ +%?PH\-:W&C!GMM8U/XJ_';QJL$H!)1FT+Q
M5H5RJ, VRX63E9%-?W(?\$!_V5=:_8[_ ."2G['?PH\6Z;-I7CO7/ 5]\8_'
M=A=P_9]1L/$7QM\1:M\3H=%U6WPI@U7POX>\2Z%X2U"!QYD-SH+Q2DR(Y/\
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M]TK26L/'5_\ #>X\-WWCGP^MLT6B>([S4]+)@>WDL;3_ !6?VN?@)XR_8O\
MVO\ X]?L]:TNH:/XJ_9]^-?C#P;IU]('ANKBS\*^);D^#_%5B[@.]GX@T&/1
M?%&BWFW%UIVI65VHVRBO]U:OXL?^#I'_ ((0^.?VNTB_X*#_ +''@NY\7?M
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M%KJ4NAVODFYMA+Y]]'Y9N(-^/-CW?Y^W_!Y-^W?^R]\>M/\ V1/V;/@5\8O
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M.>S_ &F4B8CL':WE /<HWI7Z'_\ !YO_ ,HG?AS_ -GL?"'_ -51\?*_D_\
M^#9C_@J7X1_X)A?M+?$_4OC_ *7XDTS]D?\ :/L/ 7PN^*7Q;TGP[K.LZ+\)
M/B?H5UXLU[X0>(O$LFEV5ZT^D7.EWGQ-T[4M%L8Y?$,FEW-]XHTFRU&V\):I
MI]T ?ZRU?A1_P<L_$+2?AW_P10_;=N]3N4AN/%?ACX<?#W1;<[3-J&K>-?C'
M\/=$^S6ZL0'>WTR?4]4GP=T=CIUW,@9XU1OT\T+]M;]CCQ-X"C^*?A_]J_\
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MXD>'K7Q9-;NC:EX.\#^"_$/A"]T#PW(?[/D\7:EJVO:M#J%[I7A230?] _\
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M4])LXE\BTB\=V/C:[T^R2VTS2;W3M*LK2QB /]9FORQ_8S_X*":G^VC^VO\
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M-3\8>%?",.C_  H^&/\ 8&F[5N%N?B(^DP^+DL)<20ZEXKN8YFCVML_U2/\
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M6UY>Z[;Z3X=7@:A\1?AYJE_K.I^%='!CNO%VC:]KWAZUEO==L_!^CW7\ ?\
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MJ)K35XKSX3?$?3-0\7^$+^W8H\-U<1Z+JOA[4;9F1E::>!F4Y(_W3*_SNO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI\+_ (#?&8:U>E1E8;74OB/X-^'7@U993E4%WXKM44C,SQ(58@']%]?Y9_\
MP=;?\%9/"G[<O[4/A3]E3X">*+7Q/^SQ^R+?^(;?6?%NB7B7?A[XF_'O6%BT
MOQ;K.CW<#-;:OX:^'6EV?_"$^&M9@S;W^KWOC[4=+N=2\/:IHFHW'T;^WO\
M\'#W_!1C_@K_ &_B3]DG_@EG^RS\<_ 'PD\6Q3>'?&NJ_#CP]K_Q&_:&\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\8ZOK=C=V&H.8].U?1]2\+ZVOA/QSX)L]1MM4\)VUY?>%IAI30V-S0!_H_\
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ME:ZE,&B37]9LYKX_$G6-)T$'^V-:LY_#?@C0X](@FGU?X@>&+:.YO[3]+?\
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M>&_ ^E6BR$G^S=$T#3--D0^3-:2PXCK]9?@)^SI\"/V6OASI?PC_ &<_A'X
M^"WPUT>22XLO!WPZ\,Z9X9T=K^=(H[O5]0BTZ"*75]=U 01-J>O:M+?:SJDL
M:S:A?7,HWU[/10!^:6D_\$>O^";.G?M0?$7]LO4?V4?AYXV_:.^*'BE_&GB;
MX@?$Y]>^)\5KXHD$>=<\*>#_ !]K'B'P/X*U5&ACD@U+PGX;T?4+9T4V]U$%
M4#]*C%&8S"8T,)0Q&(HIC,9788S&1M*%?E*8V[>,8XI]% 'P!_PZ=_X)9?\
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M#X8?$36I%7;'+K_C[X4:[X(\7>(9(%PL#:[K&H^2@$<86(;*^:/A1_P;<_\
M!%+X.^(;3Q3X;_85\#^(M8LIX[B!?BIX\^,/QDT M%)YL4=SX,^*?Q#\7>";
MV%6X:.]\.W"SI^[N?.3BOW%HH Q?#GAOP[X.T'2/"OA'0-%\+>%_#^GVVDZ#
MX;\.:58Z'H.B:591+!9Z9I&CZ9!:Z?INGVD*+#;65E;PVT$2K'%&B  ;5%%
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MO9W,D]_=:?\ !7Q3X"T:_O9Y2TUS<:EIEX]U,\DUSYLLCN?V/HH _GV\(?\
M!KA_P1"\(ZI%J_\ PQ[=^)[BWE$UM;>+_CQ^T+K6EQ.'#*)='_X6C;:9J$0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /P!_X.CO^4%'[<W_ ';-_P"MA_L^U_D"U_K]?\'1W_*"C]N;_NV;
M_P!;#_9]K_(%H _O\_X,8_\ G*+_ -V3?^_<5_?Y7\ ?_!C'_P Y1?\ NR;_
M -^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KR;XU_ ;X)_M(^ -4^%?[0'PG^'OQG^'&LM'+J/@KXE^$M
M$\9>'9KJ!9!::A'INNV=[;VFJV!E>33=6LU@U/39R+BPN[>=5D'K-% '\S7Q
M?_X-)/\ @C9\4=7NM8\.?#7XT? U[R::YN-.^$'QJU\Z1Y]PQ>1K73OBI8_%
M&'3H5D9FAL=-^QZ?;*1!;6D-ND<*<)X!_P"#/+_@D!X.U2#4/$4?[47Q6M(9
M%DDT/Q]\;=.T[2[I5.3#/-\+O 7PVUI8W'#&VUBWF ^Y*AYK^J"B@#Y)_90_
M8._8Y_8:\,7/A+]DO]G3X8_ [3-0AAM]:U#PAH"-XN\316S!K9?%_C[6)=4\
M<^,#:L-UL_BCQ%J[VYR863)S];444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5P7Q3\!_P#"T?ASXU^'7_"9^/OAU_PFGAS4_#O_  G7PM\1?\(C\1O"
M?]IV[V_]N^"O$_V/4/["\1Z?O\_3-3^PW7V2X5)?(DV[3WM% '\U_P =/^#7
M']AG]I_Q-:^,_P!H_P#::_X*._'GQ786KV&F^(/B]^U19_$/5=*T^1D=].TF
M[\5?#75)-*TYGBC<V&G&VM-Z*WD[E!KF/A3_ ,&GG_!.KX$>-M,^)7P1^.G_
M  4"^#WQ$T5;B/2/'?PO_:7TGP%XPTR*[C\F[AL?$GA;X8:5K%K!>0DPW<$-
MXD5U"6AG22-BI_IWHH \4_9Z^"P_9\^%'AWX4K\5_C7\;5\.SZU,/B/^T+X]
M?XF_%?6QK.M7^LB#Q%XSDTW2)-5@TG[=_9.BH]C$UCHMG86)>8V_FO[7110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0=8N8Y!$^G^*K/X6:K:21E=5T;2G/S_AC_P5_P#^"Z?Q]^.7["/[5G_!,?\
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MX.PZ)?R1-B32/%?PW\&:PMPNT6ZQM'YP!_6[17^?W\&?^#OW]KG]G3X]:K\
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M1^&/%OC71_#]]<:=X:\#^(/#7A+X>:E]AU.4K!-KOQ-2.XABFCU (SP4 ?Z
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M,?5YX$L)_%NB+.^HVX!_I145XQ^SM^T!\*?VJO@=\+_VBO@?XG@\8?"GXO\
MA'3/&?@O7X8VMY+C3-11EELM2LI/W^EZ[HM_#>:)XBT6["7VB:]IVHZ1?1Q7
MEE/&OL] !17XO_\ !3W_ (+<?LX_\$W]>\)?!#3_  AXV_:G_;2^*']G0?"K
M]D3X(Q-JGC_6KG7)C;>'KGQC?V>GZY)X*TO7[O%KH4$.@>)O&/B"1Q<>'?!F
MKZ;;ZAJ%C^5'Q2_;-_X.W-7\)7GQ9^&__!,W]D;X=>#H;637+#X4WWBW2OB3
M\<$T38;E8]6L1^T?X?36=76U"G^P=$\+:'XKDF9K(>&QJ9%E$ ?U[T5_!G^Q
M1_P>2^([/XM+\%O^"H_[,&D?!U[7Q)/X/\5_%3X*Z5XYT:X^%^OV%^^DZE;_
M !)^!/C[4O%?C&.WT>_CE7Q3/H'BZ;Q'H;6=W#9> =8NF6R@_NH\&^,O"?Q$
M\(^&/'W@/Q'HOC#P3XUT#2/%7A'Q7X<U&UU?0/$OAK7["#5-$UW1=4LI)K/4
M=+U73KJWO;&]MI9(+FVFCEB=D8&@#I**H:KJNF:%IFI:WK>I6&CZ-H]A>:KJ
M^KZK>6^GZ9I6F:?;R7=_J6I7]W)#:6-A8VD,MU>7EU+%;VUO%)--(D:,P_E[
M^(G_  <#?'7]JOXQ^-_V=_\ @AO^Q%J?[=^N_#FZ&G>/?VGOB'KP^'/[+7A7
M4FEFBA33]4U'4_"0\6:=>_9[V32[[4_'_P /;SQ)'I6H77@;1_&6CF#66 /Z
MDZ*_A._;(_X+$?\ !S[_ ,$W]-M/C#^UM^PQ^Q^_P,GU*QLM3\5^ _#'BSQM
MX!T2?4;E+>VTS6?%/@#]HWQ%KG@*ZO+F:'3='U/QY:)I>H:E/;6=@VLW<GV9
M_P!?/^"-7_!QU^S-_P %5];B^!WB?PI<?LV_M;1Z5>:K8_"K6_$,/B3PA\4-
M/T>SDO-;U#X2^-6L-%GU35-+LK>XUK6/ NN:-IWB+3=&2XU#1[GQ=I6B^(-8
MTL _HUK\EO\ @M5_P37\*?\ !4']@_XI_ U])TMOC/X7TV]^)'[-OBR[2**\
M\-?&'PW87%QH^E#4FPUGX?\ B%:"Z\ ^+%E%Q:1:5KPUP64VK:#HT]K^M-%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_ )04?MS?
M]VS?^MA_L^U_D"U_K]?\'1W_ "@H_;F_[MF_];#_ &?:_P @6@#^_P _X,8_
M^<HO_=DW_OW%?W^5_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH **** "BBB@
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M:?<6\$%Y9I9:UHKWWA_4]*U*\_'[_@XJ_P""(^K?\%9O@KX$\<_ [5="\/\
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M[Q)/$_\ @@MX2\5> _\ @D%^PGX/\<>&M?\ !WBS0/A'>6&N^&/%.CZAX?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$^*MUXTLO'?@RSFF8_8M B\2>&=,\4Z+I<.88]7\3^,+M1&;G:WVG_P=!?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX&\1Z9XL\,:?H ^&%_X2N_#NFZ9KFCV%TFGZ'<Z?:2I$]M-#);331/\ 7E%
M'S+^S!^QC^RG^Q;X*7X??LK? +X9? WPP\5O'J,7@7PU9V&M>(GM5*V]YXP\
M63K=>+/&NJ1(=@U?Q;K>M:H4"HUX550/IJBB@#,UK1-&\2:/JGA[Q%I&F:_H
M&MV%WI6M:'K5A:ZKH^KZ7?P/;7VFZIIE]%/97]A>6TDEO=V=W!+;W$$CQ31O
M&S*?Q+^+'_!MO_P13^,GBB[\8>)?V&?!?AW6;^Y>YNX?A7X^^,/P<\-R-*YD
MDC@\$_"WXA^$O!.G0LQ.$TOP]8F-?DB:-/EK]QZ* /A7]C__ ()E_L$_L#Q7
MI_9'_9=^&/P<U;4[,Z=J?C'3;'4?$WQ'U/3"R2-I.H_$[QQJ7B?XAWVD-+&D
MYTFZ\3S:<;A1<&U\[]Y7W5110!\V?$G]CG]E3XR_%"T^,_Q?_9Y^$7Q6^)MA
M\.IOA+8^*_B3X&T'QU<V/PZN==N?$MSX5L['Q19ZII-K87.M7EW>W,L&GQWM
MP+F:VFNGLY&MS^<WQ?\ ^#=3_@BY\;-4N=:\5_L%_"_P]J=S(\S/\(_$'Q*^
M!NG12NVYF@\.?!SQOX&\+QJ>0(?[$:!<DI$I (_:RB@#\MOV2_\ @BG_ ,$M
M_P!A_P 567C[]F_]CKX:^$_B#I<HN-'^(/BN]\8?%SQQX?O 4S?^%O%/Q?\
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M\2O#_B74M"TS1=.\4^#(])T.3Q9X7U+4-$LKVSU#06CO?MNJ>&;7Q#??K/\
M'7_@[L_8"TTV_@7]BKX7?M$?MO\ QU\67:Z#\-/!'@SX;:_\/_#GB;Q1>D0:
M3IMS?>+=/'Q(D>_NI(X[6Q\+_"GQ-JEXRO!]GM&:.:OI[_@DS_P3Z_:HU/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\
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M+4;&5 MS8WOQ2\=?'/Q-\0)=,NF'FSZ.OB*/1S*2R6$8"JOWU_P_T_X.FO\
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MO[_** /X _\ A_I_P=-?](5__.<G_!13_P"?)1_P_P!/^#IK_I"O_P"<Y/\
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M?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\
M/DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3
M_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0
MK_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^
M#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '
M_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)
M7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!
M13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_
M /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'3
M7_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_
MX?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI
M_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\
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M_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\
M@Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\
M ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W
M^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!1
M3_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG
M)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37
M_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X
M?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**
M?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G
M.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_
MZ0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\
MP_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44
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M44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\
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M^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\
M3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?
MP!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_
M?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\
M!13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7
M_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\
M!TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_
M (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@H
MI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*_
M_G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z
M:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\
M/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10
M!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_
M .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.
M<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_
MTA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z
M?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\
M/DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3
M_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0
MK_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^
M#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '
M_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)
M7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!
M13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_
M /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'3
M7_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_
MX?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI
M_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\
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M_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\
M@Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\
M ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W
M^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!1
M3_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG
M)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37
M_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X
M?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**
M?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G
M.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_
MZ0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\
MP_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44
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M44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\
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M^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\
M3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?
MP!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_
M?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\
M!13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7
M_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\
M!TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_
M (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@H
MI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*_
M_G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z
M:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\
M/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10
M!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_
M .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.
M<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_
MTA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z
M?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\
M/DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3
M_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0
MK_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^
M#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '
M_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)
M7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!
M13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_
M /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'3
M7_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_
MX?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI
M_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\
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M_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\
M@Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\
M ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W
M^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!1
M3_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG
M)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37
M_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X
M?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**
M?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G
M.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_
MZ0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\
MP_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44
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M44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\
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M^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\
M3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?
MP!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_
M?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\
M!13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7
M_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\
M!TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_
M (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@H
MI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*_
M_G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z
M:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\
M/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10
M!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_
M .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.
M<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_
MTA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z
M?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\
M/DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3
M_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0
MK_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^
M#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '
M_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)
M7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!
M13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_
M /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'3
M7_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_
MX?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI
M_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\
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M_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\
M@Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\
M ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W
M^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**?_/DH_X?Z?\ !TU_TA7_ /.<G_!1
M3_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG
M)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_Z0K_ /G.3_@HI_\ /DH_X?Z?\'37
M_2%?_P YR?\ !13_ .?)7]_E% '\ ?\ P_T_X.FO^D*__G.3_@HI_P#/DH_X
M?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44 ?P!_\/\ 3_@Z:_Z0K_\ G.3_ (**
M?_/DH_X?Z?\ !TU_TA7_ /.<G_!13_Y\E?W^44 ?P!_\/]/^#IK_ *0K_P#G
M.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\ GR5_?Y10!_ '_P /]/\ @Z:_
MZ0K_ /G.3_@HI_\ /DH_X?Z?\'37_2%?_P YR?\ !13_ .?)7]_E% '\ ?\
MP_T_X.FO^D*__G.3_@HI_P#/DH_X?Z?\'37_ $A7_P#.<G_!13_Y\E?W^44
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M44 ?P!_\/]/^#IK_ *0K_P#G.3_@HI_\^2C_ (?Z?\'37_2%?_SG)_P44_\
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>23
<FILENAME>sepn-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-26T21:49:08.5806+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.septerna.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:sepn="http://www.septerna.com/20241231" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets" id="StatementStatementOfBalanceSheets">
        <link:definition>100010 - Statement - Statement of Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2" id="DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2">
        <link:definition>100020 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2" id="DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2">
        <link:definition>100030 - Disclosure - Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical" id="StatementStatementOfBalanceSheetsParenthetical">
        <link:definition>100040 - Statement - Statement of Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2" id="StatementStatementsOfCashFlows2">
        <link:definition>100050 - Statement - Statements of Cash Flows 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2" id="StatementStatementsOfOperationsAndComprehensiveLossIncome2">
        <link:definition>100060 - Statement - Statements of Operations and Comprehensive (Loss) Income 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3" id="DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3">
        <link:definition>100070 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) 3</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome" id="StatementStatementsOfOperationsAndComprehensiveLossIncome">
        <link:definition>100080 - Statement - Statements of Operations and Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" id="StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit">
        <link:definition>100090 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100100 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows" id="StatementStatementsOfCashFlows">
        <link:definition>100110 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995420 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1" id="DisclosureOrganization1">
        <link:definition>995455 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995465 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" id="DisclosureBalanceSheetComponents1">
        <link:definition>995475 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset" id="DisclosureGainOnSaleOfNonfinancialAsset">
        <link:definition>995485 - Disclosure - Gain on Sale of Non-Financial Asset</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1" id="DisclosureRevenue1">
        <link:definition>995495 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements" id="DisclosureMarketableSecuritiesAndFairValueMeasurements">
        <link:definition>995505 - Disclosure - Marketable Securities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>995515 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>995525 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock" id="DisclosureConvertiblePreferredStock">
        <link:definition>995535 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock" id="DisclosureCommonStock">
        <link:definition>995545 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" id="DisclosureStockbasedCompensation">
        <link:definition>995555 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>995565 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties" id="DisclosureRelatedParties">
        <link:definition>995575 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3" id="DisclosureNetLossIncomePerShare3">
        <link:definition>995585 - Disclosure - Net (Loss) Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan" id="DisclosureEmployeeRetirementBenefitPlan">
        <link:definition>995595 - Disclosure - Employee Retirement Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>995605 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>995615 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995625 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995635 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" id="DisclosureBalanceSheetComponentsTables">
        <link:definition>995645 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsTables">
        <link:definition>995655 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables" id="DisclosureCommonStockTables">
        <link:definition>995665 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>995675 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995685 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables" id="DisclosureConvertiblePreferredStockTables">
        <link:definition>995695 - Disclosure - Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" id="DisclosureStockbasedCompensationTables">
        <link:definition>995705 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>995715 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables" id="DisclosureNetLossIncomePerShareTables">
        <link:definition>995725 - Disclosure - Net (Loss) Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>995735 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" id="DisclosureOrganizationAdditionalInformationDetails">
        <link:definition>995745 - Disclosure - Organization - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails">
        <link:definition>995755 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995765 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails" id="DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails">
        <link:definition>995775 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails" id="DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails">
        <link:definition>995785 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" id="DisclosureBalanceSheetComponentsAdditionalInformationDetails">
        <link:definition>995795 - Disclosure - Balance Sheet Components - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>995805 - Disclosure - Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails" id="DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails">
        <link:definition>995815 - Disclosure - Gain on Sale of Non-Financial Asset - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" id="DisclosureRevenueAdditionalInformationDetails">
        <link:definition>995825 - Disclosure - Revenue - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails">
        <link:definition>995835 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995845 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails">
        <link:definition>995855 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails">
        <link:definition>995865 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="DisclosureLeasesAdditionalInformationDetails">
        <link:definition>995875 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails" id="DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails">
        <link:definition>995885 - Disclosure - Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" id="DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
        <link:definition>995895 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>995905 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails" id="DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails">
        <link:definition>995915 - Disclosure - Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" id="DisclosureConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>995925 - Disclosure - Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails" id="DisclosureCommonStockAdditionalInformationDetails">
        <link:definition>995935 - Disclosure - Common Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails" id="DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails">
        <link:definition>995945 - Disclosure - Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails" id="DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails">
        <link:definition>995955 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails" id="DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails">
        <link:definition>995965 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails" id="DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails">
        <link:definition>995975 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" id="DisclosureStockbasedCompensationAdditionalInformationDetails">
        <link:definition>995985 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails" id="DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails">
        <link:definition>995995 - Disclosure - Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails">
        <link:definition>996005 - Disclosure - Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>996015 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails" id="DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails">
        <link:definition>996025 - Disclosure - Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails">
        <link:definition>996035 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails">
        <link:definition>996045 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails" id="DisclosureRelatedPartiesAdditionalInformationDetails">
        <link:definition>996055 - Disclosure - Related Parties - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails" id="DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails">
        <link:definition>996065 - Disclosure - Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails" id="DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails">
        <link:definition>996075 - Disclosure - Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails" id="DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails">
        <link:definition>996085 - Disclosure - Employee Retirement Benefit Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails" id="DisclosureSegmentInformationSummaryOfReportableSegmentDetails">
        <link:definition>996095 - Disclosure - Segment Information - Summary of Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>996105 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets" xlink:href="sepn-20241231.xsd#StatementStatementOfBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical" xlink:href="sepn-20241231.xsd#StatementStatementOfBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="sepn-20241231.xsd#StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="sepn-20241231.xsd#StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows" xlink:href="sepn-20241231.xsd#StatementStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="sepn-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureOrganizationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="sepn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureRevenueAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails" xlink:href="sepn-20241231.xsd#DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails" xlink:href="sepn-20241231.xsd#DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureCommonStockAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails" xlink:href="sepn-20241231.xsd#DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureRelatedPartiesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails" xlink:href="sepn-20241231.xsd#DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="sepn-20241231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome" xlink:href="sepn-20241231.xsd#StatementStatementsOfOperationsAndComprehensiveLossIncome" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1" xlink:href="sepn-20241231.xsd#DisclosureOrganization1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="sepn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponents1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset" xlink:href="sepn-20241231.xsd#DisclosureGainOnSaleOfNonfinancialAsset" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1" xlink:href="sepn-20241231.xsd#DisclosureRevenue1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases" xlink:href="sepn-20241231.xsd#DisclosureLeases" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="sepn-20241231.xsd#DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock" xlink:href="sepn-20241231.xsd#DisclosureConvertiblePreferredStock" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock" xlink:href="sepn-20241231.xsd#DisclosureCommonStock" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" xlink:href="sepn-20241231.xsd#DisclosureStockbasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties" xlink:href="sepn-20241231.xsd#DisclosureRelatedParties" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3" xlink:href="sepn-20241231.xsd#DisclosureNetLossIncomePerShare3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan" xlink:href="sepn-20241231.xsd#DisclosureEmployeeRetirementBenefitPlan" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:href="sepn-20241231.xsd#DisclosureSegmentInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="sepn-20241231.xsd#DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="sepn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="sepn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables" xlink:href="sepn-20241231.xsd#DisclosureMarketableSecuritiesAndFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables" xlink:href="sepn-20241231.xsd#DisclosureCommonStockTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables" xlink:href="sepn-20241231.xsd#DisclosureLeasesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="sepn-20241231.xsd#DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables" xlink:href="sepn-20241231.xsd#DisclosureConvertiblePreferredStockTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables" xlink:href="sepn-20241231.xsd#DisclosureNetLossIncomePerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:href="sepn-20241231.xsd#DisclosureSegmentInformationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="sepn-20241231.xsd#DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:href="sepn-20241231.xsd#DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="sepn-20241231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:href="sepn-20241231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails" xlink:href="sepn-20241231.xsd#DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails" xlink:href="sepn-20241231.xsd#DisclosureSegmentInformationSummaryOfReportableSegmentDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2" xlink:href="sepn-20241231.xsd#DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2" xlink:href="sepn-20241231.xsd#DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2" xlink:href="sepn-20241231.xsd#StatementStatementsOfCashFlows2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2" xlink:href="sepn-20241231.xsd#StatementStatementsOfOperationsAndComprehensiveLossIncome2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3" xlink:href="sepn-20241231.xsd#DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAsset" xlink:label="sepn_GainOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidTaxesCurrent" xlink:label="sepn_PrepaidTaxesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FourZeroOne401KPlanMember" xlink:label="sepn_FourZeroOne401KPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExternalGeneralAndAdministrativeExpenses" xlink:label="sepn_ExternalGeneralAndAdministrativeExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlan2024Member" xlink:label="sepn_EmployeeStockPurchasePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" xlink:label="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" xlink:label="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" xlink:label="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="us-gaap_RetirementPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TaxCreditCarryforwardExpirationYear" xlink:label="sepn_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheTwoMember" xlink:label="sepn_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidClinicalTrialCostsCurrent" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlanMember" xlink:label="sepn_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RestrictedStockOptionsSubjectToRepurchase" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" xlink:label="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedPreferredStockSharesAuthorized" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RepurchasesOfUnvestedRestrictedCommonStock" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RequiredPriorNoticeDurationToTerminateAgreement" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockLineItems" xlink:label="sepn_CommonStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialPublicOfferingStockOptions" xlink:label="sepn_InitialPublicOfferingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExternalResearchAndDevelopmentExpenses" xlink:label="sepn_ExternalResearchAndDevelopmentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockFinancingArrangementFinancingValue" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneMember" xlink:label="sepn_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2024PlanMember" xlink:label="sepn_Stock2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeaseCommencementPeriod" xlink:label="sepn_LeaseCommencementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsLeaseLiability" xlink:label="sepn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RisksAndUncertaintyPolicyTextBlock" xlink:label="sepn_RisksAndUncertaintyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockPolicyPolicyTextBlock" xlink:label="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" xlink:label="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchase2024PlanMember" xlink:label="sepn_EmployeeStockPurchase2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeMember" xlink:label="sepn_EmployeeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfChangeInOwnership" xlink:label="sepn_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncreaseInSharesReservedForFutureIssuanceInShares" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="us-gaap_RetirementPlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OperatingLossCarryforwardsExpirationYear" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialTrancheMember" xlink:label="sepn_InitialTrancheMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_VertexResearchServiceAgreementMember" xlink:label="sepn_VertexResearchServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStock" xlink:label="sepn_UnvestedRestrictedStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OrganizationDisclosureTextBlock" xlink:label="sepn_OrganizationDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LesseeOperatingLeaseExpirationYearAndMonth" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockTextBlock" xlink:label="sepn_CommonStockTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OriginalLeasedSpaceMember" xlink:label="sepn_OriginalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsAndCommissions" xlink:label="sepn_UnderwritingDiscountsAndCommissions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SamsaraBiocapitalLPMember" xlink:label="sepn_SamsaraBiocapitalLPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InterimChiefMedicalOfficerMember" xlink:label="sepn_InterimChiefMedicalOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EquityIncentivePlan2024Member" xlink:label="sepn_EquityIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidBonusCurrent" xlink:label="sepn_PrepaidBonusCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PerformanceConditionsMember" xlink:label="sepn_PerformanceConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentsOfDeferredOfferingCosts" xlink:label="sepn_PaymentsOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockTable" xlink:label="sepn_CommonStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation" xlink:label="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingOtherOfferingExpenses" xlink:label="sepn_UnderwritingOtherOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:label="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" xlink:label="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeasedSpaceMember" xlink:label="sepn_LeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ThirdRockVenturesViLPServiceAgreementMember" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockOptions" xlink:label="sepn_CommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:label="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnconditionalRightOnNonFinancialAsset" xlink:label="sepn_UnconditionalRightOnNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedGeneralAndAdministrativeExpenseCurrent" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PatentExpensesPolicyPolicyTextBlock" xlink:label="sepn_PatentExpensesPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TermOfResearchServiceAgreement" xlink:label="sepn_TermOfResearchServiceAgreement"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AdditionalLeasedSpaceMember" xlink:label="sepn_AdditionalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnpaidOfferingCostsIncludedInAccountsPayable" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RaCapitalManagementLPServiceAgreementMember" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAssetTextBlock" xlink:label="sepn_GainOnSaleOfNonFinancialAssetTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfInProgressResearchAndDevelopment" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ServiceAgreementExpirationYear" xlink:label="sepn_ServiceAgreementExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneAndTrancheTwoMember" xlink:label="sepn_TrancheOneAndTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuanceCostsOfConvertibleSecurities" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AgreementDescription" xlink:label="sepn_AgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedCommonStockParOrStatedValuePerShare" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncentiveStockOptionsMember" xlink:label="sepn_IncentiveStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentReceivedOnSaleOfNonFinancialAsset" xlink:label="sepn_PaymentReceivedOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedExpenseAndOtherCurrentLiabilities" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesLineItems" xlink:label="sepn_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock" xlink:label="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OptionAndIncentivePlan2024Member" xlink:label="sepn_OptionAndIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockTextBlock" xlink:label="sepn_ConvertiblePreferredStockTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesTable" xlink:label="sepn_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, liquidation preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, liquidation preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost of marketable debt securities, contractual maturity, one year to five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized cost of marketable debt securities, contractual maturity, one year to five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Convertible, Conversion Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocation of earnings to participating preferred stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Allocation of earnings to participating preferred stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">unrecognized stock-based compensation expense related to unvested restricted stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain on sale of non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain On Sale Of Non Financial Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Gain on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash proceeds from issuance of convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Proceeds From Issuance Of Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash proceeds from issuance of convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse Stock Split description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Noncash Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Taxes Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid Taxes Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FourZeroOne401KPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Four Zero One 401 K Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FourZeroOne401KPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Four zero one 401 K plan member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FourZeroOne401KPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">401(k) Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Other Segment Item, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other segment expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary equity, Conversion of convertible preferred stock to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, Conversion of convertible preferred stock to common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents and Marketable Securities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents and marketable securities, fair value disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Salaries, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of convertible preferred stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure for noncash investing and financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Features of Convertible Preferred Stock [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Unrealized Loss Positions of Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Convertible Preferred Stock to Common Stock Upon Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible preferred stock to common stock upon initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock upon initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Options Outstanding, Forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total Options Outstanding, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalGeneralAndAdministrativeExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">External general and administrative expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalGeneralAndAdministrativeExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">External General And Administrative Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalGeneralAndAdministrativeExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">External general and administrative expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Chief Financial Officer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Chief Financial Officer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncurrent Assets [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards, subject to repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, subject to repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, subject to repurchase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">(Loss) income before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">(Loss) income before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchasePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchasePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan 2024 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchasePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan 2024.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">liabilities associated with indemnification rights and agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Associated with Indemnification Rights and Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liabilities associated with indemnification rights and agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Equivalents and Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents and Marketable Securities [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash equivalents and marketable securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Lease Cost and Cash Paid for Operating Lease Liability [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of lease cost and cash paid for operating lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Expenses Recognized and Cash Paid for Leased Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward, expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding convertible preferred stock conversion in to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Convertible, Shares Issuable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Common, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive (Loss) Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (loss) income per share, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax asset, net change in total valuation allowance increase during period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Option to Extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease option to extend description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses (income):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Estimated useful Lives of Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of estimated useful lives of property, plant and equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Useful Lives of Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of marketable securities in unrealized loss positions less than 12 months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical trial costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Trial Costs Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical trial costs current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Total Options outstanding, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Total Options outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Benefit Plan [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred income tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred income tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Options Subject To Repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted stock options subject to repurchase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock options subject to repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, carrying value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Taxes Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued income taxes payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxes Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive (loss) income:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable and Other Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock 2021 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock 2021 plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents, marketable securities current and non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Marketable Securities Current and Non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash, cash equivalents, marketable securities current and non-current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options to purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officer And Director Equity Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Executive officer and director equity awards .</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Basic and Diluted Net (Loss) Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award fair value of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Undesignated Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Undesignated preferred stock, shares authorized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net (Loss) Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchases of unvested restricted common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repurchases of Unvested Restricted Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Repurchases of unvested restricted common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public offering price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivables [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity Stock Additional Funding Based on Approval</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Additional Funding Based on Approval</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock additional funding based on approval</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total Options outstanding, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock upon exercise of stock options (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Options outstanding, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Required Prior Notice Duration to Terminate Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Required prior notice duration to terminate agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Required prior notice duration to terminate agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and administrative costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized gain on marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Components</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other (expense) income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialPublicOfferingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial public offering stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialPublicOfferingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialPublicOfferingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial public offering stock options.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents and Restricted Cash:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S. Government Agency Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agency Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Corporations and Agencies Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Retirement Benefit Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash operating lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">External research and development expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">External Research And Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ExternalResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">External research and development expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of (Benefit) Provision for Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity Stock Financing Arrangement Financing Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Financing Arrangement Financing Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock financing arrangement financing value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards vested, Weighted Average Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche One.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Restricted Stock Award Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock 2024 plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock 2024 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_Stock2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock 2024 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average period for recognition of expenses related to non-vested share-based compensation arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commencement period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Long-Lived Assets to be Disposed of</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research and Development Expense Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expense current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted stock awards vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RisksAndUncertaintyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risks And Uncertainty.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RisksAndUncertaintyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks And Uncertainty [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RisksAndUncertaintyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Uncertainties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Values Restricted Stock Award Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period values restricted stock award vested.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Sale Of Research And Ddevelopment In-Progress</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain Loss on sale of research and development in-progress.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gain on sale of research and development in-progress</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate grant date fair value of shares vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Proceeds After Deducting Underwriting Discounts And Commissions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross proceeds after deducting underwriting discounts and commissions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross proceeds after deducting underwriting discounts and commissions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized cost of marketable debt securities, contractual maturity, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost of marketable debt securities, contractual maturity, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Options Outstanding, Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total Options Outstanding, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate estimated fair value of marketable debt securities, contractual maturities, one year to five year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of present value of lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties related to unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-sale - Matures After One Year Through Five Years, Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available-for-sale - matures after one year through five years, gross unrealized gains.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gains of marketable debt securities, contractual maturity, one year to five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with initial public offering, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock in connection with initial public offering, issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of common stock shares reserved for future issuance on convertible basis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Taxes Paid, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of unvested restricted common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased and Retired During Period, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchases of unvested restricted common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Sale of Non Financial Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities sale of non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchase2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase 2024 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchase2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase 2024 plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeStockPurchase2024PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase 2024 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Intrinsic value of stock options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Change in Ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of change in ownership.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of change in ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock option awards granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Options outstanding, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of outstanding number of shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted Average Assumptions used for Grants Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture, fixtures, and office equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture Fixtures and Office Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Furniture fixtures and office equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in shares reserved for future issuance, in shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase in Shares Reserved for Future Issuance, in Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in shares reserved for future issuance, in shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities, current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Total net revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research services revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustment based on tax positions related to prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Adjustment based on tax positions related to prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Effective Tax Rate Reconciliation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling, General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation And Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total effective income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total antidilutive securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialTrancheMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial Tranche [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialTrancheMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Tranche [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InitialTrancheMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Tranche</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">(Benefit) provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">(Benefit) provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">(Benefit) provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_VertexResearchServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vertex Research Service Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_VertexResearchServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vertex Research Service Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_VertexResearchServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Vertex research service agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased In Period Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options repurchased in period weighted average grant date fair value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards repurchased ,Weighted Average Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets before valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested restricted stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested restricted stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Received cash on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of unpaid principal and accrued interest outstanding into shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OrganizationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OrganizationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization disclosure text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OrganizationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Organization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Expiration Year and Month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating lease, expiration year and month.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contribution expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized losses of marketble debt securities, contractual maturity, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized losses of marketble debt securities, contractual maturity, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt maturities within one year gross unrealized loss.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred income tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-Sale Marketable Securities and Fair Value Measurements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available-for-sale marketable securities and fair value measurements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfLand_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Land</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfLand_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock upon initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OriginalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Original Leased Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OriginalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Original Leased Space [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OriginalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Original leased space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Leasing Arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Subject To Repurchase [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock subject to repurchase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested Restricted Stock Awards Subject to Repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Marketable Securities by Major Type of Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses (income)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accumulated depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts And Commissions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts and commissions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts and commissions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gains of marketable debt securites, contractual maturity, less than one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt maturities within one year gross unrealized gains.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average per share grant-date fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SamsaraBiocapitalLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Samsara BioCapital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SamsaraBiocapitalLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Samsara BioCapital L P [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SamsaraBiocapitalLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Samsara BioCapital L P.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Prepaid Expense, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InterimChiefMedicalOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interim Chief Medical Officer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InterimChiefMedicalOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interim Chief Medical Officer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_InterimChiefMedicalOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interim Chief Medical Officer.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EquityIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EquityIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan 2024 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EquityIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity incentive plan 2024.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (loss) income per share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidBonusCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid bonus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidBonusCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Bonus Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PrepaidBonusCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid bonus current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PerformanceConditionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Conditions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PerformanceConditionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance conditions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Existence of Option to Extend [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (loss) income applicable to common stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentsOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments of deferred offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentsOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of deferred offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentsOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments of deferred offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate grant date fair value of options vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions By Related Party [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Expenses Excluding Stock Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee related expenses, excluding stock based compensation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee-related expenses, excluding stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingOtherOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Other Offering Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingOtherOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting other offering expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingOtherOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting other offering expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (Loss) Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities And Fair Value Measurements [TextBlock]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketable securities and fair value measurements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities and Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator, basic:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average common shares (denominator), Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustment based on tax positions related to prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Emerging growth company status and smaller reporting company status.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Emerging Growth Company Status and Smaller Reporting Company Status, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Emerging Growth Company Status and Smaller Reporting Company Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series B Convertible Preferred Stock, issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of convertible preferred stock, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Leased Space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leased Space [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_LeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leased Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Rock Ventures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Third Rock Ventures VI L P Service Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Third Rock Ventures VI L P Service Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Proceeds Conversion Of Outstanding Convertible Promissory Notes Plus Accrued Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Proceeds Conversion Of Outstanding Convertible Promissory Notes Plus Accrued Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds conversion of outstanding convertible promissory notes plus accrued interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_CommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (Loss) Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property and equipment included in accounts payable and accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment included in accounts payable and accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Estimated Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock Options Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions based on tax positions related to current year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity (deficit):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnconditionalRightOnNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unconditional right on non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnconditionalRightOnNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unconditional right on non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnconditionalRightOnNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unconditional right on amount of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Preferred Stock Remaining Unissued Shares Agreement To Cancel</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Remaining Unissued Shares Agreement To Cancel</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock remaining unissued shares agreement to cancel</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued General and Administrative Expense Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued general and administrative expense current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued general and administrative expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator, basic:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted stock awards repurchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options repurchased.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (loss) income per share attributable to common stockholders:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax, net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PatentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PatentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Expenses, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PatentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">IPO Stock Options [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Public Offering (IPO)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">(Loss) income from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Promissory Notes, Unpaid Principal and Accrued Interest Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Notes, Unpaid Principal and Accrued Interest Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible promissory notes such as unpaid principal and accrued interest outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Research And Development Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets capitalized research and development costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sec 174 capitalized research and development costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">ASSETS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Amounts of Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (loss) income applicable to common stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale matures after one year through five years gross unrealized loss.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized losses of marketable debt securities, contractual maturity, one year to five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash proceeds on shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from issuance of Series B Convertible Preferred stock, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TermOfResearchServiceAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term of Research Service Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TermOfResearchServiceAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of research service agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TermOfResearchServiceAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of research service agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Equity Awards Options Grants Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation equity awards options grants fair value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other receivable related to sale of non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Receivable Related To Sale Of Non Financial Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivable related to sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value; 10,000,000 shares and no shares authorized as of December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and restricted cash, end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash, beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash, end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and restricted cash at end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Initial Public Offering, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock authorised to be issued during period shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Authorised To Be Issued During Period Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock shares authorized to be issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Share Issue Price Divided By Conversion Price In Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of share issue price divided by conversion price in effect.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage of share issue price divided by conversion price in effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal taxes at statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AdditionalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Leased Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AdditionalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Leased Space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AdditionalLeasedSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Leased Space [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of Series B Convertible Preferred Stock( in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock upon initial public offering (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted convertible preferred stock outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unpaid offering costs included in accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unpaid Offering Costs Included In Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unpaid Offering Costs Included In Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RA Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">RA Capital Management L P Service Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">RA Capital Management L P Service Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Income Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consulting services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAssetTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain on Sale of Non-Financial Asset [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAssetTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain on sale of non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfNonFinancialAssetTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on Sale of Non-Financial Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain on Sale of In Progress Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain on sale of in-progress research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on sale of in-progress research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted preferred stock outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over-Allotment Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Over-Allotment Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses and Other Current Assets [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ServiceAgreementExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreement Expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ServiceAgreementExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Service agreement expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ServiceAgreementExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service agreement expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting pronouncements not yet adopted.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Pronouncements Not Yet Adopted, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Pronouncements Not Yet Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneAndTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche One and Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneAndTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One and Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TrancheOneAndTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One and Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issuance Costs Of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issuance costs of convertible securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Grant Date Fair Value Per Share, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Grant Date Fair Value Per Share, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net (loss) income to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agreement Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocation of earnings to participating preferred stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Allocation of earnings to participating preferred stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Conditions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Undesignated Common Stock Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Undesignated common stock par or stated value per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities And Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incentive stock options.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Stock Options [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incentive Stock Options [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value per share, 500,000,000 and 260,590,689 shares authorized at December 31, 2024 and 2023, respectively; 44,422,505 and 3,168,134 shares issued and outstanding at December 31, 2024 and 2023, respectively; 576,829 and 1,002,044 shares subject to repurchase as of December 31, 2024 and 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentReceivedOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment received on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentReceivedOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment received on sale of non-financial asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_PaymentReceivedOnSaleOfNonFinancialAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment received on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Gain on sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expense And Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Expense And Other Current Liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total present value of operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockPlan2024And2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2024 and 2021 Stock Plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockPlan2024And2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Plan 2024 and 2021 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_StockPlan2024And2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 and 2021 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accrued Expenses and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 8)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts commissions and other offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts, Commissions and Other Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts, commissions and other offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average common shares (denominator), Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Diluted Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted-average shares outstanding used to compute net (loss) income per common share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reportable Segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncomeTaxesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncomeTaxesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accounts receivable, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of non-financial assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Non-Financial Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Non-Financial Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator, diluted:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares outstanding used in computing net (loss) income per share attributable to common stockholders:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OptionAndIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option and Incentive Plan 2024 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OptionAndIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option and incentive plan 2024.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_OptionAndIncentivePlan2024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Option and Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary equity, Conversion of convertible preferred stock to common stock shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, Conversion of convertible preferred stock to common stock shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S. Treasury Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator, diluted:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivable related to sale of non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts and Other Receivables, Net, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion of premiums (discounts), net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average exercise price, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average exercise price, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use asset recognized in exchange for operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use asset recognized in exchange for operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized gain on marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_ConvertiblePreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncomeTaxesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sepn_IncomeTaxesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term lease costs</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_GainOnSaleOfNonFinancialAsset" xlink:to="sepn_GainOnSaleOfNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PrepaidTaxesCurrent" xlink:to="sepn_PrepaidTaxesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_FourZeroOne401KPlanMember" xlink:to="sepn_FourZeroOne401KPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:to="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" xlink:to="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ExternalGeneralAndAdministrativeExpenses" xlink:to="sepn_ExternalGeneralAndAdministrativeExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentAssetsMember" xlink:to="us-gaap_OtherNoncurrentAssetsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmployeeStockPurchasePlan2024Member" xlink:to="sepn_EmployeeStockPurchasePlan2024Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" xlink:to="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" xlink:to="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" xlink:to="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="us-gaap_RetirementPlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TaxCreditCarryforwardExpirationYear" xlink:to="sepn_TaxCreditCarryforwardExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TrancheTwoMember" xlink:to="sepn_TrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PrepaidClinicalTrialCostsCurrent" xlink:to="sepn_PrepaidClinicalTrialCostsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmployeeStockPurchasePlanMember" xlink:to="sepn_EmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_RestrictedStockOptionsSubjectToRepurchase" xlink:to="sepn_RestrictedStockOptionsSubjectToRepurchase_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_Stock2021PlanMember" xlink:to="sepn_Stock2021PlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" xlink:to="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" xlink:to="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UndesignatedPreferredStockSharesAuthorized" xlink:to="sepn_UndesignatedPreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_RepurchasesOfUnvestedRestrictedCommonStock" xlink:to="sepn_RepurchasesOfUnvestedRestrictedCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" xlink:to="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_RequiredPriorNoticeDurationToTerminateAgreement" xlink:to="sepn_RequiredPriorNoticeDurationToTerminateAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_CommonStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_InitialPublicOfferingStockOptions" xlink:to="sepn_InitialPublicOfferingStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ExternalResearchAndDevelopmentExpenses" xlink:to="sepn_ExternalResearchAndDevelopmentExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityStockFinancingArrangementFinancingValue" xlink:to="sepn_TemporaryEquityStockFinancingArrangementFinancingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TrancheOneMember" xlink:to="sepn_TrancheOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_Stock2024PlanMember" xlink:to="sepn_Stock2024PlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_LeaseCommencementPeriod" xlink:to="sepn_LeaseCommencementPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:to="sepn_AccruedResearchAndDevelopmentExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_DeferredTaxAssetsLeaseLiability" xlink:to="sepn_DeferredTaxAssetsLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_RisksAndUncertaintyPolicyTextBlock" xlink:to="sepn_RisksAndUncertaintyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" xlink:to="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" xlink:to="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" xlink:to="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock" xlink:to="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" xlink:to="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" xlink:to="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmployeeStockPurchase2024PlanMember" xlink:to="sepn_EmployeeStockPurchase2024PlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmployeeMember" xlink:to="sepn_EmployeeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PercentageOfChangeInOwnership" xlink:to="sepn_PercentageOfChangeInOwnership_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_FurnitureFixturesAndOfficeEquipmentMember" xlink:to="sepn_FurnitureFixturesAndOfficeEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_IncreaseInSharesReservedForFutureIssuanceInShares" xlink:to="sepn_IncreaseInSharesReservedForFutureIssuanceInShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_OperatingLossCarryforwardsExpirationYear" xlink:to="sepn_OperatingLossCarryforwardsExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_InitialTrancheMember" xlink:to="sepn_InitialTrancheMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_VertexResearchServiceAgreementMember" xlink:to="sepn_VertexResearchServiceAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnvestedRestrictedStock" xlink:to="sepn_UnvestedRestrictedStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:to="sepn_ProceedsFromSaleOfNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_OrganizationDisclosureTextBlock" xlink:to="sepn_OrganizationDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_LesseeOperatingLeaseExpirationYearAndMonth" xlink:to="sepn_LesseeOperatingLeaseExpirationYearAndMonth_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CommonStockTextBlock" xlink:to="sepn_CommonStockTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_OriginalLeasedSpaceMember" xlink:to="sepn_OriginalLeasedSpaceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" xlink:to="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnderwritingDiscountsAndCommissions" xlink:to="sepn_UnderwritingDiscountsAndCommissions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivableCurrent" xlink:to="us-gaap_InterestReceivableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SamsaraBiocapitalLPMember" xlink:to="sepn_SamsaraBiocapitalLPMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_InterimChiefMedicalOfficerMember" xlink:to="sepn_InterimChiefMedicalOfficerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EquityIncentivePlan2024Member" xlink:to="sepn_EquityIncentivePlan2024Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PrepaidBonusCurrent" xlink:to="sepn_PrepaidBonusCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PerformanceConditionsMember" xlink:to="sepn_PerformanceConditionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PaymentsOfDeferredOfferingCosts" xlink:to="sepn_PaymentsOfDeferredOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CommonStockTable" xlink:to="sepn_CommonStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation" xlink:to="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnderwritingOtherOfferingExpenses" xlink:to="sepn_UnderwritingOtherOfferingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:to="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" xlink:to="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_LeasedSpaceMember" xlink:to="sepn_LeasedSpaceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SeriesAConvertiblePreferredStockMember" xlink:to="sepn_SeriesAConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ThirdRockVenturesViLPServiceAgreementMember" xlink:to="sepn_ThirdRockVenturesViLPServiceAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" xlink:to="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_CommonStockOptions" xlink:to="sepn_CommonStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:to="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnconditionalRightOnNonFinancialAsset" xlink:to="sepn_UnconditionalRightOnNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" xlink:to="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AccruedGeneralAndAdministrativeExpenseCurrent" xlink:to="sepn_AccruedGeneralAndAdministrativeExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SeriesBConvertiblePreferredStockMember" xlink:to="sepn_SeriesBConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PatentExpensesPolicyPolicyTextBlock" xlink:to="sepn_PatentExpensesPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" xlink:to="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:to="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TermOfResearchServiceAgreement" xlink:to="sepn_TermOfResearchServiceAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" xlink:to="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" xlink:to="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" xlink:to="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" xlink:to="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AdditionalLeasedSpaceMember" xlink:to="sepn_AdditionalLeasedSpaceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnpaidOfferingCostsIncludedInAccountsPayable" xlink:to="sepn_UnpaidOfferingCostsIncludedInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_RaCapitalManagementLPServiceAgreementMember" xlink:to="sepn_RaCapitalManagementLPServiceAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_GainOnSaleOfNonFinancialAssetTextBlock" xlink:to="sepn_GainOnSaleOfNonFinancialAssetTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_GainOnSaleOfInProgressResearchAndDevelopment" xlink:to="sepn_GainOnSaleOfInProgressResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ServiceAgreementExpirationYear" xlink:to="sepn_ServiceAgreementExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TrancheOneAndTrancheTwoMember" xlink:to="sepn_TrancheOneAndTrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_StockIssuanceCostsOfConvertibleSecurities" xlink:to="sepn_StockIssuanceCostsOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AgreementDescription" xlink:to="sepn_AgreementDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UndesignatedCommonStockParOrStatedValuePerShare" xlink:to="sepn_UndesignatedCommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_IncentiveStockOptionsMember" xlink:to="sepn_IncentiveStockOptionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_PaymentReceivedOnSaleOfNonFinancialAsset" xlink:to="sepn_PaymentReceivedOnSaleOfNonFinancialAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_AccruedExpenseAndOtherCurrentLiabilities" xlink:to="sepn_AccruedExpenseAndOtherCurrentLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_StockPlan2024And2021Member" xlink:to="sepn_StockPlan2024And2021Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:to="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_IncomeTaxesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock" xlink:to="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_OptionAndIncentivePlan2024Member" xlink:to="sepn_OptionAndIncentivePlan2024Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_ConvertiblePreferredStockTextBlock" xlink:to="sepn_ConvertiblePreferredStockTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sepn_IncomeTaxesTable" xlink:to="sepn_IncomeTaxesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorOpinionTextBlock" order="88.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RestrictedStockOptionsSubjectToRepurchase" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_RestrictedStockOptionsSubjectToRepurchase" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_6"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_19"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_20"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_21"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_22"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_19" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_21" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuanceCostsOfConvertibleSecurities" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_StockIssuanceCostsOfConvertibleSecurities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAsset" xlink:label="sepn_GainOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RepurchasesOfUnvestedRestrictedCommonStock" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnpaidOfferingCostsIncludedInAccountsPayable" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:label="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentsOfDeferredOfferingCosts" xlink:label="sepn_PaymentsOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCash" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="sepn_ProceedsFromSaleOfNonFinancialAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="sepn_GainOnSaleOfNonFinancialAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="sepn_RepurchasesOfUnvestedRestrictedCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_UnpaidOfferingCostsIncludedInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="sepn_PaymentsOfDeferredOfferingCosts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OrganizationDisclosureTextBlock" xlink:label="sepn_OrganizationDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="sepn_OrganizationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAssetTextBlock" xlink:label="sepn_GainOnSaleOfNonFinancialAssetTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="sepn_GainOnSaleOfNonFinancialAssetTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:label="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockTextBlock" xlink:label="sepn_ConvertiblePreferredStockTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="sepn_ConvertiblePreferredStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockTextBlock" xlink:label="sepn_CommonStockTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="sepn_CommonStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RisksAndUncertaintyPolicyTextBlock" xlink:label="sepn_RisksAndUncertaintyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" xlink:label="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockPolicyPolicyTextBlock" xlink:label="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock" xlink:label="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PatentExpensesPolicyPolicyTextBlock" xlink:label="sepn_PatentExpensesPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" xlink:label="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_RisksAndUncertaintyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_PatentExpensesPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" xlink:label="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" xlink:label="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended"/>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_VertexResearchServiceAgreementMember" xlink:label="sepn_VertexResearchServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneMember" xlink:label="sepn_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheTwoMember" xlink:label="sepn_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsAndCommissions" xlink:label="sepn_UnderwritingDiscountsAndCommissions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingOtherOfferingExpenses" xlink:label="sepn_UnderwritingOtherOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedPreferredStockSharesAuthorized" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedCommonStockParOrStatedValuePerShare" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfInProgressResearchAndDevelopment" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="sepn_VertexResearchServiceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_VestingAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingDiscountsAndCommissions" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingOtherOfferingExpenses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UndesignatedPreferredStockSharesAuthorized" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UndesignatedCommonStockParOrStatedValuePerShare" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_GainOnSaleOfInProgressResearchAndDevelopment" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidClinicalTrialCostsCurrent" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidBonusCurrent" xlink:label="sepn_PrepaidBonusCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidTaxesCurrent" xlink:label="sepn_PrepaidTaxesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="sepn_PrepaidClinicalTrialCostsCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_InterestReceivableCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="sepn_PrepaidBonusCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="sepn_PrepaidTaxesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_FurnitureFixturesAndOfficeEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedGeneralAndAdministrativeExpenseCurrent" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedSalariesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="sepn_AccruedResearchAndDevelopmentExpenseCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="sepn_AccruedGeneralAndAdministrativeExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_TaxesPayableCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAsset" xlink:label="sepn_GainOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnconditionalRightOnNonFinancialAsset" xlink:label="sepn_UnconditionalRightOnNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentReceivedOnSaleOfNonFinancialAsset" xlink:label="sepn_PaymentReceivedOnSaleOfNonFinancialAsset"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="sepn_GainOnSaleOfNonFinancialAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="sepn_ProceedsFromSaleOfNonFinancialAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="sepn_UnconditionalRightOnNonFinancialAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="sepn_PaymentReceivedOnSaleOfNonFinancialAsset" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_VertexResearchServiceAgreementMember" xlink:label="sepn_VertexResearchServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AgreementDescription" xlink:label="sepn_AgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TermOfResearchServiceAgreement" xlink:label="sepn_TermOfResearchServiceAgreement"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RequiredPriorNoticeDurationToTerminateAgreement" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ServiceAgreementExpirationYear" xlink:label="sepn_ServiceAgreementExpirationYear"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="sepn_VertexResearchServiceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_AgreementDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_TermOfResearchServiceAgreement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_RequiredPriorNoticeDurationToTerminateAgreement" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_ServiceAgreementExpirationYear" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_InterestReceivableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:label="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OriginalLeasedSpaceMember" xlink:label="sepn_OriginalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LesseeOperatingLeaseExpirationYearAndMonth" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AdditionalLeasedSpaceMember" xlink:label="sepn_AdditionalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeasedSpaceMember" xlink:label="sepn_LeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeaseCommencementPeriod" xlink:label="sepn_LeaseCommencementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfLand" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_OriginalLeasedSpaceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="sepn_LesseeOperatingLeaseExpirationYearAndMonth" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_AdditionalLeasedSpaceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_LeasedSpaceMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="sepn_LeaseCommencementPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeasedSpaceMember" xlink:label="sepn_LeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_LeasedSpaceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" xlink:label="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialTrancheMember" xlink:label="sepn_InitialTrancheMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneMember" xlink:label="sepn_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheTwoMember" xlink:label="sepn_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneAndTrancheTwoMember" xlink:label="sepn_TrancheOneAndTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockFinancingArrangementFinancingValue" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_InitialTrancheMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheTwoMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneAndTrancheTwoMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_VestingAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockFinancingArrangementFinancingValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockTable" xlink:label="sepn_CommonStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockLineItems" xlink:label="sepn_CommonStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncreaseInSharesReservedForFutureIssuanceInShares" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="sepn_CommonStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_IncreaseInSharesReservedForFutureIssuanceInShares" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockTable" xlink:to="sepn_CommonStockLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2024PlanMember" xlink:label="sepn_Stock2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchase2024PlanMember" xlink:label="sepn_EmployeeStockPurchase2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlanMember" xlink:label="sepn_EmployeeStockPurchasePlanMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2024PlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchase2024PlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlanMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" xlink:label="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeMember" xlink:label="sepn_EmployeeMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncentiveStockOptionsMember" xlink:label="sepn_IncentiveStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2024PlanMember" xlink:label="sepn_Stock2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OptionAndIncentivePlan2024Member" xlink:label="sepn_OptionAndIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PerformanceConditionsMember" xlink:label="sepn_PerformanceConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlan2024Member" xlink:label="sepn_EmployeeStockPurchasePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialPublicOfferingStockOptions" xlink:label="sepn_InitialPublicOfferingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="sepn_EmployeeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_IncentiveStockOptionsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2024PlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_OptionAndIncentivePlan2024Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="sepn_PerformanceConditionsMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlan2024Member" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_InitialPublicOfferingStockOptions" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesTable" xlink:label="sepn_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesLineItems" xlink:label="sepn_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OperatingLossCarryforwardsExpirationYear" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TaxCreditCarryforwardExpirationYear" xlink:label="sepn_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfChangeInOwnership" xlink:label="sepn_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="sepn_IncomeTaxesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_OperatingLossCarryforwardsExpirationYear" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesTable" xlink:to="sepn_IncomeTaxesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_TaxCreditCarryforwardExpirationYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_PercentageOfChangeInOwnership" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsLeaseLiability" xlink:label="sepn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="sepn_DeferredTaxAssetsLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ThirdRockVenturesViLPServiceAgreementMember" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RaCapitalManagementLPServiceAgreementMember" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InterimChiefMedicalOfficerMember" xlink:label="sepn_InterimChiefMedicalOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SamsaraBiocapitalLPMember" xlink:label="sepn_SamsaraBiocapitalLPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedExpenseAndOtherCurrentLiabilities" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_ThirdRockVenturesViLPServiceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_RaCapitalManagementLPServiceAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="sepn_InterimChiefMedicalOfficerMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_SamsaraBiocapitalLPMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProfessionalFees" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sepn_AccruedExpenseAndOtherCurrentLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockOptions" xlink:label="sepn_CommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStock" xlink:label="sepn_UnvestedRestrictedStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="sepn_CommonStockOptions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="sepn_UnvestedRestrictedStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="us-gaap_RetirementPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FourZeroOne401KPlanMember" xlink:label="sepn_FourZeroOne401KPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="us-gaap_RetirementPlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="sepn_FourZeroOne401KPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_RetirementPlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation" xlink:label="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExternalResearchAndDevelopmentExpenses" xlink:label="sepn_ExternalResearchAndDevelopmentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExternalGeneralAndAdministrativeExpenses" xlink:label="sepn_ExternalGeneralAndAdministrativeExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="sepn_ExternalResearchAndDevelopmentExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="sepn_ExternalGeneralAndAdministrativeExpenses" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingOtherItemAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_OperatingExpenses" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EquityIncentivePlan2024Member" xlink:label="sepn_EquityIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OptionAndIncentivePlan2024Member" xlink:label="sepn_OptionAndIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlan2024Member" xlink:label="sepn_EmployeeStockPurchasePlan2024Member"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EquityIncentivePlan2024Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_OptionAndIncentivePlan2024Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlan2024Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_PlanNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RestrictedStockOptionsSubjectToRepurchase" xlink:label="sepn_RestrictedStockOptionsSubjectToRepurchase"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_RestrictedStockOptionsSubjectToRepurchase" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" xlink:label="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" xlink:label="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockIssuanceCostsOfConvertibleSecurities" xlink:label="sepn_StockIssuanceCostsOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sepn_StockIssuanceCostsOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" xlink:label="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAsset" xlink:label="sepn_GainOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" xlink:label="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RepurchasesOfUnvestedRestrictedCommonStock" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnpaidOfferingCostsIncludedInAccountsPayable" xlink:label="sepn_UnpaidOfferingCostsIncludedInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:label="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentsOfDeferredOfferingCosts" xlink:label="sepn_PaymentsOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="sepn_ProceedsFromSaleOfNonFinancialAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="sepn_GainOnSaleOfNonFinancialAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="sepn_RepurchasesOfUnvestedRestrictedCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_UnpaidOfferingCostsIncludedInAccountsPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="sepn_PaymentsOfDeferredOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_VertexResearchServiceAgreementMember" xlink:label="sepn_VertexResearchServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneMember" xlink:label="sepn_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheTwoMember" xlink:label="sepn_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsAndCommissions" xlink:label="sepn_UnderwritingDiscountsAndCommissions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingOtherOfferingExpenses" xlink:label="sepn_UnderwritingOtherOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedPreferredStockSharesAuthorized" xlink:label="sepn_UndesignatedPreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UndesignatedCommonStockParOrStatedValuePerShare" xlink:label="sepn_UndesignatedCommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" xlink:label="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfInProgressResearchAndDevelopment" xlink:label="sepn_GainOnSaleOfInProgressResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" xlink:label="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentAssetsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="sepn_VertexResearchServiceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingDiscountsAndCommissions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UnderwritingOtherOfferingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UndesignatedPreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_UndesignatedCommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_GainOnSaleOfInProgressResearchAndDevelopment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="sepn_FurnitureFixturesAndOfficeEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_FurnitureFixturesAndOfficeEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_VertexResearchServiceAgreementMember" xlink:label="sepn_VertexResearchServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AgreementDescription" xlink:label="sepn_AgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TermOfResearchServiceAgreement" xlink:label="sepn_TermOfResearchServiceAgreement"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RequiredPriorNoticeDurationToTerminateAgreement" xlink:label="sepn_RequiredPriorNoticeDurationToTerminateAgreement"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ServiceAgreementExpirationYear" xlink:label="sepn_ServiceAgreementExpirationYear"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="sepn_VertexResearchServiceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_AgreementDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_TermOfResearchServiceAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_RequiredPriorNoticeDurationToTerminateAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="sepn_ServiceAgreementExpirationYear" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_InterestReceivableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OriginalLeasedSpaceMember" xlink:label="sepn_OriginalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LesseeOperatingLeaseExpirationYearAndMonth" xlink:label="sepn_LesseeOperatingLeaseExpirationYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AdditionalLeasedSpaceMember" xlink:label="sepn_AdditionalLeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeasedSpaceMember" xlink:label="sepn_LeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeaseCommencementPeriod" xlink:label="sepn_LeaseCommencementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfLand" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_OriginalLeasedSpaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="sepn_LesseeOperatingLeaseExpirationYearAndMonth" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_AdditionalLeasedSpaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_LeasedSpaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="sepn_LeaseCommencementPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_LeasedSpaceMember" xlink:label="sepn_LeasedSpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sepn_LeasedSpaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_ShortTermLeaseCost" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialTrancheMember" xlink:label="sepn_InitialTrancheMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" xlink:label="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneMember" xlink:label="sepn_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheTwoMember" xlink:label="sepn_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TrancheOneAndTrancheTwoMember" xlink:label="sepn_TrancheOneAndTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" xlink:label="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" xlink:label="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockFinancingArrangementFinancingValue" xlink:label="sepn_TemporaryEquityStockFinancingArrangementFinancingValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" xlink:label="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" xlink:label="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" xlink:label="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" xlink:label="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_InitialTrancheMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="sepn_TrancheOneAndTrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockFinancingArrangementFinancingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockLineItems" xlink:label="sepn_CommonStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockTable" xlink:label="sepn_CommonStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncreaseInSharesReservedForFutureIssuanceInShares" xlink:label="sepn_IncreaseInSharesReservedForFutureIssuanceInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" xlink:label="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_CommonStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_IncreaseInSharesReservedForFutureIssuanceInShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_CommonStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_CommonStockLineItems" xlink:to="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesAConvertiblePreferredStockMember" xlink:label="sepn_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2024PlanMember" xlink:label="sepn_Stock2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SeriesBConvertiblePreferredStockMember" xlink:label="sepn_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchase2024PlanMember" xlink:label="sepn_EmployeeStockPurchase2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlanMember" xlink:label="sepn_EmployeeStockPurchasePlanMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2024PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sepn_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchase2024PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_StockPlan2024And2021Member" xlink:label="sepn_StockPlan2024And2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_StockPlan2024And2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" xlink:label="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeMember" xlink:label="sepn_EmployeeMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2021PlanMember" xlink:label="sepn_Stock2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PerformanceConditionsMember" xlink:label="sepn_PerformanceConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncentiveStockOptionsMember" xlink:label="sepn_IncentiveStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_Stock2024PlanMember" xlink:label="sepn_Stock2024PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OptionAndIncentivePlan2024Member" xlink:label="sepn_OptionAndIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlan2024Member" xlink:label="sepn_EmployeeStockPurchasePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InitialPublicOfferingStockOptions" xlink:label="sepn_InitialPublicOfferingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" xlink:label="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" xlink:label="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="sepn_EmployeeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2021PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="sepn_PerformanceConditionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_IncentiveStockOptionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_Stock2024PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_OptionAndIncentivePlan2024Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlan2024Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_InitialPublicOfferingStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesLineItems" xlink:label="sepn_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_IncomeTaxesTable" xlink:label="sepn_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OperatingLossCarryforwardsExpirationYear" xlink:label="sepn_OperatingLossCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_TaxCreditCarryforwardExpirationYear" xlink:label="sepn_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PercentageOfChangeInOwnership" xlink:label="sepn_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_IncomeTaxesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sepn_IncomeTaxesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_OperatingLossCarryforwardsExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_TaxCreditCarryforwardExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="sepn_PercentageOfChangeInOwnership" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sepn_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ThirdRockVenturesViLPServiceAgreementMember" xlink:label="sepn_ThirdRockVenturesViLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RaCapitalManagementLPServiceAgreementMember" xlink:label="sepn_RaCapitalManagementLPServiceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_InterimChiefMedicalOfficerMember" xlink:label="sepn_InterimChiefMedicalOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_SamsaraBiocapitalLPMember" xlink:label="sepn_SamsaraBiocapitalLPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedExpenseAndOtherCurrentLiabilities" xlink:label="sepn_AccruedExpenseAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_ThirdRockVenturesViLPServiceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_RaCapitalManagementLPServiceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="sepn_InterimChiefMedicalOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="sepn_SamsaraBiocapitalLPMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProfessionalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sepn_AccruedExpenseAndOtherCurrentLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" xlink:label="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="us-gaap_RetirementPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_FourZeroOne401KPlanMember" xlink:label="sepn_FourZeroOne401KPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="us-gaap_RetirementPlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="us-gaap_RetirementPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="sepn_FourZeroOne401KPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_RetirementPlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EquityIncentivePlan2024Member" xlink:label="sepn_EquityIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_OptionAndIncentivePlan2024Member" xlink:label="sepn_OptionAndIncentivePlan2024Member"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_EmployeeStockPurchasePlan2024Member" xlink:label="sepn_EmployeeStockPurchasePlan2024Member"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EquityIncentivePlan2024Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_OptionAndIncentivePlan2024Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sepn_EmployeeStockPurchasePlan2024Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="us-gaap_UsefulLifeDescriptionOfTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_RestrictedCash" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="2" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="sepn_RepurchasesOfUnvestedRestrictedCommonStock" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="sepn_ProceedsFromSaleOfNonFinancialAsset" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="sepn_GainOnSaleOfNonFinancialAsset" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="sepn_PaymentsOfDeferredOfferingCosts" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="5" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="9" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="12" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="13" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="14" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_RepurchasesOfUnvestedRestrictedCommonStock" xlink:label="sepn_RepurchasesOfUnvestedRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_ProceedsFromSaleOfNonFinancialAsset" xlink:label="sepn_ProceedsFromSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_GainOnSaleOfNonFinancialAsset" xlink:label="sepn_GainOnSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PaymentsOfDeferredOfferingCosts" xlink:label="sepn_PaymentsOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="sepn_PrepaidClinicalTrialCostsCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="sepn_PrepaidBonusCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="sepn_PrepaidTaxesCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_InterestReceivableCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidClinicalTrialCostsCurrent" xlink:label="sepn_PrepaidClinicalTrialCostsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidBonusCurrent" xlink:label="sepn_PrepaidBonusCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_PrepaidTaxesCurrent" xlink:label="sepn_PrepaidTaxesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="sepn_AccruedGeneralAndAdministrativeExpenseCurrent" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="sepn_AccruedResearchAndDevelopmentExpenseCurrent" order="7" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedGeneralAndAdministrativeExpenseCurrent" xlink:label="sepn_AccruedGeneralAndAdministrativeExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="sepn_AccruedResearchAndDevelopmentExpenseCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" xlink:label="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" xlink:label="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="sepn_DeferredTaxAssetsLeaseLiability" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" xlink:label="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsLeaseLiability" xlink:label="sepn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="sepn_CommonStockOptions" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="sepn_UnvestedRestrictedStock" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:label="us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_CommonStockOptions" xlink:label="sepn_CommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="sepn-20241231.xsd#sepn_UnvestedRestrictedStock" xlink:label="sepn_UnvestedRestrictedStock"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="sepn_SamsaraBiocapitalLPMember" name="SamsaraBiocapitalLPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_FourZeroOne401KPlanMember" name="FourZeroOne401KPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" name="EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_AccruedGeneralAndAdministrativeExpenseCurrent" name="AccruedGeneralAndAdministrativeExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_InterimChiefMedicalOfficerMember" name="InterimChiefMedicalOfficerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_CommonStockLineItems" name="CommonStockLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_RestrictedStockOptionsSubjectToRepurchase" name="RestrictedStockOptionsSubjectToRepurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" name="PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_IncentiveStockOptionsMember" name="IncentiveStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_LeaseCommencementPeriod" name="LeaseCommencementPeriod" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_AgreementDescription" name="AgreementDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" name="SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" name="TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_GainOnSaleOfInProgressResearchAndDevelopment" name="GainOnSaleOfInProgressResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_RequiredPriorNoticeDurationToTerminateAgreement" name="RequiredPriorNoticeDurationToTerminateAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_UnvestedRestrictedStockSubjectToRepurchaseMember" name="UnvestedRestrictedStockSubjectToRepurchaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_GainOnSaleOfNonFinancialAssetTextBlock" name="GainOnSaleOfNonFinancialAssetTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_GainOnSaleOfNonFinancialAsset" name="GainOnSaleOfNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_ThirdRockVenturesViLPServiceAgreementMember" name="ThirdRockVenturesViLPServiceAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_UnderwritingDiscountsAndCommissions" name="UnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_TemporaryEquityStockFinancingArrangementFinancingValue" name="TemporaryEquityStockFinancingArrangementFinancingValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_FurnitureFixturesAndOfficeEquipmentMember" name="FurnitureFixturesAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" name="TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_ConvertiblePreferredStockTextBlock" name="ConvertiblePreferredStockTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_IncomeTaxesLineItems" name="IncomeTaxesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_RisksAndUncertaintyPolicyTextBlock" name="RisksAndUncertaintyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_LesseeOperatingLeaseExpirationYearAndMonth" name="LesseeOperatingLeaseExpirationYearAndMonth" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" name="ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_PrepaidClinicalTrialCostsCurrent" name="PrepaidClinicalTrialCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_OptionAndIncentivePlan2024Member" name="OptionAndIncentivePlan2024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" name="CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ExternalResearchAndDevelopmentExpenses" name="ExternalResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" name="CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_UnvestedRestrictedStock" name="UnvestedRestrictedStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_TrancheTwoMember" name="TrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset" name="OtherReceivableRelatedToSaleOfNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested" name="StockIssuedDuringPeriodValuesRestrictedStockAwardVested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_OrganizationDisclosureTextBlock" name="OrganizationDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts" name="UnderwritingDiscountsCommissionsAndOtherOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_LeasedSpaceMember" name="LeasedSpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_IncomeTaxesTable" name="IncomeTaxesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_RepurchasesOfUnvestedRestrictedCommonStock" name="RepurchasesOfUnvestedRestrictedCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_UnpaidOfferingCostsIncludedInAccountsPayable" name="UnpaidOfferingCostsIncludedInAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" name="ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset" name="DeferredTaxLiabilitiesSaleOfNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress" name="GainLossOnSaleOfResearchAndDdevelopmentInProgress" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sepn_UnderwritingOtherOfferingExpenses" name="UnderwritingOtherOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_InitialTrancheMember" name="InitialTrancheMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TrancheOneAndTrancheTwoMember" name="TrancheOneAndTrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" name="LiabilitiesAssociatedWithIndemnificationRightsAndAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_ProceedsFromSaleOfNonFinancialAsset" name="ProceedsFromSaleOfNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_PatentExpensesPolicyPolicyTextBlock" name="PatentExpensesPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" name="SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_CommonStockTable" name="CommonStockTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_PaymentsOfDeferredOfferingCosts" name="PaymentsOfDeferredOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_AdditionalLeasedSpaceMember" name="AdditionalLeasedSpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" name="AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_ExternalGeneralAndAdministrativeExpenses" name="ExternalGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ExecutiveOfficerAndDirectorEquityAwardsMember" name="ExecutiveOfficerAndDirectorEquityAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_StockIssuanceCostsOfConvertibleSecurities" name="StockIssuanceCostsOfConvertibleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect" name="PercentageOfShareIssuePriceDividedByConversionPriceInEffect" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock" name="CashProceedsFromIssuanceOfConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" name="ShareBasedCompensationEquityAwardsOptionsGrantsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_PrepaidTaxesCurrent" name="PrepaidTaxesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_Stock2024PlanMember" name="Stock2024PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_UndesignatedCommonStockParOrStatedValuePerShare" name="UndesignatedCommonStockParOrStatedValuePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sepn_EmployeeMember" name="EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TermOfResearchServiceAgreement" name="TermOfResearchServiceAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" name="CashEquivalentsAndMarketableSecuritiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_Stock2021PlanMember" name="Stock2021PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_CommonStockTextBlock" name="CommonStockTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock" name="SaleOfNonFinancialAssetsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_RaCapitalManagementLPServiceAgreementMember" name="RaCapitalManagementLPServiceAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" name="AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" name="GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_PrepaidBonusCurrent" name="PrepaidBonusCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_IncreaseInSharesReservedForFutureIssuanceInShares" name="IncreaseInSharesReservedForFutureIssuanceInShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_UnconditionalRightOnNonFinancialAsset" name="UnconditionalRightOnNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_AccruedResearchAndDevelopmentExpenseCurrent" name="AccruedResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_PerformanceConditionsMember" name="PerformanceConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" name="TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_ConvertiblePreferredStockPolicyPolicyTextBlock" name="ConvertiblePreferredStockPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock" name="MarketableSecuritiesAndFairValueMeasurementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_EquityIncentivePlan2024Member" name="EquityIncentivePlan2024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_ServiceAgreementExpirationYear" name="ServiceAgreementExpirationYear" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" name="AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" name="ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" name="DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_EmployeeStockPurchasePlan2024Member" name="EmployeeStockPurchasePlan2024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation" name="EmployeeRelatedExpensesExcludingStockBasedCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_UndesignatedPreferredStockSharesAuthorized" name="UndesignatedPreferredStockSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" name="NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_VertexResearchServiceAgreementMember" name="VertexResearchServiceAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval" name="TemporaryEquityStockAdditionalFundingBasedOnApproval" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_AccruedExpenseAndOtherCurrentLiabilities" name="AccruedExpenseAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" name="AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_PaymentReceivedOnSaleOfNonFinancialAsset" name="PaymentReceivedOnSaleOfNonFinancialAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sepn_EmployeeStockPurchase2024PlanMember" name="EmployeeStockPurchase2024PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_PercentageOfChangeInOwnership" name="PercentageOfChangeInOwnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" name="SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_CommonStockOptions" name="CommonStockOptions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sepn_InitialPublicOfferingStockOptions" name="InitialPublicOfferingStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sepn_StockPlan2024And2021Member" name="StockPlan2024And2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sepn_OriginalLeasedSpaceMember" name="OriginalLeasedSpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 17, 2025</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Septerna, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001984086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-3891440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SEPN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 East Grand Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">338-3533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text"> Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,442,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Mateo, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying balance sheets of Septerna, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive (loss) income, convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statement of Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 238,196<span></span>
</td>
<td class="nump">$ 88,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">112,727<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other receivable related to sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,730<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">356,824<span></span>
</td>
<td class="nump">112,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">69,866<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,090<span></span>
</td>
<td class="nump">4,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">23,602<span></span>
</td>
<td class="nump">12,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">456,554<span></span>
</td>
<td class="nump">130,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">2,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">7,798<span></span>
</td>
<td class="nump">4,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">1,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,849<span></span>
</td>
<td class="nump">6,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">23,625<span></span>
</td>
<td class="nump">12,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">36,507<span></span>
</td>
<td class="nump">20,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 10,000,000 shares and no shares authorized as of December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of December 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value per share, 500,000,000 and 260,590,689 shares authorized at December 31, 2024 and 2023, respectively; 44,422,505 and 3,168,134 shares issued and outstanding at December 31, 2024 and 2023, respectively; 576,829 and 1,002,044 shares subject to repurchase as of December 31, 2024 and 2023, respectively</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">538,321<span></span>
</td>
<td class="nump">8,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(118,374)<span></span>
</td>
<td class="num">(46,576)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">420,047<span></span>
</td>
<td class="num">(38,374)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">456,554<span></span>
</td>
<td class="nump">130,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">74,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 74,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FeaturesOfConvertiblePreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statement of Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">260,590,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">44,422,505<span></span>
</td>
<td class="nump">3,168,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">44,422,505<span></span>
</td>
<td class="nump">3,168,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_RestrictedStockOptionsSubjectToRepurchase', window );">Restricted stock options subject to repurchase</a></td>
<td class="nump">576,829<span></span>
</td>
<td class="nump">1,002,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">121,657,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_RestrictedStockOptionsSubjectToRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock options subject to repurchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_RestrictedStockOptionsSubjectToRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations and Comprehensive (Loss) Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">65,337<span></span>
</td>
<td class="nump">35,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">16,561<span></span>
</td>
<td class="nump">9,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(47,625)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses (income)</a></td>
<td class="nump">81,898<span></span>
</td>
<td class="num">(1,924)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(80,823)<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">8,617<span></span>
</td>
<td class="nump">2,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(90)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">8,527<span></span>
</td>
<td class="nump">2,796<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before provision for income taxes</a></td>
<td class="num">(72,296)<span></span>
</td>
<td class="nump">4,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="num">(498)<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(71,798)<span></span>
</td>
<td class="nump">4,180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income applicable to common stockholders</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net (loss) income per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="num">$ (7.26)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="num">$ (7.26)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding used in computing net (loss) income per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">9,891,126<span></span>
</td>
<td class="nump">1,928,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">9,891,126<span></span>
</td>
<td class="nump">2,177,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">$ (71,742)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,181,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2022</a></td>
<td class="num">$ (44,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (50,756)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Beginning Balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Convertible Preferred Stock, issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested', window );">Vesting of restricted common stock</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchases of unvested restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">4,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,180<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,168,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2023</a></td>
<td class="num">(38,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">8,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,576)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Ending Balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Ending Balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,694<span></span>
</td>
<td class="nump">$ 74,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,828,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Convertible Preferred Stock, issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with initial public offering, net of issuance costs</a></td>
<td class="nump">302,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">302,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares', window );">Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,000,000)<span></span>
</td>
<td class="num">(121,657,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock', window );">Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (74,694)<span></span>
</td>
<td class="num">$ (149,463)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock upon initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,839,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock upon initial public offering</a></td>
<td class="nump">224,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">224,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested', window );">Vesting of restricted common stock</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchases of unvested restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,299)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(71,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,798)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,422,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 420,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 538,321<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="num">$ (118,374)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Ending Balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Ending Balance at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period values restricted stock award vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Conversion of convertible preferred stock to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Conversion of convertible preferred stock to common stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with initial public offering, issuance costs</a></td>
<td class="nump">$ 302,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering (IPO)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">28,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_StockIssuanceCostsOfConvertibleSecurities', window );">Issuance costs</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_StockIssuanceCostsOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issuance costs of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_StockIssuanceCostsOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (71,798,000)<span></span>
</td>
<td class="nump">$ 4,180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,401,000<span></span>
</td>
<td class="nump">848,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_GainOnSaleOfNonFinancialAsset', window );">Gain on sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(47,625,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">1,383,000<span></span>
</td>
<td class="nump">807,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,152,000<span></span>
</td>
<td class="nump">1,620,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of premiums (discounts), net</a></td>
<td class="num">(1,410,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="num">(491,000)<span></span>
</td>
<td class="nump">491,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(4,297,000)<span></span>
</td>
<td class="num">(136,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(151,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other non-current assets</a></td>
<td class="num">(170,000)<span></span>
</td>
<td class="nump">165,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">723,000<span></span>
</td>
<td class="num">(653,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">3,564,000<span></span>
</td>
<td class="nump">2,471,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating leases, net</a></td>
<td class="nump">448,000<span></span>
</td>
<td class="num">(770,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(67,470,000)<span></span>
</td>
<td class="num">(38,723,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,103,000)<span></span>
</td>
<td class="num">(2,878,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ProceedsFromSaleOfNonFinancialAsset', window );">Proceeds from sale of non-financial asset</a></td>
<td class="nump">22,625,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(213,390,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">32,270,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(160,598,000)<span></span>
</td>
<td class="nump">22,122,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Initial Public Offering, net of offering costs</a></td>
<td class="nump">302,788,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Series B Convertible Preferred stock, net of issuance costs</a></td>
<td class="nump">74,942,000<span></span>
</td>
<td class="nump">74,521,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_RepurchasesOfUnvestedRestrictedCommonStock', window );">Repurchases of unvested restricted common stock</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">52,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">377,781,000<span></span>
</td>
<td class="nump">74,520,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">149,713,000<span></span>
</td>
<td class="nump">57,919,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">89,388,000<span></span>
</td>
<td class="nump">31,469,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">239,101,000<span></span>
</td>
<td class="nump">89,388,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure for noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset recognized in exchange for operating lease liability</a></td>
<td class="nump">12,462,000<span></span>
</td>
<td class="nump">12,579,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset', window );">Other receivable related to sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering', window );">Conversion of convertible preferred stock to common stock upon initial public offering</a></td>
<td class="nump">224,157,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnpaidOfferingCostsIncludedInAccountsPayable', window );">Unpaid offering costs included in accounts payable</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities', window );">Property and equipment included in accounts payable and accrued expenses and other current liabilities</a></td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">262,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents and Restricted Cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">238,196,000<span></span>
</td>
<td class="nump">88,483,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">905,000<span></span>
</td>
<td class="nump">905,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Total cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">$ 239,101,000<span></span>
</td>
<td class="nump">$ 89,388,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible preferred stock to common stock upon initial public offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_GainOnSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_GainOnSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other receivable related to sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ProceedsFromSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-financial asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ProceedsFromSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and equipment included in accounts payable and accrued expenses and other current liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_RepurchasesOfUnvestedRestrictedCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchases of unvested restricted common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_RepurchasesOfUnvestedRestrictedCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnpaidOfferingCostsIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unpaid Offering Costs Included In Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnpaidOfferingCostsIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy, and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented a cybersecurity risk management program in accordance with our risk profile and business size that is informed by recognized industry standards, including elements of the National Institute of Standards and Technology Cybersecurity Framework and International Organization for Standardization 27001 Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program is comprised of a number of components, including but not limited to written information security policies, external cybersecurity risk assessments, and system monitoring. We also have an employee privacy and data security training awareness program that includes cybersecurity risk awareness trainings and phishing campaigns. We maintain an incident response plan to help guide our response to cybersecurity incidents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We leverage the cybersecurity services of third-party vendors, including a third-party managed services provider and IT consultants, to support our cybersecurity risk management program and assist us in conducting external cybersecurity risk assessments. As part of our cybersecurity risk management program, we take a risk-based approach to the evaluation of third-party vendors. As part of our vendor diligence process we require vendors with access to our information technology systems and infrastructure to complete information security program questionnaires.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not identified any cybersecurity incidents or threats that have materially affected us or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">However, like other companies in our industry, we and our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> vendors have from time to time experienced threats relating to our and our third-party vendors&#8217; information systems and infrastructure.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For more information, please see &#8220;Item 1A, Risk Factors.&#8221;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance Related to Cybersecurity Risks</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#8217;s general risk oversight function.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#8220;IT&#8221;), and is responsible for the strategic leadership of our cybersecurity risk management program.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Head of IT relies on both internal and external cybersecurity resources to manage and remain appraised of overall cybersecurity risks to our business and our industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.</span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#8217;s general risk oversight function.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#8217;s general risk oversight function.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance Related to Cybersecurity Risks</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#8217;s general risk oversight function.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#8220;IT&#8221;), and is responsible for the strategic leadership of our cybersecurity risk management program.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Head of IT relies on both internal and external cybersecurity resources to manage and remain appraised of overall cybersecurity risks to our business and our industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.</span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#8220;IT&#8221;), and is responsible for the strategic leadership of our cybersecurity risk management program.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_OrganizationDisclosureTextBlock', window );">Organization</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Organization</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Septerna, Inc. (&#8220;Septerna&#8221; or the &#8220;Company&#8221;) is a biotechnology company pioneering a new era of G protein-coupled receptor (&#8220;GPCR&#8221;) oral small molecule drug discovery powered by its proprietary Native Complex Platform</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of its deep pipeline of product candidates focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s proprietary Native Complex Platform&#153; replicates the natural structure, function, and dynamics of GPCRs outside of cells at an industrial scale for, as the Company believes, the first time. The Company&#8217;s foundational technologies enable it to isolate, purify, and reconstitute full-length, properly folded GPCR proteins within ternary complexes with ligands and transducer proteins in a lipid bilayer that mimics the cell membrane. The Company then applies state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging its platform, the Company has transformed GPCR oral small molecule drug discovery to an industrialized and iterative structure-based drug design approach to expand the landscape of druggable GPCR targets with novel oral small molecule medicines for patients. The Company&#8217;s Native Complex Platform&#153; is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to affect GPCR signaling in different ways to achieve desired therapeutic effects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company was incorporated in Delaware in December 2019, under the name GPCR NewCo, Inc. In June 2021, the Company changed its name to Septerna, Inc. The Company is headquartered in South San Francisco, California.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Stock Split</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 18, 2024, the Company effected a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-8.6103</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of its issued and outstanding shares of common stock. Upon the effectiveness of the reverse stock split, (i) all shares of outstanding common stock were adjusted; (ii) the conversion ratio of the convertible preferred stock was adjusted; (iii) the number of shares of common stock for which each outstanding option to purchase common stock is exercisable were adjusted; and (iv) the exercise price of each outstanding option to purchase common stock was adjusted. All of the outstanding common stock (including shares of common stock subject to the Company&#8217;s options and as converted for the outstanding convertible preferred stock), share prices, exercise prices and per share amounts contained in the financial statements have been retroactively adjusted to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of common stock and preferred stock were not adjusted as a result of the reverse stock split. The number of authorized shares did not change.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Initial Public Offering</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company completed its initial public offering (&#8220;IPO&#8221;), pursuant to which it issued and sold an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock at the IPO price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, including </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares, resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting discounts and commissions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and other offering expenses payable by the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Immediately prior to the closing of the IPO, the Company&#8217;s then outstanding convertible preferred stock automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,839,774</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the closing of the IPO, no shares of convertible preferred stock were authorized or outstanding. In connection with the completion of the IPO, on October 28, 2024, the Company&#8217;s certificate of incorporation was amended and restated to (i) authorize </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which eliminates all references to the previously existing series of convertible preferred stock; and (ii) authorize </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of undesignated preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share,  that may be issued from time to time by the Company&#8217;s board of directors in one or more series.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which assumes that the Company will realize its assets and satisfies its liabilities in the normal course of business. The Company is subject to risks inherent in operating an early-stage biotechnology business. These risks include, but are not limited to, dependence on the development of marketable products, the ability to attract, retain, and motivate qualified personnel, rapid technological changes and the rapidly evolving nature of the biotechnology industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred significant losses and negative cash flows from operations since its inception and expects to incur losses as a result of its continued research and development activities. To date, none of the Company&#8217;s product candidates have been approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) for commercial sale and, therefore, the Company has not generated any revenue from product sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company historically financed its operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and most recently, through sale of its common stock in an IPO.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company incurred net loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company had an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. The Company believes its cash, cash equivalents, marketable securities, and marketable securities, non-current of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">420.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024 will be sufficient to fund its operations for, at least, 12 months from the date of issuance of the financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects to continue to generate operating losses for the foreseeable future. The Company will need additional financing to support its continuing operations and pursue its growth strategy. It expects to finance its operations through equity offerings, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain funding on acceptable terms, or at all. Any failure to raise capital as and when needed would compromise the Company&#8217;s ability to execute on its business plan and may cause the Company to significantly delay, scale back or discontinue the research and development of some of its programs or curtail any efforts to expand its product pipelines and will materially harm its business, financial position and results of operations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_OrganizationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization disclosure text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_OrganizationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;), stated in U.S. dollars and include all adjustments necessary for the fair presentation of the Company&#8217;s financial statements as of December 31, 2024 and 2023, and for the years then ended. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification and Accounting Standards Updates </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASUs</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Financial Accounting Standards Board </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FASB</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;).</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures at the date of the financial statements and reported amounts of expenses during the reporting periods. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources and adjusts those estimates and assumptions when facts and circumstances dictate. Estimates are used in determining the fair value of assets and liabilities, the useful lives of property and equipment, the rate used in determining the present value of lease payments, fair value of assets and liabilities, research and development accruals, the estimated fair value of common stock prior to the Company's IPO, and stock options, the allocation of a revenue contract&#8217;s transaction price to each distinct performance obligation on a relative standalone selling price basis, uncertain tax positions and the valuation allowance for deferred income tax assets. Actual results may differ from these estimates and assumptions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s CODM is its chief executive officer. Based on the information used by the CODM to allocate resources, the Company has determined it operates in one segment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company limits its credit risk by placing its cash, cash equivalents, and marketable securities with banks and institutions that are highly creditworthy. Such cash may be in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured limits, and the Company's cash equivalents and marketable securities are not insured by the FDIC. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and marketable securities to the extent recorded in the balance sheet.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. Management believes that the Company is not exposed to significant credit risk due to the high-credit-quality financial institutions in which those deposits are held. The Company has not experienced any losses on its cash, cash equivalents and marketable securities since inception. The Company has no significant off-balance sheet concentrations of credit risk.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to all of the risks inherent in an early-stage biotechnology company. These risks include, but are not limited to, limited management resources, efficacy of product candidates, intense competition, and dependence upon the availability of cash to sustain operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds marketable securities that consist of highly liquid, investment grade debt securities. The Company's cash and marketable securities are held or issued by financial institutions that management believes are of high credit quality. Marketable securities are classified and accounted for as available-for-sale. Marketable securities with original maturities of 90 days or less are classified as cash equivalents. Marketable securities with original maturities over 90 days and remaining maturities of less than 12 months are classified as current. Marketable securities with remaining maturities of more than 12 months for which the Company has the intent and ability to hold the security for more than 12 months are classified as non-current. The Company&#8217;s marketable securities are carried at estimated fair value, which is derived from independent pricing sources based on quoted prices in active markets for similar securities. Unrealized gains and losses are reported in stockholders&#8217; equity (deficit) as accumulated other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in interest income on the statements of operations and comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12 months. The Company does not generally intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews its portfolio of marketable securities, using both quantitative and qualitative factors, to determine if declines in fair value below amortized cost have resulted from a credit-related loss or other factors. If the decline in fair value is due to credit-related factors, the Company recognizes a loss in its statement of operations, whereas if the decline in fair value is not due to credit-related factors, the Company recognizes the loss in other comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excludes the applicable accrued interest from both the fair value and amortized cost basis of marketable securities for purposes of identifying and measuring an impairment. Accrued interest receivable on marketable securities is recorded within prepaid expenses and other current assets on the balance sheets. The Company&#8217;s accounting policy is to not measure an allowance for credit loss for accrued interest receivable and to write-off any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which is considered to be in the period in which it is determined the accrued interest will not be collected.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash is comprised of cash that is restricted as to withdrawal or use under the terms of certain contractual agreements. In connection with the Company&#8217;s lease agreement (see Note 7), the Company is required to maintain a collateral account to secure a letter of credit issued to its landlord. The collateral account is classified as restricted cash on the Company&#8217;s balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable and Other Receivables</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes a receivable when the Company has an unconditional right to payment, which is generally at the time of delivery of assets, or at the time services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An allowance for expected credit losses over the life of the receivables is reserved for based on a combination of historical experience, aging analysis, current economic trends and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. The reserve is re-evaluated on a regular basis and adjusted as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. No allowance for credit losses was recorded during the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the Company&#8217;s accounts receivable was entirely attributed to Vertex Pharmaceuticals Incorporated (&#8220;Vertex&#8221;). As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s other receivable related to sale of non-financial asset balance was entirely attributed to Vertex (see Note 4 and Note 5).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment, Net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment is recorded at cost, subject to adjustments for impairments, less accumulated depreciation. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.54%;box-sizing:content-box;"></td>
          <td style="width:1.94%;box-sizing:content-box;"></td>
          <td style="width:40.52%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer Equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease term or estimated useful life</span></span></span></p></td>
         </tr>
        </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation or amortization begins at the time the asset is placed in service. Maintenance and repairs that do not improve or extend the life of the respective asset are charged to expense as incurred. Upon disposal of assets, the cost and related accumulated depreciation is removed from the balance sheet and the resulting gain or loss is reflected in the statements of operations and comprehensive (loss) income within other income, net.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its long-lived assets for impairment, primarily its property and equipment, whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the undiscounted expected future cash flows the asset is expected to generate over its remaining life. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset or asset group and its eventual disposition are less than its carrying amount. Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of the Company&#8217;s long-lived assets for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for its leases in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2021, prior to entering into the lease agreement for its office and research and development space. At inception of a contract, the Company determines whether an arrangement is or contains a lease. For each lease, the Company determines the classification as either an operating lease or a financing lease. Lease recognition occurs at the lease commencement date and lease liability amounts are determined based on the present value of lease payments over the lease term. The lease term may include options to extend or terminate the lease only when it is reasonably certain that the Company will exercise that option.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments if the Company&#8217;s leases do not provide an implicit rate. The Company determines its incremental borrowing rate based on the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. Right-of-use assets represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s right to use underlying assets for the lease term and operating lease liabilities represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s obligation to make lease payments under the lease. Right-of-use assets also include any lease payments made prior to the commencement date and exclude lease incentives received.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to apply the practical expedient of combining lease and non-lease components for the real estate lease asset class. Fixed lease payments on operating leases are recognized as lease expense over the expected term of the lease on a straight-line basis. Variable lease expenses that are not considered fixed are recognized as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company elected the short-term lease practical expedient that allows the lessee to not record a lease liability and right-of-use asset for all leases with a term of 12 months or less. See Note 7 for additional information on the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> leases.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a deemed liquidation event, such as a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#8217;s certificate of incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred stock into shares of common stock. Convertible preferred stock is therefore classified outside of stockholders&#8217; equity (deficit) as events triggering redemption are not solely within the Company&#8217;s control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No shares of convertible preferred stock were authorized, issued or outstanding at December 31, 2024. As of December 31, 2023, the Company did not adjust the carrying values of its convertible preferred stock to the liquidation preferences because of the uncertainty of whether or when such an event would occur. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it was not probable that such a redemption would occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company generated revenue for the year ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex (see Note 5). The Company considers revenue to be earned when all of the following criteria are met: (i) the Company has a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#8217;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> revenue was entirely attributable to Vertex.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sale of Non-Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of non-financial assets that are outside the scope of the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ordinary activities are accounted for under ASC 610-20, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income - Gains and Losses from the Derecognition of Non-financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 610-20&#8221;). Pursuant to ASC 610-20, the Company applies the guidance in ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASC 606</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to determine if a contract exists, identify the distinct non-financial assets, and determine when control transfers and, therefore, when to derecognize the non-financial asset. Additionally, the Company applies the measurement principles of ASC 606 to determine the amount of consideration, if any, to include in the calculation of the gain or loss for the non-financial asset.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of clinical and preclinical materials, information technology-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations and fees paid to other entities that conduct certain research and development activities on the Company&#8217;s behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into agreements with outsourced contract manufacturing and development and clinical research vendors. The Company estimates accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. The Company periodically confirms the accuracy of its estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs to secure and maintain patents covering the Company&#8217;s technology and product candidates are expensed as incurred and are classified as general and administrative expenses in the statements of operations and comprehensive (loss) income.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The carrying values of the Company&#8217;s cash and cash equivalents, restricted cash, accounts receivable, other receivable related to sale of non-financial asset, accounts payable and accrued expenses, approximate their fair values due to their relatively short maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and restricted stock awards granted to employees and non-employees is recognized based on the grant-date fair value of the awards. The fair value of stock options is determined using the Black Scholes option pricing model on the date of grant. The fair value of restricted stock awards is determined using the estimated fair value of the Company&#8217;s common stock on the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the IPO, the Company utilized estimates and assumptions in determining the fair value of its common stock, including stock-based awards. The Company has granted stock options at exercise prices that represented the fair value of its common stock on the specific grant dates. The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants Technical Practice Aid, Valuation of Privately Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of the convertible preferred stock senior to the Company&#8217;s common stock at the time, and a probability analysis of various liquidity events, such as a public offering or sale of the Company, under differing scenarios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock-based awards with service conditions only, the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is generally the vesting term of the award of four years. For stock-based awards with vesting criteria subject to the achievement of performance-based conditions, in addition to service conditions, the Company recognizes stock-based compensation expense on an accelerated basis over the vesting period when achievement of the performance criteria becomes probable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is recorded within research and development and general and administrative expenses in the accompanying statements of operations and comprehensive (loss) income based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes the asset and liability approach to account for income taxes. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. Deferred tax assets and liabilities are determined based upon the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and for loss and credit carryforwards, using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertain tax positions recognized in the financial statements by prescribing a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related interest and penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive (Loss) Income</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive (loss) income is defined as a change in equity of a business enterprise during a period resulting from transactions from non-owner sources. The Company&#8217;s other comprehensive (loss) income is comprised solely of unrealized gains (losses) on marketable securities. The Company has not recorded any reclassifications from other comprehensive (loss) income to net loss during the periods presented.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration of potential dilutive securities. Vested restricted stock is treated as outstanding for accounting purposes. Unvested restricted stock is not considered to be outstanding for purposes of the calculation of basic net (loss) income per share. Diluted net (loss) income per share is computed by dividing the net (loss) income by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options, unvested restricted stock and convertible preferred stock. The dilutive effect of stock options and unvested restricted stock is computed using the treasury stock method and the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">dilutive effect of convertible preferred stock is calculated using the &#8220;if-converted method.&#8221; For all periods presented in a net loss position, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holders of its convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. Net (loss) income is attributed to common stockholders and participating securities based on their participation rights.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. ASU 2023-07 will improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods after December 5, 2024, with early adoption permitted. The Company adopted Topic 280 on January 1, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments &#8211; Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326),</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. Topic 326 is effective for annual periods beginning after December 15, 2022, and early adoption is permitted. The Company adopted Topic 326 on January 1, 2023, and the adoption did not have a material impact on its financial statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB, under its ASC or other standard setting bodies, and adopted by the Company as of the specified date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an accounting standard update that requires the Company to disclose more detailed information about the types of expenses (including employee compensation, depreciation, and amortization) included in each relevant income statement expense caption. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and decision usefulness of income tax disclosures. The standard is intended to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2025,  on a prospective basis. Early adoption and retrospective reporting are permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status and Smaller Reporting Company Status</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company is also a smaller reporting company as defined in the Securities Exchange Act of 1934, as  amended (the &#8220;Exchange Act&#8221;). The Company may continue to be a smaller reporting company even after it is no longer an emerging growth company. The Company may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as its voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of its second fiscal quarter, or its annual revenue is less than $100.0 million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the most recently completed fiscal year and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its second fiscal quarter.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Balance Sheet Components</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,114</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">874</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical trial costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,164</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">953</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid bonus</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">260</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,730</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,419</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment, Net</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,679</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,967</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture, fixtures, and office equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,222</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">713</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">717</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">389</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">401</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,019</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,287</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,929</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,622</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,090</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,665</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Expenses and Other Current Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,954</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,888</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued general and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">703</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued income taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Gain on Sale of Non-Financial Asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_GainOnSaleOfNonFinancialAssetTextBlock', window );">Gain on Sale of Non-Financial Asset</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Gain on Sale of Non-Financial Asset</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Vertex Asset Sale</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2023, the Company entered into an asset purchase agreement with Vertex under which Vertex acquired an IPR&amp;D asset related to a GPCR program, including all intellectual property, materials, and compounds associated with the program (the &#8220;Vertex Purchase Agreement&#8221;). Additionally, as part of the agreement, Vertex assumed all claims, counterclaims and credits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">associated with the program, and the Company gave up all rights to the intellectual property. The transfer of the IPR&amp;D asset to Vertex was completed in November 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the same time in September 2023, the Company entered into a research service agreement with Vertex under which the Company agreed to perform certain exploratory research activities for Vertex (the &#8220;Vertex Research Service Agreement&#8221;) (see Note 5).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the IPR&amp;D asset sale should be accounted for under the guidance at ASC 610-20, as this type of transaction did not meet the definition of &#8220;ordinary activities&#8221; of the Company and Vertex should not be considered a &#8220;customer&#8221; in this transaction. However, since both the Vertex Purchase Agreement and the Vertex Research Service Agreement were entered into at the same time with the same counterparty with a single commercial objective, the Company combined the contracts and applied the allocation principles under ASC 606. The Company identified the performance obligations in both contracts, determined the transaction price and allocated the transaction price to the performance obligations in the contracts based on the estimated standalone selling price for each performance obligation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a gain on sale of non-financial asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the sale of the IPR&amp;D asset to Vertex on its statements of operations and comprehensive (loss) income. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash at the closing of the agreement in September 2023 and recorded the remaining balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other receivable related to sale of non-financial asset on its balance sheet as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the sale of the IPR&amp;D asset was complete and the Company had an unconditional right to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company received the payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of this balance in the first half of 2024. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gain on sale of non-financial asset was recognized during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Vertex Purchase Agreement also provides for a potential milestone payment payable to the Company contingent upon achievement of a certain research milestone. The milestone payment amount is determined based on the timing of achievement of the research milestone. The variable consideration related to this milestone payment was determined to be improbable of receipt at this time. As a result, the milestone payment was excluded from the transaction price. After the potential milestone payment, the Company will not receive any other payments or future royalties related to this IPR&amp;D asset.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_GainOnSaleOfNonFinancialAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_GainOnSaleOfNonFinancialAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Revenue</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Vertex Research Service Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 4, the Company entered into the Vertex Research Service Agreement in September 2023 under which the Company agreed to perform certain exploratory research activities for Vertex. Although the Company accounted for the IPR&amp;D asset sale under the guidance at ASC 610-20, the research services portion of the transaction fell under the scope of the revenue from contracts with customers guidance, ASC 606.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Vertex Research Service Agreement is for a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> term, however, Vertex has the ability to terminate the agreement with a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30-day</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> notice at any time. As a result, the Company concluded that the contract duration is 30 days, representing a month-to-month service contract.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company recognizes this service revenue over the performance period of the research services as the services are provided. The Vertex Research Service Agreement also includes a provision related to additional research services, which the Company concluded met the definition of a customer option under ASC 606. The Company will recognize revenue related to the customer option if and when it is exercised.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company recorded revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> related to research activities performed in connection with the Vertex Research Service Agreement and customer options exercised. During the year ended December 31, 2023, the Company recorded revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> related to research activities performed in connection with the Vertex Research Service Agreement and no customer options were exercised.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract', window );"><strong>Available-for-Sale Marketable Securities and Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock', window );">Marketable Securities and Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Marketable Securities and Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records marketable securities and cash equivalents at their estimated fair values, which are based on market prices from a variety of industry standard data providers and generally represent quoted prices for similar assets in active markets or have been derived from observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,487</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,487</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, non-current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">414,958</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company&#8217;s marketable securities consist of debt securities, including U.S. treasury and agency securities, corporate debt securities and commercial paper. These marketable securities are carried at fair value and are included in the tables above. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. At each reporting date, the Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. The Company evaluates, among others, whether the Company has the intention to sell any of these marketable securities and whether it is not more likely than not that the Company will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met at December 31, 2024. The credit ratings of the securities held remain of the highest quality. Moreover, the Company continues to receive payments of interest and principal as they become due, and the Company's expectation is that those payments will continue to be received timely. Based on this evaluation, as of December 31, 2024, the Company determined that unrealized losses of its marketable securities were primarily attributable to changes in interest rates and non-credit related factors. As such, no allowances for credit losses were recorded at December 31, 2024. The Company did not hold marketable securities at December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest receivable as of December 31, 2024 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and is recorded as a component of prepaid expenses and other current assets on the Company&#8217;s balance sheets. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have interest receivable at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, all marketable securities in an unrealized loss position had been in an unrealized loss position for less than 12 months. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> marketable securities which have been in an unrealized loss position for a period of less than 12 months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes the amortized cost and the unrealized gains (losses) of the marketable securities presented within marketable securities, marketable securities, non-current and cash equivalents (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.42%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:15.36%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Remaining<br/>Contractual<br/>Maturity (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Estimated Fair<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,017</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,014</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,511</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,245</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,252</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total maturity less than 1 year</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">203,264</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">203,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,123</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes marketable securities in an unrealized loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 Months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>Unrealized Loss</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">987</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,172</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,469</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,508</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,136</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available-for-sale marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Leases</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office and research and development space at the Company&#8217;s headquarters in South San Francisco, California under an operating lease. In April 2021, the Company entered into a lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,560</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet, set to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In September 2022, the lease was amended to add </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,348</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,908</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Original Leased Space&#8221;), also expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In December 2022, the Company entered into another lease amendment to extend the term of the Original Leased Space and add </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,911</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Additional Leased Space&#8221;). The Company took control of the Additional Leased Space in November 2023, at which point the Company vacated the Original Leased Space to allow the landlord to renovate it.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Renovation of the Original Leased Space was completed in July 2024. Upon completion of the renovation of the Original Leased Space, the lease of the Original Leased Space commenced, resulting in the total leased premises increasing to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,819</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet (the &#8220;Leased Space&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lease term for the Leased Space expires in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 2032</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, with an </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">option to extend</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the lease for eight additional years (the &#8220;Extension Option&#8221;)</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, it was not probable that the Company would exercise the Extension Option, therefore, it was excluded from the right-of-use asset and lease liability calculations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million operating lease right-of-use asset and operating lease liability upon completion of the renovations of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,908</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square foot office and research and development space (the "Original Leased Space") as the Company occupied the property.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million operating lease right-of-use asset and operating lease liability for the Additional Leased Space as the lease commenced in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, when the Company took control of the property. These amounts are disclosed in the supplemental information of noncash activities on the statements of cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, the entire balance of the operating lease liability associated with the Additional Leased Space was classified as non-current as the Company received a rent abatement for four months in the first year of the lease and, therefore, the operating lease liability increased over the 12 month-period starting from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the weighted average remaining lease term of the Leased Space was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.6</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The weighted average incremental borrowing rate used for the calculation of the present value of lease payments over the lease term was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the remaining lease term of the Additional Leased Space was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.5</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The incremental borrowing rate used for the calculation of the present value of lease payments over the lease term at the lease commencement date was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the expenses recognized and cash paid for the Leased Space (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,462</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">964</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,018</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum rental payments for operating leases were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Future<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,469</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,760</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,071</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,851</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,851</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, non-current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not have any finance leases.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation, as the Company operates in an industry susceptible to patent or other legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company was not subject to any material legal proceedings as of December 31, 2024 and 2023, and the Company is not currently a party to any legal proceeding that, if determined adversely to the Company, in management&#8217;s opinion, is currently expected to individually or in the aggregate have a material adverse effect on the Company&#8217;s business, financial condition or results of operations taken as a whole.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. As permitted under Delaware law and in accordance with its bylaws, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is or was serving in such capacity. The Company is also party to indemnification agreements with its officers and directors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The maximum potential amount of future payments that the Company could be required to make under these provisions is not determinable; however, the Company currently holds director and officer liability insurance. This insurance limits the Company&#8217;s exposure and may enable it to recover a portion of any future amounts paid. The Company believes that the fair value of these indemnification obligations is minimal. In addition, the Company is not currently aware of any indemnification claims</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Accordingly, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t record any liabilities associated with these indemnification rights and agreements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ConvertiblePreferredStockTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the closing of the Company's IPO in October 2024, the Company&#8217;s outstanding convertible preferred stock automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,839,774</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shares of common stock. Converted preferred stock outstanding as of the date of the IPO consisted of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196,657,452</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. Each share of outstanding convertible preferred stock was converted into common stock at a ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.6103</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible preferred shares to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common share. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of convertible preferred stock were authorized, issued or outstanding at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, convertible preferred stock consisted of the following (in thousands, except for share and per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.291%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.685%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.025%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Authorized<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Issued and<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Carrying<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liquidation<br/>Preference</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Conversion Price<br/>Per Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,694</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,657,452</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,828,720</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,521</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2021, the Company executed a Series A Convertible Preferred Stock financing arrangement that would provide financing of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over an initial tranche and subsequent callable tranches through the issuance of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. In the initial tranche, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was received in cash, net of issuance costs, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was for the conversion of the then outstanding convertible promissory notes plus accrued interest. The Series A Convertible Preferred Stock financing arrangement represented an equity financing, per the terms of the outstanding convertible promissory notes, and as such the unpaid principal and accrued interest outstanding of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock. Additionally, in November 2022, the Company executed the second tranche and issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series A Convertible Preferred Stock and received net cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series A Convertible Preferred Stock Purchase Agreement provided that, upon the fulfillment of certain conditions, each investor would purchase its pro rata portion of the shares to be issued in additional Series A Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series A Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of the Company&#8217;s convertible preferred stock to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares, of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares are designated as Series B Convertible Preferred Stock, and to establish the rights, preferences, privileges and restrictions of the Series B Convertible Preferred Stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company entered into a Series B Convertible Preferred Stock financing arrangement in which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,657,452</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series B Convertible Preferred Stock were authorized to be issued at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23297</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share over two tranches, for total proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In June 2023 and July 2023, the Company issued an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series B Convertible Preferred Stock at an issuance price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23297</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the first tranche, with a potential second tranche of additional funding for up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million based on approval of the Board of Directors and consent of the majority of the holders of the then-outstanding Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock Purchase Agreement provides that, upon the fulfillment of certain conditions, each investor will purchase its pro rata portion of the shares to be issued in additional Series B Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series B Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon issuance of the Series B Convertible Preferred Stock, the Company also amended the Series A Convertible Preferred Stock agreement to cancel the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unissued shares of Series A Convertible Preferred Stock originally authorized under the agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company executed the second tranche of the Series B Convertible Preferred Stock financing arrangement and issued the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Series B Convertible Preferred Stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rights, privileges, and preferences of the Series A and Series B Convertible Preferred Stock (together, the &#8220;Convertible Preferred Stock&#8221;) are as follows:</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Redemption</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Preferred Stock does not have redemption rights, except for the contingent redemption upon the occurrence of a Deemed Liquidation Event.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Conversion</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Convertible Preferred Stock is initially convertible, at the option of the holder at any time after all authorized shares of the Convertible Preferred Stock have been issued or if otherwise approved by the holders representing at least a majority of the then outstanding shares of the Convertible Preferred Stock, including at least one holder that, together with its affiliates, holds only shares of Series B Convertible Preferred Stock and is a major investor, as defined in the Company&#8217;s amended and restated investors&#8217; rights agreement (the &#8220;Required Vote&#8221;), into shares of common stock as determined by dividing the original issue price by the conversion price in effect at the time of conversion. The Series A Convertible Preferred Stock conversion price is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and the Series B Convertible Preferred Stock conversion</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">price is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23297</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The conversion prices are subject to adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Convertible Preferred Stock. The conversion prices are subject to adjustment in the event the Company issues additional shares of common stock without consideration or for a consideration per share less than the conversion price in effect prior to such issuance, unless the Required Vote determines that no such adjustment shall be made to the conversion price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special mandatory conversion will occur if a convertible preferred stockholder fails to purchase their agreed upon share, as originally allocated to such holder in the purchase agreement, in additional closings of the Convertible Preferred Stock as defined in the purchase agreement, and such failure is not cured as specified in the purchase agreement following receipt of the subsequent closing notification. Holders of Series B Convertible Preferred Stock have the option to waive the special mandatory conversion as specified in the purchase agreement. Upon such event, each share of the Convertible Preferred Stock held by such holder will be automatically converted into that number of shares of common stock equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the original issue price divided by the conversion price in effect.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mandatory conversion of all outstanding shares of the Convertible Preferred Stock at the then effective conversion rate will also occur automatically upon (i) consent of holders representing the Required Vote or (ii) the closing of the sale of shares of common stock to the public at a price of at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.849455</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the common stock), in a firm commitment underwritten public offering resulting in at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in gross proceeds to the Company, after deducting underwriting discounts and commissions, and in connection with such offering the common stock is listed for trading on the Nasdaq, the New York Stock Exchange or another exchange approved by the board of directors, including the approval of at least a majority of the Convertible Preferred Stock directors.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Company, other than dividends on shares of common stock payable in shares of common stock, unless the holders of the Convertible Preferred Stock first receive, or simultaneously receive, a dividend on outstanding shares of the Convertible Preferred Stock in an amount at least equal to the dividend payable based on the number of shares of common stock at the then conversion rate, such that the calculation should result in the highest preferred stock dividend. The board of directors has not declared any dividends to-date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voting and Board Representation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each holder of outstanding shares of the Convertible Preferred Stock is entitled to one vote for each share of common stock into which such shares of preferred stock are convertible and shall vote together with the holders of common stock as a single class and on an as-converted to common stock basis, except as provided by law or by the other provisions of the Company&#8217;s certificate of incorporation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of shares of Series A Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect three directors of the Company. The holders of shares of Series B Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect one director of the Company. The holders of record of the shares of common stock and any other class or series of voting stock (including the Convertible Preferred Stock), as a single class, are entitled to elect the remaining directors. The size of the board shall be set and remain at seven directors.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Protective Provisions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At any time when shares of the Convertible Preferred Stock are outstanding, the Company shall first obtain the approval of the Required Vote, voting separately as a class, with respect to the following actions: (i) consummation of a liquidation, dissolution or winding up of the Company, or effect any merger, acquisition or consolidation or any other deemed liquidation event, (ii) amend, alter or repeal any provision of the Company&#8217;s certificate of incorporation or bylaws, (iii) create, authorize, issue or obligate the Company to issue shares of any equity security or increase the authorized number of shares of the Convertible Preferred Stock or of any additional class or series of stock unless it ranks junior to the Convertible Preferred Stock, (iv) reclassify, alter or amend any existing security of the Company that is pari passu with the Convertible Preferred Stock, or is junior with the Convertible Preferred Stock , in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification alteration or amendment would render such other security senior to the Convertible Preferred Stock, or in the case of a previously junior security would render such security senior to or pari passu with the Convertible Preferred Stock, (v) pay or declare any dividend, other than dividends on the Convertible Preferred Stock, or make any distribution on any shares of capital stock prior to the Convertible Preferred Stock, other than common stock or options to acquire common stock repurchased from former employees or consultants in connection with the cessation of their employment/services, pursuant to the provisions of existing plans or agreements, (vi) create, adopt, amend, terminate or repeal any equity or equity-linked compensation plan, (vii) increase or decrease the authorized number of directors constituting the Board of Directors, change the number of votes entitled to be cast by any director or directors on any matter, or adopt any provision inconsistent with Article Sixth; (viii) create or hold (or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue) any shares of capital stock in any subsidiary that is not a wholly-owned subsidiary of the Corporation, or sell, lease, transfer, exclusively license or otherwise dispose of any direct or indirect subsidiary capital stock or all or substantially all of any direct or indirect subsidiary assets; or (ix) sell, assign, license, pledge or encumber material technology or intellectual property, or enter into or grant any royalty streams related thereto, other than licenses granted in the ordinary course of business.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidation Preference</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of any voluntary or involuntary liquidation, dissolution or winding up, or in the event of a deemed liquidation event of the Company, the holders of shares of the Convertible Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, or out of the consideration payable to stockholders, as applicable, before any payment shall be made to the holders of common stock, an amount per share equal to the greater of (i) the original issue price, plus any dividends declared but unpaid, or (ii) such amount per share as would have been payable had all shares of the Convertible Preferred Stock been converted into common stock immediately prior to such event. If, upon the occurrence of such event, the assets of the Company available for distribution to its stockholders are insufficient to pay the holders of the Convertible Preferred Stock the full amount to which they are entitled, the holders of the Convertible Preferred Stock shall share ratably in any distribution of the assets available for distribution.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Classification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified the Convertible Preferred Stock outside of permanent equity on the balance sheet as these shares can be redeemed upon the occurrence of certain change in control events that are outside of the Company&#8217;s control, including liquidation, sale or transfer of the Company. The Company has not adjusted the carrying values of the convertible preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur that would obligate the Company to pay the liquidation preferences to holders of shares of convertible preferred stock, and at the balance sheet dates these circumstances were not probable. Subsequent adjustments to the carrying values of the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it was not probable that such a redemption would occur.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ConvertiblePreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ConvertiblePreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockTextBlock', window );">Common Stock</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company was authorized to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company was authorized to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">260.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of common stock of the Company to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">260.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company amended and restated its certificate of incorporation, which was filed immediately prior to the closing of its IPO and among other things, increased the number of shares of common stock authorized for issuance to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company completed its IPO of its common stock. In connection with the Company's IPO, the Company issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock, which included an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares of common stock, at the public offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As a result, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net proceeds, after deducting underwriting discounts and commissions and other offering costs payable by the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of common stock are entitled to dividends when and if declared by the board of directors, subject to the preferences applicable to outstanding shares of the Preferred Stock. The board of directors has not declared any dividends and the Company has not paid any dividends. The holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,710,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,129,284</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,123,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2021 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,634,488</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2024 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,743,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for 2024 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">369,402</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,052,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,597,558</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CommonStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CommonStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company's board of directors adopted, and its stockholders approved the 2024 Option and Incentive Plan (the &#8220;2024 Plan&#8221;) which became effective on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 25, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The 2024 Plan allows for the issuance of equity-based and cash-based incentive awards to the Company's officers, employees, directors and consultants. The 2024 Plan is administered by the Company's compensation committee. The exercise prices, vesting and other restrictions are determined at the discretion of the compensation committee, subject to the provisions of the 2024 Plan.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company initially reserved for issuance under the 2024 Plan </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase on January 1, 2025 and each January 1 thereafter through January 1, 2034, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares of the Company's common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company's compensation committee. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares remained available for future issuance under the 2024 Plan as of December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares reserved under the 2024 Plan is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization. The 2024 Plan replaced the 2021 Plan as the Company&#8217;s board of directors determined not to make additional awards under the 2021 Plan following the completion of the IPO. However, the 2021 Plan will continue to govern outstanding equity awards granted thereunder. The shares of common stock underlying any awards under the 2024 Plan and the 2021 Plan that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated (other than by exercise) will be added to the shares of the Company's common stock available for issuance under the 2024 Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Stock Option and Grant Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021, the Company adopted the Septerna, Inc. 2021 Stock Option and Grant Plan (the &#8220;2021 Plan&#8221;), which authorizes the Company to grant incentive stock options, non-qualified stock options, restricted stock awards, unrestricted stock awards and restricted stock units, to officers, employees, directors, consultants, or other key persons of the Company. The terms of the stock option and restricted stock agreements, including vesting requirements, are determined by the Board of Directors, subject to the provisions of the 2021 Plan. Stock option awards expire </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the grant date, or as otherwise determined by the Board of Directors, or in the case of incentive stock options granted to 10% stockholders, the term is no more than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the grant date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company granted and issued restricted stock awards and allowed the recipients to purchase the unvested restricted stock awards at par value per share. The shares issued for unvested restricted stock awards under the 2021 Plan are subject to repurchase by the Company at the original issuance price in the event of the holder&#8217;s termination of its relationship with the Company. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#8217; equity (deficit) as the related awards vest over the requisite service period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Plan initially authorized a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares reserved for future issuance. In June 2023, the Company amended the 2021 Stock Option and Grant Plan to, among other things, increase the shares reserved for issuance under the 2021 Plan to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares. In September 2024, the Company amended the 2021 Stock Option and Grant Plan, as amended to, among other things, increase the shares reserved for issuance under the 2021 Plan to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares remained available for future issuance under the 2021 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares re</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mained available for future issuance under the 2021 Plan as of December 31, 2024 as the 2021 plan was replaced by the 2024 Option and Incentive Plan (the &#8220;2024 Plan&#8221;), which is further discussed above.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 ESPP</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, the Company's board of directors adopted, and its stockholders approved, the 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;), which became effective upon the date immediately preceding the date on which the IPO registration statement was declared effective by the SEC. The 2024 ESPP initially reserved and authorized the issuance of up to a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company&#8217;s common stock to participating employees. The 2024 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2026 and each January 1 thereafter through January 1, 2034, by the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of common stock, (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares of common stock on the immediately preceding December 31, or (iii) such lesser number of shares of common stock as determined by the administrator of the 2024 ESPP. The number of shares reserved under the 2024 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares under the ESPP as the first offering period has not begun. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares available for issuance under the ESPP.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive Officer and Director Equity Awards Modification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company&#8217;s board of directors modified the terms of stock option awards for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company&#8217;s common stock and restricted stock awards for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of the Company's common stock to certain executive officers and members of the Company&#8217;s board of directors. Under the modified terms, accelerated vesting provisions were added associated with certain change of control events. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> incremental stock-based compensation expense was recognized as a result of the modification.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has granted restricted stock awards from the 2021 Plan and from outside of its stock plans, under the terms of restricted stock purchase agreements and subscription agreements. Unvested shares are subject to repurchase by the Company upon the holder&#8217;s termination of its relationship with the Company at the original purchase price. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#8217; equity (deficit) as the related awards vest.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes restricted stock award activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.98%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.36%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value<br/>Per Share</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,002,044</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.67</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards vested</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">410,916</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.77</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards repurchased</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.31</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">576,829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.62</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The restricted stock awards generally include a service condition for vesting and vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter, but some awards vest over different time periods. In addition, some restricted stock awards include vesting criteria subject to the achievement of performance-based conditions in addition to service conditions, for which the Company periodically assesses the probability that the performance criteria will be met and only recognizes stock-based compensation expense related to these awards when achievement of the performance criteria becomes probable. The aggregate grant date fair value of shares vested during the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes stock option activity under the 2024 and 2021 Plans:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.667%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.555%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Options Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,123,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.62</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.78</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,287</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,965,907</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,896</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.28</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,325</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.64</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.11</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">514,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.23</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,285</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options include a service condition for vesting and most stock options vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter. The aggregate intrinsic values of options outstanding and exercisable were calculated as the difference between the exercise price of the options and the closing market price of the Company&#8217;s common stock as of December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate grant date fair value of options that vested for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The options granted in the year ended December 31, 2024 had a weigh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ted-average per share grant-date fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.65</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and a total grant date fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The total intrinsic value of stock options exercised during 2024 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company granted a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of stock options to its employees. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the stock options granted in the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 include vesting criteria subject to both service conditions and the achievement of performance-based conditions, related to the consummation of the Company&#8217;s IPO or a Sale Event, while the remainder include vesting criteria subject to service conditions only. As a result of the consummation of the Company's IPO in October 2024, the performance-based condition related to these stock options was met, triggering commencement of vesting of the options, and the Company began recognizing expense related to these grants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the stock options granted in the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 also include accelerated vesting provisions associated with certain change of control events.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Valuation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, using the Black Scholes option pricing model, were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fair value of common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.65</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.01</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.56</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.03</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.90</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the fair value of the options granted, the Company uses the Black Scholes option pricing model and assumptions discussed below. This model utilizes inputs that are highly subjective including the fair value of the Company's common stock prior to the IPO, and expected volatility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the IPO in October 2024, because there had been no public market for the Company&#8217;s common stock, the Board of Directors, with input from management, determined the fair value of common stock by considering a number of objective and subjective factors including (i) valuations performed by independent third parties, (ii) important developments in the Company&#8217;s operations, (iii) the rights, preferences, and privileges of the Company&#8217;s preferred stock relative to those of the Company&#8217;s common stock, (iv) actual operating results and financial performance, including the Company&#8217;s levels of available capital resources, (v) the conditions in the capital markets, biotechnology industry and the U.S. economy in general, (vi) the stock price performance and volatility of comparable public companies and (vii) the lack of marketability of the Company&#8217;s common stock, among other factors. After completion of the IPO, the fair value of common stock is based on the closing market price on the date of grant.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected term represents the period that the Company&#8217;s stock options granted are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). The Company has very limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The Company will continue to apply this process until a sufficient amount of historical information regarding employee exercise patterns and post-vesting employment termination behavior becomes available.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the Company&#8217;s limited operating history and lack of company-specific historical volatility as a public company, due to the Company's IPO in October 2024, or implied volatility as a private company, the expected volatility was estimated based on the average volatility for comparable publicly traded biopharmaceutical companies over a period, where available, equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar size, life cycle stage and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-free Interest Rate &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend &#8212; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense for restricted stock awards and stock options recognized in the Company&#8217;s statements of operations and comprehensive (loss) income is presented as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,619</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">887</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,533</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,152</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,620</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total unrecognized stock-based compensation expense related to unvested restricted stock awards and unvested stock options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.8</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the (benefit) provision for income taxes were as follows for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">498</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">691</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded an income tax benefit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. For the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded income tax expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the Company&#8217;s effective tax rate to the statutory U.S. federal rate is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal taxes at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The types of temporary differences that give rise to significant portions of the Company&#8217;s deferred income tax assets and liabilities are set out below (in thousands):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,102</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,338</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,516</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,163</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">841</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sec 174 capitalized research and development costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,855</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,957</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,061</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,830</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">766</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">521</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,605</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,504</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,321</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred income tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has established a valuation allowance for the amount of deferred tax assets that are not more likely than not be realized. Management considered all available evidence, both positive and negative, including but not limited to the Company&#8217;s historical operating results, income or loss in recent periods, cumulative losses in recent years, forecasted earnings, future taxable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">income, and significant risk and uncertainty related to forecasts, and concluded the deferred tax assets are not more likely than not to be realized. The net change in the total valuation allowance for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was an increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of federal net operating loss carryforwards and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of state net operating loss carryforwards, available to reduce future taxable income. Of the federal net operating loss carryforwards, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million will carryforward indefinitely. The state net operating loss carryforwards will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2041</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, if not utilized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credits carryforward of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and state research and development tax credits carryforward of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, available to reduce future income taxes. The federal research and development tax credits will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2040</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized. The state research and development tax credits have no expiration date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Revenue Code section 382 (&#8220;IRC Section 382&#8221;) places a limitation (the &#8220;Section 382 Limitation&#8221;) on the amount of taxable income that can be offset by net operating loss (&#8220;NOL&#8221;) carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. When an ownership change occurs, IRC Section 382 limits the use of NOLs and credits in subsequent periods based on the annual 382 limitations. The annual 382 limitations may limit the full use of available tax attributes in one year but the identified ownership changes may not result in expiration of tax attributes for use prior to expiration of their respective carryforward periods. The Company performed a Section 382 analysis through the year ended December 31, 2024 and determined there were ownership changes in 2021 and 2023 that resulted in 382 limitations limiting the full use of carryover attributes in 2024. The ownership changes did not result in a reduction of its net operating loss or in its research and development credit carryforwards expiring unused. Accordingly, none of the tax attributes have been reduced but limited the full use in 2024. If additional ownership change occurs, the utilization of net operating loss and credit carryforwards could be significantly reduced.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,529</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,828</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions based on tax positions related to current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">998</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustment based on tax positions related to prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,567</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,529</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The reversal of the uncertain tax benefits would not impact the Company&#8217;s effective tax rate as the Company continues to maintain a full valuation allowance against its deferred tax assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. During the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recognize accrued interest and penalties related to unrecognized tax benefits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company files income taxes in the U.S. federal jurisdiction, the state of California and various other U.S. states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All income tax returns will remain open for examination by the federal, state and foreign authorities for three or four years, from the date of utilization of any NOLs or credits.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Related Parties</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third Rock Ventures</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2021, the Company entered into a service agreement with Third Rock Ventures, LLC (&#8220;TRV&#8221;), a holder of more than 5% of the Company&#8217;s outstanding capital stock, (the &#8220;TRV service agreement&#8221;) under which TRV provides consulting services to the Company. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, for such services as general and administrative expenses in the Company&#8217;s statements of operations and comprehensive (loss) income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of expense related to TRV was recorded in accrued expenses and other current liabilities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> expenses related to TRV in accrued expenses and other current liabilities on the Company&#8217;s balance sheets. at December 31, 2023. As of December 31,  2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, outstanding accounts payable to TRV was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding accounts payable to TRV at December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's former interim Chief Medical Officer, and also a member of the Company's board of directors, was designated to the Company's board of directors by TRV and is affiliated with TRV. He did not receive any cash compensation from the Company for his service as its interim Chief Medical Officer, as his services were provided to the Company through the TRV service agreement. The board member ceased serving as interim Chief Medical Officer in September 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2024, the Company entered into a separate consulting agreement with the board member, under which he may provide up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of consulting services per month, which are also provided to the Company through the TRV service agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the total fees the Company incurred under the TRV service agreement for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, were attributed to consulting services provided by the board member. Additionally, as compensation for his services as the Company's interim Chief Medical Officer, the Company granted him options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,227</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,712</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares during the year ended December 31, 2024 and 2023, at exercise prices of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.76</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">RA Capital</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P. (collectively, &#8220;RA Capital&#8221;), which held more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for total cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P., which collectively hold more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Samsara BioCapital</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P. (&#8220;Samsara BioCapital&#8221;), a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P., a holder of more than 5% of the Company&#8217;s outstanding capital stock, during the first tranche closing, for cash proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Net (Loss) Income Per Share</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.813%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,613</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">567</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,551</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,737</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">233,801</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,177,124</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198,084</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock awards subject to repurchase</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">576,829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">340,649</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total antidilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,515,811</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Retirement Benefit Plan</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15. Employee Retirement Benefit Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains a 401(k) retirement savings plan (the &#8220;401(k) Plan&#8221;) for its employees. The 401(k) Plan allows eligible employees to make contributions up to the maximum allowable by the Internal Revenue Service (&#8220;IRS&#8221;). For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company made matching contributions of and recorded contribution expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM assesses performance for the Company&#8217;s operating segment and decides how to allocate resources based on the Company&#8217;s available cash resources. Total operating expenses and net (loss) income of the Company&#8217;s operating segment are used to monitor budget versus actual results. The measure of segment assets is reported as total assets on the Company&#8217;s balance sheet.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM is regularly provided with the following significant segment expenses:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee-related expenses, excluding stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,233</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,152</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,620</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External research and development expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,786</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,106</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External general and administrative expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,511</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,415</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses*</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,216</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,834</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses (income)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,796</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,871</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">498</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">691</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(*) Other segment expenses include facility related and office costs, information technology costs, general laboratory costs, and other operating expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s property and equipment was maintained in the U.S. For the year ended December 31, 2024 and 2023, the Company&#8217;s revenue was generated from providing research services and was earned in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17. Subsequent Events</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company appointed Gil M. Labrucherie, CFA, J.D. as the Chief Financial Officer (&#8220;CFO&#8221;), principal financial officer and principal accounting officer of the Company, effective January 6, 2025. On February 7, 2025, the Compensation Committee of the Board granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of stock options to the CFO.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, the Company announced its decision to discontinue the clinical study of SEP-786. There was no impact to the assets and liabilities reported on the Company's balance sheets as a result of the discontinuation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;), stated in U.S. dollars and include all adjustments necessary for the fair presentation of the Company&#8217;s financial statements as of December 31, 2024 and 2023, and for the years then ended. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification and Accounting Standards Updates </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASUs</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Financial Accounting Standards Board </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FASB</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;).</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures at the date of the financial statements and reported amounts of expenses during the reporting periods. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources and adjusts those estimates and assumptions when facts and circumstances dictate. Estimates are used in determining the fair value of assets and liabilities, the useful lives of property and equipment, the rate used in determining the present value of lease payments, fair value of assets and liabilities, research and development accruals, the estimated fair value of common stock prior to the Company's IPO, and stock options, the allocation of a revenue contract&#8217;s transaction price to each distinct performance obligation on a relative standalone selling price basis, uncertain tax positions and the valuation allowance for deferred income tax assets. Actual results may differ from these estimates and assumptions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s CODM is its chief executive officer. Based on the information used by the CODM to allocate resources, the Company has determined it operates in one segment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_RisksAndUncertaintyPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company limits its credit risk by placing its cash, cash equivalents, and marketable securities with banks and institutions that are highly creditworthy. Such cash may be in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured limits, and the Company's cash equivalents and marketable securities are not insured by the FDIC. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and marketable securities to the extent recorded in the balance sheet.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. Management believes that the Company is not exposed to significant credit risk due to the high-credit-quality financial institutions in which those deposits are held. The Company has not experienced any losses on its cash, cash equivalents and marketable securities since inception. The Company has no significant off-balance sheet concentrations of credit risk.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to all of the risks inherent in an early-stage biotechnology company. These risks include, but are not limited to, limited management resources, efficacy of product candidates, intense competition, and dependence upon the availability of cash to sustain operations.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock', window );">Cash Equivalents and Marketable Securities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds marketable securities that consist of highly liquid, investment grade debt securities. The Company's cash and marketable securities are held or issued by financial institutions that management believes are of high credit quality. Marketable securities are classified and accounted for as available-for-sale. Marketable securities with original maturities of 90 days or less are classified as cash equivalents. Marketable securities with original maturities over 90 days and remaining maturities of less than 12 months are classified as current. Marketable securities with remaining maturities of more than 12 months for which the Company has the intent and ability to hold the security for more than 12 months are classified as non-current. The Company&#8217;s marketable securities are carried at estimated fair value, which is derived from independent pricing sources based on quoted prices in active markets for similar securities. Unrealized gains and losses are reported in stockholders&#8217; equity (deficit) as accumulated other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in interest income on the statements of operations and comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12 months. The Company does not generally intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews its portfolio of marketable securities, using both quantitative and qualitative factors, to determine if declines in fair value below amortized cost have resulted from a credit-related loss or other factors. If the decline in fair value is due to credit-related factors, the Company recognizes a loss in its statement of operations, whereas if the decline in fair value is not due to credit-related factors, the Company recognizes the loss in other comprehensive loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excludes the applicable accrued interest from both the fair value and amortized cost basis of marketable securities for purposes of identifying and measuring an impairment. Accrued interest receivable on marketable securities is recorded within prepaid expenses and other current assets on the balance sheets. The Company&#8217;s accounting policy is to not measure an allowance for credit loss for accrued interest receivable and to write-off any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which is considered to be in the period in which it is determined the accrued interest will not be collected.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash is comprised of cash that is restricted as to withdrawal or use under the terms of certain contractual agreements. In connection with the Company&#8217;s lease agreement (see Note 7), the Company is required to maintain a collateral account to secure a letter of credit issued to its landlord. The collateral account is classified as restricted cash on the Company&#8217;s balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Other Receivables</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable and Other Receivables</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes a receivable when the Company has an unconditional right to payment, which is generally at the time of delivery of assets, or at the time services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An allowance for expected credit losses over the life of the receivables is reserved for based on a combination of historical experience, aging analysis, current economic trends and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. The reserve is re-evaluated on a regular basis and adjusted as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. No allowance for credit losses was recorded during the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the Company&#8217;s accounts receivable was entirely attributed to Vertex Pharmaceuticals Incorporated (&#8220;Vertex&#8221;). As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s other receivable related to sale of non-financial asset balance was entirely attributed to Vertex (see Note 4 and Note 5).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment, Net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment is recorded at cost, subject to adjustments for impairments, less accumulated depreciation. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.54%;box-sizing:content-box;"></td>
          <td style="width:1.94%;box-sizing:content-box;"></td>
          <td style="width:40.52%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer Equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease term or estimated useful life</span></span></span></p></td>
         </tr>
        </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation or amortization begins at the time the asset is placed in service. Maintenance and repairs that do not improve or extend the life of the respective asset are charged to expense as incurred. Upon disposal of assets, the cost and related accumulated depreciation is removed from the balance sheet and the resulting gain or loss is reflected in the statements of operations and comprehensive (loss) income within other income, net.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its long-lived assets for impairment, primarily its property and equipment, whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the undiscounted expected future cash flows the asset is expected to generate over its remaining life. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset or asset group and its eventual disposition are less than its carrying amount. Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of the Company&#8217;s long-lived assets for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for its leases in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2021, prior to entering into the lease agreement for its office and research and development space. At inception of a contract, the Company determines whether an arrangement is or contains a lease. For each lease, the Company determines the classification as either an operating lease or a financing lease. Lease recognition occurs at the lease commencement date and lease liability amounts are determined based on the present value of lease payments over the lease term. The lease term may include options to extend or terminate the lease only when it is reasonably certain that the Company will exercise that option.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments if the Company&#8217;s leases do not provide an implicit rate. The Company determines its incremental borrowing rate based on the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. Right-of-use assets represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s right to use underlying assets for the lease term and operating lease liabilities represent the Company</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s obligation to make lease payments under the lease. Right-of-use assets also include any lease payments made prior to the commencement date and exclude lease incentives received.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to apply the practical expedient of combining lease and non-lease components for the real estate lease asset class. Fixed lease payments on operating leases are recognized as lease expense over the expected term of the lease on a straight-line basis. Variable lease expenses that are not considered fixed are recognized as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company elected the short-term lease practical expedient that allows the lessee to not record a lease liability and right-of-use asset for all leases with a term of 12 months or less. See Note 7 for additional information on the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> leases.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ConvertiblePreferredStockPolicyPolicyTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a deemed liquidation event, such as a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#8217;s certificate of incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred stock into shares of common stock. Convertible preferred stock is therefore classified outside of stockholders&#8217; equity (deficit) as events triggering redemption are not solely within the Company&#8217;s control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No shares of convertible preferred stock were authorized, issued or outstanding at December 31, 2024. As of December 31, 2023, the Company did not adjust the carrying values of its convertible preferred stock to the liquidation preferences because of the uncertainty of whether or when such an event would occur. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it was not probable that such a redemption would occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company generated revenue for the year ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex (see Note 5). The Company considers revenue to be earned when all of the following criteria are met: (i) the Company has a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#8217;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> revenue was entirely attributable to Vertex.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock', window );">Sale of Non-Financial Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sale of Non-Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of non-financial assets that are outside the scope of the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#8217;s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ordinary activities are accounted for under ASC 610-20, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income - Gains and Losses from the Derecognition of Non-financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 610-20&#8221;). Pursuant to ASC 610-20, the Company applies the guidance in ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASC 606</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to determine if a contract exists, identify the distinct non-financial assets, and determine when control transfers and, therefore, when to derecognize the non-financial asset. Additionally, the Company applies the measurement principles of ASC 606 to determine the amount of consideration, if any, to include in the calculation of the gain or loss for the non-financial asset.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of clinical and preclinical materials, information technology-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations and fees paid to other entities that conduct certain research and development activities on the Company&#8217;s behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into agreements with outsourced contract manufacturing and development and clinical research vendors. The Company estimates accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. The Company periodically confirms the accuracy of its estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PatentExpensesPolicyPolicyTextBlock', window );">Patent Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs to secure and maintain patents covering the Company&#8217;s technology and product candidates are expensed as incurred and are classified as general and administrative expenses in the statements of operations and comprehensive (loss) income.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The carrying values of the Company&#8217;s cash and cash equivalents, restricted cash, accounts receivable, other receivable related to sale of non-financial asset, accounts payable and accrued expenses, approximate their fair values due to their relatively short maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and restricted stock awards granted to employees and non-employees is recognized based on the grant-date fair value of the awards. The fair value of stock options is determined using the Black Scholes option pricing model on the date of grant. The fair value of restricted stock awards is determined using the estimated fair value of the Company&#8217;s common stock on the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the IPO, the Company utilized estimates and assumptions in determining the fair value of its common stock, including stock-based awards. The Company has granted stock options at exercise prices that represented the fair value of its common stock on the specific grant dates. The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants Technical Practice Aid, Valuation of Privately Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of the convertible preferred stock senior to the Company&#8217;s common stock at the time, and a probability analysis of various liquidity events, such as a public offering or sale of the Company, under differing scenarios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock-based awards with service conditions only, the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is generally the vesting term of the award of four years. For stock-based awards with vesting criteria subject to the achievement of performance-based conditions, in addition to service conditions, the Company recognizes stock-based compensation expense on an accelerated basis over the vesting period when achievement of the performance criteria becomes probable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is recorded within research and development and general and administrative expenses in the accompanying statements of operations and comprehensive (loss) income based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes the asset and liability approach to account for income taxes. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. Deferred tax assets and liabilities are determined based upon the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and for loss and credit carryforwards, using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertain tax positions recognized in the financial statements by prescribing a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related interest and penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive (Loss) Income</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive (Loss) Income</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive (loss) income is defined as a change in equity of a business enterprise during a period resulting from transactions from non-owner sources. The Company&#8217;s other comprehensive (loss) income is comprised solely of unrealized gains (losses) on marketable securities. The Company has not recorded any reclassifications from other comprehensive (loss) income to net loss during the periods presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration of potential dilutive securities. Vested restricted stock is treated as outstanding for accounting purposes. Unvested restricted stock is not considered to be outstanding for purposes of the calculation of basic net (loss) income per share. Diluted net (loss) income per share is computed by dividing the net (loss) income by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options, unvested restricted stock and convertible preferred stock. The dilutive effect of stock options and unvested restricted stock is computed using the treasury stock method and the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">dilutive effect of convertible preferred stock is calculated using the &#8220;if-converted method.&#8221; For all periods presented in a net loss position, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holders of its convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. Net (loss) income is attributed to common stockholders and participating securities based on their participation rights.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. ASU 2023-07 will improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods after December 5, 2024, with early adoption permitted. The Company adopted Topic 280 on January 1, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments &#8211; Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326),</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. Topic 326 is effective for annual periods beginning after December 15, 2022, and early adoption is permitted. The Company adopted Topic 326 on January 1, 2023, and the adoption did not have a material impact on its financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock', window );">Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB, under its ASC or other standard setting bodies, and adopted by the Company as of the specified date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an accounting standard update that requires the Company to disclose more detailed information about the types of expenses (including employee compensation, depreciation, and amortization) included in each relevant income statement expense caption. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and decision usefulness of income tax disclosures. The standard is intended to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2025,  on a prospective basis. Early adoption and retrospective reporting are permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock', window );">Emerging Growth Company Status and Smaller Reporting Company Status</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status and Smaller Reporting Company Status</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company is also a smaller reporting company as defined in the Securities Exchange Act of 1934, as  amended (the &#8220;Exchange Act&#8221;). The Company may continue to be a smaller reporting company even after it is no longer an emerging growth company. The Company may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as its voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of its second fiscal quarter, or its annual revenue is less than $100.0 million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the most recently completed fiscal year and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its second fiscal quarter.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting pronouncements not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ConvertiblePreferredStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ConvertiblePreferredStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging growth company status and smaller reporting company status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PatentExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patent expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PatentExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_RisksAndUncertaintyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks And Uncertainty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_RisksAndUncertaintyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of non-financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock', window );">Summary of Estimated Useful Lives of Property and Equipment</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:</span><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.54%;box-sizing:content-box;"></td>
          <td style="width:1.94%;box-sizing:content-box;"></td>
          <td style="width:40.52%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer Equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease term or estimated useful life</span></span></span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of estimated useful lives of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Summary of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,114</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">874</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical trial costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,164</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">953</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid bonus</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">260</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,730</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,419</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,679</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,967</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture, fixtures, and office equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,222</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">713</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">717</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">389</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">401</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,019</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,287</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,929</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,622</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,090</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,665</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,954</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,888</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued general and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">703</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued income taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract', window );"><strong>Available-for-Sale Marketable Securities and Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,487</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,487</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities, non-current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">414,958</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,779</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.53%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurement</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total measured at fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Summary of Marketable Securities by Major Type of Security</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes the amortized cost and the unrealized gains (losses) of the marketable securities presented within marketable securities, marketable securities, non-current and cash equivalents (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.42%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:15.36%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.440000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Remaining<br/>Contractual<br/>Maturity (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Estimated Fair<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,017</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,014</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,511</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,245</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,252</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less than 1</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total maturity less than 1 year</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">203,264</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">203,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,514</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 to 5</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,123</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">273,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Unrealized Loss Positions of Marketable Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the following table summarizes marketable securities in an unrealized loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 Months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>Unrealized Loss</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">987</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,172</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,469</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,508</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,136</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available-for-sale marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock', window );">Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,710,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B Convertible Preferred Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,129,284</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,123,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2021 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,634,488</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future grants under 2024 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,743,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for 2024 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">369,402</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,052,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,597,558</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of common stock shares reserved for future issuance on convertible basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock', window );">Summary of Expenses Recognized and Cash Paid for Leased Space</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the expenses recognized and cash paid for the Leased Space (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,462</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">964</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,018</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum rental payments for operating leases were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Future<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,469</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,760</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,071</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,851</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,851</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, non-current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of lease cost and cash paid for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, convertible preferred stock consisted of the following (in thousands, except for share and per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.291%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.685%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.025%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.545%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Authorized<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Issued and<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Carrying<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liquidation<br/>Preference</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Conversion Price<br/>Per Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,694</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,657,452</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,828,720</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,521</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Award Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes restricted stock award activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.98%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.36%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value<br/>Per Share</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,002,044</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.67</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards vested</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">410,916</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.77</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards repurchased</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.31</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">576,829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.62</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Assumptions used for Grants Awards</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, using the Black Scholes option pricing model, were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fair value of common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.65</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.01</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.56</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.03</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.90</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense for restricted stock awards and stock options recognized in the Company&#8217;s statements of operations and comprehensive (loss) income is presented as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,619</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">887</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,533</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,152</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,620</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member', window );">2024 and 2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes stock option activity under the 2024 and 2021 Plans:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.667%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.443999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.555%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Options Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,123,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.62</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.78</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,287</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,965,907</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,896</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.28</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,325</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.64</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.11</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">514,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.23</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,285</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of (Benefit) Provision for Income Taxes</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the (benefit) provision for income taxes were as follows for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">498</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">691</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Tax Rate Reconciliation</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the Company&#8217;s effective tax rate to the statutory U.S. federal rate is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal taxes at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Income Tax Assets and Liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The types of temporary differences that give rise to significant portions of the Company&#8217;s deferred income tax assets and liabilities are set out below (in thousands):</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,102</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,338</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,516</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,163</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">841</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sec 174 capitalized research and development costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,855</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,957</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,061</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,830</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">766</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">521</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,605</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,504</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,321</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred income tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Reconciliation of Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,529</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,828</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions based on tax positions related to current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">998</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustment based on tax positions related to prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,567</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,529</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net (Loss) Income Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.813%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,613</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">567</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, basic:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allocation of earnings to participating preferred stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,551</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income applicable to common stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Denominator, diluted:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,737</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">233,801</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding used to compute<br/>&#160;&#160;&#160;net (loss) income per common share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,891,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,177,124</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net (Loss) Income Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,938,982</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198,084</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unvested restricted stock awards subject to repurchase</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">576,829</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">340,649</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total antidilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,515,811</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Reportable Segment</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM is regularly provided with the following significant segment expenses:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee-related expenses, excluding stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,233</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,152</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,620</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External research and development expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,786</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,106</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External general and administrative expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,511</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,415</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of non-financial asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses*</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,216</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,834</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses (income)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,527</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,796</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,296</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,871</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Benefit) provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">498</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">691</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(*) Other segment expenses include facility related and office costs, information technology costs, general laboratory costs, and other operating expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 18, 2024</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse Stock Split description</a></td>
<td class="text">1-for-8.6103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Initial Public Offering, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,788<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Converted convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">260,590,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,374)<span></span>
</td>
<td class="num">(46,576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent', window );">Cash, cash equivalents, marketable securities current and non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering (IPO)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Initial Public Offering, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts', window );">Underwriting discounts commissions and other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnderwritingOtherOfferingExpenses', window );">Underwriting other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Converted convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,839,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UndesignatedPreferredStockSharesAuthorized', window );">Undesignated preferred stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UndesignatedCommonStockParOrStatedValuePerShare', window );">Undesignated common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember', window );">Vertex Research Service Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, cash equivalents, marketable securities current and non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts, commissions and other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnderwritingOtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnderwritingOtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UndesignatedCommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undesignated common stock par or stated value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UndesignatedCommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UndesignatedPreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undesignated preferred stock, shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UndesignatedPreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">Leasehold improvements<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 3,114<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PrepaidClinicalTrialCostsCurrent', window );">Prepaid clinical trial costs</a></td>
<td class="nump">1,164<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PrepaidBonusCurrent', window );">Prepaid bonus</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PrepaidTaxesCurrent', window );">Prepaid taxes</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 5,730<span></span>
</td>
<td class="nump">$ 1,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PrepaidBonusCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid bonus current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PrepaidBonusCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PrepaidClinicalTrialCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical trial costs current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PrepaidClinicalTrialCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PrepaidTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Taxes Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PrepaidTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 8,019<span></span>
</td>
<td class="nump">$ 6,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(2,929)<span></span>
</td>
<td class="num">(1,622)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,090<span></span>
</td>
<td class="nump">4,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">5,679<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures, and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">717<span></span>
</td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 401<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_FurnitureFixturesAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_FurnitureFixturesAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation expense</a></td>
<td class="nump">$ 4,129<span></span>
</td>
<td class="nump">$ 2,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AccruedResearchAndDevelopmentExpenseCurrent', window );">Accrued research and development expense</a></td>
<td class="nump">2,888<span></span>
</td>
<td class="nump">829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AccruedGeneralAndAdministrativeExpenseCurrent', window );">Accrued general and administrative expense</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued income taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 7,798<span></span>
</td>
<td class="nump">$ 4,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AccruedGeneralAndAdministrativeExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued general and administrative expense current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AccruedGeneralAndAdministrativeExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AccruedResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AccruedResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Gain on Sale of Non-Financial Asset - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_GainOnSaleOfNonFinancialAsset', window );">Gain on sale of non-financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 47,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ProceedsFromSaleOfNonFinancialAsset', window );">Received cash on sale of non-financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,625,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other receivable related to sale of non-financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">22,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnconditionalRightOnNonFinancialAsset', window );">Unconditional right on non-financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PaymentReceivedOnSaleOfNonFinancialAsset', window );">Payment received on sale of non-financial asset</a></td>
<td class="nump">$ 22,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_GainOnSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_GainOnSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PaymentReceivedOnSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment received on sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PaymentReceivedOnSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ProceedsFromSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-financial asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ProceedsFromSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnconditionalRightOnNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unconditional right on non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnconditionalRightOnNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember', window );">Vertex Research Service Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AgreementDescription', window );">Agreement description</a></td>
<td class="text">The Vertex Research Service Agreement is for a two-year term, however, Vertex has the ability to terminate the agreement with a 30-day notice at any time. As a result, the Company concluded that the contract duration is 30 days, representing a month-to-month service contract.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TermOfResearchServiceAgreement', window );">Term of research service agreement</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_RequiredPriorNoticeDurationToTerminateAgreement', window );">Required prior notice duration to terminate agreement</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_RequiredPriorNoticeDurationToTerminateAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Required prior notice duration to terminate agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_RequiredPriorNoticeDurationToTerminateAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TermOfResearchServiceAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of research service agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TermOfResearchServiceAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sepn_VertexResearchServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">$ 112,727<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">69,866<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure', window );">Total measured at fair value</a></td>
<td class="nump">414,958<span></span>
</td>
<td class="nump">86,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure', window );">Total measured at fair value</a></td>
<td class="nump">141,779<span></span>
</td>
<td class="nump">86,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure', window );">Total measured at fair value</a></td>
<td class="nump">273,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">73,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">65,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">73,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">65,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government Agency Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">8,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">14,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">2,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government Agency Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">8,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">14,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">2,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">1,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">1,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">1,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">1,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">141,779<span></span>
</td>
<td class="nump">86,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">141,779<span></span>
</td>
<td class="nump">$ 86,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">82,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">23,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">82,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">$ 23,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents and marketable securities, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Position</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">$ 953,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of marketable securities in unrealized loss positions less than 12 months | Position</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost of marketable debt securities, contractual maturity, less than one year</a></td>
<td class="nump">$ 203,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains', window );">Unrealized gains of marketable debt securites, contractual maturity, less than one year</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss', window );">Unrealized losses of marketble debt securities, contractual maturity, less than one year</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</a></td>
<td class="nump">203,313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">273,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Estimated Fair Value</a></td>
<td class="nump">273,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost of marketable debt securities, contractual maturity, less than one year</a></td>
<td class="nump">73,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains', window );">Unrealized gains of marketable debt securites, contractual maturity, less than one year</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss', window );">Unrealized losses of marketble debt securities, contractual maturity, less than one year</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</a></td>
<td class="nump">73,555<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Amortized cost of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">65,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains', window );">Unrealized gains of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss', window );">Unrealized losses of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, one year to five year</a></td>
<td class="nump">65,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government Agency Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost of marketable debt securities, contractual maturity, less than one year</a></td>
<td class="nump">22,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains', window );">Unrealized gains of marketable debt securites, contractual maturity, less than one year</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss', window );">Unrealized losses of marketble debt securities, contractual maturity, less than one year</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</a></td>
<td class="nump">22,252<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Amortized cost of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">2,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains', window );">Unrealized gains of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss', window );">Unrealized losses of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, one year to five year</a></td>
<td class="nump">2,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost of marketable debt securities, contractual maturity, less than one year</a></td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains', window );">Unrealized gains of marketable debt securites, contractual maturity, less than one year</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss', window );">Unrealized losses of marketble debt securities, contractual maturity, less than one year</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</a></td>
<td class="nump">1,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Amortized cost of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">1,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains', window );">Unrealized gains of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss', window );">Unrealized losses of marketable debt securities, contractual maturity, one year to five years</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, one year to five year</a></td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost of marketable debt securities, contractual maturity, less than one year</a></td>
<td class="nump">106,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains', window );">Unrealized gains of marketable debt securites, contractual maturity, less than one year</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss', window );">Unrealized losses of marketble debt securities, contractual maturity, less than one year</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year</a></td>
<td class="nump">$ 106,014<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available-for-sale - matures after one year through five years, gross unrealized gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale matures after one year through five years gross unrealized loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities within one year gross unrealized gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities within one year gross unrealized loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</a></td>
<td class="nump">$ 130,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</a></td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government Agency Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</a></td>
<td class="nump">6,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</a></td>
<td class="nump">52,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value</a></td>
<td class="nump">70,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">$ (9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,348<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_LesseeOperatingLeaseExpirationYearAndMonth', window );">Lease expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,602<span></span>
</td>
<td class="nump">$ 12,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,625<span></span>
</td>
<td class="nump">12,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_OriginalLeasedSpaceMember', window );">Original Leased Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_LesseeOperatingLeaseExpirationYearAndMonth', window );">Lease expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_AdditionalLeasedSpaceMember', window );">Additional Leased Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_LeaseCommencementPeriod', window );">Lease commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease liability term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As of December 31, 2023, the entire balance of the operating lease liability associated with the Additional Leased Space was classified as non-current as the Company received a rent abatement for four months in the first year of the lease and, therefore, the operating lease liability increased over the 12 month-period starting from December 31, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Percentage of present value of lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_LeasedSpaceMember', window );">Leased Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease | ft&#178;</a></td>
<td class="nump">44,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_LesseeOperatingLeaseExpirationYearAndMonth', window );">Lease expiration period</a></td>
<td class="text">2032-07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Lessee, Operating Lease, Existence of Option to Extend [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease option to extend description</a></td>
<td class="text">option to extend the lease for eight additional years (the &#8220;Extension Option&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Percentage of present value of lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_LeaseCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease commencement period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_LeaseCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_LesseeOperatingLeaseExpirationYearAndMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating lease, expiration year and month.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_LesseeOperatingLeaseExpirationYearAndMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_OriginalLeasedSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_OriginalLeasedSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_AdditionalLeasedSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_AdditionalLeasedSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_LeasedSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_LeasedSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details) - Leased Space - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities</a></td>
<td class="nump">$ 1,631<span></span>
</td>
<td class="nump">$ 897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">3,462<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 1,018<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_LeasedSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sepn_LeasedSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 4,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">4,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">4,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">4,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">5,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">13,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">37,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(12,198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total present value of operating lease liabilities</a></td>
<td class="nump">25,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">1,851<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 23,625<span></span>
</td>
<td class="nump">$ 12,566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements', window );">liabilities associated with indemnification rights and agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities associated with indemnification rights and agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, carrying value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 74,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">121,657,452<span></span>
</td>
<td class="nump">121,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, carrying value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 74,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Outstanding convertible preferred stock conversion in to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,942<span></span>
</td>
<td class="nump">$ 74,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect', window );">Percentage of share issue price divided by conversion price in effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions', window );">Gross proceeds after deducting underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of unpaid principal and accrued interest outstanding into shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding', window );">Convertible promissory notes such as unpaid principal and accrued interest outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel', window );">Convertible preferred stock remaining unissued shares agreement to cancel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Initial Tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock', window );">Cash proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest', window );">Net proceeds conversion of outstanding convertible promissory notes plus accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Maximum [Member] | Initial Tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockFinancingArrangementFinancingValue', window );">Convertible preferred stock financing arrangement financing value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,828,732<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">121,657,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,828,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="nump">60,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="nump">$ 74,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Tranche One and Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares', window );">Convertible preferred stock shares authorized to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,657,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Maximum [Member] | Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval', window );">Convertible preferred stock additional funding based on approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Maximum [Member] | Tranche One and Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Convertible Preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.849455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering (IPO)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Outstanding convertible preferred stock conversion in to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,839,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Converted preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,657,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash proceeds from issuance of convertible preferred stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock Remaining Unissued Shares Agreement To Cancel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Promissory Notes, Unpaid Principal and Accrued Interest Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds after deducting underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds Conversion Of Outstanding Convertible Promissory Notes Plus Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of share issue price divided by conversion price in effect.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Additional Funding Based on Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock authorised to be issued during period shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityStockFinancingArrangementFinancingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Financing Arrangement Financing Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityStockFinancingArrangementFinancingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=sepn_InitialTrancheMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=sepn_InitialTrancheMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=sepn_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=sepn_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=sepn_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=sepn_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=sepn_TrancheOneAndTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=sepn_TrancheOneAndTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">260,590,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,788<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering (IPO)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from initial public offering</a></td>
<td class="nump">$ 302,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts', window );">Underwriting discounts commissions and other offering costs</a></td>
<td class="nump">$ 28,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">260,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.849455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | 2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncreaseInSharesReservedForFutureIssuanceInShares', window );">Increase in shares reserved for future issuance, in shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CommonStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CommonStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_IncreaseInSharesReservedForFutureIssuanceInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in shares reserved for future issuance, in shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_IncreaseInSharesReservedForFutureIssuanceInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts, commissions and other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_Stock2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">7,052,299<span></span>
</td>
<td class="nump">25,597,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,710,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,129,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">2,938,982<span></span>
</td>
<td class="nump">1,123,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember', window );">Stock 2021 Plan [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,634,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2024PlanMember', window );">Stock 2024 Plan [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">3,743,915<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchase2024PlanMember', window );">Employee Stock Purchase 2024 Plan [Member] | Common Stock [Member] | Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">369,402<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sepn_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_Stock2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_Stock2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_Stock2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchase2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_EmployeeStockPurchase2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sepn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sepn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details) - Restricted Stock [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares Outstanding, Beginning Balance | shares</a></td>
<td class="nump">1,002,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock awards vested | shares</a></td>
<td class="num">(410,916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased', window );">Restricted stock awards repurchased | $</a></td>
<td class="num">$ (14,299)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares Outstanding, Ending Balance | shares</a></td>
<td class="nump">576,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value Per Share, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 2.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock awards vested, Weighted Average Fair Value | $ / shares</a></td>
<td class="nump">$ 2.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock awards repurchased ,Weighted Average Fair Value | $</a></td>
<td class="nump">$ 2.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value Per Share, Ending Balance | $ / shares</a></td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options repurchased in period weighted average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Total Options outstanding, Granted</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member', window );">2024 and 2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Total Options outstanding, Beginning balance</a></td>
<td class="nump">1,123,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Total Options outstanding, Granted</a></td>
<td class="nump">1,965,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Total Options outstanding, Exercised</a></td>
<td class="num">(28,896)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Total Options Outstanding, Cancelled</a></td>
<td class="num">(121,325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Total Options outstanding, Ending Balance</a></td>
<td class="nump">2,938,982<span></span>
</td>
<td class="nump">1,123,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable as of December 31, 2024</a></td>
<td class="nump">514,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Beginning balance</a></td>
<td class="nump">$ 2.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted</a></td>
<td class="nump">5.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
<td class="nump">2.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Cancelled</a></td>
<td class="nump">3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Ending balance</a></td>
<td class="nump">4.64<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable as of December 31, 2024</a></td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Outstanding</a></td>
<td class="text">9 years 1 month 9 days<span></span>
</td>
<td class="text">9 years 9 months 10 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable as of December 31, 2024</a></td>
<td class="text">8 years 2 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 53,706<span></span>
</td>
<td class="nump">$ 2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable as of December 31, 2024</a></td>
<td class="nump">$ 10,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_StockPlan2024And2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock', window );">Fair value of common stock</a></td>
<td class="nump">$ 6.65<span></span>
</td>
<td class="nump">$ 3.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.83%<span></span>
</td>
<td class="nump">4.56%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">91.10%<span></span>
</td>
<td class="nump">86.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 10 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2026</div></th>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue', window );">Total grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Aggregate grant date fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate grant date fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of expenses related to non-vested share-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average per share grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total Intrinsic value of stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=sepn_EmployeeMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_ExecutiveOfficerAndDirectorEquityAwardsMember', window );">Executive Officer And Director Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember', window );">2021 Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2024PlanMember', window );">2024 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 25,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_Stock2024PlanMember', window );">2024 Plan [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding number of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchasePlan2024Member', window );">2024 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchasePlan2024Member', window );">2024 Employee Stock Purchase Plan | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchasePlan2024Member', window );">2024 Employee Stock Purchase Plan | Maximum [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding number of shares of common stock</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation equity awards options grants fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=sepn_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=sepn_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_ExecutiveOfficerAndDirectorEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_ExecutiveOfficerAndDirectorEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_Stock2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_Stock2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_Stock2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_Stock2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sepn_EmployeeStockPurchasePlan2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sepn_EmployeeStockPurchasePlan2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,152<span></span>
</td>
<td class="nump">$ 1,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,533<span></span>
</td>
<td class="nump">$ 733<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(491)<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(491)<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="num">$ (498)<span></span>
</td>
<td class="nump">$ 691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">$ (498,000)<span></span>
</td>
<td class="nump">$ 691,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax asset, net change in total valuation allowance increase during period</a></td>
<td class="nump">20,900,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforward, expiration</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember', window );">Federal | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_OperatingLossCarryforwardsExpirationYear', window );">Operating loss carryforwards expiration year</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal taxes at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax, net of federal benefit</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="num">(34.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="num">(19.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(29.00%)<span></span>
</td>
<td class="nump">39.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total effective income tax rate</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">14.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,122<span></span>
</td>
<td class="nump">$ 3,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">4,102<span></span>
</td>
<td class="nump">2,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">7,129<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts', window );">Sec 174 capitalized research and development costs</a></td>
<td class="nump">20,855<span></span>
</td>
<td class="nump">11,313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">21,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(33,061)<span></span>
</td>
<td class="num">(12,127)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">7,371<span></span>
</td>
<td class="nump">9,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(766)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use assets</a></td>
<td class="num">(6,605)<span></span>
</td>
<td class="num">(3,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset', window );">Sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,296)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(7,371)<span></span>
</td>
<td class="num">(10,321)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (491)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets capitalized research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities sale of non-financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the beginning of the year</a></td>
<td class="nump">$ 2,529<span></span>
</td>
<td class="nump">$ 1,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to current year</a></td>
<td class="nump">998<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Adjustment based on tax positions related to prior years</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Adjustment based on tax positions related to prior years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of the year</a></td>
<td class="nump">$ 3,567<span></span>
</td>
<td class="nump">$ 2,529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Cash proceeds on shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,942,000<span></span>
</td>
<td class="nump">$ 74,521,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=sepn_ThirdRockVenturesViLPServiceAgreementMember', window );">Third Rock Ventures | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series B Convertible Preferred Stock( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,400,000<span></span>
</td>
<td class="nump">12,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Cash proceeds on shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,300,000<span></span>
</td>
<td class="nump">$ 15,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=sepn_ThirdRockVenturesViLPServiceAgreementMember', window );">Third Rock Ventures | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Outstanding accounts payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting services</a></td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_AccruedExpenseAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=sepn_ThirdRockVenturesViLPServiceAgreementMember', window );">Third Rock Ventures | Interim Chief Medical Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Total fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Options to purchase</a></td>
<td class="nump">23,227<span></span>
</td>
<td class="nump">23,227<span></span>
</td>
<td class="nump">26,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=sepn_RaCapitalManagementLPServiceAgreementMember', window );">RA Capital | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series B Convertible Preferred Stock( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Cash proceeds on shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=sepn_SamsaraBiocapitalLPMember', window );">Samsara BioCapital | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series B Convertible Preferred Stock( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Cash proceeds on shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_AccruedExpenseAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Expense And Other Current Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_AccruedExpenseAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=sepn_ThirdRockVenturesViLPServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=sepn_ThirdRockVenturesViLPServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sepn_InterimChiefMedicalOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sepn_InterimChiefMedicalOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=sepn_RaCapitalManagementLPServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=sepn_RaCapitalManagementLPServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=sepn_SamsaraBiocapitalLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=sepn_SamsaraBiocapitalLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator, basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic', window );">Allocation of earnings to participating preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,613)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income applicable to common stockholders</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator, basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">9,891,126<span></span>
</td>
<td class="nump">1,928,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator, diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Allocation of earnings to participating preferred stockholders</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3,551)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income applicable to common stockholders</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator, diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_CommonStockOptions', window );">Common stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_UnvestedRestrictedStock', window );">Unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">233,801<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding used to compute net (loss) income per common share, diluted</a></td>
<td class="nump">9,891,126<span></span>
</td>
<td class="nump">2,177,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic</a></td>
<td class="num">$ (7.26)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share, diluted</a></td>
<td class="num">$ (7.26)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_CommonStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_CommonStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_UnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unvested restricted stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_UnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total antidilutive securities</a></td>
<td class="nump">3,515,811<span></span>
</td>
<td class="nump">538,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total antidilutive securities</a></td>
<td class="nump">2,938,982<span></span>
</td>
<td class="nump">198,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sepn_UnvestedRestrictedStockSubjectToRepurchaseMember', window );">Unvested Restricted Stock Awards Subject to Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total antidilutive securities</a></td>
<td class="nump">576,829<span></span>
</td>
<td class="nump">340,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sepn_UnvestedRestrictedStockSubjectToRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sepn_UnvestedRestrictedStockSubjectToRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plan - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=sepn_FourZeroOne401KPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution expenses</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=sepn_FourZeroOne401KPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=sepn_FourZeroOne401KPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation', window );">Employee-related expenses, excluding stock-based compensation</a></td>
<td class="nump">22,233<span></span>
</td>
<td class="nump">15,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,152<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ExternalResearchAndDevelopmentExpenses', window );">External research and development expenses</a></td>
<td class="nump">32,786<span></span>
</td>
<td class="nump">15,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sepn_ExternalGeneralAndAdministrativeExpenses', window );">External general and administrative expenses</a></td>
<td class="nump">6,511<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of non-financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(47,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment expenses</a></td>
<td class="nump">17,216<span></span>
</td>
<td class="nump">9,834<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses (income)</a></td>
<td class="nump">81,898<span></span>
</td>
<td class="num">(1,924)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(80,823)<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">8,527<span></span>
</td>
<td class="nump">2,796<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before provision for income taxes</a></td>
<td class="num">(72,296)<span></span>
</td>
<td class="nump">4,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="num">(498)<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (71,798)<span></span>
</td>
<td class="nump">$ 4,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related expenses, excluding stock based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ExternalGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>External general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ExternalGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sepn_ExternalResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>External research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sepn_ExternalResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sepn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 07, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option awards granted</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "U#>UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "U#>UJWRRX5\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( "U#>UJE.',M. H  '8Z   8
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M"U&4T#%LVPB'>.E&G1Y0IU[4[X6&7!X'F%K/IE&<FMUP -$V@^*.D]0-<GD
MN7SXVIK7]= B=T%>6ECB91J/-P/;:F*=X:#CI.!()8!,D?I+70%FR]H;A@*\
M[GIMO0TF/UB.)]]A%<;Q1,WB'G]B_[H#I$SGY2TJ.,@))(UN.!.;LPINILNA
M]3I80C0.R!BT;89)1,@$ZHX L9=S5N^XTC+/S/Y@>,&)D%B/7@;1&)_?:(BN
MHRSLYZQF+^M5IR^1U$YD/.8"A]$RF4#9\17V$U:S\CW(; 8*HSB*QDO>88=I
MD,93 #N^PM$WR9PB9S=Y4:]YI];!7MY[J-@YE;=AT!T-8C\/'EAZS[Y,432V
M^8M"WS.>%P?+Q71J5CJ6PWZ: X"RXEZ:ZTV8$[[-8TFR3,?P;:N0)%/P.[K#
M?KX;[W<]K'/D(1/L8+8T&@LCA]44FW3<A_WD-V3H8[FUZ0R3-%R.<;JX$8=N
MJ*0C/N(G/F]RC[ UL?D-&(6,=VR'&3!*C]6'T#L>)$=XT-JSCV2:V-1&Z1BL
M;1.%4U![W9^?_)J". ;/9C8:1\&861QFL).0*8P=!9(C;9O8[7)M9$^S062B
M-'7!0;K#EO'T-Z$Y2I\Y@7L=N_=?Y.Q:O]_1,/B.64GH):YK+;*/6U&LN50_
MU0(0M.#3-=_D6:Z?N?MU+U<_N&$_D;=A_!UQ$W^G"9W0AL,B6B-E,C%'3X+S
M(,! :1)!]U[Q%P@'\R"H?Y#:,MG22"D.=Y7>"IG_"SZ8,KW?:^@,=S>P1+\>
MP]0#QI_2.?2-:L_KP[7BRXN>QUPI0ULU6U5::;@P&]6$=^<</4(9N"OS^QT-
M9Z93%\2O+LRR%.74M"#8OIMTS5$4=#-D<D;B8!XM@WF<+EUSI"<FR#4G83@/
M"9E'052;T#F.TSFFX;&9>L@SHB2>IV19?X\A"#(/PL,#5'7S#YB:HP7HV2N9
M;5G=[$S7F?T(9X'8BBL<JV6'S<3!$^DD&3DBR=;KW!PJ RN8$XBSO(2N:)\#
M2SA1.LX::$K)6,LX[%*\G#AN()T (WX!!OJQVE7-V4XK&\4.ZGQKSM;O.,I+
MN'?*7F*+JVC<S3ML)@08Z008\0NP/N)V$W?"LS75&<8I3:P2<!B&,52L&RCM
MY!?URZ]&&"@O^SB/31U'"Z "PK%8<-B=T4& 0^"=^*)^\64IFKD1#'=<ZMR<
M^>R'?%*OR$=$:8LQ9S_KL//UL[33;=2OVZZY-.+G);KJQ=9Q9:T:T%]OZNWG
M;V<$)SW5/Y6W839ZY_K4W]W[DO#R1FG),NU.PR.$G2<-)_(V3$.G%:G_%.9J
MNLZ=L?M>"[0!V29)&"^G%FFGZJA?U;7E^^KQY7O2<YI3>1MFHU-2-/Z_RM<K
MT1Z<AA-Y&Z:ADQ[4+ST>6KZ)]>K-*E_;) DC,GZ]M.B],S8O[-\P>9N7"A5\
M ^."\P0<R.8=>'.CQ;Y^C7PCM!:[^G++&="',8#O-P)ZTO;&O)D^_"?"ZC]0
M2P,$%     @ +4-[6O*?Q05(!   4!8  !@   !X;"]W;W)K<VAE971S+W-H
M965T,RYX;6RU6%UOVS84_2N$5@PMT$4B+<EV9AMH' S;0P$C;K>'80^T1%M<
M)%$E:;O;KR_U$4FV)=(?21YB4;SW\AR*O.>2DSWCSR(B1(+O29R*J15)F=W;
MM@@BDF!QQS*2JIXUXPF6JLDWML@XP6'AE,0V<AS?3C!-K=FD>+?@LPG;RIBF
M9,&!V"8)YO\]D)CMIQ:T7EX\T4TD\Q?V;)+A#5D2^35;<-6RZR@A34@J*$L!
M)^NI]0G>SY&7.Q06?U*R%ZUGD%-9,?:<-_X(IY:3(R(Q"60> JN?'9F3.,XC
M*1S?JJ!6/6;NV'Y^B?Y;05Z166%!YBS^BX8RFEHC"X1DC;>Q?&+[WTE%J  8
ML%@4_\&^M/7'%@BV0K*D<E8($IJ6O_A[-1$M!^CV.*#* 9WK,*@<!@71$EE!
MZQ%+/)MPM@<\MU;1\H=B;@IOQ8:F^6=<2JYZJ?*3LZ7$DJC/(@%;@P<<XS0@
M8)F'$^#] G/5$Q%) QQ_ +^ K\M'\/[=!_ .T!1\B=A6X#04$ULJ)'D\.ZA&
M?2A'13VC/I+@#@S@1X <Y':XS\]W'QRZVXI_/0FHG@14Q'-[XLU9NB-<TE5,
M@-H,:\(Y"8&:^^#Y(Q"1F@4!\%9&C-/_2=A%MXSO%_'SG;.;.1-[UV:D19!O
MUGN1X8!,+05 $+XCUNSGGZ#O_*KA-ZCY#6[F1X78=G,;&+EI1[^2FUMS<V_F
MIM*7D&JETG331= U$M1"N)*@5Q/TM 07QZ0RS,$.QUO2Q:6,-6QSN7,<>,1'
M.^*5?/R:CW\9G[,VF'_RC:!3_AU1.S5L+ [P#FN\PZOP]F^8H7$]Z2P.0(YJ
MD*.K0!I6_LB(5&=Q@'1<(QT;]FN2*/D^9RV/SUK+)JL#E-!I=-&Y .=9:[2*
MV)XLS^E>I1VFR'>\L>./QCW(6XH.+T?>OUJK:&THKNLBY#G>,>A3RP'T1W#@
M]D!N]!>:!+@#LF'MPE/-[<-]:JG'W>@JU OK$Q&2TT"^[#O LKPX%:HJ7OVK
M"E4@F:IULRT/(E5J=K(X55=OZ(_0^)C#J9U*@,AQ^S@T^@GU KHDG*K9_@3:
M2MKDDV7!Z^_/)%D1_D\GA5=2QXKH6V@M;,06ZM566TYHLQ4\3WJ-9H? &U6%
M>EF]O8:%.NFLP)^:#+VC!'>(OU%9J)?9VVI4:-;<#A,#]D9\H5Y]7Z$&A68I
M[C Q$&@T&9I$64,@IM^V-,3%J;OL).J0V$E".\K%F:",YAWS[2:+&F5'>F6O
M$M[#U0E/'_]2FJ\5[7 VFFH!F:J%:Q->%=B4\(QFA\!;9_8W/[2?<6H_-8$(
M^M[0]5 /@:9X0&]Y*D?F8WF'B>^,T&B(^O904S2@-S]U(_.QN\/$0*#1>72#
MSI^?\?2C7)P*O+,RGMVZ[LOO6C]COJ&JZ(S)6ODY=T,5@)?7EV5#LJRX 5PQ
M*5E2/$8$AX3G!JI_S9A\:>27BO4E\NP'4$L#!!0    ( "U#>UK$#8S(E@4
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M>?5Q"U1IAS90WZ\9DZ\/^@^T_U)8_ =02P,$%     @ +4-[6FP!+;K,"
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M-LT5)8\81- 6^E!: *6%*)JLK=86)T-]\2\95*"N.#G/%E<6ZWL^T+;Y4%H
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MFM?09/_$HMV-&SXT:@"EA2B:K+TV[T#U>8<OV=]*^SZZ2;J&U5P?>+!PH)D
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M7 ]"*5';CRO.%KPU OKWI1#J[8OY ]NW :_^!U!+ P04    "  M0WM:-6J
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M;EYR&'>^;_!7Z/!4O](-8%?G?JPZU\6JYC63\?>\9_*!:HQ'[K[7^6[%JFX
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MB$/Q[: Y9=T!!/I04$BI;1G_I<.:! 0U%IEI&YH6?+_-587$I85UO^!4SQ;
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M.B%Y@YZ_)-_)6^NU3QBAY"-O)$W@ CS?>)2'\H4'C/^-X<7_ %!+ P04
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MR69H53AD[@/*!4#RIJGW60TK@AE1]PWP'@'I]T5]#'<'ZP:@^Q8WWCE0G2@
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MY *Y E(/\$B<@EJG7I=N*^M6M&[)>J8ET5[6%?P(QKEH_%Q(>P&,D<-U&%1
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M5&#R!+). 2QJRPH\I!6(;=BPL* +F9-4-(M5VZD90GQ3NH^V/#+[X!_90^N
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M76F)N:Y':EG)5&F04+H(ENQ"XO4(B*=ZVFMB"^!1[Y65QWE\B7#<2WVL#DG
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MFC;@^THI6R^(07,+?_L74$L#!!0    ( "U#>UI0B9:E^@8  &$3   9
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M#VIA\?R9'(\$+_2@&J^J!9!@+ F+!:\KZ81$V& M>9%Y+N;1*)WMK^&-1TC
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M49D&5EF7K0/ZD]N6P0C@P#43\0\0] ..9Q6EOXH\N!**,VM\-J,-(V6574<
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M<:- (FX<!EL.1:A3K&;'"JJ6X@_D= KO8ZAC] 5AX<7U#BXD: \T8!<VD+"
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MW[DU4UA >!Z:K!I4  2<(_TN5#P3&N@P$5_ [%@AK,'99(.=N^09HK>$^8B
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M_([?A^X>Y[?*?Y(6,HL#.KB H=/)S=4)%\?A0V-J>CMZ;IK&K.G/E0*+67P
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MG9!"UK/_4V0]CO8#_9>Z9-4[MU3U6+%WC_<G5/&%YM25M)>&G% ZA9B$N9&
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M&@RG8P]4.^:T&R-K-UJLI*%!Q2T+F@Q160&Z7TM*DFYC#?2SYO)O4$L#!!0
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M-#XYBL"T=MI.G*Z#A2VT(T,,PY+^0&A\ .T76KO-Q"?H_FGC/U!+ P04
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MMJ1SRKJ"'\'Z%U,D%])> &/D<!T&-:/YG!WJEEF1X$> \>2B$P'T6]H,^:%
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M\ G3[A;T+VEM4 N\*SSQ"40:$FD+M]B( "&9SIX/BT_X!CPSM"]+$!Z=$$(
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MBF@GE%"K0@AKID$'V5#!3!FV.,L?@."^(ZH;(;N"'&W44F%9F;6'[RBELJ4
M:*+;,8SHZVGV)4V=4.F"8LNIHX%QO8UVNU'*D3R2^QPTY,DU[]=%+,U=0QPC
MI2(8+MP9P1YU7*%!ZS@HZ:OO=)0&#LJA@ 6-Z^41J1,4A&#3W!NSP;Y&+28E
M(0C\?%/G-#84+I3BD;K=#'HT+^GI4:Z-)CH9R::0%FHG4GW1-&N"LHD",X('
MZ>_%2PC!J.E;&!N8''AE1"LB1G=Q(M](T)NL%>8-8C$/-N6(%:.BN+?:\"/L
M=_'MDZ?$O:0CX"LQ*\8/IV<#(XHP/.3"0*4YT+#42E2#3F"YFS1.=\2L9ZC6
MIDBLZCLQID$EC2,-WMO#N-4$A)I^UQDP^OSIADPVB7W(E^134;\=7/--W6DW
M,J;HY-=! 1N]H'1]I,^1 TI^D8-KHP'>_[9Z=GYVGNT!-JY#E.D]VC=F\&UE
M*F8+X[N!6[0K"E74?X #V>'KL&0,L[BQT:"F:,>+\WC'*/9/]?(-!;+*H_;<
MVB*V!C*=3?Y7'?_%^5]W_*2S^Y@:]-Z8SKS\ 4G17MJRQ$ I<.^/#[!2W?\5
MWVN 38K?O5H]> S?#(^__.$ )/*S:>B%$:7=P%?/SUX\>\!A2?T%'"E<$M]"
MU]5[^A%G&=@&'X#/-W7=Z2^X 5;6$G@O_P]02P,$%     @ +4-[6E->'%O'
M @  )P8  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL?57?;]HP$'[O
M7W'*I&F3N@8"[2H&2- ?ZJ160Z7='J8]F.1"K#IVZG.@_/<[.Y QB?)";-]]
MWWUW]AW#M;$O5" Z>"N5IE%4.%<-XIC2 DM!9Z9"S9;<V%(XWMIE3)5%D050
MJ>*DT[F(2R%U-!Z&LYD=#TWME-0XLT!U60J[F:(RZU'4C78'CW)9.'\0CX>5
M6.(<W7,UL[R+6Y9,EJA)&@T6\U$TZ0ZF?>\?''Y*7-/>&GPF"V->_.9[-HHZ
M7A J3)UG$/Q9X14JY8E8QNN6,VI#>N#^>L=^&W+G7!:"\,JH7S)SQ2BZC"##
M7-3*/9KU'6[S.?=\J5$4?F'=^%YT(DAK<J;<@EE!*77S%6_;.NP!+M\#)%M
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MT/!J1F6GNI[6#8QL7!_92D-=R9DE_0U 91UH?2>E.0[L!L,?B_5_4$L#!!0
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M0CM7)8_QLD^5I%!NL3]]_<(+W#<=WHT:[T9=VJ=W5+C))D,02[A%I64::W+
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MLKI 52]:E/;2LA":KD#V<4UW3I1&@+XOA="'%V.@N<5._P102P,$%     @
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M9"%!?'F -4G+FN2G6;,50J>]L MC !,DL;X7?(&S;\7^GG-X'&HO]K&$NK,
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M1"9+($M09%50!>3LGJXYZ/-98#"3M0^R-NIU$S7^1M0H)N^E,(4F;T0.^7&
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M+"L.EP0GA.L$ZN]SQN3[B<Y@\X7F]']02P,$%     @ +4-[6B=E_:42 P
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MN Y0UR/&Y'&@=];UEQ3_)U!+ P04    "  M0WM:H@Q6N7<"  #>!0  &0
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MI%9"8]T>ICV8Y$*L.G%F.[#MZV<G:9*5D$EH*WV!./$]OB<YAQ,\V7%Q+T,
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M)F7 Q"2K.+LF-1Z19';.V1IQ75K1] >37Q.M,I+D6HJWDJMO$Q4G9Y^IRJ-
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M:^AF6.EF:*//+M7<C=@<I5HWZ!];#[FRDKH*I8"-#4Q?*SS,3@?#Z7G_85L
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M7% 24ZX+J._GC,G-AJZ@>L/%[%]02P,$%     @ +4-[6I?)-(S. @  1@<
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M?/D1&S\=PY?R0MI?6#:QG@/I7"I>-F"MH*2L_B>O31[6 'Y\ ! T@& ;$!T
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M!F7"H&N"529871/L,L'NFN"4"4X^]L5@Y2/M!B*831C=(99%2UJVD>O*L^4
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M^MYS0MES8U\"]A2E',5D*?'&]5">QZQX%*O8$72=/SKT2(6@2;ZY(L&"L"Q
M?KZD5+SN9$\C50_$S?X#4$L#!!0    ( "U#>UHOG44=\0\  !SN   9
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M]$'9FS);L4D+/<:YY.INJO+D9,KR7'5S+EGRC-ZA>35-Q%;(N#-?4PX"/8(
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MUK][L$FG=T@_4OZ4%@)EL%(YWLU0?0]XM>E8G4BV*??M%DQ*EI>':Z!+X#I
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M_N ;>^A: TC,0V(4B;'1SA]\2UL"R$X#),:1F !A2@F<;4K@[,^60#WW,=6
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M/U1A?V9(@X<1VD>)-1<LGMB+U\D!\067R5FZ=*^+AO$9Y^#DG:U ;5SYH?'
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M(;V+KJ8DJLY<#10O;'.;<J5;I?W,]&,&A''0\S/.U<O +- \C^)?4$L#!!0
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M*3YG<D$C.._HZB)!/$%G\M,/>-C]U<:93[#0$UB+SW[-9]^%/IE2F:"%X!%
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M_4A'@:CFTNI%\:(<[19<Z4&Q?%SK61Z$$=#[2\[5_L5\H/GOP/0_4$L#!!0
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M.EY#SO6MW(# -TNI<F[P5JU<O5' D\(ISUSF>8&;\U0XLTGQ[%G-)G)KLE3
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M:SRQ@;(&^'XII3G<V _49\#9OU!+ P04    "  M0WM:UY+%SZH"  "E"
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( "U#>UI04"D"P04  #8R   /
M>&PO=V]R:V)O;VLN>&ULQ9M;;]LX$$;_"N&G%MBL8]W<%DV!-)=N@+0U[*"O
M"T:B$R(2Z26EW'[]4E*\'3GVAWT9YRFQI,A'0W'.\)+/#];=75M[)QZKTOBC
MT6U=KSZ-QSZ_597T?]J5,N',TKI*UN&CNQG[E5.R\+=*U54YC@X/LW$EM1E]
M^;R^U\R-Z0=;J[S6UH2#[8%?6CWXW^?;C^)>>WVM2UT_'8VZWTLU$I4VNM+/
MJC@:'8Z$O[4/?UFGGZVI9;G(G2W+H]&D/_%+N5KGKPXO6L@K>>V[([6\GLL
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MT[/L;3N\Y+/I+[[K/U!+ 0(4 Q0    ( "U#>UI&QTU(E0   ,T    0
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M965T,RYX;6Q02P$"% ,4    "  M0WM:Q V,R)8%  !>&   &
M    @(%4'@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
M+4-[6FP!+;K,"   \U(  !@              ("!("0  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( "U#>UI6-V5"[0(  *@(   8
M          " @2(M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    "  M0WM:?25..V@(   9*   &               @(%%,   >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ +4-[6C5J@.=- @  H@4
M !@              ("!XS@  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( "U#>UH&R6VN\0@  $@L   8              " @68[  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  M0WM:+'5HOD,"
M  "*!@  &0              @(&-1   >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( "U#>UH\I3,X$0(  -T$   9              "
M@0='  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ +4-[
M6IK!DYCN#   TB   !D              ("!3TD  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    "  M0WM:@H_J]WPG  #[@@  &0
M        @(%T5@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( "U#>UHYE\!&.@0  $H*   9              " @2=^  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ +4-[6I:@JGAB!@  Z1
M !D              ("!F((  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    "  M0WM:O]M*12L$  #+"@  &0              @($QB0
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( "U#>UI*S);&
MW <  )$7   9              " @9.-  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ +4-[6E")EJ7Z!@  81,  !D
M ("!II4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  M
M0WM:4"&IIP\%  !E#   &0              @('7G   >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "U#>UKD%MR]%!(  #H_   9
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M970R-"YX;6Q02P$"% ,4    "  M0WM:LAVH%AX$  !W"@  &0
M    @($LW0  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M "U#>UIJ^%=GX0(  ),&   9              " @8'A  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ +4-[6N^O0<?"!   S@H  !D
M             ("!F>0  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    "  M0WM:NFRZ>B,#  #?!@  &0              @(&2Z0  >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( "U#>UJZ]1+;.BD
M ,Z0   9              " @>SL  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ +4-[6E->'%O' @  )P8  !D              ("!
M718! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  M0WM:
MJ1?SHC$$  #)"@  &0              @(%;&0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( "U#>UKDX<M1,P4  -P/   9
M      " @<,= 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ +4-[6K+1SCHI P  !@<  !D              ("!+2,! 'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  M0WM::EB 7(,#  !D"
M&0              @(&-)@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( "U#>UK$_),JO@(  /L%   9              " @4<J 0!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ +4-[6JMEIM1M
M!0  T0X  !D              ("!/"T! 'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    "  M0WM:+M[ <[4%  "L#@  &0
M@('@,@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( "U#
M>UK-ET8B3P0  '@+   9              " @<PX 0!X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ +4-[6IB)&[GA P  -@@  !D
M         ("!4CT! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
M    "  M0WM:N8(6*UD'  "M.0  &0              @(%J00$ >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( "U#>UHG9?VE$@,  .\,
M   9              " @?I( 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
M4$L! A0#%     @ +4-[6F]N'TMF @  R@4  !D              ("!0TP!
M 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    "  M0WM:]FLU
MSO4"    "0  &0              @('@3@$ >&PO=V]R:W-H965T<R]S:&5E
M=#0S+GAM;%!+ 0(4 Q0    ( "U#>UJ#1$,GL@,  %41   9
M  " @0Q2 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @
M+4-[6J(,5KEW @  W@4  !D              ("!]54! 'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"% ,4    "  M0WM: \M,V0 #  #!"   &0
M            @(&C6 $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4
M Q0    ( "U#>UKH<1?D(@,  )4+   9              " @=I; 0!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ +4-[6M69VH"E P
M* P  !D              ("!,U\! 'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"% ,4    "  M0WM:=F4^2CX&  !I,P  &0              @($/
M8P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( "U#>UKF
M7C7K[ (   <)   9              " @81I 0!X;"]W;W)K<VAE971S+W-H
M965T-3 N>&UL4$L! A0#%     @ +4-[6B=9UFLS!0  DB0  !D
M     ("!IVP! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "U#>UH,]*4?0 (  $\%   9              "
M@7F$ 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ +4-[
M6@V3C(7Q!   '"<  !D              ("!\(8! 'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6Q02P$"% ,4    "  M0WM:+YU%'?$/   <[@  &0
M        @($8C $ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0
M   ( "U#>UJT3H!.! 8  ),P   9              " @4"< 0!X;"]W;W)K
M<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ +4-[6MHQ"Y+P P  !A8
M !D              ("!>Z(! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q0
M2P$"% ,4    "  M0WM:^58#+50#  #C"0  &0              @(&BI@$
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( "U#>UK(GMS^
MV 0  %X6   9              " @2VJ 0!X;"]W;W)K<VAE971S+W-H965T
M-C(N>&UL4$L! A0#%     @ +4-[6E-9N#LR P  Y@@  !D
M ("!/*\! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    "  M
M0WM:,9,22@$+   PDP  &0              @(&EL@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( "U#>UKZX00S40,  !0,   9
M          " @=V] 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#
M%     @ +4-[6J=MC[@, P  ,PH  !D              ("!9<$! 'AL+W=O
M<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    "  M0WM:O7&O*$0$  !+
M%   &0              @(&HQ $ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM
M;%!+ 0(4 Q0    ( "U#>UI5AS%D4 ,  !P*   9              " @2/)
M 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ +4-[6H@X
MKGT7!   ^ T  !D              ("!JLP! 'AL+W=O<FMS:&5E=',O<VAE
M970V.2YX;6Q02P$"% ,4    "  M0WM:%HU8"Q,#   J"0  &0
M    @('XT $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    (
M "U#>UJ^,01?< 4  % A   9              " @4+4 0!X;"]W;W)K<VAE
M971S+W-H965T-S$N>&UL4$L! A0#%     @ +4-[6FKK1LTG!   *1   !D
M             ("!Z=D! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"
M% ,4    "  M0WM:74BT7%L#   =#   &0              @(%'W@$ >&PO
M=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( "U#>UI^=3I9CP(
M ,,&   9              " @=GA 0!X;"]W;W)K<VAE971S+W-H965T-S0N
M>&UL4$L! A0#%     @ +4-[6ER'IZ]#!   #PX  !D              ("!
MG^0! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    "  M0WM:
MUY+%SZH"  "E"   &0              @($9Z0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<V+GAM;%!+ 0(4 Q0    ( "U#>UHN2> &:0,  -T7   -
M      "  ?KK 0!X;"]S='EL97,N>&UL4$L! A0#%     @ +4-[6I>*NQS
M    $P(   L              ( !CN\! %]R96QS+RYR96QS4$L! A0#%
M  @ +4-[6E!0*0+!!0  -C(   \              ( !=_ ! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( "U#>UIS?'@L40(  /LL   :
M  "  67V 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M "U#>UK.%<Q?#P(  .HK   3              "  >[X 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !4 %0  Q<  "[[ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>169</ContextCount>
  <ElementCount>409</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>58</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Statement of Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets</Role>
      <ShortName>Statement of Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - Statement of Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical</Role>
      <ShortName>Statement of Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100080 - Statement - Statements of Operations and Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome</Role>
      <ShortName>Statements of Operations and Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100090 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100100 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100110 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995420 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy, and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Gain on Sale of Non-Financial Asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset</Role>
      <ShortName>Gain on Sale of Non-Financial Asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Marketable Securities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements</Role>
      <ShortName>Marketable Securities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Net (Loss) Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3</Role>
      <ShortName>Net (Loss) Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Employee Retirement Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan</Role>
      <ShortName>Employee Retirement Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables</Role>
      <ShortName>Marketable Securities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables</Role>
      <ShortName>Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Net (Loss) Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables</Role>
      <ShortName>Net (Loss) Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Organization - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails</Role>
      <ShortName>Organization - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Summary of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Balance Sheet Components - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails</Role>
      <ShortName>Balance Sheet Components - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Gain on Sale of Non-Financial Asset - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails</Role>
      <ShortName>Gain on Sale of Non-Financial Asset - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Revenue - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails</Role>
      <ShortName>Revenue - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails</Role>
      <ShortName>Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails</Role>
      <ShortName>Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Common Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails</Role>
      <ShortName>Common Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails</Role>
      <ShortName>Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Related Parties - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails</Role>
      <ShortName>Related Parties - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Employee Retirement Benefit Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails</Role>
      <ShortName>Employee Retirement Benefit Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Segment Information - Summary of Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails</Role>
      <ShortName>Segment Information - Summary of Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="sepn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996105 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="sepn-20241231.htm">sepn-20241231.htm</File>
    <File>sepn-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img117602972_0.jpg</File>
    <File>img117602972_1.jpg</File>
    <File>img117602972_10.jpg</File>
    <File>img117602972_11.jpg</File>
    <File>img117602972_12.jpg</File>
    <File>img117602972_13.jpg</File>
    <File>img117602972_2.jpg</File>
    <File>img117602972_3.jpg</File>
    <File>img117602972_4.jpg</File>
    <File>img117602972_5.jpg</File>
    <File>img117602972_6.jpg</File>
    <File>img117602972_7.jpg</File>
    <File>img117602972_8.jpg</File>
    <File>img117602972_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="695">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>107
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sepn-20241231.htm": {
   "nsprefix": "sepn",
   "nsuri": "http://www.septerna.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "sepn-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "sepn-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 332,
   "keyCustom": 77,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 32,
   "memberCustom": 25,
   "hidden": {
    "total": 8,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 169,
   "entityCount": 1,
   "segmentCount": 58,
   "elementCount": 723,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 695,
    "http://xbrl.sec.gov/dei/2024": 40,
    "http://xbrl.sec.gov/cyd/2024": 13,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
     "longName": "100010 - Statement - Statement of Balance Sheets",
     "shortName": "Statement of Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
     "longName": "100040 - Statement - Statement of Balance Sheets (Parenthetical)",
     "shortName": "Statement of Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome",
     "longName": "100080 - Statement - Statements of Operations and Comprehensive (Loss) Income",
     "shortName": "Statements of Operations and Comprehensive (Loss) Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
     "longName": "100090 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "shortName": "Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_271bef94-fdec-41f8-a570-9d76ab85a875",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_271bef94-fdec-41f8-a570-9d76ab85a875",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
     "longName": "100100 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "shortName": "Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows",
     "longName": "100110 - Statement - Statements of Cash Flows",
     "shortName": "Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995420 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy, and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "a",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "a",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1",
     "longName": "995455 - Disclosure - Organization",
     "shortName": "Organization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:OrganizationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:OrganizationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995465 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1",
     "longName": "995475 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset",
     "longName": "995485 - Disclosure - Gain on Sale of Non-Financial Asset",
     "shortName": "Gain on Sale of Non-Financial Asset",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:GainOnSaleOfNonFinancialAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:GainOnSaleOfNonFinancialAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1",
     "longName": "995495 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements",
     "longName": "995505 - Disclosure - Marketable Securities and Fair Value Measurements",
     "shortName": "Marketable Securities and Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:MarketableSecuritiesAndFairValueMeasurementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:MarketableSecuritiesAndFairValueMeasurementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases",
     "longName": "995515 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "longName": "995525 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock",
     "longName": "995535 - Disclosure - Convertible Preferred Stock",
     "shortName": "Convertible Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:ConvertiblePreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:ConvertiblePreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock",
     "longName": "995545 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:CommonStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:CommonStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation",
     "longName": "995555 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes",
     "longName": "995565 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties",
     "longName": "995575 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3",
     "longName": "995585 - Disclosure - Net (Loss) Income Per Share",
     "shortName": "Net (Loss) Income Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan",
     "longName": "995595 - Disclosure - Employee Retirement Benefit Plan",
     "shortName": "Employee Retirement Benefit Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation",
     "longName": "995605 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents",
     "longName": "995615 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995625 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995635 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables",
     "longName": "995645 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables",
     "longName": "995655 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)",
     "shortName": "Marketable Securities and Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables",
     "longName": "995665 - Disclosure - Common Stock (Tables)",
     "shortName": "Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables",
     "longName": "995675 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables",
     "longName": "995695 - Disclosure - Convertible Preferred Stock (Tables)",
     "shortName": "Convertible Preferred Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables",
     "longName": "995705 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables",
     "longName": "995715 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables",
     "longName": "995725 - Disclosure - Net (Loss) Income Per Share (Tables)",
     "shortName": "Net (Loss) Income Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables",
     "longName": "995735 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
     "longName": "995745 - Disclosure - Organization - Additional Information (Details)",
     "shortName": "Organization - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_c3d18edf-1da5-48a4-8374-55662573e03e",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "sepn:OrganizationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c3d18edf-1da5-48a4-8374-55662573e03e",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "sepn:OrganizationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
     "longName": "995755 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_d770876f-2396-4daa-bc4e-7986b296cd59",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d770876f-2396-4daa-bc4e-7986b296cd59",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "995765 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails",
     "longName": "995775 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details)",
     "shortName": "Balance Sheet Components - Summary of Prepaid Expenses and Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
     "longName": "995785 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Summary of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
     "longName": "995795 - Disclosure - Balance Sheet Components - Additional Information (Details)",
     "shortName": "Balance Sheet Components - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "longName": "995805 - Disclosure - Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails",
     "longName": "995815 - Disclosure - Gain on Sale of Non-Financial Asset - Additional Information (Details)",
     "shortName": "Gain on Sale of Non-Financial Asset - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:GainOnSaleOfNonFinancialAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b96aca59-b7bd-44d4-95df-86bbda19ce0e",
      "name": "sepn:UnconditionalRightOnNonFinancialAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
     "longName": "995825 - Disclosure - Revenue - Additional Information (Details)",
     "shortName": "Revenue - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c",
      "name": "sepn:AgreementDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
     "longName": "995835 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details)",
     "shortName": "Marketable Securities and Fair Value Measurements - Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails",
     "longName": "995845 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Details)",
     "shortName": "Marketable Securities and Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:InterestReceivableCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "unitRef": "U_Position",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails",
     "longName": "995855 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)",
     "shortName": "Marketable Securities and Fair Value Measurements - Summary of Marketable Securities by Major Type of Security (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
     "longName": "995865 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)",
     "shortName": "Marketable Securities and Fair Value Measurements - Schedule of Fair Values and Continuous Unrealized Loss Positions of Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "longName": "995875 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_062b5e92-e9a6-4480-9a3e-af692706a741",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "U_sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_062b5e92-e9a6-4480-9a3e-af692706a741",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "U_sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails",
     "longName": "995885 - Disclosure - Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details)",
     "shortName": "Leases - Summary of Expenses Recognized and Cash Paid for Leased Space (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails",
     "longName": "995895 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details)",
     "shortName": "Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "995905 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
     "longName": "995915 - Disclosure - Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
     "longName": "995925 - Disclosure - Convertible Preferred Stock - Additional Information (Details)",
     "shortName": "Convertible Preferred Stock - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60",
      "name": "us-gaap:PreferredStockConvertibleSharesIssuable",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60",
      "name": "us-gaap:PreferredStockConvertibleSharesIssuable",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sepn:ConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
     "longName": "995935 - Disclosure - Common Stock - Additional Information (Details)",
     "shortName": "Common Stock - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fd642eac-5407-4e19-b1fe-1a23d8f0049c",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "sepn:CommonStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
     "longName": "995945 - Disclosure - Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details)",
     "shortName": "Common Stock - Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
     "longName": "995955 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Award Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_1147e1f5-d133-45d8-8f2d-657d2695faa6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1147e1f5-d133-45d8-8f2d-657d2695faa6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
     "longName": "995965 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a3e21644-6ca9-47f4-96b3-8d6951b37099",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails",
     "longName": "995975 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details)",
     "shortName": "Stock-Based Compensation - Summary of Weighted-Average Assumptions used for Grants Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
     "longName": "995985 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:ShareBasedCompensationEquityAwardsOptionsGrantsFairValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails",
     "longName": "995995 - Disclosure - Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details)",
     "shortName": "Stock-Based Compensation - Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
     "longName": "996005 - Disclosure - Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Components of (Benefit) Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "996015 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails",
     "longName": "996025 - Disclosure - Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails",
     "longName": "996035 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2eb036f2-f593-46bc-984a-3f742b94ee9c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails",
     "longName": "996045 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_787857dc-a393-4f80-adbe-f17546eff5f9",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
     "longName": "996055 - Disclosure - Related Parties - Additional Information (Details)",
     "shortName": "Related Parties - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
     "longName": "996065 - Disclosure - Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details)",
     "shortName": "Net (Loss) Income Per Share - Computation of Basic and Diluted Net (Loss) Income Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails",
     "longName": "996075 - Disclosure - Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details)",
     "shortName": "Net (Loss) Income Per Share - Summary of Potentially Dilutive Securities not Included in Calculation of Diluted Net (Loss) Income Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails",
     "longName": "996085 - Disclosure - Employee Retirement Benefit Plan - Additional Information (Details)",
     "shortName": "Employee Retirement Benefit Plan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_04364af7-15e7-4170-a9bd-075237a2baca",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_04364af7-15e7-4170-a9bd-075237a2baca",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
     "longName": "996095 - Disclosure - Segment Information - Summary of Reportable Segment (Details)",
     "shortName": "Segment Information - Summary of Reportable Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "longName": "996105 - Disclosure - Subsequent Events - Additional Information (Details)",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_c457190a-2591-4660-96fd-0fed98a4b50f",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9763b408-328c-4770-af66-e36b06544fe2",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sepn-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting pronouncements not yet adopted.",
        "label": "Accounting Pronouncements Not Yet Adopted, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivable related to sale of non-financial asset",
        "label": "Accounts and Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total",
        "label": "Accounts Payable Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r754"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Total",
        "terseLabel": "Outstanding accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1077"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "totalLabel": "Total accounts receivable, net",
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable Net Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Accretion of premiums (discounts), net",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "sepn_AccruedExpenseAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AccruedExpenseAndOtherCurrentLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Accrued Expense And Other Current Liabilities",
        "documentation": "Accrued Expense And Other Current Liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_AccruedGeneralAndAdministrativeExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AccruedGeneralAndAdministrativeExpenseCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued General and Administrative Expense Current",
        "documentation": "Accrued general and administrative expense current.",
        "terseLabel": "Accrued general and administrative expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Accrued Liabilities Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "sepn_AccruedResearchAndDevelopmentExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AccruedResearchAndDevelopmentExpenseCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Research and Development Expense Current",
        "documentation": "Accrued research and development expense current.",
        "terseLabel": "Accrued research and development expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued compensation expense",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r702"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Accumulated depreciation and amortization",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r137",
      "r580"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "terseLabel": "Accumulated other comprehensive income",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r75",
      "r143",
      "r575",
      "r599",
      "r600"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r18",
      "r468",
      "r471",
      "r517",
      "r595",
      "r596",
      "r906",
      "r907",
      "r908",
      "r917",
      "r918",
      "r919",
      "r921"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "sepn_AdditionalLeasedSpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AdditionalLeasedSpaceMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Leased Space",
        "documentation": "Additional Leased Space.",
        "label": "Additional Leased Space [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid In Capital Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid In Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r917",
      "r918",
      "r919",
      "r921",
      "r1051",
      "r1086"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "terseLabel": "Stock-based compensation expense",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r364"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r844"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r804",
      "r814",
      "r847"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "sepn_AgreementDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AgreementDescription",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreement Description",
        "documentation": "Agreement description",
        "terseLabel": "Agreement description"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r839",
      "r848",
      "r852",
      "r860"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation expense",
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r407"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total antidilutive securities",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfLand",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of Land",
        "terseLabel": "Area of lease",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r113",
      "r139",
      "r167",
      "r206",
      "r214",
      "r231",
      "r234",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r461",
      "r465",
      "r490",
      "r569",
      "r648",
      "r713",
      "r714",
      "r754",
      "r768",
      "r950",
      "r951",
      "r1066"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r146",
      "r167",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r461",
      "r465",
      "r490",
      "r754",
      "r950",
      "r951",
      "r1066"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]",
        "terseLabel": "Auditor Opinion"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized Losses",
        "terseLabel": "Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r281",
      "r568"
     ]
    },
    "sepn_AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AvailableForSaleMarketableSecuritiesAndFairValueMeasurementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Available-for-Sale Marketable Securities and Fair Value Measurements [Abstract]",
        "documentation": "Available-for-sale marketable securities and fair value measurements."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available-for-sale - Matures After One Year Through Five Years, Gross Unrealized Gains",
        "documentation": "Available-for-sale - matures after one year through five years, gross unrealized gains.",
        "terseLabel": "Unrealized gains of marketable debt securities, contractual maturity, one year to five years"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss",
        "documentation": "Available for sale matures after one year through five years gross unrealized loss.",
        "negatedLabel": "Unrealized losses of marketable debt securities, contractual maturity, one year to five years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r720"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "Amortized cost of marketable debt securities, contractual maturity, one year to five years",
        "totalLabel": "Amortized cost of marketable debt securities, contractual maturity, one year to five years",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "Aggregate estimated fair value of marketable debt securities, contractual maturities, one year to five year",
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized cost of marketable debt securities, contractual maturity, less than one year",
        "terseLabel": "Amortized cost of marketable debt securities, contractual maturity, less than one year",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate estimated fair value of marketable debt securities, contractual maturities, less than one year",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r566"
     ]
    },
    "sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains of marketable debt securites, contractual maturity, less than one year",
        "label": "Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Gains",
        "documentation": "Available for sale securities debt maturities within one year gross unrealized gains."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized losses of marketble debt securities, contractual maturity, less than one year",
        "terseLabel": "Unrealized losses of marketble debt securities, contractual maturity, less than one year",
        "label": "Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Loss",
        "documentation": "Available for sale securities debt maturities within one year gross unrealized loss."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Securities, Available-for-Sale, Total",
        "terseLabel": "Aggregate Estimated Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r281",
      "r478",
      "r562",
      "r742",
      "r746",
      "r934",
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r291",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total measured at fair value",
        "terseLabel": "Total measured at fair value",
        "label": "Cash and Cash Equivalents and Marketable Securities, Fair Value Disclosure",
        "documentation": "Cash and cash equivalents and marketable securities, fair value disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r135",
      "r700"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails": {
       "parentTag": "sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r102"
     ]
    },
    "sepn_CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, marketable securities current and non-current",
        "label": "Cash, Cash Equivalents, Marketable Securities Current and Non-current",
        "documentation": "Cash, cash equivalents, marketable securities current and non-current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "terseLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "totalLabel": "Total cash, cash equivalents and restricted cash at end of year",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r82",
      "r165"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r82"
     ]
    },
    "sepn_CashEquivalentsAndMarketableSecuritiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CashEquivalentsAndMarketableSecuritiesPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents and Marketable Securities",
        "label": "Cash Equivalents and Marketable Securities [Policy Text Block]",
        "documentation": "Cash equivalents and marketable securities."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_CashProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CashProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash proceeds from issuance of convertible preferred stock",
        "label": "Cash Proceeds From Issuance Of Convertible Preferred Stock",
        "terseLabel": "Cash proceeds from issuance of convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "srt_ChiefFinancialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefFinancialOfficerMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]",
        "terseLabel": "Chief Financial Officer"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r140",
      "r141",
      "r142",
      "r167",
      "r190",
      "r191",
      "r198",
      "r200",
      "r208",
      "r209",
      "r273",
      "r300",
      "r302",
      "r303",
      "r304",
      "r307",
      "r308",
      "r312",
      "r313",
      "r316",
      "r317",
      "r320",
      "r490",
      "r604",
      "r605",
      "r606",
      "r607",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r636",
      "r657",
      "r679",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r885",
      "r913",
      "r922"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r208",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r604",
      "r605",
      "r606",
      "r607",
      "r723",
      "r885",
      "r913"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to purchase",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r299",
      "r762",
      "r763",
      "r764",
      "r765"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 8)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r106",
      "r571",
      "r635"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r293",
      "r294",
      "r695",
      "r947",
      "r949"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "sepn_CommonStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CommonStockLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Line Items]",
        "documentation": "Common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r760",
      "r762",
      "r763",
      "r764",
      "r765",
      "r917",
      "r918",
      "r921",
      "r1051",
      "r1083",
      "r1086"
     ]
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_CommonStockOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CommonStockOptions",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock options",
        "documentation": "Common stock options",
        "terseLabel": "Common stock options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value",
        "label": "Common Stock Par Or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized",
        "label": "Common Stock Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r636"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r69",
      "r636",
      "r654",
      "r1086",
      "r1087"
     ]
    },
    "sepn_CommonStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CommonStockTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Table]",
        "documentation": "Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_CommonStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "CommonStockTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock",
        "label": "Common Stock [Text Block]",
        "documentation": "Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.001 par value per share, 500,000,000 and 260,590,689 shares authorized at December 31, 2024 and 2023, respectively; 44,422,505 and 3,168,134 shares issued and outstanding at December 31, 2024 and 2023, respectively; 576,829 and 1,002,044 shares subject to repurchase as of December 31, 2024 and 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r573",
      "r754"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r152",
      "r154",
      "r159",
      "r563",
      "r587",
      "r588"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive (loss) income:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive (Loss) Income",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Convertible Preferred Stock to Common Stock Upon Initial Public Offering",
        "documentation": "Conversion of convertible preferred stock to common stock upon initial public offering",
        "terseLabel": "Conversion of convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of unpaid principal and accrued interest outstanding into shares",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "sepn_ConvertiblePreferredStockPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ConvertiblePreferredStockPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock.",
        "label": "Convertible Preferred Stock, Policy [Policy Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock Remaining Unissued Shares Agreement To Cancel",
        "label": "Convertible Preferred Stock Remaining Unissued Shares Agreement To Cancel",
        "terseLabel": "Convertible preferred stock remaining unissued shares agreement to cancel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted preferred stock outstanding",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r40",
      "r68",
      "r94",
      "r318"
     ]
    },
    "sepn_ConvertiblePreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ConvertiblePreferredStockTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "label": "Convertible Preferred Stock [Text Block]",
        "documentation": "Convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Promissory Notes, Unpaid Principal and Accrued Interest Outstanding",
        "label": "Convertible Promissory Notes, Unpaid Principal and Accrued Interest Outstanding",
        "terseLabel": "Convertible promissory notes such as unpaid principal and accrued interest outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r733",
      "r742",
      "r755",
      "r757",
      "r1082"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r890",
      "r915",
      "r1050"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r915"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r890",
      "r915",
      "r1050"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r871"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r871"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r873"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r873"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r875"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r873"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r866"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r867"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r867"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r868"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r870"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r870"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r871"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r785",
      "r874"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r872"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r869"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Marketable securities, continuous unrealized loss position, Less than 12 Months, Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r284",
      "r720"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Marketable securities, continuous unrealized loss position, Less than 12 Months, Gross Unrealized Losses",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r284"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of marketable securities in unrealized loss positions less than 12 months",
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r720"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Positions of Marketable Securities",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r720",
      "r943"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Prepaid Expenses and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r1049",
      "r1050"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax",
        "label": "Deferred Income Tax",
        "totalLabel": "Total deferred",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r127",
      "r915"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r104",
      "r434"
     ]
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Offering Costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r1049",
      "r1050"
     ]
    },
    "sepn_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Capitalized Research And Development Costs",
        "documentation": "Deferred tax assets capitalized research and development costs.",
        "terseLabel": "Sec 174 capitalized research and development costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets before valuation allowance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "sepn_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Lease Liability",
        "documentation": "Deferred tax assets lease liability.",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development credits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net",
        "totalLabel": "Net deferred income tax liabilities",
        "negatedTotalLabel": "Net deferred income tax liabilities",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedLabel": "Right-of-use assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "sepn_DeferredTaxLiabilitiesSaleOfNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "DeferredTaxLiabilitiesSaleOfNonFinancialAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities Sale of Non Financial Asset",
        "documentation": "Deferred tax liabilities sale of non-financial asset.",
        "negatedLabel": "Sale of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Contribution expenses",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total",
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation And Amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r35"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Depletion and Amortization, Total",
        "terseLabel": "Depreciation and amortization expense",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r206",
      "r218",
      "r234",
      "r713",
      "r714"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r366",
      "r397",
      "r398",
      "r401",
      "r735"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797",
      "r840"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net (loss) income per share attributable to common stockholders:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share Basic",
        "verboseLabel": "Net (loss) income per share, basic",
        "terseLabel": "Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r187",
      "r190",
      "r198",
      "r199",
      "r200",
      "r205",
      "r455",
      "r458",
      "r475",
      "r476",
      "r564",
      "r589",
      "r705"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share Diluted",
        "verboseLabel": "Net (loss) income per share, diluted",
        "terseLabel": "Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r190",
      "r198",
      "r199",
      "r200",
      "r205",
      "r455",
      "r458",
      "r475",
      "r476",
      "r564",
      "r589",
      "r705"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net (Loss) Income Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r202"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShare3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net (Loss) Income Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r201",
      "r203",
      "r204"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r739"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal taxes at statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r417",
      "r446",
      "r739"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r739",
      "r916",
      "r1042"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock compensation",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r916",
      "r1042",
      "r1044"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State tax, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r739",
      "r916",
      "r1042"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total",
        "terseLabel": "Tax credits",
        "negatedLabel": "Tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r422",
      "r916",
      "r1042"
     ]
    },
    "sepn_EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging growth company status and smaller reporting company status.",
        "label": "Emerging Growth Company Status and Smaller Reporting Company Status, Policy [Policy Text Block]",
        "terseLabel": "Emerging Growth Company Status and Smaller Reporting Company Status"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_EmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmployeeMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees [Member]",
        "label": "Employee [Member]",
        "documentation": "Employee."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_EmployeeRelatedExpensesExcludingStockBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmployeeRelatedExpensesExcludingStockBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Related Expenses Excluding Stock Based Compensation",
        "documentation": "Employee related expenses, excluding stock based compensation.",
        "terseLabel": "Employee-related expenses, excluding stock-based compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average period for recognition of expenses related to non-vested share-based compensation arrangements",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "unrecognized stock-based compensation expense related to unvested restricted stock awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Outstanding Stock Options",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_EmployeeStockPurchase2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmployeeStockPurchase2024PlanMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Purchase 2024 Plan [Member]",
        "documentation": "Employee stock purchase 2024 plan.",
        "terseLabel": "Employee Stock Purchase 2024 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_EmployeeStockPurchasePlan2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmployeeStockPurchasePlan2024Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan 2024 [Member]",
        "documentation": "Employee stock purchase plan 2024."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lab equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r131",
      "r156",
      "r157",
      "r158",
      "r171",
      "r172",
      "r173",
      "r175",
      "r180",
      "r182",
      "r184",
      "r207",
      "r274",
      "r275",
      "r289",
      "r322",
      "r444",
      "r445",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r500",
      "r517",
      "r585",
      "r595",
      "r596",
      "r597",
      "r614",
      "r679"
     ]
    },
    "sepn_EquityIncentivePlan2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "EquityIncentivePlan2024Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Equity Incentive Plan",
        "label": "Equity Incentive Plan 2024 [Member]",
        "documentation": "Equity incentive plan 2024."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r844"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r787",
      "r798",
      "r808",
      "r841"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "sepn_ExecutiveOfficerAndDirectorEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ExecutiveOfficerAndDirectorEquityAwardsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Officer And Director Equity Awards [Member]",
        "documentation": "Executive officer and director equity awards ."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ExternalGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ExternalGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External general and administrative expenses",
        "label": "External General And Administrative Expenses",
        "documentation": "External general and administrative expenses."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ExternalResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ExternalResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External research and development expenses",
        "label": "External Research And Development Expenses",
        "documentation": "External research and development expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r486",
      "r742"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r486",
      "r742"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurements on Cash Equivalents and Marketable Securities",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r742",
      "r1053",
      "r1054",
      "r1059"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r486",
      "r488",
      "r532",
      "r533",
      "r534",
      "r721",
      "r722",
      "r731",
      "r732",
      "r733",
      "r742",
      "r746"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r337",
      "r342",
      "r479",
      "r486",
      "r532",
      "r731",
      "r732",
      "r733",
      "r742"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r337",
      "r342",
      "r479",
      "r480",
      "r486",
      "r533",
      "r721",
      "r722",
      "r731",
      "r732",
      "r733",
      "r742"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r486",
      "r488",
      "r532",
      "r533",
      "r534",
      "r721",
      "r722",
      "r731",
      "r732",
      "r733",
      "r742",
      "r746"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_FeaturesOfConvertiblePreferredStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FeaturesOfConvertiblePreferredStockAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Features of Convertible Preferred Stock [Abstract]",
        "terseLabel": "Convertible Preferred Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r285",
      "r286",
      "r311",
      "r319",
      "r473",
      "r489",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r586",
      "r720",
      "r742",
      "r744",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r755",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r938",
      "r939",
      "r940",
      "r941",
      "r1052",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r848"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r848"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r848"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r848"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r848"
     ]
    },
    "sepn_FourZeroOne401KPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "FourZeroOne401KPlanMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Zero One 401 K Plan [Member]",
        "documentation": "Four zero one 401 K plan member.",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_FurnitureFixturesAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "FurnitureFixturesAndOfficeEquipmentMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture, fixtures, and office equipment",
        "label": "Furniture Fixtures and Office Equipment [Member]",
        "documentation": "Furniture fixtures and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Disposition of Assets",
        "totalLabel": "Gain (Loss) on Disposition of Assets, Total",
        "terseLabel": "Gain on sale of non-financial asset",
        "negatedLabel": "Gain on sale of non-financial asset",
        "negatedTerseLabel": "Gain on sale of non-financial asset",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "sepn_GainLossOnSaleOfResearchAndDdevelopmentInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "GainLossOnSaleOfResearchAndDdevelopmentInProgress",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain Loss On Sale Of Research And Ddevelopment In-Progress",
        "documentation": "Gain Loss on sale of research and development in-progress.",
        "verboseLabel": "Gain on sale of research and development in-progress"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_GainOnSaleOfInProgressResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "GainOnSaleOfInProgressResearchAndDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on Sale of In Progress Research and Development",
        "documentation": "Gain on sale of in-progress research and development.",
        "terseLabel": "Gain on sale of in-progress research and development"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_GainOnSaleOfNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "GainOnSaleOfNonFinancialAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on sale of non-financial asset.",
        "label": "Gain On Sale Of Non Financial Asset",
        "negatedTerseLabel": "Gain on sale of non-financial asset",
        "terseLabel": "Gain on sale of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_GainOnSaleOfNonFinancialAssetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "GainOnSaleOfNonFinancialAssetTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAsset"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on Sale of Non-Financial Asset [Text Block]",
        "documentation": "Gain on sale of non-financial asset.",
        "terseLabel": "Gain on Sale of Non-Financial Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "General and Administrative Expense, Total",
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative costs",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r659"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "sepn_GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Proceeds After Deducting Underwriting Discounts And Commissions",
        "documentation": "Gross proceeds after deducting underwriting discounts and commissions.",
        "verboseLabel": "Gross proceeds after deducting underwriting discounts and commissions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "IPO Stock Options [Member]",
        "terseLabel": "Initial Public Offering (IPO)",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r774",
      "r797"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of long-lived assets",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r87",
      "r743"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r89"
     ]
    },
    "sepn_IncentiveStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "IncentiveStockOptionsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive stock options.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "Incentive Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "terseLabel": "(Loss) income before provision for income taxes",
        "totalLabel": "(Loss) income before provision for income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r108",
      "r112",
      "r565",
      "r582",
      "r707",
      "r713",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r483",
      "r484",
      "r487",
      "r592",
      "r594",
      "r664",
      "r698",
      "r745",
      "r1081"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r483",
      "r484",
      "r487",
      "r592",
      "r594",
      "r664",
      "r698",
      "r745",
      "r1081"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r412",
      "r417",
      "r423",
      "r424",
      "r425",
      "r431",
      "r438",
      "r447",
      "r449",
      "r450",
      "r451",
      "r609",
      "r739"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "negatedLabel": "(Benefit) provision for income taxes",
        "totalLabel": "(Benefit) provision for income taxes",
        "verboseLabel": "(Benefit) provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r128",
      "r183",
      "r184",
      "r206",
      "r219",
      "r234",
      "r416",
      "r417",
      "r448",
      "r590",
      "r739"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r414",
      "r415",
      "r431",
      "r432",
      "r437",
      "r442",
      "r603"
     ]
    },
    "sepn_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]",
        "documentation": "Income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Taxes Paid, Net, Total",
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r164",
      "r439",
      "r440"
     ]
    },
    "sepn_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Table]",
        "documentation": "Income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "terseLabel": "Accounts payable",
        "label": "Increase Decrease In Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase Decrease In Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase Decrease In Accrued Liabilities And Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase Decrease In Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating leases, net",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r889",
      "r910"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-current assets",
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total",
        "label": "Increase Decrease In Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "sepn_IncreaseInSharesReservedForFutureIssuanceInShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "IncreaseInSharesReservedForFutureIssuanceInShares",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in shares reserved for future issuance, in shares",
        "label": "Increase in Shares Reserved for Future Issuance, in Shares",
        "documentation": "Increase in shares reserved for future issuance, in shares"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r839",
      "r848",
      "r852",
      "r860"
     ]
    },
    "sepn_InitialPublicOfferingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "InitialPublicOfferingStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial public offering stock options",
        "label": "Initial Public Offering Stock Options",
        "documentation": "Initial public offering stock options."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_InitialTrancheMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "InitialTrancheMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Tranche [Member]",
        "label": "Initial Tranche [Member]",
        "terseLabel": "Initial Tranche"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r864"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r864"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r864"
     ]
    },
    "us-gaap_InterestReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest receivable",
        "label": "Interest Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "sepn_InterimChiefMedicalOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "InterimChiefMedicalOfficerMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Chief Medical Officer",
        "label": "Interim Chief Medical Officer [Member]",
        "documentation": "Interim Chief Medical Officer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r217",
      "r234",
      "r713",
      "r909"
     ]
    },
    "sepn_LeaseCommencementPeriod": {
     "xbrltype": "gYearMonthItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "LeaseCommencementPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Commencement Period",
        "documentation": "Lease commencement period.",
        "terseLabel": "Lease commencement period"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_LeasedSpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "LeasedSpaceMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased Space.",
        "label": "Leased Space [Member]",
        "terseLabel": "Leased Space"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r515"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r516"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r516"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDescription",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Description",
        "terseLabel": "Operating lease liability term",
        "documentation": "Description of lessee's operating lease."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]",
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "sepn_LesseeOperatingLeaseExpirationYearAndMonth": {
     "xbrltype": "gYearMonthItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "LesseeOperatingLeaseExpirationYearAndMonth",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Expiration Year and Month",
        "documentation": "Lessee, operating lease, expiration year and month.",
        "terseLabel": "Lease expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Lease option to extend description",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r66",
      "r167",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r462",
      "r465",
      "r466",
      "r490",
      "r634",
      "r706",
      "r768",
      "r950",
      "r1066",
      "r1067"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities, convertible preferred stock and stockholders' equity (deficit)",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r107",
      "r577",
      "r754",
      "r914",
      "r942",
      "r1061"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_LiabilitiesAssociatedWithIndemnificationRightsAndAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "LiabilitiesAssociatedWithIndemnificationRightsAndAgreements",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "liabilities associated with indemnification rights and agreements",
        "label": "Liabilities Associated with Indemnification Rights and Agreements",
        "documentation": "Liabilities associated with indemnification rights and agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r134",
      "r167",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r462",
      "r465",
      "r466",
      "r490",
      "r754",
      "r950",
      "r1066",
      "r1067"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_MarketableSecuritiesAndFairValueMeasurementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "MarketableSecuritiesAndFairValueMeasurementsTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities And Fair Value Measurements [TextBlock]",
        "documentation": "Marketable securities and fair value measurements.",
        "terseLabel": "Marketable Securities and Fair Value Measurements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails": {
       "parentTag": "sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Marketable securities, current",
        "terseLabel": "Marketable securities",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails": {
       "parentTag": "sepn_CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Marketable securities, non-current",
        "terseLabel": "Marketable securities, non-current",
        "label": "Marketable Securities, Noncurrent",
        "documentation": "Amount of investment in marketable security, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r356",
      "r408",
      "r482",
      "r560",
      "r591",
      "r593",
      "r601",
      "r626",
      "r627",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r696",
      "r697",
      "r719",
      "r723",
      "r734",
      "r746",
      "r747",
      "r751",
      "r752",
      "r756",
      "r952",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r356",
      "r408",
      "r482",
      "r560",
      "r591",
      "r593",
      "r601",
      "r626",
      "r627",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r696",
      "r697",
      "r719",
      "r723",
      "r734",
      "r746",
      "r747",
      "r751",
      "r756",
      "r952",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided By Used In Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided By Used In Operating Activities",
        "terseLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "negatedLabel": "Net loss",
        "totalLabel": "Net (loss) income",
        "negatedTotalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r84",
      "r109",
      "r132",
      "r150",
      "r153",
      "r158",
      "r167",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r196",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r455",
      "r458",
      "r476",
      "r490",
      "r584",
      "r656",
      "r677",
      "r678",
      "r766",
      "r950"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net (loss) income applicable to common stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r176",
      "r177",
      "r178",
      "r179",
      "r187",
      "r188",
      "r197",
      "r200",
      "r458"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator, basic:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net (loss) income applicable to common stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r189",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r200"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator, diluted:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Proceeds Conversion Of Outstanding Convertible Promissory Notes Plus Accrued Interest",
        "label": "Net Proceeds Conversion Of Outstanding Convertible Promissory Notes Plus Accrued Interest",
        "terseLabel": "Net proceeds conversion of outstanding convertible promissory notes plus accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r839",
      "r848"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure for noncash investing and financing activities:",
        "label": "Noncash Investing And Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "label": "Nonoperating Income Expense",
        "terseLabel": "Other income, net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net:",
        "label": "Nonoperating Income Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses (income)",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses (income):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income Loss",
        "totalLabel": "(Loss) income from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r707",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r753"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total present value of operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Liability Noncurrent",
        "verboseLabel": "Operating lease liability",
        "terseLabel": "Operating lease liabilities, non-current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for operating lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r510"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of present value of lease payments",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r753"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r753"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "sepn_OperatingLossCarryforwardsExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards Expiration Year",
        "documentation": "Operating loss carryforwards expiration year.",
        "terseLabel": "Operating loss carryforwards expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_OptionAndIncentivePlan2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "OptionAndIncentivePlan2024Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option and Incentive Plan 2024 [Member]",
        "documentation": "Option and incentive plan 2024.",
        "terseLabel": "2024 Option and Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_OrganizationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "OrganizationDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganization1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Disclosure [Text Block]",
        "documentation": "Organization disclosure text block.",
        "verboseLabel": "Organization"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_OriginalLeasedSpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "OriginalLeasedSpaceMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original Leased Space",
        "label": "Original Leased Space [Member]",
        "documentation": "Original leased space."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r754"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Other Assets Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized gain on marketable securities",
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r10",
      "r101"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net unrealized gain on marketable securities",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r585"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome2": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r10",
      "r101",
      "r151",
      "r154",
      "r180"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "totalLabel": "Other Noncash Income (Expense), Total",
        "terseLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentAssetsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Noncurrent Assets",
        "label": "Other Noncurrent Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other (expense) income, net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "sepn_OtherReceivableRelatedToSaleOfNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "OtherReceivableRelatedToSaleOfNonFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other receivable related to sale of non-financial asset.",
        "label": "Other Receivable Related To Sale Of Non Financial Asset",
        "terseLabel": "Other receivable related to sale of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r792",
      "r803",
      "r813",
      "r846"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r806",
      "r816",
      "r849"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r806",
      "r816",
      "r849"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocation of earnings to participating preferred stockholders",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic",
        "negatedTerseLabel": "Allocation of earnings to participating preferred stockholders",
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r884"
     ]
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails2": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Allocation of earnings to participating preferred stockholders",
        "negatedTerseLabel": "Allocation of earnings to participating preferred stockholders",
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "sepn_PatentExpensesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PatentExpensesPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent expenses.",
        "label": "Patent Expenses, Policy [Policy Text Block]",
        "terseLabel": "Patent Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "sepn_PaymentReceivedOnSaleOfNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PaymentReceivedOnSaleOfNonFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment received on sale of non-financial asset",
        "documentation": "Payment received on sale of non-financial asset.",
        "terseLabel": "Payment received on sale of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_PaymentsOfDeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PaymentsOfDeferredOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of deferred offering costs",
        "label": "Payments of deferred offering costs",
        "documentation": "Payments of deferred offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Issuance costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Retirement Benefit Plan",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r733"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "sepn_PercentageOfChangeInOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PercentageOfChangeInOwnership",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Change in Ownership",
        "documentation": "Percentage of change in ownership.",
        "terseLabel": "Percentage of change in ownership"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_PercentageOfShareIssuePriceDividedByConversionPriceInEffect": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PercentageOfShareIssuePriceDividedByConversionPriceInEffect",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Share Issue Price Divided By Conversion Price In Effect",
        "documentation": "Percentage of share issue price divided by conversion price in effect.",
        "verboseLabel": "Percentage of share issue price divided by conversion price in effect"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_PerformanceConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PerformanceConditionsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Conditions [Member]",
        "documentation": "Performance conditions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Conditions [Member]",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleConversionPrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per share",
        "label": "Preferred Stock, Convertible, Conversion Price",
        "documentation": "Per share conversion price of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding convertible preferred stock conversion in to common stock",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Convertible preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r312"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Convertible preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r636"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Convertible preferred stock, shares issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r312"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted convertible preferred stock outstanding",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r636",
      "r654",
      "r1086",
      "r1087"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 10,000,000 shares and no shares authorized as of December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of December 31, 2024",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r572",
      "r754"
     ]
    },
    "sepn_PrepaidBonusCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PrepaidBonusCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid bonus",
        "label": "Prepaid Bonus Current",
        "documentation": "Prepaid bonus current."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_PrepaidClinicalTrialCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PrepaidClinicalTrialCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid clinical trial costs",
        "label": "Prepaid Clinical Trial Costs Current",
        "documentation": "Prepaid clinical trial costs current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Prepaid expenses and other current assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense And Other Assets Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Prepaid Expense, Current, Total",
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r287",
      "r288",
      "r701"
     ]
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_PrepaidTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PrepaidTaxesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPrepaidExpensesAndOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid taxes",
        "label": "Prepaid Taxes Current",
        "documentation": "Prepaid Taxes Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from Initial Public Offering, net of offering costs",
        "verboseLabel": "Net proceeds from initial public offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash proceeds on shares issued",
        "terseLabel": "Proceeds from issuance of Convertible Preferred stock, net of issuance costs",
        "label": "Proceeds from issuance of Series B Convertible Preferred stock, net of issuance costs",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Maturities of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ProceedsFromSaleOfNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ProceedsFromSaleOfNonFinancialAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of non-financial asset",
        "documentation": "Proceeds from sale of non-financial asset",
        "terseLabel": "Received cash on sale of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Fees",
        "terseLabel": "Consulting services",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r766",
      "r1084",
      "r1085"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "label": "Profit Loss",
        "terseLabel": "Net (loss) income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r150",
      "r153",
      "r162",
      "r167",
      "r174",
      "r180",
      "r183",
      "r184",
      "r273",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r455",
      "r458",
      "r460",
      "r463",
      "r464",
      "r476",
      "r490",
      "r565",
      "r583",
      "r613",
      "r656",
      "r677",
      "r678",
      "r740",
      "r741",
      "r767",
      "r908",
      "r950"
     ]
    },
    "sepn_PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment included in accounts payable and accrued expenses and other current liabilities",
        "documentation": "Property and equipment included in accounts payable and accrued expenses and other current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r515"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "terseLabel": "Total property and equipment",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r136",
      "r581"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "label": "Property Plant And Equipment Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r515",
      "r567",
      "r581",
      "r754"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r123",
      "r126",
      "r579"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r515"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "sepn_RaCapitalManagementLPServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "RaCapitalManagementLPServiceAgreementMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RA Capital",
        "label": "RA Capital Management L P Service Agreement [Member]",
        "documentation": "RA Capital Management L P Service Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r335",
      "r356",
      "r392",
      "r393",
      "r394",
      "r408",
      "r482",
      "r535",
      "r544",
      "r560",
      "r591",
      "r593",
      "r601",
      "r626",
      "r627",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r696",
      "r697",
      "r719",
      "r723",
      "r734",
      "r746",
      "r747",
      "r751",
      "r752",
      "r756",
      "r760",
      "r948",
      "r952",
      "r1056",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r335",
      "r356",
      "r392",
      "r393",
      "r394",
      "r408",
      "r482",
      "r535",
      "r544",
      "r560",
      "r591",
      "r593",
      "r601",
      "r626",
      "r627",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r696",
      "r697",
      "r719",
      "r723",
      "r734",
      "r746",
      "r747",
      "r751",
      "r752",
      "r756",
      "r760",
      "r948",
      "r952",
      "r1056",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r787",
      "r798",
      "r808",
      "r841"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r344",
      "r521",
      "r522",
      "r570",
      "r578",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r653",
      "r655",
      "r684"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r521",
      "r522",
      "r523",
      "r524",
      "r570",
      "r578",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r653",
      "r655",
      "r684"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fees",
        "label": "Related Party Transaction, Amounts of Transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r521"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r522",
      "r1065"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r660",
      "r661",
      "r664"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party Transactions By Related Party [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r344",
      "r521",
      "r522",
      "r570",
      "r578",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r653",
      "r655",
      "r684",
      "r1065"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r519",
      "r520",
      "r522",
      "r525",
      "r610",
      "r611",
      "r612",
      "r662",
      "r663",
      "r664",
      "r682",
      "r683"
     ]
    },
    "sepn_RepurchasesOfUnvestedRestrictedCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "RepurchasesOfUnvestedRestrictedCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of unvested restricted common stock",
        "label": "Repurchases of Unvested Restricted Common Stock",
        "documentation": "Repurchases of unvested restricted common stock."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_RequiredPriorNoticeDurationToTerminateAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "RequiredPriorNoticeDurationToTerminateAgreement",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Required Prior Notice Duration to Terminate Agreement",
        "documentation": "Required prior notice duration to terminate agreement.",
        "terseLabel": "Required prior notice duration to terminate agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "documentation": "Information by form of arrangement related to research and development."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r1041"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r1041"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "totalLabel": "Total research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r698",
      "r713",
      "r1074"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and Development",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r799",
      "r809",
      "r842"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r800",
      "r810",
      "r843"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r796",
      "r807",
      "r817",
      "r850"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows2": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Restricted Cash, Total",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r912",
      "r1075",
      "r1078"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r900",
      "r912"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Awards [Member]",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "sepn_RestrictedStockOptionsSubjectToRepurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "RestrictedStockOptionsSubjectToRepurchase",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Options Subject To Repurchase",
        "documentation": "Restricted stock options subject to repurchase.",
        "terseLabel": "Restricted stock options subject to repurchase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings Accumulated Deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r96",
      "r576",
      "r598",
      "r600",
      "r608",
      "r637",
      "r754"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r171",
      "r172",
      "r173",
      "r175",
      "r180",
      "r182",
      "r184",
      "r274",
      "r275",
      "r289",
      "r444",
      "r445",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r467",
      "r469",
      "r470",
      "r472",
      "r474",
      "r498",
      "r500",
      "r595",
      "r597",
      "r614",
      "r1086"
     ]
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r734",
      "r888",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r734",
      "r888",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total net revenue",
        "terseLabel": "Revenue",
        "label": "Service revenue",
        "verboseLabel": "Research services revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111",
      "r206",
      "r215",
      "r216",
      "r230",
      "r234",
      "r238",
      "r240",
      "r241",
      "r331",
      "r332",
      "r561"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenue1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r699",
      "r703"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset recognized in exchange for operating lease liability",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "negatedLabel": "Right-of-use asset recognized in exchange for operating lease liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r753"
     ]
    },
    "sepn_RisksAndUncertaintyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "RisksAndUncertaintyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks And Uncertainty.",
        "label": "Risks And Uncertainty [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "sepn_SaleOfNonFinancialAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SaleOfNonFinancialAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of non-financial assets.",
        "label": "Sale of Non-Financial Assets, Policy [Policy Text Block]",
        "terseLabel": "Sale of Non-Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public offering price per share",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_SamsaraBiocapitalLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SamsaraBiocapitalLPMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Samsara BioCapital",
        "label": "Samsara BioCapital L P [Member]",
        "documentation": "Samsara BioCapital L P."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r361",
      "r920"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r361",
      "r886",
      "r920"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net (Loss) Income Per Share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Marketable Securities by Major Type of Security",
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of (Benefit) Provision for Income Taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Income Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureEmployeeRetirementBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r45",
      "r46",
      "r47",
      "r48"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net (Loss) Income Per Share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Tax Rate Reconciliation",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r739",
      "r1042"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Stock Based Compensation Expense For Restricted Stock Awards And Stock Options",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r515"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r660",
      "r661",
      "r664"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Reportable Segment",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockBasedCompensationExpenseForRestrictedStockAwardsAndStockOptionsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r365",
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r98"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted Average Assumptions used for Grants Awards",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Award Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r92",
      "r93",
      "r95",
      "r96",
      "r140",
      "r141",
      "r142",
      "r208",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r604",
      "r605",
      "r606",
      "r607",
      "r723",
      "r885",
      "r913"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Unrecognized Tax Benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r738"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Security12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r206",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r220",
      "r221",
      "r222",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r241",
      "r708",
      "r711",
      "r712",
      "r713",
      "r715",
      "r717",
      "r718"
     ]
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Amount",
        "terseLabel": "Other segment expenses",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r221",
      "r222",
      "r234",
      "r713"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r237",
      "r240",
      "r709",
      "r710",
      "r716"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Selling, General and Administrative Expense, Total",
        "terseLabel": "General and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "sepn_SeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Convertible Preferred Stock",
        "label": "Series A Convertible Preferred Stock [Member]",
        "documentation": "Series A convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_SeriesBConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SeriesBConvertiblePreferredStockMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Convertible Preferred Stock",
        "label": "Series B Convertible Preferred Stock [Member]",
        "documentation": "Series B convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Preferred Stock",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r902",
      "r903",
      "r953"
     ]
    },
    "sepn_ServiceAgreementExpirationYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ServiceAgreementExpirationYear",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Agreement Expiration year",
        "documentation": "Service agreement expiration year",
        "terseLabel": "Service agreement expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfReportableSegmentDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "terseLabel": "Stock-based compensation",
        "label": "Share Based Compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares Outstanding, Beginning Balance",
        "periodEndLabel": "Number of Shares Outstanding, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted-Average Grant Date Fair Value Per Share, Beginning Balance",
        "periodEndLabel": "Weighted-Average Grant Date Fair Value Per Share, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r380"
     ]
    },
    "sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Restricted stock awards repurchased",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased In Period Weighted Average Grant Date Fair Value",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options repurchased in period weighted average grant date fair value.",
        "terseLabel": "Restricted stock awards repurchased ,Weighted Average Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSubjectToRepurchase",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards, subject to repurchase",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, subject to repurchase",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, subject to repurchase."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Restricted stock awards vested",
        "terseLabel": "Restricted stock awards vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Aggregate grant date fair value of shares vested",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards vested, Weighted Average Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date",
        "terseLabel": "Effective date",
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "sepn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common stock",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Common Stock",
        "documentation": "Share based compensation arrangement by share based payment award fair value of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r365",
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares reserved for issuance",
        "terseLabel": "Number of shares authorized",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable as of December 31, 2024",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable as of December 31, 2024",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total Intrinsic value of stock options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Options Outstanding, Expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Total Options Outstanding, Cancelled",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Options Outstanding, Forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Total Options Outstanding, Cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock option awards granted",
        "terseLabel": "Total Options outstanding, Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average per share grant-date fair value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value, Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Total Options outstanding, Beginning balance",
        "periodEndLabel": "Total Options outstanding, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, Beginning balance",
        "periodEndLabel": "Weighted average exercise price, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest as of December 31, 2024",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest as of December 31, 2024",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest as of December 31, 2024",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of outstanding number of shares of common stock",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incremental stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Exercised",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Cancelled",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Cancelled",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Granted",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "sepn_ShareBasedCompensationEquityAwardsOptionsGrantsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ShareBasedCompensationEquityAwardsOptionsGrantsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total grant date fair value",
        "label": "Share Based Compensation Equity Awards Options Grants Fair Value",
        "documentation": "Share based compensation equity awards options grants fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r370",
      "r389",
      "r390",
      "r391",
      "r392",
      "r395",
      "r402",
      "r403",
      "r404",
      "r405"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable as of December 31, 2024",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable as of December 31, 2024",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life, Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest as of December 31, 2024",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Aggregate grant date fair value of options vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in shares)",
        "periodEndLabel": "Ending Balance (in shares)",
        "label": "Shares Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesSummaryOfExpensesRecognizedAndCashPaidForLeasedSpaceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease costs",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r753"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r166"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r140",
      "r141",
      "r142",
      "r167",
      "r190",
      "r191",
      "r198",
      "r200",
      "r208",
      "r209",
      "r273",
      "r300",
      "r302",
      "r303",
      "r304",
      "r307",
      "r308",
      "r312",
      "r313",
      "r316",
      "r317",
      "r320",
      "r490",
      "r604",
      "r605",
      "r606",
      "r607",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r636",
      "r657",
      "r679",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r885",
      "r913",
      "r922"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Statement Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r69",
      "r72",
      "r73",
      "r131",
      "r156",
      "r157",
      "r158",
      "r171",
      "r172",
      "r173",
      "r175",
      "r180",
      "r182",
      "r184",
      "r207",
      "r274",
      "r275",
      "r289",
      "r322",
      "r444",
      "r445",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r500",
      "r517",
      "r585",
      "r595",
      "r596",
      "r597",
      "r614",
      "r679"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r207",
      "r500",
      "r561",
      "r602",
      "r625",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r655",
      "r658",
      "r659",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r761"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r361",
      "r886",
      "r887",
      "r920"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r207",
      "r242",
      "r500",
      "r561",
      "r602",
      "r625",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r655",
      "r658",
      "r659",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r761"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r802",
      "r812",
      "r845"
     ]
    },
    "sepn_Stock2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "Stock2021PlanMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfWeightedaverageAssumptionsUsedForGrantsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan [Member]",
        "label": "Stock 2021 Plan [Member]",
        "documentation": "Stock 2021 plan."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_Stock2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "Stock2024PlanMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockSummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Plan [Member]",
        "documentation": "Stock 2024 plan.",
        "label": "Stock 2024 Plan [Member]",
        "verboseLabel": "Stock 2024 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_StockIssuanceCostsOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "StockIssuanceCostsOfConvertibleSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Stock Issuance Costs Of Convertible Securities",
        "documentation": "Stock issuance costs of convertible securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of Series B Convertible Preferred Stock( in shares)",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock upon initial public offering (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r40",
      "r69",
      "r72",
      "r96",
      "r310"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of common stock",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r96",
      "r604",
      "r679",
      "r691"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total Options outstanding, Exercised",
        "verboseLabel": "Issuance of common stock upon exercise of stock options (in shares)",
        "terseLabel": "Total Options outstanding, Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r96",
      "r376"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock upon initial public offering",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r69",
      "r72",
      "r73",
      "r96"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with initial public offering, net of issuance costs",
        "verboseLabel": "Issuance of common stock in connection with initial public offering, issuance costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r96",
      "r614",
      "r679",
      "r691",
      "r767"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r69",
      "r72",
      "r73",
      "r96"
     ]
    },
    "sepn_StockIssuedDuringPeriodValuesRestrictedStockAwardVested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "StockIssuedDuringPeriodValuesRestrictedStockAwardVested",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of restricted common stock",
        "label": "Stock Issued During Period Values Restricted Stock Award Vested",
        "documentation": "Stock issued during period values restricted stock award vested."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_StockPlan2024And2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "StockPlan2024And2021Member",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfRestrictedStockAwardActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockOptionsActivityDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 and 2021 Stock Plan.",
        "label": "Stock Plan 2024 and 2021 [Member]",
        "terseLabel": "2024 and 2021 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of unvested restricted common stock (in shares)",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Repurchases of unvested restricted common stock (in shares)",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r96"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Stockholders Equity",
        "totalLabel": "Total stockholders' equity (deficit)",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r72",
      "r73",
      "r86",
      "r638",
      "r654",
      "r680",
      "r681",
      "r754",
      "r768",
      "r914",
      "r942",
      "r1061",
      "r1086"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse Stock Split description",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r527"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r527"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r527"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r527"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r527"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r528"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis",
        "label": "Summary of Common Stock Shares Reserved for Future Issuance on Convertible Basis [Table Text Block]",
        "documentation": "Summary of common stock shares reserved for future issuance on convertible basis."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Estimated useful Lives of Property, Plant and Equipment [Table Text Block]",
        "documentation": "Summary of estimated useful lives of property, plant and equipment.",
        "terseLabel": "Summary of Estimated Useful Lives of Property and Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Lease Cost and Cash Paid for Operating Lease Liability [Table Text Block]",
        "documentation": "Summary of lease cost and cash paid for operating lease liability.",
        "terseLabel": "Summary of Expenses Recognized and Cash Paid for Leased Space"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carry forwards",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "sepn_TaxCreditCarryforwardExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationYear",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward Expiration Year",
        "documentation": "Tax credit carryforward expiration year.",
        "terseLabel": "Tax credit carryforward, expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Taxes Payable, Current, Total",
        "terseLabel": "Accrued income taxes payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59"
     ]
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r37"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheets",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock",
        "terseLabel": "Convertible preferred stock, carrying value",
        "periodStartLabel": "Temporary Equity, Beginning Balance",
        "periodEndLabel": "Temporary Equity, Ending Balance",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r302",
      "r303",
      "r304",
      "r307",
      "r308",
      "r406",
      "r574"
     ]
    },
    "sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, Conversion of convertible preferred stock to common stock",
        "documentation": "Temporary equity, Conversion of convertible preferred stock to common stock.",
        "negatedLabel": "Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, Conversion of convertible preferred stock to common stock shares",
        "documentation": "Temporary equity, Conversion of convertible preferred stock to common stock shares.",
        "negatedLabel": "Temporary equity, Conversion of convertible preferred stock to common stock upon initial public offering (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, liquidation preference",
        "label": "Temporary Equity, Liquidation Preference",
        "verboseLabel": "Preferred stock, liquidation preference",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r37"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares authorized",
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares issued",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares outstanding",
        "periodStartLabel": "Temporary Equity, Beginning Balance (in shares)",
        "periodEndLabel": "Temporary Equity, Ending Balance (in shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "sepn_TemporaryEquityStockAdditionalFundingBasedOnApproval": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityStockAdditionalFundingBasedOnApproval",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Stock Additional Funding Based on Approval",
        "label": "Temporary Equity Stock Additional Funding Based on Approval",
        "terseLabel": "Convertible preferred stock additional funding based on approval"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock authorised to be issued during period shares",
        "label": "Temporary Equity Stock Authorised To Be Issued During Period Shares",
        "terseLabel": "Convertible preferred stock shares authorized to be issued"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TemporaryEquityStockFinancingArrangementFinancingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityStockFinancingArrangementFinancingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Stock Financing Arrangement Financing Value",
        "label": "Temporary Equity Stock Financing Arrangement Financing Value",
        "terseLabel": "Convertible preferred stock financing arrangement financing value"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)",
        "terseLabel": "Issuance of convertible preferred stock, shares",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "documentation": "Temporary equity stock issued during period shares new issues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Series B Convertible Preferred Stock, issuance costs",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Issuance of convertible preferred stock, value",
        "documentation": "Value of new stock classified as temporary equity issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Convertible Preferred Stock",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r37"
     ]
    },
    "sepn_TermOfResearchServiceAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TermOfResearchServiceAgreement",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term of Research Service Agreement",
        "documentation": "Term of research service agreement.",
        "terseLabel": "Term of research service agreement"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_ThirdRockVenturesViLPServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "ThirdRockVenturesViLPServiceAgreementMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Rock Ventures",
        "label": "Third Rock Ventures VI L P Service Agreement [Member]",
        "documentation": "Third Rock Ventures VI L P Service Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r929",
      "r1064"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Other Receivables",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r931",
      "r932",
      "r933"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TrancheOneAndTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TrancheOneAndTrancheTwoMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche One and Tranche Two [Member]",
        "label": "Tranche One and Tranche Two [Member]",
        "terseLabel": "Tranche One and Two"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TrancheOneMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tranche One [Member]",
        "terseLabel": "Tranche One",
        "label": "Tranche One [Member]",
        "documentation": "Tranche One."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tranche Two [Member]",
        "terseLabel": "Tranche Two",
        "label": "Tranche Two [Member]",
        "documentation": "Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r311",
      "r319",
      "r473",
      "r489",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r586",
      "r742",
      "r744",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r755",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r938",
      "r939",
      "r940",
      "r941",
      "r1052",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementOfBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Common stock, shares repurchase",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Government Agency Securities",
        "terseLabel": "U.S. Government Agency Securities",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueMeasurementsOnCashEquivalentsAndMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValuesAndContinuousUnrealizedLossPositionsOfMarketableSecuritiesDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsSummaryOfMarketableSecuritiesByMajorTypeOfSecurityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Treasury Securities",
        "terseLabel": "U.S. Treasury Securities",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r704",
      "r731",
      "r733",
      "r742",
      "r1076"
     ]
    },
    "sepn_UnconditionalRightOnNonFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnconditionalRightOnNonFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureGainOnSaleOfNonfinancialAssetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unconditional right on non-financial asset",
        "documentation": "Unconditional right on non-financial asset.",
        "terseLabel": "Unconditional right on amount of non-financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnderwritingDiscountsAndCommissions",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Discounts And Commissions",
        "documentation": "Underwriting discounts and commissions.",
        "terseLabel": "Underwriting discounts and commissions"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UnderwritingDiscountsCommissionsAndOtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnderwritingDiscountsCommissionsAndOtherOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts commissions and other offering costs",
        "label": "Underwriting Discounts, Commissions and Other Offering Costs",
        "documentation": "Underwriting discounts, commissions and other offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UnderwritingOtherOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnderwritingOtherOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Other Offering Expenses",
        "documentation": "Underwriting other offering expenses.",
        "terseLabel": "Underwriting other offering expenses"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UndesignatedCommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UndesignatedCommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undesignated common stock, par value",
        "label": "Undesignated Common Stock Par or Stated Value Per Share",
        "documentation": "Undesignated common stock par or stated value per share."
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UndesignatedPreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UndesignatedPreferredStockSharesAuthorized",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undesignated preferred stock authorized",
        "label": "Undesignated Preferred Stock, Shares Authorized",
        "documentation": "Undesignated preferred stock, shares authorized."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "sepn_UnpaidOfferingCostsIncludedInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnpaidOfferingCostsIncludedInAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid offering costs included in accounts payable",
        "label": "Unpaid Offering Costs Included In Accounts Payable",
        "documentation": "Unpaid Offering Costs Included In Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodStartLabel": "Balance at the beginning of the year",
        "periodEndLabel": "Balance at end of the year",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r428",
      "r738"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "terseLabel": "Adjustment based on tax positions related to prior years",
        "negatedTerseLabel": "Adjustment based on tax positions related to prior years",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r738"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
        "terseLabel": "Accrued interest and penalties related to unrecognized tax benefits",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r738"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to current year",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r738"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Adjustment based on tax positions related to prior years",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r738"
     ]
    },
    "sepn_UnvestedRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnvestedRestrictedStock",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested restricted stock",
        "documentation": "Unvested restricted stock",
        "terseLabel": "Unvested restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "sepn_UnvestedRestrictedStockSubjectToRepurchaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "UnvestedRestrictedStockSubjectToRepurchaseMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested Restricted Stock Subject To Repurchase [Member]",
        "documentation": "Unvested restricted stock subject to repurchase.",
        "verboseLabel": "Unvested Restricted Stock Awards Subject to Repurchase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r121",
      "r122",
      "r124",
      "r125"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Deferred tax asset, net change in total valuation allowance increase during period",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "sepn_VertexResearchServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.septerna.com/20241231",
     "localname": "VertexResearchServiceAgreementMember",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vertex Research Service Agreement",
        "label": "Vertex Research Service Agreement [Member]",
        "documentation": "Vertex research service agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares (denominator), Diluted",
        "label": "Weighted Average Number Of Diluted Shares Outstanding",
        "totalLabel": "Weighted-average shares outstanding used to compute net (loss) income per common share, diluted",
        "terseLabel": "Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator, diluted:",
        "verboseLabel": "Weighted-average shares outstanding used in computing net (loss) income per share attributable to common stockholders:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails",
      "http://www.septerna.com/20241231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares (denominator), Basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "label": "Weighted Average Number Of Shares Outstanding Basic",
        "terseLabel": "Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://www.septerna.com/20241231/taxonomy/role/DisclosureNetLossIncomePerShareComputationOfBasicAndDilutedNetLossIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Denominator, basic:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>108
<FILENAME>0000950170-25-045745-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-045745-xbrl.zip
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MJ75BUXXDHQ>!J;XONZN/?@4P*CYZV!X#D*TLZ] YE =C[;]JF=:XMG\,2/)
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M]@&WEFS3]<[*O-8I6;C-0H^91W_/T[%9C]\/\[?G;MV;P+41O)@> V'!"XB
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M[4./S*^\2K1<G;DI=U%5KNH%18S"3_S6YH^9 S^D,=.#:"#>*Z7,6.BW%$#
M')F6N^L9@Q6++'^\ ?>!"4[8S+?2;03Y27/="O(,3+_I>G&#D-P/=B62OJ:
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M50M0U)R\MRF7[&IK/MQ.=WR7&]%=D7Q(/G+L66Q:P*T,' ,28V08K3]Z&<>
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MD829/>$"A:U'7IU3F]UCG$VQ(CX_B4_/6]I2%Y+?LH+=)@AWN')G7#+1H93
M99,6O=OK^O>I12AN;9G+/CK6')V$A+-R.IGC[&'AC/F7U;_EE+2M2,5E:BR
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M=&+C27<SPFOS2!Z1M5MRF*0O6+76(PR"HI(\3G:)+XJ''A9SA2&7\0:I-$$
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M$\+6NW3#F7LB _[Q\YA/@\C6MC0HCR?ZU;QX9*5E[Z:8^?MO=9@[B_6JW3J
M-&:+=/R(+G22KWW>XTQ%O1C\= @%>X;O%^A\E*ETK"-JN6OQ>KT)B_%8_;S1
M81]!//S>&Z)U1VM[TAX[MV._2K(W:4ZJ(&-H\6&#G3CF.RA6AT]GJ63JJ'TR
MNDMG)G/I@)'M7NYBKU*W[,L#/1\T]7)!@JK\,BLJO03NK-R4NW7 ?M$!!5OJ
MQVA%SC?%X'>7O:6WKF*>SVF3TC-)_J_V$2_V7;-)V,1/EBPYWW">*)2)>2+$
M6^9@P_R332%Z(Y<Y_8^D0'U[7>#/9&.6^"1QLFB9;0GEX+:I\U3:QY*5R]_V
M_VRK=[K8J_4:&_=(<AZP0%X/ZRR90IOXCMYM&E"O;W4,=G35!0;O[@2V:WA;
MS'B#I;V\Q2;DS=YD3(\Y%#I]>9_B.]_CM]H;\>V/-5^0R-VQO@'HL8R.Z.*R
M"T?;-M;;YNNO\2!8KNET_$%3<0<ILB!..HW+7(_I_[JFF9)>_//SY]L[VOEK
M?WC-#2M*6E_O07LZXO)K06\@[JY+(O'3^6R!'7R>AQJ8&"]E# ?*6; UOC41
M8]4XOHW6H\4JQV<_;H(U)KK"@W&#:G&SM&&3<+.6-^8>N#_\Q^H(#,5D<>;2
M<G%FI,[SX5E0+P7]\*1\2YF="["THK(6+2@ QJJ1!]FXIV84EW!P_)_ZT)MP
MHATAWRKU$2'?W(7GODEQ8W'YQPP6;]U#)7(T<3BBY2"I9ID])I\5?7O97CG_
MLN<KGT_(2I2J$56_#A3A[>-*!9\R1>-N-X_O@O!>/F AF6D+$S:.4:>-QI>6
M?3Z'[_Y9IJQT>.\"XA/"6D HU7^:!@$B"#H4ZQ082K5;6!BX30(^4O+2 P+$
MQIWO!_IR$Y?^1,5C\#]""PYXS28"97/U@U[C"!,"4#QIP*3TN9K>U5.FZY$]
MKDYR/IQ_N5RDO$^PEC)MA-6@T-;,]1LD.-G*TZIH6;U48KU!VZKY+BK(WM+/
MBONAB9I5:7G >$*6=:[T6)J,985:@-0W19OQ_"PV0T:[/6-$AQW_S/<BVO(S
MI23?KR*Z.NIHSK*6*O(OW2Q25?F:2_F'^O@/W/;91E1P1LZ>FO7X+O@1/V<D
MU;ELR43DP52@"#M ) IK L@J>.:L?@5ESIXJ_WY*N5W5JA&!F*"PQR'5(S*>
M?E4$Y[VN<I'(1ZBFS6KC"N[Y9!!_XVDC9QR'G4/ITI#QO3IUT<3\:P"FAR!&
MS4@DL8 XSO BQ+O8'@CK,Q]OTZUP])QZQ37-H5)8:GS*=)GPJ1@VMX%@;6\8
M_?PYBZ7&\VV##B!^B<Z%((ML\X*ZSTYGL?[B._;8AMV_UV&78@*A-U"Z)#H)
MCP-7;.M",_6I%Z*C*Q6\;G9$(>XBL4YZW 7SLZ'E*@GM56M'S#>DLS 5G_-D
M/J5.1UE&]^BRQG]IZTU;T_@66';R/(EU:0T6%[$Y7K(QUDWD-++(*=4(%/I$
MGJI<7[[U!I_TZ:IM'5**+,QCM6%91,-J=-@ERL36KP@$%*T/BF&O#.WE8KZ[
M,*X,4L9I?D SYO@>FA_8Z. \.-&$3M:#+M'O4E_F^I*$]/MT)SM&&W)5NP6K
MBCJ$Y1KKFAQ8-2VCC>/UX$\R-E:G5C6S@[=/F5SQ]:=,+'2WFL\3RO$5'5?H
M_XS([P3& WC<K62G$<*DX$D=41LT"K.7.QAF]42(Q=*"!=:@;5&6Y0#&/.J7
M@Z=YP.QA]_";,.G)U*Y7TZ_!'9P;\8@SQ*:%G/'-@7&[POCSL+F71./@?3,2
M]+N"1(@Z]K' ?ZWZ#W\[!9WI)BM82'_<&D!2B=WYE^FAV+DVC;\!O/GGYG_O
M;[0&FACK F_S9V'8J"JQV3H/FZQRA_MKVZ\>CN\NO=G1ENL7^K#V&5A5;W><
MC7+=N@5E??_TCB]7&4FZLS?WAA?%ZM9!@MBG07X3MQS&@8$YF:L]H8 M23BA
M; 0E9\VM.=4U@K\!*792&[+LZKMNFQ%UR[!L9IDKN!D6N';\G1HFJZTRTL99
MHM)4U(#M]9T)ZN8$UCHWX4C:+X(8^D;<K)-2CXV&^(CUYPER.T6A,+3 \Y7W
MA-^&"D%B9%_+=$<,'GC\M0-TQ@3L$9B_ Y-G98TFE%W",8WLR?L=UWYEZ/#4
M=\0ML%.%8T^9F#.<-,F@N&? FT G"_(XR2#NX,3:TGI2>V PC'!K6F*\JKX?
MW@"J79\Z5'&I4Q%6;@+B0^"49#(MGYV(28(]\-]@L%)YXG5FT:KD&?G'FFT.
ME'R7%KLD_%/D4[7D[@7F2=%XFYJZSX0QI(/@B9A!V7R8YSJFY@9LK7<X1D"D
M>S=!A _"2\[_RV-\0^<*@Q^0[8["1#&T 4MO2$M/8E\X7;X<<LVS)3/*5^PS
MI2WKPF#W.. S)G*U#S(^IXLHG4=:>I-JE'K $3U+MR".I:1B&]P-&X>D,A%$
M7/^&>9ED3/_ZTV*(M=18^D,2]OUSA?)$#3-CR$6)#$$AXYG)-,J'R.J47+MR
MI-2JG1K(+;K7\F?XIX0\-A"[NHT9+?["ZTCE->O%PI,"C%?\8O)+#9U.G8A3
M)J%*'3?HK$XWK+Y) -/IDM#!#IY!WRM#!3R<H!L\#>6-^YE,%)CLH.7'UH>P
M@*X#EE^FIGF"CG*S>FA  TZ!BMN!V)(SMXR/#<+F".P4WS<$&?IS >=82CAL
M\F;39"">%>5.VHUTZ#;["M>N0Q9[O$49=.:)GC+ICSR;*Q',_6N9TD"WY3G4
MF&I&GA0B>?MT:K';5XYE/>IFSZ21A\'K1)<"EBG$GE=-Q-TH$0["7:"P3UAC
M&@*OV+B[J?1=C,!?,[JO)8'AHVLW3GI#U,DB/$#*MGP;&+NIP?(#BI2.@)W
MC^\#.C3$23GA-OHZU3>BPU>7% ^:(<\>,G@(Z216WAYGT?IXYVQ'*">0V:-R
MF"&HK,..$)C"!06[A92BHH88WT*U5>]GLF"'$:K--]B/FN+Z/XG@?A[<J>XV
M5:.;.A@K%4</E)(V6X8OG*0+X#GU*ST?OP@L)]>D5XQ7Q%?65/\L*-2.-4)]
M>Q\SDN Y7O9MPTA^O$Q#*1=LFET1ZV,UU@"K4B[M95-.*0;!K1L..\[D ,.F
MK417I)PR=>HDAXE15;=!2R<ZW=H<=2,0>1).E$BD-3K?&MM>&0WD/TA.@#W3
M$!]L'XT*:37>/-%T'#UH[4=L_EI[PY@EDZ6U0DCX+]Z\#YLGM3E1 5TZ;&$W
M $W2833DUL7T CC,9+A;.O [N(1Z7KK0H!286@U5Y^@W&:W_PZ?R&N)OC#Y.
MT1?,_C-WYA41JL3\[^/D8>+9/H^#VK2M1&5Y.$('?T1-K2 [XF'/7O%&0T 5
M[$+V\*R@"&4GXZZLWO0J3[@K&</3(N0_.V?T[\8+ U''K[[>6M$;T*UE/.H<
M3?TL"FK170"39=+R*5,D0_$=Q*T %4U.CM]?2^T\,]T#D2B"$('B_'K9Z<G"
MZL]U;8%)I(E1G]X$[D/))$2GM*N"2R A*SLT/YSWWZ'2GZBKSP4WKW6Y*V^0
M_3TMBHW9H[K)MQ._C.!A2<SAV#?%,7DB\T:-;'9M1BDO\*J7R\B_EO+$Q_#V
M4WG"#1K@?9R%E:LE.ZS(VM'$?JI;Q@@KBTXO-.)![[NRAX9&4W5H7*F.@.&R
M;U0'2]@=U'1GHS.H)K>*KD3F&J.;4ZA(CYV;$_NYNOJ4V>_KR4O\^[CGO43S
M:NV_6D?EY*OD"S)")>A_^L7Q,ZVTN@G?MGN@K97C1QY39P)VR@1WN;"NN2/O
M_EF'$DVWH="R\NRHA\30L)4,5IMOJX.WVR;K7V8>VQKDKG%^L9&^JJ.&5CG[
MG9>*3YGX('>+4;^_B%S1<1>Y!K"X4(@*\>1A9K39./J>>R60--O+@MG.51#$
M.1@O?G("XKXQ%FUJ)HI&&T+9>D\>J, RBHNAWJ$'ITS;J<=ROSH:0%\2GQ*S
M>E/A;E1;PQ&?AN0HAEQ-EK$WHDM8/=[X76&XP;0W3! (G#<*D$@M=?A@4KR=
M2 1/MO(]\:"_4H^$.&#?^J5[<K_XG..U E7O/(%5(=X^!SN+L+MPQR?R&F]^
M5Q\OOI^A<RDA?THKBB.[Z\F=@Q>C6-O,NU]KU&$9R*Z:!+_W7I*UN)2I,LMC
M3?5.<Z0?%R4PVQI31ZTN@[4_N@AB%7FV2:Z0\Q%NAQC4%_8R^A=$JH%=,CX>
MTP"-#VSU1A@ L60HH$NX MNTJ0CP=:.$D 9WBHL]6D[2TR>\N5N!9:?/TQ S
M]SWZ<:[&II'M2[NGYH?;Z>FYZ6TO:3894R_TM1_*WTI:X!J^].Q%N6C2G3N%
M3&SI?Z1/F<X# ):J1$L"3"B9CYIL $L2^TPKM 9 4$'0,;T(@>GD, F4P("'
M ?'N.H4_D^A\8:S^&"%OZVQX7J.DM6H!\]S!P+UDW997('JSZ/%Y,[4_!L(G
MQVP,XKJSNR#)3XWM9N\*4#8>WFEUE'N5D.[NG.?TYDOITMX11VE*H44E1?D%
M$#N4K*I4N6$32.66&<6.=J)R5#1O=3ZM+B]^^%1:SND1TM,H@@I4NA\_UVB#
MJVM,E/4).K?SC5<6D+::I0-&(S4:M!]3^\)WE(<3A+FGT4)5\R@1*VI5.IE5
MPJ&"Q37H(R),:F0IV:DFO$=8.*TJMPSC\<MFX>:]4O::S;>LZB9)%>>D# Y!
MEQ=1Y8RA#1'^7SRO]"M< WZRY(+,D\U&#][#P,B)^DD_GL)G2:9?*Y&:'JM-
M'^Q=\_98,Q6?T?4HC85D+1'#S =[O-W:@E27*+IY0?L [KRHDY)5A&=CK;%
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M4Q&WN0(MOJS:>2HTLL>0++C6QZW+W?EN:&MPD4P3W/CZ>5^7I3[!\EEF>1)
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M*H-*!;)X3@E0N'2G8TS;!0]O\-]H,2Q'-1<NKHN4JABL/G(F6R*#+_G@#76
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M2Q?\A"YU!BDY?M565]MA1N-2C?,O\.^@.HM$X1WGJ^LMY_K[GHM+U4]J*U8
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M3K]&7QS?>L+PH15,(TP9Q?(Z"P"(QTT:OBGZ)DWC)=ZP>D@"I3WU"N<>O;)
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M!KK+T2Y==_PFS?9!KQY!YKGHHGWO1MXVG3'Q(*Z?BK1*!ZN?GJ=)I]\:)TS
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M\5\J;=$97^[Q0(RI'W\H.%JH_38E5[T%P,DN"$FML=(RTV^3:<Z6TP,X ?M
M],"V]G.\(\!<9^"#I[YYK[3 ^'[5;;M4O?DB_F/#]ZYK!T6B.!>U(3ZN=1'>
MZ=M_$QK&_\X:0QFJEFBSFI@UE^5TW4Y2OC^)(@<//\)7H;21<<<!0?X5,V"
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M<BECL/-J]-@94R.RVX"\U'O&Q*-K>N3!\'<@(NRI!CQPR*!18Q-]I:06!/*
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MLE2(F#V5$6!]H\+1ZRL8LEM>2M;[KBV:C&U_ Z-:"0WXT":;@[\*"KMB.U6
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M<#"=[OD;M.^22@#Y#H]#-KV0C.OF0ECG,Z8?=.L0CHV6GS EK5*7;0F2A"]
M!$-I[@*Q()1'L7K,AN//-K!G3.S@-[_GA<<5% DC97#0_9>= 25P3VME.7"$
M8QMW@F:I%-4AG3O/*>&R6&+!I!<,:3V!")'G_8@C!2MJ=%D,S(@3G^%=/UA5
MK*O$NZE,;</$9>]LV9>[N+S]*/76G(9W3.KUI+6T#A<J2$ >-P1V/Y*UQYB;
M,L=CY' -[XHG) 4=Y>]E82QR15+1\0E*!.')RN1$^9+EY\>WLX-8=2NC3^QZ
M'ZTZ];7L'#VPEL*"'S]_%Z4]AA?7BK3XD6KL:\IESY)0]Y'>;7W'\0C)M:JN
M[1.'+60?4$L8UO/\3-;[ ,5RQ^O:E]Y?_)5@X)UL\F1Z=NV[>2"@19DL337H
M'DF(YJ5M=="Y7%,LQU?HT84^/L^"-VV<VR;B)XI*H#5D(!@@F8"NFI/P$&J9
M5/8K(H\M-37'F&-R)1Y"1_6E?7<AA,N3UZ_4U=:K+C1 FS34[ZAJO':'1YS.
MN+[<++PR(Y'VY E30FJ26:;&/4,&:A_+ -&S]N-HIK&Z7+2U&<H7^D@"PIPO
M:5MM6WA=Y"YM5D.$/]^LY6/SI*YH!5Q<.S4(0ELSF)Z7&%<^#YCA+>+TOUN'
MJL#H0TTY@9QY/Z=#%-HYTOMII^SIQD"U2GN.S#,FW\=>^397$OI'6.X1Q#GN
MI7E9U,RQZH&M,U1EOY!^QDTZRM2HN^8_@3Z!C'WY!3^<QNEJ*.SRQ/>,#4P@
MK(4G"F[93F3HR6J18N,6=&<R5,L..+JKW^)L+J^BF@[1Q:^P+$? R$X6Z"3J
MW(J>?Q<J]^.<+]_X0$626D_>LU&)9KG+^!]*7Y-^P3U]TITWFPY!\:6+\'Q'
M; />^(*GX2?_3<5@Q(L[*=4L8<0#67X-^F),JVBNB @#=,9T,816WQUID^C!
M0T_<**3\'*\-GA/MUE[(IT9.T1(2*8.^M;#@(Y@6@@4&JW"%T+N%T6\ZCIPP
M9>"'7R3WYO8K?').CT^*CQ7IY*FN-JG:([.U4YY)?5E7@^2:7\@+_1D<1FB(
MAV31@6FF%,IFO'AS#!XA+/^@E>6\7 >>R/+N0TNHJ./;I\22'/LOH[T4E8>5
MNOI7:\!4M$?;9ZWN=;N@0LWAARZ.SFS695GU(W)!F8AAGZ2$/GO75/H>-WB
M@S.EM')\.;4AN:"(-WI _Z<!N5!NXA9:IN]NJEUR''MWE\R\  .UY'^UBH>(
M,+_8W*-XA9M+N'9S"E4&_T14&<FYT19?F-Z00*X-J?'@[W^HEXF7.W2RN5%\
M@S5?6+K'"<DA]?HYQHH$X]7YUK?%9", $;3ZT&(@M[I;$-.BO\3%ZU80:,[_
MVZ$@HYY90.!"K(<TFYIUNF=L<D!)XM"NX%N9;]4GIGQ)U4EH.;"D:/6)-WQ
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MWH.&=]B!3#$7S#/[(:XGT+_&$4]DIOC-B2]BL#+G@ ';C!5K(*$ ]GQV 8C
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MOZS<0XS\<I__KVB^I7W=/S8[#;87[U4TZ3N:34\[F0J2@VW1LACXCRQ204Q
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MHMU=ZQ2EX^<ZA)DD>1WH/KES]?9$VZD1F4>.ISM8Q )"-W <K<\>.\J^K?[
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MQLB\D_CQ5H96*>R=;:IBP<N2$;/SMZ*K2-)#+M2UD6P3Z@9=YN1)'S-GF>Q
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MY8G2$WSG4'@,TA?P[*'<[7>#R_.OVZP8?NVK^ #J#Z3>-->4^JOD4]Q5/M]
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MMU"-D=;#_0%SR1R$G8S;&$)N)BRMKQ"AR+;VCY).$*[GA480B/_1@[W8V^U
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MHGO_;U/_PIVYLX XQ)8#W?QV=>:9T?6Z,X0@>(\K7@S5?_G?>+$/?Q\6+!5
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MY**B&@#3R!6)1<9F F=)5Q4?+"V_MVK]XC1[I5*""K#I_O&HS"# TL#"12*
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MIXC=OJW/NSO%\S=W_/\NR8.H5OFO)(],..(77*!7TV&*<&\1&9$7=H!::[]
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MNNGY#3O0Y O*CB?)_9-GVW7"7G^6:0XL]TK#[5XN7<H;S# K,?C5AB$+P^A
M=7D%TH0Q)4/5#,5?I3]27E"=NZ'C9,%IXLGK)*%X+4.;B$N "^&2Z0H-><%,
M-:TU&_C*5WU_#C8FD9%E_7FAL,^@K,FRT>*;.";SPBU)K=&<0C/C1(1:47T_
MYN[YI\E]&VIG8:'8&M=Z8?@/Y2'5XU6>U;5;ONN.VKV&',.[' 6W054NO+WK
MET0XSO7ZJ?3C%,T>O.Q7OCSOATSNWG9)S-T_/$+]<A'77<BJ.[MC/:$VK^\^
M\7G^D,@DXV+\R8F24AAN;M2SOO-=+2S%?E[A?9_),WH1Z[RV4]9OO6'/Z2+B
MRM9MCKG@^9= 5U3ZUW\%7V5N(V%;FKSUOX,'!)A#>L-<&K]M#TG>]GP>_"^_
M.EYE5>4<6M.)LC1E"=*VFJ@$[8ZA@Y%Z)X)%HO1U/R;;%.IF=\.;@\)VDAGL
MG9KNJJA<>YQ(&%L<!VJ9@%8,H5']?:+G!5FJ0I<H B^J5K _ 7Z7&'-SGQ?R
MGN3L+#&YG3]>NQ"ZV[$[$X?3[#MS6M0CNBPEV=O'[UC4AWO8AR5 6>Q:;MVT
MK>..[E#3O0VO<%'H?GI>A;-*2/[;TJW]GF<\Y3Q2BB*A[Q(MW4V++XQE!UYU
M":Y(A Y*?\H)5I=J8$SYZ:OP)<2'GS6YUX+"Q4VO57*C=G9V?%W7?-ED/D.W
M2;QA4$57O' 9Y[77F*S\,W&+32117JWF"BLK!U?0LW\L+;A<7GS(ID0CEM(1
M>'T@!]R>H)M$2,,]B_4"22('/,N)_EVJZ69"#]<&U-M1G^=:'Q<5!PVX%#<]
M2_PZ"/]8_TU3![U40&/9VBG,9+7FD0@1>% 8@IU8-:T3[ T)?A)E/+IZ_HK"
MO(;_M7W<I7\W@O6/WC;6LMK_X:.\;57$A+-WJEKF)V#.-.:,Q[8^/K@>N2"2
MZ*W#V/3C9=N<N]1JJI^QY\E MR8/NM;=NI]H%@A9VN@9[7VV9UYHSVH\)%_X
M(OHC7ZW[  3K(1%8KM-HAC2^/%YP"([38+<><--3Q=89PV9]%)^_OR_",/Z\
MQM>ASG<_L5BK_D;>;+)@6J56>FKZAE50C'*K$,:(OR-4("6NEE'L<\"\QH+8
M]7@1!I;,(BZ7I)_=JR)-!TN$,5,=A(:L_>G<P0/*"TJS[(^!G;_(1,/P;Z6'
MIYJQBW6K76J[%V!#O6I&H:/B5:T".'[W1YN"/)/_1JQ@%QS[W6K>OX@GF60D
MM?V^D!'YH/I'060P&*^%2C!U&!1 =R?QK9Q_F\D?._K02.$QN<J%Y.(E=2LH
M]<&.?S:E5 SUN9^(BX<%,X*837.L.C$BEI.GK:48WRLQ^L(EZU*6##NI>6FY
MD+U>L]9L/^]4;,'A^JDD?(9<44"\'MS+!"0VJLIB2G*I@'5'!40'8\0MEI-2
M54U<21JY:O.T_%-; 3&>'/:WW#<5@+EHN4P%/!*T(Y,29E#@G+W]/01BD?SW
M+I.$=AH"N3>"P-LA3F12B+[!O2RG8JJR%$83&DJ>.C35 1(XB<>4.!HFZF2J
M&*!\ *&Y?W,J;NY'.$6 4RJI@ S$_^]+?R]FDR'2UB\=.AK.Z:"1CS_-E'*Q
M0LH-M" 5\.L40;R708,*=%E84MP-<O/  &GA_]S1+\12S"+/+01V:0T=FTVC
M6L6!9Q:F>F2="'4:0*!!%'R4Q!Z-EK/(]APSZYP$9F4=MZ*!]E2 1"'EDCWA
M!6+P'DT6 86"Y6 :UHKCAC^F CY%?:("EFA0?\\18<EA2@6P@E,0:^&:Y&L_
M6M$;YP8(X5UO(<N;57/_J[8S#X?R??O_E)00LN]3J2C90D7,?%KP04P4(XQ)
M)5LH);N1);*&4)))C#5-UB'+Q)B$K(/);F;(GAG"8);G]GF>[Q_/\7M^O^/X
M'<?S_>/Z9^:>Z[RN^[S.\WR][_NXKEF<Y@ R8LL&^*$DZW8/ZY4"&,OF"6 U
MD4ET#)1^>3)A'ZK]4A_^D,[L>CUVH2 .2E5EK+"% >45)0//9/\5&*91JW)B
M=G,K< N*7^'8Q+!$<#00("XB\\+TW:$=OS,Y\@A&)"=.*!ZHZL#M;?^_STZJ
MTBE4'Z\!5=ZLW+(![QJ7V3VH*H^C[P-^65^(VO7B!C,Z3[@@"[5U&E\2!Q!A
M++8-_P?R=OVK"T)MU_?(^-^Z^QJ 2>UVPP;HPG4I!4"*U\R\'0C+EXXE*CA\
MLW?".G\X,:;]D^"^X2[CW2?24?%FNCG9[8B7WB]\[@GIZ\*W#TR?<L.F=*^-
MD6++2S6[&!I2\3=/4=)=S86-=F2MLW.%KAF>UOF3;EJ_^OC<NM<)5^G5.>PF
MSL<<1T:^!EAA6ES<R@CT_]W&(Q^&^>Z_>)=$@J;PC+PS DFDE<P'W2_WTLTH
M='%%^1Q[E3&RP%<(-[&\9-)MW&\JR*>DMV^/_> :LDTC7#OD6JJP&%.C#7*&
MZ<Q0-8LZF4Z=Y%\\/]1RU0B"*"C/;=?)DL2Y/10GHIR/Q[W-T'LE;W-9T]?,
M=QJVO!IL).7GJE* Z<C!IILA<D\:F:@0:XD6X\$-K,1/#66EC_W,++4FUN(@
M]YD O^_+9;^$Z(V->V1E$A9A@HNXQ.-I'AS)NQ\0!OVIUSX],(A*WY1_=M8L
MKV+Z%U[3 )!/^U>9]SU?S#!1C,C6#:T+]^-(=KC^]9L):]77?DW":E5[;_^8
M39K. +LP9S>*V?5X%[E(X6^PYQQ99L]4L*MF,VU%Z%;/^X4;S9*7NTJ-, )O
M56^-:"I,[JBK*. .&X3+(^A8EN3C*<PV$(L'401DK)-B=I%8TZN1D_@''V%J
MBCY/1C/VH*(_C($,UI"N&;,-+AG]<1V/LUVNG;6Z'GW&FGB]X%-6'(':^"&?
M;%>B6=G7OH0W[ [0((RM'-:OFQ2<\9&Q=AQ\)-8<:BYQ;CG07"9B0T*UV*OG
M-,GBB7?;S DR2X[&\#TU?)M9E]^Y?ZW\+>'"2^4\3;*-P*/L:!Z#/4/UR?R[
M__]AW[!FS-%@XHJJ9&Z<";)X_J;P>;M<NA.EVA1DD!#=0;_B&KF]?( E0=ZX
MG*&V.A%BAO,ND D14,4_.-3K(4H<$($&[ _*6?^QB*+;)0\GPYX;][(,&2:M
M8C,UWPP,,7.,<WN:M9T\709$]\/2:GG>O8]0'4#+,]/L#= C%[XC5&MO/Q27
MJ\X*ZY>^4#4R7%P_WU3#F NX13&6=/RS>DT _B7Q0:<NT0AA8F+6Y&POM!,B
MI.KYQ"!S:I(E0MAP9 8:YN12'531,I,C#6</ZLZ/VO#V_KYSM-;FL]5+(=$?
M0ONUDE!V3>"00TPDO>+;1%LS1Y*D4[N<HA1WM1H'3X3S[PL^=C7V\->;U[5)
MV?#I 23=!AH/EM15>L_:P^3QF>U1>:[F\RVHL8N->9U2<QPGF65PKOV4DQU1
M8:U21.I1N^Z&<@LT&@UFA086!I#_>8&+L%PX2&DDL30*SH1)T</23FNF*GE2
MWAVEAEJ[;3K[L,P#2[Z\E%6YD\*#3NDJUZO1+ZSJT3YC?/I+?8*6W9?7'7T^
MMGD';[Y2F70PZLCRK[HQ'+H!"V^OZ("T'>WX7"M_T<IZ.T<H0RAARTNZSDP\
M5__W*1U,I]7<Z"M_")!O0*![>[ZVM]/&9NF8(HIQD@KMOKK5Y<P'WEYY,A=H
MQ_V(ID['AE'(-RMJF5G(S/%-M]VM^O]Z-O!O:=[K"CV.K@=DNK6R[V+_K(LO
M, D;&^P\ELW.24Y7SBGFY-2RP&6&>AUEW*%E.[0ID:I==#+--XN#<\=8G"#,
MXVQQS\JHM>['#G?DYE^7]IIZZO)3T,GS]91O@^#1&U*OJ46WZ;W9-,NSV!>E
M_#JO2DR+FO6Z3W78'Q_U,3<H'2J,P5A7V](LT_4&WIJV%Y$<^_L\V ,3F4'V
MW;/#]63R'RC%>'V=+<R$KSY 34W!1JYP8M'-0('R:GC$]ENS !+Z,Y2[XN0^
M#C]JD@N22V;WR+)-.$=\8M%_-#J!:K$8!11:-)HRB@3HS7[5#TCT):S/ZPWX
M^D4F>,CIG[ZM&D-15S@2K"PNJ/4O?%4,^S L K_)!7WC@EA-0('F9>=#Y^)"
M)(#*QSG/!<VPH<QG3<=0O7AU@!0^B0&5NIZ3A5_'*I,VUU'TG)+EF=V^;?\?
M?>_L=HW'_#-Z-RYH^QB*%[_"!25R05NAYO]M]*OXT76VAA=\FYPV,3&"Q0Z6
MGM@(6ATM722UHP>;2C'S08/90[)EB9]R7?5U?$<1HVV/Q&._1GQ,S=,XDO,H
M94 D$-N!&G'@'$32"50W/$.YY7DDA1R/N>5Z+H/A2MA.[./E@OH_2FT^DI&;
M<?=JP.GQ#GZ?747]#[,&,T24EX]R05=O3'W>AM%0BUCPC .%)<%0%;"ZF1?5
M?"-U,NU<"^;$B&E'/ZR2A'A*YA\S>DD]VFYOG36NYUQR7B88]R@$%S]I-SQ7
M;:^HQ%#=N,3<H>.(\10-D0 IJX;:NO2\SX-/7N<W]OD,Z.UU6XDHBA*1>*,N
M>DKD95R^E_+OR>%2SD$OZJ3,6[ (Z\8K=WUSOD)9A\ BA._'PZL1IDG]ET9K
MU+4Z&,@+3D#R#(% /2#P40Y/B$"#9FTJM HL:UH=8XP8F1\A%#EW!]V6W\6_
MR'"\6^N>N\RC=$M=D(K-VV^4FT(=^QM X.B@@&3^ANM8BQNWPA FYI9/*J\=
M=U%K(A6-Z[JX+FTYC7W2SXMX[DRXZ:'W9;!D>.+T)\6J/(4OP=# 0MS%U-_Y
MZ\A^; ML>)3BVMRH/D)HR9$EY>9(TTP:,X:4WV7I\@0IO$Y(2WT:'CA-5QV/
M5)EZN!]$2P@"&4+Y.19XZA'D[E(O;$;N<$$T% <)4-\4<L0$UPR-0"=PSH-W
M<G1I4)X&(R]<>.?T:+V/;DO-BF?-V.^)Y9K1>C*";4/4.\L%959;FXTXEPP?
M__ Q->F%1ZJ]FD'RHFK0-B>&I3+1A-_=NL.Q0/T?QG8!<"^G'_S'" )4H=VX
M LB0D\GZ:_*P#@!R+#S LK4PC95M+LC<WA&>!F#3-IX)@R,:JA;9/FP7'R2R
MEPN*EOLG?I'M6-95@9V_47WBNR^542P?+JAS&\F,%=M(7J'?F,*R.8PZ+FB,
M"3"BB'8K;%MJ9I+IUQ*("M[>TD*5!4+03:4DCO/"5F 0NW.6?6_%:H +@M(Q
M@D*:00E)PDJC9#IVFL0YMH^=+PR+0/.B5C;_B2-D$9)N 6:>$DZ&>L%$0HQZ
MPXXRY9HYHO7T$N93B\,L\,FJWHDK)<2RIO=^AS\BD2)T"-I#[:KB=9<LWYG/
MX0'#P Q"7 AZMLKZ79\#].T$E=Z7#F"2"?!L)Z7#)@)F [F0P,>V6$N-=,C-
M,33!=3"2*EBOX"3]P/!61YF1LO07W2-E?'I==::W[+72*B>&H'>*/L2QYC9:
M_NOP@?_5AC^%FJK\@:*$<T[0DIG%30K)7P/PU]IH[=C!$E8^0-(] $D_8YES
M0>5HRB0'LXT(==T#?.35@MRPN@=D(/1?:Y4^6Y) B5P2 $*^X W+2M$44@5(
MP0\QM'V?FW5;>T='B<<WI43;!$4N/S>]GP4_3!2T*K@UDS)LI615]R;B6:JJ
MN6-O=;+@ FY;./9)HOD5LDY]1N6@3N*=;AILH&H1\]>R3["+O[R4)*G(3TV\
M3RG<IO9&I']SQ7$G3?JK?OTV<2<5^I_4OY>*4CYX;'C_7B+:6-F8:VOQEQR\
M ^H*([*,V3E5;WN8*NJYC'C:2_J)R24"%4B:=,?QQ6*&QM>L]*1"UU*[XV%R
M%G#CO@8;?ZI J.2.D[E<J*WY.XBTUX,)OX&)B;'O\-G'(9SGL/A"$]$/\SVG
M?S#^4&2(=\H#$GBOR3[GX36SCFB]\TBS]>:3(N):]T.K./=*O$!$SNFT](OC
M=XJNOZIS*#1[YS;@77U+I;TE6U[TU<A,7)I7VV.&Z=-5NWN/(_B^*C&^Z<GH
ME6:<D\K"+&>\+;!W])!-POCQ)J$+APEJ7;L;&TIY&ZO+&DZOCL$>:>=?O\1?
M5?%]H4CZ9?4.(+'YE%M"S:GLQ!ER!$0HX I5*AIR,* 03F;IZ>*6N*"R4=:5
MVLQO+X<#?#<)B@(DUC4\;X@R[9 2H6)A[V^4F&D0F2-;@QL2,VX8'#EO6!)@
M/H6-XIP/,6E@2E!\AG^%!ENR,4U[/4:V SJXH*_P+-=HSOX%E%"(-A4LN@@5
M*ABL_KO!L/"K0:A?L46Q!T3$94BG_E5U-2FZ,?_."#2KF"HACI%V27]G\RQ#
MS71W)ZZ+O(W@L8W7L81T9P_V_?0'YT[*3PP_MBHV%XZ-+ZBGI7:.>S<X(FPL
M^PK8I9;9)4UV=9ZVIT6CYKOL13U,!Z+?,$5S1!C7FI11O%<H9;Y(Z0*L>@1'
M+-Z\*:WU5)G#F.'';=-^2;&B0V9RKZ<C'$Y&]B39#<MH?Q]CQM +J:XM"$N2
M$1,])2P5 AG$EO&NI\?$5RF87*IMK.PF^;DKY@F>_ 7Z:9LJ.A=5HB6<@LQ#
M"QKX38T+</BU=RP]R$T:O2R]QS1#_XT\^FP+4)'/;PXQW/2ED@T0P51S)&]
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M0J,T_()1H?ZGKWBYNGOQ!7JK>]]_\GR"+V4FP^2FT?TC\-^SWRSD-D+H"ID
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M98J?3%_>MSO3*1S7>J-0]B8-8?JMZH3&A//"Y5/&:KA L_-+[WJ&3JM\P&?
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MSV'%8R+_$;F1,B> -S&\&:ARUGK(][!#@_EP7G"IO8/!J2OX)BD36S^#(>7
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M4^X_!75X95^H[Z3*;9^!Q2MQV$A+,Q[I[(*S:F^U%&X])2N@WK">I$6A0FF
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MXFOV@)L'(A\02P4:EP/AL/*MW\YV2J.']%RNKS$M6F50^<D3J<^WFYKE(T]
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M:-'4_5?)#KQ:(*UY.V-7^:+RNL;$Z%H#A,MNS\8^K!4<5)[_:K]TYAR0+<"
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MB*7\19X],DT&0^\W^#)3% ^B5XV.EU?7J)89EWN)E*0_[CV.60KRLA(A UF
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M2'^RQSD@[ +EI5#(^USFOC<QEPS4#%1'#G+$+LAM;SO:5^#O(XJ00%&(R#F
MT_#TH1#D8/5?"_@OA9(ILEV,@*Y73B$MD.1.U-ZL%SEWI/\L4@ //@?0'^2&
M*,>9Q)%RI02KS@%QUC!$QUM5*0R%K:W [QSP%;_$&!YEB"G>AL0N$^7.RN+(
MOS4BJ+>__CSC&E/8@9U:7OK/ZH+4:K+7F-8//@9]9Q"8]A,^)/*;]_C]TZ?8
MY?I>J&ZRSG;+/:!K:6]J1K6<Q4!(DK2A/P4I;,/(D:(&&7__F8#<=9OCJ'/
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MZ9=147AA>LQUM&)N;NUJC.#S8XF8[5N5)B=&K\N7[:&U"<?6W[0];:#]Y)>
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MEX#P>8+>6XX0YA^]YVKW+P'?^(LNR#\MOM_#V1GVGH>K_4,/5XO_10NV"9<
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MX-USZU5\H=]XXD8+8H5!L/XXX$)[<_0\^G^ATI4G=H:D=5)C<D?8K?"3D4M
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M3RO6TQK_?+)%57XK^+*]YV!?,>H>[%#W)J!.5OB%('^?JN3/P;EQ/>>YODL
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M/M#\'BGDOC22/%YX9NG+)ZMIZ^[+K9>#?GME'3VBI!80:@*Y>I2Y( VAN\>
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MJ($,G"D0W)V5%!ZJ51)8<*^9IEE>W*A8L0F3CY1]OU3^J,\;P"^:")J1/@9
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M$;__QU+=_]VB4^N#V%"K>0\V7"4^3EWW,\5[O*9NT69\0^&3E;"_;ICZV<Z
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MMF/ CZ1.#-7G)W+"+AZXHP\70_R-6=@^NNW*<ZAXH@G<QX"/B$ )1C>8\QA
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M'!:"*O?X@^GYDV8D7;3NH+I4.)<=X[AQ.'^X#GD )O@]E?,G6"[^,3M62^I
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MO*+"E!)*>'!<@#F/M) %*3H/]XGG@3&0&B7*I 5%(:#DT,;KC0.^'$^,5&,
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M:E+LG5<<K@MFR5N9_*E4;B9DVY3SR08Q?_;%B,&#.ZQEL4Q7U8V$HS\>N[E
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MAWRO(.?416*5/RZQWO,KCHJ%*W\M6;=[*'8?M7=:GU;HLI4#IEW:VS<I7X%
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M5/222$Q^P=DSSPP1AHOUH$WLD<T5?-$G!N 4?%$<7@.61VS:KU^.LL+5GKB
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M>OFM+>7X[]JF&5X+T\N0CSU6AM#H;;E=4;W  W"=P<^4T=,S1DK0"T[AQ@R
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MYLD<1JQ4QNV"X9/,3^;F+K>1>=[-F4]+U6TD1#V1-5J0]=/EW6O_#G?@?E3
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MB?\%1=M#T3]1/\V$7S[U6!>%_0R]<<8I7Z.#PI0#HW*I@*)_@G3'4-6BI)S
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M;T@@1@599^0 5N>>R@KP-_Y::GE'9"/(+"A&12C,OYWGA_#^=D.K5<$5 K2
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MMQ2^??.8SI3[Y'!D;*\<BMW[=0S1-2VLE!*YMIT?X-Z/>[B545A9.4N1(+=
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MZ:OBT6>KB&G33BNS4*\*>.\WZD&_LU0TTI0>?OTQG;+9FYDO8[<C[+=+,L\
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M:;;DN@?$8_,;<M%@O4<)#YE_/>\@S\;Q=)<XC)/QY\&C?@9PQTSE$*T(R-=
MQ]WIKJL&W3:K"8&OOY'Y2(3/4PX07M'X@U;&&9TOD*F\DND*K$EUK5:8CTCV
MQ%S(QZ=.PB^I\<]5'*)3\]IY5+KY(YQ24"9Z/R?K4!%!"#&_S(010_&OC>2>
MA'_U$(MTHXV)YF3Q)MY('^^CN8<<S],XG-_I'0I_EO_,P1]S?3,7G@OCV+B7
MTE?-</?+ZQCA0.!C<JE'48VZYT. %'WO]9[5SS@R-;!HQ#(BJ+E7>M- ]!L<
M'$:2/'UA%P865 >S%<JZU0!83O;1JP(Z_CJ8"N@XY"5T.2V8,J!B]WS'.S@Z
M189%N(0_&%D/?#D?N[F$3-84FWA.P+1O&H05U1G[?"/UM4]P#]7;M)6G3]E[
M&(-8?^<+RNAN03JDJ"QS/XRY$9K<B^!+F$5-_#?1:"SO#PV_PX,#/,$*ZN+Q
MMIW^;89"O[MVTE2:S;U[VE)'!@:;Z(#O,>$<Z285VG+>(T;%\DM;Z9BFP/'R
M">0J.FE'S.+N.UGAEYZ4SA8)/2*=!OSI>%>V<N'?G-RHR[CHS&6FE/!39M3&
M53S<!.!)P+;]$\G]03B*"1@Z XR!DYQ.]BUND%1@A4?-ZB2'#AEUTFG;+UJ5
M,\"GKLMT7T,W5#C;U9F!U%=5P=.4N>)#]%%$<55]IR-F32PN0FQHKX94X*6^
M$T;YY&;\\Z(W7^K8\]7] ;\32W.OEU]N"B]X+[MAG!"#P.00&>B]=QR2N/G8
MZW8LQT)0R1Z'^3W.U=1!I(.X/CSVZ&E"%>EH,6R*3@B?'VK%3%="1!\,<O:9
M2OX1#3ID<LG#K A^W9AS0*/__9*PX+*HNX,PW'A<7!^P=5*RNK=_W97ORFQJ
M)I^_"@,SG>9?RJ7G"GWT'SDX'[8*T*_W#()-\PLR-9Y#I>I?3!+. .U,>_!E
M&/X;0\"T*AI(\?BNR38GD2Q,VE\,,_U[_O?+PX.!4S."JH3NY3#A#%>3-)!T
MEW?EA.!7+'@6Y+6%"O>X_;;MO+1;?4(V;8Q:@$E<F:>U&V%V->H/DMALU:S\
MAM@, M?S.]Q*=^U<*THY]8K\#<06+X>Y"N&F<P,.D/"<12WR=TLJ.R;FU"@8
M00*1[^5K W 6"\1M\F;ZN":=!Q9PI3$ WYC<4J=Y@V0ZYE>P#9L<Q#P<&Y8H
MDTO*3@$G1D3,M7V!>.?63T;.]CLEMYT3+=2S8%2%28'S+H;,,KK*^-<[R#8T
M#9YYQW^WX>NXY#L_4M  BX/83_& ( YCFN7I;\G!S#)%?KDP 1;!\8.G9P":
MH$G'*_EJ)+M"6M]S%O]Z$0CR<L*L=E?>_^B"9^S@"C$X W!BVG"T;/8(!%GT
M)S\1.'4&>#SF-U>;8OE1#[S!4[>3E\& @4WL!P\?U]IV.SIGAY9KG@=L@2T\
M+(A:'G;Y<\EO@F@6]P,YOZ/7=/@>W%]+)8T/;SY\-:P0RZO8,<NG# 0<T&%
MR 72_?"A>CW<8,QD]V\6!/DN\$@&CAS%?FRF%!RJO15.A8;@&V,DH\\9 6U;
M]'7^YW7( =GNO8.?_\(R$1L\Q:[HSR9]*,JLZO5R!^;-+,['.AA4"602O-T
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MQ.9\V00S8=Q[6GZQD=42+?<K#J:]M+U41>>]:,%]'^EVJ@_OU<WX!.?M%E=
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MR7:/&2<Y\>96Z8F+9,[5_SW5FA150O_$":T'4$4I;OO?R'V-9X#N[94K*F<
M_9^;W3[W1S[P'-'AA9;<0^#5\QGA'M? >SL%5,:X-<3;L*^NV] ^V;TS@'=G
M95\QV+ W<VF+)F=ZGLQ8@/ Y+*BXF8_/E]Z-0T_M $D+W] (;3+FY. RG8!V
MN#,K*(T1Y&)$:<J%UDZ?G,902C\:4%T_)F=1=)9JT=(4C0-,V6WV.=K^0\(9
M -V H*KHNS4 ]RA0S:P !#;R<8/ 0T!X2DF=6C"P^%+\5GA*T_YZ=&_QUL(9
MX-\L\+UP)-:%8O^^YFF_.-Q]!:@>?.\,L ,6,?*6&B0WSR&*9\X 9/]"]UW
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M1O"OR]+\\5#MP,\E78VR!@D:2E.<(]([Z\&_4W4$0S;[8PI!=]*TG(7&)\S
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M_!+PB"&JR;YP_S<[X0/%=.Z11\L9V9D008[]-,X4GJMRKOMR]#UJ_6Q4+<N
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M">B29.F3CL#?%KR^'&IQLS+0&<#[^9Z"YOR&R9V9J9(W>(9[@0#5C,XEH%X
M6<:]G_'?EV6VT85+NG2J1LO6'_:?-]'3341 I9MAQMQ'3MAD06-FN)6%6_J:
M?:H-ZEP[:S_W$B!0LDZZ68DK0'\</FZ,B9R_/OH1O<#P2+6?$*^>HAZH[]7Y
MK(?R13 GNT]]"3MV/2;BB2M[-.QZZQ]Q$SK5UD&MF".^P\TS9_BT_?TXP=:A
M*9+E_L\'2=+7\#>#;RAR%V]OHZ.]D@J186_S>';<[BOU2&R/95!% P4DN9=
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M/M!I G+"G_\_D6<7L@%+XA>ICJ9FE"#6[6H^&P,;B(Q1K\%)MQ5P[]X1/N&
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M>8VR/\[IP )7X]!]:_#UIHE#TI*91L;CVM&T;?"<C #Q[.P$*-'9-9J0E)D
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MA\23P!RUEWH%N$X ;\7@-J!4,41>1]@$!<0?GOOCIT6Y[RVS_?S;?\M <M?
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MQHYWVE\PYY<SE#5M_IE*[9(B:1:R?DGX89H&RJ\4'LPO4A"S$4/'564,#&%
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MP0L0@6-^>A,Q7_KV?]>,-3[0%V_8]D_5/Q/]_#LT"9CX9%1Q0M<V\),S">L
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MFATK=49>1+7,4DL4[:O$#*TI5[>8 &E//,+E]\M4M$2W)*41LVS=$G_B89J
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MT#=&DHQB^2.,N.11(J%=E@GISM,5]NGYCLCLN\.4;PVB_'B;=!&I'$))5A+
MRJ]L17:(KW6MN7YNX@SC1E.-)\10L7#P0<XQ(()#=_QN=()M\'U;AGYB"C'
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MZ,YMS-Y3\YM+K(NRU\&+,]1H38F&;GOF;!^@(X"Q]Z7]*M#*"+D-G"47' 3
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M+DCTY7X=>EF-L<8K.E9!G+L.: H#UJ@+95L;R2[E<D$]_$$ ;_)^%)IG0J[
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MZ<>)WH4!K*,(]WSY&#GUO&@K47]!1R"TG&0:0TY(Z >?E^S3:/0Z/OJUZ%Z
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MK<BNNXA)?:U^ZCNX;?$&7/E25K/LW(0Q1:%]5AEX6X@<HNV.HR DXDD@Y"Z
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ML7H\L7IBXPBE\\7R[.)>VRBRV@2T8"%ETVFR+<!V#YMN#U<XV2H#Q%-&:7)
MPWRLH4;8 *0F*H]^CC4FPDN+HMI'R!H*CC <@Q;9N:.[(5&9TTZ^T<TVOGYG
M3L] 987QA5::%5($,^,@C3X@&C0KG\X+/O[NW3==T69;=AOXY1Y;2E6YR?,9
MC.;B2O]XQJ,,D=?M[IHY7&$BO/$%R#[KKI%(LQX_1$JAX+S<[>>S-4LGRZZ[
M[L@6E>[VTM@V.NF0:G2'&MF2EU8-^#\V].5%=L]1 GO4#/L$!82B8_+!DX8R
MN;KO9-E1Z1/\7_^$=]F'4I9H<\ 5,M,/)31_.6#K%5% @BD-/<IP&25V["W.
MR]U<<2I:G!%PNC.IHI9&XB_E*H]J^\?;GD>Y<P"*18.T5"#'T.U7#40*/#/E
MNB@KF;P;"(JK*17=!A/4K+3&SW</E$@,6I"2BI[FWZ)X47/.Z\@:!U:?Q)HU
MFY+47QV :@)?J?EJ5<BT8851?%\FU1;3RH*"?5K<_'QEKR,K-1.]AHO2V=S<
M M)[5L6LWA^U_2Z9+'"])ML/D!//5/]R_]T%7$-68DN=6.]JK7A:SKL+NVX'
M($C 1'^0W8.7>U4)OZP+<PYI0G405"KJ)O&DA(3\7P.M$?C-(E2 >*#K$%>=
MH2VE=X.=DF'/+*AU8;O%_&S 5P:\MAJM&>)V\K2SP\O6XZ,JO,MOR5'6-;J?
M;G-^_FIM+L.U?G(S"FLRJF_OUX=O,"PYID#58OP ;%CLI#G?XV'33D-=6^'2
M<N.&0G@XWC*I8@[AG*-@1JUGR+"TQ@*4=F9N+VX3G9KMLTP\-;3*8UUI^.M/
MNQ(FUL@K_[V '3K))RM]%CA&S1PY6^-$7,D\ '4.VMV]%JGN!Z?-7+@U=Y1H
MV-:5&HEY9-!/>5<2OE_Y2"SDEA!G)_@42=G$*N+1.FF]M%DO4<Y31WEM%JN\
M4!VFP[-D<+/4';RFSF/;/E;R@;Q,\G(3+<IZ4'Z?9&62&*2,*W7G"*C-?B#)
M$5?4O^#5O$/:*Q*BW&<60^ 0]CP%,G3=>WZ@6O0G'M.1)X@,Z=5[FAR^+9?M
M3UB559>5D6=^A[78K1^ YCYB07.9^A!)A2YT9,84WSTCJ@AI*+:&,P1>79MB
M0?7P\[S^5>8G_Y,S_#PJ'4&N^L'/A<\ZDSON%L4[*R >+%CA9T:F9CQ#.<@&
M.6BPR*Y(Q;B;$5^ZEGM!D$&HZD5<3:IEJ8IN7:;ATIG3UT#AI\Z\O,;V^<PN
MVW<#\7_EY.3U1+H!RN4M!N5&P78N.5LO$KIFP2\!CRY:5<,!*#E&J^7$%_76
MWQ*+CG(I3R3Y2X1&D?JT!$"$>L0(:4H^%#,3W@J;=D9FW(K[$[UPK;;I>UT#
MS[.3!I^NS8N16W+QB^,TN>\UWZ-6A>FIU\Y9""1=L/U=52_:?OSUV(LNJR[W
MR]Z^\"A,P@"5#]95H =XE5ZIC2BMRQVTR%2[8N,$N2GT]/VD:]HM[?-Y6IC;
MSQ&=1;OWJ(VKJ;=[ERC,=(@G)/)]!LV?^;GY5J9EJ]WH(6+VJ@@!B:3W'X^G
MGJAK-APBZQN\K96L;8_EV)[L,V468^'HR)"'S(]HMPV$_;#WOT8@DL)[%RKE
M^1M_X[@_;%5:I'';P-QS<_X7W0"NGB$AY-*-V%$'+S%"/3%6'MM=^,L]SNF+
M9>/(:",ZY$)U?<ON>J-#D%UYDZU&S;?,IN]-?6;[9=$495Q^Q=C=M)LO&O="
M<VSE1)N\2AM#O=V'TEBBK"EP=49W5MH(0X-ZR6R480*97^H(.__70(8<XG@$
M_R#/A'K4\5X0(?;(_8O;/+_]AD;$<Y,_(3,L4BW':V9T7$9\\SFO%!<@O#\[
MS-Q8:4?Z\#O(V=GUUXVWGRG=-"@Y5.D:Q71>KKJ;*D/*B&BVT4C]Z7)[S:*^
M;D)MYEFY5FO3PSI\S27C[)X^Y-'3NH.H@0,0UZ/YO*B?/O_+CK8@FW9ZDM4T
M#=FH"[T,-7#TZ$^>9>_,H7L!N!V"8CZSHR(W7^.NK7)AG+!$M$8%$P9.Z"N_
MV6<UZ,D,81L\="67)!O?^?%9MZ3D6J>,9E;46N0)F<OI66$$6Y75I\96/I78
M;FNG$6I#*XJ7/JX>@*ILDZ/5*U'7Z!#D4A?Z>.V4P^#YMT5#\A@*W29-\H>(
M-26J2#:]CCITY@!DEGHK!'[!/,G@A%4F5K)5ER&CY$W=(KGUQC1?.<*GTPUY
M/3R-:+P3J4OWJ2>=!!.<S-_EWN#T.XY\>,2V4A7ESJP-._T5%I]734NF9G36
M_3%62&P]@KB_NMUQZJ^Z3_,Q,J_,'=M3K0CG27-M]L?7D4/Y* BS >O!*^W%
MAWSA*SY .0#U\-_TEFA'"^XT$4'(E]/W/YRQ\ Y603B_3&Y5UY:HC_V@JV#0
M[2,UF'_3EK*CM(B\";_\L"IS[*_RT_AJG^8+53E/5*HM>X5,>6W"/+OEIR0M
MA4?>Y5RN+U0QN9OE\VN8%F>P9BDIIUL.KXS^[,P(!73F>:-99ZFNL51P1[TX
M=VXJ,D E/M&.4ZRF0:[NK1WQ;G43\OQZ$;_E<?G+#[@74Z4YN>P?4%YW2TM2
M SO1)[UF1<9W9M 6AI+#WL:LM""IA<\-M:-J#QM>Y<K?3^E4;C3P$?J=('3<
MC\*V\9<NO@*K$>D(219 B8PVRQ0 ^_W[1)?6L76%UQ9?J=BHC8K*3+HYMGFT
MT%*;.J IGE@Q..W/]KV&X_'L_(LEA@"8AJ >@ [MS]XIF7RR '$^G\KK_(WJ
MGO<)CG\U]N3Y%6G+<W@5+?-A_.2,UW7[UF;AES>P30,&'[1(6IX6YO(Y*3@Y
M^92%*<WQW#6<Y\RNQ_6F=S9U W:%N?2UXHS@Y9R*UN@5K^S/AA_!/ZU_Z_&N
M35 _A8\/8/*>_E>WLA,-OV)*.I]!D2'7[O7&%&3-[4ASC0N05?DYB\V;E0)$
MIK3,IIZX16U$O!E,<.Y/*3WR+@Z(GU-85SET&U,39&*TX;FPGP<@R:T:WVB]
M^BA-WE/(^+FEN(T:L.!*H/2)$7FJ2(QFEOJIM=-J2=7YLWBO6?FF1M-&R^OF
M:H\;HH((?%7[1(;@^N2A5SP2-NYA<^GP0"6_GI4169Q4RG9,JZ?;IS6_E.B;
MYCW[[7L^OS<F]7"\XA&+/4BG"Q+Y%74F:B5,U9QF3.D<5._AXK[GF1)??!@Q
MX-8SI2T_-NHVF]3-O!6=?J1EA=][,?P,OSJ3ZK(S0O.UC$E9<6O9"K4;]WY2
M"[6MVJEF%L :FQ^]:M_H75DQ4O[JYF9G=\+1X:B86;L=VYEP]N.2X3S<VH:/
MC!+<1)*0<WY#D#S#FOV4GK)SRI_.?3J#_UPF9'NUS?8.",1S 21:<C^80_'C
M4:P,]M$=7H:@/XOCU1M>QEWBL1 T[M)(\M^EM<&P[Q-_T.OP Y"2Y $H_"-Z
M<I"B<P"R34^S#,5 <>RL\K^F7P] [=;H/_TLQ0/0!)K[ +1"'L&^56*?G<YM
MK66^^/\<?;$:5O(/U[[93)PK8+FK%VQFD$J6-9^#K\%*P!0S[#^#%@%6WU[B
M 6@GMQ][465GGL4N<@!22/N$GH)0>UFID[B^Y8D]9SJ6U.[38K^(=A"TNK<7
MA[(G$4]X9LS*4MVK2Y;%3V:)IAR [,8VK<?[1RZV'QO4C%!6<N=@WPS:<)"
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MH12XIQ&&^5?*UYYZBHZ0J<=IHPC8(RM.HN;C<"45V1V<@F?]B,[R^'Z%]8O
M,9=@[4K<7E.5?5/K^$31>IT98X)9C/523S+D 0C4D!YI;B#O?!X)_1(K"/&
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M.U.!B*'M@K>,[.'2H@U=B>RN*.&#(.Z!KHN,Q=?5QH[D-_BO0YF2YF_3I ^
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M;+0'=Y1D+OW,YBYS?)-$M=F3H7L!W4VO\@8TQ3!U ]P.H$2H]'(8V+'7KVV
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M!C6S$0WDA:I&4<JEQY.'\CW+L*O52R)-J)%'6<(>,>RQ?^X  *'C1FLZP;,
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MGL4M-PH0&M]ZUOY"_'>3_WNGO+QVB\ ED=8/?_]N2H.96R@Q''GAKJGD2A=
M_MR-_AM*61)Q4#-@+7;W= A<A0>NOI99J)VVUTI5R4GVU1Q\''&VXT[(5ZGM
MF["+UHVA1[E=+4A) -4^(D6_0[ :%<-4\8&6/,^(.O.\"]4JOC5LUO8I^FI5
M;-'4LM1"E\>;*48 (ZT<T:DI;SD6N;-R6K'>!W0W]OXOVU.8W145-6SSAE?
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MV9I^G"_+EMIWFW=A-9&O(_O (V\(?4/ZOJD*MO-*J0!QBA7LPF1.[J0Z#Z-
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M*0 G;Q2YQFDL!;$<I8H&XI7N=R=XS%?"C558@$9-B'U5DNH$F;^D&-U/V\<
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M;'-1>\-@W%3OXMYL@7CDFUER2$VTYTWG*YZF)P&45OG7@!=;P/_T,YH,V!Y
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M664=1B^FUI+]=RZ2GRBE,#1EV1*YA7-,%M [IS@B\^R%(R5#+=1MH:60%(
M=01\J5)-NU. +PN6P#P.OR'2=[D?*DHQNEQ70YT-^W,RJ[+EWBWOBP?1'K=[
M!^<$4W2FU%5:J8=?H14N%T5QQE]65_3.4HLYJO+:596;P@2..M#6C%1Z.HD?
MZ""J8WN03O0OYK H&NVB9/W'1[V";*M>B.U\S-R8?8M6&/!9T,;!LD7W/9Y6
M/3=RVT8]9KTD6M),)M\"H28[UT/$F\;Y5\<T>^,8WG'/Z1/Y@$:FUI3>QLK
M8JPU+^)9T*V^Q5TS-]ZR$[W17L67,0\I$K[T.?"?H"N1T;6.U$UEX!MACPU-
MP5V &@P9,#\XUL3=1 Y<5=GU&82TO V*F&](4$+<&[AZ*1'?)SM1A.?33/ME
M%G^YBM6/WV$,^[OG?E6^X %(?VJR"] V9D,AAN8K/G".@UZB#NCZ";U-H C
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M=9Z-UW1M^0N\V.">F<^^3[KO8B[6UN6&1@^6FSPK=?QPT/I9VKW V4B?I<%
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M803FA713U1#+U6RZ:#FJ?<$C$E]#<]QQ-?/_RPG[B5DA$U#2E_Q0.]:JBFJ
M7GBS4F78(W1' I'Z"K5 -TT[<742/MAJDHYN):N%3F-#.7ULW*BZO@\2TVO)
M*HWO8SN%^AO\<R#K;8N!<"K69&#!H.M4_R(R=2/I65^E@B4\915)7%6!FK^0
M+: '6=!GF JG>DBRH+A9&(]A5*>0#H#'6CE:/1S(=8)^O<*D3Z8JIJK(;H-Y
MH[-7".66FSC(B5K:%UMM>@)\ZU]U;%31X!?G\-=6L]VN>KM<F:1RE4WK7_VW
MY9TI?WWTJ?%<M5W_:?&>J1Q763.Q\6! ^KWP*!AN1#HB#^;Z-)CA<,S>(=Q-
MQIQR['MC'U0G*C2)>P#.*X$P!:%-M ;"*KK;[@BXB3)-40KY*I9P;]\C^J*/
MQ=Q,T];;W\5'9US;@IYD+V0?6->"%&5S_9'+>Y ;D)(!4'=5Y9E5*_$DZ+QR
M4'9,XI&DV$,H'44UE&(T"7:G^]D.M"]#,F/)K2] X+)/65:XB3Z:#&'W??1[
M4G;IM/K[F36;:VXL+/Y)WKZ@&=G"60^$Q[*/B/<KW7VH?-WEWA"45GM^X(AQ
M_-E^/"[W "P8CBQM0625>9_I5&3Y1>VJSATN3+T(W3-5%_KC^S I %DZ79R;
MJ$!URZ+)@C'IB4HPLH1XEJ<T353.H9Z0FA#\!D)Z?6:%;#VH]0K6/*LN5DVP
M[-(DW!MO]%:DBUT=&B1!L%=8O?M3A@: 3<*")MFULA:=\^*$CMDCU5[,>K;3
MR@&9?RU8DH]:,9CDJK/#)<%#Y[A <1,E@;J.I-,F?EL$QJ/Z\3+DZPFZ2(WH
M)9)'='FY&EV._C@9,=POQ%9C(W/0@=Y'E2M.":SK$T#6F(%92[9-(A,SV"%"
MQ<O<H ]GX6ZCE,%E9!)'5PFJ]@Z-"ML>(NJU["R >>P=9>H@L7E2'M)IO72Q
MEX;8'2B=]0\M\\FA:+L&/#W-+21+YNG1G!V].!Q"38D .Q JPB$L75Q*0XOB
MF^=U/V,(7<U//=MO%?D0+];R88O#'F)$3N%&Z(T>N/,K8:!8-5=P("_I@;K;
MY0H7%W3IQ:7!H7QG.SO8M=)G7SFI4@_L&9IN/MZEBM?+ZIU\28D+A0RI2]&2
MS,1?D2\9*VL(_J*1TE'ZV@"E."::B>:W$5Q&MP?YFDFJ$^&NQ2"J:5(,LPB-
M$5$3F 8N'GW!Z-- ?_:=JNRKO1B7NSDNG_.& -CLJ15+ K8>LX7YD_P'_I$W
M)05A^@4LGVY"[.B5G5HY.&6HB]@NN5-[TY:>A$>8>T\?E=FBF)BI3(%%N@BT
M:E\<&@["8C=47KXK35C\3Q[-#<)L4PX;H\U&ERO:OLO.X3=.<+2Y+K#'$55O
M1RD"&S<E>"4NV-_K:!$R\'&AI0<.'V;F^>6I&YC\:-3)GBL6V<E]EU=5' <0
M'3A<$5WK%;G! F%&V0%K[8@D#[KX@@5B3;*8J-@/.HAA&\ DU""_L=:F6:A.
M\&LZ.DQ$,BCG:WFJ20N#Q(-^Y4'9+X1Q(>^(;I'DR'5M^1DN-0</C"C<!]IJ
M6;SE(:Q78)3[9!4_>SKP.TV[*JMQA#:-Y<92+P22MR%O#GN,Q=?3'T%6]#X'
M( Z"@Z/VF#;G$D*!-$Q2%2,B;VHJ /_ ;[\.AE\!S,?C^QQY; _=9W?HEG@-
MX;3)^SA6+F'V,0ZI#TRW02$D?1DQ?1322 %-JQN1*;Y[>DF0597&<<"ZL&"4
MW)1C &LB2_ZB0N1)78KM\GV#H:Z.<R<#QN(\%6=]YG=^:1I"["*U(O: _J](
MS6MA!@*0<E&>0=PV1MZ,7?).8<HBZ(G%@$<,GFB/LTC6J^L/L[V=$1FQM_(M
MFY6&-M<1] Z8/!?M[P??_LIQ _V!>2F+3.'J$\U&\8D<E9C1:_0F _4&TOZW
M_<%,\V/-$O #=%LG/<YA2X[)<^MGE9]WWGIPZ\'-O>*;-RY7UH;UE/IV$00C
M$<RHD0[7C2]8K#!7%JO4;NB6/W:>-S?^P5==7HC0E)%ZS:VX@V8*M0')CS%7
M2KP2[RB[9%ZX^\Z@F:0;U)EOL5Z.':8\#,GBAR1/L&^-O9]9B#HO_2;XI+1F
M0X/M!9TV204XW]YC2_/U%#7%>PP#V8A<3[PET:V'/6X7479/7L$,"K 853:D
M&!OA^C5C\?]T=V71;*_1/EHU%$T-I:I$CZF.HE5#JS'V$*J&#JJEI(X:<])4
MJ08A1<U%47(.YXBIM#6D"$Z%!#&TU4H)4M20T!I#HH8_&5Q=]]ZU[MM]O>L^
M? ][?0][[6_M;Z_?[V'_?I/9-4&>$PE!.2H6@=8CZP*8_3 R_U99FK"'^4M!
M4/PEH<FKV#XKB% " P,*6=@O37O32CMQ.BLCRBRAFG]M&I+6$IB^'F/(K$R!
M2C%?<'S2659)[SD[_0CG:W8M'*(YLJAD.N,JP_9F[;K>A2JP_'CO2Y]QNPW<
M<C?'G+Z) I2F(0D1Y!-D;OBD G%XQ81P9-&T[N8DNK#;4I=[B,#:!2DAUFY:
MK]E5:A-8,=@;Y&9Z#B*N<MQ5!C=6VYI%=#"MKD&L\!;SL^BUM9.>)VHV<YRJ
MR.0:$KSQ>?C(1\HN2)K!.[\+&A !='=!281V"K^DMK<3(D56YEOF;V)%,!<X
MAO$Z0V5)^O8H"33,FC/4S/5J:&M]5!\T%I,[ =O_;O6@R^"IRROO%.IT6DJ?
MM8/$0.W'0>8B"_]SK\/AB'6[F\@B"'3,\Z3(OI?]1^RCID7PM>:#T\?O[D_(
M7KYO#ROIT)AW6+53.(#S)5W?<+>(/C0CWAS:L:% \N"5-?M^F8V%9<\'!Y4A
MB4+"]N(^Y.U<XMVG\G$Y1BZ2Z^]UU,J+*C*J! /;X!]?A>%$M_T1A"V/8E5Q
MZP?B+H_7Q/UHGJ;:-E_>BKZY8']1-AYV7$Y2=*.CVSP-=%GD;]!91B;%T[E*
M,,Q/!JZ]+#Y%BL20)-R]5G_%OQ3?'A2U&5"(40#/Z@ZY[;L3>$YYHYTVYQ0W
M?[+T,72&E=7YTSQ !:H;/0U/+P)QLKJPXE-],MV,9*A_\<*8$*<UW"#>U.KE
M;3\9'K\V_+:Y-<'_HVBNPDL7Q*,.'S%.(!4K-2^4!&*8KF"T3H<00G12E:>J
M*0Z>,K:0ND2T=4CJO4PO;B+&W>IS/.&0X*0''6SXL#+WNO2Q?,CZV.E(C?VY
M2_8@%6N5T*=W_-3^7$C;>]_3YZ?#]BJ"[Y6$;WF[(\VE+3R.J>H3&MSFWVGF
M('F80PU V$N,K=RXJBF=5?2*9:'1:>25^MFG\=MJ(O&3W\U,&Q1I>>E KGU
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MO+G5&)$=O,IFYG>JI!LW_3NE]_SJ8AOD^Y/Q%D8,I.![YE-><@=9EL.@KDH
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M50+T4('-7MH!<TK3[JB,,]8A3/O-#8$X<,4.]/\UW"/FXKNC_P%02P,$%
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M9Y#4V<M/#IVX_JR@NOWP.1U[CO3=1T-'9,[K,I6Y_X'VOR/[?P<L^G\*V?\
M]E^XZ*"C^_;L;MX^"1 ,)!2J%2:!_A,_V^#L](Y3XBQ=QJ$-?$*^] CE/)UO
M,B;49&"@:XYQ6J[6 +K 'X%[5@[T.9E!;3(+$$L(8N;;UM'[]:[QS\T:I,P#
M0CB<<[QVP2O%#K!8*Y:J8"PS<Q2@>ETA<QB=R9$/Z<BD$,T E"EG;B)1*_!
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MFD.)$SI>IQ0UHX2'U%5K3>XFL0)PRGR#MIXOE-,8E343:!^K[0@;9JLA^ 7
M#;GZ;#P-%D,0YYMR(5U"U7>V1S'^PYK)$\.EC6/H'R5-3='=--N1!R0?GQ;J
M*.0'J7+5:_KD68N81H<I1(])I^5@[00:MO0]S'W0I9 "$[S"!PP^!=??$IX;
M:3UH;/4&)91KC-L!W>9LIC[0[=>W)]Q\3U@IJUC\Z8?HKB^=GC1_]'G*_6V;
M587%#ZTLE'<2:\8%]RX*:9D,#2PM[4EK60MX 78?3E+PFZS0^RQ%>?NY\-TW
M+BRN</ UZ]0QX]!?>JC]/1.A'[JP)MM(X;0,N*;50ZKM'8?\%*<Z"9"J5DF5
M%W#JT[X>ZM&_K 7SI0_II@0:6<9W!_3E\4.W1;503:K4ER596?JS^H8AY>B!
MR.'SWX8M5]>E_/RWP+@AY%[< +YQDP9)51)MYN+30M%QX$,_TH@JKTHP&FQ6
M+>9%CTZ?3Q-Y;M3XZEO,N?:P2ZYR)2,^PS_XQE@'[[?*<YVRLH@ (<'D1=2^
M'9#8&<[2<NH^:Z"4M8#>0#.1T039T"BHK77S%D8#(O8&UG%__.S1R[V6<6?>
M?[RJN_Y;J/F'O6VYR5(2!PFX>5RALFF,VNSNJ^OHIJ@J=[X:)R[?Q/A[*"/Q
M'^"Y\48')O#^[6,<4BQZ83?#7$OX'N-4OSMZ!!F^:G*'*$M,G.9,$8N_,5*W
M=OPCRR>Z6]2%/=IJ5_2=@^]P9ZFA5^=JA)]:45.IYRSB;XV0"@.,VX,PS&-A
M*")Q2W_3S<89;D%MTX1=!8\2I;GH#Z^H?NF'^0J 3Z$%1WSV<:(RX6F(:NMP
MR XH*:*'-KE:K]FGME9O3N4H)6Y#W3'!'?2N&6)P:"3I^Y99+=X+5?$5>4%?
M6RRBAZ^"K[N 7Q8> #20R)6U-/$@PB:.P6FQ'&0W,J2O_$)&[( N,9KQP?B"
M-4=X] ZHHP-@@+=V0)/S+E'X6HHF1ILM_"W\'&^Q^X,ES=]5(\*+F"3;J5/V
M^+_Q!TD%HU"UQ?P]K8 ZI!T9UZ@0FO\:Q5KNUPNY"6-E1T[AY<XMP54VNYWA
ME_R;\XEBB92<M6LCNOT*PVSKWBVB=]2(($3JN?/0\K0>NLT?[Q("[Z0>ASU
M2V&UN$YQK]C4+Q.\XL]"I26\@E"!?[P&8.DQOFP[ .@K%5P\6S5&>)!OR'WV
MN0Y/[[L-C("C6\W98$7@[C==ZJ&1;B.SIV6*TY'M=/>Y/&$>BC=VWYUZ_+_X
M#.NR;<5W!<B<!3=J(Z=$M\60HJC<T^&^I5="+,4Z"]Z06V_3'\=S(I&C:UJ!
M7I^U0I//#S&K75%4<?^</ J5O#2.&'V(@>Z 5KY%+8VJD=,E[$/*&CF_NF/]
MN<GU4YG(N]\_QSB6NDK9IQX)RK2LMJX;,QH+F2M2",YIMI\K2RB*?V0Q];5X
M60-(;"B([Q@F)Y'4[ KL@[9MD@ 19FG7(%U;D2'ICSO#">NT/>E+ASS9 ?FN
M2?KOL@YG?/E#1*62.@?<-=6O.HN.P8&7) $KVF$6&7"A'CLS5E5URQFGEJ,Z
MQ->OTA*D0)4;:L?#R>*X,7"=:5HLR2)R^RKV)K=_E9QL_'A<G\J) 7K:-\,H
M4B]Z&,=G.=XSZ47+N$.<U?K^^O@X8T/FM/P%O57S:Q/HM58KI@"-V&T!G^CQ
M*?Z.12N9KG3M3,OAU->YYVRE$SN4#;KT(VH[G"I,>W+T+O[(P_0]#_)^9)4C
M885XV8PQ"L/FCFEX%B0^\L=691H%E=EDFKLX$!K*Y*Y+P9\+SA52#50$U11=
M3(0[PAK/\P&>R,:3-MRO=PRZCX;@$]3?]H>58:VXR#A=T<@ /9R$+\)[KL@7
M898>573G1H55!<H>>$$SLES2?[&DSA)=:Z8H B4[H%TI+,Z79HO!+>L_A]I*
M8;S^G-"S/M+G\!K1,*2G964;O;0#,D]V?C^\[K*QASC]42]YVKK8[WDO1\?"
MZT%G9[/!1Z.RM>N.!0Y.Q161N#_S1Q[31C.:3F:<7;3$EK?)&F=D9"#:2C6J
M4T?<9KI&G$[EEZDZRS1;-XR1Y97I0Z;2R@?^+Q+^;P(< ZO? 3VE^ELCV8W\
M$\58D2&AH78!*QU0->\@*3)5&KT]N=HP$23_=@UWL.MC:RB3$2-4;DW 0 =9
M%X2B+9]EMU7;(U(;*K<R?SQ[]!GOFYV'4^7V=) !M=A/S944,<[N"ECA#R(Q
MV[Q<_"3\5MT0ULM+E3:-=A;4[BHDD@\35\LZ=6KEKQ:.S&Z*'5DP [K> N8.
M7-.29T6+L*/>W/N$H^,Y,@T\^*X8JS_QSFHIE*/'WNZ)IK$Y0T0'0/K<R_M-
M<7Y&M24-G;,S)D-]FNKXZFU]^/.*LH^B7?TLIKV864Y9:CN[:98:+C];@RU2
MBY76WP%=!%[.7:I()Z)818GD&SFY2!VA(W7VVVN\%"1A!W3O:D6_ZW5"AXXO
M4H&T;GULBC;!HYP?:;4.B.)0;&7\Z>2D8J[)3';E=\3XJ[#9*9@X)F*PO5EL
M!Q0'60=++2&R$_GN:-:TIB7'=A[.E\3WP.K-:52Z:(]06? ,=P* L64[;T(/
M8IZ#)0"K;OWA2=<NCJ UBC,<X'5GR!XLA4%$"B+ZW)[2;KLN-FPV-L*=97/^
MJ1LF!SX':VZSR FPV5?(GZF#@.J@X)7(2L$.J%SQ@]Z'=U<^>:4OQ#3Y'-X^
M//PHINF,W*->RV+D!5+8O9RV%]9NP@$FE3AM'/]]#%+4AA9COAK.<B)X.QF4
MDV6=:&;%.C,JGX#$\2S3&_%MY5G2]\&.=G%X642(L_I SFN:^>]=!HA^@F^W
MW &AP$D*8;'0$UAOP-6/ ^_,V4^GM%0 DKL*H[9C)G*F>3'B6'WY).9%%YU2
M]-:VM*\$)>G[SE]!)GV_\^8:[F"1],I!QOJ:\% ZMX^UL"K*P;/(M!;;)'C^
M$<+L0A+6,%*0:WR@&$.P;MS-H$Z4V%^+,L*3W(-45G)+Q6-KKW8/]9;1.GF^
M5D"I7RK>*]RSS+_6GY[:D#FQ VIWV@'-9H+K]%?[MV]@]%D3'4AYK!QG,][8
MA.-%8QPC/Z"<!>)[%&P:M1N+ 39+-3$PD!30JL=9ZQH7)YK$)]=]>9/O;BG:
MT!*]97C!*TY-M0F@SIJO!',KA(<]V<N0$[AAJ ;!%-#GXK9IPN.C5%_R9#Q+
M-=6+, M+6B5#F)R2:JZ4&1<94X<7 9(_;'7]J%6.JRWF7P/"V,@CZI$F=\>7
M!EV'2'5@J8@Z+M#Z^(H\]IWAXWW[C,:(1P"L5OAH2I[\0*;<>.?=:H-7'23,
M2-&A 2(B<6#T-U%5_N?]&6F!8C4%!-68U58=U$DO%GL0K]S)Y!MW<XD:P@E%
M6Y.^,YTAB][K-4?)!Q(_O7U(NC %CNNPVVK3 -Z:Z99=KV/;PX8;^1JV"9O(
MGY*"$J%V+"Q"3)0&VZL;^7A#R7NB7>#E<&UQSC_H_8]5<[[:O?<[H'\:NV'I
M" IND^^6R+_:,B'\,T^G0^B!7TS/3F=VA8\J:0C*H-+M1X7*G,%XJC\:]+(H
M7UR>KZ( _QMZR75Q6.VY8IO#KL_9(.XN0EO#*B^YWZ<="N5$K2Z]<=_'S!R=
MD' 5=P&\MO_@GP?:PO!%&/VN9_@.9&'G"TPR<R*Q;A7>CI3B:Z<]%N%":'C9
M25^*[E# C/O0%(/A^\ROL4M^?;OO?9#Z3,FQUC,:=;\OG3A+U@!\5L_LIUN,
M)Z7X,W\3BYU5\N0M2OMDZF$)[WYW'R%A/"\=H;BFY^9Z_OVI8..!J4M7L(V!
M2].@Z,M(W8QR6ZU.MKI#LT.N:W7V#NCH%&? (U1Q,&EK$8;!Q+/7>@(>B6SL
M@*Z/4LZYW3F;SZ6A3KKC;&QL 6_&Y)(ML ,"S&?[PV"10LF\BYC:3QN_\$R5
M%\Z_@AF?IO.#<R?:[-RRHQ@S@XB^FNUGO[VY^L+#5SGG6.)=9ESAJRH4;@]G
MH"@,%4[FZW.R,@OO?->QV/^P2Q>J^#Y)3B2VDMP)]9XN-L(5G708?+05],X\
M3@UV8[<\8W9 HG45*)3)5>;@$Y+6ZNDX^HP!5KT DGU4HM+N-/Y==D!"DOY5
MG9/>+Y];1QPX\;5X]?%T Q_V,>I#8=:_\P4<GZ>K7![^",;_:,C/$"WM"U%7
M$%4:V]\53F3]0D!3B7JD3Y>GOKKF04<^YAP>*LR1]Y)X@)E+?77>[("[7,7>
MP](DTYN#@XQ8/,<:.=G"E.U*P&EA(L1EEQ!QV>%!;S$^-*6SXY6AD"/ 71Y3
M.57[@E;VS5VJFFE7"2+N@ +]M\A?&-Y]@L(M4=1;Z&PS!Q]##N8-B@*/UTQP
M8X5^V?*#;K\;R(3N9@WUIBLC 0UUMF^?6P6(7VT&;G#R-V$! )+SXS]39\EB
M;C[+\XOIA.Y6![;YBA='EBU.HTIBY'%@S+D/S6GU:!$>.A5[9A8OZI=__K.>
MXM7W$!)$2WM5=]EBOC&<-,ZP?Z=_6Z6H9##LOD^CWW,6I.)[P95ZZT4!+N%"
M"V19*!_5,V^^TK0#VM\-.'%4UCHC>CJ3"6)\S+A>Q9VZ:2-Q&3YTB,I4Y @)
MISJ^]NMEQ9)F,$3E<;)RW($7SOK'/P;X/K]#[ZS^.MT7S O!UZ)7EF6WR'_C
M#WCUV$*8/D]>@#<'8C3IOB5S*C^FJ-. UI[S#>;/S+>A_ /) G@[..82NS2;
M,]&>F+Z]8"K]4W5UEQ_WKW,(JS+YTK6<K%+.PFP)@?DB-(A'.,I73/O5&9$Y
M+?1JBUYS'#:.G%U5<I>\^=>(AQATC:;?G)JYD3%QI?F;,SVV_XE KO!YQHOF
M0,$.B-GQ<1&];/L3&?13?R5L6[M_6Q78YP+@C)$%&/J(P\0WKB3J,51DU/A,
MU2 ^="_"XU1$)%D)TSWHF';UJHG&X*[;J.&L*V!EX.+!QTK#WUH_)K@-F8HU
M3$4TOC^?E:#9:VS'49Q%I^E5D"6!B=F>#KP<)NVW%KMM@F_'6>Y0.CU.EAR8
MT;3ZLWDL-$#IQQ93*^!TW/BT=UZG#*=K_[6[J2<BVDY4C0_0+AGK,PEBP%73
M:LY$#!96 ,!I.0AKI5=O,&B+=Y_7W0VUM55:\BZ$D"[/C'</J;:\SU_R;HR^
MI-SYRX9)S)QL^%[X]Y'?#W#=>)!(JB++8 AZ1AQ<<\&:?8V[P)[E7OVC_-\&
M$BD]D4H_^-$K+/9!ROSG/_I!\1_OQB]9_HX4*N)Y6MNV7ZA,,MY[K2%\5]9L
MJ_(A.Z!8L-^V[:NY*,*_NX59V_^+SY@.OVH\J/-MJB5I)@TLA20LK6N.?VN$
M59?:EVJ$S2U\2Z[_[4Y&34[=#_+2.=D"X2&1/7^]\YC\:+<UKQ&G2'__Z%>Y
M!_WAPL.%>'WEW^%%D<&:L\*O5V84FP'([+^M\'(4 II%K5_C2\W/CZ_]P=F(
M3R27<)4)J]QM/7= WXI@/;HKH:]&!LBZ<;$*,HDLV^/FY>[(7>W>'%?!(FG2
M/'3'=%$P$105.=%)Y=P^+OXA?:]W&+[[P2ZKZJ89&)P3'C'<UCC.N+3OFP'>
MKE%#]"\P<J+5A_N C[+=B[&B44XV<TS)?Z]3CZ-V-X^T(1I>N9$7A%-!W"E6
M*%:@FX>)9=4R88?HC.]9.,66-B-T$EK/3R_5^(X+PM]M<TSS"OVU,UQX2GT,
M-=;]VFY-56XQ,H^WJ7QE..44]#Z#+R3?$!/5FBYW?II)D0NV7I2)G);^B4^M
M@J%$H\(ZA@%H'ZV1'L;3;@0G!@RU&C5#^.>#_7"7DSKN!R!^C'3ZW*@??\T4
M=*<T/ZAX2\FA:.UN2YQAU<',!YNX@Z;;E@2))3A,?NT5WR#$Q'+0:KAD!+O/
M)PA5-@70[ A_C@6&0D26%'*;9X@5F"L_.B;N/-'BZQ3ZRC9?)J82$JKT7J>:
MW]IMP9A5#EX*R%\2,"::E[D"JTU\_\8G<<'^R!>NFV[4GYNO)UTG(WF\Z@+5
M3^MV/,L6I\")"V_AT?.YY^0%YJ8G;N]!&F'=!>G4>P2Z:&<6]#*PL:TE'" H
MMB)+?!_/R(U@X=RPV6R:;2+T_ A?WP=?YM^ 4ZJ>P/HP\U".=9]7]:Q1=T9)
M=2^UB][M.FKG4?+91JOD[3+E+>VDO:L/5K#7=D#'>G>%7"!^&(J_*\XW%?^;
MP?\P]-]^.S&U?OLJ96W-YU_*\=U!G+"=(-YZPXO%  D["360:&-XB?G;&R4
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M.!$1UU0U3Y^D_D>PBJ$0 \;AN/3ZSOE7]P_>YNFPL%H&42B]WK<.:.,"FX:
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M+\BGMBKO)U%L,Z+ENT\/ X=2C>R(*65/:-=_R#^8B5_8=9YD0%.?+[5K*'=
MZ:VN'"K+O.=UNBBP]J%Y;BW>V.&-&_\<,!>I\JIB\:=<U6E7 81)Y&6_=6WL
MTRLI(C(\%IMC*_^9N>/^E6Y[=&UK'U,0;,N%/BW$9-_4)Q$Q\3='0OLOU6MI
M.GZNERI=&G_(F%042+G5C-2W*:U/N?T96$?RLGTWION;WV=]O7?\A_R;]-_)
M@LH=T%^0R06DH)ER'&AADJ/Q?N!XQE$^#)QT#YA3C<%[K=&S6>BGNF1YK';3
M9S;@CIH5C4Q_BKO,(22VPMCJ58H663T=0<O@(P]:P;/JT&ZMN):2]@KAPG>A
MJ*"BJBY5<Q?HJLELV_4^YY$'H:YJ4 CN([T.T8M8DJEVG^HB^7J @4:.J]OG
M#=VD>U8"5>=A71+<JEER<LDH@/A-RE6U[?6<H0I8)&.BCXNAZP5A_)R[+]#S
MG.0<[7G^F7)__5SLUMKM%0WY9XO;8CB_TG7]U:G1S&,7V%B: >N3[/$Y%Q4=
MT8SYV^W?UF*X<BZCY+A,O80L3457 Y:&3L6AX4[/=ZWKEU>,H=0;%XN@%LQI
M.4&X"[V[NA@3=G,,>XTE!K?^7'=*U)HRKM>&OD.I']%-!=\<T?)N&ZUWA]NW
M98F:P*Q'5F9S?FQM_? -"-#RS&*Q[K!2OV+[YW!3="2?BNNEZ$_M@&X3D@FB
MQBOXKSYLV<E&_-0X@\?]I*]D**C6"EAH'(?=WQ401L6/:!=@*"!TVPX5ADB;
ME'@QV%C/[5GASJII:6><XIX9JY)4WTNH>W^@HOV.O+[L4;,CE=I5X_KB\8^'
M>7>:['(>3S8'#H9^WIY<R& >UGA_=$$,GN7V+,OJI1>K%!V6X^)D'*!^?C6D
MHGMIT=K$)I[&:("MQ+-6P\PYC;MNSY\P2>T4JG"/$7V*OBN=Y&SV@..,QENJ
M_+=B%@,\B;Y;9J]9R7DW'$;)5??29@:Z>V<B*UY]NUF0^,W;83T*K[$#JH'6
M[X .Z(_@9PMW0#*Z:TE%;$:7N^HL+WE6<)7%B,->BMR^ZD<YS0W[>TAX%A//
M"Q^J=\=WX;2 L-G$];(U;!A;7'(&%FML 2T*/LT]F*@;^=>SNG3&&N [F!BT
M ^I96+':=G+98CL)GF]<B$Q?L:47.5Z 3>_/#1F47EG PHXV2IG%2<E&=YF5
M2(DG9;!S/%71E=<<2T^4TPY<-;#4.Z-L$U1F2=0HMPL.87*_BK,.!)[O"WK_
M=4IMH*;\Y8.IBWWJ0Q4T^?IC^)6EGS3XVX58<M[M1VEGI1]NE/5)F)6 96](
MQ64:/2LZ:8HNKX@!$KF*M%V;O*[6:LYRA_7DY!.N$-%$92J-&DN0HD!0%:'!
M!\8Z'_4QT3'"XUQR(FE]+&W Z?VXZO"Y82W52%=4Q?= =&7A>ZXXX$>5Z-D!
M@0DU8:M./NEM.Z 3Y(XV*S!P#F@O7]L!-42VK^9PP?2KO#= OVH[+$%K&\:7
M%!1AM;CE@W\&V'X(4U(#1()99/$9?[IWI^R(;T1>?F;9\N&Y9=YQ#]_QB6K)
MD.7E*?=KK5\"B'%(';%,E@9+S3Y7_:=CA4UN277(N4-FC^SF\^Y$>4UVZ\]G
M9"JDFEXIT$HO^?2^%-+A#7RU5GB?CH[OF"!;IM14AEK6^YCEEFLXOJN?<5]=
M=IS[1K1@<7I#E>6:W\%1WPFQC'IT!SBE>8P2/RN*3IFH^;KDH3Y$;3"^MJV#
M&Z;LYT25U,_FW8 /M;H4+N4;<]<Z;(\"JN;C(6*1?XQC#<O\$(T)%^H/&=N6
M3&/N39V*@*VP=S/, ,^YB9^"\-*Y\*=0%:"(W1B+4P:2F:&,-,II_YE]=8#=
MMCXPU<E90AZG*&.MN>@N=')$=P$++^H;$7-\<M%#G1LPDU?L:^=FP?,L\Z"[
M]8CSM%X1>%9"A87V9&$M$[+J2-CTQRN5[("&T7L'"32R_X^!FJ-F[J_N7KP3
M(8VZ(0ZU]3M"1=BC9ZSH-\1BDW(]U<R(>C:6TH[L5664>?ML/JP/>!%7\W7M
M8H_GP\S:(QZ3MTFQX8X%TOZ/4&)PG7Z519LZC5$://_L,8I,B'_D(14BK+RB
M'7<9-TP5Q>WI"@_CZD'5OOAN^<1!6KTK=^4P%20TYM_BH.-;]8@D?G-)&0NM
MP+\,H-CBAS'^)MH3M]I&]:Y&12)&R+JK&KICY(#9$6VMJGGVKN<F8T'0'1 -
M1B\WQH^]P8U<W@$MPCHF:P'XW!I?NHCW$2CPV[Z *1'_6^DH0$0S"=*^^1 @
M@#O.8#6NO-@VPUSO[F-2.]/%I@%[6RG?&2@W/AI[CFDKYJ]@.K<#XB%ZRAEN
M LI"I[/4E&O+(CD@3-[,/*GGOL$ME7.BB:56$@A=HEV39]$QGQ:2\96S$FAF
M4N85HJ&IH:F^\E!7:W#F-ZSA:Q^YHR-:G7=K5I1O.1D;>QWM):+O9[+>.0:?
M;*Z_V:5G7UG&.K$X%(MX5NILYSBW;<@98>WV2N$%TTHK9H J*RTCYV36I9GT
M1/P^H2Y?-NOQJ,PB:2!=O!L"PDBBC_?(U;Y$6KTQ+^LJT:&7%//2H^XU*A4@
M7U"KQ5<KN LL\,HV$Z^$^[S;MW"7,.DL_=0J;;YY\2160T P=F%2#[M@9 1:
M\3'6E":V%J+/G+M_:SH%S?(>7U_U7F\*647;U#V%^.AU]4R .4,P*;3!$.SN
M(/V1P/7'M#^"NM+&3#9=O]S# M/->EQN1YT=\@GBW]0\^M@NH8/%E0M5T&5?
MKRP+=NKQ##_Y9O0^TZ.FO?Q9L'6'98I4:E-X-E5[)3WY)W]$K:]6UD'>H^2J
MJ*WLQ[A_:TV=3RR34:9.[9X>:&,M)[.0,4N'KK%<G_[^E;F(VUOEE$O !HM,
M?]J!/T$Y^ATLACN'W3_$!W,;6;$,FM856@\,A#N#F>BDB&>; V+<8/8!84L4
M2VL?[S403@1*3,QV<T=Y(-FG> IPZ%@M<0&>BY;56]L''+FY0<D6RDRL7HW:
M 9TF3X*WK\)", PV@[:J&!@13N7$[7:Q!C;02H:!:50J4Y9_8IOG*&BBZ/UG
M@6OQZ<80=#'_="O0R$X%STYGI7(6>!E *CM QY3;18[A!U42$A'$#.H1J'S7
M[(@/AW"+VT9."!4_W,6J>$TX!D3PU,\F15U'17E]_O?R6WA/\YU/@2XQ1&/M
M2^5C2W-?MH+*CAHO7;=_4RVM#/91V_; M#,FFQ]M:M@P8#U\.'P/;5DVXUZK
M]>N[9?>;KF>)'HAE&3^5@(N[7BRXWGHF-6MOC/(J$[Y$Z2;>T63)G'T=^FY]
M2' 1<V6DVQFJ,+R*.[T\(\>%I9Q)FT4AUIYBE<L!*1HBAA3^D$<F @ZN7'*G
MN\/--,6#]0WOT]:Z(]AN,S>"HDXV_/.UIY0>,L9%1QM+;'L#L':*- >:RH)-
M$OX8WJVF:44:(F"\MH!_#RBM'/0I7.1MA<CF=)/"V>AX>,0,*?14\U=_1.9(
M5_!;CSZ3T;7YWI6(=. :[$$%X_<AX3!R[WI78!D3,@GO<G[4+<Y))DCC1H07
MDYSW"1&*AS+3H=?3LUHC7B)LBK_6'CV*-JSWO7MAY(7?6\^']7X.UE??7G?[
M!_ J-)]@UKHA:$SF,:5!%:99QCVB*R10TI%%E(?WZ[BI:$JR?N1%U E(SGF6
MR?GVT')RG[@H;HI1\P#6:-N=IXU,5]J;[L@%MZ]-HIG'XDOT!!]&0VT3A2>
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M1?3; 7D"3SF:;/T/0&%#OFC"^C9:_ [?'8B:E2+1$=?^XGP5%Z.]G?J^S#-
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MZ0E6LP?G>\Q$P%&6K2,-VN3<WP.3L6**R'-/'/#%QJ/E;+/OL+%4H/"6HA*
MRJ+>WSP#9JXZL$UW,^9C/.^T B4)J"4 EQ"^F6*FUSRZAMP>7/[*_F4@?.@2
M"H>(WVNOM?+].);I75 S*'HF[$.,1][ERG-#CYW5[RV/Q#\$([)Z!QIF=YWM
M=%;TV:00LOVL6"'!@@ )^O!.4LL<(RFO[R]C-? PHJ#64R2A>X+WM[OSQ+,)
M;P7KMHLGZ^HN.N?$RMR^</KZT8?!?UCR&6DF!$2<+/TS_/=__SG]VQ^_R[@]
MJCMR]+2P4>H?"?^MU#TZ<,"7\P#7989;^Q<:(+)_=_8(L665)0*JN'++PW@"
MWP_X J]SU' KB8#PK]_V71>5_ILE>/H_^_NP=S$A "09YY^5?IDW0A4,?_::
M*PL6U9B7<W\''Q%0QY,""&":4[&E;;ZMXHL*N*+A5$3T])S0JG0&"H^^R9IL
MQ56L-C% N075%(,Y/AYQTC+9!%H*-EV?Q.BRD"HT;V SF=2^+^X]:N 93 R?
M\;T]H1W0.!X^S;&:8+8V=9 */*.3E5VL[CU[]O0X0<, /M[-RK5,(+Y;5Q"P
M.//2U ,Y*)+991=R%Y_9]:'M[R=#>N4N.O4B,C;B^2SVWUZ6M=E!9UYF*\@_
M4)1 =#LM)?;-AUJ'=04^B8F43!UL("T/%5GYL473/:HM"/(^(J)VB= CR=U?
MS]Q1T4CZV<0;^\!4W<=#@UV!4_E2*?.6X"([@")9UE4!8X+A60*&61'?F1]T
M%(Y_G:4OW$JE65YY_&Q96BJO:;GZ1&/>K,RYX"G.E\-XB@*GNA7U]U,.^ +R
M@*R4;5VQ+&'L,/6XR3G6N;*0O*CL;V;JP"8-)K3<MI1$3EX/S+,U=*=OOLH3
M^F#&]FN+3PB#Y%]X<, W\&.]D&,(]N_&' X:"_<5(BD!G-[OF!N4I%ZJ('[*
M3)Y[%GQ:$V(DG:[2#NSF5W)O 4MI9A#$ZL*F(F$CH<ZMXT<J"2>-KF5))Q<,
M]^:%A?",V,H<+YP#[PQX!(AD\?_)DP</^.9+TO& ;OJV[B_HH&XS67 &>-#?
M/7N:.A%./;[\,/@*5H'=_S0\2Q@..64"8\Z<1PB$_^R415?]([7G&OM B4+G
M:I>!TO9-21SH>W<SPW/]-Q*-ZF7KOFNU%:-RAQ*TL(HRF3!'N;0N2P4K_XOA
M:G2"O,6ILM[%\="KG^;/)?]C8J'R<>!RR=Z1[7SVV%/N0Z"E^W/+L:3A+0]Y
MTU0WK<?1:3V+K3M:+<G5P*R[3,"G#3EM@E:?F[SW28_:I.$%NT0].5?M81?^
MI##!%X_/YT+)P<2_'!>&LSJ%C)9+R+!$TCZ4=O&99,NZ$L#J=VP%S4-/&SNL
MLB(3-QX8^$I@A-JRS]5'"(?\Z,6=1/XIYL6U':M_X#>ZL-=O-TY:]X<U3I#2
M.-J.-N.$WSO'R-I&*T+K9KR!%>4"QM; %L,*N4%XX!>>)Y1\X;E,6<1SPS]^
MAX4'R7AK5K:DN3S?@57!-7LWI2:K@"LHVJ<\6UE)]FE\RF!#)D)WZ/+>:%^
M3&QEN7J_< 8^"B%J)UZE9>>;[(89YENYD><7V^WZX'F[N82SXO_GUBM.83>%
M>RY/?S:7!V!R-!/Q\X,G1P;P%U+=/E^VDD]^GYF)][9R.2JF8:TF_./: 9\
MZ$C#'@6H213)^1EQ.V NGJM:#I]5!.:2M@O#26/Z2/';I-1^V['[R/(C?LU-
MI%BU>]>SR4<" Y6SLK CO N 83Q)A!\!%3<18%*EP>,XQ6^S<NPK32QTG4Z=
M&>3Z@I#W39I14&K@FW']#'O=^V2%:$<Z1;RF7Z(-G01C__'#<$H,?GKE+G3$
MH+#V&\,R67^Z0\Z'3EI'W:::IW)L)NH(9 6C+8-GRFX;=<3S!0RFE-O",Q>W
MHEO)F7P!#@*M0_:%A8]VMVO&<SJ6G=(U;^#=6@TCC-ZDOZI9U7A44).#ERC
M"X;#:YR6^XK41JIOY*@K6^N?_S:0H6I]*2W>6:@O?/FM==H7IR4[IY>O>)#V
M_5+L<72TY2A6?K5$H(Y4PH_^[LV62F);WF@"8^I\,=?H&'/6OQAG CA !VD
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MZQI ,B$*%>-S+.EDRR2,\0'?B<U$)3:NMV2ZBJ50M<9A?F<I&'P%3^X%K:,
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MW"%1=_7OJ- ^>OPET$OQ?$A9Z=HB=_> KTL2][L(0V37E:W;#Y/DT4M$N+;
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MEN%^Z86MBUE;;+WM3\:.XAZJ5J.>W]'V]U!*MQ]O.\2U9@NF5V^XP<" EB,
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ML$CQ0:0;IF3.,EFWU>**MRQE2 0;'-^IGA(_S5 Q.IU[2U;V8?Q9\0?%ED<
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M;.@F9+[0OL._7E8*W160KML5^'T$AB'O_^>E<=&^AW8"2D&6.RFFM7HKT#-
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M^U ?PHJ?;H]ZHK%S#3?B,F57_.(Z;I H"KF@3V846M4K+_-/<2VH<D?'UO:
MCIKS*(EC$M=+LW5#< Z6E &-O460][<'$QIRFMCQ-7EK<:3Z$;WJ(-HL:8X^
MM9\EU\K^@.:?!?PJ 1UD/?" '<-869E/H)JP;"7=W.#B -V*G9M"];Y7C"&^
MP4F]A_9+9(>#$^O=Z,)HONJP>EJK""'ASY$O[-7B +RC ]G6D4!3^5+/+!N3
M7[SY..\Q\GR6CZ^UKII%1H]33;D]S5+4U*'<!_5A /5IYV@ KA8NBS@JMYUR
M[FHI CMH<'V#@0CI'(DI1/>#W+:"6T$!6Z?$?_:R=YCDE?.50!&-!CY6Q8UB
M# E?'V!](+>I J&,@*^5 :'5YB68HRQ&83R!,0-G9,>W,P)$KS5,8(-? "0X
MAQ1+N0?18X&%D9@SDTQ"8C6YBG+*?R$H 0?E/'/%:K<#KGOS?T1N4_@5'NJ-
MNP*Q<$>W>T_96_?YRI;:_D.ASZ-+.ILO<"^S)PFZ7S@Z;<32=UMW[TRA<_6-
MNTO<OSA7E!*V^^.L+G:*BZET.M2P#,0RG^;6QUWZ(CQ2+N64A78H.&WH2%*Y
M56Y@9)9WN-/PK36BP-,6<E)U+,O)ZO5H9K6,>&MLL8I#9BG,SQ@]P!,QQQ[P
MX:QM9K)S.]UUNF7F.^#'N>8<D_D4K3 6R8Q!EL1$H.0D1Z&'8%U[EG[-'B)
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M1E2;4.9!CI!??YF;W[&!\. 0Q/$CY6=+]C+D;_.< Y-O=@5B<N744<>4DLH
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M/' OKGO]E[HM$,   0JD%7@Q(,LXQ9M/:A-TQ5X%]N^M@ML ?D<, [[X'J>
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M2/56HZH8Z4C06&:^ZUC<>_C&=@0W=W.BYH,+V\*CF>^TQLEC[>_YWR'T26+
M,#8#O"6;6//2X5W++O-:W+"7:+<S9U=F(QE@Y0W?9]$H)Q+W?AV06LB ^V0
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M)X47NG""!2^$[_ S!F*K;#/# .]U[LU\$7EP#?! A6K\+:7(,,![=9!K>4_
M!- $_$BR9R6J#8GJX1MQS"0#^N]B7C]VC$78O%YTCBBIN%N5(D-7'EME4>*V
MMV"&L&EVNZDHF2S)H-:,^S8R=:M\<G,0'P^9_;Q04DOBR-QMT WT#+EA#*ZG
M!"O&B'"5^Y3=@Y$,.'?L10:(&9,!YSDH@BT5/J;T%8F#4PK8GGDP-_'>[GGD
M6BLFA:CVD PX<DR9]$;N,\92ZH I&0 $C3:"^"40E I*>%9.Y$@@Q;5$D0$1
MIQ2&TM[]HR\IA+A% ?B8%TJ( .VEK/_^.%F9%.8M1)"$_U@].G1=B>(\$?JS
M?0C]Z7Y955&(8QF"$T5J7@21K(2,!\F K[(BE.@P(G91NI5/Q&=%2,I;3%\!
MS@1X? 7-36+97R+I%9/XKU(F7:;T.!Z%<(K8,B #OE/Z$'&H'QF@B62"8U;.
MD0$?J3=N+!W3]L.7*RA5M6!UMB"9PW(+3KQA2F+0) /NS=VE@$"B%.%A,S@J
M"K1< MXW: (2A=:1Q$SMOX/M8; V'QEPNRV%R G:^T4\D<?WQ9^F_!E ?P9C
M[!O,S"D748XR/Y$"CS3+NQ7X&C<K!:1RD@.\P.4_QZD0GKU+A>+Z4C0(AX^@
M:-6P WZOTS-8$,Z,XO3HKZW1(0:I0]"?8_2/4%X.B 'OV^*&2(+7X,0Z]>(D
M2FMBITUB*#@*) 7G$#":(4-DP#_B\Q]1?/,W%/L-<9NDA)"+E/F#+&1 UKD_
MC35](\(E;B*'.V$^ 1Y]?$DI .CZC,^NSB";M5*U?-0O/2KUO#;_%/(_B^2/
MOR+P_^8(S/M/1.!?V>ZO6/O_(];X'I,!EN)__!GG;>X)XPJ"F ?<\B.M]I-"
MLGK8R0!!$._)34IC$0['F5Q//H>RITDK8=H\#O#>]@/?AAE1D) C+>8#"?(G
M:K!;7XGGBN:AY1B8@Z(7CW5/O2OO-T3LVZ].XS8\-LO:DE^./995]1]JR2=&
M.*@[8XUBIN2(H!O>Y<R&"O+2]GKCR1Z1[IDW'[>_D?CB8=;T:.,+QT30%^_D
M;5X-ZL0?53"98$<.I-\M<'/)R7.]W;$"R91P0>!I,7(YM^",&C-NQ.B\>\B5
MKR%*4.R*[<3!+4>%HR9]&7#?L5:!6^5"RA67^#%/:OG[(V>J[Z,R$1,@)J(!
M@=L+8^^U')6/*"6<'*825''@WGRZ.GQK1)<V9W(KG 7=I5@)>2$4V:7+Q,W-
M[5&Z&%SY94=B7$W3]5D)<XGE^Q9*B-R%$ZYVYRKX.S"VU,?U["LY ,.GV8QH
M7F&0]X;Y77E^5^(H:)^E0%B:-1%<.?=>Q:-YT2JO$\Z!UGBN_[H>$KN;93&O
M*^[+__W$<LCEU1++KR=?HL4'!/FBV;(@.:XW@Z75Y1FU:J1=W!)+XQ%&? XW
M2$\=6.]R7ENR+.>7K#!L*C4QR1#.-K_A='6VFC9 G.'YS_DKNPS/?AC2HQ8R
MEQ27%',;&GS4ZUJFX:Z[:&KL:K]0*/B" N@L4:P.AXCL$82YV=_]W=^R*.S%
M1IC!4)*'V[NY#71_"Z]C*_Y<K)=?.T)QX5HIZK3GBNZ55X-VAP7,ZNHP<4(5
M;A=5<*&+%B/AY_&<",:;[_8CF-<6Q5/ZE'[G<C8\,5Z?)BF%\S&. 2/*]KPT
MNUKI<%N0GU9U5D+1E/R!H@3]J.*J.M6$07]I8JOX@%+9SP=#T@VCA[O7-9T^
M2LG1A*6^+[>E0'?N#^@.P\T;*#WMX\;:X?'1 8N6BNL/DQI*E#\T4*>_>;\J
M/MTF-88;;):8<!#_7LGA&&'U@OV+VRB+7JF:=-ULY!)10IO3V(6_S68Z7RJ/
MQ9+>H,_7Q/]=UPNW4ZV:G5V@LZQ+>\;;YO*1=J 8;K9"8=Q]<^LY'M'WV15S
MO$X&,(KC6"))2DL$ED'OD-%<K8HJ],8+U\CF=C\C-O7FLG6;ZJS#[QLS2H@7
M3UV3I\\Y^7KQE@'$;7N-8=I3)'JBP3A1K!)V;1+NB6 )&<Y.A9G@;Y_P'[L4
MU!C@-7I3,*630,!\S]4$U'7;_AF6DX-$.RUU$PCF@'*TF"GNZ[,60HG4Y=IB
MG=PM:2 .=$G6IY!?MAU+9V-;5>-9.\5O#B/T<$9$UB42PV?<K@8A%;/$0##5
M:Y@@2:^]) 0-L0UC;=V !S+7&3_RK17K(UOCC*=7#)L?#J30:=VL]C;&D11R
M>Z'9?7X;TBC&Y$A??D^N5E#CX%WS9]!X,L NT^;(K&Z\RJ;,7I$T]6KP8FY;
M;/OG\R!;9'=H?^F'Y=/7HJU)&6G/]!39F\Q(GU4'@,\/$/Q$\(2Z$)&%T%RY
MKBY.".3>OEI.O'&:MP],X/V9Q/QF:F T>0:%/H9FZ5]E+4XSL) BK/*^&2E0
M=/;[106TKTW'#V%24GID82'CZNJ;@H"I'N8G@CP$3FR0_15F]9$90P-'-8T:
M7:R X1A-@VCZ, 3BKMABSBS69$RO>Q$1A\2@P#B3KA';][R0IBW!'P4#7,DS
MLNWHWV((H_S-].:2>4OQB\.E7@3A)2)'37]8C]#Z4S&3]+/X6X6_)FCH?I(!
MAJ=;[O0,*>V6XM3I]N=3HAJ*;8#]M0+)5YJ*)5:>K#0<0ZN5VJ5^])D?H][0
M&9.&*YA$G<0/W&^TFR;DEIT6]8!R%,,0(S4[-\R\,S-FNMJ#-T_N_0B>]RIK
M.3V#-TH.X4$D[3M6$X!ZW;B>&CRD]P6B;XD?VCCDO<$K%+6_K3YWI]T2IQWC
M.GY/F=?\9YZ'3.9ID_)TZES3[UH;L'1QX.K6RLF](>PH[^<5K]B>F[A@1"Q1
MZ 0*,_S:Q5G[H05MUR$4ZB43(JE=;CNK)Y9:_-53-EN;E<,YLKZ%X:8=+/:/
MK 4D7'T=1^-#N#QNM:TE(Y(]\%57 $$#+Q9QIW6\I/O@ 4MV?"+\W_+6PX=0
MZOO&R,^78$9/WGY.@_UJV7>!I=T?^AV9]=''-^-9#[<:+4S B(W@8UIS]R(4
M*^@87:6B,"EI4K65)2YD/V%5*1_I;;;^Y0UO8V2Y9$"%:L_3%QF/ZQ3'#7<D
M7Z>E=]D@911#M$,L=J9^VW7 \#@?>&RN%Y&#N]\F'@;&#?4)Q1M#$8-L;NK*
M^%SM0 RS[X/VGM 41DB O!UZX'P>UD4S;L>Z[,%+.:6][V''3J5@@GY?.I0;
M&S  IX;)GF:0E-:%FEA0W\>DU5F@(_-0HQ6E-\H)S\TIV:U+'V-[2TJW54>A
M^^:/Z:UF-]=N]2#ED1[M5TM7/Y(!-#R44YAA="D7'I-[[U<V&U\.3/?Q[RMW
M/KS\X@5;NB:HL;N0%ECA"5J.!.%,I0;C=F$LSB]P3+;=JPD>.[Q+ DQG;0_E
MKJTPO1*A/A?_VS=Q#E6-;6$K(6IC[$2?_/AVOZ>J#XO+V#3,XC0W+69X.61:
M;GHNWMR9]]7]OFAU#I'/TARXJ4J]BB1)*-I=]V$]6]</A5+ZYD"?V<Z^#>.&
MIK>8 'R%1%/(2Z)*S\1S!#N\3QOKQ0:%#-H,4>KYDV"'E2%5HO;9I%*"?F]K
M#2S7;S7YYX7%)"?]*87#^O@^U=+6I)*>AB3;4$/^?$5<3VNE%4'*$(\(OT1P
M*X,9GY9W\7F4+#B@!S +0L8S7;X51LOO"B.SHAE5NY7&3<L,*U*$K_3W7B02
M\DATE':"]GHX7TXISKD#]8/'\P,>)OXY>98FK-1\$@1]9)51YF/Y:.7M.QG0
M<A0(9U*UJ2.[W<7\>+HUCG-+F\26!^TON[?$.7&IY]P7R9/(\M6C9*LTR,]\
M%E2@^1LW0CE*MCA%1MV&<'&B9$6;]2Y[%'?R<XPD1_WU<BVS%8-!!<R7#3T_
M,9GV^A;=AW)<FSNC]@\7EAH[?WH;6FX&9QC5J%,1?$"S<\O<6V/+8"XW)#W1
M&J^R9'CZ5KK+  ,BZ%1C\(\M<DMC(IT:4VY/A_1Z^Y83)O](!9'/M)].R"SN
M2MZV+/@,(ES-2L&<JJZ (H#[("']E:O-*8#9^0T;V>(;W7CNT,<G_F^Y42&B
MDY]&90O?]9GI7<GE<]V3=11\P$!_S(Q<CH3C3*VOZ,>I<4+$/GG]''A& H:5
MQVLD#O.7/Y!-?G9]Y,X-GB^T&D#B!5<2@ZFWU*@O[K=N1[Y&A^X.3-_96SX_
MQ\VY.^!61_[4?KNL]WL>BQ>_-GK$GWV18K4],82./!A\N#:.4!OBB1MX-V V
MB#5GN.'VR,Y-4D^Q[&VFS43$=ZO)TL0*71,K7GR\V:1MY%Q\I*/@RZ3YFII]
MO4/=A8*DC'^U&0<'_X-4\/FK'_]OTWY\2,(E()'#802B&E00HW)9'RZ"<J^J
M^0;*$747R,CLN'3;Y+QM?/?_=)T,^#??R^'_T?7=B&WXT=%LRM]$%^)O6&K_
MU_0@\/]J6O[;)+DB:07>L?1A9BOESW9#\8/F;]AM.Y(!##-W;UI0D\2/ TSH
MA/8._K<J^)BR3H0[_/N@G]&)A,TH*8(3KLE)^$Q9\MYI>H_B'Y TE%+<!">_
MD"F+PLYV.55LU*.M%S0#6!O;Z$3@2CRB]]\@ _RUGTD=NB _(;F\OZE][$^^
M/O2#4'EQGDM*M7\:]0@W)6++XI"1<=/=I.KLR@U553V9LN!I,(\&=50D%B,Q
M'I_QN$:BIZ(VR>\.& 1S/'T7P@BCGX$I8N!Q@M(J1G%J8*<J]WS!K]L*-;96
MD\T"RG<@FM/ E>;QIPA1?7O0]G3T3S=S5IHUW5[18&IP$KA%'%6 9AP$X8R!
MLT$6!%;ER*:;^\C9D\.8^AFBT0J"J1<+9)D;JI@GWM*WEU7,'WIPP<']K#A=
MN)AUVE6+1P_9&(BX+9!ECQ!1!Z<\8,2PWJ-$",;: P?4N:=:99)KR@Q%PZV=
M;J0M3(7K,T_>"Y-I&AM2".1[>89^FR:UH?'<W7=6JF=-*DUCF.[T90KOG*/U
M_B)U-"#4,#,D-#N#54XA<1$E\*O]D"HX=<@0F@P8.&68Z_/W*B%8]H.:SG=Z
MX\^@#PWDM9N1K1.YAV)C^]2EZRP<_ML283EO3S3J\ NV6->AO!MJ(*$^8"Q<
M0!$4^B)#_6S*82W>-6XEZQ:D5UVD,T5+_6H3[M8IJ<FKL),TEP:AZ.4^6RL/
MZ9(>KCT[NA7KVZ"*)3FEJEV#6BJ+>:6ZIYR2ON$761/97R>:2*>V^VEKR[7,
M,(P,\)W44HG9?EL^L=S;/I&"%F-!@\#D?.$)& @?<1B&1[QGB4:S;+/4$/S-
M.WI2K/ 4"1)%$K9R(W'A=N?@K0$+"BKW&X=*3\M^N.2BF?<TV<,C^I^#DPN:
M8Q*[O*MFB;<Z";^6X?2PNU]A\N?;_!(^0^RG]HU8AY7*!2OW[#94PH*%^BVP
M.C8GAG7Y^C>^O:\($K[Y@&5S7I?/ [TV]ZN1J3QDL?-9R-. 0>_%]@6G04&^
MKWXIYY_PME1YN%9#6PY7C'"D A%V[PI[FUF[#?82G<+X:O^L;+:FE!;00@9S
M5Q0H5)V>$'BB 05BSQUNMP[L)JL,%$2"W'<9"1JHXRO-ON_LW8QP*Q9?8=2R
M':T)2C4J2U:?_:H@ [7B<3U?=H7OG!2"*Y5>&!;CJ0]GI[KT?<L6@%$A##!@
M0I]2N7%H</+JD+ID]P1,GPM9).]I*M,:X[7S/"ANXF.JOA&]=,Z'LZUQ2$_X
M;&LO">0518F%)"_I+G\OP9$EU I*4"Q_Y]"J[(+>M!:SI$XM)MY",^V)H$[Z
MBZQG=.*;3V0OM<6YQ-^#CD2+7CNZ7GB(!(E(UDG71-OMT888D+Z]H/V2<F(-
MNT*(*X&I3L)TU&1PVMCN_=_JW%^K=YJ'_42JH _0<U;S.M.H$QNK_G&;K/:X
M/FWYZK#L<_BY7C@GTCU%"/K1$@>.;(8G]] 1'/'4I M-DSL_D3.*-::&[2H]
ME?DB'LHVDPAL3\.D04E6L5ESN,[V=K&M$],OSX>A0C/APWP/I8K9"D,M3#/%
MJ:)9)(T R?*#OM8=/>U%:[S!/VMJW='^*:7K?5>0DWY2'X.DI,1R=8HB%^;G
M=?F5L-8NT3<^U88M6DWYV/L2VTCC!>SJLD2)3GQ+.@0?L\*5<V+X1(A;G1MJ
MN[P4)H-PZ2+ L4 :=U."I%B*L6.U4+/FNT7PQK:OGU]9\[?)17UKX:"'LC%A
MT!23T_H0>:(ZX00W,U0'<WCB1>1&;,!YFQ0[ICQ?0XMU"'.8805(L*)KI\X^
M7351CBG=;1HMHA9@X]$QKU<W8B-,=9K4JZ9\;<#;0\&2Z]=@ TJ-3;3N,WOH
ML*C)H+5HTF2TI9;D^W#ZLZ4(@=/\;$.C,#A=\;@LT'/_0X\@U%!*ZHUN6?!=
M"+0)HC.VF[N<@]Z*.CW*R+Z^(]V_%QP?RB!1]$^?&R#J#[O !%1GSQ(7.*Q[
M%D]*<)[POG$1\/ % PX<*]1Z;FL%AQQBQ*T,]BAVC*LY*PXWU8\A,7QX@4ET
MYDCO8<6CB9+F\9_1!V];6+R59TM>:G+XJ+Y\UQ^$#(//0(=(@W.[IV*-B%BX
M6P'50$T(&E07TLX=X:%H*P <( ,XRV>:4[8@MJ^JV;PBU15;&M.-.YXD7-8-
M$+WP_O$\TRYOLJ$$]8X0 '8?!QI@%CM 4D/#1\$3V)<::EF#]]+0,(&O=G.?
M4D=I/IBGKF11]+NSB'#\SKW4EKW:1)%'M1I7OWW\*+5,K"Y..T^W"_[T@.![
MH@OCF% +Q.<=PB=)EQ$#+%RDR<6;N(565 7F-?3*;I]ERDI0VT\#\6T?:TW>
M/"GQQBZN2Y$])N'A!JC5)1KBO=/V+DL,F(-@L00FC&(^VH-OCWFH2VY\OE)>
M >DPZF=$-%>3 8^ZNWJ25U"_?0T.4YK=T&JCSJ^P9_W-[@) "$<%L52:>JY4
M_<$B39G+YVM#^1N2M]Z&;1HQE31$T]0J ^Y(I::V^?'P)Q[PS^Q-G1@3'2B!
MM7H8WXSSZDT IW =%X2&2!$%OGJI:51M="Q6%+J#6?P@NPSE27X"()T"X[;Q
M'[B/Z[]S1]$'NDR6=?>S^VU8:3S$WQ"T5\2W(5AXE/*B\FEJ%QR?@IT9/-F$
M)U)C!5.Q"6X[,$ZGPG40GYIND72'ZL)&P#,;=QNOR)JB"%V(E.;+ 9KKNU'#
MY@!2"^?8X'<_OV'[D=[H'V+6/O0\%K0Z&W3">\P^@E<)8<NCM.@-;@=1O&!V
MV1MYO8[IG:WOG5$'<J766LX=W0GZ28LD[$5C?7F4YTHB4RZ)TD2X+J&I#]_A
M"A)[^ DS_=E+7'!,'E$,S])K6<!5-IEM.H-L!);B8F*'8AU5HHM]_*YNU?K]
MC&L.NL3:W(BT??*0?9"F:C5$K "[FP3LN1SRM6,#YF#$LRE$U7-CC0PX:VG3
MU'TBL_TY/\KSV*"DX_+BO(U:DMCDF4G#]I>-$M1G0T&U0?ISMIM!D#PW"YW:
M[8?=$96=Z/FB8:8RI?[XVFKUO?#S9I@PSM4>4<(P;JA/4!UGV;?$!AW5&E<7
M)FK:#JMQ8_2KPCM:8R]/8-NR]FPOGFE9>VOKAOJPE="M5J>?:4JH.)&&#F&9
M?P_97YY9@5/:NB>7\(<K@RJ*4=EA39TWWQ)\RV$4Z1$5B,DI1$[6P%NV]TMP
M:].B4VA5O*O8VN3XS[.-9E%7O)1.*WJX21/()LLA>*)0LQ$*Q+*NU"&^M5 %
M]>H3.NMWRV)J&3\P'8$YU=::#)$ 1K%O^71Y5&R^\.]TYNRW_*K6HNS%<TGL
ML;#0V'J:HICUF%YA:I@SC?#&=_:7$9V"YWQU7.*,'[LYF?G$)]O?5=6Y.UC9
MCTF,# UELWK)+1I/<E#S75E"(P?AM"3YD'$'^A["@.BBRFF)&OOY\N7V6C\#
M.4J+PX!LQ4>2A,>?MPGW!-2U3,P^OZ$H8#AX*8 C];U(,E@N_H@["?X$A(YF
MF=T38+<9#[FUN-'JC^0] (:3KM9-*G8K&[2J*$?N!R%HOLT[S+J#O/ 6I5QU
MOPI8WKQ L\*#1%^.RC107P*0.B00.2 GX 7"Z@"\8::7Y0),/]TT>ZB#@NDZ
MS.3X<UOSE.&[M'D-\<.HMD":@+L26+:D[:RCN&'%_04 A['F__;A7!7D<U%7
MPW^3[J=3 % ]N@UPMP*PW0:P 02HWF.[!;N64. ]=>@O4ML:Z*/Q6Q:=(J0<
MZ1J)4G0%U13Q'[&@OI0(>&,2HG^;&R,>L4\&\$#G^EL7I0LTVK@L3>SY$F38
MC1(,NO1/"#4>#E:.:4%^F1],U@I?^16<AR\7"]' ; LWP1?4;+$(.J(*P:UD
M[9#M<P4AW;H]I3_7*S:Q)4ME,*;VR4NK4<YB:W<?^SGTL%M@H,SD-92J!G?N
MYL5S:\Z<OZYTGKB$?,SGB< <#';BJWH[GH,Y'^F2A'@\@8^]V/M(AK-/B\)'
MK!T3CW _=DVF+#_9]YL%++5D;]64$:H&!"D4_UBV]>*  @VZIHC&I;IP]5,1
M@PD,)&&N8L=B<E:OY:N4KJ2MW:B$<1_;;6$AHS$'UA4$.N@03G"%! >N(.-)
MK+C//7G%ZQVGFQO<XUX1VE-$Q-;'7TP7/BN\7(S#7J,K#KRH4_+V;-L;^.'W
MTS0U8"G4RW:&I$9@,1PG@HMUL2S,"\-! 9(;N=(VD2KW.Q+EYF8-%"S&W$U1
MSE)V0XS:WL+:YC??GYMJLBQ8 W&&"$"+;9MQJS%=CD4;QS]VH_>7N-'K6<I7
M(!5=\M5W6WD=&BK9SXP<G[/V^.["M.;#7?."]M\)=X;T)[%8"[_42G_W\HYP
MN/3/7AH?NBWMRPW$\Y](YW&=JO)R7YL^-;+U8\>%KQOJO@>P.,9/S%#D(6T-
M_)NX"1DP?K,J;<S/^6L/]_KQW-V)VO3EM>8K88:\QLYEP6_[65R\!;\&L=\6
MC-$,T8/)4B06@JB.;QU:B@!1PXR7[;UZA7"=ZH)H*!+5HX#,NJFFZ(38D%XO
M(0#-.^?+9BQGKFA%Z C::GHK^%2GW:MH6Q[^XW^$"+TK!7&Y7GV(4#*@40^Z
MVV^"C%NRR ;C'W?01A= , ?(O5+=[?V37U)@_4?#@@=)'#K5=D!AZL,K\4?%
MAX]/2V&W3C1A4GF4=M5Y-$(QY?P&Z1)NM)^% 7)=JS7_ EX\2I%Q0=FFN2-#
MSJ+AE\+1KK3GZV*C\B9+-FUV^<MCXV2 !V(69#,.<ZU=+Q#H.A=0 E/KX'*0
M[[&_B[WQ7"K-Y8QJ@<JT\BMV+R711MM77U Q/WRH#F0X]]))\P4-)K ;1@E)
ME/X0A*L5G:Y54^F19-]@?J38:4Q58 BU>+^D[7VQ/315K*CPER4DW_N[/PAG
M I[M[@&EA+\82E&3+T)#0IAQN_$]0H21U0=M'B)#\M (FV V&7G]7%7MUF@K
MSPMQ@H<09Y;,+YRQ@%/Z(N1-&!4%-F:<<IR:/IX-Q,O"1%3$ 5&WC ;\><F
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MV@H7=V'T@]2:!SMFIZ!D4U!QVKF[<])3#?+,9LO^Z*ET]:%>ZOITXKO$EM3
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MTK@F]2LXEQKG8(R!2)^-\\]B>>F.I)8$O')?B(3^@N'UK7NMQ\"8U: ,GT]
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MZ.,/+=&MFGF^XN<$#5[R(":?4WCJ]_M"+4G9N@&_ZRQNF/PB>S\>>$5?:Y\
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M!B/>NDH/X,^8MJW<"KVCW9C& 15BTGTU!S?HC7(S8N>"&?9\<%A:8)U3@_B
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M=%S8D'R.\E"_JU 8=AUXQ5!HA8F'F4ZN\,&O(V4LTGHJ=TY?'=0HE3XS>'?
M<OC]B'3\%?>X<[POZU[\/FRDZMP;'6;X]100=L8_]AOM13?C[=2^&U]H0"SX
M;7_KCHU*MG7T%ZJ[K/QN_MAFM_*U@C<#WS_UM?\H.'!-^F'I\_=%5=*I'BN2
MJL<%QB^HGMG,=*PFN:ZH3@59.A@<MH55;;0[&!\62DPG\OCF .Y[WRH_KQ(8
M0XD:UBT18R:M]&G7T=>2OZLHIA[ICA2J2IA,F!0Q"H3 -?>/LB[0$;&&4*PY
MA<S+NDKW9M@]C3CJ<UI-6B//'[ZG9QB;2_YVU'X1L:3^WE18X&SJAT3QS\U$
M S^BQPJX91N,Y.N(D&+8M2UY$XS@OCB6"0 N!F("<H"Q9G_>3%MZVX>XX<S%
MZ4-'DT@_"V;>*?I'GTA;YX"2MB[L5+/.34)&>RG0Z&66S.2"IJ ]0&YU/3O,
M@A@UX*(**M:NQ%)<M$5^E!,(@^OM%4.I&H?BS]$>)[YFC==\YZ>O2*+-4F4E
M9(X69/M[6+=*,9V>=]/7 :AZUPD*.R^IG1*@UB%GI]U-L4MKW'O8OD0I*+;4
MCN<BV'5D7ZI9(;Q[INN:];/73A\GYLRTS$XLCE5$#<V%[A@(+05]A,N+#AHZ
M4!#1$\=&U*K0LJ:3B.@FL?>,K*'WCXC#?OM^/5H2X2]%#&D,>7B+C+NX&= E
M.IAUA,J^QJ-0FE#L2 8X,4+$U=N&R^UX*7DLIX+>6%)VAW'PU6-;O<:G08YI
M25Z^;XY_N1^6;_=TC/U3NK<),SJO*;2 $@A<L(IOY!VY ]@@<N<F9&O2+VS?
MJHRPS:+IOA*',M7J-%.*7;[RI1\?Z+J_-O5VP8YR@"@P">@QMMM&LC4:&2.M
M$&$@8L8>**8NN9FFF%6)]O)B;O<]>EZF7+>Z'G[2/+JJTJ3FU;VK.8$"T8Z,
M!?H5FZ=-TV<)'9$^UETCPI.K)2FB3[O7#G0)OQT(+G.(33MF7R0:''X@M\S:
MH?-LK0US-"W@C76:<UYT#DSH8JJIGKCTBV\7.KT_YC<,,_&GT[5'?<4VJWPX
MH(*M*\5WRN8>2W]/]Y>;R"HD70AU#Q#=FP0/?28"/79J,K($(MV'>T>\9^[B
MVL7T $[ <6I=Q2V31D<UTVA![XZ/'6W-;/0=VY\=*DQJ3,0UK77O,2S6[UFM
MNY6FE.:4X7%XOWTT_.Z)24;@)WI):4%1>\;'TH*"#[$6,!TWI9)?-GAX\4^5
MW+C5SO_K<4[&ICNUAB>H$)F(;I1HF"[%Z.!V:PBSH$#15M\X2]H\&$FU>/U"
M$=F7=.[<'5B\8^]B(@/;%C*22' HGH/(J^G.-JJ'2=)[8X[U$3Q+9[=NH9M?
ML'9/"I[NL'7T2'0K,;F=$5R3WOI@8KP(JELUX-PE]E#'QVGK9EU=]>?J&@(A
M6]7)_.KQVKK:K&$5]:7)*\G>'UY]O4J-T_4,NBM^4^3JKAK?TU1,2\]M'T$W
MZKB(=<$7!.)TN%^,@?"1Z$"05%.H\IM-K5\??_:CU>1:=_&PJ$@L$PJL%0$T
MYDNZ?S_*RX;>1>F(_E.PDT6M9,P\/R)8^(TF)_:SJKI OA(?TLW<.M?@Y!]6
M6/?SJOF)9LR5>L"4,<,, E(GK>0 SQ94)3C.^#  :X/Q&(8S5*'E(W_ H@O2
MT^\5&;QL@Q2K3T.!8T@-!;4T%&GKTO@EKX+2/L?SK;B5LBR&.67Z8WD5-E[G
MX@#YPH>. ^F?H 83XQV*S)?[WN+3Z_$OEM5C(.'[-^-?N5B6U>>2Y^L^Q'H6
MCKKX;*D]OC&_==]&,3WCD>/SK!+Y99!Y,Q[N^^"V!NBEB=*O)1T>5C?+$.!C
M;- F&A@"K1CQL*/;5Y&AS2*LTXS8%RR^]V0 ;T]??I^MD<B"!E(^^AWKKYK+
MDWXMJ367?.F>(E*Q6\NP,\'L-^0)RL>\5VCA!PM*5UXZ41SQ4QL74T+T[)69
MU4_]#1$P-)AT<C$P^3STUT/D':%4.-P4A^V_,^*[XA@N:IVV<+TV#F&T[U4^
M.Y_.=Y[/+PI;<%?YA:&14KURC-NPSC=#$X07?L"K,&CW_ .'TR=+!].>)C"^
M=,\6*QRYT?U>W@2$4M?_ZS<W=+9XGZ%U?I@G8+-]93[B>/98JQZFXAQ@C?+_
M  0T$P^559V%.0ZQW'V]J>K'I"2MAUT0BZYP%Q.8A7GK"=&SXM\6'.T2_ZCB
MHB&"$&]S,OH,N1J;@/+"11OS,\BMN'W(D>L#$0=[*'#<(?7&'*P#R9NM4)W1
M?K@4^\K/A7#N@._TB;3+-YO8)?D,?(QHJV<SO+ )\OR8Q)(_]KRMPV+CJ%3&
MCXF3[\8RWT29'Z0;MMK>Z2>D(48O,1_5 "\*PQPP%,DH#^!%L>[O=+9JNGF2
MI6WPRA?)=*7'RK[=E)N&G;L/[*HY<HAGD\8!\?XB &T,"%6R#2S&NC54E;D-
M'AVF<D#,0/KOE/D1SVL,V]H"5W,JG"C9(O*5F5%*R)9C7,O,U<@SWC092LCS
MFTV-G8:VRH&91(;DDL3$,<"3CF:BZ9=)L0G&&EX8D>.-@YYU X&(_>&8-F:C
M3,.GFA388_SGACJ7_6M0X<LQ*JZ#)R]5[F$7L';3%[YPJYXP [YG;##2TY2.
MB?7%UM;%F_4MW1@>=)ZPV)"T._CQM.) ]^+JU:FW+]H?@.2R^=ZSHD&H4WJ0
M"MP2F-YRC>Z122$*LG^0TIN)PBRUG<S %1+\4@7##U<$9+:^M =4K6'QTG8Q
MRRN!-5,#87;&M4$^B)RJ6KRIAC#>I;K-[4_'(H*>?J,/<J]W#&]"MVO&Q<OS
MTV=:A419;@V '44H[HD5K<'.?(@E[.O^8;=B76/9AD!XV.<+WC/S!]LO=BYJ
MU;!IMT,.OID;&YB[ CH,XIE+4MF]^9Y.7BQF]-Z@I\<9FI0@/6FNKZBXV @9
M(%2SV1(,95PIS?5^+-T,5)CZAI=6P@5M#00V]"W2NX+W-"O>55!\4A&&[?WK
M^&00=:5)+F*#2HPTWAT&&R% @^'4E4/(%*N!/V-=B6YVPX;F5(GZH>^O=+;>
M^1:X.N_4+>]8YI<O/;WWQ+C])*KH@-"%3>NGLY"CY\'?-KX0(XF5>'2C1LMD
MCTT3I-+S&<I34SSL%N!0/%_G@2WSD;9LR\Z4=55 ';Y@7.I9UA4JE]%C%$D6
M4Y\^]?QUV/XE' ?DCB'9<-W&>]_09-+H-#.* XK&%,^2JQ!159EPM-1"7=8X
M,9I(<<P-4Z\RAS?<;Q+O0L:L;E;*F6GC/3:_>B1 97!_),2AY_E^[#]EQ#>U
M,/P$\K8TB D!>B>7G&A*^$E?2=I.*WL?8+"M#_12!)]E&S'$UT593AEK% ),
M)+G5&6Z T'3_E-DF02I-[52O/(J3DX;>5)Y!2X1I[!1$Z"%G[,HS)].7A-_/
MD877K62\(8<?R87>K T_;?=H^&@M/L%%[F%0Y'=@+'CKGA;TTX6I#S]'GNX\
MOATBU)G 96L_B'TS0HXE!PQ1P@4H2K%47#2F\C?LLU+4)%G("R42(04$.1+C
M.V#TE+$.M9#=<W?!(J,Z^@??:HXEE?-*9]5HF?L5B\7*&,#VL+M1E8C6#B %
MQ5 VV<GQ#1.GH&(:U1F2BPVY+LA>I[X_#8?F2!'E@9/A!FU[6QS3MVW:#@%)
MXQYP>.UR3DU5<N<)C<C:JQP0]MU?P+AT8:]-O.:A$2O&@";VOC U#N@9VV"6
MX)'-1U]T543;7,^(F_\QE\9PB?^!4]FV>Q/;B]#J,J^-EU <*>_[3_[MX\"(
M!+-3FHJ\;6MPR?+DY8(&GL?7K3Z=*RQ>FV'O5PX(]*7C6JS@@?X^,VW#H 9"
MJ:APHV&A^Y&7(<(K,,LF@@&[FF%LV8)QVD(SJS7.PDKK(/9,R6<SO8OA!6!O
M/_.'VU<1M6L$!PRJ6/9<Y@RWP=Y:8;J*4R.*E\)CJRLI!ZW@B_.K84'3S #2
M\. V;=O*D@-ZGXAF[QGC@!B=D,IU\M:^GQS0I N1 Y+%31^:)Q$A#+W!CIW&
M'@ZHS6W]0W5Q\>2,PQ"( \*-HMJ)!43J+?*.1!<'=$"SB_V!.-2@R=H$Y^>B
MUJZ:C51Q0-7IJ1S0M-/"#F+'F /R\<:L"Y=S0%_J4>QS4.:'-_KS9Q38$TL<
M$#"%TD21ZFH72GQBV61N?R9=0JK^Q ,9D\:R]_8L+#9C6&9E9$9FAQUB\U!7
M.&0>/NT-SH],)=*$TTJ5N<*F"L7NF#>@"G!_I':*"SB@'V8M'-!N];]F!I/J
M8#N\)1"Z-IE;<MNM]FF4EO@J;[O=Y/:>FA4A\IN] QGY6]6?KZ"J ZW16^&9
M(^,OP-&^0KE1W.G/Q@V35X^DI^]8$GKRUN/K\5L%7'2!SS=1@\21+?)6/GNH
MGP.:/7Z' WJ:Q@&Q'J*77#39D;9@0 K! 76H;IJEV [[<T!'L^S.=; B>@ .
M2!(_L%YDLR#]XX@@W+9IA@WY,(GN8,SH5D:\\+/E@!+F5<TYH&\0Y3'V!_)(
ME^O'\".OQXE#ML3E,LQ4.F98B-GX6G\^!,D!X<<0; -+]F@_GXN=)9BY ^<N
M"-]4Q]@/?U&$AQ %G[*S]&2WP>PJ-V>X-%EY&V$G!Y5<.PC(<4 [R+(WX8=^
MD6 +OV]QZ==9K^.NQD;0#;R!Y:*'8S&.]1Q03M$J:AU$Z%W ;7M"N6%2ELFU
M<9C(>HQ>R@*S(^L0;#Y';M20V!"/X<!FR&^#DD?*;,C,#)BNV<L!C=CW+SBN
M0!A&P_J>W'>7,$SB%OO/B%!.%X8UPG"$L4V_A4 VW\FM$[R9Q+5KW%@)U/G3
M!]F,7$,-<T _1YC#B1S0!=_37"\NH8 E\)BCWLZ>REZ6$/=*6A7KG@L\A#D-
M'MOZSK=S6?G/PD8=!Y1B/Z(_35SCP2TX'^" OE[Q'Y';" V-"!RQFH4M<4-!
MYN!)#NB/I2F3 RKLGUT.N1GF<,N7 ]KGI\Z-A/W\8US^NH\M__6<Y[$0E87B
M.3<V>0D"+"DSEU]PH23^]2N$!(850GRAFAC4"EX_!0]+AOQ6@+AA5L+AV801
MUJ4?R'AGWE7_C[\.GN6 X+\8;*MP2(ZD$9'FUN9*XH"*11:X5A)A7]9G ?12
M!NSGLAZ>U8[UY0K]J9U,2,W*TM*!P.%'.1R0OPR$;62Z0\Q!_8";<D!-B1@.
M2!Y'N;@"8\C+R"N,A-)U#1)FWGD>X/NS^X/JFUH&W_-5?ZKE(S?(FFC-PKPQ
MXEH#I#2H?VO_]BWLBU=6[&\.$-AF=AGF<78L[E+"3D-INFXX9,)F%L/:=-G&
MD(]7317,2ZDMEY;1^+R324CL^?''Z2^R+G3<#;!5!7[NQ*$0FG+L3M=S<>J(
MZT.&-G1<J^1+;)R.:E=AF<= ZCO5^2V'AU-*3^4F+O-O?WE>$#E-+.N-(8N$
MR3#@376:?]W[Z+#0*#OBJU!7T5"9<>YBVO5[^!KABF"[4\9N&4H&J4_G]REO
M%K=C=M5D-I7T"AT(A+ZC3[M]N-7Z)DR-#MPW\6HRJQ:0O#!81C\[?VWUIK)C
M/OQ&E:.N4NK5@:UWQ%,%Z()>\<5YS:24('_VZF/GOJ")SMXK:>G+L[EQK+/K
M_]U#[__/45%VOS+S5U>P-];E#;^->K?$B+PIC% P!5WMS'[_*FG2-C%B/Q)+
M]6R%1#GBEM"T\(!6TC*.'O!7@0<&=@5G,)D.QF) 4<?UC+$64A+FV+E,J[ZR
MMJ$%F,!CX69U7^;ELT4)!7P]_&;:3F?Q$HW>'_B6UZOU Q>M\YF/[1X<V:N8
M-L%/M?[97I84=^HL"?3A4OZ<[1B[]X,W/?B-2/ 9V[[@IU?=A?X;>^\9U&3;
MK0W'#B+2I)>H"*@!$6E*BXIT 4&*U$BO(2(@04(BH/1R ]*E20E(B4B' %(C
M(M)!0@D)2"\)-4)(/NX]\\[L9\]^GF=_/][YOA\[,_FQ?ESK7-=:ZUSK.*Z9
M\UQ?Y*=#3@A6A9P0BJ+ID!?7"127]MJ,*X,(83^2-!-<@-#1(C)"4Y;<.]>9
M+1EMTKSEI:(/4\A_F?$AQZ&V02\YBO]^YK?)W]K/2E^/IJX'4Z)UQQ"RGZCY
M74 6!W).9PX+-=5J<&W(+2YO-KI<^>FHI*?D;G5=E>RFS,1#<=GT][;?[:0^
M"QF7FFHEFQ3G!VZ5]&CN-Z\'VA[,3*[6 \M1-S%.IB)MIO=I  !;[LD\'2G,
M%7'%D!7F4Z*77!??X30?FGRYO?;=9TD#R=U_:$D?H(/'?2$L;BVJY+$0A"C%
MXZL2LH[$)FIHQ<;KJG:'K!5)T[B5MC S.EM7$V&A<=KX3-A\@J VXD?"*A)P
M]!F+(C;S$-HYJ8%:T5;'N-S""L$?QN\'6O(RV]**-[5:WDC164QZ1+ 36_KQ
M4;Y1OZG.S-^_>7?F"#;%-NXJZ5F>#X>6K4-)2>+:N751U^<E;W<-R9EZQEV<
M?7E7[IM4]2K/UGKY6MG,*PE'C@=>P[?Y)3S=PS0!CA^X@K-'_U@=@I%X%)^:
M&,*$7!/61&0BM,THM8Q6%^^4*@Z11FA7U&*J)IM_KTFIO"[X:\;62KO-Q<+B
MBM^+J'KY17 U&B?-([&N#HRGB1;0'HVIR!PJ6;L)" U1;0/]J0'EO:0'+@P
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MT =56ZV41PAIR@F0VJ4^1;JN&F3G\&"\DJQJBFI$L2V -K<9@-/;U.8X>0:
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M"R*Z<Z2I-DOR\6H:/D77P0@5;!-Y)97@S HS[TJ,[:[ SC':C-)NC=Q+[@L
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MT9$>B]Z1)YTUW_5O?>D3_!@@.I_QKZ#ZRX"43<%21TEU]F2;"#C=XUSJOHX
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M:[$2@*PPE-.XBGM39;"RXQUGSK6L-$KXYTY7_U:?NOR9ZG4H>+G,Z5Y*KR@
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M<V8K_W&M%G2II9H*[41<&=LK]G=F!V<A6M!>0=9X]^H<OJA)\"RSCOGF;_C
MN\AQ([_=XM=]5TR/$A>DR4%;262#[GF>$83X6N,C$C*R67/I@SY?"\O8[N9&
MJW#T'=RF?,'83GDDYHYFR)2BC)C1C91KXV]_ N@W53A_"Q';9NF(T2]I 5"R
MFEW2G4F$H /\4EQ7D,Z%$17-IJ8$K@T;<L^'3VMJ-F0^J3"OXJ#/]G8.Y[_%
M//TEI!"V^22)LD].;_/(YUL ,&H.,\$-2#T)2SS*@TXGY]BH&893*H[G9,5,
M+FN\3,>99:)E\B]U.%IBXET=7B+J1YV3#GNW(LE*>M08TBF@FWOL9X;]'YH<
M/9F!!T;ZMYCM0M0Z#QKC'#XVD]6/^!%Z77HNX$>D?K<G:3R?/DLN^$.3=&Y.
M8H4B$3=:#+WSFLC84\!++9-/:T$U\T_G1:H;<:XHLPG_'RG2OIR#D=N?:ASZ
MW[ _QBC4>-,!A#[Z_]?=A4E VF4.ATF,?)0@?\/(/OA89,6<<[I;[#!T?+*Z
M66]ICJ]9+O[KW/C[$)L%SM^KIX!S5TX!*18$U!%?&7#OYL8>BGX-5TITOF!1
M>L&J2&ORHN6ZOE)$1E79EI31S3[G/%,A%*Q4'4?:B;MN\7YM2-WANP>#,4<<
M93P@_M-XZI['\ED4&^+J*6!DBXA(B =S+Z'YDS#\^UMVW,[L.L*[>;TZU_A)
M^C6? 08G9UG28B1]U'L)>Z< ,624W@RA)J=!NZ;7W-5Y35NF1O9Y[,G0%RCT
M0$8-AOY]X-.VVD#CB_ZFQ.)VLI P.GN\WHI'XCJ.5[O:7K<_TPHF?@RF.Y%\
MD>2]N+JEY=+ K$N,[L+,U?6>R#K0A35NYZMOFA_:B(4JW'<*HH6$AE!H]"J]
M7K>8OX1,M;WJKZY=@M?(!2TOG(O<SJ =[NJ@97J7LB/)[^IV KJL0V;10,)!
M_'BK-.WAPT#:77)8O.#YMN+$4(-#&R*2U<\)4@IWHE;]BJ1F++GQJ#,292U=
M/V_!U/?7<EK3P!;\J"Y7NE\;O3XHL_T5^WHA-8$F%K_48:\C[QK)?KZ$W?<U
MFVLR;1?V&\U?:)Z8[ #-^Q1L,XTOVKZ_6S&9B+69U !+5N"WP!OCQP['+X&+
M^?9)KP*:6,.1@ONS'PPZLK#X=@**S^MY\X&]^/=M3N]]4+2L3.U#'SYW/Z7>
M99*-[]PQ']X1OX"?G9_^KAOD$<!N#O&#BIB>)7W-S4N_=K]:0^.-U=LW>DBZ
M#'NS@HIU:WN)N*(YK\:>T@"!G.PBN[MC<W..W]I%#%WO?9AM(M>M#2(? 4GF
M?[_)Y6N]A!C&TT>=W(150$(<GM6]L$Y^+@A&,7HJZ;'5C1:VIGW#-8LI*%1?
M[VX"I-BR$J$%"Q$T[L[D+^1YHZ2!7:TEK>XCIJ"+/5HH/.Y!B_>J3.=H7.*5
MT4"[V/>>C[V&\B6-?;N,+==/ 7=)Z4".UQUEVCXO*O,N[%JGS8958]7[:*"C
MK 8Q[-BWHY)8*31!:?/_]CZO__@A.1]""MPJ/8J0@1WUMDI/-1N54G7UJ(EX
MIT@RD- ;7RX.C4I/YPXR 8;OGP+.M+N&ABI-GX\5T"?L;$ZZ)TE(_>8\$G?6
MWEBH7FTW9Z,V[O2\0$4\-+6Q;$NRFGP4=_^/;&[QL(R9-]S9%U!E_+JYTK @
M4R[]6WHU0\)7@AL@=!9F06FF?OB\(2A*0G>T,<,"]_!K60N)/EC@I3D%NS+E
M#RH5JX9Y'+.70^](T]NV!W'5L2M'&#(8K_D@?81B<N1(=:^U0A>=&:A.4^TY
M+"TX+6'B'-!A@DN>W9RH;6->G1-R?.G*U;DB>Y53P';J9DWF/7KV-V8Z:V-
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MJRIC?:0VPMU9GR>DX6C!^8X9Y1H^/3J[SG/UTLS-R4H\([-A [RT@B#5V]I
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M+)8VB9@C:U:A1S4XAR]QX_+Z 0&8]YV^++/AL4E:UT,U03@[1@D4!=2J^Q+
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M<PO^EO,JG).T_)S0VFM([KK,A(;?75A:,*PD7>N\H(R:H]$B_Q#6IZ#M5XC
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MH25YW+4= #,$?-IL?)7K[?XPQ3D=F3= Y:_M;V3G6 X9;I*5/0MI(0)[XCG
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M-7XO*8CY8SE>F1::9&"Z\1S'86 CK]=<5S_%I,9RY.GFD<?G*;1',TBS7S2
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MIWKTW[$2U?QO0#G#CC*^Z&7203P.NJ1ZQ3LY]-D3WC&J%8]>-;S9Y@.*MW=
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M,II5H/8^E*Q1N7[K^?^H %[._B]02P,$%     @ +4-[6F]7SQ#]T@  H/L
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M %?I/WTHRY5"R#F<"K&!F0.@8!#P\8_&[ -(F']EIJKN#@%'&0'U<&-6"30
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M><N>(\'6$JNAQC7!PTI53V]=)TVX#5D>.7XK^(;_XWMO#]\YJW"O;IW=SXB
MLM.R2C$(]=!TVSX^J@B?>\M%5=7U]&%_V]%FB: %K79497E51;>7T7[\"Z?$
MT%4E.?CCKH!I XB=F?R_O<2 J05'-DL&I/+V@>-L^HYI]0-<A]IB,+RI+RU;
M%8B@Y89P(NYJC">F]QBT*79;9K"NU-;7=MLO'ERXI?UXENV<&TU]+_YCLR/0
ML@ #5CG&"7SG]3T$=; (2!_#\36R#Z+%9K+UP&.<"%=GP(=9K+\)'ZFO@!>I
M8RG^E0(PIRE2H1L>8-A;&-L7!&33,1S_<,O:OH4Z0XZU_[;%(;L-+B"CP;C\
M<+N& Q=Q5EE#<#C"ZUUI\WVDQ+S E-A@I4<X8907,D8A9>!(NQH1JE0@)VI!
ML)5_JH^O40K>F7-)CF4B$[--N=Y3,7"-T%=\QZX@56N2+%Z2K?L0;S3N^EZD
M8ZXS+H/GPT/(?C5Z3_M<""+S]C##7\7G8=WI<:2*;^2)6(YF/P,-XSN#EFQH
M+.U0!SE2VFETKL8_ITD($<?4H&*O WV5Z^<]YC0:LI7?IY_IF%]>)V[&9)!I
MJ;EN8,':O*#/[@PL"BD9J2523Z@ZQQ=S&20F:_<<77Q97YRO"Q:-@WP?#O$1
M;6?G%0<N*]J %:52]118YTBQF*@HEK0!6:E1R24[CVMMT5%WEHV#SE"5LM4>
M6K=2%+ JI%ADE3[2GNXEA,0AY6CZA&T J6DIP>B*KTE_DQ>1*WX!<._+P7B^
M)B  Q_C2C/4&P;;>&^4Q!WJ#<=!I$G9;/OE4:J4K-6U!\[NZ\OB:\=6NBOI
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MQ4?R^Z=\%7S=I4,V!6R5E:LNUS2#O<-7+(M_FJ*7RM9)76J!8R&,=ED,6L'
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M703)L41LEJMU/.46X1A&,<WJL_JHKO75-*<#[WNGJ*3/F?89LZ&=WJE-A-:
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MH@BJ6P!RO&,6/F8&!FK90_8?W'6R[KK;1[=Z\0[H;I=.HME)O/A\7:NW<-=
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M6)AF/;JW>(NO&8\4'02(5P9NHCECCOR])'Y63?;E/[L?##7,]RX5Q4XV.TV
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MY[;'.5*Z\M)Y7M-LWE?L!/A2S.ZK;6=;\TY>GVW?Q]Z1GGQ(87]1^N4U C4
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MK9S[:\?ZH]>)QT'_-]JV*M:-W/4W;HQ7FJ7@SU1=X=%-T$ZUVCA:R_;!2&W
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M:)*5ZO3BNHI.*#K(W$YRR6#Y@HH_6M8K>YBE%8L9,/:2>2IA6.W$.Q'>/B'
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M\.B5*+DA\A\H+Q3*,]R3T^?4U+_X5_2^32K_>)86_VFVTAY$U7?(\*KR_SU
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MM=SMOH88(M<-;>K!;NUD\\7GLX\",9RM3:-L?P'>3;J:GCE+]TR)>[<R9'P
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MOW+6(:Y*2EZ ![-%M-VQ7B>XY-<XM+-Y+O)TU:\B5$]]8XN$D]W7U9M3AO;
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MR3K+/)(>MJ'X3ZY_C?A9MTO[F$:(U9Q5)K[BM%X3M;_'Q]S<FN4HS]3MTPV
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ME,2:P[0C')/6$J+$QN-X$0X:QD"J+\:YO"7N D0I<0(>SW&H&E=&\8Q_^[K
MN*,.O#\P'M:4G?DT4@E][QET>+T9X+@@<.JDI,C^DCYJ00*V"QW+LK] *P65
M[ -,VW :(+7-6R]/+['EIAU2;"4Y.URS-(]T;!Q8BN(\Y,,V^8^%V;J$-3V-
MN?.J?,(O[H5/P[Z_*",LV7J,V(EP<LCNEH!B*-$?TIL<H*H@[ C^0G]:QS=A
M<2=1PQ\5EN=&KH=J(COAFR8D1VW'DYY$EF&B<F6:0KM1TY1==$X0O3$397\4
M&1U*ZRS B>C2.HFJ>#OAG+1,XB[@CH1W=HM%6*%*#SR)J2/,+. ;X SP!A>
MAE;>X^$30%0"#;> ;7'FF;EJ^3;7D71[^(;Z"S+--+1EU^? ">/8B\,2';@H
M _#Z1I[W$A\)C6&0?Q*-1HAO_7RZIQK[AWL!'4;F3U8H:SUX?)64@2'T]92P
M>4>:,175RA4/G1J3_MQ(/UAR=<WRC52)KY3&PG%'C_!@\PY\:")2!:&' MEM
MU/4MAX3E74;VU@B(FZ8%#=KIZGG.O\(*IS=.."JD2K9YGT-[7X-!9_QP280;
MH[3D*V\X</.()0UG^+P51-O=X7]=/K]K%)OU7LI HJ$C>M[2QTQS K1UL(:H
M3H!(GR&V@!11/5;K/+.><E'8TXDGG%"(UD:\5I?NG?2788%Z Q%OK,;&Q*XG
MV(QZP*AXTM####6_+J*YBO1#KVUBW^>66!Y,#12T+W^>(1H %/(B2>N'?D9S
M]=_<T%$1%?<"S;AEJ^OH//>S*/OT*R4;I>$J_]V=?>]N;A%D[^$=^#+78?&M
MW"+LS47OU86:=>6IJ;(-@/:!1Z_^"K7I]=PX>+7Q:J9;;;]O]IE7W;=H&UAJ
MC[L]*>:VBP>L /P=X?RLU^69RX_,/IGEZ& <L__PCD0\<G>(=O)-P43=,DVV
M2C/-BJRIS2]B*_F?B[X]X5:SJV-A_4[< :QY]_ =KU^_[KD<QC9]GV/]BP%4
MI/<DBJ8N11C7/KR[?H_JFH='C4KN268%\#0N(^HM+F$E8X%\>8!.2C$Z^#*[
MYJ?$3/C]T[!?_MDW%^-U7]4&3*"9^OTEWAX[&8U#KI(@E3FG;1Y8BV82ZH7X
M?7JP:6@9]X$H4N?/*=)D1</Q@!Y1#/"FGLV50Q(^M".QJH5EGP\T;%01DD*#
M[%1Z>@.[)DG@[H6YW_R4'?7 $;"#=Z/(9'!$0(-FE6Y1;3L/J"19M#B4G(R7
MQ<SHZ<<L_;.YI%1O>%'R/B*,]B?*] ?M#RF \H8NC744-I"KP-Q.O^PRRK,?
MMI$3-=4SP[_-6W/RRRX<7;9A,#P/JVW5'0+>[4N/V?MT]4WH6QE$(:RY! BP
MT%G!A/7@^!3HA9F\Y/X6&T'<G6$W<H??^+^OHZTOR]@D1%')L<KW'O;64^[U
MJ7OT+R2.O+: \)%8;B9B([#0T4C4Q,>>ZVM!3;*25S91N_RZ*=4N5MG=9-UB
MG79T3E-A6M2&Y&&M"]U62JG?#&L"YDU6'R[-8"D%"YV2;A!.YK V,K>/^X;J
M[TS-HR6AL++&LM,/*^NQIEX#75V+MAB(5]YWE^9\:XV2M58/3EZLZW;/P/.^
MYN7'THMC_%27L(@A9BZ3W'<91!VHROI@&T%+=(\TW^(RRGE&A0^9;G2"A?2R
M6)&PZ)$CM+G7_)^C0TC;[_R)"=B?V5MV-WO8XMLZ;I*8JK&9T8"QZ_4#B^+R
M3]9C$V-G1A8[/0ZS&\S^W 6FNN"&^$<N<33% T8<&MS&H8QL&UB*_M9@TO^U
MIB"[M/*AO?7;TWT]FWZ9%Z7K'ORX)>V 9$F:@D 0OU!UZJE&LZQZ<ML[F=*[
M4GS"=."&EP]_C,XTS3A48C)(4<H)GN\BU\8'E<HA[3;HX,J CYRPE1>S/D/]
MUM1=U;H%1IP/@*Q%#BG!D[S178<;QI?2+;(?-N.>^,=9#@N1C7%?!49/XQ^P
M)Y%G!@WW1M^(F#W\'?OKPVH[2F+ QYB"%SI.GR'V57]J032 XXNR!225L1\(
M<T#]Z[#,5#B4D^=85 LF+;NVI"X'<CPN('HV5F]F[UM]JJ;4"\\/4;?4&LM-
M<IN&'V.+K/,+6<&4/Y[I7Y_FFCG?'IF89L26/A_]L' ,!5UO^>.=MV>E^\!4
MZ;O=[Q]=?O?.U+0D.Q#]U^C0OU&MG)@!=P??]__A*((AX"13[1,C"=[ <+KD
M5E48:[/D *QSMAG#30M4!N. J&XC-1 +7)L9>C_FYLS<#L)/M:2Y#D_X^YN=
MJGTL?3Q>4W_EW_<V:_FR':2VO:Q@5O+H<H85IHJ6;J33)XGE&Z[I1AB#<9/4
M5.:VS\3-X^!P!P<-QPI,A1IZA;!&0&= W[R@X-OW(DS<IOB/.>\GWB^>B()6
MNRF84UGZ $O<$<9=OX#8EP;;\@.I&0R>J!GEXHWYYH5I)02'S%]LM[2.F-RT
M6L(NO83K92P6LZ&N'UYK]<]BZ[4?'];FQD;OHK=W?9Y!-BS,L4H)U\B3RLM=
M!J&R/6[\UB-OXYW2.@(/-O9= ;IIZC7=3R;'6 9C^#NX-;[X%R*S#][Q'<-$
MXWCO.T_.^>$VO%A5=5E\$'1IAT'E$#1U';@V>CM+6F;G"7CRX2E3P#.<9JBW
MS!XLGARW:;=-R"@9*=#EHU0=UJ:4VHVN#M,8=UW'3+0*S9O>&?][5N2D..LX
MB1>( 7216L3/$R9"GS0)O$BBJ<@ ;POTCO<132370&I4-7B(K\,F)\HHD39=
M1^RMH:O $XZ<")=\.!1OV@[#U+W"!GDVOAG$U=ZP V4?Z(II$XG_^# -@-RT
M9^!K$L]0N/&EW6%^P&G<:LDI>B94DY%J(3'02ZI_4TO8KM.3W.*,3+Y>5J]P
M=4<V5E5='*,WE"L_S?.:+YB3.?#E$'"OS=QLR:P<4M</.GD/V85,4M.9"/#!
M)$H#G^:J:(] +.YM'KF#J^3,5TM36U :PVN2=-2) ;'NPMKLV"(4VCLFYTGQ
MK!YBUQNZOG5N!=?W;L0H2:*%%(6_ H, &,^UNQ(@HSX33<8D]OUTK&<72YO.
MU06S3@A9[6R]::*U$!EOM[T23(G<W8+DV>OY]F.]#?=.?'(=<O2_0[V5>8$O
M?8$,PN)$9=+G<L@UJ@[8 "-CA,A)1"T3.>#MPM:FI"HL5VGK_. X(Z$KHS45
M=)'I?!WV"XFG!QSGSWK9]G8-9I9?V:<[>LK"B/7V/R&X#94\BHJW1*80]WR6
MJ *8[HDC8/EDJVF[KE](&JW>EV:G!?CW%*X6#CV:,+.U9Y.O2_SYK0;MUGE=
ME$3:4G-<N.>;@6)7F&MCTO=.E\5<B973V_!)BB(%:@0!HVX\9/J$<9TPMR-V
M# <%RV;DD,[ [2VYYU+J%^;4XC0#2,YQ!^IKSH#WL;@SG)H6*R-J+#S9A'.E
MX<GG-2_ ::'/6U:]6SM53Z(/9F$KQO&'NAM&(_2;T/H)>6>K-N0AZ&5@FC.3
M$[G;Z]_7+$YDC?'9 7,+'=B'PJ&#[KE[B=> 98D6;1+9V>MY:LC.GP_+R,V=
MYL$V@+">_E'))>!:(74KP88'Z3GV"IS2*>UT)YRR?GC@R?=!W<,W=OY34&@=
M.M8@+)_GB??BAWFH9*;U#YAV E6MQ2)">Y 0\ )_J$<&JWM(TCK4]=SWQU">
M')(8T>O2F;L\?.#=%4N%PQD)RWT9MGL4^W$3MY*Q=:)&C".8 :8)3'V0-;E,
ML=-Y@9XPDY8PM0E*P ;8I@AXFM&6(<MQ)_[&&L.GS*T,18R]6ROQ*I(<8]85
M;K$STZ-8XC;@#TS][<)':OX8):UX06)IW7+(7224B23H#R.4\*.&'A_>ZDN(
MVDG?QSIL7J%M$VM8\78NS_!5)Q@OFW/Z5\Q"KPRTV)1U'31 VWW8E3=^!KLM
MVXXC2I2F(=2)_;)=GPG^@C%:<I-%<S$8,]N6NTQ22"28]C:H&Z'$'/#Q:1&:
M9O _UUYVTP#/"CR@^)6 S\=-\FYG/<MN Y#I<HC0 Y: @"JD&9Y(4HNLL>F1
M(0"W>6=AEB@.(!:$/P/Y[..?JR6W^* $SA\;-^A&??&>@ Y)7'G&EG#KE,LT
ME O&LL+*X(+@DML7ZA:9G62/E$JP"N8K2'J/PLJ$. U:I>&@TVJX8GQ\9U,W
MO3;0R7)H]&P*C[U^VH^;'%EP_ )VZI'?=%[ 0/ON0L=S+UPA>%(F\I(<<L\(
M\5):5-\:B-3S0\LA]>\ET#3^KMH'-/]1)[3*G'AM&E8HXK9/W,B]/7KR0-LS
M-#"K=GLT*VS]ZS_8L*O*L:XHD1-X@&^.$>4,$9Q*9II69$/ZJ+N+I+08Q](7
M6B47?26'A=6%&L*^S]OI#'IS7^UV3L&-\C=ZC(/,R@UZ+ZU8.<8(E\OB*,EA
MD SH3<*2$"IAMJ1.J!KA-#@+G)CTH=!GQXV[F :MPJ@4V5;"QD'F_J\CZ ;$
MMOX(WTB#8GU\S-#,-/9GQ"O<BXL.RIPPW:A-8RM(LAR"Y8Z0NU Z/XFJ/V!:
M00/$'?Z!>*IK@"UR/9YOKBF'> D#"KX7\5N-'8#2GJ3G0N_6*I#(=FNEGN^O
M1VWBSNA68I!/KF^X#EDEM!']!3H(#0GAB+180(V_MAG0<WHE9"O2!9#5$S/<
M*8=H<\$3IQDM=7T2_29&BE$4N;W)H6"IJS0I]4%<SE^;]SV_]K7W7KFLC537
MD"VV\B>^CR'&UWZ1P%\.4](L/Q38=.K9VF18LA11* J()*?6+^C\>(4>'AJ5
M/:AZS'J]I'QB%SVCM#1>%?OLPHQ; DIX#CIB*J"EML GV4E(G>Y6/E3_Q_(*
M-^$94^C6B53[@D_EG*[//3>(7<S =1&U^BQ=QD-.O[R/F7?K$,Z8UTZ+;CE'
M1I6?6*UGA+61:'M.+J<J\JHR>$ 8&_ 2&);L8R<C-TFV"^RO+1P%NLE!S]&%
MRF"P +ZEMQI$!@Q9&L([ @_<LUK8,!9JF_&=7(G1CWO65.!WM2GC*&2%,>GS
MEJU,9 <J*WH3VJ87:#:(M8CL177I3R6W1/(S/+N)AP"W%/IT<:[7L,25C[WB
MBZ,'>,R=P*I]E/GM:JUI.="9MIG]VN>#'+(.>9T[0A.PTVDM:X15_ !6BL0S
MI(R+.?<%2;9#%?EC\BSRHW42972>.:J3".NWQ&T)%45E=2AW5_%<I%?:31^L
MN0@)1YT[M\I!^_^]SD?:'W(=6AR3PGPY<Y%88Z^Z1@[=U<RSGJ$@47.$2(_1
M\HKUJBG3W__#D>;HG?>_#_'W;"O4PY<Z.0;;5#R#YLC4B%VPU^RY!7Z!3S=W
MK4P=CVD+W#LX_W-?^5#-3_IXX,\>MR;\U<;^Q55\0W\?<OO*F06<:NYIX8#?
MV:=BB'6)KDK1("G8;40< +KS6?=6V!W80^?!  %*"Z1V%QH+Z:)ROD%V$Q"2
M;N<>*[ G=>KZ=38U8U9,*L/Y<<=_^]0U?5X*L%J,_OZKWK-\S$E;==&0X" F
M$F(!ZMRLT*5#9B-$IMII3&*=+H*]PBS>1)6 E-QDN2*'Q$OT>%0C_.NQ8P T
M+;+F(-=/N)@U N)<W^1>>/.)=O7^Q*=+G$Z#CT<W<MZ27L'G6H7MLQT,XBK0
M,YCWQ,Y4D*_02B.R&P#/<,TL$'R *X>1-@J X],,Q$[JV3<#4T+B*U))F$?
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M7_*JH96W^.C&QC=N\]CMUR(9\=ZI\(<.YDJVU>YMF%@[4DA]8SU$^O?S.LN
M(#=@XX.RV;PS<@B:8X4QBSO>/MFSSP3C7Y%SX6+702?+,_]T1-Q^?HJ\]_VZ
M':\E. %<77)8B$J3;<=_\'#5:S=2$C)9 KC.K.:Q\'"C+!Y+;=HG9J*YTI[^
MR,8F5_5RZ9?Q $O=G-]?W[_:/)GDZZM16V";'78\>_?94K^Z#-N(Z:Y/D7O/
MGMZ?L%W[VY[WKHX'4F^XEF1==RW)Q^[,'HO9F3//3#&T)]Z1#2&56&&43;)^
M6)W;O(YX_PAAS= 2/#YP%2B>1&F"40):NFP;:-V] DM;AJT/YM#J76BK"/;
M>-?'IIO"C<_@FB"Z(FF&\T[OV'?K$84A)$U6LNK<.DEDF!YSSXP^O)N:2-0$
MK2:/H%)MOPUW41*;RI-* 9N.7H=OY%. S[V-^5$T7S"/X]OD[V)_Y&SFK^'
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MOU5?5'%+!H!3*(+[THM,:]2YBQ'^6KTFM2Z9%3+5^5XY%-VVZ[S?_'=%"I0
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MT2;XX>53$(6EAJ#[,\_\F8,:[%Z)GO;@EE=Y?J4>3O?#WH6J\C_N8HC_[([
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MLSG7N?=W!&+"_WUL3T("IQ"BF %60KQO(TB$=]>@^9(%(6B1@/MIZ05LM&Q
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M0:VX4(5,:2_2<49U5IZ;_NQA-;U8/.E:N37T*H#XD _!C>&.3NAA]]1@:#X
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M;?,1R=^]RFSM&>3TYP!5%6#'"';R]0&I]_F2 >NBHO$=Z'UX$5X]6[J>O#/
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MUF3^.6!/#A;HH?N_=N\+YK!CJ;*MPZ$]#!L1RP9_'M/['?-Z>@=1,8,<>K1
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M;HMMKXZ+QQ['AQ_O\@]B[A?F7CMUVMB@3N[RJ[?1?W4<E7,O<Y=(JG(7LS?
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M+S,KD1.HP.4N6P$_T;LN+13.K1N%.8Q_5I,<_?GE,MA9I2C^[1"QEU372DZ
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MRW9WN*9<>9.$@N[X;%S".W,O$V$@>DD*>,*KSO?'^E9 $_0QP8XW$ ZT;H]
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MR;1*:]4\\?#;5B!KR09H[$!*0_X\[7B2!%'/'R.+."=*3E@L@'R%VW /!4?
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M8_=^[(^CUP[QIL.:Z?N65F$)!!$_5V[B^O&J9\T$67PH-\4<6O6] R:(&^Y
MBL/8)[8R=\)?<A OYSK5*1BB"K_>2UU"?+ E2/!<?MORCS=DK:M*"D;4-94W
M#(UNZ+[[BZ8![NB4\@Y(;T.^%FY:;4/F+P&?_WN.[B*/%D\/=_0(\_MM^7*]
MC>8<Y#Y4F'15?^33$@W9'X\;8JT'\F(P >+N(AF_674-#54X'QET[0ECRN?V
MD_$$NS!IWC_<\$F&^FY<"@>V(YA1:3+Q_Y;]DMUA:+2>6M)[7#4SI&%4-E F
ME11I(%+B/:&186@^$[.T6&(@/HORF)MNH%*HE"RO^DEYKWK-Y5;LL_KPV:1\
MY\EF,N[)/TWUY93:AL<..(0#C7)XK$NPZS"UR;JQYNO"-^==#R5'+@>OGX7P
MVK;*Z#X[ID"&<1V 11HH<S(#6P,W$B-X9H6..XJ9I09Z:Y1>8O 5!S07;CK@
M.AEZ/N10M5*C!&9%%SK?\/EA2HILG7+B(FE)?61S6BV3N\RVC3120M5;=T?5
M?VRB-O67Y<&?N16A;!_-;;P\[&QRV-E!=4Q,%IX6<T#I<4XG5C M+DA[*6C3
MD*<%?F*'BCMRP\-YP=\C#:ZP#97-F13TQT5-Q7Z\^;2JX-]#?B-Y:<P5Z249
MX5LAQ??2]FD-STFT8LI[A/AO '5&&!1$L@< -_C NSYW0!^A1/SKSV,PG;$1
MW\%:PCON26EHXOT:<Z:]X9CU%M1PY4HG,"6+6+_<5[O'3Y,O@3E<J[]!LW=F
M'*RH5Y;&D)^CH[/E-N1.(Q 9KHF4$!8W[ULD6@QJJGH8GCWC7EX1T:][3TKL
MA,C,]0)!M3/;$!$CI;EMB-C)IMH!O I7@%'-#-C #-K*ZP >9/9I?QU-XWH<
M]'JHS>F=>#5XM50SL?^*5K&OA_ONI0O?!_CM7; J6'58#G)3A74C?;C.=FC<
M;C#\C)45K2K^QLOITPK?ZJ:57MY[59?Z![N,]:G^&6Q^Q,+EGY884H%9B'#\
MMWI,B6W]\X !P]2WOV%N$?-S;FY[Q,;WDS8U'GV4D"<H(<_8T=- %KZX)4R/
MNQQ%+76\50^H)9+L<2&MNR\SR2EMLRMV[C(>F474MLQWO5.;EOLU]>_M'[A\
M\^F5%T<D(>LR*[+T/^IAT&U(Y37.-F3K)D_$I>94B45CW(.*''VQR[LLX&+P
MPP*0E>N[Z_ZB[VK4WKR/QP_1T7)ZLX[7R1BU1B0!Z!YF#V8(AV>N$]FAU]IL
MDIQ08?<"+TX8<V()B\4J\28_0VWX_897F5Q,:5KWWT\NPPC_K^-H'.6H)R[3
MY.?TR%&RS<'?HRC" HP-8M1:$^(ZK?>X3&A"(L8W!!\Q<&?H/E;-,^'ST$]1
MS/O4>WOOFER<@0CD#FMS= V0QP+H0+0]SF?%<F6+@DNT&M+X.AUW-DAIB-*E
M;(UR?O-%K*3S8/;ST]WPO2F,C.KB$OM.WV+0TP*@MCAI6'R=MZTW7AVX>BJ^
MK1^>@_26[)35;[RB\-I#6/Q"W*E3EPSL.<M".*DK=*YIG/^X-B-+OG_:'KL6
MZC"C>G\I*=/-?$5W)G/$XM3E?OW#HF;O#JFPM6-YF.E)0="SW8$?S<;(&G.1
MX1H$,1239513[)V11\D8RDQ[CT4%I]?+OT95JCB^MD%-U28U@M-WHMH7YQ8D
M?GU?K)H6$<0QIM1;_ABHDU$9\S]<! !BI#]Q<>%E+4;=J;\11G*<U[->14>K
MDE65+)/;SA;JC(6_B(!=Z?V?*=TZ9.'T>$[R"E/;*L*T-MKYUJ4(FP=7F@7V
M'!*V,S63<-&V-=V5VO=,Y<P/ZY<OKBQ>.=Z[N^"_^',$BO,/BA>#FR8@%ICX
MSB;&$=#$O6 ;[=R<2JX+_^/D(;XD[^^A-=E7O$N<XJA5<BQS4L;OS0XPA,F#
MVKX*9Y2C&HTY38B6=4G6%R/YJAVPBOF,_C%=^VGK,0^Y0]^[N+?".7NWJAOU
M 2)B8%%#9.^_ZZ2'><J>^5Y(\;4ED]GV6>R1FC:R('B-X]FF'K%A1-VO=Z>O
MYHGFJ+G8[.P\^'4NH/J ETC$CC^S:PP"4FP V'.:.)H.-3J,4VZGR7$#GG#A
MCJ R%[N#^0+A83JXO1IT"3 8N1>7/2NL;0T/55NPI"%$?ZQ,SFTDQ*M'XY7S
MFDN_=N5K=D_ ^ >$L;GSNSE24:L]4<A]R[/EH.,FC*<V%':,=Y3[-DMG +,&
M"\\23F=H0X\T6A<K1;*7C&"'P9&3D3<JJRHKLQRQAT L/-&"EO4CZ#8D;*3/
M^,@N@+3XZ:3Z$F*G^PI"/TA\&8&I2*$/T#\7MR$CG8,QF\3N6'[P#HV%DL'A
M&74&X8]^#WB:O)4N\H2XT0&M6@I5O0R]&]1'Z+';ABQ3MR$R!C_HWTL(OW>L
M6SP^T!@2&OW=>!MBZ+8-H0WSO'YE;T.R*K8ADVB^)G?\R*YUY4PIWEHB?Q/)
MS?E/-^KPNRWP-<L/^8L)VUPBM#<*KJ< DY%4\G.8J.;2#<>/_M#]>$/N1-W[
M>4GY$T.KNAI=5WL8>N'?M-O-E2W+[658:#M/D_I?;E'M=GOW5GV7X$*7MMRX
MQ2Y;68T6;.0SF6/#OV5FJ&-9>LQLYJJ<- 4&\6*F>/-/)IPH<78<<S$O9K%D
M=Q]*C1VBHDN3GRY@'ZZ[R/_C^9K;<] =Z"JW%VO[_CKTX C-+8&4_D^YCOUP
M)'/A[@5K[[Z8IRV;7D5GL[/4+!,D,S)O]#VO*OJ#ZG8J"XCU/N.KM:&0GDF=
MHWW<N@F:L9&[0=^6#9_2J1%:'YH3+W5U<&:0SE8:,C!#%^;8G5L?3@L,3BLN
M;''-]/F6ZE&1=+?.7K3S>K&T'#:&IS(U*3WWB83K-.[E7<MC=:OW#SA64YNJ
MGG).Y\4Y[_]YS2395*A*_<UC:[GVRTKT(X2[]*?;$ F-Q&=I1D? ;8@;5Y9!
M.P%TC;)P:(O^'4.6[:SM!(0.HD)RSCEX/L-[I<DHL&1N;IRI1-_Y5;)TCDSK
M4VT;&M2BQ6Z:\92X'#R4ZQ[Y <=7!F,Y'G7>]?+/U<+TP=%;57UN@V\=YV76
M.G$Y[9UY+L)ZS67RD^89LD\(?KV.'\M;5IP8JR,UA]S]&DU; 9[!Y0AE47[%
MM7/OVR^4IO6<2I,O.YDII.5K=-+I>D'_!\OF[DSO(9*EQ(.7[PT,'306^K/D
M1:7A7PM#5-3@]1@SA'%)D*Z1RIP/V7%D;//-NAE 9X1 PUF(6#PT%[31;_*\
MPUVJ F.OFAN9#JXV$*)HRO#]$7E>W34!#QV:O:K?N^.>BWXX]><OVR&7_QAK
M]+>3H+)).K=S2ONIYC9$F.<)M+*0+9G8UF&I"5%NT/"JN4</8T+QC6T=,$'/
M1XO.L6:6)I)RYEGK6?FC=^H&3I3+S+0NA11)#%%FH*4?GN[:<]CDRK&G(E=%
M'J#3VX]%?Y,_P3422R,\YY34VU=?#,(>_N?"H.\Q)7412V_Z4%C%-=$8$EPZ
M+00W5?%5RI'EJC(P\R#^3-_++P9_?C2OU!I9=TFK:"S1"IUO#-]BD?5S%A%Z
MZG\6H%OK]&G3_P@F<L(/\A?SGHK_%(SR_]%%FG[V8WVY$(YIAYQR.U\.\*<_
M,9)P%I$PY<26*M].YYA&_[-2TJA5?;'*6VL.^.DJ/#0F\WRO:TT&Y_2,V>WN
MSV*F&UH3 5['T?G5"=\8TK4)!WA?+1_%>%QW]XO^%GUOK.(CUZ3[\263YZG0
M5S0U+CF\A."%>):UKX%Y?XEG6PK".3Z%>5[]GZKG-[K[H2(:79!V9LKG*EJ6
M#OR 1_7 FC3;-*9]+OOW%]'!N[0WL+R#=FHR197!TG>JCF64W9WOCS""LD2#
MNC'IU\1%RNY6',[<>ZS.,@[H"U=VR RI0[PV.?GS^[*O@TUU1DA%0)_:%IX6
M-LI)3-R&_&4@4CJ&0[?398W$<+#6@+MCXR"A#2IF(,O>\AET9N6MO:_MIV(\
M^OF[?-W/V:;-VATQ1Y]T,JU7MC7\%Y?9".D?U2X* "&ZT9!#/S1_THVT,"'+
MI(P'&M,EA\583K*J5O"Z^HKZP\Y7#"GM![Z).ET[IUY]?=ST _'P!Z/3H.('
M&-=O>9,P! 4K7 J=ZA*@Y]ZGWUL[/W@!:)\N3Y2(+D9"(TO#73JE$S[<"3^F
M:E C8D.D%#Z/#WY4&%>Z^%[W]DNTV=GI6^:?E^SU592R/LW_W!R]][]*L1+L
ME__K#+PZ&8NW\F7'&ZDLB!P T]NKX(_2EO)Q9HU:K.>G/_[TF9%7Y$I%+-*^
MA._!SDQ\>DC[>]3G4U-* NC&#9[D/!=#VN'$.\*D^UI<8C'HMA>@";-E8P$Q
MF-=/OH]QZS- DKVOSD_\G)BQ+Z-LHFVORW'J7FBX>/;03G#WI;#-=SMP39J"
M)(G9N, ;@YI-#AMW\0W.^G!JVLK/NT>DDM*.(CLC-%&DE[GG%5*N1TT2"17+
M2SG  L?SL7^#21_//1^),VV3/_'&,41]/X[8ZJ 4RPXEM.IU5[T#B:TN)_O\
M8C-5&"P_EN^$6:%YB;F[Y%N_S%LHNY'16-+6[I-LH6FCJ8E3/95E$FVSE!6A
M3L5F-]_[)SNL-][ZOIHUZF&YSMFN:RH5L\]33ISN?8L*??06W=8C&I[\V?J4
MS(OG^3D]TII2&*>@8-:FUF3>@(WG3X\:CMQNAH-)#AE,=.I;%18PK2+>'EIK
MPEI5]E/BU5I&A-*U60EYH0:2 5H!W,+DD#>OLR,4]N;ZWS8/(D72O8@CFVWU
MX^D1C6>X U/?HQM-"V\R-P*>L)>C)PXPJ4U7_9\ZYC_MO#'@W_!FH3"-*5WF
MH',\J544?@&IINVZ(OF:.SK%K J2S"3AX4!XVQC[BX56J7!E>;2,Z9?ANX+^
M+2KG1<ZFM4OY'A9)P@N#'< OCGJ'.LOS,I#6X%GL+2\W;+!;XA,U62467JNQ
M#=GO^*/&EN6^5M6%"D4?(GL&D;J^??&LJ:V&>44HI(W/S'YXD*:]J1)=44<Z
M]%!3^INN^3&F7<*-5T*J,KC&:95/.W3KE!/[:6%P'2'ZZG,--4$IIJB\GV%L
M]7(F*G=L6$/LK>'<H]& Q;>9I8I] 2&D;]L0%_Q_D[%HQWLWI9V/LIWM$J[;
M[)D>?HH:FMJ&'*1_NU1 ^+KSK',W)9;_XS1MB.TKO/LP[2A.A9V>8*3 NTOI
MG04#@8:6,,4=Q>I<"OF[9KC4#RF"@UVC#_LON>@?6,+*VY=08F4_6:NZAKQ^
M^LK5)N@O(H+\&H;>P6>C\R!VTPA_>[A1=%,71UPO8/8\P:/WP/;QM&'A)Q%2
MN]CF=_U[UW[PK$I0V0N7AV>B->1,!JZ5<]6:'DKFS<Q-R S-NJ*/"W0BJWXO
MQ0-6'($XO*P[9E,;#B1:<;'M(M)X26"BSC^?IQW2B97\0=QO(,VMN9JPCA!R
MZ@R\1[L /IP^H^8J@V?%!=N0<KSU3/*,E"EUQ+6_Z'NV(?<R!=<#@&W(TEZ@
MBG^$L$CE)!Y$RW1$X\W)N,3;8/&F)RC+(43R)>"AP,0 @Y56 :2S;5(W37GN
M7CS[AWDXJQ:"R-W8*P V(B)]"BY%D<E+>..Z]=IW$\Z-V634>[80HH,C8VDG
MYJ'[>:J>4P@)! <6$WRK,/=',(F1*:H!'R@$)\V9U"5M^SZ-V&V(D/T?5E=^
M83%*+RW3]:&GW/A,ZA=1@YN[?JS]5Q.6*\.+(0_+\&?!/YN>>!D@-*VF"#4!
M!>T!*&>Y&1H>N T15^/YLS$A5[A[(]N0^T9Q?&Q,_<"\*</H$CC$H4=JF^]0
MXP'J,U3PWK3H=V"WKB9\Q^LL)(W\EI*_!(YRB*-NZV:QG(YF<V6V<2KQ*1TU
MXH?NTN<DI'#WKKVIP\. $;72>]0!/[D3E$%JN*7K0XV4<TO*+Y,*+0=WK9):
M)Q,F=_,TN=IL9CP'%D<_B(>5[*"M_"EGP@TF_R3NFMD@Q838'%QYM;XIGE^!
M]<^G]!@(BDT8'TC*CSKN=M+SQY(@LK?1(M<.]XRAQTSAJ I8USB6JCOV4F4-
MD=<'2^U?V\PR+ =F:RL;:SQLK#,F4*?.E>R^=PP_Q[5E#S_31,0B]Y"QJ]?+
MU*@$25S'IHE58,&)NA7:,5S"]=_G;+V2EG YL#J[7S4"Q\MA9G,9[@GQKNB\
MN7)!1\'3S[6JYU>NGXP2:][]9>7&!TEEM<6@!9=9S\C.T^Y_-)T4A4(-;&![
MS[DHY2M#(UM=!T@)'3._2-=$X*HM@_DDJST5AU-OFF,]#V8UM^>^7YJY\,C'
MUOO3B+W&.L+VR^:ZP<*T-B]J1UC=" S8EGV8:#']\&J3.8:R+(WS:7%&M!D=
M#'DS*JPV_AX>3S!NVKP(OFGA:BP+P;R8]U5/IMR0DI)<3P)C$7UJ/[\==J@E
MO]J&H&.)$9+U-_L7)D4;K=C+$CL 9@8\D;TV8'0:]YL1_*!?"<QCG_8A$]BR
MO6L+JA*>>O?2?\F9G3/F8?<$/AQ3'<JC5(1: %.@=:.*!UZ:(X=HDQ%@J=-Z
M2M#RRL.-KJ$&+?-7_(]E+$>KKZDZL%6_3PI9F =P1T_N/WXG6F(?+HY^ 'ZZ
MV<.O@EHTU,;AVNFZ>CZ-/VU9_)0QA>;<JQ"4MAX,KSIFX$5W/7#'N^HMZO05
M:W%\MU:?PG+H<@@*JSS(I;.TS?OQ@9N&/"NN32HG47QTCLL["J8'WLO85T/(
MF=N(@>Y'BQ^E9IY7P&KT=@HZ.(\@VX2'<@2+90M<7WM$AWJRD9$I#)H L%6/
MEC_!-)Y-S'%YW6A<XH36EEQ22G25KJ9D?)^MJ4*J!#LJ?TPV*-/U16J$]?//
M]AL=Q$MOO5=MM X]E 0LM$X>##OA#-I:I)W)Y_=PPVK82X]&;8 "R4Z%?M.B
M<1>'>99$M@,E29*9#7^]-%U-&=C:ADQ!6]6%>-:@.M#)$7BNOO=W) \^U;5O
MO=VYEU)>.0<XCML[1REFG":7J+&S/F_L34-4C3=K*,:>(-OD[SX&B@MFG%,Z
M,=/+&0O;AUMVAQ5UR-HJ=Z('6NK7U\,F[J#N%!7Z^F[JU&FDF'<-4Q_2:%WZ
M_C67S$=_FI;]6P7+Y+FON7#CQ3$G^+'#5V0[-7Y=K[@F9%$8I)AF>C:I/4I0
MOV&O]=Y7CP^0D\(DP_H(^S03)7CW^O&&TUW05E:KRR5SC\X;P*9YP3AZW59/
M)'Q5WQ;X4M%:+7]26Z:)DG:%$MM9B_D4,[_BB#Y@N;@ER-5O1G.A[)X$&I3V
MCF4)#K<$;T/"1ZW@#_U8N&&-SDS]I=C[_2UJPG26P:1"U^$4GYX+OK5A-_@?
M"17*K3V12*AX>Y;"$$]G0XJ!<7/H(\N:#OEK-@U2SU#TS4J>'U:DOM\\PJSO
M:FIK#;0R^+M#L:3W\_G6W6L:7O+'N;RD<1QS BN"<[A Z_E0/3S_.Z,CXYH&
MS;"^*DA5[43"\6H =(37U?6G?FNL'=*4P^0-3/4;O+$$58 B9"++CPM*,9BV
M&9$MF.!YYVNW!J;*Z9&W^WBV;$=G%>O*AFJ[F8HAR@]-V=I2?Q4K"8[">QD/
MN^D[&[7?!8YV'[HT8%@5]]:S;"_N(A@R?6S"J+\1XXL"NB^XL^--6U*^7BD#
M\Z\R,\JHV=[#4ER$<H3;/LZ85\M1C(MFC)O1[]HHI:.[JX'9ND*40ZO\'J[3
M<F")$3&T /1%GI$AQ?@Y*Z%ET7-E_1"Q3I?^-W?Z!VRBLZNI=.W>2=25@25F
M?6 FKN$ZF.(^#=L_EQ'8CCUB-S>A,8PWV\U2#C>2=2*XV7_]H5?=Y(G.[_&?
M^E.F:'>/\K2S:S"7EN5XN^M<_*/VX'6R*/BHL[7ZK^Y9=(/LFR#CV=02%%E(
MKSJRL#TA;2,_7;.K:;QRW/%/@I!V=7J]_Z*Z:@+)+93DY,0R_U/%]5R? P+_
MKV6; "+!SQEQFPXZ%L]_FD:*@1Z#IGF(H"+0T[)_.E3%>-#GUKLGKH/W_06+
MK4+P:?&:;>'5[XMDK1MJ(5M&U!@[U5)VUBS\T_NGI_,;4D_$.!:ZQ5O"7[M5
M)\CBOF4VI_;OOQLN'=,F<]Q:?$A8Q:J2N=JD;3_@?FF.U12>17+53;@>Q[1=
MYXX[?+Z;:FGWY05<]M6WOY,.L.9+]DO]@)#_VB+Q/-F(??C]($D[IO%:GM>9
M4E"@/4RNS]:R,68"@W0>XETJ<D"Q;J7[=*W'7^7/HFPQU%RK&R]*:BX6.5[1
MZ-M<"O,@-)L2/+'2/#N@+)(KU>+P+@L:7@^-H<H1&'H)[]*8JCF*%+W266IV
M"Y,-JS[U[%::JK%GHT6()X9DC)8QQQRO@VS>'9XFM63"K_0V7GL'MG2T!80I
M/B$!6\1GI52HY,)&T555VL@W')I1'9P8=9+_.:3!CCK;,(!)821W)X%/5MO'
MI&:760T[EJVMA^7+=J(=[:64RC8+YB\X8*,U2E5:-Z)JA_TWBW7*EFC-!5TY
M/?[9N$='V4W)^%BBJ&97*TIT\V!KC?@JO4)[<9G,[R8*:1)$</6A\@MM1B>X
MYK-U!9TY3PP.C^1E9A'S[>*-V4\Y*SHYU5E<&[L<.&I-L(!SK6XF?<$0X=3G
M9QR^END&[Q=C9V)&K095STD&Q)U)<D479HM5[K-D"TH(Y3W><UM@%L833YGB
M-P 1P_:#C9Z%LACX-/1Y(VP:NN='@)2EL]?O";&^9!;&U+8^3>LP*:J$Q$T(
M1QN&CY=2J@-LBY7>!!6;^A>;9O/S;;N@ B44LFQ8#V'_ZA(4.< 9YL& W^SN
M]VX%=@A,P1@8Z$P!EJ(IVNO5PQ?&.C"!W\;GZDL?UPW\U!0^BT$@$GX.S:#8
M:W+:'"%S]I*I!7,UWF;2"=@:7B=$&VB^0V60H]<<X3WZG4]#A/7-*HA6@WY=
M)KOE<T@3U^Y9+[J/GTZXKF9Y7,0DNY'10I!LU)PV=,#(FO;C@X2[J&U#>3/M
M5&"YO7[?:[<@E$_-)?N)^?KN:'<2:WQ_;ES'GN$#"N1S%NTE/XM"C?[O>7'O
M)L!_?+A= !CFG1.)9FYH_GZB"95H2B7%^^\7$[9NM,+<S1X:NIFV_H U]DE(
MTHO_M_>IEIDCP_T6I'09T[K)NV>Q2;$?1^^H???MU'<[UY%VUVP!V2/01D^<
MI/!3-AUQSU$9B3%^XX$(;CW.EY%UH*K!M'^Y4>50C8_?DH3S?8?V4%GGA*-8
M=7)^36U"/_KU3/WK;Q5)P[\OJII.6X]9C"F'T^3F[MKU93"LN#[TAR'WP5W3
M&:':+0/V9K_^^MA[G>%Z^^N##Y!'4$G\WBEXJ=N'X-3?$08PK9Q2WLW>):I^
M9ZR@E6]AF]+KDJ 7SM<7:#/'KASZ,59N="<(>KJC<6XC-"'%#9V/2GMAAUH_
M;XKQ]$3+,+ 8K-A2PM&[ER5U^BX?+(+LS@O;$S9..[1%TE2/9\HD5.3B(BWZ
M_>W]5-0CKWVXB$O>AC ",CY5U8O.U1M\<4N#2KQV'?11?NN 2G_4H?QZCPJV
MV@SFQ=\U'_PS#R"P06Y KK^ZC!T.>7T ?^^7HYE;*);C*'N]=,W1&7XKJ[]E
MMH4O^(JE_R;DC0HJS=K#B__/EUV+__]I7;LL)?-@A##X%"8(1PE$$_\>LF)4
M3>9O'O5G5KQ%79PX82."EOM3$Q)^MCG[T,%RG>-0Z$@8DW^B8:M*?1OBW@Z*
M<^].,JH)(B>X-_"(-PR]NZ W?)TK_SZWNLC?F.M+YYT0'QW)*TW+UKA0U%G:
MX/C)7:Y W';4'[3F?L3CMUX2W-$PEH 56.'+5C^*JV+0#@+*'2I$%G;:DX$4
MWJ$M$3QJ!R?@E%HNG:$>-Z$V7(I7R<:A+88.O9_E22>V5H>)#?G)V5X?;!3(
MP2':UF7(D7C[C4) >YV\]8J 2B*K+RYL7N-)@HM\\<2;A",BSPGB!G)<(3#(
M/RHOW2ST/L[*;HA0)74GYD#> .O7)\>/G&2X[\E3AW>M"O^[&2*9)B#S+&R(
M#EB>R&V*<W@/=@&W497>#\:<4!63Q*\]4Q!*R&8(/!9>MYA,4"U[7UU?79M\
M>$ZX]>+%CTV>$6L[X"I%/$PE'E@()!P8O0$P7T^-HZWK^@UTIQTQ-_@=;;99
M9ZN3!VZBEZ4G6",N]N3P;UX_?9:62V?0@^/>>X04O]..':93)WE'[%^%6X.3
M@$;5A5V7H17T19Z9PA1$0"'EL:XFE]P"'<TT.L[_2I<*D]\)$DF9V?0R%BI,
M"L0:!&+>(=%(H#B;J_JSRK]@7B9OO"LZU!+CUIJ1D+A_8+4ZY3IEX/[,;AM[
M<8LM]<>@:90.27GZBPT\>:KJ[+$+C ?=%> 7]W/'W-*:9T?\#Z;:J$N?]2OX
MY$Y@?25)#ST_$=G,J0BT9)PYYST8KFMEF7++UR+&=FBDR9(Y;*;OCS+L8<K\
M:5]N9GV9E)!B%'/=...TI*"I)D1K%PK#4=UW85]VUJGRB@1]%+0EV4SNI4V-
M99M<E<'S7;(:)9TIXSN.WYZKLPJ:$( FX/LV1)K\$2I.:#;V-]1>'QLX\B.I
M&1AFU >0 *QSWQ*U5-M.)JTFI(A2A:OO=.YGJFC45'(UJ^/_R38=QDP#XPD5
M_BC4/G+QGP#H%38A H]MJTTX36(<O9]SOO E4.V9P4DUZ(S\I6MB%WP1)W,$
M-=#JYG2A]LLUOP>H]CA%HZ!;):XWS,V]5PL+0DP5NW3:7"XZ4@-6'13K-M\(
M>9R^&_7I7/OIZ;@N?8$,RZ@CG9>*LBF5;OBX@J)NLX/O'AO$MA'$&XW9F$#3
M/CK;#KU1XG**JT"3 GZ24!R1@U>P1<@V]E9@:[O)TU]W(N;;QRGD0][=Y$ Q
M[<PCMU.%]62R$+%G\L.-%$!_KNTULUTKGA6 4=[T BK&5Y]"%TQ,@-ZJCKZ>
MY+/VD1*E=@K#[%(QU;O&IA^!H:!/A:<1(]4MG1Q8A.9K?WK\RAQSZ=U\=?!7
M"HW()B487,!@"QGY"-] $F7C=SSO$DG:1S5-T,Q?(?UV6O>$K@?B!9LFWOVP
M+MSA$1M_*\0D*.!A%.F<YCF&U'/_%1Y)[O75.Q>"E)0RS_9;G_>10)F*6N@4
M#=XYY7"FY;M.;JF%J9VJPZW^EU;UR5C/G)H[$Y%?9?S;NL;#,X>6GM<[C[=1
M+H[-52&POJIQ*\=1JO=J*4$83]RQ5RS'('FILPY:[L>'/I\FA[]]23ISVB3C
M99[B?MW:9BW6<Z<9W=HVE)1N=P \PS(0>YM\'DR9PA[!+9L/:A@J<U2_/UTU
M1U\>XAF6V8W@;!GUBZSPZBJ48?@@%XFV^&1$U!MQZA2Z.G9T:+W[SL?SH48Q
M\Q_<N-(>:@G:!];\H]ZK!5NV3I7C-FYG,"]M5,-$HADW'@2DZGZ.R[OE?2E_
M6J?=3",#-=%3A=J:(X%_CID^;=3ED \Y(M <I#QB^IZH?3-)@W^TMU&'Y:=5
M87"+SE6PEBI]E"_6\^B2:.1O_(VU8LX=[K.1JP92@6RT^4VG]UD(R;F,]D*2
MYBLS[=S;7AGMT7[I)LC3N60_H.2NM9?]B+3>V;-%'A+%;EFN-FD'K?-TNN^P
MTZ<>@&=NG+]=LQXF)7)M[U%*REO7R)A,T[-5EH5G;AB7E))+1PDAF*U%[G*$
MO##W>[B?KH'*M*'M!X=M2&0+[DF.N0"#=GP ZZ/(56HJ6K!=WTA?[XE::Q#,
MU/<@^]]5G:;$F+G:\?XH")^E^32)1!GL)8UY,;/.U0*_GZG_7'3KQ:.,DMPY
M@L2(2GC0?7+VPH/YNW#XL@#R/-I0N]4A.Q)(GFP,'O^]KIF:3\K?S'PTH5,W
MM,B3YC24[F9\;PO^)B_'5.SC79K=>1%7"O.)#^[[!;ZQ;"@?F$ZTJ!-E?1RN
M808T*V*U9H]\B5UT_=5H ]/%Q;F?H]6LYQO%.SE+LU<6E0[:U;]*<$]XT'H[
MS3Z\]"!562^5>T3Y6>J9X9S$'.0N1_'(0K4S)I\7TK3,=;62S1Q- [,=5 EI
MW5U!ZBVZ-"7OB9/<31R9<Q=,O $@$M<2]US):9M*%/8BL&X[XAQ;@H?*"H,*
M4!\FFH.$AZ-\1-]5GT%KV/06YSM8ACTCM_> 2K^?PE ]$43Q,'4440POJ!GY
MA&=>ZBW0II?.4Y"'#AX'OK>.J_4@AMI*M)@3RG1Z!FOS[^&2DN?,]8RWWCFW
MXM?VAY>RL2-Z&SU'0:Q@R]N',9\ Z6'AA_O^2K-/L6GQ:#P#5V+,O(JZ>W%>
M0J6.7:F+.'!-LB)1;/YJWHW4[\;L!5\#3:>+]NS9>4O+AV_EOKWU]M55]6,Z
ML)A_QK$/LF-45@9\N5+3OQ<?;B)X-[:*2VAGKW %FH-O%18CG2; ?;*A@6V2
MECC/%J,](;O=WFFN9^8[CHU0QV1>5DUJ9?25MN<5+F@_[U =;>"770$2F/HA
M;J[3ZM%&XAEP'-*J$IA,\!?<,@J]W$[#5W1.JR"/>!],,OJ!>:ZM54&M;__E
M2&U.MOF^-A)V>AQ<9LB?I(#N0O6!$:4&]J3J;<@QK]L]8?63ZW<"TL^W]IX/
ME_!C)GOENYX\D 3QL.EH^KN;^_=*Q[?/W!PSR;64STDOI6*_(%-YU8K:Y,]?
MQW1.TCVFZ6*U58:?<(+GVCE@6)IX!"XLR$90\$5)]H/W)FEG\XX9B9]__Z25
MPW;\^L^#D=#[&A64,;9+]5GJF<W@KV]\^W-N72SJS_RNJ?2]IRRZ^FTR=7S9
ML\C,4 QVF."C'@.E3#X)NXA7!8B,)]Q SMY(1N+A'S2M:F9IF,2\"@DM?R;4
M:./G:(OD!CV<8DWEMC[$G9^' <D1:;Y^Z:RV7&;:,_B0$+T,)ABFXD4\HB&L
M?SN&806D1\_V:RPY.H&!G(^RU[GT\.G!=PGH@"&*2EO-X#[B Z<.MY*\@@&R
M1\QLEWNB5?G@ZN:QY6@]6CJ&T_,4</+."&UD;D..8.5QGK3J"#LQQ'.HQ%\&
M%9_.-EZ?M7NJ7U3\VNW@K;4>-S+H9LS-I.9]"_P=$+@>8:^QDR#1EEK!9405
MGP03RJ"J/:>>BCHLV'5Q3=TO\[+Q.N9&^[S(1<FR\YS%Q"B<-J,Q1;SYJ\$S
MJ909G>]J9S^GZEG_.OOURX#T,?B7RL]'A>1%1"-*HUL0LB9'SEJU_D.KLOIZ
MI]78AA1W9N#E6>OD@F]YBIMUZ'O9I2BMF1!]K9^9:>-ZL\D:.H'&"O?VN5N:
MEATX]B HS]94VL16NMWZF=!:^Y53.J<2@\%+ZR2N0*3!&6 ,ESA-?L+3]0]D
MTZ7PT! LE(5R\"#G+]"@_4;G074'[KYP#__3[X<HAIYW@'%RM,_/1F4]LQRG
M42T2QKUT/LGP(]039VH"A,5G.^[X"<$\,.0&L%YRBKED&G%N==/PU&U^+[7Z
M@G>Y\$6=);6P$7>)_,[6R>^CIMAH>8U$J,!K@-&I$WBNI\BF;2@!]7KVM8>\
M'^"G_'*H\"6[,L[F9+ZL5MXK:_]1TEN+Q/*T??'!FF>&2%'A9Y,>)!0%OLTA
MU6=/D%_[N@S'4T;K!O[]L>6>]9"+9KA(<",?4^E"X&B+7D\"3[5$M32_@FV^
MWTESO?2^3_:+O[FCWO4:*?8="BC-,9.M4[@<HWN/"KZ&W=]ZR1?&ZX"FFE]H
M1T'I:?6("57F"68IM91@69.J4=QT4N2P"](KP.HSWK;XROJK$IE6QZ.+DO?.
MG,,^D,Z[&$HU#O78'7<)WQ#^RT?L?>P7UY>>.O5V7SS$$AYFN)9KHBURYZZ-
MSKR\<+Z3>Q8Q,EBZ%F=H9I,EM6=&H9S2][:PW2J.E:AAG?(P-F323--_QC-O
MTO<MMSH]E ,[ #XSKB2:F5^[W;^LNMI)%)V;' W63" IJ-6'Y83F&93'#@Z4
M?;&-AF2<[/_P*BEX^)OZ8M.F".\&*,K]U>ZB!I#:L4(+K,2GL"K*Y&&O^LCG
M9$H7K(-%B-?8;P#W)<G&JA^&;T/V\_J</AVF#-ITW'G:OG*DD=]5^\2A'3$B
M##<?6(L5[%*QJ: ,KG9=G8 [;AGQ)U0:5$;MT^]7_[:IRGTQ=N5L<J7Q63V]
M9.GKG-IQ%3:"(2QH4<W40$2&[>_71.L*56=DO69C)-OY3"OQ#_=J&JF5,1RI
M\Y\4C*>3'#L#;R[=%>D'3*-?T_<"/=( <[?<8ODQM\<1@N<[O[^X5Y<O);5(
M,K_">6C_G%9S]6UY9<<_35D'K%*EW=Q>619P<3?UK"SCO&^]93'?DJ7/?%9%
MABCFC!@&5CEJ(8').%4\7#(/(Y'Z,XEC?N1J1D?X6EM"C_7 Q+PN\E;]0\$Q
MX\#W\Q/&'_JI6X9EE-'O58.8DRF;"+,AR@+4D (^X1HAY!A3Z)Y(%]$:(E^T
M$R8Q@6SFGN3/GM8(B0]P/N3^5!+8VS"&_+#^RTFQP6S/I>/QPE^,7Z?TXFW9
M051BY3Q+<358.7;5.G55#K74-5ZFX/6MMF]M]$@&R]R6X5 1H:,9JK?S-ON.
M.H[+6O9K-ICK6U>!WYO_K9@0L38Y"K<&-4M1R5Y9.OTTB39V9WLUS=F1,1QV
MHFIHEOM\7<8H7_6<3QE'YE#.WA8GY%R&%;4U4!*#D6N]J_V-38,FA(9S[H=9
MO.COFKLWIIO0XWM,SN'K[^B/IZ<4(\.=0K7#.Z:RU,\^:OT5<J.\=:A%IT,D
MSLPD[=)Y7^*IIR__..7G2+FC:DJIM_H'/NF/HW,)%GR);<A'].UM2#EJ&]+_
M2F5"I9DO0?CH^9];?J7<_H_MRQ);N3P)$L]L*Y-OP#,8:GRT#1'R(\OQ9, W
M4UMPS@UO490YP&>T9@DR*2$],ML05(^O^Z&W!JK8(*7:X2H7!V/O:B646FF?
MS)WUHC]2ZS, (HIV@O^%*,4[A>;"IWZWP"+KOS,(4<&V[3NI&^\-6DQC8_A2
MB&?!Q*?^HR+R)9(NN\&M30.TO$Q336^9NKICZ_>V^I?!H:6-FQH!F9R&:@C/
M92L2?P)(^+4> 8IJ,T2$0)F>6_RQ7OYY1YX)0%BLVH2#>@+,Z:T,2N(S^0N
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MB6F;CLP]/H2]I]<G"/A.=$HK#[L.L,0.5!R005<4 5)<W>A-'1">_?PMF"!
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M5""4X 66XJ?&&"*$:^BM:[W!C3LC6P)UWHT_DF3JK!R7=#ECM)+T;$CV>*@
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MQ#8;4":-; <P*O*Q?JX?:_M?(89P*G4E(ZJX^0:2[?*4&>^']B]3"2X:>[<
M#K5X0NU\MUJT\,*.;AU8Z$#C&-&5=YUS<+BMJ2*!!,S92B_UT?$QER6(5&W3
MQZ;D_;?1XVN( 97B5,/D<#@L+FOQC$ /&S1:L+W* *]PTV#/TT.GF2=K6=S9
M#.^U[BG)>C(>-D:>B5EF,(Y\9H,D6Z=#*#$COLPKA4!>)Y1^%QK_: R!MOS]
M=1^O6D:'H)HF#-2W9 >84'V6>\R*5H0,ZSM!D/  '#E]D@WR0#S)DVZ&,8Y#
M8R+DWK<"/C,[C)CE/;I\NP402?L, 3412'4X>!=! .OE)^*$S)I8D%!".'86
MHX7>#9OGA?!JUS^L3!%8Z?R_[@W_W_17=X&6LOH0H*VPO4DK6T"&_LIJ:$NI
M"7?#8BA0( 8BV-Q*(+1DF2;T3$PT)4D;KU:MSJ?;5_G*OYS+M9<V=LX9S?LK
MO^EB2+)KALGC'L;H=]Y%PUN%[]'E -(ZWJ?TA[4\Y^7B"1.SP@DD=^&.\6XA
M&Z3>4E2$B\+ADY+J1(-L@^CC]N,.1*D6/ [7C.)KP3<+*1KR"MZ,.WFQJ^*T
M?WF^8OD390O#1]J_?A;^+#K_LW#"IWYUPL]V8KBAPNT 4R_^ [!_ 1G.[^E3
M2<&5WD&AO?MI):\]\/WZ5ZK0M3:OOJ>Y(6J]7$Z3\,XN&ZC+2$B/F\ZK4\C"
ML1-Z55LB1?+F6LAOE?*Z%F^<;UN5EEF_.?GJM:NM]=*M-[.2I;V#I6_'7SW'
M?>N#+:U#; $1FHKZ6B?BQ.8(/:,CYP2M@PTZ$;@FY!6<*PO<8,BW9UGOZJ&Q
MU^)4[Y/_Z4&I8?Q!P]0UD%>4W%!/UO@>J? N1"X)L9BE4&VD^UW! SV?2*14
MN,HH7@ZU+'(4.WW_T_M-UVOF6FY1[8^ZK!=(S5)7M+2N7%C_>EWXY& M<E<I
MHE(A/WX]'G)S&,(7,9 !%O:#R"U@)2!'QYS!_-X1_(-U.*-M3T97F0^2TM0G
M6$SPW"_R]]NS7#CAG;55T>:#"BR?,"P<G2KO4W:0B\N4>;:$MK6)ELNAI08F
MB2+/QAV0V/6G,IT\/7I$28C].>2<U]!SY/TS3<:&8>)587_/7VRSZF[F24;<
M6!Q%E,V*F]M?[K>=+;$MMG_:;MU1NCXE(*(X^"S-^%KG4.GLI?BDE7#GR5GY
MZMXF3'/3F?QXI6X%)OZ 6+,COD(N[)<RY68LI\7A!Y6!;A2[>8_%TT#GS3WW
MJD-:B9'<4@Q<!Y]8S!K*O3S@>INI4["X8^$U;BTA\='GAK-.5LZW16W3@GW<
MGC9&E@'^G!?)X@+,J-C8!JB(&D:H1$JTKTLL2X IDQ$<JM5<I1DFODG# ?&6
MXS9QT6V^)<-5Q1_CCWJL?[8CR]!@SR)TT*L7Z@0XO+''-_MX<FZT-S9K /G$
M3G(HT$I?_52"6K]Q9M!OI8Z&>ORXN-,WL5PNF?M^D,"Y4D@?Y1+M4+YCBA0T
M>KHCXCX;A/+C[BXWS#_5/+*G,T:R2T<QSL1XO?EZUDJ5=HK[*:)D7M\UEZ:O
M08G@Z?#\!%&2_5J;V*/>?O_O!TV*)2F?>\1O)9EH+;F5SEIK'$^3=Q3.ZCY9
MX:$UJZ,KV*'XF@[(&7&1(JMUXT]8OK9VRLY0:KCYYDW0;$-C?=!21&J\0O5W
MOO9XA;>'_]^/0"<;-%$[@U@Y1 ,G@$_/ GYT@@,0.UWGN=QTH.2W?0 ?6KCJ
M/W?@IR-UQ*9/8"PC-+TC%(:U#%S(UG36RTI IE/"HSDK^EG)E--2 T0TY5HJ
M%*(G5OV.#;H/BYQ2I,-6CNT9,F_B 3>=MKQGN^0H"#]3D2X0I99Q@X3'2BQB
MN0)P*$,R1!&!#B:2=;9#S:(_H(*+O%RD/@VI"3L/;_J(\BSM0[Z=Q]_:%\]_
MHB^PG;I?TLH9\17,IQJA@HE@L.)F!#C/5Q>B_>YD6S5&!<*$@0K$)]$L\/-F
MN8),43:HHU5^N.A$2VY"(?%QZ$AZP_CS#YTE"SMD6];:T:_^O#I")]QR%>82
M7T9:6O,_?_9%SNZ^=$S\'_GM)<"HDNF]G\92!V3:6*(DIA5#V(H.:7*;X5*]
M1[)DD9V'<9(F'WUDK(>:\8.J?G5A+49W&AOCYT;[2ER<QV R$TX]PGN<';"8
M7$7&_/--,QXB5HQUEBDR5/>GLLJW^09]JH?2POH0?E);W=&XT+F;H?89*KAI
M\=?ZEP8!N=Q7/MCYB>LG_ORE<>,BYP]HK1@S1X=Y\A7K!^=,#.L#=GD6$4">
MKX["NJJ)H]4Z\X0Q/I2UB8+MFAH&N$M Z+>+$F-K8P%:D_;->W<ZFBE R8MQ
M,!BR)8-K9=-W0R?0L'8)_MQ^N^ZC&L9>.ZD%DTXPY3=^T1!!UJ!$]PH?(X$2
MQ0:M=.Y9.:+E/^?QL(ZAFX@2BX#.-CQ^S98AUN&,I:7GT/@@X>:(L<RZGHEP
MB6[*VK-9?,V'^O@-\U?PIFR+CQ\3+$GY=:!]_?Q6#38HV@7H9H.,=O;@6,J5
M/1DV:%.-_-R4WK#]-&7[#8G%*S#1O9T).=4$"%0P8:F; 'S[+FO".0P&/,M'
M6TI:?SKX!6]1-Q,?J%6N_1EMCE^3A98JU X<#RCBW0#BP(H0U3!N;%#!WGX%
M@?YF_R4;M"NV--^7A.4[,/S@Z"G(_NMFM<*(*7!=YX\\1M_V\^%6872QF1$1
M7!,V9>^EC:V%K8@P#HK^U53P6#$7;LL/,&:= !Z-(]7.#*G\ZJ\*K+#&1Z_/
MD2S?@_9A_]T5#;!!O"V,%%;*VG85&]3^>-N(#?J->"M0JU"=>."_,UHOL4$#
M^ZSA:< \X@L;M,^S1</6P=L%4A!<;)#G6C)6I!FZ%QI!(NON$*'/ID^PSGBE
MCQ.BH??'ZBJ2$&U3O"/-AL7$LDZ_/0T')].2GI"2ZQDOVP)]-"8T$Z0Z5&T-
M0?L7\UM%Z83E64:)([TO)C [;V)^N]PT"7%]4,MX$,S'^GKX9!8;!&MH2KO'
MMW=1@VMX]J^GF;%WU3O6@['_FPEN'MIV%_D3LJ>%D=TO;%5B@@<P_C3"1,)V
M2;^^&9;J%Y=E-I+I,T,80YA$*PEP8^XR,IYK2D9]&(9Z&*^Y^=RXVE_7<MW^
M?EI^4_K"ZLIUASY>U"H;1.^9/G6P,BPVR'N-*0^]CV5%[8+VU..9)< Q.G$[
M"TBC@L<1=Q@I*RU[5E[U4.Y_MG'PH_@]F7O6!JX9R=K=B3PPO5'3W$QG5-6D
M62GK>TUGA9,9%2P.)']>S'*86$CAS^%+O;'=)/FU:%>#)1Y& ^^#IU><V:#G
M\\LI;% _X2K8P^*_P<WO_VUL^SG'7L/GP(DL0=; KD"W6B2"O^X_%J*)GM<A
M)4#M*J+V>L X6-\V^@HFT?\/:V\:U436QOM&$1$1HHP*0IP E2&M3"V$1!L1
M%3&.("!$&Y$A8MH&)$I(5(0P"+3:0@LO1!E5AB@0HA 2(8&TTL@<)"B96ADC
M52V$:C)PX[GWK'/N7=T?WK-NLNH#K&3M77L_S__Y_2M5>SL<!1@]U$U,#E/]
MT 0[T%EUI69*?W?LNJ,+U9<R(S^A7%R2J:K="YV810Q'V+($T^\902S!'I-O
MH/\HY>QB.ZILU.4H"QE\9, '&);SE2=BK^,ZD#E,#EP5GWA%+!H)403HM0<N
MP730[B0?:E!#29<BZI:A\Z3JO!BN/]&Y!#N5.XO%AX6/8T///\&]/SNJ)/QK
M>]LQL;,P3:]H.=N<F,1'FZNU'X@)E6-/JTLY$:+;!<?P8V;J7R\[!G%IC7KR
M*X"/&'GG\B-_S$A]^RG!)=)6T/XL&_C4U>U44941-]?2HC0\T6F5LWMV$@-%
MSMZAS%$HC"2-":T>LP3[00U+>>A+BOK'1"G[+R=J>EPTDBRARW7 !K& "L)Y
M'&:>W"6F>BI\"Y16CEV9*:&,H*WWG--R&-*4>+A#FCNMB&E]&)G/W=^4/\/@
MIK=<&UD1'>@*4Q_]5XWJQNBK=)0_0-,RK2 & _13:A8E)KH1<[-9VV]#)-?"
M'&VAOB\;<I:K*$"5'_CN6>(;6W5AU:UKCX<(XUEMM;4U#QQ13SX=^G2@^#7F
MS)-_$X*O4Z2=ZHHBQ;-FR)UR&2[\#\F;JDAY#CU$9&B_L%J=KSM ?#<N19=)
M8A*P\E3E;LH%JX1>^6:VIEM;Y(0.VVBQ,>P_WOZZ;+'8ESC<CDW3[((NNTFD
M/7D<,\WWE$O6'C/VTJO%P'TLVDH)'V7WNA*@TQP#C57F@5K%2[)(W>3V,VU$
M01GYS$\<%[;F_R\_!F*%V--@)U7II4H2L#?$+'@R>2E;Q;.\5NQKR[!"Z&[=
M_+<=*3R"FX'6M'JBI_!K!]U[C&F6PSHDR0[-6^OU>W59^^)-YDEYHG8,&TW'
M[++%41WO5>MDLX8J)_"3=FKIWW(.KMD"M2=[4=9 'OS%,6IR.1'!L^2*N@S+
M1B8U#JW]]OAK9]5/'\3=VW/AP9:?X.]Z1DK@-Q$FK#@ T:G9SE:S47X@?F]_
M3Y;*14(1^DLLY,FED(6$GYLHTOT0H[%]61 $90/Q[>QE XFU'@&#B:W+.Y6A
MX+8;V4]KYR;M6UNR_U!?N7HJ,"EROZ_C%][.9T]L'_XFUCVFO^T_L-WXO^?4
M5-(>98"0W!N"Y-*-0Z E6%OA,!>18^,)%8-DI(VF=S&*)V*2'$#:C!IH:(MH
MOSJV@2JUR%3YDK7H/_X8;X,!%&6U$)[;?#&UW+4Y]ZYU*E0J.TR8V"(=,WAI
MSVB^956$_^T"\U73RQR[6U+]NV6%^I*[(7O.Y[M'_YGK>R'A8N")\BP8,#LR
MJW@ (96GB,A@[2E9=0IQ/.SR:+872.56@E?3=H9!E-.@Q<W$ WVL'X0KG^IT
M1=7&?!>[8YMY<\?MAC.XC+'00Q742SF?<.LI?W[%_+@$4YIA8BGJ ^0-I[$C
M>6):M@:A0JE+2>NN,CFK$9TB!/G[:>T$S5-6^4J2.(#H-BDTG@!/5?E+<C#'
M^N=G#81G)YOZ*L;N5N!#5CZN##T40R \F6"ZGY_Y\\]Y^GL"WV83R+R%WA++
M80;)(Z](>ZA7R8[/@9)'S7XS9:;7$YDY\H06C/&V_"OD/[+Q1$+<7)SWNB^E
M#VKOV-;^$;<U'Z9>7LIQ)MN3=FE'74S/YC0DW4B8_48,M$-0APR>86,#KEE@
MKU??'SW6R #H[71SXCCV_H%[R)'*]9M?WC_5&W>.Y1$XG&E[^S[?>)_+MLE9
MW+_6H!?J*HT5N1>ABS;&Y+'V*(F: 8O"0E( I"\>6,F0Y(V@0TTJ5,>AK\"P
MA-RZI98Y,Q"U<VIM=/BNP:I^.Q?4=['@^YYX?$K<QJ8@Q#[*/Q48G9FW#E_U
M%"7025 IYLP,*7U(/VIE?EP9\)&8)_%X+<K&&,\9A!':EV#U"8MN[YAB+ Q*
M[? \9<DR%S7X/OA#>&%8>&J=J(-P+0:57[O3-W%%6B3V(("<F0<;>)I50%(F
M 4.@"$L=>M9"05SAI\&K8U;J>[ZL),^FNU$4S[T(Q?FDM>5,HQ<KD\[=3'+9
M>&_9 L,,I/U3A<C[[S2<3F/KJUS4C\C;B$Q%7F\B;;1+\?#6L 3.WT"V)%YK
MG#70O.G[<';B*<"1T')\.^L&R-T6!N[EB9@-4\>OY8-"'\7ZFC(EYK=[V._T
MIN+^I5/LN$'6,N4/(>1AC:&:)OVFR1$2[%I--\=8LRM\C*.EUPM?I2M >"K;
M7F4'!#[$X[]7%^;WN5YS%5G'_B7RM;T]O'NLHPKE<;7/!^6Q%U$]&-1)^:>0
M^%LIS>/BA#IMB V8BUCJ]2BY3'DDH((4#1;P*' H5ZK\AI!3YOEH(P@CPR#>
MNV?TD;N_\S'\(.109\ZWW)LR>/^N</B*WXKX+K.AE_]^2O_M.!=S\+-41*/'
M:^2(B^(Q)!=KK1Q'D3^("@6"%%>A$1#?+K#9#%3-5"0]"H?R)'PNSH3(W]\X
M['0)<[';?7'<[]7@'/Y,HE>RDQ^VI?#->.Z80G#QD RF/OU_@+=O9M]WO:8T
M(N5FRBWD+A&"A5,F:?KS;1R@$25:A8!JI7B$(813'&<"\U49*(K84*?#LYN=
M1DA6NDUY-"VZAN0^_:GP@L7UW,>)AK^D.V1/OSK^9=MBT+\203YEN<92FZ4F
MC+R\ZU<9W[+4'20Y0M-2;+KGUABR5@MDR<4F!X&>VV[5^)R3/>I"Y_V%96>)
MMR;M\Y?%Z?R0+W&*B+Q(>83Y-^K][Z:)?+1+C!2:82[Y(T8 \ABFD:G:$H1I
M.%H-WIW%IG&TQA\ZJ)=1P]X^H='/&HKZ'W8F]8#GQ<>N]3]<"FAK7?>RY4Q;
M&CO_W]GS$XV?EZX%L';E$NR&HM!>_DEYY(-]!SR/;00%US8]U<*.YP%FKVK?
M(XAYFO5R )4W4OK>[]DVH>ZST*[O7MZ,N,8=/7CXUT6=?Q]342.'B]3^O9)M
MQLE%>2FOD0<\KC\"Q]L)!HZ>/5H?,EFC6Y"'WD'T:;,LK[5FSO1%[7J5>@34
M_2!8<7:G[5^AK!<]QBSC%&\)9D0FI5%)A\KPA71YA?(0<32@?U;"8@&TS 3D
M2+YHW[ XX][BY5H/;:9&Y1E!Z5X[OF:&'AQV;>G5^T+?LL=UV7R8Z?_GBO/_
M<]B8@=.*^] >Y6YBTD&0TCEK1M,A8D.&+O3*6<=3RJ<MT!L;!2%ODVL]C@CF
MIQVL<NRYS/ MK]*]]=J[Z.$Q;Z0X4]$DVJ*OY&OX4..TP6_D5>1OQLB;F=TH
M6@TW(29UXN"S,XZH1$ D1:3/PW5)^X'2Z4#J<6"L^AF$.VV0,&8-!A;24R1T
MXYB_<-$A[:-3YE>;4V.O'W@1<1Y2*X/);W V!*UER<LC;V$ E"SV%NBD#'-S
M?A79FBA[33:$SLL"PK_,A@PDY)A_5<2IR^/06]^SGU&BG+8LP0Y_^QVK 3CZ
MZO&(-@ST+S.K[Y=!LSXO0%_1C,5KT<WK'NTX RC$\*AB@4]&]:(<Q]9F2X-R
MQ+UNG$SWL34I)\+P6.@:)N_2G)-#^##+01+SV=]P\WQ7MCST>'K[\"G0O*P&
M_]=8+'.3M7TG)8=B1(D2+1.IL%!#[0=BQ&M/M\_%<5*XJ7-V+=X2EQZ7:%7.
MT(A UV8[VA,/JFI'18$2FX$Z7>U4155Y594WYS.?O'_/=6J_5M6&%-+$'#['
M+/:Z_>V(X4:"58S&=  57!&CV0,4]]R>[UE/<@)U?]?PH53Q(?I07A;;>JH
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M7^)RA+9,[JQQ["^J[8!M_ZB0EK$$,VU4UKKOF*.E"I^%8\V8>9J.)Q#V)&.
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MP1"4Q3.FRQ3SGQJ3F@H"XZ/>M#!+A&%5AI]ZK/8KL1&,=_"(;M*PTD7S1F1
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M=&Y>.F:9QE05 WF P[SKXW(M_AIN<$5[ V0M=/$IZ^=K@R0U."N2?PQ8BMQ
M6CVHV1J[Z):?*H&G-H7,9AYS3I-$]B%)WF45^4\K47?YC@BM8(K+$8U.S$RT
M';%;LQ.1(5I!-B2>5"2K'Y&2$1D7("<I<L,; -.IV:T-4++CU'K(Z>*B1^I
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MJ?V9OMP?GX=4UQ87[-?Z^3\26NI 'BBR!11,$6(W:2MD*Q9L@Q[RN'K(_<!
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M3KR@!9%G7,=6C-R[?YR>&]?+K8]SE1XF]]!JE0S/">- A\DE(M2$LP0+L$L
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MP 9*%"'4B 7=QP($5GG!\&0;HTCOVC';IM;1J:CYH!'+<)_8#[YG$CQ/!1=
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M8K6OM99=UYIJSF35MS;=WMO,;(X_\Z'I99)K6DBA:>;$+IUOEZ670WV,$Y4
M:B9/8@HR#)*2RTC;Z^0TU.]]<8B+H')T:?%'R X8-&!EM&4Z &=IG(@3QW+N
MS8CIM.3W+;DGOD4])GEC?SOG[3WTSSH,,N,E53L&K\,V*8"*SG2!'HZL->1X
MV;Z' 7GU"=$Z?D1$KX%]NU+UI"NLFR \1=C:AS+Q!<8?:";<'#XBLZ_Z5.OK
M6C8;B2UQ;FV8"#3]&5ZL,%>B9G8'<D<;E#"#2E/.Q@&AI?V%/)=14I@8;P#A
M3P*92;6;2\RH=CFQ8@_O"\RA1<)! C%H^+_:(M J</3ZPVZQ_L$A=>I&TL_
M]VN U=]"?2)&)ND J-9I4."9CT]C:8F=X-WD/:,&X\%-S;Z6D;^P."-6_.DH
MHOD._S/7'QL?MVO)@0\L+<P#>:(J<L<ZK YQ!S[3W;0P)1(DPYL0/=\K]TXS
MBSMF6CUP5P#S+@1_&T(=<KTP+HNH?(?5\SZ3*#MIS)EQ+_26.I\?-*F/:AZS
MW7(34\:*D/XJ^Q,/F7$62T#7,^ -'\TNS7@?0<_2!ID%-"62JYZL:P)K'@B-
MPM7-N13=Y2EUT:CLT)&\_@-=]NI!>$2R[8DI!_%73V93;7/:] [-B><6W]Z
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MQ(2AYO3WT*)]L!'S,[=H08N_\C&AH25Q5PIN=20L"/V/#U/Y!UF#)W;F^NL
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M%23/;'6=)&W!D%;UB_W9_M%3.(4Y?YWL*]'_U=R&5MYZ'9.!2MF>']EJ-JU
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M,?<D^KP'.JYOXHA&\"48.,$(*2:AEPB2 &\$J?\Z9-Y9WBD!XD_QC9!;H&B
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MVT7[_]H)%MK)L6,LFW*6*B'TE)\?+8B((K$$>!O)7%JUC/*8AH ?\E$&1DL
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M$NNC6YG\AY/*/>(',W?8:RJ.XZ*&Z; ^=D9Y&(>E=A#E*L U(L67?1(@D#[
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M,!>'X9P37.G+?-818-AWWVSI87\LY=3P-!8;GJ*L:,!2:<.>Z"A/*HC=0QZ
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M3_\^523BHGS5UF>E+FN$5R/J93@DCB4^W2H!V,4X9(6[!,BD_[AO!H,:<8,
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M.H#1C/US5)7J!K*( )'+2!P7>J0V[*?:@N/Q# YO\U3#7BCU+TA.$)<N&%;
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MKHWNO3OD,ZWYZ&3^S(\=J GPYII&/V4P<,8_8HPPF+;"\5LE85#7K-C IN5
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MW[TCO8NIU^R IY<G#@;CMF2W853@D BZ(%7-R::E0:_K2V^@>F1- NSX2UE
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M[ ?-;]6O>4HE0(I"8JSW0"S5%6@3%-ZDJ;<+B1O@4R &WA;)NTEU$C#B<-I
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MC:!)JL5RG# $D!Y?-9I0NY$I=/3IQ(I&$V$?0;)V\+@?4!TK)* I6LTZJOQ
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M3R8G0_WV7[OGR5"\'X[P#QD*NN-/_S[XPYG-/*/S)NEC"/O>Q?.F_UV5WI]
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MG=QL?:F*/N< A16,1TF"&WKB(FA)>>NXX;@<CL;[<8XRO96CCO3S*R3J\ S
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M$@S'N+%#1$[*4UC,EFG)>K&*2"_Y9X@"X]8,KG1O"5$?L&^SB13M9@KA.D&
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M;7"V[(FXZ<J7;^Z#4@<Q7(U0C*W3TNY)8GF+!>K!F)YD^8'I[YUXO&VMV"G
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MQ2J IT,$^)M0)4AHCDL]R"]702[*/V"WHF5%1;!ASSQ) =S3 Q>O*Z DD__
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M]N<;)YRG%S_JCHFQO=^4.]+=O\HNU/*6L)Z9_M/]K0^N+U.\^A]02P,$%
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M4]M/]O[!'P8\MWW  M]:G+?=1"><E7D23.V=EP+&A2MG014+8"D>+U8&$DP
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M/59(<DAP,T6DWB]1NS^2>ZSEE%V/6FB*ZHN_#X>@X(G6KX"@U(#-A'%;AY?
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M>CUEK"$"G[&N*W'NEK)5.(IM02I<I9V'3_S;<[-R=B_CKW&":,3_*K.F\-Z
M%HN\MEOE'$,GUDME"<:B+JSP8;6E[J3?PQ-X_K@>/YDW9D7)U?U%/=6MBT,9
M'M]F\5;-6]O&.QW)X!.M33<KBQ&HL^^#K[]R*:ML@&I-][SO/NKPJUA++'Z[
MP;6A>BN205KGA])!?.&;$/,W,QLA@Z]9J%>/^SSU#8F3]2_QF*8'-J%[78BP
M"+GFB$+]GZZO[->C-/.6BR2L71-_MS:6@/S?MT-_":E 'IA]%:Q\#AU P[BN
M_$&_PE\#ISA+?82&NY5\.3R.8R\VUEVG"S!>2B+X9,;R_0WZJ,4,Z1-J">M?
M!V9[(Z?X/CB#'IC<AXBW0 _CHFCSBJ/<((ZX#1#>4R<\S(YH41 V>E^693+%
M'D7_3O"DIA9K@ N[AJ ZG7JB=M.W^VR1$1UU BPA^[@?Z@*]^3DK&7N<2V 1
M(.!JC^9B$3\\#3S;+!@Y!.;U16;&U]6= 4M8>U=H><XWNM7>;QUM-@RQ;&@!
M$_L5T6V@*9N:&G-I+P=];Q_R81MSE!O*"2!F(BV!#A:\O)J31W,7 ULJ?8KE
M 8<Z%C%V!MV#2<XW3</[>[%O:2L(VT]T0RU>O(F*8@?7^+=#TT-]D!8$TFRT
MW*X!KI29N+8'5)N"(4?WRCK]JPD!X-0 3Y?SK6WW;,Q8+J(N$W4.C^&44SDJ
M+&Q:[6:7P>+.M'88!Y:!=ZQ=R955R%?0[?OEU9_[B&P)+\X3MVU:XWW155[+
MRLB=#7\QP5UXN]O8"7/=X[_WNUHB_@AR(MYLUQ1_!-A)TC;8I:@[OV\92=V'
M0)N+O$W'U^Y&1<T9V#&TN$9!4>2%Z8\F@)O37(]H?^>_.!:RB!R)%R"GSL_K
M&Q*^J\=[/W]F--_,8<@YSP@,6+Q4870H76+*C$E,Y5.B(OC#,OVL6\/5.M#"
ME-J9GKO2^^[;V[WG!"1!D;!8A97 >W,2&*[ WI<6H $ER@T!'T%[^ &A/>\U
MGP^-Z\?W(<SC0%M_W:.9S!24$EB$TL?9.G,P27@,.W7C)$YQJ0=U0/'$>Z0
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MA@/E[_90IU<()_&BU?X[:'&N<40=".M_2!#;_ 10:4$'9T$CEN*C.IRPN9N
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MP@_/O^ I HX)G0:E;JNRG[?2)YL(&Z'6;N2D?Z^$_)\;WI]?OCX 2P"71<+
M<!23W(M)YOTVP34$8*SPM.:@U&*I5Z"X;FRW'"[K#R S.4B["TMKA])&4MP5
M.'<;BZ7:&35<R\II'[0H-]B70(IK:FJ8:E%Y]=Z4P^9;6!G?,_+V(:.#A"_R
MH, ^Y%TME0]Q\J!Z'_HD7IP-372',]"MG7+L#6%<;(^[YBAONL)W869>AF.5
M%5ZR.N.]G9 5[E'U(9IJ3NUHV;W[+-J[POEG=W317->@Z>68($)?'G7Q&>FM
MYW8@YJ)J"(Q[ 9M9T"O^5S^!Z1=X[/IO.A>O#X2XW]453JO3&Q)-#GWQ8OS%
MRGAY7;2LW?-OG9]FNU.-=AV_3K"]1Z?Z,N1''HR<ZI3O#6X-2'U[O^5[)P/:
MXZK9/U$:2TK(07#ZI]CNIU\ <&\WLCS*,J'OSZIK:B3GP*Y/O%W0G[TA":YH
MNF,D\"=!(N"[.=7@HA>CO+)P!&Z&O-;F'\H8*B7&\K,-2MWHH&_Y_-DN66Z[
M_%/X5MUV:.1CTJK3EN)%SB4@(3ZX%GH<)/:?$Z)X\.A 3&[^NP[=F5JEMA^4
M-<65X3L)LV]_?%L8L95L-_O-4;UY<T^USNS<JZ!SZZJM<W6JE2JJ'<IYVD%R
MI+ HBC77/YTVVG^[^K:J%WBC-=W*_<;Q([AEYOUOVJ70.<SE@2^GEL^_N] \
M@?<*FK<*CHV_8'Z?^Q44V+V.:Z.A],"]$KPWYTL6$WK\*R*WR1>@TWYE@2K7
M1L-$U1ATK-S:E_'U<FI;4R= 3T5>8BX<)'C[\S$\S)_BUD\&3Q*2 +_\W$R6
MYEWZ']^+=+>)X.>2&:X@,%"G1:/@5O8A+?R"\R^N/<>X4X )E?8I1@%29([Z
M0*1*7*BH[@"_=(>7<U'^U_'GCZ1'U(!-5L!.'/P9#-/:)AO6]9.CW;I .7<J
M@]LO,]]/5"5'G>*^&'GRXU+2T3?ZJ%O3.SAR556%_0'[W^WM(6H5IR '7D/N
M0Q:/'T:@.^H>5=ON- ,YC8,M7SLJV [8?SR"<SP<+-_TK8[[./2R7MF6VNA5
M5K[//2GVNMM\8V:,SDC\1DY-N&1=+?$*N-+OA>OL/OF\](VTB";>6"/@:(OL
MW]5Q)+B3IY=&I//_G)G]C(PP3*][Q/4.J9QW]_T50(U'&J-*"&3CI14IG8O+
MTD_=YF_U'KCB[N)2D^5,._!#Y8\;\E..V"LQ$VB)SF# ^[4LAH8665V X+68
MF@+]#B%<]ZE]B ]&>A4E_/X>2D[G6;7F=YRN#4.35-\!QD;7*1SLZ_OEF%3;
M/"=MG?+EU]R&U,^U)V"(+F87+2T[EG9^H@0A7L@>MBH,%OX095YIKC5M-!,R
MX6<^SE8)\VRZD#9O<&S9^%V9^K7F\P/6<2OMT%DUN\]Z=BG5CEG38S9DO?:G
M*<%/'Q(>+0 WJ,>X-P'O=4<@'Z:(Z]C>R63:O\MD%:DL&I,'L*":X%K?K@O^
M$B>]&2;*O8HJ"&!K36\P%1-?@+',K:W$V'6M+8+H"D*QBQ\>1$%OF_JVT3"%
M:Q_G/\RU;4EBWV*XXK=96E#>!W=!#JIH<1\"GO:.WXA!^Z*T.SF:&VL*;*(\
M2-S.[8K'0ZO!C[X +HJ&T$S(6=R #E7>FO93U&MJXKV[8GFG8=@K.$SH*71Y
MINNM=[-=O1A%QJ3Y8HN2DY5Y6'0CW=.PKK4B1V^BBOR6Y'#JGORY;-?[V?F!
M,?;20@[][[*S*]Y1SH\%IY58,G W=)4K&(6K5CGG37,&<FXXZ)3!KN1>KKL<
M?R9%M5:\3/T_3>-'4[$G<((\&]-=QWW(]-^$'A1A"[\/Z;'TD9UQ)U;]>\>_
MZHG_L GE )C*YXK O;^U,].D85#4;S@8MIW1C0#W(4X ]'67TNM8TY8)[<S4
M$[ZR4VEX,Z9%NH7-KGU&Z6(J,>X7(:U;?94(_%.]4JR DN<X)FUBQ'&1WW@_
M>GA* .$CK'YJ#5O"&X");F6*:*62P$1VIHR?LWLU.TA6X>!4;[[7Z_>A!F@H
M+JIO7@IHH7RKPJ.9Z;*#,ZNVN_!O+;5^[=343E,V5-IOIF6@E.62%#"2^+Z.
M#IOI8$GW=U#:B@_OY3,G4 >Y:B)*3V>66#$-QXF5W A.?/W3>8.DP$T</1$E
MZ3(B/S8K$TJ4Z5&4=3+;]>MV41N\+QGR<2KU= )9_B$J7B,WX[2Q2=CEMXU=
M+A-99C^&9-+"SE6?'Y1LY.K8L4\A'GS9LTT!VY(NXH5[NT].O&V0O'PC42Z%
M?>,A%O$T!R%O00,U-$KC'F?G-9&R/HWVCN4>#_6=[ D^XMU_J5*M@8*9SK8V
MCC;[><O:,OSZZ*<GDWILAPCEAT>3DH2O=%PZ5E4E=%<9<D#Y+_5/R7S7@\EP
MG;L[WU.],,)?W2^.U=22&2V$&0%ZGFP\\?7<N>_S#H^_+?3<]!F63D;I^TV*
M*S]Q[5E<I4+!8P9)W[171U+:'[;X!I,T!H/CZQXN]$D49%.F-4/'-GPVSN62
M6[+OR.2&;:7\8QY:^6>]>6&3"$/!/5=8?:C$_HT-[NW#,S=+K$A!WM8>]__.
MN?$01=*_^=HC^%:&\V7N)W"+;R=8@-B[D2[-=ZAFZBQT.X2QOAF4%J,+AG"@
MUSF":\:[]KA8-_!*&8@QX>R:156#J7^ JR]\"!);<AA%T+,/+5H'ZW%&I080
MT*G8@5:=][@HHZ[6K'6M> )@'31M2B.*(,^R-(VVRT%+#J;_U];J\L6O6"&N
M&)LBQ])*@4<1)=R^RH81$PA>CA,\%=[[UJQ<EU"=1M^9S;;)$T-L@PC-3LVH
M(#CUA]RN,:'G-&&QS-U@[SG?G-F6X'E_=I'! %8&I8*K[1N8Q)Z(.0I>&QJ0
M<C_#:7U5/0.6,WHCV_J36[#",^!CX7]M^1..K]A:5/@TN)471"A]G+U._Q7!
MIXP_\2? S%U$3-_"8=X)KAM0$R,"9C&38Y2'644'X$''5RG^%[HXGG34;Z.?
M"YR VDJ*3V1<GKO<A+;_7]OYI%F7?F4'W7/"!4X!S[_7YS2T7)+TM,FN8%@7
MEB"R.<=U;>/L'.&!)C.!CJE!,8Y#+WB?.4M]^Y!2S%&<Y>M72T<Y7P0S7Q9W
M>_[M-;T$!?*D0-O8MVQ3Z2=+KW(]"CW=35_#P91XI.*%#*C*_;?GC42AOH\B
MBF7+'RREU"TS8B8C460X*;&O[A&L)8@V[/?EKIEV!<&;J, ]E?!N3K/VPIWN
M#@YV'>,/"+Q&F:=Z'IN9Q;4NV15_\<=I-O\L#A4$Y?8:MH2[7+8[]ZK"7/:@
M]D 7C[Q['1\\KH6'UPZ_</6/4>SH HM8J05%T%O$/F=Z4J<^JKIL6/V#GSB.
M0)/]DJPYUSE"\I<MBKT:A?YU?>J=[,9:\.YIL-1E$FG!PDZ[; =QI).X1E4K
MLDM)R*NUW..@9[5_Y)>V:K=A0M6J[$ U@1F5NH>Q']_XIM(U#A>>7NKHZBCV
M+WA&RG=\R%!X5)V6#E]_47A6I48V/=_BCT)2-+PS?RT/F_;KTMY9\,K7O6*.
MSAU04/?MQ>EM3.Q0B4T& 2-=N'L/I7.KLM/]3"M,8U!1U'A +Q)W(PN:$C=>
MA'<_<SG-(VM7E/ F.X:^L.U/;-J'\*H(0H[C+3DE/LXJ\9N6L#YWV='-NN-@
M2!\_YI: A+Y?4D3?,I]\Q>2R&2,/DL\O5 ZY+\BCW#?2*[U3RCF&Z'5(*M?A
M;Z.  )'[ TGM+5][D?5Q+E0-3[F=1O.E[]YB7[)_=)\>::JR(U_+#2K\\HR$
MD#PK8U>*@674I<:?'T2MD:W@V6=5=VO-6DKY+%#!>9RB^ARJ &:^X+V7S24%
MZ/:BD_D5IW0IO?SH1NA"TL(AI"_GBEW'I''_4,&094@?MEFZU]_2P#+*H:E-
M-G1>82+P]LO'7X"5+.,PR70RQQ,@,X.X$LY:LSO7.C.O@AWDF-$W'.?)I?X8
MG:GF($FWKR<^Z":=06RWL-*=SX?.Z3J &)W\)OAPIVQ_6^+6B$BSLT.ZSE 7
M2FGO@V.*[SZD.>CUG",[L&E7CW\BCE</YW3T\>2:.7?K@&_JP,QZ>3K.[<F_
M/FB>'0]8CT.D\Y(/C^=/%I5A?=O[MXE!I!4'QQ!><D]A2 8S[4)$0M\GIX=!
M(C&W@"T5%T'S*[W6L94R]K3QDH2P2S@SY!\Q#:;2**=!"1N*Y3ER3WIU;*G&
MF7Y/5>;9Y'XCX?CTR,UEI(-:F1<"=P]1K;=[XP;3O*QRK(QD8QTW$Y?MUL:3
M]\7*:+_<"N:$TXDBW&"-D3NATF PD->//L9F>*8')KS([W17 2<XZ2UM[=Z-
M.C9.P\\U'\_.:7!63+Z=:US&_XGT"57/!'^7ZQ-F81%3:^0!X:KN^&U"L^GV
M1O.%E&7"DAQ6=ZU<YWL_/??N$</>]DCU'[\FO-VK*7"KRP_B"GU&2Q-)WQ[,
MJ&4H%JE=2LNVR8]3&HG0=[=Y$+TZ-^LF._E]#AX=5-4UL>W[$'45P*S]!'9[
M%DZB=' 90XO2L9OI!FSC@41@E3:&L^A3/#C&Y! 2?@-VDKA.K#H8URS;W3>R
M+EF\W_TRAYS4J5(M-\Z!)F_):&Q&S5(N6ZIMW)S0[*!.ER[N)*)$\(B.4;P!
ML--+%$Y,Z?1F;2BNN L![K',#=&OD2+S2A.N/C,VONZ2CQ=^S]@Q =(S$S8-
MS=F6IH^W=V^\[!2W8C2/$$SWRE G_1&9-(KNKFU_O@#^S'MOCF,F'*: UP"K
M 79?>W@\Y5OG55^5Y.9,21R?7MQE@9$T)&(,YX+-%0WI:>^FDN:<EL?\I*8>
M?+ ("-$A)L88<L]S[I:0?.9A'&0;OYC<,O0V;P-Z@'U(<@W7T3N$N1HMM>%*
M=./'J$S_.M#?8HR"M&2F%@S[TYP?YI72!5.0%UD_J4RET<.\T(<I)7<_/R*;
M;W;/'W @G_7IF_M%N1$&#<R^7:'AB"A[GNU+JRE::&L/[G\U--,VO+5R2T5:
M?S!FM]]4@S86;WP^)-K28\5<ZG.EEL=__Z=:FI60Q=R+8K9E;@9)X71&6"H)
M85I'P%S&O^<)//TKIW$CYGFFG=+STB\9&R_RWWTW?+ 0D__G_Z#LS:*:R**^
M;VRU41 C(K.05D1F4!EE2%II0(P0F2$8TDHCDX#(%"$D*C(/41!H08C() 2(
M"@&!D @)\  B,D.0(8DR(Q5E*"&$EWZOOHOGO?AJK;JH56O56G7.'G[_VF>?
M:DRY\H_Q*?25WBB7'PTKL8#RTL8#$!W$8>T4,_Q(XZEV0 UC5^3P; MO>IS8
M84IX2%=91,'B.=/')KY@ ]!ACL!H:G5?XG?5H;]'#,4/?@[1U0NN0\-,%.1%
MLK&UBN9'=2]DFUP.U[Q<C:I,J[A>['#/E>62H&HJK7%SX6K$HF-E@>F;<LU[
M=E<[O7[;%4$S#<HU.NK4[ N,/9RK72&%V6+WF.PZ3;<*.8=RQRRG\HL592^"
M&0=V16;R2'6B#V=WZO'2 B. N.RS*W*@?"=_67@:A'+CYQ+,?;>U/YA;\LL[
M8$> A.3P=VPPIK-0&;3D2"AB!JIP+D6+='G^%#6":WOG'[[H0QJZ9-)3XF:X
M]1"\ B6\#9\IG#+823-';-_"J32 \#T@.;*7D,N% W#)+!OP>5@1SF2G*ARI
M: -D;O_Y'@BFA''17MQM%J&VH0UA%I-_<?;-T+)/ U\5;!Z91OXT"*SP)5Y_
M(WR^--Z.&?OVW>%U"3!,T<R@M;SRR+&X'!"1OY'I_.N45ZG:\EQR_'UUI_P"
MDU_/JE?XE;KF]*GT8FE[7>BR.Z+#H2Q7AWWOL:^TJK7S2C0N$V^\;8F-XQ+C
M\;_CW/FBK=#?IW&70$89%L(*PQD ^/S[G'S%WI .2CD2DG@S8ZD#59C."4?$
M7O6,F8@?H6H%:E2OE#Y,(YZV5/N9-1,"JC>LA)2-";1 11XT91I:MRO"%F4Q
M9.#^+5 >06 @^P$ROL1A$(5')W G=IZLD](+18&HQVO3"5-2#!##W;,4<!.=
MQ11JU?$%&TWUI378>Q).UP83B >>3!(7LKAPYNI1G M@G(Q7 AMI?Q8J\F_G
MG\TFP^-Q&&Z?")AAYIMY\:\F>!I-O!H;U3ZE3$]Q+\Y4LKDTLK8TWYWM(6AX
M"F6:VVW+X#\5&@ CSSD,65#?G6^09T\-Y9H1Y +W2.NTE\ ^%TT'#JZV52.=
MZ&"%6@J#<W.ZKU)@/$2%'%C4V)ORH.\XBRC5A_$.?YR_+_V:JXK4=PZ\Y]P^
M<V[LAG:IAN%CUD"'Z:JL=5>EH_.+8J_SC^>("$A"]ATC&;E_N;%7I=_P<R 3
M W,9RC6^KI5IIZ)[I+/[1!-*7;IMA^.U;Q0EETRDW;U7[DK3X 8.%:\3-'<*
M=D6"/#'2PC;&N\X5-SZQC7$\WP.<!#HY]%JNA.P,Z0,R ZYLB B1!4EM4H%Y
M!5^]]H/2,]#D*8-^\U,6';D5R""NA-N55&93**T_/&8R*,+.VZ9A"$L9S^+)
M/J8;XZ=W1:BK*0+Y$IQS?W@+?,-\YP'-PH+2/OV0H$CPG3YN2_#GDX5B-A6(
M4.^9/B(&@E?$,IT^3TV[4C,F6%O!\5&<Y@F0:J'9YTIR[H](-8/TPP]CG9CX
M_4!#@D!R9E(6"4P_QD&+_&%R ".Q+C^\;F -#IEW/>:?!WM:[JG6=3"GH)P]
MP?;\BW;F_.FO/,,?H@\(W\X0J(2=YZ("J;E=$;<^P8F1ECNQ*&G^&!M$>3'%
M/663R E%/7+;"M):]N'^]UK?VXP/AB9J>Z907[%M"[U^+P@PT38\:8<,2BZ-
M9PY0//.<7 *=RNVE \+L-</F\IXUECPKC>E2"X]E6)UP._7Y?_L8*,UAU$6U
M(Z;C&(?,7;@K8EV&Q)/H=+,VZ%ZN:;L(9>V*G*"%5*! -\[WQSE]%K5?6J.X
MZ6[VN<[N9WX&K2%B[7=%E-$E\;'=]+,CP;D\PDIZ$=9:98,A(NQ2. (_9FZ?
M>"?'E-A)3(YV+7HE@ T&_U$XSGG_WWKY,KY;\DB@)]$,.8+SY/PJN5)>_W#I
M8R]YN/3QAHG_>^_SP_XSY[+27RR,L-!(*3FJ_XZ-A +XJW6BL% FM"D(:M>&
MU=;5,G*G=:<%?OVEK$"/R1_(?^9_Z^[]J#.OOU$#K"H</&9]G/8]<:0H^R(D
M\QQ(VL]0%GNAT:V-K/>(<-A<'.@8V+!#$8[X=>?-MIA=&_52XP=7A(968_O:
M<]-#M7_NU+;#M(8B2,?055E7O$D.F8:G)$76*]5K%D]HW'SMP+S^J-P2<K5
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MJR4\7/I2V*] 7 D#]-MW1637&!.)+.5#^5?YGTIG6@@;A7O"N$;XD5'7F2B
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M%_7,1\-<1Z;47-KN[LG^;W?;&/<'OK*Z;)8T)7_TI6_MBB3@-(#<3J$:G_C
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M_OT8HGUW:,%A(YPOO>A8PK'7=*YHLT/7]O&1, []#$^HVFMBK"ED<0ZFE>8
M9:Y+O- +;< L(H[Y=5R/2OZ7>Q[;F<3R 8_ M*04P)1WY<D4E&3^XUOXV_CQ
M/6LDC,]MR(-%+P6J('4OM A/\:%)N/VE JMW+6 $9W7_(OL,ZFPU%WH"#&"/
M+,ZQ&)+F*OB\2@QHXYB#/3WH6^=IN_Q/QI9M::%X"&SG*2%P.@$#.!'2]QZ4
M^SA<3VD>(T[P4=+[L#67: [E_]9Y>? [S89/X,: WSLF.K=Z$Q-Q"&[0A9O
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M?DZ_]%&PY-;LF?1%50TUN3J2RK0SJ66!6L=@HV5)V%&.7ALEV4U!9YH5DD"
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M@6K!)2ZYAR*+7/=M@\=O8,3-SQO]RWXA/,O')!DB&"<$E_F?BH*DZRD\BF(
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M?PJ#7CPFC!F)[OZ:/7XCM#@!0#@P4O-Y<946YR7XC:RP16@(SQSC)O&]<,?
MQQ8C]MAC9VF(39D=3 %!T"JH'M.^M""$K_[]3ESIIVLW6* V>Y!#'%Q0]\LK
M<"^+O%UJK>I9ZF\W&)O]B.PVUUZ5EQWMVKB5$&-1X(?3_;.8S'P]]O*"=[ZX
MU,4K7OOR,R/+ SC[VH?-8]D"9?$M^GP)'MH,6@K#),/0YW;XUVR5RRLT! I%
M1O.QI%\/> V>,"D@Z25I5Y<&.,.X/I7Q/?MHW6=U0=G^L>_HO;O#=<L?-51$
M8 6QZ@^_C](+S$!]:6SL-N>)&R4[9R1# @+@60?/NLQ6:6CZ(*YB]O6"9P76
M!"48*I&+6JL LV/U[\_M;P^H:ALCCXT)+Z 7+^LGHB/IX6+?J6?9'?[1V:R>
M FF6<KX<'K485@.[9.3 4+ K,'(A[Q@V+[+_<+FISK#?R[/&:ZC\RR!-*V?)
MJ_20SY,VU<!O&\V_UW+#W'?E&+=?ENN'C0A<\F[E:*->4HO@*"DCXE!73SOH
MSH%#'GRG-)P70/7@-V_*W,"AYH=RE2"[HN[ASH*)7&1JF=V8*LSY$5ATNF.,
M=FI^335:;8R15'E.P"IH(-:R7'<./]3=E*G^3'6H-_*97_2]'3V6%SS^*;_<
MHKCH,'>]1*?>QMG&W:0G-E_O4->@3[0'J8ELZT72<\&-7+N?&AA']C!H_T2Q
M[6N^E/_0S=[\4PT\G#J=[ 6J PP!FD]Y24PE[.F2PVF/X@S)N.-@"C_Y)5X5
M)'-FMXM4.1TD.6QRX*US_*Y[]>]^+3".?(1<*D[BR\_HUP)HS=Y+'YQJY@ZR
M7R-$JD,<2#=IFLDE]D.WX&3%N31USMKV)7BCP4HCE\<EW-3=]1P, V8$L7P\
M17A*\I9EU<&C9W1MDV*^%F8+R/ 1ES>9*6$C.83T9GC&:M6;JF"<519";C8Z
ML.#)9"'I70A^/WX*WBC;AYB!")Z+I>0R<E-FFR@ # #JNI&[Z'^:O3MU!DPE
M\-@WYFQ!.C<\$;H*D08<U4G<=BXBW>Z7=B(*\O>UT)U3- 6NB29RUZ9,GP=9
MY#P".U-=E;I=DHVI6"SN+^*FQ'H##RICF[[A+&']-DM8LNT%.K8\I]<1]\_2
MW5A2:ZG\F.!+R7W!<W=3CTYF.U"4P^$0,[15^BV A%A_TSU<Q72+WHAWP;[&
MV_U4"S\F%4)4I5GL<EBL_T5*T,ZT GEO/D:Y:/QJSM%WYWPUQBO,/J!?ZMH)
M(XF27:?BYK76LD88/*KL$%5T9)3<-=9,R+P)W8WZ-TZN/+I8GU2-+C:MYVG%
MYSD^G<!9ASLT5\TM";Y]!IQ3,'O,A%"S7D0Z<%,*+S=5\*,>X=2'PC.2R9%-
MF<^$G=Y;ER!_=(;/^XFT8OBM\P9]:])<62,> 1I"TFF1#:(=?/<'/#,(2!B@
M/QON2.1@5,'TDR^LRZ"=_'5=5?%3FAYU>5/F71'?/]K7@P6FNP8T[SPVNNQA
M_48/H(G?2TF!K$3>Z9?<C7 7@=N%AVW*K+]!O^+@Y>>5(-V30Q6,=TK[*X)4
M@C00RIXJ+Q&0PVZ!!=%A)9$G:;5CE9]JSN<5?0'6%SW]/K2)S=9O;R!]^ ^M
M.+2Q=)L@<XYF@%4(<8B/A0UDF4O-F%7CI[-:S:U!W&Y<29=?',SQ<M4XV:5O
M% U;KS="_SPIID@)KXH/>(#GZJ8ND3O%CQ-@)GU$UJ8D?ET_70-_'+O&F-M^
M#^97+G[LRE:0YM.F)([)"9'3Q<LT:-1&_<>.@! P36%YJSXY!J5((I'D'?31
MA5 -![EE%N%V,UU[29IMYP)"WUO=#GO&+<T@6$9_NW3HO#']*OULWQ>J\;R#
M'WF;YLP-,%E=+Y4-!7*0P+VHXN;9KHK'CAL%]<53@B2A+[Z/W1JY2A ZX,Z)
M'TH.2*;ASXO21%I\)^>Q]7ID+Q0"_W,M9P.:N^XTFK!JT-L>6L_)1?K_$M %
ML\\]G6@2AY\>^U+?8!9_W'W[T5T"ZEV_KP."N$V96U<<K"7#)&V\ABBQ\5=S
M+(+;T I4^#;Q95-%4#Y"<&22>$.?KY8'TTQ/MUR]RN"05E.!L5Z[%@JG].J0
M^U13C0'_&,-2?/M:^[AF2W9B+<IZV6:^;.MP(^SW!,3!H><//NYY?V4:,Z%K
M>V');1S[@*FZ\OED%M7Q?,4.]UP?E_B"J!=M(2F)-^EN.>II97OYR*U\V1T+
MM@(,Z=*#3_;;'_[Y(MN\)K5[Y(T-P7#PR'J=-U=[QG(X_+"#\98@%<L; YS/
MM0F/@/'/W-+H[UBJ$LY3.KZNPM,]L$&2'7%"Y.>WN'W(O08]AW#'A4Z2=]<M
MD HJ7.5_P)\..J:90'\OU@([_SZ8M!<*$:>*SETVD+#0;,L?N'M"C,B)OQ6W
MNW7D,'V^%-IDMA)!QN8)_L[F4C-HR7PO+F6 K?M+&77W=XP<]OF0;QOME[;F
M]L\."AU@/1?MH58?R]]UG$W\8D&4C]9,#@E>;&VOO+<IX\<&_I;&I;-25Y-Z
MR06(R(\Y0)(\J,<E"J\2NFTW96*@,]_FDW%R8+,P&O_&0>'M/)^8#DNL .D<
M@Q4S?B*CRQ[XD4&S,EM]]&*4*G*3(I<2GY1>QO88M4Q!GYB(L<0H+MT-1@5V
MSK>Z!GUOZFH6\*<16WA  1#_PMAX:"$S_9G_-&(Y6Y%RJ,:G4-/_K-'2D4^=
MUGJO'SK7$WM@1S=.7A)!!D0F?6U=LJK%']O44 B=G*$K)6[]7ZG9%?()?WX>
M2</TO1#5#WH6Y_F_5OOC5O37JH]#>J+'DL%-&=6/;PDH9!K>I%-<%B:N7FDZ
MP=6 O#1;>8?YP)]@@-#>74?M<5!>=LTJSK;:I<SR_EL0X]U<S&9D%14*^$E3
M+9LR+^C ="S2.*AO4^;W];1O/G>;"+]?_EX=LL.^(DJ:4X1_#B_0#^[UGZWM
MUQYZ/F]PSR!,""5T;X-'$=\Q!3='X2C([X3N$](Q[<*GIL-,GH!HAAVTC_BN
MJ,_:00X03]*KK#)KL2T#IT&,,%IDT='&=^M/3VKX+,%3ZZ*O6UP+/3 ^&'5S
M:>I?;2.$"P3.EE_%XC=E1J8DO5"02B+"Q>:!WZZ:JLR;:@Q-^KBF77V_9!%=
MPVF4&RW\/;9BI>:,1\U)[[J)&D_+,-\GSU1Z71+T MC^L^*B4?/%D'_ @;YI
MO]U7\,X9G'-*D-0K 3JX5OCPBSIEHW\&-1H2B/59\3;V.=C(PZ5V^>:'+14F
MR1F]@UA4[;NL=Q'I%:X_U:174RV*!V\(3V+7.%.]9AFDI\/E0N@R*[<H,ZV<
M2]V#@_/5TVA)_ &/YA;@6J$^WRP'YSP/V8+$LH8XI/1XNB(VCC'YE5''Y,R$
M^"Z%)U2] [/=WS8Q5:4_35@JIL%5)/O!:V.<(B+>)$K7#O224D V$6<(\ 0A
MP,!J+/?6_)!9-E*.ADJI"< =Y<_58>9WFG)G?('"7+4B'E,;C.2:I=/,J+-1
M'T"(UP2FJ=/+49(/GW^$!%S,6&R)O.7\6KI$!6P3QN*V@;') +-W"G\0:,W%
MRTIZV6HT$^Z["Q/[G[MA&(F;,D"1U)BT9$Z*$Z-]=I+(F3UU/FV9 :E5($'\
M9Z:C)Z^'?*%3T/!]A&[M39GY0D*S^DN,#*@N^ B&"2^+#"=I(5).^1KY.RTD
M>9Z=BWP.(<*2RT6FP(]>Q$YL$#=_3AG S6T5-W4IL6:=8U(2R8NL0GIU5)W^
M4PL;L_DQ"]3:]T,-QRF%P&KPZ6\U7./1WI.=!HBT215EF&7@+K)+SL]&\%/\
M,^\(C_Z$5>T])3HUM86-H7?<UIG#7Q$5#$!=EI.NZ-F[*7-QP39%]QBYF*EZ
M-VSY4HES#G-QLH[#W/6AY.2S]1J&EA32Y(A<D8_VM3\*@M%ENPOUR[9"^D1G
M^-?*&T07P$R^:X#40(%2\' E1*W&<0D,;]"'1X**3@ "BM (9/=W[:"YHG6"
MI"0GAAX.F4[FK#)[U^1G%Z^'II*M2OFN_5T.H^&C%ATZ#@..(ZM/8N$??JQ.
M$,(:1.> [5UY0A4T^ZEO 8=XJTP-*$WO(2I';8BKZKD=*0=Z'8Y^=="+OD[-
M@NV<A^P"*WPF8Q:(C$3)P:F_OJ]&^I)Z(%9D;HK[JO[-@5_5A?]CA.<@6 \E
M<F9\+\$(?^J61!\OI1NJ]'"X#G;YI=UA/!2X0Z?@!Z$M:W\KY9%/)3^)/C+C
M7"F2(N+-#BSBQ"2LHY,0@#'_-<NN=\NC[5DI^>E=UM1$Q,]6F>$6W3M)G"_R
M7=L#+J YY@UZDM'2PKS;E#(/QC?;H =7>TA&36$Z)J*I;HD5=E.&\RD)D8&U
M[GUBY9=1GE:?2LZ;!R.-NX&5J(ER._>]N*Q.V%3Z$1\]VS9:\#'Y=QG##7\T
M1:S6390B%M@2N6>\60-.Z=1 _X2#JF2&O><P#35?JL+YD?&'.(<0#DU%-E_\
MBC7N?<-UXB-O2HR0N/-@"-\1(@<Z]3]#L:Y(;PX<\;QYS.&@CEH2#(&I@<A^
M/MJ]D<DALK8*O(&&]'FQO8>TS\<)W:$2FT"1(7B-I-2E2UG5$>KA1]AJZRG'
M!K5T?F--SCB"8;QR+BF5KF32?%:D5SE0@Q29@BF/%^>TFAI;1G!PSK*;$M;"
M1]@HD :)FQ=%U\3I0=P@R6NX!CP<DGX5]^>$Q4XTUY@M^3>IA=CKRU>B<))C
M?)DGVT_Q3TGDV;P3C\5I8X'C)J=U=37=F@1KZ.WCYF<HJ%<H 52T#PYXPC?L
MI#Q/RI95O_$7-F6JT'X9W+^*MF92G5*_&DT[N%=.JD 0%@.<9PWYXZ5G>;$O
M<.?X_W1%%\0J'>WE/3M"<:^C.'M5E;M#]09*7 ?F#&-]T0/!B?TOWB>J1M(]
MDJJ,MQ=<Z5+9:5#X\06L8KN\S75MRS3&F?-#7T4ZLIYE*DK+P_EU$^E-=5:$
M/7#  \+*@F>1U/"[HXJ0S^C9FS)_UB%VB@RD]SOYY:;,%AH2&./">][H?NGG
M#=!WT5#U8$5/(#3701:G.')/=*H!FQV8X@A1BBK.1D;;J377OF?/N0G8SZXG
MBE0.< FK:_7O1+Y=XMOTB]*H)!DIPLNVQ5:(0OE&.,6'(6*2*(+'AF ;NS69
MF?C?D#@,^!/H&CC-E\V-K_\- <$* T=AACPH!/N8S5E+78>J!RP'AF:T6TZM
MRPK_E'JT)@TI3 :7>PB[Z6BHKJ0/K@I#SV,4*;=$AD_ZA(:265V9$"B#O[1Q
MI[WERB))D3!/E2B,++R03$Q0&]QK$BGOHU\_'_AKJG]R<G+'\:T"&ZG!0T11
MXK\MH'O!<,%9D"K<+3KTEI:24K'D8#3V04R$_\7,D*N>_6Q<VY /N/TR^#0O
MJ%3?'K/Z)H UX_@0T=)6+ CXPBD+T\Y<M\2=[2'4OL!#*?D#RHK'"3&*'<=\
M^$FGM7K=.PM\'HP-3'Q(T+.+IBTH):[U(#5^6MBHPVIZ;4H&CO"Z]O5?;'XZ
M-UR(<*E7K*K7#JYI3XA%0^_/?UUJ.'8;U8Z-<BQ!^=1D/%GRSJ]Q)"TD4+HQ
M,Z3^=J<TO([HG+0;UR0CUPUZD+<"!:6\M5MLQ;]@)X2_+Y6I2#-0>1-$KUW?
M0"X.&BZ$2J;HP#F= XY\GX(?&68-%F_P+&1&<?[U.Q3NS@L#;B.8YIF[\%(J
M:!391P(CD2Q,GP3"_['"C@6, Z-@5G])H%%=\J YL. T]J@1=.,8"Z_=ZB')
MP5&;,JP*E]$/DQBSIJ".F4(PC[NE-@3=3LTTHUK,AGV'RDM;?);]56-+M(<H
MN4,7[)/FBSA1TJ;,8O'4)^M?*VNV'8&VRO:A\-:2L0WVB@G_ #>W_T8E]M)R
MG]4OT4#FO(99?.YV_6QG5[$!AR)2V]K-VBD6DYMZ>M'6Q<$;KUD)#0^KWD>K
M^*,"(YHILA!LII?AZ\4+Y*((4%M5,^Y\3X1M@@;9]L2)RF=@\?TKM:5.@9[U
MAEU)AYJ3J>%:+]N4CA69X'2T>V@?]8)4'[9]VML^3I;K&ZO)[NUI3NHVV-&O
MDE]3&^L]GN3I^I4GD0N8AV>PF^ K"X]"1 [BVPY_B!( '\JJ7@(?<X)/[Z7.
M%/5LRCQWZH:F2> C#MHBZX?=]%TBZTBA?31<S<%J&:ZUKV4JD(M4:V4D&[M!
M&.&($(/>;]BLN1^G,*Q5!4$PN,QA*\[AC@-TT6XGB9QY192UKL8(3:LZ&F\H
MKH5A>$.$/5C,B0G8\;KI &Q_C*M$K@06QO_M1"T8>7IJ;KF_N+F_O!I;YS@&
M0]1%6]M-Y/O=CVN'KOP4>A*Z33=E+F&V8;<*HD"B4 Y$<Z+$C^"1U#0U![D6
M<18=):Q[T8Q@50A*0 ] W8-?5<]#:$I=$ %+XK)WSX%.$K4$>D;,$\M9EZ\Q
M3HY 5=Z\CKT?,)RI5I3P.&7Q_V/GX4\XG^S^R?Z3)+N7W.AAA.(R#UA'.Q4'
MY_7^>:7M]A7=B7[/N/.5\Q\-V^+:7#PW8*9!KA"7K,M*]8<J:P^=],JMKS0:
MKS :-!IIO-J5->FL)_D+#OA 6$@>D[$I,Q/',TC#.=7@+,9$*9PUEA20<AWV
M?28H'>"[UW."H"I#_*U]Z&2..1>Q:S;J.CT+=M2VK:MX2RP'\_N2GZ8WZXR(
MSYI[GZ29^%U%.AIGQ7<(:#-6G$ ?:+T3S]25O'83VDC>ED%2+],,@6^<R)=0
M&6PC]R> ["-E%!6R!E:]$H3N^%XHX&&,R;8CW?[^0/T,&%&)NEYT*YZ0+H&^
M/7QJ<6KC^^S[2>CSZU,K6OR%WN+^>JZ9<C0;<%Y-[M444 CUZ/8OS=(_O\\O
MK'F"#NRO23 14.JB6:4_1'L<DV>=O,8QD65?)9*O20U4TZI"+C= _][[C;5;
M$EG\' &"LZ=@X2_A35"1RMI+R>Y1AREQ'@?SJZ27E>08&,EH1PI2OT_6$,2E
MCZ/H@&>'R;&AU?;2U4\5B0*T?]=82F)"HI4P._-B2J.N07G.T%-_(]L(39\K
M+5YUH19'+6J="H/?YU-.KI.:"CB'QF-.#)O'7?UTA!%QM3S4)^5YNL6EDNI6
MC5?#E?IM#RF7?0;70_[ZWLQDDI0(W2K-G9>&O":ZCHC"TOM#S?C6?\," '10
MS"DN8C65THT6.BQ)#DPVK&.F1W? (Z18$B0X !IORLA?8C#\BD,SI9^D(6'E
M%8#FF#SQ-:4#M0G&BY<3AM@\+<'X+_@+8@@C)"->(')@3A:,0''@=]C*\7 (
M-HB#Z#Z+4YTG*AK<AF'J%J_%@J<8O]2FUZ"G1LM?C$DFR*BQI4#R<$'TY$;L
M^)KGL.&,6 /^'].9_WSTPY -Y=A0]$2=7%OM74%L96>^H5?V_1@OBI$EJB_P
M:)9'3LQ><G+(\:,!%ZA[C?S3'6,QQ7&WZ]JJ[C=ZY5\HG9AQK7/6*X>LI$K[
M1I!V]")[FM#;90=B@+'^,FN^[(HEX#4_E8,+K\?!@8E/C5QZZD8K [D3"=[B
M=-4GU00L7<^=8H0D^KZ@39A)H.REP/0T2GM[85"=?=N<\X<-2 ^[D;XB)?U1
M>(T@K,%\9#=;-DBD2NR[*]*ZU<-6I*ER/N-W,WCCQ7#M/F#0Q.!T$V++ ._T
MBU*8?YEJB"'N=-[K]I>TW3:8W_XS98WZ_S#9A6@$R[O&<W*AA!*!-D79!ITN
M+&K)-#MX_7SZP?U*%W^&[YU[@RS02PY@B9N;F8]HMD(X;CM $!D3P=-=<K@_
M@%:1(8.W%<B6*#/3YG:.P#D^I(Q0@LA@@#,@N)2-EF*,+7^ U4#@')%>0;C0
M3+(;V800-PO85FX#Z?#(M;^[()LRJ;'2=D7=9K=#I3EAJ@WN3[PRH<<6F.EN
M-Q 9-?(5F-)S09&-Y/5(#($CZV C]&&*]*% #B'BUP-:@=0@+5TSGUYU++#!
M?Q'F*PGK"9LRSV0EQ@L\Z9GG)HG_\>BC.M-E_J;,@67H#I$#H/XWG/.+84&Z
M=7<!")'^G.EDUSXL4Z(,W1DUIR7]HF.@[(#06G30P8H/%U@6% E^9#>O/9/F
M,3'8/!]A:&-MROV9U:G&G\I_+==Q(=-K7.M5O4V9G7K\94&RN!R& N!<:Y$Q
M]=?+.M;]R!U@Q_Q4-UP7)^W]?3:/S6KMEB)W.LSI$98M2!>7;\I( >8YG%/6
M%()PFK1X@V:POQY9*O1K#V%.UYLNKVYLJ2.$?)?_+^')_W<_<W"7Z\'=0XJ>
MKC$'7&,.WJMXA3'N.P@YJ#08:*@K1TXM._9DQ/7@Q?QK7B9[MNRY>\*\^^#3
M/F/68&1+T@&GY"261GUQE,:-(X,Q7TQ-7M\KB%/\=AI19%SG^G]+'_G=0!4/
MK'P,XQ%RX#KK;"T1#*&ZV 4%(-V$W#EK1$:+^6*9ZFC7[J4N!S[E)DR59W.0
MOZU+ _!]QGESBL?,^9[INS3DR%<KQ_""MDV9FJT+$8H,"@LD)@M=9D A1TSO
MP2B(%"?QJN]G@ZA],5Y<ZSNX% X;NNB[L^9E$1$0,N8TP 0N50G,6HSW2K"D
M.1S@FZ7M+_+R-XDH-G8^V$'\.=<A+L/;1K-W2#VJ7-/O1A<$YPUTD39E("00
M(73RQUY8X)@1<3H&O:3IA6Z).2A7B\WK)2C%Y[HR[)SYP]E1<ZH3HI.%<RJM
M$^3Q,8:Z\CO6[&SPN[X$F\15?OQGY_Y4S?SYA<R:QPSK7I'9/;]>/XJ!0MB5
M=]H_M$ILV[I]&1&6[Z.]*C0G%D/\A8<MEHTG:N0'E<O=WTQY_OO%+6NR8_[4
ML8TWN%#$[4&>K(81-F>0:!<7O^@M*</9<C%*V($SS_@&MYO%ZGVZ.A.[G>/?
M)#/:Z^\T5T0K,V M8\?O4*J8<1'Q]X*[+6GUV[[N6$CS#\X\D*"5\),B#4OU
M8!C_%(>P\H-_#)JEZ=O&6801A,'X"?:O"A!,Y7=LE-UD+L#@0ON)*LMS.ZW;
M36MVMI ?Z^ GT43U$V0D*X =R +3("V!02&PMY3%B!!Z8MI#=Q7JC2%^0I1K
MX#\N[UZK05616P-8UM2_ZP.QAT]]2%T^7_US/_[LI_6ZK*I*BJ(#_$B/9SWT
MENHIV3N]85'A*/3!:E[U2)II5L[2&4^J4F!S>/3]0X^S3LG_E[ 38';#CKG"
MXR 50"]! KB=1TQ/;+=^2?\M"@JQ@*0[J(.Y83S,+NP!:0JT,V95HOUYP[>V
M2'?_E"CH(%[;3C%4O7,"YIR06--%I;P/7-:\O3$X6_B,?U\H*&KL EPD3(D:
MJ,5UTT]Q7,0?I/=#=+$_NHL+2RODFKI1!C<> 9$,NC8+75S9\J9>*QNS*Q1[
M==0X([[ISM>S7QH^-OY:O7T3@6>2FJQ[D*RO.IA^N*)DGY1";5^3R.%'54!$
M#UNE":*QV$Y=.<-%:DC&LZG14E??E$FC$>H#%P.A_00ED5_CR#HQH^7Z1M!R
M8%HIJF*&_;EUPR_-LOH++#2,0,@EIY.^5'N7/W3WB:CD(;<478A]AS6ZVBCP
MK^&(<]"#X[:5-<E1/.,(,#C%+W1H"U)%G1E8:'#H=A0US=M<L?O/6)5/09,,
M0\?6I]D)*7D)L]9IE-!FZ&):UJ%'=_\?><:M:6 ZL-"-W$.#AW/HT,^\X+?Q
M)"V1.9@7>8E56$<V:<WIVBDZ"Y#ZUM+M9D*B?FPDO+_%(.RB[>00E'4<DC,M
M2H-1A.G [W=JRN>6[&+F6E-I81PS;51X,."7!3O.%2LW7#X\%0#T-U/0&ZZS
M+.>/(3/Z%>3@V6F:X/DMU=?.YL[;:D=<:OYX3GR%!(W,TNGSC^B[")>HK/27
M2'F:,O#I!Z>J]3'HP&#\@.Z H?GJ 6**R&L^B98\OX4?_J]LCGB $027=TJL
M%=E@,B:=(SAT32S1?R+&=\!M+/ZA4!P:9.-0\$OQ/1K:I,U6D!SZC-2)2?!Z
M!!X0W  ?SA.G&<%\Z-\6B%2)(=]IA<EYU50'3]WHHL]CI'3D)<OQG@F-P&K7
MS8M#S],5&AHY8JCSI)]+%/7QN%F.M?!T[#'T=+(V?-*PA]+F6;G?SY3L5V8V
M1[8=LJC0UM$@>^UY:CM[9H53\.J"[O[D'9Q9,:6EW[O'C>'?@_2A9E+L,-'C
M^5>:P[/KY:YRHGT'%P,;7P<_I>.D^+KCOU;%''K\/.''5/C;[T5 9U=> M=[
MM%D=^-Y 3TP**W^_G(TZ.OKG)&9]V<1%,N12+#JA6Y$83D'.!05:C 4%A)S+
MW)9G>-71,]K-T52Z>>)J.AR-OGA>>Y[EUGJQ.<(1]C7'*^OJ?>F6XV?N\C7O
M>8[/EP\LYY!.Y87B+[E NI3D2/9)1LJ,:&]QRD_0!(A$%X1PU7LQ*F!9BM8)
MQ!:<"1_:2]J%E74?)[0D1.&,'S,>8XD\IUZ-,>^6QJ?CWU$T#]4[5$)-T&(9
MM'DLY>(NQQ/_AMVT4UY&#B-$J@^[H8 7*8?PW(K..8X41(+&?%V6#I+3TFQZ
M2VB#NP(.<*G*)[@AYKS(O\W6W[A/<29^K(Q!,AP.!"VVJZ8"XQ<D8\"GW/E9
M>^])$3HQAHMF[EQ41K%']'--R0[WR(@G[V90Q3160DY[P\-(_ :YC%3C'*/"
M]F<M7?5?O!]M-5FD[[^/GN<V-O?ET"3G27W@J6W7O;++=,G7>.J*"<$&SS\%
M?RDY\L(%:!B++5HS".VTWN%8B3I9H%E@U.]?[7G[S==Q"F(.MQ[BGAPJ5W/&
MQM"IV+C0/+6SLMPS3O VU4!>Z<EZ]>.LN_\-;_^;W7B>#1JR5ZUYI'<\@:*8
M#$=!TZ[KM=!Y:VEEV^ZL]5QK%1 )5>^6 P6=%: OL]>.G*4JO/R DV39S;47
M.F$Y[<VC'UI?W+<Y>&]JF*;"2<(K2UYMRBC2HS%:DE$X%(:LQMF!/N%"%]PU
MON7:G>\DM<^;,IH60?#4Q"Y3?E4J&E@2B'%;YV=_^XJ:\@?*\H"ATT!$5VEL
MY:+OL5=)5;/+1Y;\A=<]R \NH-T\NC_N'@K_YT+DM>J!8W<<FM".)5ZE+C8P
MTX"LOG ]5>;0"BK,D+L\V QSZ.JI)-\@NR@U&)@GE5S9BPVP^W[UWQ'OU[4_
MC*,F^Z;>/-W[%]3Z2XCS1)E1@UJNGB=EL5,5A/#@H&E$ZXVN/5CB0#%U92 V
MB3MK/R^[\D"( !-?7H_LWWX?N@MW4%PGV3^-LQV9;^/[#/1\WC>"WX\U\)NP
M:$L@*7;=(SQ: N9N56%?;5,W4V+WTV<&! -OX5'BN'FG+,D.4)T3F;[.!*7,
M;]5'Z(8M<@):5[=85?"&,F 07A!&%C3H_37M"7V9BSX+K&6N-BGX3L9W;A>9
M5"\*KC.SJAX&3II-]?A>O]SFW^8J)_^MSMWUG3>S&O&@^L2%%VC3_DM)75HL
M^[[Q'H^77$,?071E6&BIRU74^5Z7S#3R]YJ17%M'EZ;G>#\%[Z)&YC,;1:N
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MI0$BGXN?+_Z,V6%W)W2P4&W/XM4SK\[^#ZKG_ZU:L#G]?P!02P,$%     @
M+D-[6NJ.F1[KB   UX\  !(   !I;6<Q,3<V,#(Y-S)?-BYJ<&>LNPE04UFT
M[QW;@=G(/ E1D7E(*Y-B)"TV("!$YCEII)$A(B(@$4+2,H_2@D + BJ$&:)
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MPZUPF3>R%ZU.^_TL^,1Y$!0=E2TY:=>!'A%!&XYTZYD6>+&J56Y$ZUM$N?S
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M6C72QIFLR=@^#!E:]LA0J% ON5(D\4N@TO/A4MPIIVS+BK@G#[3%#/H-F5]
M;2?G?/= 7Z,>SE,CMP>S]J:+C)9J#_O[#3,MM4[W1A^YU/7:R\TKV]Q\&5@W
M]XR&:RTU=U"S:H,5/DZNL[\W9^?TP&\PG[]W%Z*KL5._"UEYA627([=H1'85
M96/GO]@E6;*/YU?\//(X4^>0L[4<Y-_A.=>^6BJ<M3%B:8:_!FINN^%_?4^
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MOLHRRR7XJ,>FE)W-M*_DUN<_=FX*]!OUN&_F)I5)>9,P%EZ_EO&/P;9:.M>
MX750:> DPOYAW9?3J6+OWUT'^92^_:ZR1>Y,CT*X5$IC5J$*-0B&O=V];;M2
M-T9.(_&HV/R1=]\ZE.R?.XF<CGXZ6D<U0QIU77&3DY?\/:&9&;@P_KC1?/_
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MZ+=0:G 2KW/Q3!X]X77145''WOD&25N!.ZOE;"TGJO^3^N_FFE &38G!]%_
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M,HE_@KT+D<!*$6NQ!-TAN#8KL.W]CT]FNQ 76DMB!)UVF'\.2.LI3Q.(@17
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MBG1V+E%.H$N8:*>WE;:OU@M]T^"=1L*Q!75S )U)AU2-7<5KDW 66%&\!N<
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MP3/04DW$).\MG$8'X.N%5#;>4%ZB:4)>>O4TZ25F)KTG4P.>0M-#R )K2>3
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MD*4+T7]X$"!"4SXQB4OTK>&O>S=@V1(. X>D+U:AMF[J)(YLC=O4:4G*4GF
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M)<?R>M]1%@CXAKP$4V^V9#]#FF?,0B2W;SPV.XX5 QM*H?O]P-@+9YC)&?A
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M\SJ2?ZOP.?\5"Y$BA)#AWC;KMV:YQT8=6]]%4L9BP02.@Q"2^5W4-^&B#L(
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M)LA,C3)V-!-]P>B;+<*K ?A:E]\\+\-V&@I@*8;>AKX?Y<2#ZUPST+N/;C
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M 4SNL+LE.RS93(SGRU:@JBC)H&K_;D0CE4EF1U8I8J8Z=1?Y&9&<=H4,4]_
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M*GW>5Y?![(2Z3M;#9.B>MD<ED:DX41 >/%OY)G@_?P3((2;@M)8831I)NOB
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MJ*^6 "7=A^2JT#@*7D$KRWE-/9#>GC)J*442N'&:KP;?MH]-'/YS^4;<>CB
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MQ6C$/HD%$*1P/ZE6D,H PQ!7K,K5<I%04ZG"U)IA9 *PWS!JR'#K5==2%)P
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M:#,ME G@->"+%]>\ 1S,G!_G>-QC5G!2V(SG&"[3UTOCYX6P=\%;=%='_YF
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M&5>NBP)=>Y IY2SG'R*6G_#QC0Z3_6S\6,1A-.EF :EV[S$)?+5 N0,<SB]
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M<;\KHMFL%Z1:F\K/$U-T% AN5!46RN&R5547VAXY<)?>WE+.]<4;E78M.+<
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M^KYX#DA((V2/:WG(S\ITU/(N_-(2LWG+U%=@$Q,'[)>< G]Y \>:@)G@$^>
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MSKP>#6D(SC?+6]>3O!L>K?LVA%?D=$$\6/.LIMY(V:U^277[1O6JEN\?<GI
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MO%RHB5&_Z:!HL*!W6F-4DOYIF8NF- YB-#X%;!CHID1 /P?<0'!;[\:30'8
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M+)P(+A\Y-ZTVL6:UM!2&@1A9ZOFE^9@@_(N]WY!$-HO57)$#:?%FE;#V9DS
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M7O<Y6]M_2AS>7YEHI;/9J7#-B(7[D]C;+S8L2)U0FXIE-$.1]JQSW9QF,X3
M%7O@0FT]EFRD*[3XW*1UB#4OM6U]S%4RRGON0>9-6GS5JFO&Y_L]SXZ]3%R6
M%2F9V[<":T!*-M!UZ(VP6MI=.A3&Y>S1SD%.HONLYW2DTPP][@TTJ,M>%YH1
M) 6K?_W <_K6<G60Z+VXLZVE>9]W9%-S&:XIB>U:FYJR<<N(^\_:8S",+#\1
M":JQ/V\%R#-DJE+0U(%QN]];K:)[R>81SO"Y4W?F5^E+Q,\C;]8DN/2D@R+6
M(,%^I@DTU6>U0Q>".:0*4Z-8GYWY.J+9)Z:8K?AHUJXZ)5'2CMNFV<]%+^CI
MITZ=U*BL[#RF)B-KUM0%-^2>8;3V[[&HKQ:])JZ"3*RTF+'M?;8V9%UI^= G
M+5I8IR+I2L/O@;Q?6ZI9WJPQOQ\,6,R-#%@X+A#!*R9;*>7%(C[YUT]H+HL2
M60I"GI4XR?5Z=;B0RRJ^\<6QX:Q!&7ZGNBU^*8IOFL%,9=:USB,0EX:7TZ8>
M7M#;SC!@0>I-KI<[N/M3_<)).SM8EP&KP)FPG"V$\\@2:7LJLB3YSN]\YK_.
M)K<6E*UN  \G.1>CZCG>E8J(9-T^#4@VYXIH#:C \;>XE7N^FYW]6BT5U2?C
M_OO7R=:]Y5ER%5)XSH0CK<I66?4,I:/7>T+\)SDD]'D.' QIKVQ&SS9D3<WI
MW5=6TD@P4]TS4Y]J0.?OK31O."=O=_X0E/1+B?P.0-1>\A-INPZ_8RMAB9<J
M;6[[^>LT,6;NW-A-#<F3-<28O5YVH8,ENC;!@B>H>>MY4JFSHT-)Z#R!D"J%
M8Q=Q4[ 9UF;I[[TY$<Y);MCJ% >TMJ?T9JVZE%<B9I9:,.>)'AVX.L#7$]+G
M=&]<5Y2?,M$<0%S+>@AKMC OO);_SUG?5DEVS39'FZW1N6KZ8;#C%[+ %RP?
M-=O2[*%-)$I70+(]\'B3O7\4XT&ODO[P@B@GG?P'V;*KRX._,_X"E2O8^7BF
MF^?Z=<VU;X;PMVD6H(@RQ-B>HIG],&['XIVIV\O(A7><'VK8KM_P[A!T+*Q^
M<1Y099V7W?W3OGGRQ6&;*EP=&9[H]#/'NSYI<1,)K<FD9S8TTYF<#.01P(4K
M%HYB(A?$?/N$1[_WO5$NT$Z9_W,=$F*=^FVH>(YG(*W;_9WCBW1IOR>D8<5?
M?[ +687GH&'2!%,SWD70?B@UM.LF-=!L^ASS&<BQ':E7INR6<5]O_.J# >C)
MK:O2MWTCCY76++RG_=)$Q(T@"*$"@L%)Q%3I":X= 2[D@0]N/![Z!,G"9> ,
MVNI'1,H]Z.4L?]RE?9:%>H&"NZ 4/!\RXF*8*E4D=!%[H0])EZ?&57G:3WU2
M$T%BUB+XLH89'\,-B4%90<5-C<EJ-^IK+(.&PL^#8K_)Q99\(N8KW'OYNW30
M7]A?UO9F_D:[D)%-8(1_Q6\3-XV+<\3 BW/[DP:W*F?M9!5!91B@3SM_1#^<
MDRY)A,<<YB.ZAQ0=*5ROPFQ\%X-0ZQ!:0'-[6^-HR9AK4K5MX+MG<C<NW%G=
MJ[*(@]>A]\LIOCT8[!FLQ]MV(1S=")MB2XU>R%7<6+/#O<O1:)E0W8O:%OC<
MW!0E2%K*,) 6_!Y#C*>+4RV)A8G(FC"UIL91':,%$3/3/OO=0SL2NS]1N_J?
M+J?FUW?;TI3/SWLD<38[Q&QWI_[)WN;<K*R_I;;;@^]).1TD]T7BO)XLA&A/
M2>D>N0C!M5!GG>JIJ>KOD4'N]CF='OQ#K7JI9L%J>8^B%AX%ITJ=,8WL5[/J
M6/PT$4MSJ%AFOW?=NGQ IR[W4['LM]5&WW+M>_? I4."Y8H3U;*R5RK+6_KG
M]%PW?P],]^O9(OV.IR?*$T2VL(B9EYO:I,L">W]/MG)<PY13FX^=":_G8&"E
MR>+L^D5TVZ3R-;WO(Y>,2:3?KD%W0%?2YGH1"< G1X!8/9W)UAO-[KVZ:E"Z
M]H(%5Y"T\^>&B4N-:0?WR&U#/7-YFZD_6;P&58?'!&P':KC,X=(1'%30?@(5
M 4-21[J<12D6T7Z@<T&5B_S(RC!H>I]&8.U:\R-R/R1<AAK8_[:[_?E)["QH
M(+AUZ+VS ^UZ4&R/UE9*^X750H&KZ"- I#CK1*ON(M1J9W&JF#B8,,L5-^4+
M%H#XE_VY8> FGA^,T!=Q[K1?6[)0=[5Y<-MSAN"=G(?[UI1_94?KI?7/C-_F
M9F4?-35->L_+RY+XVE9*1?J  :N-JC_S;(B:8=>400']&C53+5@'[(2I,E4V
M,&KW3ZM#()CBO;M$\6?&U:R RXRG;"TY61XP)^/W'UF%8[;3XL?FY*U.LLFQ
MJ(DAZ3Q]!A2)A/%%V8->[1$>SX9L/<FVVLEB\+5?PC%M@!BWT%0?V@+*SS!>
ME/Y>)W'ZV*77%W8K'ENM0F)!"F6+:!1/ER0COSQP[*$!J:\M)V!^\F$6Y-XI
MTU36R1J$VIB8%<UV7#I+&75W2YHGV?2E(DGYAV\?[[$*@O>-)&AI)+LV4GW!
MUZK]R4N#]M,6\5M^4*U!TDW[=:W$\:]U<$2WE M$H5S<$J02]W6@[MO+M<ID
M==\\OE/8EQ^%KMY+E#8SD]OZI";4._RSSGS?#FSPJ:?+W%W$<VZZ=2._=# P
MM'*N>%2'XQBF![[KJ-1XMDNV4X8V$97K>IP4]C<UF^>L/KA.[\[XK=;<!HLL
M&626 'A\M*;;Z5*,F'9NN@@Y!ED<Y/E%.5X->\8YR,B68L?AZPL.?/;B_7MC
M?*.TBE!8E$5UA!;5A7DVA79W_0C [14A\(-ZT"%@ZWPIO>M V+U[O9#S\>HA
M[ T4_?BG4UDQHFW0P$^GKFC^L=>SGR[/6O/.]W7BR99 G"EH@BD)%H#S,D4>
M&9!?/YRXN ;[L#H;<5T?K-K)(<'9/?W*P7S=4SJUNH#TVK$OX^N)LG9VK3Q'
MR+.,#T1SQPHH@D.63\_>C/[PMS?&%O>[D5$B8I%V4-_>_(+$Y^^:,[->O(U=
MX>I.H5Z.[9!X*W[JNQ_LHJ=]?ED] ?)V\RE%MXTVPUIO:)=U)H0@:SQI*G3]
MNLE7Y*@R&U@K\ U=FC#"]6-.)$GCSJ@J0V&8](OGSU0#_^=9?44SND/Q6[&9
M2]NATSN5RB0"S9IZ;++;** >X>7HZC"AQ5 NH96L K;8KOW]YH9<O9REL?E-
MLQ=F2_5W'37U7Y1LGV!'_+L&)#\ X00<QX_7SJPM-8ZPQ;9J!V3+V>E\N6JO
MHX&K$LYO3_>\A"U\'+5TYHE;VNTMD6LF<DK;4U8#.SK_/*B.0P#='V.$S(;T
M<0I>7CJ?[>HRW"ZGC>H5)R[D@11-:'F#SXD>>W9>:_TR695-#'/[-76[,@-T
M4WQ =-2WVN;ZN]]N%-T^<^7126M1UY,A-C]WDAF0;8E]0PHV\1C:D^=YR3T'
MB<\IX;'=RJ_5G14IIX:D34YI;4:7@0-J^Z&\)E(X!H)TT_3&Z_<RDKDR=NL5
M/'?D= J. (/EQ-+@1XDZGW<L?1Z:.=TJ0X)OZ<J"%>_QA""C$3]*+\]5/Z^N
MWLPG"K78KX,= BM"/6)'#?@B_VOU)?8.>,,18,.7)LT<%Q<;"S.AV:SPV\=$
MD\G.<X\\IS&??QB5EGWD,0K@[/YTV^%-G.4[[E;.UF66!>"/X@4,G8>7L$6Z
MK J;>4Z\"Q3Q$^.#725BL%%K5U",?_C/7Y4]RV-RWYM;YP&=0@A\I0(JPI(?
MC)RFZO?BZV ];>R]3(T$PGSDY6BE7_.*C4G/8\V:Z^(A"1II;#DG?)*T:M8?
MW@C_P'(!J 97Q9*-\:_@]<[I-%.ZZ@1=C%)I3XTF2G Z4',?MTRY4-W\"<8Z
MIGIM,!:.@,DAQH!>-D)'MNK)G(RDK%OB*U^+T/FU0=/5\(;V59"IUSV(D^W^
MJ)-N?HY%#:YESVBECR[@0(CM7J*ZE-$?4]W(V*YY3?4;7<5!XS84KH1=/(?]
M2HX8T0BF/CWQS"_5Z]*.OK&0K=*KO*5VY6/5=3G(Q:YPOQ#.O<*4H#Y="#\Y
M2*!/X6I2"19Q3%%J=,7:=*#Z@S\"5EU%?WQ65SFDLWF*P^FN?,BY+:H\M@,J
MMQ_)2-/Q)N.=*/OOR>NF[5.MP$]SU%B[ D'5Z13S%C#>I 6\C(DKFO@,G==(
MAU3R*<PIDF',TZ4T[:! 0B$)0>$?Z03RM/.M'6ITP<X-/LMRYF@879BD&\]?
MP8!ELA^$<I3+-<8:J;=(W;@:'Z<(L%:7+RV>A:JW@!4;2.%HN,_&><;<[DP;
M;T!=2T0 "89=3Z%>T_B"C\+9O?9+26[72E]TC],!5P;%&I 1D739XJ!#8@?S
M0@-%C.*A2G*WQ*:=V64 -Q[^(S&4IWQ^6.CVY28855*Y&W]Z+4*!.DXF<"7/
M]@G?MU?J+5>OITBVRU"][IIIMO[PHU$EDT<LTDYVJM[>F+XDQ'M6!10![W -
MNU0@STBB6V\M8F/U!!/^F:A"E]LM6@L[@.U;;4U\I5=#H%.5J@]^>![H'P38
M6<;FR/4G"2X#_^;7;P7QM8O0]<E</7.*'87UUXK)H(?D*23B\1I3LRG+S,6<
MFG2]H6FNW..0,EY5E#-ZEEOTP:"6U+T*T2=6==[;D 8:%#>WNY&Y*3,?5XF;
M!O?,0D!(F[D&M <S"_KEM!;/F7ZZQ?KL;FGC$2 E^ BPGH@]9+&V7?CPP%CW
M90CO8(#X<B$29#0\\"3OY)EMMR/ =^%,.@WR!_Y%05M9B5X(2Z6V'/N+BB-
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MYZLY$[_+U#F8,')U4@TBF)Y)68GKRWE&A3G8 BQ51H+$2H!QAX6005TCY\/
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MEG&DX:&GZ+37D!_,K73,<WBJ?MJ@.CUDBW;B>'@G&>UZ8A$=A:>](B2#"L9
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MS2G<EF&PL<.HC]M;2:?1Z[>0!<<:*7;_"(!F8+NXQ+EP&E^. .=;Y1<.)JJ
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M?PIC0=H@;ATS3S0B4+,?$^B7-:!(EY>A;X:+"R=>WWWZ3WZ&O*&*B1)>H;6
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M(WJ[Q*SCK4H-X".D+/=/@$-[?@ANBF]LV@$;V$#R:\,%W-L?[_<\ CR'+V"
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M?N24%-?'_K<D$_@/ ZI*Y'M[<%C/@"S;_F51EU+XP\!@E2?JG8^>$.6PM4<
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MJXWZQ_:P T?.-OXTK&!PW!)V3H*X<I:D'^,?BO#?YVK.NQ^F @O74%D)$R?
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MJ\E;,:,U\61THBG+3@%K(!$F2#H%D!<B#$^R0SE)SV?+%7$T$4H=(8QU[LR
MXBRGW5% %DJ43I5TV>7[$ZCX1N%?T4)5BAVO.M[A1>*A;L!QTR//F%, *J!]
M@)GZC"+B-1NRZ6.GRT4 WEAIEDZ:GK:19'V8M"3NXEA9GZW_>?!IKX!NP<4J
M/<TFZ#$=Y>D!V680Z]SM5];+Z-96GZXI_;?1T^/\]"H$&*[39!?\;U.B[*1
M(FWV=B@+RJD9BL/.PF90TEW7@@I."B :N4XS;<TW&XFX#RC0U?@)=Z&UNZ("
M523+F-L-VDI<**=Q9_!M]YREK,O>]X?BW/*7<%I.B%(+K)UT<UR?Q]V)83M$
MF =:SYJLAS]R;T G@H&S""BC?*[B$?!FZ!U*VIP1)PKO181_4'C\@]&G4]4?
MX4[NU7BNX[+DYN-*1#%,^\;,_HEP06;)SYQYE+A]S]AL-*R=/[I9BJ(S!V*@
M:A''$MW@M@C4T0],T5J]/#XA4VG5Y4!<Z$#8?(X%H,B<P^LVY;M-N6O4#N4)
M[&T]!; VJX9:5I'XDT+I [Z!:8SN7-,$7CE#XH](ETS0FU2Q>28<KL3=7;Z*
M<?"PV4DQ_*(!28=V)8R C,%RHD$QBF<C2.Y)WMCNF+Y)RHUL*FHL,*\:#97[
MGLMW7TB&VSMM.U6'6[=E12[NAMW!C'YH'LXN.TRAYKLO;4"KS-)2+U2LK,FS
M/F1<\#TI@'I3L:L= AA1UR-"9P_BM_P,E#KONWBZE=BN2DLN92WIL?=_OW#=
MCG/V\@I /UV'L[]?*Y@C'CN+!#*K"\Z+,T<KG0(80E]QQ*)'T(.^O&;3+CNK
MV<GQ4HWJ?I7PL&SQ'TVQYH*Y+WIO,'0^4!'4U)E+I@A))_J&S'!1OE+66[.9
MXQ1$MU\/%1";,K][%JYG!2@]"MS?OOG89TFAL_+"J^]6[D],W%^?YQ//&@;.
M)FC*YQ"<H]5]")ZQ?-PC<"(F\3MIA._V\=W"::DQJ>$']8.&6<5V2D><E4;H
MZLZ2&XK_7EVLCW/7T2FHMD/IB:],;^[MS)A(E90(;8?YN8][8$RJ9@8JX41]
MVM5%GU(\/G" ,/ QU,@9&C#+JV.)H@04GF3Y%X4P)PC_W?3<:,2]890 \P ;
MTZ];)?V521X<&-\E'U&>D]H#N_3')!28/T[?)VK7-O./-?+.EVTJ3EC8C+L+
M-+Q_\/?/RT]&[.VWSS?<Z+\8"B2> FA7! F\S.VJ4IBSJ2@JK<_ELE#5"MK<
M/-\UH)9(2E2AAHK0]MN+K')M&?.WYA-P8YJ\9XGJ3>7-FI?N@,4#6<_.#M7.
M(3#'230:%5BY5AKJ1&V_+2^7?!T"O:O+\>Z8:1;R*FL5G[;?@#\!36X6(9:7
M:W%NRNM5>H4H/#EXZK#,IEX9&CV#'NB(3YZPF8>W2<<=,>7. L-A3,T,+T(?
M$=%[PZ+-8^J;8>5%HYY%5HXUQ_)DU][K=LBER.Z692 9>%)/?77\##(*XE!G
ME,R*1F$_9O-'^)Z$S'VM.2#OKML+H&O'^ :.7R\*U&;*\+:;U)>_,C4?S]+B
MP0U"!$\2J<+SP$2(*B6%D!%M2H0G-3.L@BZCI>F[D0M0Y]7LEI$Q7X&**]QW
M^#7?->*2:?W\1/V!]Z> JNW-*^6A'A0KN'[!!(@BV]8Z9L_++)(&[W6#*BQD
MR9S?"%>Y:?K!6W=+0ZP8W].$\!_=VFM. 4]4!?M.6%GNCPV$2-FH(3QR:.3-
M]<HC/RTV,Z[_SQU8\-5D][ROB1>NLKWP\N:2W)UJGDUEAD8F']A;EKZ[&SD;
M%0IE^@;6U@V2Q^/_L&%0,/P!CB/@^D3[M]1=U=)9OTXK[^!WC-Z*L.N-XD&^
M[B]'TG]S<P86)MU=B*B<<552?]?NN]Y28=$[MU5=9H<^!23M%Y1*;4^ZD#\0
MA@9]/KW!^+_;4FZC:V'PZJD8VVZEL6,J);V*7CP$@SF]-[D$(J\[?JT$7 2\
M6< IH9 B?PJN^F;2A@DA=E/R!6SU#>,SBYB[O"%)YJYC&>GF0G4.XF7"OH<Y
M_M;61YKU@R1@NR<3Q7IXTQ*C)_8J/>J2A3]ODO># >6!.5OWZ"[HY9GB2<S-
M!5B&(^? L97)+\ N#-*FL MJQ[(&AG18KCO,%:+"%/N*]*1GD[_ 8\GLEA?"
MBQ^+":2D=&%[3P&\H2:(0/XYG;C&Q]_%:XK@X("[4_,7<WD>IXAV]7T\;G10
MO[I?164F)XE<B?PN*D98'_QN6)"QBK%^%^[J#UE;:AK:6^D/[C.&6Q1IF3(E
M.(NU&B]^#>)HXN @I]EH^$WX8DUO4Z:(S2'=&T8)OB\\)S_>3)U^E'9)9"L#
MG$6O[DLOB'RZLM4L0+$8 (=9<# GW&K)T%46*!.\KJW*YT:=IH*.050/SR1'
M*-KO+(XF+D:)U%Y@1GES,+Z_%%;OLP["B6R$D$0ZH-<UKP5ZMO.)!-F8WB2V
M.M9*O<D#2O"V5RXDUQO5J)&.X/R!6G&S;Y'GLLW^E,R+$I:YS,':]Y@2K5I^
MJ]?7F46,HVN2ZW8/M<-TE-K-VUISX/?>D5,\5&M7 Y0\_<@&2C6Q_(@S[NB8
MFY+6K<\Q;+:)7]39N6/VKB-\X5WP)PTU$DAFBAHPHNY5,.E"=.5_.7(![EI#
M*?H4<:#Y6A9.EY(RH;Q4B["3W/XHQ32>K(8+OY5TF4[E@%/DT)+;L9!]A+%O
M%!'K,K%8JUOSS.MO]9MP+]SDV?02QN )YBZ-<FTG]HRE(Z[U<>9FY<BG1?+X
MKY;_@OD=(Y->E+Q^E1@E95['\W-T1=65;2EU(='Z.49>6&VJU5#/>@W/-S@[
M$,<G1DQL[Z0I-E;&VH=D!*7?$7*QU[OBW)HO,-WW]Z(ZH4E_;GO3:A;*7[0X
M]J$$;#T5F3%9PX%1U=ALPH_;M40HH-L>2GS.H&-L"U>2#!WV\KPXA5@L[Q-\
M& ;V@T]VPOG><GS20,V&')K>I[]%3X\.W2=&SQJU <>S],;V^".YWAS9YQ T
M_+?;K5NG?E<-^)2XGKO8YFE<^TP[H2SIEG.3OW*'?(YMIOLN$')CZ'>/75?_
MD<*N^L&%G."RXIK1T?T#[$6__&"U Z"#+RS&G@OG,?]SV$\\ )MY6]:J;D).
M>UPX7>Y\VZ)#Z]=Y1,#]&O\;EVQO>*V'0Y&G@!=,,+90-@I4"H-<G59MK*FK
MMI.=RJ^"^6@?O!K,R'SPSEX F3[/.:#A16ZDN\!0(?-K0&!?$Q;35=(%5^?5
M&MB\;2CS'/+;& :4%V;_C3_6/)#%/$FSR;9XX<C%;UEF45AD$/::7:SXGE_=
M8N P&"-ZSP0N(BX=;!IO$>\QRF9B]N9_?G2Z02\T&YS]Z-PMA3^4."!+3L"9
MNX?H*]0ZWH:,LQIP5:YT/)9ZT"4(?&HPKN2T.>A*TP7;%?DBBQ;S[=W)\F@[
M!Z/!S;[^[P'LY0]8O]PZ/^E\M8ZA?1X@;;WLN\T7Z&R6DH\:&?9_9^&2=Z.K
M>?BN7-Y4\+(Z3J:(JI1'\!\-!9?U$KB'@ %.B]@J=^]S)WW5F;>S .>Y?QB*
M![P8"N4M'-<O6\NT#LO-3=#6\UAXDG@[Z?XY)Q' [/M+3%Z'.&D4(D"EU+>X
MRZJ$^O3:IHJ=Z/X*]4MUY$67AZ,(>V^3>+B']E3&=VX5LP#P6V2]EA$;U82(
M^UB0,-4OY9C16JZX54Y1:1&ZR>.5IS8FG-7%3S^UR2CQ\V874X(7[!MU?0')
MYY:M$[\/K_O[*ESC[B@)['.53>D-CT?/6MV R 3:ARYX3L]QGN$ASTNO79^!
MBA R^TIGKDKQ;R4OL+7AUF;Q^':IOT5FO#O#J&)&D9_0QK">\OCX#T2!18"1
MV5X(_W=_[/5&L2!45ZE-^+]?KU![ Q:"<,J1J2WU";&H.LC;]5.F1HI54WV)
MX,YVUP^HAOEB0DV7-[/ PK*03_<FS/"DV@*Q[1P9M32)>!\0KJO9/E\B<L;M
MWU9:57VGRAH\4"$-XB*K[\B>A["BK/UU"K]-Z$/*Z'<750F<JN3?)JSQY:3[
MTV\<PG5YC7[K*N^MN"V[V\PK%I#HM<)Q1B-CTSO3>L(AOM)L566B5Y.NT(=?
M4;G%>5#!814N/LXP"-DR+HQZ_K62_MX_V@WE+APG9Y=2(5A[>DU_7 (A^0,@
MD'F9K#LO(M%7NP/)-0R:M11:=2B(*5*59B+V0(YR[?TLU.Q]OZJ>9-PL/U[S
M_YMDM:_^1$:F(\Q=;:[,Q(OLZ>F-4 KRWAA)KT#9NTV$2I+*K(EW<X)\"#KQ
MQWRM>)OX^/BRR"1QT6^)"[5YX#<O8]F\OCL[";@_'X[;3SX'&88PD*:3W2O
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M$#ZO=I?IWX,K##('S%1607(E96!VAIOJBH, J=J4Q%)(C^K-Q+GQ4$&2W'Q
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M=]_%PV/;TV9[YM_H*[/WSEWAN3G=-]80,K0=GFJV6?G(S,&3CL!6/2EW&G*
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M,N#;4_OY>K#U4\B]3B@70O<LU42%.M+;_V9KG66T]:&,V/Q/(*UJ"D[T1DB
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M-8+#KA4X.3,<Q%N*9#O7U$82>LKWE5MFKQ2F^(W)D)0NPI!L,S@F/2\[#;*
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MHP0U)#>E\Y7[5*J#_]2^S:1WEWI"1S^75SU####P'XP[J6X8UWW ^PVM9"4
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M=-D_]W*V4W%+HKGA.E)J Y\&A$(Q]@,D;,DL8]0;$^/!R/%H? 6AA<>)BQV
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M+5@.JU-W[?U:-ZZU*(^Q ;&B,Q.S&J9Y^.KIR3#FL 3U,'4=\EC$HA]]\.;
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MU7-.?5CI8 A8:3]*WF3YZ]_L\7H#'[VF640*"%5YVPBUW;ZA$='I@/@S!9X
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M\J,Y_K4_]V&#2L(FS&(L3#8YK:PH;>B-"3G3+<I/?E!:TW_JON NK^[H#_Q
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M@:@LK&5ES+#IBVX@OI+*&S;<QLJ!')"U\RKZH!8]A.RO@QO41^%PX55=&,Z
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MA_/+N>8*_CJ_5&DUTK]Z+OGK+V_KS_CK6%?<$D.B_S5-+_[\9B_/8%85.0&
M>^/(^MN?WU0PV;>6PKS%4=\VP_XB<C5SRFHVTG]^,^$*"?1.,KEZ-^;%69KM
M\&F5_X]T/,D+P([JW1O[3I5>M(^HM)R,^ P15,/57]*K'1Q9%_7'5"F=V8\+
M#'92V/H/IU'@A9[O)X31A!$:A(JP.*%$"Y-H)9-$4?;&R?@8WZ+3G5T@_ J)
M_X<1/VL6=E4=:0-+/I4TC#WF<N*'S",TBES"(J.(:[1B":<B=,V;7PT?E?J7
MMTNS63TYHSTI>121R$T4H9P'1$2^2SPJ6> ;'?J>VYW<?@8G,MN#V15\=) I
M??57/?NV2;I EUA"W21ZT$RY-@$WTB5!K&!0P7W")&>$1U[HJLBE7A)U9]JR
MT _ 9OGH,XR4JP_P6_EML_WPCUMF^:'@TC+>9D-#EVH#DXLY=0F-82 AX+03
M[L8ABT-?AGX[S8;"[NSEXW%:X63+W4PA7 -P@A21ZAN3];5P@\CXQ(0L@,D*
M26 /.0E,3'W!J-8,^,$T2^L'OIQ^.7X/*%JF.UDZ N0HIAJ ]^WRU&]92I1$
MFGJA)H+#/S1V(Y+$,1!U%GD&@%=)3S]A*7$2)V&L).$!+L4D+N%*:&*\.*21
M-B8T;%U+D5S%@>='1'%X#95 7(0?ND2:V(3"3YC4XOI2/A?:Z*+0ZKC*Y=>_
M\=%4O^1I>";P(^H:0-(8_F&Q2Q+%8?>X\**()K ,]QN6L-%36,9@YD8\,$%
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M<HRI+1)+ZC 4FB-0?C2(/=0+ AI[_0^:'7H"/7M/H#6*=A$%S2R,,&0;!;J
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ME4\2CX- $&"%+1<TE(#R($X"UY-);XU^#XJ(^XO.X.A& $R[:IQF*7!VC@+
M]QP3%[LQ\Z*0$VPV0J@6"6$T28B67N12[KNLOWVA'Y3W/$>]MA@-W-C6HWDM
M_#;V##!9$Q./N]C0, Z)\+@"43P *=WX7+#>^M)>V#2SOC/PDT#%6 \-%&%"
M/4\1CD'^,?P7Q%'H>_TUC[TV(^I?<I"],BND-26R,5(&Z?*9AD=U^?JLJW%
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MZIVV 64O*;BTE00&:64](.P-Y*7GY&7W1Z$O_+2C)+THD>EH1P.A61,P!^%
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M<&'A(>*O&&*B&H>C,2J5 ID2!+8G9VK7)#X#YU_,/!0ND_H0$^@K&-+K9;[
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M*(=8_=*RE+&BM<%QY<'?+L:GH<K*^T-[\R8@ "1*0=S^-D_9&_!BG\K7$H/
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MVT=*/U98%%=_?NGV.Z?JN<*F?LRG[Q8-'QV<X=<D#7QX[O@ "'_6L=O?3(*
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M _@V< GP</--=RS\QFA X>7MDLN+<I/!T,8"-B^M<WO#06Q2FY'^I FH5[M
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MMXHT)<S15K)6)L=W1:58H$51.])*.1..MJA'H(\:7<?=='KR&/4*)??ZN8[
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MO>?T:[ZB6Z0Y4+1'=7&'J,*?5BWW^%"UW..>:KF'WSX(U7)G9Z<?I5KNBV9
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M22KTLTGL(3063N%QZ=C#DO8&"=LC5R,!.8[S,'OREJLAKI7DQS5)@R&2E"*
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M^ F]1*W]Z[XNF4#^BL&YZ]J'4#BD'XI:V\^)Y-*]=/@,&"*A]<ZZ*-=15*K
M]@EM@->1<D=$7'[WE^SG9S_'?Y*^GCBL8]X\?$G/E2?9LTYQE*( ,+P*&4N2
M"GD3!F^NHB=@QY7, .MI2KP23.@%O/8K[/NF.]^0+!+E\HQPUGT+AR@1X1$Z
M^"1%*KV6C\;78>\Q-C$M0_=$[M\?CI[3;EF-$?L8.^F-QCMF[9K_Z(1DF1Z#
M-O?9M]^D ?..QNB-C',@]P?>PV.\L?T>"X!0[MYN#]L-)^GI-\>S_1^=/'U\
M=OKTVR>/OCM[^/31T[/'W_QP1?:XQ)^_?^?<FL99^MG16#5/TC6S@CCKMV=G
M3WR@-0I:RXM/'SSXIO/48Q$"K[JG-)R@-Q?CAX^?G*:Z+>I8L,ONO7CV^$'V
MW]G#D].L>G6?M[.P- -:_N3!&*9G)!(L%L],9'RHH1IB1/WI@Q%]_[7W\=$!
MS*@K7J0EH%K['I<5H75*+6!BQ1/"22$H&TD9?^#21,=P\(:#]W$.WO,#JC Y
M?T^?/'B2GC^HF;QA2Y9OMJ-()\/.*YQX*:M)VW6L%%_ ;^L>X=.G_@33?),)
MN=>*H^\0'OJ(X2P.9_$.G<6W-]N=R;$\._ONZ?7'T@R[SOGD\WSC^91A["G9
MAP]P1,EG"WDL)7:0L^/F9-D:%5(=\S]LI%GU7+JG^#A6^J)#Q^SK=I)^RB]K
M6=?UDASE:9V4D3.;V::I)149@?Y#SZ9N'X]K_2,5X2//RRLN =<?K0JF@+CX
MJZ<QXTV$+LW3TM'FL\@E2^Y:HQ.:L"L$F_W&5PU8=DKS::8[X"])K[UQ*(9"
MM!,/1U+:PZ-^_?GM6T-'X38 1KT;P]4J_M+G+W_U5_+ [P0WY^F#(V,2[B#E
MHOCQ+"W(L)6+",H"4:?LR%.I5B61LEK\Y=WBSJP(" &/:E'(!GKYJQY'Y)#F
M>8O501BE"D2DF&<2QXSB"[1M0IL:';]1J*\)N!+QJ*)DM(*Q^TI7> BT2=!7
MQ9"D5W6V1 ])?;.\E+3(QJ_^J-_5"TW#_)AJ+A6,M1V3Z42%%5'^6Z@?KH_J
M'$Y7W>?-RHC0Z7:35Z[>MO308:/^WHWZ=;/>#GC3NX8W?33@3>_\R3N.9C>G
MIP=9IT_[6*>?/(Q8IQ]^-[!.WT+?'1WM-/P3)>QC/\G,M)/LWH^C9_>#QR/.
ML()>]IT>Q?SP[1$)X$$3Z"2[^)6\=3R-[*IG]&-LP0P9R*0S+8K+ZVIVG5?,
MQNG9=]^!SAA4:&I4<FW=Z:/Q+-]9*P(UI^-J/5S-/=6]D7XW[,?38SI-]T]L
M"7@%/*P57F6>U71(:!4*8+?-Q81+$YR+:V.]T>WQ.0G8>P]-2*/"WEU(H.4;
M.+;5JB[IQ0S'9Z=ER6$Q]HWDV'J.O^CET6,.#21Y_.@#ABZ%8.KV]']&@HA/
MWR,Q'1"1<-SITBV+:>F=,0#S0C&<?V7P2'W_U77#M;MUR(2; UIE.$82$I!_
MM!F=MT>C[,DH^W:$K%QV>B8C.7V472T-P\;'"YN"].\*ZPKN]G!><9UX<;P'
MK#96CR\G"9]^D^6,<'-Q39^<WCCCT/UJJV\0F4"7D7FM;F<(C*!JSS&T6QK;
MYNE"R=K9AHUV@)<Y/0,FR7QPQ,F@M.D2@G6^+)?&<,6@1H LC9E]GJ(P3>,P
M>[[,,&=EDF Q@VX.S56(*R2' TOPE7N!?ZH5>G;0"CWK;;IX&JS0L\<//HH5
M>A?+"CY,<1Z7(;H'4ACU2D>M.(%"4:'4IRI3V>7/^.UT8RI[X^#QGMCMMW@C
M^K;(]NU*MVO&&*JA7_\E 9STJ,#KC>A1]K^>XZ]^NKYRJ3;$MNY:;.OQ$-NZ
M\R?O3K3A^!/J^8:^'-<5,42-*SXC9/K7G@J'_9>)F3'WB(>+O\8XAGVRE@[9
M2CY=<ME6-UO(H9I. PV[IG459,NEYZB.G]\Q2O*](%PNM7HH0:./L*IUJ>2]
M3/VCR-KJM:V"I>1)\O]H#Y5KX//<9Z2D7<G>.+_&>42&E(^MY)-1K^6TT,*7
M$?+7M]:R[O?U91G(_#_*N481$NB4:%8'<1<AZE!ON<R;%;UJN_%XJ4E!,F^Z
MK*1H"F@AL%BZ ^W[:'3%C"OQ;6/[FY4[G=ZFI1>Z!LHQSV3#X%%>T2"XO(GI
M+M8X2[E6YDDMEJ\5U=8_7!09SH#Q/D55J=*;J'LAD\)R&9H0+I=NMG @T%NC
MS,Q7D;;30N3_E-R>IJVK2L; Y-+;-J+#IQD#S;'_MDNE88>XD3+9>3Y-OEWJ
MQU;YOU"9>=/<LP]7\33FTUSHW@N2O.3)*9O#@C$LD EX $G7:6'$*.OMI%1Z
M>)I2KFLA[Y+DX739>4B^PC)P,334$$V==B9JMU,0DPAYNT"7A/JJV6"Q,,F1
M:F'2S)P%8CPA9IB&CBW6U\5I@1#C\GQ=DU^CD^SE7*:P*(7U-M]921G]W=%,
M2G5WV'"81B5-I''0]Y5L_\IVT,>R..=RAKZ:[F2W7#F&2$]HU2O+(LFGN9B3
M3>;,OAGDN2M.>##?.4\2BN.XF&G2DN*ANR=V8(1DP[WG\L)%YU/L/DY\B7^>
MMH@"R3]S!UH)<+AC%(#<*'H&XUCE]5:T2ZU]97<1FIJ7WLJ[HR8ZTNQ>-C+N
M]+O*?Z9J3EW%-]9P6JKM;4]G>=G6M)#3+9_\GR^>O98#SC9,6*U(F@3>D;0<
M\\9ZTR&CU^%%#$0J>;7KV?M^W54$@*)PY\^*EMZOP#N*/N NICQ".6>T.R[>
M_@+XLE)<X,XW+R[&3QZ>COB4V'%BX1". =<C%,JGQZTL_&]X9'(LZ687L=UH
M3$R%E]\KGK/1B)%"Y-ZW3X$5I6D!.?/29TKOI<W+7*V]2H536,HZ[/G]P%GS
M ?)=B20Z/(56QQ@I0-BG8#=& SD[RQV9T+.8O?20PF'N.4W]BL?//\DN?#5(
M+-_XZ!KA]8VJJ:.81 Y<IYZX.8,BYFUNZHJ_RJZ!1^;>@=P +P!+EEC-2IC9
M JY8M$ONCDL&>2/2(6\:* =NB<*S$AX7S2)SUF[!2+MM/&=7O-^%)V*0*7$0
M'7)$X?/13AE9'PV?7XYX^\/:\)4L]],,FI4=S@MP<1<(-//QP7G:6R4Y-/QC
MFY>VVY0!CA::AC8531H,/BEHA%*KS=Q()%Z?&.B5F&PLL)VT9_%-K,?="G<&
M7:U],5+9"<$T=^IH>QN#>P'I[)HL$#9A^+MH@\1F:[WF)*F?"#]N+P("W[[>
M'Y<>Z#YO-_*0_LF55V%^Z>/7<B<?;3K%4\Y@%*L)B0]A?&9K(E^H86VG52W"
MDTP=,VZ:J1)N6F]+B 0:*EU*J^<D(QXX[TK:$16?YV3N)CME]V)OV4_=B">T
M&<FO/8$,'?(2DXJM4+5\'1QMXX?ECT1]:_HP-&W!AHFV0&L:0P6(_R@Q?NTB
M7+'*W[F]6STICIF&W*ZFBBWHB9M+)AE!BMIHAF3D3AIE^:XJ75'EK=\>O27[
M'?+^6O-VQ _HM$S4CHB.N[0B,.)Y,; WNGNU,T>T;'.OED>ZY!-G1(SP)OGU
MU["R?95"5MT,7=QD2?P<<CT)IRN]T8]PVIYD/FS,=:B9V*Z)CE!TLEABS]T5
MUTK(>=)&1"WW89)N&R-^Q-[Q4U,F/84]Q\OLDN2,=1TN-D@BN^VGY^?<D$=T
MSYJ[(6&'1\U"$IDN"BF<5@S6(ANF(JXQ"T,_.%X&R>*:9Q6/TQLF?%8M J+F
MGO>4PX%G^U6/)F?'E$(>UW<9$5-OW ZR.K!VH"093/,K;;^XT0J01TT;YFL3
M\86O\QW&#6-+8ZRD-NE5S$.Z9+X?:;Q4,8.+S6!L%'?_EA*)AN_AR316TEL:
MJ*,HF,S%EB%4).R4\M'HSM?U%FKN(*-CFT@ RF0K78JO9=IXEI/](C1Q+]@"
MD#?*4)G]V_K>L794-%Z<V">!L2JV*WEU+/3W9G2(Y\;&9K!-Q*=D*^^H8:-=
M<O6O.O3\3UC<W!A/2+0R9+!R%E?QTM)/:E]Z'S9J%U4?/I<)'RZKJ0K4@.CA
M@;<@K<-L>I-M40I?&<;A2>#J1,^"B+@[LMCVY604O\15"Q*,6OQGLB#*'C$*
MG>7>*)&RSU[]V@HRAYV5 U^%*=A*<T6Y(K#6:=)'/MQ^B59+91 <Q[#N'^<0
M?"GV7" )*(5,DI,ELVB;)+LD[$"G[111?-YH=C,. Z4V76?K%@>/#7*@G.+>
M<R!/LO/VX&&30+9O4]3'&)TH1S-EN&B>V=V;,;#)R9F3DY"CO8^$:Y@;H9Q#
MGTI<;(HH7S0FB 0PP+9Q'Q"A'Y>&)?#^MYI<OD:A1]/,&:[ G8<0!@^LT,YI
M8,^>P/J==Q:'VSBM"H9:OQ0CA]GELX(;Y@KA.Y)<=7/,QW, K=TUT-J3 ;3V
ME8'6OA!=2%JD:,W5S:?<&<V$K;9D1F0@!/\B20SGG%%$,"@GP6-6;YV!.G45
MJ1<.".=MK6$OTCVMQ*007BRYK;EX\AQ7T#YMB=^V*5;.6WE5JZ;=S.$:5BZI
MSM5TJE X7]7-.\4%57%2=&<A.>8QA]THJ>Q4M<RVH=]"9*_&ZE\, B9_WE=Q
MB+LPR<1>1N.:)%<G8H>7__3\?)2]0)MH1PO#_?\*-.D]7P@CDO+*O'AU;KPR
M">EZ@*<CUH%9BV,SH8](MMJV&WNUAK"1$.SHV\K,$%_> T-!.I8+*8ZYBE&P
MH*B$2+<69\!Q)"0B%9=%0BQ)Q^9;7;:^]R$W5N5T__XFD>[<?"0$:D#J[R1[
M[?3IUYIWW. 4;@$>3IL,2=6M4M);!@'MM5LQ30K>.%Q+)HUB[%$W@!PX>N5H
MCD"9O)0]7T6,J>F@-(BRK:(6(S6&97D1.55\(E.&^-"9-8^,IL UUSBR#:9B
MZJ$:D=8?MJ2&W8IJ"MP(WLV3B/4V_FA;U]^VM)'EG]SP/'[BX ,=K=PWUSD@
MK10*L+&(\,&$7PY>[(W\R>^ S2Y)[]4<66N=(EW1IGJU%SWRXL$WJO'M!" ,
MBCWO/WY;40%GD@K02)21[[$JVC9I6W0,\WYP%WXF^^KXXW)?VT2\I!]*@(]1
M W8AF/(AI'IG!"E28D6\A%H6P+V6IS"FIM)5!0)JLFT+!A4P&S1*F!NM2U8H
M359L.LEUCSGB!K=<UR?V-0Q"A$D4_LGF;A>68]BL?U2(B:!UM(5I4>C(D'<I
MLF9+\%\D95NR)T,3DT-6:8"&"7EMA)ADP(&W+Z)$4FR&%LA'1NDE[E[MFU)W
M)DN*#L0C",FK]AU9FFT"*#:_0)60L4H&6+$H'=5K0?5UNN3F&[N5G2/&BM!Z
M([>8LYED*HW_(C&_"%%SDKVMLZ4KUWY-=18]PAI#'J-GA*76>"'8B\).R+7T
M!=94WN[=?2WB<A2Y/ %<)X]L%<(YIZE GI1-;[K(\-=L@/+R*%%P%_N2;($(
M3Q?#PV=)AY?8.XI\,7RV^0A]$S.*M3NGK*.WR=TM3Q>_2L*%^HTCP6O(/J&%
MFHN]FGN@C>:FDP!GO% XRXWCRJ!_:CI0'5=Q-' -V&[KG7/=C1%O-=TZNC_\
MANF$8?=&&,9%@UH6D\)CAS&S9<VND@=\A9L3>PCOE/'BYNA&7N86OI+T$V0G
M0IR.HH%IG[<))$\ZL/ L%UYP^*-[S8E-4N17>GRMJL>6)S+7(I'E<5MULX:+
MQ:%D]YY$8NNM1.YJT?F=>(2<T4[^ B2T!*41C]:7V'\WQ8:$1Z9.,S?///OA
MYP"A?.T=4/6FN]TRHVF_&W;F5^GM<,E-BH+C?9_B@EF.I>#A !7F_G#;-D K
M6"IL*T-.\#E'1$#EVE3E<^D6<)2":)"=RDX-]@_WKF590W=#IM%,0 >C*D]A
M(7[LBJB1X5]UV\-Z2T%B,'@P](<)_T(!/GFS@?S/FT3?,T8T>N.TS(L5SQ%N
MXH?-_*/X!5:9@T;K!7]=(LNC$\U1Q B.$Q2Z?K)&@%BR)^^0CV#/5+LO<9BR
MVO7.2 Q90L^:%)E.5@ORRP(JBM\806CMY;6OQ4F&,W%I,'/;NOF6BSCM:P_"
M_D0\T?S6,Y[5K= _= .6!I'O2% !QRBS#B^-T7SMSX-!CU)(K^'3%./D;RQ:
M75QMZTR?*H!63!3CVE@ATJ8T?"82:H&!=Z9133P$T37.6.8*Q6+1KVN\V(*&
M>^-Z)KT_[,DX'@TEJ_*=]0')H/(]VH=707!&C?:LM-^*F: 6C[#JRMJB7TKC
M,+NC:&N%[;1D0*I,:OAN4OU%,]VNH WQ+^;PHN'P%_"K.,@HY\W=D2#$5ZD<
M.O#.I/J.I=2-)7B&HH&@ @\6&04XS7:@8['8[RHV$3]9M&FLU?JA]ZX;R6Y+
M#:'(V>C=7<]!WL)I%CKV077%<M_.L4G^%)3((N-*P99B#TMPG!-$4M 6E\6D
M$RM]=OF[U+=4(0L3CX6N]Q%&=O))JB'/([=,N2NIU[@^;"C 5"1*I7,9!JXW
MQA8UI'I>E-LFSE+E_DIQ!#JSE2@5^V9D WQ3U0Z*=^^S?+>7O/(M[\ER1DB4
M5G2K]JE:H*^+]EWVD[@*:HV^YFS#:^UU3Z_N#1@EYJFA?E>T098:SYVY=MH4
M:T-P20ZC"4^M#\4Q[H;D^K+@F+^37N1"#NAY9!3]68'$W_D%0V@QS=$$3X,-
MVCZK5P _X1#WV)[2N41ZX##>,8"X^O51<)(NBW;\7_]Y=O;HAS']&&J94%9*
MHNNG:X*$6IG%S4SU._!SH;71[*ZXGIBEA!L ]@1+1^2MD9N]T9[6<? QL:H=
M(/ ,B(,B[JG3O&&T4M\8]\F-G/V5RV4DHCOZ0ZZB,*2<*BX%KY:L5_<MC6[
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M S]C$GR'%T<.)#KF;1M!'Y$4KJ1*M8,X.E#@&T 78'+)I196)A0$Q&*1D9C
M\*2B01AR6C7/8; _?$"CV;5JAC-GX3HNPP$E30E'2 %]DI6C[125J^4%JFMI
MSTQI1W$9%ROGHM/R-,Y@>EA3%UNE\X"$(5,<\A+755I")2X2?SAXB9AJ!B57
MKEMK%9=&I7^0[V43A(9M&)6\N[FD],[/:><A8AJQ.#0ZR[2"C+W'4*,VH\G8
MR9[N?'UR/C*Y6FJY9OR*:E$7VDO67X;Q]'\<QJ4O0Y%<4A/&Y*6V69*4T%7=
MO#/#"JR1ONJ0O_WOM:P<;8"JLVNN+7<[N 1A S&WHW%2Q5.69U<-7$&8GS@<
MB4B9Y&W1>C):V18_68U.4F-W^Q%US4\FX ;_3^?7'4[NO/]Y]X6>J.)2_7:[
MBIU=?/<R!S$FB+S<+-TJEOI.WXJG<:VDBTX 3Q[2%'+7S,&#+VRJJH1?2.?8
M[U)[W[1N&NU6+,V6YP4HQJ8%,YV[RZ+>MO014ZZ5LJ([9ER2+.8NYOP],'AP
MQ=G@C]FT_LH+[/R>X"#-LJ[1D1K4RTSBNO%IBY&4!TN0*@_<"->)SW\NZ20?
MO+9H[7E>^'CC@+8XMA846H(8,>MDY3:FIZYR4FLS?9E&3P^\#M]SZ)7Q\>"W
MD 1-4"F(Q.W20??@@G]^=I'6&>_G0@U^[ZG2,D<:?MH&<%H X+]XEM9R\]E6
M>D#<R;ZY!@:UFIM&T$'9-,9 +&IYZ<IU^+J8"Q"B31#0]DBZ3I'1]*WH+( 5
MZ9_@-@Y+\X-CE,T>,$'L+LP1C*,37FZ>=V,>-%(VFC()]BN[=QX"$K(D&^D<
M+VISS,4( 2L%1%_E$)L"X]T@AXY5#G787NT<BQ74%0.LMQ%VW"]*B:I:1$=/
MBW5N ?K$^M':%&RYO5.J!X,L$,]GV;E/K>-BXTW*UI>U1&,8Q6B'8YCGWQ'6
M_JC>_)_UW6S6TH[A]38U%C'\I@AB$2RTE*7+(9*J:@MW2@2L?\S^MCE,S"1/
M#'YJGS!/F#M9!GK[#=X!/R'(^O,JC$0:L;N^\MJ(7\0:U?!]4Y;RXG#  E4C
MTB68G3WW"+L;?"+Q#I>."?'!*S;A9 JE?<_)4WT\<4KI>UBGZMIY1&>BW02T
M'<.^0WH8]O8$C6SRMJVG4GO&3]Q6X%?B][5H2;%M,R1JE6>Z<'>FL=A7J2O.
M55'@2(ZR%JE,"R: +8L3DK3H^W;6@@R%-?8U6R;LA6$?-+R-N,5?<)44?"D6
MX4@YAG/VLV&#:(HXXBZ3TDG!58L9!W%!NUS>JD>Y[60NH%ZLD0']B!.11V63
M*^@BNN:*Z7OA[8$]FC?R=.FF[[(U*4@:/OQ!]"GQ9+C00]JVQ.D(C)Q<LMT^
M2-5C4@5G4YWMV$?H%QH]@L+S ]&P0-6#4X:15+,D-YV#C$99\=34-A:[8(;F
MW)6*M?Q[B:3@&SC]-$47,/Z2I<M+.MQ < VG]VA/[\N8WWE2H\F/=3#JUL9;
M*-H  BR\T3B.9#>SH6-[S9M\)0@.1IA:P/FEZB.A5/I%ML:]O[_\Y;ZT7]E.
M2GK K&A;ET1/:+,=-Z;FF<[26YZDDT5]>51[_<I-X(+=C0-X?%B.3[]_?F$'
MWW91]M:7.+_9KHU?4PHZC_L<#-"-'J$0*M8OZU+=V-LEZ,QZ-HA$T+TA+]!N
MR5B25F2I%14>AL;-_6&QC@<O-6D*P[R.T-;?Y*$G^_;!*+0)*]V"@7'J?G R
M>Q0G&XJFS_/BQ .;<9;VPH51!$&2 /N1@).L._=YX_:BC);62-W %M%[LL.$
M[/; #/ 4^59T[KW]:]H@F5CD<E7-$\'MQV(?5OZ(*NZ5$Z@L^Y7<]8(^)S)?
M(\PC\\]:PK#B^C]]E]ZN2-DAL'_$$N&77B8+[,W =Y=XW=*]7#/J,.'72^DH
MJ;1&R&R1:U7F:VVU0G[.I*C<;*#'BT%10TG1%UI2=('CD)V*;\QHPJ(U%'B)
M/C ;JYNF'VMU1G==98I80M2H,]"YM!YO/87:;$8^$A6"8#2)"[>!T^)R:?&(
M$UQ$K7(XD0__1L3Y*)O5;;Y 'J5T#9[+79SK9JV<[*1^)C6=B567K9WT3./L
MP1S"LTZ;G B4QCM51FJ8O]V^@GM:;=J.^E!$O*6J43SQGC'E,KI#95##V1W.
M[L<\NV?IV0V(80TG966Q8L2#GCS:\FLCL 0 CHD$YKO0<_;\A>QMM9VX?]-(
M"0E*9D%N:-S>7#+#JLOWY!F>0ER##[J;V5'O.4+=@RU$TG2NAW,UG*O/>ZX>
MWG"N&,V5,_Q@_V2-L@4IB89U*+EW"U<O:+A+M5#QV0CG=W&#PHK JK1+X=8U
M>:&M^ U<+\A( 0YYHT2K]V!&)[KGC ;2]SU6-YC'[)Z2'!A/Z)TT6<*17KKN
MH_0\[S5FC'. ON^Z=EKI/.,DN^@K-"9?> Y7LW%SU]@2M)DLU:-PE;(R!A]
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M16XOCL,X,%<LV"2MD[1^:NV\[-JH4J6PK4-#M$B**7(U$UA9BGWUXNCSC+_
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MPB)'3&OB32:3JQM'N#6OZ0D"EVEH:KO;&/2W+%%C.?@ZL+55I&(-E7'JZNF
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MR1IV,?Q+.GE\C<@("2UU>M4M'ZO0^X154!65:%:;0">LLS?M,E1T#]C%)3
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MO;\I>2S/[!)R-L;;LXY;[U5[)7"TJMZ!78X[7L=U%Z5)-X !,#J@G^@ 9[W
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MPKAYM*R^T]:[4,Q@I&F^.3TX-1TQ:(\.+OYN?\H "<RLGC(3DQGY/,4<I!L
M$]WE'QR?32(SKW(>8N=E>2-59QL3!'RFF1"IF-2Y\W)AM+8//):8Y121J]1Q
M0(>?6&RO*BN9:M)T)*8C\;D\*R BO>2!\8V,CGA&/)G5 CJ?>TD[)[(&,0>4
M,+C7WK>9-! W2B7S0(KO!K(]-3#?B0;F[TW<-S4PW_4&YLFV3+;E3RZ[8B1
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M#)AIG,Y&J$F]Z[\@1**/DAJ-Z;P]JEJ3*OH]]XA>K$%7)K.#CV=LJ#D98^/
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M!&]?O#YZ\MVW[ E<.=/&+D9;MK%D> EN%.P&0EON#&VZ<UXN:6"_,A\P&E7
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M*<A<?"<DTV/^+O/$:->8EA$AK2LW!\MMB^WK'@F;*( L>QIUR,PS.<*[[VF
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MAY=_P9$B_)B5D>FU'3&C()*7\PB[J_B:S4U0X6!R#2U%>,XB*4*E:*'<NRJ
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M/:-1)LOJ*8W)DC&'?$ILNK;O'T5_W2^3.+% 7Z*;F;=LWK+WK:T0"$#]T1)
MLH@*K[E&3G0EU<8U/>]<YD+K8UYQ^$OB7TXPCA1$]" ?4*<P2X09E!@Q;0IY
MA>PS"+WPUD,=: $L%C;N@OZZRAI7@R!\RG&;Y4SREGLPL&/5+)EFL=J/<#HT
M&V9LV3FW76/)?D:/N'?-QC/&:3I3'@,4GDFU!@X/;R*2--HEX7R[J7HXA-HM
MK+CN=IW(W5TF$,JBZA$;K!#P(MM_((75UOEN3L=8]3J^(")A,KW 8<\(QB#1
M#XT_M,3KZ_05>8:G'<,1U=62 ,,W"$I\P_0V+]JF IO![WW=EMV6E8#]5_"'
M0Y#U81QFR#Z^>H.77!CUQFDDJB<YP4[*@_?*#Z-S&ZT/SDJ45%Z[+LT?%!,G
M\THDCH2J$1:\P,M\X4R(;-WO$_Q5GN%J/:_BE%<SB,OCPWB SMT6UI(Z)H+:
M4&:0>'%:F(LJ<,5J1.IP!Y;2*,&1,$ECS"T<UU9FKE@B2BJU6<+>AV=O2I)^
M)XB>NK)(X6$20)=;>*_"5HYRNAO_+W?J1,[7>L(G?KM'Y?&&MJXV:HA4F/>4
M?_@W2IU._G,IK B47F?+\"UW<+5ZBE_FGV0Z+"L=@2^12 [G_C3^ =KJ+/B
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M%EP#&QY9"9O(0I5JW7.=['AR3$&IFFP"Q!YP+/ZCI8Z]OHY0BINZH*6::08
M90#0QP, _2D#@#( Z/<8($JJJ545"V>.DLFI^^>$V)Y4/FB$&,;JSG-Q3#/(
M7M(;Z?R>EW-.:=>LSXNU,$HFL%Q&1X>O^]:1DD^8^"?5Q9]'KJ-8Q(L9ELEB
MRGF@\7XVVH5Q+U,65KD<GWCURRWZ//>>;?97L]E$Z]OG.Y)+46IJ!Q$EFZ<
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M=3;K>]9JF[#&[PDUN&5I@1VE/P$?ZGF%XP$((N.E+CV322+[+ZDI$"+D+$2
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MFH;X5$R9;8M;K_1STKW@BUB!Q%0CQ&, TBR'_()]475>+N*'#6)9D\KPAT@
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M^U2Q$\]J7+LR<8?%ZLWS5X^^_-M?*>[#\ F"2CS"D%&L[=X*%5@/L<AFD).
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M3RI=&]'74)E[(8C"->#SG_NL4ZJK0%@HK$E^W#A^EI(3:<W?/,E0?^%W??"
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M-O%LXO=KXA/:'<]^%E&?695;:H!"SH!*-3Q:)#[9T(AGL\UF^Z!FJP)S]9G
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M@Z)NF*% 8.W#+_E79A$CF!IEVML=MV(?]9'<+/N._$&1..%X1G/";6[:E\;
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M_G[:4B=FJ^D.M_I<G[I\F!X^F>Q"][H2BJ!I3[G'][2QI5/Y 4V8O\NE^VS
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M=Z[/Q]. +X![NR_:8]WW%H]S9]TD?O .%)<@9]#"J4:=LU)Z@[A&HATX 59
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M0[B%*(%]1^W._U-M3G5UV&7<,PB_"*ZQH>DH-D3FB2]'UL)R>RN"X]9:9;U
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MHUEAB@,:.P1@X!GB[)0A[\@C)G5'%6%A7@VZGC;S%!OU#L(4[,-*]YD5+3B
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MB.):0<VW;HAU0SSYAK#.4K_\(]:J2B$#"TORMYWPG%"'.\@G>VT&<HPLOPN
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M:JJ#16-U)U2*&U._-O[3A&;^6EF(C8D=FC]8B$<*S.DOI++70GO0DCM(MB&
M-)'G^;=_]R.9L+)'G6N*:S4#DBC7^&C5,HNT_<-8U3T;&*<CN-/V6S(H)X9/
MS+V$>_S,Q/'CV:V@<;/=T/%,E/%2V%>*4MNWMU79L5MV;(VFSG4WA6/,CUBJ
M_2U4VY2V"*NJEF9,4L4<A.Z.V%XI^V0,MUPSU0=@$(<JSCF#*>8I61B3DIH
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M_*WT8!9X[G,/<J;3V!6.+GRRJ"-7L=NXQ0GA/$T_*'"595@<Y\)E13-+M2;
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M_G/SMT-[':S3-SR)*A3+?U2MV (%.,Y:4@*4C*3,^NSJ< ;7UA%S\)W]F1"
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M#EV[<D:L*_'):[%.-8_DZ\9Z2%J5!7S;)N57IS.[KM!UA;ZWPQJD:4,W;A5
M>UN5A^%V"Y>R/"%V[T\]S?ZZ+M=U^;3KTBC<E6)<5^@=\?J'^X\#T+(0]ZS;
MR.D.'LJUDW%=HD^^1&^"=]F%)5B%C]ICO2TV=RT=W5MBUJF;77CM[B1TJ-EB
M_L*+0:T+=%V@3]:1D#!=;W95O^WJZ[<B]+U:6*>_;2GA7-%VHZ3*V.EA=,4Z
ML 2&$Q6@CN;L#(LIO/ ["']LQT/9%2S80>#BKF:&YC 673 $0NM,5Y94]?Y
M;IOD#9$(Q&_;?7C<S364:QIM19%&0%($AS@M\7I)H246L<-_A"<-8\),WDR=
M;@]ZM?ESUY:[2,*^BP9/UQI+J=R4*G'*(B.7R"ODHN^ A4@Q?NX!(>/":H/]
M4/B& =A1\/R':\>P*@Q.[\>&=%<@2[XS%98X)_OV<&@?Y)9,7K]7!O.:95[F
M7JJ42YQ$+:=WST7J\V'O#:<[?#4^&!H;XM,49YG1HYIJF>JI,E:&S@N[=SE
M>SA2R++@ZDII?VZ/_Y4)2 &H+I05#,GU.T7.[=.OS("NU6U-5 NN3Y%&SP.O
M9;ZW)0E(6D.++"IJI3DG0_!;I+K_FD=\?C!)' /S%@:%>IM!7PA=Z4&H$?D;
M?E.51TI8S^/G9Z<2 &B1E1;$9-AA3 M XEAAZJ00WM"_PT+9',H[DDJCWVC%
M<5DR@5?$#I0R%1F.2H0V!"8GFC6]+$(NI&^#I0DGSZ%O-T?:-N'3UQ6T1$B+
M(U428:TU"(F02MZ0=%S)*\LRI_H2^K78ZM"_9&E*%7]754<FL[FC*E;U;M;J
MQ^(SO,2R^JK:5L?KL&9^_TFQ>?'\Q:<0'KL-I^FGGQ:?OGA1_.'Y'\Z( X4/
M!@!UP^VN-M_;]T8 +*J=+3HBJ<4/9'+"_$E;/PNGV554S6A+.@WE?5D?H-%&
M:P/+M3X>JQW-9CC%QSO1VKE7_>(]JY/Q [/D"E,)7!^JZ/RD>&/JA(W?NA!^
M;"\K;V&/4KTA[CJNALH0W?&6NQN[?J3<*YE.6<(/P;$0%TD4,%2D<6QVTD8H
M^Z!NJ)L#(@&'DCFJEZ^87H7+L_RSQX9WSJJ(/Q;6,=J B2-G&%2B0_ QO>)K
MW%#JM/3;VVHW'EA [OQ@PUQ-1AL??Q>NL/GDTT_C/SY__HF]8;7Y/AJ*E]MA
MW>Q^LW]9=9!8U,-H;BO#1V>Z#)Q"/\%#;EDQQ:OK@<H4$J9BKO?U :RFX=B3
M;=43SPQ/'?IA53@5:XP]^#JJ1'5,^PL9EO1/=;-X78_5P@,(.U,X.^ZKA58R
MZ$OQ>^*J52?BBF'ID4H;J1O*$P;?9DG%RM\9VW^Z64%BUO3\T-AX:GUH)\IU
M*96]O 5#<-'(_BC"#1!^...&7[M9TKV6G/*09A^-0U8W5O*=&(67UV&JKC;?
M4I3U$(=H88#D,?9R;;>RDAG3!16^<R*V +)Q^["O@_GNPT_F#0ZL*0TM!53)
M8DQ<FVB-U\V^E UX4,TR7K:^!N@Z@[?E'04D>@B1Z&BUR_PM4+.*5C)8T,*R
MAHJ<4]B,Q42A%)Y2<_=%PO#*JT3ZD0MZUK#(*L>E1FLN(5JC4KIVX.\T[NS[
M=ELCH8 U'R/S4I>6!,#!:0WFJZ036EZZ2-^S2+>V&Z1S;I!:&]G_8'^Y'I+H
MOPT^43= DRZX_>W$F]\2-0PG!_ .9>S7#L9C&RZL\J<N=]!7PW!0F9;CW:$]
M5:2NVU$=S9B6#,K*@JPL^RJ[ZVQ0OZL/HT8GRY$-3\/94%$CAF6-K;6%]U?1
MPOMB;>']B%IXUPQ;IMT+EZS1.D2PH/1N-]+DYW.H5)+@9*=\MS\&C[$BSA@D
MLG$"XMN%_SJSA(6#$2><?E.\:0EU8G1$78>SCZ"'W])-:TF](-$R.:S@2CH1
M5CC?(F:YYO-^R8(@;WH/:5UQ*?[KVS]_CVAT\U?JW",97?))>O(QS)EB7#2)
MF<Q?WCR2@::SW-V'TQGMI\3L%0Y](:<EO0?":Y,0T,+:,E!VNLA$Y-W[20F$
MFX19%A>B=_I8E-C==B>$_G?!W8=30X-2AB\/T/P=JEZ(:I+'#"_VO7A"GS[_
M5)MVOB^[Z[*I^F??OCF$6.+E%C*Z+YZ_>&&RRM.O1(EEW79$X'YH>Z"*P@O?
M2)F*BSS@QGD3G#9LC"2*$_P[EUW"./$06XO1FY,/3NG#?&YX[Z>O22X4>ZEA
M(5[7G $+,USWQ.AZWPX596H7G@@6P"'UO)@(Y5ENZ&/4\,KM[3@8;HIEH,/6
MN:>U<CB9D )*5S%TH.S9^45)BZ-MPA7\=%N[U$.[.04?GK-"-.>D=F[M W&T
MX(#K;96;SJXX-OI;0&;KX\(UL+RV;1<\V;L6 XGGXDF7]?'-M!;U%:O*ZGB^
M!*E7C6?^J]WG2\U^<.XI,JQ_:[&/V@"WO!96#(M<PU\^N^TY'W['"98P]SR6
ML0 H.HVJQFBXXAJNN^QFQ.WT;=TB7[_ZULF.JYSYMNZVXY'\_FV5UGTXPW.@
MM 4'D&'(PV?A60YUU?G-7^]U25#BW?H][(0\!*-?0:+F0(.&Q1#^R\Y'D?:F
M:D&PC[=54LD,RWJ<+TFPOG>_N:T.R$B&C12<R'#I&AV U9MM"&;[S?_^_/GS
MJ^>;<"(<,(_6"QABE##._S4VU>;WSPO11'^0--'0#H!U-53N#=/3DZ&XKQI^
MEO_]R=6+W_]A<RW75'7QW8@1QQ2&U1!^25,7QF)/?^4:23B3L.Q%<KHD=L9P
MTP>,?-/BG*BZ1Q9(?(FX*I*$OKT,Q[)'N7]#3_[<GCL\!@V:#U 1O+KW&&Z[
MJGJ&U^#E_-C;O/W+N,0^GY9]ZT_+8#0I@7F!08KY:48"A,-\QSE+:HQO)G9Y
M*[E1MW.?_-!$Z:RO_+.L,M0K .M)O=GW[)RMD-=U07\("SI?O/39*[;:7\K1
M\S(V!GX+Y!*!%/[<AGC A04JBSTVPDR/NE!7"_*;MDUP5L*NZ0RH('O)?$UV
M #=2*9YS8Y?@C>NF63?-N]DT')T!+$&!V\5!FF2[/K0 "[#AE^R??X?MM9X[
MZQ9Z:LV=]Y=)6GLSUA7]/@@X?W6IRK4/9&8>_W(?!I$QP ^5R[S\,QR/8=U>
MD-'EU%]8Y8=#\JO+RUR< ^+<3TE9*4DA3HL71]$@86#8L9ID9I8R,MPU\(N-
M\-1W$##JA;:9$[E$OX\E&KX^<,>$U-(8:QF<J=WC-;CKBM.M4NG17-6098FN
M-E_O&9 7[W+9#3")C/( &*NK%.Q3RG>E&"@8<-<@-+FVCA( ,0+RD(LAQ2C]
M*"O@^GR3EA8'M6*BR</E'"GAYX"CGVXF^A7A<PD[%>:P8>"#9FMI&CDP9HAU
MN"9)LT+C)%APRI7&&!AH7,"(Z8,#XX48:-\K@M&^0DG1$Y=]ZGOJ:G Y3@5;
M5B32)K)#A'?T,,T];T-;XKSS+W@X@W-WG(FFA#/M-\X*Y)A!V)<TK1L>9M?>
M#1<-!&7:?U&^=]T),W5U6LF/GRS+U?6_O&'""*ZP_\A&*"^K+X(D3ILJ.2YY
M$O7(7-Z%=J?I)M12@AYJV_*0'%&]P_L2LOH,?(,6MV#U-_K]Z0VEUV9ZGWU:
M0)F"O>>K96$GXC#@(M&+/_B2V;$JZ=H[S5^%R"/LM+&O06NT*TU/K*<>])W6
MOH24&,4H]$[R@:MEM/2.GR1%.BE H0S8AIMU%:'A#B<M>U:[I,!6SIV#%[UH
M6AO\92^Z=C$^LO5Q)-3-=NPZJ=%AG?M]B[\F6.7P20C/R#XKX-?<&<Q&Q/OV
M$\AO82LC]J+2 O!9XUV%",:#7W'BA3_1^8 %5P,ORP5V\I44^=K=D4)T%8*8
M>Z+THB\9O]R*ITI;SJ9S\_ S5P2:&@M_7$=58Q,\M%; >H<#FB_#:R3Q5T[F
M3O15_#E@X++R^+2 ?[M\9)S'B5WI428'8.:C+("VY##QAUTA499\CWRA(UEZ
M?OO@4#4W?6$OC^X8JX=\_Y<OQ087CC >*YG&OQDLYL%/*-LKST@[R,Q@V?@\
ML;4'91"B^=)@P37],,7A?SMJ#,/&"R_#YAU^6>POXR?>;?Z[['?E/[$:R/RK
M)J7K/5NZ7?@^O%:W?-(A;B:.G4>V\'<13 ;K$+[7WYKF.Z$2PO)6:@+C^O.!
M:3I6-LUJ&CZ$K;E9D?F_<F3^[U=D_F\+F?^1. 7*?\I'4"0 ?,2OVOQU[.BT
M ^[LO\9P:KQX_LES/G&^:G>[9W_MRN;UYD?JX_Q^Z$@:X#M*%!QQGR_#@3&&
M0WKSJB.V-B0>*!.C*$EW!0<BWCR$\RK8>DIF ,'5R3GNSI79QQ8X\%P>4GEP
MW$$FT6WZ#'R::]^M'HN6Q'!M:GR@<H[T9CQ$^FYV;DKR9CBG4QKC4E\BW7A7
M)LT-G/ DQ&8?!OP[1%_D=]7]H=3LTK$.Y^=RET)R6+N$;Y\7&$@TMU1/2K)6
M] P,@&6\Q)ZZXIH&[#)E9V'8UZ^^O0IS[*H+:!'LC[P:U*TQ/K0PA?=UUS9V
MAOMOW08C%96S>0XY8"!K?Y_PUF!TJ?K1\<HB=_%0E0@H?"1!$82?"[0TSN:M
MU;'S5_)MFC$,B7P[87Q+XS)JFJJ+2,P')5&J4N>-OA"L.!+^G+^6UX<GJ/)"
M:](JBURMD;9:V&0I0G2:*TR6Q<'%%C0[S-*2^]4S$TY2)Y0)0AW M<,RO#>\
M(#UU,&\:$]$O"53[]>S. UD3OU3D99*=Y>)EV(.P[ZA)]<!)6HXV;%&%FV[#
M0%JO-RI ".TH:[VC35N)?TRVQB](9I+)8WP$@;O*#5$#-C-P5X!()_M3V$^2
M%N8:BN<HX'J17)E2='AX-H;RMO8F_MH"$=_&QM]@%:FS&5_K@TF0XPC*RR79
MNK3I&@,^NUIT'J=,.'@%^H@C43HT(CE.>RUPY0[<HASVTB]!UJR*=758 9T=
M/@]6H/%)#PFJ)RQ>>+!@[TKEX2UYP%6Z 90.86',%<!H&$1^A]<4*(S 0% ?
MA:,EL6B8Z4I#[;'CR0+$2"Q_MF)EL;#5FS]-ME)][!='. ZGU,AD=O#.7/BL
M*UWQPDG4W5>V< $.##?761 E8_Z<$I"$0&<:BK)W9[],U,IU]DBI3 2A83[\
M JV;_6&L$&R3QS#:B<E3?@AK;-B<,NE&Q_;7C@.;C_WF=3!2J)0Q(U\2\9?B
MB3+W!QS4-9/G)NC/,-/_G[TW;6X;R=*%_PJBHNJ.'0&JN4BBY+HS$6Z77>VY
M766'[9J^$V^\40$"20EM$.!@D<S^]?=LN0 $)4K60DI9'URVA"5Q\N39SW,D
M/CY3N0*NQNTI+L'^J,[396^K3K0)<@JO-">I8RWK$Q.Z$"-'/YEN&_TB0;"P
M&6H&DI'X%:7 ;?C?+AGS[)<YIHD<(YY@]4R2!1_O(E2YWZ0;.5Q !,)-)!U(
M=EEQIMA1Z:9S'%Y>U[6PV"@58J /HTN+;2RJKYZFHX?JM;69I+^L09B;4[0Z
MC.8(-9#\>6+BD$2)\@RL&<;M0(B((FX,T$2WK ?= OQR ZI35<J!I(#%_),2
MT]IE<HZCH%*249'7%JW+<AA^"3=IG5N[ A8/#A5EN1$@B[),=>M$,](&?;3E
M46ZG0JU+M=\W@ ?U@OP:HSDI.#7^38>1P<DDY@##$X1\GE@,(<SC5THQ'!*!
ML6 X6=>Y,(0K2GVQ@# !!!?E(H?2TIGKYZ6ULPO_731!=2[=>+4I+B+\23,(
M4:I2V[V5MIM7[Y;8WV3ZR=9:C]&D'$C4K6\T/.\J!#*-P]/+!E4-_C"9U@@\
MQ%8BLP%F\B,B0]MT93VRU,D_ UYC 8NZ#<_8L<E@1S&:LS7"![,5H2L+R"16
MY:)"PIRGL[0644.6A\Y6:Z-W[GZ[ _*'<#A1R>C'RRA-M%G9UBS8EE)RG7WH
MU'LMFLKN(<-L&D2UMKJE-)6@,X-D5G$JN+XVR" '2B Z*[:1L#'@,EHQC1&D
M24E+]L;3%KQVR\OL6F$;OY+*Q,&PEA8.,RZ;$@1SM0Y3X07K-5"SF-G#8BJ7
MY1'K5'#:;":J.VJ*3>>>A!0;8FNSHTWZW#&I>\-*IJD=$<7=&ETO@__C+?KC
M+!]81')D) %S#NEH]LAN"UE^-KO=BI/#/L<J:00B$01BC.$@\VRL$^0P!37<
M-[15O5T]J 8H9@1'?A9A7TY:49M/54M6N!-08J0V?E-.G?5<9P7$4]BDSXW]
MI<[E'@0?>H:=;>1 ?CM]7470A+"-;50)C,J X8FZ :Q)"7&TN_1 -IHP"*)B
M][Q&1WUAS['FW !H]Y%()@>6";V*DN(:3S_CZ#@EJUO3!4%)ILO,0A;_D5-C
MU>>:O ^=9?CCX/-!\.OKUQ]_>"D2M*<X(BK[@C9K(10ZHTX!-*KSDJ!1VRV1
MF#7@<!0#)YC@_%9-O0?P)8*WJL-:(>P^',#<%)8ZE5'MXFIX^#L,DX^&@_]C
M:R@T%NTVWT[!G"@@J/V,O(FJHL7+@K>:M'>%^",B"OQES.&_;;%YUD-KA&:*
MH<]6)[6FQ$V.!"$,SU;R-8E:*I*=+HBI$,]APGE:+@YTI8G*S\"YM&B;<L#0
M0!'_C;X?:V#5I3X@P!MXZ-"^Z1M8V!5$IL8XM0=E.Z;R>097L^L3J;$W' 1S
MDQ^5:ISU/4%63 A]%;UAU.82/F&;0! B$6@3#89L0_"W2+#OHV4T"\M(&)LJ
M4=V(B2Z6TY69.BZB%TRV9E%C$.<234Z4&BT3Q=@PQH8FU1BO-AUCB?23S>[,
M@+=Q:ZS+-L] ULREP@@>Y5@RM]63;.RT<A#6<K(R&4VA3JZCY7,86UD:9IV1
M#B*B-QP^ZG\U]H,SO!Y_T^0F"77;SZ-V%&O):Q @6, <K?C8 !7SDV.I(9/]
M=P5P5ZBM(X9N$VAQ8$1=S@,3PY<N[7GITJ$O77I>I4O/R%'_0*D-4^NQR7@2
M_:@CU@P@C95)%/Q798DRN*#2%I*K\S)JO(/=TU34J:GN-')N4US-H4WM>A;;
M[1^'RM@S7;%G*M'0-"=WA7&]%4?OY(&*YQM(M;44:A>4D<<TIAUMX2Z/7&10
MN8N&"\=$ZPHNC?:3="XIE+PV^J\XPDN;<0FBZB]@:V$7$KD&UR$ ZJ+:R:K3
M@\8PC\99<?FMK6K +[0%V&_?$ EGX(:K"Z6;&E?;D+&XWL\(L>*>LV%H3%(=
M^8#21""*99P,!Z=P8AD'0BAR($"5.GP0<NQZ5H&BKW$XC(DFZ"E&X$__D^U3
M\VW:6>/)P\1P"^4=F-9!9,,_S;$\$NL%,3!N@A)FQ@='EFO30OG/)CDS\1:P
M\Z@6<@ ./X>/>6Y$U&2U1*7P'E+N27&95W0%1;%-)S6.J*#H!DM/RA>#+P..
MRT'PVD1/,+1N&$U>PV"8*(9M#P+B'0 7831#BV JOY("D1"O X)GC1Y[A\ Z
M.D6]5,623_8,5T^0IO5YP6</_?Z2^+/%8E4G_N]\%J^GE[QB-;M,&N)G.Z9^
MP@TUABBD2>R@+J*N]-"R!KHBD.LUO G%V\&8*)P43KJ 'T=?<W::VZ,TW)D,
MZT'\*'<\8Y$TQ;Q',/;/K9#-TPZ@=ORRE11A*1*#'(=J>6>FB8?;H0T&DSO@
MPV:.I*+/#M/4OF+'16Q(@(=K  2;(5V]6=,V:[@TSN4?U*04+]S :A2"76><
M&^<62,IV!X1$]JVN9%GW]EVDC)ME 4PC_Y7FL"Z-85LX>+TF^-8-!6O7W:6=
MT'ZO03YSS ==^H/&0O#7[41YE&6=)[/M(VD6C4#H*B_]"7JUW<5NHPD,[5D=
MZ,"2NQJ*2$OQ>:Y!H[538K[U6NWQ+*VC]W/;.%H[95A7@U9N!X>?.E$\;@5P
M(*#;8<&;98RK*W(F_5I'AQUE-2)O-D<@I3I=SX;$0A'$+\M#"7_J,*24>:Y'
M(O$RX\+8-SC>5[@QS-@SVS349=,FI^U.Q(.'2[&<7IO)NXF]R(]4VF\K=$?&
M>LU+%2!N&PHAW=1CRN.<#A,Q&.NKL$2\-0;K_-CJHZ*JA06CXLBLZ9J<9$3J
MH ARK5A%ZB)$W=W3>]=LE467+/A^41G.VD1TB$M;BHB9E 'Z&'1>^$"UU"AI
M[@:+YRDU:*=ZT=148A_:>\S08+]Y.N]>=ZD9TBF[E710NPA5]T%H'8J:<+&L
M*YU);)6%4OR"ZPC(^%L4%U*2(WU1-J3@S;-.>.\!&$R7GCE=@J:>K*\&5G,9
M2>B;5<3RN$BG$;-3G"Q3(#HEQ9A=PY)]\&8NX"O);K+E]&Z9O>U.6Q6-U-M:
M9P@A7JA6&U>Z2)L%I957!FU,3,F[)[D.370H[.'X/>;F_4@.$P+2/;BS#%M]
MXW,5?]5-N+""N2)0%#IP[5Z7F>J4AJPW)9%!632M\VJ+]+6"T,+EHF"++DM!
MVR1B,YFZ7XNNPB-=P2"BR'"IM8]KUG@09G]\[ADV #X='5QF)\Y+]!T @BM<
M4,-1)3U\\/5G9S+ZV8RUH:)NS[:>;>^7;3F)MA(K"O^!832E:NI></U1;5WI
MI 1"!28<G-HH[SW_>OZ]]_$1U/72MB@X. 5L>5EBWW/.Q7:YG\7@^?&^D>LU
M()N 3%"L.R\0(\@F,A@-M<<$ULT+LQ*G(-9ZJ!T^BBO713+W"6;7O\4@:H$=
MT7D!"XU,(ZV&#\#WZPY;@Z3GI;<_+0\OO7DT*UH?%U&,07)5;0:UT)T-\[1E
M?$3<N"W]-?;J&H=V$OPQUIQ+!%,FC%JTW2CXGZ8HFX5G=\_N#\CN;8P)T[*#
M@6[A;&I@P<RLYTS/F0_H!N9%RSA)*V>$+>:&I=239NS@3 _N>-?FA+<@/.,^
MY*0H>'Y%DYB<$L9^XT$:-FG,.)8B4/J%TXM+%66;D[.<DO&CSSQ#/\0P/T8)
MI&R&,6M9U$JES560)5A@26QMJ^/;D.3W4H&PQ9A8W_JV%ZUO1[[U[2FVOCW+
MTD9N_+#B#Q4_7$\EI 8$3U?99='*J4<!&8LS!U6@:Z=ZX,"E0N6*VA3==.Y(
M8 <)E+$A#9ZK[LXRL$HI1P"I?I6*5ABJK%UY39%$*D3I4P<R66^V@@\D.\F,
M+[HMBMRS9*16@[PS&9%[W@U<H&E$(U@5AI;DFBD#'L+XW;:-IZV;=57M>#C1
MNMY47?W*""_!&T<K_SVZU"48.@]"H"T4Y<54<T"]2"F.XM/X&B.$JES'D.1:
M"S$B"$U9XXLPBL8LM8 J#0>0(PV+3DLME9+!W8RD@HM/A S4NF=+KFS%E71$
MXFJII+!D&MYHM6'0Y!+,4P+P:-<LLS4K,Z>5:Y+Q+,1E.E.)U"5[?F_-1<I7
MEC-O;32&5]:WP1:U*@I)^IT+XEL_>B86\)?EIE)!%W"7FB676'S=Y&@^ZZFA
MZR6F?=5]C":W6:HZ<!$\,M"B<SJ2O#,5%;^S(\G[9IGZ8NI;5;<*4W$W#0'3
MR.1#+#OE\6Q4!5]D>OA%C*V1C&,NVZYOJ5=+WG==(&J:D%3"F(X.<J),7[-%
M;^V4W#H6=/<:#;/B8MEI.%%3NXK=J%Q9;9>+[E!3J\K(9.$F%P'<0!5COD]C
M[?AZZ1MPE!NR-YJ&VC"HH(!462E FP4E:C-J5:D-;W$?Q1OD0V2J-^>8$B[-
MH.DU6\'T*UW+L!AVI=5R2786I0O6S"_2E]S@KFBF'$FX6#=26DXV:6:=;U/G
M438/X7:Y7VY"7+-2EVCC6W"YZ,UA_\B<F$O_8B8XW&$P3Y,&.!8^-&DP+W?)
M1T0FKKB5_-CI590X_*:7=5LX44ADR^KMLP;+OF[=49F2";QLRJHAF*B";F@I
MN^W,KMO%4?3,T2LX[H53IGXNK4]+A)9EG7H!9RBA3"<<:6PFBI41'6CK%_.7
M ;' Q36T8'>C6C-)3:^51OQ.BK@N$>7(#"/2Q'E'K&@Z7/18(AZ(L.DJV]!G
M1C7S*.FF<L6NV2N+.@'F<<,M1]1=5JQC45Q1C"_4G?.4IAN>:SJ*;H9C\T&?
MJX08AD#/< "%:"!AK#;P(M@86YYU^(XBN] 0;-2>AQUS[7WE+L[R%K346_M.
M5K]Q9UNNT'6LW,IWTCEC6Y]8MT:6%;1=,?!LVP5[ _ISB27AV;@K5YAE*1H
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MI7!#FQ1.B&@XBKM2;.SE6"=M0#OM*0'NWCR>$V'#R2B<X#54M&E42V?7-L2
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MBN$H[NIMT-B0X][GH9C@5=ACLH8ME$CSRC!P<"P$$<U<2F;X$J[3Y1L:+4^
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M[ %/;18S,$>RR/Z8])-$&; ?U0'I!NW3LT,.W?2320.:8GG:K\K=L /":W6
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M2)^WRD4O5)Y(RX0^4U'K CZFB7V KCUEH?V%05>RFHM9J>: )W$46Q][*N$
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M.\;,,;##)[.5+0+6@QC-O,"+*,WXB14M6% ,8IHUF1 <%8ZUX"^BKG_MZVP
M<-V%?=]X"AY&.4_^)("J/RESI=#(VFT=/3D UW^G533"?7VTU/2J^JIY[0X
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M<RAOK+B;!1$>;0^-Q WJM,:DJZZG<09ZZ5I^VNOKF!&)!3_& ="Q2S#!C-#
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MBYO)]XE/EU<UZ_,W;@(&S4F?+@8T_* JS&"J#4BQ6P K.R7!=PFQW-N241G
M:=T_>A"\G^._YU&:&5"U/KQI>:18A3U/IKF)J%.R%:91<@SLE-1F-Q/[?KT7
MBD"ZL3:ZKW&OV$ _;9AJU2')V/YIZ/A;9^*WU%<%ES0Q>:;<J<A10K,&\6\T
M>0[T@CM6I'+FBEPH'BQ"ECD66-*X9V,>]T#J;]!Z>NR@VTK05E&LXO102&=4
M=5?3=3.3O9I.FU=Q WX!,$W7:/<5CGM7X7CL*QR?687C'EI[MS1@/IA&L;?2
MI^5MF7;#7T\K'86O*M+8+]*75X SNJUO+U*X](KR-'WQ'D5Y'L*^=DC[BR6M
M9](--.IG/^[/-/FW#(?4 O_:JDM)#DMJ>8WC#X+K7Z(/A6TB@H>RQ4(W-9@\
M+6)I0*ZX^9*G4>AU;:X!\Q-,MA57UPLC*[V^:\B"T 2_'RD\/OGIY^>*=S ]
M&H^F)\>'I^/)]' Z/O+@![_PN:=S[A226(;[#E0-E_%.#X;'1\^7\4Y/3L?3
MD^'1T?3H<#0\O3.^.ST^'.\EWW5+;8TTU)5'PI$ML $0C5*<NE%XLL)R A!H
M]TF=#O5Z<$C(?;U3&&4+J>9*]WCKQ"&6$J6)'JK3J3]6I6,[6L0[CN#;I,&F
M:FEJ1<%81J0[D#@)V5OUO'6=M8N=R\_;HJ\%HVWXH)DZC[)YV+4 J,,CSZ4,
M@SY/VCTPFF6C34Z]F:VR[D#T]ZSU;B "O>#Q@F<C6K_FN.T$#;._<\C6&JZL
MS.!KUZ2$.70;&A0^M1H4UD153Q,"17+5M1)IF\-KGGZC4WQGP%O>-O6VZ<:C
MNN:(>@/5ZXD',U"C55EDV<!"L;49$/.A44D6S4SE:IZ*X49@(3)Z&<,VX,IS
M(A)C)VJQS(H52FYJF661O(51=B<HG)[;/;=OQ$#<SK%J6SO7-81NFKG%M@MU
MK[/7HSO@]5F[T]E<GNT]VV]B>S"5J:C"2'ER3K'!7:TS/+;;JK^45'A)^)N8
MZM4W6A3&M6=BC=ZYBA(];PG=WI1U@MQU+^:TYW7/ZZUA-XSHV>7JOG&2&/]!
M9 <<T%@M048790O@TP:+J!)'X^BO]! (>,$&=]*=8.+<9W#COFA/>.U@>:#;
M*X9]XW0#:CB\.BPJ%7I<'TS_Y*@'_'!%M5$Z4G 0O*$;2$=+;?>&<&%4MMH-
M3>\)T$9=1%ECJO!,LR1"\MCR.OFM%'_%01U57ZN@J1A.QG(+?5%41ZWZK:9"
M\"=DUPN5)X4$8=VHJ38YY*[2)R+;S8"M>?"(NN. 35S#36[MGQLM"VVG !J(
M7W&+0'Z>4?>/\YB#X&^ZFA\NE:)2O@/?OIZ&1BXP83O#,,!Q*;"!BB,$UV"\
M(+X>61/4+7I<B')<%L!X"S0WEXR)^4\5L]-&C<)8?!G2/;B."D&6X-V(/H_:
MEPH3]Z,X_GDRLM--%@J:,#=V117X'C,<N@%Z?4&XH67P-2\N22+E$8\OXC8Y
M-M'TA8;O6'CI":Y<-RQP2+G"FN2H7%U3,2QYCROK?T-N/]L*2@;7</6\6:W7
M::4@V)$2J@.XAH7*LZK(FAH/8)9%I<6@6:_CUCC-A<R[Q=D[A!VS913#-3$<
M[+--TTH0B6H#$%ER08TNU.Z$CRQ9P%0=":.1I6?J+,VO#.+S=311J&=SI!GI
MBC+RK<95, _PJTC3.H4_G:8?T&#D%/<,FL?O<-&VKYLXS)U6A)I8:61@C7I'
M)\!PL%FN>>35)>MI10<D8\P\/'D#<NCM2;JB;'\SS!P\]CP].X?'-KD8'_@-
M*?TF8;ZCA3<+519@ I1I)7A2Y@8V33I$=7BNC]\6<OI8>Z$B*)H:NU\M''!>
MET7F6L\,_*M?NO*E.CX=<F\JSNGF=N$BN^4,+>"R!PHG>U[UO+K&JR"?9S0D
M$M%7BZ6ZDE'%K"?=F(!EGRA!2J\:Y=G5L^L]Q\;:_75Z'C1K?9F!L]'.,JQ+
M%D]A$7AIRB16CGD&]@S\0#/,V#I@&WU9IC1*)YJKFER7>9HI-H7?__[+0*%;
M3)ELJ;WS7.JY]*&L @SYI@;2/*I3U9KRI:>7=>8]7L^AOE5W/UIUI[Y5]PFU
MZGH5X57$W:D(ZH$L&9K<9BB[RH B=!++5(DW7CQGWG-!*($"UCSY CF0LT.>
M\3SCW2_C.0D4S7\JQ]ID&=E@4RT\EE%2^.&&+%>&(,]!4M(\5^PFX]E'E-,3
MF$_,AWB^]GQ]_ZK>X>UV/5!7V5/4@B,9.,4E4Z6.UU'&'DLVH]@$.20KBQ8"
M5M]7V!)5<(X>W_K'P>>#X%U1<+WG+V5S%KQV,#Y@!2_P,BE*>_?+:]N?];9!
MX'8@WF\J26.<+Q:\/E-Y;&O8WO[F7"YI8UU[M\"B$DJH%R7X%^VT:E.?%Z7/
MS_BS]^"1&#EC,J"+83YZ$OZ>+3U;/E2*.[0XX51B7"XJC;O87Z"#4)41=J?&
M)&"]8/4<O .91)L+[,S%= 9S>J;T3'G_8M4%"&\#V%K.+$K/C)X9'S)5;?&:
MKY@WB5[4(OIZQ4!C:?9HH5]X3O:<?,^!.:=UAHK9SH$W:;8UMGSF"ZX:(CM4
M=S Y9NE9DR8HC3V?>CZ]?_6?+I:$'<::?X;]=5@[3--^RV9IL,0ZL[P9MA[\
MITKI-ICV!'F2P9?GX'SA.*6B_.K9V;/S/;M8U)%",0)=J$G_2-0<9\U+>;S"
MWM&8>CVBFIH6[3Q/#L?VSN.4F9V>BST7WR\79U&3QUT;F&>L;&R-HODH'//"
MUOS+<T6,'&4XUZXH&=_-#3.0="9N]Y!MGJL?@*L=@8SS+#FK3-W7L5K6%)GM
ME"-;9(!N'^ <6+FXI"=)F-=C0/2V/H-!1ZZ',@@/15.#5#&!'J9Q9>=Z8N,F
M3OU98"8S:F$ \)-, 2XWTG-[)VU%SW2Z[0#@@W<(@/8MPBPO"3*\]=TOK\/@
M[6^O;Y,H78')62H>,D2)*X2#V-SD&\S4JJ!"B8)P GCX$[9"QRF:"*:ENY4&
M8R+T9J:[(Z'6/YKRORD-E<).WS)5&'USJ9TH.,.5'J7=7;$TN_94?<!S-:(O
M]K=7/,U43W(R7X 1Z&\T0ZOEJ]JN8CL/JE05+"%69K>5GKMU_>=39_H"IRHB
MG,-U4ZZN;G+W0S7LR?[5&4+RNC6$Q(_5Z*?2AE$M_3,O3$M]%^1Q#42<U)K*
M*7C.8]0R&:K<ZT2$0:;.D-M5&_0@+LIE08/;%E%=$T)O"Q_/8OK2.>%A(-Q,
MW^"1Q;]9R+PPJ*-OM!Q&8:"D?2:.NX;0PV;UJBEIY?)U>K2-78T%+\.GO?_2
M@D-;PS-CZB"X!HF@R[12K<:-:R$I#H*/_90W\,OKV)KA]>":)% ,2@)-HU5Q
M@WP@^Q&*N.,]=,E[W@#+61'H@I1W.&H.5CM1V.,(]>!0N<@D6TQ0NF]L$GDN
MK@8!^'BV3@<^PX3"SLKBLCXG548SE1W+0!L+>KE-:1Z>N!@>9GRPUF]V0 _]
M<MG,0 &P>9.OKD-A([V;$K\:4ZML]!!.&U@V #6?W[[AT$?/PTB F'/@J&9G
M*G#;LG--^>Y2U#<Q$]%3U!$7?+U8'I2?"66H4%$ZL(JE(X^ )1=I(S&9'AE&
M,L&/9=S[7J\3W^OUA'J]=M@B?XRQC&0DO,_1W0[AF1L'WNVS&7Y+VKQ',83P
M8$P>[[/TD"8ETFC_I-(N!?T.K.B<P30I.!!5YR']&:"2!6]:Z6%!\-%?E437
MP.3E6L<@X4H*B_CI?>L-!S=X(3-57[:.\&XN_&YP'Y_(.?H@F3S>165V,5>U
M/5,MI[\3*9U':1D@3JU%>>N>L'.5D5^[@(6LY*P1/#+"'".F*!Q0-"2+"D=R
M\D/FZ3=TGZM*R1'5<4Q&DXE7"'0*SBM/XCDCK)F2GK9'A_01U.U?.1P0O/B(
M>+X8-GE)3J&<XR_1-S\7N>.74Q-4,_LG.>=N#.J//$5G[W/-V1:5&'>]PA_I
M4U5'W\@?.P@^<,26Z1Z\D- ,;X"]V,&$+B4BA*&6,K'NXVL3>L&WYTE4)L&;
M(J'X-+=?22_5Z\]O="]5,#T<AL%NBV;GNS8QY2XPA09H%DQL#JM@]00-">,M
M9 !NS ZA#".NR%+3<H?A_"CF8(DM<8\""_B-V,V7'&M#Z0;6#.*3BW1$Z>R^
M3P0E/8ZD=D)9;6#&BRC-R*Y1N%)X7!C D8.EDY-VP9&\7)U%'.:S 9594U.(
M,DL7J8-J?YYBC('R%S8VPS$;1L6GK!E+8HYEQ@3QQ8CI8'XUBX:]0KI$N1>M
MP%[#^0\@Z4&'$'9]1+M1!2_X8E!,$JW"0X6?I347_OZEQ#B=3 TBFW: 35=N
M5$>_2R*60#L)PW):;HW"!MYZ 3<";;XBOG4-&I&QMPM.'@'7_VM?P*Z?EE;<
M=HPXLBL>I@^F4L\K/4N@+Q0AUL4#VB_B<098#\.@R9J&3K6C#B_320X4#L (
M?H'#37V2DU$8C(?C0SII\)=)%^GW=C1_*@$BI("0>KU.B )V[4@M?@Q>/LBB
M5='()?RFD^'!\"=].14T+2OU2B/R:YI0H1[?]@.^'5YO8HEHHK"N>J7OEXO@
MJJ1=37,T/3B<3G]RHWSRF1SF^\N&^T8'D]/36]QVBUN&!]/I\<.\RG_43G[4
M__Y+77:97*+6J.9F4?SUK 3;,QF(T)W3?VX]&H?*\0?]HGA=M'37VHZC#T=I
M_O,%6"5H3<F-+*?6,BD859<?E1)II[O[0^@G=R0@OR\-LJ;&;VRGP)XE3Y.&
MFZEVV^2"2RG8(?S-O_]P_,-=4,VD;'16;UD'59&E2:"98&?H>K^\^=]DU;Q=
MLVKNDV7WB/CWR]3W2TN6]L/)<Z&F$1'CYR8B]IE+GPTMO;6V'QK16VM>%.\J
M;V*HR<OIO==YWC)[+EQZ[^)@XL6!%P=[1DTO#NY''+RA*B8O$![-CZ-4VKHC
M%\/AGL<;'+FM?+3>C^GL&ES^G1['O68AMV7]+;/=%RIO;L/JVU#R3MRW1TKI
MWJ^V<]^;%_M)NS8C;D^T'W>#VWH%WWW2D-Y^KZ=Y% ZG1\^4&Q_XT'J1]QR9
MS(N\G1-Y1Z-GRHM>X'F!YP7>LQ-XI[=*7#P%7GR<F,/-D\>W218_IYC#!],:
M8J T7G"GQLM7.Y(RWF-]=,<QX1T6JSN?J?"T\X?5']9]9CA/.W]8_6'=$X9[
MXK1[C'2IVVMY!.^XS_2IV]&([W+?/7RH%L\[3J[V0W7N1FSDR<EG'_W8O7#O
M;LCD.SW5QT?A9#+U7+A'7.A%W5[1;C^9[ F*NLE1>#H]]5RX1USH1=U>T6X_
MF>P)BKKQ:3@Y.O%<N"N951^>N/?PQ.;)+KLA9;PJVRO:>56V(ZIL=!P>'?NJ
MR'WB0B_J]HIV^\ED3U#4G8;3\=@SX1XQH9=T>T6[_62R)RCICL.3B8_$^NJ)
M9Q2>H+$M.4XKI>DQ</' #E0FQ/W=D#9>I3T\Y,7.RYM[9<-;DO()JD6<7S,:
M>U9^BJQ\&S0G+W4]JWJI>]]2]\7A-#P>/S32R/ZP\FV[IE_N$D][\?NL>-:+
MW[T1OU[Z[F"XZ&ZK6<;#!XP7T<OV/V#TI:A;@R?7T 5\N,AKSAV5-UYS/HCF
M/!F%)Z</7>7I.=F[*U[H>E9]KD+WQ2A\>-"R_>%D'RSRTG??>-9+W[V1OB>3
M\.3!:R2?%R?[01:/'_QY\?>BJEX&'.D)YF6QT)&@(J]\X,=KP1V5'5X+/HP/
M<C($-7B;&6_/@Y6]$^+%[[[QK!>_>R-^QX\PF,@SLI>Y7N9Z5GVN,O?%R=@G
M.Q_*Y/5S11X_!/2A/E>E1(#"(%>UGR;B,<^WEKT>\_RYT<X?5L]P_K#N">W\
M8?4,YP^KGR9RF_Z&IX&'\1Z94%6U>#@^I[U' ;Y=H=W.A^]V6!3?;556>#SR
M,T3VB0F]I-LKVNTGDSU!23<.IR?'G@GWB F]I-LKVNTGDSU!27<4GDP\[/K^
M8B[XD,3M,JXO!&CAI9M[W0TIXU79$RO:V'EEY^N/3/W1Z="SL2^W]Z+WB?"L
M%[U[(WI'7O(^12[V M>SZIZPZC,3N"]&0R]R=[30_F[K5CPPYZV!.;OE^3Y$
MY-6F5YO/66V>A$?CAZZ"\8SL714O<SVK/E>9.PZGIP]=C^,9V<M<+W,]JSY7
MF7L43A^\,NAY,?)CU YY",ZK(#AG:EZ4*EB6Q45:I44>P#_U[^KHF_*@G/ND
M%G>%=CNO])Z+2GLQ'8?C!W<D=H4-]Z=^9U<HYH6>%WI[+_0.PY.IK_#?)R;T
MDFZO:+>?3/8$)=V+Z30<'3_7#O6]KUCQH8D.._]5Y0I^]-+'(YZ&PGI>T4T?
MIG\8I7?HX9*?0,C#IT@]SWK9NV>R]_C4)TB?(AM[B>M9=4]8]9E)W%$X.CGU
MC.R+4G8M'G&G7/Z[JH,7F5.8XL,\>ZOXQ@=C%!A)T<PRM7,2X[8.\H^/K -O
M0-4GJ 5?3$?A])'#/D^3KQ\[\-.AJG=$/-]Z>;SS\O@0O)+'A5+8;:[>,P?;
M"^'GS:Y>".^C$'XQ/0I/I]XH?N *(?A_!!]+?S4?Y,*_'!X<328_/10&S&8F
MLN^^ZG7?(49;%-C\N2?7K."> D^7',.;%5ER8WK0JUZE-:PBO@&%/JD+E3=J
M$XENQ"3'CT.UNV::#TT95*J\2&,5E$R>H)@'/XX.1@$\.L,:KRA/@A^'!V/S
M RSZJL]5L%)1&2@@6!+\HF*UF*DRF(S"8#P<'])=\)=)",^MEBJNTPN5K<+@
M,JJ",Y6K,JKAOGE9+/ ">%)\'D1X55JG\#%+5<)K%G@)O.V_0/RI;T&:![#T
M'!\&R[A,ZW-:A_Q6?T=T5BJU@.\[T#N]"Y0..FR7I!=!G$55A2K@3 U$<.-2
MX%G 'GB!K/E?Q);?7@TF/\\S]6V0I"73X!5\3;/(?T[2:IE%JU?XVS6M<' $
MXAV7)6%S_L$_FZI.YRN]0KIU )OY\[*H4GIVJ;((=PUTRC<D!WZB42_?ME08
MH_'M#XJU!'9A T?#=J(']D?^Q.T\-\D)^: TS](<5E9'9?TJ:NKBY_8O@-3\
M8]Y]RE!$<_C>5U%V&:VJGW_XB^&37E,!-]%AC+4-OMM]?"I*T>[8-LS[?'3C
MAR5*9+@L>,N#"*K@Q7O*];R\N4EQ,^5XK/'Y'E0]WMJ&T+HJ1ZT'.JU8HJYY
M!*/B<>BV'5@A:.5YD67%)7(4&>1!U2Q@_?"B*BC ZBA=0B:6D('2_*?-#.#,
MM$@JT/X)N$!H-<Q6 :M NKG)(W@3_R8NJAHX%PR%^KQH*OAU]?+5G>S-4Q&
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M 9J4\'_X8$4.WKRIFU+!][8O742K8)XU<=U@]-A);H+^I:S@4I5I0<3COX7
MEDM8(\5P<WI-G7*"($\XY QR"%Y5Z6A:?UA[8ZSJ1I+J>[RV71)5>)Y3#+MC
M\A1)3\RF\PDVIFZ-H_J\+)JS<]J M*H:X_K#0ZD."S<=CL<"?EF4*TQH2[B@
M?8&:*Q(@\/+X*^<:%@6&%Q1ZM=DJ-&^B _D!I)C)>N-OMXQ[[J^($(,2/[)E
M4?+R[//N691$-3T\AG-+1X_?)<'G)1@"YQ@OBLY*I2CY<Z>BYWTW6W>I2#-F
MJA8>!<X(<1G(B"2@V!B_9.:4Q%D%QA$IN3-8YAD*'/@,5[$%U7E4:C9>+/ '
MR);!"RK.J3"/"[\:7W\#O<E=#GYC@Q]]6<*9+JM_ U&ERCCE#"W\-L5SIC-9
MEIZVPH/?])(#=/8+D"& Q6*E$F?79JN@D;(*?#-F/,D F0R=0"&<-HRC@$!-
M0 #C3I@5XC^H5*71L3K\/" EYRPITT;A[&(.YQ>OYB3=,EJ1M.?W4TU7RVY8
MLT#:!LB/A^.A8R$)[X5KT<-P<_@PM#L_4UD*!RRXA,?!/X*JP<1HJGA'YDV^
M)M[H0\4%<%0)T!7>71)C5UQH NR:4='.R7YX=L]5JTDI%1FKF  &?AU(H!I.
ME(+#$Y5EE)_)WC)3U^<1EP(AP19LD=#1-.*-LLN)JN(RG;&0_!WT6W""C(4W
M4J4$%D4825O5<%HU V&E'Q8C9I6Z/,=ZD!0MF;0*7N=Y0^XGE@SX=-I5F_L&
M9<*[K+CTX3:W'YW,;EWD(,*Q6:#1]B_44\";)$SG2#ACT+!IC9R9I%PG^X(X
MLF@J$(G5RU=W0N*G$AI'"@AE6YD,0JRD5$4[1X4?@Y</LFA5-'()OVDZ/!C^
MI"\'GLFB9:5>50I\?M@&31-N0:#;?N@"/F#\<T8U0J_T_3U(#ORVX^.#T]/)
M3VY^0SZ3$QQ_V7#?Z.!X?(N[;G$+6"<GDZ'][S;/>.[?=P4LR,G-44%ZS]GZ
MV=RB8><^P"M.[DC"?%\&=4W[W=A6V[;I:?]H>+]=C[!#^)M__^'XAR=%M?OE
MO/^FPI"W:]ZV9\A[@F/R<G>'N-_+W3N4NV,C=\6(E9J;C<!KMR'JG<*Z[3/K
M8K#L.N[U^_!@8 N;2+T&/7''Q+X-M,4^D]M+F\>2-M>.S?;[\%@VY;W->O$0
MG^W=^5W5'#-M*@[U2\((2PY,.8%'^-PC5*-=H=W^(!8]%S2B%\?3\'#Z7"?.
MWI8?7WI^] +1"\0=8<"[%8B3DW!ZO1O@^?%Z@>CA^G?(EG\AQOQ++)Z[2!.N
MF>.V56_9>T6V Z"-7G_=A?X"ZH9'IP\-,+HK?.@M>F_1>T&XIWQWMSC+XW T
M?N@9B$^)"WTH?H?,=]=HEQI[;[3OJZYZ7E/[_/C)AYGN,IV&TY.19^4GR,I7
MU[_L!C-[0>RYUPMB>/+T,#P:/W1&]7EQLL\L[(9KTH+$[FU<U[,_ZC*--3RF
M]U7V5D7N]N2H_<FF^X%H#GSJX6DX'3UTQGV?^'K/C+\;S:7<#8;VDME+9B^9
MN]0_FH:G(S\P^&%\&3^J\H;0/T]V*@UZ5@3V\X?T7WPP_1>O^Q(^SQX#:*N&
M%9GO.77PN+>:&\'X<_E6K]@*X=89,5&X@+D('N?BY1I@-\3HCD!Z$E!E,9\C
M[.)LQ3/,#@]&+83<(A_0,N-SV#I94:)P&&<JB%XXS&Q1P./^%3% +0'X#68T
MR LQ!E5>R6_,T^S'9N3NFX&1B4:SM%#D>EQ:J6I9%+Q]D3:+*GAA$/9>(D+C
M!C@[GK[%(\+6X'_AN_(SU=D Q'3D2$.61H0-Y/%.;W]$)B<W',R',Y;NZGA,
M>N=%M1$^73Z/$AQ70@"<#J;H5AB@F\Z4/I3]J*-Z<-[$@6U\\(,GDTG7SIXY
M/'QZ3N_N]/BA-'LWE*:="O9#:?;1%-Z+H30/:!&_^$-W,7QT"J+>FRZ&=?MX
M%\[BW8#4/E5CO:\'A4<P' ][L,BWM:U_'(\F[>&V&F2:GMYK?.K1<J.-MRU+
MU)PR/ 7S7#)QN\^88.SO6*7+6L.',Q1X2C/OQ^[':>#JJ^#9@58M7/%%5..Z
M5T2L26>:<>_W>9OXVN+*C=PX=MEB:TO6,*.+-V_@R[?9]G[> B8]O2&3[A&Z
M\@-J%%>/O#.%M3[.\EW5R.)(3J<WG/[C.)+7OF)K?; VWZP]%$#[1NN'4D_Y
MT'-56@,/TMR,5O]_['UI=]O(E>A?P7&F9^QY!(U]L:9SCKQEG+AM/<M)WGS2
M*0 %"VF2X "@)/:O?_?>*BQ<M)H2 :JR6!*)I>K6W5<2&KZS:6Y=0^<T]7OM
MV:>\P$V]U=YUAH6<-,-"3O&=JO'^H5 &(,MV+^0=/"R[((QK!O\]6YSMGP3<
MPWR!CS2P2ONX$+.FOG5&@/S,(>YA)\K>6AO*)R@=1]00\8I1:>4U0V%&'<;0
M#&<2#L<+/LE)EUR9.S86FA39<\A\6M^B=%>6^+)L"INM!-_J##&#Y5R>\QF.
MKYDS^J9U<V(P &?\I!,>RP&C-)*I]6+BPA=563&!LRR6 WSD6)X1!2)P&E*S
M$MP( 'S.LO9#919U$>8MC]FB&=.DS1937N0+.(>L_%W ;P%"H*C D!4V<UGF
MZ.0&*%]FU7F#,Z,5A*E'*N$,*-BS\(&3L7+.BBGL:D'I 2A_<#A322.26(%#
MI.HH -IE4QP!A<OB5X!-Z%"'\UX;?(?#F>1,H^X<(S&*3XSE([S'"U<&'='<
M)#%M3\2G9B!BX35Y <L10VS@GI$6+2H:LC,!%!81A_5Y(1UW.5PQU2=96>E\
M0N^AHX.5OEASP=(T#< R*_AEU4.^QI.VNL+)<7M$R*3C&\LW&%= U^T&VK7G
MCBCM_](?/'3&OFN9?N YH67[CF^YOW0SMG_G? [KG#30D;YI M(-4$&_:F!9
M7N-8[3BIY8@)P_AE[:E]H4;2P&+ [)'DF",Q8(^736[U8E*1V4_155#$EG@)
MCV$71%$=*AQI$Q;E0",XH+"J_1Q(F?7%50'4*73(G 0'42/0$Y!+ K17MM[I
MU8B"PGB%\;O#^$9<DR=SMD N+&8G;L=*0MAU)":;92:DO=!MZ#+A&27,GZ,Q
MA8ZV;<))8;K"]*? =/QC98 GQ9'%U$6:<$4<F\8U(E>F@7TK,_Q(Z\)@JQR<
M69UG12*\QIRF4U/T5&C[!=TN18)B\0KQ>\'B!8LFY2;-)K52 IB)H2MBU7-&
M9 (X-I&S*4$EQUA:)>-I%.J8 7^/:RD!W_$)6HX+85:(D BE#)=- HVP K9>
MJM<)18#SV511A:**IZ0*1-"4;S&O\:J.IL]B,&!%Z@R*!T2N+*8<,9S7W0J%
M+3H3^HEY?#Z#[?[(%-M7"/[8"$Z#@L7L3NG/81%@TXKRLJ[Q@,[.+N!/\@'Q
M8HJ>F!2'LR/P%,8JC'TZEBQ]A91A7,88%5L(%;HV/$=PR8_%1+A7Q,#VKND:
MLWF37ZM05Z'NT^K8TO&]Z8-O0\>"M<Z6'6=WRZ3Q#PP%D]XM/2BC-0PGK3HK
M1?(^/KN+\B/ROHB9]#>Y<1H[F'+G+O@6A\T1ODE1D**@1Z6@@E_PV8*W5"$1
M,A&Y$2TE";JX'JU'6GF>+R;)+<A_/;Z/K\'UYQVH_"<7$;L9AR/IJ) 8VZ/@
M]I3SJ@UL,W&E,*VV!0BW.9%'TN%VIT"X*+^)%B4@<5FNAC\;)CO6?C; 2A;@
M74*KUV'CS9%5$5,E=*[[^[3PRA<5$*I8Y5J<7P)A8[FD(2V*HEXJ@UW%V5RZ
M5B2TRPK$C2H[.H"RH]66RZKLZ$#*CIZEA/D[L"K@30O@^\ @A28 C+>@O"3@
MHL!4M1]\AFR0PV41)B)AJG[#=1L5XE(HXS%%>D3:)E_+NP+F"V+@!X@8Y.81
M7%/S<9115.:1<E2S2\RLB:HV^Q,^6'6;8&TIKNE'%J.?),.WE=(B;53W%44=
M))_P&Y+:T8DNC;7ON=8-5)VSBI1SEF$=:L=Q(R5$O8MN64.] <RA;E-%:1/=
MRF]^E8F4!$JQ/L\G0'TE*I"F?Z3EEP!G,$/FY*W'EG(R82="?^AD >)DU)3&
MD*=("MARI<)GRI;2NN&P8UA7PFH "$D_IP163A"CS;($5@P*/9CT< !Q=?,R
MZ_A"N9(N+B\::^]7#J[.1I,9LQ),S=="\[Q@V40DLXFU7^034!+9CX)+M856
M6>\)_<)P.WQ,V4D4#"F:#GQU;*3CA:O8[P @0,TL16R):P1"I&<8/D3936MM
MSQI/#I?SNTBZ:SS0Y%.N$6%%*:!J:)#D]"1@+ADPD@3@\2G=BDQ2A9.H=!?D
M[@;V[XK;M3K5"9<2I2*<S]D%J48%6G*XP7,-%/$%:4SRC&4#AZX/?52;V9+P
M<:F<H=.R42 I>X=-:<7;E#/X&+Z?57+-G'R@ I_IH'%QF'P&:-_QC.;:HH'F
MJFYW"VQ;TESC*=<%FS%9$_5H)#<)JXBO^,82$*5@+1'^X<9ABUP$&XHI<C7!
M^-HTP1H*79TV+ZYW6/ 4%/6J"ZKV0.K(=LOKMEE:-1.[)*N,=GF)4!*D>,US
M8-' !2Y4NNB&%78.U)87J,=/:N[%U[.*.TG%70E1UQ00L^X*!SBU*7R)GE3
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M5$)O:QHU AP:1Z80B_\ '9]?$1'#8LLLH>"K>#3< (0.3YYA;!$=4=+Z(:$
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MS0>TK0GXI"E,6=2ABAL VCED>6 =.0MJT203P9>J[K<-2@2V3A4-H+5)#NI
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M3LK'"PUGT70"J1TREYQ<CI3AN(BF6=5Q+7;MHE$]0*A(9,X59G;AK^5BB@G
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MH;:ZBO[\)B<9=.PMN 1+-I7K?3?V\.'0LEU3[9DPXD'9 )3KN:_*'A-!])J
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MWPD33&&/="=P73WDCH']S>,@-4(CC1Z!G]\C$<-X2#J:%QNFP5)8EV''NI/
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MCCWB?@'-R3:P++>CTDN=#<T?4E*V6F(T_3R*7\_B-'O,Z*?E$JF?7_1D0'[
MPMSQD%J/]:7W []@.W!6<-8A V[/;;?KBAS0 N(Q0]I-M+4_:=?MAIR73&9G
M9?5V/S+/O6-H2*GZ-YC6#U;>1N$MS4T293.QH!)QICURV$44-4M>XLA%$MT,
M;2\YY6@:7E\QRIME=M;10(848\9VO@T9'&]@A@)V/S20'0R[&XU-XE8@97G(
M3!THLB0$E#"E.O]FA%BK<O2XP>O-LSL38Z.@R7I_1ZHA-]M";O:W.(VEJ$-)
MS6S(1U7-O&ZWK?>#6D&_!V4[T.]>Z[?'/#@L./)"YNR,A)*=T81$B"%&3CRF
MJHOL;,4J6;Z/;G!*MPI.Y%A(F&L>M.L!OP_*=L,$V<'PNV-<<44SJ_O $/?"
M(JLR:SNGC).8D, ZR<^VP^]FK"@%>M]E@@:39SM/T&PU'64';[(#E6I'^6!T
M57//-DV$>;0A*?EP.FGT7NNAS<ZWHP'-B.*4!F0P3XA;2I&-.*#H%/&*:A[6
MF[@]*MO+%%4JF1U/7U?-1?G#XU16%L\;\KA@(%5?8T#_B?6LP$M30E_N.A(
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M@%*8\.[C(X()[X,*M 8\B+=ALBX-A1H8/QUFG ;CIT 7V\W<3G-T,0>Z +H
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MG%$^FL_KRBWFUDWBI]G[S/?3^0T-^,?'USGOS<\V?R*[+@6(?4\)^%@:#BH
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MO0A9]R!O B!O <A+B<6L+[8$Q@6@ N,"X^XOD(%Q :B# "HP+@!Y+X ,C M
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M0D\,V0>! ..! P\#8C""!"#<.0B!YP9DNF%"#'@.0+AS$ +/#<ATPX08\!R
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M4'<H>3XGPC--2I*N&.**4F1$PBBQR 1GVF'O;^?YG@M%#+:("D,0EQ(C(U-
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M#H$.@0Z!#O5$AW!005*<LZ H7$Z%2$ .&XXT58YY&:5RG??QWEDJ1+@9<\E
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M.O]:5WX>P\5FOF\UU>T')4/",R#3[;?J0\(#( 2> YX;*L2 YP"$.P<A\-R
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MOU0^+O?;?XA^]GG:?DI;_[RC(N=L3 2%#?@'X,>PKA=0MV>H@RCYL$$(4?*
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ME$;WHSK_NS@?E288HT73MLV^7J,_^\X7F/N$: 6B%8A6=A2M:&X(9TZA0*E
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MO*Z:LUEC)W_+4G.6S\A_ETNKIHL8CL]B;=M551U%$=J,V>XKQP(7P&PHR!9
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M!=]++&PKO=1P"7#R;R>?3[P/=:V#V>^A ?54*")6BIFUXOUF@ #QX?UI!\T
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ME$$W-K7/\WG-.UG)NB)*$*F0P^QA6?ID@(%LA&@U@#D+;/J%0+5L<*=@AJV
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MS,YI;+6!GV-&+K-!4 MGD@,6S[ZKZ>[&ICJ#]"=TRMDOU*)RWQ/L"M.<<W!
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M;5CWW!4+F6 81,;K=<-MT<<6?V^_WN&.[9C@4KV'NFG'E4:V9@8GQC=K>0W
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M)RQL8QA\V\&X8GX5VA-;N<++%;4>AJ.[K[0T,1?JA$P_.D<WK8-%!XAYDU)
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MM\_OW^BRR+^]B=Y@1]@%F[=_>T/4;[KAZF]OJJ^KMXOU!1'UBI@CWOP]F@6
MJ3M^OK^_X@WX#++*2?O7RFQ.VA^/M \YBZ,T]TFA_B<T2!AAH2^5Y(Y*F8F$
MRJ+8E/9IEF9Q*F J&4C[,O,)$X4D99#&-)%E&9?Y4TK[+'6R_A%D_?V\L6NC
M],X;>Z WQN?5 DC@K1H-I]VNG&?F=/7S"PNGHA]-1>>QS/PH%VK)HB#4IP$I
M1,J(4M-ESH0,8C]XB$.&, %&P+PS\N57$"^Z(/&@JCJ8!8E3UB]B_SEA?W3T
M.UYF>S7"/I4AY8&2V4DB<D)962C/+*.$ATSZ*2W"@.</\<<>4=B7U5<IR']E
M4P/_(/B>D_13<<M<DNPQ]O"/=F1]CQH]'9GI%/31T<\IZ,DKZ$**V"_B@$@*
MWE@>YR0/(%M6"I$G*??#9&MDSWW28U:T_-))EL-Z8GD<.>W\$G:>$_-'1[_C
M9;97(^:3G&94.58DRK),B6R:D"SQ"Y+FF?*T>!'[_M;<B?ODQ0XLYIT/-F$?
MS*7&'C,U5M2+M<N%.;7\_-+!J>5'4\N9$-+/TY)(P02A0180)I."!($(LS@.
M1)[&A\J%?0\"Y;!.5YCX3AV_A WGI/O1T>]XF>W52'>6RYC)*"4L32A4.O@D
M4ZX72=*T* I6)BF@)QTF^?4(TCU*,R?=I^)LN8378SI;./MF.A+2J>.CHY]3
MQY-7QWY0\*!,!(FS5!+*LHBP, Q)P-,TS:*8YMF6.KZOLX63S0ZLCG.GC5_"
M?G/"_>CH=[S,]FJ$>TDYDX7RL&3B*T$=R8)D<1"3-&.AI$7FQ_Y6).V^OM8C
M"/<T=L)]*JZ6RVL]QK;]N .S>#IRTBGEQT;[.6(Q\JCL^'#PI)>MV"-1^B+A
M*>$T]962CA@IPEP02J-,!+$,_#P\1('B )3^P$DR?Q)),K=MGVK;W@?,SVD:
MQ[).TSPS4E149&%4!"2(::[TBW(A"\XCXF=I'N>)**5(#E$C^6B:)@^=HCD>
M-]-E]!XSHW?CO!SG>QZ]11">A"!<1+V&>3Y3DR['!1MV;\J^&O- %E'J1T5*
M,I\'A$:%4O6T8"23-,Y%+HH\I8<'DAR/2SNLO1#/TFB"ONFTM_41FOH;!'7^
MZ2MD6Z>-7I8VXCP)TX!F)&."$EKX(2FB7)(\+V/)*$VRY!& +A]3&P4S&DRB
MQ.68MO5CN+#J9VC<_+M]%V:,[-_-&.C7-3/T-H][A'.>\5;WF6)<+]4VND*O
M^H<_UM42QF?/U-57CS:W.,@XDRR)2!1!6$XF,<G]("=*D@4\S&5.?7:(N<7V
MV3[-V6*E!%WW>&XR\<V\('M>6,B5FT7L9A&_[MF\K^UYW2SB^PLG-P'S:"=\
MN5G$]^9 -XO8S2)VLXA?IB1V(T5?,L>Z6<3/;' \+GW=+.+7R[MN%O%+%1RN
M1FTZ-6H_L:(/F+HZM"/,_$^%?L>5U7_=&7LA<AFG14[R*&.Z%JP0N4]XF29A
M$"0\#+8@>$6:^EF:E"2,\H10P1@I.)4 VYL489YP$>_(V._)8_VCJ=OV8*5C
M23J)9/U4=N)1E(5-A5A.[#NQ_UK$?L&BLDA"F&\(Y0LL3DB>1CD)LT+]'["(
M%]FFV,^BD.<TBDF6).J<+%3G9#$E?J8.CGB4QXP]B]BGLSQ)G=B?2@N10ZIX
MC'W\8:T.6JT;.?-*M0O4#^U,MQ&59<6E<]V<#I^0Y'"J^]%4=Q"6+(A*3F(:
M,0"<R$G!F""I'R>2^W[&Y-;PRBB605PH=9\4$24TEP')BBPE@F4\Y&4I*=W1
M\?,$JCN8A>$D^H/=!CQ"8CEI_UJ9[=5(>YJQ/"Y\2B(>QH0**@FC04J"B >!
M+P)6L"T$09X5A6!%K!Z3JG-*]4^1RXB J$_BI$CBX'FD?1JX<8B3<=-<%NU1
MLFB2M?*\G@NONE@V]:6$/>1@'9R6?GXQX;3THVGIM,CCG(4AB5@2*)^,,J(\
MJX*D+(QX4J1))K= W(O,IRQ(?9(D2JG3H"P)"]0Y1>)GH1\%<0HAV&?1TBZ8
M^B*VGY/U1T>_XV6V5R/K"^Z'>5#D2EI#&BPH E*D<:&D?L[C(A*1"+9DO90L
M+K,R)DD:EP1\.E+P0$G]J$S]+!>)I,6SR/HH<_42D_'(7.+L,7;QN_IBN5;R
MR&7(CEI#OSX 3P>[^XQ:/@LS&K,T(!P B2B#+!M/<Y+Y$2MB'LJ ;V79\J10
MFCV3)$SRD-"0"<)27Y(L\-,@2*(\CV^/[W'0 AD_F(*6=UOXJ;:P ]-S+'MD
M+.NT#OB6J4]]/R\(*T-&:"E2D@>,DS1.<QY$5(3%5K8OI[(,$AJ3(/1]J <)
M21&&&8F2(B^Y+%*6A<^B=<)@$I.:7]\6?LY\X!!S#&_TF.[H$)D*;S:\NW\-
MV-ETO=5?ZQ6;>\N=*&;.;W46Q!&('V=!/&>]4$HI@TDQ11E20F/!E"U1%"3P
M8S\HLJP,N7\8//@GL""RF3]%\%VWB9WGZO2.8UFG=P;Q4NG[I9 9*6B<0UY3
M$J5"4A)E9<S2/*=9O#40\W[([T^@=Y)9F$VB!N;U;6*7.9V.+_J3;-NWWBGG
MZXOUG*VD4'M(7897##<^^*;LHE;D^2]^X-Q39R8<@81Q9L*3F G?6/H_L2'"
M<^%'F8P(BR,HQ2TS]5.0$,YE1@'"($V#0SC  ['X?B 5U<]S"3\HV^1T(!SW
MVBV'"K;/\M"YRD^"5_+MU"2+\YE?'>\Z9>B4X6VF@V9)Y =90+*0EH0J%YUD
M95B2($QYGJ5)GFU'@^_CE4],&0:S9!JH L<C4 ZN#%U3ZG0<^6N&8CFG_>CM
ME&G/@CPN5$ WXO5&^*% )*&?9$24(E/^=9:1//8+0D60)CPH,YX];H+Y9WFX
M2>-^[B:-OWS/PTT:=VSKU-#+4D,R*A-?J142EBPF- V5EZH\!^(G?E&*2$2,
M;G7A'C3??#@U1&=)$CLU]/SY9C=B?.?DXSN-D0Y?QACI]]<ENCWY=2D7K?2^
ML-;[TZ[0WAW6]"0S'@):\#(G6<&Y,MD9(WDJ)< 6I%+]37BYC2%WCUGEMPG]
M[969R4AFQC=%^$[H7HDY!?[QU/GS04W$)-8$?'P$["I#SL/$#PFC4OF5F>\3
M0*DE45CZ02:9R.(M=BWRA'$6YXJG"Z%87%#EE8J29 E (08YE[Y\1G;U3_:W
M0DV"-:;(KHJBWNI<>E>2-:TGE0(2H\F\'HQ\1*:&$6XSKY'M4BK:7LKYU<E.
M3;9?;079\^BMK9%U=Z BWNIMM5*KX'>@ZRGGS5J1\@>MQ%JDX$=%Z,9[MVX:
M=9#W4\6*:EZM*CE"+E16T#TD1K?-C3EEE5(8<!8IC<*B%(!-BY3D822)*.,P
MB1CC27 0I?29GTNQGLN/I7GPP</]"N;>K^KZW\]K_OL;3ZK-O02+1QVWK\_L
M1@LH>1D6D&43.623&MF$&S:9]Y2$%]56[0JF9\.>+>OYO/ZB;N)]4RW4)_6Z
M5>>WW[Z]X[Y\00:U=3+0Q]C%66R]JJT/!BN$6ZAG@L/)G%W5:W.(OENJ?*\_
MV\,5D\S9LI5O6[ED#5M)2QKMIN%I;W9EXRZKML)W>/767F-/FDW?-4E.\CR"
M^WX%BL$2S2.KM_#UNS=_N>;<X"0)[WGF/4\+3[(L\OL_][V.>][MTYYHHONV
M='P!D\C=1/>CG5@['LV<'&0T\V0H][@<>-J"=3"TX!U+/D'+S*$D\1-)WBG,
MO':2^#C2FIT<#@\BAX]X2OOC<BP$6AZ;:8^8^,^9OW^N_@$G.%X&[SZZX(B<
MX)BD6>@*L)^P -L&4WE] ='441;956 ?8>G;5.AW7&5MK[MDC<59GI20UXYX
M2FA."\**."-%7#!*@Y*S9&OF^CT[DT'8?&9SUE2R-4F]@Q6K!=/H,Y[*#CR*
M>NBI$,N)>R?N7XNX]Y7OXY=^1D2!<X)$JB1]EI"4\C17JL"/BN) O;>/)^[#
M61[OK[1[A3OP>;TSAW/UF-Y9(UO)&GZ.I2Y"7LIYC:7^SE-SJGLR@L-I[$?3
MV#R,XE!F,0FE\ G-,DZR,@I()'(6QS*(F-CJ*;J+@];*Y<*JZU^,K#E=B/>]
MI#$UF8?6X5DVB4D,;BL>(;&<W'^MS/9JY'[I%TI81RGQ(PZSW@0CF:"4E(6R
MP$M?%B)Y4"_I,\G]S 7JIN.YN;S:8WIN9W(A&S;7G9I"'5VUJX9!*Y#SW9P.
MGXSH<#K\T71XPE,N4AJ3O,PIH:ERX%BI?BW]*,RHD#*+Z*%\MW]H:0.MHB-9
M\RA://4CI\5?PE9T<O_HZ'>\S/9JY'[N)T&6ARD)2V@C3OV,9%+"W)F4^V$<
M2#]@A_+=GE3NA[[SWB;CO;F\VV-Z;]6"UQ?26[&O:FE+=@4=S],1I4YO'QW]
MG-Z>O-[V>2"3G#$2"Y82&@0!8:&DRFEC0<"B@&?I06!D?P6A\DG+E <IZ++Z
M*@7YKVQJX)HL#,+OG'Y^"5O.R?>CH]_Q,MNKD>^1#.)2I(R(.."$YF%.\HAR
MPDL9BCQ@:2F20U0_'DR^[W# )H$-_M+VG$N?3<<!^[@/SFLZ M-IYQ<X;.@H
M]+>;7G8#3&O,,C],?+7DN"2418SD/)0D#)(XCD+*E:H_A >'0FH;N_' 6;9)
M%$BZ'?Q4.]C- '$L>V0LZY0.3)\*:9"P*"#2+T)">2 (RR).?.KGA1_X(I?I
M(=S*)U$ZV02G?KR&'>QR@--Q0>\&,^W\TJ,W$:8]5NBX&NS=F+ ;P]!9I.R%
MK"2"!KG2_;XD6<H3(G@0<!X'27&8:96/[I_.TGR"+NJT-_,16OQN5*5C6Z>#
M7I8.BN.X2&D<D9#%":%IZBM]DH8D94F>A\H#C>@6[M<#@& >30?169BF3@<]
MO\]ZPYS*G9^J4U_?O)V_(CUV39^*2RF"-&>DA+Y?*L* Y##*G N9QF&2E:P,
M'S)]"LO&_\&JQ<?%9P;#IWY66Z9:L 6OV/RT;>5JW]@IO&FU4!OY='7;E?XG
MN!UG'^&0LUN]>WKB :T])7*!VC!F0M&;= 3WD.)W'#WU3'.\GF$BW+^5X)5?
M-9&0@ \? _M"AJ#]J!A*+E=Z8(F>,@C3S=[5%VIQ5QZ:+5C OJH]M5J&%%RN
M&W[.6NFQLT9*!)#Z4JW./4/FM2)AXZEGX-U'C/^QKN!"ZAH_?OKE_V47R^_>
MFZLU<LY6ZBNX@_>/3^]^\99-?=:PBQG4S<_7H.4\-I_#(N1\+OEJK1A^:<96
MSSRESY7<4QI^AJ$U0""&J&8+EZ]A^J6Z-BX/'LQ<VOL&?H$JU]#_SJSQDWVJ
M4_M4^'WPW;<GWJG2M6 ,J&6H.S(HXF^Z47 =%6;=X[:M$L8"5\WGK+I0:^-J
M46JA^E>]4D60:M6%_*; #N/)'?O4+(Q)5,_1MF#XG$DR'NGV9C1'\;^XH[Z^
M)=%WY5Q^)4*Q =I5,(YM?;'X3E3M<LZNWL*W6[;02:R,&EBLB5SK#XPJMNO&
M4XE<B.^6=8NOZ2WR5'4IAV.^.J/JZ[/8X3>]Q)OF2C_$SGK,AWT8ZOZA&?@#
MF=)V"I+1?M+&J]U%YUU:QE"W6LRKA5K82LD6/=%P_(7B</VQWG28FV&E(OY;
M-O_"KEHSO&ZX^\9^">R=P7[<VE<3V3YW"\L\_ISXD=S;_=C7W5I[S<;H94.W
M^8"&[PLQ1ZY1V5J[#XV3,W8IO?42M2R*W!9L"#ABIZ5PXOVJOEHU;-&6RCXQ
MRGO3&E%7,$K\"VO1F)C+%5I RN*^[.VDW?.7[V1"WBCRC^2EG:Z0DBV#%D=U
M%:#5[8W*'I2TE<UEQ6]C50ZOAD>C]:C>,H1W/*Y. &=)?ETJ@K!5W5P-D$]A
M?K:>Z OCM\W%=YB#%L=*/8I>UI99Z'W32JFX8B6]^%O'#QT__#IX.^I3,.'A
M!9VSU<X=UX)#VY[7Z[GP"O7VN;:4!;X?_=;AM+-U)92SJPY8>:>?WWE)X)/0
M1V-\=5ZI?ZZ6Z!?C!C?A25$);U&OO LI];V%+*L%ZC@XU+QPI=B4'ZV8I.<-
M\XJMD.AX34D@PQYFP7!UM6@<#BV0JYF]+%=6:JU,9WLM'!,-"^T7>.+]G_J+
MO)3-S&LK>#;U:C5W[_5).BEX(YMZ7]1Z-C;;YD[MA"Q^9%P4\&VN]%<,UG4V
MAZ\NU*-@J*$N_E</H1_O:G5$H:P4O3A@!HB?:D>'+9?SRGRCA'7-M19<-NJ9
M*R5?6_.:\;7ZB1;4]KH5;)ZJM.>;38Z<4!>*]_%:+5 7B=?=>:9>MGJ8BVY-
M0\90MP9.6@B[GKW'&(URS6W'SUNHMR4@3@,?2^6G7.#%E5&W$&RNMHT2<_,Y
MN+3Z^L#DDJGWM_L.3JQT8N7]N@&R 5VO%,LKS@:Q,IRVZ@VG<4UAR>,=HAQ?
ML*%!1)R98%YK@GGJ*J3L@GE:+JJ/_[3K8>ZPTJ>H5\S\B&:<DJ",(T+3J""9
M4.9LE#.6LR 5\?;,ER)/&&=Q3HJT$(1204D>BY)D25$(%N1<^O+V<>:]R9]D
ME/R);TK^I"?)WMS/%)C)4^?/@? @,K3,ULQSO1D+;TK))26 5J@6<$8Q6,1&
M@MF862//I5)BRJ3^9EZW[;<&M&(LC!4+2W6(. ;.I&DF>1(*$G&>$>ISIKQE
MX9,XC<(XR@4/?/Y@SOS4U%R9G^V'IKYX7/X,XY/][9J3XD\EVCAKSZVUP14[
M@>#>C)9NNPG(BYV4A(,;>:&V/IQ=L+E6C4<A%4,IBS@L E(D04!HD7+EVI>"
MA$QF+!$T"<M#9<3!9FM/%P(+NG_!_0FYT_9GN;HI.WY'!@R/14"";L4"VZ8C
MQS#+<*W2U=+2<EM[#IX#0YDYI4?=LGI.O.WA\Q,UAZY36\.8RU:\YYQA_FBM
M]-+"IF-TX,=:Z4<@&3+!\BR+2Y(4 ,7MBP+V.R-*B= B*H*T++>&)MU9*_TV
M)-$O0*&/BT?32\<B%O98,NC=L2O42,>A7#@5D?#3@+ B+)1RD24IXD207*9%
M5/IQ(%FT5?*;,A:G.027RYA0)@N2\R@F9<+2TI=EFO,Q(N G39)?#)D>V_H^
M&B[2DJOJ582) )15TZZ4B)J7< 3,DS_9J3&FQ4H15W9%$88DE8DDE(-D23.A
M; Z>9R63E&=;H,*'K1+:YI^>:W[\^<.(;4@K.; .-"2U<O'F[S_7T^:9V[CY
MH/+ YCU;J+L+3^R,<DSIJ39-#.IB5*/0]S6AVWE;0SKJLA(F_<"\90VG CNH
M6\MV!1%"JXX,4J2U;@8Q]95:"1RQ7BKN8OR\DI?2:C#6)4"ZI$=W::T#M^_$
M+L"-\)18&P1-1Z',575AG+B-VVDW;?>-+EE3X1/8^+@._ YL<12EV^N!33$,
MW]809*\N%.T*O)ZZ+RKPY4I[F1!6KR!8H:Q@S"BMYRMM;>Z^MOQJLA*E\MMW
M1W[5M2"WKNV#_2]I'.+[HI0$Y@2,>>'!A]H7,<<K*[WQRO5JW2BRU5=LCJFH
M38ILV,4GFV4YPVSR@1+46Q6DE-%$L+ DOA#*ZHR4F9$'?@K>;)CP.,@*N04\
M?!?=8'W87Q0S+=82(BCO3!C]?ZK5^3N3/ME71GJKM'CP4@M"XQ//T,T5?5Y?
M]+D_0>:*0&T"7PG;JH4XG2UT4-XWO29I?[O\XW9\[S%S^$I>SU?G]?ILX]*C
M=/+>_//->>:1GC.E"JW2#,VJ\PK&6J242A?TUVUYO92]PL2]J]5/GSS$G*O-
M&[?=4F9=9G1ZEM;#]4Q.1<%#'BL]D_N$AI(1Q?*"",ZBHO3++$F#33W#LE*4
M0<X)C2'K)%+EMV0A)V49BU!&F:\<F#' O>7*]TJ)-,IN4&]H(KOOU]MM)FLP
M/M"IW/,20IE)G\F84!DR0GU?$,"P) F/_$SPE JY%5.X\TOX5=ES'TO[D.89
MNT?<=O64+]2Y>I-X5:LO-0&OK-N&FQ72T_'2/#">9]ZYK2\Q'':.Y3)*N&$'
MW14:G&AE*_-S(SUC"D >A]_R)(OC),]('$O%.RP.21X%C!1%R@))RU QY(/Y
M[1>INPX^-57=**6FN.W]6OL@O]:_VL<^)@:,?"+8U3&PWP+)#4H4M/ >Y^R:
M*C&K%"$@8HIF6R_R/?7X[4Q=9 FZ&/U@=<T+=?"Y4F\$?^@*">TU3HZ!8!O!
M:1T/,K5M]H&LV5!?6L=T4#2D?JYJL>62=Z:*V?G][XVTP0BAW?6;M1!&,'17
M#EQ!G]]N^/1,]-F9S57,=EA__=N_V%FFQSJ3R*M1<5]7+H8>>$>_CF(C!UMN
M7; J,=OTY5Q"_@]837Z%<C=E$)],BDNF9P!.NQR,[BG!ZG;2461\9)XJ$XP*
M$NI9$GY$BI)3(D46Q!"4X7(+B?0NVO*6H9@?OIIV/(C<J[_B5_;U0/F?X"28
M=BC?I'\FM::!4-OE&QOEH'UZ==I"-][U1;^WD/=0'#:6E4/1Z-VR)O-%;,(L
M3FE4*L>(^R%LPK0D>2)SXG.UK<I"EL&VR<I#%HJXA,+(S =DC(+D>1(2E@8\
M27@19Y&8SB;T3T*W":>Y"1?U]C[4]?U;=LI-K;N[';(B+-(BX9P4,H%Q%DK/
M9%F<D2 K?%^(,H\3\>!,\+]8\[M$:(_/DBO1 10Z78@/K&K^S>9K^2_)VG6C
MRU1O"Q]QFX7?MHONQ:8+E)'<T][KB8^\!>3WD/[>\ 6X\/B.?B:MNUKOHJ=F
M.Z8FEKY"X.%226#(]VF'5I&X[P8I@>*70/'.(0)OK$NXZJOK/&2K@\0,DZER
M=07:4KT )0R:*]-6T@CE%J^8]>8:O1 S,GY^U7O+WA_K&NYO+UPW7ELIZBC-
MC;%P[&=!X27-&C!=>0Z-EH54OI&Z.!9-X9+J KPZI(%9,*QBNOZ2PS.XYV9T
M> 8.ST#C&:0.S^!EX1GLPR:XI55U+V,L'$O4AR<3>!3%0D2"T!+P!V41DRP5
MC!1EYM."4RF"K?#(?2I5.CL5*Q?!<AU $1K327Q<_ (& ?C%ZH"?ZT5C?_V>
MM57[*^C+6]2TO,J8'EA:O6WD70RLT8U6;!Q0FG[7[C"WE.FSQSI3)M:@F]@D
M&LIZ/J^_0!1CKASON4["VZ+>?BWGE3*FE']VY7V#7];K5MVI_?;MP\WDER)8
M+'BC(?Q(%\!2M; ?&U?P0' X4293O3:'Z+OE_HG_9WNXXL@Y6[;RK?(C6:.,
M:$L7#7^)I[W9-?( TA,ZU_G67F//+ -]UUBICNC/0T5AGEAKBK]<<VIP$H;W
M//-^I^7JAJ'?_[GG9>Y[VDG@'M<][C$^[@WS4;*[CT?9*79O/3/E,29U9"\4
M)-W1:I-6BC_AV[^]">B;0Q#NX2.Z+!T>D=0/<].W JZWK9/=T6)+'YN1C_A]
M/"KS.RD^=<GD:'4/*1X>1(B_3I'PJ%SGJ.>H=WM;S'>VV&/:8KN3ULX4<Z:8
M,R^<*38I4^R(A<;CRO!?ZQ6;.Y%]W,;>-?2]?KCCZZ"PDR5/(TM^@N2M%SAI
MXJ3)"Z:PDR9/*4U")TV<-'G!%';2Y"FE2>2DR22#4U@2MQV=XDHZE/PIHE/J
MFP>&6YYP6OL#W]2[C7+-MQ,*6CU37>:S2O.+2HBY?-V$<\1Z#&)-7*JY_3A9
MPCEBN?WH]N-T".>(Y?:CVX_3(9PCUF/Z_==6I=S:Q1\V .*-=C[I@43"L,<.
M;S:\N_]4G8<'C1/\2WUY96$E2O5ZVGMNB=O0W44/;DO!17V<]!OSYNT)]Z?I
M<-W.&.J3HWX\ <Y:D85QP@4GF8P9H055<ICG/BE%3HN@I "EMMG-'P5A1IF?
MDR@/0T+]6!*6^8*$M)0RC0H_85O=_!"*/%T(^.^'/B#9]?B_UXCXZT;N15>+
M1NAJT4T0AS28I6F^%V'M%6[+)Y)@(V4</Z4RCI]+&3N%X13&:U$82>;[<2$H
MS#:$D9II1#(>E80QEH4E\X.4;PTJ"O,L%(REA&>I4C*IE*1(?9]PF211R&,9
MIDYA3&];.H7A%,8T.=,IC"DJ#(2)"E\S7SJ)Z23F-#G324PG,:?(EQ,N.W3I
MAZ<J4ZPO+@!7G\V])5O*9CHBQR4?CHY^ST JI]_N%D(J2Y[%>9D2'L8YH7X9
M$I;3G*21\,,B\GE6A)LA)!&'$>,B(S0KU3DT3$C&BHR$N2]I1F42%ENS79XZ
MA)2%LSA,701IDIOQU5< .4YS8M^Y-:^/'9W@<YSF!-^SUM@$*9,L]DF0R)#0
ML*0D"Z2R8J,@+,,<,J/;X]YYHHQ<FI'"CP)">5Z2/&:%>FH_%,IX#N-".GO7
M;48G]AVG.;'O[-T7PHZNB^!XP_B_G7P^\<YJ1:"%GJ1[)A?\:C 3:CHRR"F\
MHZ.?4W@34GA[XOHAS_P\BD@<^LK/X2DG>>AG)"G#),D2&?ER*ZXOXSR):"8)
MCW*?T#+CA"6^)"%/?"K3-(QX^NQ^SLR/76'H-/>B<W,<ISFI[]R<5\>.3O Y
M3G."[SG-7<IE%O,R)]Q/"T+3C!'&RY*DO$S+-$QX$&Z%]=,PBT3J<Q((FA :
M!(*P.& D57^B-(F5?,V=N>OVHI/ZCM.<U'?F[LM@1X<)/)TH_;\0Y8<5<SF(
MS,\\]5,#J0>'$#Q1O/<)2]T)@; Y^CF<1+=KCXWK'/W<KG6[]MBXSM'/[5JW
M:X^-ZQS]7,WA"ZLY7#4XD]Z5&DY VKBPIXO"/T'NU1<)$TF<$.;G 6 "Q"3+
MDHR((A%%$%&6Y<D6"F7$:%JPDM!$"D*9K\XN*"5Q6-!,72?U>;B9>^VCI9\[
MV?).ATH/E&U-HUD<QR[=.LGM]^I-=,=I3M"[=.OK8T<G^!RG.<'WK* !,HUD
M1D.2Y6"MYFE!BBRB) KS(/-#(6@6;UJX<9DE 64IR6@DE86;2F7A%H+D?A!E
MU&?JDRV0+&?AONKMYP2]XS0GZ)V%>USLZ-!^CS=D[]!^G7Z;G$!Q^NW1'!G&
M\R+-9$&$GRBGA <%R2%4S_W(IV'HY[*4AT#[?7Q')HQF-'-X9T^__=R\$Z<8
MILF93C$XQV="[.@$I1.4T^1,)RCO;T'+J QBW\^)'U .A2N,,.E34L@L++(@
MC(H\.P1^L+.@7^SV<XK!*89I<J93#,Z"GG[JP%7[3R%UX!"&G<*;OH1Q"N_Q
M$(:ER&4449+Y,B'4YX)D+,D(B\)<!%+&C+-#( P_OB<4T%F01\X3FN3V<T51
MCM.<H'>>S:MC1R?X'*<YP?><%JY@-$PY#XB?91FA:9X35H0%27F1,QK3*$[Y
M(4"%G87[JK>?$_2.TYR@=Q;N<;&C*_L_WMC]N[I9U@U;265#%"L7LW>*;DJ2
MQ2FZ1_-HN"Q8E#)!XE@R0K,P)7DF?,(D#0H99T4IML:DA#+/>.0G1/)2G2,2
M3AC+E1=42$K#,BK2R'\&CV9&\] Y-)/<?<ZA<9SFY+QS:%X=.SK!YSC-";YG
M+4JA>5Y$0I R3F)"PSPA19!04F1!*64HDD2*30.W2$5 $TZ5*1REA/HT(GD1
MAR0/ Q9':4BESYV!ZW:?D_..TYR<=P;NL;+C(U3;N\E_AYW\I\XA;OJ?FVTR
MR=D<;K:)FTCD=NW+YCI'/[=KW:X]-JYS]'.[UNW:8^,Z1S]74_AR:@K=]#\7
MB9]LZ--%XA\/$"U/BC*BC&2<EX06M"!%Z*>DC/,BB+.$1MD6(-JAIO_]7"_X
M09.N23RC?N*RKI/<@:_>2G><YF2]R[J^/G9T@L]QFA-\SXH$$*91P6).\C0O
M",TY(WG(<A(6,2U$P?. /]H 0&?DOJ8=Z&2]XS0GZYV1>USLZ(!\CSQP[X!\
MG<*;M(1Q"N_1G)N <M^7RJ4I AH02OV,*%E=DD3*1'!6LCS9ZIDZ%)#OP9V;
M<!8'U/DVD]R SK=QG.9$O?-M7AT[.L'G.,T)ON>T<7/*RR0H&8DXC0A55BO)
M:4Y)$"917 91'"1;52J'@O)U-NXKVH!.U#M.<Z+>V;C'Q8ZN\/YXX_<.S/<E
M*;I"[1W9=)^<Q$OU2NMY)3S++E.A\%&HPGN2\P4JRSW5^ZF,TZ#D)(?2),I9
M0!@3.2DCEBL'A_D!#1\+$/C@?E$PR^DDZIK<)CZ<YW0-+77]@!]-AII.Z;PB
M?G5*9\H>FF-I)X*="'[A_.I$\'WM?IK3N"SSD+ T2 C-8D883S*2RKQDF>0!
M+8O'PDEV=K_;Q$[I.*5SI/SJE(ZS^Z?$TL_9>_$",N('Y?M?ZQ6;>Q<(@B2%
MQU9>R:K&NV3SM73IF*/7D.%)"/)$U&L [IZ:0!ES\NV)^Z<)*,L[4/8%JLL]
M?1E2BB0)2Y*$.5<^FDR5CU8(PJ0O@J (DK3(MW,SA1\E90CP2Q&A2<&5MT89
MB<J4AD5.I<P['ZV5R\7;=ZP]/UT(^.^'/]:5DE1J2:WZ9)?G]D$)LW^#+'M?
MM7Q>@Y [D M' SK+XVQZ3MRTM_R$S.);N7$;U'2.W"OD6:>F7I::RD5:LJ+P
M20S3UJC(?)+)/"=^'@L:I#[+XV!33>6^B+,RB8B42JM1'C#"BC0B(LUR/RJS
M();I%-540(-9FN9.31VMFKJHA)A+IZF<IG*:ZK5IJJP(:08>5% 6H=)414%8
M&OJDX DO\ZB(Z394;12)5/Q?]M[TN9$;/1S^GK^B:Q(G=A4A VB<FOUMU?C*
MZ]2NQV7/)I5/*9RC7E.DEDW.C/:O?Q^@FS>IDY2:4D^RLD3V 3QX[I-A#I**
M8#"HC$36J("$"RY$3 0591<E%97E@/22JI=4SP[27E+UDJJ75%V/E'4;OX\1
M*X/?DS#N$D-<OONFUST"&/.MMY-'MVNBS&PZGF-&6F%Z!6PH78Z&YGH\:R]I
MWJ8!([Z:7PYD,317=3@'-<BD>J0Y7!KDR;>]V16H_%35E:V&U?3Z?/Z,/1'(
MYJT<G_$RO?9+ EA:8;MC.($O;]]\>\.MY(S2!][YL-LTO)#BY;\'/N:AMYV1
M?KO]=D]QN[=D-:BGFU5=W6-PUV[1J%Z<=OW:8;*8ET?8[H%Y]P'0[2E+._9[
M1) N5>N':+V?&P*UXZ&_!\S?U<4X%C\$%RYMF!0E&104T_*HB'D:<'_.@7L]
ME^VY;!>X[)ZII/>!SXLGY8-@40^E'DK;.@[N=9Q#Z#@IV%/D:$_QUR9#./5;
M[U6<7L5Y'>*\A\EQ59S3(/;C\MA<@-&SU!.@YKO4=[X.2/8\X+ \X"_A4Q@6
MI.<"/1<X(4CV7. 87(#V7*#G B<$R9X+'(,+]'&DYW6R/*1_].&\+'LJ$Y\]
M3?.Q?9]-?5&$98KY^3,X7TX\<?C^W+8[N-05J=Y#Y#5#Y/X4M+^LX44"J =*
M#Y2>E'JLZ8'2DU)W -0#I0L]]*K##C]:/935FIX7,N?HK_#E=7&9JZB+",=P
M_P%'CZY<?&EX?U=(';X+Y[-[7^X.POL7R1ZX0O86E^)+*87=W;0!ERHZ57*D
M2R$18\HC$ZU&&MXBG'!,$+_9M,$$YXC7#$DK-=P3.+)<.N05E\*5TL%_-SN5
M[^[;<+P&#4H,N#S %->72*E/S=Z.T)J\EQ0GC'^]I#A%2:%TY)$; FP><\2T
MDD@99Q&F1C-M)696;$H*80CCPF(DL 7IHE(W(,9*!"2L28 G6N][2=%=2NV*
MI+AKLYY>6+PX%.R%1;>%Q4,[[+Q$7.W99<\N>W;9L\N>73XINSQ">MS=P@L'
MBB:<8KC@H*-X^L#!L["!W4T)GQTS3TAH[8;@"Q1;>UQ".&)/24"^Q (Q$3DR
M6!&D&6%6:D-DE)LN(:FDXM([9,HT0B<JC(RW 44B.1,A1AYU%SL^=])-U!D*
M[HKE<Z>0PKZ6SKT4.6D<[*7(:4H1;8WQ(EB$06(@AJE#EL82D>"855$KYK?F
M!@1?>H)%1$X'#E*$261D21%('"^H),P%UDN14Z/@KDB1Q\X&Z 7)2:-A+TBZ
M+D@ZX47K#+[V;+-GFQU PYYM]FSSE/#U&.&'Q=235L/_9789)I6#OWWUJ4OL
M[>BS4.ZR5W7+ZX\4X-CJ=7$/8.17G5=36(6[3W7%PLHLEF;F3FBM5I*P,UZ6
M7]U03B*>!X"'1I[=[>G9H)A>A.+[\24L\3KS+OFV;DM4F@D["U F]T!=U=/T
M'!_L=.6K05&-W'"6F%+QM[/?SXKI)$>MK@LS\H7Y&$;N>NUR-YY<C=.$G<TG
MY1O<^!)(VE5F6%R9JS Y*SY<A#KL69:9A,*9R:3:C)$U+X=OF\7!U]4H;S<_
M FZTXT\A/WL.@&(28&4^K:(PP^'XLQFYD+P-A9L$7TV+X;BNX<[/%V%4S$:P
MR2$<DY]_G-[EX;W3<7L]FH0A;-+#HMQT/*G/BG?3(AAW 2^"_4\3O#Q<L'8*
M14BKAT_KU5U^KJ87.UX)K_(!!"<<>TC+@N=,BGH&;V@N@).)L)OKP5T6]V'7
M(N#.RS&L<YP>#7_-7[*ZX@M3Y[^KC&W)[01OJ<-PF%Z=\&5ZT_G!*<T?"B"N
MZF(TGA:78UCOL/HC#*_A;CB/]"'\,EU[\><*WF$#@/,?LRH%2;??>PG?Q_2P
M=+8@3^>?IVW!"218NC%@M36 W&= 6U5>R6+1#I8)\L44GP,\Y#),$Y)MT5$#
MO!9+ +'A9.OYBU;V>A&&'A9R:0 3VV\O@%$&>/\_9B8-D#HK_@J+30M=1XI$
MR=5HUAPY;"54GP)0QW5JP)S?E& _20]*\+R: ,Y75T! S<E< Q" JC(&#/(5
M*\_^C[H(7ZZ"FYK&8UC/X3RN5UZ103U?15I$!GM>!SP-^-(0UOZ=J>&O=/X7
M\)@6A^"A@[2.6_G/$I5]LX1M?$\;G>YC4/F$8.OP+3!+.*?II+*SYK*$]H!&
M'^$R@/T"6)-,9PD@P#W1_/RVJ+;.-#6 BY9\H=[%&$*+:!/?<*,]B++8<.4S
M8E^ G-Q''ML/*<_F8JT+DJ5XO(PE]&4(V9\7:)4)(Q_E'L0O/L,7_[;K'.^Q
MLB>('!!FHI2,(<:C1PPKCC2.#KE22H$]8033S<@!%TX$)R62TI:(46&0=E$@
M01P+@2@= MTL29B#[K<%Y+Z?32:PLKU1 ;$6%>"WS;T_PWM# EU G0+N'\*B
M.K6FQ!>!CR\9&K"CI)U=P5VCK C" JX,,+$D0$9URTJSJE"XYOS@ICHD$37:
MJ6I:,\Q*5GT1X*IM[MA]"K%"!\F90X8)CIA5 EEO ?DQM\8Z'2@)6[$U:Z24
MD2#BG$.,18U,D [IR"0NJ=%ANVCG'A2RI(N??_EIC3 02)9$'"D#KPZC-W\>
MC3M-%B :S:>P(J]7&.MT)W(\UTI[(7TB0GJO)0R:W1X=##1&LV7P%5?CNLI\
MX,)XT(;#Z+;KDKX(AF?=&#2$@I$SFEXT^N6N)74)@=85]6S'=)\ULQ@#I5JC
MP#DH(HD_*QP$BL1HK16U(4T_7&?--%A<BDA1Y"EY3EC@RHH95$;)J-6@P&BW
MR9I_"':Z]#F]^V2J84*AG\:3WT%5^;XQFL:S^F\+S/@+(,:O+5[\!5#B V $
MH7_-^/#++&'!^SC_OEYC\/-/;^+RV^I/*3K-YO<9=!>5NV@DP%WIRQ178*V/
M?2*H7;36J5VO<>5T/JU];=H#2@[M?X&KX+^%&X(BE8(&'P-:'V\-V)\N:#?S
MS\S0OYRC\FT<AB_(5R ST_/2:.K9Y>BMK^JKH;D^3]]NA1+.>#7*ZVT3^YL/
M_CZKIU6\GB\]WXK"R+^=@_X\F\S5I[ Z%W<1D_CR+&&=V\[Q-G%V9,?\,S6A
M/C0._X2Z1%%$K5%4#@@MJ.AB4;720K<:#:L1+&QJ)NUT]_4O ,.;CQNBRZ4K
M)@+PS\WPL[FNVVG/J]2W%M/+M+-"CUMTU1'RZ5I8:XWOW5^Q:+2!558ZM]2H
ME5: P66# *M+&XF4X@H193'V/FHN_/_1=79Z[_<N(Y+M6R77G&I<(F$U@;<2
MC90&=:046@8GJ77;'A3'N"0:&T1YND<(C+2('N$8O%:&68[CIA+RN[L(?C8,
M[^.F K)43<!V'(]<-:PR6#ZD:S[ 6[\;CMT?;XI0.W.5S(+)++SIS82D0G2)
MN>UQGL=Q\DBG4%*K/\TNDP/\GZ'>%>:8^_Y7E*B/IAK5Q=>-"_N;>5QBMT8&
M.ZR3_/$Y( 7ZV,[+!OL^SD[VN5\H1?HV.L 77^<0':C*\&W]S?E3R=2.<<!Y
MID,+P#6AE1LB9JFTK@6F#:7+$>AVXUE[2?,V@O$9_FI^/:#OT%S5X;P.5R;%
M/^: R5I4<]^;7;6>GZJZLE4*4IW/G[&GB+-Y;5F>,?K5JDAKM]S(M&]ON)6<
ML0?>R,]*\=3O?-AMZHPQO/+O@8]YZ&W];OO='NI]^$P?\85/-/]V6QS<FK1W
MALE])I#,/YJT)D"^^^5-+"KNG?QXJG!\GM3F>T+K]KX4G8'G<?'RMYQW Y?]
MR4Z^_7/RRB97Z,P,\]]_-=.DIEYG%?0ZF$G]S3.>S")AOS-G\_P][WN\?QC>
MOYM;@"W>U].>Y;P8%MXSBM>$K<=E%,OP9.84_YG\0CVKZ%G%"4.T9Q5/PBK^
MDGW'/:_H><4)0[3G%4>R/SY^G(2/9AHRJ_BQGE:7N;PBM8#)'_WW@SH:OMSC
MZ."@L,=V\FR ^8CV8O<XG-/I\/G]1J'C VG@!8#U.>7EH<&W8ZO=S0>[$WC_
MLDRD/"*,[^GP[T;SB*X@[GT;1G2%\)^NH\D+1\0G2*?WG%@M<,J*UPXQSBPR
M@F$4C&8T6$MCT)N9;)[3TCBO$%,Q#;*C BEC%:(:!Z98$-1N53KMSU]+B?9M
MH ;^^I^<@O1^%/XWF,G"RYT<W =J)4BP&& B']]+\.70:X=D\DF2:2\O>GG1
M"41\ GEAN'8D8H)LB8'W1R&0"9X@+#!5.F4QZZWRJ_O(B]QU]D'"XC\GXWJE
M&BM'.@XD,_876KU":CU=:?&*;>!31;9>-'11-'S]F!**1PB?DCEO(N%(1#!1
MF L8*6$U"B5ATAL&HL5T0OBDV-F!9(_N9<_CV<%#T_YZ(=0+H5X(=5,([181
M45E*?=!("@(\WZ2Q2L1(Q+0'AB\U5X8_FS]K,2#CH+ZL \S%>#FT^KPAU1LK
M5/J0Z@,I?;W];+VS$7 ?6NU#JWUHM?,:0%<0][6+M]>*?T\QW1-TSN#32+92
ME8C9DB#%.$;1&1P\DR[*<JM!66F8M"8B)H('K14+9"QCB%/+E,%:8K?57;4S
M$559#C@AO1+:4VDO)7K\>PGX]Q0=ACGF00*?ES$JQ*@72%DB40A!."NE%&1K
M!O1]I$0GXZBL=U6\""I]Q19OCVR]2#B22,".<5<*B;AC$K%()0)30B,;,&&*
M&1%T[(1(>'AT,U9?8)G_#)/QRE2]7B*</I'V$N'DX'>ZR/9J)((+'F/K(\+4
M 7=7UH"1P#"BW!"G&<=,BF=S)1TZF)G<2)SWXJ KL<R^//1HL<R/:1;@Z#)W
MS-T<I-F1J-PK%NA]4+,/:O;NZA.4<Z\5_YZD["<(H9@"312#:NF\1<8HAP0M
MN<9&"N>WTNH"UZ)D*B!7:HQ8A,N-P %1)S +4M+2R<X&-2D=4-9KH]VDTEZ1
MZ3&MEP?/*0\"%<RP%+X42B%&"$56*X.P)1(3X91A6^'+^\B#3H8OR?YQPSV5
M/B>57E;>#T.7@=6+A!>#;+U(>+;R3XZU$88A[K!,$[8MLC$*D")$"<^\+,/6
MU+5G$3H'+/\L>Y'3EW_VLJ>7/;WLN4$R2.$]84RD)'N#F-)@CD01D(+?/)6"
M^5(]FWOJT('2Y)KBM)<+70F4]D6?QR#T[\>3JW$:9=G'1CLDP_O8:!\;?16Q
MT8.VEC\)X7=4#'T@.+N!PT^1^^T5#UQ0)'FJ'.7)M6&#!'VVI$*R4G.,MS+]
M@E:NQ (%%T'I]0(46*,MDC8P1F-I98D[&U\E Z8[43/:$_KAQ/V!A\^\"HVJ
MQ]=>,'58, FC;&E=1"&("$*&2V1*Z9#SO/2E)31R\AC!U,U ;R^83I30]T>"
M>]G4HVPG4;:730_N]>@\X88'Q+U( TQ\B92()?(L1BU,"%YM=]IY#MGTX@IF
M>T)_*D+O95./LB>&LKUL2J6[4> 8B4->88:88PYIZ3&*D3)="F?]]IR4)W/H
M';P/\8#I3@2D7Q^1/V=M;]YB-?*PSN9%QPRTMO!-L&Q>MOKV]FA.+,3]83PU
MP^*RH='K8KB,(A;70*4/I)]5N/ G/!3^7&?2%8WDQ<3&NP[0/A#>B]1>;WZA
M>C,W.EAAD>&4@]YL(U*.8!1B-,;P4A"WW00M6%R*2%'D.OF!+.C:BAE41LFH
MU2P$[3H;"*>X'%#1B<:8/:EWPZO3#6+O!5:/Q;W NKTS!BY=Q%@C+X5&3&&!
M=$D,<I%Z2[ GE&S-)+R/P.ID@%ST$?)71>E]%*)'V1-#V5<FG)ZK)ML1PG2T
M&EEA5*JBPT@+0A&)402CE:'1=T+\'; FF_2QCA=<MMV+P1YW>S%XHF)P3Z*8
MH,Z4EB J#4,,$XT,IB523FIE2RY*]7Q.Q8.7A^-R4)).] UY?63>5Y!W)[Q^
MX+'!?5R]8V'@DXNK'Q2[23$=%[R/LG<39U][)Y77BG]/H,QR2ID)DB&GDL=%
MJX@4=1Q9X1P7D;F W5,.A?EM/!S"5I(J^^'S^,,%:#8?+WZJ/H6U:/EWIJX.
M%GW@ T9E%Q3<GFQ?!MGV8J/'OQ<N-IC4E&.BD'%6($:T0=9[ADC4-"C*J+/;
M!0F/G2Z9I42HWT4 ;.ON6!$0Z<_ZB%'JLI<1+X)&>\?ZR<'O=)'M!0J$YXH-
M*QI<<$Z@4J>NK,Y29+FTR @I0J"82+$=&WYZD7/ R#!7O<0YU;AO5Z#6BYY>
M]+P8T;,G:4@1$6E4R!M.$-,6(U4RA4J,58P!2\*V!CD\BPOKT+'9Y+G"HI<1
M70F\]C..CQ9X[6<<=UFX]S'54XBIOF($?>WRK-<^CY<-6$;LN8@H$(41\](@
MHZE".DI28AH85T\Z+.;I ZBT*_UZ>JKM%9@>TWKYT"WY()Q1&EL4K36(85PB
M2S5#&,MHC1%:LJV6UX\>,_F\D5+:2X-NTF@_V;A'MEX@/+- 4,(*;G!$@GN)
M&,4$&>(P\CA*)8D42FP-YWD&@?#BNDSW)'J"P.KEP6M%ME<C#PRUK.3>(NZ4
M0HR1@$PPP."5MMQ*:XC9RFMY%@?2P4M+!YQTHE/=2R/6OFRT.]'+ PX>[DM&
M^_!F'][LN,+0%9SMFROT/50ZK/0&4WI&;(DH*25BH,8B98)$V(#&ZTK,G=B*
MFAYSH,G31TW)0#/<!>VWI_RGHOR^3W./Q:>/Q;W\ OGEL9*&1X&<)Q2!]!'(
M8FP0%R**,KJHRL,/,G[>J&XGRE][,N^&L.I# 3W*=@YE7YED>JY"W%#RZ(R+
MB*@(MAO\@4"N"22\8II;P?5V /L99-\A6S3WHN_E5NKV,K#'W5X&GJ@,W"VA
M!)%"A.B1(H$C9C1%5I0$E::4I56.&UMVPKMX^-')FG6B(/CU$7P_.OG$1R?W
M4?G3TD%.-+NDZ^#K?II45R#X.)E(SV@2BGX\ _VA<U+QH2;<OW5 '[X'9%^-
M1NQ%=%B+$HDR:<0R.*0,=<@+Z90I";%A1[S]\3-+DAZ\U(J/5X(LRP&A'9Q2
MTFTJ/PFQ<R- ^Y!ZC\F]O'IY\LH00@2A 0F/4W\V&I'E6J/2ZA(KRTO*ML<2
M'%Y>.3>[G W--/@=@?7O LBD\,%\.=@@R Z&V+M-]B]=@/76U8M$VUY:G:JT
M>JZ8.S:42&PY$E@9Q#2G2#O%D.'PJ<",!V*?4QZF8/NAY:'L8-C]9?*5+@3>
M>[G8XV\O%T]5+N[I?<6CI-9CA+%78,4IC(P3#,F(&3-><&)W9$D?>E+R\J]#
M>ANE[J73\T?:X?=T[G^>G\4OL\LPJ1S\[:M/71(2RW??]+K'@ @VO&>W-[UQ
M0;HMY.;^%VVTY=H@$PA#S J)5"DQ"H[HZ(Q1@LI-RG6,2Z*Q091K I0K,-(B
M>H1C\%H99CF.FY2[H5]NT/&Z?OGKN*X2G2V29CZD2S_  KX;CMT?;XH U'P%
M#Y].9F$5OU?#Y.R,E^57-\3*Z2T .U*>PJ'QXUU=C&/Q&&OET"OZ(;AP:<.D
M*,F@H)BR03&]",!IA\/Q9[B[R)1<U+-+ #&\NR[@OW^$]M,%CA35J(#-S!:H
M40P!-XJK%CF*K^'[Z<5X5IN1K[\Y7Z605\0-YNRQA=YV^HB93<=SZ9%6F%X!
M&TJ7HZ&Y'L_:2YJW29 :7\TO!P0:FJLZG-?ARJ36%G.X- (FW_9F5RK4IZJN
M;#6LIM?G\V?LR7%JWBK$F=9E>N^7!+&TQ';+< 1?WK[Y]H9[R9F@#[SS@;?1
M,Z5*O/SWT.?T^]V^[9;D.G7_AC8[:?/."7?'R)E1+]1X[6&U"2O S_3M_WLC
MWAP";H_/!K^A(\VA(/VXAC2?&SJWXZ&_QU'\)8!B,+V UQ%:_!4^OGAHZZ77
M<!9'Q?N>@7>=*?6P>@ #IST#/R8#3Y9^D4W]GF\_#]]^ O@^)-+3LX^7@;O'
M91\Y1OTG._GVSTM'8I$\B3TWZ:06V(_5/,W&M'U9T7,&^+L"O],*WK_NP#QG
MRL=(%2*$&,0LID@SKI'4%BOX'V-\*[SWD +YF\-[W\/SJ]%L/*MW!_J2_^;#
MA1D1VCAO#A2^UZH3>=9=H=L.Y5!W7/[V$J*7$"]/0CQ;&S&I2L\X1MIZCIA3
M')F4[64)UU$'9[$+W9-!*RG0+ZW!V*FSB;U9S/T\E"Z9G9>78>(J,RRNS%68
M=(>U]PK%R<&O0ZIKKT?LD?)IVB67)<@ZK!"+DB!=QHBL4JRT03A7;DEYSVEI
M7,H85U$C$.P"*6,5HAH'IE@0U/J3L#0E'A#9#T-^>HI=:XCVE%VYR*MOR]5C
M9B]+3M8FY2HR2YA"3@6)&.:@^I=2(BHH!ZXN H^Q>]+J.#9I)^J;NL(=.F*3
M]J'08_""OYW]?E9\' ,$1I?P26$^AI&[[N.BO6+1*Q8O3+'8TVT*DZ UUX@J
M&A!S3B&E#4-8*VV](KCD^A CN#MII(H!$[VL[VW47I3TF-F+DN[;J-I3R8T!
M.26%08S+U!H1"V0\<YAJ@UTTW1-6Q[%1.]'QMRO<H2,V:A\W/9J-.@5 UK-)
M;YJ>N#[Q^J;C]..PGM.\=:4M<=1(E)0A%H0 C4%21(-WI5)$VQUMN$K#I#41
M,1%2 ^:D8%C&$*>6*8.UQ(Z>A'G+Z8!CU04]H:?Z(UK !RDP[*WD'K][J=8Y
MJ?9LEK861CGB$"D9!TL;8V2="XB7I3%<<.,8[Y[</(ZES7L1>HK&>#]?L@O&
M^V/F2_:6>G=TFF[WUSVM\JJ^>_9MZH?D5BJK#"JU!GV":8Q49"4B.F!EM0B.
M'61F7R?-=E+B 2D[.,NZVSR@0Y;-G0SU?NI#C[.]W#I5N?5\:=J>6:]Y,TV"
M11!PEDF,G!.QY" ?K=K1ON*Y)>-Q#/-^2E*G3/-;!E*D3UV#-Z8]J_0YW-PA
MT?84W>G_E,&Q:_0$4*4.I5,H1.\0"\8!F5N/J#%&V=)PQ;?R6QXR>B*19PCO
MK\($3F+T\2_!U*'>-TVB: \M^'?3NR[R_\C=D%L]S\2)K9YZASYV>58T0+WG
M# 9Q>O#(KSJOIK *=P\(+9#O)D#=:WK),\'NT*CSX2(4WX\O8277Q3"#IAC'
M6+E0F)$O)J$.9N(N\A\^? K#\54NW,A+*\PT#Q9I[__W?U64R+=U<1&,_\?,
M3$#SRD-$?A_/IA?%[[!9$)PC5]5N/"B^!UB N!U5!J0S2+0T:F2\.*6\E+/B
MYU'Q[FI2#=,4$S)8?5F1%;O@X?G3<6&:&Y+\WCF)Y1Z@>XH1DQ'STEF.'-<4
M,55B9(V,H&DP+Q0AAKAR*Z^P++7Q5B,54\C#!(R,=A$I5C*J@G1:;N45O@-=
MZ7W\"YS=F@94_R-.5Q6?GW_YZ=9YR0,N\%[MIPMX7-0)XP #0I@.BCH 9HZ+
M\.6J@L\ !1^)%&]V"U#%I1.&:U1JZ1$C0B$#>C'B5*H 1UJ&2#</LA2B5%[
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M=L@7$]J\"5UE;IDH:9+OS5Z_3I_I"7#([EI/.ZOQVC*T!H]32>3'@-I"QK1
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MH+==FFJTU+)64ZVW%,/C6"%"BA!2*R11*IZ&\PFDO,8H!ND%=[3$<KLP7(G
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M%*UU62+FA<?*4D)(>0C+ZVC\G0PPV=_SOR>Z@]A>\'LJ>MW3;O*5E0T?MEN
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M&GFYB(]E12NG!*5[D_RNDZ]@CW+_[49B=5]OTM>;]/4F]ZPWH7V]R<NJ-WF
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MW;"_1ME<EBS/87%A?.;A=S_@?/M&SOMZS.\24*QJ;.;UJIF,:F?%SW&PKY7
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MAB]AXJIZGL17358ZA2_;?=\V%F Q#&JS>^>BN^T)A!.,BB4ML4&@/ %R<V'
MAJ 6"6LP]9H97&[%HK#E7)6@K96@K<$]L40F2(=\R2BH<L('0YZRJ>VMS;=5
MUZ?G; 2%3=L';ETLMXWP_"F@E0,I6C+@?]9ZCIBEP/^DX,A24F*)2Q;UUM27
MAPCD78.R?V[&X_R:J?)]2Y0'ZOI:8GHJ$]FKT=J$]8=V>6TZG#6)OW,&Y\;U
MM%[V1[Q>0]/3X'L@C1W@88FTT6"%:D*0<0PCPJ776)11EMO-O.^!H#F,L;,;
M\4HKXG<C_SY!=HZDWR>X'@A3Z:FHCGVON@5(-EJOK;M[-IJ>+8NVVF1\GQH4
M+ NX]K=!7FF9WI26+U/6EY5JN3_ WFZ..V<RW;\/Z7QDW&:]0R[?6[MTJRW=
MC;!9=)!<EJGE-@W#M@Z\;LL$TS5M24@+K]7:KC7$?(SK=BM1/:6<,ZPM*JD!
MYD.\1RH:AZ@/46I66BW)HQ/5?T^-82;7[^.6#VQO-/7]:*46Y[O4LO)#PH5]
M>>X]N:XJ9PU,-[KU[+,<=K0,;5N$)E]NS*>R<.F>=XIM/YY=OY3 SK\4^=^?
MIIEAKL?BTE*;8-MZ<#MM*%V.AN8:^&MS2?,VB<_P5_/+7;)ZKNIP/F\2-8=+
MC@TWM[V9KP"6L(@%IHX6MAI6T^OS^3-6+H0K_0)R^:U"G&DAOUJ-U+5;;D)U
MW]YP+SDCXH%W/O"V\JSD#UULO\?VKF^GDUV8TX9R4X&1->Z/CQ-05SUJ^4S,
M_]Y^!NQL(L?G3?PX?;";^VS3[:YUKP>8,:E&;[,  I6WO;EA!%N9'2G<W'XT
M:4/0^>[=L675B62%K;JD!^343/W+A>,C+;T=D?=-:,%)I6^S,?62('=<#-PN
M\NI1\A HV7/BTZ*#GA,?@1/3@W#B17;9/._S:EKD9J7%'!DZ ]OCXNAJ]>VQ
MT/2$@'U\1#XN/!MNC\O7!-&>-1R--90]:^B$:I?=4MNZG0-2CVZ/;G=GM6WG
MQC9.$"Y_I )R5*_>02. =YGT\T"ZN NH#Z+N/9,/]?A"<O7=H_%IPN\90'4@
M9-O)))^\M.D)XOV$<N^55X@1X?]_]MYUN9'C6!=]E0X=ZVPI D77K>LRL[8C
M1B/)9W9X20I)]@[_<M1UB&40H-' S%!/?[*J 1 @ %X!LANL62LL$.A+=7;F
M]V56964B'J1%*BJ'F-%6$>5E+=C-)3<9A';8UHBP0!'7QB.ML41>&&$BK8F5
M\9:$\_=MD>,[UMQVYO/=DGP>AU^"1W^$Z21IDZ*$OMV[S%],L4>F6'"_=_+K
MK[*]&MP7)$9!L4?*<XLX)P1I3"0RGG(G)57<;>6W<JRBPTH#.2B".! 'T@#V
M2-0,!Z-X78>M_-:CX_Y6@I<:2(('7._/;"T6^<SAVZU3\R5\>UKX=FL[U.X@
M:Z'QWLFOT'CW:3QR+Y6+2$?M$&>!(.M3[4LNN=!:UBR&FS1N : AN*L1)5XB
M[J)"V@J#-(W&64D#<[>5+RSA6S'%;@NKX/YK5;97@_M,$&P)=LA3Z1&/$,B9
M.M0(N,#06"NK KZ)^W7PENB:(9%VW'(>,+(V8A2E8U98K8GU+Q^^$3X@5 \@
M "WXWY7XK2R_'<.R?U[TUEPK*[&VLZ@[H%H8O'?R*PS>>0:WBCFJO4X%0GDJ
M318@ +,&!:<U$P9[)[<6WK!C3&K&D:J-2O6*+;+82N099J96P.MI]_A+,S@=
M:*8&6M%"X*=@D07^>R>__BK;JX%_ Y&:L$HA$PA!7 N*K" <H%R[X'&4M-9;
MZV_<&FL40RZ8M-4Y**2E,L@[$JEVFH6Z _!/('YC ZKW%XLN%EG6WTX@?FL-
MZ7J'^]H.]=S O&DKR:0*A:3Z963&W8'9PNF]DU_A],YSNG1.J=H+9&Q*J.1,
M(H-91-PQZR$\"Y3ZFYPNA+5*I J_.A5$Q#$BK5U$1LHHM3"ICG59C"NF6'"_
M*%O/E.W5X+ZRP3,#T1C!.)6M OBVD:B$X34QACAOMA;CL&4\!EVC&'Q,O>X,
MLBK5NY+>2A8XK5/QW)>/Y03C Z[VEW8L%EG6XEY7+,=++%<XO1L(4CC]>+%<
MVM!@E4,X$-^V\],R"N1DK+D(5M.PM3_"U<IX)1PRRFO$A31(Q5@C7PNG#(1_
M.CY_++==JGD@.1MH4A=./P6++/#?._GU5]E>#?P3IH1E$,U9(B"D,TPAA8-'
MPIBHL"-4BNWM<9I+B/8,DM3".3)"2,>L130&J0@W*CA6IO).TQ3+NERW8[D<
MM_WPVR^_= =+"W&_3/&D7N#)4=7QD>)\->2OK>..*8VLYA#'6:V0YLH@P9S3
MA&$A]=:F.F(U$XP)!$@C$.>6(T,Y1DX;YFLFE0W/7Q-E._83>L!Q)Q(SBTT_
METT_IE1BH:&BLH6&7C@&5:ZFF'.()S%0"HL2I?Q/5#..C79$2"ZVTDF(YE0R
M@[C+[;L"15H8AX+5FA/&N"2RQ*"OU9R[ON+8_0CJH&;_V++IIR'*T_ "Z!E-
MN.$G\U1]YU2!XQG]@ <(]-5X M$HJAR5B$F,4QOWB+1S"EFL2/"6:R?X34^
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MQ6C2?->=E]LULYJBWK5X=AI6([PQ&;A8-9X VPW3;.UJ=JV=6;PY&9W^:".
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MU01%:BSWA-D0MTH_O$3F]8^3:0S#V7QZ/9OQ],QK2@:,UEV8D>@/KO1K6OS
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M$ ,>"*[5S$>SY4!N&=S_:H<%K_MG-YLDD29QMH1XBP!N/'YS4XV2QWT1X/'
M)_SX,62/(,V3I^GXI7R73[<Y!3]8O8XE']OPT:0;NLG'\?"/=$;XDHP^; \B
M:V_3K2FIXADN1=$K+N/4&R<%1Q[7!KPJII%BT2'CB)2V]L:[K=HQ+S]1=7 N
MDX7+GIW+X-U,KI=MG0NC,,TXMT3,R^GDT[!IN:MI)FZ8?\V+LBY,9\ BE3M/
M^I/DDNXTG8RJD/BFV1VHWH(]ZF6PYW.[F=5.1O[!8L^W>C,$J!FZ!R^;MV95
MI4F,;(E/4947>(@-NO'#3SO>\%UL\M7NO-(ZX$@UP*#C @ QPB=-P3-P7%H/
M@:3TY# S]^X\^/DH_!QWXUY^3<LUN.5;>M> @]-^]WM*"O@=QO#=" [\J@J
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MDZ2T*X0O0'(?(+G>@M%)./E^'I9.XA:I+RSKVD]H]:UEX247MEQY!8,-#D#
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MU+55A5UK=26XZRJ!]Q@%RD1I#Q;,G!0\2.R04T8C'B)!5CF*J-%2$N&H<NZ
MH=^>+>MEO:RLEQ7T[X2<"OIW)O2R5"BOB$:*,(8XKCF":,NEPKB"1A.B8_Z
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M0"/B7%-DA;$H,LI"K V+8:N EU12U:D[KF&) Z+"R'@;4"2RYB+$6$?]\AS
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M[8>+>;WS<RS_4C=UV[GE['!UC;4#U^<D=W>5\D 3]OMUI%T^<@>U?_S.N>1
MTBW/W/(T>J#YMHO=]AFUWJ]G7!_NO,XY2U,L(ZRS_E^?9]/%)*"EKDOM/Z]S
MKXW.\COL[+_\Q?4:<%-N[SBL^\Z3N>\Q=5OWPMG8L"+NGV9^CZ'GPZ/C T,[
MWY]IWE(+WE3^M0V@[(!REV?#@Q,#4-E,QW789C+\D'GT?]K"\Y\V O>/S;H#
M>@&/RMQ/I-.?2(=?8_+MF;SLHTZ_GW6^<XU.GU.C[S_'KF<Q]4R;]X'XC\_H
MCTO?#@LP*XKCY?'NHRL.5A1'+\W"-CBV:1?F9D?)/X5="+\\T'AYU-CBXPI&
M&XBW\^ELU(5H#WMD$SY3R+:GNOTVY7$AV3W:U>^1W5'H5P2W".Z^,-X+H-]V
M=M-WXVEW-I&N?;#]M)ON9B9=W:S>DNGO0M>B@N]*P<ETF/2[S)IW)]SO^L-U
M_="_.Y7Q5P])FGQ VK<U*:K((@HN)<1S!S<KA$>,:\DU"T;)C3E=VV0_@0[K
M,KIR=M>-2=WL4E(W_)6'#\"G6[*[%1DIHV],\"Y"?F<F^;$_0EZ@97#T*]#2
M1VBYH4^WIX;D=E-:>H$X3119RO(@(Z&QP%0)ME$#ZXRTW@J#G,H]-WC@R(B0
M&] Z%VP>(8$W9DALJ?B_7\DV(OKFEAHO4/!Z'"TO7M^68GLT'D_]>1IS7.:,
MMYW0;29*?6K;!NZGYZ60;8UB5^K8]$>C%AQ_GERN02B<1V7'A^^)[K<)@(,+
MA#*,J)8&3(  ZCMAAAP7S%@JE E^%[[?QW5]=5'9_B[/%N]F4AQ-PM\FX>+O
M585,MAG:ZICM#(=4?XL!_3O.IID/-27T=1^LAB+F3R7FV^3T%&0J+%N0:=_C
MG@D[ECQA2*64:W\E1S9AA< 9%B)) ?[LQHB>;=S?9\.^#:>9C22YN0%,T25/
M$44MNZK]\:\W=E4K>WHZ!F(L9U'#5R>Y&5%QJO?)=*$'-.N;,%WDU[PO"N=Y
M NA;4[;8,3NS8TSD/EEFD==Y\ 2-&-D@%'(Z:"LP-P)O#&9]\/[MT1=;C]LN
M%=.WK9;\M*8D[VFS#&V']R6HD^?9!?XN98LG7_BWP.%@X/"&6612DZ 2H)/C
M&)QN ?Z,# I9%WWP45FC-I*-'KSGO$NP^GZ/27GS*-PBX$/;MRY57KNJ\GH7
M)U/XK=1Y#:!<9-"!Z4$4E!0*#ZS&ORB(PKX]8=\73N&R>]*?W9-_M#2/ 5D@
M@OT<SX<VK,U.6#0Q+'=23A?S^"<W^^/R#:__]_I6K*O=EWS5I=58=E]*N&D0
MWFB),CUKE(DP3H1C%"7/*>(N.:2-(TC[Z%507L<D=K$ELE*!1YT&_&616SY^
M2-U<GP\7>G SQK0:XW,17,*WQ);,2!LR(E26"--+D^D7Z+,4MAT^VQ8HRF-:
M(Y<<6X,HSQGV6"KD>&#(4_A?]#(XLY,-CZ>$(C(R5(^$+E!4-CO*9L=W6MHM
M9XV4S8Z^QC)[C$V#B%06^A7!+8*[+XSW NA7-A#ZLX%0FMKU16WL0P.4866*
M]EC_[D511.2,)!4DDLQQQ)43R&#*D.;:I9""L7BCN+,TM=M;(2]-[0JT%&C9
M+VBY(=XN9/ ,]#>H_ 1*G$=D#%,H&1Z\=3(E$TM3NX$(7H_CY<7K*TWM"H[O
M6[N/ 6ZZ#RP]^ E, !XQIII8Y$($.%="($VP0%9S&40$,!<;?6V?OJG=NVYO
ML+2U*X)>RE@*-NT_R[XP;'JNR*<T6( +ZQ'WT2(>-0'@BQ@IPV-*4HL4=N(
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M/,?NF41'[@TB'UXZ7O2SXZ?X*W:@&)7HR[,TJ&[[3/[Q4V4F<^HH)T]E2F@
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MZ [OPHB'SFS:T-A&D.A8$S4*Z1I$QL+IDS>5E7U?#5-S& U#11M0MWW^3VI
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MNU[CFNA=7>FYZF*/\48^Y"R1/WYE01P+UXTPQ?$AE^9_>;NST"TST%'8ZC7
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MIGKV!%^R)^+$6_$DGJTOP/JR%I^O+ ]I*?"QXQ';5L>>I<YUJ>^#XP/(R%7
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ML5B3,^,<N^D*Q%- VHY>89$$&S J4]<;4$6!7U$<-\4$3J0XPSW8XK>RV )
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MVD'%AH[H#ZRM(W2+HY6!MZ3>$9 UFI.&@7P)I Y\-*3%#SRN&)D#9:K6EFV
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M_YE_AQ,O8J%\A,1D'*&<'!.HC< 'L0CZ.EPD,MX>>R_^'3MC7PP-V$@H)XZ
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M*1$-(@4$3_P@4=4=TD U\R7X07J_Y5+)94KM;]22M P6NUT4OCC^1!U]);$
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M&OT]#5&-/BC3\^2JH*/JD)5@7]B7T+&C;!P-G@%4LJ-]@$Q#$'4Y??L#)1K
M:48N5=#[DFC*YH2RL2,T]2:I4=#][%F?=?N@1K_XAC3-199KAD<CW^/HQ0/]
M49VB^@:<-$ O2P^^F)J5Y=]!.+\)D[_CY ZOPDT Z-Y,?7L91OPK*'>B(G3L
M6(2.,5=G*E!%>1MP8&?AGQ$7/HG($83!,6."^04?L^2H*UF;+;F9:)?)YCWP
M?<_YK(-"S0\]@BQ@:(\!,U1TZHBK\^EL21W3NDGYPY%(-L&*.29/@>&EU)!,
M3C.6KDH>2D?]-7\#2[RPW:3WT%?$C'PJ-')B-7T@\WW7E#[0IKN_!J[[*(.U
MQ_X)_IB[>&;]4&U)X=[HIJTG,B8DF;DRV.-XYBA*&,Q5#="E"888Y,$4ISF6
M/-H,*,2XWO*A7ACIXFC<]LS#@/0SW0I$I!U%&8><DY-$/T&(PKBC#^!-9"")
M^6R&HD88&^F$(05229UC*#=T@!\TXN1G9^QV1[I!/837UV&PN?9>B(!+E_=#
M>(K/O7A'WD7N<CT6CCJC#T<NM'!,FQ  *4S_*)HA90Z6X0*\>(%K'[CV*==Z
MSS8JURU6JRC%;JMP,,T[D[> N@0$W>Z:NMDMR>F"[2Z< (%NI%=\U\AWP2&U
M)].FDMAD48W7.>KIU&0]X+\AD3M"7R(#$,LJ.:H*4:Y@+B',&42(5<+53XRK
M@'I"NP^S8<Z4Y^C(@<K?;2VNM[^[,1KLG/Q['2%UDNU(]V*M]Z4XF,B1Q*2]
MHN%=Q1W"15JF!<LH'Q)7)8GG7#YGF>A:PAS?ZQ5R%+-7U57Z1F8)XB(!>_HQ
M6.$H<;P@F0K(49HHV@#%Z)*:T#LUZGD2&M<Z7DRJ5S6Q5[B *(].@4<#\LL-
M?N6QCEZPN8W"@'QD>OI8)3 .:0;E[:!B0S85YKKY+\H8*WHC-HV#_HC,A>N2
M,O$9^;B,'L+7L4Z#/!B3DSM"0!""N(&D@:#?=)M2NW%3*NU)_@H2?=22@MR4
M X V=DM/^AX\:S>Y4QEQ8BHP+FCJ3^0%NVJ1NEX21L)>-';%,2J9V4D[@ [W
M=>6 KI!<!XQ<X!HP.@^5<)_-H%T%5>IQH!_:22%+!:VMX$*K/WKNLL02'9VG
MD+V0O8"H-4!*#<=\".%1Q=Y*4[@#"G -D4F+)&AD":3O6^!8/&*S94EX9.T)
MIQ?68I,?Z<]:50 F1Z+6H9!EP$(N&Q'NM/7"1B2JU8IPI8C>Q\07(@ #*.TR
M@"!]2%Z;:[4E9?-50&2H#4@A(Y<%M$/SYZ%E@* IM%R7,(YEW?95<"P:/&SV
M2VLA'P;8^@YSK&[4\'O!\8ZW>^"KH.CE24=AX  8SBH[+6VYZL2SJC*6&\E0
M"V @$L)7"8_D,8BPXX,S)"PX$4F=.0M,RIK=!X4D;Y_M0]&#@E> YBS;W5@M
M9R&\7-,PC3O&:Z(8/VG(T#^NO8"\6A*\U>_C9$IW3^U<APP4\NW!N4R;DGJ0
MIPT]$%WX6$1YXFC9>@U2[-(%6[=(=[=8DWZ>8S==P5/A,7!Q] I[,M@ D@8%
M20.714#OB^,)2>IIHRA+LD>;15F[2&X892U3^4QJ^QL:EK)\1H=G)X;'H</C
M9L.3RL/C9L,#8LLJ[X-F6<WH^)0$-Q7#,TL$M,46,I?_"XZR$1'V,ORD($1U
M&2-PX_8'@QHW;<SD8_E]S)0+;?F80DMS0]RK?74]/'L1@UI8DF,GAC@W<GA=
MN>1X]M8>4]IRC%L<JWUBT:8Y.$/6.!V?8O,H:]_08^J"/N(R&\2#\W9')@A"
MQX*5YWLB/(Z?P60)< ?$>MELPJ++.B+G8("^H&)G:#!<WIT\6J<SB(X(>RL#
M$*/V1[008$_U?7+XI?;G>8;,QK)6Y/'SU#!%=?D5L3U6@R8 S-8\B[XQEFL>
M@34+W@@N7H-V2R""BY=\W !2?H=WY!9Y"$]#".A0K-3*8,FS7K0 E+.>@(:+
M]L70Z3OZA7N3@JV80U7$BS1Y#B.XC*>)WXRJ]$H%Q6D$T0T03^QQ(]HW/RB%
MK-OE(7$RLM_\.*A3-N6CR/J$%L9&D4=*T/A0(NV!<=ZOI$Z:=ND0R@?)A3@\
M><IN2IS*I)1\?1*LV2[Z918!Z$6T3JS"GYQ%)7#:I>2%T-*,3P%U Z+N'%A*
MD9"B5_J]Q.<PE+7Q'"VKRUB"[KY:AKO0)]4W\'!_> T?GJ,PW3Q?DF>.$6S_
M8=H%WE>N/P0,4]Y?!!VFRH?8I"'#WACKST AM&$@.J]A=$VHQHH8BR4X?J&9
MAF<W?_-/2@;(2  4$AFB'8C$Y$#+QHQ%3>SXF^[0&>=[LH(K6<D.(-JB*AIC
MNA6P% NL(R*><*$DSC0MMSAP?.H5$+@TQ0Q9Z3S.=>1(R"U2B4BT>23KJ;)V
MF4J/MXQXT]_0J,B6"!5#8RAYELD1J@FQ]@37, 2[;$ DV+14'DN(R7KB7=0;
M:5ZZE^A-A)G1C]L3I$N(7IO40I<[;("GU6BHE<(]3WVUCA'O C<<P]5-305U
M]S<S%DK.([0SW^* E>$*Z@9NRP>.R3SYK<P'+KN:R<!MZ,"E^<!MH%.:00WL
MC)R\&Q]+#(^S ];*.WI7G92\LY0T5T5H4VEQM60*U;M"]'(I=!T2=]5TR,;#
MUPPPWI0%ML2]_J"UV_2),'+IA\[$W(&,$**4M*L,6CSZ;_ K_64\9%U3),.1
M2&,'\9:LC8-DM#8$AYRZ<F@*J'_(21M@EI+KU4N>R5?D"":G[H[-=+@F*Y5J
M10),O3<\(^$\6H>F:'A1,CAF1Z42P'^#Q_N;5* 68.G3J891YEI&WP]?3=B?
M5'#6 =MC "SL/MT2X69/#=)D/=%%S(PO=]RH1R0QED1#K+YE(%T0IT[LQ=-0
M[$O0VZQ#,*FL2SPZBUN$[F13(T_ND6^+ ,EW%^W;MSYZOIYA,P[_;W\DR_%R
M^8@6SMHZF_>:C:@GC>A*&M$GZ)SV!%-M%Q#]+;-/0&Z1>)K.HO$J2G?D(^9-
M4(,X_3ID;1_\&/07RE@18;7)&C2378CJ8\]QO(H\VH%K+\ T0&9B)B&NYY4H
M&XV^D;#D1/KWD8%'A?<.MVQ+0')_.1Q.Q SE! 7LI@%8A")2-Q&%< RII":*
M0KE>F###4E,1BH:4P I8D=<60''O"!WF&\482X#X_/GPVV9#IR;@G-_$#Z3@
M-&E24$) :JY=]@WVM7!1WN$=*?(,?@PT3U4"GBKRO<DDL&DH2*()D 52D9^D
M 8 "?2 O629@Z7<ATC@"!2E!:H,GWJ*ME,4&UM)!<MV 0BH:B><R]65(0>G.
M9( #-V&0I=>FCWK%R,(,<H*,!FE(2N1-FSI<IMM (R69*L-9@.1/ZXQYJN0P
MAB*ID/O:57_?S*/.ZX>["NU//C\]>,EPZ(*",R,0 !Y./G]X^E[X7&D#R%31
M?7'>YF00I6,IA4M"L\"3TW2<,Y8D"3>F=#E"#D\V#W<(?W(:D8_U\%P6F6FP
M+GS >1L'R9DO,;6HR\VS*,^C;C9YEJ/[9XRSE$J3DDH7DBKEMUJ&SU&38&D.
MB:=%@-5Y2AT)P*' 4)YEZJL"[1TZ_Z6,JS]IO<6S'(W4Z,UE2R5)2P5EKK,3
MM$VG,=7 8$DTRQAE(O>NP*C^-+,:&"PDIK(^C1UQCO<)V8=XLR?WP)?P!4=P
M4N*IJMG6H$900[,VC^B5FC=K%C5)W! <L?,Y]%W2:240L/GML^1HI)PZ,@H.
M*[0WEUZ\<GR1]G653M*>9"HA1E4@6%*Z!\%,6;5ED(_"B:/N<(G-W@5J[K4#
MZ'+#3:7?:CHYVHL9]N("3-A5D$1>$'LKR_!M4B0=[Z:,T9;U<N9 ;1J'NAK%
MF0]*#L8FF[ SX[9V4V[%PXA\."-_>^Q%N@XCFK7HCL.6JG2K@L^L*51HZR@#
MRSUPYAOS',NXKRO:GG:]PUU;"C\=C!T40WX-+S6Y)@^*IZK?7V1XJNB-G<<L
M+M=GSW *7P7+UX"LH&=O-S8W0"$.DE&%.R>C>S@<E422(F>KC+-0T-?[>%;*
M6G/D:@U?<Y<+O@"(:B84T'B@B3ZHTGTO4@-2I-;YXS@H&(MF8(M0AA[X\KL9
M$ WB..N5+(L;23D[>C#EPT<"H* ;Y:OSYFW3K;HC2%IF*"@#*Y7\37]/(Z9N
M'1;'6^H>5YWR#FK/XQ.%.QPE>]#- L8F*.RHU#/NW)*$*D'YB.I]641U1IUO
M-D/V4L5,5@[G':=/><2"^&%QQ?+0W"=.E R:P%.\\8( UBVW+!XBVQ>!.XCI
M"[93#Y)COS^CVD_V]"DFVP4><2_<<7.:%3RCARA!ZL9IV-)-#;RQPE!@1O"
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M8>Q=$)YX;CY4;'JE8;LP6<Z.'3PW@7+;?J>!-XB8@1=^(S?QDJZ.FU'</Z*
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M9EG[^-GRNKQ+L*Y9WEC).%;-^+2YUD-*TA62*GY!TZ(1%/S KQ?4QPS_+U:
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MH'(#-\(&32^=O)#X:?'PC42W$:M_*)7_58VM(*600\\/Q8__&> CGGBOAUM
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MM"TB%&FH>"+Q8[4WM>)K%'$NU.Y)XYI;PN+5S:T@IWG<F1N4QUJPH\#55TJ
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M-)(53(##(,EM8)*M;@Y%_U&L('ZL*BM(O9.?N&FFMH/-8M'P_XO?V]0/O';
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MC2*/E3H<J-ZJOOC_[X_EVF_Q3\)?R!_V0CD;^#N;I$$(YE2&DLC] ^;5'\%
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M+"QIIN6= T[-![ H(+S)&D84B>39W7=Q\2ZYP&MYB1.U>%)MM:P$1:7@(F>
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M%EBU$M[9TZCX&-"RB6!^C2/@/,(*G_(<M?4P1L8#HD7=KMP$*C^EP@FY1-O
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MG%Z/ 0RZ>_?[D%PL;LCOQ)MH&R<[JL!U7*B:O4T^X[RP+X2)X^VG?J+K#>W
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MC8HAG9E<%:3(VTY\=9=IX.EZ^T1,($C<0NUUOWKT/LYC2V-MFM<O.TG<1?*
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M>Q),'26V!T(+(-Z3_RS.ELA;H(D6[V%^ZO0D=DIH(L5]_9\%70F=F#A\:G9
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MI4DA@6RKF9F9O 2?0&(FK69V"U>6+(V_GY2&CASU-F-6.?CTGFY<[FJ\NA,
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MWW&<U\/B^2G)!=R UUR2W/A]G-H1=*F$RIO2Z*19KF)HSW2;B_B:T3.F&\9
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M]D_X>[M:1+A+89NH_$QM.:9"9,0M]/1T46_,30$>$:PO/\#N W"3U?4>SGD
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MNKOP,N5PJF!E F*-,_ 7YGH=5I%6FX2_8%,$0!MPJT[#7\ IHJ,=^E:;AKN
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MZ^T6?1>RIROLX]J)*3,.(NFB\3M%(8HV@MV*3\1#JR$T<?@ N[UF:GH.]ED
M@ZL8]2$$_;!ADQ&[L47!;X>&>_L*$IRA!'L81OLXB?%%@$.8*P]$I@PHU=G:
MXE9A2(AX$QRQ:E-90-$\'],D+']@K$RFI\T+9 NRC%@S[@!3!;YHIIGT*Q_4
M:I<1-B150 45.\Q!K:]M->ZW +L Y6OX%+^]YX\%/JV(G9PL!=?!;@>BJV/5
M+JL:LO9DZ*ANP7'["6 89TC4B+'PT9WM%Q40A&.Y88J5M;ZU*P$,,W"9> !#
MWWE-W;)R#S)]M6M,<0Q)4R]3P38_M4B29^^911R6E*GHG+):Q6XS._QXY=XN
MS2JS@X=GFFD=RGX,<.H<3>)=0(+[3[W,57\3&@N\F2/&%>F4;7@F7&QF*,-1
MR7BJM8[ZB2I*EME9>'[Q115)H_#LD))EA4H6Z%GXPVEC@ARK]U0K=O7C>1PK
M_#PH3O0\TJ0JFH6@1NFOBY37LI+(/8[,(J^%:='N8?J5Y(;0HM1;UBQ2@/34
MUSI/9K/(\:$"E>*;WJ0KSPTAM<$/A^,5HYL"LN(W2"/)0]PK[O<(<IQ3KXP5
MV0!(GA=Q#JXBK^*_KX(L#G'"HWA7(.RI';P,B4 K*5>!U[/Z0 O 5^1+BE:_
MQV5BD*#[GNX0%60E!'SWR+ZC67N;;TU89E'VIOH;P*<21*L/)%&_@1-;)$_A
MZR+/\B")D,@MLT_]QO)CZ3J6;+%L6  3-(NL9BJ"C60V=WZO-%'HX 4S/+0:
M'&M]H(7-LUJYP<JXO+>ZQ+3Q\NYX]KS[<,!B&!](EMRSO'B#S0[Q*YEC$GU'
M='/ZN3X_>(W5,E@N@5K&]A0:'F/5,;+FP_L]^0!93C)5HF^&.3T<@-O4GV.L
MZ_CZL&0>':J.XMH-66W#Q0VG=D$R1W%&HN'M(;VM,U/GGSA6:S>L!@,5O:8Q
MH:,T3=W)99#BU<1-48V9A;.?2-]ATIT*"<\"R;Z*U\F 35-YIGZV!RM-K9<2
M/>J'5LP=3\^C\5;2HN%H=55R''L5UMOS#IR%Y]=@QLM45V<!GU86W$-[-@*R
M:ZFA34G_,MJZ$3<RUP V(\=>4/PL7/*&,-3>1I:%2GM>^1?$.6U?/A4(&:8O
M$ZYF#@:T#$&J>SMK]35C8>6>#\ISL=\'\+C>;M(<?3(.=KLC@2;^:(2Y/Z;X
M/MD5$:Z"<1WLPF)7N:U,SEUEA4"(+@$(]H";+DW8S9Z)>7_8I4< &F87;@XU
M=GM[J6*HX-Y^EA1)\F<W7:DNF.*1/@ G19')+SKSV."=Y\?9RWW@_L@E9M7R
M$5\/S8,@9;&VX7T%J(RA,X-.-?8X3@O/Q>N_09B_I$_@4,#P/<@ .TN:\AAN
M2(JRMWI+8F1?G#-)^C/"O=N*HA%NTM0?BU04&MV7X=2QU7T?BBE7^2J9Q2NR
M&2%.XV[PV=8\CPG]INPI5<PNW8JCA/YP$=1K-DN+5>M7+<T]@3R&)!R_*KV#
MBS%/J0!-O3R\+J'9BME<L^IQEQ;P_P*8KA/P\]^^_!_\,;:.P6[L@.7A!M%,
M J(&\61G(LOD# LR8UA,6MXE"6Y*?VIC:Y.OD+U.D](%!QU2/+$SNB*SAL(
MKBVRXG 0SQ4"PL[@L=F(:[$8.*B]W,?HA@-)5E[L270F2.G:PRHCN"%9B)C\
M23;CL-V9Z1H*;+N=#H7.#*>N!? O 3Y"<S'6J-\U3=R&,O%9G-\>S)UN(I,Z
M_E,GV,'<4(7BIZ]1/H,W3(H-C?'D3/$$#BG, U(J@#3R4I>LYEXN1AQ0SVQN
M497Y $D!2D-(0B;S6YR_7Q=9GNX!+ TE>*99!M#_X7J\3#U'?23-*O39@$&2
M\U19H++3IXG5[2K(\/D\<TV:?MUS)'O*=^79QEV9H+'NS?@DC&+WA XP8L#O
M.'$/(I%=>L!'H$:4"KY<3T/S%61+Y,Y8V-<:@7Q%\B9V/UOCJ^A0E2%?;_%A
M9!>Z$72R6/2KS49)DC=\J7+5=U$O:\M9'P D 5,,$F.WLS]E8>(F6DM[20Z0
ME-*>#[] '+N]M26<8:QOVC@I,#67\\1I3 &2MD#9#EVR^-9"; @)FS%6E(CL
MB7-NXCLZ)?EA2?)PD+'.C<DO6H813;;:T$K.YT)PV=J-;!TLXA6E3+.A7PGD
MY;;9I(=H.@N=7P;%00+Q+&(>56B1)5_/(A1,GMPD1?Y9Q"@IHR96/&:1'EOE
M6(JT&JV!2^U, KY")M2=9I$86P4QBGIF),6U:W&JO3"BY*32F[C:9Y0XZF>%
MU2_+J1M#SZWE6[UJ@L^DR=2':Z@F[XJJ<HZIN?>^C)"VP.YK7O&:@3\++,HC
MS3S/IN,2*N4(:M;]\_;/ M$-(BL<8OX!\,=P([8+*+^#7LM4!O,&C.BG,X3H
MA]]?\":OM_=)%'_$48%TF$MW2'8[NU/%)B5B'L%7RGM\>$EO$9[=0HN\10A&
ML/=*TCZN#P*W3F9SQQXU5[A 2ED7].IX;K()COA7JQ\!C*K,B5]))97[9 ,0
M5XZ^0K:IU,27[&49%_LDN^&)W*&X%_0ISIQ9K5V:/O?^8+<?E0,^89JF7RN=
MOXXZK6_!9[PO]LR)M?\^/F*,*^W\-U?HD)NYA-YV5#1/M3Z?D>02('[)0);>
M;MRI5E_^GF0'$,;;&$1,L8#=UA7"X ;>T)JZ,O%,Y%7':FZ%6.Y2",(@HY]#
M3L-1)TL*A=_%29"$\46I\(L9\UIK5H-*@6J51 J:D+"/(3=#\GJZJ2)W)10V
MB6YNV$($(3,"57723_!"=9>@U$?1G+QKO4 =%3^W#]3\9I*11A2--+<8)(&6
MV2([MD8W5908&F'-Q3I:V>11H''R%CQ314#:J,$Y+[,1 +@J;$TV'.5Q;D3$
M"I9CLN:9 72AX/) FG8@II39I7O$NBKWE,'I^8!50\95_"?-N"656[$!8A[.
MT0(6SKD&1PEK=I> I*Q#\_ ;EZ"AAM1M A.7Z$96*J*F4='J*^\3*AR#FPEW
M>)^@$5O63!3NZ)MA(L*9,>*.1UK'_ZOZ;2\_M?-M5/]CO;T*T%D*P?,[ 'EF
M+TE$/:$+FV?W(>NRH;TWN'HNW&?#=B-[>>I)P(?@F;#3R-ID[T"0XQPRZ^UU
MFGP F,<(NTU]!HG8(%B)R@C6EOD"]H<4!O!8/A==!Q >L5\M"3-9Y65ZG++F
MVH:P0L9BU<>Q3(;7!<33D*+&;EM[.0*##(?KX?]@G#^"';%+Y#7<OP:[@L4%
MY/K:6]HNR-!1(<>"ZZ!%::CYY?@90)PEFWEJV8_'DCVM@?P0!Z_QCB17EJ-_
M3@=[YS<,,5/)-L$1,Y1J7JP#3&_LP@Z@P]@L8%DR3OG]X'>W+Y$TSRG/8939
MWD=6]#N2GX-B9Q5_19)RD8C:7)-WJ]%:6IOVMP#^ :IL>742>SY[XO4P<JM=
M];[5A#UM7@BP0'KQQ5W%OA,8[>UG:GH 00;JF1UQ9"1W*>)^-O-9UR6:N6)I
MMYE3IU>X 8).UH6D)Q ").NC^3V"7$Y4HG9Q[63PER+H9&\Q.(U#@^^(SS>[
M@SW2.@64;H*8E-$]Q'FP:QQD%H&).UJ4.'#,?W[$9OT<B=98$B+Y<- 98(H>
MG"[6#SZ:$"&>\VG.I#D OZ\+NA-_'2[=[(VYB&=KE6R*?4'RCY&MQQZ]$+R#
M)(L_P#F,'I'!>LO.+JPZBB.WRE/\]HYF]#T#Q-XG=:ET^]C4E0Z(G589(>JC
MVS)<LG4G84^KXF.<[T')CLK,(F\@"=GGB-?#9A&B *>:KTN6-4X(3D(?,I-9
M2G2TN*BZ0AZV)@N%&&9S-YX 9$S_+MESI.TXEN7<$D Y$?>BK672X-*$$\($
MU?S;TVI,6]#9$8#J1W%V'\.+B?+_%V>? ='_]__DD*CZU2\1$P:?^>V.6'BQ
M.8FD[V&Y89S\&.(D_Z\HWI^\,(+=CN%\P7RT;[E>=%[).6X6O9'XVP42VV!W
M3EDMO=2(V)'_LF]9X_HLNOO:[OFB>[S'-]'H\<[M.6#<9^XF-)*/RI[#P7[4
M.?F$RK[[>HZ$^!&XQ488KZW3 4'J';8)"0] IV&)]U@33Y._1*T#P+A=6 ^X
M+=Y!.56>0% ]U)K X/0*[#86,I*&RKF@OMJZC, [&AF&Q2OXRXDN!/3 ]NYE
M4XS+"$C+$=PK@BYIF%CWI;YA6<J6OT<\AT-:G.0Z07@.@K00*7:S\!P)92&2
MY:$Q'1R4Y4@)IP_/T5'#X])CQ//EBZ].D<^)"0!^<O#2X+NK>(Z"&J\4.;Q,
M!PQUALEQG_$<%C4@9%QP/ =$S#OY+CLFEO_?#G-.@;^/YW"HL="QY$P[  RQ
M5WJ/@R*?5/5J\AP=,=,4.#Z96/_/#G)-*:<IS\$8PC*XWE>>XZ*&A(P#E^>
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M-K^C&RHH=A:K/HG853/;Q1!B[#.P4Z T^7-S[KB01LG8LZS8E[_K#=" CS@
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MO7N9[3BN3Y[C(76/-CRK7%ZN8_>HIA/M,N*NW, 2[G0NYU%PC' Y:IG+*+I
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MA79&=/R3%.9_-BW,CUX205&8G[C[YTAB#L=\Y#F"CE<<&<&;4I*C2!F^7(;
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MH5ZZKUOLC$M4O!Z:H:=^2HRZ3#?]U3E/ ;KUF5K_0#H]SN1#FR._@S5R^)[
MDZ$+P5CQ]>S$[S< Z>YY##(22YH#B)2F51C"@EGQ<LB(WKV9""T/S60@'9/
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MVNDVD1#X]XXI0B+V_&^:S=9<V#*,I>A!Z!$BMZD?*0*(0C?RB9M/YVZ>!WW
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M*Y;*F_FV-.%]UD>IMZO#CU_7.8'[=:CH$*B0S!/D\098QOP? T8(ND.7-B[
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MTEXB%5:Q7B1F"D -/ ELOYR4BBIQ]T3:$^E&B=1 #+"5EJL=QJU#=)7DQ=
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M6G:Z#("!/97F,16P8X37(E VEM$$Y-..V%V:#U;(5.@=DC,^WPA%WO5S)BE
MEY&[5V(Y7([3"0.=0SO8(#@R-+K34@=:?0IFL&I3$\&:8Y4C/.*P5K.L8'NV
MDL([H]TV04R:!GYG*BUZCS7UJM!AP&4U"/+K4#O"HO$<4J<.^Z7 W=A=;L%W
MM;9*[M8=H1E@S!T;T$,1R3%5JF%UXD,)$S@X/G:H#HGO9O7Z,Z[J<?#RZ(BR
MD<2,1?IVU'&S[]8E@\J5<MOUDV#J]#&3$D$.<>R4UPH[BXDM5>]D^X8;R?CO
MA4@O1&Z)2D1>[/S\+@: &A.RP8861KY"YSWT5"\#$41'PTARU4"AXMWAJ@(L
MCSMZLV(KG$8*)[Z<$50\0Y\T=4FE;#5VY+H-6&WK5<IMGA8$X/#$+XK!@:E\
MGF@4[91;FHX=D(0$<+WZ9.]<W2;GZN&WX5P],Z@IJD[KE];OV4IK$HI!0#/^
MRKJM5MO.E*V6AB7U'*^Z,*RXVFLI81Q<7!*VS%$5HDN-TH-F^"15W$BW\HZ?
M8<8=B 5TX7F]*$C);>O9,,G3$HO'^FFZC3E1EC/68ZE'M(SCRH3>>O17C_ZZ
MA\F\Z-%?74=_;8E6<K_VT@:D\*9JIAU]&VK)6PI<A2[F\W.>?I1<_LOJV)<@
M4$M]DYKR[>LD3YQ2,I^FIC-55>YLC%U5/R=(9E0;UA:,/3JBU=^+I(CQ.:3"
M-#V.2OM0]NH9I^3HHP(H-(H9'^8_5O0 Q,$G-GIN["T[J"DBX$ TSOWG-?B!
MU:5^LO7(' 8.V,T8UIZNL$T#@G#JW;KJ'DBO9U;-_^H7I6N+IK*SU/2>,@BG
M;B%X>AMSFVS,XV^%F0?O1C&VY3!'ZHR]800%J*%Z>F.SX<.J[#QG?_G WY1K
M,G$D!P,X*:^S7&/-&5=DQ72]RE$MGDN=QM*O: 4CY)+8O!W @V .7'\<OL9E
MZC:N6X>AL*U9*GAF+=N)ZD1=WYFM]A#='NJ_U-*HI4Y POW>R=].?0)94_%K
M+#4RRJG7BZ:@+!4JHG8[&+UT"8!5SQT;1.:,.]?_9_5)Y,H&(;)YG-M2/-B>
M*U)I6!^B5JH^1@,KT$E7CDY^ EDOC4M)M$$S(EB!.,VH9AX_Z>B4TQW44K2<
M?.JV$!6MU/H!$<K-2"X["(>E-;<J-O.US5)OF!P&N6TW4[LKYK(4G6H: \K1
MH*G)U79O1B7]1K@NF1U'4![I1'J]E1PCHW=T]1K"5!<QDT"D<,L01TZ<<EP"
M,VY;M+E ?=Q;,]E8G\LTB%-D_)PXPN288]0G\8B0,'MV558!X"WYH*9+12.6
MI$ 5];]-*8E55$IN1:H+@1$/7!$"(#9T>KRCF+:60/C\7;6$Y(:WR0#N' A'
MXP9KQ[DZ7$4:.5U(ZCIW+C;'?NU"&O%GG:"^6+.)S&;B]CGLU^T#/%NE?#_]
M-I3O5[76R[W&O3881AU<&>A+^7LYUAE(@HJ/4+$:%%2^G#+-OU?JM .?/U&.
MD.F'W8:D=+"K5@BQ*ZT0)/!^#?8#VWIN)(WW0%3B'7;9O4E=&MIJ0LOO!F/M
MJ%WFCM4R..<+L.%0)='ZM]]1:AF=5M53<I-#81'**D)63Z-DI 2+ U@&&+1M
M5#0@3.1L/=JTY\9;Q8V??1O<N*VX1L^-5_L_(ED(%6N;]M'45!N95CM>#7#_
M2F[_BB58L)6K2%@#-@#!_='3O8/@?2R270,VM0QEA]S/RQ4@=\G3KO07.MI)
M$HSL36LA^,MN<=\QCRR;G.G&M*..<>2%3DSS=<O-*<2-,X>S$IJN<Z7]WCG
M*]:,WG+8CIS02D5J-']33M<&"JB]J?%\%]+#!]@!!\&?N.B(L'+]9@=&]"DK
MBA*<M+FW%F]@>>"VL(D'10.H@15%(2JTK7OL[_@U4'FTM.\$!+;(7TJAWZ4W
MI1VV%7#,7L^L4P#[!( @T03;&RU,)(&0>E1\^=HJ_\O8;8Y$F-##;F-S3&"D
M%GYH2\H8K_K&B%.]C/HP5.2H%K<+7M0;8[1HNB::$'CME^;#-Z"B[?"'FF54
MN DNG:AK4[G)7S38V^I =-D9UH-7>O#*'2;SL@>O=!V\\HA0 6T*AS6L=-7E
MUI5!M4*=+V?E:FZJU:VIVK?*4#6:@@:IPBK8F/J')*TE7BLA"Q(_(A^WU2K@
MI2-L[K&P+C5$-JYR48(\^K3@-@.N[1ZI%K!%6 FV!%L0TT>HSP H(IB$-055
MG\K\>>V$,%U143[)4AN2^@N%TSQ-V!\I)[F<4(J4[4>RNE=0]ZCO :I-O1H^
M.:><,5S-WA;?)EO\FZDK(O?.;%Y.TR;HC?(51KEO5R];6%Y%LUM86;52W1YZ
M#,WZNO.//'OX9I4/,JN7+:U:-YB,5-\X=_[6&PM C*U)[#L0@!C\MVF3K<::
MH[QA1*F1S75-":4R 8%+B;%+[<Z4,)E'58*I;9CC"5IJF4/"S-P'IRM!D97G
M^'SDBII+6NDB+\W><! 6I)WM^T7%,IPY1MD"M0%KXS6&JT;33;O.%96]/']5
MB6)_N7:JHOM;D!%;$6R7C N7&1M(S ^1NJ)W6P09U:(6+<V6*\/*^\O'RM0O
MI%++<+\IU&""1;=TH'=A??JZW"L;*5/Z:91F!57=TUQ*1]9.J"O)@VS:MBF@
MEH%XX+E#SM*QYUI]A4%KL4>QQ:G*>KZI?(?$NDRC?2AFJ]2_;R3S\=PVCCL'
MHBX6WT9']H=H&OE)YB$&"]#!2\K5N[I1UP6&:/P13M^IROFS]ECK&5:U!3.>
M!L<?EZ"W6'S"M0^4=B7(-R#TE,-609I99S[HRJ SZF9+',^; 1/]+9V#4#8%
M9MR8]?P*2BTO\YPQ82TQ"EWWMZ^JPD(/R0EGYW4_JS *7ENU#$.7-NNS+2I2
ME2'V6@2\XM9JM"2NH:.G6S<[3!;U?D$FF!\%9>9PBQ6YM:_MBN*SWNIYU4.6
M-=E;->9LIPIXF3>PDJG;O1;"J5%,J8UB5F#[:;JT9?;X<F)!_2,(X%#-WBT&
M!=)J2S*@Y4ZP0Q,OD;V6OZ@M([O"R'3#ADIT.?4X'G"TCH@ /65<Y#KBG<3J
M/-:-1FXSFA\.9^)W(,$18QK16: *V.V;9[-\*(8'O/$C&BTXNBL R"6!\2YV
M6!9V#^B482] D\XC%C>MRW9W\'X _GXE/@6_>_M/%K,KJT0<_X=_).K.1;,W
MP^\[;6EVJXSMY@6CSS[J.7H5(*!B)<3JK[%=,OOI_2)>= %P!;H&IE/$+KB\
M=%F)1(E3X#@]/!<HV9]*C?<CT$WLUK[W$1YFVEZQ*?29$.N:BQPXXB27SG-B
M,Q[!9@FM>'(LB4 *S9D0^MR!%AIP#Y6TM,9KE3\];_M,W=7: *RXOK<J1-?<
M/ZR^=ING=6F]-L?.,FI&JT(XK),Z8\.G5[W FFPNQW:15:9/X/I_E2:]85E]
M)9+TO>O$4NP(UM<*NO,U\86:][?R)R]%20_W#X^#=83OFR ^<)DQPB?$)HFS
ML<:%^70J0Y>2+19I&6-<2 M4JTTNEQ-@F5:%BS'G QFXOYC<!X+GU 2_M0:C
MJQ?&QY]:+DQ@:5(2Z]MC\TDH+D&*9Y?(MT<D]8BD^VBIO=]#DGI(4F?.!H@\
M%!!Y6DZFJ^7HKM<-%!U0'*Q:K?)RT3/GC&AS'=5$0XLC;;V68%PMGZ%M=V\K
M'T"U?CU\\KL :L^;X)[M,DKN/<4,"!Y7Q68T5!CJ]<Y'@_EO4U$-&AWXU33-
M8;I1K6+_RD(+9L"S,E(%?D\]=1T$_^<45+1A<!;'9L*ZJL+03%C@:Q_':;@=
MLNCLPU5P<7$!S.G)V9OSMZ_AOZOM69][5XJNUM"UI5Y3/'W<K,50,?]F!4HB
M.S(T,/0 +TTI.J&C9(ILI.-NX12VAPJ^TBGYY_#)V:N_O7WW^]_/7_]ZONZ@
M/$IY\;MDD%PD8Q(; @@\6]PD+$R,RT8(*[<#5ZCP,WQJ1X<:((H$6RE2@8PT
M&)?4#^I.(W 6+RG950DW'LEZ2EDGAKL09NY.>A4+/1?AU-R+,5!7%,C$*$7H
M>F X=/N"^EQ46<5FQ2ALA4Y:AP?T8IO< .*F\!_%2S&YVCF!5T;Y< ,%(1V1
M":G$Q)]=4ZQJXIQ09E(!+4XQHNF"FNHUNO>\219YCYUG*2M\S*^;80IX2S6;
M%>5FUNR>9<L^B!+HW%_OM0NZ@BZ]!$TJF8-,W\$79V /V)J/FKEWD6(FWB^I
M20(T<4!R2U6TX*H9USN=^,015;.-;C_=6E>/)<$T8-0<$)<7Q5^UP30ARI@W
M!YE#"KF<E+$@78P\:IQ.@(7]*8N0(Z+FCH4-EY+'L.Y?W%V=*=@M\=?#]/SE
M^!_$'2^Y1%>S=?07RR1,RUQ8FC;GE$_XNASBKZR?AY0WW)6%_F_\V1[5Z_Z+
M_!/\\R1X!U( 2Y =#"@,\'A7Y)S2R8&M5FMR>-RZ*+WOO?>]W\7W?M#[WA^Y
M[_W.(I#&B&28<L_;$W)@4UJL!CU@4W#H__WMXN>+J^!LF_2$C?LH+J_>O?I;
M</7A[.WEV:NKBW=O@P_G__./\\L[>/.>W3"I30O/^RME^][#)&P DW)_$[T\
M?W]U_N'MV2"X>/OJ'@RA^YM9!<=897I>D.=@Y$IH]@M]-XMS!\VA#>8?WM]4
MC2W?I=6KT@XQ'7#!;<N+*N6P@=9O]&*EGK@1>G1LQN])EUYNP[[XFI)F]/C/
MU=/V-Z>G?<4W5K-)H//PK]_!+X>'A_O/CIX_/_I_^\,_LLEWB!)K_Z*66/;L
M\"C[=&HTN^?[!QE9-K=_C://$KY;L'6]6=J;I7<Q2P][L_0;,$OOAYVU\^6#
M57SYH(TO'[VL^/+ABYXO/\@[?QXWN=4*W!'U]=]OWUV=GP1ORKA062R#."VT
MBV[&G U(F3NF"@%6DZ#@'Z4,8D'7I5ZBCXA)]:_[=1PGO>[6ZVY;J+L=];K;
M-Z"[/;Z0PL]]2,$/QK>C'3LYUQZNXZ^&<\DOP0XO+.904$45^H2.&)7UL%T1
MZ>//A<Q1&9<,"#H16*$E'&[<HWV_O8?NQ:.]@4)Z6'@F&)<Y0>Q6X!K-CLVH
M?%F:<%%@+$HB$\U=Q-KR\E>!MTS'N1:T*)(4%W69+=S.+K6=T$,[^:^5:WU'
M([!3J>"P?[%.O=.XO,$6/^JEA;DZS[6B/S+'*M"VEU:%9#9GWF#QU(S;.=4A
MFC@0Y8 W&JH.B*"X:+1+ UJ#2+6<Q ^TX(.QZ0+FC&=[5%UI;'H<,H2T7AFT
M!B:N(I'5?1.#SL:Q&RU&8/'%Q*9N+PTAJ90:+AF,@!/"C+L=O0M#8MM"U]:)
MGV-2H-HJ'C7?$*')KMSE2'))C 1&PFY]-R[;]C:+?2"GP,-F"GG<F,#3N/F%
M*LJ"@?7:K^UN"03(@L]=HT3[K0_63;6]7$:$TKKDOIGUTT8&\JU/5Y/"5[,'
M1+5K3G[*<D6]G5,60-(3/X_<:U9021XSE[H_!>>.W^[%8I&6QC[D@5\>#_>_
M/S67 \W'(M/RQ#HGV2J$L9VYB9F:7+#YQ%YM+H*KHKIG_,7P8/_P>]^%8E[!
M^E!^**(5MQX>#9\?/KW;O0?/A\]?'-_QWJ/AX?[1W>X]>CX\>/'\-O?"+WES
M8:U]C5322DE>X5(VW_$#GR:I@E++9EB/&!$\FN_F;ZH7NS_<?XX>L@:?AVN7
M/&G>K?0H=^\*;]CA9H$#MV70MTO5!F(_J?E;6K;Y'A?2^1*MDS(KC!NB2TO\
MA8O:XL5ZH%4-_C*FG_VC?GW[X]\"WJ/\/U G>A[PU6BT30A^AN#SY!R0 MR2
M_/6[H^^^9)MX43I#]Y^G8CXPP^C7KE^[^V("=]2$>X;0$_5&/#RW6LFW8K89
MY6'U0G9,?WAPOM'SBIY7]&OWB-:N5QXZNC&/@*CO57FX4D7<:P]?GW' OQ@6
MJ4>+_&YJQ_OW!>KI>O3HL817+R56%8-9R2@X:P19B_3D<8<0^]?M!,UO')3V
MJXJ#-\/@[V*4E^%4YDKV*U/!]>I%P_J5X94)?T@;*,Q^97AE#I_N!^="%\&O
M.>)CSJYE4O8'RLK;M"RFP:5(@E^P9[G283H(7L'$QRG<+8*7Q_LO]AN+U2<'
M;8LVU:WD(+]NW6/29;Y.<M"//XS2:/'3?_SXP[28Q3_]?U!+ P04    "  N
M0WM:*_\14TT#  !X$0  #P   '-E<&XM97@R,U\Q+FAT;>U8;6_;-A#^WE]Q
M2X%V!4R_KFL@:0&"+BV*M5V0#-CVD9).UBT429!4;??7[TC)79IV0S'$:X#%
M@"V+O+?GT9$G7M&&3IT\@*)%6?,5BD!!X<G9;V*YFBZ*V7#+ K-1HBA-O0,?
M=@I_.+*RKDFOLV.[S3OIUJ0SV0?S#776N"!UR(^2T9K>W5 1P=AL/GU*.G\O
M2->XS<0J[TB+%FG=AFS!,]9X"F1TYE#)0.\P+\U6>'H??9;&U>@$C["3PN[M
M-T:'*(+98F[#&-7@+4]SC>Q([;)?J$,/;W$#%Z:3>B]8FA!,Q[(!MT%(16N=
M*6PBD"*J[]UL6@HHO)459M:AV#AI\VN^%^S[NKO'IS88_WCBI?;"HZ-FF+Y"
MIR,:;30F^!NJ0YLU%$3%\Y@H?/1P\?T\+V91XZ286?XRHXG90^)V\4'<!%X9
M95SV<)X^^=_3L!D>8VE4G=^([9_"^7)2SK8ME11@R-,/U!R:E'^3#+<'^I-,
MN(=[JW K]HONSN;\<Z,]_P/3P"O>,RWR#]]>X)H\QXTUG/>EH@I.J\KT.K!!
M>$&NNT^8_Q+NEZ;+;8/_%:$:$R08""T"Z<HX+L4R5E$H=^"PX33159Q*$D/J
MC *700;LHOZW+XSKX%(<PULSA=5J)9;'R^/5LR=@D0L[Q6#V3I;SY8)5374%
M/]MD1^H:7CHN_W"NI)Y$B>\^E7BEXVKCJIZDTE 2/.NL,CO$4>.\=U4K_2C%
MF7^)EG-=RTFT,(TCIG>,++YR0,T(:G@C60>6SY+KIQ/84&A9PENL/G#3D):Z
M(JGXL8VP_6?,,X6JK]EF(HP\G&K=L]+%X&\@:C$7/SV!QKAD>8?205R:-?R(
M%78E.E@M!AJF]TOQ4'#_Z'V@9G=75N/,S^#,:1_@D>QL#K_SAKR&UZ_/[S/@
M_[ 97_)F]8;W%3.!YQP=[PV:Y&&Y2+IWE(Z/=^2OS\/7/;_=4= '7OJQ"U I
MZ7WL JQ1C"?X& \;Y%BOM0FN-04:A5M1D^/:'7L!G,%]I_.:O%5RE\79FWV#
ML1+LXTDR@@OR9QH*1^-9^J\3=>OV,8P$DU:DF;8@74CMC?SC"38\# ^@',HK
M(1M^A\BDVLB=3SV08A;[)B</BEGJN/P)4$L#!!0    ( "Y#>UK1X,\;80D
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MM43?>WQH 0$LGK#;1(TE!$.H%2#4!?H"A6TG*F-4BXN$\63"\B33.:#V/+.
M(EAR%N.5%@C<D/M8I)F*<0F3J4+N@4 "/AC#]81$8GX+V.],FP;+ E0&NY04
M\% ?). +[><QBB58'37!]2)#B_D1,SG]F]8?@X:R$1I +(S$Y2X:A8U%%N$
M30J^59#:13X(%> P1U@M8-YDU@P;EKT*EK6_+Y8!"T6"."9*3'%;0XJA.-[6
M,_=%$J(3X)0YP>^^S -L$[DQ ](:\DIH.6$X'$.L)+9*.:5=B7BST#5J&MB4
M3(TD<HD"R#6%T+7=&:N/STW$0JG&IB*BAB&B77/LB%-AH3=J69OADZF4>:#M
MAE*O@E*=M:34]1S^WIJ2+N7:@Z9X%88"+[?-CH7E*>,:+ $0T,*30$!E@%;P
M$& 1U2"Q&#T<>3FZQI'[4ID<ZU''6LF"":E6/@18;-@V C\ 9%*![L&='_%D
M"*R/;N4RERAA\Q+=;2BTL'D)NMJQW2^R""4H&G17P8P2S014Q,O^X=[T4;XL
M63KUPW;W%9&E6V\==@[:^\UVL]-M=P_V5D2<;;ZSCLPY 8//!/%JHZ7/8[Q&
M@9S/<_/T*A11>8#$*'LJ8C25:VP (3H2QOH:E(+$MD.I@JF7FO5TQ1X!DK$,
MTJ9LJ95>D&X*]%BHBU%2!#RSBGI&!()K00,012AI?6]"+>6&PCL[91@;"UK/
MI R@0AEZ0JJ4XE,6?BXY.50<EE5B&B9BC2+HG(V5\9L')(B/$.M#L!(?MV'R
M2S/96TLF;U]PS8?8?&076H3[--<F)U>"(+\:'+-+Q!0^9W:F3)VUV\Y!JWVP
MV^XXG?W#@SW+6BIL'[9LX6&[V=[90'8M(.NO)60'(RYS.T/35 IAB*L1,8($
MS))5!49U3_ UQ>7R)8;U.5@1_80I%C*>RK-/]_T4;\COI8%6:>'G<P?,J]9_
MUG]"80/4IT>-;^BV#G0+UI)N)P6>'_*"<GCE4L7>6:"=2&R"658L8(3KF81!
MT4H1$6'DIGP_UX3[F3!IKKU8F0Q+:*,.6S$^-O%7CI;%1K<?"(=(VBQ:E"O5
M],F;4;*1\I V25[HLE-H$G%S'T=BV,8MR2&P,:P=/3<JP17?A$EQ"[+,/"[(
MUYYAD)51>I/8>"YGNS]*8L-N( 45U6M3=T/>;Y9Z4\]#%'HRIFL/%U^H%\>E
M5Z9TX2#IKBW QF(;B\)2?^XIKJW3# 3J9*MO(S41^(;<,W[2TJ^:0^"O7*#*
M=M;($]_F(G<VR9&U<)CKF1SI2\DH:2&08K2,HMR>+P )44::]TF*,=J'0D<P
ME6LJTAUVVZO*G'\1S<I\0I&F7.*G>( 5#=R[J264](04F15&=N%CK!61J\&P
MU>0QHA+-98=1A@%+=Q<V4>G:D&P]\Q9]##Y#C>ZBAI 'Z]Z0-':'MF17K8CF
M1#)2<@04TB5\6&XTZ](C0IQ*-0&\.XY4X0/Y''>1:\^,;NN?8,$33C%]]F#L
MFASO8@LGFFB[!)81G$Z(]\K3VZ08M8RC(G$'(8C+[D+D'IUUQ&<ICX.3/#7@
M&LJ:(@8JZ]@SVD4]>^0<^]=5YY1%+N8[MZI?"J%4,$^&=J/>?C-[S+P<8'7.
M?#<+/E&S66^TOJYFY^NJ[77J>P=/J8I?]*)-JE/VC7H3$>!Q_W:H59X$3@F?
MT/XMA\_,C&3_.U2PQ*+S1_T;]D1_662!4):-*&#%!5R)Z0+G]Y(5[.?K%X^[
M+'SAX__/(=G3UMZ(8Y?]R37Z]-9^C;4:K>[<Z?8E$-C8]LMGI14:$J5_)"N^
MG[C? )#W;_B4A=T41T<;=\N-O,0@]T:W]^@U(PR,]NMMG*A?X#$\[ZS^DQ[$
MKME=/$3]9_VD7F,7$7XL>T:;R?]U4^N%)JB-(5=DR%@$@83OQ) /W@=:+X@^
M-L,_8NGZ?O?KEUC_P*2^N@G]L-[I;F;T[W,BVAAR8\C-C+X>,_J%!B-HL6%3
MZ,>1@) -[L#/Z1@).R^VY;[T9?W7/NCM"RT27Z1</ASKSF.>##\I^?=#O0R[
MF"V=V2Y)^1"<^?SHUES:?N8',VR2O]@AI=_)P-'D<3*_=_* C?2;&PL_M+%T
M[P"2X+7\ L=7O+![L/"HWAYC4YX6;VN&)\8QH$7XG)=V%S/]T7TP5HZCW)NQ
M.S!%8GK^!IJW*"Z>MXV\>(@D=;D<\XFQ$=C1+OW<RKN?CG;M#[7\'U!+ P04
M    "  N0WM:K:]B+7L)  #*1   #P   '-E<&XM97@S,5\R+FAT;>U<;5/C
M.!+^OK]"Q];<0%5L\@XX[%1E(.QR-PM3P%3-?91M.=8A2U[)3LC^^NN6[;R1
M88"!VV0)'P#++:G5>AYUJZ7D.,X2\>$G<APS&L)?<ISQ3+ /@Z].J^$VC_>+
M1Q#8+R6.?15.B,DF@OVRD](PY'+H':9WO83J(9<>S3/U#YZD2F=49KT=VVC(
M1TM5G$RE7MWM<-G[T^$R9'>>T^HE7#HQX\,X\QKP)E6&9UQ)3S-!,SYB/5_=
M.8;_B7WZ2H=,.U "G1RG5?N1DAF*,*]13[-2JZ*WGGT7T82+B7?#$V;(!1N3
M*Y5060GZ*LM4 K(9N\L<*O@0>D>%L!.L7_43**&T]W/=_O3&,<^88U(:,"_5
MS!EKFA;=C8OA^$J$O27='E+'OKME6N)0I9+,VF;,PRSV(IXY ;QGUKZ#NYC[
M/"/%?&&]#\?[Z>M:1+#HGD&^;8*B[^:+C?B?/S>Z]=[\6/<!8!9HTT&7RJ.B
MWH';[AZ\6[;^G!VZWU'M 4L$H!+3:PN.D\'5S?G9^4G_YOSR@GS^<G7]I7]Q
M0VXNYZRW8+=7 ,N:F^CJRZ?!-6FTJ--H[](]TK\X)8U.6#Y]N3@=7)&;WP;D
M>G#RY>K\YAR$!U]/?NM?_#H@_9,;<GE&&D>M=FUKT<JB_6O2/[W\?#,XG4<<
M&M"BL%5OHM&L3?M7'_L7@VOG\NNGP7\J<S;K]>;3K?G=!>:)Z]ECS?G2UCNO
MD5^Y(+^[Y!/U=1[$3'-6(P'3&8\F)(MIYBU9!]UK(*@QO^R EHDCN,D<)EC"
M<+I!TY3IG6I<(3>IH!,O$NSNGOW^FQOLI5+'"CDFHSKK64LYV+[Q?&J8X#B(
M)9O.!M5UN[CHKHV12WW&$#4XOF;TUKME+ 751*^R")<X)L<:Y@%#['QHN-4$
MS 4V13>->OW=4H-K RP2TQ$CFHTX&[,0D,0-Z4N94T&N& 9L1$ERIG1"&G7G
MWT1%Y)JEL-!(6B/G,G!G+A?=[<SIO@C\NEOT/1)]S8U$WT>8M! !EDS(K51C
MP<(A+&L6A+I 7ZB@;:DR@K4HEX3*"<EEIG,&VM/, @IA24D"3YH#<",:0)$F
M*H$0.%.%W#T!R0)F#-43%$GH+8-^Y]HT4!:",M"E0-^(?:! P'60)R FH3IH
M OL- A8+8F)R_#6K/V::E8W@ !)N!&R7P"ADS+,8!FA2%E@%L5W@ U<A#',$
MU4+B3^;-L&796K"L]?=B&2,1EX!CI,0,MS6@&(C#:SWWGLL(G #%G3?\'X@\
MA#:!&W,@K0&ON!83 L,QR$IDJQ SVI6(-TM=@Z:AW=+74"(7( !<4P!=VYVQ
M^@34Q"02:FPJ(FHV!+1K"AU1+"ST!BUK<WPRE3+WM-U2:BTHU=Y(2MTLX.^]
M*>E2QN.XQ*LHXO"X:_8L+,\)U<P2  #-?<$0J(2!%7P 6(PU4"P!#X=>#I]A
MY(%0)H=ZV+%6HF!"JE7 0B@V9!> 'S)@4H'NP5T04SEDI ]NY2H7(&&WL)U=
M5FAAM[#XM&>[7V812& TZ+T$,^9S+5WWX*@[F\K7)4O;/6IUUH@L';=YU#YL
M'31:C7:GU3GLOA!Q=NG>)C+GE!F8$\"KC9:^C_$:!G(!S<WCJV!$Y3,@1ME3
M$:.I7$,# -$1-];7@!23MAW</L^\U+RG*W+,0,8R2)NQI59Z07S)P6.!+D8)
M'M+,*NH;'G(*FW08 "]"2>M[);:4&PSO[))A;"QH/9,R#!3*P!-BI11FF0>Y
MH.A085A6B5F8"#6*H',^5H;_?(:",(50GX4OXN.V3'YM)OL;R>3=SU33(30?
MVXT6XC[-M<G1E0#(KP<GY HP!?-,+I1Q2:OE'#9;A_NMMM,^.#KL6M9B8>NH
M:0N/6HW6WA:R&P'98",A.QA1D=L5&I=2%D6P&^$C)IE9L:N J.X1OJ9X7+W%
ML#X'*H*?,,5&QE=Y]NV^'^,-Z52:X2XM^G[N@/C5_L_Z3U;8 /3I8>-;NFT"
MW<*-I-MI@>?[O, <7KE5L6^6:,>E33"+B@4$<3V7,"A:*2(BB-Q4$.0:<3\7
M)BVTERB300F>D$$K)H F_LC!LM#H[CWA"$B;Q<MRI9H!>C-,-F(>TB;)"UWV
M"DUB:J9Q)(1MU)*<A3:&M:.G1DG8\4V(X+=,E)G')?G:#QCDQ2B]36S\*&<[
M;R6Q80^0PHKJM9F[0>\W3[V9YT$*/1K3M?N;+]"+PM8K4[IPD/C6%D!CB8U%
MV4I_[BNJK=,,.>ADJ^\"-0'X!MTS_,6M7[6&L#]R#BK;52.7@<U%[FV3(QOA
M,#<S.=(7@F#2@@/%<!N%N;V ,R!$&6E.DQ1CL ^&CLQ4KJE(=]ACKRIS_B2:
ME?F$(DVYPD_1$"H:-G53*RCI<\$S*PSL@FFL%9&K@;#5Y F@$LQEAU&& 2M/
M%S8S*K47)=X@SS8S==&'^#/2X#%J@'IF/1SPQA[2E@2K%0$=ER,E1@RC.DF'
MY5FS+ITB2U*A)@S>CF-5N$&Z0%^@VP\&N"[Y!A-6WFEL--R#^H.7&I]X'\J*
MK^\53WLUF>)AR@ICX)WC7GD?&+7#YNL]*^X (F$C7HA,P>H"7$MYP*6@J6&>
MP3PJ0**RB[WU6]2SEYBA?UUUCGGE8@7TJOJE$$B%B]QHU=W6N_F+R^4HJYO+
M^UGXC9H-M]Y\7LWV\ZIUVV[W\#%5X1^];)/JWG;=;0 ,?!K<#K7*9>B4S(_L
MSVKFSRU0]K>#!2LLNGAYO&[OB)=%%@AEV0A#6-C2E5 N$#Z5K&*EQ?K%=)>%
MKWRA_$<<Q.-VXX!CC_Q.-7CYYD&--.O-SL)]Z140V-KV<;8EKV-(D'Y+5OPX
M\?X"0$X_,U(6=E(8'1[EK3;R"H-,C6[?X0=7)'[ H-5\R!7_11>]'S41^V9_
MY7WCD[-^C?S+/7573=-V_?\_?GSFN9^)>5MK_!K;;_V7]C4VWM/!]Q96[1==
ML8_<=F>[9*]36+GE_Q8)6T,^Y3.,FV79M^"B3F+.(G(V371>%H>)*Y>YO\N8
M=S]K#J--8;CW!FY/0V;O^T$ KM:>QI0">P_Y;?B+Z<Q7_VCQ<]*^+Y>L7YGV
MG3L)2NF0.8N)WIV%XXBY[Y*PAQ?%X2]^A03,<Y[(Q6.A>XS%KZ-8^@Z*E6<B
M3(;K\N44SYBPPZ7Y>G\"3?F:OZ\9*HUC()R,?LS[+QY@Q-.(LQQ'>>9D3Y:*
M#/OB"S!O45S,MPTO:03D]:@8TXFQ8>;Q/GX3R8>?CO?M=YC\#U!+ P04
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M-%5'C595_HS X9M65?T P7]02P$"% ,4    "  M0WM:@'X0])H6 0 2&P$
M$@              @ $     :6UG,3$W-C R.3<R7S N:G!G4$L! A0#%
M  @ +4-[6I8'0;00VP  N^(  !(              ( !RA8! &EM9S$Q-S8P
M,CDW,E\Q+FIP9U!+ 0(4 Q0    ( "U#>UH72W4L*  " "P* @ 3
M      "  0KR 0!I;6<Q,3<V,#(Y-S)?,3 N:G!G4$L! A0#%     @ +4-[
M6G#TSN(X4P$ 8UX! !,              ( !8_(# &EM9S$Q-S8P,CDW,E\Q
M,2YJ<&=02P$"% ,4    "  M0WM::^-PM8*]   'Q@  $P
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M-C R.3<R7S0N:G!G4$L! A0#%     @ +D-[6F1\GYC0L   J[8  !(
M         ( !EL$* &EM9S$Q-S8P,CDW,E\U+FIP9U!+ 0(4 Q0    ( "Y#
M>UKJCID>ZX@  ->/   2              "  99R"P!I;6<Q,3<V,#(Y-S)?
M-BYJ<&=02P$"% ,4    "  N0WM:'#):M&](  #S3   $@
M@ &Q^PL :6UG,3$W-C R.3<R7S<N:G!G4$L! A0#%     @ +D-[6E ^?<MU
M( $ TBD! !(              ( !4$0, &EM9S$Q-S8P,CDW,E\X+FIP9U!+
M 0(4 Q0    ( "Y#>UJ;DQJ #;L  #[&   2              "  ?5D#0!I
M;6<Q,3<V,#(Y-S)?.2YJ<&=02P$"% ,4    "  N0WM:CI^"4EDK!0"=*C@
M$0              @ $R( X <V5P;BTR,#(T,3(S,2YH=&U02P$"% ,4
M"  N0WM:..N-Q\N+ 0#47Q@ $0              @ &Z2Q, <V5P;BTR,#(T
M,3(S,2YX<V102P$"% ,4    "  N0WM:8+)T^SPV   OV@$ #P
M    @ &TUQ0 <V5P;BUE>#$Y7S$N:'1M4$L! A0#%     @ +D-[6BO_$5--
M P  >!$   \              ( !'0X5 '-E<&XM97@R,U\Q+FAT;5!+ 0(4
M Q0    ( "Y#>UK1X,\;80D  *]%   /              "  9<1%0!S97!N
M+65X,S%?,2YH=&U02P$"% ,4    "  N0WM:K:]B+7L)  #*1   #P
M        @ $E&Q4 <V5P;BUE>#,Q7S(N:'1M4$L! A0#%     @ +D-[6G#(
MK_/'!@  AT    \              ( !S205 '-E<&XM97@S,E\Q+FAT;5!+
4!08     %0 5 #,%  #!*Q4    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>sepn-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sepn="http://www.septerna.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sepn-20241231.xsd" xlink:type="simple"/>
    <context id="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8255216d-10ae-416d-bcd2-76adfb6ba4d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-01</endDate>
        </period>
    </context>
    <context id="C_829daf10-7ff1-4266-a786-57da4f5434c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sepn:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_832c9435-8669-4826-9854-08cb83c395aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8484b4a9-981f-46d8-9a3b-93c7b6a966e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_855d4ac2-b358-4d6c-84c7-2390fea37329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8c5cb769-ec5e-4f34-abf9-683e73b6808f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sepn:UnvestedRestrictedStockSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8d0f375e-d4b5-4c8c-83f1-7f68a5d08c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_902b0c5f-744e-4d30-b174-d36f4e83674d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_90d58f63-eee7-4c1a-ab73-d78903f815e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_922c53ab-31f7-4a05-a8b6-af09fe6e78db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9268f199-df5e-4067-91e6-ed2fd39554e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_92c1f558-0199-426d-b08a-1870d1dc5677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="C_92e936a1-7cb3-40e9-993e-bbcd2f3f805e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_94ef1645-1200-4432-b228-36b9fceb7a82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_96b8a98e-2692-42ad-a70e-81071163995f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9763b408-328c-4770-af66-e36b06544fe2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-07</startDate>
            <endDate>2025-02-07</endDate>
        </period>
    </context>
    <context id="C_9b829192-5a7d-4ce3-9261-f21a9ef581b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">sepn:FourZeroOne401KPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a3e21644-6ca9-47f4-96b3-8d6951b37099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a6ecf43d-7b17-4dea-a8f9-87bcd2d46ebb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a74bff72-f9bc-4001-b025-78bfed5e56c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a88f3222-aa43-4a22-9616-3208194c63fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sepn:VertexResearchServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ac644248-b031-4c9f-95ab-fa02d59f25be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_aecc1d94-7b79-44e5-b57c-d8576c37c857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_b1dfbbba-4ed3-4a5b-8cf4-81747534a7f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b7d146c4-9837-4043-9b52-921a53724e0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b804a170-664e-41ff-a1cb-b608203157b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b818b396-8516-4e7d-b65d-8f906bbc24a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b9128e20-7131-4bd4-a8bd-4763f5a273df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-01</endDate>
        </period>
    </context>
    <context id="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bea6a04f-86e9-4c8b-acac-b19b1baa9ae1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c0577abf-fcd1-41ee-8a8a-8523f830af0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c07f1042-7166-4a92-ad8c-816792ab533e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_c2a2d5f3-4780-477b-9962-a71c66cb583d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sepn:VertexResearchServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c39d72cd-1218-4091-b5a2-620203948c8c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c3d18edf-1da5-48a4-8374-55662573e03e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2024-10-18</startDate>
            <endDate>2024-10-18</endDate>
        </period>
    </context>
    <context id="C_c457190a-2591-4660-96fd-0fed98a4b50f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c58ad86c-a8d9-467a-8ff5-d56c8a6e29f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:SamsaraBiocapitalLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c86e56ac-1ccf-4198-83f7-d9fc66656386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c8bbdab5-fa45-4f45-b9e3-c2cf656b651c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ce391cd8-82f6-405a-84f5-86572717253e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_cf0a11bc-e4a7-4986-9563-1992ae142565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:RaCapitalManagementLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d3127ac5-59a1-444d-b791-71cb86e3ef50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d523acd8-48f9-4426-8ab8-290e484e62bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d5e147f5-aa16-43c8-b905-14514eea7f77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d770876f-2396-4daa-bc4e-7986b296cd59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_d928477a-8ca4-45d7-99e7-77f499e78e0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_da578283-3385-4d7f-84d8-e4e87678a27a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_da5e58c0-03a1-48bc-97cf-7fa1915eebf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="C_e09fe0d5-bb64-4a89-8423-2d8d7f22d329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_e2dd8888-638d-419e-b998-f0ffd00c0ded">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_e339adb9-8faf-4ae0-a9cf-843428e7c977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_e596348e-c390-4f8c-a60e-2c604e7723c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e5a48d22-6857-4c55-a508-102ecc5e3e17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_eba777f1-1ccc-44f9-ae7c-9f47032a9edd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ecb04bc3-c92f-466d-8619-25482aaef50a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ecda3b22-85c8-4a2c-910d-24b3feaec947">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:InitialTrancheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="C_ed3d106f-c9e5-4f47-a732-17fd62714ce4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_eea5f8f5-675f-48a9-bc1e-43f7089d6e4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f1221a25-caf1-4805-ad5a-d8ab5144be88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f21eea93-3c79-4715-83bd-5decab49af76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_fab6a00f-2fe1-456a-bccf-9474c007d17a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_fb922ca6-bc1b-4ee2-9ad5-6fa73f26af51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:OriginalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fe927fe9-4989-430c-8a64-55c8c20c07c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_00cbb4d7-f34c-4862-a6ea-df21ab1ac4ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_04364af7-15e7-4170-a9bd-075237a2baca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">sepn:FourZeroOne401KPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_062b5e92-e9a6-4480-9a3e-af692706a741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_094c93bc-0e0d-4909-afb4-955d4d337209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_09bfaeb9-dddb-4966-a602-14fa0623c76f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0a283eb0-f11e-47f7-8c48-261df37e83d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0b34fe95-fedf-421a-b8dd-87db73e425eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_0b6e5099-66b3-4a19-9c22-90249dab9674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0c337934-85a8-4a6b-b0b7-d303a586df92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0dbb3934-d7b1-4512-9408-c82380a608be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_0e7e5752-e6a2-4a70-b4fa-b116c9416205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0ee21c41-88a0-4de2-9908-edb048f164fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_1147e1f5-d133-45d8-8f2d-657d2695faa6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_119c49a2-1fd6-4e17-adcd-69be80143f5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1aec0dd0-2f1a-4cc5-908a-9f57b03ace96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="C_1b936336-2026-44b4-a240-c9a3d5378bef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sepn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchase2024PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1c7d04aa-a092-489a-8d60-29ccf842d41e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1e38905a-c12f-4042-a1c7-538930041c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:AdditionalLeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_21bcef87-7441-4e70-b3d2-6468e2fd40eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="C_22e5ca43-623f-4048-99d6-c3938708def1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:ExecutiveOfficerAndDirectorEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_23a47baf-46ed-4a06-ab44-52b48a0970c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_23cbaddc-7e72-4392-96bd-b68571b9aa1f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_25a4e3cd-6869-41f0-a089-39e4a21d16f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2025-03-17</instant>
        </period>
    </context>
    <context id="C_271bef94-fdec-41f8-a570-9d76ab85a875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_273f0762-59ef-4b7e-8052-83d122342ed9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_27aa5798-cdf5-4aeb-9c35-f6a7f0ef79c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_2982daa7-c87a-47ee-b700-ce6632c5e27f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_29adb2c9-12a7-43f9-8228-3116b1608be4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2bb60e06-e9a7-4ee2-9f51-82882892bb75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_2c23db88-ff79-4c64-b0f7-eb3460655b08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="C_2d8e9c9f-db9a-4ef1-8b3c-d563c2fca200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sepn:InterimChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2eb036f2-f593-46bc-984a-3f742b94ee9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2ed61538-be83-4373-9c74-22d2ecd37bbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneAndTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_2ed84efc-d353-46ca-bae3-39bc435baebb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2f0eb5d6-7026-4c35-ad8b-a69f0b83d927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_31284a09-3922-405e-a80d-24fee73b06af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_33d7d405-ee10-46a7-ba8e-6cecef016263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_35342a71-3904-46c9-8baf-50e827a2f8e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_35e15b2a-6b34-49e1-8b87-da8c2cffe44c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_36638d69-8200-457e-b4df-f22570660294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_39410be2-488e-40ba-b03f-47c8c6cb10a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-01</instant>
        </period>
    </context>
    <context id="C_39c2eb82-be3a-4f23-96b2-b18b9af896bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3b38a128-728f-4bd5-af3c-a2799bc33330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:SamsaraBiocapitalLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3ca64227-cc61-40d5-9ccb-5795c36c5007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:StockPlan2024And2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3d630fbe-3eb4-461e-8c9f-d264488141b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_3eda2d3e-77c3-4ee9-833b-51522ca25c9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_40118209-d74e-499d-a2c3-dad899119cee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_408fc089-3a81-45dd-951b-6530ea8455e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4189834c-9f3e-45b5-8e93-de02f8ede50d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:RaCapitalManagementLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_42ad5efb-0c6f-42c1-afc8-5cc756e5312e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_44baba83-cea1-46e8-978a-dc1f29c93e52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_489a951a-d17d-48d1-be9f-c29fef36aa29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4947aa1a-72b3-47fa-b3bb-2fe7814a8ec3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4c5f565b-9309-42f7-86c8-bb16495c890f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_513d2df9-958a-4c81-a310-f93896216a3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchasePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_56c6ec77-77b3-426a-9cf6-61c4ee189ee2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_570c8595-7c25-477a-88df-9154a31cf161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sepn:ThirdRockVenturesViLPServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_59dc2c7f-ff1c-470d-b96b-f1599335ca16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_5b8fa8c3-5da3-44aa-abac-9a9744adb4a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:InitialTrancheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5f0437bd-6f52-4254-b099-4a45c3a53aa8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="C_5f26eed0-95b3-4a32-95cd-288d74605af3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_612e0da3-d172-44b9-afd1-b4b5f1733b29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_6194273a-4c93-49e2-96ac-eb9941334717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sepn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:EmployeeStockPurchase2024PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_64df0564-4699-4346-a9c4-4d4616c5b486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_659a2626-2f0b-4d2e-abe1-7f6b4d5d0915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sepn:UnvestedRestrictedStockSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_66bb86ba-4924-40ff-99cf-a77f796a2d06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6989d380-63a6-42fa-baac-f46b7758f062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6a1456b0-60b7-4820-b443-f0391e89fbdd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6c2685d2-81ab-435e-a0e2-34a378301c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7079165a-aa57-4eb8-9488-ec1604a2095c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_71f42ff7-1a0f-4075-b1ad-7f3659f2ab90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7283d70c-1d46-411d-a51a-777737652129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_734505df-bb5a-463c-bec8-cd2fb71849a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sepn:LeasedSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_75b103c5-2b1b-4a43-a69a-77670e68c96e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">sepn:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_78682e7a-e6dd-4d19-864a-4e2b28c3d80e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="C_787857dc-a393-4f80-adbe-f17546eff5f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_794848e1-09b7-4a43-8aea-81d6a449cd8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_79b58927-86fc-40d3-9f46-ab96913ff7a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sepn:Stock2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001984086</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sepn:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_Position">
        <measure>sepn:Position</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_63151228-9489-435d-9784-ebf8edc88d49">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_fe1cca66-608d-4aa3-b620-14c932fe5210">0001984086</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_aef3afc0-37d1-4ba2-9ca9-a6150d604186">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      id="F_f504efa2-7a40-47fd-bb84-8a0759752c52"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      id="F_686e415e-ba5e-4706-8773-3961fbf8dc1e"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      id="F_cad73126-da80-4c10-b250-cf7f5b289ceb"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      id="F_1f32640f-4a7f-4970-8dac-aab166485b20"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      id="F_906a3f33-fb42-4fdf-8d46-17d92b98968d">http://fasb.org/us-gaap/2024#LeaseholdImprovementsMember</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <dei:DocumentType
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_62186c3c-07d7-42f8-8e9b-4de9b1923d0c">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_d2302bdf-9abb-4d5e-9269-5a637c1c8f8a">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f9feb204-b961-470e-b956-6091466d0598">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_e0dc04b9-e2fd-4a82-8772-034adf2d0c00">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_9c2538da-4e16-41b1-87bb-e2233ad53e02">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1fcf788a-c8ce-4f33-82e7-4d9bfc043b7c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_37d8b421-6ee3-4eb1-bd9a-7b5104209892">001-42382</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_b9decf49-d026-4e54-a95d-d40be795ae5c">Septerna, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_0d319b36-31aa-4113-8c82-a3df0ce082a2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_dfabc283-48ff-4769-85db-64a0dcde1256">84-3891440</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_504439ab-3d8a-49d0-9137-e8864fe417fb">250 East Grand Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_9f0adcfb-9500-4242-9ce4-8d13de3f7f7a">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1493e679-0fb5-421f-a925-a00ba229a511">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_3aac3ad4-c188-460c-97fe-2ce96255e1f2">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_ab0d2bc9-d6f6-4363-8fe7-2f0865e828ff">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c25ee667-7b07-441b-9bad-c535e6d9e1c3">338-3533</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_082cb7d2-f8a5-4fc5-8eeb-f4a5dc0838f3">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_76dd384a-95c7-4f6a-9f80-dd6afb307745">SEPN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c43b12d2-cabc-48a6-8a70-f56a058cadaa">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_391cd3e1-b08c-4eae-87f3-9834a682ada9">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_cd7e28da-b7a9-4b40-b0f9-5e7cd7da1d30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c276ac8f-0cdf-450b-b108-18b3602e17cf">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_9a21189e-68e6-4c3f-a2df-f704b073ce2b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_384f415f-2806-4834-9e38-51ccb20e536d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_04eca609-6c7b-4cdf-aa16-157f7623c9e0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_dd7222ef-bc5c-477e-b87a-05c8d7bfd9f5">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_343f9b70-6867-44c3-b946-6259d54c6e5a">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_7f64d82e-cb41-45cd-b191-95718d6b469b">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1ba6402f-d460-4261-bcd4-f55c68b39b4c">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5f971126-500f-49ea-a9cb-5cd00f855381">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_78682e7a-e6dd-4d19-864a-4e2b28c3d80e"
      decimals="0"
      id="F_8b84aff5-5cb7-4b17-a9a1-ccac4fd255f2"
      unitRef="U_USD">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_25a4e3cd-6869-41f0-a089-39e4a21d16f3"
      decimals="INF"
      id="F_7d913c3d-90d7-4fd6-99fb-cf48ffa49743"
      unitRef="U_shares">44442496</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_704f5e29-250b-4812-a20e-e0b623172f78">&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of the registrant&#x2019;s fiscal year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_97ab89d2-7260-49f2-86f0-e968080186dc">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Risk Management and Strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have implemented a cybersecurity risk management program in accordance with our risk profile and business size that is informed by recognized industry standards, including elements of the National Institute of Standards and Technology Cybersecurity Framework and International Organization for Standardization 27001 Framework.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management program is comprised of a number of components, including but not limited to written information security policies, external cybersecurity risk assessments, and system monitoring. We also have an employee privacy and data security training awareness program that includes cybersecurity risk awareness trainings and phishing campaigns. We maintain an incident response plan to help guide our response to cybersecurity incidents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We leverage the cybersecurity services of third-party vendors, including a third-party managed services provider and IT consultants, to support our cybersecurity risk management program and assist us in conducting external cybersecurity risk assessments. As part of our cybersecurity risk management program, we take a risk-based approach to the evaluation of third-party vendors. As part of our vendor diligence process we require vendors with access to our information technology systems and infrastructure to complete information security program questionnaires.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have not identified any cybersecurity incidents or threats that have materially affected us or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;However, like other companies in our industry, we and our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;third-party&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; vendors have from time to time experienced threats relating to our and our third-party vendors&#x2019; information systems and infrastructure.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; For more information, please see &#x201c;Item 1A, Risk Factors.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance Related to Cybersecurity Risks&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#x2019;s general risk oversight function.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#x201c;IT&#x201d;), and is responsible for the strategic leadership of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our Head of IT relies on both internal and external cybersecurity resources to manage and remain appraised of overall cybersecurity risks to our business and our industry.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_0d2a9db3-ead3-47c8-9054-afa3128d5d59">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_ab46c9e1-bbc0-4111-afba-91b67605b2ff">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_234f46f8-3ef2-4e01-8d53-2f32609569aa">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_6643f76f-33ee-4dfc-8521-94c9a70f6a4d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance Related to Cybersecurity Risks&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#x2019;s general risk oversight function.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#x201c;IT&#x201d;), and is responsible for the strategic leadership of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our Head of IT relies on both internal and external cybersecurity resources to manage and remain appraised of overall cybersecurity risks to our business and our industry.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_93a95915-cf1b-4393-b464-bccf50c3354e">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#x2019;s general risk oversight function.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_0311ff13-87be-4025-95c6-82176cbe718e">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors has delegated cybersecurity risk management to our Audit Committee as part of the Audit Committee&#x2019;s general risk oversight function.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_0fa09c90-de95-4e4d-a61f-995f9c049b6c">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee, through the oversight of the General Administrative Leadership team, is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1db187d6-c87f-41df-9af6-5790def05757">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by our General Administrative Leadership team, which consists of our CEO, CFO, COO, CPO, Vice President of Finance and Business, Vice President of Technology and our Head of Information Technology (&#x201c;IT&#x201d;), and is responsible for the strategic leadership of our cybersecurity risk management program.&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_90bd8c01-389d-4015-8971-ab24bc6333bc">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT, who also serves as our Information Security Officer, is responsible for the day-to-day management of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The individual who is currently in this role has over thirty years of experience in information technology and cybersecurity risk management.&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_ffee996d-cb4f-43bf-b9aa-ed9e91927b0f">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_e262a680-977f-494c-a34c-558371b501d7">&lt;p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The General Administrative Leadership team provides regular briefings regarding cybersecurity risk and related matters to our Audit Committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Such briefings may include a discussion of cybersecurity risks and applicable risk assessments, key updates regarding our cyber strategy and related initiatives, and the emerging cybersecurity threats that may impact our business. We also provided the full board of directors with updates on matters relating to cybersecurity risk management, as necessary.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c296fcb1-d97d-435a-8641-b7e7e8f57a75">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f"
      id="F_34b4ff66-fe94-467f-8582-df70ea245768">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f"
      id="F_81f33637-4305-42c6-87b9-2f5ee0f60005">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f"
      id="F_5d955eb8-2ec0-4ae7-bf4a-ddb647ecca09">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_298bfb3a-eb7e-498f-b4cb-1e4e1af76f3f"
      id="F_ac760b36-a6a2-47b6-9883-fba97dc376ce">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_77e8e60b-33a6-497c-9d9e-c943b2332764">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_10f4e458-f188-4a44-93e7-6cf05d7e337e">42</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_972cce12-91e1-4379-bb8e-407212cf0437">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying balance sheets of Septerna, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive (loss) income, convertible preferred stock and stockholders&#x2019; equity (deficit), and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_05001549-071e-41ae-b58a-80a5259a4903">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f96be0ca-7bd7-4bb4-b6a4-2614cae4a221">San Mateo, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b16c16ac-868e-46d0-90f3-21c0c28f6b25"
      unitRef="U_USD">238196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_56737c68-2bbe-4d56-83b6-0b276a26eaa5"
      unitRef="U_USD">88483000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1480639b-17c5-46a1-95b7-e4c2bb1f5dd2"
      unitRef="U_USD">112727000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_18f14376-9ac7-4243-9a3a-df221f68858c"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_794adb4e-ce81-4456-bf13-45285f0510e7"
      unitRef="U_USD">171000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_78c56094-0adf-48bc-ace5-ee5d7263148f"
      unitRef="U_USD">151000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b4cf34e9-f297-4fce-a33b-aa79ee40a373"
      unitRef="U_USD">0</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_10bac446-8852-4e29-92f4-f83e4694e8c0"
      unitRef="U_USD">22625000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8054cac2-4c37-4880-b597-52ce89f84cd3"
      unitRef="U_USD">5730000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_9f0b03b5-417b-43e1-89d3-3309bc101abb"
      unitRef="U_USD">1419000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_4a9df592-4e75-450f-ac7c-3581f6b33348"
      unitRef="U_USD">356824000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_b0f4b594-f26e-4ee8-a70c-7e63dea6bd03"
      unitRef="U_USD">112678000</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_7cc2cfbc-b08f-4a18-9bf2-0e8a01ba419d"
      unitRef="U_USD">69866000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a7ff1a9e-87c1-4752-8318-b96c75155c4d"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_20de920d-e130-4d4f-b7a1-2f3f12f2af78"
      unitRef="U_USD">5090000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_56e8c2be-b842-4f1e-a1a6-3e12a0a29dbf"
      unitRef="U_USD">4665000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1c6bde1c-d241-4ca1-ae98-50c7da08e021"
      unitRef="U_USD">23602000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_288c2248-9edf-4b68-896c-eb9087f0d734"
      unitRef="U_USD">12522000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_04e44f94-9d41-40b5-bda3-752f0553ea01"
      unitRef="U_USD">905000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_615a4244-7716-411f-abc4-ed7622831789"
      unitRef="U_USD">905000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_6d38b83d-3603-4a58-b400-d7f45a2ba67d"
      unitRef="U_USD">267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_540e54e6-e5c5-4854-b96c-41b864407c38"
      unitRef="U_USD">97000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_a0a0adb6-9e5f-48a4-b44c-97dc8123cdb3"
      unitRef="U_USD">456554000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_5358a71d-fc75-4751-97c7-130d4e2f7dca"
      unitRef="U_USD">130867000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_189950f6-8024-4428-b475-aca178a2a9f3"
      unitRef="U_USD">3200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_d14b3a0f-927f-40e6-bb0c-fc3981ed43b6"
      unitRef="U_USD">2637000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_0f6fcdba-58cf-42c0-a118-7927ceeab009"
      unitRef="U_USD">7798000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_7ffb7f83-5d53-4b6c-b78d-a56eae4bb91d"
      unitRef="U_USD">4277000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_f3a6884e-d38c-493d-bb06-636b9356f023"
      unitRef="U_USD">1851000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_99d03004-f7ad-43d8-8719-47d2f1297548"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_3832fd11-f4f3-46af-b7fa-9efdad2f4cb2"
      unitRef="U_USD">12849000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a05d7d5a-ab98-4923-8969-8070c0c1ac40"
      unitRef="U_USD">6914000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_36503753-880d-41ae-92f8-1db1a83895e7"
      unitRef="U_USD">23625000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a7bc753d-4d5a-4ff1-b24b-ba96107045d8"
      unitRef="U_USD">12566000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_df2866f8-eab0-4bcf-8658-fb8e6cdd320a"
      unitRef="U_USD">33000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_08782caf-2425-4026-b8ef-564b8c5d4a69"
      unitRef="U_USD">546000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8187ea64-4b54-4272-a6c6-b1a19ab7cdfb"
      unitRef="U_USD">36507000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_21946412-0590-4961-b45d-e875544a8a2d"
      unitRef="U_USD">20026000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_aa08920a-e479-4c6b-a3b1-e0955a35e719"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_193b2d5b-a2a1-4bca-81b1-f525928d60e6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_63b59963-a34a-43d2-9c04-847b53c340e0"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_f9b5930b-635c-4952-9d43-5458b27b716e"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_7ea836f7-9998-46ae-97f8-3068c94d812e"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_50e057c0-6eb3-4308-a398-63361596720d"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_035b4ca3-191e-4779-b8bf-3e2d98304b03"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_4f3614a9-fd9a-48f8-bcbd-9346794d9819"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="-3"
      id="F_211d185e-f8e4-4876-be52-976fa1babd33"
      unitRef="U_USD">75000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="-3"
      id="F_c2ac1c62-aba4-4069-be3e-ce8428117015"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="-3"
      id="F_25b2be69-ef5e-4e5b-afb7-6580fea8ad97"
      unitRef="U_USD">74694000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_0b681c06-4e0c-4c9c-ace9-e07611da3783"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_6b7b90be-8198-4c90-85f9-0fc7d25a9a14"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_3d0d5265-4db1-49e7-8bbb-ef586e9168b0"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_285f150c-0487-45aa-b489-30706e216c16"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_ff6fe47c-1365-4abd-af36-ac430dde3e9a"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_da1c4f5c-a027-4d25-b8b6-9c60c61fa364"
      unitRef="U_shares">121657452</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_fbae4dca-d2f7-4228-99c5-d3043e31f2ba"
      unitRef="U_shares">60828720</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_061ed718-cffe-4c5b-a50f-82af4c7712a9"
      unitRef="U_shares">60828720</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="-3"
      id="F_b42e5170-e2b8-4aae-8c1f-b154861cc3d3"
      unitRef="U_USD">75000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="-3"
      id="F_37aae099-cdca-4dc7-9ed1-648c31a1dac6"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="-3"
      id="F_7559cd27-6821-4046-9cc2-23cc62ab2a57"
      unitRef="U_USD">74521000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_2a18bbf2-e8d6-4350-958a-31826b9f1888"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_8bb64737-a55d-4512-bd7c-cff4322c7c8b"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_c90a9ebe-3db1-47f8-94df-9c30ae1d01af"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="0"
      id="F_d7b3749d-3a8b-4855-9e40-e87c8f090fb8"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="0"
      id="F_6c010afc-903c-4d8b-880a-bc1f8751311b"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="0"
      id="F_993a3547-55f4-47a9-85c5-f599c9e2eda2"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="0"
      id="F_33394037-21f8-48d2-a35c-a5b0e96f013e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_a047a432-bc69-4f24-88da-831fe946c532"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_963e9659-c2b2-43b7-b91d-18516307821e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_9e31daf8-5d6b-4198-8fb6-99672587eba6"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_513a74b2-067c-449d-b5fa-9e0bab2ad854"
      unitRef="U_shares">260590689</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="0"
      id="F_70cf36a5-e113-4d72-a8b6-d4cdb6f67f33"
      unitRef="U_shares">44422505</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="0"
      id="F_ae912afb-5896-4d8c-80aa-e7926058e8ba"
      unitRef="U_shares">44422505</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="0"
      id="F_a0ad0afd-9521-4edf-a78d-bbcf14133ba4"
      unitRef="U_shares">3168134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="0"
      id="F_7432e112-79b9-4202-be4a-830c3c56b53c"
      unitRef="U_shares">3168134</us-gaap:CommonStockSharesIssued>
    <sepn:RestrictedStockOptionsSubjectToRepurchase
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_cebc654b-3c24-4068-9f07-ee8a0418b237"
      unitRef="U_shares">576829</sepn:RestrictedStockOptionsSubjectToRepurchase>
    <sepn:RestrictedStockOptionsSubjectToRepurchase
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_a2ca6988-43ea-4171-8076-8dcbb5053704"
      unitRef="U_shares">1002044</sepn:RestrictedStockOptionsSubjectToRepurchase>
    <us-gaap:CommonStockValue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_09f0a63f-9521-4ce5-a619-efaaa74284e7"
      unitRef="U_USD">44000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_bdc7c797-7333-4eaa-adb4-96df5ba7d7fa"
      unitRef="U_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_a1be35de-9a54-4d45-87e0-d6cabdc3b74d"
      unitRef="U_USD">538321000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_24609f62-961d-4e7d-ab5f-c611ab5b8394"
      unitRef="U_USD">8199000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_7204a819-43c0-428f-affa-71348f2c2780"
      unitRef="U_USD">56000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a091a7f3-98dd-4c2f-a7bb-0164b9263b1f"
      unitRef="U_USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b9a92a53-62e2-4495-b609-3451ec3a5949"
      unitRef="U_USD">-118374000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_d523ede4-47e4-4420-abba-77fc9cb9f838"
      unitRef="U_USD">-46576000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_44ecf5d4-0a1d-49b2-b2c8-532ead95f069"
      unitRef="U_USD">420047000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_ca108eec-c7c2-4329-b761-f44fa59ba4be"
      unitRef="U_USD">-38374000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_652ef7c2-9c0a-4a01-9283-6523ad2eab94"
      unitRef="U_USD">456554000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_f1bef332-3c02-4285-bfb9-b3398b575a38"
      unitRef="U_USD">130867000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_19a9ebcb-fa44-4769-b6c3-60f8c00adb0a"
      unitRef="U_USD">1075000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_360458d9-b6df-4772-b607-c533bd075f9e"
      unitRef="U_USD">151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c849f580-a526-438c-b0be-e83fc60e45f5"
      unitRef="U_USD">65337000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_9809f4a5-7a4d-46d2-a1dd-f0228a1d9554"
      unitRef="U_USD">35979000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c04db054-c566-41dc-b02f-5dedee41c027"
      unitRef="U_USD">16561000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b347472c-bcd3-4c5a-a791-bb79b6011d34"
      unitRef="U_USD">9722000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_8317422d-904f-4a22-ae0d-eb71c7284d69"
      unitRef="U_USD">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_41aefb92-aa72-4dac-8a54-acb000ca879c"
      unitRef="U_USD">47625000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:OperatingExpenses
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_cc3675be-fc54-4c88-b03e-4a393c8eabaa"
      unitRef="U_USD">81898000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_c20e87c6-e626-41ad-9e20-c3dcee01b2cc"
      unitRef="U_USD">-1924000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_62dd6e49-b8cd-4be9-8b45-8e780cb7978d"
      unitRef="U_USD">-80823000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8a118970-7206-484c-8462-604d9b2ebad2"
      unitRef="U_USD">2075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_97959dbe-81ac-4b14-a132-62ec1dd5220e"
      unitRef="U_USD">8617000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_a7d9570e-62ab-43b0-b9ce-8d6c6744aa38"
      unitRef="U_USD">2786000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_0c5cb5f3-33f7-4211-90c8-8dbde1e447b7"
      unitRef="U_USD">-90000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_09a8b99c-4946-4c7b-a493-617207c59d42"
      unitRef="U_USD">10000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_6fc6469a-10a4-46e3-8b99-1504d0722ed5"
      unitRef="U_USD">8527000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_c74daead-0327-4317-8ea1-80915b7b8819"
      unitRef="U_USD">2796000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_e1942474-32a7-4cfe-987f-5dfe2607de01"
      unitRef="U_USD">-72296000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_e1b964e4-c83c-47ef-b44d-50d375e9a127"
      unitRef="U_USD">4871000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_239b4425-9ce0-4b44-bc97-d525ff827d17"
      unitRef="U_USD">-498000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_97bbe10c-dbfa-480b-bcc9-80d0199fe9c3"
      unitRef="U_USD">691000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_0b997ba9-7fbe-4f15-9f72-265f9f862f62"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_35f96db2-39d1-4ff8-8205-32201f6d4951"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_47a9b043-95f1-4f4e-aa65-2fb61d290eab"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_146d7339-9343-4db3-bdbd-5177df5a54b5"
      unitRef="U_USD">567000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_9862d201-4663-4cdb-ac40-47880c58927d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_46399a22-19ed-46b0-9a37-8af3ed04a9a4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_501f79ca-5ee7-4eb1-8eeb-c0a311847754"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_05006552-b673-477e-ad28-3f3d3e7536d5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_92fb0537-d6ec-4ecb-b6cd-f4cd663cc8a0"
      unitRef="U_shares">9891126</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_afdd2238-6613-48b2-aa2f-b86843eb4e27"
      unitRef="U_shares">1928586</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_4c64166f-3f0d-4e2c-9d1a-6b13d49ceb89"
      unitRef="U_shares">9891126</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_daf2c125-45ba-48ad-95a7-08176d6e4d4a"
      unitRef="U_shares">2177124</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_8ac18a4c-8515-4314-bb02-f6083a7200dd"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_98760558-d5e4-414e-9185-83ca77c9c9ef"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_08eda6e6-6783-400d-a253-10de70fd37da"
      unitRef="U_USD">56000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_615d63ba-f248-459b-b0bc-88f2b28a2473"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_cddd5395-619b-48bc-ad92-b9c5a1d8a0a0"
      unitRef="U_USD">56000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_9a9ce68b-c3eb-4c24-82cb-21bf3ffbfce1"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_82020cde-eb7f-44b4-8429-0992e832a9c9"
      unitRef="U_USD">-71742000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_98734c28-8c40-483c-a742-788bf6395353"
      unitRef="U_USD">4180000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ecb04bc3-c92f-466d-8619-25482aaef50a"
      decimals="INF"
      id="F_149734c7-38bb-4e3f-acad-a4ad0a763ab0"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ecb04bc3-c92f-466d-8619-25482aaef50a"
      decimals="-3"
      id="F_7aaaf6ac-8157-4f6c-8596-575cb02331f2"
      unitRef="U_USD">74694000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_271bef94-fdec-41f8-a570-9d76ab85a875"
      decimals="INF"
      id="F_9f5dc6ec-087d-467f-90ee-1ff0e9e8095a"
      unitRef="U_shares">3181829</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_271bef94-fdec-41f8-a570-9d76ab85a875"
      decimals="-3"
      id="F_525bc5da-5a1e-439d-aa7f-76888e84327a"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_00cbb4d7-f34c-4862-a6ea-df21ab1ac4ff"
      decimals="-3"
      id="F_063af631-c7f2-4da1-8225-e6df6bcf81ec"
      unitRef="U_USD">6552000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1c7d04aa-a092-489a-8d60-29ccf842d41e"
      decimals="-3"
      id="F_3ad6954f-b389-47bc-9674-3a80048e2fce"
      unitRef="U_USD">-50756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56"
      decimals="-3"
      id="F_240f9406-102e-438d-959e-cbd44efc3954"
      unitRef="U_USD">-44201000</us-gaap:StockholdersEquity>
    <sepn:StockIssuanceCostsOfConvertibleSecurities
      contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5"
      decimals="-3"
      id="F_ad9e5924-67e4-4113-b73b-00f20277793a"
      unitRef="U_USD">479000</sepn:StockIssuanceCostsOfConvertibleSecurities>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5"
      decimals="INF"
      id="F_e415f833-a366-4cca-949d-b6d8100d765a"
      unitRef="U_shares">60828720</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_34941ee9-9ed2-4d16-ae0c-1f0ebc03f1f5"
      decimals="-3"
      id="F_b71e3a83-2e96-4089-8f27-b4747799ff36"
      unitRef="U_USD">74521000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested
      contextRef="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca"
      decimals="-3"
      id="F_697b7a87-c46e-456b-b8ee-6064d6ca9e3c"
      unitRef="U_USD">27000</sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested>
    <sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_272fb09f-acd3-4aa2-934e-e83a2a8b1194"
      unitRef="U_USD">27000</sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_f21eea93-3c79-4715-83bd-5decab49af76"
      decimals="INF"
      id="F_8791b0ab-048d-48e3-b83d-e258262d15b1"
      unitRef="U_shares">13695</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_9bc27b12-834e-46c0-b612-7e6bbd6324ca"
      decimals="-3"
      id="F_7c6ecb32-59ca-4701-ba96-854acd405523"
      unitRef="U_USD">1620000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_154702ad-7ec2-4bb9-b797-ba8fd23b85fe"
      unitRef="U_USD">1620000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_5b8fa8c3-5da3-44aa-abac-9a9744adb4a5"
      decimals="-3"
      id="F_1c636e06-ba43-4db5-a74b-5d186967f0b4"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b2d5b4e1-17f2-4328-acf7-397cfb4c8ae9"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_14fe7bda-0629-4b6c-aae9-3d84c56441b3"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="-3"
      id="F_c8b1cdff-23dc-4b1f-9d2f-c0fb2303c3e0"
      unitRef="U_USD">74694000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_1d3d956c-746b-45e3-be87-94c702ae0555"
      unitRef="U_shares">60828720</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="-3"
      id="F_5554de34-353f-43de-9d7b-dde584754540"
      unitRef="U_USD">74521000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa"
      decimals="0"
      id="F_28a1a856-72bc-47a8-b699-f5e7f782cc89"
      unitRef="U_shares">3168134</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa"
      decimals="-3"
      id="F_9d6110fe-87ac-4e74-be57-44c901bc222c"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c0577abf-fcd1-41ee-8a8a-8523f830af0b"
      decimals="-3"
      id="F_a3cb370b-caa9-45dc-990d-c80fc72fb07c"
      unitRef="U_USD">8199000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_094c93bc-0e0d-4909-afb4-955d4d337209"
      decimals="-3"
      id="F_2151956e-6236-4218-8659-8829f33ebe79"
      unitRef="U_USD">-46576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_e1e5c118-9d0d-4c78-8493-e76ca76001f5"
      unitRef="U_USD">-38374000</us-gaap:StockholdersEquity>
    <sepn:StockIssuanceCostsOfConvertibleSecurities
      contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"
      decimals="-3"
      id="F_bb966053-2185-4a15-b248-893011df6b5d"
      unitRef="U_USD">58000</sepn:StockIssuanceCostsOfConvertibleSecurities>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"
      decimals="INF"
      id="F_74b22863-b2cd-4455-8101-647493ab73c7"
      unitRef="U_shares">60828732</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"
      decimals="-3"
      id="F_74646486-5f50-498a-9470-c186bc9ea893"
      unitRef="U_USD">74942000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d"
      decimals="-3"
      id="F_f7b1463c-4d33-4ce4-ac6e-f89f94957d3f"
      unitRef="U_USD">28431000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="0"
      id="F_6f291f75-8065-4de4-8fc9-3327081b874e"
      unitRef="U_shares">18400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="-3"
      id="F_c977527d-e28f-4a9b-be02-9b04741c5e12"
      unitRef="U_USD">18000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"
      decimals="-3"
      id="F_9ec88eba-1687-4a2d-b420-c1054878b9e7"
      unitRef="U_USD">302749000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_415c381a-8173-4722-95f0-f3e35438b0cc"
      unitRef="U_USD">302767000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares
      contextRef="C_6989d380-63a6-42fa-baac-f46b7758f062"
      decimals="INF"
      id="F_5ca071af-f8db-430e-bfbc-c36467a9aa70"
      unitRef="U_shares">75000000</sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares>
    <sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock
      contextRef="C_6989d380-63a6-42fa-baac-f46b7758f062"
      decimals="-3"
      id="F_eab61c13-695f-4d4b-a7d2-6a1423a5ad8c"
      unitRef="U_USD">74694000</sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock>
    <sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares
      contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"
      decimals="INF"
      id="F_bf4820e2-971e-4cb6-9277-e935978a0a82"
      unitRef="U_shares">121657452</sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStockShares>
    <sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock
      contextRef="C_80b6bcac-bc6a-423d-aecb-05d57e4f0c81"
      decimals="-3"
      id="F_0d7d620f-4e5b-4d1d-b094-827b3c6e67b7"
      unitRef="U_USD">149463000</sepn:TemporaryEquityConversionOfConvertiblePreferredStockToCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="INF"
      id="F_c4e96fe9-c329-4aec-8777-6a33491ab7bb"
      unitRef="U_shares">22839774</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="-3"
      id="F_04bb01d0-dac7-4477-b936-159e2bab3f04"
      unitRef="U_USD">23000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"
      decimals="-3"
      id="F_fc7f5076-dca3-4855-93b9-1c06a3ae0dfe"
      unitRef="U_USD">224134000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_b6f92bd8-5d53-497f-8689-acd5d3d83c70"
      unitRef="U_USD">224157000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="0"
      id="F_9f597429-132e-4eb7-9814-fb8fd370ff0b"
      unitRef="U_shares">28896</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"
      decimals="-3"
      id="F_cbbd6fd3-1161-4b97-a1c8-41968980c46e"
      unitRef="U_USD">66000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_2b86185b-5a54-4e03-a63c-43e798a34666"
      unitRef="U_USD">66000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested
      contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"
      decimals="-3"
      id="F_205064d6-a42b-4807-923b-ed7dc2a9a21d"
      unitRef="U_USD">21000</sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested>
    <sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_34eafcd4-a479-4a43-8fd5-b0c3667026b0"
      unitRef="U_USD">21000</sepn:StockIssuedDuringPeriodValuesRestrictedStockAwardVested>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_f1221a25-caf1-4805-ad5a-d8ab5144be88"
      decimals="0"
      id="F_9086ae62-6663-4cb2-807d-b81a445e69fc"
      unitRef="U_shares">14299</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_794848e1-09b7-4a43-8aea-81d6a449cd8a"
      decimals="-3"
      id="F_3e863014-1248-4fbc-9915-adae5227807f"
      unitRef="U_USD">3152000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_21c7cbbb-28c0-4f09-b0e9-a64f4ee633ec"
      unitRef="U_USD">3152000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0a283eb0-f11e-47f7-8c48-261df37e83d8"
      decimals="-3"
      id="F_767a35a8-9a92-4790-878c-43cf726b5d18"
      unitRef="U_USD">56000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_5213e98e-4c99-4c03-baf4-15e31f1199ec"
      unitRef="U_USD">56000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_489a951a-d17d-48d1-be9f-c29fef36aa29"
      decimals="-3"
      id="F_96b98c19-9989-4a4e-aa50-ec549d1c24b4"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_e36c6762-d603-4660-9d78-2e1053b23491"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"
      decimals="0"
      id="F_73b4428c-7514-4a14-9ebc-ee6a5a1d4b29"
      unitRef="U_shares">44422505</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"
      decimals="-3"
      id="F_3a390976-d6c6-44df-af9f-05553ab51004"
      unitRef="U_USD">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0e7e5752-e6a2-4a70-b4fa-b116c9416205"
      decimals="-3"
      id="F_81dbdfd0-ddf5-4a4d-9dba-e10a12be9a9b"
      unitRef="U_USD">538321000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_92e936a1-7cb3-40e9-993e-bbcd2f3f805e"
      decimals="-3"
      id="F_37987824-24b3-4181-b77a-b780f6c2a9bf"
      unitRef="U_USD">56000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_35342a71-3904-46c9-8baf-50e827a2f8e2"
      decimals="-3"
      id="F_19e49f90-e675-4265-8620-f25c55744a03"
      unitRef="U_USD">-118374000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_7a9efbc0-d1b9-4eae-8c43-5f17f8d8c8a3"
      unitRef="U_USD">420047000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_2b719b12-ecd6-4298-98d7-b821a0da9001"
      unitRef="U_USD">-71798000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_edc9924c-0de3-4c2c-8bf4-a03d0859c0f0"
      unitRef="U_USD">4180000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_dcd11cc7-5e6c-4fe2-87a8-9066d14b7b65"
      unitRef="U_USD">1401000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8b28b8bc-b455-4dfa-969d-86650f1c4ef5"
      unitRef="U_USD">848000</us-gaap:DepreciationAndAmortization>
    <sepn:GainOnSaleOfNonFinancialAsset
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_01d348da-9de8-477c-9b20-81045eaad639"
      unitRef="U_USD">0</sepn:GainOnSaleOfNonFinancialAsset>
    <sepn:GainOnSaleOfNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_0866bcc2-8d2e-4420-952a-12812fc7f08d"
      unitRef="U_USD">47625000</sepn:GainOnSaleOfNonFinancialAsset>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_596b9514-9605-4ddb-b4b3-c608977bae3d"
      unitRef="U_USD">1383000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8606e2a7-2a89-43b6-88b5-956cce55718c"
      unitRef="U_USD">807000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_0f40d2dc-5a72-4d5a-82ac-d05e4d46b965"
      unitRef="U_USD">3152000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_96f7276a-9067-4e03-8d67-4652f5569afa"
      unitRef="U_USD">1620000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a68f7ac4-ee6c-4316-bd0a-e8db30ed5922"
      unitRef="U_USD">1410000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_02f1c4a7-039f-4ca4-90eb-9196b7ea6cd1"
      unitRef="U_USD">0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_619d64b9-7161-4645-a0fb-77eaaa4714bd"
      unitRef="U_USD">-491000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_6e2af7e1-31cf-4d0e-8ca2-5e7c28b07e48"
      unitRef="U_USD">491000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_8de27708-0e40-411d-a0a4-00672ce3ed88"
      unitRef="U_USD">-45000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_967b78d3-25ed-48a4-a3b6-90a371b48d07"
      unitRef="U_USD">-30000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_2ae7832e-18c6-4c6b-9d14-8448fc43076f"
      unitRef="U_USD">4297000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_e29211d5-9a26-4149-a544-0f32e4317b6c"
      unitRef="U_USD">136000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c8227842-3acf-4025-8284-7b6a63f28eed"
      unitRef="U_USD">20000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_96cb6013-6bcd-4033-99ac-0a817a62c23a"
      unitRef="U_USD">151000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_37bdca54-baff-4e9f-a5f7-3a3dac79df9b"
      unitRef="U_USD">170000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8a573dbd-8aff-4ec7-b098-ff345eb10439"
      unitRef="U_USD">-165000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_17df319f-0ef8-40d7-8cec-1382e06acf72"
      unitRef="U_USD">723000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b6474e9c-0029-4e75-8ac2-dd9ffe649d65"
      unitRef="U_USD">-653000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_14460b3b-10f0-4c2b-8330-a30dd7c04100"
      unitRef="U_USD">3564000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_7668aa2b-bb41-473d-b16f-62a6676aaf98"
      unitRef="U_USD">2471000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_3b88324c-31fe-4734-852c-b1de53e0630d"
      unitRef="U_USD">448000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_4fc04d91-790c-4d6a-bf7a-b8b5624248cc"
      unitRef="U_USD">-770000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_849143b7-d225-4e33-bbf3-d1b45c819bbe"
      unitRef="U_USD">-67470000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_6b05c156-5056-4dee-8915-bb8cab33c647"
      unitRef="U_USD">-38723000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_0b2fb0e0-cc97-419c-b475-8573a86a41f1"
      unitRef="U_USD">2103000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_f17fc123-06a9-443f-a199-7f8ef74c3bfb"
      unitRef="U_USD">2878000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <sepn:ProceedsFromSaleOfNonFinancialAsset
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c5855f83-4d95-4140-a736-d7ce5250a146"
      unitRef="U_USD">22625000</sepn:ProceedsFromSaleOfNonFinancialAsset>
    <sepn:ProceedsFromSaleOfNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_63f3ef3c-a93b-4a90-930c-a9540e9826ce"
      unitRef="U_USD">25000000</sepn:ProceedsFromSaleOfNonFinancialAsset>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a0b6adeb-3b33-4871-a89c-d5f9b5790aa1"
      unitRef="U_USD">213390000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_e67d9fec-5902-4aed-af7a-8d47f49069b0"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_b06dcb12-68e6-4c27-a660-3bcef8cb0291"
      unitRef="U_USD">32270000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_91419886-038b-4770-b25a-ae70602a99e7"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_f1c2a464-d97f-4768-bdbf-fd51d1238cac"
      unitRef="U_USD">-160598000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_6b4f8a6e-b51e-49e7-948a-55bc1520e05e"
      unitRef="U_USD">22122000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_5786167f-6cab-465c-ba5a-218f7a99a08d"
      unitRef="U_USD">302788000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_336c6ead-7374-4a25-b533-4fe7874ab7ae"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c8fdd304-0d89-4f33-8d74-2d76aa4260c1"
      unitRef="U_USD">74942000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_874b08be-681d-4191-a319-26d0f14aaa6a"
      unitRef="U_USD">74521000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <sepn:RepurchasesOfUnvestedRestrictedCommonStock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a7b098a0-5a7b-420c-b69e-229b0a978a51"
      unitRef="U_USD">1000</sepn:RepurchasesOfUnvestedRestrictedCommonStock>
    <sepn:RepurchasesOfUnvestedRestrictedCommonStock
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_0f535992-0a38-4895-bdd3-61aed0867ec0"
      unitRef="U_USD">1000</sepn:RepurchasesOfUnvestedRestrictedCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_59da83c1-11d5-4bc0-8cec-b0af5c9bb772"
      unitRef="U_USD">52000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_ce9baa0c-b5cf-427a-a94f-59811d00c403"
      unitRef="U_USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_927c6965-2df9-46e2-8392-ffb15661b75f"
      unitRef="U_USD">377781000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_0f17892f-54d4-4e69-b689-3633b88f0ca8"
      unitRef="U_USD">74520000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_10fbdeed-b74d-4183-92a8-e4cc237b1a8e"
      unitRef="U_USD">149713000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_4298511f-a74a-4815-b2a9-7fa253b88324"
      unitRef="U_USD">57919000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_c3e9405c-74a6-4f57-9b87-5f9f1214268c"
      unitRef="U_USD">89388000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56"
      decimals="-3"
      id="F_bd03b425-83aa-4196-90bd-06a5cc0a7060"
      unitRef="U_USD">31469000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1e224858-97fe-4917-a6cd-ca3f7aca5fbd"
      unitRef="U_USD">239101000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_aa39b14c-edbb-44c7-8c53-ae98ac8e8b32"
      unitRef="U_USD">89388000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a83ea36f-bfc3-4df1-8eb6-0e1741c3f06e"
      unitRef="U_USD">232000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_f4568e6d-9281-4768-9308-e11d8ad8cec9"
      unitRef="U_USD">75000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_128e7be3-b15f-446a-a691-dd9c08a1aa25"
      unitRef="U_USD">12462000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_437b05f1-0bc6-4dae-838c-0612bf94e978"
      unitRef="U_USD">12579000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_b31dbebd-6f12-45f8-90e4-bcee11f95bb1"
      unitRef="U_USD">0</sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset>
    <sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_ba209983-bd3e-42dc-b2f1-e8530386047c"
      unitRef="U_USD">22625000</sepn:OtherReceivableRelatedToSaleOfNonFinancialAsset>
    <sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_34b81f02-981e-44d8-bdc7-5f4e8431d43d"
      unitRef="U_USD">224157000</sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering>
    <sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_aabd0b34-72bb-4886-a1a6-b1917c012567"
      unitRef="U_USD">0</sepn:ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering>
    <sepn:UnpaidOfferingCostsIncludedInAccountsPayable
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c0efb19b-3c22-4179-83d8-c7736b213355"
      unitRef="U_USD">21000</sepn:UnpaidOfferingCostsIncludedInAccountsPayable>
    <sepn:UnpaidOfferingCostsIncludedInAccountsPayable
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_39a74a8c-37f7-47c1-8bdc-ff0a6cafd81b"
      unitRef="U_USD">0</sepn:UnpaidOfferingCostsIncludedInAccountsPayable>
    <sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_545369b5-eaeb-40f8-a2cc-b0718569e091"
      unitRef="U_USD">37000</sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities>
    <sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_ebb149a9-3e8a-4537-9cb0-dbfba008a322"
      unitRef="U_USD">262000</sepn:PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d5865863-db22-4196-9100-09f083ba4b8f"
      unitRef="U_USD">238196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_6d33bf56-556e-4e88-b334-f2dee5b2e71b"
      unitRef="U_USD">88483000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_4a4b2fe2-7891-44c9-8697-3565ab8e02c3"
      unitRef="U_USD">905000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_fed5dca2-7723-4e98-a8a4-dd754c3abd5f"
      unitRef="U_USD">905000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1d139f1c-4e96-4d2c-ae47-ca967eb0a6e1"
      unitRef="U_USD">239101000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_c4b5ff4c-3c70-4fe7-ae5a-5e7abd49e5bd"
      unitRef="U_USD">89388000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <sepn:OrganizationDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_b3836b39-b9b3-4c59-a1b5-9499684fb314">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1. Organization&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of the Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Septerna, Inc. (&#x201c;Septerna&#x201d; or the &#x201c;Company&#x201d;) is a biotechnology company pioneering a new era of G protein-coupled receptor (&#x201c;GPCR&#x201d;) oral small molecule drug discovery powered by its proprietary Native Complex Platform&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company&#x2019;s industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of its deep pipeline of product candidates focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s proprietary Native Complex Platform&#x99; replicates the natural structure, function, and dynamics of GPCRs outside of cells at an industrial scale for, as the Company believes, the first time. The Company&#x2019;s foundational technologies enable it to isolate, purify, and reconstitute full-length, properly folded GPCR proteins within ternary complexes with ligands and transducer proteins in a lipid bilayer that mimics the cell membrane. The Company then applies state-of-the-art discovery tools and technologies to these defined and tunable protein complexes to structurally design, screen for, and optimize potential product candidates. Leveraging its platform, the Company has transformed GPCR oral small molecule drug discovery to an industrialized and iterative structure-based drug design approach to expand the landscape of druggable GPCR targets with novel oral small molecule medicines for patients. The Company&#x2019;s Native Complex Platform&#x99; is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to affect GPCR signaling in different ways to achieve desired therapeutic effects.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company was incorporated in Delaware in December 2019, under the name GPCR NewCo, Inc. In June 2021, the Company changed its name to Septerna, Inc. The Company is headquartered in South San Francisco, California.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reverse Stock Split&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 18, 2024, the Company effected a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1-for-8.6103&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reverse stock split of its issued and outstanding shares of common stock. Upon the effectiveness of the reverse stock split, (i) all shares of outstanding common stock were adjusted; (ii) the conversion ratio of the convertible preferred stock was adjusted; (iii) the number of shares of common stock for which each outstanding option to purchase common stock is exercisable were adjusted; and (iv) the exercise price of each outstanding option to purchase common stock was adjusted. All of the outstanding common stock (including shares of common stock subject to the Company&#x2019;s options and as converted for the outstanding convertible preferred stock), share prices, exercise prices and per share amounts contained in the financial statements have been retroactively adjusted to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of common stock and preferred stock were not adjusted as a result of the reverse stock split. The number of authorized shares did not change.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Initial Public Offering&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, the Company completed its initial public offering (&#x201c;IPO&#x201d;), pursuant to which it issued and sold an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its common stock at the IPO price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, including &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares, resulting in net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, after deducting underwriting discounts and commissions of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and other offering expenses payable by the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Immediately prior to the closing of the IPO, the Company&#x2019;s then outstanding convertible preferred stock automatically converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,839,774&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Following the closing of the IPO, no shares of convertible preferred stock were authorized or outstanding. In connection with the completion of the IPO, on October 28, 2024, the Company&#x2019;s certificate of incorporation was amended and restated to (i) authorize &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which eliminates all references to the previously existing series of convertible preferred stock; and (ii) authorize &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of undesignated preferred stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share,  that may be issued from time to time by the Company&#x2019;s board of directors in one or more series.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which assumes that the Company will realize its assets and satisfies its liabilities in the normal course of business. The Company is subject to risks inherent in operating an early-stage biotechnology business. These risks include, but are not limited to, dependence on the development of marketable products, the ability to attract, retain, and motivate qualified personnel, rapid technological changes and the rapidly evolving nature of the biotechnology industry.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has incurred significant losses and negative cash flows from operations since its inception and expects to incur losses as a result of its continued research and development activities. To date, none of the Company&#x2019;s product candidates have been approved by the U.S. Food and Drug Administration (the &#x201c;FDA&#x201d;) for commercial sale and, therefore, the Company has not generated any revenue from product sales.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company historically financed its operations primarily through the issuances of convertible promissory notes and convertible preferred stock, and most recently, through sale of its common stock in an IPO.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company incurred net loss of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company had an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024. The Company believes its cash, cash equivalents, marketable securities, and marketable securities, non-current of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;420.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024 will be sufficient to fund its operations for, at least, 12 months from the date of issuance of the financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expects to continue to generate operating losses for the foreseeable future. The Company will need additional financing to support its continuing operations and pursue its growth strategy. It expects to finance its operations through equity offerings, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain funding on acceptable terms, or at all. Any failure to raise capital as and when needed would compromise the Company&#x2019;s ability to execute on its business plan and may cause the Company to significantly delay, scale back or discontinue the research and development of some of its programs or curtail any efforts to expand its product pipelines and will materially harm its business, financial position and results of operations.&lt;/span&gt;&lt;/p&gt;</sepn:OrganizationDisclosureTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_c3d18edf-1da5-48a4-8374-55662573e03e"
      id="F_70392097-1415-4b49-acce-5b9e63138d9f">1-for-8.6103</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="INF"
      id="F_fe17e5d9-370a-4c0b-807d-7056ce09d0b4"
      unitRef="U_shares">18400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="2"
      id="F_a11a0861-5389-4ed5-ad17-03c9c4bb1561"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654"
      decimals="-5"
      id="F_db3d2bc8-fdad-45ac-a154-e70b77fd9f20"
      unitRef="U_shares">2400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_f8803fb0-d4ef-407e-9749-5767a60c0d8d"
      unitRef="U_USD">302800000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <sepn:UnderwritingDiscountsAndCommissions
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_77912a1c-80dd-413c-9c18-818410677df1"
      unitRef="U_USD">23200000</sepn:UnderwritingDiscountsAndCommissions>
    <sepn:UnderwritingOtherOfferingExpenses
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_65f6e817-04ab-46b9-95ec-f5f117f4fb67"
      unitRef="U_USD">5200000</sepn:UnderwritingOtherOfferingExpenses>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="INF"
      id="F_523581b3-2d87-4177-bd54-f6118ffd1475"
      unitRef="U_shares">22839774</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"
      decimals="INF"
      id="F_f13bee4b-dee6-4e43-ad14-3fc2b91af385"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"
      decimals="INF"
      id="F_4f3b6590-3290-4c96-9982-5823a56e869b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <sepn:UndesignatedPreferredStockSharesAuthorized
      contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"
      decimals="INF"
      id="F_de95328b-e9fa-4a7e-8390-7028c7b164c9"
      unitRef="U_shares">10000000</sepn:UndesignatedPreferredStockSharesAuthorized>
    <sepn:UndesignatedCommonStockParOrStatedValuePerShare
      contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"
      decimals="INF"
      id="F_b3443ecc-9e25-4936-bdae-72fdcddcdc4c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</sepn:UndesignatedCommonStockParOrStatedValuePerShare>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_83b256fb-1b64-4224-807d-4c6f66fe77aa"
      unitRef="U_USD">-71800000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-5"
      id="F_e9f7f312-93e3-4f97-9eda-ffe2a3cdd280"
      unitRef="U_USD">-118400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <sepn:CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-5"
      id="F_f63c81d5-3161-48c0-a5c7-b4d94569b2ba"
      unitRef="U_USD">420800000</sepn:CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_374c8556-8592-4dbd-b81e-352112f665f6">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;), stated in U.S. dollars and include all adjustments necessary for the fair presentation of the Company&#x2019;s financial statements as of December 31, 2024 and 2023, and for the years then ended. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification and Accounting Standards Updates &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASUs&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, of the Financial Accounting Standards Board &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;FASB&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures at the date of the financial statements and reported amounts of expenses during the reporting periods. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources and adjusts those estimates and assumptions when facts and circumstances dictate. Estimates are used in determining the fair value of assets and liabilities, the useful lives of property and equipment, the rate used in determining the present value of lease payments, fair value of assets and liabilities, research and development accruals, the estimated fair value of common stock prior to the Company's IPO, and stock options, the allocation of a revenue contract&#x2019;s transaction price to each distinct performance obligation on a relative standalone selling price basis, uncertain tax positions and the valuation allowance for deferred income tax assets. Actual results may differ from these estimates and assumptions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#x2019;s CODM is its chief executive officer. Based on the information used by the CODM to allocate resources, the Company has determined it operates in one segment.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company limits its credit risk by placing its cash, cash equivalents, and marketable securities with banks and institutions that are highly creditworthy. Such cash may be in excess of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insured limits, and the Company's cash equivalents and marketable securities are not insured by the FDIC. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and marketable securities to the extent recorded in the balance sheet.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. Management believes that the Company is not exposed to significant credit risk due to the high-credit-quality financial institutions in which those deposits are held. The Company has not experienced any losses on its cash, cash equivalents and marketable securities since inception. The Company has no significant off-balance sheet concentrations of credit risk.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to all of the risks inherent in an early-stage biotechnology company. These risks include, but are not limited to, limited management resources, efficacy of product candidates, intense competition, and dependence upon the availability of cash to sustain operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company holds marketable securities that consist of highly liquid, investment grade debt securities. The Company's cash and marketable securities are held or issued by financial institutions that management believes are of high credit quality. Marketable securities are classified and accounted for as available-for-sale. Marketable securities with original maturities of 90 days or less are classified as cash equivalents. Marketable securities with original maturities over 90 days and remaining maturities of less than 12 months are classified as current. Marketable securities with remaining maturities of more than 12 months for which the Company has the intent and ability to hold the security for more than 12 months are classified as non-current. The Company&#x2019;s marketable securities are carried at estimated fair value, which is derived from independent pricing sources based on quoted prices in active markets for similar securities. Unrealized gains and losses are reported in stockholders&#x2019; equity (deficit) as accumulated other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in interest income on the statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12 months. The Company does not generally intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews its portfolio of marketable securities, using both quantitative and qualitative factors, to determine if declines in fair value below amortized cost have resulted from a credit-related loss or other factors. If the decline in fair value is due to credit-related factors, the Company recognizes a loss in its statement of operations, whereas if the decline in fair value is not due to credit-related factors, the Company recognizes the loss in other comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excludes the applicable accrued interest from both the fair value and amortized cost basis of marketable securities for purposes of identifying and measuring an impairment. Accrued interest receivable on marketable securities is recorded within prepaid expenses and other current assets on the balance sheets. The Company&#x2019;s accounting policy is to not measure an allowance for credit loss for accrued interest receivable and to write-off any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which is considered to be in the period in which it is determined the accrued interest will not be collected.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted cash is comprised of cash that is restricted as to withdrawal or use under the terms of certain contractual agreements. In connection with the Company&#x2019;s lease agreement (see Note 7), the Company is required to maintain a collateral account to secure a letter of credit issued to its landlord. The collateral account is classified as restricted cash on the Company&#x2019;s balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounts Receivable and Other Receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes a receivable when the Company has an unconditional right to payment, which is generally at the time of delivery of assets, or at the time services are rendered.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;An allowance for expected credit losses over the life of the receivables is reserved for based on a combination of historical experience, aging analysis, current economic trends and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. The reserve is re-evaluated on a regular basis and adjusted as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. No allowance for credit losses was recorded during the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, the Company&#x2019;s accounts receivable was entirely attributed to Vertex Pharmaceuticals Incorporated (&#x201c;Vertex&#x201d;). As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company&#x2019;s other receivable related to sale of non-financial asset balance was entirely attributed to Vertex (see Note 4 and Note 5).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment is recorded at cost, subject to adjustments for impairments, less accumulated depreciation. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:40.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation or amortization begins at the time the asset is placed in service. Maintenance and repairs that do not improve or extend the life of the respective asset are charged to expense as incurred. Upon disposal of assets, the cost and related accumulated depreciation is removed from the balance sheet and the resulting gain or loss is reflected in the statements of operations and comprehensive (loss) income within other income, net.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its long-lived assets for impairment, primarily its property and equipment, whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the undiscounted expected future cash flows the asset is expected to generate over its remaining life. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset or asset group and its eventual disposition are less than its carrying amount. Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of the Company&#x2019;s long-lived assets for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for its leases in accordance with FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 842&#x201d;). The Company adopted ASC 842 on January 1, 2021, prior to entering into the lease agreement for its office and research and development space. At inception of a contract, the Company determines whether an arrangement is or contains a lease. For each lease, the Company determines the classification as either an operating lease or a financing lease. Lease recognition occurs at the lease commencement date and lease liability amounts are determined based on the present value of lease payments over the lease term. The lease term may include options to extend or terminate the lease only when it is reasonably certain that the Company will exercise that option.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments if the Company&#x2019;s leases do not provide an implicit rate. The Company determines its incremental borrowing rate based on the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. Right-of-use assets represent the Company&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s right to use underlying assets for the lease term and operating lease liabilities represent the Company&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s obligation to make lease payments under the lease. Right-of-use assets also include any lease payments made prior to the commencement date and exclude lease incentives received.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company elected to apply the practical expedient of combining lease and non-lease components for the real estate lease asset class. Fixed lease payments on operating leases are recognized as lease expense over the expected term of the lease on a straight-line basis. Variable lease expenses that are not considered fixed are recognized as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Company elected the short-term lease practical expedient that allows the lessee to not record a lease liability and right-of-use asset for all leases with a term of 12 months or less. See Note 7 for additional information on the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; leases.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a deemed liquidation event, such as a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#x2019;s certificate of incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred stock into shares of common stock. Convertible preferred stock is therefore classified outside of stockholders&#x2019; equity (deficit) as events triggering redemption are not solely within the Company&#x2019;s control.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;No shares of convertible preferred stock were authorized, issued or outstanding at December 31, 2024. As of December 31, 2023, the Company did not adjust the carrying values of its convertible preferred stock to the liquidation preferences because of the uncertainty of whether or when such an event would occur. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, it was not probable that such a redemption would occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company generated revenue for the year ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex (see Note 5). The Company considers revenue to be earned when all of the following criteria are met: (i) the Company has a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#x2019;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; revenue was entirely attributable to Vertex.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Sale of Non-Financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sales of non-financial assets that are outside the scope of the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ordinary activities are accounted for under ASC 610-20, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Other Income - Gains and Losses from the Derecognition of Non-financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 610-20&#x201d;). Pursuant to ASC 610-20, the Company applies the guidance in ASC 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASC 606&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to determine if a contract exists, identify the distinct non-financial assets, and determine when control transfers and, therefore, when to derecognize the non-financial asset. Additionally, the Company applies the measurement principles of ASC 606 to determine the amount of consideration, if any, to include in the calculation of the gain or loss for the non-financial asset.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of clinical and preclinical materials, information technology-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations and fees paid to other entities that conduct certain research and development activities on the Company&#x2019;s behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has entered into agreements with outsourced contract manufacturing and development and clinical research vendors. The Company estimates accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. The Company periodically confirms the accuracy of its estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs to secure and maintain patents covering the Company&#x2019;s technology and product candidates are expensed as incurred and are classified as general and administrative expenses in the statements of operations and comprehensive (loss) income.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&#x2014;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&#x2014;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&#x2014;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The carrying values of the Company&#x2019;s cash and cash equivalents, restricted cash, accounts receivable, other receivable related to sale of non-financial asset, accounts payable and accrued expenses, approximate their fair values due to their relatively short maturities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense related to stock options and restricted stock awards granted to employees and non-employees is recognized based on the grant-date fair value of the awards. The fair value of stock options is determined using the Black Scholes option pricing model on the date of grant. The fair value of restricted stock awards is determined using the estimated fair value of the Company&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the IPO, the Company utilized estimates and assumptions in determining the fair value of its common stock, including stock-based awards. The Company has granted stock options at exercise prices that represented the fair value of its common stock on the specific grant dates. The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants Technical Practice Aid, Valuation of Privately Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of the convertible preferred stock senior to the Company&#x2019;s common stock at the time, and a probability analysis of various liquidity events, such as a public offering or sale of the Company, under differing scenarios.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For stock-based awards with service conditions only, the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is generally the vesting term of the award of four years. For stock-based awards with vesting criteria subject to the achievement of performance-based conditions, in addition to service conditions, the Company recognizes stock-based compensation expense on an accelerated basis over the vesting period when achievement of the performance criteria becomes probable.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense is recorded within research and development and general and administrative expenses in the accompanying statements of operations and comprehensive (loss) income based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company utilizes the asset and liability approach to account for income taxes. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. Deferred tax assets and liabilities are determined based upon the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and for loss and credit carryforwards, using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for uncertain tax positions recognized in the financial statements by prescribing a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related interest and penalties.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive (Loss) Income&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive (loss) income is defined as a change in equity of a business enterprise during a period resulting from transactions from non-owner sources. The Company&#x2019;s other comprehensive (loss) income is comprised solely of unrealized gains (losses) on marketable securities. The Company has not recorded any reclassifications from other comprehensive (loss) income to net loss during the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration of potential dilutive securities. Vested restricted stock is treated as outstanding for accounting purposes. Unvested restricted stock is not considered to be outstanding for purposes of the calculation of basic net (loss) income per share. Diluted net (loss) income per share is computed by dividing the net (loss) income by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options, unvested restricted stock and convertible preferred stock. The dilutive effect of stock options and unvested restricted stock is computed using the treasury stock method and the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;dilutive effect of convertible preferred stock is calculated using the &#x201c;if-converted method.&#x201d; For all periods presented in a net loss position, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holders of its convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. Net (loss) income is attributed to common stockholders and participating securities based on their participation rights.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. ASU 2023-07 will improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods after December 5, 2024, with early adoption permitted. The Company adopted Topic 280 on January 1, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments &#x2013; Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326),&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. Topic 326 is effective for annual periods beginning after December 15, 2022, and early adoption is permitted. The Company adopted Topic 326 on January 1, 2023, and the adoption did not have a material impact on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB, under its ASC or other standard setting bodies, and adopted by the Company as of the specified date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, an accounting standard update that requires the Company to disclose more detailed information about the types of expenses (including employee compensation, depreciation, and amortization) included in each relevant income statement expense caption. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which enhances the transparency and decision usefulness of income tax disclosures. The standard is intended to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2025,  on a prospective basis. Early adoption and retrospective reporting are permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Emerging Growth Company Status and Smaller Reporting Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company is also a smaller reporting company as defined in the Securities Exchange Act of 1934, as  amended (the &#x201c;Exchange Act&#x201d;). The Company may continue to be a smaller reporting company even after it is no longer an emerging growth company. The Company may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as its voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of its second fiscal quarter, or its annual revenue is less than $100.0 million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;during &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the most recently completed fiscal year and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its second fiscal quarter.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_4cbc813e-cdde-46d0-a3fa-545b21ae644a">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;), stated in U.S. dollars and include all adjustments necessary for the fair presentation of the Company&#x2019;s financial statements as of December 31, 2024 and 2023, and for the years then ended. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification and Accounting Standards Updates &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASUs&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, of the Financial Accounting Standards Board &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;FASB&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_2fd40fdc-3b88-4bde-a1d0-c429245c2602">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures at the date of the financial statements and reported amounts of expenses during the reporting periods. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources and adjusts those estimates and assumptions when facts and circumstances dictate. Estimates are used in determining the fair value of assets and liabilities, the useful lives of property and equipment, the rate used in determining the present value of lease payments, fair value of assets and liabilities, research and development accruals, the estimated fair value of common stock prior to the Company's IPO, and stock options, the allocation of a revenue contract&#x2019;s transaction price to each distinct performance obligation on a relative standalone selling price basis, uncertain tax positions and the valuation allowance for deferred income tax assets. Actual results may differ from these estimates and assumptions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_82962e70-e5cc-4cab-a753-d339ec59bf55">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#x2019;s CODM is its chief executive officer. Based on the information used by the CODM to allocate resources, the Company has determined it operates in one segment.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <sepn:RisksAndUncertaintyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5870e22f-1032-4886-b9ee-61a5b023feb8">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company limits its credit risk by placing its cash, cash equivalents, and marketable securities with banks and institutions that are highly creditworthy. Such cash may be in excess of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insured limits, and the Company's cash equivalents and marketable securities are not insured by the FDIC. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and marketable securities to the extent recorded in the balance sheet.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. Management believes that the Company is not exposed to significant credit risk due to the high-credit-quality financial institutions in which those deposits are held. The Company has not experienced any losses on its cash, cash equivalents and marketable securities since inception. The Company has no significant off-balance sheet concentrations of credit risk.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to all of the risks inherent in an early-stage biotechnology company. These risks include, but are not limited to, limited management resources, efficacy of product candidates, intense competition, and dependence upon the availability of cash to sustain operations.&lt;/span&gt;&lt;/p&gt;</sepn:RisksAndUncertaintyPolicyTextBlock>
    <sepn:CashEquivalentsAndMarketableSecuritiesPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_8d90b95f-50b7-4d51-9175-a4d1954d1458">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company holds marketable securities that consist of highly liquid, investment grade debt securities. The Company's cash and marketable securities are held or issued by financial institutions that management believes are of high credit quality. Marketable securities are classified and accounted for as available-for-sale. Marketable securities with original maturities of 90 days or less are classified as cash equivalents. Marketable securities with original maturities over 90 days and remaining maturities of less than 12 months are classified as current. Marketable securities with remaining maturities of more than 12 months for which the Company has the intent and ability to hold the security for more than 12 months are classified as non-current. The Company&#x2019;s marketable securities are carried at estimated fair value, which is derived from independent pricing sources based on quoted prices in active markets for similar securities. Unrealized gains and losses are reported in stockholders&#x2019; equity (deficit) as accumulated other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in interest income on the statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12 months. The Company does not generally intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews its portfolio of marketable securities, using both quantitative and qualitative factors, to determine if declines in fair value below amortized cost have resulted from a credit-related loss or other factors. If the decline in fair value is due to credit-related factors, the Company recognizes a loss in its statement of operations, whereas if the decline in fair value is not due to credit-related factors, the Company recognizes the loss in other comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excludes the applicable accrued interest from both the fair value and amortized cost basis of marketable securities for purposes of identifying and measuring an impairment. Accrued interest receivable on marketable securities is recorded within prepaid expenses and other current assets on the balance sheets. The Company&#x2019;s accounting policy is to not measure an allowance for credit loss for accrued interest receivable and to write-off any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which is considered to be in the period in which it is determined the accrued interest will not be collected.&lt;/span&gt;&lt;/p&gt;</sepn:CashEquivalentsAndMarketableSecuritiesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_d672a573-e22a-4f9b-93ce-ffbf984f13a1">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted cash is comprised of cash that is restricted as to withdrawal or use under the terms of certain contractual agreements. In connection with the Company&#x2019;s lease agreement (see Note 7), the Company is required to maintain a collateral account to secure a letter of credit issued to its landlord. The collateral account is classified as restricted cash on the Company&#x2019;s balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_565b1e79-52d4-4155-97d7-3aef9cc2faad">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounts Receivable and Other Receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes a receivable when the Company has an unconditional right to payment, which is generally at the time of delivery of assets, or at the time services are rendered.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;An allowance for expected credit losses over the life of the receivables is reserved for based on a combination of historical experience, aging analysis, current economic trends and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. The reserve is re-evaluated on a regular basis and adjusted as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. No allowance for credit losses was recorded during the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, the Company&#x2019;s accounts receivable was entirely attributed to Vertex Pharmaceuticals Incorporated (&#x201c;Vertex&#x201d;). As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company&#x2019;s other receivable related to sale of non-financial asset balance was entirely attributed to Vertex (see Note 4 and Note 5).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_300c602f-5600-4b49-a30f-1bfe03218a0c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment is recorded at cost, subject to adjustments for impairments, less accumulated depreciation. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:40.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation or amortization begins at the time the asset is placed in service. Maintenance and repairs that do not improve or extend the life of the respective asset are charged to expense as incurred. Upon disposal of assets, the cost and related accumulated depreciation is removed from the balance sheet and the resulting gain or loss is reflected in the statements of operations and comprehensive (loss) income within other income, net.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <sepn:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5a702a49-41f7-4519-bd98-65c9f159344c">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company depreciates property and equipment using the straight-line method over the estimated useful lives of the respective assets, as follows:&lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:40.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_906a3f33-fb42-4fdf-8d46-17d92b98968d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</sepn:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_d770876f-2396-4daa-bc4e-7986b296cd59"
      id="F_12867c50-d3a4-4496-8bed-787760d8d788">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_7079165a-aa57-4eb8-9488-ec1604a2095c"
      id="F_af40efa3-c530-4b35-834b-bfb4144444e4">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0b6e5099-66b3-4a19-9c22-90249dab9674"
      id="F_a1bfb1df-e539-4fc0-a3a3-2682c9fa6c18">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_96b8a98e-2692-42ad-a70e-81071163995f"
      id="F_8cd094bc-09f0-447b-9109-7b1071a22a29">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_487bdae9-b16a-4c47-b3c0-552bc85ff104">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its long-lived assets for impairment, primarily its property and equipment, whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the undiscounted expected future cash flows the asset is expected to generate over its remaining life. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset or asset group and its eventual disposition are less than its carrying amount. Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of the Company&#x2019;s long-lived assets for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="INF"
      id="F_556c718b-f25d-47e9-9cd1-43c4efe395e2"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="INF"
      id="F_86b0fa77-ae37-4651-9702-d64c3ac382a2"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_95ac5ad5-d231-4fea-a739-1f9f244e68d1">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for its leases in accordance with FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 842&#x201d;). The Company adopted ASC 842 on January 1, 2021, prior to entering into the lease agreement for its office and research and development space. At inception of a contract, the Company determines whether an arrangement is or contains a lease. For each lease, the Company determines the classification as either an operating lease or a financing lease. Lease recognition occurs at the lease commencement date and lease liability amounts are determined based on the present value of lease payments over the lease term. The lease term may include options to extend or terminate the lease only when it is reasonably certain that the Company will exercise that option.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments if the Company&#x2019;s leases do not provide an implicit rate. The Company determines its incremental borrowing rate based on the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. Right-of-use assets represent the Company&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s right to use underlying assets for the lease term and operating lease liabilities represent the Company&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s obligation to make lease payments under the lease. Right-of-use assets also include any lease payments made prior to the commencement date and exclude lease incentives received.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company elected to apply the practical expedient of combining lease and non-lease components for the real estate lease asset class. Fixed lease payments on operating leases are recognized as lease expense over the expected term of the lease on a straight-line basis. Variable lease expenses that are not considered fixed are recognized as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Company elected the short-term lease practical expedient that allows the lessee to not record a lease liability and right-of-use asset for all leases with a term of 12 months or less. See Note 7 for additional information on the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; leases.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <sepn:ConvertiblePreferredStockPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_4e8cb3d7-48fd-4eef-afc3-105ca675a33d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a deemed liquidation event, such as a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#x2019;s certificate of incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred stock into shares of common stock. Convertible preferred stock is therefore classified outside of stockholders&#x2019; equity (deficit) as events triggering redemption are not solely within the Company&#x2019;s control.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;No shares of convertible preferred stock were authorized, issued or outstanding at December 31, 2024. As of December 31, 2023, the Company did not adjust the carrying values of its convertible preferred stock to the liquidation preferences because of the uncertainty of whether or when such an event would occur. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, it was not probable that such a redemption would occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</sepn:ConvertiblePreferredStockPolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_a3f2c478-07fb-4778-9155-82c3a7cb3683">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company generated revenue for the year ended December 31, 2024 and 2023 from service revenue for research activities performed related to an agreement with Vertex (see Note 5). The Company considers revenue to be earned when all of the following criteria are met: (i) the Company has a contract with a customer that creates enforceable rights and obligations; (ii) promised products or services are identified; (iii) the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; (iv) and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. When a contract contains variable consideration and the variable consideration is constrained to the extent that it is not probable that it will be received, it is excluded from the transaction price. A contract&#x2019;s transaction price is allocated to each distinct performance obligation on a relative standalone selling price basis and recognized as revenue when, or as, control of the distinct good or service is transferred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; revenue was entirely attributable to Vertex.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <sepn:SaleOfNonFinancialAssetsPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_82051a25-16e6-49ae-96f1-3c4ac9963e31">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Sale of Non-Financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sales of non-financial assets that are outside the scope of the &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ordinary activities are accounted for under ASC 610-20, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Other Income - Gains and Losses from the Derecognition of Non-financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 610-20&#x201d;). Pursuant to ASC 610-20, the Company applies the guidance in ASC 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASC 606&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to determine if a contract exists, identify the distinct non-financial assets, and determine when control transfers and, therefore, when to derecognize the non-financial asset. Additionally, the Company applies the measurement principles of ASC 606 to determine the amount of consideration, if any, to include in the calculation of the gain or loss for the non-financial asset.&lt;/span&gt;&lt;/p&gt;</sepn:SaleOfNonFinancialAssetsPolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_daeebddc-2e81-429d-affd-7c6492a1ad28">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and development expenses consist primarily of employee-related costs, including salaries, benefits and stock-based compensation for employees engaged in research and development activities, costs related to research activities, preclinical studies and clinical trials, production of clinical and preclinical materials, information technology-related costs, allocated overhead costs including facility-related expenses, contract manufacturing, consulting fees, costs related to laboratory operations and fees paid to other entities that conduct certain research and development activities on the Company&#x2019;s behalf. Payments made prior to the receipt of goods and services to be used in research and development are deferred and recognized as expense in the period in which the related goods are received or services are rendered.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has entered into agreements with outsourced contract manufacturing and development and clinical research vendors. The Company estimates accrued research and development expenses as of each balance sheet date based on facts and circumstances known at that time. The Company periodically confirms the accuracy of its estimates with internal management personnel and external service providers, and makes adjustments, if necessary. Research and development accruals are estimated based on the level of services performed, progress of the studies, including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses on the balance sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and other current assets until the services are rendered.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <sepn:PatentExpensesPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_3da9a726-9a15-4a20-b915-4749878faebf">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs to secure and maintain patents covering the Company&#x2019;s technology and product candidates are expensed as incurred and are classified as general and administrative expenses in the statements of operations and comprehensive (loss) income.&lt;/span&gt;&lt;/p&gt;</sepn:PatentExpensesPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_dd02b5b2-1968-4c23-a157-3a5fe1c189de">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&#x2014;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&#x2014;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&#x2014;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f1cbbc43-e254-4981-97bd-e258ee26014c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The carrying values of the Company&#x2019;s cash and cash equivalents, restricted cash, accounts receivable, other receivable related to sale of non-financial asset, accounts payable and accrued expenses, approximate their fair values due to their relatively short maturities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_877c63d2-ccc6-41df-bd83-2d4d65f4f75d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense related to stock options and restricted stock awards granted to employees and non-employees is recognized based on the grant-date fair value of the awards. The fair value of stock options is determined using the Black Scholes option pricing model on the date of grant. The fair value of restricted stock awards is determined using the estimated fair value of the Company&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the IPO, the Company utilized estimates and assumptions in determining the fair value of its common stock, including stock-based awards. The Company has granted stock options at exercise prices that represented the fair value of its common stock on the specific grant dates. The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants Technical Practice Aid, Valuation of Privately Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of the convertible preferred stock senior to the Company&#x2019;s common stock at the time, and a probability analysis of various liquidity events, such as a public offering or sale of the Company, under differing scenarios.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For stock-based awards with service conditions only, the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is generally the vesting term of the award of four years. For stock-based awards with vesting criteria subject to the achievement of performance-based conditions, in addition to service conditions, the Company recognizes stock-based compensation expense on an accelerated basis over the vesting period when achievement of the performance criteria becomes probable.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense is recorded within research and development and general and administrative expenses in the accompanying statements of operations and comprehensive (loss) income based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_181c3f8a-24d7-4a44-9b16-5091979594df">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company utilizes the asset and liability approach to account for income taxes. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. Deferred tax assets and liabilities are determined based upon the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and for loss and credit carryforwards, using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for uncertain tax positions recognized in the financial statements by prescribing a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related interest and penalties.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1612229c-a351-4830-96d0-303b1576fb2c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive (Loss) Income&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive (loss) income is defined as a change in equity of a business enterprise during a period resulting from transactions from non-owner sources. The Company&#x2019;s other comprehensive (loss) income is comprised solely of unrealized gains (losses) on marketable securities. The Company has not recorded any reclassifications from other comprehensive (loss) income to net loss during the periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_e770a503-f780-4e84-b932-22061cf29a1e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration of potential dilutive securities. Vested restricted stock is treated as outstanding for accounting purposes. Unvested restricted stock is not considered to be outstanding for purposes of the calculation of basic net (loss) income per share. Diluted net (loss) income per share is computed by dividing the net (loss) income by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options, unvested restricted stock and convertible preferred stock. The dilutive effect of stock options and unvested restricted stock is computed using the treasury stock method and the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;dilutive effect of convertible preferred stock is calculated using the &#x201c;if-converted method.&#x201d; For all periods presented in a net loss position, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holders of its convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. Net (loss) income is attributed to common stockholders and participating securities based on their participation rights.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_70286c28-15d5-449d-a4bf-056ab149ee33">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. ASU 2023-07 will improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods after December 5, 2024, with early adoption permitted. The Company adopted Topic 280 on January 1, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments &#x2013; Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326),&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. Topic 326 is effective for annual periods beginning after December 15, 2022, and early adoption is permitted. The Company adopted Topic 326 on January 1, 2023, and the adoption did not have a material impact on its financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <sepn:AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_8f0e05c0-a809-44e7-9e1e-40f29e2e74f7">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB, under its ASC or other standard setting bodies, and adopted by the Company as of the specified date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, an accounting standard update that requires the Company to disclose more detailed information about the types of expenses (including employee compensation, depreciation, and amortization) included in each relevant income statement expense caption. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which enhances the transparency and decision usefulness of income tax disclosures. The standard is intended to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2025,  on a prospective basis. Early adoption and retrospective reporting are permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</sepn:AccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock>
    <sepn:EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_597e2f82-56f8-41cc-82da-de323e232fcc">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Emerging Growth Company Status and Smaller Reporting Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company is also a smaller reporting company as defined in the Securities Exchange Act of 1934, as  amended (the &#x201c;Exchange Act&#x201d;). The Company may continue to be a smaller reporting company even after it is no longer an emerging growth company. The Company may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as its voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of its second fiscal quarter, or its annual revenue is less than $100.0 million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;during &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the most recently completed fiscal year and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its second fiscal quarter.&lt;/span&gt;&lt;/p&gt;</sepn:EmergingGrowthCompanyStatusAndSmallerReportingCompanyStatusPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_aed3e266-dce7-47a4-af8c-b58c8e89103c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3. Balance Sheet Components&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical trial costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,164&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid bonus&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,622&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization expense was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued general and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued income taxes payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_e2fc14aa-ab47-44f1-8ec4-9e6db0170bfe">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical trial costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,164&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid bonus&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d0a7be18-6445-4938-8f0d-52e25f3d242e"
      unitRef="U_USD">3114000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_2ca53790-ba53-416a-a20e-3f3fe8d64ebb"
      unitRef="U_USD">874000</us-gaap:PrepaidExpenseCurrent>
    <sepn:PrepaidClinicalTrialCostsCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_95e8039d-fadb-4041-bd7a-20ef9ade1501"
      unitRef="U_USD">1164000</sepn:PrepaidClinicalTrialCostsCurrent>
    <sepn:PrepaidClinicalTrialCostsCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_7e24c193-66d9-4afb-ba84-c2ae074b21c9"
      unitRef="U_USD">0</sepn:PrepaidClinicalTrialCostsCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_bed50b51-e4db-4959-9118-6fdd967c0263"
      unitRef="U_USD">953000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_69484787-3888-4646-860b-7987dccb5007"
      unitRef="U_USD">0</us-gaap:InterestReceivableCurrent>
    <sepn:PrepaidBonusCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8dde097f-edad-4181-ae6b-11d28551d975"
      unitRef="U_USD">260000</sepn:PrepaidBonusCurrent>
    <sepn:PrepaidBonusCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a9e5ae37-a764-4040-8464-677bbbaf670f"
      unitRef="U_USD">378000</sepn:PrepaidBonusCurrent>
    <sepn:PrepaidTaxesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_01bc1f6d-587e-4a83-a222-1c777835498f"
      unitRef="U_USD">39000</sepn:PrepaidTaxesCurrent>
    <sepn:PrepaidTaxesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_f4caeb40-e603-43eb-8515-78a2e4b80505"
      unitRef="U_USD">75000</sepn:PrepaidTaxesCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_3df0d6c7-c470-4f3a-b29d-4438d15e1092"
      unitRef="U_USD">200000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_d3b823b1-1549-44eb-bcc3-0879596dfed6"
      unitRef="U_USD">92000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_eb3703b7-80c1-43b0-a4ba-8e459d9db974"
      unitRef="U_USD">5730000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_cc627148-8ad4-4b02-b39e-99f5ea44686b"
      unitRef="U_USD">1419000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_18caea63-3349-4e65-9019-57d1c29e940a">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,622&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_d770876f-2396-4daa-bc4e-7986b296cd59"
      decimals="-3"
      id="F_dd9e57b9-938a-46bc-bd90-cf762116c217"
      unitRef="U_USD">5679000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_832c9435-8669-4826-9854-08cb83c395aa"
      decimals="-3"
      id="F_ba3fb62a-2049-4a56-9739-28b9731a3cb8"
      unitRef="U_USD">4967000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_35e15b2a-6b34-49e1-8b87-da8c2cffe44c"
      decimals="-3"
      id="F_12fa13fc-543a-4439-baad-7056ec008ae9"
      unitRef="U_USD">1222000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c8bbdab5-fa45-4f45-b9e3-c2cf656b651c"
      decimals="-3"
      id="F_48a95b04-3c25-4d4e-a417-13c110d1aba5"
      unitRef="U_USD">713000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b804a170-664e-41ff-a1cb-b608203157b8"
      decimals="-3"
      id="F_7b959a22-3a61-444a-a8cb-7a23c6b768ef"
      unitRef="U_USD">717000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_eea5f8f5-675f-48a9-bc1e-43f7089d6e4b"
      decimals="-3"
      id="F_bc0291b9-a169-41b1-b75b-449c5b3d3d1f"
      unitRef="U_USD">389000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_96b8a98e-2692-42ad-a70e-81071163995f"
      decimals="-3"
      id="F_82845a71-cf80-4a39-bc79-803ab5c2e1c9"
      unitRef="U_USD">401000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_94ef1645-1200-4432-b228-36b9fceb7a82"
      decimals="-3"
      id="F_b704009b-af2a-4fd7-91ac-7579c134d2b5"
      unitRef="U_USD">218000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_4744a549-bf24-45da-afbb-10501b88f2c0"
      unitRef="U_USD">8019000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_8e00fde8-b459-43fe-84a7-38f5a7994852"
      unitRef="U_USD">6287000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_c9d038e3-a531-44f8-a516-cce84832c771"
      unitRef="U_USD">2929000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_e8630181-824f-400f-8f2f-127c987698c0"
      unitRef="U_USD">1622000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_11d62068-dfd8-4488-950b-4d176c1f8c80"
      unitRef="U_USD">5090000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_e3f60eb0-2fa5-4720-a0fc-060bfd3d3a4f"
      unitRef="U_USD">4665000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_dd14bcf9-8bcc-44aa-97ee-b757e57e6cf5"
      unitRef="U_USD">1400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_e2cc2602-a4eb-4800-8c2c-32f018ead855"
      unitRef="U_USD">800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_d21ca3fd-a375-4db7-923e-df5263aac615">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued general and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued income taxes payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_a5896f02-a3c7-494b-ab58-b5ba441fca68"
      unitRef="U_USD">4129000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_00230f08-db69-41d7-b586-74c7958903bb"
      unitRef="U_USD">2954000</us-gaap:AccruedSalariesCurrent>
    <sepn:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_c2352e85-2ed0-488c-8f31-3d9a55e13adf"
      unitRef="U_USD">2888000</sepn:AccruedResearchAndDevelopmentExpenseCurrent>
    <sepn:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_f0b74237-03c0-4ada-8d44-fbbacf0ebd6f"
      unitRef="U_USD">829000</sepn:AccruedResearchAndDevelopmentExpenseCurrent>
    <sepn:AccruedGeneralAndAdministrativeExpenseCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_6c7cd745-9f94-47d0-af45-f03284dee834"
      unitRef="U_USD">703000</sepn:AccruedGeneralAndAdministrativeExpenseCurrent>
    <sepn:AccruedGeneralAndAdministrativeExpenseCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_90618927-2f75-4708-8ee7-387c0251e01a"
      unitRef="U_USD">209000</sepn:AccruedGeneralAndAdministrativeExpenseCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_0c1e69aa-5da7-4111-a2e4-afa11a31c870"
      unitRef="U_USD">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_3e15fd7a-d51c-4929-934c-cfe2d91a7fd6"
      unitRef="U_USD">200000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_e5a80260-fa5f-4a3a-9c2e-21655324ccfe"
      unitRef="U_USD">78000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_12416a31-e0b2-4c1d-a83c-0409b010d9e7"
      unitRef="U_USD">85000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_38316a8f-d419-4f0e-87c6-dc11cc516b80"
      unitRef="U_USD">7798000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_555b7453-2a56-4770-9872-7a699246e348"
      unitRef="U_USD">4277000</us-gaap:AccruedLiabilitiesCurrent>
    <sepn:GainOnSaleOfNonFinancialAssetTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5fed179a-f237-4d21-9488-cde75268faf2">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4. Gain on Sale of Non-Financial Asset&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Vertex Asset Sale&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2023, the Company entered into an asset purchase agreement with Vertex under which Vertex acquired an IPR&amp;amp;D asset related to a GPCR program, including all intellectual property, materials, and compounds associated with the program (the &#x201c;Vertex Purchase Agreement&#x201d;). Additionally, as part of the agreement, Vertex assumed all claims, counterclaims and credits&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;associated with the program, and the Company gave up all rights to the intellectual property. The transfer of the IPR&amp;amp;D asset to Vertex was completed in November 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the same time in September 2023, the Company entered into a research service agreement with Vertex under which the Company agreed to perform certain exploratory research activities for Vertex (the &#x201c;Vertex Research Service Agreement&#x201d;) (see Note 5).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that the IPR&amp;amp;D asset sale should be accounted for under the guidance at ASC 610-20, as this type of transaction did not meet the definition of &#x201c;ordinary activities&#x201d; of the Company and Vertex should not be considered a &#x201c;customer&#x201d; in this transaction. However, since both the Vertex Purchase Agreement and the Vertex Research Service Agreement were entered into at the same time with the same counterparty with a single commercial objective, the Company combined the contracts and applied the allocation principles under ASC 606. The Company identified the performance obligations in both contracts, determined the transaction price and allocated the transaction price to the performance obligations in the contracts based on the estimated standalone selling price for each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded a gain on sale of non-financial asset of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the sale of the IPR&amp;amp;D asset to Vertex on its statements of operations and comprehensive (loss) income. The Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash at the closing of the agreement in September 2023 and recorded the remaining balance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in other receivable related to sale of non-financial asset on its balance sheet as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the sale of the IPR&amp;amp;D asset was complete and the Company had an unconditional right to the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company received the payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of this balance in the first half of 2024. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; gain on sale of non-financial asset was recognized during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Vertex Purchase Agreement also provides for a potential milestone payment payable to the Company contingent upon achievement of a certain research milestone. The milestone payment amount is determined based on the timing of achievement of the research milestone. The variable consideration related to this milestone payment was determined to be improbable of receipt at this time. As a result, the milestone payment was excluded from the transaction price. After the potential milestone payment, the Company will not receive any other payments or future royalties related to this IPR&amp;amp;D asset.&lt;/span&gt;&lt;/p&gt;</sepn:GainOnSaleOfNonFinancialAssetTextBlock>
    <sepn:GainOnSaleOfNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_180348c4-1f53-473b-8d37-39aa9a17d568"
      unitRef="U_USD">47600000</sepn:GainOnSaleOfNonFinancialAsset>
    <sepn:ProceedsFromSaleOfNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_478ec62d-3cc8-40ca-afd0-5732539dc10c"
      unitRef="U_USD">25000000</sepn:ProceedsFromSaleOfNonFinancialAsset>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-5"
      id="F_2eeb52b1-b611-4b7c-94fd-2ae8a6d462f8"
      unitRef="U_USD">22600000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <sepn:UnconditionalRightOnNonFinancialAsset
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_8da9885f-6bc0-40db-a39a-eed4b3b17ffb"
      unitRef="U_USD">22600000</sepn:UnconditionalRightOnNonFinancialAsset>
    <sepn:PaymentReceivedOnSaleOfNonFinancialAsset
      contextRef="C_27aa5798-cdf5-4aeb-9c35-f6a7f0ef79c9"
      decimals="-5"
      id="F_c4d3d071-ab2b-4bef-b56d-9e7b3f051ea3"
      unitRef="U_USD">22600000</sepn:PaymentReceivedOnSaleOfNonFinancialAsset>
    <sepn:GainOnSaleOfNonFinancialAsset
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="INF"
      id="F_3ceffb22-7e6e-4cd4-978d-f1c98fae4c84"
      unitRef="U_USD">0</sepn:GainOnSaleOfNonFinancialAsset>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_4a46da2f-0ddd-43ef-9107-4b726c518bea">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Vertex Research Service Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As disclosed in Note 4, the Company entered into the Vertex Research Service Agreement in September 2023 under which the Company agreed to perform certain exploratory research activities for Vertex. Although the Company accounted for the IPR&amp;amp;D asset sale under the guidance at ASC 610-20, the research services portion of the transaction fell under the scope of the revenue from contracts with customers guidance, ASC 606.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Vertex Research Service Agreement is for a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; term, however, Vertex has the ability to terminate the agreement with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;30-day&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; notice at any time. As a result, the Company concluded that the contract duration is 30 days, representing a month-to-month service contract.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The Company recognizes this service revenue over the performance period of the research services as the services are provided. The Vertex Research Service Agreement also includes a provision related to additional research services, which the Company concluded met the definition of a customer option under ASC 606. The Company will recognize revenue related to the customer option if and when it is exercised.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, the Company recorded revenue of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; related to research activities performed in connection with the Vertex Research Service Agreement and customer options exercised. During the year ended December 31, 2023, the Company recorded revenue of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; related to research activities performed in connection with the Vertex Research Service Agreement and no customer options were exercised.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <sepn:AgreementDescription
      contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c"
      id="F_94dbc2c5-0d90-42ea-aced-dca3bf0f8671">The Vertex Research Service Agreement is for a two-year term, however, Vertex has the ability to terminate the agreement with a 30-day notice at any time. As a result, the Company concluded that the contract duration is 30 days, representing a month-to-month service contract.</sepn:AgreementDescription>
    <sepn:TermOfResearchServiceAgreement
      contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c"
      id="F_2e8e0ae5-4e2a-400d-91a7-6c308dc74de3">P2Y</sepn:TermOfResearchServiceAgreement>
    <sepn:RequiredPriorNoticeDurationToTerminateAgreement
      contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c"
      id="F_96855698-55e3-4a52-931a-bb7a1e4f22e8">P30D</sepn:RequiredPriorNoticeDurationToTerminateAgreement>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a8fdf19c-4553-4d74-982c-ff5d2e380f1c"
      decimals="-5"
      id="F_e97c744d-2da7-4103-bfc4-ed8159107cee"
      unitRef="U_USD">1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c2a2d5f3-4780-477b-9962-a71c66cb583d"
      decimals="-5"
      id="F_85743f0d-c027-417f-96e9-0c82cfbef1e8"
      unitRef="U_USD">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sepn:MarketableSecuritiesAndFairValueMeasurementsTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_b2b7b6cc-be6c-49a7-8858-18b00ddf956d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. Marketable Securities and Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records marketable securities and cash equivalents at their estimated fair values, which are based on market prices from a variety of industry standard data providers and generally represent quoted prices for similar assets in active markets or have been derived from observable market data.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.53%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities, current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities, non-current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;414,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.53%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company&#x2019;s marketable securities consist of debt securities, including U.S. treasury and agency securities, corporate debt securities and commercial paper. These marketable securities are carried at fair value and are included in the tables above. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. At each reporting date, the Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. The Company evaluates, among others, whether the Company has the intention to sell any of these marketable securities and whether it is not more likely than not that the Company will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met at December 31, 2024. The credit ratings of the securities held remain of the highest quality. Moreover, the Company continues to receive payments of interest and principal as they become due, and the Company's expectation is that those payments will continue to be received timely. Based on this evaluation, as of December 31, 2024, the Company determined that unrealized losses of its marketable securities were primarily attributable to changes in interest rates and non-credit related factors. As such, no allowances for credit losses were recorded at December 31, 2024. The Company did not hold marketable securities at December 31, 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest receivable as of December 31, 2024 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and is recorded as a component of prepaid expenses and other current assets on the Company&#x2019;s balance sheets. The Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t have interest receivable at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, all marketable securities in an unrealized loss position had been in an unrealized loss position for less than 12 months. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; marketable securities which have been in an unrealized loss position for a period of less than 12 months.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the following table summarizes the amortized cost and the unrealized gains (losses) of the marketable securities presented within marketable securities, marketable securities, non-current and cash equivalents (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Maturity (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total maturity less than 1 year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;203,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;203,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the following table summarizes marketable securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 Months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;Unrealized Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</sepn:MarketableSecuritiesAndFairValueMeasurementsTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c335dd3d-4f56-4eb5-87da-bf804bc4ed1e">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.53%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities, current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities, non-current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;414,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.53%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_31284a09-3922-405e-a80d-24fee73b06af"
      decimals="-3"
      id="F_b8256cdc-8e5a-4b4d-bc90-fd94b1f44780"
      unitRef="U_USD">141779000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_2982daa7-c87a-47ee-b700-ce6632c5e27f"
      decimals="-3"
      id="F_68005bd4-cdf0-4073-8c3f-aaa82fa017ca"
      unitRef="U_USD">141779000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_ffc859f7-c259-40f2-a949-73d02b30c8b2"
      unitRef="U_USD">82527000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_ac644248-b031-4c9f-95ab-fa02d59f25be"
      decimals="-3"
      id="F_b17aea50-16e2-42f4-81e9-4312f29daa73"
      unitRef="U_USD">82527000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_f2c80933-5202-4c7c-9208-6f26686e30e2"
      unitRef="U_USD">8059000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_7283d70c-1d46-411d-a51a-777737652129"
      decimals="-3"
      id="F_4ce85cf9-c07b-478a-acff-7cf7f726c123"
      unitRef="U_USD">8059000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_0d6ad656-a091-48f5-8868-db6db134a896"
      unitRef="U_USD">73555000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d"
      decimals="-3"
      id="F_be73e842-89ed-497b-b834-3291802dd485"
      unitRef="U_USD">73555000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_ac9b78eb-d06e-4c1b-9868-c03042209efe"
      unitRef="U_USD">23487000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_ac644248-b031-4c9f-95ab-fa02d59f25be"
      decimals="-3"
      id="F_e3f15009-014c-4a0a-ae04-be82b8123b98"
      unitRef="U_USD">23487000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_fed9e334-80e6-40cd-8a68-a329d1ee5aca"
      unitRef="U_USD">14193000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_7283d70c-1d46-411d-a51a-777737652129"
      decimals="-3"
      id="F_da427cc1-0888-4799-ab2b-7cb9a454357c"
      unitRef="U_USD">14193000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_ceba37ad-55ea-4827-98d0-ae41be58bfd3"
      unitRef="U_USD">1492000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_b7d146c4-9837-4043-9b52-921a53724e0c"
      decimals="-3"
      id="F_f499b3dd-f565-4296-b164-b81fee2d66ed"
      unitRef="U_USD">1492000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_e96bf34a-8ccf-4b4b-b207-f59b15864388"
      unitRef="U_USD">65406000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_5f8614a7-843e-4a7e-abbd-9013840a4a7d"
      decimals="-3"
      id="F_d273ba5c-979b-49ca-92a9-2b54bdbc91c5"
      unitRef="U_USD">65406000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_14c00eca-b141-4408-bacf-6ee6dcafa96d"
      unitRef="U_USD">2514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_7283d70c-1d46-411d-a51a-777737652129"
      decimals="-3"
      id="F_94cf61fa-3c43-4c39-9494-12635f135168"
      unitRef="U_USD">2514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_e7e571fc-9bbd-4ca1-aad9-f3a9521a0142"
      unitRef="U_USD">1946000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_b7d146c4-9837-4043-9b52-921a53724e0c"
      decimals="-3"
      id="F_4945ff92-a716-485a-ac68-7e9fa8ec14fb"
      unitRef="U_USD">1946000</us-gaap:MarketableSecuritiesNoncurrent>
    <sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1eed662f-629c-48e7-acbd-ae0d11b167b9"
      unitRef="U_USD">414958000</sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure>
    <sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
      contextRef="C_90d58f63-eee7-4c1a-ab73-d78903f815e7"
      decimals="-3"
      id="F_9d7fabb0-5296-4d80-8e99-095d4170a951"
      unitRef="U_USD">141779000</sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure>
    <sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
      contextRef="C_33d7d405-ee10-46a7-ba8e-6cecef016263"
      decimals="-3"
      id="F_8b248cbd-1fb2-4dbb-a720-bc6cf93b5488"
      unitRef="U_USD">273179000</sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_aecc1d94-7b79-44e5-b57c-d8576c37c857"
      decimals="-3"
      id="F_038fc835-9367-448d-afb9-9ace6c6c461d"
      unitRef="U_USD">86574000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_6a1456b0-60b7-4820-b443-f0391e89fbdd"
      decimals="-3"
      id="F_89f5f5a1-d805-4987-8acb-02a949b704b6"
      unitRef="U_USD">86574000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_80f0d21e-d306-46f5-a081-9414b79a17f7"
      unitRef="U_USD">86574000</sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure>
    <sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
      contextRef="C_ed3d106f-c9e5-4f47-a732-17fd62714ce4"
      decimals="-3"
      id="F_9baad6eb-09a1-402c-b2f3-1ec4b8f984d8"
      unitRef="U_USD">86574000</sepn:CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_56c6ec77-77b3-426a-9cf6-61c4ee189ee2"
      decimals="-5"
      id="F_14af7744-45fd-4085-90fc-c37760d14102"
      unitRef="U_USD">1000000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_eba777f1-1ccc-44f9-ae7c-9f47032a9edd"
      decimals="INF"
      id="F_b69e754c-a465-4b86-bdb7-705babc9e21e"
      unitRef="U_USD">0</us-gaap:InterestReceivableCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_4ffe2299-e553-4465-80e6-f1a99982be14"
      unitRef="U_Position">36</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_75952903-6b91-4919-8953-3697ec72bc02">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the following table summarizes the amortized cost and the unrealized gains (losses) of the marketable securities presented within marketable securities, marketable securities, non-current and cash equivalents (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.440000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Maturity (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less than 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total maturity less than 1 year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;203,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;203,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1 to 5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;273,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_d51b9603-469c-454b-a640-ea942ebb2fe9"
      unitRef="U_USD">106017000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_a59c1f01-b309-4f66-aed1-060289a4b594"
      unitRef="U_USD">6000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_34cdaf15-6f40-4ce0-86b9-e3147da4442a"
      unitRef="U_USD">9000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_f8b22de9-7618-4a81-91a7-49d90e7958a5"
      unitRef="U_USD">106014000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_8a81eda1-4383-4b31-8450-fca0ed47cf73"
      unitRef="U_USD">73511000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_b505e706-7ff8-42d6-8b17-eee6cb777617"
      unitRef="U_USD">44000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_0c45c367-5c47-4f27-a819-be01484a6e9f"
      unitRef="U_USD">0</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_ced00bdf-02cd-48ba-8b40-25a1c9450476"
      unitRef="U_USD">73555000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_a5e66848-020f-4cdb-aa8c-623590a76cd5"
      unitRef="U_USD">22245000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_e264a406-7688-4112-b98a-0b17016c8a47"
      unitRef="U_USD">10000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_3509a6a4-5c07-44fb-bff6-a6186d4d73e2"
      unitRef="U_USD">3000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_76dd1446-fcaa-4892-bf6e-8892d2764d38"
      unitRef="U_USD">22252000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_0d85e562-75a1-45fb-bbe7-fc3267439500"
      unitRef="U_USD">1491000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_6a8b3bcf-ee6f-4d57-a37c-cd53d3b12f51"
      unitRef="U_USD">1000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_fcd15a5e-5d63-46d3-86f3-d4ff96aeed83"
      unitRef="U_USD">0</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_cf60ff1c-d804-4c4c-97d0-ff24936cbd94"
      unitRef="U_USD">1492000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_c5a9eb6b-a525-4cbf-8c10-effaaa5361cf"
      unitRef="U_USD">203264000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_a03cf009-d769-4806-931a-cf2db10d121a"
      unitRef="U_USD">61000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains>
    <sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_c1149fb9-b6a8-4f80-9612-1ff6ea98a2fd"
      unitRef="U_USD">12000</sepn:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_f62ca3b1-27a4-4019-a023-8c798b35638f"
      unitRef="U_USD">203313000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_5224ae74-c8a8-498f-82c5-b6cc56f4ce0c"
      unitRef="U_USD">65427000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_47925018-acb6-419a-bdd4-1f92e8242cb4"
      unitRef="U_USD">37000</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_82ececc6-39aa-4cb2-b57b-a676ee20176d"
      unitRef="U_USD">58000</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_c816f2f8-da51-49b0-8348-3008ffe07142"
      unitRef="U_USD">65406000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_f3f0d56f-e180-4d7a-a928-9f71302e4588"
      unitRef="U_USD">2492000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_f6ca890b-fbba-4003-b294-007fbaa69741"
      unitRef="U_USD">22000</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_86b65a0f-65d7-4201-a1c0-d0f787176860"
      unitRef="U_USD">0</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_a2b435db-5c88-441e-aeac-a89b5b7ba1ad"
      unitRef="U_USD">2514000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_ea3d41b3-2137-4c39-8ae7-0ab7bc305c68"
      unitRef="U_USD">1940000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_d087a5f6-cd12-42f6-b00a-566f63fcf831"
      unitRef="U_USD">7000</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains>
    <sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_e35fcacf-18f7-45fc-8c36-6d8495b65960"
      unitRef="U_USD">1000</sepn:AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_61766efd-81e5-4a92-b631-3a373b8c5ab3"
      unitRef="U_USD">1946000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d6fc0963-63e5-47ec-8a2c-d67c8a311be8"
      unitRef="U_USD">273123000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_a111612e-6d0d-4a2f-b599-3b9308b5324c"
      unitRef="U_USD">127000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_0a2170b5-608a-4952-9c84-a570b6045e1b"
      unitRef="U_USD">71000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_f5f72bd0-00d8-4a80-ac64-7f044ad651b1"
      unitRef="U_USD">273179000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_a9a9b59a-ae14-4b67-8370-ec19fcaa8627">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the following table summarizes marketable securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 Months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;Unrealized Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_548dff28-111a-4b02-9459-79b089b04457"
      unitRef="U_USD">987000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_2e98c306-ecfa-4d6c-aa9b-7be442f3b730"
      decimals="-3"
      id="F_e783d450-9bd5-4c85-a6bc-b159f9ecb0ce"
      unitRef="U_USD">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_e6b65573-de08-4f71-93ff-b8843be6cc3e"
      unitRef="U_USD">70172000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_d523acd8-48f9-4426-8ab8-290e484e62bd"
      decimals="-3"
      id="F_58f4b148-c8e7-405d-b377-2625dec6e5ff"
      unitRef="U_USD">9000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_a01e9959-282e-4cc8-89a4-0989bd810359"
      unitRef="U_USD">6469000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_e596348e-c390-4f8c-a60e-2c604e7723c7"
      decimals="-3"
      id="F_9d275aae-476a-457f-b506-ad4c029a0cfa"
      unitRef="U_USD">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_ac3b30f9-6324-4e66-b572-2edc38819bb1"
      unitRef="U_USD">52508000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_23a47baf-46ed-4a06-ab44-52b48a0970c2"
      decimals="-3"
      id="F_996a8c1c-1345-4500-bcce-533aa565ac45"
      unitRef="U_USD">58000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_75b78b8a-399f-4490-8f43-19e08b96ec48"
      unitRef="U_USD">130136000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_58d4bd95-ac64-4f4a-b470-cc6f3519eb87"
      unitRef="U_USD">71000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_9849e3c8-efdc-4eac-acbd-2aaa8b3a585a">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7. Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases office and research and development space at the Company&#x2019;s headquarters in South San Francisco, California under an operating lease. In April 2021, the Company entered into a lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,560&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet, set to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;February 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. In September 2022, the lease was amended to add &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,348&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet, totaling &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,908&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet (the &#x201c;Original Leased Space&#x201d;), also expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;February 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. In December 2022, the Company entered into another lease amendment to extend the term of the Original Leased Space and add &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,911&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet (the &#x201c;Additional Leased Space&#x201d;). The Company took control of the Additional Leased Space in November 2023, at which point the Company vacated the Original Leased Space to allow the landlord to renovate it.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Renovation of the Original Leased Space was completed in July 2024. Upon completion of the renovation of the Original Leased Space, the lease of the Original Leased Space commenced, resulting in the total leased premises increasing to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,819&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet (the &#x201c;Leased Space&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The lease term for the Leased Space expires in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 2032&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, with an &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;option to extend&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the lease for eight additional years (the &#x201c;Extension Option&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, it was not probable that the Company would exercise the Extension Option, therefore, it was excluded from the right-of-use asset and lease liability calculations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million operating lease right-of-use asset and operating lease liability upon completion of the renovations of the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,908&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square foot office and research and development space (the "Original Leased Space") as the Company occupied the property.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million operating lease right-of-use asset and operating lease liability for the Additional Leased Space as the lease commenced in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, when the Company took control of the property. These amounts are disclosed in the supplemental information of noncash activities on the statements of cash flows. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023, the entire balance of the operating lease liability associated with the Additional Leased Space was classified as non-current as the Company received a rent abatement for four months in the first year of the lease and, therefore, the operating lease liability increased over the 12 month-period starting from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the weighted average remaining lease term of the Leased Space was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7.6&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years. The weighted average incremental borrowing rate used for the calculation of the present value of lease payments over the lease term was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the remaining lease term of the Additional Leased Space was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years. The incremental borrowing rate used for the calculation of the present value of lease payments over the lease term at the lease commencement date was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the expenses recognized and cash paid for the Leased Space (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;964&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum rental payments for operating leases were as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Future&lt;br/&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total present value of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did not have any finance leases.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="C_e339adb9-8faf-4ae0-a9cf-843428e7c977"
      decimals="INF"
      id="F_0f053cb5-c592-4830-ba7f-de4d6811a1c3"
      unitRef="U_sqft">12560</us-gaap:AreaOfLand>
    <sepn:LesseeOperatingLeaseExpirationYearAndMonth
      contextRef="C_36638d69-8200-457e-b4df-f22570660294"
      id="F_857c6a59-397d-4168-a6f3-5278eba73ef2">2023-02</sepn:LesseeOperatingLeaseExpirationYearAndMonth>
    <us-gaap:AreaOfLand
      contextRef="C_062b5e92-e9a6-4480-9a3e-af692706a741"
      decimals="INF"
      id="F_bbb738ca-1b77-4c4f-853c-340ce2f15477"
      unitRef="U_sqft">9348</us-gaap:AreaOfLand>
    <us-gaap:AreaOfLand
      contextRef="C_fb922ca6-bc1b-4ee2-9ad5-6fa73f26af51"
      decimals="INF"
      id="F_6e5ae9cb-9022-486f-804d-e37ab261a450"
      unitRef="U_sqft">21908</us-gaap:AreaOfLand>
    <sepn:LesseeOperatingLeaseExpirationYearAndMonth
      contextRef="C_e2dd8888-638d-419e-b998-f0ffd00c0ded"
      id="F_de4c479e-9883-4b18-9a5b-8e1138ff8941">2023-02</sepn:LesseeOperatingLeaseExpirationYearAndMonth>
    <us-gaap:AreaOfLand
      contextRef="C_1e38905a-c12f-4042-a1c7-538930041c98"
      decimals="INF"
      id="F_c9d64df7-78fc-4dc8-85d8-51bbdcd6adff"
      unitRef="U_sqft">22911</us-gaap:AreaOfLand>
    <us-gaap:AreaOfLand
      contextRef="C_21bcef87-7441-4e70-b3d2-6468e2fd40eb"
      decimals="INF"
      id="F_19530eda-bbcd-46ad-9ec2-aa856388d8fd"
      unitRef="U_sqft">44819</us-gaap:AreaOfLand>
    <sepn:LesseeOperatingLeaseExpirationYearAndMonth
      contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe"
      id="F_eb210713-1ef6-4706-b7f0-b5c34314cb62">2032-07</sepn:LesseeOperatingLeaseExpirationYearAndMonth>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe"
      id="F_f511122c-bd04-48bd-889d-563cf09478b4">option to extend the lease for eight additional years (the &#x201c;Extension Option&#x201d;)</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend
      contextRef="C_d7cd90c5-74ef-4d1f-9d9d-6900566fc5fe"
      id="F_33d58c4f-05ed-4122-b664-affc42bed7ae">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17"
      decimals="-5"
      id="F_c6fcaff3-0647-48dc-b44c-1d5b4cf5e1c2"
      unitRef="U_USD">12500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17"
      decimals="-5"
      id="F_8167dd1d-999d-4ac8-8a37-0c5d9fd5cb49"
      unitRef="U_USD">12500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AreaOfLand
      contextRef="C_e5a48d22-6857-4c55-a508-102ecc5e3e17"
      decimals="INF"
      id="F_755857a7-be8d-43d3-8565-44570de54335"
      unitRef="U_sqft">21908</us-gaap:AreaOfLand>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5"
      decimals="-5"
      id="F_72c49de2-7751-4757-965d-3ae8839b73b7"
      unitRef="U_USD">12600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5"
      decimals="-5"
      id="F_9380f5b0-b007-418c-a994-87d15e2cb6ae"
      unitRef="U_USD">12600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <sepn:LeaseCommencementPeriod
      contextRef="C_b1dfbbba-4ed3-4a5b-8cf4-81747534a7f0"
      id="F_cd660af0-6177-476c-bab6-f1806a1efdcc">2023-11</sepn:LeaseCommencementPeriod>
    <us-gaap:LesseeOperatingLeaseDescription
      contextRef="C_cf0a11bc-e4a7-4986-9563-1992ae142565"
      id="F_28a474ac-6178-4d1a-9e2a-94d2ba2f3505">As of December 31, 2023, the entire balance of the operating lease liability associated with the Additional Leased Space was classified as non-current as the Company received a rent abatement for four months in the first year of the lease and, therefore, the operating lease liability increased over the 12 month-period starting from December 31, 2023</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_c86e56ac-1ccf-4198-83f7-d9fc66656386"
      id="F_676ee99f-6385-4056-8d90-fe7d65c2307a">P7Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_c86e56ac-1ccf-4198-83f7-d9fc66656386"
      decimals="4"
      id="F_afa8e7bc-33d5-4693-823b-52c7a56419d0"
      unitRef="U_pure">0.1134</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5"
      id="F_5fab8a83-bf7d-44b9-a658-be012bd46a76">P8Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_a94109cf-ce36-4735-b5c9-1a5fd3aa34c5"
      decimals="3"
      id="F_89c5e0a5-5261-46cb-8591-1081e2991284"
      unitRef="U_pure">0.123</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_3b52bbb3-2dcd-4e72-b5a3-1bae67ae0b55">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the expenses recognized and cash paid for the Leased Space (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;964&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</sepn:SummaryOfLeaseCostAndCashPaidForOperatingLeaseLiabilityTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b"
      decimals="-3"
      id="F_567b3364-5961-4801-ba62-624c8507e07b"
      unitRef="U_USD">1631000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2"
      decimals="-3"
      id="F_fdb22502-9ed3-4b90-861f-36c31509cd27"
      unitRef="U_USD">897000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseCost
      contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b"
      decimals="-3"
      id="F_8dee0330-c77f-4b4c-a9f7-2b2d0b565401"
      unitRef="U_USD">3462000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2"
      decimals="-3"
      id="F_c95c83e0-0a54-447a-b8cb-d88325995e52"
      unitRef="U_USD">964000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_3baa6fa2-c091-4167-93e8-aa0dd3198d9b"
      decimals="-3"
      id="F_760846af-e566-40f9-9d1c-d0cc2a4e6b2a"
      unitRef="U_USD">644000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_734505df-bb5a-463c-bec8-cd2fb71849a2"
      decimals="-3"
      id="F_9ed8df0a-b7ad-4994-9933-4d6d08b21113"
      unitRef="U_USD">1018000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_a2f15bd8-f3eb-4cfa-afff-ce3b43128dcf">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum rental payments for operating leases were as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Future&lt;br/&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total present value of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_1af6b153-2f99-4e7d-8e43-b1cafeaa3a28"
      unitRef="U_USD">4469000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_0379ebf7-a809-4404-b359-db4f5f2d7b22"
      unitRef="U_USD">4611000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_6faa473a-117f-4ca4-b338-7f3c3eeabb0e"
      unitRef="U_USD">4760000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_2d868904-a969-4505-ae92-279ee032069c"
      unitRef="U_USD">4912000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d5a2057e-4559-4989-acfc-c158c01c6299"
      unitRef="U_USD">5071000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_2ab64750-176c-46ec-b334-8104362fcdc0"
      unitRef="U_USD">13851000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d4b95648-02ab-4883-904a-7cfa022dce0a"
      unitRef="U_USD">37674000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_9e686620-8bb9-4ad7-9352-3bd7f2851a95"
      unitRef="U_USD">12198000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b2c5f467-37e2-4654-bda6-b524f4634a82"
      unitRef="U_USD">25476000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b9087660-feee-45c1-bf34-ec0955c69918"
      unitRef="U_USD">1851000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_f4e072da-3b98-4d2a-a7ca-7ba68e9cf5a4"
      unitRef="U_USD">23625000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_7826adf7-81ed-4055-9e6e-6f356c244fb2"
      unitRef="U_USD">25476000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f7507e2b-aa44-4906-8dfd-28abf33ce614">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Proceedings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation, as the Company operates in an industry susceptible to patent or other legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company was not subject to any material legal proceedings as of December 31, 2024 and 2023, and the Company is not currently a party to any legal proceeding that, if determined adversely to the Company, in management&#x2019;s opinion, is currently expected to individually or in the aggregate have a material adverse effect on the Company&#x2019;s business, financial condition or results of operations taken as a whole.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnifications&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. As permitted under Delaware law and in accordance with its bylaws, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is or was serving in such capacity. The Company is also party to indemnification agreements with its officers and directors.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The maximum potential amount of future payments that the Company could be required to make under these provisions is not determinable; however, the Company currently holds director and officer liability insurance. This insurance limits the Company&#x2019;s exposure and may enable it to recover a portion of any future amounts paid. The Company believes that the fair value of these indemnification obligations is minimal. In addition, the Company is not currently aware of any indemnification claims&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Accordingly, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t record any liabilities associated with these indemnification rights and agreements as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_7dce2358-1cf2-41ee-8f34-9dbb51ec5129"
      unitRef="U_USD">0</sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements>
    <sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_dcfd680c-c403-4d3f-b940-a3e05ba066d0"
      unitRef="U_USD">0</sepn:LiabilitiesAssociatedWithIndemnificationRightsAndAgreements>
    <sepn:ConvertiblePreferredStockTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_939d4e76-7d03-43b8-a10e-9ed5693ce42d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9. Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Immediately prior to the closing of the Company's IPO in October 2024, the Company&#x2019;s outstanding convertible preferred stock automatically converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,839,774&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;shares of common stock. Converted preferred stock outstanding as of the date of the IPO consisted of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196,657,452&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares. Each share of outstanding convertible preferred stock was converted into common stock at a ratio of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.6103&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; convertible preferred shares to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; common share. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of convertible preferred stock were authorized, issued or outstanding at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023, convertible preferred stock consisted of the following (in thousands, except for share and per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:26.291%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.685%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.025%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Series&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Conversion Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,657,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,828,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2021, the Company executed a Series A Convertible Preferred Stock financing arrangement that would provide financing of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million over an initial tranche and subsequent callable tranches through the issuance of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series A Convertible Preferred Stock at an issuance price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. In the initial tranche, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series A Convertible Preferred Stock for net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was received in cash, net of issuance costs, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was for the conversion of the then outstanding convertible promissory notes plus accrued interest. The Series A Convertible Preferred Stock financing arrangement represented an equity financing, per the terms of the outstanding convertible promissory notes, and as such the unpaid principal and accrued interest outstanding of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series A Convertible Preferred Stock. Additionally, in November 2022, the Company executed the second tranche and issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series A Convertible Preferred Stock and received net cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Series A Convertible Preferred Stock Purchase Agreement provided that, upon the fulfillment of certain conditions, each investor would purchase its pro rata portion of the shares to be issued in additional Series A Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series A Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of the Company&#x2019;s convertible preferred stock to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares, of which &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares are designated as Series B Convertible Preferred Stock, and to establish the rights, preferences, privileges and restrictions of the Series B Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2023, the Company entered into a Series B Convertible Preferred Stock financing arrangement in which &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,657,452&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series B Convertible Preferred Stock were authorized to be issued at an issuance price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23297&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share over two tranches, for total proceeds of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In June 2023 and July 2023, the Company issued an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series B Convertible Preferred Stock at an issuance price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23297&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to the first tranche, with a potential second tranche of additional funding for up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million based on approval of the Board of Directors and consent of the majority of the holders of the then-outstanding Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock Purchase Agreement provides that, upon the fulfillment of certain conditions, each investor will purchase its pro rata portion of the shares to be issued in additional Series B Convertible Preferred Stock closings. Further, the Company agreed to sell, and issue said shares of Series B Convertible Preferred Stock on the same terms as the first tranche in the Purchase Agreement. The Company did not separately account for tranche purchase rights described above as they were not freestanding from the associated shares of convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon issuance of the Series B Convertible Preferred Stock, the Company also amended the Series A Convertible Preferred Stock agreement to cancel the remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unissued shares of Series A Convertible Preferred Stock originally authorized under the agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2024, the Company executed the second tranche of the Series B Convertible Preferred Stock financing arrangement and issued the remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Series B Convertible Preferred Stock for net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The rights, privileges, and preferences of the Series A and Series B Convertible Preferred Stock (together, the &#x201c;Convertible Preferred Stock&#x201d;) are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Convertible Preferred Stock does not have redemption rights, except for the contingent redemption upon the occurrence of a Deemed Liquidation Event.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Conversion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each share of the Convertible Preferred Stock is initially convertible, at the option of the holder at any time after all authorized shares of the Convertible Preferred Stock have been issued or if otherwise approved by the holders representing at least a majority of the then outstanding shares of the Convertible Preferred Stock, including at least one holder that, together with its affiliates, holds only shares of Series B Convertible Preferred Stock and is a major investor, as defined in the Company&#x2019;s amended and restated investors&#x2019; rights agreement (the &#x201c;Required Vote&#x201d;), into shares of common stock as determined by dividing the original issue price by the conversion price in effect at the time of conversion. The Series A Convertible Preferred Stock conversion price is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and the Series B Convertible Preferred Stock conversion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;price is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23297&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The conversion prices are subject to adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Convertible Preferred Stock. The conversion prices are subject to adjustment in the event the Company issues additional shares of common stock without consideration or for a consideration per share less than the conversion price in effect prior to such issuance, unless the Required Vote determines that no such adjustment shall be made to the conversion price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Special mandatory conversion will occur if a convertible preferred stockholder fails to purchase their agreed upon share, as originally allocated to such holder in the purchase agreement, in additional closings of the Convertible Preferred Stock as defined in the purchase agreement, and such failure is not cured as specified in the purchase agreement following receipt of the subsequent closing notification. Holders of Series B Convertible Preferred Stock have the option to waive the special mandatory conversion as specified in the purchase agreement. Upon such event, each share of the Convertible Preferred Stock held by such holder will be automatically converted into that number of shares of common stock equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the original issue price divided by the conversion price in effect.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Mandatory conversion of all outstanding shares of the Convertible Preferred Stock at the then effective conversion rate will also occur automatically upon (i) consent of holders representing the Required Vote or (ii) the closing of the sale of shares of common stock to the public at a price of at least $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.849455&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the common stock), in a firm commitment underwritten public offering resulting in at least $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in gross proceeds to the Company, after deducting underwriting discounts and commissions, and in connection with such offering the common stock is listed for trading on the Nasdaq, the New York Stock Exchange or another exchange approved by the board of directors, including the approval of at least a majority of the Convertible Preferred Stock directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Company, other than dividends on shares of common stock payable in shares of common stock, unless the holders of the Convertible Preferred Stock first receive, or simultaneously receive, a dividend on outstanding shares of the Convertible Preferred Stock in an amount at least equal to the dividend payable based on the number of shares of common stock at the then conversion rate, such that the calculation should result in the highest preferred stock dividend. The board of directors has not declared any dividends to-date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Voting and Board Representation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each holder of outstanding shares of the Convertible Preferred Stock is entitled to one vote for each share of common stock into which such shares of preferred stock are convertible and shall vote together with the holders of common stock as a single class and on an as-converted to common stock basis, except as provided by law or by the other provisions of the Company&#x2019;s certificate of incorporation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The holders of shares of Series A Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect three directors of the Company. The holders of shares of Series B Convertible Preferred Stock, exclusively and as a separate class, are entitled to elect one director of the Company. The holders of record of the shares of common stock and any other class or series of voting stock (including the Convertible Preferred Stock), as a single class, are entitled to elect the remaining directors. The size of the board shall be set and remain at seven directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Protective Provisions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At any time when shares of the Convertible Preferred Stock are outstanding, the Company shall first obtain the approval of the Required Vote, voting separately as a class, with respect to the following actions: (i) consummation of a liquidation, dissolution or winding up of the Company, or effect any merger, acquisition or consolidation or any other deemed liquidation event, (ii) amend, alter or repeal any provision of the Company&#x2019;s certificate of incorporation or bylaws, (iii) create, authorize, issue or obligate the Company to issue shares of any equity security or increase the authorized number of shares of the Convertible Preferred Stock or of any additional class or series of stock unless it ranks junior to the Convertible Preferred Stock, (iv) reclassify, alter or amend any existing security of the Company that is pari passu with the Convertible Preferred Stock, or is junior with the Convertible Preferred Stock , in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification alteration or amendment would render such other security senior to the Convertible Preferred Stock, or in the case of a previously junior security would render such security senior to or pari passu with the Convertible Preferred Stock, (v) pay or declare any dividend, other than dividends on the Convertible Preferred Stock, or make any distribution on any shares of capital stock prior to the Convertible Preferred Stock, other than common stock or options to acquire common stock repurchased from former employees or consultants in connection with the cessation of their employment/services, pursuant to the provisions of existing plans or agreements, (vi) create, adopt, amend, terminate or repeal any equity or equity-linked compensation plan, (vii) increase or decrease the authorized number of directors constituting the Board of Directors, change the number of votes entitled to be cast by any director or directors on any matter, or adopt any provision inconsistent with Article Sixth; (viii) create or hold (or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue) any shares of capital stock in any subsidiary that is not a wholly-owned subsidiary of the Corporation, or sell, lease, transfer, exclusively license or otherwise dispose of any direct or indirect subsidiary capital stock or all or substantially all of any direct or indirect subsidiary assets; or (ix) sell, assign, license, pledge or encumber material technology or intellectual property, or enter into or grant any royalty streams related thereto, other than licenses granted in the ordinary course of business.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidation Preference&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up, or in the event of a deemed liquidation event of the Company, the holders of shares of the Convertible Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, or out of the consideration payable to stockholders, as applicable, before any payment shall be made to the holders of common stock, an amount per share equal to the greater of (i) the original issue price, plus any dividends declared but unpaid, or (ii) such amount per share as would have been payable had all shares of the Convertible Preferred Stock been converted into common stock immediately prior to such event. If, upon the occurrence of such event, the assets of the Company available for distribution to its stockholders are insufficient to pay the holders of the Convertible Preferred Stock the full amount to which they are entitled, the holders of the Convertible Preferred Stock shall share ratably in any distribution of the assets available for distribution.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Classification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has classified the Convertible Preferred Stock outside of permanent equity on the balance sheet as these shares can be redeemed upon the occurrence of certain change in control events that are outside of the Company&#x2019;s control, including liquidation, sale or transfer of the Company. The Company has not adjusted the carrying values of the convertible preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur that would obligate the Company to pay the liquidation preferences to holders of shares of convertible preferred stock, and at the balance sheet dates these circumstances were not probable. Subsequent adjustments to the carrying values of the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, it was not probable that such a redemption would occur.&lt;/span&gt;&lt;/p&gt;</sepn:ConvertiblePreferredStockTextBlock>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="INF"
      id="F_34d5a781-1de6-4936-a86f-fa5450901be3"
      unitRef="U_shares">22839774</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="INF"
      id="F_1a80f53a-fb12-4078-ae02-9e73311dabfa"
      unitRef="U_shares">196657452</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="INF"
      id="F_dd1474fa-24de-4019-b356-75f4b8f2ee59"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.6103</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="C_b0854ac0-0cb4-44f3-92e8-8e5dc4c15f60"
      decimals="INF"
      id="F_e6239742-4a8a-45ee-9fc7-3bc6112055a8"
      unitRef="U_shares">1</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_56e6a7c4-155f-4302-a011-c371ec7a7796"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_c09103c7-876a-4c98-9202-120a3d40ec43"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_3fe2f917-0041-4bb4-99bf-e7a69f5a3b55"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_af299ae4-d593-4905-8748-997aaaf76270">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023, convertible preferred stock consisted of the following (in thousands, except for share and per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:26.291%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.685%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.025%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.545%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Series&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Conversion Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,657,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,828,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_2c409db0-842e-4c29-b0d1-08530726b5eb"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_6dde23cf-3618-4f65-a666-5fa9c11707d6"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_1510339b-96a3-4432-9640-56fdc69d9f35"
      unitRef="U_shares">75000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="-3"
      id="F_1df51d84-02df-48d0-be7d-e2f93fdefb16"
      unitRef="U_USD">74694000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="-3"
      id="F_850adab2-647d-4557-b43f-21fa92a9b4c8"
      unitRef="U_USD">75000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_864c2e47-7f2f-4f77-8cd9-6c52756c8838"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_81ac9a67-cc6a-4ea6-b005-16067db51d59"
      unitRef="U_shares">121657452</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_e2e6ea57-f655-471e-8910-8a7be6d3b3f3"
      unitRef="U_shares">60828720</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_b50b4379-7cfd-46cf-8d4f-d3549e537193"
      unitRef="U_shares">60828720</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="-3"
      id="F_084b82b1-3aed-4b1f-aee5-ed15f653659b"
      unitRef="U_USD">74521000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="-3"
      id="F_97cd32d0-abd3-4601-9e1e-14cb7037da00"
      unitRef="U_USD">75000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_f7e1fa91-27c7-4b66-8ed3-fed627f7814c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.23297</us-gaap:PreferredStockConvertibleConversionPrice>
    <sepn:TemporaryEquityStockFinancingArrangementFinancingValue
      contextRef="C_ecda3b22-85c8-4a2c-910d-24b3feaec947"
      decimals="-5"
      id="F_e00f01cf-aac1-4be4-9bf4-3d5d27dba408"
      unitRef="U_USD">100000000</sepn:TemporaryEquityStockFinancingArrangementFinancingValue>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d928477a-8ca4-45d7-99e7-77f499e78e0e"
      decimals="INF"
      id="F_6fbf62c3-99ec-4065-a611-c0ef5c71cde8"
      unitRef="U_shares">100000000</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_5f0437bd-6f52-4254-b099-4a45c3a53aa8"
      decimals="INF"
      id="F_c4d20e83-df5a-4abb-bbe5-f805f9909314"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1</us-gaap:PreferredStockConvertibleConversionPrice>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00"
      decimals="INF"
      id="F_b5008c54-2677-4c7d-a567-7e3245a303a3"
      unitRef="U_shares">45000000</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00"
      decimals="-5"
      id="F_d1993104-4264-4dd5-99e7-37daa58676e3"
      unitRef="U_USD">44700000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <sepn:CashProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00"
      decimals="-5"
      id="F_149ec3c8-3d48-4164-bf5d-6d7e1d066c10"
      unitRef="U_USD">30000000</sepn:CashProceedsFromIssuanceOfConvertiblePreferredStock>
    <sepn:NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest
      contextRef="C_5e9ba96e-3e6e-4be2-942c-87aa0891df00"
      decimals="-5"
      id="F_3934c264-c924-4124-b840-f44f7217217c"
      unitRef="U_USD">14700000</sepn:NetProceedsConversionOfOutstandingConvertiblePromissoryNotesPlusAccruedInterest>
    <sepn:ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding
      contextRef="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd"
      decimals="-5"
      id="F_05c8689f-1fa5-4a40-871d-07181e0011dd"
      unitRef="U_USD">14700000</sepn:ConvertiblePromissoryNotesUnpaidPrincipalAndAccruedInterestOutstanding>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_53ee58bf-4add-4827-a7aa-0b2b8aee91fd"
      decimals="INF"
      id="F_6be11bfa-108a-4fa4-b9e6-e732760a8a4e"
      unitRef="U_shares">14700000</us-gaap:ConversionOfStockSharesIssued1>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_2ed84efc-d353-46ca-bae3-39bc435baebb"
      decimals="INF"
      id="F_14311b8b-23d7-4095-acf4-81f134b099a2"
      unitRef="U_shares">30000000</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_2ed84efc-d353-46ca-bae3-39bc435baebb"
      decimals="-5"
      id="F_745acd1b-f61b-4fbd-8c53-4b712e40e534"
      unitRef="U_USD">30000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_42ad5efb-0c6f-42c1-afc8-5cc756e5312e"
      decimals="INF"
      id="F_b775d871-47c5-4a6e-b867-aa6168a8b368"
      unitRef="U_shares">196700000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_ce391cd8-82f6-405a-84f5-86572717253e"
      decimals="INF"
      id="F_99a3cc11-3473-4caf-b200-3d05a54adc12"
      unitRef="U_shares">121700000</us-gaap:TemporaryEquitySharesAuthorized>
    <sepn:TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares
      contextRef="C_c07f1042-7166-4a92-ad8c-816792ab533e"
      decimals="INF"
      id="F_4116205d-da40-457a-9046-2ba149888f25"
      unitRef="U_shares">121657452</sepn:TemporaryEquityStockAuthorisedToBeIssuedDuringPeriodShares>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_2ed61538-be83-4373-9c74-22d2ecd37bbc"
      decimals="INF"
      id="F_3f78e160-6434-4e2d-bba5-b254646fc1f0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.23297</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_23cbaddc-7e72-4392-96bd-b68571b9aa1f"
      decimals="-5"
      id="F_826e8c8c-b58c-4162-94c4-2374074e1311"
      unitRef="U_USD">150000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_75b103c5-2b1b-4a43-a69a-77670e68c96e"
      decimals="INF"
      id="F_af01b48b-9b59-44aa-a553-0bb1c7385803"
      unitRef="U_shares">60800000</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_1aec0dd0-2f1a-4cc5-908a-9f57b03ace96"
      decimals="INF"
      id="F_8abfed12-714a-496c-845f-fa3a90867bba"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.23297</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_75b103c5-2b1b-4a43-a69a-77670e68c96e"
      decimals="-5"
      id="F_236629e1-68bd-4dfb-815b-db90038e16b0"
      unitRef="U_USD">74500000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <sepn:TemporaryEquityStockAdditionalFundingBasedOnApproval
      contextRef="C_3d630fbe-3eb4-461e-8c9f-d264488141b7"
      decimals="-5"
      id="F_646d8111-ded3-45fb-9d06-5ee436c99356"
      unitRef="U_USD">75000000</sepn:TemporaryEquityStockAdditionalFundingBasedOnApproval>
    <sepn:ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel
      contextRef="C_e09fe0d5-bb64-4a89-8423-2d8d7f22d329"
      decimals="INF"
      id="F_131094e0-a13b-4642-a732-5195212e0507"
      unitRef="U_shares">25000000</sepn:ConvertiblePreferredStockRemainingUnissuedSharesAgreementToCancel>
    <sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_2c23db88-ff79-4c64-b0f7-eb3460655b08"
      decimals="INF"
      id="F_0d5268e8-27e8-4945-b053-6a13a9b1a1f2"
      unitRef="U_shares">60800000</sepn:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_2c23db88-ff79-4c64-b0f7-eb3460655b08"
      decimals="-5"
      id="F_7c731249-60e7-4d4b-bd67-44f4876e734d"
      unitRef="U_USD">74900000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_4570712b-f8dc-4aba-ad62-16f6774744f6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_e19dc350-bea5-4d3f-be7b-caeaea4d6362"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.23297</us-gaap:PreferredStockConvertibleConversionPrice>
    <sepn:PercentageOfShareIssuePriceDividedByConversionPriceInEffect
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_454ab157-85b3-4cdd-ad52-eed2e6a6dcb6"
      unitRef="U_pure">0.10</sepn:PercentageOfShareIssuePriceDividedByConversionPriceInEffect>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"
      decimals="6"
      id="F_33600461-f1de-4808-ba43-e74743f387f8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.849455</us-gaap:SaleOfStockPricePerShare>
    <sepn:GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_b509442c-9f4e-4302-9059-77c2151c5b34"
      unitRef="U_USD">50000000</sepn:GrossProceedsAfterDeductingUnderwritingDiscountsAndCommissions>
    <sepn:CommonStockTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_95482d06-b883-4e8c-bcfd-459757c29804">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10. Common Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company was authorized to issue &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company was authorized to issue &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;260.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of common stock of the Company to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;260.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, the Company amended and restated its certificate of incorporation, which was filed immediately prior to the closing of its IPO and among other things, increased the number of shares of common stock authorized for issuance to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, the Company completed its IPO of its common stock. In connection with the Company's IPO, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its common stock, which included an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares of common stock, at the public offering price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. As a result, the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net proceeds, after deducting underwriting discounts and commissions and other offering costs payable by the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The holders of common stock are entitled to dividends when and if declared by the board of directors, subject to the preferences applicable to outstanding shares of the Preferred Stock. The board of directors has not declared any dividends and the Company has not paid any dividends. The holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,710,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,129,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,123,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future grants under 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,634,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future grants under 2024 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,743,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for 2024 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;369,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,052,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,597,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</sepn:CommonStockTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"
      decimals="-5"
      id="F_8ab549a1-319f-4846-b1be-025e2e147d7f"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_fd642eac-5407-4e19-b1fe-1a23d8f0049c"
      decimals="INF"
      id="F_0ec78476-3ff7-41cc-af7d-2333f6226dbc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa"
      decimals="-5"
      id="F_e7fc106c-c219-421d-a262-e9246c7e877c"
      unitRef="U_shares">260600000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_2ee7a966-6f6e-4a6d-88be-c0428ecac3aa"
      decimals="INF"
      id="F_2250ac4c-26b5-4840-a4a6-b654c705bfbf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <sepn:IncreaseInSharesReservedForFutureIssuanceInShares
      contextRef="C_2bb60e06-e9a7-4ee2-9f51-82882892bb75"
      decimals="-5"
      id="F_0ff2609e-c27b-4923-885b-54d9d2f74dab"
      unitRef="U_shares">260600000</sepn:IncreaseInSharesReservedForFutureIssuanceInShares>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_ed0a66e7-9bfc-4c80-80df-f309d1e2fcc0"
      decimals="INF"
      id="F_85e09513-4dbf-4ead-81ba-4617545939bf"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_b007e1fb-96c7-4839-b684-715cc475d5ea"
      unitRef="U_shares">18400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0fa2073d-da24-49b2-bdfe-1ca4bc503654"
      decimals="-5"
      id="F_ed1eb5bb-97fb-4f3e-b49d-d70bf3e952eb"
      unitRef="U_shares">2400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_0b5583ba-3617-45f3-ae7c-d3424ea6dea1"
      decimals="2"
      id="F_a8f3230a-cc0b-456a-bc2b-6ba02d94a03c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_c55c343d-bbd5-4b22-b765-b21307034f92"
      unitRef="U_USD">302800000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <sepn:UnderwritingDiscountsCommissionsAndOtherOfferingCosts
      contextRef="C_fe927fe9-4989-430c-8a64-55c8c20c07c0"
      decimals="-5"
      id="F_bdfc7033-9a93-4911-ac40-157d9063f738"
      unitRef="U_USD">28400000</sepn:UnderwritingDiscountsCommissionsAndOtherOfferingCosts>
    <sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5719409b-32a3-41dd-8fac-2def7943b971">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,710,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,129,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,123,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future grants under 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,634,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future grants under 2024 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,743,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for 2024 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;369,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,052,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,597,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</sepn:SummaryOfCommonStockSharesReservedForFutureIssuanceOnConvertibleBasisTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_7e69c0b5-13e2-49ad-9907-d6a6af251b7f"
      decimals="INF"
      id="F_125dd8d8-416d-4e7b-8f8c-3a9b818d7563"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_408fc089-3a81-45dd-951b-6530ea8455e1"
      decimals="INF"
      id="F_61ff620d-8d4b-4411-9017-ad24c77284cc"
      unitRef="U_shares">8710490</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_bbac9b85-21d7-4cf8-9b6a-92facb72e3cc"
      decimals="INF"
      id="F_6f4d78cf-9f9c-43e1-bdbe-0474699753fe"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5edb1953-6dfe-44e0-bbf0-f7c3b6b991bd"
      decimals="INF"
      id="F_3610b10c-d27d-4f0d-a5e5-78ca2f58b8e0"
      unitRef="U_shares">14129284</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0c337934-85a8-4a6b-b0b7-d303a586df92"
      decimals="INF"
      id="F_b83c29d9-54d4-459e-92ba-ec9936a0dc73"
      unitRef="U_shares">2938982</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_44baba83-cea1-46e8-978a-dc1f29c93e52"
      decimals="INF"
      id="F_a78c6b88-ae11-4962-b614-d39ced0f7259"
      unitRef="U_shares">1123296</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_66bb86ba-4924-40ff-99cf-a77f796a2d06"
      decimals="INF"
      id="F_7cc885d6-abd8-4437-a03f-4c3bd586e22d"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0b34fe95-fedf-421a-b8dd-87db73e425eb"
      decimals="INF"
      id="F_8bed3ae8-1003-41cf-bf18-a7751aa1cda0"
      unitRef="U_shares">1634488</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_c58ad86c-a8d9-467a-8ff5-d56c8a6e29f6"
      decimals="INF"
      id="F_7ea84b8c-0e1d-4923-97f6-c7f546eb92ec"
      unitRef="U_shares">3743915</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_4947aa1a-72b3-47fa-b3bb-2fe7814a8ec3"
      decimals="INF"
      id="F_1386b303-b163-4a38-80ed-6aaf80c1276c"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1b936336-2026-44b4-a240-c9a3d5378bef"
      decimals="INF"
      id="F_9bc4c389-b949-4b98-948a-63cc9130679e"
      unitRef="U_shares">369402</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6194273a-4c93-49e2-96ac-eb9941334717"
      decimals="INF"
      id="F_18c52044-7206-43f7-baba-5340a9c16746"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_fa828c27-3700-483f-9cc8-b081edb49c64"
      unitRef="U_shares">7052299</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_a4fd9a10-9e79-4981-80f5-b43c32029d40"
      unitRef="U_shares">25597558</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_a094afd0-eaa9-4774-bd59-a9830514b2fb">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11. Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, the Company's board of directors adopted, and its stockholders approved the 2024 Option and Incentive Plan (the &#x201c;2024 Plan&#x201d;) which became effective on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 25, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The 2024 Plan allows for the issuance of equity-based and cash-based incentive awards to the Company's officers, employees, directors and consultants. The 2024 Plan is administered by the Company's compensation committee. The exercise prices, vesting and other restrictions are determined at the discretion of the compensation committee, subject to the provisions of the 2024 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company initially reserved for issuance under the 2024 Plan &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase on January 1, 2025 and each January 1 thereafter through January 1, 2034, by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding number of shares of the Company's common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company's compensation committee. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares remained available for future issuance under the 2024 Plan as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The number of shares reserved under the 2024 Plan is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization. The 2024 Plan replaced the 2021 Plan as the Company&#x2019;s board of directors determined not to make additional awards under the 2021 Plan following the completion of the IPO. However, the 2021 Plan will continue to govern outstanding equity awards granted thereunder. The shares of common stock underlying any awards under the 2024 Plan and the 2021 Plan that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated (other than by exercise) will be added to the shares of the Company's common stock available for issuance under the 2024 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2021 Stock Option and Grant Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2021, the Company adopted the Septerna, Inc. 2021 Stock Option and Grant Plan (the &#x201c;2021 Plan&#x201d;), which authorizes the Company to grant incentive stock options, non-qualified stock options, restricted stock awards, unrestricted stock awards and restricted stock units, to officers, employees, directors, consultants, or other key persons of the Company. The terms of the stock option and restricted stock agreements, including vesting requirements, are determined by the Board of Directors, subject to the provisions of the 2021 Plan. Stock option awards expire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the grant date, or as otherwise determined by the Board of Directors, or in the case of incentive stock options granted to 10% stockholders, the term is no more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the grant date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Additionally, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Company granted and issued restricted stock awards and allowed the recipients to purchase the unvested restricted stock awards at par value per share. The shares issued for unvested restricted stock awards under the 2021 Plan are subject to repurchase by the Company at the original issuance price in the event of the holder&#x2019;s termination of its relationship with the Company. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#x2019; equity (deficit) as the related awards vest over the requisite service period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2021 Plan initially authorized a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares reserved for future issuance. In June 2023, the Company amended the 2021 Stock Option and Grant Plan to, among other things, increase the shares reserved for issuance under the 2021 Plan to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares. In September 2024, the Company amended the 2021 Stock Option and Grant Plan, as amended to, among other things, increase the shares reserved for issuance under the 2021 Plan to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares remained available for future issuance under the 2021 Plan as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares re&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;mained available for future issuance under the 2021 Plan as of December 31, 2024 as the 2021 plan was replaced by the 2024 Option and Incentive Plan (the &#x201c;2024 Plan&#x201d;), which is further discussed above.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 ESPP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, the Company's board of directors adopted, and its stockholders approved, the 2024 Employee Stock Purchase Plan (the &#x201c;2024 ESPP&#x201d;), which became effective upon the date immediately preceding the date on which the IPO registration statement was declared effective by the SEC. The 2024 ESPP initially reserved and authorized the issuance of up to a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of the Company&#x2019;s common stock to participating employees. The 2024 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2026 and each January 1 thereafter through January 1, 2034, by the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of common stock, (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding number of shares of common stock on the immediately preceding December 31, or (iii) such lesser number of shares of common stock as determined by the administrator of the 2024 ESPP. The number of shares reserved under the 2024 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company's capitalization.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares under the ESPP as the first offering period has not begun. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares available for issuance under the ESPP.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Executive Officer and Director Equity Awards Modification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2024, the Company&#x2019;s board of directors modified the terms of stock option awards for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of the Company&#x2019;s common stock and restricted stock awards for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of the Company's common stock to certain executive officers and members of the Company&#x2019;s board of directors. Under the modified terms, accelerated vesting provisions were added associated with certain change of control events. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; incremental stock-based compensation expense was recognized as a result of the modification.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has granted restricted stock awards from the 2021 Plan and from outside of its stock plans, under the terms of restricted stock purchase agreements and subscription agreements. Unvested shares are subject to repurchase by the Company upon the holder&#x2019;s termination of its relationship with the Company at the original purchase price. Consideration received for shares associated with the unvested restricted stock awards is initially recorded as a liability and subsequently reclassified into stockholders&#x2019; equity (deficit) as the related awards vest.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following summarizes restricted stock award activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,002,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;410,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards repurchased&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;576,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The restricted stock awards generally include a service condition for vesting and vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter, but some awards vest over different time periods. In addition, some restricted stock awards include vesting criteria subject to the achievement of performance-based conditions in addition to service conditions, for which the Company periodically assesses the probability that the performance criteria will be met and only recognizes stock-based compensation expense related to these awards when achievement of the performance criteria becomes probable. The aggregate grant date fair value of shares vested during the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following summarizes stock option activity under the 2024 and 2021 Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.667%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.555%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Options Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,123,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.78&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,965,907&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,325&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.11&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;514,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.23&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock options include a service condition for vesting and most stock options vest over four years with a one-year cliff vesting and pro-rata monthly vesting thereafter. The aggregate intrinsic values of options outstanding and exercisable were calculated as the difference between the exercise price of the options and the closing market price of the Company&#x2019;s common stock as of December 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The aggregate grant date fair value of options that vested for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The options granted in the year ended December 31, 2024 had a weigh&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ted-average per share grant-date fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.65&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and a total grant date fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The total intrinsic value of stock options exercised during 2024 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company granted a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of stock options to its employees. A total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the stock options granted in the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 include vesting criteria subject to both service conditions and the achievement of performance-based conditions, related to the consummation of the Company&#x2019;s IPO or a Sale Event, while the remainder include vesting criteria subject to service conditions only. As a result of the consummation of the Company's IPO in October 2024, the performance-based condition related to these stock options was met, triggering commencement of vesting of the options, and the Company began recognizing expense related to these grants.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the stock options granted in the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 also include accelerated vesting provisions associated with certain change of control events.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Option Valuation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, using the Black Scholes option pricing model, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fair value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.03&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.90&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the fair value of the options granted, the Company uses the Black Scholes option pricing model and assumptions discussed below. This model utilizes inputs that are highly subjective including the fair value of the Company's common stock prior to the IPO, and expected volatility.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Common Stock &#x2014; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the IPO in October 2024, because there had been no public market for the Company&#x2019;s common stock, the Board of Directors, with input from management, determined the fair value of common stock by considering a number of objective and subjective factors including (i) valuations performed by independent third parties, (ii) important developments in the Company&#x2019;s operations, (iii) the rights, preferences, and privileges of the Company&#x2019;s preferred stock relative to those of the Company&#x2019;s common stock, (iv) actual operating results and financial performance, including the Company&#x2019;s levels of available capital resources, (v) the conditions in the capital markets, biotechnology industry and the U.S. economy in general, (vi) the stock price performance and volatility of comparable public companies and (vii) the lack of marketability of the Company&#x2019;s common stock, among other factors. After completion of the IPO, the fair value of common stock is based on the closing market price on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Term &#x2014; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The expected term represents the period that the Company&#x2019;s stock options granted are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). The Company has very limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The Company will continue to apply this process until a sufficient amount of historical information regarding employee exercise patterns and post-vesting employment termination behavior becomes available.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Volatility &#x2014; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Due to the Company&#x2019;s limited operating history and lack of company-specific historical volatility as a public company, due to the Company's IPO in October 2024, or implied volatility as a private company, the expected volatility was estimated based on the average volatility for comparable publicly traded biopharmaceutical companies over a period, where available, equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar size, life cycle stage and area of specialty.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk-free Interest Rate &#x2014; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the options.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Dividend &#x2014; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense for restricted stock awards and stock options recognized in the Company&#x2019;s statements of operations and comprehensive (loss) income is presented as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, total unrecognized stock-based compensation expense related to unvested restricted stock awards and unvested stock options was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_79b58927-86fc-40d3-9f46-ab96913ff7a1"
      id="F_5509993f-1df3-4d5f-9a2e-fb65a5126867">2024-10-25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_59dc2c7f-ff1c-470d-b96b-f1599335ca16"
      decimals="INF"
      id="F_09b7d0b6-f984-4d94-98dd-b593bdb8d26b"
      unitRef="U_shares">3700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_b9128e20-7131-4bd4-a8bd-4763f5a273df"
      decimals="INF"
      id="F_671a7347-77e8-4422-b211-ff8d7c2fd06f"
      unitRef="U_pure">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_3eda2d3e-77c3-4ee9-833b-51522ca25c9a"
      decimals="-5"
      id="F_80953114-796b-45c2-8322-4daefc9709df"
      unitRef="U_shares">3700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_2f0eb5d6-7026-4c35-ad8b-a69f0b83d927"
      id="F_b483ebb2-3e3b-48b0-9b24-b7ab765ef769">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_fab6a00f-2fe1-456a-bccf-9474c007d17a"
      id="F_a6253d66-b971-4cc5-bb2d-86aeffe1d7f9">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_9268f199-df5e-4067-91e6-ed2fd39554e8"
      decimals="-5"
      id="F_ba5926e8-1f0e-4ec9-9981-4071a23773bd"
      unitRef="U_shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_612e0da3-d172-44b9-afd1-b4b5f1733b29"
      decimals="-5"
      id="F_2c706372-9401-4df2-9c01-79e7053e786e"
      unitRef="U_shares">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0dbb3934-d7b1-4512-9408-c82380a608be"
      decimals="-5"
      id="F_f54fe4af-88de-48e7-a079-02db5205ce45"
      unitRef="U_shares">5400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_71f42ff7-1a0f-4075-b1ad-7f3659f2ab90"
      decimals="-5"
      id="F_35095459-ab5e-4838-b2ed-a06349ff3d63"
      unitRef="U_shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_902b0c5f-744e-4d30-b174-d36f4e83674d"
      decimals="INF"
      id="F_54af3a9f-4f2f-489e-a3e8-d0c81324cc12"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_513d2df9-958a-4c81-a310-f93896216a3a"
      decimals="INF"
      id="F_91df1eb9-83ee-4eeb-be48-2b8b4d81b524"
      unitRef="U_shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_39410be2-488e-40ba-b03f-47c8c6cb10a8"
      decimals="INF"
      id="F_d17f8309-5b9c-479b-98e4-595f00ffa78a"
      unitRef="U_shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_8255216d-10ae-416d-bcd2-76adfb6ba4d9"
      decimals="INF"
      id="F_b9fc3416-225f-4650-b89c-c344a8c2b21a"
      unitRef="U_pure">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_29adb2c9-12a7-43f9-8228-3116b1608be4"
      decimals="INF"
      id="F_d1bca1b8-4366-48df-bc53-2aa9ef16abca"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_d3127ac5-59a1-444d-b791-71cb86e3ef50"
      decimals="INF"
      id="F_d4d6b273-f587-4133-bb53-a43de8980071"
      unitRef="U_shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_92c1f558-0199-426d-b08a-1870d1dc5677"
      decimals="-5"
      id="F_fa25152a-2285-45a0-9144-94c7feae7107"
      unitRef="U_shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_da5e58c0-03a1-48bc-97cf-7fa1915eebf3"
      decimals="INF"
      id="F_665e52c8-b929-4b63-aa0b-49f6889a4746"
      unitRef="U_shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="C_22e5ca43-623f-4048-99d6-c3938708def1"
      decimals="INF"
      id="F_26fdb75c-dd1b-498c-82eb-aa1760abbb62"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_164dcd11-4396-4f00-9006-e3fb9cf52f31">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following summarizes restricted stock award activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,002,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;410,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards repurchased&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;576,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_1147e1f5-d133-45d8-8f2d-657d2695faa6"
      decimals="INF"
      id="F_68656850-e687-4bae-b16d-afb27fb5da43"
      unitRef="U_shares">1002044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_1147e1f5-d133-45d8-8f2d-657d2695faa6"
      decimals="2"
      id="F_ca43932b-87f5-4587-ac5b-378aecb6e3fc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4"
      decimals="INF"
      id="F_848acf00-ac04-447d-a026-35e39213af06"
      unitRef="U_shares">410916</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4"
      decimals="2"
      id="F_3e389903-ac32-4a6f-a9cb-87ba705e2122"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased
      contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4"
      decimals="INF"
      id="F_c1657d00-5527-4019-9c79-d7bc59172c00"
      unitRef="U_USD">14299</sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchased>
    <sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_c00e5c83-b480-45e1-95f4-2fc5fd175ab4"
      decimals="2"
      id="F_7b63304d-74d6-4291-8d4a-0c47efd62ea9"
      unitRef="U_USD">2.31</sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchasedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_119c49a2-1fd6-4e17-adcd-69be80143f5c"
      decimals="INF"
      id="F_1ecde77d-7a28-43ba-8a33-817c464d79b6"
      unitRef="U_shares">576829</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_119c49a2-1fd6-4e17-adcd-69be80143f5c"
      decimals="2"
      id="F_9d5dc31c-c62f-4d9c-a47b-c58ec7e3d9e2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_d3ed56c5-295d-4162-bb18-4641b0ef59a5"
      unitRef="U_USD">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      id="F_77054231-3911-4a26-8171-1ac9d6409b1e">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following summarizes stock option activity under the 2024 and 2021 Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.667%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.443999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.555%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Options Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,123,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.78&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,965,907&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,325&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.11&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;514,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.23&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd"
      decimals="INF"
      id="F_187a6d1c-c494-4fda-b630-aa34f2359c74"
      unitRef="U_shares">1123296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd"
      decimals="2"
      id="F_77c73294-6161-4f85-b828-5b73790f348b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_09bfaeb9-dddb-4966-a602-14fa0623c76f"
      id="F_7bf49bb0-6ea2-4f6f-9afa-d3f7752aead8">P9Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0ee21c41-88a0-4de2-9908-edb048f164fd"
      decimals="-3"
      id="F_d32c046e-d2fc-4135-b8e7-178a364d9fe1"
      unitRef="U_USD">2287000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="INF"
      id="F_54e1df9d-c97c-47eb-9d41-9a6cbe60de84"
      unitRef="U_shares">1965907</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="2"
      id="F_d9d9d900-5b90-43db-b935-30bd1487d0b3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="INF"
      id="F_b41c4f1d-464e-4c84-81d0-925078aa040d"
      unitRef="U_shares">28896</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="2"
      id="F_a4f570ac-3eb2-4d7a-9023-626ab75a04ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="INF"
      id="F_d77ccbbb-4975-48d9-9351-f2ab4d13befb"
      unitRef="U_shares">121325</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      decimals="2"
      id="F_ed5e39b2-2a37-4787-98d7-cdd62a15d6c4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="INF"
      id="F_5f165d97-870f-45ba-b7cf-19c73a93d2ab"
      unitRef="U_shares">2938982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="2"
      id="F_6d73993f-7175-4cf0-ae48-f13e8fc7d69f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      id="F_76d6bc30-310b-4b39-a1bd-42560c6102de">P9Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="-3"
      id="F_3229afcf-d456-46e9-8477-e99d60b6bd55"
      unitRef="U_USD">53706000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="INF"
      id="F_a5ffe730-fa31-454c-a2c9-ec4de232ec4c"
      unitRef="U_shares">514144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="2"
      id="F_0ae57dc9-b4d2-4b9d-b2b7-e8fdf835d9d4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_a3e21644-6ca9-47f4-96b3-8d6951b37099"
      id="F_70b1bc67-e7cc-482a-9ec4-12a346ec845c">P8Y2M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_3ca64227-cc61-40d5-9ccb-5795c36c5007"
      decimals="-3"
      id="F_83ff5174-7f9f-4f18-94b8-05d1799cd336"
      unitRef="U_USD">10285000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_02e1c944-87b8-40b1-b803-b5101885c75b"
      unitRef="U_USD">1500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_16e257e6-12d0-4dd4-88b0-56fe239834b3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <sepn:ShareBasedCompensationEquityAwardsOptionsGrantsFairValue
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_8c49d095-741a-4312-86cc-be1a945a78f6"
      unitRef="U_USD">13100000</sepn:ShareBasedCompensationEquityAwardsOptionsGrantsFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_e103e3f8-84bf-4966-9b0d-ae212f0faab6"
      unitRef="U_USD">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_829daf10-7ff1-4266-a786-57da4f5434c0"
      decimals="-5"
      id="F_cc017ebe-4444-4138-a641-4cc818230a48"
      unitRef="U_shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_a7b912dc-7bf1-4e6f-8c0c-c4277fb3f94d"
      decimals="-5"
      id="F_b1efc23c-3a19-4fc3-a0f7-8a8a7ceeaf6b"
      unitRef="U_shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_42dac764-d05a-4439-83fc-ac177b5dadcf"
      unitRef="U_shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5e0f2939-c46a-4f39-92ce-c47bd9da7d13">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, using the Black Scholes option pricing model, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fair value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.03&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.90&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_7ced8e00-83fe-4bff-b1dd-9479d6017b00"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.65</sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock>
    <sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_567a6007-d17d-405d-abcd-8b89105f7ffc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.01</sepn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="4"
      id="F_5a0734de-ae89-4332-a351-35611fe7d6a7"
      unitRef="U_pure">0.0383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="4"
      id="F_d200db2e-6d91-44a2-8f2d-de49ba2b4150"
      unitRef="U_pure">0.0456</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_c0e8e78c-3d2a-42fd-992d-689490500303"
      unitRef="U_pure">0.911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_71d56c05-7982-43b0-a218-e8a500278bef"
      unitRef="U_pure">0.862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_9de8869f-c6c3-4ec6-ab03-dd109f41c6b9">P6Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      id="F_ffb283c8-aa80-4e96-b2fe-8895b3babd3b">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_4cd837af-865f-49ba-954d-7625402b5ccc"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_80231069-7172-40e3-ba90-5c153ba5b2b1"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_c40706ab-1d2c-4834-8e09-356c6eea91fc">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense for restricted stock awards and stock options recognized in the Company&#x2019;s statements of operations and comprehensive (loss) income is presented as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a88f3222-aa43-4a22-9616-3208194c63fc"
      decimals="-3"
      id="F_ace821d4-62eb-46bf-85b8-07b87902a993"
      unitRef="U_USD">1619000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_4c5f565b-9309-42f7-86c8-bb16495c890f"
      decimals="-3"
      id="F_332a2d82-b96a-46bc-b761-fd73ede844f1"
      unitRef="U_USD">887000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_8484b4a9-981f-46d8-9a3b-93c7b6a966e2"
      decimals="-3"
      id="F_e11c63af-f626-45c4-942c-c5c20cfc12c1"
      unitRef="U_USD">1533000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_6c2685d2-81ab-435e-a0e2-34a378301c88"
      decimals="-3"
      id="F_4e112702-7714-416d-873a-82256fa1d9ea"
      unitRef="U_USD">733000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_53e9b36f-0e57-414d-93ba-57999b65e727"
      unitRef="U_USD">3152000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_4a208bb9-2a56-407b-8488-736e1c1f6b74"
      unitRef="U_USD">1620000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-5"
      id="F_a0d71888-a41b-41be-a22c-1b122183f5b7"
      unitRef="U_USD">15000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_97afab74-0b1a-4ecb-ae29-70457177d492">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_b2a549c5-a277-44da-9517-e4f30f292b06">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the (benefit) provision for income taxes were as follows for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Benefit) provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded an income tax benefit of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. For the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded income tax expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the Company&#x2019;s effective tax rate to the statutory U.S. federal rate is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal taxes at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The types of temporary differences that give rise to significant portions of the Company&#x2019;s deferred income tax assets and liabilities are set out below (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sec 174 capitalized research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,855&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,830&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sale of non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has established a valuation allowance for the amount of deferred tax assets that are not more likely than not be realized. Management considered all available evidence, both positive and negative, including but not limited to the Company&#x2019;s historical operating results, income or loss in recent periods, cumulative losses in recent years, forecasted earnings, future taxable&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;income, and significant risk and uncertainty related to forecasts, and concluded the deferred tax assets are not more likely than not to be realized. The net change in the total valuation allowance for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was an increase of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of federal net operating loss carryforwards and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of state net operating loss carryforwards, available to reduce future taxable income. Of the federal net operating loss carryforwards, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million will carryforward indefinitely. The state net operating loss carryforwards will begin to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, if not utilized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal research and development tax credits carryforward of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and state research and development tax credits carryforward of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, available to reduce future income taxes. The federal research and development tax credits will begin to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2040&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; if not utilized. The state research and development tax credits have no expiration date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Internal Revenue Code section 382 (&#x201c;IRC Section 382&#x201d;) places a limitation (the &#x201c;Section 382 Limitation&#x201d;) on the amount of taxable income that can be offset by net operating loss (&#x201c;NOL&#x201d;) carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. When an ownership change occurs, IRC Section 382 limits the use of NOLs and credits in subsequent periods based on the annual 382 limitations. The annual 382 limitations may limit the full use of available tax attributes in one year but the identified ownership changes may not result in expiration of tax attributes for use prior to expiration of their respective carryforward periods. The Company performed a Section 382 analysis through the year ended December 31, 2024 and determined there were ownership changes in 2021 and 2023 that resulted in 382 limitations limiting the full use of carryover attributes in 2024. The ownership changes did not result in a reduction of its net operating loss or in its research and development credit carryforwards expiring unused. Accordingly, none of the tax attributes have been reduced but limited the full use in 2024. If additional ownership change occurs, the utilization of net operating loss and credit carryforwards could be significantly reduced.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustment based on tax positions related to prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The reversal of the uncertain tax benefits would not impact the Company&#x2019;s effective tax rate as the Company continues to maintain a full valuation allowance against its deferred tax assets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. During the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recognize accrued interest and penalties related to unrecognized tax benefits.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company files income taxes in the U.S. federal jurisdiction, the state of California and various other U.S. states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All income tax returns will remain open for examination by the federal, state and foreign authorities for three or four years, from the date of utilization of any NOLs or credits.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_8cbb31ae-3a4c-4d3b-8418-77c3f04f1194">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the (benefit) provision for income taxes were as follows for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Benefit) provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_9a4ced94-0bd2-4267-ac1f-e89ca676c5d5"
      unitRef="U_USD">-7000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_1ac5dbcf-c668-4c23-bd40-a8ed557bc392"
      unitRef="U_USD">200000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a0b1d5fb-0738-44ce-b69f-43d155062b82"
      unitRef="U_USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_231d97d6-8c38-4ac8-99ef-d710bb90a907"
      unitRef="U_USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_c764e70c-c8a9-4ef1-b8c2-2a97716c28cc"
      unitRef="U_USD">-7000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b268d819-8133-4054-a90c-84862faefc3d"
      unitRef="U_USD">200000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_73f2762a-c593-46a1-9086-6e83046c8f21"
      unitRef="U_USD">-491000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_179929a7-e91a-4f9d-8d4d-49f9e98e9047"
      unitRef="U_USD">491000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_b4ba24b8-632c-47b3-a1c6-c92fe532b8f4"
      unitRef="U_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_0a9ababb-2313-420c-8d3b-e957e6ad9212"
      unitRef="U_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_765329d2-0dbb-4d0d-8b8b-c267e32daf77"
      unitRef="U_USD">-491000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_6738773c-f36e-473a-bca1-6890036d797a"
      unitRef="U_USD">491000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_9f247323-0d33-488b-8925-fa6fa3ee8e7c"
      unitRef="U_USD">-498000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_5de72a67-e2a5-4b19-b0b8-05341c1c5123"
      unitRef="U_USD">691000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_521f78c1-bcd7-4067-b06a-c1da6db56dad"
      unitRef="U_USD">-500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_fd838b0b-b39b-498b-b007-97c26f2f0d9a"
      unitRef="U_USD">700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_1acdf1a2-317d-4e32-b7ac-1efa006f2820">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the Company&#x2019;s effective tax rate to the statutory U.S. federal rate is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal taxes at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="INF"
      id="F_b8110d5a-78a3-4e8e-8ee2-c3ca0cd3492f"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="INF"
      id="F_9aa3952a-6587-4a0c-999b-21fbfc3b99a7"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_f4c702bd-7049-4cab-a7dc-3db60a9e6720"
      unitRef="U_pure">0.08</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_c2d1ed88-0f32-435d-8042-4916aa2a6b98"
      unitRef="U_pure">-0.342</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_43e6d59b-83b2-42a2-91f9-9a467b78e31e"
      unitRef="U_pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_e1e05821-5e61-4e1d-81fb-a87ff765cf0e"
      unitRef="U_pure">0.069</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_12e9ee61-55b2-493a-bb3f-599d90f8cc95"
      unitRef="U_pure">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_27e81d23-d0c8-4b0f-a712-41b1a91498be"
      unitRef="U_pure">0.191</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_babdf0c0-69f0-4b76-90c0-b409608ebcab"
      unitRef="U_pure">-0.29</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_109a867d-1049-4b4a-886d-c2598bd1e66d"
      unitRef="U_pure">0.395</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_dc3e86a4-823e-4643-8d4c-21559e9953d0"
      unitRef="U_pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_9ecc0c7f-e8f4-467d-ace7-1a05db59394f"
      unitRef="U_pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="3"
      id="F_0130fb29-a16d-4dbb-a09a-958452dcbcea"
      unitRef="U_pure">0.007</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="3"
      id="F_b7c20d67-d046-4998-9a96-0567440914c1"
      unitRef="U_pure">0.142</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_142de06c-9414-4df5-a7fa-c201ac98acd6">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The types of temporary differences that give rise to significant portions of the Company&#x2019;s deferred income tax assets and liabilities are set out below (in thousands):&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sec 174 capitalized research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,855&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,830&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sale of non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_e577cf6e-8d49-4dc4-a29d-c5276b22e0a1"
      unitRef="U_USD">7122000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_8226f4ef-7e2f-4492-b6ab-f323ef5a3feb"
      unitRef="U_USD">3940000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_41c7e801-f2dc-49e8-922a-7b203dae99bf"
      unitRef="U_USD">4102000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_fb7934e5-951c-4265-b1ce-fa83604ce299"
      unitRef="U_USD">2338000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <sepn:DeferredTaxAssetsLeaseLiability
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_eac9f5e4-b86d-494c-b889-dcfac6415f99"
      unitRef="U_USD">7129000</sepn:DeferredTaxAssetsLeaseLiability>
    <sepn:DeferredTaxAssetsLeaseLiability
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_0462104e-c3b1-4ee8-a259-390671438872"
      unitRef="U_USD">3516000</sepn:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_d9e580fe-4a61-4cbb-9787-e39cc9ece3ee"
      unitRef="U_USD">61000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_42a7811c-215d-44cc-a98c-3dc2ddf12b0f"
      unitRef="U_USD">9000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_55019d7c-72f8-479a-9be8-36988bb01081"
      unitRef="U_USD">1163000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_a40fedb4-cfee-42d1-a959-fae34ce371bf"
      unitRef="U_USD">841000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_3727e500-ae44-458b-b803-8ebd40af466a"
      unitRef="U_USD">20855000</sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_c9cb2ffd-2f0a-46d7-9c5a-b1f467ff6433"
      unitRef="U_USD">11313000</sepn:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_65a2d777-cdc4-4591-a164-da684a84a423"
      unitRef="U_USD">40432000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_8723b53e-488d-4d1b-bddd-f4c81da0e6ec"
      unitRef="U_USD">21957000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8044b8a9-a094-4cf9-b34b-ed50ac9da1b2"
      unitRef="U_USD">33061000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_aefb70d8-c2b6-432b-a98e-6560b63048c3"
      unitRef="U_USD">12127000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_c9c075a5-37d5-489c-883d-4638ed5559a4"
      unitRef="U_USD">7371000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_4d8bf463-39e4-416d-8a8b-1376f64933fe"
      unitRef="U_USD">9830000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8d7fc10c-f0c8-4c53-9f70-b25f89f36f89"
      unitRef="U_USD">766000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_136629a0-d1e6-4be3-9d50-e94306f8e6c6"
      unitRef="U_USD">521000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_6a359925-11bb-465e-b14a-f78ef422b55c"
      unitRef="U_USD">6605000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_3df4fd08-af65-4e13-a823-9f25df131094"
      unitRef="U_USD">3504000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_b6ae0f7c-0501-4296-9a16-25a40df3b10b"
      unitRef="U_USD">0</sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset>
    <sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_7eeb85a8-c14e-463b-853e-0fff49ef7ba4"
      unitRef="U_USD">6296000</sepn:DeferredTaxLiabilitiesSaleOfNonFinancialAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_8b85cfa6-86bf-4be5-bc69-a00af6c10210"
      unitRef="U_USD">7371000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_e60129b9-ce65-4260-b997-8ed220aef1b5"
      unitRef="U_USD">10321000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_90692118-4d66-45a4-9a5e-d6369f07ab75"
      unitRef="U_USD">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_654c452c-8f13-4044-9c1e-f2f5ec45091d"
      unitRef="U_USD">491000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-5"
      id="F_ecb147a2-cf3d-408c-b5e6-1bd721869c1e"
      unitRef="U_USD">20900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-5"
      id="F_b7690278-4e71-496a-9959-12ba67f80794"
      unitRef="U_USD">1900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_da578283-3385-4d7f-84d8-e4e87678a27a"
      decimals="-5"
      id="F_aa3c7820-91f0-45d4-a345-a5ccc4961743"
      unitRef="U_USD">13200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_a6ecf43d-7b17-4dea-a8f9-87bcd2d46ebb"
      decimals="-5"
      id="F_1e1dd8e4-f54e-4010-bfd7-881aaad7330b"
      unitRef="U_USD">75000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_da578283-3385-4d7f-84d8-e4e87678a27a"
      decimals="-5"
      id="F_cba54910-3d2e-4216-acf3-7719c569d6ab"
      unitRef="U_USD">13200000</us-gaap:OperatingLossCarryforwards>
    <sepn:OperatingLossCarryforwardsExpirationYear
      contextRef="C_d5e147f5-aa16-43c8-b905-14514eea7f77"
      id="F_58ccac04-7522-4072-ba37-603f582366f5">2041</sepn:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_5f26eed0-95b3-4a32-95cd-288d74605af3"
      decimals="-5"
      id="F_b10d5649-390c-455d-9b67-5ff9e4b338d2"
      unitRef="U_USD">4000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_39c2eb82-be3a-4f23-96b2-b18b9af896bd"
      decimals="-5"
      id="F_37b80574-5b4e-4162-a6d9-3c8cd8a2e7c0"
      unitRef="U_USD">2900000</us-gaap:TaxCreditCarryforwardAmount>
    <sepn:TaxCreditCarryforwardExpirationYear
      contextRef="C_8d0f375e-d4b5-4c8c-83f1-7f68a5d08c43"
      id="F_68449311-641e-4ef6-9f40-5b25e9e40083">2040</sepn:TaxCreditCarryforwardExpirationYear>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_cf7fab1d-22a3-47ae-b12f-c1640bf7874f">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustment based on tax positions related to prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_961d9eb0-bd3b-4fad-8291-83d518610591"
      unitRef="U_USD">2529000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_c91d8c22-95ae-4c1a-bbb9-cc425bbe3f56"
      decimals="-3"
      id="F_22cd24e9-5b88-41bf-b465-2d4a8ad66aad"
      unitRef="U_USD">1828000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_55ab8b2d-13e1-48d7-82af-79901f5d0297"
      unitRef="U_USD">998000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_307dbd2e-070e-43f5-8e76-dfce692cce5d"
      unitRef="U_USD">728000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_d45d2e0c-7a47-4e66-822c-f9fb584e15b2"
      unitRef="U_USD">40000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_ab93e12f-3a97-462a-ae27-704696402ac1"
      unitRef="U_USD">27000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="-3"
      id="F_7279c585-c387-4e8c-a2e2-1161d24b653d"
      unitRef="U_USD">3567000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="-3"
      id="F_08eb6644-dbba-4afc-b98d-285f962553bc"
      unitRef="U_USD">2529000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_787857dc-a393-4f80-adbe-f17546eff5f9"
      decimals="INF"
      id="F_6a01e548-c9f5-4600-b30f-2971da2a7eeb"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_2eb036f2-f593-46bc-984a-3f742b94ee9c"
      decimals="INF"
      id="F_40ec9324-38d3-4987-bb41-6c7c1099e327"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_e609fca9-cc22-41d8-8edc-d9f8110f5d44">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13. Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Third Rock Ventures&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#x2019;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to Third Rock Ventures VI, L.P., a holder of more than 5% of the Company&#x2019;s outstanding capital stock, during the first tranche closing, for cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2021, the Company entered into a service agreement with Third Rock Ventures, LLC (&#x201c;TRV&#x201d;), a holder of more than 5% of the Company&#x2019;s outstanding capital stock, (the &#x201c;TRV service agreement&#x201d;) under which TRV provides consulting services to the Company. For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, for such services as general and administrative expenses in the Company&#x2019;s statements of operations and comprehensive (loss) income. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of expense related to TRV was recorded in accrued expenses and other current liabilities. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; expenses related to TRV in accrued expenses and other current liabilities on the Company&#x2019;s balance sheets. at December 31, 2023. As of December 31,  2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, outstanding accounts payable to TRV was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. There was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding accounts payable to TRV at December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's former interim Chief Medical Officer, and also a member of the Company's board of directors, was designated to the Company's board of directors by TRV and is affiliated with TRV. He did not receive any cash compensation from the Company for his service as its interim Chief Medical Officer, as his services were provided to the Company through the TRV service agreement. The board member ceased serving as interim Chief Medical Officer in September 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2024, the Company entered into a separate consulting agreement with the board member, under which he may provide up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of consulting services per month, which are also provided to the Company through the TRV service agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Of the total fees the Company incurred under the TRV service agreement for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, were attributed to consulting services provided by the board member. Additionally, as compensation for his services as the Company's interim Chief Medical Officer, the Company granted him options to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,227&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,712&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares during the year ended December 31, 2024 and 2023, at exercise prices of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.76&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;RA Capital&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P. (collectively, &#x201c;RA Capital&#x201d;), which held more than 5% of the Company&#x2019;s outstanding capital stock, during the second tranche closing in May 2024, for total cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to entities affiliated with RA Capital Management, L.P., which collectively hold more than 5% of the Company&#x2019;s outstanding capital stock, during the first tranche closing, for cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Samsara BioCapital&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P. (&#x201c;Samsara BioCapital&#x201d;), a holder of more than 5% of the Company&#x2019;s outstanding capital stock, during the second tranche closing in May 2024, for cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of its Series B Convertible Preferred Stock to Samsara BioCapital, L.P., a holder of more than 5% of the Company&#x2019;s outstanding capital stock, during the first tranche closing, for cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184"
      decimals="-5"
      id="F_6e03371f-55e6-4c1a-9589-8b753806898d"
      unitRef="U_shares">12400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_524e2ab4-e5d5-45df-bcb8-7b0ebb1e5184"
      decimals="-5"
      id="F_956cae5c-d73d-4ea8-b24f-c485e622cd0e"
      unitRef="U_USD">15300000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_855d4ac2-b358-4d6c-84c7-2390fea37329"
      decimals="-5"
      id="F_d09bffcc-1f09-480e-aae1-efc55e3214ab"
      unitRef="U_shares">12400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_855d4ac2-b358-4d6c-84c7-2390fea37329"
      decimals="-5"
      id="F_75f141e5-0eb7-4dd7-a16d-87a37f3865b3"
      unitRef="U_USD">15200000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_570c8595-7c25-477a-88df-9154a31cf161"
      decimals="-5"
      id="F_8b5fd424-0ad7-4c10-ba9b-e037614b10b7"
      unitRef="U_USD">300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_c39d72cd-1218-4091-b5a2-620203948c8c"
      decimals="-5"
      id="F_e32d8109-4bc7-4be4-a90b-ff2b7a862011"
      unitRef="U_USD">300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <sepn:AccruedExpenseAndOtherCurrentLiabilities
      contextRef="C_b818b396-8516-4e7d-b65d-8f906bbc24a9"
      decimals="-5"
      id="F_e292c94a-77d6-4581-9b8d-b238ffb75437"
      unitRef="U_USD">100000</sepn:AccruedExpenseAndOtherCurrentLiabilities>
    <sepn:AccruedExpenseAndOtherCurrentLiabilities
      contextRef="C_273f0762-59ef-4b7e-8052-83d122342ed9"
      decimals="INF"
      id="F_f813e13d-2d8f-4333-95be-ff72019ee70f"
      unitRef="U_USD">0</sepn:AccruedExpenseAndOtherCurrentLiabilities>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="C_273f0762-59ef-4b7e-8052-83d122342ed9"
      decimals="-5"
      id="F_7dcd2c7d-46bc-4fa1-89e6-bd2be028a7a6"
      unitRef="U_USD">100000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="C_b818b396-8516-4e7d-b65d-8f906bbc24a9"
      decimals="INF"
      id="F_236676c9-091d-4777-9225-3094edd69d8a"
      unitRef="U_USD">0</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:ProfessionalFees
      contextRef="C_40118209-d74e-499d-a2c3-dad899119cee"
      decimals="0"
      id="F_e437cd2b-abe1-4fcb-85ad-d241b0a73992"
      unitRef="U_USD">9500</us-gaap:ProfessionalFees>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_2d8e9c9f-db9a-4ef1-8b3c-d563c2fca200"
      decimals="-5"
      id="F_7fcff006-faa6-4c0b-8186-a7b91c82a5c1"
      unitRef="U_USD">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_a74bff72-f9bc-4001-b025-78bfed5e56c9"
      decimals="-5"
      id="F_bff23dcd-db38-43f9-a383-709aaa856855"
      unitRef="U_USD">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5"
      decimals="INF"
      id="F_34d770f9-4612-4a86-aa67-91861af05ae4"
      unitRef="U_shares">23227</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_bea6a04f-86e9-4c8b-acac-b19b1baa9ae1"
      decimals="INF"
      id="F_d9dec50e-a4fc-4b23-98da-170ee2d5b308"
      unitRef="U_shares">26712</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0bc8c5b9-74e4-49af-ae3f-d601177cacf5"
      decimals="2"
      id="F_081b4d15-e01a-4929-9e9e-2ca52dc590ef"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.76</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_4189834c-9f3e-45b5-8e93-de02f8ede50d"
      decimals="-5"
      id="F_82a7ad8e-97a2-43d2-a0b6-096fdd263c1e"
      unitRef="U_shares">12200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_4189834c-9f3e-45b5-8e93-de02f8ede50d"
      decimals="-5"
      id="F_0449e278-2122-4f7e-8e8a-44947cfe2136"
      unitRef="U_USD">15000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601"
      decimals="-5"
      id="F_f7a54033-80f5-4e96-96bd-eb82d29e4aba"
      unitRef="U_shares">12200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_d2ccce6f-dbbd-4ac9-b4ef-7af39ce0d601"
      decimals="-5"
      id="F_6aa91e64-0056-4c76-ac78-323e07fd7b9e"
      unitRef="U_USD">15000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_3b38a128-728f-4bd5-af3c-a2799bc33330"
      decimals="-5"
      id="F_2b36dd49-0f10-4f8f-b248-fb81ebf2fb5f"
      unitRef="U_shares">4300000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_3b38a128-728f-4bd5-af3c-a2799bc33330"
      decimals="-5"
      id="F_473d8228-381a-44f6-8374-deafa5f065f2"
      unitRef="U_USD">5200000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a"
      decimals="-5"
      id="F_10792e08-ad7f-483a-bd9a-b823e5f4a23f"
      unitRef="U_shares">4300000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_c607c7e8-3f54-4523-bd6d-6229e8eb937a"
      decimals="-5"
      id="F_695f09c1-5511-471b-aabd-6f1009555469"
      unitRef="U_USD">5200000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f4fcf633-7c14-4d32-91cd-7436cff33a0a">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;14. Net (Loss) Income Per Share&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.813%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator, basic:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Allocation of earnings to participating preferred stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income applicable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Denominator, basic:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator, diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Allocation of earnings to participating preferred stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income applicable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Denominator, diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unvested restricted stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;233,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,177,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income per share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income per share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unvested restricted stock awards subject to repurchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;576,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;340,649&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total antidilutive securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,515,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_f2c4153d-1dbe-4140-bce6-82839bdf40ca">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.813%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator, basic:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Allocation of earnings to participating preferred stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income applicable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Denominator, basic:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator, diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Allocation of earnings to participating preferred stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income applicable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Denominator, diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unvested restricted stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;233,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding used to compute&lt;br/&gt;&#160;&#160;&#160;net (loss) income per common share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,891,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,177,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income per share, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income per share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a9fe7e3e-dbff-4e3f-a55c-3486483d9767"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_bc291e93-86c5-42f2-a23d-8f5805027532"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_0dbd1230-2869-42dd-bf03-b4539a2579dc"
      unitRef="U_USD">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_f0b3fc13-7ff4-4d64-af07-6c555f65bda4"
      unitRef="U_USD">3613000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_9e4cfa3a-c822-42e0-ad57-b8d8a5049501"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8681d7f7-bb40-4d5d-b6d7-abecdce7a977"
      unitRef="U_USD">567000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_13415b32-fc42-4bfb-89b1-8cec7d7c8ef5"
      unitRef="U_shares">9891126</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_2e4640a9-2469-4067-b4d3-c2c2cec6db97"
      unitRef="U_shares">1928586</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_e431f7d6-63b4-47b5-9023-848bfdfd9a04"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_256dc391-7b5f-464e-9937-f94dcab6ff9e"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_4e00281a-bded-4755-8105-a846d5ee0e52"
      unitRef="U_USD">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_690544dc-4cea-4e81-a8e0-794eff685fde"
      unitRef="U_USD">3551000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_af40d9b6-42db-4770-96aa-73c6c225faa5"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b3f7c999-b2ff-44f9-9b0c-30d2e1882a18"
      unitRef="U_USD">629000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_984bb4ae-6031-4788-94fc-fa3e04086cde"
      unitRef="U_shares">9891126</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_450e539a-e93c-4552-89a7-15075436d1e8"
      unitRef="U_shares">1928586</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <sepn:CommonStockOptions
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_7793cb3f-3db6-41b4-b98a-10418ddd009e"
      unitRef="U_shares">0</sepn:CommonStockOptions>
    <sepn:CommonStockOptions
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_13226636-6018-4f5b-8e37-5569f5c8b739"
      unitRef="U_shares">14737</sepn:CommonStockOptions>
    <sepn:UnvestedRestrictedStock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_bcca64b5-54b3-475b-ae8d-c9bf7cd5261e"
      unitRef="U_shares">0</sepn:UnvestedRestrictedStock>
    <sepn:UnvestedRestrictedStock
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_6433fc2f-e490-4df0-9be1-ec702cac2e26"
      unitRef="U_shares">233801</sepn:UnvestedRestrictedStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_d7389d4b-d154-4fda-bc24-eda74e39ea57"
      unitRef="U_shares">9891126</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_343e863b-d37d-4bc5-ad1f-67641db421b9"
      unitRef="U_shares">2177124</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_660fb9d1-2ea3-4dbc-a6a5-efb057166042"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_5dfe2a6a-dcae-4f9b-b9bd-52a1d5449c52"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="2"
      id="F_d9d606b9-d345-4abe-992f-b563b686d7bc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="2"
      id="F_8321118f-fb1e-432f-852b-7d51d3b1f0b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_85db8757-6268-4471-90f2-d38adfa0681e">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,938,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unvested restricted stock awards subject to repurchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;576,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;340,649&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total antidilutive securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,515,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_64df0564-4699-4346-a9c4-4d4616c5b486"
      decimals="0"
      id="F_8701dd6a-c07d-40d9-818f-926e7e6c4597"
      unitRef="U_shares">2938982</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_922c53ab-31f7-4a05-a8b6-af09fe6e78db"
      decimals="0"
      id="F_287bedc6-0381-4b0b-b5c3-fdea7118917c"
      unitRef="U_shares">198084</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8c5cb769-ec5e-4f34-abf9-683e73b6808f"
      decimals="0"
      id="F_40cdfa90-7974-4229-85f6-b7c191b3ccf0"
      unitRef="U_shares">576829</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_659a2626-2f0b-4d2e-abe1-7f6b4d5d0915"
      decimals="0"
      id="F_afaa1f29-1600-43e5-8d3c-0ee233b3e893"
      unitRef="U_shares">340649</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="0"
      id="F_0d97db2a-9804-42aa-9ec5-b0f45a6810f9"
      unitRef="U_shares">3515811</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="0"
      id="F_f282f046-fba1-4b7c-aac2-ce91fae1b068"
      unitRef="U_shares">538733</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_91697a72-fe54-4ea0-8b5c-22611f66e248">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;15. Employee Retirement Benefit Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains a 401(k) retirement savings plan (the &#x201c;401(k) Plan&#x201d;) for its employees. The 401(k) Plan allows eligible employees to make contributions up to the maximum allowable by the Internal Revenue Service (&#x201c;IRS&#x201d;). For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company made matching contributions of and recorded contribution expenses of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_04364af7-15e7-4170-a9bd-075237a2baca"
      decimals="-5"
      id="F_0b9622ca-6932-4251-94b6-54d583fff8c4"
      unitRef="U_USD">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_9b829192-5a7d-4ce3-9261-f21a9ef581b0"
      decimals="-5"
      id="F_f6a3bc66-96cb-491f-9fa4-e3d8353dfa6f"
      unitRef="U_USD">100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_5806bb06-b936-4144-b458-dc35dcf6e8ff">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;16. Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM assesses performance for the Company&#x2019;s operating segment and decides how to allocate resources based on the Company&#x2019;s available cash resources. Total operating expenses and net (loss) income of the Company&#x2019;s operating segment are used to monitor budget versus actual results. The measure of segment assets is reported as total assets on the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM is regularly provided with the following significant segment expenses:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Employee-related expenses, excluding stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;External research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,106&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;External general and administrative expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on sale of non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment expenses*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses (income)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Loss) income from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Loss) income before provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Benefit) provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(*) Other segment expenses include facility related and office costs, information technology costs, general laboratory costs, and other operating expenses.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all of the Company&#x2019;s property and equipment was maintained in the U.S. For the year ended December 31, 2024 and 2023, the Company&#x2019;s revenue was generated from providing research services and was earned in the U.S.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_164ffcb7-73b0-4ce8-a07f-59506e2f5808">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM is regularly provided with the following significant segment expenses:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Employee-related expenses, excluding stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;External research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,106&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;External general and administrative expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on sale of non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment expenses*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses (income)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Loss) income from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Loss) income before provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(Benefit) provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(*) Other segment expenses include facility related and office costs, information technology costs, general laboratory costs, and other operating expenses.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_912069d7-ea94-4a0f-a445-858cfa4195a9"
      unitRef="U_USD">1075000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_87eb56c5-ae76-4b5c-bee8-dd33aad5b38d"
      unitRef="U_USD">151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_011bf971-2936-42f8-a0a5-9f016a61236c"
      unitRef="U_USD">22233000</sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation>
    <sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_7c7d882f-4f61-4c6f-b0db-0a391d4aa969"
      unitRef="U_USD">15726000</sepn:EmployeeRelatedExpensesExcludingStockBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a68ddce7-189b-4e53-94d4-e3a960034b61"
      unitRef="U_USD">3152000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_e098617b-a1f7-4bd5-8c75-0e44d3e05b91"
      unitRef="U_USD">1620000</us-gaap:ShareBasedCompensation>
    <sepn:ExternalResearchAndDevelopmentExpenses
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_41243c4f-7bf4-4aa5-8936-ce966d04f013"
      unitRef="U_USD">32786000</sepn:ExternalResearchAndDevelopmentExpenses>
    <sepn:ExternalResearchAndDevelopmentExpenses
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_4ffe30e9-498e-4caf-8a1f-648e4a9cf18a"
      unitRef="U_USD">15106000</sepn:ExternalResearchAndDevelopmentExpenses>
    <sepn:ExternalGeneralAndAdministrativeExpenses
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_800b9d1f-d0d7-47d9-adf1-474e1797f0ff"
      unitRef="U_USD">6511000</sepn:ExternalGeneralAndAdministrativeExpenses>
    <sepn:ExternalGeneralAndAdministrativeExpenses
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_5d338378-7f9f-482f-a70c-70c0f195f527"
      unitRef="U_USD">3415000</sepn:ExternalGeneralAndAdministrativeExpenses>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_1844dff2-a32d-48a9-83e1-a58902d88ffd"
      unitRef="U_USD">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_6445d974-b9f1-4463-92b9-e4f61b6e0113"
      unitRef="U_USD">47625000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_b5855e50-ef84-4f12-870e-97ddf999f39a"
      unitRef="U_USD">17216000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b2bb8a30-7b58-4c1a-8801-ee9315b4dedb"
      unitRef="U_USD">9834000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingExpenses
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_3662d7f9-cebe-4465-a734-23ce20872652"
      unitRef="U_USD">81898000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_8872e2b4-777f-4136-8a28-936bdbf34c69"
      unitRef="U_USD">-1924000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_2d501b38-2088-465e-8d46-f32b77d2e892"
      unitRef="U_USD">-80823000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_aa6f0bef-3641-45fb-8e51-d62c405b12b1"
      unitRef="U_USD">2075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_a39d8237-0d36-4fd5-817f-1f42c299040c"
      unitRef="U_USD">8527000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_b51a4686-78f4-4d47-b5cf-876ef074f362"
      unitRef="U_USD">2796000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_ed5281a1-f98b-4a8f-abe9-83939bf32a9c"
      unitRef="U_USD">-72296000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_e3193958-91e4-4b8c-b968-254187da17a0"
      unitRef="U_USD">4871000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_1451f5ea-223a-47ac-91c1-1feb0fc08213"
      unitRef="U_USD">-498000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_96aaed9e-3648-4aaf-8c88-27525727435d"
      unitRef="U_USD">691000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      decimals="-3"
      id="F_dbbaa5fe-0720-41dc-88e4-c856fd80a7db"
      unitRef="U_USD">-71798000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b96aca59-b7bd-44d4-95df-86bbda19ce0e"
      decimals="-3"
      id="F_de7489c5-26a4-4e1d-8797-a9f4c639b29f"
      unitRef="U_USD">4180000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_c457190a-2591-4660-96fd-0fed98a4b50f"
      id="F_a4b1ce0a-90cc-4259-a0c2-9af624a4819b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;17. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company appointed Gil M. Labrucherie, CFA, J.D. as the Chief Financial Officer (&#x201c;CFO&#x201d;), principal financial officer and principal accounting officer of the Company, effective January 6, 2025. On February 7, 2025, the Compensation Committee of the Board granted &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of stock options to the CFO.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In February 2025, the Company announced its decision to discontinue the clinical study of SEP-786. There was no impact to the assets and liabilities reported on the Company's balance sheets as a result of the discontinuation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_9763b408-328c-4770-af66-e36b06544fe2"
      decimals="-5"
      id="F_f56d9c23-a79a-4985-a6ca-cd8daff274ab"
      unitRef="U_shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
